nct_id,results_due,has_results,pending_results,any_results,overdue,reported_late,available_completion_date,due_date,first_results_submission,sponsor,sponsor_type,sponsor_class,industry_collab,us_gov_collab,phase_cat,phase,terminated,start_year,full_completion,contains_drug,contains_biological,contains_device,contains_diagnostic,contains_radiation,contains_combi_product,contains_genetic,contains_us_loc,act_flag,included_pact_flag,sponsored_trials
NCT00002663,0,0,0,0,0,0,2019-07-31,2020-07-31,,Atara Biotherapeutics,Industry,1,0,1,0.0,Phase 1/Phase 2,0,1995.0,1,0,1,0,0,0,0,0,0,0,1,10
NCT00003270,1,0,0,0,1,0,2017-10-16,2018-10-16,,Roswell Park Cancer Institute,Other,0,0,0,1.0,Phase 2,0,1997.0,1,1,1,0,0,1,0,0,0,0,1,294
NCT00004088,1,1,0,1,0,1,2018-01-09,2019-01-09,2019-05-01,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,1999.0,1,1,1,0,0,0,0,0,0,0,1,358
NCT00074490,1,1,0,1,0,1,2017-07-20,2018-07-20,2018-10-22,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2004.0,1,1,0,0,0,0,0,1,0,0,1,3004
NCT00136435,0,0,0,0,0,0,2019-07-31,2020-07-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2002.0,0,1,0,0,0,1,0,0,1,0,1,647
NCT00160732,0,0,0,0,0,0,2022-10-31,2023-10-31,,University of Chicago,Other,0,0,0,0.0,Phase 1/Phase 2,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT00278629,0,0,0,0,0,0,2018-12-31,2019-12-31,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2005.0,0,0,1,0,0,0,0,0,0,0,1,925
NCT00291525,0,0,0,0,0,0,2020-09-30,2021-09-30,,"On-X Life Technologies, Inc.",Industry,1,1,0,5.0,,0,2006.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT00299195,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2006.0,0,1,0,0,0,0,0,0,1,0,1,1432
NCT00317772,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00338728,0,0,0,0,0,0,2018-11-27,2019-11-27,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2003.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00357565,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2005.0,0,1,1,0,0,0,0,0,0,0,1,218
NCT00397813,1,1,0,1,0,1,2017-09-18,2018-09-18,2018-09-25,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2006.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT00414076,1,1,0,1,0,1,2017-07-13,2018-07-13,2018-08-09,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00467987,0,0,0,0,0,0,2019-06-30,2020-06-30,,University at Buffalo,Other,0,1,0,5.0,,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,65
NCT00470704,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Nancy Lin, MD",Other,0,1,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT00489281,0,1,0,1,0,0,2018-12-29,2019-12-29,2019-03-25,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,1,2008.0,1,1,1,0,0,1,0,0,0,0,1,461
NCT00494728,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00495040,1,1,0,1,0,0,2017-06-14,2018-06-14,2018-02-26,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2006.0,1,0,0,0,0,1,0,0,0,0,1,2066
NCT00500890,1,0,0,0,1,0,2017-12-14,2018-12-14,,M.D. Anderson Cancer Center,Other,0,0,0,3.0,Phase 3,0,2005.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT00515281,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Chicago,Other,0,0,0,2.0,Phase 2/Phase 3,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT00540995,0,0,0,0,0,0,2019-06-30,2020-06-30,,City of Hope Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2006.0,1,1,0,0,0,1,0,0,0,0,1,358
NCT00611585,0,0,0,0,0,0,2026-12-31,2027-12-31,,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2006.0,0,0,0,1,0,0,0,0,0,0,1,83
NCT00632853,0,0,0,0,0,0,2023-06-30,2024-06-30,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2008.0,0,1,0,0,0,1,0,0,1,0,1,456
NCT00670358,0,0,0,0,0,0,2020-12-01,2021-12-01,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2008.0,0,1,1,0,0,0,0,1,0,0,1,1898
NCT00694655,0,0,0,0,0,0,2020-12-31,2021-12-31,,Emory University,Other,0,0,1,5.0,,0,2008.0,0,0,1,0,0,0,0,0,0,0,1,947
NCT00695409,1,1,0,1,0,1,2017-03-27,2018-03-27,2018-04-04,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,1,0,0,1,0,0,0,0,1,358
NCT00703105,0,0,0,0,0,0,2020-07-31,2021-07-31,,Loyola University,Other,0,0,0,1.0,Phase 2,0,2008.0,0,0,1,0,0,0,0,0,0,0,1,102
NCT00715442,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00746018,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-01-04,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2008.0,1,0,0,1,0,0,0,0,0,0,1,1432
NCT00761228,0,0,0,0,0,0,2018-12-31,2019-12-31,,NeuroHealing Pharmaceuticals Inc.,Industry,1,0,1,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT00770822,0,0,0,0,0,0,2020-07-31,2021-07-31,,SonaCare Medical,Industry,1,0,0,5.0,,0,2007.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT00826020,1,0,1,1,0,1,2017-08-31,2018-08-31,2019-04-22,University of Nebraska,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,327
NCT00836186,0,0,0,0,0,0,2020-03-31,2021-03-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2009.0,0,0,0,0,0,1,0,0,0,0,1,461
NCT00877500,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00896493,0,0,0,0,0,0,2022-12-31,2023-12-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,1309
NCT00909363,1,1,0,1,0,1,2017-05-15,2018-05-15,2018-12-21,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,1,2009.0,1,1,0,0,1,0,0,0,0,0,1,586
NCT00916747,0,0,0,0,0,0,2019-07-31,2020-07-31,,Boston Children’s Hospital,Other,0,1,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,400
NCT00943800,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Chicago,Other,0,0,0,5.0,,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT00946712,1,1,0,1,0,1,2017-08-31,2018-08-31,2018-12-06,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2009.0,1,1,1,0,0,0,0,0,1,0,1,288
NCT00980460,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT00981656,0,0,0,0,0,0,2018-10-31,2019-10-31,,Radiation Therapy Oncology Group,Other,0,0,1,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,156
NCT01000051,1,1,0,1,0,1,2018-04-04,2019-04-04,2019-06-18,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01010126,1,1,0,1,0,1,2017-03-13,2018-03-13,2018-09-20,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2009.0,1,1,1,0,0,0,0,0,1,0,1,3004
NCT01012817,0,0,0,0,0,0,2020-08-31,2021-08-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01036087,0,0,0,0,0,0,2021-11-30,2022-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01040000,1,0,1,1,0,0,2017-03-31,2018-03-31,2018-01-17,"Precision Biologics, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01042379,0,0,0,0,0,0,2020-12-31,2021-12-31,,QuantumLeap Healthcare Collaborative,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01064479,0,0,0,0,0,0,2021-02-28,2022-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01077518,0,0,0,0,0,0,2018-01-03,2019-01-03,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2010.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01088802,0,0,0,0,0,0,2021-08-31,2022-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT01097642,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Jenny C. Chang, MD",Other,0,1,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,11
NCT01150045,0,0,0,0,0,0,2019-12-31,2020-12-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,456
NCT01154920,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT01183884,0,0,0,0,0,0,2018-11-09,2019-11-09,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,1,0,1,0,0,0,0,0,0,0,1,1432
NCT01186978,0,0,0,0,0,0,2021-05-31,2022-05-31,,Duke University,Other,0,0,0,5.0,,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,1342
NCT01201356,0,0,0,0,0,0,2018-10-19,2019-10-19,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01204684,0,0,0,0,0,0,2020-01-31,2021-01-31,,Jonsson Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,277
NCT01206530,1,0,0,0,1,0,2017-09-30,2018-09-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,273
NCT01217931,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01233960,0,0,0,0,0,0,2019-02-28,2020-02-28,,Mesoblast International Sàrl,Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,17
NCT01256398,1,1,0,1,0,1,2017-11-14,2018-11-14,2019-02-04,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01265433,1,0,0,0,1,0,2017-07-25,2018-07-25,,Sellas Life Sciences Group,Industry,1,0,1,1.0,Phase 2,0,2010.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT01272245,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-03-19,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01274338,0,0,0,0,0,0,2020-05-01,2021-05-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2011.0,0,0,1,0,0,0,0,0,1,0,1,3004
NCT01302834,1,0,0,0,1,0,2018-07-12,2019-07-12,,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2011.0,0,1,1,0,0,0,0,0,1,0,1,156
NCT01306656,0,1,0,1,0,1,2017-02-28,2018-02-28,2018-05-02,Columbia University,Other,0,0,1,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT01307501,1,0,1,1,0,1,2018-08-30,2019-08-30,2019-09-06,Galil Medical,Industry,1,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,1,0,1,8
NCT01344356,1,0,0,0,1,0,2018-05-31,2019-05-31,,Mercy Research,Other,0,0,0,4.0,Phase 4,0,2008.0,1,0,0,0,0,1,0,0,0,0,1,15
NCT01352598,1,0,0,0,1,0,2018-06-30,2019-06-30,,Mercy Research,Other,0,0,0,4.0,Phase 4,0,2011.0,1,0,0,0,0,1,0,0,0,0,1,15
NCT01353313,0,0,0,0,0,0,2020-01-31,2021-01-31,,NICHD Neonatal Research Network,Other,0,0,1,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,59
NCT01359969,0,0,0,0,0,0,2017-07-17,2018-07-17,,Pharming Technologies B.V.,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,11
NCT01362595,1,0,0,0,1,0,2018-06-30,2019-06-30,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,271
NCT01369212,0,0,0,0,0,0,2019-08-31,2020-08-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,1,5.0,,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,495
NCT01396148,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-02-12,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT01400607,0,0,0,0,0,0,2020-09-30,2021-09-30,,"ISTO Technologies, Inc.",Industry,1,0,0,3.0,Phase 3,1,2011.0,0,0,1,0,0,0,0,0,0,0,1,3
NCT01409811,0,0,0,0,0,0,2019-04-30,2020-04-30,,City of Hope Medical Center,Other,0,0,1,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT01420237,0,0,0,0,0,0,2026-06-30,2027-06-30,,Stryker Orthopaedics,Industry,1,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,1,0,1,24
NCT01420627,0,0,0,0,0,0,2019-05-29,2020-05-29,,"Leadiant Biosciences, Inc.",Industry,1,0,0,3.0,Phase 3,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT01451853,0,0,0,0,0,0,2019-06-26,2020-06-26,,"Sound Pharmaceuticals, Incorporated",Industry,1,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT01456949,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-11-21,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,1,0,1,169
NCT01459497,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,626
NCT01462006,0,0,0,0,0,0,2018-11-30,2019-11-30,,University of Virginia,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT01474148,0,0,0,0,0,0,2020-01-31,2021-01-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT01479829,0,0,0,0,0,0,2019-03-31,2020-03-31,,Loyola University,Other,0,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,102
NCT01485393,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-01-04,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01488097,1,1,0,1,0,0,2017-06-21,2018-06-21,2016-01-14,Alexion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,86
NCT01495637,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mark Hall,Other,0,0,1,4.0,Phase 4,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01499888,0,0,0,0,0,0,2021-05-31,2022-05-31,,University of Illinois at Chicago,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,242
NCT01510184,1,0,0,0,1,0,2018-02-28,2019-02-28,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,1,2012.0,1,1,0,0,0,0,0,0,1,0,1,67
NCT01517451,0,0,0,0,0,0,2021-05-22,2022-05-22,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT01522404,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-10-31,Emory University,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT01530269,0,0,0,0,0,0,2019-01-31,2020-01-31,,Phoenix Molecular Imaging,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01534052,1,1,0,1,0,0,2017-04-18,2018-04-18,2018-03-26,Astellas Pharma Inc,Industry,1,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,506
NCT01535157,1,0,0,0,1,0,2018-06-30,2019-06-30,,South Plains Oncology Consortium,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT01555541,1,1,0,1,0,1,2017-07-06,2018-07-06,2019-03-03,C. Babis Andreadis,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01570387,0,0,0,0,0,0,2018-11-30,2019-11-30,,Vaishali Sanchorawala,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01573572,0,0,0,0,0,0,2019-11-01,2020-11-01,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,180
NCT01578109,0,0,0,0,0,0,2018-12-31,2019-12-31,,National Cancer Institute (NCI),NIH,2,0,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01579162,0,0,0,0,0,0,2019-12-31,2020-12-31,,"HepQuant, LLC",Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT01582672,1,0,0,0,1,0,2018-04-30,2019-04-30,,Argos Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2012.0,1,1,1,0,0,0,0,0,1,0,1,10
NCT01588821,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-12-11,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01591902,1,0,0,0,1,0,2018-05-31,2019-05-31,,Theratechnologies,Industry,1,0,0,4.0,Phase 4,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT01594827,1,1,0,1,0,0,2017-12-30,2018-12-30,2018-09-17,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT01596127,1,1,0,1,0,0,2017-03-23,2018-03-23,2018-02-28,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01597778,0,0,0,0,0,0,2020-06-30,2021-06-30,,Medical College of Wisconsin,Other,0,0,1,3.0,Phase 3,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,315
NCT01598753,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-06-03,University of Washington,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01600105,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-05,Bachir Taouli,Other,0,0,0,4.0,Phase 4,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01601652,0,0,0,0,0,0,2021-11-30,2022-11-30,,Arthur J De Lorimier,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01601847,1,1,0,1,0,0,2017-03-12,2018-03-12,2018-03-11,Case Western Reserve University,Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,89
NCT01620216,0,0,0,0,0,0,2019-03-30,2020-03-30,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,163
NCT01622868,0,0,0,0,0,0,2019-08-31,2020-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,1,0,1,3004
NCT01624805,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01640951,1,1,0,1,0,0,2017-05-04,2018-05-04,2018-04-23,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01644656,0,0,0,0,0,0,2018-09-30,2019-09-30,,VA Connecticut Healthcare System,U.S. Fed,2,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,36
NCT01650194,1,1,0,1,0,0,2018-01-04,2019-01-04,2018-12-13,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,135
NCT01655719,1,1,0,1,0,0,2017-03-31,2018-03-31,2017-08-21,University of Michigan,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT01676818,0,0,0,0,0,0,2020-08-09,2021-08-09,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,483
NCT01678586,0,0,0,0,0,0,2019-08-31,2020-08-31,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01721954,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-08-12,Sirtex Medical,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,1,0,0,0,0,1,0,1,6
NCT01729091,0,0,0,0,0,0,2019-06-28,2020-06-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01734850,0,0,0,0,0,0,2017-09-30,2018-09-30,,"Calimmune, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,2
NCT01736267,0,0,0,0,0,0,2022-11-30,2023-11-30,,Massachusetts Eye and Ear Infirmary,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,50
NCT01750190,0,0,0,0,0,0,2018-09-20,2019-09-20,,FibroGen,Industry,1,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT01752426,1,0,1,1,0,1,2018-08-09,2019-08-09,2019-08-27,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01759771,0,0,0,0,0,0,2018-12-31,2019-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT01766219,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-02,Wake Forest University Health Sciences,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT01767194,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-06-24,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,1,1,1,0,0,0,0,0,1,0,1,3004
NCT01771731,1,0,1,1,0,1,2017-05-12,2018-05-12,2019-09-03,"University of California, San Francisco",Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT01773278,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT01774019,0,0,0,0,0,0,2020-07-31,2021-07-31,,Boston Scientific Corporation,Industry,1,0,0,4.0,Phase 4,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,340
NCT01783041,0,0,0,0,0,0,2019-12-31,2020-12-31,,Montefiore Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,240
NCT01783535,0,0,0,0,0,0,2020-06-30,2021-06-30,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,302
NCT01785771,0,0,0,0,0,0,2018-01-31,2019-01-31,,Intarcia Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT01786343,0,0,0,0,0,0,2019-05-06,2020-05-06,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01787487,0,0,0,0,0,0,2020-07-26,2021-07-26,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01794117,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,91
NCT01794702,1,1,0,1,0,1,2018-01-11,2019-01-11,2019-02-08,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01795313,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Ian F. Pollack, M.D.",Other,0,0,1,5.0,,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,5
NCT01807182,0,0,0,0,0,0,2020-06-30,2021-06-30,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,393
NCT01808573,0,0,0,0,0,0,2018-09-28,2019-09-28,,"Puma Biotechnology, Inc.",Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,34
NCT01811368,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of California, Davis",Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,1,0,0,0,0,1,530
NCT01814501,0,0,0,0,0,0,2019-12-31,2020-12-31,,John Hays,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,2
NCT01829165,1,1,0,1,0,0,2017-01-20,2018-01-20,2018-01-19,Stanford University,Other,0,0,1,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,1309
NCT01829958,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01832350,1,0,0,0,1,0,2017-11-30,2018-11-30,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,1,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT01832727,0,0,0,0,0,0,2019-06-25,2020-06-25,,Amgen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT01832896,1,0,0,0,1,0,2017-07-31,2018-07-31,,"Mark Davis-Lorton, MD",Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01837862,0,0,0,0,0,0,2020-04-30,2021-04-30,,Julie Krystal,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01838174,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of Colorado, Denver",Other,0,1,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT01838317,1,0,1,1,0,1,2017-09-20,2018-09-20,2019-01-24,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT01847755,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Barry Miskin, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01862315,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01862536,0,0,0,0,0,0,2019-08-31,2020-08-31,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01864018,0,0,0,0,0,0,2020-10-22,2021-10-22,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01869322,0,0,0,0,0,0,2021-12-31,2022-12-31,,Oregon Health and Science University,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,475
NCT01881763,1,0,1,1,0,1,2017-03-31,2018-03-31,2018-06-29,Northwell Health,Other,0,0,0,4.0,Phase 4,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,271
NCT01881867,0,1,0,1,0,1,2017-05-15,2018-05-15,2018-08-09,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,393
NCT01886872,1,0,0,0,1,0,2018-08-07,2019-08-07,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2013.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT01893307,0,0,0,0,0,0,2023-08-31,2024-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,2.0,Phase 2/Phase 3,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01893827,0,0,0,0,0,0,2019-09-12,2020-09-12,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT01899833,0,0,0,0,0,0,2019-12-31,2020-12-31,,Cell>Point LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,5
NCT01900002,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT01901874,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-04-09,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,52
NCT01904136,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,1,0,0,0,0,1,2066
NCT01906866,1,1,0,1,0,0,2018-03-27,2019-03-27,2018-10-02,Neurim Pharmaceuticals Ltd.,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,12
NCT01908192,0,0,0,0,0,0,2018-12-31,2019-12-31,,SyneuRx International (Taiwan) Corp,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,3
NCT01914939,1,0,0,0,1,0,2017-11-30,2018-11-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01918397,0,0,0,0,0,0,2020-03-31,2021-03-31,,Boston University,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,188
NCT01919489,0,0,0,0,0,0,2019-12-31,2020-12-31,,Emory University,Other,0,1,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT01921218,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Andrew B Adams, MD, PhD",Other,0,1,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01923311,1,1,0,1,0,0,2017-11-03,2018-11-03,2018-04-24,Gilead Sciences,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT01925378,0,0,0,0,0,0,2022-12-31,2023-12-31,,Joseph Anthony Lucci III,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01938378,0,0,0,0,0,0,2020-12-31,2021-12-31,,Octapharma,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,54
NCT01940367,1,0,0,0,1,0,2017-03-31,2018-03-31,,Walter Reed National Military Medical Center,U.S. Fed,2,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,47
NCT01944046,0,0,0,0,0,0,2017-11-30,2018-11-30,,Linmarie Sikich,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01945866,1,1,0,1,0,1,2017-06-05,2018-06-05,2018-06-12,Jaeb Center for Health Research,Other,0,1,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT01947140,0,0,0,0,0,0,2020-01-31,2021-01-31,,Jennifer Amengual,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01956942,1,0,0,0,1,0,2017-07-31,2018-07-31,,David Belyea,Other,0,0,0,4.0,Phase 4,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT01964560,0,0,0,0,0,0,2022-06-30,2023-06-30,,"UCB BIOSCIENCES, Inc.",Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT01971346,1,1,0,1,0,0,2017-11-01,2018-11-01,2018-10-12,University of Michigan,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT01982448,0,0,0,0,0,0,2019-04-30,2020-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01982942,0,0,0,0,0,0,2017-05-31,2018-05-31,,MediciNova,Industry,1,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT01985360,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,1,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT01986075,0,0,0,0,0,0,2019-11-30,2020-11-30,,New York State Psychiatric Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT01996605,0,0,0,0,0,0,2020-12-31,2021-12-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT01999920,1,1,0,1,0,0,2017-03-31,2018-03-31,2017-04-27,New York State Psychiatric Institute,Other,0,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02005289,0,0,0,0,0,0,2019-10-31,2020-10-31,,Ohio State University Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,198
NCT02008396,0,0,0,0,0,0,2017-08-31,2018-08-31,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02013791,1,1,0,1,0,0,2017-04-12,2018-04-12,2018-04-12,Allergan,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02019420,1,1,0,1,0,0,2018-06-22,2019-06-22,2019-06-10,Cubist Pharmaceuticals LLC,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,3,0,1,65
NCT02027428,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-09-13,Celgene,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02030990,0,0,0,0,0,0,2020-01-31,2021-01-31,,"United States Naval Medical Center, San Diego",U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,52
NCT02034110,0,0,0,0,0,0,2020-06-29,2021-06-29,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02037048,0,0,0,0,0,0,2020-02-29,2021-02-28,,Case Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,374
NCT02043548,0,0,0,0,0,0,2019-07-30,2020-07-30,,Chester Oddis,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02043691,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Alabama at Birmingham,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,801
NCT02049138,0,0,0,0,0,0,2021-02-20,2022-02-20,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02053727,1,0,0,0,1,0,2018-06-30,2019-06-30,,Suzanne Kafaja,Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02073682,1,1,0,1,0,1,2017-09-15,2018-09-15,2018-09-26,"Daiichi Sankyo, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,207
NCT02075970,0,0,0,0,0,0,2019-06-30,2020-06-30,,John A Widness,Other,0,1,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02076191,1,0,0,0,1,0,2018-07-20,2019-07-20,,John Mascarenhas,Other,0,1,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02080221,0,0,0,0,0,0,2019-09-30,2020-09-30,,howard safran,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT02089230,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02092324,0,0,0,0,0,0,2019-04-01,2020-04-01,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT02103270,1,1,0,1,0,0,2018-07-25,2019-07-25,2019-04-02,Stanford University,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02106598,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02108522,0,0,0,0,0,0,2018-01-31,2019-01-31,,ViraCyte,Industry,1,0,0,5.0,,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,5
NCT02108964,0,0,0,0,0,0,2018-03-22,2019-03-22,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02110355,0,0,0,0,0,0,2018-12-11,2019-12-11,,Amgen,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02111772,1,1,0,1,0,1,2017-04-20,2018-04-20,2018-04-26,University of Virginia,Other,0,0,1,5.0,,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,402
NCT02112877,0,1,0,1,0,1,2017-12-05,2018-12-05,2019-05-24,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,340
NCT02118584,0,0,0,0,0,0,2025-08-16,2026-08-16,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02122562,0,0,0,0,0,0,2021-09-30,2022-09-30,,Mark Niciu,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02130453,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02133326,1,0,1,1,0,1,2017-01-31,2018-01-31,2018-05-15,Tufts University School of Dental Medicine,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02133924,0,0,0,0,0,0,2019-12-31,2020-12-31,,John Levine,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02137369,0,0,0,0,0,0,2019-11-30,2020-11-30,,Emory University,Other,0,0,1,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02143778,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-27,Exalenz Bioscience LTD.,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,16
NCT02145143,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2014.0,0,1,0,1,0,0,0,0,0,0,1,1432
NCT02145260,0,0,0,0,0,0,2019-06-30,2020-06-30,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT02145351,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mayo Clinic,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02152540,1,1,0,1,0,1,2017-09-30,2018-09-30,2019-02-06,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT02152995,0,0,0,0,0,0,2021-07-31,2022-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,3004
NCT02155608,1,1,0,1,0,0,2018-05-30,2019-05-30,2019-02-26,"University of California, Los Angeles",Other,0,0,1,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,692
NCT02158884,1,0,1,1,0,1,2017-08-31,2018-08-31,2018-12-13,Major Extremity Trauma Research Consortium,Other,0,0,1,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,22
NCT02163226,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,0,3.0,Phase 3,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT02164461,1,0,0,0,1,0,2017-04-30,2018-04-30,,"Advaxis, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,10
NCT02169271,1,0,0,0,1,0,2018-07-13,2019-07-13,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02169505,1,1,0,1,0,0,2017-08-14,2018-08-14,2018-04-06,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02173379,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-04-20,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,419
NCT02183272,1,0,0,0,1,0,2017-11-30,2018-11-30,,University of Cincinnati,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,222
NCT02183909,1,0,0,0,1,0,2017-03-31,2018-03-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02187679,1,0,0,0,1,0,2017-06-30,2018-06-30,,Detroit Clinical Research Center,Other,0,1,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02188745,0,0,0,0,0,0,2021-08-31,2022-08-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,306
NCT02191579,1,1,0,1,0,0,2017-05-09,2018-05-09,2018-05-07,Allergan,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,495
NCT02194738,0,0,0,0,0,0,2021-09-28,2022-09-28,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02208466,0,0,0,0,0,0,2019-06-30,2020-06-30,,Spaulding Rehabilitation Hospital,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,1,0,0,0,0,0,0,1,69
NCT02211131,0,0,0,0,0,0,2019-04-30,2020-04-30,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,685
NCT02216214,1,1,0,1,0,0,2017-11-29,2018-11-29,2018-11-26,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,135
NCT02218541,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-22,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02221869,0,1,0,1,0,1,2017-02-28,2018-02-28,2018-11-23,Jazz Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,55
NCT02222545,0,0,0,0,0,0,2019-10-31,2020-10-31,,Omeros Corporation,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,19
NCT02222714,1,1,0,1,0,1,2017-04-18,2018-04-18,2018-07-27,"ZZ Biotech, LLC",Industry,1,0,1,1.0,Phase 2,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,2
NCT02225665,1,0,0,0,1,0,2018-06-30,2019-06-30,,Sangamo Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,1,0,0,1,18
NCT02227251,0,0,0,0,0,0,2020-06-30,2021-06-30,,Karyopharm Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,22
NCT02229227,1,1,0,1,0,0,2017-07-24,2018-07-24,2018-06-01,GlaxoSmithKline,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02237001,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,83
NCT02240108,1,1,0,1,0,1,2017-10-06,2018-10-06,2019-08-15,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02242773,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Miami,Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,476
NCT02243332,1,0,0,0,1,0,2017-03-31,2018-03-31,,Articulate Labs,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02243709,0,0,0,0,0,0,2020-12-31,2021-12-31,,Brown University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,152
NCT02249039,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02250326,1,1,0,1,0,0,2017-07-17,2018-07-17,2018-07-13,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02254421,1,1,0,1,0,0,2017-04-17,2018-04-17,2018-03-27,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02265510,0,0,0,0,0,0,2019-02-27,2020-02-27,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,143
NCT02265744,1,1,0,1,0,0,2017-10-26,2018-10-26,2018-10-25,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02270970,0,0,0,0,0,0,2018-12-31,2019-12-31,,Oklahoma Medical Research Foundation,Other,0,1,0,4.0,Phase 4,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,11
NCT02271100,0,0,0,0,0,0,2019-12-31,2020-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,377
NCT02275533,0,0,0,0,0,0,2021-08-31,2022-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,3004
NCT02283658,0,0,1,1,0,0,2018-11-30,2019-11-30,2018-08-15,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02290444,0,0,0,0,0,0,2018-11-01,2019-11-01,,State University of New York at Buffalo,Other,0,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,105
NCT02291913,0,0,0,0,0,0,2020-01-31,2021-01-31,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,167
NCT02297542,0,0,0,0,0,0,2019-12-31,2020-12-31,,Health Sciences North Research Institute,Other,0,0,0,4.0,Phase 4,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,5
NCT02301039,0,0,0,0,0,0,2018-11-30,2019-11-30,,Sarcoma Alliance for Research through Collaboration,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT02301416,1,1,0,1,0,1,2018-06-27,2019-06-27,2019-07-05,Wake Forest University Health Sciences,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT02302339,1,1,0,1,0,0,2018-06-14,2019-06-14,2019-06-12,Celldex Therapeutics,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,27
NCT02304159,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-02-04,"Tarek I. Hassanein, M.D., FACP, FAG, AGAF",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02308488,0,0,0,0,0,0,2021-07-31,2022-07-31,,NYU Langone Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02312622,1,1,0,1,0,0,2018-09-08,2019-09-08,2019-08-01,Joel Neal,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02313883,0,0,0,0,0,0,2018-11-30,2019-11-30,,Geistlich Pharma AG,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02314169,0,0,0,0,0,0,2020-01-31,2021-01-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,3004
NCT02316548,1,1,0,1,0,1,2017-02-01,2018-02-01,2018-02-27,NRG Oncology,Other,0,0,1,1.0,Phase 2,1,2015.0,1,0,0,0,0,1,0,0,1,0,1,27
NCT02320669,0,0,0,0,0,0,2019-10-31,2020-10-31,,Seattle Children's Hospital,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,137
NCT02333188,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Chicago,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02336373,1,0,0,0,1,0,2017-02-28,2018-02-28,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02340221,1,1,0,1,0,1,2017-10-15,2018-10-15,2018-12-18,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02345265,0,0,0,0,0,0,2019-10-31,2020-10-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02345889,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-31,Indiana University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,497
NCT02352896,0,0,0,0,0,0,2021-12-31,2022-12-31,,Edison Pharmaceuticals Inc,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02359006,1,1,0,1,0,1,2017-04-19,2018-04-19,2018-11-16,Yale University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02360111,1,1,0,1,0,1,2017-09-30,2018-09-30,2018-10-01,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02362451,0,0,0,0,0,0,2021-03-01,2022-03-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02363322,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-08-07,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2133
NCT02363959,0,0,0,0,0,0,2018-09-30,2019-09-30,,Duke University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02364713,0,0,0,0,0,0,2025-02-28,2026-02-28,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,1898
NCT02366130,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02368691,1,0,0,0,1,0,2017-09-22,2018-09-22,,GTx,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT02373241,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Alabama at Birmingham,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02374021,0,0,0,0,0,0,2020-03-31,2021-03-31,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT02379052,0,0,0,0,0,0,2017-02-17,2018-02-17,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,176
NCT02382380,0,0,0,0,0,0,2019-10-31,2020-10-31,,Loyola University,Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,102
NCT02384395,0,0,0,0,0,0,2021-07-31,2022-07-31,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02385799,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-04-18,"Randi J. Hagerman, MD",Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02387788,0,0,0,0,0,0,2017-04-30,2018-04-30,,Aerpio Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02387840,0,0,0,0,0,0,2019-07-31,2020-07-31,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,374
NCT02391584,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-07-10,"Entellus Medical, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,10
NCT02396238,1,0,0,0,1,0,2017-09-19,2018-09-19,,Cytori Therapeutics,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,17
NCT02397083,0,0,0,0,0,0,2026-09-30,2027-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,2066
NCT02400281,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,17
NCT02400463,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,213
NCT02400905,1,1,0,1,0,0,2017-11-08,2018-11-08,2018-11-05,Veryan Medical Ltd.,Industry,1,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,3
NCT02402374,0,0,0,0,0,0,2019-06-30,2020-06-30,,Regen Lab SA,Industry,1,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT02402660,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Alkeus Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02403193,0,0,0,0,0,0,2020-10-31,2021-10-31,,Palobiofarma SL,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT02404220,0,0,0,0,0,0,2018-11-16,2019-11-16,,Gilead Sciences,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02404350,1,1,0,1,0,0,2017-08-16,2018-08-16,2018-07-19,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,1895
NCT02406599,0,0,0,0,0,0,2019-08-31,2020-08-31,,Dune Medical Devices,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02409355,1,1,0,1,0,0,2017-12-07,2018-12-07,2018-10-08,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02411084,1,0,1,1,0,1,2017-07-31,2018-07-31,2019-03-18,Adienne SA,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,0,1,0,0,0,0,0,1,0,1,1
NCT02412878,0,1,0,1,0,1,2017-06-15,2018-06-15,2018-10-24,Amgen,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02414698,1,0,1,1,0,0,2017-12-31,2018-12-31,2018-03-23,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02417142,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of Massachusetts, Worcester",Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT02419742,0,0,0,0,0,0,2020-12-28,2021-12-28,,Hoffmann-La Roche,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,1731
NCT02421367,0,0,0,0,0,0,2019-06-30,2020-06-30,,U.S. Army Medical Research and Development Command,U.S. Fed,2,1,1,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,136
NCT02422290,1,0,0,0,1,0,2018-01-01,2019-01-01,,New York State Psychiatric Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02422940,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-02-06,Acorda Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,38
NCT02427464,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Helixmith Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,0,0,0,0,0,1,0,0,1,13
NCT02429375,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02431936,0,0,0,0,0,0,2019-04-16,2020-04-16,,Augusta University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,117
NCT02432807,1,0,0,0,1,0,2018-05-31,2019-05-31,,Kurobe LLC,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02435069,1,1,0,1,0,1,2017-03-28,2018-03-28,2019-07-11,Nemours Children's Clinic,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,75
NCT02436681,1,0,1,1,0,0,2018-07-31,2019-07-31,2019-06-17,Miromatrix Medical Inc.,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02437071,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT02437162,1,1,0,1,0,0,2017-03-22,2018-03-22,2018-03-22,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02440568,0,0,0,0,0,0,2019-05-05,2020-05-05,,University of Illinois at Chicago,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,242
NCT02441517,1,1,0,1,0,0,2017-03-15,2018-03-15,2018-03-08,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,135
NCT02446093,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Advantagene, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,1,0,0,1,0,1,9
NCT02446847,0,0,0,0,0,0,2017-03-25,2018-03-25,,Rockefeller University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,104
NCT02446912,0,0,0,0,0,0,2018-07-17,2019-07-17,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,1,0,0,0,0,0,1,0,1,2450
NCT02448446,1,0,0,0,1,0,2018-06-30,2019-06-30,,"South Coast Retina Center; Carson, McBeath, Boswell, Inc.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02448641,0,0,0,0,0,0,2018-12-05,2019-12-05,,"SanBio, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02449239,0,0,0,0,0,0,2020-12-31,2021-12-31,,Viventia Bio,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,5
NCT02450591,1,1,0,1,0,0,2017-12-11,2018-12-11,2018-03-21,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02451176,0,0,0,0,0,0,2019-12-31,2020-12-31,,Michael Rosen,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02452060,1,0,1,1,0,1,2017-04-13,2018-04-13,2019-07-12,NYU Langone Health,Other,0,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02452255,0,0,0,0,0,0,2022-12-31,2023-12-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,158
NCT02452359,1,0,1,1,0,1,2017-01-21,2018-01-21,2018-03-09,Venus Concept,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,23
NCT02452424,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-08-22,Plexxikon,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,21
NCT02452931,1,0,0,0,1,0,2018-09-05,2019-09-05,,Tolmar Inc.,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02453594,0,0,0,0,0,0,2021-04-20,2022-04-20,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,3,0,1,2145
NCT02454179,1,1,0,1,0,1,2018-05-31,2019-05-31,2019-07-19,Acerta Pharma BV,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02456532,0,0,0,0,0,0,2021-07-31,2022-07-31,,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,151
NCT02457520,1,0,0,0,1,0,2018-04-30,2019-04-30,,Sun Pharmaceutical Industries Limited,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02458638,0,0,0,0,0,0,2018-04-04,2019-04-04,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02460198,0,0,0,0,0,0,2019-09-09,2020-09-09,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,3,0,1,2145
NCT02460991,1,1,0,1,0,0,2017-06-05,2018-06-05,2017-10-07,Boston Scientific Corporation,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,1,0,0,0,0,0,0,1,340
NCT02461550,1,1,0,1,0,0,2017-02-28,2018-02-28,2017-10-26,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1432
NCT02462837,0,0,0,0,0,0,2019-01-30,2020-01-30,,Southern Illinois University,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,26
NCT02462928,0,0,0,0,0,0,2018-04-18,2019-04-18,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02465567,0,0,0,0,0,0,2019-07-26,2020-07-26,,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02471144,0,0,0,0,0,0,2018-12-13,2019-12-13,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,1895
NCT02471716,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Five Prime Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,11
NCT02472223,0,0,0,0,0,0,2020-01-31,2021-01-31,,Washington University School of Medicine,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02473913,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-07-24,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02475681,0,0,0,0,0,0,2019-02-28,2020-02-28,,Acerta Pharma BV,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02476955,0,0,0,0,0,0,2020-12-31,2021-12-31,,ArQule,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,32
NCT02477202,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT02485366,0,0,0,0,0,0,2021-06-30,2022-06-30,,Duke University,Other,0,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT02486406,0,0,0,0,0,0,2020-11-26,2021-11-26,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02487485,0,0,0,0,0,0,2019-08-31,2020-08-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02488057,0,0,0,0,0,0,2019-03-31,2020-03-31,,Ohio State University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,315
NCT02489045,0,0,0,0,0,0,2019-03-31,2020-03-31,,Thomas Jefferson University,Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,186
NCT02489344,0,0,0,0,0,0,2018-11-20,2019-11-20,,"Genzyme, a Sanofi Company",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,300
NCT02492269,0,0,0,0,0,0,2019-12-31,2020-12-31,,Aymen N Naguib,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT02492854,0,0,0,0,0,0,2019-10-31,2020-10-31,,Boston Medical Center,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,225
NCT02497404,0,0,0,0,0,0,2019-06-27,2020-06-27,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,586
NCT02498444,0,0,0,0,0,0,2019-06-30,2020-06-30,,Stanford University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02498717,1,0,0,0,1,0,2017-02-09,2018-02-09,,Florida Hospital,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,63
NCT02499159,1,1,0,1,0,1,2017-07-31,2018-07-31,2019-08-13,Inova Health Care Services,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,41
NCT02500381,0,0,0,0,0,0,2022-05-31,2023-05-31,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,32
NCT02500784,0,0,0,0,0,0,2025-04-30,2026-04-30,,Palo Alto Veterans Institute for Research,Other,0,1,0,1.0,Phase 2,0,2023.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT02502669,0,0,0,0,0,0,2017-06-06,2018-06-06,,"Elorac, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02503332,1,0,0,0,1,0,2017-08-31,2018-08-31,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,14
NCT02506933,0,0,0,0,0,0,2019-12-31,2020-12-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,358
NCT02508324,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,586
NCT02508649,0,0,0,0,0,0,2017-10-03,2018-10-03,,Ferring Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,208
NCT02509026,0,0,0,0,0,0,2019-07-11,2020-07-11,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,2856
NCT02509598,0,0,0,0,0,0,2019-03-06,2020-03-06,,"Cardinal Health 414, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02509793,0,0,0,0,0,0,2019-07-31,2020-07-31,,"William Ondo, MD",Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02511132,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Gradalis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,15
NCT02513498,1,1,0,1,0,0,2018-01-05,2019-01-05,2018-12-19,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,393
NCT02515058,1,1,0,1,0,0,2017-09-30,2018-09-30,2017-09-27,The University of Texas Health Science Center at San Antonio,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,257
NCT02517996,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-05-09,Johns Hopkins University,Other,0,0,0,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02523092,0,0,0,0,0,0,2025-12-31,2026-12-31,,"University of California, San Francisco",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT02524119,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Texas Southwestern Medical Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02524275,0,0,0,0,0,0,2020-04-01,2021-04-01,,University of Nebraska,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,327
NCT02524860,1,0,0,0,1,0,2017-09-30,2018-09-30,,Focal Healthcare Inc.,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02526576,1,0,0,0,1,0,2017-07-31,2018-07-31,,Antria,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT02528409,0,0,1,1,0,0,2018-11-30,2019-11-30,2019-07-08,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02528942,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of Colorado, Denver",Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,882
NCT02530476,0,0,0,0,0,0,2019-04-08,2020-04-08,,M.D. Anderson Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02531126,0,0,0,0,0,0,2022-02-28,2023-02-28,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02532621,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Phraxis, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02534844,0,0,0,0,0,0,2018-03-28,2019-03-28,,"Vtesse, Inc., a Mallinckrodt Pharmaceuticals Company",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02535091,0,0,0,0,0,0,2020-12-31,2021-12-31,,"SK Life Science, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,30
NCT02535715,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-10-02,The University of Texas Health Science Center at San Antonio,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02536976,1,1,0,1,0,0,2018-08-01,2019-08-01,2018-11-28,HealthPartners Institute,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,101
NCT02538198,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02540109,0,0,0,0,0,0,2019-09-30,2020-09-30,,Soterix Medical,Industry,1,0,1,1.0,Phase 2,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02542124,0,0,0,0,0,0,2019-02-28,2020-02-28,,Neumedicines Inc.,Industry,1,0,1,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,5
NCT02542293,0,0,0,0,0,0,2019-08-22,2020-08-22,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,1,0,0,0,0,0,1,0,1,2450
NCT02544113,0,0,0,0,0,0,2020-09-30,2021-09-30,,The Cleveland Clinic,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02544763,0,0,0,0,0,0,2019-01-22,2020-01-22,,GW Research Ltd,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT02545283,0,0,0,0,0,0,2019-12-10,2020-12-10,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02553733,0,0,0,0,0,0,2020-12-31,2021-12-31,,"David N. Proctor, PhD",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02553915,1,0,1,1,0,1,2018-07-13,2019-07-13,2019-08-23,Massachusetts General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02556918,0,0,0,0,0,0,2018-11-06,2019-11-06,,Emory University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02559778,0,0,0,0,0,0,2025-09-30,2026-09-30,,Giselle Sholler,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT02562755,0,0,0,0,0,0,2020-12-31,2021-12-31,,"SillaJen, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,2
NCT02564263,0,0,0,0,0,0,2018-10-15,2019-10-15,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02565186,0,0,0,0,0,0,2019-09-20,2020-09-20,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02566395,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwell Health,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,1,0,0,0,0,1,271
NCT02566850,0,0,0,0,0,0,2019-01-31,2020-01-31,,Ekso Bionics,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02566993,0,0,0,0,0,0,2020-02-29,2021-02-28,,PharmaMar,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,36
NCT02567968,1,1,0,1,0,1,2017-05-01,2018-05-01,2018-06-19,University of Chicago,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02573324,0,0,0,0,0,0,2020-07-18,2021-07-18,,AbbVie,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,1,0,0,1,0,1,430
NCT02574312,0,0,0,0,0,0,2019-03-28,2020-03-28,,DePuy Orthopaedics,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,39
NCT02575833,0,1,0,1,0,1,2017-01-23,2018-01-23,2018-05-21,Amgen,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02576509,0,0,0,0,0,0,2019-05-30,2020-05-30,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02578862,1,1,0,1,0,0,2018-06-30,2019-06-30,2018-07-02,Ochsner Health System,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,37
NCT02581891,0,0,0,0,0,0,2019-04-26,2020-04-26,,Bayer,Industry,1,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1343
NCT02582515,1,1,0,1,0,1,2017-08-31,2018-08-31,2019-03-11,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,692
NCT02582775,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT02584933,0,0,0,0,0,0,2020-12-14,2021-12-14,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02585843,1,1,0,1,0,1,2017-03-31,2018-03-31,2019-02-02,Columbia University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02586857,0,0,0,0,0,0,2019-12-31,2020-12-31,,Acerta Pharma BV,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT02592798,0,0,0,0,0,0,2019-12-11,2020-12-11,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1104
NCT02595216,1,0,0,0,1,0,2017-12-31,2018-12-31,,Syneron Medical,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02595372,0,0,0,0,0,0,2019-12-31,2020-12-31,,Kathy Miller,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02595996,0,0,0,0,0,0,2020-12-31,2021-12-31,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT02596893,1,1,0,1,0,0,2018-01-05,2019-01-05,2019-01-02,Celgene,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02599064,1,0,0,0,1,0,2018-04-30,2019-04-30,,"RXi Pharmaceuticals, Corp.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02599402,0,0,0,0,0,0,2019-10-08,2020-10-08,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,1104
NCT02601209,0,0,0,0,0,0,2020-09-01,2021-09-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02604810,0,0,0,0,0,0,2017-09-30,2018-09-30,,Grifols Therapeutics LLC,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,40
NCT02605434,0,0,0,0,0,0,2019-07-31,2020-07-31,,Intec Pharma Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02606136,0,0,0,0,0,0,2020-04-30,2021-04-30,,FibroGen,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT02608268,0,0,0,0,0,0,2019-11-29,2020-11-29,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02612194,0,0,0,0,0,0,2021-01-31,2022-01-31,,Earle Burgess,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02614196,0,1,0,1,0,1,2017-03-29,2018-03-29,2018-08-23,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02616562,0,0,0,0,0,0,2018-03-01,2019-03-01,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,981
NCT02623504,0,0,0,0,0,0,2021-01-31,2022-01-31,,Validus Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02624388,1,0,0,0,1,0,2018-08-31,2019-08-31,,University of Virginia,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT02625623,1,1,0,1,0,0,2017-09-14,2018-09-14,2018-09-10,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT02632721,0,0,0,0,0,0,2019-11-01,2020-11-01,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT02635360,0,0,0,0,0,0,2019-05-31,2020-05-31,,Linda R Duska,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,2
NCT02635542,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-01-22,University of Chicago,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02635893,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,476
NCT02635984,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-06-22,Augusta University,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,117
NCT02636699,0,0,0,0,0,0,2017-08-18,2018-08-18,,DBV Technologies,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,11
NCT02642029,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mclean Hospital,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,126
NCT02644668,0,0,0,0,0,0,2018-05-31,2019-05-31,,Cytokinetics,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT02646982,0,0,0,0,0,0,2021-09-30,2022-09-30,,Emory University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02647437,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02647788,1,1,0,1,0,0,2018-01-19,2019-01-19,2019-01-18,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02648932,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,594
NCT02649842,1,0,1,1,0,0,2018-08-27,2019-08-27,2019-08-20,Abbott Medical Optics,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,33
NCT02650206,1,0,0,0,1,0,2018-08-31,2019-08-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02650804,0,0,0,0,0,0,2019-06-11,2020-06-11,,"Berg, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,9
NCT02652949,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-10,Medtronic Endovascular,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,64
NCT02655601,0,0,0,0,0,0,2021-09-30,2022-09-30,,"BioMimetix JV, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,6
NCT02655887,0,1,0,1,0,0,2018-06-19,2019-06-19,2019-04-05,C. R. Bard,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,77
NCT02658877,1,0,1,1,0,1,2018-07-19,2019-07-19,2019-09-04,NYU Langone Health,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02664116,1,0,0,0,1,0,2017-07-31,2018-07-31,,Scripps Health,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,28
NCT02665234,0,0,0,0,0,0,2017-02-28,2018-02-28,,"Mimetogen Pharmaceuticals USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02669615,1,1,0,1,0,1,2017-06-09,2018-06-09,2018-07-10,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,315
NCT02671500,1,1,0,1,0,0,2018-01-05,2019-01-05,2018-12-20,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02674399,1,0,0,0,1,0,2018-03-12,2019-03-12,,Nature Cell Co. Ltd.,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02677701,0,0,0,0,0,0,2019-12-31,2020-12-31,,Seattle Children's Hospital,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,137
NCT02679573,0,0,0,0,0,0,2018-07-31,2019-07-31,,"Melinta Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,25
NCT02681887,0,0,0,0,0,0,2021-06-30,2022-06-30,,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT02687165,1,0,0,0,1,0,2018-02-28,2019-02-28,,New York State Psychiatric Institute,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02688712,0,0,0,0,0,0,2021-12-31,2022-12-31,,Providence Health & Services,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT02690558,0,0,0,0,0,0,2019-09-30,2020-09-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT02700464,0,0,0,0,0,0,2019-12-31,2020-12-31,,Nucleix Ltd.,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,3
NCT02701153,0,0,0,0,0,0,2020-02-03,2021-02-03,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,277
NCT02702271,0,0,0,0,0,0,2021-06-30,2022-06-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT02702505,1,0,0,0,1,0,2017-12-31,2018-12-31,,Texas A & M University Baylor College Of Dentistry,Other,0,0,0,4.0,Phase 4,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02703220,0,0,0,0,0,0,2019-12-02,2020-12-02,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02706730,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Otonomy, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02710396,0,0,0,0,0,0,2019-03-31,2020-03-31,,Naiyer Rizvi,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02711553,0,0,0,0,0,0,2018-02-16,2019-02-16,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02713867,0,0,0,0,0,0,2022-06-30,2023-06-30,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02717156,0,0,0,0,0,0,2020-11-21,2021-11-21,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,483
NCT02717728,0,0,0,0,0,0,2020-12-31,2021-12-31,,Boston Children’s Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,400
NCT02720211,0,0,0,0,0,0,2018-11-06,2019-11-06,,University of Utah,Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,578
NCT02722304,1,0,0,0,1,0,2018-09-14,2019-09-14,,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,1,2016.0,1,0,1,0,0,0,0,0,1,0,1,107
NCT02724072,0,0,0,0,0,0,2021-07-31,2022-07-31,,Bolton Medical,Industry,1,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,12
NCT02724956,0,0,0,0,0,0,2020-11-01,2021-11-01,,M.D. Anderson Cancer Center,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2066
NCT02725463,0,0,0,0,0,0,2020-03-31,2021-03-31,,Johns Hopkins University,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02726386,0,0,0,0,0,0,2019-08-31,2020-08-31,,NeuroDerm Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,14
NCT02727803,0,0,0,0,0,0,2020-05-19,2021-05-19,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,2066
NCT02730377,0,0,0,0,0,0,2019-07-31,2020-07-31,,Novo Nordisk A/S,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02736890,1,1,0,1,0,0,2018-07-17,2019-07-17,2019-02-05,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02740634,0,0,0,0,0,0,2021-03-31,2022-03-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02744287,0,0,0,0,0,0,2019-12-31,2020-12-31,,Bellicum Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,15
NCT02747433,0,0,0,0,0,0,2018-11-10,2019-11-10,,Spaulding Rehabilitation Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,69
NCT02748122,0,0,0,0,0,0,2019-03-27,2020-03-27,,NYU Langone Health,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,869
NCT02750618,1,1,0,1,0,0,2017-04-20,2018-04-20,2018-04-19,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,36
NCT02753400,0,0,0,0,0,0,2017-11-30,2018-11-30,,Acucela Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02754362,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,869
NCT02754492,1,1,0,1,0,0,2017-02-15,2018-02-15,2018-02-08,Terumo BCT,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT02755116,0,0,0,0,0,0,2019-09-05,2020-09-05,,Jaime B Hyman,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02756403,1,0,0,0,1,0,2017-07-31,2018-07-31,,Medstar Health Research Institute,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,79
NCT02757326,0,0,0,0,0,0,2019-05-31,2020-05-31,,RedHill Biopharma Limited,Industry,1,1,1,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02758717,0,0,0,0,0,0,2019-11-13,2020-11-13,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,32
NCT02759185,0,0,0,0,0,0,2019-01-31,2020-01-31,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02760264,1,1,0,1,0,0,2018-05-01,2019-05-01,2018-09-28,"ReveraGen BioPharma, Inc.",Industry,1,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02763033,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Pavan Reddy, MD",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02764437,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of Wisconsin, Madison",Other,0,0,1,5.0,,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,715
NCT02765165,0,0,0,0,0,0,2022-09-30,2023-09-30,,"Proximagen, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02768870,1,0,0,0,1,0,2017-11-30,2018-11-30,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,77
NCT02770547,0,0,0,0,0,0,2018-12-14,2019-12-14,,Indiana University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,497
NCT02771366,1,0,1,1,0,0,2018-07-27,2019-07-27,2019-07-23,University of Florida,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,849
NCT02773212,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Illinois at Chicago,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,242
NCT02774681,0,0,0,0,0,0,2019-11-30,2020-11-30,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,925
NCT02780167,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-02-23,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02788279,1,1,0,1,0,0,2018-03-09,2019-03-09,2019-03-08,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02790138,0,0,0,0,0,0,2020-05-08,2021-05-08,,Takeda,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,650
NCT02790515,0,0,0,0,0,0,2020-06-30,2021-06-30,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,1,1,0,0,0,0,0,0,1,302
NCT02791230,0,0,0,0,0,0,2024-12-07,2025-12-07,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02793375,0,0,0,0,0,0,2020-02-28,2021-02-28,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT02795767,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-03-20,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02802176,0,0,0,0,0,0,2019-03-31,2020-03-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1443
NCT02802865,1,0,1,1,0,1,2018-05-31,2019-05-31,2019-08-21,Rachel Mejia,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02804178,1,0,0,0,1,0,2017-08-17,2018-08-17,,"Millendo Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02806414,0,0,0,0,0,0,2019-07-31,2020-07-31,,"University of California, San Diego",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT02806726,1,1,0,1,0,0,2017-11-09,2018-11-09,2018-11-09,Abbott Medical Optics,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,2,0,1,33
NCT02807805,0,0,0,0,0,0,2020-05-31,2021-05-31,,Chong-xian Pan,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02808104,1,0,0,0,1,0,2017-03-28,2018-03-28,,NLS-1 Pharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02811302,1,1,0,1,0,0,2018-05-07,2019-05-07,2019-04-25,Medtronic - MITG,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,146
NCT02813265,0,0,0,0,0,0,2017-10-31,2018-10-31,,"Kala Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02814630,0,0,0,0,0,0,2018-11-02,2019-11-02,,Asthma Inc Clinical Research Center,Other,0,0,0,5.0,,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,1
NCT02818946,0,0,0,0,0,0,2020-12-31,2021-12-31,,Duke University,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT02820350,1,0,0,0,1,0,2018-07-31,2019-07-31,,"CytoPherx, Inc",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02820714,0,0,0,0,0,0,2017-01-31,2018-01-31,,Braintree Laboratories,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,43
NCT02825212,0,0,0,0,0,0,2019-07-19,2020-07-19,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02826161,1,0,0,0,1,0,2017-04-24,2018-04-24,,"Boston Biomedical, Inc",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,27
NCT02826486,0,0,0,0,0,0,2021-12-31,2022-12-31,,"BioLineRx, Ltd.",Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,17
NCT02827500,0,0,1,1,0,0,2018-10-15,2019-10-15,2019-09-12,Duke University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02829918,0,0,0,0,0,0,2019-10-31,2020-10-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02830594,0,0,0,0,0,0,2020-04-30,2021-04-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,1,0,0,0,0,1,358
NCT02831283,0,0,0,0,0,0,2021-06-30,2022-06-30,,William Charles Kreisl,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT02831816,0,0,0,0,0,0,2017-08-03,2018-08-03,,"Zurex Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02835443,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Enspire DBS Therapy, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02835950,0,0,0,0,0,0,2019-06-30,2020-06-30,,SoniVie Ltd.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT02840084,0,0,0,0,0,0,2020-09-15,2021-09-15,,"Nina S. Naidu, MD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02841280,0,0,0,0,0,0,2021-01-31,2022-01-31,,Indiana University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,497
NCT02842866,0,0,0,0,0,0,2017-02-08,2018-02-08,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,285
NCT02844465,0,0,0,0,0,0,2022-05-31,2023-05-31,,"Medtronic Navigation, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02852967,1,0,0,0,1,0,2018-07-31,2019-07-31,,"Kadmon Corporation, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT02853617,1,0,0,0,1,0,2018-04-23,2019-04-23,,"Alopexx Vaccine, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,1
NCT02856828,0,0,1,1,0,1,2018-02-06,2019-02-06,2019-09-12,Duke University,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT02857816,1,1,0,1,0,0,2017-11-21,2018-11-21,2018-11-20,MedtronicNeuro,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,57
NCT02861417,0,0,0,0,0,0,2021-08-31,2022-08-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02864147,0,0,0,0,0,0,2021-04-30,2022-04-30,,Yale University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02867384,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02871778,0,0,0,0,0,0,2018-11-20,2019-11-20,,Vertex Pharmaceuticals Incorporated,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02873936,0,0,0,0,0,0,2018-03-20,2019-03-20,,Gilead Sciences,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02877134,0,0,0,0,0,0,2019-11-01,2020-11-01,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,558
NCT02879448,0,0,0,0,0,0,2020-02-29,2021-02-28,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,419
NCT02880163,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Arsenal Medical, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,1
NCT02880293,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02881151,0,0,0,0,0,0,2019-11-30,2020-11-30,,Jaimie M. Henderson,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02881255,0,0,0,0,0,0,2020-08-31,2021-08-31,,Population Health Research Institute,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,77
NCT02887976,1,0,0,0,1,0,2017-08-31,2018-08-31,,"GU Research Network, LLC",Other,0,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02888119,0,0,0,0,0,0,2020-07-31,2021-07-31,,NYU Langone Health,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT02891447,0,0,0,0,0,0,2021-09-01,2022-09-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02891603,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT02896296,0,1,0,1,0,1,2017-08-23,2018-08-23,2018-10-02,Indivior Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,45
NCT02900495,0,0,0,0,0,0,2019-08-31,2020-08-31,,Northwell Health,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,271
NCT02902081,1,1,0,1,0,1,2017-03-31,2018-03-31,2019-04-05,University of Chicago,Other,0,1,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02903966,0,0,0,0,0,0,2019-06-17,2020-06-17,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02905266,1,1,0,1,0,0,2017-10-23,2018-10-23,2018-10-23,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,2,0,1,1104
NCT02907918,0,0,0,0,0,0,2021-10-31,2022-10-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,1,0,1,0,1151
NCT02908490,0,0,0,0,0,0,2020-03-31,2021-03-31,,Kimberly Liang,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02908841,0,0,0,0,0,0,2019-09-30,2020-09-30,,Danbury Hospital,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,6
NCT02909088,1,0,0,0,1,0,2017-08-31,2018-08-31,,"Gerald Maguire, MD",Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02909959,0,0,0,0,0,0,2019-05-30,2020-05-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT02910102,1,0,1,1,0,1,2017-11-30,2018-11-30,2019-01-15,Axovant Sciences Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02911792,0,0,0,0,0,0,2022-09-01,2023-09-01,,The University of Texas Health Science Center at San Antonio,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,257
NCT02912507,1,0,0,0,1,0,2018-06-30,2019-06-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,37
NCT02913313,0,0,0,0,0,0,2022-12-15,2023-12-15,,Bristol-Myers Squibb,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02913482,0,0,0,0,0,0,2023-11-17,2024-11-17,,Hoffmann-La Roche,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02914184,1,0,1,1,0,0,2018-06-27,2019-06-27,2019-06-26,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,3276
NCT02914639,1,0,0,0,1,0,2017-06-26,2018-06-26,,"SciFluor Life Sciences, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02915523,0,0,0,0,0,0,2019-07-31,2020-07-31,,Syndax Pharmaceuticals,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,21
NCT02916953,0,0,0,0,0,0,2021-05-31,2022-05-31,,"AgNovos Healthcare, LLC",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,1
NCT02917629,0,0,0,0,0,0,2019-08-27,2020-08-27,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3004
NCT02918630,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-06-05,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02921490,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02922036,0,0,0,0,0,0,2019-09-30,2020-09-30,,"EBR Systems, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT02922985,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-27,"The University of Texas Medical Branch, Galveston",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,158
NCT02923986,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Bio-Path Holdings, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT02924272,0,0,0,0,0,0,2021-10-01,2022-10-01,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT02925494,0,0,0,0,0,0,2018-05-07,2019-05-07,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02926352,1,0,0,0,1,0,2018-05-31,2019-05-31,,University of Texas at Austin,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,135
NCT02926898,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT02927080,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Acceleron Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT02927327,1,1,0,1,0,0,2017-09-20,2018-09-20,2018-07-26,GE Healthcare,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,119
NCT02928029,0,0,0,0,0,0,2019-03-20,2020-03-20,,Bayer,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1343
NCT02928172,0,0,0,0,0,0,2019-12-31,2020-12-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,279
NCT02930122,0,0,0,0,0,0,2023-06-30,2024-06-30,,"Cale Jacobs, PhD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02932891,1,1,0,1,0,1,2017-04-14,2018-04-14,2018-11-12,Taro Pharmaceuticals USA,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02933502,1,1,0,1,0,1,2017-09-20,2018-09-20,2018-11-12,Taro Pharmaceuticals USA,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02936843,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Michigan,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT02937701,0,1,0,1,0,1,2018-04-16,2019-04-16,2019-08-08,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,685
NCT02942966,0,0,0,0,0,0,2019-07-11,2020-07-11,,Intact Vascular,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,6
NCT02943460,1,1,0,1,0,0,2018-02-28,2019-02-28,2019-02-21,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02944578,0,0,0,0,0,0,2021-08-31,2022-08-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT02945800,0,0,0,0,0,0,2020-03-31,2021-03-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02946177,0,0,0,0,0,0,2020-12-31,2021-12-31,,Center for Human Reproduction,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,11
NCT02949921,1,1,0,1,0,0,2018-01-02,2019-01-02,2018-12-27,"Merz North America, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,35
NCT02951195,0,0,0,0,0,0,2018-01-31,2019-01-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,141
NCT02953873,1,0,1,1,0,0,2018-09-10,2019-09-10,2019-08-30,Medical University of South Carolina,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,511
NCT02954042,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT02958774,0,0,0,0,0,0,2020-03-31,2021-03-31,,Melissa Mitchell,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,2
NCT02959853,1,0,0,0,1,0,2017-07-31,2018-07-31,,Baylor College of Medicine,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT02959970,0,0,0,0,0,0,2018-02-08,2019-02-08,,"Almirall, S.A.",Industry,1,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,33
NCT02960412,1,0,1,1,0,1,2018-03-31,2019-03-31,2019-04-29,University of South Florida,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT02960893,0,0,0,0,0,0,2017-08-18,2018-08-18,,"Biohaven Pharmaceuticals, Inc.",Industry,1,1,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT02961894,0,0,0,0,0,0,2019-02-28,2020-02-28,,Rex Medical,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT02963558,0,0,0,0,0,0,2020-06-30,2021-06-30,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT02966002,1,1,0,1,0,0,2017-05-25,2018-05-25,2018-04-17,University of Michigan,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT02969837,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT02970331,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Maruho Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,26
NCT02970669,1,1,0,1,0,0,2018-03-19,2019-03-19,2019-03-14,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02971397,1,0,0,0,1,0,2018-03-31,2019-03-31,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02972359,0,0,0,0,0,0,2019-01-09,2020-01-09,,Grünenthal GmbH,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,71
NCT02973100,1,1,0,1,0,0,2017-07-15,2018-07-15,2018-07-13,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02974816,0,0,0,0,0,0,2020-02-01,2021-02-01,,Glooko,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT02974985,0,0,0,0,0,0,2018-09-30,2019-09-30,,Abington Memorial Hospital,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,9
NCT02975973,0,0,0,0,0,0,2019-06-30,2020-06-30,,Baylor College of Medicine,Other,0,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,518
NCT02978183,0,0,0,0,0,0,2017-02-28,2018-02-28,,"Noveome Biotherapeutics, formerly Stemnion",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,10
NCT02978365,1,0,0,0,1,0,2018-03-22,2019-03-22,,Uri Gottlieb,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT02978859,0,0,0,0,0,0,2020-01-31,2021-01-31,,Matthew Ingham,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02979639,1,1,0,1,0,0,2017-04-12,2018-04-12,2018-04-11,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,0,0,1,3276
NCT02982018,0,1,0,1,0,1,2017-02-18,2018-02-18,2018-05-07,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,138
NCT02982915,0,0,0,0,0,0,2019-06-30,2020-06-30,,Longeveron LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,5
NCT02984761,0,0,0,0,0,0,2026-09-30,2027-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,1012
NCT02985684,1,0,0,0,1,0,2018-07-30,2019-07-30,,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,52
NCT02985957,0,0,0,0,0,0,2021-06-28,2022-06-28,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT02987829,0,0,0,0,0,0,2019-06-30,2020-06-30,,Tracon Pharmaceuticals Inc.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT02988115,0,0,0,0,0,0,2018-03-19,2019-03-19,,Esperion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02988713,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,340
NCT02988817,0,0,0,0,0,0,2021-02-28,2022-02-28,,Genmab,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,20
NCT02990338,0,0,0,0,0,0,2018-11-22,2019-11-22,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT03000309,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-02-07,"Derm Research, PLLC",Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,13
NCT03002506,0,0,0,0,0,0,2020-01-31,2021-01-31,,Texas Tech University Health Sciences Center,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,78
NCT03006068,0,0,0,0,0,0,2022-01-07,2023-01-07,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03009110,0,0,0,0,0,0,2020-01-31,2021-01-31,,Washington University School of Medicine,Other,0,1,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03011333,0,0,0,0,0,0,2018-02-01,2019-02-01,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT03016325,0,0,0,0,0,0,2019-06-24,2020-06-24,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT03018275,0,0,0,0,0,0,2020-05-30,2021-05-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,0,1,2133
NCT03020797,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stony Brook University,Other,0,1,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,119
NCT03022318,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Snyder, Robert W., M.D., Ph.D., P.C.",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03025087,0,0,0,0,0,0,2020-03-31,2021-03-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03026504,0,0,0,0,0,0,2020-06-30,2021-06-30,,Matthew J Koster,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03028415,0,0,0,0,0,0,2020-06-30,2021-06-30,,Ferring Pharmaceuticals,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,208
NCT03028740,0,0,0,0,0,0,2021-10-14,2022-10-14,,"Tobira Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03034213,0,0,0,0,0,0,2020-10-01,2021-10-01,,University of South Florida,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,240
NCT03036124,0,0,0,0,0,0,2019-07-17,2020-07-17,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2450
NCT03037749,1,0,0,0,1,0,2018-08-31,2019-08-31,,University of New Mexico,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,200
NCT03038178,0,0,0,0,0,0,2019-10-31,2020-10-31,,Kevin Winthrop,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT03039192,0,0,0,0,0,0,2018-12-18,2019-12-18,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT03039738,1,1,0,1,0,0,2018-01-04,2019-01-04,2018-12-07,Medtronic - MITG,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,146
NCT03041116,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Retrophin, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03043664,0,0,0,0,0,0,2020-06-01,2021-06-01,,Duke University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03050294,1,1,0,1,0,0,2017-06-01,2018-06-01,2018-05-16,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,616
NCT03051100,0,0,0,0,0,0,2017-06-01,2018-06-01,,Esperion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03051945,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Utah,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03052530,1,1,0,1,0,0,2017-07-24,2018-07-24,2018-03-08,OrbusNeich,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,9
NCT03053271,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Millendo Therapeutics US, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03053401,0,0,0,0,0,0,2019-12-30,2020-12-30,,Akron Children's Hospital,Other,0,0,0,5.0,,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,28
NCT03053518,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03053856,0,0,0,0,0,0,2021-05-13,2022-05-13,,Samsung Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,684
NCT03054155,0,0,0,0,0,0,2019-10-31,2020-10-31,,Wayne State University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,145
NCT03054519,0,0,0,0,0,0,2022-09-30,2023-09-30,,Northwestern University,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03054870,0,0,0,0,0,0,2019-10-31,2020-10-31,,Cyclomedica Australia PTY Limited,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03057951,0,0,0,0,0,0,2020-10-09,2021-10-09,,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03063632,0,0,0,0,0,0,2020-05-01,2021-05-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03065556,0,0,0,0,0,0,2017-07-06,2018-07-06,,"Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,16
NCT03066206,0,0,0,0,0,0,2021-03-17,2022-03-17,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03066817,0,0,0,0,0,0,2020-03-31,2021-03-31,,New York City Health and Hospitals Corporation,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03066999,1,1,0,1,0,1,2017-10-01,2018-10-01,2019-06-07,The Pur Clinic,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03067441,0,0,0,0,0,0,2019-12-31,2020-12-31,,Esperion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03068091,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Missouri-Columbia,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,1,0,0,0,0,1,0,214
NCT03068442,0,0,0,0,0,0,2019-12-31,2020-12-31,,Scott Mcnally,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03068754,0,0,0,0,0,0,2021-10-31,2022-10-31,,Mallinckrodt,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,91
NCT03070834,0,0,0,0,0,0,2019-07-01,2020-07-01,,Lawson Health Research Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,468
NCT03071744,1,1,0,1,0,1,2018-03-09,2019-03-09,2019-04-19,Joseph Ma,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03072043,0,0,0,0,0,0,2020-05-31,2021-05-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03073759,0,0,0,0,0,0,2020-03-31,2021-03-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT03076762,1,0,0,0,1,0,2017-08-31,2018-08-31,,Buddhist Tzu Chi General Hospital,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,36
NCT03077620,0,0,0,0,0,0,2021-06-30,2022-06-30,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT03077711,0,0,0,0,0,0,2019-06-30,2020-06-30,,NorthShore University HealthSystem,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,61
NCT03079297,0,0,0,0,0,0,2022-03-01,2023-03-01,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03081858,0,0,0,0,0,0,2020-01-31,2021-01-31,,"TesoRx Pharma, LLC",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03082664,1,0,0,0,1,0,2018-08-31,2019-08-31,,University of Arizona,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,265
NCT03085004,0,0,0,0,0,0,2023-04-30,2024-04-30,,Milton S. Hershey Medical Center,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03085485,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Alabama at Birmingham,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03086018,1,0,1,1,0,0,2017-05-17,2018-05-17,2017-11-16,Bernafon AG,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT03089398,0,0,0,0,0,0,2024-03-31,2025-03-31,,Emilia Bagiella,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT03090737,0,0,0,0,0,0,2020-09-28,2021-09-28,,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03091179,1,1,0,1,0,0,2018-07-18,2019-07-18,2019-06-21,Stanford University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1309
NCT03091803,0,0,0,0,0,0,2020-04-04,2021-04-04,,University of Southern California,Other,0,0,1,5.0,,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,483
NCT03094832,0,0,0,0,0,0,2021-06-30,2022-06-30,,ArQule,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,32
NCT03095352,0,0,0,0,0,0,2021-09-01,2022-09-01,,"Hope Rugo, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,5
NCT03096730,1,0,1,1,0,0,2017-05-31,2018-05-31,2018-02-24,Tianjin Medical University General Hospital,Other,0,0,0,5.0,,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,20
NCT03097068,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Louis C. Glazer, MD",Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03100149,0,0,0,0,0,0,2019-12-10,2020-12-10,,Hoffmann-La Roche,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03100994,1,0,0,0,1,0,2018-07-31,2019-07-31,,Tri-Service General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,65
NCT03101163,0,0,0,0,0,0,2020-12-31,2021-12-31,,"KLSMC Stem Cells, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,1
NCT03103893,0,0,0,0,0,0,2018-11-30,2019-11-30,,Drexel University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,64
NCT03104127,0,0,0,0,0,0,2019-05-01,2020-05-01,,University of Winchester,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,5
NCT03105102,0,0,0,0,0,0,2025-10-18,2026-10-18,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03110107,0,0,0,0,0,0,2023-11-03,2024-11-03,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03110926,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,1,0,0,1,0,470
NCT03112174,0,0,0,0,0,0,2022-03-31,2023-03-31,,Pharmacyclics LLC.,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,54
NCT03113071,0,0,0,0,0,0,2019-01-08,2020-01-08,,Fox Chase Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,156
NCT03113500,0,0,0,0,0,0,2020-01-21,2021-01-21,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,358
NCT03117140,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-04-17,Melinda Seering,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT03118674,0,0,0,0,0,0,2023-08-30,2024-08-30,,Wake Forest University Health Sciences,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03120390,0,0,0,0,0,0,2023-03-08,2024-03-08,,University of Southern California,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,483
NCT03124368,0,0,0,0,0,0,2018-12-21,2019-12-21,,Achillion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,21
NCT03125629,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,1,0,0,0,0,0,0,1,1309
NCT03128021,0,0,0,0,0,0,2022-04-30,2023-04-30,,Howard Aizenstein,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03129100,0,0,0,0,0,0,2020-05-22,2021-05-22,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03132532,0,0,0,0,0,0,2023-12-31,2024-12-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,1898
NCT03133936,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Rochester,Other,0,0,0,5.0,,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,470
NCT03135522,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03136809,0,0,0,0,0,0,2019-05-31,2020-05-31,,Collaborative Medicinal Development Pty Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,5
NCT03142932,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-08-23,Johns Hopkins University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1143
NCT03144674,0,0,0,0,0,0,2020-03-31,2021-03-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03146962,0,0,0,0,0,0,2019-12-31,2020-12-31,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03147885,0,0,0,0,0,0,2020-06-30,2021-06-30,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,134
NCT03149003,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Boston Biomedical, Inc",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,27
NCT03149822,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of Colorado, Denver",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03154827,0,0,0,0,0,0,2021-03-17,2022-03-17,,"BioLineRx, Ltd.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,17
NCT03156270,0,0,0,0,0,0,2019-08-31,2020-08-31,,Aerin Medical,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03161327,1,1,0,1,0,0,2017-09-14,2018-09-14,2018-08-16,St. Louis University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,126
NCT03162055,1,1,0,1,0,0,2018-05-04,2019-05-04,2019-04-30,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2450
NCT03164616,0,0,0,0,0,0,2021-04-30,2022-04-30,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03167281,0,0,0,0,0,0,2020-02-16,2021-02-16,,Prisma Health-Midlands,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,0,0,0,0,1,0,0,1,0,4
NCT03168438,0,0,0,0,0,0,2021-04-19,2022-04-19,,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,1,0,1,0,3276
NCT03168711,0,0,0,0,0,0,2019-10-31,2020-10-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03170349,0,0,0,0,0,0,2019-12-31,2020-12-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,77
NCT03170518,0,0,0,0,0,0,2021-06-28,2022-06-28,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03172910,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Perosphere, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03173911,1,0,1,1,0,1,2017-02-01,2018-02-01,2018-10-05,Universidade Norte do Paraná,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,11
NCT03174158,0,0,0,0,0,0,2019-01-17,2020-01-17,,Massachusetts General Hospital,Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1699
NCT03174366,1,0,0,0,1,0,2018-03-29,2019-03-29,,Western University of Health Sciences,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03175120,0,0,0,0,0,0,2019-03-05,2020-03-05,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,981
NCT03178422,1,0,0,0,1,0,2017-10-18,2018-10-18,,"Chrono Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03181633,0,0,0,0,0,0,2020-12-30,2021-12-30,,Achillion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,21
NCT03181893,0,0,0,0,0,0,2020-12-20,2021-12-20,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03182725,0,0,0,0,0,0,2020-02-29,2021-02-28,,"University of California, San Diego",Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03182842,1,0,0,0,1,0,2017-07-01,2018-07-01,,"University of Ljubljana, Faculty of Medicine",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,9
NCT03186261,0,0,0,0,0,0,2018-11-01,2019-11-01,,Cairo University,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1190
NCT03188042,0,0,0,0,0,0,2020-03-31,2021-03-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03189433,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Eagle Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03191864,0,0,0,0,0,0,2019-01-30,2020-01-30,,"Adare Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1
NCT03192306,1,1,0,1,0,0,2017-12-11,2018-12-11,2018-06-18,Topical Remedy,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03194737,0,0,0,0,0,0,2018-12-31,2019-12-31,,"NeoTract, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,5
NCT03198169,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Atteris Healthcare, LLC",Industry,1,1,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03198507,0,0,0,0,0,0,2018-10-24,2019-10-24,,RedHill Biopharma Limited,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03200574,0,0,0,0,0,0,2019-03-31,2020-03-31,,LivaNova,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,1,0,0,0,1,1,0,43
NCT03201757,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,70
NCT03205982,0,0,0,0,0,0,2021-08-31,2022-08-31,,Columbia University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03206762,0,0,0,0,0,0,2022-11-30,2023-11-30,,Midwest Cardiovascular Research Foundation,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03207555,0,0,0,0,0,0,2020-07-31,2021-07-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03208257,0,0,0,0,0,0,2020-12-31,2021-12-31,,Samuel Brown,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03209505,1,0,0,0,1,0,2018-04-13,2019-04-13,,University of Houston,Other,0,0,0,4.0,Phase 4,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,47
NCT03212274,0,0,0,0,0,0,2020-07-31,2021-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03213626,0,0,0,0,0,0,2020-02-28,2021-02-28,,Patrick Joseph Loehrer Sr.,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03214367,0,0,0,0,0,0,2018-09-06,2019-09-06,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1512
NCT03216902,1,0,0,0,1,0,2018-02-28,2019-02-28,,Santen Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,29
NCT03218592,0,0,0,0,0,0,2018-12-03,2019-12-03,,"University of North Carolina, Chapel Hill",Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03218787,0,0,0,0,0,0,2020-07-31,2021-07-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,419
NCT03221842,0,0,0,0,0,0,2026-01-15,2027-01-15,,CSL Behring,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,81
NCT03222414,0,0,0,0,0,0,2020-05-01,2021-05-01,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,422
NCT03223298,0,0,0,0,0,0,2020-01-01,2021-01-01,,Weill Medical College of Cornell University,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03226119,1,0,0,0,1,0,2018-07-10,2019-07-10,,"MP Biomedicals, LLC",Industry,1,0,0,4.0,Phase 4,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,3
NCT03227445,1,0,1,1,0,0,2018-01-04,2019-01-04,2019-01-04,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3276
NCT03228394,0,0,0,0,0,0,2019-06-30,2020-06-30,,Marinus Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03228641,1,0,0,0,1,0,2017-08-31,2018-08-31,,"Cytrellis Biosystems, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT03231228,0,0,0,0,0,0,2019-07-31,2020-07-31,,B. Braun Medical Inc.,Industry,1,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT03233308,1,1,0,1,0,0,2018-04-19,2019-04-19,2019-04-18,Aerie Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,28
NCT03237325,0,0,0,0,0,0,2020-03-31,2021-03-31,,Soligenix,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03240549,1,0,0,0,1,0,2018-08-31,2019-08-31,,Beijing Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,19
NCT03240692,0,0,0,0,0,0,2020-05-30,2021-05-30,,Stanford University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03241862,1,0,0,0,1,0,2017-06-30,2018-06-30,,DeNova Research,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT03245463,1,0,1,1,0,1,2018-02-13,2019-02-13,2019-08-09,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,157
NCT03247088,0,0,0,0,0,0,2021-07-30,2022-07-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03247543,0,0,0,0,0,0,2018-10-17,2019-10-17,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,26
NCT03247738,0,0,0,0,0,0,2018-12-13,2019-12-13,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,849
NCT03248570,0,0,0,0,0,0,2020-09-30,2021-09-30,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03249428,0,0,0,0,0,0,2021-09-30,2022-09-30,,Ottawa Hospital Research Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,384
NCT03252353,0,0,0,0,0,0,2019-06-13,2020-06-13,,"Chiasma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03253679,0,0,0,0,0,0,2020-09-30,2021-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03256968,0,0,0,0,0,0,2018-12-01,2019-12-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,801
NCT03257202,1,0,1,1,0,1,2018-01-01,2019-01-01,2019-06-20,University of Southern California,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,483
NCT03258541,0,0,0,0,0,0,2019-01-31,2020-01-31,,Thomas Zilli,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,1,0,0,2,0,1,3
NCT03259165,0,0,0,0,0,0,2020-09-30,2021-09-30,,Indiana University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT03259334,0,0,0,0,0,0,2020-08-09,2021-08-09,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,342
NCT03263273,0,0,0,0,0,0,2019-03-01,2020-03-01,,Hovione Scientia Limited,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03263429,0,0,0,0,0,0,2020-09-30,2021-09-30,,Vanderbilt-Ingram Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,1,0,0,0,0,0,1,0,180
NCT03264131,0,0,0,0,0,0,2021-01-30,2022-01-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03265951,0,0,0,0,0,0,2019-09-30,2020-09-30,,State University of New York at Buffalo,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,105
NCT03269669,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03277144,1,0,0,0,1,0,2018-09-11,2019-09-11,,"University of Turin, Italy",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,110
NCT03277703,0,0,0,0,0,0,2020-04-30,2021-04-30,,Stony Brook University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,119
NCT03278782,0,0,0,0,0,0,2020-11-30,2021-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03279471,0,0,0,0,0,0,2022-02-15,2023-02-15,,"University of California, Davis",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03279731,0,0,0,0,0,0,2019-09-01,2020-09-01,,Kelly Allison,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03280277,0,0,0,0,0,0,2019-07-01,2020-07-01,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT03285555,0,0,0,0,0,0,2019-05-31,2020-05-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,581
NCT03288324,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03289143,0,0,0,0,0,0,2020-06-24,2021-06-24,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03292952,0,0,0,0,0,0,2018-05-16,2019-05-16,,"KemPharm, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03295734,0,0,0,0,0,0,2022-09-30,2023-09-30,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03297450,1,0,0,0,1,0,2018-03-30,2019-03-30,,University Ghent,Other,0,0,0,1.0,Phase 2,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,151
NCT03301649,1,0,0,0,1,0,2018-05-01,2019-05-01,,Actavis Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,93
NCT03301766,0,0,0,0,0,0,2020-06-30,2021-06-30,,John H. Stroger Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03302494,0,0,0,0,0,0,2020-12-01,2021-12-01,,Coherex Medical,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03304184,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Michigan,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03304639,0,0,0,0,0,0,2022-02-07,2023-02-07,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,3004
NCT03309956,0,0,0,0,0,0,2020-07-31,2021-07-31,,Columbia University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03312543,1,1,0,1,0,0,2018-01-12,2019-01-12,2019-01-04,Johnson & Johnson Consumer Inc. (J&JCI),Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03318523,0,0,0,0,0,0,2020-05-25,2021-05-25,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03320018,0,0,0,0,0,0,2020-08-02,2021-08-02,,Stony Brook University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,119
NCT03321968,1,0,0,0,1,0,2017-11-16,2018-11-16,,Medicago,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,13
NCT03322462,0,0,0,0,0,0,2018-08-31,2019-08-31,,Avid Radiopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,50
NCT03325114,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Rochester,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03325894,0,0,0,0,0,0,2019-01-18,2020-01-18,,Shire,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,342
NCT03329248,0,0,0,0,0,0,2018-11-30,2019-11-30,,"NantKwest, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03329846,0,0,0,0,0,0,2020-07-31,2021-07-31,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03330457,0,0,0,0,0,0,2019-12-31,2020-12-31,,Portola Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,28
NCT03331614,1,0,0,0,1,0,2018-04-30,2019-04-30,,"Rosenblum, Jonathan I., DPM",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03332238,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Hospital for Special Surgery, New York",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,157
NCT03335267,0,0,0,0,0,0,2019-10-31,2020-10-31,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03336528,0,0,0,0,0,0,2020-12-31,2021-12-31,,Emory University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03337087,0,0,0,0,0,0,2021-12-31,2022-12-31,,Academic and Community Cancer Research United,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT03337581,0,0,0,0,0,0,2018-12-31,2019-12-31,,Chinese Medical Association,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,12
NCT03340142,1,0,0,0,1,0,2018-09-04,2019-09-04,,Catheter Precision. Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03340402,0,0,0,0,0,0,2020-11-30,2021-11-30,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,1,0,0,0,1,0,1699
NCT03340727,0,0,0,0,0,0,2022-10-31,2023-10-31,,NICHD Neonatal Research Network,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,59
NCT03341962,0,0,0,0,0,0,2021-01-01,2022-01-01,,Immunic AG,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03342417,0,0,0,0,0,0,2019-05-29,2020-05-29,,ExcellaBio LLC,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,0,1,0,0,0,0,0,0,1,0,1
NCT03342911,0,0,0,0,0,0,2020-06-30,2021-06-30,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,162
NCT03344536,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03345771,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,1,0,0,1,0,0,1,0,869
NCT03348748,0,0,0,0,0,0,2022-07-15,2023-07-15,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,294
NCT03349528,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sheppard Pratt Health System,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,10
NCT03355300,0,0,0,0,0,0,2019-11-30,2020-11-30,,INSYS Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,50
NCT03357029,0,0,0,0,0,0,2019-04-30,2020-04-30,,Jens Brøndum Frøkjær,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03357952,0,0,0,0,0,0,2018-10-24,2019-10-24,,"Janssen Research & Development, LLC",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,558
NCT03358472,1,1,0,1,0,0,2018-07-19,2019-07-19,2019-07-19,Incyte Corporation,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03361748,0,0,0,0,0,0,2024-11-01,2025-11-01,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,306
NCT03362957,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,1,0,0,0,0,1,0,910
NCT03363893,0,0,0,0,0,0,2021-03-31,2022-03-31,,Carrick Therapeutics Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03364231,0,0,0,0,0,0,2020-01-31,2021-01-31,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03364491,0,0,0,0,0,0,2020-12-31,2021-12-31,,The George Washington University Biostatistics Center,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03367793,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Houston,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,47
NCT03368079,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Davis",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,530
NCT03369418,0,0,0,0,0,0,2018-10-20,2019-10-20,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,692
NCT03370120,0,0,0,0,0,0,2022-07-31,2023-07-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03371251,0,0,0,0,0,0,2020-08-31,2021-08-31,,Boston Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03375294,0,0,0,0,0,0,2020-01-15,2021-01-15,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03376321,0,0,0,0,0,0,2020-04-02,2021-04-02,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03380091,0,0,0,0,0,0,2021-04-30,2022-04-30,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03380572,1,1,0,1,0,1,2017-12-01,2018-12-01,2019-02-19,Imperial College London,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,515
NCT03381625,0,0,0,0,0,0,2019-12-31,2020-12-31,,"BioMimetix JV, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03384966,0,0,0,0,0,0,2018-09-18,2019-09-18,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,79
NCT03386253,0,0,0,0,0,0,2018-11-21,2019-11-21,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,749
NCT03386539,0,0,0,0,0,0,2022-04-30,2023-04-30,,Boston Children’s Hospital,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03388008,0,0,0,0,0,0,2021-01-31,2022-01-31,,Washington University School of Medicine,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03391986,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-05,Columbia University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,675
NCT03393013,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Kezar Life Sciences, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03394365,0,0,0,0,0,0,2020-11-30,2021-11-30,,Atara Biotherapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,10
NCT03395210,0,0,0,0,0,0,2021-06-30,2022-06-30,,Principia Biopharma Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03395808,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Avenue Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03396588,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Kentucky,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,77
NCT03396835,0,1,0,1,0,1,2018-01-16,2019-01-16,2019-07-03,Masimo Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03398005,0,0,0,0,0,0,2019-07-31,2020-07-31,,Acasti Pharma Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03400137,0,0,0,0,0,0,2020-12-31,2021-12-31,,NYU Langone Health,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,869
NCT03400787,0,0,0,0,0,0,2019-02-01,2020-02-01,,"Spirox, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03402152,0,0,0,0,0,0,2019-12-31,2020-12-31,,"NeuroRx, Inc.",Industry,1,1,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03402659,0,0,0,0,0,0,2019-06-30,2020-06-30,,EIP Pharma Inc,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,5
NCT03403192,0,0,0,0,0,0,2019-10-31,2020-10-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03404609,0,0,0,0,0,0,2020-02-01,2021-02-01,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03406377,0,0,0,0,0,0,2019-03-08,2020-03-08,,OPKO Ireland Global Holdings Ltd.,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03409731,1,1,0,1,0,0,2018-05-31,2019-05-31,2018-12-07,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,419
NCT03412396,0,0,0,0,0,0,2023-02-28,2024-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03412877,0,0,0,0,0,0,2027-03-23,2028-03-23,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03414658,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Ian E. Krop, MD, PhD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03415854,0,0,0,0,0,0,2020-07-15,2021-07-15,,HonorHealth Research Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03416153,0,0,0,0,0,0,2021-11-21,2022-11-21,,University of Michigan Rogel Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,213
NCT03416374,0,0,0,0,0,0,2020-08-31,2021-08-31,,Takeda,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,650
NCT03418324,0,0,0,0,0,0,2020-01-31,2021-01-31,,Cedars-Sinai Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03418623,0,0,0,0,0,0,2019-12-31,2020-12-31,,Laboratorio Farmaceutico Ct S.r.l.,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03419741,0,0,0,0,0,0,2019-10-20,2020-10-20,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,511
NCT03421691,0,0,0,0,0,0,2018-11-30,2019-11-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,37
NCT03423342,0,0,0,0,0,0,2019-04-11,2020-04-11,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT03425019,0,0,0,0,0,0,2020-02-05,2021-02-05,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT03428997,1,1,0,1,0,0,2018-02-05,2019-02-05,2019-01-25,Johnson & Johnson Consumer Inc. (J&JCI),Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03429400,0,0,0,0,0,0,2019-01-31,2020-01-31,,West-Ward Pharmaceutical,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03429556,1,1,0,1,0,0,2018-07-10,2019-07-10,2019-07-02,Allergan,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,1,0,0,0,0,0,0,1,0,495
NCT03433183,0,0,0,0,0,0,2021-09-30,2022-09-30,,Sarcoma Alliance for Research through Collaboration,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03433391,0,0,0,0,0,0,2020-05-01,2021-05-01,,FzioMed,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03433911,0,0,0,0,0,0,2019-12-31,2020-12-31,,Femasys Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03434496,1,0,0,0,1,0,2018-03-30,2019-03-30,,"IRCCS Centro Neurolesi ""Bonino-Pulejo""",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,15
NCT03436199,0,0,0,0,0,0,2019-09-01,2020-09-01,,"Adamas Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03439774,1,0,0,0,1,0,2018-02-28,2019-02-28,,"Topcon Medical Systems, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,27
NCT03444844,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Five Eleven Pharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03445650,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03446612,0,0,0,0,0,0,2020-01-21,2021-01-21,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,3276
NCT03448718,0,0,0,0,0,0,2022-03-31,2023-03-31,,Matthew Galsky,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03450070,1,1,0,1,0,0,2017-12-22,2018-12-22,2018-12-20,"Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03451045,0,0,0,0,0,0,2019-09-30,2020-09-30,,Corbus Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03452202,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03452579,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT03454477,0,0,0,0,0,0,2018-10-01,2019-10-01,,Fujian Medical University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,52
NCT03455556,0,0,0,0,0,0,2019-09-11,2020-09-11,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03456726,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Eisai Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,129
NCT03463031,0,0,1,1,0,0,2018-11-14,2019-11-14,2019-08-28,Glenmark Specialty S.A.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03463889,0,0,0,0,0,0,2020-01-01,2021-01-01,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03464461,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03464552,0,0,0,0,0,0,2019-06-30,2020-06-30,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1190
NCT03465748,0,0,0,0,0,0,2020-05-31,2021-05-31,,Illinois College of Optometry,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03465891,0,0,0,0,0,0,2021-03-31,2022-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03466502,0,0,0,0,0,0,2019-03-31,2020-03-31,,"University of Nevada, Reno",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03467048,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Cleveland Clinic,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03468920,0,1,0,1,0,0,2019-02-14,2020-02-14,2019-04-12,TriHealth Inc.,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,74
NCT03469284,0,0,0,0,0,0,2021-02-25,2022-02-25,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03471650,0,0,0,0,0,0,2022-03-07,2023-03-07,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03472469,0,0,0,0,0,0,2019-04-25,2020-04-25,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03472885,0,0,0,0,0,0,2019-09-30,2020-09-30,,Achillion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03473743,0,0,0,0,0,0,2019-10-21,2020-10-21,,"Janssen Research & Development, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03474549,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rapid Medical,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03476850,0,0,0,0,0,0,2020-02-28,2021-02-28,,Medical University of South Carolina,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,511
NCT03479216,1,1,0,1,0,0,2018-07-01,2019-07-01,2018-08-09,Derince Training and Research Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,18
NCT03481309,0,0,1,1,0,0,2019-01-31,2020-01-31,2019-09-11,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03483051,0,0,0,0,0,0,2019-03-13,2020-03-13,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1052
NCT03485287,0,0,0,0,0,0,2019-09-30,2020-09-30,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,24
NCT03486938,0,0,0,0,0,0,2021-11-30,2022-11-30,,AgeneBio,Industry,1,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03488524,0,0,0,0,0,0,2020-01-01,2021-01-01,,Amylyx Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03490513,0,0,0,0,0,0,2023-04-14,2024-04-14,,Baylor College of Medicine,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,518
NCT03491397,0,0,0,0,0,0,2021-06-01,2022-06-01,,"Siddharth Padia, MD",Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03493542,0,0,0,0,0,0,2019-05-01,2020-05-01,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,2145
NCT03495921,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Gradalis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,15
NCT03496662,0,0,0,0,0,0,2025-01-31,2026-01-31,,Washington University School of Medicine,Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03497845,0,0,0,0,0,0,2019-09-02,2020-09-02,,Biomedical Advanced Research and Development Authority,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,4
NCT03499210,0,0,0,0,0,0,2018-11-30,2019-11-30,,"ReWalk Robotics, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03499795,0,0,0,0,0,0,2021-05-31,2022-05-31,,Inovio Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,1,0,0,0,0,1,1,0,25
NCT03499964,0,0,0,0,0,0,2019-11-30,2020-11-30,,Urotronic Inc.,Industry,1,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,5
NCT03503253,0,0,0,0,0,0,2021-05-31,2022-05-31,,Texas Cardiac Arrhythmia Research Foundation,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT03504189,1,0,1,1,0,0,2018-06-27,2019-06-27,2019-01-13,"Nuvo-Group, Ltd.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,1,1,0,2
NCT03504761,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Precision Biopsy, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03504956,0,0,0,0,0,0,2021-12-31,2022-12-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,279
NCT03505099,0,0,0,0,0,0,2020-10-31,2021-10-31,,"AveXis, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,8
NCT03505567,1,0,0,0,1,0,2018-09-01,2019-09-01,,"Kowa Research Institute, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,33
NCT03505710,0,0,0,0,0,0,2020-08-25,2021-08-25,,"Daiichi Sankyo, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT03506048,0,0,0,0,0,0,2021-01-31,2022-01-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03508726,0,0,0,0,0,0,2021-06-30,2022-06-30,,Varun Monga,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03508921,0,0,0,0,0,0,2020-06-01,2021-06-01,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03509207,0,0,0,0,0,0,2019-02-04,2020-02-04,,Medical University of Graz,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,247
NCT03513848,1,0,1,1,0,1,2018-06-27,2019-06-27,2019-09-09,Rush University Medical Center,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,227
NCT03515629,0,0,0,0,0,0,2020-11-18,2021-11-18,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03517969,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03519451,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,2066
NCT03519971,0,0,0,0,0,0,2020-09-30,2021-09-30,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,1,0,0,2,1,0,2450
NCT03520842,0,0,0,0,0,0,2019-09-01,2020-09-01,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03520998,0,0,0,0,0,0,2019-05-24,2020-05-24,,"Alkahest, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03521505,0,0,0,0,0,0,2020-01-22,2021-01-22,,Chang Gung Memorial Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,486
NCT03522298,0,0,0,0,0,0,2020-03-30,2021-03-30,,Kazia Therapeutics Limited,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03525678,0,0,0,0,0,0,2019-06-21,2020-06-21,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03529149,0,0,0,0,0,0,2019-06-01,2020-06-01,,"Xuanwu Hospital, Beijing",Other,0,0,0,4.0,Phase 4,0,2018.0,1,0,0,0,0,0,1,0,2,1,0,58
NCT03532737,0,0,0,0,0,0,2021-09-30,2022-09-30,,Kuwait Cancer Control Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03532958,0,0,0,0,0,0,2021-03-31,2022-03-31,,Bioniz Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT03534180,0,0,0,0,0,0,2020-09-30,2021-09-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,358
NCT03536052,0,0,0,0,0,0,2021-09-01,2022-09-01,,Johns Hopkins University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03536819,0,0,0,0,0,0,2018-12-31,2019-12-31,,InMode MD Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03536949,0,0,0,0,0,0,2019-03-14,2020-03-14,,RevitaLid Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03540134,0,0,0,0,0,0,2018-12-18,2019-12-18,,"Jeff Elias, MD",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03541980,0,0,0,0,0,0,2020-04-30,2021-04-30,,Newark Beth Israel Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03544593,0,0,0,0,0,0,2019-03-31,2020-03-31,,Hunstad Kortesis Bharti Cosmetic Sugrery,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03547518,0,0,0,0,0,0,2020-05-23,2021-05-23,,William Beaumont Hospitals,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,84
NCT03549689,0,0,0,0,0,0,2021-07-01,2022-07-01,,Philip Grant,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03550794,0,0,0,0,0,0,2022-06-30,2023-06-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03552523,1,1,0,1,0,1,2018-03-29,2019-03-29,2019-08-01,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1699
NCT03553199,0,0,0,0,0,0,2019-05-31,2020-05-31,,Istituto Clinico Humanitas,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,110
NCT03554317,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03554486,0,0,0,0,0,0,2018-11-30,2019-11-30,,Stanford University,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1309
NCT03554629,0,0,0,0,0,0,2019-05-31,2020-05-31,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,146
NCT03555266,0,0,0,0,0,0,2019-10-31,2020-10-31,,Jacques E. Chelly,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03556761,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03557333,0,0,0,0,0,0,2019-10-18,2020-10-18,,Impel NeuroPharma Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,4
NCT03559049,0,0,0,0,0,0,2024-07-31,2025-07-31,,University of Michigan Rogel Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03560258,0,0,0,0,0,0,2020-11-30,2021-11-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03560518,0,0,0,0,0,0,2019-07-08,2020-07-08,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03562481,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03564795,0,0,0,0,0,0,2021-10-31,2022-10-31,,"KeraNetics, LLC",Industry,1,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03566979,0,0,0,0,0,0,2019-03-26,2020-03-26,,"Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03567681,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Collaborative Care Initiative, LLC",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03568383,0,0,0,0,0,0,2025-06-18,2026-06-18,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2133
NCT03568604,0,0,0,0,0,0,2019-06-30,2020-06-30,,San Diego Sexual Medicine,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03570931,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Retrotope, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03574038,0,0,0,0,0,0,2020-07-01,2021-07-01,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT03574441,1,1,0,1,0,1,2018-03-11,2019-03-11,2019-06-17,Augusta University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,117
NCT03574857,1,0,0,0,1,0,2018-08-31,2019-08-31,,University of Virginia,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,402
NCT03575793,0,0,0,0,0,0,2021-09-30,2022-09-30,,Jyoti Malhotra,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03576183,1,0,0,0,1,0,2018-06-26,2019-06-26,,Valneva Austria GmbH,Industry,1,0,1,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,31
NCT03576469,0,0,0,0,0,0,2019-12-31,2020-12-31,,IMMUNOe Research Centers,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03578783,0,0,0,0,0,0,2019-12-31,2020-12-31,,Plethora Solutions Ltd,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03580239,0,0,0,0,0,0,2023-01-31,2024-01-31,,Tianjin Medical University Second Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,8
NCT03580655,0,0,0,0,0,0,2020-12-31,2021-12-31,,Blueprint Medicines Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03582007,0,0,0,0,0,0,2019-07-17,2020-07-17,,Polyphor Ltd.,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,12
NCT03582150,0,0,0,0,0,0,2021-03-31,2022-03-31,,Stanford University,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03582618,0,0,0,0,0,0,2020-12-31,2021-12-31,,"TaiRx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03583996,0,0,0,0,0,0,2019-10-31,2020-10-31,,"HepQuant, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,4
NCT03586687,0,0,0,0,0,0,2020-07-30,2021-07-30,,Milton S. Hershey Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03586830,0,0,0,0,0,0,2019-04-05,2020-04-05,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,558
NCT03586999,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of Colorado, Denver",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03588806,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Ajay Wasan, MD, Msc",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03589976,0,0,0,0,0,0,2021-08-31,2022-08-31,,NYU Langone Health,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03591146,0,0,0,0,0,0,2019-01-05,2020-01-05,,Taiwan Liposome Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03593044,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Jeffrey J. Walline, OD PhD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03599258,0,0,0,0,0,0,2020-01-15,2021-01-15,,HonorHealth Research Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03599635,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03601949,0,0,0,0,0,0,2020-10-31,2021-10-31,,Avanos Medical,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03602339,0,0,0,0,0,0,2019-12-30,2020-12-30,,Bayer,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03603964,0,0,0,0,0,0,2020-07-01,2021-07-01,,Astex Pharmaceuticals,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,38
NCT03605862,0,0,0,0,0,0,2018-12-11,2019-12-11,,Romark Laboratories L.C.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,23
NCT03606213,0,0,0,0,0,0,2020-12-01,2021-12-01,,Steven Deeks,Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,1,0,0,0,0,0,1,0,1
NCT03606642,0,0,0,0,0,0,2020-07-23,2021-07-23,,HonorHealth Research Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,9
NCT03610685,0,0,0,0,0,0,2019-08-31,2020-08-31,,NHS Greater Glasgow and Clyde,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,120
NCT03611582,0,0,0,0,0,0,2020-03-17,2021-03-17,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,981
NCT03616327,0,0,0,0,0,0,2019-08-15,2020-08-15,,Zephyr Sleep Technologies,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03616964,0,0,0,0,0,0,2021-04-21,2022-04-21,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03619902,0,0,0,0,0,0,2019-09-30,2020-09-30,,"AnaptysBio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03621085,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Texas Southwestern Medical Center,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03622294,0,0,0,0,0,0,2018-11-06,2019-11-06,,Beekley Medical,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03622749,0,0,0,0,0,0,2019-10-01,2020-10-01,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1699
NCT03628456,0,0,0,0,0,0,2018-09-30,2019-09-30,,International Biophysics Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03628599,0,1,0,1,0,0,2018-09-25,2019-09-25,2019-06-13,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03629171,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03629340,0,0,0,0,0,0,2021-06-30,2022-06-30,,Marc A. Simon,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03630939,0,0,0,0,0,0,2019-06-05,2020-06-05,,Escalier Biosciences B.V.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1
NCT03632798,0,0,0,0,0,0,2021-07-30,2022-07-30,,"Cordgenics, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,3
NCT03633526,0,0,0,0,0,0,2019-01-18,2020-01-18,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,141
NCT03634241,0,0,0,0,0,0,2022-10-22,2023-10-22,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03635996,0,0,0,0,0,0,2021-12-31,2022-12-31,,Milestone Pharmaceuticals Inc.,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03636542,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03637803,0,0,0,0,0,0,2023-03-31,2024-03-31,,4D pharma plc,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03639610,0,0,0,0,0,0,2019-08-31,2020-08-31,,Oncopeptides AB,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,5
NCT03639870,0,0,0,0,0,0,2021-09-30,2022-09-30,,Glaukos Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,34
NCT03640481,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Kadmon Corporation, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03644706,0,0,0,0,0,0,2021-02-01,2022-02-01,,Advicenne Pharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03646214,0,0,0,0,0,0,2019-01-31,2020-01-31,,Texas A&M University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,57
NCT03648827,0,0,0,0,0,0,2020-03-24,2021-03-24,,PTC Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,42
NCT03650842,0,0,0,0,0,0,2018-10-08,2019-10-08,,Nationwide Children's Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,161
NCT03652597,0,0,0,0,0,0,2019-05-02,2020-05-02,,Utrecht University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,5
NCT03653247,0,0,0,0,0,0,2022-09-30,2023-09-30,,Bioverativ - a sanofi company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,1,0,1,0,2
NCT03654040,0,0,0,0,0,0,2025-07-31,2026-07-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03654326,0,0,0,0,0,0,2020-06-16,2021-06-16,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03654976,0,0,0,0,0,0,2022-06-30,2023-06-30,,ALK-Abelló A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,55
NCT03657342,0,0,0,0,0,0,2021-12-31,2022-12-31,,Breath Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03661281,0,0,0,0,0,0,2019-05-01,2020-05-01,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,869
NCT03661385,0,0,0,0,0,0,2021-12-31,2022-12-31,,Warwick Butt,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03661632,0,0,0,0,0,0,2023-09-12,2024-09-12,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03663816,0,0,0,0,0,0,2019-03-15,2020-03-15,,University of Florida,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,849
NCT03667053,0,0,0,0,0,0,2019-06-28,2020-06-28,,Zealand Pharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03669133,0,0,0,0,0,0,2022-12-31,2023-12-31,,Indiana University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,94
NCT03669861,0,0,0,0,0,0,2019-12-21,2020-12-21,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03670056,0,0,0,0,0,0,2020-09-30,2021-09-30,,Yale University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03670628,0,0,0,0,0,0,2020-05-01,2021-05-01,,University of Miami,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03670836,0,0,0,0,0,0,2020-04-30,2021-04-30,,Columbia University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,675
NCT03672032,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Iowa,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,158
NCT03672175,0,0,0,0,0,0,2019-11-30,2020-11-30,,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03673566,0,0,0,0,0,0,2020-12-31,2021-12-31,,Philips Healthcare,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,45
NCT03674411,0,0,0,0,0,0,2023-07-31,2024-07-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,218
NCT03680131,0,0,0,0,0,0,2020-05-31,2021-05-31,,Edesa Biotech Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03680781,0,0,0,0,0,0,2020-12-31,2021-12-31,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03680911,0,0,0,0,0,0,2020-02-20,2021-02-20,,Bradley Goldstein,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03682536,0,0,0,0,0,0,2021-04-06,2022-04-06,,Celgene,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03684044,0,0,0,0,0,0,2021-07-10,2022-07-10,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03687957,0,0,0,0,0,0,2022-01-31,2023-01-31,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1151
NCT03688282,0,0,0,0,0,0,2018-11-29,2019-11-29,,"Theranova, L.L.C.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03689335,0,0,0,0,0,0,2020-07-31,2021-07-31,,Royal Infirmary of Edinburgh,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,7
NCT03689543,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Institute of Mental Health (NIMH),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,330
NCT03690388,0,0,0,0,0,0,2020-07-31,2021-07-31,,Exelixis,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT03691207,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Ayala Pharmaceuticals, Inc,",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03691610,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,285
NCT03693300,0,0,0,0,0,0,2023-02-21,2024-02-21,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03693963,0,0,0,0,0,0,2020-06-01,2021-06-01,,Cagent Vascular LLC,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT03694522,0,0,0,0,0,0,2022-07-01,2023-07-01,,"Five Prime Therapeutics, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03697304,0,0,0,0,0,0,2021-05-21,2022-05-21,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03697720,0,0,0,0,0,0,2020-05-01,2021-05-01,,NorthShore University HealthSystem,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,61
NCT03698552,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03699631,0,0,0,0,0,0,2020-04-01,2021-04-01,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03700385,0,0,0,0,0,0,2018-12-21,2019-12-21,,"Farapulse, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03701581,0,0,0,0,0,0,2021-10-01,2022-10-01,,University of Rochester,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03702920,0,0,0,0,0,0,2021-12-31,2022-12-31,,Grifols Therapeutics LLC,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,40
NCT03703466,0,0,0,0,0,0,2019-07-29,2020-07-29,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03704714,0,0,0,0,0,0,2021-05-11,2022-05-11,,Northwestern University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03705845,0,0,0,0,0,0,2022-11-30,2023-11-30,,Texas Tech University Health Sciences Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,78
NCT03712904,0,0,0,0,0,0,2020-07-13,2021-07-13,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,1,0,0,0,1,0,162
NCT03713099,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Ethicon, Inc.",Industry,1,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,59
NCT03714503,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Kansas Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,219
NCT03714828,0,0,0,0,0,0,2020-03-30,2021-03-30,,University of Arizona,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,265
NCT03716050,0,0,0,0,0,0,2019-10-31,2020-10-31,,Wake Forest University Health Sciences,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,616
NCT03717129,0,0,0,0,0,0,2019-09-30,2020-09-30,,Johns Hopkins University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03717623,0,0,0,0,0,0,2020-06-30,2021-06-30,,Melbourne Health,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,47
NCT03717896,0,0,0,0,0,0,2023-04-21,2024-04-21,,Beth Israel Deaconess Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03720990,0,0,0,0,0,0,2020-04-01,2021-04-01,,University of Nebraska,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,327
NCT03728608,0,0,0,0,0,0,2022-02-01,2023-02-01,,University of Florida,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03729596,0,0,0,0,0,0,2020-08-31,2021-08-31,,MacroGenics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,31
NCT03729804,0,0,0,0,0,0,2021-12-24,2022-12-24,,University of Chicago,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03732352,0,0,0,0,0,0,2020-11-01,2021-11-01,,Jonsson Comprehensive Cancer Center,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,277
NCT03732950,0,0,0,0,0,0,2019-12-01,2020-12-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,277
NCT03735680,0,0,0,0,0,0,2019-12-31,2020-12-31,,"OncoNano Medicine, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03738332,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Pennsylvania,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03738865,0,0,0,0,0,0,2019-03-29,2020-03-29,,Xeris Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,14
NCT03739580,0,0,0,0,0,0,2018-12-01,2019-12-01,,"Xuanwu Hospital, Beijing",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,58
NCT03740204,0,0,0,0,0,0,2023-09-30,2024-09-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03741205,0,0,0,0,0,0,2021-01-31,2022-01-31,,Brain Sentinel,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,11
NCT03742895,0,0,0,0,0,0,2023-04-30,2024-04-30,,Merck Sharp & Dohme Corp.,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03744975,0,0,0,0,0,0,2021-06-30,2022-06-30,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03745326,0,0,0,0,0,0,2027-12-01,2028-12-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03746769,0,0,0,0,0,0,2023-12-31,2024-12-31,,City of Hope Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT03753243,0,0,0,0,0,0,2020-06-03,2021-06-03,,"Mark Garzotto, MD",U.S. Fed,2,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03755804,0,0,0,0,0,0,2027-01-01,2028-01-01,,St. Jude Children's Research Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,302
NCT03758417,0,0,0,0,0,0,2020-07-20,2021-07-20,,Nanjing Legend Biotech Co.,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2
NCT03758989,0,0,0,0,0,0,2022-06-01,2023-06-01,,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03759431,0,0,0,0,0,0,2024-12-12,2025-12-12,,Centre hospitalier de l'Université de Montréal (CHUM),Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,1,1,0,179
NCT03759639,0,0,0,0,0,0,2020-04-01,2021-04-01,,IntraBio Inc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03760497,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Sao Paulo,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,2,1,0,767
NCT03760796,0,0,0,0,0,0,2019-09-30,2020-09-30,,Johns Hopkins University,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT03762603,0,0,0,0,0,0,2021-04-20,2022-04-20,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03763175,0,0,0,0,0,0,2020-01-01,2021-01-01,,Cedars-Sinai Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03763877,0,0,0,0,0,0,2020-02-29,2021-02-28,,Poxel SA,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03765762,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Alkahest, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03767881,0,0,0,0,0,0,2020-09-30,2021-09-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,340
NCT03769350,0,0,0,0,0,0,2022-06-01,2023-06-01,,Massachusetts General Hospital,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03769649,0,0,0,0,0,0,2019-12-31,2020-12-31,,InMode MD Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03770689,0,0,0,0,0,0,2020-04-20,2021-04-20,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,42
NCT03771638,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Public Health Foundation Enterprises, Inc.",Other,0,1,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03771820,0,0,0,0,0,0,2021-04-30,2022-04-30,,"NanoCarrier Co., Ltd.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03772327,0,0,1,1,0,0,2018-11-30,2019-11-30,2019-07-29,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,3,0,1,586
NCT03776864,0,0,0,0,0,0,2022-11-01,2023-11-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,910
NCT03778203,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Rochester,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,470
NCT03779113,0,0,0,0,0,0,2021-12-31,2022-12-31,,Hutchison Medipharma Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,53
NCT03779334,0,0,0,0,0,0,2021-06-21,2022-06-21,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03780257,0,0,0,0,0,0,2019-12-31,2020-12-31,,ProQR Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03781596,0,0,0,0,0,0,2020-10-02,2021-10-02,,Claire Daniels,U.S. Fed,2,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,1
NCT03783026,0,0,0,0,0,0,2020-11-11,2021-11-11,,Celgene,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03785873,0,0,0,0,0,0,2023-05-31,2024-05-31,,University of Michigan Rogel Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03787147,0,0,0,0,0,0,2020-02-01,2021-02-01,,Albert Einstein College of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,155
NCT03787303,0,0,0,0,0,0,2023-01-31,2024-01-31,,Aultman Health Foundation,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03787927,0,0,0,0,0,0,2021-12-03,2022-12-03,,Bloodworks,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03790111,0,0,0,0,0,0,2020-12-31,2021-12-31,,Lexicon Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,41
NCT03790332,0,0,0,0,0,0,2021-09-09,2022-09-09,,Pharmacyclics LLC.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,54
NCT03790865,0,0,0,0,0,0,2020-06-30,2021-06-30,,Millendo Therapeutics SAS,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03796676,0,0,0,0,0,0,2020-04-09,2021-04-09,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03797612,0,0,0,0,0,0,2020-06-01,2021-06-01,,"Adynxx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03799614,0,0,0,0,0,0,2019-12-30,2020-12-30,,Virginia Commonwealth University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,417
NCT03805386,0,0,0,0,0,0,2020-01-01,2021-01-01,,Mayo Clinic,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03805581,0,0,0,0,0,0,2021-01-31,2022-01-31,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03805750,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of California, San Diego",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03807544,0,0,0,0,0,0,2019-03-13,2020-03-13,,"Theranova, L.L.C.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03808272,0,0,0,0,0,0,2019-09-30,2020-09-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,340
NCT03808480,0,0,0,0,0,0,2022-05-31,2023-05-31,,"National Cancer Center, Korea",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,156
NCT03808662,0,0,0,0,0,0,2022-01-31,2023-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03810196,0,0,0,0,0,0,2024-01-31,2025-01-31,,Children's Hospital of Philadelphia,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,324
NCT03811093,0,1,0,1,0,0,2019-02-09,2020-02-09,2019-04-02,"IR Technology, LLC",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03811535,0,0,0,0,0,0,2021-06-05,2022-06-05,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03813524,0,0,0,0,0,0,2020-04-30,2021-04-30,,Boston Biomedical Associates,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03814746,0,0,0,0,0,0,2022-05-30,2023-05-30,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03817216,0,0,0,0,0,0,2022-06-30,2023-06-30,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,374
NCT03818555,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Sebacia, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,5
NCT03823001,0,0,0,0,0,0,2022-03-31,2023-03-31,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,374
NCT03823131,0,0,0,0,0,0,2022-01-01,2023-01-01,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1443
NCT03823300,0,0,0,0,0,0,2021-08-31,2022-08-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03824704,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Clovis Oncology, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT03825341,0,0,0,0,0,0,2020-06-30,2021-06-30,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,302
NCT03828682,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Simon Tremblay, PharmD, PhD",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03828864,0,0,0,0,0,0,2020-02-01,2021-02-01,,BioElectronics Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,6
NCT03829566,0,0,0,0,0,0,2025-01-01,2026-01-01,,Northwestern University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03831113,0,0,0,0,0,0,2023-05-31,2024-05-31,,"Steve N. Caritis, MD",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03835338,0,0,0,0,0,0,2021-11-30,2022-11-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,340
NCT03835988,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Calgary,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,361
NCT03837743,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Therapeutics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03838133,0,0,0,0,0,0,2019-12-31,2020-12-31,,Taiwan Liposome Company,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03838367,0,0,0,0,0,0,2020-03-31,2021-03-31,,"CytoDyn, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03840616,0,0,0,0,0,0,2020-07-31,2021-07-31,,Mycovia Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03841331,0,0,0,0,0,0,2020-04-30,2021-04-30,,Menlo Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03841773,0,0,0,0,0,0,2020-03-15,2021-03-15,,"Tonix Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,19
NCT03842189,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Momenta Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03842410,0,0,0,0,0,0,2020-09-15,2021-09-15,,Michigan Institution of Women's Health PC,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,6
NCT03843489,0,0,0,0,0,0,2024-02-29,2025-02-28,,Medline Industries,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,30
NCT03843632,0,0,0,0,0,0,2020-05-22,2021-05-22,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2145
NCT03844048,0,0,0,0,0,0,2025-05-23,2026-05-23,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03844646,0,0,0,0,0,0,2020-10-31,2021-10-31,,Stanford University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03846531,1,0,0,0,1,0,2017-11-13,2018-11-13,,"Pulse Biosciences, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03847233,0,0,0,0,0,0,2019-09-30,2020-09-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,340
NCT03849456,0,0,0,0,0,0,2021-07-31,2022-07-31,,GW Research Ltd,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,29
NCT03850197,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Pittsburgh,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1054
NCT03850782,0,0,0,0,0,0,2023-07-17,2024-07-17,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03852771,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Radial Medical, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03853200,1,0,0,0,1,0,2018-02-01,2019-02-01,,Dow University of Health Sciences,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,24
NCT03853746,0,0,0,0,0,0,2022-07-31,2023-07-31,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03855280,0,0,0,0,0,0,2021-08-01,2022-08-01,,Aptevo Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,7
NCT03858686,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Foresee Pharmaceuticals Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT03859427,0,0,0,0,0,0,2021-12-10,2022-12-10,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03860012,0,0,0,0,0,0,2019-12-31,2020-12-31,,Le Bonheur Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03860181,0,0,0,0,0,0,2020-03-20,2021-03-20,,Medical University of South Carolina,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,511
NCT03860597,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03861845,0,0,0,0,0,0,2019-08-31,2020-08-31,,Florida International University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,40
NCT03862027,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03863704,0,0,0,0,0,0,2021-12-31,2022-12-31,,Northwell Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03865121,0,0,0,0,0,0,2019-09-02,2020-09-02,,El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,7
NCT03865290,0,0,0,0,0,0,2025-03-31,2026-03-31,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03866200,0,0,0,0,0,0,2021-04-01,2022-04-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03866798,0,0,0,0,0,0,2022-03-31,2023-03-31,,Octapharma,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,54
NCT03867240,0,0,0,0,0,0,2020-04-30,2021-04-30,,Emory University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03867383,0,0,0,0,0,0,2021-04-30,2022-04-30,,Stanford University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03868735,0,0,0,0,0,0,2020-05-01,2021-05-01,,Rush University Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,227
NCT03870477,0,0,0,0,0,0,2020-12-31,2021-12-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,215
NCT03870672,0,0,0,0,0,0,2024-04-30,2025-04-30,,The Cleveland Clinic,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03871556,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwestern University,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,925
NCT03872206,0,0,0,0,0,0,2021-05-01,2022-05-01,,Harpoon Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03873402,0,0,0,0,0,0,2022-01-28,2023-01-28,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03875378,0,0,0,0,0,0,2023-08-30,2024-08-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1699
NCT03876158,0,0,0,0,0,0,2021-03-31,2022-03-31,,Rush University Medical Center,Other,0,1,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,227
NCT03879811,0,0,0,0,0,0,2021-03-31,2022-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03881449,0,0,0,0,0,0,2020-04-30,2021-04-30,,Durham VA Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,14
NCT03881670,0,0,0,0,0,0,2019-02-08,2020-02-08,,Indiana University,Other,0,1,0,4.0,Phase 4,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,497
NCT03882632,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Brown Physicians, Inc.",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03882788,0,0,0,0,0,0,2019-12-01,2020-12-01,,Stanford University,Other,0,0,0,5.0,,0,2013.0,0,1,0,1,0,0,0,0,0,0,1,1309
NCT03883360,0,0,0,0,0,0,2024-06-30,2025-06-30,,"University of Maryland, Baltimore",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,144
NCT03885154,0,0,0,0,0,0,2022-05-31,2023-05-31,,Kimberly S Jones,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03886311,0,0,0,0,0,0,2022-10-15,2023-10-15,,"Sarcoma Oncology Research Center, LLC",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03887715,0,0,0,0,0,0,2022-08-31,2023-08-31,,LivaNova,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,43
NCT03890731,0,0,0,0,0,0,2023-11-09,2024-11-09,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03891264,0,0,0,0,0,0,2020-06-30,2021-06-30,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03893825,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,101
NCT03896425,0,0,0,0,0,0,2024-04-30,2025-04-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03897088,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sun Pharma Global FZE,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03897998,0,0,0,0,0,0,2023-07-30,2024-07-30,,"University of Maryland, College Park",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03899532,0,0,0,0,0,0,2021-05-30,2022-05-30,,University of Arizona,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,265
NCT03901092,0,0,0,0,0,0,2019-04-26,2020-04-26,,Avid Radiopharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,50
NCT03903562,0,0,0,0,0,0,2020-04-18,2021-04-18,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2145
NCT03904849,0,0,0,0,0,0,2020-04-30,2021-04-30,,Medical University of South Carolina,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03905031,0,0,0,0,0,0,2020-05-31,2021-05-31,,Dayton Children's Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03907813,0,0,0,0,0,0,2020-06-30,2021-06-30,,Wright State University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03911713,0,0,0,0,0,0,2020-06-30,2021-06-30,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,141
NCT03913143,0,0,0,0,0,0,2020-12-31,2021-12-31,,ProQR Therapeutics,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03914742,0,0,0,0,0,0,2022-04-30,2023-04-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03915964,0,0,0,0,0,0,2026-02-01,2027-02-01,,Eli Lilly and Company,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03919929,0,0,0,0,0,0,2024-10-31,2025-10-31,,"University of Colorado, Denver",Other,0,0,1,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03920254,0,0,0,0,0,0,2028-09-30,2029-09-30,,Theravance Biopharma,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,53
NCT03921008,0,0,0,0,0,0,2021-05-31,2022-05-31,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1151
NCT03924856,0,0,0,0,0,0,2025-01-15,2026-01-15,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03925532,0,0,0,0,0,0,2020-12-20,2021-12-20,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,294
NCT03925740,0,0,0,0,0,0,2019-12-01,2020-12-01,,King Abdulaziz University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,30
NCT03926169,0,0,0,0,0,0,2020-10-02,2021-10-02,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03926611,0,0,0,0,0,0,2020-08-17,2021-08-17,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03928886,0,0,0,0,0,0,2020-12-01,2021-12-01,,Parc de Salut Mar,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,104
NCT03929757,0,0,0,0,0,0,2020-12-22,2021-12-22,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,29
NCT03931408,0,0,0,0,0,0,2021-01-16,2022-01-16,,University of Louisville,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03934840,0,0,0,0,0,0,2025-05-31,2026-05-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,218
NCT03935256,0,0,0,0,0,0,2021-03-31,2022-03-31,,Loyola University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,102
NCT03935646,0,0,0,0,0,0,2020-05-15,2021-05-15,,University of Wyoming,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03935880,0,0,0,0,0,0,2022-04-30,2023-04-30,,"University of Wisconsin, Madison",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,715
NCT03936387,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston Children’s Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,400
NCT03936569,0,0,0,0,0,0,2019-01-25,2020-01-25,,Procter and Gamble,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,59
NCT03937882,0,0,0,0,0,0,2020-04-30,2021-04-30,,"ReGenTree, LLC",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03938883,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Eyegate Pharmaceuticals, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,13
NCT03939689,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Progenics Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,8
NCT03943342,0,0,0,0,0,0,2021-12-31,2022-12-31,,Kerry Rogers,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03943823,0,0,0,0,0,0,2022-05-01,2023-05-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03945071,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Oklahoma,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,234
NCT03945981,0,0,0,0,0,0,2020-08-03,2021-08-03,,ViiV Healthcare,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,200
NCT03946878,0,0,0,0,0,0,2024-02-08,2025-02-08,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03947450,0,0,0,0,0,0,2025-04-01,2026-04-01,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1143
NCT03948490,0,0,0,0,0,0,2022-01-31,2023-01-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03948867,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,1,0,0,0,1,1,0,437
NCT03950232,0,0,0,0,0,0,2024-10-31,2025-10-31,,Arena Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,21
NCT03950674,0,0,0,0,0,0,2020-01-31,2021-01-31,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,2,1,0,2145
NCT03951064,0,0,0,0,0,0,2021-06-30,2022-06-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03952611,0,0,0,0,0,0,2020-01-20,2021-01-20,,Midwest Biomedical Research Foundation,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,22
NCT03954106,0,0,0,0,0,0,2021-04-30,2022-04-30,,Jazz Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,55
NCT03954886,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Houston,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,47
NCT03955211,0,0,0,0,0,0,2019-12-31,2020-12-31,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,18
NCT03959423,0,0,0,0,0,0,2020-01-31,2021-01-31,,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,48
NCT03962543,0,0,0,0,0,0,2022-07-31,2023-07-31,,"SpringWorks Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03962790,0,0,0,0,0,0,2019-07-10,2020-07-10,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03963232,0,0,0,0,0,0,2021-10-29,2022-10-29,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03965234,0,0,0,0,0,0,2029-05-25,2030-05-25,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,294
NCT03966235,0,0,0,0,0,0,2021-06-01,2022-06-01,,Chinese PLA General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,217
NCT03966716,0,0,0,0,0,0,2022-12-31,2023-12-31,,Uppsala University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,216
NCT03969147,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Vermont,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,155
NCT03970044,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Consano Clinical Research, LLC",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03970200,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03970720,0,0,0,0,0,0,2023-04-30,2024-04-30,,Simon Fisher,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03972657,0,0,0,0,0,0,2024-10-30,2025-10-30,,Regeneron Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03975647,0,0,0,0,0,0,2024-04-30,2025-04-30,,"Seattle Genetics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,77
NCT03976648,0,0,0,0,0,0,2021-07-31,2022-07-31,,Galapagos NV,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,79
NCT03977233,0,0,0,0,0,0,2022-12-31,2023-12-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03978637,0,0,0,0,0,0,2020-12-09,2021-12-09,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03978897,0,0,0,0,0,0,2021-07-01,2022-07-01,,Akron General Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03980041,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Infinity Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03980236,0,0,0,0,0,0,2019-11-30,2020-11-30,,Livongo Health,Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03980561,0,0,0,0,0,0,2022-12-01,2023-12-01,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,511
NCT03981614,0,0,0,0,0,0,2020-12-28,2021-12-28,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT03983317,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Theranova, L.L.C.",Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03985878,0,0,0,0,0,0,2026-11-30,2027-11-30,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,32
NCT03986203,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Theranova, L.L.C.",Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03988062,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Shape Memory Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03989349,0,0,0,0,0,0,2021-12-31,2022-12-31,,Galderma R&D,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03992430,0,0,0,0,0,0,2024-10-31,2025-10-31,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,32
NCT03992846,0,0,0,0,0,0,2022-01-31,2023-01-31,,ObsEva SA,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03993535,0,0,0,0,0,0,2021-12-21,2022-12-21,,University of Sao Paulo,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,767
NCT03994081,0,0,0,0,0,0,2021-05-31,2022-05-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03995212,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Cara Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03996291,0,0,0,0,0,0,2025-01-13,2026-01-13,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1222
NCT03996473,0,0,0,0,0,0,2023-09-19,2024-09-19,,Bayer,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1343
NCT04001803,0,0,0,0,0,0,2019-11-28,2020-11-28,,ViiV Healthcare,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,200
NCT04003103,0,0,0,0,0,0,2020-12-23,2021-12-23,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2145
NCT04005079,0,0,0,0,0,0,2022-07-31,2023-07-31,,Montefiore Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT04006457,0,0,0,0,0,0,2023-05-01,2024-05-01,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT04009109,0,0,0,0,0,0,2024-10-01,2025-10-01,,"Alliance Foundation Trials, LLC.",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,16
NCT04009499,0,0,0,0,0,0,2024-09-30,2025-09-30,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,75
NCT04009967,0,0,0,0,0,0,2021-09-01,2022-09-01,,CHU de Quebec-Universite Laval,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,94
NCT04011280,0,0,0,0,0,0,2021-06-15,2022-06-15,,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,561
NCT04011449,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,749
NCT04012814,0,0,0,0,0,0,2020-07-15,2021-07-15,,Venus Concept,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT04015778,0,0,0,0,0,0,2020-08-31,2021-08-31,,Guangdong Association of Clinical Trials,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,2,1,0,25
NCT04016623,0,0,0,0,0,0,2019-05-15,2020-05-15,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,85
NCT04018937,0,0,0,0,0,0,2027-01-31,2028-01-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT04019795,0,0,0,0,0,0,2019-05-25,2020-05-25,,"PhotonMD, Inc",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,0,1,0,0,0,0,2,0,1,1
NCT04024891,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Ocuphire Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT04026568,0,0,0,0,0,0,2021-10-31,2022-10-31,,Milton S. Hershey Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,334
NCT04026763,0,0,0,0,0,0,2021-12-31,2022-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,412
NCT04027946,0,0,0,0,0,0,2021-04-30,2022-04-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,3004
NCT04030507,0,0,0,0,0,0,2022-07-01,2023-07-01,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT04035109,0,0,0,0,0,0,2022-10-31,2023-10-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,910
NCT04037254,0,0,0,0,0,0,2023-12-31,2024-12-31,,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,27
NCT04042103,0,0,0,0,0,0,2020-02-28,2021-02-28,,Dermavant Sciences GmbH,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04042623,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Aravive, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT04042844,0,0,0,0,0,0,2023-02-02,2024-02-02,,BioRestorative Therapies,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,1,0,0,0,0,0,3,1,0,1
NCT04044534,0,0,0,0,0,0,2020-12-31,2021-12-31,,VA Connecticut Healthcare System,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,36
NCT04045145,0,0,0,0,0,0,2020-06-30,2021-06-30,,Neurocrine Biosciences,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,34
NCT04045470,0,0,0,0,0,0,2023-01-01,2024-01-01,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT04046107,0,0,0,0,0,0,2023-04-30,2024-04-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,2133
NCT04046731,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1898
NCT04047355,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Rutgers, The State University of New Jersey",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,227
NCT04047602,0,0,0,0,0,0,2021-06-30,2022-06-30,,Indiana University,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,497
NCT04048135,0,0,0,0,0,0,2020-06-30,2021-06-30,,89bio Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04048343,0,0,0,0,0,0,2021-05-14,2022-05-14,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2450
NCT04050501,0,0,0,0,0,0,2021-12-31,2022-12-31,,Leiden University Medical Center,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,134
NCT04056611,0,0,0,0,0,0,2022-08-15,2023-08-15,,Janssen Sciences Ireland UC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,24
NCT04058366,0,0,0,0,0,0,2022-08-31,2023-08-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,141
NCT04058964,0,0,0,0,0,0,2020-10-01,2021-10-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT04063124,0,0,0,0,0,0,2020-08-31,2021-08-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,257
NCT04063865,0,0,0,0,0,0,2027-12-31,2028-12-31,,Indiana University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT04064190,0,0,0,0,0,0,2021-12-30,2022-12-30,,"MedPacto, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,7
NCT04064645,0,0,0,0,0,0,2019-07-25,2020-07-25,,Biosency,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT04065451,0,0,0,0,0,0,2020-12-15,2021-12-15,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT04066114,0,0,0,0,0,0,2021-04-30,2022-04-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT04066374,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT04068649,0,0,0,0,0,0,2024-09-09,2025-09-09,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,294
NCT04068831,0,0,0,0,0,0,2022-08-31,2023-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT04069910,0,0,0,0,0,0,2021-09-01,2022-09-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,277
NCT04070170,0,0,0,0,0,0,2018-11-06,2019-11-06,,Ildeu Andrade Jr.,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,2,0,1,1
NCT04071106,0,0,0,0,0,0,2019-12-01,2020-12-01,,Zagazig University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,59
NCT04072380,0,0,0,0,0,0,2020-04-30,2021-04-30,,Suven Life Sciences Limited,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT04072575,0,0,0,0,0,0,2022-05-06,2023-05-06,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,558
NCT04075266,0,0,0,0,0,0,2021-05-26,2022-05-26,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT04081220,0,0,0,0,0,0,2021-10-31,2022-10-31,,The University of Texas Health Science Center at San Antonio,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,257
NCT04082533,0,0,0,0,0,0,2021-07-01,2022-07-01,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT04086186,0,0,0,0,0,0,2018-11-25,2019-11-25,,"Good Samaritan Regional Medical Center, Oregon",Other,0,0,0,4.0,Phase 4,0,2017.0,1,0,0,0,0,0,0,0,0,1,0,3
NCT04087096,0,0,0,0,0,0,2022-12-01,2023-12-01,,Massachusetts General Hospital,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT00003645,1,0,0,0,1,0,2017-03-20,2018-03-20,,M.D. Anderson Cancer Center,Other,0,1,1,3.0,Phase 3,0,1999.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00104858,1,1,0,1,0,0,2018-03-30,2019-03-30,2019-03-27,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2004.0,1,1,1,0,0,1,0,0,1,0,1,393
NCT00195091,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00258427,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2002.0,0,1,1,0,0,0,0,0,0,0,1,218
NCT00309842,0,0,0,0,0,0,2019-11-22,2020-11-22,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2005.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT00365157,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT00392353,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT00410956,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2007.0,0,1,1,0,0,0,0,1,0,0,1,1432
NCT00488072,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00488696,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2006.0,0,0,0,1,0,0,0,0,0,0,1,1443
NCT00496119,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2006.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT00574496,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2007.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT00597870,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Rodney A. White, M.D.",Other,0,0,0,5.0,,0,2002.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT00599170,0,0,0,0,0,0,2020-01-10,2021-01-10,,University of Southern California,Other,0,0,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,483
NCT00602667,1,1,0,1,0,0,2017-09-27,2018-09-27,2018-09-26,St. Jude Children's Research Hospital,Other,0,0,1,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,1,0,1,302
NCT00625378,0,0,0,0,0,0,2020-06-30,2021-06-30,,Bayer,Industry,1,1,0,3.0,Phase 3,0,2007.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT00630253,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,0.0,Phase 1/Phase 2,0,2000.0,0,1,1,0,0,0,0,0,0,0,1,218
NCT00640133,1,0,1,1,0,1,2017-02-28,2018-02-28,2018-05-23,Butler Hospital,Other,0,0,1,1.0,Phase 2,0,2008.0,1,0,0,1,0,0,0,0,0,0,1,79
NCT00658021,0,0,0,0,0,0,2020-03-10,2021-03-10,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2008.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT00703664,1,1,0,1,0,0,2017-12-01,2018-12-01,2018-06-15,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT00716066,0,0,0,0,0,0,2020-03-31,2021-03-31,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,1,0,0,0,0,0,0,0,1,393
NCT00763828,0,0,0,0,0,0,2021-02-28,2022-02-28,,Life Recovery Systems,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT00775476,1,0,0,0,1,0,2017-10-31,2018-10-31,,State University of New York - Upstate Medical University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,125
NCT00796068,0,0,0,0,0,0,2021-12-31,2022-12-31,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT00812838,1,0,0,0,1,0,2017-07-31,2018-07-31,,Mohit Khera,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT00827359,1,0,0,0,1,0,2018-01-31,2019-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT00866879,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-04-09,Northwestern University,Other,0,1,0,4.0,Phase 4,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT00872950,0,0,0,0,0,0,2020-06-30,2021-06-30,,Lahey Clinic,Other,0,0,0,5.0,,0,2001.0,0,1,0,0,0,0,0,0,0,0,1,49
NCT00887068,1,0,0,0,1,0,2018-08-20,2019-08-20,,M.D. Anderson Cancer Center,Other,0,1,0,3.0,Phase 3,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00910104,0,0,0,0,0,0,2019-01-23,2020-01-23,,Mark Puder,Other,0,0,0,2.0,Phase 2/Phase 3,0,2004.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT00914940,0,0,0,0,0,0,2019-12-31,2020-12-31,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2009.0,0,1,1,0,0,1,0,0,0,0,1,393
NCT00935090,0,0,0,0,0,0,2021-04-30,2022-04-30,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,5.0,,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,134
NCT00948922,1,1,0,1,0,1,2017-04-20,2018-04-20,2018-08-07,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT00966979,0,0,0,0,0,0,2029-01-31,2030-01-31,,Stryker Orthopaedics,Industry,1,0,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,1,0,1,24
NCT00977860,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Pittsburgh,Other,0,0,0,1.0,Phase 2,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,1054
NCT00980954,0,0,0,0,0,0,2021-08-31,2022-08-31,,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,156
NCT01003769,0,0,0,0,0,0,2018-12-14,2019-12-14,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01035099,0,0,0,0,0,0,2019-10-31,2020-10-31,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT01054196,0,0,0,0,0,0,2022-12-31,2023-12-31,,Weill Medical College of Cornell University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT01076231,1,0,0,0,1,0,2018-05-24,2019-05-24,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,273
NCT01076543,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-08-15,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01084252,0,0,0,0,0,0,2018-12-21,2019-12-21,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT01098266,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-06-05,MolMed S.p.A.,Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT01118299,0,0,0,0,0,0,2018-12-06,2019-12-06,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2010.0,1,0,0,1,0,0,0,0,0,0,1,419
NCT01146652,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT01175980,1,0,0,0,1,0,2018-06-08,2019-06-08,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,3004
NCT01183897,0,1,0,1,0,0,2018-09-25,2019-09-25,2019-07-24,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,1,0,1,0,0,0,0,0,0,0,1,1432
NCT01197378,1,1,0,1,0,0,2017-06-26,2018-06-26,2018-06-26,"Horizon Pharma USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,19
NCT01208051,0,0,0,0,0,0,2020-02-01,2021-02-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01208324,0,0,1,1,0,0,2018-12-31,2019-12-31,2018-12-13,University of Pennsylvania,Other,0,0,1,5.0,,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01237587,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-25,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT01241500,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Onconova Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT01243424,1,0,1,1,0,0,2018-08-21,2019-08-21,2019-08-21,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT01280565,0,0,0,0,0,0,2019-12-31,2020-12-31,,AB Science,Industry,1,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,30
NCT01306019,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2133
NCT01306929,1,0,0,0,1,0,2018-01-05,2019-01-05,,Prilenia,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT01307579,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-06-11,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,389
NCT01315132,0,0,1,1,0,0,2018-09-19,2019-09-19,2019-09-04,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2008.0,0,0,0,1,0,0,0,0,0,0,1,162
NCT01316523,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of California, Davis",Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,530
NCT01316770,1,1,0,1,0,0,2017-04-17,2018-04-17,2018-04-16,National Institute of Dental and Craniofacial Research (NIDCR),NIH,2,0,0,1.0,Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,88
NCT01332630,1,1,0,1,0,0,2017-04-14,2018-04-14,2018-03-28,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01341080,0,0,0,0,0,0,2018-12-31,2019-12-31,,Rush University Medical Center,Other,0,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,227
NCT01341652,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,715
NCT01377389,1,0,1,1,0,1,2017-04-07,2018-04-07,2018-05-07,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01390220,0,1,0,1,0,1,2017-03-31,2018-03-31,2019-05-09,"Proximagen, LLC",Industry,1,0,0,3.0,Phase 3,1,2011.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT01410630,0,0,0,0,0,0,2023-10-01,2024-10-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2019.0,0,1,0,0,1,0,0,0,1,1,0,277
NCT01412372,0,0,0,0,0,0,2019-04-22,2020-04-22,,University of Utah,Other,0,1,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,578
NCT01415440,1,1,0,1,0,1,2018-06-30,2019-06-30,2019-07-05,New York State Psychiatric Institute,Other,0,1,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT01415752,0,0,0,0,0,0,2020-03-31,2021-03-31,,Eastern Cooperative Oncology Group,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,1,0,0,0,0,0,1,0,1,175
NCT01419067,0,0,0,0,0,0,2021-05-31,2022-05-31,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,1,0,0,0,0,0,0,1,302
NCT01439880,1,1,0,1,0,0,2018-06-20,2019-06-20,2019-06-17,Amgen,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,0,1,0,0,0,0,0,1,0,1,685
NCT01468831,0,0,0,0,0,0,2019-04-12,2020-04-12,,National Eye Institute (NEI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,263
NCT01473628,0,0,0,0,0,0,2027-05-31,2028-05-31,,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT01478321,0,0,0,0,0,0,2019-11-30,2020-11-30,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,1,0,0,1,0,0,0,0,1,925
NCT01481974,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Abhinav Humar, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01490892,0,0,0,0,0,0,2019-04-05,2020-04-05,,Thomas Jefferson University,Other,0,1,1,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,186
NCT01494662,0,0,0,0,0,0,2022-12-31,2023-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01498978,1,1,0,1,0,0,2017-02-28,2018-02-28,2018-01-22,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,163
NCT01509547,1,1,0,1,0,0,2018-01-26,2019-01-26,2019-01-23,Medical University of South Carolina,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT01514682,1,1,0,1,0,0,2017-04-17,2018-04-17,2018-01-04,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,318
NCT01525082,0,0,0,0,0,0,2019-01-31,2020-01-31,,Stanford University,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,1,0,0,0,0,0,0,0,1,1309
NCT01526889,0,1,0,1,0,1,2017-02-16,2018-02-16,2018-08-15,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01547429,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ophtec USA,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,2
NCT01550003,0,0,0,0,0,0,2021-07-31,2022-07-31,,UCB BIOSCIENCES GmbH,Industry,1,1,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT01560923,0,0,0,0,0,0,2018-12-12,2019-12-12,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2012.0,1,0,1,0,0,0,0,0,0,0,1,218
NCT01568528,1,1,0,1,0,1,2017-03-15,2018-03-15,2019-07-23,Emory University,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT01570998,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,1443
NCT01583842,0,0,0,0,0,0,2020-01-01,2021-01-01,,Katherine Matthay,Other,0,0,0,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,1
NCT01596751,1,0,0,0,1,0,2017-07-05,2018-07-05,,"Hope Rugo, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01602666,0,0,0,0,0,0,2021-12-31,2022-12-31,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,1,0,1,389
NCT01607255,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-13,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01610336,0,0,0,0,0,0,2019-08-01,2020-08-01,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,2,0,1,1895
NCT01612806,1,0,0,0,1,0,2017-02-28,2018-02-28,,Integra LifeSciences Corporation,Industry,1,0,0,5.0,,1,2011.0,1,0,0,1,0,0,0,0,0,0,1,40
NCT01614821,1,0,0,0,1,0,2018-09-15,2019-09-15,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT01618305,0,0,0,0,0,0,2018-12-11,2019-12-11,,Westat,Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT01623167,0,0,0,0,0,0,2020-01-30,2021-01-30,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT01633541,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,213
NCT01636388,1,0,0,0,1,0,2017-06-30,2018-06-30,,New York Medical College,Other,0,0,0,1.0,Phase 2,1,2013.0,1,0,1,0,0,0,0,0,0,0,1,40
NCT01638546,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-02-27,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01649869,0,0,0,0,0,0,2019-07-27,2020-07-27,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT01650376,0,0,0,0,0,0,2018-12-31,2019-12-31,,Swedish Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,34
NCT01651403,1,1,0,1,0,0,2017-08-07,2018-08-07,2018-08-03,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT01657331,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Owen A, O'Connor, M.D., Ph.D.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT01662466,0,0,0,0,0,0,2020-06-30,2021-06-30,,Center for Human Reproduction,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,11
NCT01664897,0,0,0,0,0,0,2018-10-25,2019-10-25,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01668719,0,0,0,0,0,0,2019-12-31,2020-12-31,,Southwest Oncology Group,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,288
NCT01670981,0,0,0,0,0,0,2018-03-07,2019-03-07,,Vericel Corporation,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,1,0,1,13
NCT01674140,0,0,0,0,0,0,2022-12-31,2023-12-31,,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT01682226,0,0,0,0,0,0,2019-09-30,2020-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT01686659,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Society for the Advancement of Blood Management, Inc",Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,1,0,1,1
NCT01697371,0,0,0,0,0,0,2024-09-30,2025-09-30,,Loma Linda University,Other,0,0,0,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,194
NCT01705964,1,0,0,0,1,0,2018-04-30,2019-04-30,,University of Louisville,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,214
NCT01708707,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Mednax Center for Research, Education, Quality and Safety",Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,30
NCT01709721,0,0,0,0,0,0,2018-02-28,2019-02-28,,"Piramal Critical Care, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,1,0,0,0,0,0,0,1,3
NCT01711983,0,0,0,0,0,0,2018-11-26,2019-11-26,,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,52
NCT01720225,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01723774,0,0,0,0,0,0,2022-04-30,2023-04-30,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT01725750,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-08-14,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,412
NCT01728454,0,1,0,1,0,1,2017-03-15,2018-03-15,2019-05-23,Repros Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT01734382,0,0,0,0,0,0,2019-09-07,2020-09-07,,Hoffmann-La Roche,Industry,1,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT01736683,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-30,Celgene,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT01754363,0,0,0,0,0,0,2030-02-01,2031-02-01,,DePuy International,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,42
NCT01766206,1,1,0,1,0,0,2018-01-22,2019-01-22,2018-07-20,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2013.0,1,0,1,0,0,0,0,0,2,0,1,3276
NCT01771471,0,0,0,0,0,0,2020-09-30,2021-09-30,,"ISTO Technologies, Inc.",Industry,1,0,0,1.0,Phase 2,1,2012.0,0,0,1,0,0,0,0,0,0,0,1,3
NCT01774071,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01778556,1,0,1,1,0,1,2018-02-23,2019-02-23,2019-06-24,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,495
NCT01784588,1,1,0,1,0,1,2018-01-17,2019-01-17,2019-04-17,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,1,0,1,340
NCT01789268,0,0,0,0,0,0,2019-07-01,2020-07-01,,University of Rochester,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,470
NCT01789840,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Merit Medical Systems, Inc.",Industry,1,0,0,5.0,,1,2013.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT01793051,0,0,0,0,0,0,2019-12-29,2020-12-29,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01796106,0,0,0,0,0,0,2018-10-31,2019-10-31,,DMG Dental Material Gesellschaft mbH,Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,9
NCT01796197,0,0,0,0,0,0,2018-12-31,2019-12-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,647
NCT01807637,1,1,0,1,0,0,2017-11-17,2018-11-17,2018-10-02,University of Arkansas,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,285
NCT01808196,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,437
NCT01809132,0,0,0,0,0,0,2018-10-31,2019-10-31,,Mack Mitchell,Other,0,0,1,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01811940,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-08-16,New York State Psychiatric Institute,Other,0,0,1,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT01813734,1,0,0,0,1,0,2018-06-30,2019-06-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01814813,1,1,0,1,0,1,2017-04-03,2018-04-03,2019-04-08,Alliance for Clinical Trials in Oncology,Other,0,1,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,456
NCT01818492,0,0,0,0,0,0,2019-01-31,2020-01-31,,NovImmune SA,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,0,1,0,0,0,0,0,1,0,1,14
NCT01821781,0,0,0,0,0,0,2022-03-31,2023-03-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT01839110,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-11-30,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01840124,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1443
NCT01841723,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01854385,1,0,0,0,1,0,2018-02-28,2019-02-28,,University of Washington,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01864109,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,1,0,1,0,0,0,0,1,1432
NCT01871220,0,0,0,0,0,0,2018-10-03,2019-10-03,,Christopher Barwacz,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT01876511,0,0,0,0,0,0,2021-06-30,2022-06-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT01878253,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-04-26,Zimmer Biomet,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,1,0,1,215
NCT01879228,0,0,0,0,0,0,2019-12-14,2020-12-14,,University of Pennsylvania,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT01885949,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01892345,1,1,0,1,0,0,2018-07-17,2019-07-17,2019-06-07,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,86
NCT01898494,0,0,0,0,0,0,2020-02-29,2021-02-28,,Eastern Cooperative Oncology Group,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,175
NCT01901848,1,1,0,1,0,1,2017-07-30,2018-07-30,2018-08-13,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01905150,0,0,0,0,0,0,2019-02-28,2020-02-28,,Bruckner Oncology,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01906008,0,0,0,0,0,0,2019-02-14,2020-02-14,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01919619,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01923298,1,0,0,0,1,0,2018-06-30,2019-06-30,,University of Arizona,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,265
NCT01927068,0,0,0,0,0,0,2022-04-05,2023-04-05,,Spectranetics Corporation,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,2,0,1,18
NCT01935089,1,0,0,0,1,0,2017-07-31,2018-07-31,,The Wistar Institute,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT01935128,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Toledo Health Science Campus,Other,0,1,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT01938001,1,1,0,1,0,0,2018-06-22,2019-06-22,2019-06-21,Celgene,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01948180,1,0,1,1,0,1,2018-04-16,2019-04-16,2019-07-09,Cell Medica Ltd,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,0,1,0,0,0,0,0,1,0,1,8
NCT01949324,0,0,0,0,0,0,2017-04-14,2018-04-14,,Neurotech Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,0,1,1,0,0,0,0,1,0,1,10
NCT01949662,0,0,0,0,0,0,2021-01-01,2022-01-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01950351,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01951118,0,0,0,0,0,0,2019-05-31,2020-05-31,,New York State Psychiatric Institute,Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT01951326,0,0,0,0,0,0,2018-12-31,2019-12-31,,RedHill Biopharma Limited,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,12
NCT01958086,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Richard A. Andersen, PhD",Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT01963481,1,0,1,1,0,1,2017-10-01,2018-10-01,2019-04-24,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT01964300,0,0,0,0,0,0,2018-12-09,2019-12-09,,Pediatric Brain Tumor Consortium,Other,0,0,1,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,27
NCT01964924,1,0,1,1,0,1,2017-06-01,2018-06-01,2018-12-17,National Cancer Institute (NCI),NIH,2,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01976728,0,0,0,0,0,0,2018-02-23,2019-02-23,,Ferring Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,208
NCT01978236,1,1,0,1,0,0,2017-04-26,2018-04-26,2018-04-25,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT01979367,0,0,0,0,0,0,2023-01-31,2024-01-31,,American Association of Sensory Electrodiagnostic Medicine,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT01994382,0,0,0,0,0,0,2019-12-31,2020-12-31,,Portola Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,28
NCT01994889,1,1,0,1,0,0,2018-02-07,2019-02-07,2019-01-31,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02004392,1,0,0,0,1,0,2017-08-31,2018-08-31,,FORUM Pharmaceuticals Inc,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT02012296,0,0,0,0,0,0,2019-12-01,2020-12-01,,University of Chicago,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02013414,1,0,1,1,0,0,2018-07-23,2019-07-23,2019-07-22,Emory University,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,947
NCT02018042,1,1,0,1,0,1,2017-07-31,2018-07-31,2019-03-27,Columbia University,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02019706,0,0,0,0,0,0,2020-08-15,2021-08-15,,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,413
NCT02020018,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-04-16,Mayo Clinic,Other,0,1,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02020278,1,0,0,0,1,0,2017-10-23,2018-10-23,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,185
NCT02023905,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02024087,1,0,0,0,1,0,2017-07-05,2018-07-05,,"Acceleron Pharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02024204,0,0,0,0,0,0,2019-08-31,2020-08-31,,NYU Langone Health,Other,0,0,1,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02024555,0,0,0,0,0,0,2019-04-01,2020-04-01,,Vanderbilt University,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,499
NCT02025023,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Washington,Other,0,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02031536,1,0,1,1,0,0,2017-02-28,2018-02-28,2017-08-24,Eastern Cooperative Oncology Group,Other,0,0,1,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,175
NCT02037295,0,0,0,0,0,0,2019-03-29,2020-03-29,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02037620,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Louisville,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,214
NCT02038140,0,0,0,0,0,0,2027-03-31,2028-03-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,215
NCT02038478,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,626
NCT02040142,0,0,0,0,0,0,2019-11-30,2020-11-30,,Albert Einstein College of Medicine,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,155
NCT02041494,0,0,0,0,0,0,2018-09-30,2019-09-30,,Hobart Harris,Other,0,0,1,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02043392,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1443
NCT02048059,0,0,0,0,0,0,2017-09-30,2018-09-30,,Angiochem Inc,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02049866,0,0,0,0,0,0,2020-02-28,2021-02-28,,Elizabeth Shane,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02073968,1,0,0,0,1,0,2017-12-31,2018-12-31,,Albert Einstein College of Medicine,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,155
NCT02074631,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,218
NCT02077166,0,0,0,0,0,0,2019-10-31,2020-10-31,,Pharmacyclics LLC.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,54
NCT02078817,1,0,0,0,1,0,2018-03-31,2019-03-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02080637,1,1,0,1,0,1,2017-07-20,2018-07-20,2019-08-01,Kevin Hill,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02081391,0,0,0,0,0,0,2019-03-03,2020-03-03,,Grünenthal GmbH,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,71
NCT02082210,0,0,0,0,0,0,2017-12-05,2018-12-05,,Eli Lilly and Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1512
NCT02084147,0,0,0,0,0,0,2018-10-31,2019-10-31,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,374
NCT02090283,1,0,1,1,0,1,2018-06-04,2019-06-04,2019-09-10,"Scioderm, Inc.",Industry,1,0,1,5.0,,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02096471,1,1,0,1,0,0,2017-08-09,2018-08-09,2018-08-07,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT02100891,0,0,0,0,0,0,2019-12-31,2020-12-31,,Monica Thakar,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02101021,1,1,0,1,0,0,2017-04-10,2018-04-10,2018-04-06,"Sierra Oncology, Inc.",Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT02116608,0,0,0,0,0,0,2022-01-31,2023-01-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02119468,0,0,0,0,0,0,2018-11-30,2019-11-30,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT02122081,0,0,0,0,0,0,2019-12-31,2020-12-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,1,1,0,0,1,0,0,0,0,1,198
NCT02125786,0,0,0,0,0,0,2023-05-31,2024-05-31,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,1,0,1,0,0,1,0,1,302
NCT02127398,0,0,0,0,0,0,2022-05-31,2023-05-31,,Duke University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,1342
NCT02128230,0,0,0,0,0,0,2025-05-31,2026-05-31,,University of Arkansas,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,285
NCT02129673,1,0,0,0,1,0,2017-05-31,2018-05-31,,ViSci Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02132598,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Liza Villaruz, MD",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02134366,1,0,0,0,1,0,2017-07-31,2018-07-31,,The Cooper Health System,Other,0,1,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,37
NCT02135484,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,1,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02135692,1,1,0,1,0,0,2017-10-05,2018-10-05,2018-03-29,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,1,0,0,0,0,0,1,0,1,3276
NCT02140151,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Southern California Desert Retina Consultants, MC",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02140255,0,0,0,0,0,0,2022-04-01,2023-04-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT02141490,0,1,0,1,0,0,2018-11-20,2019-11-20,2019-08-06,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,1,0,0,0,0,0,1,3004
NCT02145390,1,1,0,1,0,0,2017-04-25,2018-04-25,2017-08-24,University of Miami,Other,0,0,0,5.0,,1,2016.0,1,0,0,0,0,1,0,0,0,0,1,476
NCT02148705,1,0,0,0,1,0,2018-06-12,2019-06-12,,MediWound Ltd,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,10
NCT02152163,1,0,0,0,1,0,2017-04-30,2018-04-30,,Delray Medical Center,Other,0,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02160730,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Shlomo Melmed, MD",Other,0,0,1,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02167074,1,0,1,1,0,1,2017-06-01,2018-06-01,2018-08-07,Foundation for Liver Research,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,28
NCT02177838,0,0,0,0,0,0,2020-06-01,2021-06-01,,"Rutgers, The State University of New Jersey",Other,0,0,1,5.0,,0,2015.0,0,1,1,0,0,1,0,0,0,0,1,227
NCT02179190,1,1,0,1,0,1,2017-07-21,2018-07-21,2018-10-25,Medtronic Neurovascular Clinical Affairs,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,21
NCT02182687,0,0,0,0,0,0,2020-07-31,2021-07-31,,Lahey Clinic,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,49
NCT02187783,1,1,0,1,0,0,2018-01-17,2019-01-17,2019-01-16,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02194829,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02195011,1,1,0,1,0,0,2017-06-04,2018-06-04,2018-06-04,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,1,0,0,0,0,0,0,1,167
NCT02196025,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Florida,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,849
NCT02198651,1,1,0,1,0,0,2018-05-03,2019-05-03,2019-04-29,AbbVie,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,430
NCT02204124,1,1,0,1,0,0,2017-08-23,2018-08-23,2018-07-20,Washington University School of Medicine,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,1151
NCT02205307,1,0,0,0,1,0,2017-05-31,2018-05-31,,"Novadaq Technologies ULC, now a part of Stryker",Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02205801,1,1,0,1,0,0,2017-02-10,2018-02-10,2018-01-12,University of Chicago,Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02206425,0,0,0,0,0,0,2020-06-30,2021-06-30,,Oncotherapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,17
NCT02206984,0,0,0,0,0,0,2019-12-31,2020-12-31,,Priscilla McAuliffe,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02209519,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Alabama at Birmingham,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02213068,0,0,0,0,0,0,2022-07-31,2023-07-31,,Lorenzo Gallon,Other,0,1,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02213757,1,0,0,0,1,0,2017-09-30,2018-09-30,,Medstar Health Research Institute,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,79
NCT02214550,0,0,0,0,0,0,2019-09-30,2020-09-30,,NorthShore University HealthSystem,Other,0,0,1,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,61
NCT02215902,1,0,0,0,1,0,2017-03-10,2018-03-10,,Aethlon Medical Inc.,Industry,1,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02220855,1,1,0,1,0,1,2017-03-27,2018-03-27,2018-08-09,Patrick Joseph Loehrer Sr.,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT02228408,0,0,0,0,0,0,2019-04-15,2020-04-15,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,698
NCT02228889,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Jeffrey E Janis, MD",Other,0,0,0,4.0,Phase 4,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02229136,0,0,0,0,0,0,2019-09-30,2020-09-30,,US Oncology Research,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02229903,1,0,0,0,1,0,2017-06-30,2018-06-30,,Brainsway,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,16
NCT02232477,0,0,0,0,0,0,2020-06-30,2021-06-30,,agnes chen,Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02234596,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02234934,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, Los Angeles",Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,692
NCT02240706,0,0,0,0,0,0,2020-01-20,2021-01-20,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT02241512,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT02242097,0,0,0,0,0,0,2019-06-30,2020-06-30,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02246439,0,1,0,1,0,1,2017-02-13,2018-02-13,2018-11-30,RedHill Biopharma Limited,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02247557,1,0,0,0,1,0,2017-02-28,2018-02-28,,Buddhist Tzu Chi General Hospital,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,2,0,1,36
NCT02248688,1,0,0,0,1,0,2017-10-31,2018-10-31,,Dayton Interventional Radiology,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02250651,0,0,0,0,0,0,2018-10-25,2019-10-25,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,495
NCT02251431,0,0,0,0,0,0,2019-12-31,2020-12-31,,Baylor Research Institute,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,131
NCT02252887,0,0,0,0,0,0,2019-09-30,2020-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02263326,1,1,0,1,0,1,2017-07-31,2018-07-31,2018-08-24,Babafemi Taiwo,Other,0,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02264288,1,0,0,0,1,0,2018-02-28,2019-02-28,,Celularity Incorporated,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,0,1,0,0,0,0,0,0,0,1,11
NCT02264990,0,0,0,0,0,0,2019-10-31,2020-10-31,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02266888,0,0,0,0,0,0,2019-06-30,2020-06-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2133
NCT02267187,1,1,0,1,0,0,2017-06-21,2018-06-21,2018-04-18,University of Pittsburgh,Other,0,0,1,5.0,,0,2014.0,1,1,0,1,0,0,0,0,0,0,1,1054
NCT02272686,1,1,0,1,0,0,2017-12-22,2018-12-22,2018-10-02,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02273973,1,1,0,1,0,0,2017-03-13,2018-03-13,2018-03-06,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT02276911,1,0,0,0,1,0,2017-06-01,2018-06-01,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT02277613,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Athersys, Inc",Industry,1,0,1,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,7
NCT02282345,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02285595,1,0,0,0,1,0,2017-06-22,2018-06-22,,"Sonendo, Inc.",Industry,1,0,0,4.0,Phase 4,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02289222,1,1,0,1,0,0,2017-08-07,2018-08-07,2018-02-12,Ashraf Badros,Other,0,1,0,0.0,Phase 1/Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02296138,1,1,0,1,0,0,2017-03-08,2018-03-08,2018-03-07,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02302963,1,0,0,0,1,0,2017-01-31,2018-01-31,,University of Virginia,Other,0,1,1,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,402
NCT02303041,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-12-18,Anne Chang,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02306694,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-05-28,Oregon Health and Science University,Other,0,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT02307279,0,0,0,0,0,0,2017-06-30,2018-06-30,,"Gelesis, Inc.",Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,9
NCT02307630,0,0,0,0,0,0,2019-11-30,2020-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT02308007,0,0,0,0,0,0,2018-06-30,2019-06-30,,"Curatek Pharmaceuticals, LLC",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02309411,1,1,0,1,0,0,2017-04-05,2018-04-05,2018-03-28,Bayer,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT02311582,0,0,0,0,0,0,2021-02-28,2022-02-28,,Washington University School of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,1,0,0,0,0,0,0,1,1151
NCT02312206,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-03,Prothena Therapeutics Ltd.,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02313194,0,0,0,0,0,0,2019-08-30,2020-08-30,,"University of California, Los Angeles",Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,692
NCT02314988,0,0,0,0,0,0,2021-07-31,2022-07-31,,Columbia University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT02315898,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Michigan,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT02316379,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,437
NCT02317640,0,0,0,0,0,0,2022-10-31,2023-10-31,,Kessler Foundation,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,79
NCT02318784,0,0,0,0,0,0,2020-02-01,2021-02-01,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,167
NCT02318992,1,1,0,1,0,0,2018-04-30,2019-04-30,2018-09-27,"The University of Texas Health Science Center, Houston",Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,490
NCT02323100,0,0,0,0,0,0,2021-06-30,2022-06-30,,National Jewish Health,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,81
NCT02324322,1,0,0,0,1,0,2017-12-31,2018-12-31,,Kessler Foundation,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,79
NCT02324699,1,1,0,1,0,1,2018-02-08,2019-02-08,2019-04-04,Icahn School of Medicine at Mount Sinai,Other,0,1,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02327403,0,0,0,0,0,0,2020-03-31,2021-03-31,,Brigham and Women's Hospital,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT02336230,0,0,0,0,0,0,2018-01-31,2019-01-31,,Mesoblast International Sàrl,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT02337907,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-08-29,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02341287,0,0,0,0,0,0,2019-12-31,2020-12-31,,Weill Medical College of Cornell University,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,586
NCT02341430,1,0,0,0,1,0,2017-09-11,2018-09-11,,Anne Arundel Health System Research Institute,Other,0,1,0,4.0,Phase 4,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02341560,0,0,0,0,0,0,2019-07-01,2020-07-01,,Quark Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02343952,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Nasser Hanna, M.D.",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02354612,0,0,0,0,0,0,2021-12-31,2022-12-31,,Tracon Pharmaceuticals Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT02355691,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-02-15,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02358681,0,0,0,0,0,0,2020-06-30,2021-06-30,,Columbia University,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT02359552,1,0,0,0,1,0,2018-08-29,2019-08-29,,The Cleveland Clinic,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,581
NCT02359864,0,0,0,0,0,0,2021-05-31,2022-05-31,,William Beaumont Hospitals,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,84
NCT02361554,0,0,0,0,0,0,2020-06-30,2021-06-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02362594,1,1,0,1,0,0,2018-01-08,2019-01-08,2018-12-10,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02366195,1,1,0,1,0,0,2017-06-26,2018-06-26,2018-06-21,Amgen,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,685
NCT02370160,1,0,0,0,1,0,2018-04-08,2019-04-08,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,218
NCT02370251,0,0,0,0,0,0,2018-09-27,2019-09-27,,University of Oklahoma,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,234
NCT02371980,0,0,0,0,0,0,2019-04-25,2020-04-25,,Takeda,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,650
NCT02372877,1,0,0,0,1,0,2017-12-07,2018-12-07,,"Fenwal, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02373813,0,0,0,0,0,0,2019-11-12,2020-11-12,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,685
NCT02374671,1,0,0,0,1,0,2018-05-31,2019-05-31,,"Refocus Group, Inc.",Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02378428,0,0,0,0,0,0,2020-03-31,2021-03-31,,Mark Ranalli,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02380573,0,0,0,0,0,0,2022-07-31,2023-07-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02382016,1,1,0,1,0,0,2017-10-25,2018-10-25,2018-10-25,Actelion,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,128
NCT02383498,0,0,0,0,0,0,2019-03-01,2020-03-01,,"NantCell, Inc.",Industry,1,0,1,1.0,Phase 2,0,2015.0,0,0,1,1,0,1,0,0,0,0,1,12
NCT02384200,1,1,0,1,0,1,2017-02-01,2018-02-01,2019-07-14,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,561
NCT02384954,0,0,0,0,0,0,2020-12-31,2021-12-31,,Altor BioScience,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,18
NCT02385110,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02389946,0,1,0,1,0,1,2017-04-30,2018-04-30,2019-03-08,"Biotronik, Inc.",Industry,1,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,26
NCT02395471,1,1,0,1,0,0,2018-04-24,2019-04-24,2019-04-24,Medtronic - MITG,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,146
NCT02396745,1,1,0,1,0,0,2018-03-22,2019-03-22,2018-11-29,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),Other,0,1,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,10
NCT02398266,1,0,1,1,0,0,2018-07-01,2019-07-01,2019-06-05,Oregon Health and Science University,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT02401542,0,0,0,0,0,0,2021-03-31,2022-03-31,,Rainier Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02404441,0,0,0,0,0,0,2020-05-20,2021-05-20,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,1895
NCT02406742,0,0,0,0,0,0,2020-06-09,2021-06-09,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02407457,0,0,0,0,0,0,2018-10-31,2019-10-31,,Endologix,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,14
NCT02408016,0,0,0,0,0,0,2020-06-30,2021-06-30,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,393
NCT02408965,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-05-09,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02414178,0,0,0,0,0,0,2020-02-29,2021-02-28,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT02415400,0,0,0,0,0,0,2018-11-10,2019-11-10,,Bristol-Myers Squibb,Industry,1,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02421354,1,1,0,1,0,1,2018-04-13,2019-04-13,2019-04-23,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,1,2015.0,1,0,1,0,0,0,0,0,0,0,1,2066
NCT02423902,1,0,0,0,1,0,2017-08-31,2018-08-31,,Ziopharm,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,34
NCT02424955,0,0,0,0,0,0,2019-12-14,2020-12-14,,Stanford University,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,1,0,0,0,0,0,1,1309
NCT02429830,0,0,0,0,0,0,2019-10-31,2020-10-31,,Torax Medical Incorporated,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT02431494,1,0,0,0,1,0,2017-05-12,2018-05-12,,Nova Southeastern University,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,38
NCT02432378,0,0,0,0,0,0,2019-12-31,2020-12-31,,Roswell Park Cancer Institute,Other,0,1,1,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,294
NCT02435849,0,0,0,0,0,0,2022-11-28,2023-11-28,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,1895
NCT02436876,1,0,0,0,1,0,2018-09-01,2019-09-01,,Microbion Corporation,Industry,1,1,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02437890,0,1,0,1,0,0,2018-01-31,2019-01-31,2018-11-16,Ablynx,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,26
NCT02441322,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Pennsylvania,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1052
NCT02443077,0,0,0,0,0,0,2022-10-07,2023-10-07,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02445222,0,0,0,0,0,0,2034-12-28,2035-12-28,,Novartis Pharmaceuticals,Industry,1,0,0,5.0,,0,2015.0,0,0,0,0,0,0,0,1,1,0,1,1895
NCT02446821,1,0,0,0,1,0,2017-05-31,2018-05-31,,Sebela Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02446886,0,0,0,0,0,0,2019-12-31,2020-12-31,,Weill Medical College of Cornell University,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT02451423,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02452463,1,0,0,0,1,0,2018-08-22,2019-08-22,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,294
NCT02457195,1,1,0,1,0,0,2018-02-19,2019-02-19,2019-02-13,Milton S. Hershey Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT02457819,0,0,0,0,0,0,2017-02-02,2018-02-02,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT02462148,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-06-01,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT02467478,0,0,0,0,0,0,2019-04-30,2020-04-30,,George Washington University,Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,85
NCT02468336,1,0,0,0,1,0,2017-02-15,2018-02-15,,"Everist Genomics, Inc",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,3
NCT02469246,1,1,0,1,0,0,2017-04-07,2018-04-07,2018-03-29,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02477124,0,0,0,0,0,0,2020-08-31,2021-08-31,,Duke University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,1342
NCT02477800,0,0,0,0,0,0,2020-01-30,2021-01-30,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,324
NCT02479698,0,0,0,0,0,0,2020-07-31,2021-07-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02481245,1,0,0,0,1,0,2018-06-30,2019-06-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02484547,0,0,0,0,0,0,2020-01-30,2021-01-30,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,324
NCT02485418,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02492620,1,0,0,0,1,0,2017-11-30,2018-11-30,,"Denver Nephrologists, P.C.",Other,0,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02492763,1,1,0,1,0,0,2017-04-18,2018-04-18,2018-01-18,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,3,0,1,2145
NCT02494258,0,0,0,0,0,0,2020-11-30,2021-11-30,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,306
NCT02494544,0,0,0,0,0,0,2020-06-30,2021-06-30,,"ConforMIS, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,18
NCT02495077,0,0,0,0,0,0,2021-06-30,2022-06-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,2133
NCT02498301,0,0,0,0,0,0,2019-04-30,2020-04-30,,Uniformed Services University of the Health Sciences,U.S. Fed,2,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,35
NCT02499081,1,0,0,0,1,0,2018-05-17,2019-05-17,,University of Arkansas,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,285
NCT02499835,0,0,0,0,0,0,2020-07-01,2021-07-01,,"University of Wisconsin, Madison",Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,715
NCT02501629,1,1,0,1,0,1,2017-06-19,2018-06-19,2018-08-09,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02505945,1,1,0,1,0,1,2017-10-31,2018-10-31,2018-11-15,Torax Medical Incorporated,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,11
NCT02513472,0,0,0,0,0,0,2019-07-31,2020-07-31,,Eisai Inc.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,328
NCT02513914,0,0,0,0,0,0,2022-07-31,2023-07-31,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,48
NCT02515630,0,0,0,0,0,0,2017-07-18,2018-07-18,,"Sierra Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,19
NCT02515942,0,1,0,1,0,1,2017-08-14,2018-08-14,2018-11-12,Alcon Research,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,3,0,1,492
NCT02522767,0,0,0,0,0,0,2018-02-06,2019-02-06,,Ferring Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,208
NCT02524379,0,0,0,0,0,0,2022-03-31,2023-03-31,,Ohio State University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT02527200,0,0,0,0,0,0,2020-07-27,2021-07-27,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,981
NCT02527512,0,0,0,0,0,0,2019-02-01,2020-02-01,,Boston Children’s Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT02528214,1,1,0,1,0,0,2017-09-20,2018-09-20,2018-07-27,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02531438,0,1,0,1,0,1,2017-02-05,2018-02-05,2018-11-02,Paratek Pharmaceuticals Inc,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02532283,0,0,0,0,0,0,2017-02-24,2018-02-24,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02533713,0,0,0,0,0,0,2020-10-31,2021-10-31,,Craig Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT02536963,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Rebiscan, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT02540993,0,0,0,0,0,0,2020-04-26,2021-04-26,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02547805,1,0,0,0,1,0,2017-01-31,2018-01-31,,Allena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02547922,0,0,0,0,0,0,2019-11-27,2020-11-27,,AstraZeneca,Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,2450
NCT02549989,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02552277,1,0,0,0,1,0,2017-03-07,2018-03-07,,Celularity Incorporated,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,11
NCT02553460,0,0,0,0,0,0,2020-02-29,2021-02-28,,St. Jude Children's Research Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,302
NCT02554279,1,1,0,1,0,0,2017-01-26,2018-01-26,2018-01-25,Ferring Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,208
NCT02556931,0,0,0,0,0,0,2018-11-30,2019-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,1,0,0,0,0,1,461
NCT02558296,0,0,0,0,0,0,2019-08-31,2020-08-31,,Theracos,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT02559505,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Rochester,Other,0,0,0,5.0,,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,470
NCT02560038,1,1,0,1,0,0,2017-09-14,2018-09-14,2018-09-12,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02560805,0,0,0,0,0,0,2020-08-31,2021-08-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02561195,1,1,0,1,0,0,2017-03-07,2018-03-07,2018-03-05,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2856
NCT02570542,0,0,0,0,0,0,2019-10-31,2020-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02570984,0,0,0,0,0,0,2023-11-27,2024-11-27,,Boston Children’s Hospital,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT02572856,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Washington,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT02573493,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,1151
NCT02574455,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Immunomedics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT02578901,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Washington,Other,0,0,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02579057,1,1,0,1,0,0,2017-06-30,2018-06-30,2017-09-20,Johns Hopkins University,Other,0,1,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02579811,0,0,0,0,0,0,2019-08-21,2020-08-21,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,374
NCT02580305,0,0,0,0,0,0,2019-09-30,2020-09-30,,Suven Life Sciences Limited,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT02581839,1,0,0,0,1,0,2018-07-02,2019-07-02,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,374
NCT02583178,0,0,0,0,0,0,2020-08-31,2021-08-31,,Aegis Medical Innovations,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT02583893,0,0,0,0,0,0,2019-10-08,2020-10-08,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,162
NCT02586025,1,1,0,1,0,0,2017-10-23,2018-10-23,2018-10-22,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,1731
NCT02587351,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02588339,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02590068,1,0,0,0,1,0,2017-09-08,2018-09-08,,Rockefeller University,Other,0,0,1,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,104
NCT02595528,0,0,0,0,0,0,2017-10-18,2018-10-18,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02595749,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Southern California,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,483
NCT02595892,0,0,0,0,0,0,2019-09-02,2020-09-02,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02597023,1,0,0,0,1,0,2017-12-31,2018-12-31,,"University of Colorado, Boulder",Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,49
NCT02597452,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Pennsylvania,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1052
NCT02606305,0,0,0,0,0,0,2021-01-31,2022-01-31,,"ImmunoGen, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02607956,1,1,0,1,0,0,2017-05-12,2018-05-12,2018-05-03,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02610140,0,0,0,0,0,0,2017-05-31,2018-05-31,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT02613884,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins All Children's Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02614261,0,1,0,1,0,1,2017-03-16,2018-03-16,2018-10-19,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02619682,0,0,0,0,0,0,2020-12-31,2021-12-31,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,393
NCT02623426,0,0,0,0,0,0,2020-01-31,2021-01-31,,JHSPH Center for Clinical Trials,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT02624986,0,0,0,0,0,0,2019-05-20,2020-05-20,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02626130,0,0,0,0,0,0,2021-03-01,2022-03-01,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02626845,1,0,0,0,1,0,2017-07-31,2018-07-31,,"Hospital for Special Surgery, New York",Other,0,1,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,157
NCT02630316,0,0,0,0,0,0,2019-12-31,2020-12-31,,United Therapeutics,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,72
NCT02638948,1,1,0,1,0,0,2018-05-03,2019-05-03,2019-05-01,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02642159,1,1,0,1,0,0,2017-03-22,2018-03-22,2018-03-20,Sanofi,Industry,1,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02643303,0,0,0,0,0,0,2022-08-31,2023-08-31,,Ludwig Institute for Cancer Research,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,46
NCT02643966,0,0,0,0,0,0,2021-12-31,2022-12-31,,Wendie Berg,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02646826,1,1,0,1,0,1,2017-10-31,2018-10-31,2019-05-28,"Wellesley Pharmaceuticals, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02648204,1,1,0,1,0,0,2017-04-10,2018-04-10,2018-04-09,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02652468,1,0,0,0,1,0,2018-09-01,2019-09-01,,"University of Wisconsin, Madison",Other,0,0,1,5.0,,0,2016.0,1,1,1,0,0,1,0,0,0,0,1,715
NCT02654639,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-04-17,Georgetown University,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,214
NCT02657434,0,0,0,0,0,0,2019-11-30,2020-11-30,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02659488,1,0,0,0,1,0,2017-09-30,2018-09-30,,Lindner Center of HOPE,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02660242,1,1,0,1,0,1,2017-02-15,2018-02-15,2018-06-06,Jaeb Center for Health Research,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT02663622,0,0,0,0,0,0,2020-11-30,2021-11-30,,"OncoImmune, Inc.",Industry,1,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT02663817,0,0,0,0,0,0,2019-04-04,2020-04-04,,University of Miami,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,476
NCT02664441,0,0,0,0,0,0,2019-12-31,2020-12-31,,Seattle Children's Hospital,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,137
NCT02664558,0,0,0,0,0,0,2017-11-30,2018-11-30,,Eiger BioPharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02667418,0,0,0,0,0,0,2022-05-31,2023-05-31,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02668666,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Oana Danciu, MD",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02668952,1,1,0,1,0,1,2017-02-04,2018-02-04,2018-02-15,University of New Mexico,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,200
NCT02674490,0,0,0,0,0,0,2021-03-31,2022-03-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02675426,0,0,0,0,0,0,2017-04-21,2018-04-21,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02684344,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-01-02,University of Rochester,Other,0,0,0,5.0,,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,470
NCT02685033,1,1,0,1,0,0,2017-12-12,2018-12-12,2018-12-11,"Durata Therapeutics Inc., an affiliate of Allergan plc",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,7
NCT02686762,0,0,0,0,0,0,2019-01-29,2020-01-29,,Conatus Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT02688855,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Encore Medical, L.P.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,19
NCT02689258,0,0,0,0,0,0,2017-03-31,2018-03-31,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT02689440,0,0,0,0,0,0,2040-12-31,2041-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02690545,0,0,0,0,0,0,2021-10-26,2022-10-26,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,229
NCT02691247,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Caladrius Biosciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,10
NCT02691455,0,0,0,0,0,0,2023-01-31,2024-01-31,,Robert Feldman,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02695628,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-03-13,Sanjiv Sam Gambhir,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,1,0,0,0,0,0,1,8
NCT02697136,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Cerenis Therapeutics, SA",Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02697617,0,0,0,0,0,0,2019-10-31,2020-10-31,,Indiana University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,497
NCT02698254,0,0,0,0,0,0,2020-07-31,2021-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,0,1,0,0,1,0,0,0,0,1,2066
NCT02700984,1,1,0,1,0,0,2018-04-18,2019-04-18,2019-04-10,Alcon Research,Industry,1,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,492
NCT02705196,0,0,0,0,0,0,2019-11-30,2020-11-30,,Lokon Pharma AB,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2
NCT02705729,0,0,0,0,0,0,2020-03-31,2021-03-31,,Louisiana State University Health Sciences Center in New Orleans,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,42
NCT02706197,0,0,0,0,0,0,2020-06-30,2021-06-30,,Periannan Kuppusamy,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02706353,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT02706873,0,0,0,0,0,0,2018-03-15,2019-03-15,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02708836,0,0,0,0,0,0,2021-01-01,2022-01-01,,Milton S. Hershey Medical Center,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,334
NCT02710734,0,0,0,0,0,0,2020-04-30,2021-04-30,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,156
NCT02712905,0,0,0,0,0,0,2021-06-17,2022-06-17,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT02713243,1,1,0,1,0,0,2018-01-25,2019-01-25,2019-01-25,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02713997,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02714881,0,0,0,0,0,0,2020-04-30,2021-04-30,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,698
NCT02720692,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Recro Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,9
NCT02723773,0,0,0,0,0,0,2023-07-28,2024-07-28,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,3276
NCT02724878,0,0,0,0,0,0,2019-10-31,2020-10-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02725554,0,0,0,0,0,0,2021-05-31,2022-05-31,,"StimRelieve, LLC",Industry,1,0,0,3.0,Phase 3,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT02725710,1,1,0,1,0,0,2018-06-13,2019-06-13,2019-06-12,Duke University,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02726906,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Southern California,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,1,0,0,0,0,1,483
NCT02729714,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Burdick, Daniel, M.D.",Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02730234,0,0,0,0,0,0,2019-12-31,2020-12-31,,Midwest Cardiovascular Research Foundation,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT02733991,0,0,0,0,0,0,2018-10-31,2019-10-31,,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,48
NCT02734979,0,0,0,0,0,0,2023-06-30,2024-06-30,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT02736825,0,0,0,0,0,0,2017-01-20,2018-01-20,,"Ulthera, Inc",Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,46
NCT02737046,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Miami,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,476
NCT02737475,0,0,0,0,0,0,2021-05-12,2022-05-12,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02739542,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Texas Southwestern Medical Center,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02741115,0,0,0,0,0,0,2018-12-27,2019-12-27,,Mezzion Pharma Co. Ltd,Industry,1,0,1,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT02741518,0,0,0,0,0,0,2018-10-18,2019-10-18,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,698
NCT02742103,0,0,0,0,0,0,2017-06-30,2018-06-30,,CSL Behring,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,81
NCT02743819,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02746068,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Axsome Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,10
NCT02748616,0,0,0,0,0,0,2019-11-30,2020-11-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT02748863,0,1,0,1,0,1,2017-08-08,2018-08-08,2019-06-07,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02752191,0,0,0,0,0,0,2021-04-30,2022-04-30,,Paul Finn,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02753790,0,0,0,0,0,0,2020-12-31,2021-12-31,,New Mexico Cancer Care Alliance,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,67
NCT02756078,1,1,0,1,0,0,2017-10-02,2018-10-02,2018-09-28,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,138
NCT02760407,0,0,0,0,0,0,2019-12-31,2020-12-31,,R-Pharm,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,44
NCT02766023,0,0,0,0,0,0,2019-02-11,2020-02-11,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,2133
NCT02769000,0,0,0,0,0,0,2020-04-30,2021-04-30,,Virginia Commonwealth University,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,417
NCT02770391,0,0,0,0,0,0,2020-04-30,2021-04-30,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,374
NCT02773940,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Precision Biopsy, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02774265,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-06-27,"University of Maryland, College Park",Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,318
NCT02781818,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-02-09,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02782325,0,1,0,1,0,0,2018-12-03,2019-12-03,2019-02-18,"University of North Carolina, Chapel Hill",Other,0,1,0,0.0,Phase 1/Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,910
NCT02782923,0,0,0,0,0,0,2019-11-30,2020-11-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT02783066,0,0,0,0,0,0,2019-01-31,2020-01-31,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,518
NCT02784249,1,0,0,0,1,0,2017-12-31,2018-12-31,,"New World Medical, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02785250,0,0,0,0,0,0,2020-02-29,2021-02-28,,"ImmunoVaccine Technologies, Inc. (IMV Inc.)",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02786719,0,0,0,0,0,0,2019-03-22,2020-03-22,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02795156,0,0,0,0,0,0,2019-12-01,2020-12-01,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,167
NCT02795520,0,0,0,0,0,0,2019-12-31,2020-12-31,,"OncoTherapy Science, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02795676,0,0,0,0,0,0,2019-03-31,2020-03-31,,Protalix,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,17
NCT02796352,1,1,0,1,0,1,2017-02-16,2018-02-16,2018-02-19,Ahmad Tarhini,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02796677,1,1,0,1,0,0,2017-06-08,2018-06-08,2018-06-08,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02801630,1,0,0,0,1,0,2017-08-31,2018-08-31,,"Rosenblum, Jonathan I., DPM",Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02802514,1,0,1,1,0,0,2017-08-10,2018-08-10,2018-07-30,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,3276
NCT02803073,0,0,0,0,0,0,2019-08-31,2020-08-31,,Texas Tech University Health Sciences Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,78
NCT02805517,0,0,0,0,0,0,2019-12-31,2020-12-31,,Loma Linda University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,194
NCT02807363,1,0,0,0,1,0,2018-06-18,2019-06-18,,Enteris BioPharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT02810392,0,0,0,0,0,0,2020-04-30,2021-04-30,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02811133,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ronald M. Glick,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02811419,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-03-25,"University of California, San Francisco",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1443
NCT02818556,1,0,0,0,1,0,2017-01-31,2018-01-31,,The Maas Clinic,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02824224,1,1,0,1,0,1,2018-01-08,2019-01-08,2019-04-08,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT02826681,0,0,0,0,0,0,2019-09-30,2020-09-30,,"American Regent, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,48
NCT02830724,0,0,0,0,0,0,2027-01-01,2028-01-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT02830880,0,0,0,0,0,0,2018-12-01,2019-12-01,,Emory University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02831257,0,0,0,0,0,0,2020-03-31,2021-03-31,,Massachusetts General Hospital,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02833844,0,0,0,0,0,0,2019-07-09,2020-07-09,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT02835339,0,0,0,0,0,0,2019-06-30,2020-06-30,,Oregon Health and Science University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT02836990,0,0,0,0,0,0,2019-07-31,2020-07-31,,State University of New York at Buffalo,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,105
NCT02839876,0,0,0,0,0,0,2018-10-02,2019-10-02,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT02846623,0,0,0,0,0,0,2021-01-31,2022-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT02847013,0,0,0,0,0,0,2019-12-31,2020-12-31,,Milton S. Hershey Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT02847182,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-08-20,"Joanne Kurtzberg, MD",Other,0,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,15
NCT02848131,0,1,0,1,0,0,2019-06-02,2020-06-02,2019-06-04,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02849223,0,0,0,0,0,0,2020-01-31,2021-01-31,,Minneapolis Veterans Affairs Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,31
NCT02850081,0,0,0,0,0,0,2021-10-31,2022-10-31,,Columbia University,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT02853032,0,0,0,0,0,0,2019-08-31,2020-08-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,257
NCT02854605,1,1,0,1,0,0,2018-01-09,2019-01-09,2019-01-07,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02856581,0,0,0,0,0,0,2021-02-28,2022-02-28,,Alliance for Clinical Trials in Oncology,Other,0,1,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,456
NCT02862158,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Miami,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,476
NCT02862548,1,1,0,1,0,0,2018-02-08,2019-02-08,2019-02-06,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,510
NCT02864082,0,0,0,0,0,0,2018-02-13,2019-02-13,,"Patagonia Pharmaceuticals, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02864316,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-07-16,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,461
NCT02868554,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02871492,0,0,0,0,0,0,2017-08-29,2018-08-29,,AiCuris Anti-infective Cures GmbH,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02876575,0,0,0,0,0,0,2018-10-24,2019-10-24,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,146
NCT02882191,1,0,0,0,1,0,2018-07-17,2019-07-17,,Sebela Pharmaceuticals Inc.,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT02883062,0,0,0,0,0,0,2020-07-01,2021-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02885987,0,0,0,0,0,0,2022-03-31,2023-03-31,,Loma Linda University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,194
NCT02886884,0,0,0,0,0,0,2023-09-30,2024-09-30,,Ivonne Schulman,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02887820,0,0,0,0,0,0,2020-02-29,2021-02-28,,Stephen Esper,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02890355,0,0,0,0,0,0,2019-05-01,2020-05-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02895386,0,0,0,0,0,0,2019-05-01,2020-05-01,,"ROX Medical, Inc.",Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT02898545,1,0,0,0,1,0,2017-07-20,2018-07-20,,University of Cincinnati,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,222
NCT02899000,1,0,0,0,1,0,2017-03-28,2018-03-28,,"Galderma Laboratories, L.P.",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,49
NCT02899988,0,0,0,0,0,0,2017-06-19,2018-06-19,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02901067,0,0,0,0,0,0,2021-12-31,2022-12-31,,Denver Health and Hospital Authority,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,66
NCT02901899,0,0,0,0,0,0,2019-08-31,2020-08-31,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,925
NCT02902172,1,1,0,1,0,0,2017-10-08,2018-10-08,2018-08-22,St. Louis University,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,126
NCT02905578,0,0,0,0,0,0,2023-12-31,2024-12-31,,Joseph J. Cullen,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT02906579,0,0,0,0,0,0,2017-04-30,2018-04-30,,Cyclerion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02907385,1,0,0,0,1,0,2018-03-31,2019-03-31,,LifeBond Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT02907619,0,0,0,0,0,0,2018-11-22,2019-11-22,,Pfizer,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,0,1,0,0,0,0,0,1,0,1,2856
NCT02910505,1,0,0,0,1,0,2018-06-30,2019-06-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,37
NCT02913131,0,0,0,0,0,0,2019-10-31,2020-10-31,,Rahul Aggarwal,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,6
NCT02913417,0,0,0,0,0,0,2020-01-31,2021-01-31,,"David Minor, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,1
NCT02914522,0,0,0,0,0,0,2020-04-30,2021-04-30,,Gilead Sciences,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02915783,0,0,0,0,0,0,2019-04-18,2020-04-18,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,328
NCT02917265,0,0,1,1,0,1,2017-05-31,2018-05-31,2019-02-16,Aikaterini Thanou,Other,0,0,0,1.0,Phase 2,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02918006,0,0,0,0,0,0,2017-05-19,2018-05-19,,Vaxart,Industry,1,0,1,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,13
NCT02919865,1,0,0,0,1,0,2018-06-30,2019-06-30,,Ottawa Hospital Research Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,384
NCT02921789,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT02923180,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02923349,0,0,0,0,0,0,2019-03-26,2020-03-26,,Incyte Biosciences International Sàrl,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02926833,0,0,0,0,0,0,2019-02-14,2020-02-14,,"Kite, A Gilead Company",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,14
NCT02927184,0,0,0,0,0,0,2019-03-26,2020-03-26,,"Viking Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02927470,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT02927834,0,0,0,0,0,0,2018-12-31,2019-12-31,,Loma Linda University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,194
NCT02927912,0,0,0,0,0,0,2020-11-01,2021-11-01,,Ohio State University Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,198
NCT02928978,0,0,0,0,0,0,2022-01-31,2023-01-31,,Julie Nangia,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02931175,0,0,0,0,0,0,2019-07-31,2020-07-31,,Quan Dong Nguyen,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02931565,0,0,0,0,0,0,2018-05-01,2019-05-01,,Cyclerion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02931838,0,0,0,0,0,0,2017-11-16,2018-11-16,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02932943,0,0,0,0,0,0,2018-09-21,2019-09-21,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02933450,1,1,0,1,0,1,2017-08-31,2018-08-31,2019-02-07,Baylor College of Medicine,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02936622,0,0,0,0,0,0,2019-04-23,2020-04-23,,Cook Group Incorporated,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,75
NCT02938520,1,0,1,1,0,0,2018-08-30,2019-08-30,2019-08-05,ViiV Healthcare,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,200
NCT02942355,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Antoinette Tan, MD",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02943447,0,0,0,0,0,0,2018-07-27,2019-07-27,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02949284,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,227
NCT02951104,0,0,0,0,0,0,2020-01-31,2021-01-31,,Santa Barbara Cottage Hospital,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,9
NCT02952898,1,1,0,1,0,1,2017-07-11,2018-07-11,2018-08-24,"Gage Development Company, LLC",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02953821,0,0,0,0,0,0,2019-08-31,2020-08-31,,Mallinckrodt,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,91
NCT02954536,0,0,0,0,0,0,2019-11-30,2020-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02956616,1,1,0,1,0,0,2018-06-15,2019-06-15,2019-02-17,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT02959047,0,0,0,0,0,0,2020-07-17,2021-07-17,,University of Virginia,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT02959307,0,0,0,0,0,0,2018-11-30,2019-11-30,,Massachusetts General Hospital,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1699
NCT02959567,1,0,0,0,1,0,2017-10-31,2018-10-31,,Aqueduct Medical Ltd,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02959944,0,0,0,0,0,0,2020-07-31,2021-07-31,,Pharmacyclics LLC.,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,54
NCT02961374,0,0,0,0,0,0,2020-03-28,2021-03-28,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02961790,1,1,0,1,0,0,2018-04-27,2019-04-27,2019-04-16,Academic and Community Cancer Research United,Other,0,0,1,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT02965846,1,1,0,1,0,0,2017-06-13,2018-06-13,2018-06-13,Allergan,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02966340,1,1,0,1,0,1,2018-03-12,2019-03-12,2019-04-11,"University of Wisconsin, Madison",Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,715
NCT02969798,0,0,0,0,0,0,2022-07-31,2023-07-31,,The University of Texas Health Science Center at San Antonio,Other,0,1,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02971007,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-09-07,"Matinas BioPharma Nanotechnologies, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02971501,0,0,0,0,0,0,2020-07-01,2021-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT02972632,1,1,0,1,0,0,2018-02-06,2019-02-06,2019-02-06,Takeda,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,650
NCT02974296,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York State Psychiatric Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,361
NCT02975206,1,1,0,1,0,0,2018-01-16,2019-01-16,2019-01-14,Menlo Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02976012,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Southeast Retina Center, Georgia",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02979899,0,0,0,0,0,0,2019-04-11,2020-04-11,,Tracon Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,18
NCT02990169,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Intuor Technologies, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT02990468,0,0,0,0,0,0,2020-02-29,2021-02-28,,"BioMimetix JV, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,6
NCT02993159,0,0,0,0,0,0,2019-07-15,2020-07-15,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,925
NCT02994082,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mark Vander Weg,U.S. Fed,2,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02995733,0,0,0,0,0,0,2021-05-31,2022-05-31,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT02999399,0,0,0,0,0,0,2019-10-01,2020-10-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02999737,1,0,0,0,1,0,2017-08-31,2018-08-31,,Skin Care and Laser Physicians of Beverly Hills,Other,0,0,0,4.0,Phase 4,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT03000673,0,0,0,0,0,0,2017-10-23,2018-10-23,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1104
NCT03001700,1,0,0,0,1,0,2017-05-31,2018-05-31,,Cagent Vascular LLC,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,3
NCT03001817,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Kowa Research Institute, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,33
NCT03003741,0,0,0,0,0,0,2018-04-16,2019-04-16,,University of Michigan,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT03007979,0,0,0,0,0,0,2019-08-31,2020-08-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03009019,0,0,0,0,0,0,2017-11-30,2018-11-30,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,212
NCT03010358,0,0,0,0,0,0,2022-02-28,2023-02-28,,OHSU Knight Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,163
NCT03010800,1,1,0,1,0,0,2017-02-28,2018-02-28,2017-05-08,Watkins Conti Products. Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT03012282,0,0,0,0,0,0,2025-09-30,2026-09-30,,University of Washington,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03013998,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Beat AML, LLC",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,1
NCT03015623,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Sentien Biotechnologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,1,0,0,0,0,0,1,0,1
NCT03015740,0,0,0,0,0,0,2023-04-23,2024-04-23,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03015896,0,0,0,0,0,0,2020-04-30,2021-04-30,,Kami Maddocks,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,6
NCT03016533,0,0,0,0,0,0,2023-12-29,2024-12-29,,ViiV Healthcare,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,200
NCT03021460,0,0,0,0,0,0,2021-02-01,2022-02-01,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03021538,0,0,0,0,0,0,2021-03-31,2022-03-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03023631,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03025828,0,0,0,0,0,0,2021-07-31,2022-07-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03028363,1,1,0,1,0,0,2017-11-28,2018-11-28,2018-11-28,"Dermira, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,17
NCT03029091,0,0,0,0,0,0,2019-04-02,2020-04-02,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,437
NCT03029156,0,0,0,0,0,0,2018-12-31,2019-12-31,,Tufts Medical Center,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,121
NCT03032198,0,0,0,0,0,0,2019-12-31,2020-12-31,,Seno Medical Instruments Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03033225,0,0,0,0,0,0,2020-01-31,2021-01-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT03033511,0,0,0,0,0,0,2019-11-30,2020-11-30,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03035214,1,0,0,0,1,0,2017-12-31,2018-12-31,,Maadi Military Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03036852,1,0,1,1,0,0,2018-08-13,2019-08-13,2019-08-12,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,510
NCT03038308,0,0,0,0,0,0,2020-07-31,2021-07-31,,Columbia University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT03038880,0,0,0,0,0,0,2018-01-12,2019-01-12,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1731
NCT03039543,1,1,0,1,0,0,2017-11-10,2018-11-10,2018-01-08,Seoul National University Bundang Hospital,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,221
NCT03041259,0,0,0,0,0,0,2022-01-31,2023-01-31,,"Reven Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03041467,0,0,0,0,0,0,2018-12-06,2019-12-06,,Medtronic Endovascular,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,64
NCT03042585,0,0,0,0,0,0,2018-12-31,2019-12-31,,Loyola University,Other,0,0,0,5.0,,0,2006.0,1,0,0,0,0,1,0,0,0,0,1,102
NCT03044353,0,0,0,0,0,0,2019-01-03,2020-01-03,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,1,0,0,0,0,0,1,1,0,3276
NCT03044912,0,0,0,0,0,0,2019-02-01,2020-02-01,,Buddhist Tzu Chi General Hospital,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,36
NCT03046927,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Benjamin U. Nwosu, MD",Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03047629,1,0,0,0,1,0,2018-04-25,2019-04-25,,Enterin Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03048201,0,0,0,0,0,0,2030-03-31,2031-03-31,,Limacorporate S.p.a,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03050060,0,0,0,0,0,0,2021-12-01,2022-12-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,910
NCT03053102,0,0,0,0,0,0,2018-11-14,2019-11-14,,Achillion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,21
NCT03054506,1,1,0,1,0,0,2018-05-10,2019-05-10,2019-03-11,Massachusetts General Hospital,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1699
NCT03055494,0,0,0,0,0,0,2018-04-26,2019-04-26,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,1895
NCT03055858,0,0,0,0,0,0,2019-08-31,2020-08-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,419
NCT03056001,0,0,0,0,0,0,2020-07-31,2021-07-31,,Edward Kim,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03058536,0,0,0,0,0,0,2019-03-31,2020-03-31,,Mario Henrique Burlacchini de Carvalho,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,1
NCT03060629,0,0,0,0,0,0,2020-11-02,2021-11-02,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,29
NCT03060980,0,0,0,0,0,0,2018-01-26,2019-01-26,,Intarcia Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,21
NCT03063606,0,0,0,0,0,0,2023-10-31,2024-10-31,,Yale University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03064152,0,0,0,0,0,0,2019-09-30,2020-09-30,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,698
NCT03066830,0,0,0,0,0,0,2019-04-30,2020-04-30,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03068455,0,0,0,0,0,0,2020-11-08,2021-11-08,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03070119,0,0,0,0,0,0,2021-02-26,2022-02-26,,Biogen,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03070964,1,0,0,0,1,0,2018-07-31,2019-07-31,,PharmaMar,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT03072147,0,0,0,0,0,0,2020-10-31,2021-10-31,,Michael Zuscik,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03072953,0,0,0,0,0,0,2018-05-22,2019-05-22,,Arena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,21
NCT03074695,0,0,0,0,0,0,2020-12-31,2021-12-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03075163,1,1,0,1,0,1,2017-04-30,2018-04-30,2019-04-18,"University of California, Davis",Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,530
NCT03075527,0,0,1,1,0,0,2020-09-30,2021-09-30,2019-08-23,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03076021,0,0,0,0,0,0,2026-07-26,2027-07-26,,University of Washington,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT03077451,0,0,0,0,0,0,2019-10-31,2020-10-31,,AIDS Malignancy Consortium,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,46
NCT03077659,0,1,0,1,0,0,2018-10-04,2019-10-04,2019-07-02,"NanOlogy, LLC",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03078751,0,0,0,0,0,0,2020-03-25,2021-03-25,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1895
NCT03080883,0,0,0,0,0,0,2020-05-01,2021-05-01,,Academic and Community Cancer Research United,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT03082391,0,0,0,0,0,0,2020-04-20,2021-04-20,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03082534,0,0,0,0,0,0,2019-12-30,2020-12-30,,Assuntina G. Sacco,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03083470,1,1,0,1,0,1,2018-03-12,2019-03-12,2019-04-02,"DFB Soria, LLC",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03087604,1,1,0,1,0,1,2017-10-11,2018-10-11,2018-10-24,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,616
NCT03087877,1,0,0,0,1,0,2017-03-04,2018-03-04,,"DexCom, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,21
NCT03088410,0,0,0,0,0,0,2021-03-31,2022-03-31,,Ann & Robert H Lurie Children's Hospital of Chicago,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,112
NCT03088904,0,0,0,0,0,0,2018-12-12,2019-12-12,,Stanford University,Other,0,0,1,4.0,Phase 4,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,1309
NCT03092323,0,0,0,0,0,0,2024-07-01,2025-07-01,,Sarcoma Alliance for Research through Collaboration,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,18
NCT03093324,0,0,0,0,0,0,2019-06-27,2020-06-27,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,70
NCT03094442,0,0,0,0,0,0,2019-06-30,2020-06-30,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,581
NCT03096314,0,0,0,0,0,0,2018-10-06,2019-10-06,,Massachusetts General Hospital,Other,0,0,1,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1699
NCT03097666,0,0,0,0,0,0,2018-11-01,2019-11-01,,"C2 Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,9
NCT03098615,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-09-26,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT03099187,0,0,0,0,0,0,2018-11-21,2019-11-21,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1731
NCT03100344,1,0,1,1,0,0,2018-07-19,2019-07-19,2019-07-18,Galderma R&D,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,28
NCT03101748,0,0,0,0,0,0,2026-01-01,2027-01-01,,M.D. Anderson Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03105479,1,1,0,1,0,0,2018-04-17,2019-04-17,2019-01-08,Actelion,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,128
NCT03108079,1,0,0,0,1,0,2017-05-31,2018-05-31,,The Pelvic Floor Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03115177,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-04-18,Rush University Medical Center,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,227
NCT03115801,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,586
NCT03116542,0,0,0,0,0,0,2019-05-31,2020-05-31,,Hamad Medical Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,47
NCT03116737,1,0,0,0,1,0,2017-07-21,2018-07-21,,Lachlan Pharma Holdings,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03116997,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03117920,1,0,0,0,1,0,2018-05-15,2019-05-15,,Queen Mary University of London,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,112
NCT03118518,0,0,0,0,0,0,2020-07-01,2021-07-01,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,169
NCT03118934,1,1,0,1,0,0,2017-07-07,2018-07-07,2018-07-03,Alcon Research,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,492
NCT03120897,0,0,0,0,0,0,2018-10-31,2019-10-31,,Masimo Corporation,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,39
NCT03121092,1,0,1,1,0,1,2017-03-07,2018-03-07,2019-04-11,State University of New York - Downstate Medical Center,Other,0,0,0,5.0,,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT03122457,1,0,0,0,1,0,2018-07-19,2019-07-19,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT03122717,0,0,0,0,0,0,2020-04-30,2021-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03126227,0,0,0,0,0,0,2018-08-31,2019-08-31,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,11
NCT03127124,0,0,0,0,0,0,2018-10-31,2019-10-31,,"NantPharma, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03129126,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Lipella Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,2
NCT03129360,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,869
NCT03131648,0,0,0,0,0,0,2018-08-07,2019-08-07,,LEO Pharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,171
NCT03133793,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Kansas Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03135912,1,0,1,1,0,1,2017-08-02,2018-08-02,2018-09-05,South End Skin Care,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03136055,0,0,0,0,0,0,2019-06-19,2020-06-19,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03137498,0,0,0,0,0,0,2019-03-06,2020-03-06,,The Brooklyn Hospital Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03138512,0,0,0,0,0,0,2022-09-05,2023-09-05,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03151005,0,0,0,0,0,0,2018-12-03,2019-12-03,,Xinqiao Hospital of Chongqing,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,27
NCT03151148,0,0,0,0,0,0,2019-06-07,2020-06-07,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,1,0,0,0,0,0,0,1,0,2133
NCT03151707,0,0,0,0,0,0,2019-07-31,2020-07-31,,Mclean Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,126
NCT03155724,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Biotronik, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,26
NCT03156608,1,0,1,1,0,1,2017-06-28,2018-06-28,2018-10-08,"Intermountain Health Care, Inc.",Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,93
NCT03159000,1,0,0,0,1,0,2017-12-31,2018-12-31,,Thomas Jefferson University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,1,0,0,1,0,186
NCT03160170,0,1,0,1,0,0,2018-10-31,2019-10-31,2019-04-23,University of Miami,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,476
NCT03161223,0,0,0,0,0,0,2020-02-29,2021-02-28,,Columbia University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,675
NCT03161522,0,0,0,0,0,0,2023-07-31,2024-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,2066
NCT03162432,1,0,0,0,1,0,2018-07-30,2019-07-30,,Boston Children’s Hospital,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,400
NCT03163667,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Calithera Biosciences, Inc",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03164356,0,0,0,0,0,0,2020-05-01,2021-05-01,,University of Washington,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,0,0,0,0,0,1,910
NCT03164772,0,0,0,0,0,0,2021-03-31,2022-03-31,,Ludwig Institute for Cancer Research,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,46
NCT03165110,1,1,0,1,0,1,2017-05-12,2018-05-12,2019-01-21,Ascensia Diabetes Care,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,36
NCT03168542,1,1,0,1,0,0,2017-05-04,2018-05-04,2018-05-01,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03174678,1,0,1,1,0,1,2017-05-01,2018-05-01,2019-01-09,Aydin Adnan Menderes University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,38
NCT03175354,1,0,0,0,1,0,2018-06-29,2019-06-29,,"Ralexar Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03176173,0,0,0,0,0,0,2020-06-28,2021-06-28,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,1,0,0,0,1,0,1309
NCT03176758,1,0,0,0,1,0,2018-06-01,2019-06-01,,Meir Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,3,1,0,336
NCT03179891,1,0,0,0,1,0,2018-07-25,2019-07-25,,Aquestive Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03180489,0,0,0,0,0,0,2018-12-21,2019-12-21,,Christopher Bell,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03180671,0,0,0,0,0,0,2019-01-01,2020-01-01,,Lukasz Adamczyk,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03180905,0,0,0,0,0,0,2020-06-30,2021-06-30,,"ImPACT Applications, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03182374,0,0,0,0,0,0,2019-09-30,2020-09-30,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,215
NCT03183024,0,0,0,0,0,0,2018-11-06,2019-11-06,,"Jonathan A. Bernstein, MD",Other,0,0,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,1
NCT03183128,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Seres Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03186378,0,0,0,0,0,0,2018-06-25,2019-06-25,,Verrica Pharmaceuticals Inc.,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,0,0,0,0,0,1,0,0,1,0,5
NCT03193853,0,0,0,0,0,0,2021-06-09,2022-06-09,,Baylor Research Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,131
NCT03193996,0,0,0,0,0,0,2021-04-01,2022-04-01,,"Kristin Zhao, PhD",Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03194698,0,0,0,0,0,0,2018-12-06,2019-12-06,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1898
NCT03196297,0,0,0,0,0,0,2018-06-22,2019-06-22,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03198728,0,0,0,0,0,0,2019-10-25,2020-10-25,,Marius Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03199469,0,0,0,0,0,0,2024-03-31,2025-03-31,,Audentes Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,0,0,1,1,1,0,5
NCT03202095,0,0,0,0,0,0,2019-11-01,2020-11-01,,University of Utah,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03202472,0,0,0,0,0,0,2019-02-01,2020-02-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,277
NCT03202615,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Abdelwahed, Mai Mahmoud Mohamed, M.D.",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1
NCT03204188,0,0,0,0,0,0,2027-12-31,2028-12-31,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1091
NCT03204526,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of California, Davis",Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,530
NCT03204786,0,0,0,0,0,0,2022-12-31,2023-12-31,,Stanford University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03206073,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03206749,0,0,0,0,0,0,2017-12-01,2018-12-01,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,141
NCT03211234,0,0,0,0,0,0,2019-12-31,2020-12-31,,Santen Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,29
NCT03211910,1,0,0,0,1,0,2018-06-01,2019-06-01,,Richmond University Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03215719,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,869
NCT03216512,0,0,0,0,0,0,2019-01-31,2020-01-31,,Duke University,Other,0,0,0,5.0,,0,2018.0,1,0,0,0,0,0,0,0,0,1,0,1342
NCT03217136,0,0,0,0,0,0,2021-06-18,2022-06-18,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03219034,0,0,0,0,0,0,2019-03-20,2020-03-20,,Texas A&M University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,57
NCT03219164,0,0,0,0,0,0,2020-01-31,2021-01-31,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03221595,0,0,0,0,0,0,2019-10-22,2020-10-22,,Denver Health and Hospital Authority,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,66
NCT03223896,1,0,0,0,1,0,2017-06-30,2018-06-30,,"National Institute for Health and Welfare, Finland",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,35
NCT03224039,0,0,1,1,0,0,2019-01-01,2020-01-01,2018-07-05,The Brooklyn Hospital Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT03224351,0,0,0,0,0,0,2018-02-28,2019-02-28,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03226678,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03230097,0,0,0,0,0,0,2022-04-27,2023-04-27,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03234933,0,0,0,0,0,0,2020-08-31,2021-08-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT03236428,0,0,0,0,0,0,2020-08-31,2021-08-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03237065,0,0,0,0,0,0,2018-05-29,2019-05-29,,Pharmacosmos A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,30
NCT03238469,1,0,0,0,1,0,2018-04-01,2019-04-01,,M.B.A. van Doorn,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT03238937,0,0,0,0,0,0,2022-07-10,2023-07-10,,"Steward St. Elizabeth's Medical Center of Boston, Inc.",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,16
NCT03239873,1,1,0,1,0,0,2018-08-14,2019-08-14,2019-08-08,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,2145
NCT03245853,0,0,0,0,0,0,2019-09-01,2020-09-01,,Comprehensive EyeCare of Central Ohio,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03247517,0,0,0,0,0,0,2018-10-17,2019-10-17,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,26
NCT03248375,0,0,0,0,0,0,2020-07-31,2021-07-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,412
NCT03250923,0,0,0,0,0,0,2020-12-31,2021-12-31,,"CelaCare Technologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03251053,0,0,0,0,0,0,2021-03-28,2022-03-28,,Miami VA Healthcare System,U.S. Fed,2,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,9
NCT03252756,0,0,0,0,0,0,2019-11-30,2020-11-30,,NYU Langone Health,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03253913,0,0,0,0,0,0,2020-01-30,2021-01-30,,University of Cincinnati,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,222
NCT03256253,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York State Psychiatric Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03257163,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,227
NCT03257267,0,0,0,0,0,0,2023-04-04,2024-04-04,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03257865,0,0,0,0,0,0,2019-01-22,2020-01-22,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,185
NCT03259893,0,0,0,0,0,0,2019-11-30,2020-11-30,,Boston Medical Center,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,225
NCT03260790,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03261830,0,0,0,0,0,0,2020-08-31,2021-08-31,,Sumit Gupta,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03261960,1,0,0,0,1,0,2018-03-26,2019-03-26,,Braintree Laboratories,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,43
NCT03265119,0,1,0,1,0,0,2018-09-24,2019-09-24,2019-06-25,Aevi Genomic Medicine,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03266640,0,0,0,0,0,0,2020-12-31,2021-12-31,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03267004,1,0,0,0,1,0,2018-08-03,2019-08-03,,"The University of Tennessee, Knoxville",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,61
NCT03272217,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Arjun Balar, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03273426,1,0,0,0,1,0,2017-10-31,2018-10-31,,Seoul National University Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,1227
NCT03274999,0,0,0,0,0,0,2017-11-09,2018-11-09,,Allergan,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,495
NCT03277170,0,0,0,0,0,0,2021-08-31,2022-08-31,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03277352,0,0,0,0,0,0,2020-03-31,2021-03-31,,Incyte Biosciences International Sàrl,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03278691,0,0,0,0,0,0,2020-08-02,2021-08-02,,Ascension South East Michigan,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03280550,0,0,0,0,0,0,2019-03-11,2020-03-11,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1731
NCT03281629,0,0,0,0,0,0,2022-12-30,2023-12-30,,"University of Maryland, Baltimore",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,144
NCT03282916,0,0,0,0,0,0,2022-08-31,2023-08-31,,New York State Psychiatric Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03284229,1,0,0,0,1,0,2018-05-31,2019-05-31,,Spectranetics Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,18
NCT03285529,0,0,0,0,0,0,2019-02-28,2020-02-28,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,581
NCT03286465,0,0,0,0,0,0,2018-09-30,2019-09-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03286569,0,0,0,0,0,0,2020-02-01,2021-02-01,,"University of Alberta, Graduate Orthodontic Program",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,5
NCT03287414,0,0,0,0,0,0,2021-12-03,2022-12-03,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03287947,0,0,0,0,0,0,2021-09-01,2022-09-01,,Jimmy Hwang,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03291431,0,0,0,0,0,0,2019-06-01,2020-06-01,,Stanford University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03294577,0,0,0,0,0,0,2020-01-15,2021-01-15,,BeyondSpring Pharmaceuticals Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03295578,1,0,0,0,1,0,2017-11-17,2018-11-17,,TNO,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,28
NCT03297125,0,0,0,0,0,0,2021-05-01,2022-05-01,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03297944,0,0,0,0,0,0,2018-10-25,2019-10-25,,Marion Coe,Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03299049,0,0,0,0,0,0,2019-06-06,2020-06-06,,ViiV Healthcare,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,200
NCT03304080,0,0,0,0,0,0,2019-11-01,2020-11-01,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03304522,0,0,0,0,0,0,2018-10-12,2019-10-12,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03309072,1,0,0,0,1,0,2018-06-12,2019-06-12,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03311334,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Boston Biomedical, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03312231,0,0,0,0,0,0,2019-09-30,2020-09-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03312920,1,0,0,0,1,0,2018-09-06,2019-09-06,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03314662,0,0,0,0,0,0,2017-12-11,2018-12-11,,Seqirus,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,41
NCT03314935,0,0,0,0,0,0,2020-03-25,2021-03-25,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03320057,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03320434,1,0,0,0,1,0,2018-02-16,2019-02-16,,"ORA, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,20
NCT03322475,0,0,0,0,0,0,2019-07-30,2020-07-30,,"Focus Medical, LLC",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03322813,0,0,0,0,0,0,2020-06-30,2021-06-30,,InSightec,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,61
NCT03323229,0,0,0,0,0,0,2019-04-01,2020-04-01,,University of Aberdeen,Other,0,0,0,5.0,,0,2017.0,1,0,0,0,1,0,0,0,2,1,0,94
NCT03326193,0,0,0,0,0,0,2020-10-30,2021-10-30,,"Tesaro, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,31
NCT03329378,0,0,0,0,0,0,2019-10-16,2020-10-16,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03330405,0,0,0,0,0,0,2020-08-04,2021-08-04,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03333057,0,0,0,0,0,0,2018-05-18,2019-05-18,,Novaliq GmbH,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03333577,0,1,0,1,0,0,2018-11-02,2019-11-02,2019-01-16,Cochlear,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,35
NCT03334240,0,0,0,0,0,0,2018-10-30,2019-10-30,,"Maruho Co., Ltd.",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,26
NCT03334409,0,0,0,0,0,0,2020-08-01,2021-08-01,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT03338049,0,0,0,0,0,0,2019-12-31,2020-12-31,,Veran Medical Technologies,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03339310,0,0,0,0,0,0,2019-11-20,2020-11-20,,Impulse Dynamics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,7
NCT03344562,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03344965,0,0,0,0,0,0,2020-01-30,2021-01-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03345901,0,0,0,0,0,0,2019-04-03,2020-04-03,,Jaeb Center for Health Research,Other,0,1,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,93
NCT03346499,0,0,0,0,0,0,2018-11-13,2019-11-13,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,749
NCT03346850,0,0,0,0,0,0,2019-04-01,2020-04-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03347123,0,0,0,0,0,0,2021-01-21,2022-01-21,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03349034,0,0,0,0,0,0,2020-05-31,2021-05-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03350672,1,0,0,0,1,0,2018-03-29,2019-03-29,,Philadelphia Fight,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03353415,0,0,0,0,0,0,2019-10-31,2020-10-31,,Joslin Diabetes Center,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,60
NCT03353675,0,0,0,0,0,0,2019-09-30,2020-09-30,,Transgene,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,14
NCT03357614,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Iterum Therapeutics, International Limited",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03360110,0,0,0,0,0,0,2017-12-15,2018-12-15,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,85
NCT03360851,0,0,0,0,0,0,2020-03-31,2021-03-31,,MJM Bonten,Other,0,1,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,2,1,0,5
NCT03361501,0,0,0,0,0,0,2019-08-31,2020-08-31,,Acasti Pharma Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03365102,0,0,0,0,0,0,2020-01-30,2021-01-30,,Lifespan,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03366337,0,0,0,0,0,0,2019-01-02,2020-01-02,,"Reata Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,44
NCT03372382,1,1,0,1,0,0,2018-04-10,2019-04-10,2019-04-04,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,490
NCT03372811,1,0,0,0,1,0,2018-03-14,2019-03-14,,Psoriasis Research Institute of Guangzhou,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03373006,0,0,0,0,0,0,2019-06-30,2020-06-30,,Desert Medical Imaging,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03373461,0,0,0,0,0,0,2021-04-12,2022-04-12,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03376139,0,0,0,0,0,0,2019-08-31,2020-08-31,,Pharmacotherapies for Alcohol and Substance Abuse Consortium,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03377621,0,0,0,0,0,0,2018-09-30,2019-09-30,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,692
NCT03380624,1,0,0,0,1,0,2018-06-30,2019-06-30,,Ohio State University,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,315
NCT03381248,0,0,0,0,0,0,2019-02-08,2020-02-08,,Avanos Medical,Other,0,0,0,5.0,,0,2017.0,0,0,1,1,0,0,0,0,0,1,0,3
NCT03382041,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03383627,1,0,0,0,1,0,2018-08-21,2019-08-21,,Northwell Health,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,271
NCT03384238,0,0,0,0,0,0,2020-02-07,2021-02-07,,Eben Rosenthal,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,9
NCT03385343,0,0,0,0,0,0,2020-08-01,2021-08-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,1898
NCT03386305,0,0,0,0,0,0,2019-12-13,2020-12-13,,Albert Einstein Healthcare Network,Other,0,1,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,45
NCT03388164,0,0,0,0,0,0,2021-01-01,2022-01-01,,"Laureate Institute for Brain Research, Inc.",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,30
NCT03388346,0,0,0,0,0,0,2020-01-01,2021-01-01,,Michael Graham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03391076,0,0,0,0,0,0,2018-09-30,2019-09-30,,Bin Cao,Other,0,1,0,5.0,,0,2017.0,1,0,0,0,1,0,0,0,2,1,0,2
NCT03394781,0,0,0,0,0,0,2019-01-31,2020-01-31,,Durect,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03395184,0,0,0,0,0,0,2022-11-30,2023-11-30,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03400423,1,0,0,0,1,0,2018-06-01,2019-06-01,,"Western University, Canada",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,104
NCT03401749,0,0,0,0,0,0,2020-01-01,2021-01-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03402789,0,0,0,0,0,0,2020-03-31,2021-03-31,,Johns Hopkins University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03403634,0,0,0,0,0,0,2019-09-01,2020-09-01,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT03405792,0,0,0,0,0,0,2023-02-28,2024-02-28,,University of Florida,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,849
NCT03406338,0,0,0,0,0,0,2021-05-31,2022-05-31,,Region Skane,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,163
NCT03408145,0,0,0,0,0,0,2018-12-31,2019-12-31,,The Foundation for Sports Medicine and Arthritis Research,Other,0,0,0,5.0,,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,2
NCT03409679,0,0,0,0,0,0,2019-07-17,2020-07-17,,Polyphor Ltd.,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,12
NCT03410056,0,0,0,0,0,0,2021-08-04,2022-08-04,,Amgen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03414502,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Nebraska,Other,0,0,0,3.0,Phase 3,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,327
NCT03414645,0,0,0,0,0,0,2019-09-30,2020-09-30,,Cambium Medical Technologies LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03417960,0,0,0,0,0,0,2019-04-01,2020-04-01,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,511
NCT03418038,0,0,0,0,0,0,2024-03-15,2025-03-15,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03418662,1,0,1,1,0,0,2018-09-13,2019-09-13,2019-07-30,Indiana University,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,497
NCT03419403,0,0,0,0,0,0,2020-02-17,2021-02-17,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,1,0,0,1,1,0,430
NCT03420768,0,0,0,0,0,0,2020-08-30,2021-08-30,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1104
NCT03421275,0,0,0,0,0,0,2022-12-01,2023-12-01,,"Anna Meuronen, MD",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03421652,0,0,0,0,0,0,2020-01-31,2021-01-31,,Barbara Ann Karmanos Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,134
NCT03423199,0,0,0,0,0,0,2022-02-28,2023-02-28,,"National Cancer Center, Japan",Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,4
NCT03425396,0,0,0,0,0,0,2019-05-15,2020-05-15,,Paratek Pharmaceuticals Inc,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03426098,0,0,0,0,0,0,2019-05-30,2020-05-30,,"Goldman, Butterwick, Fitzpatrick and Groff",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,12
NCT03428932,0,0,0,0,0,0,2019-07-01,2020-07-01,,Nemours Children's Clinic,Other,0,0,1,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,75
NCT03429543,0,0,0,0,0,0,2021-07-05,2022-07-05,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03430544,0,0,0,0,0,0,2020-07-31,2021-07-31,,Anna Rose Childress,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03430856,0,0,0,0,0,0,2019-02-06,2020-02-06,,Biocon Limited,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,6
NCT03431077,1,0,0,0,1,0,2018-04-14,2019-04-14,,La Jolla Pharmaceutical Company,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03431467,0,0,0,0,0,0,2021-01-01,2022-01-01,,University of Pennsylvania,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03434275,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Recro Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT03434418,0,0,0,0,0,0,2021-06-30,2022-06-30,,Duke University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03434730,0,0,0,0,0,0,2021-02-07,2022-02-07,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03438266,1,1,0,1,0,0,2018-05-29,2019-05-29,2019-05-29,Allergan,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,495
NCT03439319,0,0,0,0,0,0,2020-09-30,2021-09-30,,MyndTec Inc.,Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,2
NCT03439462,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Aadi, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03439735,0,0,0,0,0,0,2020-07-01,2021-07-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03439891,0,0,0,0,0,0,2020-05-29,2021-05-29,,Robin Kate Kelley,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03446157,0,0,0,0,0,0,2020-07-13,2021-07-13,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03447769,0,0,0,0,0,0,2021-08-31,2022-08-31,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03451006,0,0,0,0,0,0,2020-04-30,2021-04-30,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03451396,1,0,0,0,1,0,2018-02-01,2019-02-01,,Lifelong Vision Foundation,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT03451825,0,0,0,0,0,0,2022-06-01,2023-06-01,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03452072,0,0,0,0,0,0,2019-12-29,2020-12-29,,Brigham and Women's Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03452267,0,0,0,0,0,0,2019-12-31,2020-12-31,,Wayne State University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,145
NCT03452540,0,0,0,0,0,0,2019-12-31,2020-12-31,,Afimmune,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03452943,0,0,0,0,0,0,2019-10-22,2020-10-22,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,1,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,101
NCT03453619,0,0,0,0,0,0,2019-12-22,2020-12-22,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03455829,0,0,0,0,0,0,2021-04-30,2022-04-30,,"G1 Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03456115,0,0,0,0,0,0,2020-05-31,2021-05-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03456674,0,0,0,0,0,0,2019-05-31,2020-05-31,,LUTRONIC Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,9
NCT03456804,0,0,0,0,0,0,2019-10-31,2020-10-31,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,134
NCT03461289,0,0,0,0,0,0,2020-11-30,2021-11-30,,"AveXis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,8
NCT03467763,0,0,0,0,0,0,2019-12-01,2020-12-01,,Weill Medical College of Cornell University,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03467919,0,0,0,0,0,0,2019-06-30,2020-06-30,,Stanford University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03470545,0,0,0,0,0,0,2020-06-30,2021-06-30,,"MyoKardia, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03471936,0,0,0,0,0,0,2019-12-01,2020-12-01,,University of Leipzig,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,1,0,0,0,2,0,1,105
NCT03472326,0,0,0,0,0,0,2020-02-29,2021-02-28,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,510
NCT03473171,0,0,0,0,0,0,2019-03-31,2020-03-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03474029,0,0,0,0,0,0,2023-12-31,2024-12-31,,Centers for Disease Control and Prevention,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,267
NCT03476330,0,0,0,0,0,0,2023-09-30,2024-09-30,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03476798,0,0,0,0,0,0,2021-02-28,2022-02-28,,University of Oklahoma,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,234
NCT03484429,0,0,0,0,0,0,2020-01-30,2021-01-30,,Hunter Holmes Mcguire Veteran Affairs Medical Center,U.S. Fed,2,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,19
NCT03485924,0,0,0,0,0,0,2020-04-12,2021-04-12,,Johns Hopkins University,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1143
NCT03487276,0,0,0,0,0,0,2019-05-28,2020-05-28,,InflaRx GmbH,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03491150,0,0,0,0,0,0,2019-05-31,2020-05-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1731
NCT03491683,0,0,0,0,0,0,2021-01-18,2022-01-18,,Inovio Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,1,0,0,0,1,0,25
NCT03493425,0,0,0,0,0,0,2023-02-28,2024-02-28,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,75
NCT03497689,0,0,0,0,0,0,2020-01-31,2021-01-31,,United Therapeutics,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,72
NCT03497897,0,0,0,0,0,0,2020-08-17,2021-08-17,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03503578,1,0,1,1,0,1,2018-08-01,2019-08-01,2019-08-02,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1699
NCT03507036,0,0,0,0,0,0,2019-01-30,2020-01-30,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03507686,0,0,0,0,0,0,2020-03-31,2021-03-31,,NightstaRx Ltd,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03508453,0,0,0,0,0,0,2020-05-15,2021-05-15,,Implicit Bioscience,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,5
NCT03508700,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Tonix Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,19
NCT03511976,0,0,0,0,0,0,2021-06-30,2022-06-30,,Florida International University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03512288,0,0,0,0,0,0,2020-02-01,2021-02-01,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2856
NCT03513731,0,0,0,0,0,0,2020-03-31,2021-03-31,,"InGeneron, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,5
NCT03514641,0,0,0,0,0,0,2018-11-30,2019-11-30,,Theracos,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03515707,0,0,0,0,0,0,2022-04-15,2023-04-15,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,393
NCT03516838,0,0,0,0,0,0,2018-12-31,2019-12-31,,University Ghent,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,151
NCT03517553,0,0,0,0,0,0,2019-06-01,2020-06-01,,Bradley S. Dixon,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT03519178,0,0,0,0,0,0,2022-10-29,2023-10-29,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03519945,0,0,0,0,0,0,2023-08-23,2024-08-23,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03523117,0,0,0,0,0,0,2020-01-31,2021-01-31,,"American Regent, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,48
NCT03528577,0,0,0,0,0,0,2019-03-11,2020-03-11,,Sun Pharmaceutical Industries Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03529942,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Flexion Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,15
NCT03531905,0,0,0,0,0,0,2019-07-31,2020-07-31,,Esperion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03532776,0,0,0,0,0,0,2018-12-02,2019-12-02,,"bioRASI, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,6
NCT03535506,0,0,0,0,0,0,2019-12-31,2020-12-31,,Georgetown University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03537651,0,0,0,0,0,0,2020-12-31,2021-12-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,141
NCT03538795,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,801
NCT03541174,0,0,0,0,0,0,2021-02-08,2022-02-08,,Idorsia Pharmaceuticals Ltd.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03542877,0,0,0,0,0,0,2022-03-31,2023-03-31,,Academic Thoracic Oncology Medical Investigators Consortium,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03544216,1,1,0,1,0,0,2018-05-06,2019-05-06,2018-12-28,Ohio State University,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,315
NCT03547635,0,0,0,0,0,0,2019-08-31,2020-08-31,,Integra LifeSciences Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,40
NCT03547908,0,0,0,0,0,0,2021-03-31,2022-03-31,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03552016,0,0,0,0,0,0,2021-10-10,2022-10-10,,University of Missouri-Columbia,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03552276,0,0,0,0,0,0,2023-06-30,2024-06-30,,Sun Pharma Global FZE,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,17
NCT03554473,0,0,0,0,0,0,2023-01-15,2024-01-15,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03554772,1,0,0,0,1,0,2018-08-20,2019-08-20,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,212
NCT03556280,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Cognito Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03557034,0,0,0,0,0,0,2019-11-30,2020-11-30,,The Cleveland Clinic,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03557372,0,0,0,0,0,0,2020-06-01,2021-06-01,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,647
NCT03558087,0,0,0,0,0,0,2020-06-30,2021-06-30,,Matthew Galsky,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03559829,1,1,0,1,0,1,2018-02-02,2019-02-02,2019-03-15,Stanford University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1309
NCT03560362,0,0,0,0,0,0,2018-10-31,2019-10-31,,University of Tennessee Health Science Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT03562273,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,318
NCT03565783,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03566017,0,0,0,0,0,0,2022-09-30,2023-09-30,,Protalix,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,17
NCT03567824,0,0,0,0,0,0,2019-03-31,2020-03-31,,Pharmalyte Solutions LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,2
NCT03567980,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03568162,0,0,0,0,0,0,2020-04-30,2021-04-30,,Glenmark Pharmaceuticals S.A.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03569293,0,0,0,0,0,0,2019-12-20,2020-12-20,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03571945,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sir Ganga Ram Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,13
NCT03574779,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Tesaro, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT03576885,0,0,0,0,0,0,2021-08-31,2022-08-31,,Florida Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,63
NCT03578029,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Lenus Therapeutics, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03579771,0,0,0,0,0,0,2021-09-30,2022-09-30,,Emory University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03580616,0,0,0,0,0,0,2022-06-30,2023-06-30,,Elijah W. Stommel,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03581474,1,0,0,0,1,0,2018-07-03,2019-07-03,,Ambu A/S,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03582176,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Calgary,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,361
NCT03582722,0,0,0,0,0,0,2021-04-30,2022-04-30,,Emory University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03583359,0,0,0,0,0,0,2019-05-22,2020-05-22,,"Merz North America, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,35
NCT03583918,1,0,0,0,1,0,2018-06-13,2019-06-13,,"Cytrellis Biosystems, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03584100,0,0,0,0,0,0,2019-11-01,2020-11-01,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03584776,0,0,0,0,0,0,2021-10-31,2022-10-31,,Gillette Children's Specialty Healthcare,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03585114,0,0,0,0,0,0,2019-12-31,2020-12-31,,Emerson Lim,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03588910,0,0,0,0,0,0,2019-07-04,2020-07-04,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03590366,0,0,0,0,0,0,2019-02-11,2020-02-11,,AOBiome LLC,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,10
NCT03591094,0,0,0,0,0,0,2019-02-18,2020-02-18,,"Proteostasis Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03591575,0,0,0,0,0,0,2020-12-01,2021-12-01,,ApoPharma,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,25
NCT03592264,0,0,0,0,0,0,2021-08-31,2022-08-31,,"OBI Pharma, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03592472,0,0,0,0,0,0,2022-01-17,2023-01-17,,"Xynomic Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03595124,0,0,0,0,0,0,2024-01-09,2025-01-09,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03597295,0,0,0,0,0,0,2020-12-31,2021-12-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03600441,0,0,0,0,0,0,2020-09-01,2021-09-01,,"Xynomic Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03602560,0,0,0,0,0,0,2020-12-31,2021-12-31,,"CymaBay Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,18
NCT03606187,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stimgenics LLC,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03610581,0,0,0,0,0,0,2020-08-09,2021-08-09,,Janssen Vaccines & Prevention B.V.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,29
NCT03611270,0,0,0,0,0,0,2020-07-31,2021-07-31,,SoniVie Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03611985,0,0,0,0,0,0,2022-09-30,2023-09-30,,University of Florida,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03612648,0,0,0,0,0,0,2026-08-31,2027-08-31,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,1151
NCT03612869,0,0,0,0,0,0,2022-01-31,2023-01-31,,LYSOGENE,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03616717,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03617172,0,0,0,0,0,0,2022-11-30,2023-11-30,,Vanderbilt University Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03617705,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Florida,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03619551,0,0,0,0,0,0,2026-08-01,2027-08-01,,"Michael Pulsipher, MD",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,4
NCT03619811,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,882
NCT03620448,1,0,0,0,1,0,2017-05-15,2018-05-15,,"Kilimanjaro Christian Medical Centre, Tanzania",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,2
NCT03621410,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03622112,0,0,0,0,0,0,2019-10-02,2020-10-02,,AstraZeneca,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03623074,0,0,0,0,0,0,2021-11-30,2022-11-30,,"SightGlass Vision, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,3
NCT03623529,0,0,0,0,0,0,2023-03-31,2024-03-31,,La Jolla Pharmaceutical Company,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,18
NCT03624101,0,0,0,0,0,0,2020-11-01,2021-11-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03624985,0,0,0,0,0,0,2020-06-04,2021-06-04,,University of Vermont Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03625401,0,0,0,0,0,0,2019-07-31,2020-07-31,,Zhejiang Hisun Pharmaceutical Co. Ltd.,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03626701,0,0,0,0,0,0,2020-10-31,2021-10-31,,Avita Medical,Industry,1,0,1,5.0,,0,2018.0,0,0,0,1,0,0,1,0,3,1,0,9
NCT03633318,0,0,0,0,0,0,2019-06-30,2020-06-30,,Yale University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1053
NCT03633994,0,0,0,0,0,0,2019-09-01,2020-09-01,,The Christ Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03635099,0,0,0,0,0,0,2019-10-18,2020-10-18,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03635788,0,0,0,0,0,0,2022-09-01,2023-09-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03636373,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Rutgers, The State University of New Jersey",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,227
NCT03636555,0,0,0,0,0,0,2022-09-30,2023-09-30,,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03638128,0,0,0,0,0,0,2024-03-15,2025-03-15,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03638726,0,0,0,0,0,0,2019-03-31,2020-03-31,,Dar El Oyoun Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,2
NCT03639311,0,0,0,0,0,0,2020-01-13,2021-01-13,,ViiV Healthcare,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,200
NCT03641326,0,0,0,0,0,0,2021-06-03,2022-06-03,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,3004
NCT03644342,0,0,0,0,0,0,2021-03-01,2022-03-01,,Michelle S Ludwig,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03645395,0,0,0,0,0,0,2020-12-17,2021-12-17,,"Molecular Templates, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03647332,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rothman Institute Orthopaedics,Other,0,0,0,5.0,,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,58
NCT03647488,0,0,0,0,0,0,2022-01-18,2023-01-18,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03648853,0,0,0,0,0,0,2018-11-30,2019-11-30,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1443
NCT03649724,0,0,0,0,0,0,2020-12-31,2021-12-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03650738,0,0,0,0,0,0,2019-12-30,2020-12-30,,The First Affiliated Hospital with Nanjing Medical University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,90
NCT03653741,0,0,0,0,0,0,2020-03-18,2021-03-18,,Weill Medical College of Cornell University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03656536,0,0,0,0,0,0,2022-03-31,2023-03-31,,Incyte Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03657160,0,0,0,0,0,0,2020-10-23,2021-10-23,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,209
NCT03657641,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Southern California,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,483
NCT03659929,0,0,0,0,0,0,2019-06-28,2020-06-28,,"Arbor Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03660475,0,0,0,0,0,0,2018-11-01,2019-11-01,,"Eugene B. McLaurin, M.D., F.A.C.S.",Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03660943,0,0,0,0,0,0,2020-05-31,2021-05-31,,Centrexion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03663543,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Pennsylvania,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT03663855,0,0,0,0,0,0,2020-12-31,2021-12-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03664518,0,0,0,0,0,0,2019-10-31,2020-10-31,,Institute of Hematology & Blood Diseases Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,30
NCT03666000,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Precision BioSciences, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,1,0,1,0,2
NCT03669146,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Donald O Mutti, OD, PhD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03671213,0,0,0,0,0,0,2021-12-31,2022-12-31,,Moximed,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03671811,0,0,0,0,0,0,2020-12-07,2021-12-07,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT03673241,0,0,0,0,0,0,2019-01-30,2020-01-30,,TurnCare Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03673670,0,0,1,1,0,0,2018-11-13,2019-11-13,2019-06-20,Verona Pharma plc,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,9
NCT03674528,0,0,0,0,0,0,2021-05-01,2022-05-01,,"University of Wisconsin, Madison",Other,0,0,1,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,715
NCT03675126,0,0,0,0,0,0,2024-07-31,2025-07-31,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,32
NCT03675737,0,0,0,0,0,0,2024-02-02,2025-02-02,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03677596,0,0,0,0,0,0,2024-08-09,2025-08-09,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03680092,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Dimitrios Tzachanis, MD PhD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03681184,0,0,0,0,0,0,2019-12-31,2020-12-31,,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,45
NCT03681990,1,0,1,1,0,1,2017-07-04,2018-07-04,2019-03-13,3M,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,56
NCT03683433,0,0,0,0,0,0,2021-09-20,2022-09-20,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03684785,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Exicure, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03687736,0,0,0,0,0,0,2019-11-30,2020-11-30,,Q-Med AB,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,56
NCT03689374,0,0,0,0,0,0,2020-10-02,2021-10-02,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,981
NCT03690869,0,0,0,0,0,0,2025-01-27,2026-01-27,,Regeneron Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,176
NCT03691844,0,0,0,0,0,0,2019-07-09,2020-07-09,,Amzell,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1
NCT03692364,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Sahlgrenska University Hospital, Sweden",Other,0,1,0,5.0,,0,2003.0,0,0,0,1,0,0,0,0,3,0,1,149
NCT03693625,0,0,0,0,0,0,2020-09-29,2021-09-29,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03697564,0,0,0,0,0,0,2021-12-31,2022-12-31,,Hitendra Patel,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03699033,0,0,0,0,0,0,2020-10-01,2021-10-01,,"Krishna Reddy, MD, PhD",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT03699839,0,0,0,0,0,0,2020-01-31,2021-01-31,,Oriol Manuel,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,1
NCT03705286,0,0,0,0,0,0,2022-06-30,2023-06-30,,Oregon Health and Science University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,475
NCT03711058,0,0,0,0,0,0,2021-01-31,2022-01-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03711253,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Southern California,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03711578,0,0,0,0,0,0,2020-02-29,2021-02-28,,Rhizen Pharmaceuticals SA,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03714880,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of California, Davis",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03718429,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03722407,0,0,0,0,0,0,2022-05-01,2023-05-01,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03724253,0,0,0,0,0,0,2019-06-20,2020-06-20,,Advanced Accelerator Applications,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,14
NCT03724422,0,0,0,0,0,0,2020-10-30,2021-10-30,,University of Louisville,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,214
NCT03724552,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03727022,0,0,0,0,0,0,2020-08-31,2021-08-31,,Samumed LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03728985,0,0,0,0,0,0,2026-06-30,2027-06-30,,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,52
NCT03729362,0,0,0,0,0,0,2020-12-31,2021-12-31,,Amicus Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,34
NCT03733301,0,0,0,0,0,0,2019-07-29,2020-07-29,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1512
NCT03733925,0,0,0,0,0,0,2021-01-25,2022-01-25,,Johnson & Johnson Private Limited,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03734471,0,0,0,0,0,0,2019-07-01,2020-07-01,,Crozer-Keystone Health System,Other,0,0,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT03736720,0,0,0,0,0,0,2021-09-05,2022-09-05,,Roswell Park Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,294
NCT03736967,0,0,0,0,0,0,2020-03-30,2021-03-30,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03738618,0,0,0,0,0,0,2021-07-31,2022-07-31,,Ferring Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,208
NCT03738891,0,0,0,0,0,0,2019-08-31,2020-08-31,,Zeltiq Aesthetics,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,32
NCT03739619,0,0,0,0,0,0,2022-11-30,2023-11-30,,Emory University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03739814,0,0,0,0,0,0,2021-02-01,2022-02-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03740750,0,0,0,0,0,0,2018-12-31,2019-12-31,,Future Sciene Technology,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03740919,0,0,0,0,0,0,2021-01-02,2022-01-02,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03742479,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Goldman, Butterwick, Fitzpatrick and Groff",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03742973,0,0,0,0,0,0,2019-09-26,2020-09-26,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1512
NCT03743662,0,0,0,0,0,0,2021-11-30,2022-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03745118,0,0,0,0,0,0,2020-12-01,2021-12-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03745313,0,0,0,0,0,0,2020-06-30,2021-06-30,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,77
NCT03746405,0,0,0,0,0,0,2019-12-31,2020-12-31,,Duke University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03747484,0,0,0,0,0,0,2033-10-15,2034-10-15,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,393
NCT03749018,0,0,0,0,0,0,2021-12-31,2022-12-31,,Kami Maddocks,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,6
NCT03749317,0,0,0,0,0,0,2020-10-31,2021-10-31,,IVIEW Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03749447,0,0,0,0,0,0,2024-02-29,2025-02-28,,"Reata Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,44
NCT03752632,0,0,0,0,0,0,2019-04-15,2020-04-15,,Physeon GmbH,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03752905,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Phoenix Tissue Repair, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03754933,0,0,0,0,0,0,2020-08-31,2021-08-31,,"PNP Therapeutics, Inc.",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03756012,0,0,0,0,0,0,2019-11-20,2020-11-20,,Kettering Health Network,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03757689,0,0,0,0,0,0,2021-04-30,2022-04-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03758157,0,0,0,0,0,0,2018-11-15,2019-11-15,,Wello Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,1
NCT03759340,0,0,0,0,0,0,2019-08-27,2020-08-27,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2019.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03761277,0,0,0,0,0,0,2021-08-31,2022-08-31,,MedtronicNeuro,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,57
NCT03762798,0,0,0,0,0,0,2019-10-25,2020-10-25,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03765229,0,0,0,0,0,0,2020-12-31,2021-12-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03767153,0,0,0,0,0,0,2019-10-05,2020-10-05,,Venus Concept,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT03768713,0,0,0,0,0,0,2020-08-31,2021-08-31,,Michigan Technological University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03769207,0,0,0,0,0,0,2019-07-05,2020-07-05,,Apple Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03769311,0,0,0,0,0,0,2022-03-31,2023-03-31,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03769467,0,0,0,0,0,0,2023-09-30,2024-09-30,,Atara Biotherapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,10
NCT03770299,0,0,0,0,0,0,2023-03-14,2024-03-14,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03771313,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03771898,0,0,0,0,0,0,2022-08-15,2023-08-15,,Shire,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,342
NCT03772717,0,0,0,0,0,0,2020-10-31,2021-10-31,,Emory University,Other,0,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,947
NCT03774394,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03776461,0,0,0,0,0,0,2020-02-01,2021-02-01,,Venus Concept,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT03776812,0,0,0,0,0,0,2023-03-31,2024-03-31,,Corcept Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03777059,0,0,0,0,0,0,2020-02-05,2021-02-05,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03781063,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sermonix Pharmaceuticals LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03781479,0,0,0,0,0,0,2019-12-15,2020-12-15,,"Catalyst Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,12
NCT03781726,0,0,0,0,0,0,2021-12-31,2022-12-31,,Raymond Chung,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03782571,0,0,0,0,0,0,2019-03-25,2020-03-25,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,138
NCT03783078,0,0,0,0,0,0,2021-09-13,2022-09-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03783546,0,0,0,0,0,0,2021-01-01,2022-01-01,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT03788434,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Vedanta Biosciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03790280,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,692
NCT03792555,0,0,0,0,0,0,2020-06-30,2021-06-30,,Crinetics Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03793387,0,0,0,0,0,0,2019-10-10,2020-10-10,,National Taiwan University Hospital Hsin-Chu Branch,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,9
NCT03793608,0,0,0,0,0,0,2020-08-13,2021-08-13,,Regeneron Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03794960,0,0,0,0,0,0,2021-12-14,2022-12-14,,"Tolerion, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,3
NCT03795116,0,0,0,0,0,0,2019-12-31,2020-12-31,,State University of New York - Downstate Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,19
NCT03796689,0,0,0,0,0,0,2021-02-28,2022-02-28,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1443
NCT03800693,0,0,0,0,0,0,2021-03-31,2022-03-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03801616,0,0,0,0,0,0,2019-05-01,2020-05-01,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,279
NCT03804944,0,0,0,0,0,0,2021-12-30,2022-12-30,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,586
NCT03805711,0,0,0,0,0,0,2020-08-31,2021-08-31,,HLT Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,5
NCT03806933,0,0,0,0,0,0,2020-10-31,2021-10-31,,Merz Pharmaceuticals GmbH,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,58
NCT03808077,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03809117,0,0,0,0,0,0,2019-08-19,2020-08-19,,Andrew Meltzer,Other,0,1,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,3
NCT03811002,0,0,0,0,0,0,2024-05-11,2025-05-11,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,3004
NCT03812263,0,0,0,0,0,0,2022-11-30,2023-11-30,,Rocket Pharmaceuticals Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03812523,0,0,0,0,0,0,2021-02-28,2022-02-28,,Southeastern Regional Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03813407,0,0,0,0,0,0,2021-01-07,2022-01-07,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03814096,0,0,0,0,0,0,2022-10-29,2023-10-29,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1309
NCT03814317,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Florida,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03816956,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Aridis Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03817398,0,0,0,0,0,0,2023-12-31,2024-12-31,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,389
NCT03819985,0,0,0,0,0,0,2023-08-31,2024-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,2066
NCT03821402,0,0,0,0,0,0,2020-08-24,2021-08-24,,"Revance Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,26
NCT03822312,0,0,0,0,0,0,2023-12-31,2024-12-31,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03823287,0,0,0,0,0,0,2021-08-31,2022-08-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03824938,0,0,0,0,0,0,2021-01-31,2022-01-31,,Columbia University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03829124,0,0,0,0,0,0,2021-01-19,2022-01-19,,Chang Gung Memorial Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,486
NCT03831711,0,0,0,0,0,0,2021-06-18,2022-06-18,,Andrei Iagaru,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,12
NCT03832114,0,0,0,0,0,0,2020-08-18,2021-08-18,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03835754,0,0,0,0,0,0,2020-01-31,2021-01-31,,TransMedics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT03836001,0,0,0,0,0,0,2021-09-30,2022-09-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03836209,0,0,0,0,0,0,2022-11-30,2023-11-30,,"PrECOG, LLC.",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,14
NCT03838497,1,0,0,0,1,0,2017-01-31,2018-01-31,,Korea University Guro Hospital,Other,0,0,0,4.0,Phase 4,0,2015.0,1,0,1,0,0,0,0,0,3,0,1,41
NCT03844412,0,0,0,0,0,0,2022-10-01,2023-10-01,,Duke University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03847090,0,0,0,0,0,0,2023-01-31,2024-01-31,,Allena Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03847922,0,0,0,0,0,0,2020-12-01,2021-12-01,,Baylor Research Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,131
NCT03850366,0,0,0,0,0,0,2023-01-01,2024-01-01,,Henry Ford Health System,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,151
NCT03850483,0,0,0,0,0,0,2020-05-13,2021-05-13,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03850964,0,0,0,0,0,0,2020-12-31,2021-12-31,,Cure HHT,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03852459,0,0,0,0,0,0,2019-04-04,2020-04-04,,"Aponia Laboratories, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03856099,0,0,0,0,0,0,2020-11-15,2021-11-15,,PharmAbcine,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT03857321,0,0,0,0,0,0,2020-03-31,2021-03-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,616
NCT03857581,0,0,0,0,0,0,2021-07-31,2022-07-31,,Augusta University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,117
NCT03858205,0,0,0,0,0,0,2021-03-11,2022-03-11,,University of Southern California,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,483
NCT03859973,0,0,0,0,0,0,2020-11-27,2021-11-27,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03861338,0,0,0,0,0,0,2019-11-30,2020-11-30,,New York State Psychiatric Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03861767,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Derek C. Angus, MD, MPH",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03862807,0,0,0,0,0,0,2021-01-14,2022-01-14,,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,45
NCT03863574,0,0,0,0,0,0,2020-09-02,2021-09-02,,Zydus Discovery DMCC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03866382,0,0,0,0,0,0,2023-02-28,2024-02-28,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03870269,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Ceevra, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03872401,0,0,0,0,0,0,2024-05-29,2025-05-29,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03877640,0,0,0,0,0,0,2020-01-31,2021-01-31,,San Diego Sexual Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03878446,0,0,0,0,0,0,2020-06-08,2021-06-08,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03879629,0,0,0,0,0,0,2022-12-31,2023-12-31,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03885245,0,0,0,0,0,0,2024-06-30,2025-06-30,,"University of Colorado, Denver",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,882
NCT03888807,0,0,0,0,0,0,2018-10-01,2019-10-01,,Sport and Spine Rehab Clinical Research Foundation,Other,0,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03894553,0,0,0,0,0,0,2020-11-01,2021-11-01,,"Jeff Elias, MD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03895840,0,0,0,0,0,0,2020-06-10,2021-06-10,,University of Kansas Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03897959,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Nellie Medical, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03898479,0,0,0,0,0,0,2020-12-31,2021-12-31,,Concert Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03901053,0,0,0,0,0,0,2023-09-30,2024-09-30,,Jason Wilken,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03901573,0,0,0,0,0,0,2022-05-31,2023-05-31,,NeoImmuneTech,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03904264,0,0,0,0,0,0,2021-01-01,2022-01-01,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03904446,0,0,0,0,0,0,2021-01-31,2022-01-31,,Nicole M. Masse,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03905525,0,0,0,0,0,0,2021-10-12,2022-10-12,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03906253,0,0,0,0,0,0,2025-12-31,2026-12-31,,"Jeffrey B. Travers, MD, PhD",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03906721,0,0,0,0,0,0,2021-02-28,2022-02-28,,Spaulding Rehabilitation Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,69
NCT03907072,0,0,0,0,0,0,2021-08-31,2022-08-31,,Wave Life Sciences Ltd.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT03907969,0,0,0,0,0,0,2023-05-08,2024-05-08,,AstraZeneca,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2450
NCT03910439,0,0,0,0,0,0,2023-07-01,2024-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,1,0,0,0,1,0,3004
NCT03911154,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Pennsylvania,Other,0,1,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03914157,0,0,0,0,0,0,2023-12-01,2024-12-01,,Mayo Clinic,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03914625,0,0,0,0,0,0,2027-06-30,2028-06-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03916419,0,0,0,0,0,0,2024-12-31,2025-12-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,1,0,1,0,0,0,1,0,1151
NCT03917160,0,0,0,0,0,0,2020-03-11,2021-03-11,,InMode MD Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03918252,0,0,0,0,0,0,2025-06-30,2026-06-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03921554,0,0,0,0,0,0,2025-06-30,2026-06-30,,"Adeline Vanderver, MD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03924752,0,0,0,0,0,0,2020-12-31,2021-12-31,,Georgia Institute of Technology,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,10
NCT03924947,0,0,0,0,0,0,2020-07-18,2021-07-18,,AbbVie,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03926026,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Nicox Ophthalmics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03927001,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vesalio,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03927911,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,53
NCT03931291,0,0,0,0,0,0,2021-07-31,2022-07-31,,Aprea Therapeutics AB,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03934905,0,0,0,0,0,0,2021-06-01,2022-06-01,,Texas Tech University Health Sciences Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,78
NCT03935932,0,0,0,0,0,0,2020-06-20,2021-06-20,,Frank C Sciurba,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03938792,0,0,0,0,0,0,2022-11-30,2023-11-30,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03943537,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mclean Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,126
NCT03943888,0,0,0,0,0,0,2019-12-01,2020-12-01,,Seoul National University Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1227
NCT03944941,0,0,0,0,0,0,2022-12-31,2023-12-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,456
NCT03947723,0,0,0,0,0,0,2020-01-31,2021-01-31,,Ochsner Health System,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,37
NCT03959163,0,0,0,0,0,0,2023-05-31,2024-05-31,,"University of Wisconsin, Madison",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,715
NCT03960008,0,0,0,0,0,0,2021-12-31,2022-12-31,,Lahey Clinic,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,1,0,0,3,1,0,49
NCT03960554,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Thomas Nickolas, MD MS",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03960957,0,0,0,0,0,0,2020-02-29,2021-02-28,,Q-Med AB,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,56
NCT03962738,0,0,0,0,0,0,2020-03-18,2021-03-18,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03963999,0,0,0,0,0,0,2024-04-30,2025-04-30,,Children's Mercy Hospital Kansas City,Other,0,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,1,0,0,0,0,1,0,138
NCT03965351,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03967847,0,0,0,0,0,0,2020-01-31,2021-01-31,,University Hospitals Cleveland Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,185
NCT03968939,0,0,0,0,0,0,2021-05-30,2022-05-30,,James A. Keeney,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03969121,0,0,0,0,0,0,2020-10-30,2021-10-30,,Kyoto Breast Cancer Research Network,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03969641,0,0,0,0,0,0,2021-09-14,2022-09-14,,Duke University,Other,0,0,1,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1342
NCT03969836,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Louisville,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,214
NCT03970304,0,0,0,0,0,0,2024-06-30,2025-06-30,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,144
NCT03970447,0,0,0,0,0,0,2022-12-31,2023-12-31,,Global Coalition for Adaptive Research,Other,0,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT03973775,0,0,0,0,0,0,2018-11-13,2019-11-13,,"bioRASI, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03975153,0,0,0,0,0,0,2020-07-31,2021-07-31,,Oregon Health and Science University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,475
NCT03976076,0,0,0,0,0,0,2020-02-02,2021-02-02,,"Bio-Pharm Solutions Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03977454,0,0,0,0,0,0,2021-06-01,2022-06-01,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1053
NCT03980990,0,0,0,0,0,0,2020-06-17,2021-06-17,,University of Saskatchewan,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,166
NCT03984331,0,0,0,0,0,0,2019-09-30,2020-09-30,,Kerecis Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03989115,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Revolution Medicines, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03992196,0,0,0,0,0,0,2023-01-31,2024-01-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,75
NCT03993457,0,0,0,0,0,0,2021-06-01,2022-06-01,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03993717,0,0,0,0,0,0,2023-06-30,2024-06-30,,Emory University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,947
NCT03994406,0,0,0,0,0,0,2019-08-30,2020-08-30,,"Glia, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03994991,0,0,0,0,0,0,2021-08-31,2022-08-31,,Emine Bayman,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03996460,0,0,0,0,0,0,2021-01-31,2022-01-31,,Georgetown University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03997448,0,0,0,0,0,0,2021-08-31,2022-08-31,,Nataliya Uboha,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03997916,0,0,0,0,0,0,2019-06-30,2020-06-30,,University Hospitals Cleveland Medical Center,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,1,0,0,0,0,1,0,185
NCT03998436,0,0,0,0,0,0,2020-06-30,2021-06-30,,Novalead Pharma Private Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT04002830,0,0,0,0,0,0,2022-08-01,2023-08-01,,Ari Zimran,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT04003298,0,0,0,0,0,0,2019-07-26,2020-07-26,,"Water Pik, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT04003623,0,0,0,0,0,0,2021-09-30,2022-09-30,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,143
NCT04005209,0,0,0,0,0,0,2019-12-31,2020-12-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT04006925,0,0,0,0,0,0,2020-12-31,2021-12-31,,Stanford University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT04008706,0,0,0,0,0,0,2025-08-24,2026-08-24,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2450
NCT04009213,0,0,0,0,0,0,2020-07-31,2021-07-31,,Advanced Medical Solutions Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT04009681,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Synthorx, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT04015414,0,0,0,0,0,0,2021-07-15,2022-07-15,,University of Zagreb,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,28
NCT04016259,0,0,0,0,0,0,2020-06-15,2021-06-15,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT04018586,0,0,0,0,0,0,2019-07-31,2020-07-31,,Jeff Moore,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT04018976,0,0,0,0,0,0,2019-07-31,2020-07-31,,San Diego State University,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,56
NCT04020718,0,0,0,0,0,0,2020-03-31,2021-03-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT04021537,0,0,0,0,0,0,2023-09-30,2024-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT04022239,0,0,0,0,0,0,2022-07-01,2023-07-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,2066
NCT04023097,0,0,0,0,0,0,2019-07-09,2020-07-09,,Home Skinovations Ltd.,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT04023695,1,0,1,1,0,0,2018-08-30,2019-08-30,2019-08-29,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,422
NCT04026334,0,0,0,0,0,0,2020-01-31,2021-01-31,,"KCI USA, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT04030026,0,0,0,0,0,0,2020-12-20,2021-12-20,,Trevi Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,9
NCT04033419,0,0,0,0,0,0,2021-02-28,2022-02-28,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT04035005,0,0,0,0,0,0,2025-04-01,2026-04-01,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT04038099,0,0,0,0,0,0,2020-07-14,2021-07-14,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT04041479,0,0,0,0,0,0,2024-02-29,2025-02-28,,Weill Medical College of Cornell University,Other,0,0,1,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,586
NCT04045301,0,0,0,0,0,0,2021-08-31,2022-08-31,,Philippe Bégin,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT04046445,0,0,0,0,0,0,2021-01-15,2022-01-15,,Amal Therapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04046848,0,0,0,0,0,0,2020-03-31,2021-03-31,,Octapharma,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,54
NCT04047498,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Oxford,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,501
NCT04049539,0,0,0,0,0,0,2021-12-31,2022-12-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,198
NCT04052516,0,0,0,0,0,0,2021-07-05,2022-07-05,,NorthSea Therapeutics B.V.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04056741,0,0,0,0,0,0,2020-05-31,2021-05-31,,ONY,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,4
NCT04057365,0,0,0,0,0,0,2022-08-31,2023-08-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT04058561,0,0,0,0,0,0,2021-08-31,2022-08-31,,Children's Spine Foundation,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT04059250,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of California, San Francisco",Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT04059484,0,0,0,0,0,0,2021-02-28,2022-02-28,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1222
NCT04060394,0,0,0,0,0,0,2021-09-01,2022-09-01,,Laekna Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT04060784,0,0,0,0,0,0,2020-08-31,2021-08-31,,Loma Linda University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,194
NCT04065919,0,0,0,0,0,0,2020-09-30,2021-09-30,,Florida Heart and Lung Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04068857,0,0,0,0,0,0,2020-12-31,2021-12-31,,Indiana University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT04069312,0,0,0,0,0,0,2023-02-28,2024-02-28,,Johns Hopkins University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT04072835,0,0,0,0,0,0,2021-08-31,2022-08-31,,Milestone Pharmaceuticals Inc.,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT04073186,0,0,0,0,0,0,2019-10-20,2020-10-20,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,138
NCT04074317,0,0,0,0,0,0,2019-11-01,2020-11-01,,Xeris Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT04075513,0,0,0,0,0,0,2020-09-30,2021-09-30,,Sanofi,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1222
NCT04080531,0,0,0,0,0,0,2021-12-31,2022-12-31,,Emory University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,947
NCT04080739,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT04081389,0,0,0,0,0,0,2022-07-30,2023-07-30,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT04083235,0,0,0,0,0,0,2022-12-31,2023-12-31,,Ipsen,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,214
NCT04085341,0,0,0,0,0,0,2020-03-31,2021-03-31,,Graybug Vision,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT04086264,0,0,0,0,0,0,2022-06-16,2023-06-16,,"ImmunoGen, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,16
NCT04086472,0,0,0,0,0,0,2020-02-24,2021-02-24,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,2145
NCT04086927,0,0,0,0,0,0,2020-11-01,2021-11-01,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,511
NCT04087122,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Advanced Cooling Therapy, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT04087941,0,0,0,0,0,0,2022-12-31,2023-12-31,,Brigham and Women's Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,698
NCT04089865,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT00088413,1,1,0,1,0,0,2018-04-01,2019-04-01,2018-09-14,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2004.0,1,1,1,0,0,0,0,0,0,0,1,3004
NCT00147056,0,0,0,0,0,0,2022-12-31,2023-12-31,,InSightec,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,61
NCT00256217,0,0,0,0,0,0,2018-12-12,2019-12-12,,"Rita Sanghvi, Mehta",Other,0,1,0,1.0,Phase 2,0,2004.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT00285935,0,0,0,0,0,0,2020-02-29,2021-02-28,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT00348946,0,0,0,0,0,0,2020-04-30,2021-04-30,,Thomas Jefferson University,Other,0,0,1,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,186
NCT00351611,0,0,0,0,0,0,2019-11-11,2020-11-11,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2006.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT00352794,1,1,0,1,0,1,2018-03-08,2019-03-08,2019-04-23,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00363649,1,1,0,1,0,1,2017-09-30,2018-09-30,2018-10-10,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2006.0,1,0,1,0,0,0,0,0,0,0,1,461
NCT00382395,1,0,0,0,1,0,2017-07-31,2018-07-31,,"SOLX, Inc.",Industry,1,0,0,3.0,Phase 3,0,2005.0,1,0,0,1,0,0,0,0,1,0,1,3
NCT00490529,1,0,0,0,1,0,2017-12-14,2018-12-14,,Ronald Levy,Other,0,0,1,1.0,Phase 2,0,2009.0,1,1,1,0,0,0,0,0,0,0,1,5
NCT00497926,0,0,0,0,0,0,2026-03-31,2027-03-31,,University of Louisville,Other,0,0,0,1.0,Phase 2,0,2008.0,0,0,1,0,0,0,0,0,0,0,1,214
NCT00504023,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-04-05,Memorial Sloan Kettering Cancer Center,Other,0,0,1,5.0,,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00583024,0,0,0,0,0,0,2020-07-31,2021-07-31,,David M Lubaroff,Other,0,0,1,1.0,Phase 2,0,2007.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT00588185,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00612716,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,1999.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT00630032,1,0,0,0,1,0,2017-06-30,2018-06-30,,UNICANCER,Other,0,0,0,3.0,Phase 3,0,2007.0,0,1,0,0,0,0,0,0,1,0,1,150
NCT00694733,0,0,0,0,0,0,2020-03-31,2021-03-31,,Oregon Health and Science University,Other,0,0,1,5.0,,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,475
NCT00695786,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT00739362,0,0,0,0,0,0,2025-01-30,2026-01-30,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2008.0,0,0,0,1,0,0,0,0,0,0,1,495
NCT00743340,1,1,0,1,0,0,2017-02-13,2018-02-13,2018-02-12,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT00745615,1,1,0,1,0,1,2017-07-23,2018-07-23,2019-03-04,"Teva Pharmaceutical Industries, Ltd.",Industry,1,0,0,1.0,Phase 2,1,2005.0,1,1,0,0,0,0,0,0,2,0,1,14
NCT00752323,0,0,0,0,0,0,2019-02-20,2020-02-20,,Case Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,374
NCT00774345,0,0,0,0,0,0,2020-10-27,2021-10-27,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT00809991,0,0,0,0,0,0,2022-11-30,2023-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2008.0,0,0,0,0,0,1,0,0,0,0,1,461
NCT00832429,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00835328,0,0,0,0,0,0,2019-12-31,2020-12-31,,Diva De Leon,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT00858364,1,1,0,1,0,0,2017-06-07,2018-06-07,2018-06-07,Amgen,Industry,1,0,0,3.0,Phase 3,1,2009.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT00884312,1,1,0,1,0,0,2017-05-17,2018-05-17,2018-04-09,Amgen,Industry,1,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT00906984,0,0,0,0,0,0,2018-12-31,2019-12-31,,Nadine Abi-Jaoudeh,Other,0,0,0,5.0,,0,2002.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT00948129,0,0,0,0,0,0,2021-05-31,2022-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2009.0,0,0,0,0,0,0,0,0,0,0,1,2066
NCT00950430,0,0,0,0,0,0,2023-04-30,2024-04-30,,Mayo Clinic,Other,0,0,1,4.0,Phase 4,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01004029,0,0,0,0,0,0,2018-10-31,2019-10-31,,"AMAG Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,23
NCT01042522,0,0,0,0,0,0,2024-01-02,2025-01-02,,Gynecologic Oncology Group,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,0,0,1,200
NCT01044433,1,0,1,1,0,1,2017-03-31,2018-03-31,2019-04-16,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT01085630,1,1,0,1,0,1,2017-07-31,2018-07-31,2019-02-05,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT01089101,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01094301,1,1,0,1,0,0,2017-07-25,2018-07-25,2018-07-25,"SPR Therapeutics, Inc.",Industry,1,1,0,5.0,,0,2010.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT01114971,1,0,0,0,1,0,2018-08-31,2019-08-31,,Cedars-Sinai Medical Center,Other,0,0,0,4.0,Phase 4,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,279
NCT01125293,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01127373,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,1432
NCT01158651,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Alabama at Birmingham,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT01158950,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT01198158,1,1,0,1,0,1,2017-12-15,2018-12-15,2019-02-06,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,1,2010.0,1,1,1,0,0,0,0,0,0,0,1,3004
NCT01210352,1,1,0,1,0,1,2017-10-06,2018-10-06,2018-12-20,Endo Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,91
NCT01218542,0,0,0,0,0,0,2020-07-31,2021-07-31,,Emory University,Other,0,0,0,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,947
NCT01220583,0,0,0,0,0,0,2023-10-31,2024-10-31,,Radiation Therapy Oncology Group,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,0,1,0,1,156
NCT01234649,0,1,0,1,0,0,2019-04-24,2020-04-24,2019-06-10,Woman's,Other,0,1,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT01239160,0,0,0,0,0,0,2019-12-31,2020-12-31,,Centre for Research & Implementation of Clinical Practice,Other,0,1,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,1,0,1,1
NCT01275339,1,1,0,1,0,1,2017-04-14,2018-04-14,2018-10-24,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT01275729,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Chicago,Other,0,0,0,5.0,,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT01286272,1,1,0,1,0,1,2017-05-24,2018-05-24,2018-10-12,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,1,0,0,1,0,0,0,0,1,3004
NCT01314911,1,1,0,1,0,1,2017-11-18,2018-11-18,2019-01-11,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,2133
NCT01327079,1,0,0,0,1,0,2017-12-31,2018-12-31,,John van den Anker,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01345539,0,0,0,0,0,0,2020-12-31,2021-12-31,,Dwight Heron,Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,6
NCT01349881,0,0,0,0,0,0,2025-07-31,2026-07-31,,Southwest Oncology Group,Other,0,1,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT01360866,1,1,0,1,0,1,2017-04-18,2018-04-18,2018-05-25,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,185
NCT01372566,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwestern University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,925
NCT01378273,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Washington,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT01379469,0,0,0,0,0,0,2021-01-31,2022-01-31,,Washington University School of Medicine,Other,0,1,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT01385059,0,0,0,0,0,0,2019-11-30,2020-11-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT01393717,1,1,0,1,0,0,2017-02-01,2018-02-01,2018-01-31,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT01406444,0,0,0,0,0,0,2019-05-31,2020-05-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01410942,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01424982,0,0,0,0,0,0,2020-10-31,2021-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01446965,0,0,0,0,0,0,2019-05-31,2020-05-31,,"University of California, San Francisco",Other,0,1,0,5.0,,0,2008.0,1,0,0,1,0,0,0,0,1,0,1,1443
NCT01451502,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,218
NCT01465100,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ira Fox,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,1,1,0,0,0,1,0,3
NCT01466114,0,0,0,0,0,0,2018-11-30,2019-11-30,,"University of California, Los Angeles",Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,692
NCT01482949,1,0,0,0,1,0,2018-05-31,2019-05-31,,Argos Therapeutics,Industry,1,0,0,1.0,Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT01490502,0,0,0,0,0,0,2021-03-31,2022-03-31,,Johns Hopkins University,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT01493778,1,1,0,1,0,0,2017-08-16,2018-08-16,2018-08-14,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT01496118,0,0,0,0,0,0,2019-12-31,2020-12-31,,"SCRI Development Innovations, LLC",Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,167
NCT01512589,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01512888,0,0,0,0,0,0,2025-08-31,2026-08-31,,St. Jude Children's Research Hospital,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,1,0,0,0,1,0,0,1,302
NCT01516216,0,0,0,0,0,0,2019-11-30,2020-11-30,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01517802,0,0,0,0,0,0,2021-04-09,2022-04-09,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,558
NCT01543087,1,0,1,1,0,0,2018-01-31,2019-01-31,2018-12-14,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT01551420,1,1,0,1,0,1,2017-12-19,2018-12-19,2018-12-21,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT01560949,0,0,0,0,0,0,2019-02-20,2020-02-20,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT01570361,0,0,0,0,0,0,2018-12-19,2019-12-19,,"Biosense Webster, Inc.",Industry,1,0,0,4.0,Phase 4,0,2012.0,1,1,0,1,0,0,0,0,2,0,1,41
NCT01576783,1,1,0,1,0,1,2017-04-06,2018-04-06,2018-11-29,Sarah Keim,Other,0,0,1,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01591291,1,0,0,0,1,0,2017-12-31,2018-12-31,,Bankole Johnson,Other,0,0,1,2.0,Phase 2/Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT01595529,0,0,0,0,0,0,2019-06-30,2020-06-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2133
NCT01605903,1,1,0,1,0,1,2017-02-15,2018-02-15,2018-02-23,Massachusetts Eye and Ear Infirmary,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT01606488,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of California, San Francisco",Other,0,1,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT01610206,1,0,0,0,1,0,2018-06-01,2019-06-01,,Linda R Duska,Other,0,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01628029,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,1,0,0,0,0,0,0,1,2066
NCT01630850,0,0,0,0,0,0,2025-05-31,2026-05-31,,University of Chicago,Other,0,0,0,5.0,,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,594
NCT01635998,0,0,0,0,0,0,2020-09-30,2021-09-30,,Vivek Reddy,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,15
NCT01649765,1,1,0,1,0,0,2018-01-24,2019-01-24,2018-07-23,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,3276
NCT01652040,1,1,0,1,0,0,2017-12-30,2018-12-30,2018-03-30,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2012.0,1,1,0,1,0,0,0,0,0,0,1,1012
NCT01652872,1,1,0,1,0,0,2017-10-19,2018-10-19,2018-10-11,Amgen,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,0,1,0,0,0,0,0,0,0,1,685
NCT01657942,0,0,0,0,0,0,2019-12-31,2020-12-31,,InSightec,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,61
NCT01664182,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01665573,0,0,0,0,0,0,2020-01-31,2021-01-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT01668602,0,0,0,0,0,0,2019-10-31,2020-10-31,,Emory University,Other,0,0,1,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,947
NCT01670110,0,0,0,0,0,0,2018-09-30,2019-09-30,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT01675154,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT01678209,1,0,1,1,0,1,2018-04-30,2019-04-30,2019-05-22,Icahn School of Medicine at Mount Sinai,Other,0,0,1,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT01684397,0,0,0,0,0,0,2019-09-13,2020-09-13,,Roswell Park Cancer Institute,Other,0,1,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,294
NCT01688466,1,1,0,1,0,0,2017-03-30,2018-03-30,2017-12-21,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01696877,1,1,0,1,0,1,2017-08-31,2018-08-31,2018-09-28,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,461
NCT01697800,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT01726582,1,0,0,0,1,0,2018-06-30,2019-06-30,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,315
NCT01726738,1,0,0,0,1,0,2018-09-14,2019-09-14,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,229
NCT01728779,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT01728857,1,0,0,0,1,0,2017-06-30,2018-06-30,,Zeltiq Aesthetics,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,32
NCT01737502,0,0,0,0,0,0,2020-08-21,2021-08-21,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01747837,0,0,0,0,0,0,2019-01-09,2020-01-09,,Vivek Reddy,Other,0,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,1,0,1,15
NCT01749215,0,0,0,0,0,0,2019-07-31,2020-07-31,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT01752920,0,0,0,0,0,0,2018-09-25,2019-09-25,,Basilea Pharmaceutica,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,32
NCT01755767,0,0,0,0,0,0,2017-03-28,2018-03-28,,"Daiichi Sankyo, Inc.",Industry,1,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,207
NCT01761604,1,0,0,0,1,0,2017-09-30,2018-09-30,,Chicago Anesthesia Pain Specialists,Other,0,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT01765712,1,0,0,0,1,0,2017-08-31,2018-08-31,,Brian Walters,Other,0,0,0,4.0,Phase 4,0,2012.0,1,0,1,0,0,0,0,0,0,0,1,1
NCT01767311,0,0,0,0,0,0,2021-08-31,2022-08-31,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,328
NCT01776424,1,1,0,1,0,0,2017-07-21,2018-07-21,2018-07-16,Bayer,Industry,1,1,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT01790113,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Arthrex, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT01796795,0,0,0,0,0,0,2020-12-31,2021-12-31,,"G&E Herbal Biotechnology Co., LTD",Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,7
NCT01797185,1,1,0,1,0,1,2017-07-31,2018-07-31,2018-11-15,Sun Pharma Advanced Research Company Limited,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT01797965,0,0,0,0,0,0,2018-09-24,2019-09-24,,Biogen,Industry,1,1,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,324
NCT01799213,0,0,0,0,0,0,2018-10-05,2019-10-05,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01802879,0,0,0,0,0,0,2018-11-19,2019-11-19,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01811381,0,0,0,0,0,0,2019-09-01,2020-09-01,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT01814046,1,1,0,1,0,0,2017-05-01,2018-05-01,2017-05-31,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2013.0,1,1,1,0,0,0,0,0,0,0,1,3004
NCT01817751,0,0,0,0,0,0,2020-06-30,2021-06-30,,Virginia Commonwealth University,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,417
NCT01824394,1,1,0,1,0,0,2017-11-26,2018-11-26,2018-11-26,"Biosense Webster, Inc.",Industry,1,0,0,3.0,Phase 3,1,2013.0,1,0,0,1,0,0,0,0,1,0,1,41
NCT01835223,0,0,0,0,0,0,2018-12-24,2019-12-24,,Roswell Park Cancer Institute,Other,0,1,1,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,294
NCT01840592,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01856868,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Craig McDonald, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01866410,1,1,0,1,0,1,2018-03-30,2019-03-30,2019-04-25,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01871727,0,0,0,0,0,0,2019-12-31,2020-12-31,,Eisai Inc.,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,328
NCT01872689,1,1,0,1,0,0,2017-07-28,2018-07-28,2018-07-24,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT01874860,0,0,0,0,0,0,2022-08-31,2023-08-31,,University of Louisville,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT01891318,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,374
NCT01891643,0,0,0,0,0,0,2019-07-31,2020-07-31,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2013.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT01892436,1,1,0,1,0,0,2018-01-11,2019-01-11,2019-01-10,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01897571,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Epizyme, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,11
NCT01907191,0,0,0,0,0,0,2019-01-30,2020-01-30,,Saint Francis Care,Other,0,0,0,5.0,,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT01912612,0,0,0,0,0,0,2022-03-31,2023-03-31,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT01916707,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Intermountain Health Care, Inc.",Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT01924169,1,1,0,1,0,0,2017-02-21,2018-02-21,2018-02-09,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2014.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01926587,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Onconova Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT01927744,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01928394,0,0,0,0,0,0,2019-02-05,2020-02-05,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT01928576,0,0,0,0,0,0,2022-08-31,2023-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT01931033,0,0,0,0,0,0,2019-06-30,2020-06-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01950234,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT01951339,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-02-20,"University of Colorado, Denver",Other,0,1,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT01957150,1,1,0,1,0,0,2018-03-26,2019-03-26,2019-03-21,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT01959204,0,0,0,0,0,0,2020-01-31,2021-01-31,,"VistaPharm, Inc.",Industry,1,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01961297,1,1,0,1,0,0,2017-06-30,2018-06-30,2017-09-29,Kristina Simonyan,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01962870,1,1,0,1,0,1,2017-05-30,2018-05-30,2019-03-30,Stanford University,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT01967173,1,1,0,1,0,1,2017-07-01,2018-07-01,2018-09-10,Milton S. Hershey Medical Center,Other,0,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT01968564,1,0,0,0,1,0,2017-06-30,2018-06-30,,"University of Colorado, Boulder",Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,49
NCT01969851,1,1,0,1,0,0,2018-04-10,2019-04-10,2019-04-10,UCB Pharma,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,246
NCT01973452,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01974765,0,0,0,0,0,0,2019-10-31,2020-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01976091,0,0,0,0,0,0,2019-03-14,2020-03-14,,Jerry R. Mendell,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01976390,1,0,0,0,1,0,2018-05-31,2019-05-31,,Dr.Ronald Pelletier,Other,0,1,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01979523,1,0,1,1,0,1,2017-09-01,2018-09-01,2018-12-04,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,3004
NCT01984164,0,0,0,0,0,0,2018-12-03,2019-12-03,,Ihab M. Hajjar,Other,0,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01984710,0,0,0,0,0,0,2023-09-30,2024-09-30,,Emory University,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,947
NCT01986140,1,1,0,1,0,1,2017-02-10,2018-02-10,2018-07-13,Julie Nangia,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT01987700,1,0,0,0,1,0,2018-06-30,2019-06-30,,Musculoskeletal Transplant Foundation,Other,0,0,0,4.0,Phase 4,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT01987895,1,1,0,1,0,0,2017-02-26,2018-02-26,2018-02-23,Actelion,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,128
NCT01992653,0,0,0,0,0,0,2018-12-19,2019-12-19,,"Genentech, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT01995578,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01995669,0,0,0,0,0,0,2019-05-31,2020-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01997840,0,0,0,0,0,0,2021-01-27,2022-01-27,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02003898,1,1,0,1,0,0,2018-02-20,2019-02-20,2019-02-11,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,48
NCT02004691,0,0,0,0,0,0,2019-10-29,2020-10-29,,"Genzyme, a Sanofi Company",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02006147,0,0,0,0,0,0,2019-12-31,2020-12-31,,Taiwan Liposome Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,2,0,1,15
NCT02010034,0,0,0,0,0,0,2019-02-05,2020-02-05,,Children's Medical Center Dallas,Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02016560,0,0,0,0,0,0,2017-07-28,2018-07-28,,Avid Radiopharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02018445,1,0,1,1,0,1,2017-05-31,2018-05-31,2018-09-26,"SeaSpine, Inc.",Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02019927,1,0,0,0,1,0,2017-09-30,2018-09-30,,Wills Eye,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,69
NCT02021669,1,1,0,1,0,0,2018-09-13,2019-09-13,2019-07-12,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02022982,0,0,0,0,0,0,2019-11-30,2020-11-30,,Dana-Farber Cancer Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02024581,1,0,0,0,1,0,2017-09-30,2018-09-30,,ViroXis Corporation,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02029638,1,1,0,1,0,0,2017-09-06,2018-09-06,2018-08-24,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,1,2014.0,1,1,1,0,0,1,0,0,0,0,1,2133
NCT02032524,0,0,0,0,0,0,2021-12-16,2022-12-16,,"Genzyme, a Sanofi Company",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02033616,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Aivita Biomedical, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT02039726,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Daiichi Sankyo, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,207
NCT02044991,1,1,0,1,0,0,2017-02-22,2018-02-22,2017-04-03,Loyola University,Other,0,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,102
NCT02046330,0,0,0,0,0,0,2022-11-30,2023-11-30,,"The University of Texas Health Science Center, Houston",Other,0,1,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,490
NCT02050919,1,0,1,1,0,1,2018-05-07,2019-05-07,2019-09-12,OHSU Knight Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,1,0,0,0,0,1,163
NCT02051868,1,0,0,0,1,0,2017-08-31,2018-08-31,,Royal Marsden NHS Foundation Trust,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,184
NCT02058849,1,1,0,1,0,1,2018-04-01,2019-04-01,2019-04-16,David Travis Thomas,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02060383,0,1,0,1,0,1,2018-02-05,2019-02-05,2019-02-28,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02066636,0,0,0,0,0,0,2022-01-31,2023-01-31,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02075840,1,1,0,1,0,0,2017-02-09,2018-02-09,2018-02-06,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02079662,0,0,0,0,0,0,2021-06-30,2022-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2013.0,0,0,0,0,0,0,0,0,0,0,1,2066
NCT02080403,0,0,0,0,0,0,2018-10-31,2019-10-31,,Dexcel Pharma Technologies Ltd.,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02085408,0,0,0,0,0,0,2019-06-30,2020-06-30,,Eastern Cooperative Oncology Group,Other,0,0,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,175
NCT02088047,0,0,0,0,0,0,2018-10-04,2019-10-04,,University of Arkansas,Other,0,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,285
NCT02089594,1,0,0,0,1,0,2018-03-31,2019-03-31,,Louisiana State University Health Sciences Center in New Orleans,Other,0,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,42
NCT02090959,0,0,0,0,0,0,2018-06-21,2019-06-21,,PTC Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02092467,0,0,0,0,0,0,2020-03-03,2021-03-03,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2014.0,0,1,1,0,0,0,0,0,1,0,1,2856
NCT02097420,0,0,0,0,0,0,2019-03-31,2020-03-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,419
NCT02098343,0,0,0,0,0,0,2019-04-30,2020-04-30,,Aprea Therapeutics AB,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02111850,0,0,0,0,0,0,2023-12-29,2024-12-29,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02114697,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-17,Emory University,Other,0,0,0,4.0,Phase 4,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02115295,0,0,0,0,0,0,2021-05-19,2022-05-19,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02117297,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT02135419,0,0,0,0,0,0,2022-06-30,2023-06-30,,AIDS Malignancy Consortium,Other,0,1,1,3.0,Phase 3,0,2014.0,0,1,0,1,0,0,0,0,0,0,1,46
NCT02136797,0,0,0,0,0,0,2019-06-30,2020-06-30,,Atara Biotherapeutics,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,10
NCT02155946,0,0,0,0,0,0,2020-12-31,2021-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT02156154,0,0,0,0,0,0,2019-03-31,2020-03-31,,The Cleveland Clinic,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02158091,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-10-30,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02166905,0,0,0,0,0,0,2022-02-12,2023-02-12,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,294
NCT02167035,1,1,0,1,0,0,2018-03-31,2019-03-31,2018-03-29,"Cornerstone Health Care, PA",Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02167451,0,0,1,1,0,0,2018-09-30,2019-09-30,2019-09-12,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,437
NCT02168842,0,0,0,0,0,0,2018-11-30,2019-11-30,,University of Rochester,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,470
NCT02170870,1,1,0,1,0,0,2017-11-17,2018-11-17,2018-11-09,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02172911,0,0,0,0,0,0,2017-09-07,2018-09-07,,Inovio Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,25
NCT02177136,1,1,0,1,0,0,2017-03-07,2018-03-07,2018-03-07,Intercept Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,14
NCT02178072,1,0,0,0,1,0,2018-07-31,2019-07-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02180711,0,0,0,0,0,0,2023-05-31,2024-05-31,,Acerta Pharma BV,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT02186418,0,0,0,0,0,0,2035-12-31,2036-12-31,,Aruvant Sciences GmbH,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,0,0,0,0,0,1,1,0,1,1
NCT02186821,1,0,1,1,0,0,2017-12-13,2018-12-13,2018-12-11,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02188121,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mclean Hospital,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,126
NCT02190721,0,1,0,1,0,1,2017-04-04,2018-04-04,2018-05-18,"Teva Pharmaceutical Industries, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,14
NCT02192827,1,0,0,0,1,0,2018-03-31,2019-03-31,,University at Buffalo,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,65
NCT02193958,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Fujifilm Pharmaceuticals U.S.A., Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02200042,1,1,0,1,0,1,2018-07-02,2019-07-02,2019-07-31,NRG Oncology,Other,0,0,1,3.0,Phase 3,1,2014.0,1,0,0,0,0,1,0,0,1,0,1,27
NCT02207556,0,0,0,0,0,0,2019-09-30,2020-09-30,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,315
NCT02208037,1,1,0,1,0,1,2017-10-31,2018-10-31,2018-12-04,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT02212574,0,0,0,0,0,0,2021-05-31,2022-05-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02215161,1,1,0,1,0,1,2017-02-15,2018-02-15,2018-04-26,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02221310,0,0,0,0,0,0,2019-06-30,2020-06-30,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT02224599,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Kiromic, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,4
NCT02224703,1,1,0,1,0,1,2018-04-09,2019-04-09,2019-07-11,GW Research Ltd,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,29
NCT02229968,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Srijaya K. Reddy, MD, MBA",Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02232516,0,0,0,0,0,0,2019-07-31,2020-07-31,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02235298,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,476
NCT02239120,1,1,0,1,0,0,2018-08-14,2019-08-14,2019-08-13,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02245412,1,1,0,1,0,0,2017-02-27,2018-02-27,2017-09-08,Alexion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,0,1,0,0,0,0,0,1,0,1,86
NCT02247804,0,0,0,0,0,0,2018-02-21,2019-02-21,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02249182,1,1,0,1,0,0,2018-06-15,2019-06-15,2019-02-15,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02251938,1,0,0,0,1,0,2017-11-01,2018-11-01,,Santen Inc.,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,29
NCT02256917,0,0,1,1,0,0,2018-09-30,2019-09-30,2019-08-28,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,54
NCT02259582,1,1,0,1,0,1,2017-04-07,2018-04-07,2018-05-21,"OncoMed Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,28
NCT02262832,0,0,0,0,0,0,2025-07-31,2026-07-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT02266004,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Miami,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,476
NCT02266914,1,1,0,1,0,1,2017-12-01,2018-12-01,2019-03-04,Ohio State University,Other,0,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,315
NCT02269150,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT02269670,0,0,0,0,0,0,2019-10-31,2020-10-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02272634,1,0,1,1,0,0,2017-10-31,2018-10-31,2018-02-09,"Yungjin Pharm. Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02272790,0,0,0,0,0,0,2018-12-13,2019-12-13,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02276482,0,1,0,1,0,0,2018-09-17,2019-09-17,2019-07-12,Cubist Pharmaceuticals LLC,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,3,0,1,65
NCT02280356,0,0,0,0,0,0,2019-10-31,2020-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,1432
NCT02281357,1,1,0,1,0,0,2017-09-07,2018-09-07,2018-03-01,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,2450
NCT02282020,0,0,0,0,0,0,2018-10-10,2019-10-10,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02282514,0,0,0,0,0,0,2020-10-31,2021-10-31,,Northwestern University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,925
NCT02284568,0,1,0,1,0,1,2017-05-04,2018-05-04,2018-08-16,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02289950,0,0,0,0,0,0,2019-05-31,2020-05-31,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,328
NCT02296125,1,1,0,1,0,0,2017-06-19,2018-06-19,2018-06-13,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02299050,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-30,The University of Texas Health Science Center at San Antonio,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02305563,0,0,0,0,0,0,2019-06-04,2020-06-04,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02306291,0,0,0,0,0,0,2017-12-31,2018-12-31,,GlycoMimetics Incorporated,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,9
NCT02306954,0,0,0,0,0,0,2020-01-31,2021-01-31,,Providence Health & Services,Other,0,1,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,1,0,0,0,0,1,55
NCT02307682,0,0,0,0,0,0,2017-04-22,2018-04-22,,Alcon Research,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,492
NCT02309944,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,218
NCT02310490,0,0,0,0,0,0,2018-12-31,2019-12-31,,DermAvance,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02314026,1,1,0,1,0,1,2017-06-30,2018-06-30,2019-02-07,Exalenz Bioscience LTD.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,16
NCT02317783,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Utah,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,578
NCT02320825,1,1,0,1,0,0,2018-07-26,2019-07-26,2019-01-31,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2014.0,1,0,0,0,0,1,0,0,0,0,1,1432
NCT02322333,0,0,0,0,0,0,2017-06-30,2018-06-30,,Pharmalyte Solutions LLC,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02323646,0,1,0,1,0,1,2017-04-06,2018-04-06,2019-05-24,Repros Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02331368,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-07-02,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,213
NCT02333331,1,1,0,1,0,0,2018-06-26,2019-06-26,2019-06-13,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02335099,1,0,0,0,1,0,2018-01-31,2019-01-31,,University of Virginia,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT02340117,0,0,0,0,0,0,2019-12-31,2020-12-31,,"SynerGene Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,1,1,0,1,6
NCT02341014,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02342379,0,0,0,0,0,0,2019-07-31,2020-07-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02342444,0,0,0,0,0,0,2020-12-31,2021-12-31,,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,475
NCT02343939,0,0,0,0,0,0,2018-10-03,2019-10-03,,Gilead Sciences,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02346526,0,0,0,0,0,0,2019-07-31,2020-07-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02349971,0,0,0,0,0,0,2019-08-31,2020-08-31,,Children's Research Institute,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,51
NCT02350777,1,1,0,1,0,0,2017-10-25,2018-10-25,2018-04-05,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,1432
NCT02357979,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT02359019,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-06-30,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,134
NCT02360371,0,0,0,0,0,0,2020-04-30,2021-04-30,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02366312,0,0,0,0,0,0,2019-08-31,2020-08-31,,NYU College of Dentistry,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02371889,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Pennsylvania,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02375555,0,0,0,0,0,0,2019-10-31,2020-10-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02384239,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02384434,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pittsburgh,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1054
NCT02389712,1,1,0,1,0,0,2018-05-23,2019-05-23,2019-05-21,Mayo Clinic,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02392364,0,0,0,0,0,0,2018-11-15,2019-11-15,,California Retina Consultants,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02392429,0,0,0,0,0,0,2019-10-01,2020-10-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02392624,1,1,0,1,0,0,2017-03-09,2018-03-09,2018-02-21,"Genentech, Inc.",Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,427
NCT02393690,0,0,0,0,0,0,2020-02-01,2021-02-01,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,32
NCT02397473,1,1,0,1,0,0,2018-02-12,2019-02-12,2019-02-08,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02398773,0,0,0,0,0,0,2022-04-04,2023-04-04,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02401815,0,0,0,0,0,0,2019-08-31,2020-08-31,,Plexxikon,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,21
NCT02408315,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-05-22,Indiana University,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,497
NCT02409342,0,0,0,0,0,0,2019-10-01,2020-10-01,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02413489,1,1,0,1,0,0,2017-06-01,2018-06-01,2018-05-28,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02420847,0,0,0,0,0,0,2021-07-31,2022-07-31,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02421601,0,0,0,0,0,0,2018-02-28,2019-02-28,,Seikagaku Corporation,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,11
NCT02421939,0,0,1,1,0,0,2018-09-17,2019-09-17,2019-09-12,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,135
NCT02423915,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT02424617,1,0,0,0,1,0,2017-12-31,2018-12-31,,BerGenBio ASA,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02428959,0,0,0,0,0,0,2018-12-31,2019-12-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02432339,0,0,0,0,0,0,2019-11-30,2020-11-30,,Augusta University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,117
NCT02432456,1,0,0,0,1,0,2018-08-31,2019-08-31,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,315
NCT02433210,1,0,0,0,1,0,2018-05-31,2019-05-31,,University of Missouri-Columbia,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,214
NCT02434809,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02435862,1,0,0,0,1,0,2017-08-10,2018-08-10,,"Allegro Ophthalmics, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02436356,0,0,0,0,0,0,2020-02-29,2021-02-28,,Vanderbilt University Medical Center,Other,0,1,1,5.0,,0,2015.0,0,0,0,1,0,1,0,0,0,0,1,422
NCT02437903,1,1,0,1,0,0,2017-04-05,2018-04-05,2017-04-13,Baumann Cosmetic and Research Institute,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02440334,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-02-12,Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,186
NCT02441712,1,0,0,0,1,0,2017-05-31,2018-05-31,,University of Virginia,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,402
NCT02442687,1,1,0,1,0,0,2017-09-24,2018-09-24,2018-08-24,Manal Abdelmalek,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02445248,0,0,0,0,0,0,2023-02-20,2024-02-20,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,1895
NCT02446366,0,0,0,0,0,0,2020-05-12,2021-05-12,,University of Southern California,Other,0,0,1,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,483
NCT02446600,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02448225,0,0,0,0,0,0,2020-09-30,2021-09-30,,Vanderbilt-Ingram Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,180
NCT02448381,0,0,0,0,0,0,2019-12-31,2020-12-31,,Soligenix,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02452190,1,1,0,1,0,1,2017-12-04,2018-12-04,2018-12-05,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02454933,1,1,0,1,0,0,2017-08-21,2018-08-21,2018-07-16,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,2450
NCT02459964,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02462252,1,0,0,0,1,0,2018-01-31,2019-01-31,,"BioLineRx, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT02462486,0,0,0,0,0,0,2018-04-12,2019-04-12,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02464878,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02465138,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT02466243,0,0,0,0,0,0,2017-08-31,2018-08-31,,Corbus Pharmaceuticals Inc.,Industry,1,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02466971,0,0,0,0,0,0,2023-07-23,2024-07-23,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,3004
NCT02473250,0,0,0,0,0,0,2019-09-30,2020-09-30,,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02473952,1,1,0,1,0,0,2018-01-31,2019-01-31,2019-01-29,Grifols Therapeutics LLC,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,40
NCT02474927,0,0,0,0,0,0,2020-06-30,2021-06-30,,"John F. McDyer, MD",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02475655,1,1,0,1,0,0,2018-02-18,2019-02-18,2019-02-14,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT02478450,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Q Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,0,1,0,0,0,0,0,3,1,0,2
NCT02484950,0,0,0,0,0,0,2018-11-30,2019-11-30,,Rush University Medical Center,Other,0,0,0,5.0,,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,227
NCT02485717,1,1,0,1,0,0,2018-06-25,2019-06-25,2018-11-30,ParaPRO LLC,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT02486211,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-06-28,"Jon Rittenberger, MD",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02486653,1,1,0,1,0,1,2018-04-01,2019-04-01,2019-04-04,"University of Wisconsin, Madison",Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,715
NCT02487160,0,0,0,0,0,0,2018-12-31,2019-12-31,,Lenstec Incorporated,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT02488005,1,1,0,1,0,1,2017-08-17,2018-08-17,2019-04-19,Icahn School of Medicine at Mount Sinai,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,412
NCT02488408,1,0,0,0,1,0,2018-08-31,2019-08-31,,BerGenBio ASA,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02489591,0,0,0,0,0,0,2020-12-31,2021-12-31,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,698
NCT02518464,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-07-17,Columbia University,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02522429,0,0,0,0,0,0,2019-04-30,2020-04-30,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,692
NCT02524106,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-04-05,"University of California, San Francisco",Other,0,1,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02527798,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of North Carolina, Chapel Hill",Other,0,1,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02528188,0,0,0,0,0,0,2018-10-05,2019-10-05,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,1,0,0,0,0,0,1,0,1,2856
NCT02531113,0,0,0,0,0,0,2019-10-12,2020-10-12,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02536508,0,0,0,0,0,0,2017-09-12,2018-09-12,,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,42
NCT02547129,1,1,0,1,0,1,2017-01-23,2018-01-23,2018-04-25,Mayo Clinic,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02547441,0,0,0,0,0,0,2017-07-05,2018-07-05,,"Maruho Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,26
NCT02548494,0,0,0,0,0,0,2023-12-01,2024-12-01,,Chattanooga-Hamilton County Hospital Authority,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02550938,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Align Technology, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT02551692,0,0,0,0,0,0,2019-01-07,2020-01-07,,Duke University,Other,0,0,1,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02551809,1,0,0,0,1,0,2018-08-31,2019-08-31,,United Neuroscience Ltd.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,1,0,0,0,0,0,2,0,1,3
NCT02552225,0,0,0,0,0,0,2022-10-31,2023-10-31,,Boston Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,225
NCT02560324,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-08-23,University of Pennsylvania,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02560558,0,0,0,0,0,0,2019-09-30,2020-09-30,,Emory University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02561455,0,0,0,0,0,0,2024-07-31,2025-07-31,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,135
NCT02562612,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Tyme, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT02563067,0,0,0,0,0,0,2019-07-04,2020-07-04,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02564471,1,0,0,0,1,0,2018-08-31,2019-08-31,,State University of New York - Upstate Medical University,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,125
NCT02564744,0,0,0,0,0,0,2020-02-15,2021-02-15,,Debiopharm International SA,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,36
NCT02565446,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02569671,0,0,0,0,0,0,2019-10-31,2020-10-31,,Institut Straumann AG,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,26
NCT02569892,0,0,0,0,0,0,2020-12-31,2021-12-31,,Stanford University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1309
NCT02572167,1,1,0,1,0,0,2018-03-01,2019-03-01,2019-02-13,"Seattle Genetics, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,77
NCT02575807,1,1,0,1,0,0,2018-04-26,2019-04-26,2018-12-14,"Aduro Biotech, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,1,0,0,0,0,0,1,0,1,12
NCT02577302,0,0,0,0,0,0,2019-10-31,2020-10-31,,"StimGuard, LLC.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT02577497,1,0,0,0,1,0,2018-07-06,2019-07-06,,University of Virginia,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT02583399,0,0,0,0,0,0,2019-07-02,2020-07-02,,Cumberland Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,48
NCT02583477,1,1,0,1,0,0,2018-07-09,2019-07-09,2019-05-08,AstraZeneca,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02584829,0,0,0,0,0,0,2022-06-20,2023-06-20,,Fred Hutchinson Cancer Research Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,1,0,0,0,0,1,393
NCT02587650,1,0,0,0,1,0,2018-01-15,2019-01-15,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02592551,0,0,0,0,0,0,2019-12-01,2020-12-01,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT02594098,1,1,0,1,0,1,2018-01-30,2019-01-30,2019-04-18,Icahn School of Medicine at Mount Sinai,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02600208,0,0,0,0,0,0,2019-12-31,2020-12-31,,Julie-An M. Talano,Other,0,1,0,2.0,Phase 2/Phase 3,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1
NCT02600351,1,1,0,1,0,0,2017-03-21,2018-03-21,2018-03-13,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02605304,1,1,0,1,0,0,2017-01-20,2018-01-20,2018-01-10,AIDS Clinical Trials Group,Other,0,0,1,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,62
NCT02608905,0,0,0,0,0,0,2019-03-31,2020-03-31,,Baylor College of Medicine,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02609737,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02616094,0,0,0,0,0,0,2020-03-31,2021-03-31,,Yale University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1053
NCT02618434,1,0,0,0,1,0,2018-05-31,2019-05-31,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02624375,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Washington,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02624908,0,0,0,0,0,0,2019-05-31,2020-05-31,,Atlanta Research and Education Foundation,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02626182,1,1,0,1,0,1,2018-01-18,2019-01-18,2019-05-08,National Jewish Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,81
NCT02626780,1,1,0,1,0,1,2017-01-22,2018-01-22,2018-04-24,The GID Group,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02630459,1,1,0,1,0,0,2017-09-25,2018-09-25,2018-09-17,Amgen,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,685
NCT02631577,0,0,0,0,0,0,2018-10-23,2019-10-23,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02634307,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,70
NCT02634853,0,0,0,0,0,0,2017-02-28,2018-02-28,,"Mimetogen Pharmaceuticals USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02639637,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-05-29,Vanderbilt University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,499
NCT02640573,1,0,1,1,0,1,2017-11-16,2018-11-16,2019-08-29,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02649062,0,0,0,0,0,0,2017-01-31,2018-01-31,,"NGM Biopharmaceuticals, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,13
NCT02650986,0,0,0,0,0,0,2021-08-20,2022-08-20,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT02652624,1,1,0,1,0,0,2017-10-09,2018-10-09,2018-10-02,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02654977,0,0,0,0,0,0,2025-02-28,2026-02-28,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT02655510,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-06-11,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02657486,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02658097,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,374
NCT02660528,0,0,0,0,0,0,2020-11-30,2021-11-30,,Brigham and Women's Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT02661672,0,0,0,0,0,0,2020-01-31,2021-01-31,,J. Mocco,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02662569,1,1,0,1,0,0,2017-12-06,2018-12-06,2018-11-30,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,1,0,0,0,0,0,1,0,1,685
NCT02666768,0,0,0,0,0,0,2019-03-11,2020-03-11,,Los Angeles Biomedical Research Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,60
NCT02668510,0,0,0,0,0,0,2018-12-31,2019-12-31,,William Beaumont Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,9
NCT02668653,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Daiichi Sankyo, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,207
NCT02673372,1,1,0,1,0,0,2018-02-28,2019-02-28,2018-10-25,Antonios Likourezos,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02678312,0,0,0,0,0,0,2021-04-21,2022-04-21,,Novartis Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02679079,0,0,0,0,0,0,2017-03-31,2018-03-31,,Neurocrine Biosciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02680535,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Nanospectra Biosciences, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02680847,1,1,0,1,0,0,2018-01-10,2019-01-10,2018-07-10,Pfizer,Industry,1,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,2856
NCT02683161,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-04-19,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02683993,1,0,0,0,1,0,2017-09-30,2018-09-30,,Lumenis Ltd.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,16
NCT02684058,0,0,0,0,0,0,2021-02-11,2022-02-11,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT02684487,0,0,0,0,0,0,2022-07-31,2023-07-31,,Massachusetts General Hospital,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02684591,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-07-29,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT02685072,1,1,0,1,0,1,2017-12-18,2018-12-18,2019-01-29,Yale University,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02686658,0,0,0,0,0,0,2019-11-30,2020-11-30,,Ophthotech Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,15
NCT02689219,0,0,0,0,0,0,2018-11-13,2019-11-13,,Costantine Albany,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02689427,0,0,0,0,0,0,2020-09-30,2021-09-30,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02693262,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of California, San Diego",Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,561
NCT02696993,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,1,0,0,0,0,1,2066
NCT02697591,0,0,0,0,0,0,2020-03-31,2021-03-31,,Incyte Biosciences International Sàrl,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02697773,1,1,0,1,0,0,2017-12-05,2018-12-05,2018-12-05,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,2856
NCT02707276,0,0,0,0,0,0,2020-03-31,2021-03-31,,Mclean Hospital,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,126
NCT02710240,0,0,0,0,0,0,2020-09-30,2021-09-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,273
NCT02713178,1,0,0,0,1,0,2017-07-31,2018-07-31,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,53
NCT02716675,0,0,0,0,0,0,2020-10-05,2021-10-05,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,2133
NCT02717442,1,0,0,0,1,0,2017-08-31,2018-08-31,,"Otonomy, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02719574,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Forma Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02723331,0,0,0,0,0,0,2019-08-31,2020-08-31,,Academic Thoracic Oncology Medical Investigators Consortium,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02726399,0,0,0,0,0,0,2019-02-26,2020-02-26,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02728752,0,0,0,0,0,0,2019-10-31,2020-10-31,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,54
NCT02729207,1,0,0,0,1,0,2017-02-28,2018-02-28,,"Teikoku Seiyaku Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02730169,1,0,0,0,1,0,2018-02-15,2019-02-15,,Mereo BioPharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02732899,1,1,0,1,0,0,2017-03-20,2018-03-20,2017-06-20,"Maturi, Raj K., M.D., P.C.",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02734537,0,0,0,0,0,0,2022-05-01,2023-05-01,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,75
NCT02739984,1,1,0,1,0,0,2017-08-03,2018-08-03,2018-08-02,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,1,0,0,0,0,0,1,0,1,685
NCT02741687,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-04-30,Emory University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02742974,0,0,0,0,0,0,2018-12-31,2019-12-31,,CAMC Health System,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,38
NCT02745535,0,1,0,1,0,0,2018-10-24,2019-10-24,2019-02-01,"University of Maryland, College Park",Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,318
NCT02748135,0,0,0,0,0,0,2022-06-30,2023-06-30,,Oncurious NV,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02750306,0,0,0,0,0,0,2018-09-30,2019-09-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,2145
NCT02756013,1,0,0,0,1,0,2018-08-16,2019-08-16,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,374
NCT02759120,0,0,0,0,0,0,2019-07-31,2020-07-31,,Weill Medical College of Cornell University,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,586
NCT02759588,0,0,0,0,0,0,2019-12-31,2020-12-31,,Genelux Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,4
NCT02759731,0,0,0,0,0,0,2020-01-01,2021-01-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02759861,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Nebraska,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,327
NCT02760849,0,0,0,0,0,0,2041-05-31,2042-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,0,0,0,0,0,0,0,0,1,2066
NCT02765854,0,0,0,0,0,0,2019-09-30,2020-09-30,,Emory University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02766478,0,0,0,0,0,0,2019-10-31,2020-10-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT02766608,1,0,1,1,0,0,2017-12-01,2018-12-01,2018-11-30,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02770807,0,0,0,0,0,0,2019-12-31,2020-12-31,,Erydel,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT02771574,0,0,0,0,0,0,2017-06-30,2018-06-30,,Tracey McLaughlin,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02771899,0,0,0,0,0,0,2019-12-31,2020-12-31,,Columbia University,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,675
NCT02773524,0,0,0,0,0,0,2020-05-31,2021-05-31,,Australasian Gastro-Intestinal Trials Group,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02777385,0,0,0,0,0,0,2020-08-31,2021-08-31,,"David A. Clump, MD, PhD",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,2
NCT02781558,1,1,0,1,0,0,2017-10-06,2018-10-06,2018-10-04,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02783729,0,0,0,0,0,0,2018-01-30,2019-01-30,,Eisai Inc.,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,328
NCT02784275,1,1,0,1,0,0,2017-05-03,2018-05-03,2018-02-21,"NovMetaPharma Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02788019,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT02788513,0,0,0,0,0,0,2019-09-20,2020-09-20,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT02789410,1,1,0,1,0,1,2017-09-30,2018-09-30,2019-03-29,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02790073,1,1,0,1,0,1,2017-11-15,2018-11-15,2019-07-30,Laboratoris Sanifit,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02793011,0,0,0,0,0,0,2021-07-25,2022-07-25,,Nationwide Children's Hospital,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,161
NCT02793583,0,0,0,0,0,0,2021-05-31,2022-05-31,,"TG Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT02794844,1,1,0,1,0,1,2017-01-23,2018-01-23,2018-04-09,Nemours Children's Clinic,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,75
NCT02796170,0,0,0,0,0,0,2019-05-31,2020-05-31,,Tulane University,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,33
NCT02796638,0,0,0,0,0,0,2021-10-31,2022-10-31,,Veterans Medical Research Foundation,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,30
NCT02797132,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-09-30,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02799095,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Alkermes, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,70
NCT02799277,1,0,0,0,1,0,2018-05-05,2019-05-05,,University of Texas at Austin,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,135
NCT02799485,0,0,0,0,0,0,2020-11-30,2021-11-30,,AIDS Malignancy Consortium,Other,0,1,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,46
NCT02799758,1,0,0,0,1,0,2017-07-31,2018-07-31,,"Kowa Research Institute, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,33
NCT02802228,0,0,0,0,0,0,2018-07-17,2019-07-17,,Cumberland Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,48
NCT02803957,0,0,0,0,0,0,2020-07-31,2021-07-31,,NeoChord,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02804945,0,0,0,0,0,0,2019-06-13,2020-06-13,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,2066
NCT02805595,0,0,0,0,0,0,2020-06-30,2021-06-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT02807454,0,0,0,0,0,0,2020-04-05,2021-04-05,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02807948,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-08-07,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,419
NCT02809131,0,0,0,0,0,0,2020-07-31,2021-07-31,,Vanderbilt University Medical Center,Other,0,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,422
NCT02811861,0,0,0,0,0,0,2020-04-24,2021-04-24,,Eisai Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,328
NCT02814643,1,1,0,1,0,0,2017-01-24,2018-01-24,2017-12-12,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2450
NCT02817061,0,0,0,0,0,0,2019-09-01,2020-09-01,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1699
NCT02819284,0,0,0,0,0,0,2017-09-30,2018-09-30,,"Kala Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02820363,0,0,0,0,0,0,2019-12-31,2020-12-31,,BONESUPPORT AB,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT02821754,0,0,0,0,0,0,2020-04-30,2021-04-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02823145,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02829047,1,0,0,0,1,0,2017-03-31,2018-03-31,,Vibrant Ltd.,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,8
NCT02829996,1,1,0,1,0,0,2017-05-24,2018-05-24,2017-11-28,Inotek Pharmaceuticals Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02834754,0,0,0,0,0,0,2019-09-30,2020-09-30,,Marc Schwartz,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02836418,1,0,0,0,1,0,2017-04-18,2018-04-18,,"aTyr Pharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02836652,0,0,0,0,0,0,2019-02-21,2020-02-21,,Abbott Medical Devices,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,1,0,0,0,0,1,0,1,419
NCT02836964,1,0,0,0,1,0,2018-02-28,2019-02-28,,Loma Linda University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,194
NCT02837328,1,1,0,1,0,1,2017-09-15,2018-09-15,2019-02-01,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,749
NCT02840721,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-29,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02842242,0,0,0,0,0,0,2017-11-30,2018-11-30,,"MyoKardia, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02845297,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02845466,0,0,0,0,0,0,2020-09-30,2021-09-30,,McMaster University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,1,1,0,0,0,0,2,1,0,434
NCT02846740,1,0,1,1,0,1,2018-01-22,2019-01-22,2019-04-24,"University of Maryland, College Park",Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,318
NCT02848417,0,0,0,0,0,0,2019-01-31,2020-01-31,,South Florida Veterans Affairs Foundation for Research and Education,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02849626,0,0,0,0,0,0,2019-02-05,2020-02-05,,Eisai Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,328
NCT02849990,0,0,0,0,0,0,2018-12-10,2019-12-10,,University of Washington,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT02858908,0,0,0,0,0,0,2018-01-31,2019-01-31,,AMO Pharma Limited,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,2
NCT02859597,0,0,0,0,0,0,2018-09-28,2019-09-28,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,240
NCT02859727,0,0,0,0,0,0,2025-09-02,2026-09-02,,Novartis Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02862730,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-02-28,Oregon Health and Science University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,475
NCT02863809,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Joseph B. Ciolino, MD",Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,3
NCT02864953,0,0,0,0,0,0,2021-03-31,2022-03-31,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT02871219,0,0,0,0,0,0,2019-12-06,2020-12-06,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02872714,0,0,0,0,0,0,2019-12-31,2020-12-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT02873819,0,0,0,0,0,0,2021-06-30,2022-06-30,,Gliknik Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT02874924,0,1,0,1,0,0,2018-09-30,2019-09-30,2018-10-16,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02875353,0,0,0,0,0,0,2022-01-31,2023-01-31,,VA Office of Research and Development,U.S. Fed,2,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT02880319,0,0,0,0,0,0,2020-03-31,2021-03-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,647
NCT02882022,1,0,0,0,1,0,2017-07-31,2018-07-31,,University of Virginia,Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,402
NCT02882282,0,0,0,0,0,0,2024-06-30,2025-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT02882711,0,0,0,0,0,0,2019-03-31,2020-03-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02887859,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Humacyte, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,8
NCT02891837,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Asklepion Pharmaceuticals, LLC",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT02892760,0,0,0,0,0,0,2019-01-08,2020-01-08,,"The University of Texas Health Science Center, Houston",Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT02894658,0,0,0,0,0,0,2020-04-30,2021-04-30,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,616
NCT02897557,1,0,0,0,1,0,2017-02-28,2018-02-28,,Insulet Corporation,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02898077,0,0,0,0,0,0,2019-06-30,2020-06-30,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT02898454,1,0,1,1,0,0,2018-08-27,2019-08-27,2019-08-23,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02899728,0,0,0,0,0,0,2020-04-07,2021-04-07,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02903355,0,0,0,0,0,0,2017-12-31,2018-12-31,,Southern Illinois University,Other,0,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,26
NCT02905656,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Virginia,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,402
NCT02905981,1,0,0,0,1,0,2018-03-15,2019-03-15,,"Rockwell Medical Technologies, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,3,0,1,15
NCT02906371,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Pennsylvania,Other,0,0,0,5.0,,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,1052
NCT02906670,0,0,0,0,0,0,2020-05-31,2021-05-31,,Symphogen A/S,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,14
NCT02907593,1,0,1,1,0,0,2018-04-30,2019-04-30,2019-03-20,Cynthia McEvoy,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02908035,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Mercator MedSystems, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT02910726,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02912845,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Kamada, Ltd.",Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT02913105,0,0,0,0,0,0,2018-08-15,2019-08-15,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02913612,0,0,0,0,0,0,2020-02-15,2021-02-15,,Chiara Melloni,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02914314,0,0,0,0,0,0,2020-03-02,2021-03-02,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,328
NCT02914587,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Restoration Robotics, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02915198,0,0,0,0,0,0,2024-08-21,2025-08-21,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT02915302,1,1,0,1,0,0,2017-03-06,2018-03-06,2018-03-06,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,285
NCT02916498,1,0,1,1,0,0,2018-07-23,2019-07-23,2019-07-23,Boston Scientific Corporation,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,340
NCT02918552,0,0,0,0,0,0,2018-12-02,2019-12-02,,"Gladwin, Mark, MD",Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT02919423,1,1,0,1,0,0,2018-01-25,2019-01-25,2018-11-28,Duke University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1342
NCT02921412,1,1,0,1,0,0,2017-02-01,2018-02-01,2017-12-22,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,85
NCT02921919,0,0,0,0,0,0,2020-09-30,2021-09-30,,Pfizer,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02922725,0,0,0,0,0,0,2019-12-31,2020-12-31,,Brent Kious,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02923739,0,0,0,0,0,0,2025-05-31,2026-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT02924883,1,1,0,1,0,0,2017-12-11,2018-12-11,2018-12-09,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02926248,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,157
NCT02926651,1,0,0,0,1,0,2017-07-31,2018-07-31,,Rush University Medical Center,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,227
NCT02926950,0,0,0,0,0,0,2019-03-22,2020-03-22,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02927340,0,0,0,0,0,0,2020-03-31,2021-03-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02927873,0,0,0,0,0,0,2019-02-19,2020-02-19,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,0,1,3276
NCT02934191,1,0,0,0,1,0,2018-08-17,2019-08-17,,Children's Hospital of Philadelphia,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,324
NCT02935595,0,0,0,0,0,0,2019-09-30,2020-09-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,490
NCT02938884,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,749
NCT02941926,0,0,0,0,0,0,2019-09-05,2020-09-05,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02944825,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Diego",Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02944955,0,0,0,0,0,0,2021-12-31,2022-12-31,,"BioLite, Inc.",Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,6
NCT02948569,1,0,0,0,1,0,2017-12-18,2018-12-18,,University of Missouri-Columbia,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,214
NCT02950558,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Cincinnati,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,222
NCT02951156,0,0,0,0,0,0,2019-06-16,2020-06-16,,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,2856
NCT02953340,1,0,0,0,1,0,2017-08-27,2018-08-27,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,67
NCT02953782,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Forty Seven, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02954523,0,0,0,0,0,0,2019-12-31,2020-12-31,,Giuseppe Giaccone,Other,0,1,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02954952,1,1,0,1,0,1,2018-01-11,2019-01-11,2019-03-05,Masimo Corporation,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,39
NCT02955394,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of Colorado, Denver",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT02955602,0,0,0,0,0,0,2019-07-31,2020-07-31,,"CymaBay Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,18
NCT02956486,0,0,0,0,0,0,2023-11-21,2024-11-21,,"Eisai Co., Ltd.",Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,129
NCT02960399,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of South Florida,Other,0,1,0,5.0,,1,2015.0,1,0,1,0,0,0,0,0,0,0,1,240
NCT02961218,0,0,0,0,0,0,2020-06-10,2021-06-10,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT02962492,0,0,0,0,0,0,2018-10-31,2019-10-31,,University at Buffalo,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,65
NCT02964377,1,0,0,0,1,0,2018-07-31,2019-07-31,,"Craig McDonald, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02965703,0,0,0,0,0,0,2021-07-01,2022-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02967133,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Alliance Foundation Trials, LLC.",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,16
NCT02968758,1,1,0,1,0,1,2017-08-02,2018-08-02,2018-10-16,GenePOC,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,4
NCT02970136,0,0,0,0,0,0,2020-08-30,2021-08-30,,University of Miami,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT02970981,0,0,0,0,0,0,2018-11-30,2019-11-30,,NYU Langone Health,Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,869
NCT02971839,0,0,0,0,0,0,2017-08-31,2018-08-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,141
NCT02972840,0,0,0,0,0,0,2022-10-31,2023-10-31,,Acerta Pharma BV,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT02974907,0,0,0,0,0,0,2017-09-30,2018-09-30,,"ReGenTree, LLC",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02978144,0,0,0,0,0,0,2019-07-31,2020-07-31,,Columbia University,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,1,0,0,0,1,0,675
NCT02978885,0,0,0,0,0,0,2019-09-30,2020-09-30,,Columbia University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,675
NCT02979925,0,0,0,0,0,0,2019-09-30,2020-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT02980692,0,0,0,0,0,0,2019-03-01,2020-03-01,,Sun Pharma Global FZE,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT02981368,1,0,0,0,1,0,2018-07-31,2019-07-31,,"Progenics Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02981940,0,0,0,0,0,0,2020-04-30,2021-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT02982954,0,0,0,0,0,0,2020-03-30,2021-03-30,,Bristol-Myers Squibb,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1104
NCT02983604,1,1,0,1,0,0,2018-07-19,2019-07-19,2019-07-15,Gilead Sciences,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,0,1,510
NCT02984644,0,0,0,0,0,0,2018-11-16,2019-11-16,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,257
NCT02988895,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Salutaris Medical Devices, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,1
NCT02989025,0,0,0,0,0,0,2020-01-31,2021-01-31,,Babbette Lamarca,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02989844,0,0,0,0,0,0,2022-01-31,2023-01-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,218
NCT02991040,0,1,0,1,0,1,2017-08-31,2018-08-31,2018-10-01,Prollenium Medical Technologies Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02992301,0,0,0,0,0,0,2019-11-30,2020-11-30,,Westside Medical Associates of Los Angeles,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02992418,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,2,0,1,285
NCT02993900,0,0,0,0,0,0,2021-09-30,2022-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,461
NCT02994784,0,0,0,0,0,0,2020-01-31,2021-01-31,,Shayna Sarosiek,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02994927,0,0,0,0,0,0,2019-09-30,2020-09-30,,ChemoCentryx,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,17
NCT02998021,0,0,0,0,0,0,2019-07-31,2020-07-31,,Alicia Koontz,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT02998502,0,0,0,0,0,0,2019-09-30,2020-09-30,,Johns Hopkins University,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02998671,1,0,1,1,0,0,2018-08-01,2019-08-01,2019-07-31,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,0,1,0,0,0,0,0,1,0,1,1895
NCT03003195,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Arkansas,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,285
NCT03004976,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Joanne Kurtzberg, MD",Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,15
NCT03005379,0,0,0,0,0,0,2022-05-30,2023-05-30,,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03007147,0,0,0,0,0,0,2028-06-30,2029-06-30,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,389
NCT03010488,0,0,0,0,0,0,2020-11-30,2021-11-30,,New York State Psychiatric Institute,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,361
NCT03011931,0,0,0,0,0,0,2019-01-31,2020-01-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT03012594,0,0,0,0,0,0,2019-02-28,2020-02-28,,Northwell Health,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,271
NCT03014674,1,1,0,1,0,0,2017-08-11,2018-08-11,2018-07-17,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,1,0,0,0,0,1,0,1,3276
NCT03016871,0,0,0,0,0,0,2019-10-22,2020-10-22,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT03018249,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03019627,1,1,0,1,0,1,2017-08-31,2018-08-31,2018-10-19,Dompé Farmaceutici S.p.A,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,28
NCT03021304,1,1,0,1,0,0,2017-08-08,2018-08-08,2018-01-05,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03023878,0,0,0,0,0,0,2019-04-04,2020-04-04,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03026166,0,0,0,0,0,0,2019-07-03,2020-07-03,,AbbVie,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,430
NCT03029247,0,0,0,0,0,0,2019-12-16,2020-12-16,,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3276
NCT03029585,0,0,0,0,0,0,2019-09-30,2020-09-30,,"NanOlogy, LLC",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03030118,0,0,0,0,0,0,2021-09-30,2022-09-30,,Milton S. Hershey Medical Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03030248,0,0,0,0,0,0,2019-05-31,2020-05-31,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,315
NCT03032510,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-07-12,"Tetraphase Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,15
NCT03033134,1,1,0,1,0,0,2018-02-01,2019-02-01,2018-10-15,Boston Scientific Japan K.K.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03040219,1,0,0,0,1,0,2017-11-01,2018-11-01,,Ain Shams University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,460
NCT03046836,0,0,0,0,0,0,2020-05-31,2021-05-31,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03047239,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sensimed AG,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,28
NCT03049280,1,0,0,0,1,0,2017-11-14,2018-11-14,,Intuitive Surgical,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,18
NCT03049852,1,0,0,0,1,0,2018-04-30,2019-04-30,,"Cloudbreak Therapeutics, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03050398,0,0,0,0,0,0,2019-03-08,2020-03-08,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03051360,0,0,0,0,0,0,2019-12-31,2020-12-31,,Seoul National University Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1227
NCT03051672,0,0,1,1,0,0,2018-10-18,2019-10-18,2019-07-05,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,647
NCT03052426,1,1,0,1,0,1,2017-08-27,2018-08-27,2018-10-11,West Virginia University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,74
NCT03054831,0,0,0,0,0,0,2020-06-30,2021-06-30,,Boston Children’s Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03055195,1,1,0,1,0,0,2017-12-06,2018-12-06,2018-12-03,GlaxoSmithKline,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03057795,0,0,0,0,0,0,2019-10-08,2020-10-08,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT03061903,0,0,0,0,0,0,2020-01-31,2021-01-31,,Columbia University,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,675
NCT03064568,0,0,0,0,0,0,2021-06-30,2022-06-30,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT03067480,0,0,0,0,0,0,2019-12-31,2020-12-31,,East Tennessee State University,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,16
NCT03068780,0,0,0,0,0,0,2019-12-31,2020-12-31,,Amryt Research Limited,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03070002,1,1,0,1,0,0,2018-03-06,2019-03-06,2018-10-22,Northwestern University,Other,0,1,1,1.0,Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,925
NCT03070392,0,0,0,0,0,0,2020-07-31,2021-07-31,,Immunocore Ltd,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,7
NCT03071055,0,0,0,0,0,0,2019-11-01,2020-11-01,,"Southeast Clinical Research Associates, LLC",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03071211,0,0,0,0,0,0,2018-12-07,2019-12-07,,Hartford Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,65
NCT03072238,0,0,0,0,0,0,2020-05-12,2021-05-12,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03074006,0,0,0,0,0,0,2019-07-31,2020-07-31,,"MedPacto, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03074682,1,1,0,1,0,1,2017-06-15,2018-06-15,2018-11-16,Yale University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1053
NCT03077087,0,0,0,0,0,0,2019-11-28,2020-11-28,,HealthPartners Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,101
NCT03077204,0,0,0,0,0,0,2019-12-30,2020-12-30,,Seton Healthcare Family,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,1,1,0,0,0,0,0,1,0,21
NCT03077724,1,1,0,1,0,0,2018-01-23,2019-01-23,2018-11-12,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,422
NCT03078270,1,1,0,1,0,1,2017-09-12,2018-09-12,2018-11-15,Daniel Lieberman,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03078647,0,1,0,1,0,0,2018-11-02,2019-11-02,2019-05-29,Syneron Medical,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,41
NCT03079505,0,0,0,0,0,0,2018-09-23,2019-09-23,,Hamad Medical Corporation,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,47
NCT03081806,0,0,0,0,0,0,2021-12-30,2022-12-30,,Techfields Pharma Co. Ltd,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03083379,1,1,0,1,0,1,2017-04-21,2018-04-21,2018-05-03,University of Virginia,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,402
NCT03084315,0,0,0,0,0,0,2019-03-01,2020-03-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,749
NCT03084588,0,0,0,0,0,0,2019-07-31,2020-07-31,,NorthShore University HealthSystem,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,61
NCT03085095,0,0,0,0,0,0,2019-12-15,2020-12-15,,Myovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03086902,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sheba Medical Center,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,553
NCT03087071,0,0,0,0,0,0,2021-12-30,2022-12-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03088800,0,0,0,0,0,0,2019-10-31,2020-10-31,,Antonios Likourezos,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03089580,0,0,1,1,0,0,2018-11-01,2019-11-01,2019-08-22,University of Michigan,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,934
NCT03089905,0,0,0,0,0,0,2022-04-30,2023-04-30,,Murdoch Childrens Research Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03090412,0,0,0,0,0,0,2020-11-02,2021-11-02,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,294
NCT03090672,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Ryan Welter, MD, PhD",Other,0,0,0,5.0,,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,1
NCT03091400,1,0,0,0,1,0,2018-06-11,2019-06-11,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03092089,0,0,0,0,0,0,2019-07-31,2020-07-31,,Harald Becher,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,2,1,0,2
NCT03093454,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Scott Hollenbeck, MD",Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03094416,0,0,0,0,0,0,2020-04-30,2021-04-30,,IBSA Institut Biochimique SA,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,25
NCT03094715,0,0,0,0,0,0,2022-08-31,2023-08-31,,University Hospital Heidelberg,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,87
NCT03096639,0,0,0,0,0,0,2019-09-30,2020-09-30,,Lungpacer Medical Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,5
NCT03098277,0,0,0,0,0,0,2020-06-06,2021-06-06,,University of Southern California,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,483
NCT03098394,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,318
NCT03099356,0,0,0,0,0,0,2022-05-12,2023-05-12,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03101111,0,0,0,0,0,0,2019-04-02,2020-04-02,,Themis Bioscience GmbH,Industry,1,0,1,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,7
NCT03102242,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Alliance Foundation Trials, LLC.",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03103867,1,0,0,0,1,0,2018-05-04,2019-05-04,,Centre Hospitalier du Luxembourg,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,4
NCT03108066,0,0,0,0,0,0,2022-04-30,2023-04-30,,"Peloton Therapeutics, Inc.",Industry,1,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03111316,1,1,0,1,0,1,2018-01-05,2019-01-05,2019-02-27,University of Oklahoma,Other,0,1,0,5.0,,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,234
NCT03118232,0,0,0,0,0,0,2022-06-30,2023-06-30,,"University of California, Irvine",Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,310
NCT03118960,1,0,0,0,1,0,2017-09-30,2018-09-30,,Northeast Center for Rehabilitation and Brain Injury,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT03119649,1,1,0,1,0,0,2017-10-19,2018-10-19,2018-10-19,Galapagos NV,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,79
NCT03122522,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03123016,0,0,0,0,0,0,2019-08-05,2020-08-05,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03123614,1,0,0,0,1,0,2018-07-31,2019-07-31,,University of Utah,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,578
NCT03124069,0,0,0,0,0,0,2017-05-26,2018-05-26,,Fisher and Paykel Healthcare,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,56
NCT03125928,0,0,0,0,0,0,2020-12-31,2021-12-31,,Fox Chase Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03126110,0,0,0,0,0,0,2020-01-31,2021-01-31,,Incyte Biosciences International Sàrl,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03130738,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Hill Dermaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03130959,0,0,0,0,0,0,2021-06-14,2022-06-14,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03131570,0,0,0,0,0,0,2020-07-31,2021-07-31,,"James G. Krueger, MD, PhD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03131713,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-07-12,Tufts Medical Center,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,121
NCT03134053,1,0,0,0,1,0,2017-12-01,2018-12-01,,Mackay Memorial Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,60
NCT03135210,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03136601,1,0,0,0,1,0,2018-01-01,2019-01-01,,Los Angeles Biomedical Research Institute,Other,0,0,0,5.0,,0,2016.0,1,0,0,0,0,0,0,0,0,0,1,60
NCT03137160,1,0,0,0,1,0,2018-08-16,2019-08-16,,Ohio State University,Other,0,1,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,315
NCT03138447,0,0,0,0,0,0,2019-01-30,2020-01-30,,"Amalgam Rx, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03139318,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Arkansas,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,285
NCT03139487,1,0,0,0,1,0,2017-11-30,2018-11-30,,Asan Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,395
NCT03141788,0,0,0,0,0,0,2019-10-31,2020-10-31,,3M,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,56
NCT03141970,0,0,0,0,0,0,2020-10-31,2021-10-31,,"All India Institute of Medical Sciences, New Delhi",Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,122
NCT03147534,1,0,0,0,1,0,2018-05-08,2019-05-08,,ARC Devices,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT03148327,0,0,0,0,0,0,2020-06-01,2021-06-01,,Jonsson Comprehensive Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,277
NCT03148496,0,0,0,0,0,0,2020-12-31,2021-12-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT03149042,1,0,0,0,1,0,2017-12-31,2018-12-31,,State University of New York at Buffalo,Other,0,0,0,5.0,,0,2016.0,1,0,0,0,1,0,0,0,0,0,1,105
NCT03149887,0,0,0,0,0,0,2019-02-26,2020-02-26,,Steven Orebaugh,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03150043,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-07-05,"The University of Texas Medical Branch, Galveston",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,158
NCT03150173,0,0,0,0,0,0,2021-06-30,2022-06-30,,Montefiore Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03150758,1,0,0,0,1,0,2018-04-28,2019-04-28,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,0,1,374
NCT03151265,1,1,0,1,0,1,2017-12-21,2018-12-21,2019-02-06,dorsaVi Ltd,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT03154333,0,0,1,1,0,0,2018-10-15,2019-10-15,2019-09-05,"Castle Creek Pharmaceuticals, LLC",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,7
NCT03154762,1,0,0,0,1,0,2017-10-31,2018-10-31,,"National Institute of Respiratory Diseases, Mexico",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,5
NCT03157531,1,1,0,1,0,0,2018-04-27,2019-04-27,2019-03-25,Eximo Medical Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,2
NCT03163992,0,0,0,0,0,0,2019-09-30,2020-09-30,,Samsung Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,684
NCT03164967,0,0,0,0,0,0,2021-03-31,2022-03-31,,Biotest Pharmaceuticals Corporation,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,10
NCT03166215,0,0,0,0,0,0,2018-09-19,2019-09-19,,Takeda,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,650
NCT03167515,1,0,0,0,1,0,2017-11-28,2018-11-28,,"Ferndale Laboratories, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03168841,0,0,0,0,0,0,2018-12-20,2019-12-20,,Western University of Health Sciences,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03170271,0,0,0,0,0,0,2019-09-12,2020-09-12,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03172052,0,0,0,0,0,0,2019-06-01,2020-06-01,,Assiut University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,3,1,0,1331
NCT03173937,0,0,0,0,0,0,2021-04-29,2022-04-29,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1091
NCT03178344,1,1,0,1,0,1,2017-11-04,2018-11-04,2018-11-07,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03180398,0,0,0,0,0,0,2020-12-30,2021-12-30,,Henry Ford Health System,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,151
NCT03180593,1,0,0,0,1,0,2018-01-25,2019-01-25,,Trinity Hypertension & Metabolic Research Institute,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03181100,0,0,0,0,0,0,2023-07-27,2024-07-27,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03183141,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Seres Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03185819,0,0,0,0,0,0,2021-10-07,2022-10-07,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03187509,0,0,0,0,0,0,2020-01-31,2021-01-31,,New York City Health and Hospitals Corporation,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03190590,0,0,0,0,0,0,2020-03-20,2021-03-20,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03192137,0,0,0,0,0,0,2019-06-11,2020-06-11,,InSite Vision,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03192566,1,0,0,0,1,0,2018-08-31,2019-08-31,,Children's Research Institute,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,51
NCT03192995,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03193281,0,0,0,0,0,0,2023-12-31,2024-12-31,,"University of Auckland, New Zealand",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,36
NCT03194555,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Allodynic Therapeutics, LLC",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03196193,0,0,0,0,0,0,2019-11-30,2020-11-30,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,215
NCT03196427,0,0,0,0,0,0,2025-02-08,2026-02-08,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,650
NCT03197922,0,0,0,0,0,0,2021-10-01,2022-10-01,,Emory University,Other,0,0,1,3.0,Phase 3,0,2017.0,0,0,0,0,0,0,1,0,0,1,0,947
NCT03198078,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,185
NCT03199911,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03200717,0,0,0,0,0,0,2019-07-29,2020-07-29,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03202394,0,0,0,0,0,0,2019-08-31,2020-08-31,,"BioMarck Pharmaceuticals, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03205345,0,0,0,0,0,0,2019-08-31,2020-08-31,,Conatus Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03207087,0,0,0,0,0,0,2020-12-30,2021-12-30,,"Sequent Medical, Inc",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,5
NCT03208036,0,0,0,0,0,0,2021-01-01,2022-01-01,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03208244,0,0,0,0,0,0,2021-12-31,2022-12-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03210155,0,0,0,0,0,0,2019-08-01,2020-08-01,,"Christina Murphey, RN, PhD",Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03210662,0,0,0,0,0,0,2020-11-30,2021-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,1,0,0,0,1,0,2066
NCT03212963,0,0,0,0,0,0,2018-12-31,2019-12-31,,Sun Pharmaceutical Industries Limited,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03213834,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03215511,0,0,0,0,0,0,2019-08-31,2020-08-31,,Bayer,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03215927,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Rohit Aggarwal, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03216200,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-08-25,"DeviceFarm, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03216356,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston University Charles River Campus,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,63
NCT03217175,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-12,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,1699
NCT03220113,1,0,0,0,1,0,2018-07-01,2019-07-01,,"Corona Doctors Medical Clinics, Inc.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,0,0,0,0,1,0,0,1,0,1
NCT03220776,0,0,0,0,0,0,2022-02-01,2023-02-01,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03221387,0,0,0,0,0,0,2019-10-30,2020-10-30,,Temple University,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,152
NCT03228017,0,0,0,0,0,0,2019-06-01,2020-06-01,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03228992,1,0,0,0,1,0,2017-07-31,2018-07-31,,Jean Brown Research,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03229538,0,0,0,0,0,0,2021-02-28,2022-02-28,,Kevin Hill,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03230318,0,0,0,0,0,0,2020-07-31,2021-07-31,,Basilea Pharmaceutica,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,32
NCT03231878,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Minoryx Therapeutics, S.L.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03232073,0,0,0,0,0,0,2022-04-02,2023-04-02,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03233828,0,0,0,0,0,0,2020-12-01,2021-12-01,,Carman Giacomantonio,Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,2
NCT03236909,0,0,0,0,0,0,2020-09-30,2021-09-30,,Med-El Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,8
NCT03237910,0,0,0,0,0,0,2020-09-30,2021-09-30,,Mario Negri Institute for Pharmacological Research,Other,0,1,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,2,1,0,83
NCT03240146,1,0,0,0,1,0,2017-12-21,2018-12-21,,BioElectronics Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03242317,0,0,0,0,0,0,2020-09-01,2021-09-01,,"Fichte, Endl & Elmer Eyecare",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT03244644,0,0,0,0,0,0,2020-06-30,2021-06-30,,Rebiotix Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03246958,0,0,0,0,0,0,2021-03-31,2022-03-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03247439,0,0,0,0,0,0,2023-01-31,2024-01-31,,"Cartiva, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,7
NCT03248128,0,0,0,0,0,0,2020-10-19,2021-10-19,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03249779,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-04-25,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT03253796,0,0,0,0,0,0,2021-05-31,2022-05-31,,Merck Sharp & Dohme Corp.,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,2145
NCT03257462,0,0,0,0,0,0,2019-04-15,2020-04-15,,Spruce Biosciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03257670,0,0,0,0,0,0,2018-10-01,2019-10-01,,University of Cincinnati,Other,0,1,0,5.0,,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,222
NCT03259568,0,0,0,0,0,0,2021-09-01,2022-09-01,,Duke University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03259763,0,0,0,0,0,0,2020-12-31,2021-12-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,1143
NCT03261336,1,0,0,0,1,0,2018-02-28,2019-02-28,,"Donald Trump, MD",Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03264157,0,0,0,0,0,0,2018-07-13,2019-07-13,,Bio Products Laboratory,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,1,0,0,0,0,0,0,1,0,27
NCT03265717,0,0,0,0,0,0,2020-12-31,2021-12-31,,Invectys,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03268811,0,0,0,0,0,0,2020-06-01,2021-06-01,,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,1,0,0,0,0,2,1,0,342
NCT03269695,0,0,0,0,0,0,2021-07-27,2022-07-27,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03271372,0,0,0,0,0,0,2024-09-01,2025-09-01,,University of Washington,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03272347,0,0,0,0,0,0,2020-10-22,2021-10-22,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03273257,0,0,0,0,0,0,2020-07-31,2021-07-31,,International CTEPH Association,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03277066,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Noven Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03277183,0,0,0,0,0,0,2021-03-02,2022-03-02,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03278028,1,1,0,1,0,1,2018-03-01,2019-03-01,2019-03-07,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03280056,0,0,0,0,0,0,2019-07-30,2020-07-30,,Brainstorm-Cell Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03282227,0,0,0,0,0,0,2019-05-17,2020-05-17,,Zosano Pharma Corporation,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03282981,0,0,0,0,0,0,2022-08-01,2023-08-01,,VA Office of Research and Development,U.S. Fed,2,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03283982,0,0,0,0,0,0,2019-09-30,2020-09-30,,The Cleveland Clinic,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03284411,0,0,0,0,0,0,2019-03-15,2020-03-15,,MedtronicNeuro,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,57
NCT03285308,0,0,0,0,0,0,2019-11-23,2020-11-23,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03287687,0,0,0,0,0,0,2019-04-09,2020-04-09,,Warren Bishop,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03288129,0,0,0,0,0,0,2021-04-27,2022-04-27,,Eisai Inc.,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,328
NCT03289351,0,0,0,0,0,0,2020-12-22,2021-12-22,,Phoenix Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,35
NCT03290196,0,0,0,0,0,0,2020-01-31,2021-01-31,,Andrews Research & Education Foundation,Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT03291067,0,0,0,0,0,0,2018-10-19,2019-10-19,,"Mitsubishi Tanabe Pharma Development America, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT03291743,0,0,0,0,0,0,2019-02-10,2020-02-10,,Dario Sorrentino,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03295539,0,0,0,0,0,0,2018-10-01,2019-10-01,,Lancashire Care NHS Foundation Trust,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,4
NCT03297762,0,0,0,0,0,0,2019-05-01,2020-05-01,,Stanford University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1309
NCT03299062,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Arkansas,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,285
NCT03300674,1,0,0,0,1,0,2018-08-16,2019-08-16,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03301220,0,0,0,0,0,0,2021-12-16,2022-12-16,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03304418,0,0,0,0,0,0,2022-11-30,2023-11-30,,University of Utah,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,578
NCT03305068,1,0,0,0,1,0,2018-03-31,2019-03-31,,St. Louis Joint Replacement Institute,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT03305614,0,0,0,0,0,0,2021-10-01,2022-10-01,,University Ghent,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,151
NCT03306433,0,0,0,0,0,0,2019-01-31,2020-01-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,882
NCT03309332,0,0,0,0,0,0,2025-12-31,2026-12-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,419
NCT03312556,0,0,0,0,0,0,2020-09-21,2021-09-21,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,422
NCT03312972,0,0,0,0,0,0,2020-03-31,2021-03-31,,Loyola University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,102
NCT03316131,1,1,0,1,0,0,2018-07-19,2019-07-19,2019-06-27,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2450
NCT03318757,0,0,0,0,0,0,2020-08-31,2021-08-31,,Boston University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,188
NCT03319212,1,0,1,1,0,0,2018-08-15,2019-08-15,2019-08-02,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,138
NCT03322033,0,0,0,0,0,0,2027-01-15,2028-01-15,,Baylor Research Institute,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,131
NCT03322215,0,0,0,0,0,0,2021-10-31,2022-10-31,,Theodoros Foukakis,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03322540,0,0,0,0,0,0,2019-01-10,2020-01-10,,Incyte Corporation,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03323437,0,0,0,0,0,0,2022-10-31,2023-10-31,,Weill Medical College of Cornell University,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03323749,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stealth BioTherapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,0,0,0,0,1,0,1,1,0,25
NCT03324529,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03325647,0,0,0,0,0,0,2022-04-30,2023-04-30,,"University of Colorado, Denver",Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03326856,0,0,0,0,0,0,2018-06-11,2019-06-11,,Eirion Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,4
NCT03328832,1,0,0,0,1,0,2018-07-30,2019-07-30,,Chang Gung Memorial Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,486
NCT03330067,0,0,0,0,0,0,2020-09-30,2021-09-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,412
NCT03330262,0,0,0,0,0,0,2018-11-30,2019-11-30,,"Barron Associates, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03331185,0,0,1,1,0,0,2019-04-02,2020-04-02,2019-08-20,University of Manitoba,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,0,1,0,0,0,0,0,2,1,0,344
NCT03331328,0,0,0,0,0,0,2019-07-10,2020-07-10,,Michigan Institution of Women's Health PC,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03332017,0,0,0,0,0,0,2020-01-31,2021-01-31,,BeiGene,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03333590,0,0,0,0,0,0,2020-11-30,2021-11-30,,Kevin Flanigan,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03334617,0,0,0,0,0,0,2021-07-30,2022-07-30,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03336619,0,0,0,0,0,0,2019-03-26,2020-03-26,,Romark Laboratories L.C.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,23
NCT03337451,0,0,0,0,0,0,2019-01-10,2020-01-10,,Opsona Therapeutics Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03337724,0,0,0,0,0,0,2021-12-22,2022-12-22,,Hoffmann-La Roche,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03339349,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,578
NCT03339492,0,0,0,0,0,0,2021-12-31,2022-12-31,,Orthofix Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,10
NCT03339713,0,0,0,0,0,0,2018-07-23,2019-07-23,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,29
NCT03340610,0,1,0,1,0,0,2018-12-31,2019-12-31,2019-04-09,"Southeast Retina Center, Georgia",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT03341910,1,0,0,0,1,0,2018-05-18,2019-05-18,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,212
NCT03343067,0,0,0,0,0,0,2018-10-23,2019-10-23,,AbbVie,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,430
NCT03345082,0,0,0,0,0,0,2020-03-31,2021-03-31,,Opthea Limited,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,3
NCT03345979,0,0,0,0,0,0,2019-03-12,2020-03-12,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,1,0,0,1,0,70
NCT03346135,0,0,0,0,0,0,2020-09-30,2021-09-30,,City of Hope Medical Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT03346694,0,0,0,0,0,0,2018-12-31,2019-12-31,,Stanford University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,1309
NCT03347422,0,0,0,0,0,0,2020-08-31,2021-08-31,,Bioverativ Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,19
NCT03350542,0,0,0,0,0,0,2020-02-29,2021-02-28,,Boston Scientific Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,340
NCT03351101,1,0,0,0,1,0,2017-11-10,2018-11-10,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,180
NCT03351361,0,0,0,0,0,0,2021-06-30,2022-06-30,,Rennes University Hospital,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,327
NCT03351842,0,0,0,0,0,0,2019-09-01,2020-09-01,,"Shanghai Pulmonary Hospital, Shanghai, China",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,25
NCT03353246,1,1,0,1,0,0,2018-05-04,2019-05-04,2019-05-03,Duke University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT03358329,1,0,0,0,1,0,2018-01-03,2019-01-03,,Intersect ENT,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,0,0,0,0,1,0,0,1,0,9
NCT03359785,0,0,0,0,0,0,2020-01-16,2021-01-16,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,650
NCT03359954,0,0,0,0,0,0,2019-10-01,2020-10-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,2066
NCT03360617,0,0,0,0,0,0,2018-10-31,2019-10-31,,University Medical Center of Southern Nevada,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03361137,0,0,0,0,0,0,2020-12-16,2021-12-16,,"Genentech, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,427
NCT03361423,0,0,0,0,0,0,2018-11-25,2019-11-25,,Theranica,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,4
NCT03362229,0,0,0,0,0,0,2021-01-31,2022-01-31,,Royal Infirmary of Edinburgh,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,0,0,0,2,1,0,7
NCT03362970,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Calgary,Other,0,1,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,361
NCT03363659,0,0,0,0,0,0,2020-03-31,2021-03-31,,Aurora Health Care,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03364270,0,0,0,0,0,0,2019-12-31,2020-12-31,,Balaji Tamarappoo,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03364725,1,0,0,0,1,0,2018-09-01,2019-09-01,,Id Care,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03365362,0,0,0,0,0,0,2022-09-30,2023-09-30,,Albert Einstein College of Medicine,Other,0,1,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03365934,1,1,0,1,0,0,2018-02-12,2019-02-12,2019-02-11,Johnson & Johnson Consumer Inc. (J&JCI),Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03371082,0,0,0,0,0,0,2019-10-01,2020-10-01,,"Gan and Lee Pharmaceuticals, USA",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,3
NCT03372070,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Sommetrics, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03373903,1,0,0,0,1,0,2018-05-03,2019-05-03,,Restorbio Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03375164,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT03379662,1,0,0,0,1,0,2017-10-28,2018-10-28,,Erchonia Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,29
NCT03381196,0,0,0,0,0,0,2020-05-01,2021-05-01,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03384836,0,0,0,0,0,0,2019-10-11,2020-10-11,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT03385707,0,0,0,0,0,0,2019-11-30,2020-11-30,,Joslin Diabetes Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,60
NCT03386929,0,0,0,0,0,0,2023-10-31,2024-10-31,,Worldwide Innovative Networking Association,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03387111,0,0,0,0,0,0,2019-12-31,2020-12-31,,"NantKwest, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03387514,0,0,0,0,0,0,2021-01-15,2022-01-15,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03389698,0,0,0,0,0,0,2019-02-28,2020-02-28,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03391362,0,0,0,0,0,0,2021-06-30,2022-06-30,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,647
NCT03391973,0,0,0,0,0,0,2022-01-14,2023-01-14,,AHS Cancer Control Alberta,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,136
NCT03392909,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Southern California,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03393845,0,0,0,0,0,0,2021-01-01,2022-01-01,,"Nancy Chan, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03395340,0,0,0,0,0,0,2020-10-01,2021-10-01,,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,91
NCT03396068,0,0,0,0,0,0,2020-09-30,2021-09-30,,"NeuroRx, Inc.",Industry,1,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03396276,0,0,0,0,0,0,2020-11-01,2021-11-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03396874,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03399604,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Liquidia Technologies, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03400943,0,0,0,0,0,0,2021-11-13,2022-11-13,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03401866,0,0,0,0,0,0,2021-01-31,2022-01-31,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,48
NCT03404180,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Florida,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03405142,0,0,0,0,0,0,2021-02-01,2022-02-01,,Eben Rosenthal,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03405311,0,0,0,0,0,0,2020-01-31,2021-01-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,158
NCT03405714,0,0,0,0,0,0,2020-04-30,2021-04-30,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03406975,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03407976,0,0,0,0,0,0,2023-06-30,2024-06-30,,University of Utah,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03408080,0,0,0,0,0,0,2019-07-31,2020-07-31,,"University of California, Los Angeles",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03409185,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Toronto,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,251
NCT03412812,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,801
NCT03414229,0,0,0,0,0,0,2021-01-31,2022-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03423082,0,0,0,0,0,0,2019-12-01,2020-12-01,,Nghi Nguyen,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT03423186,0,0,0,0,0,0,2020-01-31,2021-01-31,,Swedish Orphan Biovitrum,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,40
NCT03424304,0,0,0,0,0,0,2019-07-30,2020-07-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03426436,1,0,0,0,1,0,2018-08-16,2019-08-16,,Nihon Kohden,Industry,1,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,1
NCT03430609,0,0,0,0,0,0,2020-03-01,2021-03-01,,Faculdade de Ciências Médicas da Santa Casa de São Paulo,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,2,1,0,32
NCT03432494,0,0,0,0,0,0,2019-06-30,2020-06-30,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1091
NCT03433599,0,0,0,0,0,0,2022-07-31,2023-07-31,,University of Miami,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,476
NCT03433781,0,0,0,0,0,0,2022-07-01,2023-07-01,,NYU Langone Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03434041,0,0,0,0,0,0,2021-04-28,2022-04-28,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03434392,0,0,0,0,0,0,2021-11-15,2022-11-15,,Dhiraj Yadav,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,1
NCT03435835,0,0,0,0,0,0,2019-12-31,2020-12-31,,Indiana University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT03437941,0,0,0,0,0,0,2021-03-31,2022-03-31,,Corcept Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,40
NCT03439033,0,0,0,0,0,0,2021-10-31,2022-10-31,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03439280,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,209
NCT03439670,0,0,0,0,0,0,2020-05-01,2021-05-01,,"ReveraGen BioPharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03440619,1,1,0,1,0,1,2018-02-14,2019-02-14,2019-02-25,Masimo Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03445390,1,1,0,1,0,1,2017-10-01,2018-10-01,2018-12-06,Stanford University,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT03446001,0,0,0,0,0,0,2020-12-31,2021-12-31,,TauRx Therapeutics Ltd,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03450083,0,0,0,0,0,0,2019-12-30,2020-12-30,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03451071,0,0,0,0,0,0,2019-12-01,2020-12-01,,University of Alabama at Birmingham,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03459196,0,0,0,0,0,0,2018-10-08,2019-10-08,,"Biosense Webster, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,41
NCT03459443,0,0,0,0,0,0,2019-12-31,2020-12-31,,Achillion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03460340,0,0,0,0,0,0,2019-04-30,2020-04-30,,Shalvata Mental Health Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,62
NCT03461718,0,0,0,0,0,0,2019-11-01,2020-11-01,,Brooke Army Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,71
NCT03462459,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03464292,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Florida,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03469141,0,0,0,0,0,0,2020-10-30,2021-10-30,,"Rancho Research Institute, Inc.",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03469310,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Minerva Romero Arenas, MD, MPH",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03469570,0,0,0,0,0,0,2018-12-21,2019-12-21,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,77
NCT03470441,1,0,0,0,1,0,2018-07-14,2019-07-14,,"Faraday Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1
NCT03470922,0,0,0,0,0,0,2020-07-14,2021-07-14,,Bristol-Myers Squibb,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03472495,0,0,0,0,0,0,2021-03-31,2022-03-31,,Virginia Commonwealth University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03473340,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Michigan,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03475186,0,0,0,0,0,0,2020-09-30,2021-09-30,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03476382,0,0,0,0,0,0,2018-11-15,2019-11-15,,Coastal Carolinas Integrated Medicine,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03477175,0,0,0,0,0,0,2020-09-25,2021-09-25,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,328
NCT03477838,0,0,0,0,0,0,2019-12-31,2020-12-31,,Virginia Commonwealth University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,417
NCT03479502,0,0,0,0,0,0,2020-01-31,2021-01-31,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03481634,0,0,0,0,0,0,2020-09-11,2021-09-11,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03483961,0,0,0,0,0,0,2020-04-30,2021-04-30,,"PaxVax, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,12
NCT03484455,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Organ Recovery Systems, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03485157,0,0,0,0,0,0,2019-12-31,2020-12-31,,"MiMedx Group, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,32
NCT03485976,0,0,0,0,0,0,2019-10-31,2020-10-31,,Oregon Health and Science University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT03487445,0,0,0,0,0,0,2018-11-10,2019-11-10,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,79
NCT03488108,1,0,1,1,0,0,2018-05-31,2019-05-31,2019-05-29,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03489876,0,0,0,0,0,0,2023-12-31,2024-12-31,,University of Oklahoma,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,234
NCT03490201,0,0,0,0,0,0,2021-12-31,2022-12-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT03492281,0,0,0,0,0,0,2019-01-10,2020-01-10,,Urovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,7
NCT03496844,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Arizona,Other,0,1,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,265
NCT03499314,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03500549,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03500770,0,0,0,0,0,0,2020-12-30,2021-12-30,,Spaulding Rehabilitation Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,69
NCT03501966,0,0,0,0,0,0,2021-06-30,2022-06-30,,Jaeb Center for Health Research,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,93
NCT03502668,0,0,0,0,0,0,2020-12-31,2021-12-31,,Astex Pharmaceuticals,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,38
NCT03502915,0,0,0,0,0,0,2019-02-14,2020-02-14,,"University of North Carolina, Chapel Hill",Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03505905,0,0,0,0,0,0,2022-03-31,2023-03-31,,University of Texas Southwestern Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03506113,0,0,0,0,0,0,2021-03-31,2022-03-31,,Osaka General Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03506412,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03506724,0,0,0,0,0,0,2019-04-05,2020-04-05,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03508648,0,0,0,0,0,0,2018-09-21,2019-09-21,,GTx,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT03512262,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Radius Health, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03512756,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Tyme, Inc",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03514017,0,0,0,0,0,0,2021-12-31,2022-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03514446,0,0,0,0,0,0,2021-05-01,2022-05-01,,Thomas Benfield,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03517449,0,0,0,0,0,0,2022-02-24,2023-02-24,,Eisai Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,328
NCT03519932,0,0,0,0,0,0,2018-10-15,2019-10-15,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03521063,0,0,0,0,0,0,2019-10-30,2020-10-30,,"Hospital Central ""Dr. Ignacio Morones Prieto""",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03521154,0,0,0,0,0,0,2021-10-29,2022-10-29,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03522480,0,0,0,0,0,0,2019-08-31,2020-08-31,,My Music Machines Inc.,Industry,1,0,1,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03522584,0,0,0,0,0,0,2020-02-15,2021-02-15,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,910
NCT03523871,0,0,0,0,0,0,2020-06-30,2021-06-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03524118,0,0,0,0,0,0,2022-04-11,2023-04-11,,Merck Sharp & Dohme Corp.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03525600,0,0,0,0,0,0,2021-03-30,2022-03-30,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03526159,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Southern California,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03530592,0,0,0,0,0,0,2028-12-31,2029-12-31,,Baltimore VA Medical Center,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,18
NCT03530800,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Chicago,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03531632,0,0,0,0,0,0,2020-04-30,2021-04-30,,MacroGenics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,31
NCT03532035,0,0,0,0,0,0,2019-05-10,2020-05-10,,Chimerix,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,16
NCT03537586,0,0,0,0,0,0,2020-06-01,2021-06-01,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,869
NCT03538301,0,0,0,0,0,0,2020-03-31,2021-03-31,,Nitto Denko Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03538756,0,0,0,0,0,0,2020-12-31,2021-12-31,,RxFunction Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03538951,0,0,0,0,0,0,2019-01-15,2020-01-15,,Vidac Pharma,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03539302,0,0,0,0,0,0,2021-05-31,2022-05-31,,InCarda Therapeutics Australia Pty Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03541486,0,0,0,0,0,0,2029-12-31,2030-12-31,,Joseph J. Cullen,Other,0,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,1,0,0,0,1,0,5
NCT03541850,0,0,0,0,0,0,2021-11-01,2022-11-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,277
NCT03542851,0,0,0,0,0,0,2019-09-30,2020-09-30,,Balance Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03543774,0,0,0,0,0,0,2020-03-15,2021-03-15,,Hue University of Medicine and Pharmacy,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03544827,0,0,0,0,0,0,2019-02-08,2020-02-08,,State University of New York College of Optometry,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03546582,0,0,0,0,0,0,2024-07-31,2025-07-31,,"RTOG Foundation, Inc.",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,1,1,0,5
NCT03547349,0,0,0,0,0,0,2020-06-30,2021-06-30,,My Music Machines Inc.,Industry,1,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03548584,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,185
NCT03551392,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Florida,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03551821,0,0,0,0,0,0,2018-11-06,2019-11-06,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03553004,0,0,0,0,0,0,2021-02-01,2022-02-01,,University of Kansas Medical Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03554018,0,0,0,0,0,0,2019-09-30,2020-09-30,,Montefiore Medical Center,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03554356,0,0,0,0,0,0,2021-07-31,2022-07-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03558997,0,0,0,0,0,0,2019-05-14,2020-05-14,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,176
NCT03559257,0,0,0,0,0,0,2019-06-19,2020-06-19,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03559946,0,0,0,0,0,0,2019-04-30,2020-04-30,,Stony Brook University,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,119
NCT03560739,0,0,0,0,0,0,2019-08-26,2020-08-26,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03562637,0,0,0,0,0,0,2025-11-30,2026-11-30,,"OBI Pharma, Inc",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,1,0,0,0,0,1,1,0,6
NCT03564444,0,0,0,0,0,0,2018-12-27,2019-12-27,,MedImmune LLC,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,269
NCT03567447,0,0,0,0,0,0,2019-11-01,2020-11-01,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,48
NCT03567616,0,0,0,0,0,0,2020-08-20,2021-08-20,,AbbVie,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03568708,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03571256,0,0,0,0,0,0,2020-05-04,2021-05-04,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,101
NCT03572933,0,0,0,0,0,0,2020-07-31,2021-07-31,,Marinus Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,15
NCT03573505,0,0,0,0,0,0,2021-11-17,2022-11-17,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03574610,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Rose Khavari, M.D.",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03579147,0,0,0,0,0,0,2019-05-30,2020-05-30,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,20
NCT03580044,0,0,0,0,0,0,2021-10-07,2022-10-07,,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,1,0,1,1,0,2856
NCT03580343,0,0,0,0,0,0,2019-12-01,2020-12-01,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03580928,0,0,0,0,0,0,2022-01-31,2023-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03581123,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,1,0,0,1,0,749
NCT03583086,0,0,0,0,0,0,2023-07-31,2024-07-31,,Vanderbilt-Ingram Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,180
NCT03588078,0,0,0,0,0,0,2020-05-01,2021-05-01,,Groupe Francophone des Myelodysplasies,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,33
NCT03588299,0,0,0,0,0,0,2021-03-16,2022-03-16,,Bayer,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03594981,0,0,0,0,0,0,2021-07-31,2022-07-31,,Catherine Bollard,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,11
NCT03595215,0,0,0,0,0,0,2019-07-10,2020-07-10,,"Theranova, L.L.C.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03595553,0,0,0,0,0,0,2021-06-30,2022-06-30,,Summit Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03597100,0,0,0,0,0,0,2019-05-29,2020-05-29,,"Cala Health, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03600376,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Eagle Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,5
NCT03600818,0,0,0,0,0,0,2022-08-31,2023-08-31,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03601455,0,0,0,0,0,0,2021-11-01,2022-11-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,277
NCT03602586,0,0,0,0,0,0,2021-04-30,2022-04-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03608371,0,0,0,0,0,0,2019-04-16,2020-04-16,,"BlackThorn Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03610724,0,0,0,0,0,0,2021-03-31,2022-03-31,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03611881,0,0,0,0,0,0,2022-02-01,2023-02-01,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03612232,0,0,0,0,0,0,2021-12-31,2022-12-31,,Wuerzburg University Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,45
NCT03613792,0,0,0,0,0,0,2019-12-31,2020-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03615040,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Leicester,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,85
NCT03617445,0,0,0,0,0,0,2023-12-31,2024-12-31,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03618095,0,0,0,0,0,0,2021-01-30,2022-01-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,340
NCT03619174,0,0,0,0,0,0,2019-07-05,2020-07-05,,Viveve Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,3
NCT03619876,0,0,0,0,0,0,2021-06-30,2022-06-30,,Columbia University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03621696,0,0,0,0,0,0,2024-07-31,2025-07-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1151
NCT03622307,0,0,0,0,0,0,2019-10-01,2020-10-01,,Sheba Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,553
NCT03624192,0,0,0,0,0,0,2019-12-31,2020-12-31,,Avita Medical,Industry,1,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03624816,0,0,0,0,0,0,2019-10-31,2020-10-31,,Q-Med AB,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,56
NCT03625622,0,0,0,0,0,0,2020-06-01,2021-06-01,,"AriBio Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03630185,0,0,0,0,0,0,2018-11-30,2019-11-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03632447,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Renovia, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03633058,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rett Syndrome Research Trust,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03634332,0,0,0,0,0,0,2020-10-31,2021-10-31,,Pancreatic Cancer Research Team,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,8
NCT03634579,0,0,0,0,0,0,2019-03-15,2020-03-15,,Emory University,Other,0,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,947
NCT03635645,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Michigan,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03635983,0,0,0,0,0,0,2024-06-16,2025-06-16,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03639220,1,0,0,0,1,0,2018-08-14,2019-08-14,,University of Nove de Julho,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,123
NCT03639935,0,0,0,0,0,0,2022-01-31,2023-01-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03640312,0,0,0,0,0,0,2021-11-30,2022-11-30,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03643510,0,0,0,0,0,0,2021-08-31,2022-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03643796,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Arkansas,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,285
NCT03644667,0,0,0,0,0,0,2022-08-31,2023-08-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03645070,0,0,0,0,0,0,2018-10-01,2019-10-01,,University of Sao Paulo General Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,368
NCT03647501,0,0,0,0,0,0,2022-08-01,2023-08-01,,Ohio State University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03650413,0,0,0,0,0,0,2022-12-17,2023-12-17,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03652454,0,0,0,0,0,0,2018-10-03,2019-10-03,,Izmir Katip Celebi University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,24
NCT03653091,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Fractyl Laboratories, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03653364,0,0,0,0,0,0,2020-09-02,2021-09-02,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03654560,0,0,0,0,0,0,2019-08-05,2020-08-05,,"United Health Products, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03657810,0,0,0,0,0,0,2018-04-16,2019-04-16,,"Charleston Laboratories, Inc",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03660553,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT03662126,0,0,0,0,0,0,2021-08-01,2022-08-01,,"Kartos Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03663283,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03672487,0,0,0,0,0,0,2023-05-31,2024-05-31,,Tulane University School of Public Health and Tropical Medicine,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03673865,0,0,0,0,0,0,2020-09-30,2021-09-30,,Emory University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT03674372,0,0,0,0,0,0,2021-01-31,2022-01-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03674541,0,0,0,0,0,0,2019-10-15,2020-10-15,,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03675477,0,0,0,0,0,0,2020-07-31,2021-07-31,,Reistone Biopharma Company Limited,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03678311,0,0,0,0,0,0,2019-04-29,2020-04-29,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,581
NCT03678480,0,0,0,0,0,0,2021-10-04,2022-10-04,,HighTide Biopharma Pty Ltd,Industry,1,0,0,1.0,Phase 2,0,2021.0,0,1,0,0,0,0,0,0,3,1,0,6
NCT03678753,0,0,0,0,0,0,2021-11-30,2022-11-30,,"SK Life Science, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,30
NCT03681561,0,0,0,0,0,0,2020-09-30,2021-09-30,,Veronika Bachanova,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03682653,0,0,0,0,0,0,2021-04-30,2022-04-30,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1443
NCT03683017,0,0,0,0,0,0,2020-06-30,2021-06-30,,Biolux Research Ltd.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,7
NCT03683186,0,0,0,0,0,0,2024-09-30,2025-09-30,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,72
NCT03685890,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Sahlgrenska University Hospital, Sweden",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,149
NCT03686878,1,0,1,1,0,1,2017-07-14,2018-07-14,2019-05-22,EV Clinical Trials,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03687255,0,0,0,0,0,0,2019-11-30,2020-11-30,,Allecra,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03687892,0,0,0,0,0,0,2021-04-01,2022-04-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03688451,0,0,0,0,0,0,2022-03-31,2023-03-31,,Tahir Latif,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03688568,0,0,0,0,0,0,2020-09-01,2021-09-01,,Indiana University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT03689452,0,0,0,0,0,0,2019-06-03,2020-06-03,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,412
NCT03691779,0,0,0,0,0,0,2020-01-31,2021-01-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,141
NCT03693170,0,0,0,0,0,0,2020-06-30,2021-06-30,,Pierre Fabre Medicament,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,46
NCT03695172,0,0,0,0,0,0,2020-02-01,2021-02-01,,Duke University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,1342
NCT03696537,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Naoyuki G. Saito, M.D., Ph.D.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT03698396,0,0,0,0,0,0,2021-11-01,2022-11-01,,"Kenneth Brayman, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT03700723,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Entegrion, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03701165,0,0,0,0,0,0,2019-01-31,2020-01-31,,"VMS Medical Products, Inc",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03704298,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Kite, A Gilead Company",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,14
NCT03704467,0,0,0,0,0,0,2020-11-30,2021-11-30,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03705585,0,0,0,0,0,0,2023-10-31,2024-10-31,,"University of Maryland, College Park",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03711604,0,0,0,0,0,0,2020-10-31,2021-10-31,,Rhizen Pharmaceuticals SA,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03711890,0,0,0,0,0,0,2021-12-31,2022-12-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,198
NCT03712137,0,0,0,0,0,0,2019-11-30,2020-11-30,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,495
NCT03712345,0,0,0,0,0,0,2020-06-30,2021-06-30,,InflaRx GmbH,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03713294,0,0,0,0,0,0,2023-10-08,2024-10-08,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03713684,0,0,0,0,0,0,2021-08-31,2022-08-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1222
NCT03718065,0,0,0,0,0,0,2024-04-01,2025-04-01,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03718767,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03719560,0,0,0,0,0,0,2022-12-31,2023-12-31,,Brown University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,152
NCT03719729,0,0,0,0,0,0,2020-02-22,2021-02-22,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03721029,0,0,0,0,0,0,2020-11-30,2021-11-30,,Herlev and Gentofte Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,17
NCT03721978,0,0,0,0,0,0,2021-04-30,2022-04-30,,Inovio Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,1,0,0,0,0,1,1,0,25
NCT03723447,0,0,0,0,0,0,2019-08-31,2020-08-31,,Cedars-Sinai Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03726489,0,0,0,0,0,0,2022-07-31,2023-07-31,,University of Pennsylvania,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03727074,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Sol-Gel Technologies, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03727841,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03730779,0,0,0,0,0,0,2020-01-01,2021-01-01,,Beth Israel Deaconess Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03733860,0,0,0,0,0,0,2018-12-31,2019-12-31,,Cairo University,Other,0,0,0,5.0,,0,2018.0,1,0,0,0,0,0,0,0,2,1,0,1190
NCT03734029,0,0,0,0,0,0,2023-01-01,2024-01-01,,"Daiichi Sankyo, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT03735329,0,0,0,0,0,0,2019-01-31,2020-01-31,,ChroniSense Medical Ltd.,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03738150,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Acceleron Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,21
NCT03740945,0,0,0,0,0,0,2021-03-31,2022-03-31,,EndoCeutics Inc.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,9
NCT03742596,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Jordan,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,32
NCT03743246,0,0,0,0,0,0,2023-12-11,2024-12-11,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03745222,0,0,0,0,0,0,2019-06-26,2020-06-26,,Celgene,Industry,1,1,0,3.0,Phase 3,1,2019.0,1,1,0,0,0,0,0,0,1,1,0,306
NCT03746080,0,0,0,0,0,0,2022-07-11,2023-07-11,,Lawrence Recht,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,3
NCT03747497,0,0,0,0,0,0,2019-05-30,2020-05-30,,MicuRx,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03753906,1,0,0,0,1,0,2018-07-31,2019-07-31,,Krishnadevaraya College of Dental Sciences & Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,14
NCT03756246,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Texas at Austin,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,135
NCT03758443,0,0,0,0,0,0,2025-06-30,2026-06-30,,Theravance Biopharma,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,53
NCT03759665,0,0,0,0,0,0,2020-04-01,2021-04-01,,IntraBio Inc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03760250,0,0,0,0,0,0,2020-01-01,2021-01-01,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03761953,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03762668,0,0,0,0,0,0,2019-01-07,2020-01-07,,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03762811,0,0,0,0,0,0,2021-03-31,2022-03-31,,"NanoFUSE Biologics, LLC",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03765489,1,0,0,0,1,0,2018-06-21,2019-06-21,,University of Chile,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,92
NCT03767738,0,0,0,0,0,0,2019-02-13,2020-02-13,,Regeneron Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,176
NCT03768063,0,0,0,0,0,0,2028-12-28,2029-12-28,,Hoffmann-La Roche,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03770091,0,0,0,0,0,0,2019-10-31,2020-10-31,,John Fowler,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03770273,0,0,0,0,0,0,2024-08-01,2025-08-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03770416,0,0,0,0,0,0,2023-06-15,2024-06-15,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03773406,0,0,0,0,0,0,2021-07-31,2022-07-31,,Shirley Ryan AbilityLab,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,71
NCT03774264,0,0,0,0,0,0,2020-09-02,2021-09-02,,University of Miami,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT03774849,0,0,0,0,0,0,2020-06-30,2021-06-30,,Candela Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03777436,0,0,0,0,0,0,2020-08-19,2021-08-19,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03778957,0,0,0,0,0,0,2021-03-31,2022-03-31,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03781310,0,0,0,0,0,0,2019-06-30,2020-06-30,,Tel-Aviv Sourasky Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,415
NCT03782480,0,0,0,0,0,0,2021-01-02,2022-01-02,,Center for Vulvovaginal Disorders,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03783923,0,0,0,0,0,0,2020-08-31,2021-08-31,,PTC Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03787628,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of California, Los Angeles",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,692
NCT03789318,0,0,0,0,0,0,2019-05-16,2020-05-16,,Concentric Analgesics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03794206,0,0,0,0,0,0,2019-08-30,2020-08-30,,"Solace Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03794973,0,0,0,0,0,0,2021-12-14,2022-12-14,,"Tolerion, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03795428,0,0,0,0,0,0,2024-01-15,2025-01-15,,PhaseBio Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03796559,0,0,0,0,0,0,2021-01-31,2022-01-31,,Endomagnetics Inc,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03800602,0,0,0,0,0,0,2021-01-31,2022-01-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03802799,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Zynerba Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03803475,0,0,0,0,0,0,2020-12-11,2021-12-11,,Thomas Hope,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,5
NCT03805269,0,0,0,0,0,0,2019-12-31,2020-12-31,,Seoul National University Bundang Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,221
NCT03805438,0,0,0,0,0,0,2020-09-30,2021-09-30,,Duke University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03806023,0,0,0,0,0,0,2020-07-31,2021-07-31,,Bronx VA Medical Center,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,15
NCT03808688,0,0,0,0,0,0,2019-07-26,2020-07-26,,Aerie Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,28
NCT03809143,0,0,0,0,0,0,2020-11-01,2021-11-01,,The University of New South Wales,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,60
NCT03810690,0,0,0,0,0,0,2022-11-30,2023-11-30,,"ModernaTX, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,14
NCT03811886,0,0,0,0,0,0,2021-11-01,2022-11-01,,Case Comprehensive Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,374
NCT03813095,0,0,0,0,0,0,2025-09-30,2026-09-30,,Aphios,Industry,1,0,0,1.0,Phase 2,0,2023.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03817554,0,0,0,0,0,0,2022-02-01,2023-02-01,,Dong Jie,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03821272,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Arkansas,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,285
NCT03821792,0,0,0,0,0,0,2022-10-01,2023-10-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03822832,0,0,0,0,0,0,2020-02-14,2021-02-14,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03823534,0,0,0,0,0,0,2020-08-01,2021-08-01,,St. Louis University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,126
NCT03824119,0,0,0,0,0,0,2020-12-11,2021-12-11,,University of Southern California,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03826550,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-05-31,Encube Ethicals Pvt. Ltd.,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03827122,0,0,0,0,0,0,2019-11-11,2020-11-11,,Riyadh Colleges of Dentistry and Pharmacy,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,26
NCT03827291,0,0,0,0,0,0,2020-04-01,2021-04-01,,Duke University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1342
NCT03827876,0,0,0,0,0,0,2019-09-15,2020-09-15,,Psoriasis Treatment Center of Central New Jersey,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03829761,0,0,0,0,0,0,2020-05-31,2021-05-31,,The Mind Research Network,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03832907,0,0,0,0,0,0,2020-02-29,2021-02-28,,Emory University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,1,0,0,0,0,1,0,947
NCT03833661,0,0,0,0,0,0,2021-03-03,2022-03-03,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03834272,0,0,0,0,0,0,2019-11-01,2020-11-01,,"Lumicell, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,7
NCT03834766,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Tris Pharma, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03836482,0,0,0,0,0,0,2021-02-28,2022-02-28,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,934
NCT03839771,0,0,0,0,0,0,2023-03-31,2024-03-31,,Stichting Hemato-Oncologie voor Volwassenen Nederland,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,18
NCT03842436,0,0,0,0,0,0,2020-02-01,2021-02-01,,Peter Chai,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT03844542,0,0,0,0,0,0,2022-12-31,2023-12-31,,Forsyth Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03849768,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,32
NCT03850444,1,1,0,1,0,0,2018-09-04,2019-09-04,2019-08-05,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT03852160,0,0,0,0,0,0,2021-07-25,2022-07-25,,Janssen-Cilag International NV,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,64
NCT03852992,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,749
NCT03854474,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03858036,0,0,0,0,0,0,2024-12-31,2025-12-31,,"Center for Sight, Sacramento, CA",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT03863522,0,0,0,0,0,0,2021-04-01,2022-04-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,461
NCT03865082,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Idera Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03873207,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Jeffrey A. Gusenoff, MD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03874325,0,0,0,0,0,0,2022-03-11,2023-03-11,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03875833,0,0,0,0,0,0,2022-12-01,2023-12-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT03876457,0,0,0,0,0,0,2021-05-01,2022-05-01,,"The University of Texas Health Science Center, Houston",Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT03876860,0,0,0,0,0,0,2021-04-01,2022-04-01,,Margaret Liotta,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03879174,0,0,0,0,0,0,2022-08-01,2023-08-01,,Mediclinic Middle East,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03882359,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Microvascular Therapeutics, LLC",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,1
NCT03883477,0,0,0,0,0,0,2020-12-31,2021-12-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,279
NCT03885011,0,0,0,0,0,0,2019-09-30,2020-09-30,,Orasis Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03885609,0,0,0,0,0,0,2019-04-12,2020-04-12,,Home Skinovations Ltd.,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03888469,0,0,0,0,0,0,2019-06-24,2020-06-24,,Alcon Research,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03888703,1,0,0,0,1,0,2017-05-05,2018-05-05,,Miami Dermatology and Laser Institute,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,3,0,1,1
NCT03890939,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Arizona,Other,0,1,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,265
NCT03891446,0,0,0,0,0,0,2023-04-30,2024-04-30,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03892434,0,0,0,0,0,0,2019-12-18,2020-12-18,,Yeungnam University College of Medicine,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,23
NCT03896009,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Axsome Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03897205,0,0,0,0,0,0,2020-04-30,2021-04-30,,Hansa Biopharma AB,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,8
NCT03898804,0,0,0,0,0,0,2024-03-01,2025-03-01,,"Jonathan Miller, MD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03899467,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Suzhou Kintor Pharmaceutical Inc,",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03907033,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03908073,0,0,0,0,0,0,2020-06-15,2021-06-15,,Queen Mary University of London,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,112
NCT03908944,0,0,0,0,0,0,2021-01-02,2022-01-02,,Steven Edelstein,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03909152,0,0,0,0,0,0,2021-04-30,2022-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03911557,0,0,0,0,0,0,2023-06-30,2024-06-30,,"John L. Villano, MD, PhD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03911739,0,0,0,0,0,0,2024-01-31,2025-01-31,,"Theresa Winhusen, PhD",Other,0,1,1,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03913442,0,0,0,0,0,0,2021-05-15,2022-05-15,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03913702,0,0,0,0,0,0,2020-05-15,2021-05-15,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,158
NCT03915067,0,0,0,0,0,0,2020-05-21,2021-05-21,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03915587,0,0,0,0,0,0,2020-04-08,2021-04-08,,"University of Colorado, Aurora",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03916380,0,0,0,0,0,0,2020-01-31,2021-01-31,,Shirley M. Tsunoda,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,0,0,0,0,0,3,1,0,1
NCT03917121,0,0,0,0,0,0,2020-05-31,2021-05-31,,Cairo University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1190
NCT03918915,0,0,0,0,0,0,2023-06-30,2024-06-30,,"Sydnexis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03920007,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1222
NCT03920345,0,0,0,0,0,0,2019-05-16,2020-05-16,,"joimax, Inc.",Industry,1,1,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03920878,0,0,0,0,0,0,2020-02-29,2021-02-28,,Emory University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03921021,0,0,0,0,0,0,2021-03-28,2022-03-28,,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03921411,0,0,0,0,0,0,2020-02-29,2021-02-28,,Galderma R&D,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,28
NCT03926130,0,0,0,0,0,0,2022-02-01,2023-02-01,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03928288,0,0,0,0,0,0,2023-02-28,2024-02-28,,Boston Children’s Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03928743,0,0,0,0,0,0,2021-01-31,2022-01-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03936478,0,0,0,0,0,0,2022-07-01,2023-07-01,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,715
NCT03937479,0,0,0,0,0,0,2019-10-31,2020-10-31,,Verona Pharma plc,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03938337,0,0,0,0,0,0,2022-09-01,2023-09-01,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03942211,0,0,0,0,0,0,2022-06-20,2023-06-20,,Actelion,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,128
NCT03944512,0,0,0,0,0,0,2026-06-30,2027-06-30,,The George Washington University Biostatistics Center,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03945175,0,0,0,0,0,0,2021-06-30,2022-06-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03947216,0,0,0,0,0,0,2022-01-31,2023-01-31,,"University Hospital, Strasbourg, France",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,412
NCT03948178,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Orion Corporation, Orion Pharma",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,86
NCT03950609,0,0,0,0,0,0,2021-05-07,2022-05-07,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03952325,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Odonate Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03953079,0,0,0,0,0,0,2021-03-31,2022-03-31,,Graybug Vision,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03957070,0,0,0,0,0,0,2019-08-31,2020-08-31,,Sonic Incytes,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,1,1,0,1
NCT03959241,0,0,0,0,0,0,2023-02-28,2024-02-28,,Medical College of Wisconsin,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03960684,0,0,0,0,0,0,2020-06-30,2021-06-30,,Levita Magnetics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,4
NCT03961204,0,0,0,0,0,0,2021-01-20,2022-01-20,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03962582,0,0,0,0,0,0,2019-03-30,2020-03-30,,Shirley Ryan AbilityLab,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,71
NCT03963375,0,0,0,0,0,0,2023-06-30,2024-06-30,,Washington University School of Medicine,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1151
NCT03964337,0,0,0,0,0,0,2020-11-30,2021-11-30,,Duke University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03969888,0,0,0,0,0,0,2021-02-19,2022-02-19,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03970096,0,0,0,0,0,0,2023-08-01,2024-08-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,393
NCT03970616,0,0,0,0,0,0,2021-08-31,2022-08-31,,"AVEO Pharmaceuticals, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,29
NCT03971474,0,0,0,0,0,0,2023-02-01,2024-02-01,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,288
NCT03979066,0,0,0,0,0,0,2022-05-31,2023-05-31,,Gulam Manji,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03979638,0,0,0,0,0,0,2020-04-15,2021-04-15,,Bellus Health Inc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03980184,0,0,0,0,0,0,2021-06-30,2022-06-30,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1053
NCT03980366,0,0,0,0,0,0,2021-03-31,2022-03-31,,Eastern Virginia Medical School,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,33
NCT03980964,0,0,0,0,0,0,2020-12-01,2021-12-01,,"CyMedica Orthopedics, Inc",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03981822,0,0,0,0,0,0,2020-08-12,2021-08-12,,Verrica Pharmaceuticals Inc.,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,5
NCT03983304,0,0,0,0,0,0,2020-11-30,2021-11-30,,Zeltiq Aesthetics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,32
NCT03985527,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Respicardia, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,8
NCT03987295,0,0,0,0,0,0,2021-03-30,2022-03-30,,Alector Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03988049,0,0,0,0,0,0,2019-08-01,2020-08-01,,David Smart,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03988166,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Vascular Solutions, Inc",Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,5
NCT03988530,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Repurposed Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03990051,0,0,0,0,0,0,2019-10-21,2020-10-21,,"Glia, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03990571,0,0,0,0,0,0,2022-12-30,2023-12-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03993353,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,561
NCT03994380,0,0,0,0,0,0,2020-03-31,2021-03-31,,National Jewish Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,81
NCT03996863,0,0,0,0,0,0,2020-05-31,2021-05-31,,Otolith Labs,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03999996,0,0,0,0,0,0,2023-03-30,2024-03-30,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,650
NCT04000737,0,0,0,0,0,0,2021-11-02,2022-11-02,,Yiviva Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT04001517,0,0,0,0,0,0,2020-06-30,2021-06-30,,EIP Pharma Inc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT04002791,0,0,0,0,0,0,2019-09-16,2020-09-16,,Total Cardiovascular Solutions,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT04011748,0,0,0,0,0,0,2020-10-31,2021-10-31,,Tianhe Stem Cell Biotechnologies Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,6
NCT04016376,0,0,0,0,0,0,2023-07-31,2024-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT04019288,0,0,0,0,0,0,2020-09-30,2021-09-30,,M.D. Anderson Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT04019704,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Axsome Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04020185,0,0,0,0,0,0,2023-02-16,2024-02-16,,ImmuneSensor Therapeutics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04022889,0,0,0,0,0,0,2020-08-31,2021-08-31,,Cerus Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,12
NCT04023084,0,0,0,0,0,0,2020-07-31,2021-07-31,,Ann & Robert H Lurie Children's Hospital of Chicago,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,112
NCT04024254,0,0,0,0,0,0,2021-08-31,2022-08-31,,Rush University Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,227
NCT04024462,0,0,0,0,0,0,2021-06-23,2022-06-23,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,1,0,0,2,1,0,1731
NCT04026256,0,0,0,0,0,0,2021-11-30,2022-11-30,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT04027361,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Tris Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT04028960,0,0,0,0,0,0,2019-12-31,2020-12-31,,HealthPartners Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,101
NCT04030598,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,69
NCT04032171,0,0,0,0,0,0,2023-06-30,2024-06-30,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT04038346,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Desiree Neville, MD",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04039204,0,0,0,0,0,0,2021-05-31,2022-05-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT04039529,0,0,0,0,0,0,2020-08-31,2021-08-31,,Clear Guide Medical,Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT04040205,0,0,0,0,0,0,2023-09-01,2024-09-01,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT04040725,0,0,0,0,0,0,2020-12-31,2021-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT04041843,0,0,0,0,0,0,2020-05-31,2021-05-31,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT04042376,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Janssen Research & Development, LLC",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,558
NCT04043455,0,0,0,0,0,0,2020-12-31,2021-12-31,,Arena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT04045613,0,0,0,0,0,0,2022-04-30,2023-04-30,,Basilea Pharmaceutica,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,32
NCT04047784,0,0,0,0,0,0,2021-06-01,2022-06-01,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT04054921,0,0,0,0,0,0,2021-05-10,2022-05-10,,Protagonist Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,4
NCT04055623,0,0,0,0,0,0,2023-09-01,2024-09-01,,The Methodist Hospital System,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,36
NCT04056949,0,0,0,0,0,0,2021-02-01,2022-02-01,,Junling Li,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT04057118,0,0,0,0,0,0,2020-04-14,2021-04-14,,Oscotec Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT04058197,0,0,0,0,0,0,2020-12-31,2021-12-31,,TauTona Group,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT04060667,0,0,0,0,0,0,2020-09-30,2021-09-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,1,0,3,1,0,1699
NCT04062123,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Keith M. Vogt, MD, PhD",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT04063215,0,0,0,0,0,0,2020-08-29,2021-08-29,,Hope Biosciences,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT04063657,0,0,0,0,0,0,2021-08-29,2022-08-29,,"University of California, Davis",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,530
NCT04063943,0,0,0,0,0,0,2027-07-12,2028-07-12,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,215
NCT04064710,0,0,0,0,0,0,2019-12-15,2020-12-15,,"Lenoss Medical, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04066491,0,0,0,0,0,0,2022-11-24,2023-11-24,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT04071236,0,0,0,0,0,0,2021-03-01,2022-03-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,3,1,0,3004
NCT04076774,0,0,0,0,0,0,2019-09-30,2020-09-30,,Prof Mags Beksinska,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT04079348,0,0,0,0,0,0,2021-07-31,2022-07-31,,Cook Biotech Incorporated,Industry,1,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT04080544,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Neil M Rofsky, MD, MHA",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04081103,0,0,0,0,0,0,2020-10-31,2021-10-31,,"OcuNexus Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,8
NCT04082143,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Illinois at Chicago,Other,0,1,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,242
NCT04083339,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Applied Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04083963,0,0,0,0,0,0,2022-02-05,2023-02-05,,University of Illinois at Chicago,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,242
NCT04084236,0,0,0,0,0,0,2019-10-30,2020-10-30,,"Omron Healthcare Co., Ltd.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT04088292,0,0,0,0,0,0,2021-06-05,2022-06-05,,"Rigshospitalet, Denmark",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,605
NCT04089059,0,0,0,0,0,0,2022-05-31,2023-05-31,,"Endotronix, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,4
NCT04089566,0,0,0,0,0,0,2022-06-13,2023-06-13,,Biogen,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,324
NCT04089761,0,0,0,0,0,0,2020-08-30,2021-08-30,,Theranica,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT00001337,0,0,0,0,0,0,2020-03-31,2021-03-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,1993.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT00063882,1,0,1,1,0,1,2017-05-31,2018-05-31,2019-05-21,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2003.0,0,0,0,0,0,1,0,0,1,0,1,156
NCT00112125,0,0,0,0,0,0,2019-04-30,2020-04-30,,Impulse Dynamics,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2005.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT00112827,0,0,0,0,0,0,2019-11-30,2020-11-30,,City of Hope Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2004.0,0,1,1,0,0,1,0,1,0,0,1,358
NCT00167219,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,0.0,Phase 1/Phase 2,0,1999.0,0,1,1,0,0,0,0,0,0,0,1,218
NCT00214097,1,0,1,1,0,1,2017-08-21,2018-08-21,2019-05-22,"University of Wisconsin, Madison",Other,0,0,1,0.0,Phase 1/Phase 2,0,2002.0,1,0,0,0,0,1,0,0,0,0,1,715
NCT00293475,0,0,0,0,0,0,2019-01-31,2020-01-31,,OHSU Knight Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2005.0,0,1,1,0,0,0,0,0,0,0,1,163
NCT00338377,0,0,0,0,0,0,2030-02-28,2031-02-28,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2006.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT00401518,1,0,0,0,1,0,2017-08-31,2018-08-31,,Globus Medical Inc,Industry,1,0,0,5.0,,0,2006.0,1,0,0,1,0,0,0,0,0,0,1,13
NCT00439556,1,1,0,1,0,1,2018-06-07,2019-06-07,2019-07-26,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2007.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT00468715,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,1,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00481091,0,0,0,0,0,0,2020-09-04,2021-09-04,,AbbVie,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2007.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT00508443,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2002.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT00573989,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-05-11,Wake Forest University Health Sciences,Other,0,0,1,0.0,Phase 1/Phase 2,1,2008.0,1,1,0,0,0,1,0,0,0,0,1,616
NCT00619528,0,0,0,0,0,0,2022-06-30,2023-06-30,,Northwestern University,Other,0,0,1,5.0,,0,2007.0,0,0,1,0,0,0,0,0,0,0,1,925
NCT00629798,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00667615,1,1,0,1,0,0,2017-02-28,2018-02-28,2017-09-07,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00712582,1,0,0,0,1,0,2018-07-31,2019-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00713193,1,0,1,1,0,1,2017-09-20,2018-09-20,2018-12-11,Ohio State University,Other,0,0,1,3.0,Phase 3,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,315
NCT00769379,0,0,0,0,0,0,2020-01-31,2021-01-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2008.0,0,0,1,0,0,1,0,0,1,0,1,3004
NCT00787722,0,0,0,0,0,0,2018-12-31,2019-12-31,,Northwestern University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT00788671,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2008.0,0,0,0,1,0,0,0,0,0,0,1,2066
NCT00794040,1,1,0,1,0,1,2018-02-01,2019-02-01,2019-03-22,National Institute of Mental Health (NIMH),NIH,2,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,330
NCT00834665,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2006.0,1,0,1,0,0,0,0,0,0,0,1,1052
NCT00835770,0,0,0,0,0,0,2020-09-28,2021-09-28,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,324
NCT00838435,1,0,0,0,1,0,2018-09-14,2019-09-14,,BioMarin Pharmaceutical,Industry,1,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,85
NCT00846430,1,0,0,0,1,0,2017-10-31,2018-10-31,,Spectrum Health Hospitals,Other,0,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,43
NCT00846742,0,0,0,0,0,0,2019-01-11,2020-01-11,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,302
NCT00853489,1,1,0,1,0,0,2017-02-17,2018-02-17,2018-02-14,St. Louis University,Other,0,0,0,4.0,Phase 4,1,2011.0,1,0,0,1,0,0,0,0,0,0,1,126
NCT00871923,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT00882895,0,0,0,0,0,0,2028-06-01,2029-06-01,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT00904345,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,213
NCT00914628,0,0,0,0,0,0,2021-03-31,2022-03-31,,MolMed S.p.A.,Industry,1,0,0,3.0,Phase 3,0,2010.0,0,0,0,0,0,0,0,1,1,0,1,18
NCT00916578,1,1,0,1,0,0,2017-06-06,2018-06-06,2018-05-15,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT00950001,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,3.0,Phase 3,0,2009.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT00963105,1,1,0,1,0,0,2017-09-05,2018-09-05,2018-08-31,Celgene,Industry,1,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT00966693,1,0,1,1,0,0,2018-07-20,2019-07-20,2019-04-22,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00987389,1,0,1,1,0,1,2017-08-31,2018-08-31,2018-10-31,University of Pennsylvania,Other,0,0,1,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,1052
NCT01005108,0,0,0,0,0,0,2019-02-28,2020-02-28,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT01047319,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-11-28,"Teva Pharmaceutical Industries, Ltd.",Industry,1,0,0,3.0,Phase 3,1,2010.0,1,1,0,0,0,0,0,0,1,0,1,14
NCT01093612,0,0,0,0,0,0,2019-12-31,2020-12-31,,City of Hope Medical Center,Other,0,0,0,5.0,,0,2011.0,0,0,0,0,0,1,0,1,0,0,1,358
NCT01103778,1,1,0,1,0,1,2017-04-17,2018-04-17,2018-09-21,The Rogosin Institute,Other,0,0,0,4.0,Phase 4,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT01116648,0,0,0,0,0,0,2018-10-31,2019-10-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01147016,1,0,0,0,1,0,2017-07-01,2018-07-01,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,1,0,0,0,0,0,0,0,1,134
NCT01163786,0,0,0,0,0,0,2019-06-30,2020-06-30,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT01168921,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01177683,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Sherif Farag, MB, BS",Other,0,1,0,0.0,Phase 1/Phase 2,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01201850,0,0,0,0,0,0,2019-02-28,2020-02-28,,"University of Colorado, Denver",Other,0,1,0,5.0,,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT01217060,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT01217775,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Pherin Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01247090,1,1,0,1,0,0,2018-08-31,2019-08-31,2011-04-04,Columbia University,Other,0,0,0,1.0,Phase 2,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT01247701,0,0,0,0,0,0,2024-11-30,2025-11-30,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT01254877,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-29,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT01257737,1,1,0,1,0,0,2017-02-16,2018-02-16,2018-02-16,"Horizon Therapeutics, LLC",Industry,1,0,0,4.0,Phase 4,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,3
NCT01259063,1,1,0,1,0,0,2017-06-30,2018-06-30,2017-12-06,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01263379,0,0,0,0,0,0,2023-12-31,2024-12-31,,Stanford University,Other,0,1,1,0.0,Phase 1/Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,1309
NCT01265849,0,0,0,0,0,0,2019-09-30,2020-09-30,,CEL-SCI Corporation,Industry,1,1,0,3.0,Phase 3,0,2010.0,0,1,1,0,0,1,0,0,1,0,1,2
NCT01279954,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-09-08,Oregon Health and Science University,Other,0,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT01299038,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-05,Beth Israel Deaconess Medical Center,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT01310530,0,0,0,0,0,0,2023-05-31,2024-05-31,,Loma Linda University,Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,194
NCT01311518,0,0,0,0,0,0,2019-03-31,2020-03-31,,"RegeneRx Biopharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT01311648,0,0,0,0,0,0,2021-04-30,2022-04-30,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2011.0,0,0,1,0,0,0,0,0,1,0,1,1343
NCT01329900,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01342367,0,0,0,0,0,0,2020-10-01,2021-10-01,,University of Chicago,Other,0,0,0,5.0,,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,594
NCT01369199,1,1,0,1,0,1,2017-02-14,2018-02-14,2018-03-07,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,1,3.0,Phase 3,1,2012.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT01393821,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01395030,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-06-09,Queen's Medical Centre,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,0,0,1,0,0,0,0,0,1,9
NCT01416428,0,0,0,0,0,0,2019-08-12,2020-08-12,,Amgen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,685
NCT01424722,1,0,1,1,0,1,2017-06-30,2018-06-30,2019-02-25,Abbott Medical Devices,Industry,1,0,0,5.0,,1,2011.0,1,0,0,1,0,0,0,0,0,0,1,419
NCT01434602,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01446133,0,0,0,0,0,0,2019-12-01,2020-12-01,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01449149,0,0,0,0,0,0,2019-12-31,2020-12-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,5.0,,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,273
NCT01455389,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Genprex, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01461291,1,0,0,0,1,0,2017-08-04,2018-08-04,,Glaukos Corporation,Industry,1,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,34
NCT01462630,0,0,0,0,0,0,2019-12-15,2020-12-15,,Fox Chase Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,156
NCT01466972,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Hope Rugo, MD",Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01468844,0,0,0,0,0,0,2019-04-15,2020-04-15,,National Eye Institute (NEI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,2,0,1,263
NCT01471106,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01471444,0,0,0,0,0,0,2019-11-01,2020-11-01,,M.D. Anderson Cancer Center,Other,0,1,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01482715,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Clovis Oncology, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT01484431,1,1,0,1,0,1,2017-04-21,2018-04-21,2018-09-17,Eli Lilly and Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT01506141,0,0,0,0,0,0,2021-07-01,2022-07-01,,Shire,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,342
NCT01517243,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,306
NCT01523275,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-04-04,"University of California, San Francisco",Other,0,0,0,5.0,,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT01529034,0,1,0,1,0,1,2017-04-30,2018-04-30,2019-05-09,"Proximagen, LLC",Industry,1,0,0,3.0,Phase 3,1,2012.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT01530373,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Arkansas,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,285
NCT01543776,1,1,0,1,0,1,2017-09-30,2018-09-30,2019-03-26,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,594
NCT01561053,1,1,0,1,0,1,2018-03-06,2019-03-06,2019-05-13,"Instituto Grifols, S.A.",Industry,1,1,0,2.0,Phase 2/Phase 3,0,2012.0,1,0,1,0,0,0,0,0,1,0,1,15
NCT01567891,1,1,0,1,0,1,2017-06-06,2018-06-06,2018-07-13,Adaptimmune,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,11
NCT01570348,0,0,0,0,0,0,2019-02-03,2020-02-03,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT01572922,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-03-01,St. Jude Children's Research Hospital,Other,0,0,1,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,302
NCT01574287,0,1,0,1,0,0,2019-05-15,2020-05-15,2019-06-14,"David M. Schuster, MD",Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01580969,1,1,0,1,0,0,2018-01-12,2019-01-12,2019-01-11,University of Utah,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,1,0,0,0,0,1,578
NCT01589094,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-07-22,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01593670,0,1,0,1,0,0,2018-10-23,2019-10-23,2017-03-29,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,218
NCT01595061,0,0,0,0,0,0,2019-09-30,2020-09-30,,Gynecologic Oncology Group,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,200
NCT01596699,0,0,0,0,0,0,2019-06-30,2020-06-30,,Christopher Dvorak,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01602120,0,1,0,1,0,1,2017-11-08,2018-11-08,2019-01-23,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,1,2012.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT01603407,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Rochester,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,470
NCT01630889,0,0,0,0,0,0,2018-10-31,2019-10-31,,FibroGen,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT01635283,0,0,1,1,0,0,2019-08-31,2020-08-31,2019-05-06,Jonsson Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,277
NCT01639508,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01648023,0,0,0,0,0,0,2020-07-31,2021-07-31,,Robert C. Martin,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,1,0,0,0,0,0,0,1,2
NCT01681433,1,1,0,1,0,1,2017-06-21,2018-06-21,2018-09-20,Costantine Albany,Other,0,1,0,1.0,Phase 2,1,2012.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT01697527,0,0,0,0,0,0,2020-11-02,2021-11-02,,Jonsson Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,1,0,0,1,0,0,0,0,1,277
NCT01700049,1,1,0,1,0,1,2017-07-03,2018-07-03,2019-03-21,Mayo Clinic,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT01705067,0,0,0,0,0,0,2024-04-30,2025-04-30,,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,83
NCT01709981,0,0,0,0,0,0,2019-08-30,2020-08-30,,NYU Langone Health,Other,0,1,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT01710137,0,1,0,1,0,0,2018-09-30,2019-09-30,2019-08-14,University of Pennsylvania,Other,0,0,1,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01717053,1,1,0,1,0,0,2017-08-24,2018-08-24,2018-08-23,Duke University,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,1342
NCT01720316,1,1,0,1,0,0,2017-05-31,2018-05-31,2017-04-16,Mclean Hospital,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,126
NCT01733186,0,0,0,0,0,0,2017-06-02,2018-06-02,,Medipost Co Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,15
NCT01740323,1,0,1,1,0,0,2018-07-27,2019-07-27,2019-07-16,Andrew H Miller,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01742299,0,0,0,0,0,0,2023-04-21,2024-04-21,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01757288,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Texas Southwestern Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT01757418,0,0,0,0,0,0,2022-09-30,2023-09-30,,Albert Einstein College of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,155
NCT01757626,0,0,0,0,0,0,2021-12-31,2022-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT01760005,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,1,1,2.0,Phase 2/Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,1151
NCT01772693,0,0,0,0,0,0,2019-03-31,2020-03-31,,InSightec,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,61
NCT01780662,1,0,1,1,0,1,2017-09-30,2018-09-30,2019-02-07,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01784861,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT01798407,0,0,0,0,0,0,2019-08-31,2020-08-31,,Wayne Goodman MD,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT01799889,0,0,0,0,0,0,2017-09-14,2018-09-14,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT01807065,0,0,0,0,0,0,2018-12-31,2019-12-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,0,1,0,0,1,0,0,0,0,1,358
NCT01808118,1,1,0,1,0,0,2017-02-21,2018-02-21,2018-02-16,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,0,1,0,0,0,0,0,3,0,1,430
NCT01812252,0,0,0,0,0,0,2021-04-01,2022-04-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,393
NCT01816230,1,0,0,0,1,0,2017-06-30,2018-06-30,,Gamida Cell ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT01818479,0,0,0,0,0,0,2019-04-01,2020-04-01,,University of Utah,Other,0,0,0,0.0,Phase 1/Phase 2,1,2013.0,1,0,1,0,0,0,0,0,0,0,1,578
NCT01830972,1,1,0,1,0,0,2017-02-14,2018-02-14,2018-02-14,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT01833806,0,0,0,0,0,0,2020-06-30,2021-06-30,,InSightec,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,61
NCT01836276,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-06-19,"Nikki Nollen, PhD, MA",Other,0,1,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01837043,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Nair, Vinay, D.O.",Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01842282,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT01849783,0,0,0,0,0,0,2020-06-30,2021-06-30,,Yogesh Jethava,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01856192,0,0,0,0,0,0,2019-08-31,2020-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01858922,0,0,0,0,0,0,2019-06-30,2020-06-30,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT01864291,0,0,0,0,0,0,2022-11-30,2023-11-30,,Massachusetts Eye and Ear Infirmary,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,50
NCT01867606,1,0,1,1,0,0,2018-07-31,2019-07-31,2018-08-28,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,1898
NCT01876953,1,0,0,0,1,0,2018-04-25,2019-04-25,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT01883362,1,0,1,1,0,0,2018-04-30,2019-04-30,2019-04-29,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01885897,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,218
NCT01887912,1,1,0,1,0,0,2018-06-12,2019-06-12,2019-06-11,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,1,2013.0,1,0,1,0,0,0,0,0,1,0,1,285
NCT01894802,0,0,0,0,0,0,2023-08-31,2024-08-31,,Michael Boninger,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT01897714,1,0,0,0,1,0,2017-12-31,2018-12-31,,Oncopeptides AB,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT01908101,0,0,0,0,0,0,2019-05-04,2020-05-04,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT01921387,1,1,0,1,0,1,2017-07-26,2018-07-26,2018-07-30,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT01922999,1,0,0,0,1,0,2017-12-31,2018-12-31,,Southeast Renal Research Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT01923129,1,1,0,1,0,0,2017-11-22,2018-11-22,2018-10-26,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,279
NCT01924988,1,0,1,1,0,1,2017-04-30,2018-04-30,2019-05-16,"James B. Spies, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01932697,1,0,1,1,0,1,2018-06-13,2019-06-13,2019-08-28,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,1898
NCT01934010,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-02-08,"Auris Medical, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01936519,0,0,0,0,0,0,2019-07-31,2020-07-31,,Milton S. Hershey Medical Center,Other,0,1,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT01940094,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Pennsylvania,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1052
NCT01941745,1,1,0,1,0,1,2017-08-25,2018-08-25,2019-07-02,Tufts Medical Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,121
NCT01949311,0,0,0,0,0,0,2022-04-06,2023-04-06,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,176
NCT01951105,1,0,1,1,0,1,2017-09-25,2018-09-25,2019-06-04,Northwestern University,Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT01951209,1,0,0,0,1,0,2018-08-31,2019-08-31,,"David E. Kaplan, MD MSc",U.S. Fed,2,1,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01951885,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,374
NCT01953588,0,0,0,0,0,0,2020-04-30,2021-04-30,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT01958281,1,1,0,1,0,0,2017-07-18,2018-07-18,2018-07-13,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT01960348,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-07,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,45
NCT01964430,0,0,0,0,0,0,2018-12-31,2019-12-31,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01965366,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-04-26,Emory University,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT01969136,1,0,0,0,1,0,2017-01-31,2018-01-31,,FORUM Pharmaceuticals Inc,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT01970306,0,0,0,0,0,0,2019-10-31,2020-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT01983215,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Dr. Jean E. Starr, MD",Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT01984138,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Polly A. Niravath, MD",Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01984346,0,0,0,0,0,0,2019-08-31,2020-08-31,,"AtriCure, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,17
NCT01986348,0,0,0,0,0,0,2019-12-31,2020-12-31,,Karyopharm Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,22
NCT01987609,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-08-22,"Tissa Hata, MD",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01990573,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-09-09,Washington University School of Medicine,Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT01994590,1,1,0,1,0,0,2017-06-05,2018-06-05,2018-04-30,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02000115,0,0,0,0,0,0,2019-07-31,2020-07-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,419
NCT02003911,1,0,0,0,1,0,2018-06-01,2019-06-01,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02004275,0,0,0,0,0,0,2021-03-31,2022-03-31,,Alliance for Clinical Trials in Oncology,Other,0,1,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT02016755,1,0,0,0,1,0,2018-03-31,2019-03-31,,"AnGes USA, Inc.",Industry,1,0,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,5
NCT02016924,0,0,0,0,0,0,2020-12-31,2021-12-31,,Gilead Sciences,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02018861,0,0,0,0,0,0,2019-12-31,2020-12-31,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,143
NCT02019693,0,0,0,0,0,0,2020-01-01,2021-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02019875,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Washington,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02028221,0,0,0,0,0,0,2018-11-30,2019-11-30,,University of Arizona,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,265
NCT02030821,1,1,0,1,0,0,2017-11-12,2018-11-12,2018-11-09,Duke University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02038179,1,0,0,0,1,0,2018-08-31,2019-08-31,,University of Alabama at Birmingham,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT02038738,0,0,0,0,0,0,2019-03-31,2020-03-31,,Ochsner Health System,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,37
NCT02041260,0,0,0,0,0,0,2020-03-31,2021-03-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT02048917,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Kentucky,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,77
NCT02051452,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-04-25,Massachusetts General Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02057640,1,0,0,0,1,0,2018-05-15,2019-05-15,,Case Comprehensive Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,374
NCT02059057,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-07-16,"PneumRx, Inc.",Industry,1,0,0,5.0,,1,2013.0,1,0,0,1,0,0,0,0,1,0,1,10
NCT02059213,1,1,0,1,0,1,2017-09-09,2018-09-09,2018-12-05,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,213
NCT02063867,0,1,0,1,0,0,2019-02-28,2020-02-28,2019-04-29,"University of California, Irvine",Other,0,0,1,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,310
NCT02069899,0,0,0,0,0,0,2020-09-30,2021-09-30,,NovImmune SA,Industry,1,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,14
NCT02070705,0,0,0,0,0,0,2019-12-31,2020-12-31,,OHSU Knight Cancer Institute,Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT02073097,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,374
NCT02074904,1,1,0,1,0,0,2017-03-31,2018-03-31,2017-10-27,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02077959,0,0,0,0,0,0,2019-05-24,2020-05-24,,Yvonne Efebera,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,3
NCT02097121,0,0,0,0,0,0,2022-04-28,2023-04-28,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,495
NCT02103634,0,0,0,0,0,0,2018-12-21,2019-12-21,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,374
NCT02110069,0,0,0,0,0,0,2022-09-30,2023-09-30,,Boston Children’s Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT02115607,0,0,1,1,0,0,2019-01-14,2020-01-14,2019-09-10,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,162
NCT02123121,0,0,0,0,0,0,2019-05-02,2020-05-02,,University of Florida,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,849
NCT02123992,0,0,0,0,0,0,2019-04-30,2020-04-30,,ASTORA Women's Health,Industry,1,0,0,4.0,Phase 4,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT02125461,1,1,0,1,0,0,2017-02-13,2018-02-13,2018-02-13,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02137837,0,0,0,0,0,0,2022-05-31,2023-05-31,,Southwest Oncology Group,Other,0,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT02138916,1,1,0,1,0,0,2018-04-10,2019-04-10,2019-03-19,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02150863,1,0,0,0,1,0,2017-06-30,2018-06-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1699
NCT02158858,0,0,0,0,0,0,2020-12-31,2021-12-31,,Constellation Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02160145,0,1,0,1,0,1,2017-04-18,2018-04-18,2018-05-01,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,185
NCT02162849,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02163694,0,0,0,0,0,0,2020-04-28,2021-04-28,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02169739,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,692
NCT02173522,1,1,0,1,0,1,2017-06-16,2018-06-16,2018-11-19,Shivank Bhatia,Other,0,1,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02174731,0,0,0,0,0,0,2018-09-26,2019-09-26,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02176928,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Miami,Other,0,0,1,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,476
NCT02177695,0,0,0,0,0,0,2020-02-29,2021-02-28,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT02181829,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,1432
NCT02182440,1,0,1,1,0,1,2017-05-25,2018-05-25,2018-11-05,AM-Pharma,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,8
NCT02186600,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Nancy L. Waltman, BSN MSN PhD",Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02189629,0,0,1,1,0,1,2017-02-23,2018-02-23,2019-04-18,Galderma R&D,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,28
NCT02197416,0,0,0,0,0,0,2019-10-16,2020-10-16,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT02198794,0,0,0,0,0,0,2020-11-21,2021-11-21,,"Auspex Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02204085,0,0,0,0,0,0,2019-11-30,2020-11-30,,Dana-Farber Cancer Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02213913,0,0,0,0,0,0,2019-07-29,2020-07-29,,University of Chicago,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,594
NCT02231008,1,0,0,0,1,0,2017-07-31,2018-07-31,,Vanda Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,37
NCT02239900,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT02242487,1,1,0,1,0,1,2018-05-31,2019-05-31,2019-06-12,Acorda Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,38
NCT02245217,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-02-08,University of Utah,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,578
NCT02247531,0,1,0,1,0,0,2018-01-23,2019-01-23,2019-01-17,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02250300,0,0,0,0,0,0,2021-09-30,2022-09-30,,Mehdi Hamadani,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02253316,0,0,0,0,0,0,2019-11-30,2020-11-30,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,1151
NCT02254408,1,1,0,1,0,0,2017-07-14,2018-07-14,2018-07-10,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02257528,0,0,0,0,0,0,2019-03-05,2020-03-05,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02266147,1,0,0,0,1,0,2017-04-30,2018-04-30,,Dynavax Technologies Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,1,0,0,0,0,1,21
NCT02267317,0,0,0,0,0,0,2018-09-30,2019-09-30,,Nicolas Musi,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02278003,1,1,0,1,0,0,2017-05-10,2018-05-10,2017-11-20,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02281383,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT02285855,0,0,0,0,0,0,2019-01-05,2020-01-05,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT02289456,1,1,0,1,0,0,2017-02-22,2018-02-22,2018-02-22,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,306
NCT02291978,0,0,0,0,0,0,2020-11-30,2021-11-30,,Stanford University,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1309
NCT02294357,0,0,0,0,0,0,2019-11-30,2020-11-30,,Oncotherapeutics,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,17
NCT02294630,1,0,0,0,1,0,2018-07-31,2019-07-31,,"Sood, Beena G., MD, MS",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02296320,0,0,0,0,0,0,2018-10-02,2019-10-02,,MedImmune LLC,Industry,1,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,269
NCT02300545,0,0,0,0,0,0,2019-05-31,2020-05-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02305758,1,1,0,1,0,0,2017-09-22,2018-09-22,2018-09-10,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,3,0,1,430
NCT02318368,1,0,0,0,1,0,2017-01-31,2018-01-31,,"AVEO Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,29
NCT02322281,1,1,0,1,0,0,2018-03-29,2019-03-29,2019-03-19,"Clovis Oncology, Inc.",Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT02328014,0,0,0,0,0,0,2020-03-31,2021-03-31,,Acerta Pharma BV,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT02332668,0,0,0,0,0,0,2022-09-01,2023-09-01,,Merck Sharp & Dohme Corp.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,2145
NCT02336451,0,0,0,0,0,0,2019-02-06,2020-02-06,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02338973,1,1,0,1,0,0,2018-06-01,2019-06-01,2019-05-31,National Eye Institute (NEI),NIH,2,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,263
NCT02342548,1,1,0,1,0,0,2017-02-06,2018-02-06,2018-02-02,Pfizer,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02343458,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-07-11,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02348749,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02349477,1,0,1,1,0,1,2018-08-27,2019-08-27,2019-08-29,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT02353728,0,0,0,0,0,0,2020-01-31,2021-01-31,,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT02354586,0,0,0,0,0,0,2018-02-28,2019-02-28,,"Tesaro, Inc.",Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02357147,0,0,0,0,0,0,2018-11-30,2019-11-30,,Morphotek,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02357797,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwell Health,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,271
NCT02365467,0,0,0,0,0,0,2019-10-31,2020-10-31,,Medtronic Endovascular,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,64
NCT02367794,0,0,0,0,0,0,2018-10-03,2019-10-03,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02371746,0,0,1,1,0,0,2019-02-13,2020-02-13,2019-07-15,Envisia Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02382614,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Spiration, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,9
NCT02384421,0,0,0,0,0,0,2025-01-31,2026-01-31,,Stanford University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1309
NCT02388997,1,1,0,1,0,0,2017-05-04,2018-05-04,2018-05-03,University of Virginia,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,402
NCT02389465,0,0,0,0,0,0,2019-12-06,2020-12-06,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02389764,1,1,0,1,0,1,2018-06-08,2019-06-08,2019-06-26,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02397837,1,0,1,1,0,0,2018-07-26,2019-07-26,2019-07-26,Brigham and Women's Hospital,Other,0,0,1,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT02399228,1,0,1,1,0,1,2017-05-20,2018-05-20,2019-04-11,"Santalis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02400437,0,0,0,0,0,0,2019-10-31,2020-10-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02403284,0,0,0,0,0,0,2019-12-31,2020-12-31,,Phoenix VA Health Care System,U.S. Fed,2,1,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02403622,0,0,0,0,0,0,2017-10-31,2018-10-31,,Microbiome Health Research Institute,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02405078,0,0,0,0,0,0,2019-10-01,2020-10-01,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02410551,1,1,0,1,0,1,2017-01-20,2018-01-20,2018-02-28,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02414347,0,0,0,0,0,0,2019-10-31,2020-10-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02416206,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Northside Hospital, Inc.",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,16
NCT02416622,0,0,0,0,0,0,2019-04-30,2020-04-30,,Applied Genetic Technologies Corp,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,9
NCT02418273,0,0,0,0,0,0,2021-06-30,2022-06-30,,Indiana University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT02418455,0,0,0,0,0,0,2019-03-26,2020-03-26,,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT02418793,0,0,0,0,0,0,2018-09-30,2019-09-30,,Opko Biologics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02422641,0,0,0,0,0,0,2019-09-30,2020-09-30,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02424500,1,0,0,0,1,0,2017-06-30,2018-06-30,,Hygieia Research LLC,Other,0,0,1,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02426892,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02431572,0,0,0,0,0,0,2019-02-28,2020-02-28,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,1,0,1,0,0,1,0,0,0,0,1,1699
NCT02431806,0,0,0,0,0,0,2019-08-19,2020-08-19,,Forest Laboratories,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,169
NCT02432274,0,0,0,0,0,0,2019-07-31,2020-07-31,,Eisai Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,40
NCT02433977,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Gladwin, Mark, MD",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02434471,1,1,0,1,0,0,2017-06-01,2018-06-01,2018-05-01,Duke University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1342
NCT02437084,0,0,0,0,0,0,2019-02-28,2020-02-28,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02441803,0,0,0,0,0,0,2022-09-30,2023-09-30,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,1,0,0,0,0,1,2066
NCT02442778,0,0,0,0,0,0,2019-09-30,2020-09-30,,Avanir Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,29
NCT02453386,1,1,0,1,0,1,2018-01-12,2019-01-12,2019-01-31,Biotie Therapies Inc.,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02458976,1,0,0,0,1,0,2018-06-30,2019-06-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1699
NCT02460172,1,1,0,1,0,1,2017-02-15,2018-02-15,2018-11-26,ZipLine Medical Inc.,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT02460679,1,0,0,0,1,0,2018-07-31,2019-07-31,,Edison Pharmaceuticals Inc,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02465775,1,0,0,0,1,0,2017-09-30,2018-09-30,,Syneron Medical,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02470377,0,0,0,0,0,0,2022-01-31,2023-01-31,,"Laureate Institute for Brain Research, Inc.",Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,30
NCT02470585,0,0,0,0,0,0,2020-07-24,2021-07-24,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02472314,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-11-28,Wayne State University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,145
NCT02473445,1,1,0,1,0,0,2017-03-06,2018-03-06,2018-03-06,"Horizon Pharma USA, Inc.",Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT02476786,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02477579,1,0,0,0,1,0,2017-08-10,2018-08-10,,Nitiloop Ltd.,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,4
NCT02477670,0,0,0,0,0,0,2017-07-21,2018-07-21,,Avanir Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT02478320,0,0,0,0,0,0,2022-08-31,2023-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02478775,0,0,0,0,0,0,2020-02-29,2021-02-28,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02481297,0,0,0,0,0,0,2019-08-15,2020-08-15,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02486718,0,0,0,0,0,0,2020-11-26,2021-11-26,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02491099,0,0,0,0,0,0,2023-06-30,2024-06-30,,Yale University,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02493361,1,1,0,1,0,0,2018-04-26,2019-04-26,2019-04-26,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02494141,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02494206,1,1,0,1,0,0,2018-05-31,2019-05-31,2018-09-14,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02500147,0,0,0,0,0,0,2019-06-30,2020-06-30,,Columbia University,Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT02500251,1,0,0,0,1,0,2018-06-30,2019-06-30,,E. Steve Woodle,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02501954,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Women's Cancer Care Associates, LLC",Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,1,0,0,1,0,1,1
NCT02504580,0,0,0,0,0,0,2017-03-31,2018-03-31,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT02516605,1,0,1,1,0,0,2018-08-02,2019-08-02,2019-08-01,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02518750,1,1,0,1,0,0,2018-03-11,2019-03-11,2019-03-08,St. Jude Children's Research Hospital,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,302
NCT02519712,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-01-05,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02522884,1,0,0,0,1,0,2018-05-31,2019-05-31,,Intact Vascular,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,6
NCT02525432,0,0,0,0,0,0,2020-10-31,2021-10-31,,"The University of Texas Health Science Center, Houston",Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,490
NCT02525692,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Oncoceutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02530125,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-02-06,Northwestern University,Other,0,0,1,1.0,Phase 2,1,2015.0,1,0,1,0,0,0,0,0,0,0,1,925
NCT02531971,0,0,0,0,0,0,2018-10-16,2019-10-16,,"University of Maryland, Baltimore",Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,144
NCT02535338,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02535533,0,0,0,0,0,0,2020-06-30,2021-06-30,,Yousef Zakharia,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02536846,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mclean Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,126
NCT02539160,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT02540148,0,0,0,0,0,0,2020-03-31,2021-03-31,,The Eye Machine Canada Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT02542202,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Chicago,Other,0,0,1,5.0,,0,2015.0,1,0,0,0,0,1,0,0,0,0,1,594
NCT02542410,0,0,0,0,0,0,2018-09-30,2019-09-30,,Boston Children’s Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,400
NCT02547220,0,0,0,0,0,0,2019-05-31,2020-05-31,,Shire,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,1,0,0,0,0,0,1,0,1,342
NCT02547987,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mothaffar Rimawi,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02548559,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Staci Gruber, Ph.D.",Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT02551718,0,0,0,0,0,0,2020-07-01,2021-07-01,,University of Washington,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,1,0,0,1,910
NCT02552212,0,0,1,1,0,0,2018-04-30,2019-04-30,2019-04-27,UCB BIOSCIENCES GmbH,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,21
NCT02554383,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Pittsburgh,Other,0,0,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1054
NCT02554773,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02554903,0,0,0,0,0,0,2020-06-01,2021-06-01,,Actelion,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,128
NCT02555280,0,0,0,0,0,0,2020-07-31,2021-07-31,,Paradigm Spine,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02556736,0,0,0,0,0,0,2020-12-03,2021-12-03,,Allergan,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT02558972,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York Medical College,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT02559713,0,0,0,0,0,0,2019-02-21,2020-02-21,,Takeda,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,650
NCT02560012,1,1,0,1,0,0,2017-07-27,2018-07-27,2018-07-27,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02560298,0,0,0,0,0,0,2020-08-31,2021-08-31,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,75
NCT02563002,0,0,0,0,0,0,2021-12-15,2022-12-15,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02564718,1,1,0,1,0,0,2017-12-18,2018-12-18,2018-06-12,Bayer,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1343
NCT02565914,0,0,0,0,0,0,2019-05-31,2020-05-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,141
NCT02566577,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-29,Emory University,Other,0,0,0,4.0,Phase 4,1,2013.0,1,0,1,1,0,0,0,0,0,0,1,947
NCT02567643,1,0,0,0,1,0,2017-03-31,2018-03-31,,The Cooper Health System,Other,0,0,0,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,37
NCT02569242,0,0,0,0,0,0,2019-09-30,2020-09-30,,Ono Pharmaceutical Co. Ltd,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,55
NCT02574637,0,0,0,0,0,0,2017-07-28,2018-07-28,,Allergan,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02575339,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Bert O'Neil, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02579421,1,1,0,1,0,1,2017-07-27,2018-07-27,2019-03-12,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02579967,0,0,0,0,0,0,2019-12-21,2020-12-21,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02580591,0,1,0,1,0,1,2017-09-12,2018-09-12,2018-09-20,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02582684,1,1,0,1,0,0,2017-02-28,2018-02-28,2018-02-28,AIDS Clinical Trials Group,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,62
NCT02585778,1,1,0,1,0,0,2017-04-03,2018-04-03,2018-04-01,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02588651,0,0,0,0,0,0,2019-06-30,2020-06-30,,Deepa Jagadeesh,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02593032,1,0,0,0,1,0,2017-04-30,2018-04-30,,University of Pennsylvania,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1052
NCT02593175,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02595008,1,1,0,1,0,1,2017-02-22,2018-02-22,2018-11-12,Taro Pharmaceuticals USA,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02595424,0,0,0,0,0,0,2024-01-01,2025-01-01,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,75
NCT02597478,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,1,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02599649,0,0,0,0,0,0,2019-01-30,2020-01-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02600104,1,0,0,0,1,0,2017-12-31,2018-12-31,,Syneron Medical,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02600429,0,0,0,0,0,0,2020-08-31,2021-08-31,,"ReGenTree, LLC",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02603432,0,0,0,0,0,0,2020-06-03,2021-06-03,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,2856
NCT02605174,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-28,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1512
NCT02609425,1,0,0,0,1,0,2017-04-30,2018-04-30,,Henry Ford Health System,Other,0,1,0,4.0,Phase 4,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,151
NCT02610816,1,1,0,1,0,0,2018-05-16,2019-05-16,2018-06-07,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,437
NCT02611830,1,0,1,1,0,0,2018-05-30,2019-05-30,2019-05-29,Takeda,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT02615002,0,0,0,0,0,0,2019-11-30,2020-11-30,,Neurim Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02616172,0,0,0,0,0,0,2018-09-30,2019-09-30,,"James Baumgartner, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,0,0,0,0,0,1,0,0,1,3
NCT02620150,0,0,0,0,0,0,2022-01-31,2023-01-31,,University of Pennsylvania,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02621931,0,1,0,1,0,1,2017-04-11,2018-04-11,2018-10-10,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02626169,1,0,0,0,1,0,2018-01-31,2019-01-31,,Baylor College of Medicine,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02626299,0,0,0,0,0,0,2021-02-28,2022-02-28,,University of Kansas Medical Center,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,219
NCT02627300,0,0,0,0,0,0,2019-09-05,2020-09-05,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT02627443,0,0,0,0,0,0,2020-11-30,2021-11-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02628964,1,0,1,1,0,1,2018-03-26,2019-03-26,2019-07-24,NYU Langone Health,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,869
NCT02630017,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Arkansas,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,285
NCT02632409,0,0,0,0,0,0,2020-11-30,2021-11-30,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02633800,1,1,0,1,0,0,2018-01-11,2019-01-11,2018-11-14,"Daiichi Sankyo, Inc.",Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,2,0,1,207
NCT02634827,1,1,0,1,0,1,2017-03-18,2018-03-18,2019-06-24,Mayo Clinic,Other,0,0,1,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02635282,1,0,1,1,0,1,2017-03-23,2018-03-23,2018-10-09,University of Tennessee Health Science Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02635867,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Illinois at Chicago,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,242
NCT02637687,0,0,0,0,0,0,2020-09-30,2021-09-30,,Bayer,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02639884,1,0,0,0,1,0,2017-10-31,2018-10-31,,Masimo Corporation,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,39
NCT02640209,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Pennsylvania,Other,0,0,0,5.0,,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1052
NCT02640820,1,0,0,0,1,0,2018-01-31,2019-01-31,,"RXi Pharmaceuticals, Corp.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02641145,0,0,0,0,0,0,2020-03-30,2021-03-30,,Brigham and Women's Hospital,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,1,0,0,0,0,1,698
NCT02641639,1,0,0,0,1,0,2017-10-31,2018-10-31,,Mateon Therapeutics,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02644343,1,0,0,0,1,0,2017-05-17,2018-05-17,,Cochlear,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,35
NCT02644967,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Idera Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,13
NCT02646566,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-09-26,Acacia Pharma Ltd,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,14
NCT02647866,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Kyowa Kirin Pharmaceutical Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,23
NCT02648919,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Hawaii,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,64
NCT02649868,0,0,0,0,0,0,2019-12-15,2020-12-15,,National Institutes of Health Clinical Center (CC),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,1,0,0,0,0,1,325
NCT02651688,0,1,0,1,0,1,2017-05-02,2018-05-02,2019-05-23,Repros Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02653092,0,0,0,0,0,0,2019-07-31,2020-07-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02654054,0,0,0,0,0,0,2018-01-18,2019-01-18,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02654782,1,1,0,1,0,1,2017-10-09,2018-10-09,2018-11-16,William C. Oliver,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02657655,1,0,0,0,1,0,2017-02-28,2018-02-28,,Great Lakes NeuroTechnologies Inc.,Industry,1,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,16
NCT02657928,1,0,0,0,1,0,2018-05-21,2019-05-21,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02659202,0,0,0,0,0,0,2020-01-31,2021-01-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02663271,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Florida,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,849
NCT02664909,0,0,0,0,0,0,2019-06-30,2020-06-30,,UConn Health,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,148
NCT02667587,0,0,0,0,0,0,2022-02-11,2023-02-11,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,1,0,0,1,0,1,1104
NCT02669784,1,1,0,1,0,1,2017-05-31,2018-05-31,2019-04-01,Milton S. Hershey Medical Center,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT02670538,1,1,0,1,0,0,2018-01-18,2019-01-18,2019-01-15,Forest Laboratories,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,169
NCT02671266,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-07-16,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02672436,0,0,0,0,0,0,2019-11-28,2020-11-28,,"Energenesis Biomedical Co., Ltd.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT02675231,0,0,0,0,0,0,2019-04-08,2020-04-08,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02675751,1,0,1,1,0,0,2018-07-27,2019-07-27,2019-07-23,Abbott Medical Optics,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,33
NCT02678767,1,0,0,0,1,0,2017-09-30,2018-09-30,,Beau Nakamoto,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02680574,0,0,0,0,0,0,2020-08-31,2021-08-31,,Akebia Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,25
NCT02683980,1,0,0,0,1,0,2017-09-30,2018-09-30,,Lumenis Ltd.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,16
NCT02684435,1,1,0,1,0,0,2018-07-09,2019-07-09,2019-06-12,"University of North Carolina, Chapel Hill",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02685293,1,1,0,1,0,0,2018-06-06,2019-06-06,2019-06-06,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,42
NCT02687542,1,1,0,1,0,0,2017-11-10,2018-11-10,2018-10-30,Pfizer,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02691182,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02691793,0,0,0,0,0,0,2018-12-31,2019-12-31,,Samsung Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,684
NCT02692586,1,0,0,0,1,0,2017-11-30,2018-11-30,,Inari Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02692755,0,0,0,0,0,0,2019-11-30,2020-11-30,,Georgetown University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT02695771,1,0,0,0,1,0,2018-04-30,2019-04-30,,Spectrum Health Hospitals,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,43
NCT02696785,0,0,0,0,0,0,2017-12-08,2018-12-08,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02697253,0,0,0,0,0,0,2020-12-31,2021-12-31,,Columbia University,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT02700932,1,0,0,0,1,0,2017-09-30,2018-09-30,,Syneron Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02703818,1,0,0,0,1,0,2017-08-31,2018-08-31,,Nevro Corp,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT02707055,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,96
NCT02707965,1,0,1,1,0,0,2018-08-02,2019-08-02,2019-08-02,Food and Drug Administration (FDA),U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT02709889,0,0,0,0,0,0,2019-08-27,2020-08-27,,AbbVie,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,430
NCT02712008,1,1,0,1,0,0,2017-07-10,2018-07-10,2018-07-10,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,176
NCT02713373,0,0,0,0,0,0,2019-08-15,2020-08-15,,Roswell Park Cancer Institute,Other,0,1,1,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,294
NCT02713542,0,1,0,1,0,1,2018-07-02,2019-07-02,2019-07-19,"Arthrex, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02713828,1,1,0,1,0,0,2018-05-29,2019-05-29,2019-05-14,"PrECOG, LLC.",Other,0,1,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02715648,0,0,0,0,0,0,2019-09-30,2020-09-30,,Boston Urogynecology Associates,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT02716077,0,0,0,0,0,0,2023-03-31,2024-03-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,273
NCT02718495,1,0,0,0,1,0,2017-11-28,2018-11-28,,"Proteostasis Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT02724228,0,0,0,0,0,0,2022-10-31,2023-10-31,,BioMarin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,85
NCT02728258,0,0,1,1,0,0,2020-06-30,2021-06-30,2019-07-23,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT02734004,0,0,0,0,0,0,2022-08-05,2023-08-05,,AstraZeneca,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02735551,1,1,0,1,0,1,2017-03-13,2018-03-13,2018-09-21,Oregon Health and Science University,Other,0,1,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT02736227,0,0,0,0,0,0,2020-03-31,2021-03-31,,Northwestern University,Other,0,1,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02737722,1,0,1,1,0,1,2017-08-31,2018-08-31,2019-07-05,Lakewood-Amedex Inc,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02740114,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02741791,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Axsome Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02745119,0,1,0,1,0,0,2018-01-31,2019-01-31,2019-01-23,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02748018,0,0,0,0,0,0,2021-08-31,2022-08-31,,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,48
NCT02748928,1,1,0,1,0,1,2017-02-15,2018-02-15,2019-02-12,Syneron Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02749903,0,0,0,0,0,0,2019-02-21,2020-02-21,,Alliance for Clinical Trials in Oncology,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT02753283,0,0,0,0,0,0,2021-12-31,2022-12-31,,Susan L. Greenspan,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02758847,0,0,0,0,0,0,2020-08-31,2021-08-31,,Rabih A. Chaer,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02759562,1,1,0,1,0,0,2017-07-06,2018-07-06,2018-06-04,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02760602,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-08,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02764229,1,1,0,1,0,0,2018-07-18,2019-07-18,2019-01-29,Lycera Corp.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02764762,0,0,0,0,0,0,2020-09-29,2021-09-29,,Takeda,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,650
NCT02766465,0,0,0,0,0,0,2022-03-31,2023-03-31,,Medical College of Wisconsin,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,315
NCT02766907,1,1,0,1,0,1,2017-01-31,2018-01-31,2019-01-18,Tissue Tech Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,10
NCT02767934,0,0,0,0,0,0,2021-01-01,2022-01-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,0,1,910
NCT02768727,0,0,0,0,0,0,2020-06-10,2021-06-10,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02769481,0,0,0,0,0,0,2019-06-14,2020-06-14,,Theracos,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02771626,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Calithera Biosciences, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02778867,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT02779075,0,0,0,0,0,0,2019-07-31,2020-07-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02780310,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02784210,0,0,0,0,0,0,2020-12-01,2021-12-01,,National Institute of Neurological Disorders and Stroke (NINDS),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,560
NCT02784496,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02784704,1,1,0,1,0,1,2017-05-08,2018-05-08,2018-12-21,"Tetraphase Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,15
NCT02785939,0,0,0,0,0,0,2022-04-01,2023-04-01,,Southwest Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT02791191,0,0,0,0,0,0,2018-07-02,2019-07-02,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02791945,1,0,0,0,1,0,2018-05-31,2019-05-31,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02794883,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,925
NCT02795858,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02796755,0,0,0,0,0,0,2019-11-30,2020-11-30,,Emory University,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02798406,0,0,0,0,0,0,2020-12-31,2021-12-31,,"DNAtrix, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,3
NCT02799446,0,0,0,0,0,0,2019-07-31,2020-07-31,,Joshua S. Jacobs,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02802319,0,1,0,1,0,0,2018-09-30,2019-09-30,2018-12-13,The University of Texas Health Science Center at San Antonio,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,257
NCT02805504,0,0,0,0,0,0,2019-12-31,2020-12-31,,Loma Linda University,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,194
NCT02808429,0,0,0,0,0,0,2020-07-08,2021-07-08,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT02810457,0,0,0,0,0,0,2019-01-24,2020-01-24,,Centus Biotherapeutics Limited,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT02812186,0,0,0,0,0,0,2019-01-17,2020-01-17,,Stony Brook University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,119
NCT02813447,0,0,0,0,0,0,2020-08-31,2021-08-31,,Duke University,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1342
NCT02814175,0,0,0,0,0,0,2019-09-27,2020-09-27,,AbbVie,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,430
NCT02819440,0,0,0,0,0,0,2020-12-31,2021-12-31,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,422
NCT02823990,0,0,0,0,0,0,2019-08-31,2020-08-31,,Karen Kelly,Other,0,1,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT02826694,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2016.0,1,0,0,0,0,0,0,1,0,0,1,910
NCT02828111,1,1,0,1,0,0,2017-11-09,2018-11-09,2018-11-06,"PellePharm, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02832284,1,1,0,1,0,1,2017-06-08,2018-06-08,2018-09-11,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,340
NCT02838017,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-06-06,NorthShore University HealthSystem,Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,61
NCT02839798,0,0,0,0,0,0,2020-06-30,2021-06-30,,Butler Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,79
NCT02842125,0,0,0,0,0,0,2020-02-20,2021-02-20,,"MultiVir, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02842736,0,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-25,Channel Medsystems,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,1
NCT02846987,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02849496,0,0,0,0,0,0,2020-08-31,2021-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02851472,0,0,0,0,0,0,2021-02-05,2022-02-05,,New York Medical College,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT02854540,1,0,0,0,1,0,2018-08-31,2019-08-31,,Stanford University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1309
NCT02856113,0,0,0,0,0,0,2021-06-11,2022-06-11,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,650
NCT02858362,1,0,0,0,1,0,2018-04-11,2019-04-11,,Summit Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT02862600,1,1,0,1,0,0,2017-04-28,2018-04-28,2017-06-25,Heart Metabolics Limited,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,1,0,0,0,0,0,0,1,2
NCT02863575,1,1,0,1,0,0,2018-04-06,2019-04-06,2019-02-28,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2856
NCT02866682,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of California, Los Angeles",Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT02867592,0,0,0,0,0,0,2021-06-30,2022-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02870478,0,0,0,0,0,0,2019-05-31,2020-05-31,,"University of California, Berkeley",Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,51
NCT02870738,0,0,0,0,0,0,2019-08-31,2020-08-31,,William Beaumont Hospitals,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,84
NCT02871635,0,0,0,0,0,0,2019-04-30,2020-04-30,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02874404,0,0,0,0,0,0,2019-07-01,2020-07-01,,"Matthew Lunning, DO",Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02875067,0,0,0,0,0,0,2022-08-31,2023-08-31,,NYU Langone Health,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,869
NCT02876900,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Noven Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02877485,1,0,0,0,1,0,2018-07-31,2019-07-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02877927,0,1,0,1,0,1,2017-05-26,2018-05-26,2018-11-02,Paratek Pharmaceuticals Inc,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02879006,0,0,0,0,0,0,2020-12-31,2021-12-31,,Xiu-Min Li,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02882854,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-11-20,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,422
NCT02883673,0,0,0,0,0,0,2019-12-31,2020-12-31,,Alydia Health,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02884908,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of Maryland, Baltimore",Other,0,0,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,144
NCT02887248,0,0,0,0,0,0,2019-12-20,2020-12-20,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,167
NCT02888743,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,1,0,0,1,1,0,3004
NCT02889809,0,0,0,0,0,0,2021-02-13,2022-02-13,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3276
NCT02891161,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Monika Joshi, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,2
NCT02891681,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1151
NCT02891850,0,0,0,0,0,0,2020-03-30,2021-03-30,,Bayer,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02895945,0,0,0,0,0,0,2021-04-02,2022-04-02,,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,107
NCT02902120,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Maryland, College Park",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT02906917,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-28,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02908672,0,0,0,0,0,0,2019-10-09,2020-10-09,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02911116,0,0,0,0,0,0,2020-07-18,2021-07-18,,National Eye Institute (NEI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,263
NCT02912572,0,0,0,0,0,0,2020-04-30,2021-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02914509,0,0,0,0,0,0,2019-03-30,2020-03-30,,"Ocular Therapeutix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT02914613,1,0,0,0,1,0,2017-05-16,2018-05-16,,"SciFluor Life Sciences, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02916056,0,0,0,0,0,0,2018-06-01,2019-06-01,,vTv Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,12
NCT02918045,0,0,0,0,0,0,2019-07-16,2020-07-16,,University of Sao Paulo General Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,368
NCT02918162,0,0,0,0,0,0,2019-06-30,2020-06-30,,Gulam Manji,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT02918279,0,0,0,0,0,0,2019-02-14,2020-02-14,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02920528,1,0,0,0,1,0,2018-06-22,2019-06-22,,Los Angeles Biomedical Research Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,60
NCT02921737,0,0,0,0,0,0,2020-11-01,2021-11-01,,University of Florida,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT02922413,0,0,0,0,0,0,2022-09-30,2023-09-30,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,158
NCT02922894,0,0,0,0,0,0,2020-09-30,2021-09-30,,John D. Dingell VA Medical Center,U.S. Fed,2,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02924324,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,1432
NCT02924935,0,0,0,0,0,0,2020-04-30,2021-04-30,,Lawson Health Research Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,0,0,0,0,0,0,2,1,0,468
NCT02925299,0,0,0,0,0,0,2020-06-30,2021-06-30,,Jaeb Center for Health Research,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,93
NCT02926209,1,1,0,1,0,1,2017-11-08,2018-11-08,2019-04-28,GI View Ltd.,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,1,1,0,4
NCT02926937,0,0,0,0,0,0,2019-06-05,2020-06-05,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02927366,1,1,0,1,0,0,2018-06-07,2019-06-07,2019-06-03,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT02929329,0,0,0,0,0,0,2021-02-07,2022-02-07,,Amgen,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,685
NCT02934932,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-01-02,Duke University,Other,0,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT02935478,0,0,0,0,0,0,2020-12-31,2021-12-31,,St. Louis University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,126
NCT02938949,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-06-28,Virginia Commonwealth University,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,417
NCT02942771,0,0,0,0,0,0,2020-06-30,2021-06-30,,Linda Van Eldik,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02946034,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02946788,1,0,0,0,1,0,2018-06-01,2019-06-01,,"BioPharmX, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT02946918,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT02946996,0,0,0,0,0,0,2019-12-01,2020-12-01,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02949947,0,0,0,0,0,0,2019-03-06,2020-03-06,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2066
NCT02950649,0,0,0,0,0,0,2019-07-25,2020-07-25,,Loma Linda University,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,194
NCT02953548,0,0,0,0,0,0,2018-10-31,2019-10-31,,GW Research Ltd,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,29
NCT02953678,0,1,0,1,0,1,2018-01-31,2019-01-31,2019-06-24,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,143
NCT02956122,1,1,0,1,0,0,2018-05-03,2019-05-03,2019-03-21,Baxalta now part of Shire,Industry,1,1,0,2.0,Phase 2/Phase 3,1,2017.0,1,1,1,0,0,0,0,0,0,1,0,107
NCT02962648,0,0,0,0,0,0,2018-06-12,2019-06-12,,Pharmacosmos A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,30
NCT02963831,0,0,0,0,0,0,2020-07-31,2021-07-31,,Ludwig Institute for Cancer Research,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,46
NCT02963974,0,0,0,0,0,0,2021-04-30,2022-04-30,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT02964507,0,0,0,0,0,0,2021-01-16,2022-01-16,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT02965924,0,0,0,0,0,0,2018-10-31,2019-10-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02966275,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-04-19,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1699
NCT02968602,0,0,0,0,0,0,2019-07-23,2020-07-23,,"University of Maryland, Baltimore",Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,144
NCT02969044,1,1,0,1,0,0,2017-12-12,2018-12-12,2018-11-06,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02971228,0,0,0,0,0,0,2017-05-24,2018-05-24,,Zealand Pharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,21
NCT02973321,0,0,0,0,0,0,2017-12-27,2018-12-27,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02973893,0,0,0,0,0,0,2018-11-30,2019-11-30,,Factor Therapeutics Ltd.,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,1
NCT02980042,0,0,0,0,0,0,2019-05-30,2020-05-30,,"University of Colorado, Denver",Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,882
NCT02980601,1,1,0,1,0,1,2017-08-18,2018-08-18,2019-04-26,Wake Forest University Health Sciences,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,616
NCT02987959,0,0,0,0,0,0,2019-01-30,2020-01-30,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT02988245,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Geneticure, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT02991937,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02993406,0,0,0,0,0,0,2021-12-31,2022-12-31,,Esperion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT03002974,0,0,0,0,0,0,2018-06-30,2019-06-30,,Swedish Orphan Biovitrum,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT03003949,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03004365,0,0,0,0,0,0,2017-03-29,2018-03-29,,"Armata Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03005054,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Stratatech, a Mallinckrodt Company",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03005418,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Humacyte, Inc.",Industry,1,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,8
NCT03007732,0,0,0,0,0,0,2020-04-30,2021-04-30,,Lawrence Fong,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,4
NCT03007966,1,0,0,0,1,0,2018-02-17,2019-02-17,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,616
NCT03008616,0,0,0,0,0,0,2020-03-31,2021-03-31,,"AMAG Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,23
NCT03013751,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mezzion Pharma Co. Ltd,Industry,1,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03014622,1,0,0,0,1,0,2017-11-14,2018-11-14,,"Revance Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,26
NCT03015259,0,0,0,0,0,0,2018-02-08,2019-02-08,,3M,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,56
NCT03016078,1,1,0,1,0,0,2017-04-01,2018-04-01,2018-01-16,Molnlycke Health Care AB,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03017924,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,437
NCT03018288,0,0,0,0,0,0,2021-01-09,2022-01-09,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03020069,0,0,0,0,0,0,2019-11-30,2020-11-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT03021941,0,0,0,0,0,0,2020-06-30,2021-06-30,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03023059,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Snyder, Robert W., M.D., Ph.D., P.C.",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03023540,0,0,0,0,0,0,2019-09-30,2020-09-30,,Pharnext SA,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03024489,0,0,0,0,0,0,2024-12-31,2025-12-31,,Mahidol University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,2,1,0,419
NCT03025308,0,0,0,0,0,0,2025-04-30,2026-04-30,,Gilead Sciences,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03028246,0,0,0,0,0,0,2021-03-31,2022-03-31,,InSightec,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,61
NCT03029143,0,0,0,0,0,0,2020-01-26,2021-01-26,,Takeda,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,650
NCT03029494,0,0,0,0,0,0,2018-09-30,2019-09-30,,Croatian Science Foundation,Other,0,0,0,5.0,,0,2015.0,0,1,0,1,0,0,0,0,2,0,1,1
NCT03029780,1,1,0,1,0,0,2017-11-27,2018-11-27,2018-11-27,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03031938,0,0,0,0,0,0,2022-04-04,2023-04-04,,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03032484,0,0,0,0,0,0,2021-04-10,2022-04-10,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,257
NCT03035266,0,0,0,0,0,0,2020-08-12,2021-08-12,,Keller Army Community Hospital,U.S. Fed,2,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03035409,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03036085,1,0,0,0,1,0,2017-12-31,2018-12-31,,Massachusetts General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,1699
NCT03036254,0,0,0,0,0,0,2023-07-31,2024-07-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,412
NCT03037931,0,0,0,0,0,0,2021-01-31,2022-01-31,,"American Regent, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,48
NCT03040804,0,0,0,0,0,0,2019-12-31,2020-12-31,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,240
NCT03043313,0,0,0,0,0,0,2020-06-30,2021-06-30,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,32
NCT03043651,0,0,0,0,0,0,2021-12-31,2022-12-31,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,72
NCT03044730,0,0,0,0,0,0,2021-03-31,2022-03-31,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03047213,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT03049215,0,0,0,0,0,0,2020-03-31,2021-03-31,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,422
NCT03052244,0,0,0,0,0,0,2020-03-15,2021-03-15,,Loewenstein Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,3,1,0,16
NCT03052725,1,1,0,1,0,0,2018-02-22,2019-02-22,2019-02-18,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,101
NCT03054363,0,0,0,0,0,0,2019-10-31,2020-10-31,,Academic Thoracic Oncology Medical Investigators Consortium,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03056222,0,0,0,0,0,0,2020-07-31,2021-07-31,,I-Med-Pro GmbH,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03056339,0,0,0,0,0,0,2022-06-30,2023-06-30,,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03059992,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Scynexis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03061812,0,0,0,0,0,0,2020-02-12,2021-02-12,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03064126,0,0,0,0,0,0,2019-09-30,2020-09-30,,Boston Scientific Corporation,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,1,0,0,0,0,1,1,0,340
NCT03065244,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of California, San Diego",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03065712,0,0,0,0,0,0,2020-02-22,2021-02-22,,Rathan Subramaniam,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03066804,0,0,0,0,0,0,2019-12-04,2020-12-04,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03069508,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Eiger Group International, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03070886,0,0,0,0,0,0,2026-05-31,2027-05-31,,NRG Oncology,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,1,0,0,0,0,1,27
NCT03073980,0,0,0,0,0,0,2020-06-01,2021-06-01,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03074513,0,0,0,0,0,0,2021-03-31,2022-03-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03076034,0,0,0,0,0,0,2020-06-01,2021-06-01,,Beth Israel Deaconess Medical Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,377
NCT03077828,0,0,0,0,0,0,2019-11-30,2020-11-30,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03082573,1,0,0,0,1,0,2018-02-28,2019-02-28,,Iraj Sabahi Research Inc.,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03085563,0,0,0,0,0,0,2018-11-08,2019-11-08,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,882
NCT03086486,0,0,0,0,0,0,2020-12-31,2021-12-31,,Global Alliance for TB Drug Development,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,23
NCT03087058,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Relypsa, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03088878,0,0,0,0,0,0,2020-10-01,2021-10-01,,"University of California, San Diego",Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03091075,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Southern California,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03093701,0,0,0,0,0,0,2019-12-31,2020-12-31,,Taiwan Liposome Company,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03093922,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03095612,0,0,0,0,0,0,2021-05-01,2022-05-01,,University of Texas Southwestern Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03096197,0,0,0,0,0,0,2020-09-30,2021-09-30,,Kessler Foundation,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,79
NCT03096392,1,0,0,0,1,0,2017-11-15,2018-11-15,,Diasome Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03097484,1,1,0,1,0,1,2017-04-30,2018-04-30,2019-04-01,John M. Daniel,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03097861,0,0,0,0,0,0,2017-06-11,2018-06-11,,Sucampo AG,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03098563,0,0,0,0,0,0,2020-06-01,2021-06-01,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03098810,1,0,0,0,1,0,2017-09-01,2018-09-01,,Ain Shams University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,460
NCT03099499,0,0,0,0,0,0,2021-10-01,2022-10-01,,Fox Chase Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03101930,0,0,0,0,0,0,2021-03-01,2022-03-01,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03103100,0,0,0,0,0,0,2019-07-01,2020-07-01,,University of Alabama at Birmingham,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT03106025,0,0,0,0,0,0,2019-05-31,2020-05-31,,Loma Linda University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,194
NCT03107481,1,0,0,0,1,0,2017-11-14,2018-11-14,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03108131,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03108690,0,0,0,0,0,0,2018-10-31,2019-10-31,,Sara Thønnings,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,1
NCT03109574,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Angiodynamics, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,12
NCT03110315,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Theodore R. Brown, MD MPH",Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03111459,0,0,0,0,0,0,2020-05-31,2021-05-31,,The Christ Hospital,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03111875,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,581
NCT03114124,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Florida,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,849
NCT03115333,0,0,0,0,0,0,2022-05-07,2023-05-07,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,0,0,0,0,0,0,0,1,0,75
NCT03115944,1,0,0,0,1,0,2017-11-30,2018-11-30,,Alma Lasers Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT03121001,1,0,0,0,1,0,2018-09-12,2019-09-12,,University of Illinois at Chicago,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,1,0,0,0,1,0,242
NCT03122470,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT03123471,1,1,0,1,0,0,2018-08-13,2019-08-13,2019-08-12,Celgene,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,306
NCT03125148,0,0,0,0,0,0,2020-03-19,2021-03-19,,Medical College of Wisconsin,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03125512,0,0,0,0,0,0,2018-12-10,2019-12-10,,Changi General Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,46
NCT03126903,0,0,0,0,0,0,2019-12-30,2020-12-30,,"KeraMed, Inc.",Industry,1,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03127722,0,0,0,0,0,0,2024-12-31,2025-12-31,,Bayer,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1343
NCT03130946,0,0,0,0,0,0,2019-12-01,2020-12-01,,Peking University People's Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,189
NCT03134196,0,0,0,0,0,0,2020-12-31,2021-12-31,,NYU Langone Health,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03135834,0,0,0,0,0,0,2018-12-12,2019-12-12,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2856
NCT03137472,0,0,0,0,0,0,2021-06-29,2022-06-29,,Stanford University,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03138876,1,0,1,1,0,1,2018-08-16,2019-08-16,2019-08-30,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,1898
NCT03139032,0,0,0,0,0,0,2017-12-06,2018-12-06,,Arena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,21
NCT03139240,1,1,0,1,0,1,2018-05-31,2019-05-31,2019-06-06,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,475
NCT03140254,0,0,0,0,0,0,2017-03-17,2018-03-17,,CareFusion,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT03140631,1,1,0,1,0,0,2017-11-16,2018-11-16,2018-08-25,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,934
NCT03141177,0,0,0,0,0,0,2020-01-30,2021-01-30,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03142321,0,0,0,0,0,0,2020-06-30,2021-06-30,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03144804,0,0,0,0,0,0,2020-11-30,2021-11-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03145558,0,0,0,0,0,0,2021-05-31,2022-05-31,,Teclison Ltd.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03145766,0,0,0,0,0,0,2018-01-05,2019-01-05,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,1222
NCT03146663,0,0,0,0,0,0,2019-06-30,2020-06-30,,NuCana plc,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03146871,0,0,0,0,0,0,2019-03-19,2020-03-19,,University of Southern California,Other,0,0,1,1.0,Phase 2,1,2017.0,1,1,1,0,0,0,0,0,0,1,0,483
NCT03148275,0,0,0,0,0,0,2023-12-31,2024-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03149575,0,0,0,0,0,0,2019-06-30,2020-06-30,,"DelMar Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03150511,0,0,0,0,0,0,2020-12-31,2021-12-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03152058,0,0,0,0,0,0,2020-05-31,2021-05-31,,Ware Branch,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03153202,0,0,0,0,0,0,2020-04-10,2021-04-10,,Joshua Brody,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03158142,1,0,0,0,1,0,2017-11-20,2018-11-20,,State University of New York College of Optometry,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03158220,0,0,0,0,0,0,2018-11-19,2019-11-19,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,2145
NCT03163446,0,0,0,0,0,0,2019-03-07,2020-03-07,,ContraFect,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,1,0,0,0,0,0,1,1,0,2
NCT03169491,0,0,0,0,0,0,2019-08-30,2020-08-30,,Instituto Nacional de Enfermedades Respiratorias,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,9
NCT03170219,0,1,0,1,0,0,2018-09-20,2019-09-20,2018-11-29,Adrian Hernandez,Other,0,0,0,1.0,Phase 2,1,2018.0,1,0,0,0,0,0,1,0,0,1,0,6
NCT03170960,0,0,0,0,0,0,2020-03-31,2021-03-31,,Exelixis,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT03173560,0,0,0,0,0,0,2020-01-31,2021-01-31,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,328
NCT03174288,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Virginia,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,402
NCT03175432,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03176459,0,0,0,0,0,0,2018-11-20,2019-11-20,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,53
NCT03179163,0,0,0,0,0,0,2020-08-31,2021-08-31,,Penn State University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,145
NCT03180619,0,0,0,0,0,0,2019-03-27,2020-03-27,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03181828,1,0,0,0,1,0,2018-06-05,2019-06-05,,Nicholas Ah Mew,Other,0,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03186989,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,69
NCT03188991,0,0,0,0,0,0,2019-12-31,2020-12-31,,"NanOlogy, LLC",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03190265,0,0,0,0,0,0,2023-10-31,2024-10-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03190668,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,849
NCT03190824,0,0,0,0,0,0,2021-06-24,2022-06-24,,Syneos Health,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT03192696,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Avinger, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03193801,0,0,0,0,0,0,2020-08-01,2021-08-01,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,77
NCT03194373,0,0,0,0,0,0,2019-02-01,2020-02-01,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03194789,0,0,0,0,0,0,2020-12-31,2021-12-31,,Montefiore Medical Center,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,240
NCT03196219,0,0,0,0,0,0,2017-11-22,2018-11-22,,"Armata Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03198871,0,0,0,0,0,0,2019-07-07,2020-07-07,,Kathirvel Subramaniam,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03200912,1,0,0,0,1,0,2017-03-07,2018-03-07,,Actavis Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT03201445,0,0,0,0,0,0,2021-01-31,2022-01-31,,Gilead Sciences,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03203330,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Kolon TissueGene, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03204331,0,0,0,0,0,0,2019-12-15,2020-12-15,,Myovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03205423,0,0,0,0,0,0,2019-08-31,2020-08-31,,New York State Psychiatric Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03206216,1,1,0,1,0,0,2017-10-30,2018-10-30,2018-09-26,Stanford University,Other,0,0,0,5.0,,1,2017.0,1,0,0,0,1,0,0,0,0,1,0,1309
NCT03207763,0,0,0,0,0,0,2019-05-15,2020-05-15,,Emory University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,947
NCT03207945,0,0,0,0,0,0,2021-11-30,2022-11-30,,"University of California, San Francisco",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03214250,0,0,0,0,0,0,2022-07-01,2023-07-01,,Parker Institute for Cancer Immunotherapy,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03214640,0,0,0,0,0,0,2019-09-01,2020-09-01,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,616
NCT03215667,0,0,0,0,0,0,2019-07-31,2020-07-31,,Sunstar Americas,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03216226,0,0,0,0,0,0,2018-02-14,2019-02-14,,Zealand Pharma,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,21
NCT03218137,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03218566,0,0,0,0,0,0,2019-09-30,2020-09-30,,Penumbra Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT03219866,0,0,0,0,0,0,2019-09-30,2020-09-30,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,616
NCT03220035,0,0,0,0,0,0,2023-12-31,2024-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03221426,0,0,0,0,0,0,2023-07-26,2024-07-26,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03223350,0,0,0,0,0,0,2019-08-05,2020-08-05,,Henry Ford Health System,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,151
NCT03223883,0,0,0,0,0,0,2022-12-31,2023-12-31,,Diana Jalal,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03224234,0,0,0,0,0,0,2019-09-30,2020-09-30,,Emory University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT03225612,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Mitralign, Inc.",Industry,1,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03229200,0,0,0,0,0,0,2027-07-02,2028-07-02,,Pharmacyclics Switzerland GmbH,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03230864,0,0,0,0,0,0,2019-02-05,2020-02-05,,H. Lundbeck A/S,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,152
NCT03231306,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03232138,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Jian-Min Yuan, MD",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03233230,0,0,0,0,0,0,2019-10-15,2020-10-15,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03234595,0,0,0,0,0,0,2020-12-30,2021-12-30,,"Everfront Biotech Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03235154,0,0,0,0,0,0,2019-08-31,2020-08-31,,Community Research Initiative of New England,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03237286,0,0,0,0,0,0,2022-10-31,2023-10-31,,Rebecca Price,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03238781,0,0,0,0,0,0,2018-10-16,2019-10-16,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,685
NCT03241459,0,0,0,0,0,0,2020-04-30,2021-04-30,,"SurModics, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03242824,0,0,0,0,0,0,2019-12-01,2020-12-01,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1898
NCT03244384,0,0,0,0,0,0,2025-06-01,2026-06-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03256526,1,1,0,1,0,0,2018-03-30,2019-03-30,2019-03-12,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2856
NCT03257631,0,0,0,0,0,0,2018-11-23,2019-11-23,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03258008,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03259295,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Florida,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03259425,0,0,0,0,0,0,2018-09-21,2019-09-21,,University of Utah,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03261453,0,0,0,0,0,0,2019-05-01,2020-05-01,,Allurion Technologies,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03267212,1,0,0,0,1,0,2018-07-14,2019-07-14,,Spaulding Rehabilitation Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,69
NCT03268057,0,0,0,0,0,0,2020-05-01,2021-05-01,,Vaccinex Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03268837,0,0,0,0,0,0,2019-10-31,2020-10-31,,Lawson Health Research Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,468
NCT03269643,1,0,0,0,1,0,2017-11-24,2018-11-24,,Darma Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03270657,0,0,0,0,0,0,2022-02-27,2023-02-27,,"Dennis Turner, M.D.",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03271021,1,0,0,0,1,0,2018-09-04,2019-09-04,,Foamix Ltd.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,16
NCT03274856,0,0,0,0,0,0,2019-06-12,2020-06-12,,GLWL Research Inc.,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,2
NCT03275350,0,0,0,0,0,0,2019-11-30,2020-11-30,,Oregon Health and Science University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT03275922,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Impax Laboratories, LLC",Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03276871,0,0,0,0,0,0,2019-09-30,2020-09-30,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03281577,0,0,0,0,0,0,2019-07-12,2020-07-12,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,650
NCT03282240,0,0,0,0,0,0,2017-11-02,2018-11-02,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,285
NCT03283371,0,0,0,0,0,0,2020-01-16,2021-01-16,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03287245,0,0,0,0,0,0,2019-11-08,2020-11-08,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03289858,0,0,0,0,0,0,2019-01-01,2020-01-01,,"University of Massachusetts, Worcester",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,163
NCT03290027,1,0,0,0,1,0,2018-04-19,2019-04-19,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,212
NCT03290326,0,0,0,0,0,0,2019-05-14,2020-05-14,,Beth Israel Deaconess Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,377
NCT03294863,0,0,0,0,0,0,2028-03-31,2029-03-31,,"University of California, Davis",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,530
NCT03296813,0,0,0,0,0,0,2022-08-14,2023-08-14,,Duke University,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03298113,1,0,1,1,0,0,2018-07-10,2019-07-10,2019-07-08,3M,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,56
NCT03300609,0,0,0,0,0,0,2022-02-27,2023-02-27,,University of Southern California,Other,0,1,1,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,483
NCT03301350,0,0,0,0,0,0,2022-10-31,2023-10-31,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03301597,0,0,0,0,0,0,2019-03-18,2020-03-18,,"Nohla Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,1,0,0,0,0,0,1,1,0,6
NCT03302858,0,0,0,0,0,0,2019-10-31,2020-10-31,,Stephen E. Goldstone,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03303170,1,0,0,0,1,0,2018-04-10,2019-04-10,,"Sebacia, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03306264,0,0,0,0,0,0,2019-06-30,2020-06-30,,Astex Pharmaceuticals,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,38
NCT03308578,0,0,0,0,0,0,2022-10-01,2023-10-01,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03310632,0,0,0,0,0,0,2020-08-27,2021-08-27,,Golden Biotechnology Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03310957,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Seattle Genetics, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,77
NCT03311906,1,0,0,0,1,0,2017-08-15,2018-08-15,,Riyadh Colleges of Dentistry and Pharmacy,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,26
NCT03313323,0,0,0,0,0,0,2021-02-16,2022-02-16,,VU University Medical Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,159
NCT03315130,0,0,0,0,0,0,2018-12-10,2019-12-10,,Ra Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03315975,0,0,0,0,0,0,2019-12-30,2020-12-30,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1052
NCT03316118,0,0,0,0,0,0,2019-10-05,2020-10-05,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03316872,0,0,0,0,0,0,2021-04-02,2022-04-02,,"University Health Network, Toronto",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,2,1,0,931
NCT03317158,0,0,0,0,0,0,2020-09-01,2021-09-01,,"Noah Hahn, M.D.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,5
NCT03317899,0,0,0,0,0,0,2021-06-30,2022-06-30,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,162
NCT03318497,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rathan Subramaniam,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03318796,0,0,0,0,0,0,2019-12-30,2020-12-30,,"Tryton Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03319134,0,0,0,0,0,0,2018-09-17,2019-09-17,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,29
NCT03319810,1,1,0,1,0,0,2018-07-19,2019-07-19,2019-03-22,Sutter Health,Other,0,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,6
NCT03321630,0,0,0,0,0,0,2019-07-31,2020-07-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03321721,0,0,0,0,0,0,2019-05-31,2020-05-31,,St. Louis University,Other,0,0,0,5.0,,1,2014.0,1,0,0,0,0,0,0,0,0,0,1,126
NCT03322137,0,0,0,0,0,0,2018-09-10,2019-09-10,,Sienna Biopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03324607,0,0,0,0,0,0,2020-03-31,2021-03-31,,Bastiaan Driehuys,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03325673,0,0,0,0,0,0,2018-11-29,2019-11-29,,Allergan,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,495
NCT03325816,0,0,0,0,0,0,2019-12-31,2020-12-31,,Giuseppe Giaccone,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,3
NCT03326141,0,0,0,0,0,0,2021-05-01,2022-05-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03326869,0,0,0,0,0,0,2020-04-30,2021-04-30,,Eye Center of North Florida,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03331666,0,0,0,0,0,0,2021-07-01,2022-07-01,,Columbia University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03332303,0,0,0,0,0,0,2018-03-15,2019-03-15,,Prasco LLC,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03333317,0,0,0,0,0,0,2018-03-23,2019-03-23,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT03333616,0,0,0,0,0,0,2021-05-31,2022-05-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03334214,0,0,0,0,0,0,2018-11-28,2019-11-28,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,69
NCT03334435,0,0,0,0,0,0,2021-09-02,2022-09-02,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03336216,0,0,0,0,0,0,2020-12-14,2021-12-14,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03337698,0,0,0,0,0,0,2022-02-02,2023-02-02,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03338062,0,0,0,0,0,0,2019-09-02,2020-09-02,,Indiana University,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,497
NCT03338673,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Michigan,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03339401,0,0,0,0,0,0,2019-05-10,2020-05-10,,Chimerix,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,16
NCT03340350,1,0,0,0,1,0,2018-06-01,2019-06-01,,Sriram Ramaswamy,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03340792,0,0,0,0,0,0,2019-10-31,2020-10-31,,China Medical University Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,211
NCT03342898,0,0,0,0,0,0,2018-05-29,2019-05-29,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,650
NCT03345108,1,1,0,1,0,0,2017-12-15,2018-12-15,2018-12-14,GlaxoSmithKline,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3276
NCT03345693,0,0,0,0,0,0,2020-07-31,2021-07-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03350750,0,0,0,0,0,0,2020-11-30,2021-11-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,1143
NCT03351049,0,0,0,0,0,0,2021-06-01,2022-06-01,,David Brienza,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03351608,0,0,0,0,0,0,2020-07-22,2021-07-22,,Merck Sharp & Dohme Corp.,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03351998,0,0,0,0,0,0,2022-07-01,2023-07-01,,University of Kansas Medical Center,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03352427,0,0,0,0,0,0,2023-12-31,2024-12-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03352609,0,0,0,0,0,0,2018-12-12,2019-12-12,,Medical University of South Carolina,Other,0,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,511
NCT03353597,0,0,0,0,0,0,2020-06-15,2021-06-15,,Chandra Duggirala,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03353896,0,0,0,0,0,0,2020-12-15,2021-12-15,,University of Southern California,Other,0,1,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,483
NCT03355560,0,0,0,0,0,0,2020-05-31,2021-05-31,,Trisha Wise-Draper,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03357731,0,0,0,0,0,0,2019-05-10,2020-05-10,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1104
NCT03360721,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03361228,0,0,0,0,0,0,2019-03-28,2020-03-28,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,143
NCT03361306,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Saad Z. Usmani, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03363763,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Aucta Pharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03364608,1,1,0,1,0,0,2018-03-30,2019-03-30,2019-03-29,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2450
NCT03366220,0,0,0,0,0,0,2019-03-26,2020-03-26,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,490
NCT03367429,0,0,0,0,0,0,2020-10-31,2021-10-31,,Weill Medical College of Cornell University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03367572,0,0,0,0,0,0,2022-12-01,2023-12-01,,Gary Morrow,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,23
NCT03368742,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Solid Biosciences, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,0,0,1,0,1,0,1
NCT03368937,1,1,0,1,0,1,2017-12-11,2018-12-11,2019-02-01,University of Virginia,Other,0,1,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,402
NCT03370510,0,0,0,0,0,0,2021-01-31,2022-01-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03371719,0,0,0,0,0,0,2024-02-16,2025-02-16,,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,1,1,0,27
NCT03376659,0,0,0,0,0,0,2021-12-31,2022-12-31,,Georgetown University,Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,214
NCT03377361,0,0,0,0,0,0,2021-09-21,2022-09-21,,Bristol-Myers Squibb,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03377595,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03383419,0,0,0,0,0,0,2020-03-30,2021-03-30,,Baylor Research Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,131
NCT03384654,0,0,0,0,0,0,2020-10-05,2021-10-05,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,558
NCT03385564,0,0,0,0,0,0,2022-03-29,2023-03-29,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03389555,0,0,0,0,0,0,2019-12-30,2020-12-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03390296,0,0,0,0,0,0,2023-12-29,2024-12-29,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03390907,0,0,0,0,0,0,2019-12-01,2020-12-01,,Milton S. Hershey Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,334
NCT03394404,0,0,0,0,0,0,2019-12-31,2020-12-31,,Barts & The London NHS Trust,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,76
NCT03395704,0,0,0,0,0,0,2019-09-30,2020-09-30,,La Jolla Pharmaceutical Company,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,18
NCT03396809,1,0,0,0,1,0,2018-07-07,2019-07-07,,University of New Mexico,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,200
NCT03396913,1,0,0,0,1,0,2018-08-15,2019-08-15,,Lumenis Ltd.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,16
NCT03397966,0,0,0,0,0,0,2023-01-02,2024-01-02,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03400826,0,0,0,0,0,0,2024-01-01,2025-01-01,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03401073,0,0,0,0,0,0,2020-06-01,2021-06-01,,Beth Israel Deaconess Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03404960,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Pennsylvania,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03410108,0,0,0,0,0,0,2020-08-13,2021-08-13,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,650
NCT03417505,0,0,0,0,0,0,2019-01-04,2020-01-04,,Tangible Science,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03418727,1,0,0,0,1,0,2018-03-29,2019-03-29,,Ocugen,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03419897,0,0,0,0,0,0,2021-03-31,2022-03-31,,BeiGene,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,57
NCT03421379,1,0,1,1,0,0,2018-08-20,2019-08-20,2019-08-14,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1512
NCT03422653,0,0,0,0,0,0,2019-04-06,2020-04-06,,"Cara Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03427268,0,0,0,0,0,0,2019-10-31,2020-10-31,,PharmaMar,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT03428126,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03428360,0,0,0,0,0,0,2019-04-30,2020-04-30,,Aquestive Therapeutics,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03429244,0,0,0,0,0,0,2021-10-31,2022-10-31,,Indiana University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,497
NCT03430895,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03431974,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Syntrix Biosystems, Inc.",Industry,1,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03432416,0,0,0,0,0,0,2020-03-20,2021-03-20,,Health Decisions,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03434379,0,0,0,0,0,0,2020-11-29,2021-11-29,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03436654,0,0,0,0,0,0,2020-02-14,2021-02-14,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03438708,0,0,0,0,0,0,2019-10-29,2020-10-29,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03441178,0,0,0,0,0,0,2019-08-31,2020-08-31,,Ethicon Endo-Surgery,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,38
NCT03441269,0,0,0,0,0,0,2019-06-30,2020-06-30,,Antonios Likourezos,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03446118,0,0,0,0,0,0,2020-01-15,2021-01-15,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03446456,0,0,0,0,0,0,2019-08-15,2020-08-15,,"University of Maryland, College Park",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,318
NCT03447262,0,0,0,0,0,0,2021-04-24,2022-04-24,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,141
NCT03448081,0,0,0,0,0,0,2018-11-21,2019-11-21,,Sienna Biopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,2
NCT03448978,0,0,0,0,0,0,2020-02-26,2021-02-26,,Cartesian Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03451760,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Glovia Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03454529,0,0,0,0,0,0,2020-05-31,2021-05-31,,Michael Simon,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03456076,0,0,0,0,0,0,2023-06-30,2024-06-30,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03457896,0,0,0,0,0,0,2020-12-31,2021-12-31,,NSABP Foundation Inc,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,63
NCT03461445,0,0,0,0,0,0,2019-12-13,2020-12-13,,"University of California, Davis",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03461783,1,0,0,0,1,0,2018-08-03,2019-08-03,,"Brock Liden, DPM",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03463187,0,0,0,0,0,0,2019-05-27,2020-05-27,,"Jiangsu HengRui Medicine Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,187
NCT03466658,0,0,0,0,0,0,2019-08-30,2020-08-30,,Milton S. Hershey Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,334
NCT03466918,0,0,0,0,0,0,2019-12-31,2020-12-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,77
NCT03467113,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03467698,0,0,0,0,0,0,2018-12-17,2019-12-17,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03468478,0,0,0,0,0,0,2020-06-18,2021-06-18,,Hospital do Rim e Hipertensão,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03470766,0,0,0,0,0,0,2020-08-01,2021-08-01,,Guy's and St Thomas' NHS Foundation Trust,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,133
NCT03473301,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Joanne Kurtzberg, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,15
NCT03473756,0,0,0,0,0,0,2023-04-19,2024-04-19,,Bayer,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03474510,0,0,0,0,0,0,2019-05-12,2020-05-12,,TriHealth Inc.,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,74
NCT03475706,0,0,0,0,0,0,2019-01-24,2020-01-24,,"Velicept Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03477552,0,0,0,0,0,0,2020-03-31,2021-03-31,,Assistance Publique - Hôpitaux de Paris,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,1790
NCT03478293,0,0,0,0,0,0,2021-06-30,2022-06-30,,Glaukos Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,34
NCT03478657,0,0,0,0,0,0,2018-12-07,2019-12-07,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,1,0,0,0,0,1,1,0,3276
NCT03479372,0,0,0,0,0,0,2019-05-27,2020-05-27,,"PanOptica, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,3
NCT03481595,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Cleveland Clinic,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03482505,1,0,0,0,1,0,2018-08-31,2019-08-31,,Masimo Corporation,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03482635,0,0,0,0,0,0,2022-05-02,2023-05-02,,Boehringer Ingelheim,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03484650,0,0,0,0,0,0,2019-10-01,2020-10-01,,Carilion Clinic,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,22
NCT03486080,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Recardio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03488433,0,0,0,0,0,0,2020-09-01,2021-09-01,,Milton S. Hershey Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,334
NCT03490760,0,0,0,0,0,0,2020-07-31,2021-07-31,,Baptist Health South Florida,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,17
NCT03490942,0,0,0,0,0,0,2020-02-29,2021-02-28,,Xeris Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03492671,0,0,0,0,0,0,2024-09-30,2025-09-30,,Loma Linda University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,194
NCT03492840,0,0,0,0,0,0,2019-05-06,2020-05-06,,Raziel Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03493412,0,0,0,0,0,0,2020-07-01,2021-07-01,,"University of Nebraska, Omaha",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,12
NCT03495115,0,0,0,0,0,0,2021-04-15,2022-04-15,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT03496207,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Acceleron Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03496467,0,0,0,0,0,0,2018-12-17,2019-12-17,,Mati Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,0,0,0,0,1,0,0,1,0,13
NCT03496623,0,0,0,0,0,0,2020-09-30,2021-09-30,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,72
NCT03498196,0,0,0,0,0,0,2020-05-31,2021-05-31,,Baylor College of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,518
NCT03500289,0,0,0,0,0,0,2019-08-30,2020-08-30,,Johns Hopkins University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1143
NCT03500419,0,0,0,0,0,0,2021-03-23,2022-03-23,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03502824,0,0,0,0,0,0,2020-10-31,2021-10-31,,Organogenesis,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,19
NCT03503162,0,0,0,0,0,0,2019-05-20,2020-05-20,,Motus GI Medical Technologies Ltd,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,9
NCT03503305,0,0,0,0,0,0,2020-03-01,2021-03-01,,"InGeneron, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,5
NCT03503513,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Michigan,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03503877,0,0,0,0,0,0,2020-02-14,2021-02-14,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03504020,0,0,0,0,0,0,2021-05-31,2022-05-31,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,169
NCT03504423,0,0,0,0,0,0,2021-10-31,2022-10-31,,Rafael Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03506360,0,0,0,0,0,0,2024-03-29,2025-03-29,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03507439,0,0,0,0,0,0,2020-12-31,2021-12-31,,Bayer,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,1343
NCT03508752,0,0,0,0,0,0,2023-12-31,2024-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,626
NCT03512002,0,0,0,0,0,0,2020-05-31,2021-05-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03512210,0,0,0,0,0,0,2020-12-15,2021-12-15,,AIDS Clinical Trials Group,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,62
NCT03513328,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Florida,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03513562,0,0,0,0,0,0,2021-02-28,2022-02-28,,Ohio State University Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,198
NCT03513757,0,0,0,0,0,0,2018-12-31,2019-12-31,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,315
NCT03513939,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sernova Corp,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,1
NCT03514784,0,0,0,0,0,0,2023-09-30,2024-09-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,490
NCT03517085,0,0,0,0,0,0,2020-09-19,2021-09-19,,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,0,0,1,1,1,0,36
NCT03517228,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1432
NCT03518086,0,0,0,0,0,0,2020-09-07,2021-09-07,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03523156,0,0,0,0,0,0,2020-06-30,2021-06-30,,Emory University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,947
NCT03523702,0,0,0,0,0,0,2020-07-31,2021-07-31,,Albert Einstein College of Medicine,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03523858,0,0,0,0,0,0,2023-09-29,2024-09-29,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03525808,0,0,0,0,0,0,2020-01-31,2021-01-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT03526354,0,0,0,0,0,0,2020-03-19,2021-03-19,,"University of Massachusetts, Worcester",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT03526549,0,0,0,0,0,0,2023-10-31,2024-10-31,,Endo Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,91
NCT03526874,0,0,0,0,0,0,2021-11-30,2022-11-30,,Children's Hospital of Philadelphia,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03527472,0,0,0,0,0,0,2022-10-31,2023-10-31,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03528369,0,0,0,0,0,0,2018-10-14,2019-10-14,,Vizuri Health Sciences LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03528564,0,0,0,0,0,0,2021-06-30,2022-06-30,,"St. Michael's Hospital, Toronto",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,303
NCT03528928,1,0,0,0,1,0,2018-04-17,2019-04-17,,"Elidah, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03530124,0,0,0,0,0,0,2020-10-31,2021-10-31,,Duke University,Other,0,0,1,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1342
NCT03530631,0,0,1,1,0,0,2018-12-18,2019-12-18,2019-07-29,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,801
NCT03531489,0,0,0,0,0,0,2018-12-30,2019-12-30,,Right-Air,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03534206,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Ceevra, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03535857,0,0,0,0,0,0,2020-07-01,2021-07-01,,Women and Infants Hospital of Rhode Island,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,50
NCT03537716,0,0,0,0,0,0,2019-05-15,2020-05-15,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,20
NCT03538054,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03538431,0,0,0,0,0,0,2020-06-15,2021-06-15,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03538808,0,0,0,0,0,0,2020-09-01,2021-09-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03539848,0,0,0,0,0,0,2021-03-30,2022-03-30,,University of Miami,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03540758,0,0,0,0,0,0,2020-11-30,2021-11-30,,Albert Einstein College of Medicine,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03544333,0,0,0,0,0,0,2019-01-22,2020-01-22,,Northwell Health,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,271
NCT03544632,0,0,0,0,0,0,2019-12-07,2020-12-07,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03545191,0,0,0,0,0,0,2019-10-01,2020-10-01,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03545646,0,0,0,0,0,0,2019-05-15,2020-05-15,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,20
NCT03547778,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of South Florida,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03548116,0,0,0,0,0,0,2020-03-31,2021-03-31,,John Pellerito,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03549312,0,0,0,0,0,0,2019-06-30,2020-06-30,,Saskatchewan Health Authority - Regina Area,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,10
NCT03549520,0,0,0,0,0,0,2019-07-31,2020-07-31,,Children's Hospital of Philadelphia,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03549871,0,0,0,0,0,0,2021-06-29,2022-06-29,,"Genzyme, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,300
NCT03551678,0,0,0,0,0,0,2022-12-31,2023-12-31,,VA Palo Alto Health Care System,U.S. Fed,2,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,34
NCT03552263,0,0,0,0,0,0,2019-09-20,2020-09-20,,"Tasly Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03552757,0,0,0,0,0,0,2020-03-16,2021-03-16,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03553758,0,0,0,0,0,0,2019-11-30,2020-11-30,,Massachusetts General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03554642,0,0,0,0,0,0,2019-12-31,2020-12-31,,Burke Medical Research Institute,Other,0,1,0,3.0,Phase 3,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,11
NCT03555552,0,0,0,0,0,0,2020-06-30,2021-06-30,,Duke University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03556020,0,0,0,0,0,0,2020-01-31,2021-01-31,,PhaseBio Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03556358,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Tanvex BioPharma USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,1
NCT03558152,0,0,0,0,0,0,2021-08-11,2022-08-11,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03560271,0,0,0,0,0,0,2019-06-30,2020-06-30,,"NovMetaPharma Co., Ltd.",Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03562416,0,0,0,0,0,0,2021-12-31,2022-12-31,,Temple University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,152
NCT03563053,0,0,0,0,0,0,2019-08-31,2020-08-31,,Erydel,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,0,0,0,0,1,0,1,1,0,7
NCT03563716,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03565913,0,0,0,0,0,0,2020-01-22,2021-01-22,,University of Texas Southwestern Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03567057,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Adamas Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03569007,0,0,0,0,0,0,2021-08-31,2022-08-31,,Innovate Biopharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03571334,0,0,0,0,0,0,2020-06-01,2021-06-01,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,315
NCT03572478,0,0,0,0,0,0,2020-10-14,2021-10-14,,University of Chicago,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03573648,0,0,0,0,0,0,2020-08-31,2021-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03573817,0,0,0,0,0,0,2018-09-25,2019-09-25,,Theravance Biopharma,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,53
NCT03576755,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Monika Sarkar, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03577522,0,0,0,0,0,0,2024-12-31,2025-12-31,,Canadian Radiostereometric Analysis Network,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,3
NCT03578926,0,0,0,0,0,0,2018-10-08,2019-10-08,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03579602,0,0,0,0,0,0,2020-04-30,2021-04-30,,Blaze Bioscience Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,5
NCT03580967,0,0,0,0,0,0,2020-08-01,2021-08-01,,Todd Doyle,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03582046,0,0,0,0,0,0,2020-09-30,2021-09-30,,Potrero Medical,Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03582488,0,0,0,0,0,0,2023-06-25,2024-06-25,,Kejal Kantarci,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03585296,0,0,0,0,0,0,2019-04-25,2020-04-25,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03585712,0,0,0,0,0,0,2020-01-30,2021-01-30,,HRA Pharma,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03586583,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Fujifilm Medical Systems USA, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03586960,1,0,0,0,1,0,2018-08-31,2019-08-31,,Silver Falls Dermatology,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03587701,0,0,0,0,0,0,2022-09-01,2023-09-01,,Northwell Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,271
NCT03588884,0,0,0,0,0,0,2020-03-17,2021-03-17,,OPKO Ireland Global Holdings Ltd.,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03589339,0,0,0,0,0,0,2023-03-30,2024-03-30,,Nanobiotix,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03589547,0,0,0,0,0,0,2020-10-31,2021-10-31,,Hina Khan,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT03590704,1,0,0,0,1,0,2017-08-29,2018-08-29,,"Instituto Nacional de Cancer, Brazil",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,24
NCT03594266,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Biotronik, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,26
NCT03595566,0,0,0,0,0,0,2021-06-30,2022-06-30,,Summit Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03597594,0,0,0,0,0,0,2027-07-01,2028-07-01,,St. Jude Children's Research Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,302
NCT03598140,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03598257,0,0,0,0,0,0,2023-07-31,2024-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,3004
NCT03601637,0,0,0,0,0,0,2020-09-30,2021-09-30,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,141
NCT03602261,0,0,0,0,0,0,2020-12-31,2021-12-31,,OPKO Ireland Global Holdings Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03606486,0,0,0,0,0,0,2019-09-15,2020-09-15,,University of Washington,Other,0,0,1,5.0,,0,2018.0,1,0,0,0,0,0,0,0,0,1,0,910
NCT03607487,0,0,0,0,0,0,2019-11-30,2020-11-30,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,143
NCT03610165,0,0,0,0,0,0,2019-06-01,2020-06-01,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03617328,0,0,0,0,0,0,2021-01-08,2022-01-08,,"Craig L Slingluff, Jr",Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,19
NCT03617484,0,0,0,0,0,0,2022-03-31,2023-03-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03618550,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03618823,0,0,0,0,0,0,2019-10-31,2020-10-31,,"David Chi, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03620162,0,0,0,0,0,0,2021-03-03,2022-03-03,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03622372,0,0,0,0,0,0,2020-01-31,2021-01-31,,CoNextions Medical,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03622905,0,0,0,0,0,0,2023-10-01,2024-10-01,,Functional Neuromodulation Ltd,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,2
NCT03623321,0,0,0,0,0,0,2022-01-31,2023-01-31,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,24
NCT03624023,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Transwell Biotech Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03626636,0,0,0,0,0,0,2019-04-05,2020-04-05,,"Allegro Ophthalmics, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03627065,0,0,0,0,0,0,2019-08-31,2020-08-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03627403,0,0,0,0,0,0,2024-03-14,2025-03-14,,University of Utah,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03627546,0,0,0,0,0,0,2021-07-10,2022-07-10,,Weill Medical College of Cornell University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03628066,0,0,0,0,0,0,2021-11-01,2022-11-01,,NSABP Foundation Inc,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,1,0,0,0,1,1,0,63
NCT03630952,0,0,0,0,0,0,2020-12-20,2021-12-20,,"Chengdu Kanghong Biotech Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,15
NCT03631199,0,0,0,0,0,0,2021-05-31,2022-05-31,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03632135,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Cordgenics, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,3
NCT03633708,0,0,0,0,0,0,2023-01-31,2024-01-31,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03635775,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03636347,0,0,0,0,0,0,2019-09-02,2020-09-02,,Mereo BioPharma,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03637348,0,0,0,0,0,0,2019-07-08,2020-07-08,,Price Vision Group,Industry,1,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03637816,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03639675,0,0,0,0,0,0,2019-02-14,2020-02-14,,Bayer,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1343
NCT03639883,0,0,0,0,0,0,2019-12-31,2020-12-31,,Aiviva BioPharma Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03641677,0,0,0,0,0,0,2020-11-01,2021-11-01,,Lung Bioengineering Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03642158,0,0,0,0,0,0,2020-06-30,2021-06-30,,Hunter Holmes Mcguire Veteran Affairs Medical Center,U.S. Fed,2,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,19
NCT03643861,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,801
NCT03644017,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Merit Medical Systems, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,12
NCT03644953,0,0,0,0,0,0,2020-08-31,2021-08-31,,Children's Research Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03649074,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Akili Interactive Labs, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03649321,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Texas Southwestern Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03652311,0,0,0,0,0,0,2019-10-31,2020-10-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03652753,0,0,0,0,0,0,2023-01-31,2024-01-31,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03652922,0,0,0,0,0,0,2019-11-30,2020-11-30,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,1699
NCT03654274,0,0,0,0,0,0,2020-12-30,2021-12-30,,Myovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03654885,0,0,0,0,0,0,2020-09-30,2021-09-30,,Allergan,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,495
NCT03657043,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Seattle Genetics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,77
NCT03660839,0,0,0,0,0,0,2019-11-30,2020-11-30,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1222
NCT03663166,0,0,0,0,0,0,2022-03-01,2023-03-01,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,344
NCT03665038,0,0,0,0,0,0,2020-06-30,2021-06-30,,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03665688,0,0,0,0,0,0,2020-11-07,2021-11-07,,"The University of Texas Medical Branch, Galveston",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,158
NCT03667014,0,0,0,0,0,0,2020-10-31,2021-10-31,,"University of California, San Francisco",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03668431,0,0,0,0,0,0,2021-03-01,2022-03-01,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03668808,0,0,0,0,0,0,2019-08-31,2020-08-31,,Sansum Diabetes Research Institute,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,26
NCT03669042,0,0,0,0,0,0,2020-02-29,2021-02-28,,"CryoLife, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT03669302,0,0,0,0,0,0,2021-05-30,2022-05-30,,City University of New York,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03669640,0,0,0,0,0,0,2020-07-02,2021-07-02,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1731
NCT03670641,0,0,0,0,0,0,2019-09-30,2020-09-30,,Sandra Sobel,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT03671044,0,0,0,0,0,0,2022-03-31,2023-03-31,,Jina Pharmaceuticals Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03673943,0,0,0,0,0,0,2019-03-23,2020-03-23,,"Radiomedix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03674567,0,0,0,0,0,0,2021-05-31,2022-05-31,,"RAPT Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03675451,0,0,0,0,0,0,2019-09-01,2020-09-01,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03675724,0,0,0,0,0,0,2019-09-28,2020-09-28,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03676634,0,0,0,0,0,0,2019-10-31,2020-10-31,,California Department of Public Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03677830,0,0,0,0,0,0,2022-04-01,2023-04-01,,St. Louis University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,126
NCT03677934,0,0,0,0,0,0,2021-02-28,2022-02-28,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1731
NCT03678545,0,0,0,0,0,0,2024-01-31,2025-01-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,1,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03678948,0,0,0,0,0,0,2020-06-30,2021-06-30,,Christopher Kaeding,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03679663,0,0,0,0,0,0,2020-07-30,2021-07-30,,Tel-Aviv Sourasky Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,415
NCT03680521,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mirati Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03681977,0,0,0,0,0,0,2020-12-15,2021-12-15,,Lady Davis Institute,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,18
NCT03682705,0,0,0,0,0,0,2019-11-17,2020-11-17,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03685149,0,0,0,0,0,0,2020-08-31,2021-08-31,,Wojciech Zareba,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03687931,0,0,0,0,0,0,2019-02-28,2020-02-28,,"iDrop, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03691935,0,0,0,0,0,0,2020-02-28,2021-02-28,,Milton S. Hershey Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03694353,0,0,0,0,0,0,2019-12-31,2020-12-31,,BioMarin Pharmaceutical,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,85
NCT03694756,0,0,0,0,0,0,2020-11-01,2021-11-01,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,240
NCT03696199,0,0,0,0,0,0,2020-06-01,2021-06-01,,"University of Massachusetts, Worcester",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,163
NCT03701061,0,0,0,0,0,0,2020-01-01,2021-01-01,,Emory University,Other,0,0,1,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,947
NCT03701321,0,0,0,0,0,0,2023-10-31,2024-10-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03702686,0,0,0,0,0,0,2019-10-31,2020-10-31,,Molex Ventures LLC,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03702829,0,0,0,0,0,0,2022-01-31,2023-01-31,,Brigham and Women's Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03703895,0,0,0,0,0,0,2018-11-30,2019-11-30,,The Center for Clinical and Cosmetic Research,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03704376,1,1,0,1,0,0,2017-11-16,2018-11-16,2018-11-16,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,490
NCT03708354,0,0,0,0,0,0,2022-12-31,2023-12-31,,Texas Tech University Health Sciences Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,78
NCT03710239,0,0,0,0,0,0,2020-10-02,2021-10-02,,Albany Medical College,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,51
NCT03710564,0,0,0,0,0,0,2020-06-09,2021-06-09,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1895
NCT03711500,0,0,0,0,0,0,2020-12-31,2021-12-31,,New York State Psychiatric Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03711929,0,0,0,0,0,0,2022-06-30,2023-06-30,,Santen Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03712371,0,0,0,0,0,0,2021-12-30,2022-12-30,,Medical University of South Carolina,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03713320,0,0,0,0,0,0,2021-04-30,2022-04-30,,"miRagen Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03714867,0,0,0,0,0,0,2020-11-01,2021-11-01,,Augusta University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,117
NCT03715465,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Michigan,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03718299,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sun Pharma Global FZE,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03719664,0,0,0,0,0,0,2020-04-30,2021-04-30,,Frontier Biotechnologies Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03720210,0,0,0,0,0,0,2019-07-31,2020-07-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03722264,0,0,0,0,0,0,2019-12-31,2020-12-31,,Virginia Commonwealth University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,417
NCT03723603,0,0,0,0,0,0,2019-06-04,2020-06-04,,Medline Industries,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,30
NCT03725202,0,0,0,0,0,0,2022-03-25,2023-03-25,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03726346,0,0,0,0,0,0,2018-12-13,2019-12-13,,Fisher and Paykel Healthcare,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,56
NCT03726658,0,0,0,0,0,0,2019-10-09,2020-10-09,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03728673,0,0,0,0,0,0,2020-12-31,2021-12-31,,Nicole Shonka,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03729778,0,0,0,0,0,0,2020-01-01,2021-01-01,,VA Eastern Colorado Health Care System,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,37
NCT03732703,0,0,0,0,0,0,2022-02-10,2023-02-10,,Multiple Myeloma Research Consortium,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03734679,0,0,0,0,0,0,2019-12-31,2020-12-31,,"SurModics, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03734822,1,1,0,1,0,1,2017-12-20,2018-12-20,2019-01-28,Nationwide Children's Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,1,0,0,0,0,0,1,161
NCT03736616,0,0,0,0,0,0,2021-09-30,2022-09-30,,Swedish Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,34
NCT03737604,0,0,0,0,0,0,2019-10-04,2020-10-04,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03738397,0,0,0,0,0,0,2020-09-08,2021-09-08,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03739593,0,0,0,0,0,0,2020-01-31,2021-01-31,,Aerie Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,28
NCT03739983,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,715
NCT03740763,0,0,0,0,0,0,2023-05-31,2024-05-31,,Göteborg University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,165
NCT03741400,0,0,0,0,0,0,2020-09-30,2021-09-30,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03742141,0,0,0,0,0,0,2020-09-26,2021-09-26,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,412
NCT03742804,0,0,0,0,0,0,2019-12-31,2020-12-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1053
NCT03745716,0,0,0,0,0,0,2020-12-31,2021-12-31,,Aprea Therapeutics AB,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03749928,0,0,0,0,0,0,2020-11-30,2021-11-30,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03750422,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Goldman, Butterwick, Fitzpatrick and Groff",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03752151,0,0,0,0,0,0,2019-07-31,2020-07-31,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,169
NCT03755791,0,0,0,0,0,0,2020-08-01,2021-08-01,,Exelixis,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT03756285,0,0,0,0,0,0,2020-07-15,2021-07-15,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03758222,0,0,0,0,0,0,2019-12-31,2020-12-31,,"MedeonBio, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03759587,0,0,0,0,0,0,2019-03-17,2020-03-17,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,650
NCT03760146,0,0,0,0,0,0,2020-01-02,2021-01-02,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2856
NCT03762109,0,0,0,0,0,0,2020-12-31,2021-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03763162,0,0,0,0,0,0,2023-12-31,2024-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03764007,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, San Francisco",Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT03769168,0,0,0,0,0,0,2024-10-02,2025-10-02,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03769363,0,0,0,0,0,0,2022-06-01,2023-06-01,,Massachusetts General Hospital,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03769675,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03770572,0,0,0,0,0,0,2022-12-31,2023-12-31,,Nationwide Children's Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,161
NCT03772535,0,0,0,0,0,0,2020-06-30,2021-06-30,,Anderson Orthopaedic Research Institute,Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,13
NCT03772964,0,0,0,0,0,0,2020-05-31,2021-05-31,,Brian Zuckerbraun,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03778931,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Radius Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03781622,0,0,0,0,0,0,2020-06-30,2021-06-30,,"880 Medical, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03781791,0,0,0,0,0,0,2019-09-30,2020-09-30,,Enterin Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03781960,0,0,0,0,0,0,2021-01-31,2022-01-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03782103,0,0,0,0,0,0,2019-05-12,2020-05-12,,"Zurex Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03783091,0,0,0,0,0,0,2023-12-31,2024-12-31,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03783884,0,0,0,0,0,0,2020-12-30,2021-12-30,,Lungpacer Medical Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03784287,0,0,0,0,0,0,2023-10-31,2024-10-31,,BioMarin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,85
NCT03786081,0,0,0,0,0,0,2021-04-30,2022-04-30,,Genmab,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,20
NCT03788291,0,0,0,0,0,0,2023-02-01,2024-02-01,,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03789474,1,0,0,0,1,0,2018-07-30,2019-07-30,,"All India Institute of Medical Sciences, Rishikesh",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,0,1,2
NCT03793179,0,0,0,0,0,0,2021-09-30,2022-09-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,3004
NCT03801434,0,0,0,0,0,0,2021-04-30,2022-04-30,,Stanford University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03801915,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03802396,0,0,0,0,0,0,2021-04-17,2022-04-17,,"Miles Berger, MD PhD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03804619,0,0,0,0,0,0,2021-12-01,2022-12-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03804983,0,0,0,0,0,0,2019-02-16,2020-02-16,,University of Virginia,Other,0,1,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,402
NCT03807349,0,0,0,0,0,0,2021-01-31,2022-01-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,215
NCT03807843,0,0,0,0,0,0,2021-03-04,2022-03-04,,Themis Bioscience GmbH,Industry,1,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,7
NCT03808376,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Senseonics, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03808610,0,0,0,0,0,0,2023-12-31,2024-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03809286,0,0,0,0,0,0,2021-12-31,2022-12-31,,New York State Psychiatric Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,361
NCT03811873,0,0,0,0,0,0,2020-04-01,2021-04-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,1898
NCT03816384,0,0,0,0,0,0,2021-12-31,2022-12-31,,Potrero Medical,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,5
NCT03818035,0,0,0,0,0,0,2022-08-28,2023-08-28,,Janssen-Cilag G.m.b.H,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,11
NCT03819660,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Catalyst Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,12
NCT03821857,0,0,0,0,0,0,2023-03-31,2024-03-31,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1898
NCT03822494,0,0,0,0,0,0,2023-07-12,2024-07-12,,Crozer-Keystone Health System,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,3
NCT03823911,0,0,0,0,0,0,2019-12-01,2020-12-01,,"University of Maryland, College Park",Other,0,1,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03829514,0,0,0,0,0,0,2019-10-31,2020-10-31,,Medical University of South Carolina,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03831854,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Cleveland Clinic,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03833388,0,0,0,0,0,0,2019-05-14,2020-05-14,,Topivert Pharma Ltd,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03834623,0,0,0,0,0,0,2023-05-14,2024-05-14,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03835429,0,0,0,0,0,0,2019-12-30,2020-12-30,,Texas A&M University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,57
NCT03840967,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Shadia Jalal, MD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03843463,0,0,0,0,0,0,2024-02-29,2025-02-28,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03844607,0,0,0,0,0,0,2020-05-31,2021-05-31,,Minneapolis Veterans Affairs Medical Center,U.S. Fed,2,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,31
NCT03844789,0,0,0,0,0,0,2020-03-01,2021-03-01,,University of Virginia,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,402
NCT03845023,0,0,0,0,0,0,2019-09-30,2020-09-30,,Apnimed,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03847467,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03847896,0,0,0,0,0,0,2020-05-11,2021-05-11,,Bond Avillion 2 Development LP,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,3
NCT03848871,0,0,0,0,0,0,2018-11-30,2019-11-30,,"Derm Research, PLLC",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03850574,0,0,0,0,0,0,2020-12-31,2021-12-31,,Hanmi Pharmaceutical Company Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,123
NCT03850691,0,0,0,0,0,0,2025-12-31,2026-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,218
NCT03854617,0,0,0,0,0,0,2021-12-20,2022-12-20,,Chinese Academy of Medical Sciences,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,185
NCT03855904,0,0,0,0,0,0,2023-05-31,2024-05-31,,King Chulalongkorn Memorial Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,19
NCT03856450,0,0,0,0,0,0,2020-02-01,2021-02-01,,GE Healthcare,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,119
NCT03856632,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT03856944,0,0,0,0,0,0,2019-08-05,2020-08-05,,Gainesville Eye Associates,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03857139,0,0,0,0,0,0,2022-01-31,2023-01-31,,University of Houston,Other,0,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,47
NCT03860662,0,0,0,0,0,0,2019-06-21,2020-06-21,,Mustafa Kemal University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,1,0,0,0,2,1,0,15
NCT03860857,0,0,0,0,0,0,2023-12-22,2024-12-22,,"University of California, Irvine",Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,310
NCT03861091,0,0,0,0,0,0,2023-08-31,2024-08-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03862157,0,0,0,0,0,0,2024-01-01,2025-01-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03864068,0,0,0,0,0,0,2022-08-31,2023-08-31,,Milton S. Hershey Medical Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03864614,0,0,0,0,0,0,2021-04-30,2022-04-30,,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03865407,0,0,0,0,0,0,2020-04-30,2021-04-30,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03866772,0,0,0,0,0,0,2021-03-31,2022-03-31,,Bnai Zion Medical Center,Other,0,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,69
NCT03866993,0,0,0,0,0,0,2020-12-31,2021-12-31,,Akeso,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,6
NCT03867201,0,0,0,0,0,0,2022-02-09,2023-02-09,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,1895
NCT03868839,0,0,0,0,0,0,2020-02-01,2021-02-01,,Xiaoduo Fan,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03869866,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,285
NCT03870451,0,0,0,0,0,0,2020-02-29,2021-02-28,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03873818,0,0,0,0,0,0,2020-05-01,2021-05-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03875326,0,0,0,0,0,0,2023-08-01,2024-08-01,,University of Michigan,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03875911,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03877510,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Impax Laboratories, LLC",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03878979,0,0,0,0,0,0,2021-07-31,2022-07-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03881111,0,0,0,0,0,0,2021-05-11,2022-05-11,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,2,1,0,2145
NCT03883945,0,0,0,0,0,0,2019-09-30,2020-09-30,,Aiviva BioPharma Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03884374,0,0,0,0,0,0,2025-06-01,2026-06-01,,University of Florida,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03887286,0,0,0,0,0,0,2019-05-30,2020-05-30,,University of Miami,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,476
NCT03888105,0,0,0,0,0,0,2024-07-11,2025-07-11,,Regeneron Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03888274,0,0,0,0,0,0,2019-02-13,2020-02-13,,Tivic Health Systems,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03894397,0,0,0,0,0,0,2019-09-01,2020-09-01,,KU Leuven,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,195
NCT03896295,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Momenta Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03897140,0,0,0,0,0,0,2019-07-01,2020-07-01,,Sara Guttas,Industry,1,0,0,5.0,,0,2019.0,1,0,0,0,1,0,0,0,0,1,0,2
NCT03899181,0,0,0,0,0,0,2023-02-28,2024-02-28,,Augusta University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,117
NCT03899987,0,0,0,0,0,0,2022-01-02,2023-01-02,,Roswell Park Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT03902080,0,0,0,0,0,0,2020-11-30,2021-11-30,,Urovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03903692,0,0,0,0,0,0,2020-06-01,2021-06-01,,Medline Industries,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,30
NCT03904199,0,0,0,0,0,0,2022-04-03,2023-04-03,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03904550,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03905811,0,0,0,0,0,0,2019-10-31,2020-10-31,,Jordan Schultz,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03910478,0,0,0,0,0,0,2024-12-30,2025-12-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2133
NCT03912220,0,0,0,0,0,0,2021-10-31,2022-10-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03913130,0,0,0,0,0,0,2021-03-31,2022-03-31,,ProQR Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03917381,0,0,0,0,0,0,2021-10-31,2022-10-31,,Genmab,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,20
NCT03922035,0,0,0,0,0,0,2021-12-24,2022-12-24,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,358
NCT03923790,0,0,0,0,0,0,2019-12-01,2020-12-01,,"The University of Texas Health Science Center, Houston",Other,0,0,1,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,490
NCT03925155,0,0,0,0,0,0,2021-08-01,2022-08-01,,Montefiore Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,240
NCT03927703,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Novan, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03929822,0,0,0,0,0,0,2021-04-30,2022-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1432
NCT03933462,0,0,0,0,0,0,2019-09-30,2020-09-30,,Philips Respironics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,33
NCT03935399,0,0,0,0,0,0,2019-11-30,2020-11-30,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03935659,0,0,0,0,0,0,2021-03-31,2022-03-31,,Henry Ford Health System,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,151
NCT03936322,0,0,0,0,0,0,2023-12-31,2024-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03937466,0,0,0,0,0,0,2020-03-31,2021-03-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03937635,0,0,0,0,0,0,2023-11-30,2024-11-30,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,75
NCT03940963,0,0,0,0,0,0,2021-11-30,2022-11-30,,Axogen Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03941288,0,0,0,0,0,0,2024-06-30,2025-06-30,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03941535,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Joseph M. Still Research Foundation, Inc.",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03941860,0,0,0,0,0,0,2022-06-30,2023-06-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03943693,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Oklahoma,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,234
NCT03944772,0,0,0,0,0,0,2022-11-11,2023-11-11,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03947619,0,0,0,0,0,0,2023-10-31,2024-10-31,,Abiomed Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,13
NCT03952039,0,0,0,0,0,0,2022-05-23,2023-05-23,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,306
NCT03954639,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,53
NCT03955315,0,0,0,0,0,0,2021-02-01,2022-02-01,,"DiscGenics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2
NCT03960437,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Thomas Nickolas, MD MS",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03960658,0,0,0,0,0,0,2020-04-30,2021-04-30,,Minneapolis Veterans Affairs Medical Center,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT03960866,0,0,0,0,0,0,2019-09-15,2020-09-15,,"Ocuphire Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03961347,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Florida,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03961672,0,0,0,0,0,0,2022-04-29,2023-04-29,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT03966157,0,0,0,0,0,0,2020-05-30,2021-05-30,,St. Louis University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,126
NCT03970213,0,0,0,0,0,0,2019-08-30,2020-08-30,,Glasgold Group Plastic Surgery,Other,0,0,0,4.0,Phase 4,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03971409,0,0,0,0,0,0,2020-06-01,2021-06-01,,"Hope Rugo, MD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,5
NCT03971669,0,0,0,0,0,0,2024-06-30,2025-06-30,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,144
NCT03972930,0,0,0,0,0,0,2023-07-01,2024-07-01,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,715
NCT03974113,0,0,0,0,0,0,2023-02-28,2024-02-28,,"Genzyme, a Sanofi Company",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,300
NCT03977467,0,0,0,0,0,0,2021-06-30,2022-06-30,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,167
NCT03978234,0,0,0,0,0,0,2020-05-28,2021-05-28,,University Foot and Ankle Foundation,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03978741,0,0,0,0,0,0,2020-06-30,2021-06-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03980223,0,0,0,0,0,0,2023-03-31,2024-03-31,,"University of California, San Francisco",Other,0,1,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03980470,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Zurich,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,751
NCT03981198,0,0,0,0,0,0,2019-08-05,2020-08-05,,Soliton,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03981328,0,0,0,0,0,0,2021-06-30,2022-06-30,,Medical University of Vienna,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,744
NCT03982199,0,0,0,0,0,0,2021-06-10,2022-06-10,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,29
NCT03983980,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dermavant Sciences GmbH,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03986593,0,0,0,0,0,0,2021-06-15,2022-06-15,,Instituto do Cancer do Estado de São Paulo,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,46
NCT03987022,0,0,0,0,0,0,2020-07-31,2021-07-31,,MetroHealth Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,65
NCT03987750,0,0,0,0,0,0,2021-04-30,2022-04-30,,Zambon SpA,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,17
NCT03988582,0,0,0,0,0,0,2022-06-30,2023-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1432
NCT03989362,0,0,0,0,0,0,2022-04-30,2023-04-30,,"Jounce Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03990363,0,0,0,0,0,0,2020-09-09,2021-09-09,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03991299,0,0,0,0,0,0,2020-08-31,2021-08-31,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,422
NCT03993171,0,0,0,0,0,0,2020-04-30,2021-04-30,,Clene Nanomedicine,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03993392,0,0,0,0,0,0,2020-03-31,2021-03-31,,Indivior Inc.,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,45
NCT03994965,0,0,0,0,0,0,2023-01-31,2024-01-31,,Bjorn H. Ebdrup,Other,0,1,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03996954,0,0,0,0,0,0,2020-10-07,2021-10-07,,Blackpool Teaching Hospitals NHS Foundation Trust,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT04002947,0,0,0,0,0,0,2023-05-31,2024-05-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT04004169,0,0,0,0,0,0,2030-06-28,2031-06-28,,"University of California, San Francisco",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT04005469,0,0,0,0,0,0,2020-07-01,2021-07-01,,Rhode Island Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,120
NCT04005859,0,0,0,0,0,0,2020-02-22,2021-02-22,,Atrium Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,95
NCT04006288,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT04011592,0,0,0,0,0,0,2020-09-30,2021-09-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT04015219,0,0,0,0,0,0,2020-07-01,2021-07-01,,Tissue Tech Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,10
NCT04015375,0,0,0,0,0,0,2020-03-31,2021-03-31,,Torrent Pharmaceuticals Limited,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,71
NCT04017767,0,0,0,0,0,0,2022-12-01,2023-12-01,,University of Miami,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT04017975,0,0,0,0,0,0,2022-08-31,2023-08-31,,Aditya Kaza,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,2
NCT04019054,0,0,0,0,0,0,2020-02-28,2021-02-28,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT04019613,0,0,0,0,0,0,2021-10-31,2022-10-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1898
NCT04021082,0,0,0,0,0,0,2022-12-31,2023-12-31,,Portola Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,28
NCT04025879,0,0,0,0,0,0,2023-05-24,2024-05-24,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT04026412,0,0,0,0,0,0,2023-10-11,2024-10-11,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT04030962,0,0,0,0,0,0,2020-09-01,2021-09-01,,Allergan,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT04033497,0,0,0,0,0,0,2021-07-01,2022-07-01,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT04034485,0,0,0,0,0,0,2021-03-31,2022-03-31,,LIB Therapeutics LLC,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT04034693,0,0,0,0,0,0,2022-01-15,2023-01-15,,"Telefónica Innovación Alpha, S.L",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04035486,0,0,0,0,0,0,2023-03-21,2024-03-21,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2450
NCT04036838,1,0,1,1,0,1,2017-06-14,2018-06-14,2019-07-29,"ARJ Medical, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,0,0,1,0,1,0,0,0,1,1
NCT04037085,0,0,0,0,0,0,2021-01-01,2022-01-01,,"Grace Lim, MD, MS",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT04038671,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Brock Liden, DPM",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT04039113,0,0,0,0,0,0,2022-02-14,2023-02-14,,AstraZeneca,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT04039607,0,0,0,0,0,0,2023-09-16,2024-09-16,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT04040452,0,0,0,0,0,0,2020-12-31,2021-12-31,,Phoenix Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,35
NCT04042727,0,0,0,0,0,0,2019-12-30,2020-12-30,,Stony Brook University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,119
NCT04045093,0,0,0,0,0,0,2021-09-30,2022-09-30,,The University of Hong Kong,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,547
NCT04045964,1,0,1,1,0,1,2018-06-28,2019-06-28,2019-08-06,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,490
NCT04046224,0,0,0,0,0,0,2021-09-28,2022-09-28,,Sangamo Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,18
NCT04046536,0,0,0,0,0,0,2024-09-30,2025-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT04047628,0,0,0,0,0,0,2025-10-31,2026-10-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT04048434,0,0,0,0,0,0,2021-09-30,2022-09-30,,Hannover Medical School,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,139
NCT04050033,0,0,0,0,0,0,2020-07-19,2021-07-19,,InMode MD Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT04050722,0,0,0,0,0,0,2019-11-16,2020-11-16,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3276
NCT04052828,0,0,0,0,0,0,2023-09-30,2024-09-30,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT04053452,0,0,0,0,0,0,2021-06-30,2022-06-30,,Duke University,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1342
NCT04058028,0,0,0,0,0,0,2021-11-28,2022-11-28,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,685
NCT04060017,0,0,0,0,0,0,2021-12-31,2022-12-31,,Phoenix Children's Hospital,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,35
NCT04060654,0,0,0,0,0,0,2020-04-30,2021-04-30,,Indivior Inc.,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,45
NCT04062266,0,0,0,0,0,0,2030-10-31,2031-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT04062890,0,0,0,0,0,0,2021-12-30,2022-12-30,,University of Arizona,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,265
NCT04064827,0,0,0,0,0,0,2024-01-08,2025-01-08,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT04065438,0,0,0,0,0,0,2023-04-01,2024-04-01,,Kaneka Pharma America LLC,Industry,1,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT04067726,0,0,0,0,0,0,2025-08-31,2026-08-31,,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT04070326,0,0,0,0,0,0,2021-12-17,2022-12-17,,Shire,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,342
NCT04070573,0,0,0,0,0,0,2024-08-31,2025-08-31,,Weill Medical College of Cornell University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT04072354,0,0,0,0,0,0,2021-09-03,2022-09-03,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,134
NCT04073446,0,0,0,0,0,0,2020-10-15,2021-10-15,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT04074252,0,0,0,0,0,0,2020-07-15,2021-07-15,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,692
NCT04075916,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Pennsylvania,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT04076943,0,0,0,0,0,0,2020-07-31,2021-07-31,,FibroGen,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT04077398,0,0,0,0,0,0,2019-12-01,2020-12-01,,Bruce Ben-David,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04081545,0,0,0,0,0,0,2022-02-01,2023-02-01,,Christine Oryhan,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04082364,0,0,0,0,0,0,2024-05-31,2025-05-31,,MacroGenics,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,31
NCT04084080,0,0,0,0,0,0,2025-12-31,2026-12-31,,Mark Gladwin,Other,0,0,1,3.0,Phase 3,0,2020.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT04089072,0,0,0,0,0,0,2021-10-01,2022-10-01,,Carilion Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,22
NCT04089852,0,0,0,0,0,0,2020-04-30,2021-04-30,,Boston Children’s Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT00058370,0,0,0,0,0,0,2019-06-30,2020-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,5.0,,0,2003.0,1,1,0,0,0,1,0,0,0,0,1,1432
NCT00088699,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-30,National Institute of Mental Health (NIMH),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2004.0,1,1,0,0,0,0,0,0,0,0,1,330
NCT00103038,0,0,0,0,0,0,2018-12-31,2019-12-31,,OHSU Knight Cancer Institute,Other,0,0,1,5.0,,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT00194714,0,0,0,0,0,0,2019-08-30,2020-08-30,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,910
NCT00255801,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-03-16,Memorial Sloan Kettering Cancer Center,Other,0,1,1,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00310180,1,1,0,1,0,0,2018-03-02,2019-03-02,2018-12-17,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2006.0,0,1,0,0,0,1,0,0,1,0,1,3004
NCT00335816,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,0,0,0,1,0,1,1,0,1,1432
NCT00445965,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2006.0,0,0,0,0,0,1,0,1,0,0,1,1432
NCT00452023,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00478426,0,0,1,1,0,0,2019-01-31,2020-01-31,2019-09-12,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT00492999,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00501826,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00542451,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Eric Winer, MD",Other,0,1,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT00544466,0,0,0,0,0,0,2019-07-31,2020-07-31,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2006.0,1,1,0,0,0,1,0,0,0,0,1,358
NCT00553618,0,0,0,0,0,0,2022-08-31,2023-08-31,,James Graham Brown Cancer Center,Other,0,0,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT00583414,1,1,0,1,0,1,2017-10-31,2018-10-31,2018-11-30,The Cleveland Clinic,Other,0,0,0,5.0,,0,1998.0,1,0,0,1,0,0,0,0,0,0,1,581
NCT00585507,0,0,0,0,0,0,2020-04-30,2021-04-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,1.0,Phase 2,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT00588770,1,0,0,0,1,0,2018-06-05,2019-06-05,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2008.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT00685919,0,0,0,0,0,0,2019-10-31,2020-10-31,,Vanderbilt University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT00686374,1,1,0,1,0,0,2017-04-04,2018-04-04,2018-03-20,"AbbVie (prior sponsor, Abbott)",Industry,1,0,0,3.0,Phase 3,0,2008.0,1,0,1,0,0,0,0,0,3,0,1,227
NCT00692276,1,0,0,0,1,0,2017-02-28,2018-02-28,,"VertiFlex, Incorporated",Industry,1,0,0,5.0,,0,2008.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT00715143,0,0,0,0,0,0,2023-12-31,2024-12-31,,Exactech,Industry,1,0,0,4.0,Phase 4,0,2008.0,0,0,0,1,0,0,0,0,0,0,1,6
NCT00720876,1,1,0,1,0,0,2017-06-08,2018-06-08,2018-06-08,City of Hope Medical Center,Other,0,1,1,1.0,Phase 2,0,2008.0,1,1,1,0,0,0,0,0,0,0,1,358
NCT00796978,1,0,0,0,1,0,2018-01-12,2019-01-12,,"Cynthia Owusu, MD",Other,0,0,1,1.0,Phase 2,0,2008.0,0,0,1,0,0,0,0,0,0,0,1,1
NCT00858117,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,1,0,1.0,Phase 2,0,2005.0,0,0,1,0,0,0,0,0,0,0,1,925
NCT00910650,0,0,0,0,0,0,2022-01-31,2023-01-31,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2009.0,0,1,1,0,0,0,0,0,0,0,1,277
NCT00942331,0,0,0,0,0,0,2018-11-02,2019-11-02,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2009.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT00946192,0,0,0,0,0,0,2020-03-31,2021-03-31,,Massachusetts General Hospital,Other,0,0,1,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT00960752,0,0,0,0,0,0,2020-05-31,2021-05-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01005615,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",Other,0,0,1,0.0,Phase 1/Phase 2,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,47
NCT01008462,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-05-08,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,0,0,0,1,0,0,0,0,1,393
NCT01016769,1,1,0,1,0,0,2018-06-30,2019-06-30,2018-10-09,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01037790,0,0,0,0,0,0,2019-10-31,2020-10-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT01038778,0,0,0,0,0,0,2019-05-22,2020-05-22,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,1,1,0,0,1,0,0,0,0,1,3004
NCT01063751,0,0,0,0,0,0,2021-11-30,2022-11-30,,Stryker Orthopaedics,Industry,1,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,24
NCT01079780,0,0,0,0,0,0,2019-08-01,2020-08-01,,Pam Cogliano,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,0,0,1,1
NCT01088815,1,1,0,1,0,1,2017-12-01,2018-12-01,2019-04-02,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,461
NCT01108666,1,0,0,0,1,0,2018-07-31,2019-07-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,273
NCT01116661,1,1,0,1,0,0,2017-12-28,2018-12-28,2018-12-27,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT01130077,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Ian F. Pollack, M.D.",Other,0,0,0,5.0,,0,2009.0,0,0,1,0,0,0,0,0,0,0,1,5
NCT01173159,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,437
NCT01179009,0,0,0,0,0,0,2019-06-30,2020-06-30,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT01190930,0,0,0,0,0,0,2019-03-31,2020-03-31,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,389
NCT01224106,0,0,0,0,0,0,2020-08-28,2021-08-28,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT01228318,1,1,0,1,0,0,2017-04-13,2018-04-13,2018-03-27,Emory University,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT01240629,1,0,1,1,0,1,2017-02-02,2018-02-02,2019-04-29,University of Southern California,Other,0,1,1,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,483
NCT01312857,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01326104,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Florida,Other,0,0,1,0.0,Phase 1/Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,849
NCT01330446,0,0,0,0,0,0,2019-05-31,2020-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01330966,1,0,0,0,1,0,2018-02-28,2019-02-28,,Vector Oncology,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT01335399,0,0,0,0,0,0,2019-11-10,2020-11-10,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2011.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT01338987,1,1,0,1,0,0,2017-12-01,2018-12-01,2018-11-30,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,3004
NCT01347307,1,0,1,1,0,1,2017-09-30,2018-09-30,2019-02-19,Mercy Research,Other,0,0,0,5.0,,0,2008.0,1,0,0,0,0,1,0,0,0,0,1,15
NCT01350336,0,0,0,0,0,0,2020-01-31,2021-01-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,1,0,1,340
NCT01351753,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Iowa,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,158
NCT01357525,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pittsburgh,Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,1054
NCT01364480,0,0,0,0,0,0,2020-12-31,2021-12-31,,Michael Boninger,Other,0,0,1,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT01379222,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-19,Medtronic Endovascular,Industry,1,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,64
NCT01386710,0,0,0,0,0,0,2022-05-31,2023-05-31,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,271
NCT01409200,0,0,0,0,0,0,2020-02-28,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01411319,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Miami,Other,0,0,0,5.0,,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,476
NCT01419561,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01428193,1,1,0,1,0,0,2017-08-31,2018-08-31,2017-09-08,University of Virginia,Other,0,0,1,5.0,,1,2006.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT01431209,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Nebraska,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,327
NCT01434472,0,0,0,0,0,0,2020-07-24,2021-07-24,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,1,0,0,1,0,0,0,0,1,393
NCT01465997,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-06-27,UCB BIOSCIENCES GmbH,Industry,1,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT01468532,1,0,1,1,0,1,2017-03-31,2018-03-31,2019-01-02,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT01480180,0,0,0,0,0,0,2018-12-10,2019-12-10,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT01483027,0,0,0,0,0,0,2019-10-31,2020-10-31,,BTG International Inc.,Other,0,1,0,3.0,Phase 3,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,34
NCT01492582,0,0,0,0,0,0,2019-02-08,2020-02-08,,University of Alabama at Birmingham,Other,0,1,1,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,801
NCT01495598,0,0,0,0,0,0,2023-09-30,2024-09-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01497067,1,1,0,1,0,0,2018-06-15,2019-06-15,2019-06-03,Alcon Research,Industry,1,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,492
NCT01498289,1,1,0,1,0,1,2018-03-31,2019-03-31,2019-07-15,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT01503229,0,0,0,0,0,0,2019-09-12,2020-09-12,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01524991,1,0,0,0,1,0,2017-07-15,2018-07-15,,Hoosier Cancer Research Network,Other,0,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,27
NCT01535053,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-03-08,Gynecologic Oncology Group,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,1,0,0,0,0,0,1,0,1,200
NCT01553942,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,1699
NCT01562626,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Anaeropharma Science, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01573754,0,0,0,0,0,0,2020-08-31,2021-08-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,158
NCT01579513,1,1,0,1,0,0,2018-05-25,2019-05-25,2019-05-07,Medical University of South Carolina,Other,0,0,1,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT01581749,1,0,0,0,1,0,2017-12-31,2018-12-31,,Albert DeNittis,Other,0,0,0,4.0,Phase 4,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,1
NCT01589523,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,3.0,Phase 3,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT01590628,0,0,0,0,0,0,2019-09-30,2020-09-30,,Gamida Cell ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT01614990,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Garcia, Jose M., MD, PhD",Other,0,1,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01620190,0,0,0,0,0,0,2021-04-20,2022-04-20,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT01638676,1,0,0,0,1,0,2018-06-30,2019-06-30,,James Graham Brown Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT01639248,1,0,0,0,1,0,2017-06-30,2018-06-30,,"CASI Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,20
NCT01652079,1,0,0,0,1,0,2018-03-31,2019-03-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01659151,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01659541,0,0,0,0,0,0,2020-05-31,2021-05-31,,MetroHealth Medical Center,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,65
NCT01661088,1,1,0,1,0,0,2017-08-10,2018-08-10,2018-06-26,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,1,0,0,0,0,1,213
NCT01663623,1,1,0,1,0,0,2017-02-06,2018-02-06,2018-01-30,"Human Genome Sciences Inc., a GSK Company",Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,1,0,0,0,0,0,1,0,1,15
NCT01665768,1,1,0,1,0,1,2017-10-31,2018-10-31,2018-11-09,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,461
NCT01666080,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2012.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT01667419,1,1,0,1,0,0,2017-06-23,2018-06-23,2018-06-05,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT01681589,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,869
NCT01688492,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01691898,1,1,0,1,0,0,2017-03-08,2018-03-08,2018-03-06,"Genentech, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT01712438,0,0,0,0,0,0,2018-12-14,2019-12-14,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,0,1,0,0,0,0,0,1,0,1,54
NCT01716806,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Seattle Genetics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,77
NCT01717859,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-07-09,"University of California, Los Angeles",Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,692
NCT01733147,0,0,0,0,0,0,2019-06-30,2020-06-30,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01737398,0,1,0,1,0,1,2017-03-03,2018-03-03,2018-11-02,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,69
NCT01740596,0,0,0,0,0,0,2018-09-19,2019-09-19,,CHF Solutions,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT01741454,1,1,0,1,0,0,2018-03-30,2019-03-30,2019-02-25,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,715
NCT01742988,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Curis, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT01744574,1,1,0,1,0,1,2017-07-27,2018-07-27,2018-10-08,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT01748292,1,1,0,1,0,0,2017-02-28,2018-02-28,2017-08-08,"Charles C Wykoff, PhD, MD",Other,0,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01750879,1,0,1,1,0,0,2017-07-11,2018-07-11,2018-07-11,Massachusetts General Hospital,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01752036,0,0,0,0,0,0,2019-08-31,2020-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,461
NCT01753999,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-06-25,"Rutgers, The State University of New Jersey",Other,0,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,227
NCT01754155,1,0,0,0,1,0,2017-12-31,2018-12-31,,Central DuPage Hospital,Other,0,1,0,5.0,,0,2013.0,1,0,0,0,0,1,0,0,0,0,1,6
NCT01763931,0,0,0,0,0,0,2019-09-30,2020-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT01771809,1,1,0,1,0,0,2017-12-13,2018-12-13,2018-12-11,Shire,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,342
NCT01783444,1,0,1,1,0,0,2018-07-02,2019-07-02,2019-04-29,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01788306,0,0,0,0,0,0,2018-10-31,2019-10-31,,University of Washington,Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01789281,0,0,0,0,0,0,2023-05-12,2024-05-12,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01790503,0,0,1,1,0,1,2017-11-30,2018-11-30,2019-08-22,Plexxikon,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,21
NCT01796392,1,1,0,1,0,1,2017-09-30,2018-09-30,2019-01-02,"Pulmonx, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,6
NCT01812213,1,0,0,0,1,0,2018-06-30,2019-06-30,,Navidea Biopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT01818986,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,626
NCT01824693,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-10-09,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,389
NCT01831024,0,0,0,0,0,0,2020-10-31,2021-10-31,,Target Health Inc.,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT01839487,0,0,0,0,0,0,2018-05-01,2019-05-01,,Halozyme Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT01839916,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-06-12,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,594
NCT01841736,0,0,0,0,0,0,2019-03-05,2020-03-05,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01850108,0,0,0,0,0,0,2020-05-31,2021-05-31,,Vanderbilt-Ingram Cancer Center,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,180
NCT01852370,0,0,0,0,0,0,2019-12-31,2020-12-31,,Paul Szabolcs,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,5
NCT01856114,0,0,0,0,0,0,2019-05-31,2020-05-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01856582,1,0,0,0,1,0,2018-08-15,2019-08-15,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,1,2010.0,1,0,1,0,0,0,0,0,0,0,1,437
NCT01857271,1,0,0,0,1,0,2017-08-31,2018-08-31,,Albert Einstein College of Medicine,Other,0,0,1,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,155
NCT01865851,1,0,0,0,1,0,2018-05-31,2019-05-31,,"Nimmagadda, Usharani, M.D.",Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT01873495,1,0,1,1,0,1,2018-07-31,2019-07-31,2019-09-05,Emory University,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT01877655,1,1,0,1,0,0,2017-09-28,2018-09-28,2018-09-17,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,3.0,Phase 3,0,2013.0,0,1,1,0,0,0,0,0,1,0,1,135
NCT01886820,1,0,0,0,1,0,2018-06-30,2019-06-30,,Navidea Biopharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT01899222,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Rochester,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,470
NCT01900691,0,0,0,0,0,0,2018-12-10,2019-12-10,,Cook Group Incorporated,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,75
NCT01903733,0,0,0,0,0,0,2020-05-15,2021-05-15,,Pfizer,Industry,1,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT01904682,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Onconova Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT01904903,0,0,0,0,0,0,2019-01-31,2020-01-31,,Washington Hospital Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT01905397,0,0,0,0,0,0,2019-12-01,2020-12-01,,Duke University,Other,0,1,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT01905592,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Tesaro, Inc.",Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT01906385,0,0,0,0,0,0,2025-01-31,2026-01-31,,Andrew Brenner,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01909245,0,0,0,0,0,0,2021-07-31,2022-07-31,,City of Hope Medical Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,358
NCT01920555,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-12-28,Massachusetts General Hospital,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01934556,1,0,0,0,1,0,2017-04-30,2018-04-30,,"Palmetto Retina Center, LLC",Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,1,0,0,0,0,0,0,1,3
NCT01942486,1,0,1,1,0,1,2017-10-31,2018-10-31,2019-04-12,University of Utah,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,578
NCT01946165,1,0,1,1,0,1,2017-07-28,2018-07-28,2019-01-09,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01950390,0,0,0,0,0,0,2019-10-01,2020-10-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT01953432,1,0,0,0,1,0,2017-09-01,2018-09-01,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01954173,0,0,0,0,0,0,2030-07-31,2031-07-31,,Emory University,Other,0,0,0,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,947
NCT01958112,1,1,0,1,0,1,2017-11-30,2018-11-30,2018-12-11,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT01959139,0,0,0,0,0,0,2019-04-30,2020-04-30,,Southwest Oncology Group,Other,0,1,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT01961778,0,0,0,0,0,0,2019-11-30,2020-11-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,1699
NCT01963780,1,0,0,0,1,0,2017-10-30,2018-10-30,,TransMedics,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,1,0,1,11
NCT01964859,0,0,0,0,0,0,2020-12-31,2021-12-31,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1143
NCT01967810,0,0,0,0,0,0,2017-09-30,2018-09-30,,Angiochem Inc,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT01970527,0,0,0,0,0,0,2018-11-03,2019-11-03,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2014.0,1,0,1,0,0,1,0,0,0,0,1,910
NCT01972529,1,1,0,1,0,0,2017-01-26,2018-01-26,2017-12-27,Eisai Inc.,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,328
NCT01978184,1,1,0,1,0,1,2018-02-06,2019-02-06,2019-03-03,"Nathan Bahary, MD",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01981122,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-07-24,Dendreon,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,19
NCT01990950,0,0,0,0,0,0,2020-08-31,2021-08-31,,Cook Research Incorporated,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,20
NCT01991457,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT01991795,0,0,0,0,0,0,2019-01-25,2020-01-25,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02004704,0,0,0,0,0,0,2023-09-30,2024-09-30,,"Genzyme, a Sanofi Company",Industry,1,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02007239,0,0,0,0,0,0,2021-01-31,2022-01-31,,Children's Hospital of Philadelphia,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,324
NCT02012608,0,1,0,1,0,0,2019-04-30,2020-04-30,2019-04-29,University of Arkansas,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,285
NCT02013141,0,0,0,0,0,0,2020-12-31,2021-12-31,,Cumberland Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,48
NCT02015559,0,0,0,0,0,0,2018-11-30,2019-11-30,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,277
NCT02018627,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-29,"Steven J. Russell, MD, PhD",Other,0,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02021032,1,0,0,0,1,0,2018-02-28,2019-02-28,,"Medifocus, Inc.",Industry,1,0,0,4.0,Phase 4,0,2006.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02022436,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Pittsburgh,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1054
NCT02023333,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02026089,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,1,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,882
NCT02029846,1,1,0,1,0,0,2017-02-28,2018-02-28,2017-04-17,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02031250,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,213
NCT02032784,0,0,0,0,0,0,2018-12-31,2019-12-31,,Florida Hospital,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,63
NCT02038634,0,0,0,0,0,0,2021-08-31,2022-08-31,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,1,0,0,0,0,0,0,1,315
NCT02038946,1,1,0,1,0,0,2017-05-17,2018-05-17,2018-05-16,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02040857,1,0,0,0,1,0,2018-05-31,2019-05-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT02046057,0,0,0,0,0,0,2019-12-31,2020-12-31,,Loma Linda University,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,194
NCT02046122,1,1,0,1,0,0,2017-06-15,2018-06-15,2018-06-11,Duke University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,1342
NCT02047253,1,1,0,1,0,1,2017-06-08,2018-06-08,2018-08-29,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT02048813,0,0,0,0,0,0,2020-03-15,2021-03-15,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02052882,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT02053792,0,0,0,0,0,0,2022-01-31,2023-01-31,,CSL Behring,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,81
NCT02055157,0,0,0,0,0,0,2017-10-02,2018-10-02,,BioMarin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,85
NCT02055586,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,374
NCT02056626,0,1,0,1,0,0,2018-11-30,2019-11-30,2019-05-23,University of Rochester,Other,0,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,470
NCT02057718,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Mirum Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02061384,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Washington,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02061774,1,0,1,1,0,1,2018-01-11,2019-01-11,2019-09-11,Texas Tech University Health Sciences Center,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,78
NCT02064673,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02064764,0,0,0,0,0,0,2020-06-30,2021-06-30,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,169
NCT02065622,0,0,0,0,0,0,2019-09-06,2020-09-06,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02066181,1,0,1,1,0,1,2018-01-01,2019-01-01,2019-03-22,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02085070,0,0,0,0,0,0,2019-03-31,2020-03-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02085551,1,0,0,0,1,0,2017-12-31,2018-12-31,,Penumbra Inc.,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,20
NCT02091063,0,0,0,0,0,0,2019-02-25,2020-02-25,,Jennifer Amengual,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02093221,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-03-23,Grifols Therapeutics LLC,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,0,1,0,0,0,0,0,0,0,1,40
NCT02111681,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT02111785,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-08-20,University of Virginia,Other,0,0,0,2.0,Phase 2/Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT02112656,1,0,0,0,1,0,2018-08-31,2019-08-31,,Celsion,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,12
NCT02115633,1,1,0,1,0,0,2017-07-28,2018-07-28,2018-07-09,RxFunction Inc.,Industry,1,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,2
NCT02118337,0,0,0,0,0,0,2019-07-15,2020-07-15,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,269
NCT02127281,1,1,0,1,0,0,2017-04-24,2018-04-24,2017-08-17,The Cleveland Clinic,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,581
NCT02130882,0,0,0,0,0,0,2020-06-01,2021-06-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2133
NCT02132520,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-10-10,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,749
NCT02138734,0,0,0,0,0,0,2021-07-31,2022-07-31,,Altor BioScience,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,18
NCT02143830,0,0,0,0,0,0,2024-07-31,2025-07-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,437
NCT02147990,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Clovis Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT02148783,1,0,0,0,1,0,2018-08-31,2019-08-31,,Uniformed Services University of the Health Sciences,U.S. Fed,2,0,1,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,35
NCT02153983,1,1,0,1,0,0,2018-08-15,2019-08-15,2019-06-13,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,413
NCT02155660,1,1,0,1,0,0,2018-04-09,2019-04-09,2019-03-18,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02160808,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,306
NCT02163850,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Direct Flow Medical, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02164513,1,1,0,1,0,0,2017-07-17,2018-07-17,2018-07-06,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02172664,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-23,Indiana University,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,497
NCT02173548,1,1,0,1,0,0,2017-04-11,2018-04-11,2018-04-09,Virginia Commonwealth University,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT02176291,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-04-26,Jordan F. Karp,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02176967,0,0,0,0,0,0,2026-06-30,2027-06-30,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,389
NCT02179853,0,0,0,0,0,0,2020-10-31,2021-10-31,,"University of California, San Diego",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02182830,1,1,0,1,0,0,2017-05-18,2018-05-18,2018-05-16,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1852
NCT02192931,0,0,0,0,0,0,2021-10-31,2022-10-31,,Perry Renshaw,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02193490,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-07-23,University of Illinois at Chicago,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,242
NCT02193880,1,1,0,1,0,0,2018-03-13,2019-03-13,2018-12-17,Ayman Saad,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02195232,0,0,1,1,0,0,2022-12-31,2023-12-31,2019-07-25,"Jeffrey Zwicker, MD",Other,0,1,1,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02199496,0,0,0,0,0,0,2019-08-16,2020-08-16,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,2133
NCT02202551,1,0,0,0,1,0,2018-03-31,2019-03-31,,"Adamas Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02203552,0,0,0,0,0,0,2019-08-31,2020-08-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,198
NCT02206048,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02206620,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-03-13,Oregon Health and Science University,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT02213081,1,0,1,1,0,1,2017-06-30,2018-06-30,2019-04-18,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT02217345,0,0,0,0,0,0,2021-01-31,2022-01-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02217501,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02226120,1,1,0,1,0,0,2017-12-28,2018-12-28,2018-12-18,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02231775,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02235701,0,0,0,0,0,0,2018-12-31,2019-12-31,,CytRx,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02238847,1,0,1,1,0,1,2018-02-21,2019-02-21,2019-07-25,Boston Scientific Corporation,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,340
NCT02240238,0,0,0,0,0,0,2019-11-30,2020-11-30,,"NanoCarrier Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02242578,1,0,0,0,1,0,2018-05-31,2019-05-31,,Seton Healthcare Family,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,21
NCT02243579,1,1,0,1,0,1,2018-01-04,2019-01-04,2019-01-07,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,3004
NCT02244463,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02245997,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,1432
NCT02247479,0,1,0,1,0,0,2018-01-29,2019-01-29,2019-01-22,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02251821,0,0,0,0,0,0,2021-03-11,2022-03-11,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT02252042,1,1,0,1,0,0,2017-05-15,2018-05-15,2018-05-04,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02255435,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Reata Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,44
NCT02258152,1,1,0,1,0,0,2017-10-03,2018-10-03,2018-09-14,Biotie Therapies Inc.,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02260531,0,0,0,0,0,0,2018-11-30,2019-11-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02260765,0,0,0,0,0,0,2019-01-31,2020-01-31,,Brainsway,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,16
NCT02263508,0,0,0,0,0,0,2022-07-29,2023-07-29,,Amgen,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,685
NCT02264574,1,1,0,1,0,0,2018-03-26,2019-03-26,2019-03-25,Pharmacyclics LLC.,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,54
NCT02270359,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2014.0,0,1,0,1,0,0,0,0,0,0,1,869
NCT02270463,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Stemline Therapeutics, Inc.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02272998,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sameek Roychowdhury,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02274038,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Pennsylvania,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02279394,0,0,0,0,0,0,2020-01-31,2021-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02283294,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of South Florida,Other,0,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02284906,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-05-07,Takeda,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT02289209,0,0,0,0,0,0,2020-12-31,2021-12-31,,Dan Zandberg,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT02293096,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of Colorado, Denver",Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,1,0,0,1,882
NCT02293655,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT02294981,1,0,1,1,0,1,2017-09-30,2018-09-30,2019-04-01,"University of California, San Francisco",Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,1443
NCT02296684,0,0,0,0,0,0,2020-03-31,2021-03-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,1,0,0,0,0,1,1151
NCT02299297,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-03-27,Columbia University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02300987,1,0,1,1,0,0,2018-02-21,2019-02-21,2018-08-21,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02301156,0,0,0,0,0,0,2019-12-31,2020-12-31,,"TG Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT02301988,1,1,0,1,0,0,2017-08-02,2018-08-02,2018-07-26,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT02309099,1,1,0,1,0,0,2017-11-08,2018-11-08,2018-10-05,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02314364,0,0,0,0,0,0,2021-11-30,2022-11-30,,Massachusetts General Hospital,Other,0,0,1,1.0,Phase 2,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,1699
NCT02319837,0,0,0,0,0,0,2020-07-07,2021-07-07,,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02323581,0,0,0,0,0,0,2022-12-31,2023-12-31,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,586
NCT02323698,0,0,0,0,0,0,2020-05-31,2021-05-31,,Spaulding Rehabilitation Hospital,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,69
NCT02324153,0,0,0,0,0,0,2019-06-26,2020-06-26,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1143
NCT02324543,0,0,0,0,0,0,2020-01-31,2021-01-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02325466,1,0,1,1,0,1,2018-05-04,2019-05-04,2019-05-06,Icahn School of Medicine at Mount Sinai,Other,0,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02330211,1,0,0,0,1,0,2018-08-30,2019-08-30,,Stacy A. Kahn,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,2
NCT02341495,1,0,1,1,0,0,2018-01-31,2019-01-31,2018-01-12,Elizabeth Henry,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02343042,0,0,0,0,0,0,2020-05-31,2021-05-31,,Karyopharm Therapeutics Inc,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,22
NCT02344225,1,0,0,0,1,0,2018-06-30,2019-06-30,,State University of New York - Downstate Medical Center,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT02344355,0,0,0,0,0,0,2020-04-30,2021-04-30,,Bryan Allen,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,3
NCT02347410,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Spineology, Inc",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02349178,1,1,0,1,0,1,2017-03-16,2018-03-16,2018-12-12,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,315
NCT02354014,0,0,0,0,0,0,2021-03-11,2022-03-11,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,558
NCT02354261,0,0,0,0,0,0,2019-03-31,2020-03-31,,"HedgePath Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02360319,0,0,0,0,0,0,2019-03-31,2020-03-31,,Vanguard Research Group,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02361086,1,0,0,0,1,0,2017-12-31,2018-12-31,,Innocrin Pharmaceutical,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02364076,0,0,1,1,0,0,2021-06-30,2022-06-30,2019-08-06,Georgetown University,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT02364336,1,1,0,1,0,1,2018-05-21,2019-05-21,2019-06-10,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02365870,0,0,0,0,0,0,2019-10-31,2020-10-31,,Johns Hopkins University,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02367456,0,0,0,0,0,0,2020-01-29,2021-01-29,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02368431,0,0,0,0,0,0,2018-10-01,2019-10-01,,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02368886,1,1,0,1,0,1,2017-09-01,2018-09-01,2019-06-06,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT02374476,0,0,0,0,0,0,2019-12-31,2020-12-31,,Srinivas Dukkipati,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02375984,1,0,0,0,1,0,2017-06-01,2018-06-01,,John Wayne Cancer Institute,Other,0,0,0,1.0,Phase 2,1,2016.0,1,0,1,0,0,0,0,0,0,0,1,20
NCT02384382,0,0,0,0,0,0,2019-05-03,2020-05-03,,Pfizer,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2856
NCT02385669,0,1,0,1,0,0,2019-10-31,2020-10-31,2019-06-07,"Craig L Slingluff, Jr",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,19
NCT02387203,0,0,0,0,0,0,2018-12-31,2019-12-31,,Mercy Medical Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02391987,0,0,0,0,0,0,2019-03-31,2020-03-31,,Mayo Clinic,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02397668,0,0,0,0,0,0,2020-12-31,2021-12-31,,"CorMatrix Cardiovascular, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT02408445,1,0,1,1,0,1,2018-01-31,2019-01-31,2019-02-21,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT02410902,0,0,0,0,0,0,2017-12-22,2018-12-22,,Curemark,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02411773,0,0,0,0,0,0,2021-06-30,2022-06-30,,Emory University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02419014,1,0,0,0,1,0,2017-02-28,2018-02-28,,Tripler Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,8
NCT02425644,0,0,0,0,0,0,2019-05-16,2020-05-16,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,128
NCT02427841,0,0,0,0,0,0,2019-06-01,2020-06-01,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,163
NCT02431260,1,1,0,1,0,0,2018-01-31,2019-01-31,2019-01-29,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,143
NCT02438475,1,0,0,0,1,0,2017-08-31,2018-08-31,,Medstar Health Research Institute,Other,0,1,0,4.0,Phase 4,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,79
NCT02443116,0,0,0,0,0,0,2019-09-30,2020-09-30,,"NGM Biopharmaceuticals, Inc",Industry,1,1,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,13
NCT02443688,1,1,0,1,0,1,2018-04-20,2019-04-20,2019-04-29,"Celtaxsys, Inc.",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02446249,0,0,0,0,0,0,2022-11-01,2023-11-01,,MeiraGTx UK II Ltd,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,10
NCT02446444,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Sydney,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,1,0,0,1,0,1,60
NCT02448771,0,0,0,0,0,0,2019-08-31,2020-08-31,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02449174,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-19,"The University of Texas Health Science Center, Houston",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,490
NCT02451215,0,0,0,0,0,0,2025-04-30,2026-04-30,,Children's Hospitals and Clinics of Minnesota,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,44
NCT02452697,0,0,0,0,0,0,2021-07-31,2022-07-31,,"David Rizzieri, MD",Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,10
NCT02458235,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,1443
NCT02460978,1,1,0,1,0,0,2017-09-02,2018-09-02,2018-08-24,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02462603,0,0,0,0,0,0,2019-12-31,2020-12-31,,Edison Pharmaceuticals Inc,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,12
NCT02465060,0,0,0,0,0,0,2022-06-30,2023-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02476916,0,0,0,0,0,0,2017-05-08,2018-05-08,,"Agios Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,33
NCT02477215,1,0,1,1,0,1,2018-05-02,2019-05-02,2019-08-14,Parameswaran Hari,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02484092,0,0,0,0,0,0,2021-08-04,2022-08-04,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,2856
NCT02484664,0,0,0,0,0,0,2019-06-30,2020-06-30,,Brigham and Women's Hospital,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT02485704,1,1,0,1,0,0,2018-08-03,2019-08-03,2018-11-30,ParaPRO LLC,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT02486796,1,1,0,1,0,1,2017-03-03,2018-03-03,2018-07-09,Midwestern Regional Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,1,0,0,0,0,0,3,0,1,9
NCT02489500,1,1,0,1,0,1,2017-04-28,2018-04-28,2018-05-03,Boston Medical Center,Other,0,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,225
NCT02491788,0,0,0,0,0,0,2018-11-30,2019-11-30,,VA Palo Alto Health Care System,U.S. Fed,2,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02493660,0,0,0,0,0,0,2019-06-30,2020-06-30,,OrthoSpace Ltd.,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,7
NCT02498535,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Novoteris, LLC",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT02502266,0,0,0,0,0,0,2023-06-30,2024-06-30,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02506114,0,0,0,0,0,0,2019-05-06,2020-05-06,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,1443
NCT02509052,0,0,0,0,0,0,2018-09-18,2019-09-18,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT02509312,1,0,0,0,1,0,2017-12-31,2018-12-31,,University Hospitals Cleveland Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,185
NCT02513394,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Alliance Foundation Trials, LLC.",Other,0,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02516462,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Foundation for Fertility Research,Other,0,0,0,5.0,,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,3
NCT02519036,0,1,0,1,0,1,2017-11-08,2018-11-08,2019-05-06,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,69
NCT02522650,0,0,0,0,0,0,2020-10-31,2021-10-31,,Georgetown University,Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT02523469,0,0,0,0,0,0,2019-11-30,2020-11-30,,Medical University of South Carolina,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,511
NCT02530151,1,1,0,1,0,1,2017-05-31,2018-05-31,2019-04-19,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT02531035,0,0,0,0,0,0,2017-04-30,2018-04-30,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02532231,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02532452,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,437
NCT02533570,1,1,0,1,0,0,2017-06-05,2018-06-05,2018-05-11,"Seattle Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,77
NCT02535312,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02536170,0,0,0,0,0,0,2020-08-31,2021-08-31,,Emory University,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02536300,0,0,0,0,0,0,2021-08-31,2022-08-31,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02536833,0,0,0,0,0,0,2017-04-20,2018-04-20,,Samumed LLC,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,16
NCT02538341,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,801
NCT02542696,0,0,0,0,0,0,2023-03-01,2024-03-01,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,134
NCT02544750,0,0,0,0,0,0,2022-02-28,2023-02-28,,GW Research Ltd,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,29
NCT02544984,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-21,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02548650,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,849
NCT02549859,1,0,0,0,1,0,2017-05-31,2018-05-31,,University of Chicago,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,594
NCT02552732,1,0,1,1,0,1,2017-05-03,2018-05-03,2018-07-19,Fisher and Paykel Healthcare,Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,1,0,1,56
NCT02554812,0,0,0,0,0,0,2022-12-16,2023-12-16,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02559115,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02559895,0,0,0,0,0,0,2017-02-28,2018-02-28,,"Alder Biopharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02561078,0,0,0,0,0,0,2017-05-09,2018-05-09,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1512
NCT02562716,0,0,0,0,0,0,2020-05-31,2021-05-31,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT02570139,1,1,0,1,0,0,2017-06-23,2018-06-23,2017-10-30,3M,Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,56
NCT02570854,0,0,0,0,0,0,2020-07-07,2021-07-07,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,1895
NCT02571725,0,0,0,0,0,0,2020-02-29,2021-02-28,,New Mexico Cancer Care Alliance,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,67
NCT02572323,0,0,0,0,0,0,2021-11-30,2022-11-30,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT02576574,0,0,0,0,0,0,2020-06-08,2021-06-08,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT02578732,0,0,0,0,0,0,2020-01-31,2021-01-31,,howard safran,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT02579928,0,0,0,0,0,0,2018-09-28,2019-09-28,,Yale University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02581930,1,1,0,1,0,1,2018-02-10,2019-02-10,2019-04-03,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02582593,0,0,0,0,0,0,2018-09-16,2019-09-16,,University of Florida,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,849
NCT02586688,1,0,0,0,1,0,2018-01-31,2019-01-31,,Neuronetics,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02587598,0,0,0,0,0,0,2020-01-31,2021-01-31,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,143
NCT02589171,1,1,0,1,0,1,2018-04-25,2019-04-25,2019-07-26,"The University of Texas Health Science Center, Houston",Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,490
NCT02593682,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02594111,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02597673,1,0,0,0,1,0,2018-05-31,2019-05-31,,University of Tennessee,Other,0,0,1,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,99
NCT02599961,0,0,0,0,0,0,2019-12-31,2020-12-31,,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,36
NCT02600611,1,1,0,1,0,1,2017-01-30,2018-01-30,2018-03-20,Motif Bio,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02602184,1,0,0,0,1,0,2017-06-30,2018-06-30,,Arava Bio Tech Ltd.,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02603081,1,0,0,0,1,0,2017-08-31,2018-08-31,,"Sound Pharmaceuticals, Incorporated",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02603705,1,0,0,0,1,0,2017-06-15,2018-06-15,,Egalet Ltd,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02604511,0,0,0,0,0,0,2021-02-28,2022-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02605863,1,1,0,1,0,0,2018-02-28,2019-02-28,2018-03-01,University of Rochester,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,470
NCT02611817,0,0,0,0,0,0,2019-05-06,2020-05-06,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT02616419,0,0,0,0,0,0,2018-09-30,2019-09-30,,St. Justine's Hospital,Other,0,0,0,5.0,,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,105
NCT02617589,0,0,0,0,0,0,2019-01-17,2020-01-17,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,1,0,0,1,0,1,1104
NCT02620761,0,0,0,0,0,0,2021-05-31,2022-05-31,,Jeffrey L Segar,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02621619,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-09-14,Montefiore Medical Center,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02625480,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Kite, A Gilead Company",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,14
NCT02628405,0,0,0,0,0,0,2020-05-20,2021-05-20,,Academic and Community Cancer Research United,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,32
NCT02629393,0,0,0,0,0,0,2020-12-31,2021-12-31,,Origin Biosciences,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02630121,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of South Florida,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT02630966,1,0,1,1,0,0,2018-09-04,2019-09-04,2019-09-04,Takeda,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT02631148,1,0,0,0,1,0,2018-01-31,2019-01-31,,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT02631746,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-02-06,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02632786,1,1,0,1,0,0,2018-03-31,2019-03-31,2018-10-03,Prothena Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02634814,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-01-25,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02635386,0,0,0,0,0,0,2019-06-30,2020-06-30,,Woman's,Other,0,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02637947,0,0,0,0,0,0,2022-12-31,2023-12-31,,Stereotaxis,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,8
NCT02641652,1,0,0,0,1,0,2018-06-30,2019-06-30,,University Hospital Olomouc,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,16
NCT02642965,0,0,0,0,0,0,2018-12-31,2019-12-31,,Children's Oncology Group,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,1,1,1,0,0,0,0,0,1,0,1,389
NCT02643550,0,0,0,0,0,0,2021-09-30,2022-09-30,,Innate Pharma,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,13
NCT02643849,0,0,0,0,0,0,2019-01-31,2020-01-31,,SRS Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02654236,0,0,0,0,0,0,2019-12-31,2020-12-31,,Suthat Liangpunsakul,Other,0,1,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02656303,0,0,0,0,0,0,2020-09-30,2021-09-30,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,27
NCT02656511,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of California, San Francisco",Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02658357,1,0,0,0,1,0,2017-08-31,2018-08-31,,Braeburn Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02658448,1,0,0,0,1,0,2018-06-30,2019-06-30,,GTx,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT02658812,0,0,0,0,0,0,2021-08-01,2022-08-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02659150,0,0,0,0,0,0,2019-06-30,2020-06-30,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,3,0,1,1699
NCT02660138,0,0,0,0,0,0,2018-11-09,2019-11-09,,Ipsen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,1,0,0,0,0,0,1,0,1,214
NCT02662907,0,0,0,0,0,0,2026-02-28,2027-02-28,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,2066
NCT02665143,0,0,0,0,0,0,2019-12-31,2020-12-31,,Yale University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02669511,0,0,0,0,0,0,2018-01-12,2019-01-12,,PIQUR Therapeutics AG,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,3,0,1,9
NCT02674750,0,0,0,0,0,0,2019-07-26,2020-07-26,,"Curis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02675855,1,0,0,0,1,0,2017-07-31,2018-07-31,,Osiris Therapeutics,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,9
NCT02677740,1,1,0,1,0,1,2017-03-19,2018-03-19,2019-06-12,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,749
NCT02678689,0,0,0,0,0,0,2023-06-30,2024-06-30,,BioMarin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,1,0,0,0,0,1,0,1,85
NCT02681614,0,0,0,0,0,0,2019-02-28,2020-02-28,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,374
NCT02682381,1,1,0,1,0,0,2017-08-18,2018-08-18,2018-08-03,Shire,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,342
NCT02684578,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of California, San Francisco",Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02688647,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Kadmon Corporation, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,29
NCT02688764,0,1,0,1,0,0,2019-02-21,2020-02-21,2019-08-08,Vifor Fresenius Medical Care Renal Pharma,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT02691962,0,0,0,0,0,0,2020-07-31,2021-07-31,,C. R. Bard,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,77
NCT02692703,1,1,0,1,0,0,2017-04-13,2018-04-13,2018-03-08,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,430
NCT02693119,0,0,0,0,0,0,2020-01-31,2021-01-31,,Stealth BioTherapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,25
NCT02694822,0,0,0,0,0,0,2019-11-30,2020-11-30,,Agenus Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,19
NCT02701413,0,0,0,0,0,0,2019-09-30,2020-09-30,,Northwestern University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,925
NCT02702115,0,0,0,0,0,0,2020-01-31,2021-01-31,,Sangamo Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,18
NCT02704858,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Neonc Technologies, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02706626,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Criterium, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT02706899,1,1,0,1,0,0,2017-11-06,2018-11-06,2018-10-18,"Seattle Genetics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,77
NCT02707861,0,0,0,0,0,0,2018-11-30,2019-11-30,,TaiMed Biologics Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02708186,1,0,0,0,1,0,2018-05-31,2019-05-31,,Axovant Sciences Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02710214,0,0,0,0,0,0,2019-04-24,2020-04-24,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02710526,1,0,1,1,0,1,2017-03-31,2018-03-31,2018-09-13,Braeburn Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02711137,0,0,0,0,0,0,2019-01-31,2020-01-31,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,143
NCT02714205,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT02715856,0,0,0,0,0,0,2020-05-31,2021-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,0,0,0,0,0,1,2066
NCT02716857,1,0,0,0,1,0,2017-08-31,2018-08-31,,Egalet Ltd,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02720198,1,1,0,1,0,0,2018-06-12,2019-06-12,2019-06-12,Duke University,Other,0,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT02724020,0,0,0,0,0,0,2019-11-08,2020-11-08,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT02724631,0,0,0,0,0,0,2019-12-31,2020-12-31,,Children's Hospital of Philadelphia,Other,0,1,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,324
NCT02725268,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT02726581,0,0,0,0,0,0,2020-03-15,2021-03-15,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02732691,0,0,0,0,0,0,2019-09-30,2020-09-30,,"JenaValve Technology, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,3
NCT02733042,0,0,0,0,0,0,2019-03-06,2020-03-06,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02734771,0,0,0,0,0,0,2020-06-30,2021-06-30,,Patrick Reagan,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02735980,0,0,0,0,0,0,2017-07-31,2018-07-31,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02736409,0,0,0,0,0,0,2019-11-22,2020-11-22,,Shire,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,342
NCT02736955,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-10-10,Neurocrine Biosciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02740335,0,0,0,0,0,0,2021-06-30,2022-06-30,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,54
NCT02740972,0,0,0,0,0,0,2018-03-31,2019-03-31,,"NS Pharma, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02742441,0,1,0,1,0,1,2017-02-27,2018-02-27,2018-09-17,"Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,16
NCT02743364,0,0,0,0,0,0,2019-12-15,2020-12-15,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02747875,0,0,0,0,0,0,2019-02-07,2020-02-07,,Andrew Waberski,Other,0,0,0,5.0,,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02760069,1,0,1,1,0,1,2017-11-30,2018-11-30,2019-07-08,Brooke Army Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,71
NCT02763072,1,0,0,0,1,0,2017-06-30,2018-06-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,37
NCT02764996,1,0,0,0,1,0,2017-06-30,2018-06-30,,Mike O'Callaghan Military Hospital,U.S. Fed,2,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,31
NCT02768792,0,0,0,0,0,0,2020-09-30,2021-09-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT02769312,1,1,0,1,0,1,2017-12-19,2018-12-19,2019-02-12,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT02772237,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Virginia,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,402
NCT02772965,0,0,0,0,0,0,2020-10-31,2021-10-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02773849,0,0,0,0,0,0,2019-05-24,2020-05-24,,FKD Therapies Oy,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT02775851,0,0,0,0,0,0,2028-12-01,2029-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02779777,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Kura Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02779959,1,0,1,1,0,1,2017-10-31,2018-10-31,2018-12-04,Los Angeles Biomedical Research Institute,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,60
NCT02781727,0,0,0,0,0,0,2019-01-17,2020-01-17,,Ascendis Pharma A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02782949,0,0,0,0,0,0,2020-12-01,2021-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3004
NCT02784288,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,213
NCT02784535,0,0,0,0,0,0,2020-07-31,2021-07-31,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,422
NCT02785120,0,0,0,0,0,0,2020-10-31,2021-10-31,,Techfields Inc,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02785900,1,1,0,1,0,0,2017-10-03,2018-10-03,2018-10-01,"Seattle Genetics, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,77
NCT02788227,0,0,0,0,0,0,2021-10-31,2022-10-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,2133
NCT02793778,1,0,0,0,1,0,2018-06-01,2019-06-01,,Prometheus Laboratories,Industry,1,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02796144,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02796391,0,0,0,0,0,0,2020-04-30,2021-04-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT02796898,0,0,0,0,0,0,2019-05-30,2020-05-30,,"Tyme, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02803775,0,0,0,0,0,0,2018-12-31,2019-12-31,,Deborah Heart and Lung Center,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT02805257,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1443
NCT02805660,0,0,0,0,0,0,2019-04-30,2020-04-30,,Mirati Therapeutics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT02806713,1,1,0,1,0,1,2017-08-31,2018-08-31,2018-09-05,"University of Massachusetts, Worcester",Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,163
NCT02809859,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-10-08,Fisher and Paykel Healthcare,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,56
NCT02810964,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sheppard Pratt Health System,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT02811809,0,0,0,0,0,0,2024-12-31,2025-12-31,,Robert J Amato,Other,0,1,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02815332,1,0,0,0,1,0,2017-03-24,2018-03-24,,"BioPharmX, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02818998,0,0,0,0,0,0,2018-11-13,2019-11-13,,Bayer,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,2,0,1,1343
NCT02819856,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Sound Pharmaceuticals, Incorporated",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT02822508,0,0,0,0,0,0,2017-04-30,2018-04-30,,Braintree Laboratories,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,43
NCT02827747,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Miami,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,476
NCT02828566,0,0,0,0,0,0,2019-01-31,2020-01-31,,Lawson Health Research Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,468
NCT02829034,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-11-30,University of Pennsylvania,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02830165,0,0,0,0,0,0,2020-03-10,2021-03-10,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,277
NCT02832063,1,0,0,0,1,0,2017-07-19,2018-07-19,,AOBiome LLC,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,10
NCT02833233,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02834767,0,0,0,0,0,0,2019-05-04,2020-05-04,,University of Florida,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,849
NCT02837913,1,1,0,1,0,0,2018-01-01,2019-01-01,2018-08-23,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,279
NCT02839343,0,0,0,0,0,0,2020-03-31,2021-03-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,1,0,1,456
NCT02841774,0,0,0,0,0,0,2020-03-31,2021-03-31,,Matthew Feinstein,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02842086,0,0,0,0,0,0,2019-01-31,2020-01-31,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02843659,1,1,0,1,0,0,2017-07-24,2018-07-24,2018-07-24,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02844816,0,0,0,0,0,0,2021-04-01,2022-04-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3004
NCT02851797,0,0,0,0,0,0,2020-06-30,2021-06-30,,Italfarmaco,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,20
NCT02855125,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Taiho Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,37
NCT02855359,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-12-18,"Seattle Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,77
NCT02860130,0,0,0,0,0,0,2018-05-12,2019-05-12,,Baxter Healthcare Corporation,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02861495,1,0,0,0,1,0,2018-08-09,2019-08-09,,Florida Orthopaedic Institute,Other,0,1,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT02862210,0,0,0,0,0,0,2020-09-30,2021-09-30,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT02867761,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Michigan,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT02872116,0,0,0,0,0,0,2021-03-28,2022-03-28,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02873338,0,0,0,0,0,0,2019-06-30,2020-06-30,,Cantex Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02873585,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT02874430,0,0,0,0,0,0,2021-02-28,2022-02-28,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,162
NCT02875314,0,0,0,0,0,0,2020-09-30,2021-09-30,,Nationwide Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,161
NCT02876055,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-03-01,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02877004,1,1,0,1,0,1,2018-07-28,2019-07-28,2019-08-12,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02879578,0,0,0,0,0,0,2017-11-30,2018-11-30,,Neurocrine Biosciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02880020,0,0,0,0,0,0,2020-09-30,2021-09-30,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,277
NCT02880267,1,0,0,0,1,0,2017-07-31,2018-07-31,,"DexCom, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,21
NCT02885012,1,1,0,1,0,1,2017-07-07,2018-07-07,2018-09-05,Medical University of South Carolina,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT02896855,1,1,0,1,0,0,2018-06-27,2019-06-27,2019-06-18,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,1731
NCT02898233,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Texas at Austin,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,135
NCT02900092,1,1,0,1,0,1,2018-01-12,2019-01-12,2019-01-15,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02902718,1,0,0,0,1,0,2017-09-30,2018-09-30,,Iluminage Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT02905006,0,0,0,0,0,0,2017-06-30,2018-06-30,,UCB Biopharma S.P.R.L.,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,75
NCT02905591,0,0,0,0,0,0,2024-07-31,2025-07-31,,"Joseph J. Cullen, MD, FACS",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT02905825,1,1,0,1,0,0,2017-10-30,2018-10-30,2018-03-25,Exalenz Bioscience LTD.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,1,1,0,0,0,1,1,0,16
NCT02911974,1,0,0,0,1,0,2017-07-31,2018-07-31,,Florida Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,63
NCT02912455,1,0,0,0,1,0,2018-07-19,2019-07-19,,The Cleveland Clinic,Other,0,1,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,0,1,581
NCT02915835,1,0,1,1,0,0,2018-08-24,2019-08-24,2019-07-25,"Dinesh Khanna, MD, MS",Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02919111,0,0,0,0,0,0,2018-10-31,2019-10-31,,"University of California, San Francisco",Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02919436,0,0,0,0,0,0,2020-09-30,2021-09-30,,Maine Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,25
NCT02919592,0,0,0,0,0,0,2028-09-01,2029-09-01,,"Mentor Worldwide, LLC",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,17
NCT02923232,0,0,0,0,0,0,2019-12-31,2020-12-31,,Pacific University,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02926924,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT02927249,0,0,0,0,0,0,2021-04-30,2022-04-30,,Alliance for Clinical Trials in Oncology,Other,0,1,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,456
NCT02938078,1,0,0,0,1,0,2017-05-31,2018-05-31,,"Minnesota Eye Consultants, P.A.",Industry,1,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02943668,0,0,0,0,0,0,2020-03-02,2021-03-02,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,393
NCT02945150,0,0,0,0,0,0,2019-08-20,2020-08-20,,Massachusetts General Hospital,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02945280,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Intermountain Health Care, Inc.",Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,93
NCT02946047,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT02946268,0,0,0,0,0,0,2019-11-30,2020-11-30,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT02946489,1,0,0,0,1,0,2018-08-31,2019-08-31,,New York State Psychiatric Institute,Other,0,0,1,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02951598,0,0,0,0,0,0,2020-10-28,2021-10-28,,Eli Lilly and Company,Industry,1,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1512
NCT02952976,0,0,0,0,0,0,2019-07-31,2020-07-31,,Sociedade Brasileira de Atendimento Integrado ao Trauma,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT02953353,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Sao Paulo,Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,767
NCT02953886,1,1,0,1,0,0,2017-04-20,2018-04-20,2018-04-02,Heba Mitwalli,Other,0,0,0,4.0,Phase 4,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02954497,0,0,0,0,0,0,2021-04-30,2022-04-30,,New England Research Institutes,Other,0,1,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,49
NCT02954575,1,0,1,1,0,0,2018-03-29,2019-03-29,2019-03-20,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,54
NCT02955186,0,0,0,0,0,0,2019-04-24,2020-04-24,,Yale University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1053
NCT02955290,0,0,0,0,0,0,2020-06-09,2021-06-09,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,294
NCT02955511,0,0,0,0,0,0,2019-10-31,2020-10-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,279
NCT02955940,0,0,0,0,0,0,2019-11-30,2020-11-30,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,143
NCT02957682,0,0,0,0,0,0,2020-03-05,2021-03-05,,Regeneron Pharmaceuticals,Industry,1,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,176
NCT02960204,0,0,0,0,0,0,2018-10-02,2019-10-02,,Conatus Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT02960555,0,0,0,0,0,0,2022-02-01,2023-02-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT02962427,0,0,0,0,0,0,2019-03-31,2020-03-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02962960,0,0,1,1,0,1,2018-01-22,2019-01-22,2019-07-11,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2450
NCT02964741,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Michigan,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT02964884,0,0,0,0,0,0,2020-11-30,2021-11-30,,Vanderbilt University,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT02965573,0,0,0,0,0,0,2017-10-20,2018-10-20,,argenx BVBA,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,1,0,1,12
NCT02965768,0,0,0,0,0,0,2020-08-01,2021-08-01,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02966184,0,0,0,0,0,0,2020-02-29,2021-02-28,,Norton Healthcare,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT02966873,0,0,0,0,0,0,2021-08-01,2022-08-01,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02968940,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,1,0,0,0,1,0,869
NCT02969356,1,1,0,1,0,1,2018-04-26,2019-04-26,2019-05-16,Ipsen,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,214
NCT02974686,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02977299,0,0,0,0,0,0,2021-10-31,2022-10-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,1,1,0,1699
NCT02978716,0,0,0,0,0,0,2018-07-30,2019-07-30,,"G1 Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT02979977,0,0,0,0,0,0,2019-12-31,2020-12-31,,Yale University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT02980666,0,0,0,0,0,0,2020-01-13,2021-01-13,,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,0,1,342
NCT02981628,0,0,0,0,0,0,2020-03-30,2021-03-30,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,389
NCT02983825,0,0,0,0,0,0,2019-07-08,2020-07-08,,University of Pennsylvania,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT02985801,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Massimo Raimondo, M.D.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02988843,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,218
NCT02989168,1,0,0,0,1,0,2017-10-23,2018-10-23,,Global Blood Therapeutics,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,14
NCT02989610,0,0,0,0,0,0,2020-01-31,2021-01-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT02993107,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,11
NCT02993783,1,1,0,1,0,0,2018-05-09,2019-05-09,2019-05-01,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,209
NCT02997189,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Otonomy, Inc.",Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02998151,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT02998528,0,0,0,0,0,0,2020-04-08,2021-04-08,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT03000348,1,0,0,0,1,0,2018-04-30,2019-04-30,,NovaBiotics Ltd.,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT03000608,1,1,0,1,0,1,2017-12-13,2018-12-13,2019-04-11,"Santalis Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03002428,1,0,0,0,1,0,2018-05-31,2019-05-31,,"Pfenex, Inc",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT03003390,0,0,0,0,0,0,2019-07-10,2020-07-10,,Yale University,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1053
NCT03003533,0,0,0,0,0,0,2019-08-31,2020-08-31,,Spark Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,0,0,0,0,1,1,0,1,13
NCT03005067,1,1,0,1,0,0,2017-06-07,2018-06-07,2018-04-25,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3276
NCT03006302,0,0,0,0,0,0,2021-02-28,2022-02-28,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,461
NCT03007030,0,0,0,0,0,0,2022-04-30,2023-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03008369,0,0,0,0,0,0,2019-08-15,2020-08-15,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03010436,0,0,0,0,0,0,2018-12-31,2019-12-31,,National Jewish Health,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,81
NCT03011372,0,0,0,0,0,0,2020-07-31,2021-07-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT03011892,0,0,0,0,0,0,2018-01-10,2019-01-10,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,143
NCT03015532,0,0,0,0,0,0,2018-04-20,2019-04-20,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT03019185,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Reata Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,44
NCT03019640,0,0,0,0,0,0,2020-03-31,2021-03-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03020030,0,0,0,0,0,0,2021-12-31,2022-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,647
NCT03020966,0,0,0,0,0,0,2019-06-16,2020-06-16,,"Hospital for Special Surgery, New York",Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,157
NCT03021486,0,0,0,0,0,0,2020-06-05,2021-06-05,,M.D. Anderson Cancer Center,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03021902,0,0,0,0,0,0,2022-03-31,2023-03-31,,Clinical Evaluation Research Unit at Kingston General Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,9
NCT03027115,0,0,0,0,0,0,2020-01-13,2021-01-13,,Memorial Health University Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT03027609,0,0,0,0,0,0,2019-04-25,2020-04-25,,"Aridis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03033589,1,0,0,0,1,0,2017-07-31,2018-07-31,,Henry Ford Health System,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,151
NCT03036566,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Michigan,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT03036657,0,0,0,0,0,0,2019-12-31,2020-12-31,,Oregon Health and Science University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,475
NCT03037515,1,0,0,0,1,0,2017-08-15,2018-08-15,,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,151
NCT03037580,0,0,0,0,0,0,2020-07-31,2021-07-31,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,72
NCT03038620,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Texas Southwestern Medical Center,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03039790,0,0,0,0,0,0,2021-10-26,2022-10-26,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,650
NCT03041038,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT03041181,0,0,1,1,0,0,2019-05-23,2020-05-23,2019-07-10,"Nasser Hanna, M.D.",Other,0,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03042598,1,0,0,0,1,0,2017-04-30,2018-04-30,,University Medical Center of Southern Nevada,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT03043872,0,0,0,0,0,0,2019-09-30,2020-09-30,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03045861,1,1,0,1,0,0,2018-04-23,2019-04-23,2019-04-01,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03050775,1,1,0,1,0,1,2017-02-05,2018-02-05,2018-04-03,Mayo Clinic,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,3,0,1,1898
NCT03054350,0,0,0,0,0,0,2017-10-24,2018-10-24,,Akebia Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,25
NCT03056638,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03058692,0,0,0,0,0,0,2019-01-14,2020-01-14,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,2133
NCT03058835,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Rutgers, The State University of New Jersey",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,227
NCT03060148,0,0,0,0,0,0,2018-12-31,2019-12-31,,Chang Gung Memorial Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,486
NCT03060772,0,0,0,0,0,0,2019-12-20,2020-12-20,,Emory University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03060993,1,0,0,0,1,0,2018-01-01,2019-01-01,,McGill University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,130
NCT03061279,0,0,0,0,0,0,2019-03-01,2020-03-01,,Stanford University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03061474,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, Irvine",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,310
NCT03061643,0,0,0,0,0,0,2020-02-29,2021-02-28,,Samsung Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,684
NCT03062449,0,0,0,0,0,0,2020-12-31,2021-12-31,,Aleksandra Stark,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03063892,0,0,0,0,0,0,2021-06-01,2022-06-01,,Gregory Georgiadis,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03065179,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,626
NCT03065400,0,0,0,0,0,0,2020-04-30,2021-04-30,,John Mascarenhas,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03066076,0,0,0,0,0,0,2019-02-01,2020-02-01,,Medical University of Vienna,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,744
NCT03066258,0,0,0,0,0,0,2019-11-30,2020-11-30,,Regenxbio Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,0,0,1,0,1,0,7
NCT03066622,1,1,0,1,0,1,2018-05-17,2019-05-17,2019-07-03,HealthPartners Institute,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,101
NCT03066947,0,0,0,0,0,0,2018-11-22,2019-11-22,,BriaCell Therapeutics Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,1,0,0,0,0,0,0,1,0,2
NCT03068949,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Rochester,Other,0,0,1,4.0,Phase 4,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,470
NCT03069352,0,0,0,0,0,0,2020-07-13,2021-07-13,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03071692,0,0,0,0,0,0,2022-04-30,2023-04-30,,"Kowa Research Institute, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,33
NCT03078907,0,0,0,0,0,0,2020-02-28,2021-02-28,,Actelion,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03079401,0,0,0,0,0,0,2020-11-30,2021-11-30,,Boston Children’s Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,400
NCT03079531,0,0,0,0,0,0,2019-01-25,2020-01-25,,Anne Chang,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03080493,0,0,0,0,0,0,2018-11-05,2019-11-05,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,530
NCT03080714,1,0,0,0,1,0,2017-08-30,2018-08-30,,"Topcon Medical Systems, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,27
NCT03082898,0,0,0,0,0,0,2019-11-30,2020-11-30,,Vanderbilt University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,499
NCT03084666,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,801
NCT03085433,0,0,0,0,0,0,2019-07-01,2020-07-01,,"University of California, San Francisco",Other,0,0,0,3.0,Phase 3,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1443
NCT03086317,0,0,0,0,0,0,2020-01-31,2021-01-31,,Emory University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT03086512,0,0,0,0,0,0,2022-04-30,2023-04-30,,"St. Paul's Hospital, Canada",Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,20
NCT03087656,0,0,0,0,0,0,2021-02-23,2022-02-23,,University of Southern California,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03090191,0,0,0,0,0,0,2020-09-28,2021-09-28,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2856
NCT03092310,1,0,0,0,1,0,2017-12-20,2018-12-20,,Sansum Diabetes Research Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,26
NCT03093116,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Turning Point Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03093844,0,0,0,0,0,0,2022-02-10,2023-02-10,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03095456,0,1,0,1,0,1,2017-11-25,2018-11-25,2018-12-06,Theravance Biopharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,1,0,0,1,0,53
NCT03098082,0,0,0,0,0,0,2020-08-01,2021-08-01,,Indiana University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT03098433,0,0,0,0,0,0,2020-03-31,2021-03-31,,Virginia Commonwealth University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03099096,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-05-21,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03100058,0,0,1,1,0,1,2018-03-02,2019-03-02,2019-07-30,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03102762,1,0,1,1,0,1,2018-01-03,2019-01-03,2019-03-17,Cairo University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,0,1,1190
NCT03103087,0,0,0,0,0,0,2019-06-19,2020-06-19,,Myovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03104374,0,0,0,0,0,0,2019-07-17,2020-07-17,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03105219,0,0,0,0,0,0,2021-05-30,2022-05-30,,"Nanjing First Hospital, Nanjing Medical University",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,41
NCT03106415,0,0,0,0,0,0,2020-05-15,2021-05-15,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03106545,1,0,0,0,1,0,2017-06-26,2018-06-26,,"Admir Hadzic, M.D., Ph.D.",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,0,1,2
NCT03107195,0,0,0,0,0,0,2020-03-31,2021-03-31,,Boston Children’s Hospital,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03107416,0,0,0,0,0,0,2020-04-05,2021-04-05,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03108469,0,0,0,0,0,0,2019-04-26,2020-04-26,,"Smith, Timothy R., M.D.",Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03110900,1,1,0,1,0,0,2018-04-04,2019-04-04,2018-04-09,University of Arkansas,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,285
NCT03111732,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03112902,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03113409,0,0,0,0,0,0,2019-12-30,2020-12-30,,New York State Psychiatric Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03113799,1,0,0,0,1,0,2018-08-15,2019-08-15,,Aqueduct Critical Care,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03113968,0,0,0,0,0,0,2021-03-01,2022-03-01,,The Cleveland Clinic,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03115424,0,0,0,0,0,0,2020-05-31,2021-05-31,,Mayo Clinic,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03115580,0,0,0,0,0,0,2019-03-26,2020-03-26,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,412
NCT03118570,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mereo BioPharma,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03119233,0,0,0,0,0,0,2021-04-30,2022-04-30,,"PQ Bypass, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03121534,0,0,0,0,0,0,2020-06-01,2021-06-01,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03122899,0,0,0,0,0,0,2020-10-31,2021-10-31,,"SI-BONE, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03123367,1,0,0,0,1,0,2017-06-27,2018-06-27,,Ceek Enterprises,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03123783,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Apexigen, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03124381,1,1,0,1,0,0,2017-09-06,2018-09-06,2018-09-04,Johnson & Johnson Consumer Inc. (J&JCI),Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03126448,1,0,0,0,1,0,2018-07-31,2019-07-31,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2015.0,1,0,0,0,1,0,0,0,0,0,1,318
NCT03126630,0,0,0,0,0,0,2020-02-02,2021-02-02,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,3004
NCT03126994,1,0,0,0,1,0,2017-05-19,2018-05-19,,"PhysioWave, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03127267,0,0,0,0,0,0,2021-05-31,2022-05-31,,AB Science,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,30
NCT03127774,0,0,0,0,0,0,2022-05-31,2023-05-31,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03128307,1,1,0,1,0,0,2017-05-03,2018-05-03,2017-09-30,"Zyppah, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03128723,1,1,0,1,0,0,2017-06-08,2018-06-08,2018-06-06,Johnson & Johnson Consumer Inc. (J&JCI),Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03131687,0,1,0,1,0,0,2018-08-01,2019-08-01,2019-07-31,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1512
NCT03136406,0,0,0,0,0,0,2018-10-31,2019-10-31,,"NantKwest, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,1,0,0,0,0,0,0,1,0,27
NCT03137082,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stony Brook University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,119
NCT03138655,0,0,0,0,0,0,2020-02-15,2021-02-15,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,650
NCT03139578,1,1,0,1,0,0,2017-10-22,2018-10-22,2018-10-18,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,138
NCT03141671,0,0,0,0,0,0,2020-09-30,2021-09-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,647
NCT03143816,1,0,0,0,1,0,2017-12-15,2018-12-15,,University of Colorado Denver School of Medicine Barbara Davis Center,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03146806,0,0,0,0,0,0,2020-06-01,2021-06-01,,Emory University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03148236,1,1,0,1,0,0,2018-03-13,2019-03-13,2019-02-22,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,417
NCT03149770,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03151551,0,1,0,1,0,0,2018-11-15,2019-11-15,2019-02-22,Eli Lilly and Company,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1512
NCT03154047,1,1,0,1,0,0,2018-05-30,2019-05-30,2018-11-15,Prothena Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,6
NCT03155594,1,0,0,0,1,0,2017-07-15,2018-07-15,,Methodist Medical Center of Illinois,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03160430,0,0,0,0,0,0,2021-03-15,2022-03-15,,Resverlogix Corp,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,9
NCT03160885,0,0,0,0,0,0,2018-09-04,2019-09-04,,LEO Pharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,171
NCT03163303,0,0,0,0,0,0,2019-01-31,2020-01-31,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1443
NCT03164265,0,0,0,0,0,0,2023-06-30,2024-06-30,,Angus W. Thomson PhD DSc,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03166384,0,0,0,0,0,0,2020-05-01,2021-05-01,,Severance Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,46
NCT03166618,1,1,0,1,0,0,2017-07-21,2018-07-21,2018-07-20,Allergan,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,495
NCT03168529,0,0,0,0,0,0,2019-12-31,2020-12-31,,Phillip Levy,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03168919,1,1,0,1,0,0,2018-06-12,2019-06-12,2019-03-20,University of Alabama at Birmingham,Other,0,0,0,5.0,,1,2016.0,1,1,0,1,0,1,0,0,0,0,1,801
NCT03172624,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03173092,0,0,0,0,0,0,2023-11-30,2024-11-30,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,209
NCT03173716,0,0,0,0,0,0,2020-01-01,2021-01-01,,Mayo Clinic,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03173820,1,0,0,0,1,0,2017-12-31,2018-12-31,,Khon Kaen University,Other,0,0,0,5.0,,0,2015.0,1,0,0,0,0,0,0,1,2,0,1,115
NCT03174353,0,0,0,0,0,0,2020-04-01,2021-04-01,,University of Washington,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03174782,0,0,0,0,0,0,2018-12-30,2019-12-30,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,1443
NCT03176225,0,0,0,0,0,0,2020-06-30,2021-06-30,,LeMaitre Vascular,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,3
NCT03176472,0,0,0,0,0,0,2021-10-31,2022-10-31,,Regenacy Pharmaceuticals LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03178149,0,0,0,0,0,0,2021-04-30,2022-04-30,,Astellas Institute for Regenerative Medicine,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03178552,0,0,0,0,0,0,2020-02-13,2021-02-13,,Hoffmann-La Roche,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03179800,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Vascular Dynamics, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,5
NCT03180515,0,0,1,1,0,0,2018-10-31,2019-10-31,2019-09-05,Stanford University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1309
NCT03181503,0,0,0,0,0,0,2018-09-26,2019-09-26,,Galderma R&D,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,28
NCT03181932,0,0,0,0,0,0,2020-03-31,2021-03-31,,Savara Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03184558,1,0,0,0,1,0,2018-08-30,2019-08-30,,BerGenBio ASA,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,5
NCT03187379,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Cleveland Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03188549,1,0,0,0,1,0,2018-06-15,2019-06-15,,Sheba Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,0,0,0,0,0,0,0,2,1,0,553
NCT03188705,0,0,0,0,0,0,2020-09-30,2021-09-30,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,144
NCT03189914,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Rexahn Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03190473,0,0,0,0,0,0,2020-06-28,2021-06-28,,"Svelte Medical Systems, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03190941,0,0,0,0,0,0,2027-06-29,2028-06-29,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03191266,0,0,0,0,0,0,2021-05-31,2022-05-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03201965,0,0,0,0,0,0,2020-02-28,2021-02-28,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03203447,0,0,0,0,0,0,2018-12-18,2019-12-18,,"Clearside Biomedical, Inc.",Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,11
NCT03206788,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Miami,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT03207347,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Florida,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03207685,0,0,0,0,0,0,2019-06-26,2020-06-26,,"Empatica, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,2
NCT03208127,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03211988,0,0,0,0,0,0,2019-08-31,2020-08-31,,Antonio Fojo,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03212209,1,0,0,0,1,0,2018-02-14,2019-02-14,,Associação Fundo de Incentivo à Pesquisa,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,20
NCT03213041,0,0,0,0,0,0,2021-06-01,2022-06-01,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03213665,0,0,0,0,0,0,2024-09-30,2025-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03215264,0,0,0,0,0,0,2021-07-10,2022-07-10,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03215706,0,0,0,0,0,0,2020-02-25,2021-02-25,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03217747,0,0,0,0,0,0,2022-09-30,2023-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,2066
NCT03219073,1,0,0,0,1,0,2018-06-16,2019-06-16,,"University of Colorado, Denver",Other,0,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,882
NCT03222492,0,0,0,0,0,0,2020-09-30,2021-09-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2133
NCT03222752,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Electromedical Products International, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03226067,0,0,0,0,0,0,2019-04-11,2020-04-11,,Genkyotex SA,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03226626,0,0,0,0,0,0,2021-01-01,2022-01-01,,"HK Surgical, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,1,0,0,0,0,3,1,0,1
NCT03229278,0,0,0,0,0,0,2022-07-30,2023-07-30,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,227
NCT03229486,0,0,0,0,0,0,2019-04-30,2020-04-30,,Pusan National University Yangsan Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,21
NCT03230175,0,0,0,0,0,0,2019-01-10,2020-01-10,,Tissue Tech Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,10
NCT03233399,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03235050,0,0,0,0,0,0,2018-05-03,2019-05-03,,AstraZeneca,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2450
NCT03236311,1,1,0,1,0,0,2018-07-23,2019-07-23,2019-06-17,Sanofi,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03236792,0,0,0,0,0,0,2020-06-30,2021-06-30,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03237234,0,0,0,0,0,0,2020-11-01,2021-11-01,,"Shepherd Center, Atlanta GA",Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT03237780,0,0,0,0,0,0,2020-01-31,2021-01-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03242018,0,0,0,0,0,0,2019-05-31,2020-05-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03243058,0,0,0,0,0,0,2023-01-31,2024-01-31,,Jay S. Skyler,Other,0,0,1,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03243942,0,0,0,0,0,0,2019-06-26,2020-06-26,,Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,186
NCT03244163,0,0,0,0,0,0,2020-06-30,2021-06-30,,Chinese University of Hong Kong,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,557
NCT03245762,1,1,0,1,0,0,2018-01-04,2019-01-04,2019-01-02,University of Florida,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,849
NCT03247686,1,0,0,0,1,0,2018-07-15,2019-07-15,,Resolve Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,3
NCT03249337,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Marian Macsai, MD",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03249454,0,0,0,0,0,0,2018-10-31,2019-10-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03249584,0,0,0,0,0,0,2019-04-30,2020-04-30,,MedtronicNeuro,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,57
NCT03250338,0,0,0,0,0,0,2021-10-31,2022-10-31,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,17
NCT03252223,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of California, San Diego",Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03256500,0,0,0,0,0,0,2019-12-30,2020-12-30,,North Florida/South Georgia Veterans Health System,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT03259620,1,0,0,0,1,0,2018-08-22,2019-08-22,,"Maruho Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,26
NCT03262038,0,0,0,0,0,0,2021-12-01,2022-12-01,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03263091,0,0,0,0,0,0,2021-04-30,2022-04-30,,FibroGen,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT03264261,0,0,0,0,0,0,2020-07-30,2021-07-30,,Shirley Ryan AbilityLab,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,71
NCT03264456,0,0,0,0,0,0,2019-01-30,2020-01-30,,University of Alabama at Birmingham,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,1,0,0,0,0,1,0,801
NCT03266588,0,0,0,0,0,0,2019-07-15,2020-07-15,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03267264,1,1,0,1,0,0,2018-04-24,2019-04-24,2019-04-10,"Becton, Dickinson and Company",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,26
NCT03269409,0,0,0,0,0,0,2020-06-30,2021-06-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,1,1,0,0,0,0,0,1,0,1898
NCT03270241,0,0,0,0,0,0,2020-09-01,2021-09-01,,Johns Hopkins University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03272139,0,0,0,0,0,0,2018-12-30,2019-12-30,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,157
NCT03273543,1,0,0,0,1,0,2018-07-03,2019-07-03,,DeNova Research,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,12
NCT03273907,0,0,0,0,0,0,2021-10-31,2022-10-31,,Alcon Research,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,492
NCT03277196,0,0,0,0,0,0,2021-06-07,2022-06-07,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,141
NCT03277469,0,0,0,0,0,0,2022-09-15,2023-09-15,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,1,0,0,0,1,0,647
NCT03278379,0,0,0,0,0,0,2020-09-20,2021-09-20,,Sunnybrook Health Sciences Centre,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,352
NCT03279328,1,0,0,0,1,0,2018-07-31,2019-07-31,,University of Arizona,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,265
NCT03280160,0,0,0,0,0,0,2019-10-31,2020-10-31,,PETHEMA Foundation,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,79
NCT03281889,0,0,0,0,0,0,2021-03-31,2022-03-31,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,1699
NCT03282344,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03283865,1,0,0,0,1,0,2018-01-31,2019-01-31,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2017.0,1,0,0,0,1,0,0,0,0,1,0,518
NCT03285490,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Athenex, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03286426,0,0,0,0,0,0,2019-09-30,2020-09-30,,Duke University,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,1342
NCT03286543,0,0,0,0,0,0,2019-12-31,2020-12-31,,"SPR Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03286868,0,0,0,0,0,0,2020-01-31,2021-01-31,,Nova Scotia Health Authority,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,140
NCT03287791,1,1,0,1,0,1,2017-06-22,2018-06-22,2019-06-26,Actavis Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT03289754,0,0,0,0,0,0,2020-12-31,2021-12-31,,"ConforMIS, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,18
NCT03290079,0,0,0,0,0,0,2020-12-31,2021-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03292484,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,11
NCT03294330,0,0,0,0,0,0,2019-12-31,2020-12-31,,Milton S. Hershey Medical Center,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03294941,0,0,0,0,0,0,2022-05-31,2023-05-31,,"HepQuant, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,0,0,0,0,1,0,0,1,0,4
NCT03297424,0,0,0,0,0,0,2020-12-31,2021-12-31,,Plexxikon,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03298061,0,0,0,0,0,0,2020-01-02,2021-01-02,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,3276
NCT03298451,0,0,0,0,0,0,2020-06-30,2021-06-30,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03300505,0,0,0,0,0,0,2024-05-31,2025-05-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03301051,1,0,0,0,1,0,2018-04-30,2019-04-30,,Medicago,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,13
NCT03303066,0,0,0,0,0,0,2020-11-30,2021-11-30,,FibroGen,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,31
NCT03305692,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Alan J. Bank, MD",Other,0,1,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,2
NCT03307577,0,0,0,0,0,0,2018-05-31,2019-05-31,,"Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,16
NCT03310879,0,0,0,0,0,0,2021-04-30,2022-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03312634,0,0,0,0,0,0,2020-09-30,2021-09-30,,Clementia Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03314012,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Cibiem, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,2,0,1,1
NCT03314584,0,0,0,0,0,0,2020-09-30,2021-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03315182,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Abeona Therapeutics, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,3
NCT03316560,0,0,0,0,0,0,2023-03-31,2024-03-31,,Applied Genetic Technologies Corp,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,9
NCT03318575,0,0,0,0,0,0,2019-04-30,2020-04-30,,"CellAegis US, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,1,1,0,1
NCT03318939,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,67
NCT03321526,0,0,0,0,0,0,2019-06-13,2020-06-13,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,558
NCT03324932,0,0,0,0,0,0,2022-09-30,2023-09-30,,Kyoto Prefectural University of Medicine,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03325166,0,0,0,0,0,0,2019-09-15,2020-09-15,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,163
NCT03326674,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Odonate Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03329599,0,0,0,0,0,0,2020-08-01,2021-08-01,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,511
NCT03330041,1,0,0,0,1,0,2018-08-09,2019-08-09,,"University of California, Davis",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,530
NCT03331341,0,0,0,0,0,0,2020-06-15,2021-06-15,,University of Washington,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,910
NCT03331861,0,0,0,0,0,0,2020-02-29,2021-02-28,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03332147,1,0,1,1,0,0,2018-05-25,2019-05-25,2019-04-12,Darma Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03333382,0,0,0,0,0,0,2023-02-28,2024-02-28,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,422
NCT03333486,0,0,0,0,0,0,2021-09-06,2022-09-06,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,294
NCT03334695,0,0,0,0,0,0,2018-07-10,2019-07-10,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,1,0,0,0,0,0,2,1,0,29
NCT03334786,1,0,0,0,1,0,2018-08-23,2019-08-23,,"Flex Pharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03338959,0,0,0,0,0,0,2020-06-15,2021-06-15,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,393
NCT03339726,1,1,0,1,0,0,2018-04-16,2019-04-16,2019-04-16,Johnson & Johnson Consumer Inc. (J&JCI),Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,15
NCT03341468,1,0,0,0,1,0,2018-08-31,2019-08-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1699
NCT03344354,0,0,0,0,0,0,2019-12-31,2020-12-31,,Molnlycke Health Care AB,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,37
NCT03345472,0,0,0,0,0,0,2019-02-04,2020-02-04,,MedtronicNeuro,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,57
NCT03345823,0,0,0,0,0,0,2022-01-31,2023-01-31,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03349710,0,0,0,0,0,0,2019-10-06,2020-10-06,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,1,0,0,1,1,0,1104
NCT03350724,1,1,0,1,0,0,2017-05-19,2018-05-19,2018-02-19,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,490
NCT03352414,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03355482,0,0,0,0,0,0,2019-12-31,2020-12-31,,Oklahoma Medical Research Foundation,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03356977,0,0,0,0,0,0,2019-04-12,2020-04-12,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,2856
NCT03359863,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03360071,1,1,0,1,0,1,2018-06-30,2019-06-30,2019-07-01,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT03361956,0,0,0,0,0,0,2019-10-18,2020-10-18,,Janssen Sciences Ireland UC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,24
NCT03364114,0,0,0,0,0,0,2019-10-11,2020-10-11,,"Interscope, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,2
NCT03365635,0,0,0,0,0,0,2019-12-01,2020-12-01,,University of Pennsylvania,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03365791,0,0,0,0,0,0,2019-02-21,2020-02-21,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1895
NCT03370185,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Verastem, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,35
NCT03371017,0,0,0,0,0,0,2023-01-01,2024-01-01,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03372096,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03376854,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of Maryland, Baltimore",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,144
NCT03377803,0,0,0,0,0,0,2018-09-26,2019-09-26,,Verrica Pharmaceuticals Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,5
NCT03380377,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Stanley Jordan, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03381833,0,0,0,0,0,0,2019-10-31,2020-10-31,,La Jolla Pharmaceutical Company,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,18
NCT03382769,0,0,0,0,0,0,2021-08-02,2022-08-02,,Cochlear,Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,35
NCT03383458,0,0,0,0,0,0,2022-04-17,2023-04-17,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03386448,0,1,0,1,0,0,2018-11-20,2019-11-20,2019-05-10,The Taub Group,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03387449,0,0,0,0,0,0,2019-12-31,2020-12-31,,Blythedale Children's Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03389100,0,0,0,0,0,0,2022-06-30,2023-06-30,,Columbia University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03390231,0,0,0,0,0,0,2020-12-30,2021-12-30,,Tianhe Stem Cell Biotechnologies Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,0,0,0,0,1,0,2,1,0,6
NCT03391232,0,0,0,0,0,0,2021-03-30,2022-03-30,,Treos Bio Zrt,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1
NCT03391882,0,0,0,0,0,0,2020-03-24,2021-03-24,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,134
NCT03392532,1,1,0,1,0,0,2018-01-26,2019-01-26,2019-01-07,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03395314,0,0,0,0,0,0,2020-02-15,2021-02-15,,Yale University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03395613,1,0,0,0,1,0,2018-06-30,2019-06-30,,Karolinska University Hospital,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,180
NCT03396315,0,0,0,0,0,0,2023-01-01,2024-01-01,,Columbia University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03396926,0,0,0,0,0,0,2022-01-03,2023-01-03,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1443
NCT03397121,0,0,0,0,0,0,2019-08-27,2020-08-27,,The Medicines Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,59
NCT03398655,0,0,0,0,0,0,2022-12-31,2023-12-31,,Vascular Biogenics Ltd. operating as VBL Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03400332,0,0,0,0,0,0,2023-11-26,2024-11-26,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03404206,1,1,0,1,0,0,2018-07-06,2019-07-06,2019-06-27,Bayer,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1343
NCT03408873,0,0,0,0,0,0,2020-09-01,2021-09-01,,Martha Sajatovic,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03410797,0,0,0,0,0,0,2019-09-30,2020-09-30,,Jacqueline Gartner-Schmidt,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03412591,0,0,0,0,0,0,2020-06-14,2021-06-14,,Milton S. Hershey Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03417466,0,1,0,1,0,0,2018-09-20,2019-09-20,2019-06-26,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,48
NCT03425422,0,0,0,0,0,0,2021-12-31,2022-12-31,,LivaNova,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,43
NCT03425643,0,0,0,0,0,0,2024-01-20,2025-01-20,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03426865,0,0,0,0,0,0,2019-12-30,2020-12-30,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03427047,0,0,0,0,0,0,2021-01-01,2022-01-01,,Medacta USA,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT03428100,0,0,0,0,0,0,2019-11-28,2020-11-28,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03429712,0,0,0,0,0,0,2019-04-12,2020-04-12,,Duke University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT03430921,0,0,0,0,0,0,2018-09-30,2019-09-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03431350,0,0,0,0,0,0,2021-07-01,2022-07-01,,"Janssen Research & Development, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03432858,0,0,0,0,0,0,2022-12-31,2023-12-31,,WellSpan Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03433417,1,0,0,0,1,0,2018-03-15,2019-03-15,,Cutera Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03433703,0,0,0,0,0,0,2018-11-14,2019-11-14,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,328
NCT03435003,0,0,0,0,0,0,2019-08-20,2020-08-20,,Stony Brook University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,119
NCT03435796,0,0,0,0,0,0,2032-11-30,2033-11-30,,Celgene,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,0,0,0,0,0,1,1,1,0,306
NCT03436563,0,0,0,0,0,0,2019-11-01,2020-11-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03437369,0,0,0,0,0,0,2019-10-31,2020-10-31,,Hospital Universitario Ramon y Cajal,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,16
NCT03437928,0,0,0,0,0,0,2023-08-19,2024-08-19,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,518
NCT03443427,0,0,0,0,0,0,2020-05-19,2021-05-19,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,3276
NCT03445195,1,1,0,1,0,0,2018-05-17,2019-05-17,2019-05-14,Entasis Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,9
NCT03445754,0,0,0,0,0,0,2019-05-30,2020-05-30,,University of Oklahoma,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,234
NCT03446040,0,0,0,0,0,0,2023-07-04,2024-07-04,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03446326,0,0,0,0,0,0,2023-01-01,2024-01-01,,University of Calgary,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,361
NCT03449134,0,0,0,0,0,0,2020-07-10,2021-07-10,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03451851,0,0,0,0,0,0,2023-01-25,2024-01-25,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03454919,0,0,0,0,0,0,2019-12-31,2020-12-31,,Beijing Cancer Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,65
NCT03456089,0,0,0,0,0,0,2019-06-30,2020-06-30,,Christopher Cooper,Other,0,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,1
NCT03456908,0,0,0,0,0,0,2020-03-31,2021-03-31,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,1898
NCT03457636,0,1,0,1,0,0,2018-11-01,2019-11-01,2019-02-28,"Derm Research, PLLC",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03460470,0,0,0,0,0,0,2018-12-31,2019-12-31,,Hartford Hospital,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,65
NCT03461731,1,0,0,0,1,0,2017-07-30,2018-07-30,,College of Charleston,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03465111,0,0,0,0,0,0,2020-06-01,2021-06-01,,Metropolitan Eye Research & Surgery Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03465592,0,0,0,0,0,0,2022-03-31,2023-03-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03465735,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,1,0,0,0,0,1,0,0,0,1,1898
NCT03466060,1,0,1,1,0,0,2018-06-19,2019-06-19,2019-06-19,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03467750,0,0,0,0,0,0,2020-08-24,2021-08-24,,Emory University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03468075,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Mohammed Milhem, MBBS",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03472560,0,0,0,0,0,0,2020-09-18,2021-09-18,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03474107,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT03476811,0,0,0,0,0,0,2019-08-09,2020-08-09,,University of Arizona,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,265
NCT03477006,0,0,0,0,0,0,2021-11-30,2022-11-30,,Jason Sperry,Other,0,0,1,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03478696,0,0,0,0,0,0,2019-03-18,2020-03-18,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,1,0,0,0,0,1,1,0,3276
NCT03480802,0,0,0,0,0,0,2020-02-10,2021-02-10,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03481621,0,0,0,0,0,0,2020-12-31,2021-12-31,,"McLean Center for Complementary and Alternative Medicine, PLC",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03482011,0,0,0,0,0,0,2019-03-21,2020-03-21,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03483753,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Sao Paulo,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,767
NCT03484078,0,0,0,0,0,0,2022-05-31,2023-05-31,,University of Georgia,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,37
NCT03485131,1,0,0,0,1,0,2017-07-31,2018-07-31,,Manhattan Psychiatric Center,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,8
NCT03487588,0,0,1,1,0,0,2018-11-14,2019-11-14,2019-09-12,"Aclaris Therapeutics, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03487731,0,0,0,0,0,0,2025-12-01,2026-12-01,,Joshua M Hare,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,15
NCT03488563,0,0,0,0,0,0,2019-06-17,2020-06-17,,AOBiome LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,10
NCT03490838,0,0,0,0,0,0,2022-06-24,2023-06-24,,Advanced Accelerator Applications,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03492177,0,0,0,0,0,0,2020-09-30,2021-09-30,,Actelion,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03495427,0,0,0,0,0,0,2022-06-30,2023-06-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,344
NCT03495986,0,0,0,0,0,0,2022-04-30,2023-04-30,,Milton S. Hershey Medical Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,334
NCT03497026,1,0,0,0,1,0,2018-07-10,2019-07-10,,"Auris Health, Inc.",Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03499808,0,0,0,0,0,0,2021-10-30,2022-10-30,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,288
NCT03505021,0,0,0,0,0,0,2020-08-30,2021-08-30,,"Orion Corporation, Orion Pharma",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,86
NCT03509246,0,0,0,0,0,0,2022-03-31,2023-03-31,,Seoul National University Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1227
NCT03510715,0,0,0,0,0,0,2019-08-31,2020-08-31,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1222
NCT03511066,1,0,0,0,1,0,2018-04-30,2019-04-30,,Celltrion,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,31
NCT03511339,0,0,0,0,0,0,2020-01-31,2021-01-31,,TecTraum Inc.,Industry,1,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03515109,1,0,0,0,1,0,2018-03-25,2019-03-25,,Aretaieio Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,0,0,0,0,0,2,1,0,2
NCT03515304,0,0,0,0,0,0,2019-12-30,2020-12-30,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03515538,0,0,0,0,0,0,2019-07-31,2020-07-31,,"EpicentRx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,12
NCT03516487,0,0,0,0,0,0,2019-06-20,2020-06-20,,Synlogic,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03521869,1,0,0,0,1,0,2017-06-02,2018-06-02,,Rothman Institute Orthopaedics,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,58
NCT03522246,0,0,0,0,0,0,2024-12-30,2025-12-30,,"Clovis Oncology, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT03523351,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03525548,0,0,0,0,0,0,2018-12-28,2019-12-28,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03526432,0,0,0,0,0,0,2021-05-25,2022-05-25,,University of Oklahoma,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,234
NCT03531320,0,0,0,0,0,0,2019-10-31,2020-10-31,,InnoPharmax Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03533114,0,0,0,0,0,0,2020-09-30,2021-09-30,,Jazz Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,55
NCT03533517,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Ancora Heart, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03533946,0,0,0,0,0,0,2023-07-31,2024-07-31,,University of Utah,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03534219,0,0,0,0,0,0,2019-12-01,2020-12-01,,Northwell Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03537508,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,285
NCT03542110,0,0,0,0,0,0,2021-02-28,2022-02-28,,Minneapolis Heart Institute Foundation,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03542955,0,0,0,0,0,0,2019-07-30,2020-07-30,,BioElectronics Corporation,Industry,1,0,0,5.0,,0,2018.0,1,1,0,1,0,0,0,0,2,1,0,6
NCT03546491,1,1,0,1,0,1,2018-06-22,2019-06-22,2019-07-02,Procter and Gamble,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,59
NCT03546907,0,0,0,0,0,0,2019-10-02,2020-10-02,,Sanofi,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03547687,0,0,0,0,0,0,2021-05-31,2022-05-31,,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,475
NCT03548246,0,0,0,0,0,0,2024-08-31,2025-08-31,,University of Texas Southwestern Medical Center,Other,0,0,1,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03550209,0,0,0,0,0,0,2020-01-30,2021-01-30,,Sarah Keim,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03552380,0,0,0,0,0,0,2019-08-31,2020-08-31,,Roberto Pili,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03552705,0,0,0,0,0,0,2022-12-31,2023-12-31,,Stanford University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03553498,0,0,0,0,0,0,2019-07-31,2020-07-31,,Albert Einstein College of Medicine,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,155
NCT03554720,0,0,0,0,0,0,2019-12-31,2020-12-31,,Canadian Radiostereometric Analysis Network,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,3
NCT03555838,0,0,0,0,0,0,2019-01-01,2020-01-01,,Burke Medical Research Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,1,0,0,0,0,0,0,0,0,1,0,11
NCT03556384,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Adam Burgoyne, MD, PhD",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03556579,0,0,0,0,0,0,2018-09-20,2019-09-20,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03557294,0,0,0,0,0,0,2021-12-31,2022-12-31,,Arizona State University,Other,0,1,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,100
NCT03557931,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,135
NCT03558919,1,0,0,0,1,0,2017-12-30,2018-12-30,,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,0,1,41
NCT03560531,0,0,0,0,0,0,2020-06-30,2021-06-30,,Zeno Alpha Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03561090,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Ironwood Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,22
NCT03562494,0,0,0,0,0,0,2020-12-31,2021-12-31,,Neurocrine Biosciences,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,34
NCT03563105,0,0,0,0,0,0,2019-05-01,2020-05-01,,Modulated Imaging Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03563248,0,0,0,0,0,0,2021-12-31,2022-12-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1699
NCT03564340,0,0,0,0,0,0,2022-05-05,2023-05-05,,Regeneron Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03565666,0,1,0,1,0,0,2018-11-19,2019-11-19,2019-04-15,Massachusetts General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,1699
NCT03566641,0,0,0,0,0,0,2019-04-01,2020-04-01,,University of Toledo Health Science Campus,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,31
NCT03566823,0,0,0,0,0,0,2021-08-27,2022-08-27,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,342
NCT03571620,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Qurient Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03571737,0,0,0,0,0,0,2018-12-30,2019-12-30,,East Carolina University,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,51
NCT03573102,0,0,0,0,0,0,2019-03-31,2020-03-31,,Nahla H Tohami,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03573557,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT03573908,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Ironwood Pharmaceuticals, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,22
NCT03574571,0,0,0,0,0,0,2022-06-30,2023-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1432
NCT03575195,0,0,0,0,0,0,2020-09-30,2021-09-30,,"University of California, San Francisco",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03575351,0,0,0,0,0,0,2023-05-20,2024-05-20,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,1,1,1,0,306
NCT03575897,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Alabama at Birmingham,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,801
NCT03577431,0,0,0,0,0,0,2025-02-28,2026-02-28,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03579407,0,0,0,0,0,0,2020-01-01,2021-01-01,,Advanced Orthopaedic Specialists,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,1
NCT03579901,0,0,0,0,0,0,2020-03-30,2021-03-30,,Motiva USA LLC,Industry,1,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT03581084,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03581279,0,0,0,0,0,0,2019-10-31,2020-10-31,,T2 Biosystems,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03581591,0,0,0,0,0,0,2019-06-30,2020-06-30,,Redwood Dermatology Sciences,Other,0,1,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,1
NCT03583372,0,0,0,0,0,0,2020-01-05,2021-01-05,,Urovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03584022,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03584217,0,0,0,0,0,0,2023-06-30,2024-06-30,,University of Colorado Denver School of Medicine Barbara Davis Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03588091,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Jiangsu HengRui Medicine Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,187
NCT03588624,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Sight Sciences, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03588871,0,0,0,0,0,0,2019-05-01,2020-05-01,,Grupo de Investigação em Bioquímica e Biologia Oral,Other,0,1,0,4.0,Phase 4,0,2017.0,1,0,0,0,0,0,0,0,2,1,0,4
NCT03590652,0,0,0,0,0,0,2020-10-01,2021-10-01,,"Caitlin Costello, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03593915,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Tolero Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,9
NCT03595371,0,0,0,0,0,0,2020-06-30,2021-06-30,,Olatec Therapeutics LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03595579,0,0,0,0,0,0,2019-01-07,2020-01-07,,"Axsome Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03596762,0,0,0,0,0,0,2019-11-30,2020-11-30,,Nerre Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03597022,0,0,0,0,0,0,2019-11-05,2020-11-05,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1343
NCT03598608,0,0,0,0,0,0,2025-07-18,2026-07-18,,Merck Sharp & Dohme Corp.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03599089,0,0,0,0,0,0,2018-10-10,2019-10-10,,Concentric Analgesics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03599713,0,0,0,0,0,0,2020-09-30,2021-09-30,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03600116,0,0,0,0,0,0,2018-11-20,2019-11-20,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03600350,0,0,0,0,0,0,2020-10-31,2021-10-31,,"University of Wisconsin, Madison",Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,715
NCT03602014,0,0,0,0,0,0,2019-12-31,2020-12-31,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,41
NCT03602898,0,0,0,0,0,0,2023-09-17,2024-09-17,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,393
NCT03605836,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,185
NCT03606460,0,0,0,0,0,0,2019-05-01,2020-05-01,,"Genentech, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,427
NCT03609398,0,0,0,0,0,0,2023-12-31,2024-12-31,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,136
NCT03609580,0,0,0,0,0,0,2020-05-02,2021-05-02,,Hackensack Meridian Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,55
NCT03610464,1,1,0,1,0,0,2018-05-23,2019-05-23,2019-05-16,"Tris Pharma, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03610763,0,0,0,0,0,0,2019-09-14,2020-09-14,,University of Missouri-Columbia,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,214
NCT03612570,0,0,0,0,0,0,2018-11-28,2019-11-28,,"Pulse Biosciences, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03613727,0,0,0,0,0,0,2021-10-31,2022-10-31,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03615326,0,0,0,0,0,0,2023-06-01,2024-06-01,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03617536,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Cara Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03617926,1,0,0,0,1,0,2018-06-30,2019-06-30,,Oystershell NV,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03619837,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03620747,0,0,0,0,0,0,2021-09-30,2022-09-30,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03621787,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Michigan,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03623243,0,0,0,0,0,0,2020-01-14,2021-01-14,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1895
NCT03624478,0,0,0,0,0,0,2020-08-17,2021-08-17,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,1898
NCT03627052,0,0,0,0,0,0,2021-02-28,2022-02-28,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03628144,0,0,0,0,0,0,2022-09-30,2023-09-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,344
NCT03628560,0,0,0,0,0,0,2019-11-30,2020-11-30,,Duke University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03628911,0,0,0,0,0,0,2019-09-01,2020-09-01,,EP Sciences,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03629535,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03630081,0,0,0,0,0,0,2020-12-25,2021-12-25,,Wockhardt,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,32
NCT03632109,0,0,0,0,0,0,2019-03-12,2020-03-12,,University of Washington,Other,0,0,1,2.0,Phase 2/Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03632941,0,0,0,0,0,0,2020-10-31,2021-10-31,,Herbert Lyerly,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03638947,0,0,0,0,0,0,2020-10-01,2021-10-01,,Randy Loftus,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03639701,0,0,0,0,0,0,2024-04-01,2025-04-01,,Columbia University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03639948,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Kansas Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03641469,0,0,0,0,0,0,2020-05-24,2021-05-24,,National Scoliosis Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03642210,0,0,0,0,0,0,2021-01-01,2022-01-01,,Medicines360,Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,2
NCT03647774,0,0,0,0,0,0,2023-08-31,2024-08-31,,Lars Tanum,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03650400,0,0,0,0,0,0,2020-01-28,2021-01-28,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03651128,0,0,0,0,0,0,2025-06-23,2026-06-23,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,306
NCT03651830,0,0,0,0,0,0,2020-09-30,2021-09-30,,Seattle Institute for Biomedical and Clinical Research,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,40
NCT03653169,0,0,0,0,0,0,2020-06-30,2021-06-30,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,698
NCT03653325,0,0,0,0,0,0,2020-03-31,2021-03-31,,Centre Hospitalier Universitaire Saint Pierre,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,43
NCT03654755,0,0,0,0,0,0,2021-08-31,2022-08-31,,Asana BioSciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03655717,0,0,0,0,0,0,2020-09-17,2021-09-17,,Massachusetts General Hospital,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03656718,0,0,0,0,0,0,2021-09-26,2022-09-26,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03657095,0,0,0,0,0,0,2019-08-31,2020-08-31,,Lung Biotechnology PBC,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,8
NCT03657433,0,0,0,0,0,0,2019-08-30,2020-08-30,,University of Arizona,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,265
NCT03658811,0,1,0,1,0,0,2018-10-30,2019-10-30,2018-12-06,Toyos Clinic,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03663179,0,0,1,1,0,0,2019-03-31,2020-03-31,2019-09-09,University of Pennsylvania,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03663582,0,0,0,0,0,0,2019-08-16,2020-08-16,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,1,0,0,0,0,2,1,0,342
NCT03664232,0,0,0,0,0,0,2021-02-17,2022-02-17,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,558
NCT03668600,0,0,0,0,0,0,2019-07-03,2020-07-03,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03670225,0,0,0,0,0,0,2019-10-20,2020-10-20,,Medela AG,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03670810,0,0,0,0,0,0,2020-03-26,2021-03-26,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03674320,0,0,0,0,0,0,2022-08-01,2023-08-01,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,158
NCT03677375,0,1,0,1,0,0,2019-02-04,2020-02-04,2019-04-19,Masimo Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03679884,0,0,0,0,0,0,2020-07-01,2021-07-01,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03682276,0,0,0,0,0,0,2020-12-01,2021-12-01,,Imperial College London,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,515
NCT03682770,0,0,0,0,0,0,2020-06-01,2021-06-01,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03684707,0,0,0,0,0,0,2019-06-15,2020-06-15,,Ain Shams University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,460
NCT03687125,0,0,0,0,0,0,2019-03-15,2020-03-15,,Mundipharma-EDO GmbH,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,3
NCT03688711,0,0,0,0,0,0,2019-03-11,2020-03-11,,Zealand Pharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03689244,0,0,0,0,0,0,2022-02-01,2023-02-01,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03690466,0,0,0,0,0,0,2020-03-17,2021-03-17,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03691571,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pennsylvania,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03693430,0,0,0,0,0,0,2021-01-29,2022-01-29,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03694210,0,0,0,0,0,0,2019-08-22,2020-08-22,,"Interscope, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,1,1,0,2
NCT03695250,0,0,0,0,0,0,2021-12-01,2022-12-01,,Edward Kim,Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3
NCT03697148,0,0,0,0,0,0,2020-08-01,2021-08-01,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,75
NCT03698409,0,0,0,0,0,0,2019-06-01,2020-06-01,,State University of New York - Upstate Medical University,Other,0,0,0,4.0,Phase 4,0,2019.0,1,0,0,0,0,0,0,0,3,1,0,125
NCT03699176,0,0,0,0,0,0,2021-09-13,2022-09-13,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1343
NCT03699930,0,0,0,0,0,0,2020-01-01,2021-01-01,,Casa Colina Hospital and Centers for Healthcare,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03701919,0,0,0,0,0,0,2020-04-01,2021-04-01,,Albany Medical College,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03703791,0,0,0,0,0,0,2018-11-23,2019-11-23,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,1,2018.0,1,0,1,0,0,0,0,0,2,1,0,11
NCT03705065,0,0,0,0,0,0,2018-10-08,2019-10-08,,Heron Therapeutics,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03705962,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Virginia,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,402
NCT03706079,0,0,0,0,0,0,2022-03-25,2023-03-25,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03707847,0,0,0,0,0,0,2020-02-01,2021-02-01,,Mingzhi Zhang,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,13
NCT03709576,0,0,0,0,0,0,2020-01-31,2021-01-31,,Milton S. Hershey Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03709823,0,0,0,0,0,0,2019-04-23,2020-04-23,,Achieve Life Sciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,23
NCT03712189,0,0,0,0,0,0,2019-05-31,2020-05-31,,Children's Hospital Los Angeles,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,82
NCT03712878,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,162
NCT03713632,0,0,0,0,0,0,2021-07-09,2022-07-09,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03714178,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Farapulse, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03714659,1,1,0,1,0,1,2018-03-01,2019-03-01,2019-08-19,"New Jersey Regenerative Institute, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,0,1,0,0,0,0,3,0,1,1
NCT03716102,0,0,0,0,0,0,2019-07-15,2020-07-15,,"Svelte Medical Systems, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03716349,0,0,0,0,0,0,2021-10-01,2022-10-01,,Erica Teixeira,Other,0,0,0,5.0,,0,2019.0,0,1,0,1,1,1,0,0,0,1,0,1
NCT03718039,0,0,0,0,0,0,2019-01-31,2020-01-31,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,18
NCT03719313,0,0,0,0,0,0,2021-04-01,2022-04-01,,Eiger BioPharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,13
NCT03720899,0,0,0,0,0,0,2021-03-03,2022-03-03,,University of Alabama at Birmingham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03721172,0,0,0,0,0,0,2020-01-17,2021-01-17,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03722147,0,0,0,0,0,0,2020-03-01,2021-03-01,,Akeso,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,6
NCT03722485,0,0,0,0,0,0,2020-06-30,2021-06-30,,"KCI USA, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,1,1,0,0,0,0,0,1,0,23
NCT03723551,0,0,0,0,0,0,2020-07-23,2021-07-23,,Debiopharm International SA,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT03727100,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Sollis Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,2
NCT03733067,0,0,0,0,0,0,2026-06-30,2027-06-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03733249,0,0,0,0,0,0,2021-06-30,2022-06-30,,Bellicum Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,2,1,0,15
NCT03735004,0,0,0,0,0,0,2020-08-31,2021-08-31,,Stanford University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03735628,0,0,0,0,0,0,2021-04-30,2022-04-30,,Bayer,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03737214,0,0,0,0,0,0,2022-06-22,2023-06-22,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03737643,0,0,0,0,0,0,2022-05-18,2023-05-18,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03740243,0,0,0,0,0,0,2020-06-30,2021-06-30,,Stony Brook University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,119
NCT03742414,0,0,0,0,0,0,2020-04-30,2021-04-30,,Stanford University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,0,0,1,0,1,1,0,1309
NCT03742661,0,0,0,0,0,0,2021-01-31,2022-01-31,,Brain Sentinel,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT03743766,0,0,0,0,0,0,2020-10-31,2021-10-31,,John Kirkwood,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03744663,0,0,0,0,0,0,2020-03-31,2021-03-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03745768,0,0,0,0,0,0,2020-02-28,2021-02-28,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03747640,0,0,0,0,0,0,2019-11-01,2020-11-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT03750344,0,0,0,0,0,0,2018-11-09,2019-11-09,,ChroniSense Medical Ltd.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03750955,0,0,0,0,0,0,2019-06-03,2020-06-03,,University of Washington,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03752242,0,0,0,0,0,0,2022-09-30,2023-09-30,,"BioMimetix JV, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03759197,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03760666,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Clear Creek Bio, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03761056,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Kite, A Gilead Company",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,14
NCT03761264,0,0,0,0,0,0,2019-12-15,2020-12-15,,University of Malaya,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,109
NCT03762213,0,0,0,0,0,0,2019-08-29,2020-08-29,,Tufts Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,121
NCT03766295,0,0,0,0,0,0,2020-06-30,2021-06-30,,AB Science,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,2,0,1,30
NCT03767270,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Translate Bio, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,2
NCT03767439,0,0,0,0,0,0,2019-12-31,2020-12-31,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,675
NCT03768505,0,0,0,0,0,0,2020-12-31,2021-12-31,,"MEI Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03769298,0,0,0,0,0,0,2022-10-31,2023-10-31,,"University of Wisconsin, Madison",Other,0,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03769506,0,0,0,0,0,0,2020-12-15,2021-12-15,,"Rakuten Medical, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,1,0,1,1,0,2
NCT03770403,0,0,0,0,0,0,2021-06-30,2022-06-30,,argenx BVBA,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,12
NCT03773978,0,0,0,0,0,0,2021-08-21,2022-08-21,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03776071,0,0,0,0,0,0,2022-06-30,2023-06-30,,Denovo Biopharma LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,3,1,0,2
NCT03776357,0,0,0,0,0,0,2023-06-30,2024-06-30,,Derek Amanatullah,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03776747,0,0,0,0,0,0,2020-12-31,2021-12-31,,Eric A. Hoffman,Other,0,0,1,4.0,Phase 4,0,2008.0,0,1,0,0,1,0,0,0,0,0,1,5
NCT03777657,0,0,0,0,0,0,2022-08-31,2023-08-31,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03781583,0,0,0,0,0,0,2020-03-31,2021-03-31,,James Weiland,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03781765,0,0,0,0,0,0,2023-07-31,2024-07-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03782792,0,0,0,0,0,0,2021-06-08,2022-06-08,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03783442,0,0,0,0,0,0,2021-03-30,2022-03-30,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03785678,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Genentech, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,427
NCT03788616,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Marina F Fahmy, MD",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03789240,0,0,0,0,0,0,2027-01-01,2028-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03791619,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Johnson & Johnson Surgical Vision, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03792620,0,0,0,0,0,0,2020-05-31,2021-05-31,,Grupo de Estudos Multicentricos em Onco-Hematologia,Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,2,1,0,7
NCT03792945,0,0,0,0,0,0,2019-04-30,2020-04-30,,Ahi Evran University Education and Research Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,1,1,0,1,0,0,0,0,2,1,0,4
NCT03793140,0,0,0,0,0,0,2021-12-31,2022-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03794544,0,0,0,0,0,0,2022-01-21,2023-01-21,,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,1,0,1,1,0,269
NCT03796598,0,0,0,0,0,0,2023-06-01,2024-06-01,,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03797209,0,0,0,0,0,0,2020-10-30,2021-10-30,,Boston Scientific Japan K.K.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03798366,0,0,0,0,0,0,2020-05-31,2021-05-31,,Galapagos NV,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03799874,0,0,0,0,0,0,2022-12-31,2023-12-31,,Brigham and Women's Hospital,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03800784,0,0,0,0,0,0,2023-01-01,2024-01-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03802201,0,0,0,0,0,0,2020-02-29,2021-02-28,,Protagonist Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03802916,0,0,0,0,0,0,2019-08-31,2020-08-31,,ApoPharma,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,25
NCT03806127,0,0,0,0,0,0,2020-03-31,2021-03-31,,Urovant Sciences GmbH,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03807089,1,1,0,1,0,1,2017-05-11,2018-05-11,2019-05-29,Massachusetts General Hospital,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,3,0,1,1699
NCT03809533,0,0,0,0,0,0,2024-05-01,2025-05-01,,"Amit D Tevar, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03810417,0,0,0,0,0,0,2021-09-30,2022-09-30,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,144
NCT03810573,0,0,0,0,0,0,2022-06-30,2023-06-30,,Bone Biologics Corp,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03811847,0,0,0,0,0,0,2021-01-30,2022-01-30,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03812341,0,0,0,0,0,0,2019-04-10,2020-04-10,,"University of California, Irvine",Other,0,0,0,5.0,,0,2018.0,1,0,0,0,0,0,0,0,0,1,0,310
NCT03812510,0,0,0,0,0,0,2019-11-15,2020-11-15,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03813251,0,0,0,0,0,0,2019-08-31,2020-08-31,,ForConti Medical,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,3,1,0,2
NCT03814824,0,0,0,0,0,0,2020-01-31,2021-01-31,,Northwell Health,Other,0,1,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,271
NCT03815552,0,0,0,0,0,0,2019-12-31,2020-12-31,,Kinderkrankenhaus auf der Bult,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,11
NCT03815825,0,0,0,0,0,0,2022-10-31,2023-10-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,69
NCT03816709,0,0,0,0,0,0,2019-02-15,2020-02-15,,North Dakota State University,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,12
NCT03816891,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Kiniksa Pharmaceuticals, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03817411,0,0,0,0,0,0,2020-03-30,2021-03-30,,"EddingPharm Oncology Co., LTD.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03817606,0,0,0,0,0,0,2021-02-28,2022-02-28,,Riverside Medical Center,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03818191,0,0,0,0,0,0,2022-12-31,2023-12-31,,Mayo Clinic,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03818854,0,0,0,0,0,0,2023-07-01,2024-07-01,,Michael A. Matthay,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03819231,0,0,0,0,0,0,2023-12-31,2024-12-31,,University of Southern California,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03821246,0,0,0,0,0,0,2021-09-30,2022-09-30,,Lawrence Fong,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03824808,0,0,0,0,0,0,2020-02-01,2021-02-01,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03827213,0,0,0,0,0,0,2019-03-29,2020-03-29,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,1,1,0,1,0,0,0,0,0,1,0,240
NCT03827408,0,0,0,0,0,0,2019-04-30,2020-04-30,,Nourhan M.Aly,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT03828058,0,0,0,0,0,0,2022-12-31,2023-12-31,,Methodist Healthcare,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03829332,0,0,0,0,0,0,2022-03-08,2023-03-08,,Merck Sharp & Dohme Corp.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03830515,0,0,0,0,0,0,2019-10-31,2020-10-31,,"KitoTech Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03832959,0,0,0,0,0,0,2019-11-30,2020-11-30,,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,179
NCT03834571,0,0,0,0,0,0,2025-01-31,2026-01-31,,AIDS Malignancy Consortium,Other,0,0,1,1.0,Phase 2,0,2020.0,0,1,0,0,0,1,0,0,2,1,0,46
NCT03835260,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Jennifer Marler, MD",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03837756,0,0,0,0,0,0,2020-07-01,2021-07-01,,University of Aarhus,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,831
NCT03839355,0,0,0,0,0,0,2022-12-31,2023-12-31,,Mayo Clinic,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03840148,0,0,0,0,0,0,2020-07-31,2021-07-31,,"VenatoRx Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03840993,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Mitsubishi Tanabe Pharma Development America, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03842943,0,0,0,0,0,0,2021-03-01,2022-03-01,,University of Louisville,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,214
NCT03843437,0,0,0,0,0,0,2020-09-28,2021-09-28,,Johns Hopkins University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03844620,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03845231,0,0,0,0,0,0,2020-03-19,2021-03-19,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03849820,0,0,0,0,0,0,2021-02-28,2022-02-28,,Intuitive Surgical,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,18
NCT03850730,0,0,0,0,0,0,2023-09-30,2024-09-30,,Cure HHT,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03852524,0,0,0,0,0,0,2020-12-01,2021-12-01,,Ohio State University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03860753,0,0,0,0,0,0,2019-12-31,2020-12-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03866551,0,0,0,0,0,0,2019-12-01,2020-12-01,,"CardioRenal Systems, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT03869372,0,0,0,0,0,0,2022-01-31,2023-01-31,,David Levinthal,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03869905,0,0,0,0,0,0,2022-12-31,2023-12-31,,James Varani,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03875053,0,0,0,0,0,0,2019-11-30,2020-11-30,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,134
NCT03875859,0,0,0,0,0,0,2021-04-01,2022-04-01,,Kavita Sarin,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03876808,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Missouri-Columbia,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT03877042,0,0,0,0,0,0,2021-12-31,2022-12-31,,Xijing Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,178
NCT03877406,0,0,0,0,0,0,2019-12-31,2020-12-31,,Seoul National University Bundang Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,221
NCT03877926,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Emergent Product Development Gaithersburg, Inc.",Industry,1,0,1,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03878277,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Colorado Denver School of Medicine Barbara Davis Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03880565,0,0,0,0,0,0,2023-01-01,2024-01-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03883386,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03887026,0,0,0,0,0,0,2019-05-18,2020-05-18,,"Emergo Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03890367,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,285
NCT03891381,0,0,0,0,0,0,2020-12-28,2021-12-28,,NorthShore University HealthSystem,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,61
NCT03892980,0,0,0,0,0,0,2020-07-31,2021-07-31,,Intuitive Surgical,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,18
NCT03893630,0,0,0,0,0,0,2020-06-30,2021-06-30,,"John O'Brien, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03894007,0,0,0,0,0,0,2024-12-31,2025-12-31,,Renske Altena,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03896438,0,0,0,0,0,0,2024-04-30,2025-04-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03896633,0,0,0,0,0,0,2018-11-17,2019-11-17,,"Bausch Health Americas, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,180
NCT03897257,0,0,0,0,0,0,2019-11-29,2020-11-29,,"Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03899883,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Colorado Denver School of Medicine Barbara Davis Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03900468,0,0,0,0,0,0,2027-03-31,2028-03-31,,MedtronicNeuro,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,57
NCT03902184,0,0,0,0,0,0,2022-03-01,2023-03-01,,Innate Pharma,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,13
NCT03902496,0,0,0,0,0,0,2019-05-17,2020-05-17,,"Avulux, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03902951,0,0,0,0,0,0,2021-07-01,2022-07-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,277
NCT03903718,0,0,0,0,0,0,2020-10-09,2021-10-09,,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,1,0,0,0,0,0,0,1,0,269
NCT03904147,0,0,0,0,0,0,2022-08-31,2023-08-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,419
NCT03905681,0,0,0,0,0,0,2019-05-16,2020-05-16,,William Beaumont Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,9
NCT03905863,0,0,0,0,0,0,2020-01-25,2021-01-25,,Inotec AMD Limited,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03906448,0,0,0,0,0,0,2022-04-30,2023-04-30,,University of Florida,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,849
NCT03912805,0,0,0,0,0,0,2019-05-02,2020-05-02,,Eirion Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03913689,0,0,0,0,0,0,2027-04-30,2028-04-30,,Bioness Inc,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,8
NCT03915444,0,0,0,0,0,0,2020-04-15,2021-04-15,,HonorHealth Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03916068,0,0,0,0,0,0,2021-05-01,2022-05-01,,Legacy Health System,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,26
NCT03916627,0,0,0,0,0,0,2022-06-20,2023-06-20,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03917719,0,0,0,0,0,0,2022-06-30,2023-06-30,,Catabasis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03918590,0,0,1,1,0,0,2019-05-01,2020-05-01,2019-05-19,The New York Eye & Ear Infirmary,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT03920293,0,0,0,0,0,0,2021-12-31,2022-12-31,,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,86
NCT03920644,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Naval Aeromedical Research Unit, Dayton",U.S. Fed,2,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03923868,0,0,0,0,0,0,2020-05-01,2021-05-01,,InventisBio Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03924245,0,0,0,0,0,0,2022-12-31,2023-12-31,,Vanderbilt-Ingram Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03927690,0,0,0,0,0,0,2020-11-09,2021-11-09,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03929211,0,0,0,0,0,0,2021-09-30,2022-09-30,,Wake Forest University Health Sciences,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03930771,0,0,0,0,0,0,2023-09-01,2024-09-01,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03933904,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03935971,0,0,0,0,0,0,2021-09-30,2022-09-30,,Brigham and Women's Hospital,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,698
NCT03936699,0,0,0,0,0,0,2019-05-30,2020-05-30,,"Elira Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03936894,0,0,0,0,0,0,2020-04-30,2021-04-30,,Children's Research Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03938454,0,0,0,0,0,0,2021-05-21,2022-05-21,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03938740,0,0,0,0,0,0,2019-12-20,2020-12-20,,Diasome Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03939533,0,0,0,0,0,0,2021-03-31,2022-03-31,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,54
NCT03939897,0,0,0,0,0,0,2021-04-30,2022-04-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03940586,0,0,0,0,0,0,2023-03-22,2024-03-22,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03941730,0,0,0,0,0,0,2022-04-30,2023-04-30,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03942653,0,0,0,0,0,0,2022-01-31,2023-01-31,,Big Ten Cancer Research Consortium,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03943446,0,0,0,0,0,0,2021-09-08,2022-09-08,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03944707,0,0,0,0,0,0,2020-12-28,2021-12-28,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1895
NCT03944915,0,0,0,0,0,0,2022-07-01,2023-07-01,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,594
NCT03945292,0,0,0,0,0,0,2023-05-01,2024-05-01,,Arrowhead Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03946904,0,0,0,0,0,0,2019-04-15,2020-04-15,,Chen Laser Institute,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03948412,0,0,0,0,0,0,2021-05-31,2022-05-31,,Royal North Shore Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,16
NCT03948646,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Brickell Biotech, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,11
NCT03950492,0,0,0,0,0,0,2020-09-30,2021-09-30,,West Virginia University,Other,0,1,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,74
NCT03952117,0,0,0,0,0,0,2021-06-30,2022-06-30,,Lebanese American University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,8
NCT03952299,0,0,0,0,0,0,2025-12-31,2026-12-31,,"University of California, Davis",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03955458,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,53
NCT03958201,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Washington,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,0,0,0,0,0,3,1,0,910
NCT03959683,0,0,0,0,0,0,2020-09-30,2021-09-30,,Indiana University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,497
NCT03961360,0,0,0,0,0,0,2020-05-01,2021-05-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03961698,0,0,0,0,0,0,2022-08-01,2023-08-01,,"Infinity Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,21
NCT03965962,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,285
NCT03968159,0,0,0,0,0,0,2021-05-31,2022-05-31,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03969251,0,0,0,0,0,0,2021-03-31,2022-03-31,,Nassima Ait-Daoud Tiouririne,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03969992,0,0,0,0,0,0,2020-03-01,2021-03-01,,Aerogen Pharma Limited,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03970512,0,0,0,0,0,0,2019-10-30,2020-10-30,,"Lentechs, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03971227,0,0,0,0,0,0,2019-09-01,2020-09-01,,"Acuity Polymers, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03971422,0,0,0,0,0,0,2021-01-31,2022-01-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,75
NCT03971617,0,0,0,0,0,0,2022-06-01,2023-06-01,,Stony Brook University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,119
NCT03972202,0,0,0,0,0,0,2022-01-01,2023-01-01,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,1,0,0,0,0,1,0,1443
NCT03973697,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03974100,0,0,0,0,0,0,2021-12-28,2022-12-28,,Sandoz,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,120
NCT03976323,0,0,0,0,0,0,2024-08-13,2025-08-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03979313,0,0,0,0,0,0,2022-05-02,2023-05-02,,MedImmune LLC,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,269
NCT03982030,0,0,0,0,0,0,2021-01-31,2022-01-31,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,616
NCT03984045,0,0,0,0,0,0,2021-06-30,2022-06-30,,Newark Beth Israel Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03984448,0,0,0,0,0,0,2028-04-01,2029-04-01,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,3004
NCT03987919,0,0,0,0,0,0,2021-03-23,2022-03-23,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03992482,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Sandeep Jain, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03993938,0,0,0,0,0,0,2019-12-01,2020-12-01,,Henry Ford Health System,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,151
NCT03994796,0,0,0,0,0,0,2021-07-31,2022-07-31,,Alliance for Clinical Trials in Oncology,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,456
NCT03996369,0,0,0,0,0,0,2021-11-30,2022-11-30,,Arena Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,21
NCT03996876,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03997812,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Vivozon, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03998319,0,0,0,0,0,0,2023-12-31,2024-12-31,,University of Sydney,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,60
NCT03999515,0,0,0,0,0,0,2021-03-12,2022-03-12,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT04001413,0,0,0,0,0,0,2024-09-30,2025-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT04002115,0,0,0,0,0,0,2021-08-31,2022-08-31,,Milton S. Hershey Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,334
NCT04002362,0,0,0,0,0,0,2024-06-30,2025-06-30,,Emory University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT04002999,0,0,0,0,0,0,2020-12-31,2021-12-31,,Harvard School of Dental Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT04003207,0,0,0,0,0,0,2020-04-30,2021-04-30,,Swathi Sethuram,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04003389,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT04006158,0,0,0,0,0,0,2020-12-31,2021-12-31,,"LED Intellectual Properties, LLC",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04006847,0,0,0,0,0,0,2021-08-01,2022-08-01,,Milton S. Hershey Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,334
NCT04007991,0,0,0,0,0,0,2020-09-30,2021-09-30,,Emalex Biosciences Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04013334,0,0,0,0,0,0,2020-09-20,2021-09-20,,Momotaro-Gene Inc.,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT04013789,0,0,0,0,0,0,2019-11-30,2020-11-30,,Alcon Research,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,492
NCT04014530,0,0,0,0,0,0,2021-08-01,2022-08-01,,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,229
NCT04016805,0,0,0,0,0,0,2022-07-31,2023-07-31,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT04018755,0,0,0,0,0,0,2021-10-31,2022-10-31,,Los Angeles Biomedical Research Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,60
NCT04019561,0,0,0,0,0,0,2020-10-15,2021-10-15,,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,269
NCT04020887,0,0,0,0,0,0,2020-02-01,2021-02-01,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT04021108,0,0,0,0,0,0,2022-01-08,2023-01-08,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT04022213,0,0,0,0,0,0,2024-07-31,2025-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT04024072,0,0,0,0,0,0,2020-01-31,2021-01-31,,Perrigo Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,39
NCT04026958,0,0,0,0,0,0,2024-07-31,2025-07-31,,Emory University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT04029480,0,0,0,0,0,0,2025-06-30,2026-06-30,,Merck Sharp & Dohme Corp.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,2145
NCT04030091,0,0,0,0,0,0,2019-11-30,2020-11-30,,Sciema UG,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT04031729,0,0,0,0,0,0,2024-01-31,2025-01-31,,Massachusetts General Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT04032132,1,0,0,0,1,0,2018-05-06,2019-05-06,,Ain Shams University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,460
NCT04033588,0,0,0,0,0,0,2024-09-01,2025-09-01,,Meril Life Sciences Pvt. Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,8
NCT04034927,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,3004
NCT04035187,0,0,0,0,0,0,2020-09-01,2021-09-01,,"University of Maryland, Baltimore",Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,144
NCT04035434,0,0,0,0,0,0,2026-07-31,2027-07-31,,CRISPR Therapeutics AG,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,1
NCT04038489,0,0,0,0,0,0,2023-03-31,2024-03-31,,University of Virginia,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT04039386,0,0,0,0,0,0,2020-08-01,2021-08-01,,Michael C Willey,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04041063,0,0,0,0,0,0,2022-12-31,2023-12-31,,Burke Medical Research Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT04043195,0,0,0,0,0,0,2023-12-31,2024-12-31,,Hatim Husain,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04046055,0,0,0,0,0,0,2020-04-01,2021-04-01,,Craig Workman,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04047797,0,0,0,0,0,0,2022-06-01,2023-06-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT04049097,0,0,0,0,0,0,2022-05-22,2023-05-22,,Orphazyme,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT04049305,0,0,0,0,0,0,2020-02-28,2021-02-28,,Changhua Christian Hospital,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,44
NCT04049643,0,0,0,0,0,0,2020-08-31,2021-08-31,,Yu-Hsiang Wu,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT04050280,0,0,0,0,0,0,2022-09-30,2023-09-30,,"University of Maryland, Baltimore",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,144
NCT04050696,0,0,0,0,0,0,2020-06-30,2021-06-30,,BrainQ Technologies Ltd.,Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,2
NCT04051606,0,0,0,0,0,0,2020-12-31,2021-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT04053634,0,0,0,0,0,0,2023-11-20,2024-11-20,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT04054973,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of Massachusetts, Worcester",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT04055428,0,0,0,0,0,0,2024-09-30,2025-09-30,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,801
NCT04056013,0,0,0,0,0,0,2021-09-01,2022-09-01,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT04057040,0,0,0,0,0,0,2021-02-28,2022-02-28,,Protagonist Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT04058145,0,0,0,0,0,0,2022-08-31,2023-08-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT04058353,0,0,0,0,0,0,2020-10-31,2021-10-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,141
NCT04058743,0,0,0,0,0,0,2020-09-01,2021-09-01,,Rush University Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,227
NCT04061148,0,0,0,0,0,0,2019-12-30,2020-12-30,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT04062318,0,0,0,0,0,0,2021-08-31,2022-08-31,,Brown University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,152
NCT04063358,0,0,0,0,0,0,2021-08-31,2022-08-31,,Second Military Medical University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,21
NCT04063709,0,0,0,0,0,0,2023-07-16,2024-07-16,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,910
NCT04065711,0,0,0,0,0,0,2019-12-12,2020-12-12,,Soliton,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT04066894,0,0,0,0,0,0,2025-07-31,2026-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2066
NCT04067830,0,0,0,0,0,0,2023-01-22,2024-01-22,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,294
NCT04068753,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Oklahoma,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,234
NCT04068948,0,0,0,0,0,0,2020-06-20,2021-06-20,,University of Washington,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT04069260,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Eloxx Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT04072783,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Arkansas,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,285
NCT04074265,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT04074590,0,0,0,0,0,0,2021-04-01,2022-04-01,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT04074967,0,0,0,0,0,0,2021-10-30,2022-10-30,,"Jason J. Luke, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04075604,0,0,0,0,0,0,2021-05-31,2022-05-31,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT04076891,0,0,0,0,0,0,2019-05-02,2020-05-02,,Raziel Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT04079296,0,0,0,0,0,0,2023-02-28,2024-02-28,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,135
NCT04080128,0,0,0,0,0,0,2025-07-01,2026-07-01,,Ohio State University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT04080505,0,0,0,0,0,0,2020-12-31,2021-12-31,,Columbia University,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT04083170,0,0,0,0,0,0,2022-12-31,2023-12-31,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,393
NCT04086121,0,0,0,0,0,0,2021-09-20,2022-09-20,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1852
NCT04086693,0,0,0,0,0,0,2020-10-31,2021-10-31,,William Beaumont Hospitals,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,84
NCT04087720,0,0,0,0,0,0,2021-03-31,2022-03-31,,Horizon Pharma Rheumatology LLC,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT00003816,0,0,0,0,0,0,2019-08-01,2020-08-01,,Roswell Park Cancer Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,1998.0,0,1,1,0,0,1,0,0,0,0,1,294
NCT00042289,0,0,0,0,0,0,2020-09-30,2021-09-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,1,4.0,Phase 4,0,2003.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT00066690,0,1,0,1,0,0,2031-12-31,2032-12-31,2015-07-14,International Breast Cancer Study Group,Other,0,0,1,3.0,Phase 3,0,2003.0,0,1,0,0,0,1,0,0,1,0,1,29
NCT00075387,0,0,0,0,0,0,2020-04-30,2021-04-30,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT00076310,0,0,0,0,0,0,2019-01-31,2020-01-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2004.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00102544,0,0,0,0,0,0,2022-01-02,2023-01-02,,National Institutes of Health Clinical Center (CC),NIH,2,0,0,3.0,Phase 3,0,2005.0,0,0,0,1,0,0,0,0,0,0,1,325
NCT00142519,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-02-18,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00230607,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,4.0,Phase 4,0,2006.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT00262470,0,0,0,0,0,0,2022-12-31,2023-12-31,,Satish R. Raj,Other,0,0,1,0.0,Phase 1/Phase 2,0,1997.0,0,1,0,1,0,1,0,0,0,0,1,7
NCT00303849,0,0,0,0,0,0,2020-12-31,2021-12-31,,OHSU Knight Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT00390793,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00392327,0,0,0,0,0,0,2020-07-30,2021-07-30,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2007.0,0,1,1,0,0,1,0,0,1,0,1,389
NCT00477412,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2007.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT00483249,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2005.0,0,0,0,1,0,0,0,0,0,0,1,1443
NCT00493961,0,0,0,0,0,0,2020-05-31,2021-05-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,1999.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT00494182,0,0,0,0,0,0,2020-05-31,2021-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00498160,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Louisville,Other,0,0,0,0.0,Phase 1/Phase 2,0,2005.0,0,0,1,0,0,0,0,0,0,0,1,214
NCT00528437,0,0,0,0,0,0,2019-07-31,2020-07-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,1,0,1,869
NCT00545532,1,1,0,1,0,0,2017-05-02,2018-05-02,2018-04-24,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2008.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT00549848,0,0,0,0,0,0,2020-11-30,2021-11-30,,St. Jude Children's Research Hospital,Other,0,1,1,3.0,Phase 3,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,302
NCT00555399,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00576680,0,0,0,0,0,0,2019-08-31,2020-08-31,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT00590954,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00619879,0,0,0,0,0,0,2020-01-31,2021-01-31,,Ann & Robert H Lurie Children's Hospital of Chicago,Other,0,0,0,3.0,Phase 3,0,2007.0,0,1,0,0,0,1,0,0,0,0,1,112
NCT00623389,0,0,0,0,0,0,2025-05-31,2026-05-31,,Case Western Reserve University,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,89
NCT00654732,1,0,0,0,1,0,2018-09-05,2019-09-05,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT00715611,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT00729586,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-06-12,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT00737893,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT00756639,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2008.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT00772317,0,0,0,0,0,0,2020-12-31,2021-12-31,,SonaCare Medical,Industry,1,0,0,5.0,,0,2008.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT00831623,0,0,0,0,0,0,2019-07-18,2020-07-18,,Loma Linda University,Other,0,0,0,5.0,,0,2009.0,1,0,0,0,0,1,0,0,0,0,1,194
NCT00840047,0,0,0,0,0,0,2020-05-31,2021-05-31,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,302
NCT00887146,0,0,0,0,0,0,2025-10-31,2026-10-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2009.0,0,1,0,0,0,1,0,0,1,0,1,456
NCT00890162,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-06-12,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT00905645,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Sientra, Inc.",Industry,1,0,0,5.0,,0,2002.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT00910247,1,1,0,1,0,0,2017-04-15,2018-04-15,2018-04-13,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,134
NCT00912041,0,0,0,0,0,0,2022-09-30,2023-09-30,,"Leigh R. Hochberg, MD, PhD.",Other,0,0,1,5.0,,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT00936858,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT00957853,1,0,0,0,1,0,2018-08-15,2019-08-15,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00967577,0,0,0,0,0,0,2019-12-31,2020-12-31,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT00979810,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00983398,0,0,0,0,0,0,2019-12-31,2020-12-31,,OHSU Knight Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT01022138,1,0,0,0,1,0,2018-01-31,2019-01-31,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,1,0,0,0,0,0,0,0,1,134
NCT01027949,0,0,0,0,0,0,2020-12-31,2021-12-31,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2006.0,0,1,0,0,0,0,0,0,1,0,1,72
NCT01028716,0,0,0,0,0,0,2024-01-04,2025-01-04,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,1,0,0,1,0,0,0,0,1,393
NCT01074970,0,0,0,0,0,0,2018-12-31,2019-12-31,,Hoosier Cancer Research Network,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,27
NCT01086540,0,0,0,0,0,0,2018-06-05,2019-06-05,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,1,0,1,0,0,0,0,0,1,2133
NCT01102088,0,0,0,0,0,0,2019-06-08,2020-06-08,,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,0,0,0,0,1,0,0,0,0,1,2066
NCT01107665,1,1,0,1,0,0,2018-02-28,2019-02-28,2019-01-07,"University of California, Irvine",Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,310
NCT01144338,1,1,0,1,0,0,2017-04-21,2018-04-21,2018-04-13,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT01153035,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Arkansas,Other,0,1,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,0,0,1,285
NCT01178411,0,0,0,0,0,0,2019-03-31,2020-03-31,,ArQule,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,32
NCT01178814,0,0,0,0,0,0,2020-02-29,2021-02-28,,Columbia University,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT01185509,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-04-17,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT01191840,1,1,0,1,0,0,2017-03-04,2018-03-04,2017-11-12,Duke University,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,1342
NCT01196936,0,0,0,0,0,0,2018-12-11,2019-12-11,,University of Alabama at Birmingham,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,1,1,0,1,801
NCT01200329,0,0,1,1,0,0,2018-12-06,2019-12-06,2019-07-29,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01215136,1,0,0,0,1,0,2018-06-30,2019-06-30,,Matthew Galsky,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT01238120,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Rochester,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,470
NCT01241864,0,0,0,0,0,0,2025-12-31,2026-12-31,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,594
NCT01247207,0,0,0,0,0,0,2020-12-31,2021-12-31,,PTC Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT01258075,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Daiichi Sankyo, Inc.",Industry,1,0,0,4.0,Phase 4,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,207
NCT01261728,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01269853,0,0,0,0,0,0,2020-10-31,2021-10-31,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,271
NCT01309126,1,0,0,0,1,0,2017-02-28,2018-02-28,,Biothera,Industry,1,0,0,3.0,Phase 3,1,2011.0,1,1,1,0,0,0,0,0,1,0,1,10
NCT01347762,1,1,0,1,0,0,2017-06-09,2018-06-09,2018-05-30,Mclean Hospital,Other,0,0,1,2.0,Phase 2/Phase 3,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,126
NCT01352520,0,0,0,0,0,0,2021-01-31,2022-01-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01371630,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2011.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01371825,1,1,0,1,0,0,2018-01-03,2019-01-03,2016-01-14,Alexion Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,86
NCT01376310,1,1,0,1,0,0,2018-01-18,2019-01-18,2019-01-18,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2010.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01383759,0,0,0,0,0,0,2019-04-30,2020-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01386385,0,0,0,0,0,0,2021-01-02,2022-01-02,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,3004
NCT01392183,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01394679,0,0,0,0,0,0,2020-12-31,2021-12-31,,Cell>Point LLC,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT01419535,0,0,0,0,0,0,2017-11-29,2018-11-29,,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,413
NCT01437605,0,0,1,1,0,0,2019-07-31,2020-07-31,2019-07-18,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01439854,1,0,0,0,1,0,2018-06-30,2019-06-30,,The University of Texas Health Science Center at San Antonio,Other,0,0,1,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT01441947,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01446094,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-01-31,Dipan Shah,Other,0,1,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01457118,1,0,0,0,1,0,2017-08-31,2018-08-31,,Nektar Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,20
NCT01463306,0,0,0,0,0,0,2019-08-15,2020-08-15,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT01465659,0,0,0,0,0,0,2019-08-31,2020-08-31,,Northwestern University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT01490723,0,0,0,0,0,0,2019-04-24,2020-04-24,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01508390,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston Medical Center,Other,0,0,0,5.0,,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,225
NCT01516515,1,0,0,0,1,0,2017-12-31,2018-12-31,,"G&E Herbal Biotechnology Co., LTD",Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT01527149,0,0,0,0,0,0,2020-10-05,2021-10-05,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,1,0,0,0,0,0,0,0,1,294
NCT01527747,0,0,0,0,0,0,2020-11-30,2021-11-30,,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,475
NCT01528072,1,0,1,1,0,1,2017-04-30,2018-04-30,2019-06-05,Zimmer Biomet,Industry,1,0,0,5.0,,1,2012.0,1,0,0,1,0,0,0,0,0,0,1,215
NCT01542879,0,0,0,0,0,0,2019-06-30,2020-06-30,,Heike E Daldrup-Link,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01552369,1,1,0,1,0,0,2018-06-22,2019-06-22,2019-06-13,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT01555957,0,0,0,0,0,0,2018-10-30,2019-10-30,,University of Rochester,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,470
NCT01560624,0,0,0,0,0,0,2018-06-24,2019-06-24,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,72
NCT01567462,1,1,0,1,0,0,2017-03-28,2018-03-28,2017-09-14,Emory University,Other,0,1,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,947
NCT01575548,0,0,0,0,0,0,2022-08-01,2023-08-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01590069,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,1,0,1,0,0,0,0,0,0,0,1,2066
NCT01590433,0,0,0,0,0,0,2019-01-31,2020-01-31,,Jody Dushay,Other,0,1,0,4.0,Phase 4,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01598025,1,1,0,1,0,0,2017-10-16,2018-10-16,2018-03-19,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,1,2012.0,1,1,1,0,0,1,0,0,0,0,1,1432
NCT01598896,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-07-09,Mclean Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,126
NCT01603628,1,1,0,1,0,0,2017-06-28,2018-06-28,2018-06-12,Allergan,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,1,0,0,0,0,0,1,0,1,495
NCT01609933,1,1,0,1,0,0,2017-05-03,2018-05-03,2018-03-28,"AbbVie (prior sponsor, Abbott)",Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,3,0,1,227
NCT01611090,0,0,0,0,0,0,2019-01-23,2020-01-23,,"Janssen Research & Development, LLC",Industry,1,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT01627821,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Jarvik Heart, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT01640288,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-08-09,Hal C Charles,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT01642056,0,0,0,0,0,0,2021-01-01,2022-01-01,,National Human Genome Research Institute (NHGRI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,191
NCT01657435,0,0,0,0,0,0,2024-01-01,2025-01-01,,DePuy Orthopaedics,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,39
NCT01660607,0,0,0,0,0,0,2022-12-31,2023-12-31,,Everett Meyer,Other,0,0,1,0.0,Phase 1/Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,4
NCT01664910,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01671488,1,1,0,1,0,0,2018-02-28,2019-02-28,2016-12-13,Brown University,Other,0,0,0,0.0,Phase 1/Phase 2,1,2013.0,1,1,1,0,0,1,0,0,0,0,1,152
NCT01680887,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-06-24,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01683422,0,0,0,0,0,0,2019-03-31,2020-03-31,,Loma Linda University,Other,0,0,0,1.0,Phase 2,0,2011.0,1,0,0,0,0,1,0,0,0,0,1,194
NCT01685073,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-05-01,Johns Hopkins University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT01685411,0,0,0,0,0,0,2025-09-30,2026-09-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,218
NCT01687400,1,1,0,1,0,0,2017-06-23,2018-06-23,2018-06-13,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT01688999,1,0,0,0,1,0,2017-12-11,2018-12-11,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01706458,1,1,0,1,0,0,2017-06-12,2018-06-12,2018-05-17,"University of Wisconsin, Madison",Other,0,1,0,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,715
NCT01708941,1,1,0,1,0,1,2017-08-08,2018-08-08,2018-10-12,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT01714739,0,0,0,0,0,0,2019-10-15,2020-10-15,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT01716715,0,0,1,1,0,0,2018-10-01,2019-10-01,2019-06-26,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01722240,0,0,0,0,0,0,2018-11-30,2019-11-30,,University at Buffalo,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,65
NCT01728805,0,1,0,1,0,1,2017-03-31,2018-03-31,2018-10-11,"Kyowa Kirin Pharmaceutical Development, Inc.",Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,1,0,0,0,0,0,1,0,1,23
NCT01730833,0,0,0,0,0,0,2019-08-31,2020-08-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,358
NCT01744223,0,0,0,0,0,0,2018-03-26,2019-03-26,,Bellicum Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,15
NCT01745588,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01746849,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,1,0,0,1,0,0,0,0,1,1432
NCT01756833,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of Maryland, Baltimore",Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,144
NCT01783574,1,1,0,1,0,0,2017-01-27,2018-01-27,2018-01-18,Massachusetts General Hospital,Other,0,1,1,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01783756,0,0,0,0,0,0,2019-06-28,2020-06-28,,Jonsson Comprehensive Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,277
NCT01785004,0,0,0,0,0,0,2019-07-31,2020-07-31,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT01789333,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stephen Trokel,Other,0,0,0,5.0,,0,2010.0,0,1,0,1,0,0,0,0,0,0,1,3
NCT01792115,0,0,0,0,0,0,2019-08-30,2020-08-30,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT01794403,0,0,0,0,0,0,2023-03-31,2024-03-31,,University of Miami,Other,0,0,0,5.0,,0,2013.0,0,0,0,0,0,1,0,0,1,0,1,476
NCT01800422,0,0,0,0,0,0,2019-02-28,2020-02-28,,Northwestern University,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT01802333,1,1,0,1,0,0,2017-06-15,2018-06-15,2018-05-21,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,3004
NCT01807091,0,0,0,0,0,0,2019-10-01,2020-10-01,,University of Washington,Other,0,0,1,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT01818661,0,0,0,0,0,0,2023-06-01,2024-06-01,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT01832402,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01832480,1,1,0,1,0,1,2017-06-05,2018-06-05,2018-09-10,Tulane University Health Sciences Center,Other,0,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT01838551,1,0,0,0,1,0,2018-04-30,2019-04-30,,Cortendo AB,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT01846208,1,1,0,1,0,0,2017-09-28,2018-09-28,2018-09-24,"Hugh A Sampson, MD",Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01852292,1,1,0,1,0,0,2017-03-30,2018-03-30,2018-03-30,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01867671,0,0,0,0,0,0,2018-07-02,2019-07-02,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,2133
NCT01873833,0,0,0,0,0,0,2020-07-27,2021-07-27,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,483
NCT01875250,0,0,0,0,0,0,2020-02-01,2021-02-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01878006,1,1,0,1,0,1,2017-04-27,2018-04-27,2018-08-10,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,96
NCT01887717,1,0,1,1,0,1,2017-12-18,2018-12-18,2019-08-22,BTG International Inc.,Other,0,1,0,3.0,Phase 3,1,2013.0,1,1,0,1,0,0,0,0,1,0,1,34
NCT01888081,0,0,0,0,0,0,2020-12-31,2021-12-31,,Angimmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2014.0,0,1,0,0,0,1,0,0,0,0,1,4
NCT01890278,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Good Samaritan Hospital Medical Center, New York",Other,0,0,0,5.0,,0,2013.0,1,0,0,0,0,1,0,0,0,0,1,2
NCT01891968,1,1,0,1,0,1,2017-01-18,2018-01-18,2018-02-12,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01892722,0,1,0,1,0,0,2017-07-14,2018-07-14,2018-06-08,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01898221,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Miguel X. Valderrabano, MD",Other,0,0,1,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01919086,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01931046,1,0,0,0,1,0,2018-07-06,2019-07-06,,Momotaro-Gene Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01931566,1,1,0,1,0,0,2018-07-24,2019-07-24,2019-07-22,Takeda,Industry,1,1,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT01937351,1,1,0,1,0,0,2017-05-31,2018-05-31,2017-04-05,"Avinger, Inc.",Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,7
NCT01937949,0,0,0,0,0,0,2020-01-31,2021-01-31,,Mayo Clinic,Other,0,1,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT01952054,0,0,0,0,0,0,2018-10-10,2019-10-10,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01960413,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-07,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,422
NCT01968798,0,0,0,0,0,0,2019-01-31,2020-01-31,,Hennepin Healthcare Research Institute.,Other,0,1,1,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,61
NCT01972763,1,0,0,0,1,0,2018-07-31,2019-07-31,,Northern California Retina Vitreous Associates,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT01972919,0,0,0,0,0,0,2020-12-31,2021-12-31,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,315
NCT01976585,0,0,0,0,0,0,2020-11-30,2021-11-30,,Joshua Brody,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01977937,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-02,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT01979536,0,0,0,0,0,0,2021-03-31,2022-03-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01980654,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-11-02,Pharmacyclics LLC.,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT01982123,1,1,0,1,0,0,2017-09-13,2018-09-13,2018-09-03,University of Washington,Other,0,0,1,5.0,,0,2014.0,1,1,0,0,1,1,0,0,0,0,1,910
NCT01983241,0,0,0,0,0,0,2023-11-30,2024-11-30,,Grifols Therapeutics LLC,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,0,1,0,0,0,0,0,1,0,1,40
NCT01988090,0,1,0,1,0,0,2019-01-31,2020-01-31,2019-01-31,Mothaffar Rimawi,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT01993186,0,0,0,0,0,0,2017-09-07,2018-09-07,,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT01997333,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-11-30,Celldex Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT01998789,1,0,0,0,1,0,2018-06-30,2019-06-30,,Tomoaki Kato,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02012309,1,0,0,0,1,0,2018-06-30,2019-06-30,,"University of Colorado, Denver",Other,0,0,1,5.0,,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,882
NCT02013778,0,0,0,0,0,0,2019-11-30,2020-11-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT02015104,0,0,0,0,0,0,2018-09-30,2019-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02028559,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Washington,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT02029534,1,0,0,0,1,0,2017-06-30,2018-06-30,,Creighton University,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,110
NCT02029937,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Anandasabapathy, Sharmila, M.D.",Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02030847,1,1,0,1,0,0,2018-04-26,2019-04-26,2019-04-05,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,1052
NCT02032433,1,1,0,1,0,0,2017-01-25,2018-01-25,2017-11-24,NYU Langone Health,Other,0,1,1,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02034058,0,0,0,0,0,0,2019-08-31,2020-08-31,,Stryker Neurovascular,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,18
NCT02039947,0,1,0,1,0,1,2017-05-12,2018-05-12,2019-01-30,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02045446,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,626
NCT02058706,0,0,0,0,0,0,2018-12-31,2019-12-31,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT02060630,0,0,0,0,0,0,2019-12-31,2020-12-31,,New England Research Institutes,Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,49
NCT02063828,0,0,0,0,0,0,2019-09-03,2020-09-03,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,616
NCT02066571,1,0,0,0,1,0,2017-04-30,2018-04-30,,Henry Ford Health System,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,151
NCT02067013,1,0,0,0,1,0,2017-07-31,2018-07-31,,California Retina Consultants,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02069379,1,1,0,1,0,1,2017-03-24,2018-03-24,2018-08-19,University of Michigan,Other,0,0,1,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT02070757,1,1,0,1,0,0,2018-05-15,2019-05-15,2019-05-07,Cubist Pharmaceuticals LLC,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,3,0,1,65
NCT02071979,1,0,0,0,1,0,2018-01-31,2019-01-31,,"Arteriocyte, Inc.",Industry,1,0,0,5.0,,1,2014.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT02077192,0,0,0,0,0,0,2020-03-31,2021-03-31,,Rigel Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT02079181,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Southern California,Other,0,0,1,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,483
NCT02080364,0,0,0,0,0,0,2018-06-01,2019-06-01,,vTv Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,12
NCT02081326,0,0,0,0,0,0,2020-07-31,2021-07-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1699
NCT02081755,0,0,0,0,0,0,2019-08-31,2020-08-31,,Baylor Research Institute,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,131
NCT02086500,0,0,0,0,0,0,2019-11-30,2020-11-30,,Jason Sperry,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02088541,1,0,0,0,1,0,2018-01-08,2019-01-08,,Karyopharm Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,22
NCT02089217,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Thomas G. Brott, M.D.",Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,1
NCT02091531,0,0,1,1,0,0,2018-10-31,2019-10-31,2019-09-09,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02098512,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York Medical College,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT02100228,1,1,0,1,0,0,2017-02-08,2018-02-08,2018-01-17,Pfizer,Industry,1,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02101554,0,0,0,0,0,0,2019-06-26,2020-06-26,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2856
NCT02101918,1,0,1,1,0,1,2018-01-31,2019-01-31,2019-05-10,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,1,0,0,0,0,1,3004
NCT02102854,0,0,0,0,0,0,2018-10-31,2019-10-31,,The Methodist Hospital System,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,36
NCT02105558,1,1,0,1,0,1,2017-04-13,2018-04-13,2018-06-22,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02106351,0,0,0,0,0,0,2017-09-21,2018-09-21,,Ipsen,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,214
NCT02106650,0,0,0,0,0,0,2018-10-31,2019-10-31,,Acrotech Biopharma LLC,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02106988,0,0,0,0,0,0,2022-01-31,2023-01-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT02107755,0,0,0,0,0,0,2019-12-31,2020-12-31,,Ohio State University Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,1,0,0,0,0,1,198
NCT02107859,0,0,0,0,0,0,2017-06-30,2018-06-30,,PTC Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02109744,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Rochester,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,470
NCT02115542,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02118610,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of Maryland, Baltimore",Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,144
NCT02120079,0,0,0,0,0,0,2017-04-30,2018-04-30,,Tufts Medical Center,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,1,0,0,0,0,0,1,121
NCT02120365,0,0,0,0,0,0,2020-04-30,2021-04-30,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,417
NCT02130466,0,0,0,0,0,0,2021-07-10,2022-07-10,,Merck Sharp & Dohme Corp.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02132845,1,0,0,0,1,0,2018-05-10,2019-05-10,,Fox Chase Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,156
NCT02134353,0,0,0,0,0,0,2017-02-28,2018-02-28,,Pharmaxis,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,28
NCT02134808,1,0,0,0,1,0,2017-06-27,2018-06-27,,Perry Renshaw,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02138617,0,0,0,0,0,0,2021-05-31,2022-05-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT02141919,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,626
NCT02143414,0,0,0,0,0,0,2021-07-01,2022-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02147964,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Washington,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT02148250,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-07-10,University of Minnesota - Clinical and Translational Science Institute,Other,0,1,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02155465,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-03-19,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02156674,0,0,0,0,0,0,2019-09-01,2020-09-01,,"Masonic Cancer Center, University of Minnesota",Other,0,1,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,218
NCT02156843,1,0,0,0,1,0,2017-12-31,2018-12-31,,"NephroGenex, Inc.",Industry,1,1,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02164864,1,1,0,1,0,0,2017-06-05,2018-06-05,2018-06-05,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02175316,1,0,0,0,1,0,2017-07-25,2018-07-25,,David Grant U.S. Air Force Medical Center,U.S. Fed,2,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,20
NCT02175758,1,1,0,1,0,0,2018-06-21,2019-06-21,2019-02-28,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02179177,0,0,0,0,0,0,2017-09-03,2018-09-03,,Nirmish Shah,Other,0,1,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02181738,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-31,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02188147,0,0,0,0,0,0,2020-02-29,2021-02-28,,Zoll Medical Corporation,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,17
NCT02194751,0,0,0,0,0,0,2022-01-31,2023-01-31,,XEME Biopharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT02196831,0,0,0,0,0,0,2019-01-16,2020-01-16,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02196857,0,0,0,0,0,0,2018-11-27,2019-11-27,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02199015,0,0,0,0,0,0,2020-12-31,2021-12-31,,Juan Carlos M. Andreani MD,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT02199652,1,1,0,1,0,0,2017-09-01,2018-09-01,2018-06-26,Augusta University,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,117
NCT02200770,0,0,0,0,0,0,2018-10-26,2019-10-26,,MedImmune LLC,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,269
NCT02209636,0,0,0,0,0,0,2019-06-28,2020-06-28,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02210325,1,0,0,0,1,0,2017-02-22,2018-02-22,,"Melinta Therapeutics, Inc.",Industry,1,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,25
NCT02214121,1,1,0,1,0,0,2017-02-27,2018-02-27,2018-02-05,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02217410,1,1,0,1,0,0,2017-11-29,2018-11-29,2018-11-28,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,1,0,0,0,0,0,1,0,1,1895
NCT02220985,0,0,0,0,0,0,2020-02-03,2021-02-03,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT02225275,0,0,0,0,0,0,2023-03-01,2024-03-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02229851,0,0,0,0,0,0,2017-04-21,2018-04-21,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02242942,1,0,1,1,0,0,2018-08-17,2019-08-17,2019-08-15,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02246374,0,0,0,0,0,0,2020-04-30,2021-04-30,,InSightec,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,61
NCT02248597,0,0,0,0,0,0,2019-09-30,2020-09-30,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02248701,0,0,0,0,0,0,2020-05-31,2021-05-31,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02250937,0,0,0,0,0,0,2019-10-01,2020-10-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02255552,0,0,0,0,0,0,2019-06-14,2020-06-14,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT02257138,0,0,0,0,0,0,2019-02-01,2020-02-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02257736,0,0,0,0,0,0,2018-03-19,2019-03-19,,"Aragon Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02258451,0,0,0,0,0,0,2019-12-30,2020-12-30,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02261519,0,0,0,0,0,0,2018-12-31,2019-12-31,,SyneuRx International (Taiwan) Corp,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT02269163,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Prometic Biotherapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,5
NCT02278055,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02281084,0,0,0,0,0,0,2019-06-19,2020-06-19,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02281994,0,0,0,0,0,0,2018-12-31,2019-12-31,,Orthofix Inc.,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,3,0,1,10
NCT02283177,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,17
NCT02286089,0,0,0,0,0,0,2020-12-31,2021-12-31,,BioTime Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,1
NCT02286726,0,0,0,0,0,0,2021-05-31,2022-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02286843,0,0,0,0,0,0,2019-11-30,2020-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,1,5.0,,0,2014.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02286947,1,1,0,1,0,1,2017-04-21,2018-04-21,2019-01-30,"Sarepta Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT02290106,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-03-22,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02291237,1,1,0,1,0,0,2017-01-20,2018-01-20,2018-01-19,Gilead Sciences,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02292654,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02292784,0,0,0,0,0,0,2019-07-28,2020-07-28,,GlaxoSmithKline,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02296242,1,1,0,1,0,1,2017-06-15,2018-06-15,2018-06-28,"BioMed Valley Discoveries, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02302157,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Asterias Biotherapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02302222,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-11,"KCI USA, Inc.",Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,23
NCT02302833,0,0,0,0,0,0,2020-02-28,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02302989,1,0,0,0,1,0,2018-07-31,2019-07-31,,"Leonard Feiner, MD, PhD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02304484,1,1,0,1,0,0,2018-03-09,2019-03-09,2019-02-27,Amgen,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,685
NCT02305849,0,0,0,0,0,0,2017-06-20,2018-06-20,,Astellas Pharma Inc,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,2,0,1,506
NCT02306850,1,1,0,1,0,0,2018-06-08,2019-06-08,2019-06-03,St. Louis University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,126
NCT02310867,0,0,0,0,0,0,2021-12-31,2022-12-31,,Linda Cendales,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02312258,0,0,0,0,0,0,2019-08-12,2020-08-12,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT02314156,0,0,0,0,0,0,2020-10-31,2021-10-31,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02315430,0,0,1,1,0,0,2019-02-09,2020-02-09,2019-08-16,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02317042,1,0,1,1,0,0,2017-11-30,2018-11-30,2017-05-14,ResMed,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,2,0,1,60
NCT02318901,1,1,0,1,0,0,2018-08-31,2019-08-31,2018-10-01,Western Regional Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT02329327,0,0,0,0,0,0,2022-11-30,2023-11-30,,Portola Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,28
NCT02330653,0,0,0,0,0,0,2019-04-08,2020-04-08,,Stacy A. Kahn,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2
NCT02338193,0,1,0,1,0,0,2019-02-13,2020-02-13,2019-03-14,Woman's,Other,0,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02339233,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Louisville,Other,0,0,1,5.0,,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,214
NCT02339740,0,0,0,0,0,0,2021-06-30,2022-06-30,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,389
NCT02340728,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT02341417,1,1,0,1,0,0,2017-03-15,2018-03-15,2018-03-07,Amgen,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02345850,0,0,0,0,0,0,2020-09-30,2021-09-30,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT02351726,0,0,0,0,0,0,2024-12-31,2025-12-31,,LivaNova,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,43
NCT02352831,1,1,0,1,0,0,2017-10-20,2018-10-20,2018-10-16,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02354807,1,0,0,0,1,0,2017-10-31,2018-10-31,,Otto Muzik,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02358538,0,0,0,0,0,0,2018-01-16,2019-01-16,,Marinus Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,15
NCT02358850,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Nebraska,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,327
NCT02365701,1,0,0,0,1,0,2018-02-28,2019-02-28,,"Dong-A ST Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,61
NCT02366611,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Michigan,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT02366728,0,0,0,0,0,0,2020-06-30,2021-06-30,,Gary Archer Ph.D.,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,12
NCT02366871,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02367820,0,0,0,0,0,0,2017-12-31,2018-12-31,,Nektar Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02369211,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-08-03,Brigham and Women's Hospital,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT02370095,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-09,"University of North Carolina, Chapel Hill",Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02370238,0,0,0,0,0,0,2018-12-31,2019-12-31,,Dompé Farmaceutici S.p.A,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,28
NCT02371369,0,0,1,1,0,0,2019-12-31,2020-12-31,2019-08-26,"Daiichi Sankyo, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,207
NCT02371941,1,0,1,1,0,1,2017-07-31,2018-07-31,2019-04-22,University of Tennessee,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,99
NCT02372006,0,0,0,0,0,0,2020-03-15,2021-03-15,,Boehringer Ingelheim,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT02373137,1,1,0,1,0,0,2018-04-04,2019-04-04,2019-03-26,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,475
NCT02376257,1,1,0,1,0,1,2017-04-21,2018-04-21,2018-05-20,Boston University Charles River Campus,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,63
NCT02379819,0,0,0,0,0,0,2023-12-31,2024-12-31,,Cochlear,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,35
NCT02383927,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Kura Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02386501,1,0,0,0,1,0,2017-04-30,2018-04-30,,"Advaxis, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02387970,0,0,0,0,0,0,2019-06-30,2020-06-30,,Columbia University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,675
NCT02389985,0,0,0,0,0,0,2018-06-04,2019-06-04,,NewLink Genetics Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02392286,0,0,0,0,0,0,2019-06-30,2020-06-30,,Yale University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02394548,0,0,0,0,0,0,2019-07-31,2020-07-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,1699
NCT02395692,1,1,0,1,0,1,2017-02-16,2018-02-16,2019-01-28,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02396511,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-04-16,Tracon Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,18
NCT02397096,1,1,0,1,0,0,2018-02-22,2019-02-22,2019-02-04,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,3,0,1,2145
NCT02399215,0,0,0,0,0,0,2019-09-01,2020-09-01,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,294
NCT02404103,1,1,0,1,0,0,2017-05-31,2018-05-31,2017-07-05,University of Louisville,Other,0,1,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,214
NCT02405091,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-09-11,Neurocrine Biosciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,34
NCT02406885,0,0,0,0,0,0,2020-03-31,2021-03-31,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT02409680,0,0,0,0,0,0,2019-04-30,2020-04-30,,NICHD Global Network for Women's and Children's Health,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT02410278,1,1,0,1,0,0,2017-04-27,2018-04-27,2018-04-27,Biogen,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,324
NCT02411916,0,0,0,0,0,0,2019-02-16,2020-02-16,,New York City Health and Hospitals Corporation,Other,0,0,0,5.0,,0,2012.0,1,0,1,0,0,0,0,0,0,0,1,18
NCT02412735,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Mesoblast, Ltd.",Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,15
NCT02414399,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Washington,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,910
NCT02415556,0,0,0,0,0,0,2020-05-31,2021-05-31,,Beth Israel Deaconess Medical Center,Other,0,1,1,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT02416102,0,0,0,0,0,0,2017-04-03,2018-04-03,,University of Miami,Other,0,0,0,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,476
NCT02416336,1,0,0,0,1,0,2017-03-31,2018-03-31,,Oncovision Inc,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02418195,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Alabama at Birmingham,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02422446,1,1,0,1,0,1,2017-03-01,2018-03-01,2018-05-03,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT02423343,0,0,0,0,0,0,2018-12-13,2019-12-13,,Eli Lilly and Company,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02426086,0,0,0,0,0,0,2018-04-26,2019-04-26,,Geron Corporation,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,13
NCT02430818,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-07-03,Washington University School of Medicine,Other,0,0,0,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02433379,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,340
NCT02435212,0,0,0,0,0,0,2018-05-31,2019-05-31,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02435680,0,0,0,0,0,0,2019-09-19,2020-09-19,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02438826,1,1,0,1,0,1,2018-03-27,2019-03-27,2019-04-02,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02441088,0,0,0,0,0,0,2020-01-31,2021-01-31,,Sue O'Dorisio,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,8
NCT02443545,0,0,0,0,0,0,2021-10-31,2022-10-31,,ApoPharma,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,25
NCT02446704,0,0,0,0,0,0,2020-08-31,2021-08-31,,Massachusetts General Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02446899,0,0,0,0,0,0,2018-09-27,2019-09-27,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,1,0,0,0,0,0,1,0,1,2450
NCT02448680,1,0,0,0,1,0,2017-06-30,2018-06-30,,"LFB USA, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,2
NCT02448810,1,1,0,1,0,0,2017-02-15,2018-02-15,2018-02-15,Baxalta now part of Shire,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,1,0,0,0,0,0,0,0,1,107
NCT02452775,1,0,0,0,1,0,2018-05-30,2019-05-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,5.0,,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,273
NCT02453191,0,0,0,0,0,0,2019-01-22,2020-01-22,,Mohammed M Milhem,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,3
NCT02453282,0,0,0,0,0,0,2018-10-04,2019-10-04,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,2450
NCT02458482,0,0,0,0,0,0,2022-06-30,2023-06-30,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,422
NCT02460263,0,0,0,0,0,0,2019-12-31,2020-12-31,,Outset Medical,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02464501,0,0,0,0,0,0,2019-08-31,2020-08-31,,Horizons International Peripheral Group,Other,0,1,0,5.0,,0,2015.0,0,0,0,0,0,0,0,0,0,0,1,3
NCT02464969,0,0,0,0,0,0,2021-04-29,2022-04-29,,Pfizer,Industry,1,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02466074,0,0,0,0,0,0,2022-09-30,2023-09-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT02469090,0,0,0,0,0,0,2017-12-11,2018-12-11,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,134
NCT02469896,1,0,1,1,0,1,2018-07-11,2019-07-11,2019-08-06,Barrow Neurological Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02470299,0,0,0,0,0,0,2020-07-31,2021-07-31,,New Mexico Cancer Care Alliance,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,67
NCT02470806,1,0,1,1,0,1,2017-11-21,2018-11-21,2019-06-11,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,83
NCT02473198,1,0,0,0,1,0,2017-02-28,2018-02-28,,The New England Baptist Hospital,Other,0,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02477839,0,0,0,0,0,0,2020-06-30,2021-06-30,,"UCB BIOSCIENCES, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT02480114,0,0,0,0,0,0,2020-04-30,2021-04-30,,Vanderbilt-Ingram Cancer Center,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,180
NCT02481310,0,0,0,0,0,0,2019-07-31,2020-07-31,,Northwestern University,Other,0,1,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,925
NCT02481674,0,0,0,0,0,0,2020-05-31,2021-05-31,,Vaccinex Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,4
NCT02482987,1,0,0,0,1,0,2018-07-31,2019-07-31,,Eisenhower Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02484248,0,0,0,0,0,0,2020-03-31,2021-03-31,,Children's Mercy Hospital Kansas City,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,138
NCT02487095,0,0,0,0,0,0,2024-05-31,2025-05-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02488967,0,0,0,0,0,0,2021-07-31,2022-07-31,,NRG Oncology,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT02501434,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Robert F James, MD, FACS, FAANS",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02503280,0,0,0,0,0,0,2030-03-31,2031-03-31,,Joshua M Hare,Other,0,0,0,0.0,Phase 1/Phase 2,0,2025.0,0,1,0,1,0,0,0,0,0,1,0,15
NCT02503423,0,0,0,0,0,0,2021-06-30,2022-06-30,,Astex Pharmaceuticals,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,38
NCT02505269,0,0,0,0,0,0,2019-06-30,2020-06-30,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02505984,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02506192,0,0,0,0,0,0,2020-01-31,2021-01-31,,Minneapolis Veterans Affairs Medical Center,U.S. Fed,2,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT02507687,0,0,0,0,0,0,2019-12-28,2020-12-28,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,495
NCT02509585,0,1,0,1,0,1,2017-07-31,2018-07-31,2019-01-16,"Cardinal Health 414, LLC",Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02511405,1,0,0,0,1,0,2017-11-03,2018-11-03,,Vascular Biogenics Ltd. operating as VBL Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02511678,1,1,0,1,0,1,2018-03-12,2019-03-12,2019-08-07,Galil Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,8
NCT02513745,1,1,0,1,0,1,2017-05-05,2018-05-05,2018-06-22,"Carolina Eyecare Physicians, LLC",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02514798,1,0,0,0,1,0,2017-12-31,2018-12-31,,Tufts Medical Center,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,121
NCT02515097,0,0,0,0,0,0,2017-03-31,2018-03-31,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02515708,0,0,0,0,0,0,2019-09-30,2020-09-30,,Cristiano Quintini,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02516228,0,0,0,0,0,0,2018-05-31,2019-05-31,,"Electrical Geodesics, Inc.",Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02518555,0,0,0,0,0,0,2019-11-30,2020-11-30,,Jennifer Woyach,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,4
NCT02520011,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Tolero Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,9
NCT02520518,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-08-14,Christopher Bell,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02522221,0,0,0,0,0,0,2019-03-30,2020-03-30,,Espero Biopharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,1
NCT02523014,0,0,0,0,0,0,2020-08-31,2021-08-31,,Alliance for Clinical Trials in Oncology,Other,0,1,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT02528318,1,1,0,1,0,1,2017-05-31,2018-05-31,2019-05-28,Windtree Therapeutics,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,0,0,1,0,0,1,0,1,0,1,9
NCT02530385,1,1,0,1,0,0,2018-06-27,2019-06-27,2019-06-27,Massachusetts General Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,1699
NCT02531633,1,1,0,1,0,0,2018-03-21,2019-03-21,2019-03-21,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02562443,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Onconova Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT02564952,1,1,0,1,0,1,2017-06-07,2018-06-07,2018-07-11,GW Research Ltd,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,29
NCT02566369,0,1,0,1,0,1,2017-11-14,2018-11-14,2019-04-18,Galderma R&D,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,28
NCT02571738,1,0,0,0,1,0,2017-04-30,2018-04-30,,Osiris Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,0,1,0,0,0,0,0,0,0,1,9
NCT02572791,0,0,0,0,0,0,2021-05-31,2022-05-31,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02574286,0,0,0,0,0,0,2020-12-30,2021-12-30,,Shire,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,342
NCT02574650,1,0,0,0,1,0,2018-05-31,2019-05-31,,"Mitralign, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02575963,0,0,0,0,0,0,2018-11-30,2019-11-30,,Actinium Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,1,0,0,0,0,0,0,0,1,5
NCT02576431,0,0,0,0,0,0,2021-05-31,2022-05-31,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02576938,1,1,0,1,0,0,2017-02-28,2018-02-28,2018-02-16,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02577354,0,0,0,0,0,0,2018-11-30,2019-11-30,,Mainstay Medical,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,3
NCT02580877,1,0,0,0,1,0,2018-03-31,2019-03-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02584452,1,0,0,0,1,0,2017-11-02,2018-11-02,,Vanderbilt University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,499
NCT02589353,0,0,0,0,0,0,2021-10-31,2022-10-31,,Oregon State University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT02590432,1,1,0,1,0,0,2018-02-05,2019-02-05,2019-02-05,Forest Laboratories,Industry,1,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,169
NCT02593773,1,1,0,1,0,0,2017-03-21,2018-03-21,2018-03-21,"Horizon Pharma Ireland, Ltd., Dublin Ireland",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT02596971,1,1,0,1,0,0,2018-04-11,2019-04-11,2019-04-09,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02601027,0,0,0,0,0,0,2020-01-31,2021-01-31,,Stanford University,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,1309
NCT02601313,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Kite, A Gilead Company",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,14
NCT02603120,1,1,0,1,0,0,2017-05-09,2018-05-09,2018-05-01,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02604342,1,1,0,1,0,0,2017-01-26,2018-01-26,2018-01-24,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1731
NCT02608944,1,0,0,0,1,0,2017-09-30,2018-09-30,,University of Utah,Other,0,0,0,5.0,,0,2012.0,1,1,0,1,0,0,0,0,0,0,1,578
NCT02609503,0,0,0,0,0,0,2019-03-19,2020-03-19,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,229
NCT02609984,0,0,0,0,0,0,2019-03-29,2020-03-29,,Immune Design,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,7
NCT02610283,0,0,0,0,0,0,2018-02-28,2019-02-28,,Quark Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02614560,0,1,0,1,0,1,2017-02-10,2018-02-10,2018-09-05,"Seattle Genetics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,77
NCT02615249,0,0,0,0,0,0,2018-12-31,2019-12-31,,Allerderm,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,10
NCT02618408,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02623699,0,0,0,0,0,0,2020-05-29,2021-05-29,,Biogen,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,324
NCT02625181,1,1,0,1,0,0,2017-11-02,2018-11-02,2018-10-30,Vanderbilt University,Other,0,0,0,5.0,,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,499
NCT02626364,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,17
NCT02628600,1,0,0,0,1,0,2018-08-31,2019-08-31,,Insmed Incorporated,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,15
NCT02629159,0,0,0,0,0,0,2017-10-27,2018-10-27,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02633137,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02633540,1,0,0,0,1,0,2017-10-31,2018-10-31,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,1,2015.0,1,0,0,0,0,1,0,0,0,0,1,156
NCT02635724,1,0,0,0,1,0,2018-04-30,2019-04-30,,BioCryst Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,42
NCT02637141,0,0,0,0,0,0,2017-02-15,2018-02-15,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,2,0,1,685
NCT02639559,1,1,0,1,0,0,2018-04-12,2019-04-12,2019-04-09,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02640729,1,0,1,1,0,1,2017-11-30,2018-11-30,2019-01-15,Axovant Sciences Ltd.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02642939,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Check, Jerome H., M.D., Ph.D.",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02643381,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,626
NCT02643979,0,0,0,0,0,0,2019-11-30,2020-11-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT02649972,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02653456,1,1,0,1,0,1,2017-05-03,2018-05-03,2018-08-27,Ra Medical Systems,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02654990,0,0,0,0,0,0,2019-10-01,2020-10-01,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02657707,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Microvention-Terumo, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,14
NCT02659059,0,0,0,0,0,0,2018-06-22,2019-06-22,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02660112,0,0,0,0,0,0,2018-12-30,2019-12-30,,Ralitza Gavrilova,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02666430,1,0,0,0,1,0,2017-03-31,2018-03-31,,Mylan Inc.,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,30
NCT02668198,0,0,0,0,0,0,2018-10-31,2019-10-31,,Michael Wallace,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02668432,0,1,0,1,0,0,2018-09-20,2019-09-20,2018-11-19,The University of Texas Health Science Center at San Antonio,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02673151,0,0,0,0,0,0,2021-08-31,2022-08-31,,Andrei Iagaru,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT02674633,0,0,0,0,0,0,2017-07-31,2018-07-31,,"Akili Interactive Labs, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,8
NCT02676466,1,1,0,1,0,0,2018-06-22,2019-06-22,2019-06-18,University of Florida,Other,0,1,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,849
NCT02679092,0,0,0,0,0,0,2020-02-29,2021-02-28,,Stanford University,Other,0,0,0,5.0,,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,1309
NCT02680834,0,0,0,0,0,0,2019-01-31,2020-01-31,,Tactile Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,8
NCT02681094,1,1,0,1,0,0,2017-07-15,2018-07-15,2018-07-06,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02687139,0,0,0,0,0,0,2019-04-30,2020-04-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02687451,0,0,0,0,0,0,2020-06-30,2021-06-30,,Endo Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,91
NCT02690207,0,0,0,0,0,0,2019-03-15,2020-03-15,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,3276
NCT02691728,1,0,0,0,1,0,2017-02-28,2018-02-28,,"Peter J. Ruane, M.D., Inc.",Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02693093,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Stason Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02695472,1,0,0,0,1,0,2017-06-30,2018-06-30,,Neuralstem Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02696031,0,0,0,0,0,0,2020-12-16,2021-12-16,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02699697,0,0,0,0,0,0,2019-09-30,2020-09-30,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,616
NCT02700945,0,0,0,0,0,0,2020-07-31,2021-07-31,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,169
NCT02702102,0,0,0,0,0,0,2019-09-30,2020-09-30,,William Charles Kreisl,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT02704364,0,0,0,0,0,0,2017-06-30,2018-06-30,,"NGM Biopharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,13
NCT02705378,0,0,0,0,0,0,2019-04-30,2020-04-30,,Massachusetts General Hospital,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02709655,0,0,0,0,0,0,2021-05-31,2022-05-31,,H. Lundbeck A/S,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,152
NCT02710253,0,0,0,0,0,0,2021-05-01,2022-05-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT02711852,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Verastem, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,35
NCT02711956,0,0,0,0,0,0,2019-10-31,2020-10-31,,Zenith Epigenetics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02712320,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-08-16,"Foresee Pharmaceuticals Co., Ltd.",Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02718131,0,0,0,0,0,0,2021-05-31,2022-05-31,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,801
NCT02725372,1,0,0,0,1,0,2018-08-31,2019-08-31,,Bellerophon Pulse Technologies,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02726997,0,0,0,0,0,0,2021-07-30,2022-07-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02727777,1,0,0,0,1,0,2018-07-10,2019-07-10,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,2066
NCT02730130,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT02730195,1,1,0,1,0,0,2018-07-31,2019-07-31,2018-11-01,Emory University,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02730793,0,0,0,0,0,0,2019-12-31,2020-12-31,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT02730871,1,1,0,1,0,0,2018-07-13,2019-07-13,2019-04-23,Alcon Research,Industry,1,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,492
NCT02732015,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02733653,1,1,0,1,0,0,2017-06-29,2018-06-29,2018-06-27,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,340
NCT02735174,0,0,0,0,0,0,2018-11-29,2019-11-29,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,437
NCT02737358,0,0,0,0,0,0,2019-11-01,2020-11-01,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02737969,0,0,0,0,0,0,2019-08-21,2020-08-21,,NYU Langone Health,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,869
NCT02740543,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02741713,1,1,0,1,0,0,2017-06-29,2018-06-29,2018-06-28,Wake Forest University Health Sciences,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT02742532,0,0,0,0,0,0,2019-07-01,2020-07-01,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT02744612,0,0,0,0,0,0,2019-11-30,2020-11-30,,City of Hope Medical Center,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT02744755,0,1,0,1,0,1,2017-01-31,2018-01-31,2018-09-21,Sandoz,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,120
NCT02748317,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-02-07,Medstar Health Research Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,79
NCT02749227,0,0,0,0,0,0,2020-03-31,2021-03-31,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT02749370,1,1,0,1,0,0,2017-08-14,2018-08-14,2018-07-24,Amgen,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,685
NCT02752646,1,0,0,0,1,0,2017-03-01,2018-03-01,,"MDbackline, LLC",Other,0,1,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02753127,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Boston Biomedical, Inc",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT02754570,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-06-26,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT02754661,1,0,1,1,0,0,2018-08-07,2019-08-07,2019-08-01,Medtronic - MITG,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,146
NCT02756572,0,0,0,0,0,0,2019-11-01,2020-11-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,910
NCT02756897,0,0,0,0,0,0,2024-07-01,2025-07-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02759575,0,0,0,0,0,0,2020-01-31,2021-01-31,,Vinita Takiar,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,1
NCT02760615,0,0,0,0,0,0,2019-07-01,2020-07-01,,Takeda,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,650
NCT02763644,0,1,0,1,0,1,2017-02-10,2018-02-10,2018-06-29,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02766335,0,0,0,0,0,0,2022-04-01,2023-04-01,,Southwest Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,288
NCT02775695,0,0,0,0,0,0,2020-04-30,2021-04-30,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT02776735,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sanofi,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT02777203,0,0,0,0,0,0,2019-06-30,2020-06-30,,Charles Miller,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02778685,0,0,0,0,0,0,2020-09-30,2021-09-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT02781324,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-05-13,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,882
NCT02784821,0,0,0,0,0,0,2019-09-11,2020-09-11,,University of Florida,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,849
NCT02786537,0,0,0,0,0,0,2019-06-13,2020-06-13,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT02786706,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Michigan,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT02787083,0,0,0,0,0,0,2018-12-31,2019-12-31,,Philadelphia Urosurgical Associates,Other,0,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02787226,1,0,0,0,1,0,2017-04-28,2018-04-28,,Eric Shepard,Other,0,1,0,4.0,Phase 4,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02787551,1,1,0,1,0,0,2018-05-25,2019-05-25,2019-05-23,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02789020,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Florida,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,849
NCT02790736,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-07-12,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02791204,0,0,0,0,0,0,2020-12-31,2021-12-31,,Yale University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1053
NCT02792257,0,0,0,0,0,0,2020-08-31,2021-08-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT02792582,0,0,0,0,0,0,2025-06-30,2026-06-30,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,302
NCT02797080,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-29,"Horizon Pharma Ireland, Ltd., Dublin Ireland",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT02797808,1,0,1,1,0,1,2017-01-31,2018-01-31,2018-04-30,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02799602,0,0,0,0,0,0,2022-08-01,2023-08-01,,Bayer,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02802553,0,0,0,0,0,0,2019-11-30,2020-11-30,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT02805985,1,0,0,0,1,0,2018-06-30,2019-06-30,,Expanding Orthopedics Ltd.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02811679,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02812160,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Spatz FGIA, Inc",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02812771,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,180
NCT02815267,0,0,0,0,0,0,2017-10-13,2018-10-13,,Foamix Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,16
NCT02815670,0,0,0,0,0,0,2019-11-19,2020-11-19,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT02817906,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Intra-Cellular Therapies, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02822599,0,0,0,0,0,0,2019-08-26,2020-08-26,,Nicklaus Children's Hospital f/k/a Miami Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT02823470,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-31,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,4.0,Phase 4,1,2016.0,1,1,0,1,0,0,0,0,1,0,1,141
NCT02823964,1,1,0,1,0,0,2018-03-31,2019-03-31,2018-04-19,Anthera Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,25
NCT02825043,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Oklahoma,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,234
NCT02831855,0,0,0,0,0,0,2018-11-19,2019-11-19,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02832674,1,1,0,1,0,0,2017-02-20,2018-02-20,2018-01-05,"ThermiGen, LLC",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02833610,0,0,0,0,0,0,2020-10-31,2021-10-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02833792,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Stemedica Cell Technologies, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02835222,0,0,0,0,0,0,2020-10-31,2021-10-31,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT02839681,1,1,0,1,0,0,2018-06-12,2019-06-12,2019-02-27,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2016.0,1,1,0,1,0,0,0,0,0,0,1,3004
NCT02841267,0,0,0,0,0,0,2019-01-31,2020-01-31,,Kathryn Wagner,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02845752,1,0,0,0,1,0,2018-08-06,2019-08-06,,Los Angeles Biomedical Research Institute,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,60
NCT02846324,1,0,0,0,1,0,2017-09-30,2018-09-30,,Global Blood Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02849080,0,0,0,0,0,0,2018-02-28,2019-02-28,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02851407,0,0,0,0,0,0,2021-01-31,2022-01-31,,Jazz Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,55
NCT02853331,0,0,0,0,0,0,2018-10-18,2019-10-18,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02853500,0,0,0,0,0,0,2020-07-31,2021-07-31,,Dana-Farber Cancer Institute,Other,0,1,0,5.0,,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,647
NCT02856685,1,0,0,0,1,0,2017-07-31,2018-07-31,,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,35
NCT02856802,0,0,0,0,0,0,2017-02-10,2018-02-10,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,212
NCT02857374,0,0,0,0,0,0,2019-06-21,2020-06-21,,Roswell Park Cancer Institute,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,294
NCT02859415,0,0,0,0,0,0,2028-08-03,2029-08-03,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02860546,1,0,0,0,1,0,2017-11-03,2018-11-03,,"Taiho Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,37
NCT02861183,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Anika Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,9
NCT02861950,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT02865811,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02874690,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT02875860,0,0,0,0,0,0,2020-12-31,2021-12-31,,Michael Belfort,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT02876822,1,0,0,0,1,0,2017-03-16,2018-03-16,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,437
NCT02880228,1,1,0,1,0,1,2017-07-06,2018-07-06,2019-06-25,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,1898
NCT02881112,1,0,0,0,1,0,2017-12-14,2018-12-14,,"Regenesis Biomedical, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,10
NCT02881554,0,0,0,0,0,0,2022-06-01,2023-06-01,,University of Washington,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02882074,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02884206,0,0,0,0,0,0,2021-07-14,2022-07-14,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02886715,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-31,Fougera Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02892201,0,0,0,0,0,0,2019-12-31,2020-12-31,,Yale University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02893176,0,0,0,0,0,0,2020-02-29,2021-02-28,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,692
NCT02895100,0,0,0,0,0,0,2018-03-26,2019-03-26,,Protagonist Therapeutics,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT02896348,0,0,0,0,0,0,2020-08-31,2021-08-31,,Spaulding Rehabilitation Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,69
NCT02898753,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Valerion Therapeutics, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT02899156,0,0,0,0,0,0,2019-04-16,2020-04-16,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,530
NCT02901184,0,0,0,0,0,0,2021-12-31,2022-12-31,,Uppsala University,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,216
NCT02903511,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of Colorado, Denver",Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02906644,1,1,0,1,0,0,2018-03-27,2019-03-27,2019-03-01,Duke University,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02910401,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Virginia,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,402
NCT02910492,1,0,0,0,1,0,2018-06-30,2019-06-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,37
NCT02911142,0,0,0,0,0,0,2022-10-01,2023-10-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02911688,0,0,0,0,0,0,2019-02-13,2020-02-13,,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02911844,0,0,0,0,0,0,2018-12-05,2019-12-05,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1052
NCT02912728,0,0,0,0,0,0,2018-12-31,2019-12-31,,Jaeb Center for Health Research,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,93
NCT02912949,0,0,0,0,0,0,2021-09-30,2022-09-30,,Merus N.V.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02914535,0,0,0,0,0,0,2023-02-28,2024-02-28,,Gilead Sciences,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT02916446,0,0,0,0,0,0,2017-09-22,2018-09-22,,DBV Technologies,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,11
NCT02916693,0,0,0,0,0,0,2019-07-31,2020-07-31,,Johns Hopkins University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1143
NCT02917031,0,0,0,0,0,0,2019-08-23,2020-08-23,,AstraZeneca,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02920892,0,0,0,0,0,0,2020-07-01,2021-07-01,,Elizabeth Berry-Kravis,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02921776,0,0,0,0,0,0,2019-10-10,2020-10-10,,Ohio State University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT02923531,0,0,0,0,0,0,2018-08-08,2019-08-08,,X4 Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02924727,0,0,0,0,0,0,2020-07-09,2021-07-09,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02929862,0,0,0,0,0,0,2019-03-31,2020-03-31,,Lycera Corp.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02934568,0,0,0,0,0,0,2019-01-21,2020-01-21,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02935634,0,0,0,0,0,0,2021-11-17,2022-11-17,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02937870,1,1,0,1,0,0,2017-04-05,2018-04-05,2018-02-26,GlaxoSmithKline,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3276
NCT02939976,0,0,0,0,0,0,2020-06-30,2021-06-30,,"David Kong, M.D.",Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02944383,1,0,0,0,1,0,2018-01-11,2019-01-11,,"Gemphire Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02944656,1,1,0,1,0,1,2018-06-26,2019-06-26,2019-07-17,Emory University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02949388,1,0,0,0,1,0,2017-11-30,2018-11-30,,"Innovation Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02949960,1,0,0,0,1,0,2017-07-14,2018-07-14,,Dermata Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02950181,0,0,0,0,0,0,2022-01-31,2023-01-31,,Arkansas Children's Hospital Research Institute,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,82
NCT02953457,0,0,0,0,0,0,2019-10-15,2020-10-15,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT02956447,0,0,0,0,0,0,2022-03-31,2023-03-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02964247,1,1,0,1,0,1,2018-05-04,2019-05-04,2019-05-07,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,981
NCT02966028,0,0,0,0,0,0,2019-08-31,2020-08-31,,Laboratoris Sanifit,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02967172,0,0,0,0,0,0,2018-09-21,2019-09-21,,Kyle Hancock,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02967393,1,1,0,1,0,0,2017-02-01,2018-02-01,2018-01-09,Vanderbilt University Medical Center,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,422
NCT02969590,1,0,1,1,0,1,2017-08-23,2018-08-23,2019-04-04,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT02971761,0,0,0,0,0,0,2019-10-08,2020-10-08,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT02972827,0,0,0,0,0,0,2019-05-31,2020-05-31,,Santa Barbara Cottage Hospital,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,9
NCT02974647,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02981108,0,0,0,0,0,0,2018-11-30,2019-11-30,,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,32
NCT02981966,0,0,0,0,0,0,2021-12-31,2022-12-31,,The University of Texas Health Science Center at San Antonio,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,257
NCT02983305,0,0,1,1,0,0,2018-11-21,2019-11-21,2019-08-23,University of Michigan,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,934
NCT02983578,0,0,0,0,0,0,2021-03-31,2022-03-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT02985125,0,0,0,0,0,0,2020-12-31,2021-12-31,,Georgetown University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT02985736,1,0,1,1,0,1,2017-01-27,2018-01-27,2018-04-06,Psoriasis Treatment Center of Central New Jersey,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02988297,0,0,0,0,0,0,2022-07-31,2023-07-31,,Revalesio Corporation,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,12
NCT02989493,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT02992743,0,0,0,0,0,0,2021-06-15,2022-06-15,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,0,0,1,0,0,1,3276
NCT02993523,0,0,0,0,0,0,2020-02-01,2021-02-01,,AbbVie,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT02996474,0,0,0,0,0,0,2019-04-02,2020-04-02,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT03000439,0,0,0,0,0,0,2023-08-06,2024-08-06,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03003728,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Arkansas,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,285
NCT03004586,0,0,0,0,0,0,2021-12-31,2022-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2066
NCT03006978,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Sight Sciences, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT03007472,0,0,0,0,0,0,2019-07-30,2020-07-30,,Cochlear,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,35
NCT03007888,0,0,0,0,0,0,2017-08-01,2018-08-01,,"Impax Laboratories, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT03008278,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03010527,0,0,0,0,0,0,2018-09-30,2019-09-30,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,75
NCT03012425,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT03015649,1,0,0,0,1,0,2018-09-10,2019-09-10,,"Sheridan Healthcare, Inc.",Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03015792,0,0,0,0,0,0,2022-02-15,2023-02-15,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03018353,1,0,0,0,1,0,2018-03-04,2019-03-04,,San Francisco Department of Public Health,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT03026790,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03029299,1,0,0,0,1,0,2017-09-15,2018-09-15,,"BioFire Diagnostics, LLC",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,10
NCT03029702,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Maisa N. Feghali, MD",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03032705,0,0,0,0,0,0,2019-10-31,2020-10-31,,Tufts University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,152
NCT03033628,1,0,0,0,1,0,2017-06-01,2018-06-01,,Cairo University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,1190
NCT03034200,0,0,0,0,0,0,2020-01-31,2021-01-31,,Peter Anderson,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03034317,0,0,0,0,0,0,2019-02-28,2020-02-28,,Synapse Biomedical,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,6
NCT03036150,0,0,0,0,0,0,2020-11-27,2021-11-27,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03038477,0,0,0,0,0,0,2019-04-01,2020-04-01,,"University of Colorado, Denver",Other,0,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,882
NCT03038594,0,0,0,0,0,0,2020-10-31,2021-10-31,,"The University of Texas Medical Branch, Galveston",Other,0,1,1,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,158
NCT03038867,0,0,0,0,0,0,2020-09-30,2021-09-30,,Weill Medical College of Cornell University,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT03039686,0,0,0,0,0,0,2020-12-30,2021-12-30,,Hoffmann-La Roche,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03040323,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-06-25,Indiana University,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,497
NCT03040791,0,0,0,0,0,0,2019-07-01,2020-07-01,,Hospital Moinhos de Vento,Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,12
NCT03040999,0,0,0,0,0,0,2021-04-16,2022-04-16,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,1,0,0,1,1,0,2145
NCT03047746,0,0,0,0,0,0,2022-01-31,2023-01-31,,Children's Hospital of Philadelphia,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,324
NCT03050554,0,0,0,0,0,0,2020-10-31,2021-10-31,,Andrew Sharabi,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT03051256,0,0,0,0,0,0,2019-07-29,2020-07-29,,"Relmada Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03051386,0,0,0,0,0,0,2022-04-01,2023-04-01,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,136
NCT03051516,0,0,0,0,0,0,2021-12-21,2022-12-21,,Fred Hutchinson Cancer Research Center,Other,0,0,1,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,393
NCT03052751,0,0,0,0,0,0,2018-05-31,2019-05-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,75
NCT03052842,0,0,0,0,0,0,2017-04-05,2018-04-05,,"Armata Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03053440,0,0,0,0,0,0,2021-06-30,2022-06-30,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03053830,0,0,0,0,0,0,2020-01-30,2021-01-30,,VA Connecticut Healthcare System,U.S. Fed,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,36
NCT03054844,1,1,0,1,0,1,2017-10-10,2018-10-10,2019-03-09,Columbia University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,675
NCT03055806,0,0,0,0,0,0,2017-11-17,2018-11-17,,Ixchelsis Limited,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03057652,0,0,0,0,0,0,2020-12-31,2021-12-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,490
NCT03058029,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Gelesis, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,9
NCT03065218,0,0,0,0,0,0,2019-07-31,2020-07-31,,Washington Hospital Center,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,15
NCT03065647,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Michigan,Other,0,1,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03066440,0,0,0,0,0,0,2020-04-01,2021-04-01,,State University of New York at Buffalo,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,105
NCT03069326,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03069937,0,0,0,0,0,0,2020-02-01,2021-02-01,,Medical University of South Carolina,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03072446,1,0,0,0,1,0,2018-06-30,2019-06-30,,University Hospital Southampton NHS Foundation Trust,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,76
NCT03075501,1,0,0,0,1,0,2018-07-31,2019-07-31,,University of Illinois at Chicago,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,242
NCT03075748,0,0,0,0,0,0,2024-01-31,2025-01-31,,University of South Florida,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,240
NCT03075904,0,0,0,0,0,0,2018-11-30,2019-11-30,,"Syntimmune, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03076164,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03077698,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Xenetic Biosciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03077893,1,1,0,1,0,1,2017-12-26,2018-12-26,2019-05-31,"Regenesis Biomedical, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,10
NCT03078569,1,0,0,0,1,0,2018-03-31,2019-03-31,,Wolfson Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,87
NCT03079102,0,0,0,0,0,0,2021-06-30,2022-06-30,,Cameron Dezfulian,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03079999,0,0,0,0,0,0,2021-02-28,2022-02-28,,Massachusetts Eye and Ear Infirmary,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,50
NCT03081767,0,0,0,0,0,0,2020-04-01,2021-04-01,,Stanford University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,1309
NCT03082599,1,0,1,1,0,0,2018-04-03,2019-04-03,2019-01-30,"Carolina Eyecare Physicians, LLC",Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03082963,0,0,0,0,0,0,2019-12-31,2020-12-31,,Jeffrey Goldberger,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03083873,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Iovance Biotherapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,0,1,5
NCT03085238,1,0,0,0,1,0,2018-09-12,2019-09-12,,"MTrap, Inc.",Industry,1,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03086460,0,0,0,0,0,0,2018-07-23,2019-07-23,,Chiesi Farmaceutici S.p.A.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,130
NCT03087019,0,0,0,0,0,0,2020-10-31,2021-10-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,647
NCT03088345,0,0,0,0,0,0,2018-11-01,2019-11-01,,Medical College of Wisconsin,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,315
NCT03088540,0,0,0,0,0,0,2023-02-15,2024-02-15,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,176
NCT03090230,0,0,0,0,0,0,2019-06-17,2020-06-17,,Bolton Medical,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03091673,1,1,0,1,0,1,2017-09-07,2018-09-07,2018-10-17,Xeris Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,14
NCT03092726,1,1,0,1,0,0,2018-03-06,2019-03-06,2019-03-06,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,135
NCT03095027,0,1,0,1,0,1,2017-05-15,2018-05-15,2019-01-08,Alcon Research,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03098550,0,0,0,0,0,0,2020-08-30,2021-08-30,,Bristol-Myers Squibb,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03098823,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Ampel BioSolutions, LLC",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03099265,0,0,0,0,0,0,2022-02-28,2023-02-28,,Yale University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03100370,0,0,0,0,0,0,2019-05-31,2020-05-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,490
NCT03100968,0,0,1,1,0,0,2018-10-01,2019-10-01,2019-08-21,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,801
NCT03102437,0,0,0,0,0,0,2020-01-15,2021-01-15,,Impulse Dynamics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03103542,0,0,0,0,0,0,2019-10-31,2020-10-31,,Swedish Orphan Biovitrum,Industry,1,1,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,40
NCT03103880,1,0,0,0,1,0,2018-03-31,2019-03-31,,CoheroHealth,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03104439,0,0,0,0,0,0,2020-10-31,2021-10-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1699
NCT03104816,1,0,1,1,0,1,2017-10-31,2018-10-31,2019-07-14,University of Southern California,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,483
NCT03106038,0,0,0,0,0,0,2018-11-19,2019-11-19,,"Li-Cor, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03106519,1,0,0,0,1,0,2017-06-28,2018-06-28,,"Admir Hadzic, M.D., Ph.D.",Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,0,1,2
NCT03106844,0,0,0,0,0,0,2019-04-30,2020-04-30,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,698
NCT03107065,1,0,1,1,0,1,2017-07-31,2018-07-31,2018-09-25,"ThermiGen, LLC",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT03107377,0,0,0,0,0,0,2019-09-30,2020-09-30,,Evofem Inc.,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03107962,0,0,0,0,0,0,2018-12-31,2019-12-31,,Mingzhi Zhang,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,13
NCT03110601,1,1,0,1,0,0,2017-10-12,2018-10-12,2018-10-12,Stimgenics LLC,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03111420,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Aggredyne, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,1,0,1,0,0,0,0,3,0,1,3
NCT03112993,1,0,0,0,1,0,2018-08-13,2019-08-13,,University of Missouri-Columbia,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,214
NCT03113994,0,0,0,0,0,0,2020-12-31,2021-12-31,,Dr. B. Catharine. Craven,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03115515,1,0,0,0,1,0,2018-02-28,2019-02-28,,Medstar Health Research Institute,Other,0,0,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,79
NCT03115567,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03118843,1,1,0,1,0,0,2018-03-19,2019-03-19,2019-03-08,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,510
NCT03119610,0,0,0,0,0,0,2018-12-17,2019-12-17,,Sara Espinoza,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03120520,1,0,1,1,0,0,2018-09-07,2019-09-07,2019-08-27,"Bausch Health Americas, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,180
NCT03120780,0,0,0,0,0,0,2020-03-31,2021-03-31,,Ohio State University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03122145,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Florida,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,849
NCT03123068,0,0,0,0,0,0,2018-11-25,2019-11-25,,Stanford University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1309
NCT03126344,1,0,0,0,1,0,2018-01-01,2019-01-01,,Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,45
NCT03127137,0,0,0,0,0,0,2021-12-31,2022-12-31,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03127371,1,0,0,0,1,0,2018-08-31,2019-08-31,,Albert Einstein Healthcare Network,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,45
NCT03129295,1,0,0,0,1,0,2017-09-30,2018-09-30,,Mission Pharmacal,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03129945,1,0,0,0,1,0,2018-04-30,2019-04-30,,"University of California, Irvine",Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,310
NCT03131817,0,0,0,0,0,0,2020-12-16,2021-12-16,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1443
NCT03134209,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03137173,0,0,0,0,0,0,2019-02-25,2020-02-25,,Basilea Pharmaceutica,Industry,1,0,1,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,32
NCT03138161,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Sarcoma Oncology Research Center, LLC",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03138603,0,0,0,0,0,0,2021-12-31,2022-12-31,,Washington University School of Medicine,Other,0,0,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT03138720,0,0,0,0,0,0,2019-12-15,2020-12-15,,HonorHealth Research Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03139604,0,0,0,0,0,0,2019-04-05,2020-04-05,,Incyte Corporation,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03140722,0,0,0,0,0,0,2018-03-21,2019-03-21,,Akebia Therapeutics,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,25
NCT03141255,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Chicago,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,594
NCT03144453,0,0,0,0,0,0,2019-12-31,2020-12-31,,Regina Elena Cancer Institute,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,16
NCT03149055,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03149315,0,0,0,0,0,0,2018-11-14,2019-11-14,,Ann & Robert H Lurie Children's Hospital of Chicago,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,112
NCT03150719,1,1,0,1,0,0,2018-08-09,2019-08-09,2019-08-08,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03152591,1,1,0,1,0,0,2018-06-25,2019-06-25,2019-03-28,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03153956,0,0,0,0,0,0,2018-12-07,2019-12-07,,NYU Langone Health,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT03164447,0,0,0,0,0,0,2020-05-31,2021-05-31,,United BioPharma,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,9
NCT03164564,0,0,0,0,0,0,2022-05-31,2023-05-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2133
NCT03165149,0,0,0,0,0,0,2019-08-31,2020-08-31,,Assiut University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1331
NCT03165734,0,0,0,0,0,0,2019-07-31,2020-07-31,,CTI BioPharma,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,36
NCT03168308,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Texas Southwestern Medical Center,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03169140,1,0,0,0,1,0,2018-08-14,2019-08-14,,Sport and Spine Rehab Clinical Research Foundation,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03170869,1,0,1,1,0,0,2018-09-11,2019-09-11,2018-10-12,"University of Colorado, Denver",Other,0,1,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,882
NCT03172494,0,0,0,0,0,0,2019-06-14,2020-06-14,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,981
NCT03175224,0,0,0,0,0,0,2021-09-30,2022-09-30,,Apollomics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03176134,0,0,0,0,0,0,2021-09-18,2022-09-18,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03179631,0,0,0,0,0,0,2020-03-31,2021-03-31,,PTC Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03181529,0,0,0,0,0,0,2020-12-31,2021-12-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03182582,1,1,0,1,0,0,2017-03-17,2018-03-17,2018-03-16,Stanford University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,0,1,1309
NCT03184870,0,0,0,0,0,0,2020-12-10,2021-12-10,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03187353,0,0,0,0,0,0,2022-07-01,2023-07-01,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03187535,0,0,0,0,0,0,2020-07-20,2021-07-20,,Ohio State University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03188822,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Rochester,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,470
NCT03189173,0,0,0,0,0,0,2019-06-30,2020-06-30,,Brigham and Women's Hospital,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,1,0,0,0,0,1,1,0,698
NCT03190213,0,0,0,0,0,0,2018-12-13,2019-12-13,,University of Utah,Other,0,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,578
NCT03190369,0,0,0,0,0,0,2019-01-28,2020-01-28,,"Genzyme, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,300
NCT03190915,0,0,0,0,0,0,2020-12-30,2021-12-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03192826,1,1,0,1,0,1,2017-07-08,2018-07-08,2019-04-16,University Hospital of Patras,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,17
NCT03193437,0,0,0,0,0,0,2019-12-31,2020-12-31,,Georgetown University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03193684,0,0,0,0,0,0,2022-01-31,2023-01-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,257
NCT03194776,0,0,0,0,0,0,2018-09-07,2019-09-07,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03196973,1,0,0,0,1,0,2018-08-31,2019-08-31,,Salvat,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,9
NCT03197493,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Snyder, Robert W., M.D., Ph.D., P.C.",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03200704,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Novadaq Technologies ULC, now a part of Stryker",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,1,1,0,4
NCT03201458,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03203473,0,0,0,0,0,0,2020-11-30,2021-11-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03203850,0,0,0,0,0,0,2022-03-10,2023-03-10,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03205046,0,0,0,0,0,0,2020-12-31,2021-12-31,,Acerta Pharma BV,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT03207243,0,0,0,0,0,0,2019-02-15,2020-02-15,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03207867,0,0,0,0,0,0,2020-11-06,2021-11-06,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03211039,0,0,0,0,0,0,2019-08-30,2020-08-30,,Rady Pediatric Genomics & Systems Medicine Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,0,0,0,0,1,0,1,0,3
NCT03212365,0,0,0,0,0,0,2019-06-02,2020-06-02,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03213704,0,0,0,0,0,0,2024-09-30,2025-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03214562,0,0,0,0,0,0,2023-09-30,2024-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03216005,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Intervene, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03217838,0,0,0,0,0,0,2021-02-09,2022-02-09,,AstraZeneca,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2450
NCT03219294,1,1,0,1,0,1,2018-04-30,2019-04-30,2019-08-19,Craig Curry,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03223220,0,0,0,0,0,0,2020-09-30,2021-09-30,,Doylestown Health,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03226223,0,0,0,0,0,0,2019-07-30,2020-07-30,,New York State Psychiatric Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT03227757,0,0,0,0,0,0,2023-10-31,2024-10-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT03231969,0,0,0,0,0,0,2017-10-11,2018-10-11,,"Faes Farma, S.A.",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03233048,0,0,0,0,0,0,2019-07-31,2020-07-31,,Imad Absah,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03233347,0,0,0,0,0,0,2023-08-01,2024-08-01,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,32
NCT03237481,0,0,0,0,0,0,2017-12-22,2018-12-22,,Heron Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,1,0,0,0,0,1,1,0,18
NCT03238157,0,0,0,0,0,0,2019-09-01,2020-09-01,,The Cleveland Clinic,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,581
NCT03238963,0,0,0,0,0,0,2020-02-20,2021-02-20,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03240432,0,0,0,0,0,0,2019-06-06,2020-06-06,,Jaeb Center for Health Research,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,93
NCT03242408,1,1,0,1,0,1,2017-05-31,2018-05-31,2019-08-16,Lipocine Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,4
NCT03243981,1,0,1,1,0,1,2018-03-30,2019-03-30,2019-08-15,Stanford University,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1309
NCT03246126,0,0,0,0,0,0,2019-09-30,2020-09-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03246724,0,0,0,0,0,0,2019-09-30,2020-09-30,,Boston Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,225
NCT03246906,0,0,0,0,0,0,2022-08-15,2023-08-15,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,393
NCT03248531,0,0,0,0,0,0,2018-11-23,2019-11-23,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,75
NCT03248882,0,0,0,0,0,0,2019-02-26,2020-02-26,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2856
NCT03250247,0,0,0,0,0,0,2021-12-31,2022-12-31,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03251963,0,0,0,0,0,0,2019-03-27,2020-03-27,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,578
NCT03252145,0,0,0,0,0,0,2019-12-30,2020-12-30,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03253263,0,0,0,0,0,0,2022-08-31,2023-08-31,,Shire,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,342
NCT03254160,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Dart NeuroScience, LLC",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,7
NCT03254927,0,0,0,0,0,0,2020-07-31,2021-07-31,,Celldex Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03255733,1,1,0,1,0,0,2017-03-13,2018-03-13,2017-08-21,Guided Therapy Systems,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT03257995,1,1,0,1,0,0,2018-01-17,2019-01-17,2019-01-08,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03263117,0,0,0,0,0,0,2020-06-30,2021-06-30,,"The University of Texas Health Science Center, Houston",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03265132,0,0,0,0,0,0,2019-02-13,2020-02-13,,Swedish Orphan Biovitrum,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,1,0,0,0,0,0,1,1,0,40
NCT03266081,0,0,0,0,0,0,2021-08-31,2022-08-31,,McMaster University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,434
NCT03266627,0,0,0,0,0,0,2020-12-31,2021-12-31,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03267433,0,0,0,0,0,0,2027-01-31,2028-01-31,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,75
NCT03269994,0,0,0,0,0,0,2020-08-28,2021-08-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1432
NCT03271489,0,0,0,0,0,0,2023-08-18,2024-08-18,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03272711,0,0,0,0,0,0,2019-01-24,2020-01-24,,Washington University School of Medicine,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT03274414,0,0,0,0,0,0,2020-09-01,2021-09-01,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03275285,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03277248,0,0,0,0,0,0,2021-03-31,2022-03-31,,"TG Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03278613,0,0,0,0,0,0,2020-10-31,2021-10-31,,NICHD Pelvic Floor Disorders Network,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,13
NCT03279562,0,0,0,0,0,0,2019-12-30,2020-12-30,,Yale University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03279692,0,0,0,0,0,0,2021-03-31,2022-03-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03283085,0,0,0,0,0,0,2025-02-11,2026-02-11,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,342
NCT03288493,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Poseida Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03289650,0,0,0,0,0,0,2020-09-30,2021-09-30,,Lorenzo Gallon,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03290950,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03292861,0,0,0,0,0,0,2020-10-01,2021-10-01,,Cedars-Sinai Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03293524,0,0,0,0,0,0,2020-06-30,2021-06-30,,GenSight Biologics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,1,1,1,0,8
NCT03294304,0,0,0,0,0,0,2021-11-01,2022-11-01,,"Masonic Cancer Center, University of Minnesota",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,218
NCT03301246,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Eminence Clinical Research, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03301636,0,0,0,0,0,0,2019-12-31,2020-12-31,,NewLink Genetics Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,34
NCT03301779,0,0,1,1,0,0,2018-12-30,2019-12-30,2019-08-13,Hemanext,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03302156,0,0,0,0,0,0,2021-08-01,2022-08-01,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03303911,0,0,0,0,0,0,2018-10-05,2019-10-05,,Achieve Life Sciences,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,23
NCT03304587,0,0,0,0,0,0,2020-11-30,2021-11-30,,Michigan State University,Other,0,0,1,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,70
NCT03304873,0,0,0,0,0,0,2019-02-13,2020-02-13,,NYU Langone Health,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,869
NCT03305016,0,0,0,0,0,0,2019-03-19,2020-03-19,,Ascendis Pharma A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,10
NCT03305588,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03306615,0,0,0,0,0,0,2020-12-31,2021-12-31,,NYU Langone Health,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03309813,0,0,0,0,0,0,2019-12-31,2020-12-31,,InSightec,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,61
NCT03311295,0,0,0,0,0,0,2019-02-03,2020-02-03,,"Mvrx, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03311555,0,0,0,0,0,0,2024-03-31,2025-03-31,,"Tian Zhang, MD",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT03312907,0,0,0,0,0,0,2020-05-25,2021-05-25,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03315104,0,0,0,0,0,0,2019-06-17,2020-06-17,,Emergent BioSolutions,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,23
NCT03316300,0,0,0,0,0,0,2021-03-31,2022-03-31,,Neurotech Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,0,0,0,0,1,0,1,1,0,10
NCT03320850,0,0,0,0,0,0,2019-10-27,2020-10-27,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03322423,1,1,0,1,0,0,2017-11-04,2018-11-04,2018-10-31,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03325322,0,0,0,0,0,0,2021-01-31,2022-01-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03327220,0,0,0,0,0,0,2018-10-30,2019-10-30,,"MyoScience, Inc",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,18
NCT03327727,0,0,0,0,0,0,2019-01-14,2020-01-14,,Vical,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,13
NCT03328026,0,0,0,0,0,0,2020-12-31,2021-12-31,,BriaCell Therapeutics Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03329469,0,0,0,0,0,0,2020-03-31,2021-03-31,,Northwell Health,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03330847,0,0,0,0,0,0,2021-01-20,2022-01-20,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03332160,0,0,0,0,0,0,2019-06-04,2020-06-04,,Tactile Medical,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03332485,1,0,0,0,1,0,2018-03-14,2019-03-14,,Sebela Pharmaceuticals Development LLC,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03333135,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT03333876,1,1,0,1,0,1,2017-12-03,2018-12-03,2018-12-11,Philips Respironics,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,33
NCT03335033,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,1,0,0,1,0,0,1,0,1898
NCT03337490,1,0,0,0,1,0,2017-12-04,2018-12-04,,"bioRASI, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03340311,1,0,0,0,1,0,2018-04-28,2019-04-28,,Leslie Balcazar De Martinez,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03340714,0,0,0,0,0,0,2020-01-31,2021-01-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,162
NCT03341637,0,1,0,1,0,0,2019-01-26,2020-01-26,2019-07-23,Takeda,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,650
NCT03343730,0,0,0,0,0,0,2018-10-01,2019-10-01,,Bassett Healthcare,Other,0,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,18
NCT03344458,0,0,0,0,0,0,2021-12-31,2022-12-31,,Ascendis Pharma A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03345550,0,0,0,0,0,0,2020-07-27,2021-07-27,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03347110,0,0,0,0,0,0,2020-11-30,2021-11-30,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03347396,0,0,0,0,0,0,2020-06-30,2021-06-30,,Bioverativ Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,19
NCT03347708,0,0,0,0,0,0,2020-04-30,2021-04-30,,"DiscGenics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03348956,0,0,0,0,0,0,2019-09-30,2020-09-30,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,306
NCT03349268,0,0,0,0,0,0,2022-05-31,2023-05-31,,University of Michigan,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03350451,0,0,0,0,0,0,2021-09-30,2022-09-30,,Alnylam Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,45
NCT03350620,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Nevakar, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03350906,0,0,0,0,0,0,2020-12-01,2021-12-01,,Mayo Clinic,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03352882,0,0,1,1,0,0,2019-04-03,2020-04-03,2019-07-22,University of Pennsylvania,Other,0,0,1,5.0,,1,2016.0,1,0,0,0,1,0,0,0,0,0,1,1052
NCT03353220,0,0,0,0,0,0,2020-01-31,2021-01-31,,Columbia University,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03354598,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Iterum Therapeutics, International Limited",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03362177,0,0,0,0,0,0,2021-09-21,2022-09-21,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,685
NCT03363321,0,0,0,0,0,0,2020-08-11,2021-08-11,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2856
NCT03363919,0,0,0,0,0,0,2021-12-31,2022-12-31,,Mayo Clinic,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03364738,0,0,0,0,0,0,2020-06-05,2021-06-05,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,342
NCT03365752,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Hospital for Special Surgery, New York",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT03367312,0,0,0,0,0,0,2020-08-31,2021-08-31,,Bastiaan Driehuys,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03367715,0,0,0,0,0,0,2020-01-31,2021-01-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,869
NCT03368963,0,0,0,0,0,0,2020-02-29,2021-02-28,,Emory University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03369197,0,0,0,0,0,0,2019-10-30,2020-10-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03371654,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Illinois at Chicago,Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,242
NCT03371979,0,0,0,0,0,0,2020-12-31,2021-12-31,,Aeglea Biotherapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03373435,0,0,0,0,0,0,2018-09-19,2019-09-19,,Eiger BioPharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03373591,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-08-12,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03375203,0,0,0,0,0,0,2019-04-03,2020-04-03,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT03377491,0,0,0,0,0,0,2022-12-31,2023-12-31,,NovoCure Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,1,1,0,14
NCT03379870,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03380156,0,0,0,0,0,0,2019-05-30,2020-05-30,,University of Oklahoma,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,234
NCT03380845,0,0,0,0,0,0,2018-09-30,2019-09-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,1699
NCT03381170,0,0,0,0,0,0,2019-09-30,2020-09-30,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,27
NCT03381339,1,0,0,0,1,0,2018-06-25,2019-06-25,,Marquette University,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,19
NCT03382119,0,0,0,0,0,0,2020-12-01,2021-12-01,,University of Michigan,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03382639,0,0,0,0,0,0,2020-07-07,2021-07-07,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03383094,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Loren Mell, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT03383302,0,0,0,0,0,0,2021-06-30,2022-06-30,,Royal Marsden NHS Foundation Trust,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,2,1,0,184
NCT03383575,0,0,0,0,0,0,2022-02-28,2023-02-28,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03384329,0,0,0,0,0,0,2018-12-31,2019-12-31,,Russian Academy of Medical Sciences,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,30
NCT03384589,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of British Columbia,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,881
NCT03384745,0,0,0,0,0,0,2019-11-01,2020-11-01,,Bond Avillion 2 Development LP,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03386344,0,0,0,0,0,0,2019-06-01,2020-06-01,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03387605,0,0,0,0,0,0,2020-01-31,2021-01-31,,Loyola University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03390790,0,0,0,0,0,0,2019-03-29,2020-03-29,,Atlantic Health System,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,40
NCT03391804,0,0,0,0,0,0,2019-12-31,2020-12-31,,Allena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03393520,0,0,0,0,0,0,2021-06-30,2022-06-30,,Avanir Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,29
NCT03395301,1,0,0,0,1,0,2018-06-30,2019-06-30,,Wenzhou Medical University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,2,0,1,57
NCT03395392,0,0,0,0,0,0,2019-03-31,2020-03-31,,"NeuroRx, Inc.",Industry,1,1,0,2.0,Phase 2/Phase 3,0,2019.0,1,1,0,0,0,0,0,0,3,1,0,5
NCT03398837,0,0,0,0,0,0,2020-03-31,2021-03-31,,Corbus Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03405935,0,0,0,0,0,0,2018-11-20,2019-11-20,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,510
NCT03406169,0,0,0,0,0,0,2021-12-31,2022-12-31,,Brooke Army Medical Center,U.S. Fed,2,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,71
NCT03406780,0,0,0,0,0,0,2019-12-31,2020-12-31,,Capricor Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,6
NCT03407170,0,0,0,0,0,0,2021-12-13,2022-12-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2145
NCT03410862,0,0,0,0,0,0,2020-04-30,2021-04-30,,michael macknin,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03411070,0,0,0,0,0,0,2022-06-01,2023-06-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,277
NCT03412929,0,0,0,0,0,0,2019-01-10,2020-01-10,,Medline Industries,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,30
NCT03414307,0,0,0,0,0,0,2020-09-30,2021-09-30,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,215
NCT03414684,0,0,0,0,0,0,2021-06-30,2022-06-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03414983,0,0,0,0,0,0,2021-08-16,2022-08-16,,Bristol-Myers Squibb,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03416985,0,0,0,0,0,0,2018-11-01,2019-11-01,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,692
NCT03417141,0,0,0,0,0,0,2019-08-30,2020-08-30,,Mayo Clinic,Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1898
NCT03417544,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Nancy Lin, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03417882,0,0,0,0,0,0,2020-03-31,2021-03-31,,BrightPath Biotherapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03418714,0,0,0,0,0,0,2020-02-01,2021-02-01,,Johns Hopkins University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03419234,0,0,0,0,0,0,2020-04-01,2021-04-01,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,75
NCT03425539,0,0,0,0,0,0,2020-05-20,2021-05-20,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03426631,0,0,0,0,0,0,2019-10-01,2020-10-01,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03429049,0,0,0,0,0,0,2019-11-30,2020-11-30,,Centrexion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03432897,0,0,0,0,0,0,2019-09-30,2020-09-30,,Dr Anthony Mega,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03440801,0,0,0,0,0,0,2019-01-03,2020-01-03,,Tokorozawa Heart Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03440944,0,0,0,0,0,0,2019-11-30,2020-11-30,,Boston Medical Center,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,225
NCT03441789,0,1,0,1,0,0,2018-10-01,2019-10-01,2019-02-11,"L.H. Kircik, M.D.",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03443076,1,0,0,0,1,0,2018-04-05,2019-04-05,,Midwest Center for Metabolic and Cardiovascular Research,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03448406,0,0,0,0,0,0,2019-10-04,2020-10-04,,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03450473,0,0,0,0,0,0,2020-01-03,2021-01-03,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03451084,0,0,0,0,0,0,2020-04-30,2021-04-30,,Aslan Pharmaceuticals,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,16
NCT03452917,0,0,0,0,0,0,2021-02-08,2022-02-08,,University of Washington,Other,0,0,1,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03455218,0,0,0,0,0,0,2019-04-20,2020-04-20,,Medical College of Wisconsin,Other,0,1,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,315
NCT03456648,1,0,0,0,1,0,2018-08-24,2019-08-24,,Universitaire Ziekenhuizen Leuven,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,525
NCT03460743,0,0,0,0,0,0,2020-01-31,2021-01-31,,Laboratorios Liomont,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,1
NCT03460990,0,0,0,0,0,0,2018-09-26,2019-09-26,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03462550,1,0,0,0,1,0,2017-10-30,2018-10-30,,"University Hospital, Ghent",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,367
NCT03463395,0,0,0,0,0,0,2019-11-30,2020-11-30,,Medical College of Wisconsin,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03463837,1,0,0,0,1,0,2018-07-27,2019-07-27,,"Juul Labs, Inc.",Industry,1,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03465904,0,1,0,1,0,0,2019-01-11,2020-01-11,2019-06-05,Cefaly Technology,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03467152,0,0,0,0,0,0,2020-03-11,2021-03-11,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,328
NCT03467867,0,0,0,0,0,0,2023-10-15,2024-10-15,,Georgetown University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03468855,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03468998,0,0,0,0,0,0,2019-12-30,2020-12-30,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03471351,0,0,0,0,0,0,2019-02-13,2020-02-13,,Rhizen Pharmaceuticals SA,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2018.0,1,1,1,0,0,0,0,0,0,1,0,9
NCT03472040,0,0,0,0,0,0,2024-02-29,2025-02-28,,BioCryst Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03472521,0,0,0,0,0,0,2021-03-31,2022-03-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03473925,0,0,0,0,0,0,2020-01-08,2021-01-08,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03475212,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Michael Pulsipher, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03475888,0,0,0,0,0,0,2022-10-01,2023-10-01,,Erasmus Medical Center,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,158
NCT03476369,0,0,0,0,0,0,2020-03-31,2021-03-31,,The Guthrie Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03476941,0,0,0,0,0,0,2021-05-01,2022-05-01,,Paolo Goffredo,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03478514,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Alliance Foundation Trials, LLC.",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03478969,0,0,0,0,0,0,2020-02-29,2021-02-28,,Hoffmann-La Roche,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,1731
NCT03479476,0,0,0,0,0,0,2021-05-31,2022-05-31,,"University of California, Davis",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03480009,0,0,0,0,0,0,2019-06-30,2020-06-30,,Study Investigator-Sponsor,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03480971,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Matrix Biomed, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03482557,0,0,0,0,0,0,2021-04-30,2022-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT03485209,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Seattle Genetics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,77
NCT03486197,0,0,0,0,0,0,2020-11-01,2021-11-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,1,0,0,0,1,0,910
NCT03486587,1,0,0,0,1,0,2018-08-31,2019-08-31,,Sun Yat-sen University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,711
NCT03489239,0,0,0,0,0,0,2020-01-15,2021-01-15,,Thomas Jefferson University,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,186
NCT03491059,0,0,0,0,0,0,2019-02-16,2020-02-16,,Ohio State University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,315
NCT03496805,0,0,0,0,0,0,2020-12-31,2021-12-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03497507,0,0,0,0,0,0,2020-01-23,2021-01-23,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,412
NCT03498521,0,0,0,0,0,0,2021-06-25,2022-06-25,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1731
NCT03499353,0,0,0,0,0,0,2021-09-01,2022-09-01,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03500263,0,0,0,0,0,0,2019-03-13,2020-03-13,,"Proteostasis Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,7
NCT03500406,0,0,0,0,0,0,2021-03-23,2022-03-23,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03501043,0,0,0,0,0,0,2019-06-26,2020-06-26,,Albert Einstein Healthcare Network,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,45
NCT03501654,1,0,0,0,1,0,2018-05-31,2019-05-31,,Seoul National University Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,1227
NCT03502070,0,0,0,0,0,0,2019-03-19,2020-03-19,,Mylan Inc.,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,30
NCT03502798,0,0,0,0,0,0,2019-10-31,2020-10-31,,Duke University,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03503617,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Flint Rehabilitation Devices, LLC",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03504163,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03504644,0,0,0,0,0,0,2021-04-30,2022-04-30,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,75
NCT03504839,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Emile Daoud, MD",Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03504995,0,0,0,0,0,0,2020-04-30,2021-04-30,,I.M. Sechenov First Moscow State Medical University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,15
NCT03506620,0,0,0,0,0,0,2019-06-30,2020-06-30,,Columbia University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,675
NCT03509961,0,0,0,0,0,0,2021-04-01,2022-04-01,,Children's Hospital Los Angeles,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,82
NCT03510182,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Michigan,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT03512353,0,0,0,0,0,0,2020-02-28,2021-02-28,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,685
NCT03518996,0,0,0,0,0,0,2022-12-01,2023-12-01,,Gen Shinozaki,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03526250,0,0,0,0,0,0,2023-03-30,2024-03-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03527238,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Florida,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,849
NCT03529929,0,0,0,0,0,0,2020-05-01,2021-05-01,,Texas A&M University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,57
NCT03530293,0,0,0,0,0,0,2019-07-12,2020-07-12,,Neurocrine Biosciences,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,34
NCT03530852,0,0,0,0,0,0,2021-06-15,2022-06-15,,Boston Children’s Hospital,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,400
NCT03531255,0,0,0,0,0,0,2020-12-20,2021-12-20,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03533751,0,0,0,0,0,0,2019-06-30,2020-06-30,,"AnaptysBio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,6
NCT03539081,0,0,0,0,0,0,2020-05-01,2021-05-01,,Marshall Holland,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,1,0,0,0,0,0,1,1
NCT03540160,0,0,0,0,0,0,2021-05-31,2022-05-31,,Menlo Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03543124,0,0,0,0,0,0,2022-06-30,2023-06-30,,VA Greater Los Angeles Healthcare System,U.S. Fed,2,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT03549338,0,0,1,1,0,0,2019-03-09,2020-03-09,2019-06-07,Symphogen A/S,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,14
NCT03551028,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Virginia,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,402
NCT03554083,0,0,0,0,0,0,2023-06-29,2024-06-29,,Mayo Clinic,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03554291,0,0,0,0,0,0,2022-07-31,2023-07-31,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03554811,0,0,0,0,0,0,2020-07-31,2021-07-31,,Fresno Community Hospital and Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03559192,0,0,0,0,0,0,2019-11-11,2020-11-11,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03559699,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Agios Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,33
NCT03560232,0,0,0,0,0,0,2020-06-30,2021-06-30,,Mercy Health Ohio,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03563365,0,0,0,0,0,0,2020-01-04,2021-01-04,,Yardley Dermatology Associates,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03565640,0,0,0,0,0,0,2020-05-31,2021-05-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03565900,0,0,0,0,0,0,2021-11-10,2022-11-10,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03566511,0,0,0,0,0,0,2020-12-31,2021-12-31,,Albert Einstein College of Medicine,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03567187,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Kansas Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,219
NCT03567720,0,0,0,0,0,0,2020-01-31,2021-01-31,,OncoSec Medical Incorporated,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,0,1,1,0,0,0,0,1,1,0,7
NCT03568643,0,0,0,0,0,0,2021-05-31,2022-05-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,1443
NCT03570619,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03574753,0,0,0,0,0,0,2022-10-01,2023-10-01,,Southwest Oncology Group,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,288
NCT03575104,0,0,0,0,0,0,2019-09-18,2020-09-18,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03576820,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York City Health and Hospitals Corporation,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03577899,0,0,0,0,0,0,2020-10-20,2021-10-20,,"Chengdu Kanghong Biotech Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,15
NCT03579966,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Catalyst Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03580135,0,0,0,0,0,0,2019-01-02,2020-01-02,,Cairo University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1190
NCT03581734,0,0,0,0,0,0,2020-01-25,2021-01-25,,"International Centre for Diarrhoeal Disease Research, Bangladesh",Other,0,0,1,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,135
NCT03583255,0,0,0,0,0,0,2020-05-31,2021-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03583697,0,0,0,0,0,0,2021-05-31,2022-05-31,,BioMarin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,85
NCT03584516,0,0,0,0,0,0,2023-08-17,2024-08-17,,Incyte Corporation,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03586050,0,0,0,0,0,0,2019-12-18,2020-12-18,,"Ethicon, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,59
NCT03586427,0,0,0,0,0,0,2019-07-22,2020-07-22,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,495
NCT03587636,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03587844,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03588663,0,0,0,0,0,0,2018-10-08,2019-10-08,,University of Winchester,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,5
NCT03591510,0,0,0,0,0,0,2022-05-12,2023-05-12,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03592745,0,0,0,0,0,0,2020-07-31,2021-07-31,,Northwell Health,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03595488,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rochester General Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03596034,0,0,0,0,0,0,2018-09-26,2019-09-26,,"Juul Labs, Inc.",Industry,1,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03597139,0,0,0,0,0,0,2018-11-09,2019-11-09,,Aurinia Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03598595,0,0,0,0,0,0,2020-03-02,2021-03-02,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03598777,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ipsen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,214
NCT03599362,0,0,0,0,0,0,2022-08-31,2023-08-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,869
NCT03601923,0,0,0,0,0,0,2022-02-28,2023-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03602066,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Arizona,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,265
NCT03602859,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Tesaro, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT03603899,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03605667,0,0,0,0,0,0,2020-01-02,2021-01-02,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03606408,0,0,0,0,0,0,2023-02-28,2024-02-28,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03606746,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Medeor Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03606967,0,0,0,0,0,0,2019-07-31,2020-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,1,1,1,0,0,0,0,0,3,1,0,3004
NCT03607175,0,0,0,0,0,0,2019-06-30,2020-06-30,,Marina Boruk,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,1
NCT03607643,0,0,0,0,0,0,2020-06-30,2021-06-30,,Leaf Vertical Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03607890,0,0,0,0,0,0,2022-10-31,2023-10-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03608020,0,0,0,0,0,0,2022-08-31,2023-08-31,,"BioMimetix JV, LLC",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,6
NCT03608163,0,0,0,0,0,0,2020-07-31,2021-07-31,,Albert Einstein College of Medicine,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03608397,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Revance Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,26
NCT03609216,0,0,0,0,0,0,2027-02-28,2028-02-28,,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,456
NCT03616470,0,0,0,0,0,0,2020-12-31,2021-12-31,,GlycoMimetics Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03616834,0,0,0,0,0,0,2019-10-31,2020-10-31,,Effector Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03617367,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Revance Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,26
NCT03619213,0,0,0,0,0,0,2021-06-22,2022-06-22,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03621657,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03622593,0,0,0,0,0,0,2021-09-30,2022-09-30,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03625011,0,0,0,0,0,0,2019-12-31,2020-12-31,,Children's Healthcare of Atlanta,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,88
NCT03625687,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03626285,0,0,0,0,0,0,2020-12-31,2021-12-31,,OHSU Knight Cancer Institute,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,163
NCT03626649,0,0,0,0,0,0,2019-11-30,2020-11-30,,EPIX Therapeutics,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03628716,0,0,0,0,0,0,2021-12-31,2022-12-31,,Bavarian Nordic,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,33
NCT03631030,0,0,0,0,0,0,2020-01-31,2021-01-31,,"International Spine, Pain and Performance Center",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03631407,0,0,0,0,0,0,2020-05-13,2021-05-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03631771,0,0,0,0,0,0,2024-08-31,2025-08-31,,GE Healthcare,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,119
NCT03632772,0,0,0,0,0,0,2019-07-31,2020-07-31,,Buddhist Tzu Chi General Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,36
NCT03632993,0,0,0,0,0,0,2019-01-24,2020-01-24,,Endo Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,91
NCT03633461,0,0,0,0,0,0,2018-09-20,2019-09-20,,"Oyster Point Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03635320,0,0,0,0,0,0,2020-06-02,2021-06-02,,Synthes GmbH,Industry,1,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,10
NCT03636152,0,0,0,0,0,0,2022-04-01,2023-04-01,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03640286,0,0,0,0,0,0,2020-10-01,2021-10-01,,Neurovalens Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT03641755,0,0,0,0,0,0,2020-06-22,2021-06-22,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03644550,0,0,0,0,0,0,2020-08-31,2021-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03645681,0,0,0,0,0,0,2019-11-30,2020-11-30,,"InnAVasc Medical, Inc.",Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03645928,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Iovance Biotherapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,5
NCT03647046,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Rochester,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,470
NCT03649477,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Levo Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03652376,0,0,0,0,0,0,2019-05-01,2020-05-01,,University of Rostock,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,36
NCT03652818,0,0,0,0,0,0,2018-09-20,2019-09-20,,"Nevakar, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03654768,0,0,0,0,0,0,2022-01-01,2023-01-01,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,288
NCT03659617,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Theodoros Katsaros, DDS, MSD",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03662542,0,0,0,0,0,0,2020-11-17,2021-11-17,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03664024,0,0,0,0,0,0,2019-12-12,2020-12-12,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03670953,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Impax Laboratories, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,17
NCT03673176,0,0,0,0,0,0,2021-12-30,2022-12-30,,Stanford University,Other,0,0,0,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,1309
NCT03674281,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Virginia,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,402
NCT03675321,0,0,0,0,0,0,2022-06-30,2023-06-30,,Medical College of Wisconsin,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03676751,0,0,0,0,0,0,2020-07-01,2021-07-01,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1443
NCT03677869,0,0,0,0,0,0,2019-09-30,2020-09-30,,Jaeb Center for Health Research,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,93
NCT03682055,0,0,0,0,0,0,2021-10-31,2022-10-31,,Cullinan Apollo Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03682601,0,0,0,0,0,0,2020-07-30,2021-07-30,,"GTO Pharmaceutical, LLC",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03682848,0,0,0,0,0,0,2020-10-01,2021-10-01,,ViiV Healthcare,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,200
NCT03685461,0,0,0,0,0,0,2023-08-31,2024-08-31,,Medical College of Wisconsin,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,315
NCT03685617,0,0,0,0,0,0,2019-09-01,2020-09-01,,The Second Hospital of Hebei Medical University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,10
NCT03686384,0,0,0,0,0,0,2020-10-31,2021-10-31,,Salvat,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,9
NCT03686787,0,0,0,0,0,0,2019-07-31,2020-07-31,,Laser and Skin Surgery Center of New York,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03686904,0,0,0,0,0,0,2019-09-30,2020-09-30,,Georgetown University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03687502,0,0,0,0,0,0,2020-01-01,2021-01-01,,Children's Mercy Hospital Kansas City,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,138
NCT03688074,0,0,0,0,0,0,2021-01-11,2022-01-11,,AstraZeneca,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03688880,0,0,0,0,0,0,2019-07-31,2020-07-31,,Grünenthal GmbH,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,71
NCT03689699,0,0,0,0,0,0,2020-01-31,2021-01-31,,Charles G. Drake,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03692273,0,0,0,0,0,0,2022-12-01,2023-12-01,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,0,0,0,0,3,1,0,1699
NCT03692871,0,0,0,0,0,0,2021-04-27,2022-04-27,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03693846,0,0,0,0,0,0,2020-11-30,2021-11-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03694821,0,0,0,0,0,0,2020-07-31,2021-07-31,,UConn Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,148
NCT03698864,0,0,0,0,0,0,2020-02-29,2021-02-28,,Processa Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03699826,0,0,0,0,0,0,2023-12-31,2024-12-31,,Aaron Boes,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03701295,0,0,0,0,0,0,2020-06-14,2021-06-14,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03703102,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Kyowa Kirin Pharmaceutical Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,23
NCT03703882,0,0,0,0,0,0,2020-06-30,2021-06-30,,Catabasis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03705325,0,0,0,0,0,0,2020-04-30,2021-04-30,,VitalFlo Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03705793,0,0,0,0,0,0,2019-06-30,2020-06-30,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,1151
NCT03708224,0,0,0,0,0,0,2022-03-31,2023-03-31,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1443
NCT03710187,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Tennessee Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03711305,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Jiangsu HengRui Medicine Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,187
NCT03712605,0,0,0,0,0,0,2023-10-31,2024-10-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,3004
NCT03720223,0,0,0,0,0,0,2018-12-31,2019-12-31,,Urology of Virginia,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT03721016,0,0,0,0,0,0,2020-02-01,2021-02-01,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03721705,0,0,0,0,0,0,2019-11-12,2020-11-12,,"Renew Research, LLC",Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03722238,0,0,0,0,0,0,2020-05-13,2021-05-13,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03722927,0,0,0,0,0,0,2020-10-31,2021-10-31,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03732807,0,0,0,0,0,0,2021-03-28,2022-03-28,,Pfizer,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03733431,0,0,0,0,0,0,2019-10-31,2020-10-31,,Turkish Stroke Research and Clinical Trials Network,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03734861,0,0,0,0,0,0,2019-12-31,2020-12-31,,Connecticut Children's Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,35
NCT03735589,0,0,0,0,0,0,2020-05-03,2021-05-03,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,294
NCT03736564,0,0,0,0,0,0,2020-06-01,2021-06-01,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,1898
NCT03738566,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03738735,0,0,0,0,0,0,2020-01-31,2021-01-31,,Rothman Institute Orthopaedics,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,58
NCT03739996,0,0,0,0,0,0,2020-10-30,2021-10-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03740529,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Loxo Oncology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03745820,0,0,0,0,0,0,2020-04-06,2021-04-06,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03747614,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Zhongshan Ophthalmic Center, Sun Yat-sen University",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,2,1,0,23
NCT03749109,0,0,0,0,0,0,2020-11-30,2021-11-30,,Ferring Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,208
NCT03749915,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of British Columbia,Other,0,0,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,2,1,0,881
NCT03750968,0,0,0,0,0,0,2021-12-31,2022-12-31,,Paul S. Bernstein,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03751943,0,0,0,0,0,0,2021-03-31,2022-03-31,,"NanoFUSE Biologics, LLC",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03752619,0,0,0,0,0,0,2023-01-01,2024-01-01,,MetroHealth Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,65
NCT03755518,0,0,0,0,0,0,2022-06-06,2023-06-06,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03755882,0,0,0,0,0,0,2018-12-26,2019-12-26,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,138
NCT03759288,0,0,0,0,0,0,2022-12-04,2023-12-04,,Allergan,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03759834,0,0,0,0,0,0,2019-12-01,2020-12-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03760510,1,1,0,1,0,1,2018-04-14,2019-04-14,2019-06-19,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,422
NCT03761030,0,0,0,0,0,0,2021-05-31,2022-05-31,,New York State Psychiatric Institute,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03761225,0,0,0,0,0,0,2020-03-31,2021-03-31,,AB Science,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,2,0,1,30
NCT03761394,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of Massachusetts, Worcester",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,163
NCT03761914,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sellas Life Sciences Group,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3
NCT03762265,0,0,0,0,0,0,2021-12-31,2022-12-31,,Principia Biopharma Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03763643,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03764059,0,0,0,0,0,0,2020-01-11,2021-01-11,,3M,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,56
NCT03765918,0,0,0,0,0,0,2025-07-30,2026-07-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,1,0,0,1,1,0,2145
NCT03767257,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03767972,0,0,0,0,0,0,2019-07-30,2020-07-30,,"University of California, Irvine",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,310
NCT03768089,0,0,0,0,0,0,2019-05-03,2020-05-03,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,141
NCT03769376,0,0,0,0,0,0,2021-01-31,2022-01-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03772340,0,0,0,0,0,0,2019-03-31,2020-03-31,,Vanda Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,37
NCT03772613,0,0,0,0,0,0,2021-01-31,2022-01-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03776175,0,0,0,0,0,0,2019-09-09,2020-09-09,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03777267,0,0,0,0,0,0,2021-01-31,2022-01-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03779841,0,0,0,0,0,0,2020-02-29,2021-02-28,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03780543,0,0,0,0,0,0,2020-06-30,2021-06-30,,Assembly Biosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03782194,0,0,0,0,0,0,2022-01-31,2023-01-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,692
NCT03782402,0,0,0,0,0,0,2021-02-28,2022-02-28,,New York State Psychiatric Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,361
NCT03783689,0,0,0,0,0,0,2022-10-31,2023-10-31,,"SPR Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03783936,0,0,0,0,0,0,2021-02-28,2022-02-28,,Michael Sangmin Lee,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03787212,0,0,0,0,0,0,2019-01-28,2020-01-28,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03789097,0,0,0,0,0,0,2023-06-30,2024-06-30,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,412
NCT03790137,0,0,0,0,0,0,2020-02-29,2021-02-28,,Elizabeth Thiele,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03792295,0,0,0,0,0,0,2019-07-01,2020-07-01,,Khashayar Vaziri,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03793829,0,0,0,0,0,0,2022-12-31,2023-12-31,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03794076,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Vishwajit Nimgaonkar, MD PhD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03797521,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Promentis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03799198,0,0,0,0,0,0,2020-08-23,2021-08-23,,Novo Nordisk A/S,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,981
NCT03800030,0,0,0,0,0,0,2019-04-30,2020-04-30,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03800537,0,0,0,0,0,0,2022-03-31,2023-03-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03801031,0,0,0,0,0,0,2020-07-31,2021-07-31,,David Bender,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03804268,0,0,0,0,0,0,2020-03-31,2021-03-31,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03804801,0,0,0,0,0,0,2019-04-01,2020-04-01,,Sulaiman AlRajhi Colleges,Other,0,0,0,4.0,Phase 4,0,2019.0,1,0,0,0,0,0,0,0,3,1,0,4
NCT03805607,0,0,0,0,0,0,2019-12-31,2020-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,377
NCT03809663,0,0,0,0,0,0,2020-03-01,2021-03-01,,Amgen,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03811821,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03812029,0,0,0,0,0,0,2019-12-31,2020-12-31,,Enyo Pharma,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03812653,0,0,0,0,0,0,2023-11-30,2024-11-30,,University of Michigan,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03814967,0,0,0,0,0,0,2024-01-31,2025-01-31,,"University of California, Davis",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,530
NCT03817528,0,0,0,0,0,0,2020-01-01,2021-01-01,,New York State Psychiatric Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03818997,0,0,0,0,0,0,2021-04-30,2022-04-30,,European Organisation for Research and Treatment of Cancer - EORTC,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,320
NCT03820388,1,0,0,0,1,0,2018-07-13,2019-07-13,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,530
NCT03822117,0,0,0,0,0,0,2021-12-17,2022-12-17,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03824405,0,0,0,0,0,0,2020-02-20,2021-02-20,,Botanix Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03825796,0,0,0,0,0,0,2021-01-01,2022-01-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,277
NCT03826693,0,0,0,0,0,0,2021-04-30,2022-04-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03828214,0,0,0,0,0,0,2019-06-30,2020-06-30,,"College of St. Scholastica, Inc.",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03829319,0,0,0,0,0,0,2023-08-21,2024-08-21,,Merck Sharp & Dohme Corp.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03833206,0,0,0,0,0,0,2020-08-31,2021-08-31,,"BioLite, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03834220,0,0,0,0,0,0,2020-08-31,2021-08-31,,Debiopharm International SA,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT03835819,0,0,0,0,0,0,2021-10-01,2022-10-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03839342,0,0,0,0,0,0,2021-09-30,2022-09-30,,"University Health Network, Toronto",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,931
NCT03840538,0,0,0,0,0,0,2018-12-01,2019-12-01,,Cairo University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1190
NCT03840902,0,0,0,0,0,0,2024-03-04,2025-03-04,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,1,1,0,42
NCT03841526,0,0,0,0,0,0,2019-11-30,2020-11-30,,Xeris Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,14
NCT03841617,0,0,0,0,0,0,2025-11-01,2026-11-01,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,495
NCT03844945,0,0,0,0,0,0,2019-10-31,2020-10-31,,Aerie Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,28
NCT03846609,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mercy Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03848650,0,0,0,0,0,0,2019-06-30,2020-06-30,,Columbia University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03849651,0,0,0,0,0,0,2024-07-01,2025-07-01,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,1,0,0,0,0,0,1,0,302
NCT03851081,0,0,0,0,0,0,2021-12-12,2022-12-12,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT03852316,0,0,0,0,0,0,2019-11-24,2020-11-24,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2133
NCT03855137,0,0,0,0,0,0,2021-01-22,2022-01-22,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03856047,0,0,0,0,0,0,2020-01-31,2021-01-31,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03856866,0,0,0,0,0,0,2020-10-31,2021-10-31,,The Hospital for Sick Children,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,403
NCT03857542,0,0,0,0,0,0,2020-05-19,2021-05-19,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03858985,0,0,0,0,0,0,2024-01-31,2025-01-31,,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03859700,0,0,0,0,0,0,2023-06-30,2024-06-30,,DBV Technologies,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,11
NCT03860259,0,0,0,0,0,0,2020-01-31,2021-01-31,,Jacques E. Chelly,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03860987,0,0,0,0,0,0,2025-08-31,2026-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03861169,0,0,0,0,0,0,2020-08-30,2021-08-30,,"Sight Sciences, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03861273,0,0,0,0,0,0,2021-07-23,2022-07-23,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2856
NCT03861481,0,0,0,0,0,0,2020-07-31,2021-07-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03861728,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Miami,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03864328,0,0,0,0,0,0,2020-10-31,2021-10-31,,Respivant Sciences GmbH,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03865940,0,0,0,0,0,0,2020-04-30,2021-04-30,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03866473,0,0,0,0,0,0,2019-07-21,2020-07-21,,Jaeb Center for Health Research,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,93
NCT03866980,0,0,0,0,0,0,2020-11-30,2021-11-30,,Akeso,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,6
NCT03868462,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Optos, PLC",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03873298,0,0,0,0,0,0,2020-03-04,2021-03-04,,Rabin Medical Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,309
NCT03873779,0,0,0,0,0,0,2020-08-31,2021-08-31,,Zeltiq Aesthetics,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,32
NCT03874715,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1222
NCT03875183,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Innolife Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03875404,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1898
NCT03878953,0,0,0,0,0,0,2020-07-15,2021-07-15,,Shire,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,342
NCT03879538,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Cleveland Clinic,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03882671,0,0,0,0,0,0,2020-12-01,2021-12-01,,Seer Medical Pty Ltd,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03883607,0,0,0,0,0,0,2020-11-30,2021-11-30,,Genfit,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03885323,0,0,0,0,0,0,2019-04-15,2020-04-15,,Home Skinovations Ltd.,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03885596,0,0,0,0,0,0,2019-07-02,2020-07-02,,Concentric Analgesics,Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03887481,0,0,0,0,0,0,2026-01-31,2027-01-31,,Johns Hopkins University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03889314,0,0,0,0,0,0,2019-12-31,2020-12-31,,Minneapolis Heart Institute Foundation,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03889639,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03891576,0,0,0,0,0,0,2021-02-01,2022-02-01,,Mario Negri Institute for Pharmacological Research,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,83
NCT03892720,0,0,0,0,0,0,2024-04-01,2025-04-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,277
NCT03893045,0,0,0,0,0,0,2020-07-31,2021-07-31,,"AMAG Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,23
NCT03894891,0,0,0,0,0,0,2021-11-30,2022-11-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,647
NCT03896945,0,0,0,0,0,0,2022-07-31,2023-07-31,,Avanir Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03898856,0,0,0,0,0,0,2021-04-01,2022-04-01,,"The University of Texas Health Science Center, Houston",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,490
NCT03899792,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Loxo Oncology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03900325,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Bird Rock Bio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03902613,0,0,0,0,0,0,2019-07-08,2020-07-08,,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,361
NCT03903822,0,0,0,0,0,0,2020-05-23,2021-05-23,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03906071,0,0,0,0,0,0,2022-04-30,2023-04-30,,Mirati Therapeutics Inc.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03906617,0,0,0,0,0,0,2020-04-10,2021-04-10,,The Cooper Health System,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,37
NCT03906968,0,0,0,0,0,0,2019-11-01,2020-11-01,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,511
NCT03908697,0,0,0,0,0,0,2019-09-15,2020-09-15,,Quanovate Tech Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03910972,0,0,0,0,0,0,2022-06-30,2023-06-30,,Baylor College of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,518
NCT03911466,0,0,0,0,0,0,2023-01-31,2024-01-31,,"Theresa Winhusen, PhD",Other,0,1,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03911869,0,0,0,0,0,0,2022-10-31,2023-10-31,,Array BioPharma,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,65
NCT03913091,0,0,0,0,0,0,2022-03-01,2023-03-01,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03917823,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, San Diego",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,561
NCT03918447,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Reata Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,44
NCT03919773,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Texas Southwestern Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03921151,0,0,0,0,0,0,2019-09-30,2020-09-30,,Virginia Commonwealth University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,417
NCT03921528,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Scholar Rock, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,1
NCT03921814,0,0,0,0,0,0,2021-11-30,2022-11-30,,Philips Healthcare,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,45
NCT03924154,0,0,0,0,0,0,2020-02-28,2021-02-28,,Altavant Sciences GmbH,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03924895,0,0,0,0,0,0,2025-02-12,2026-02-12,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03925727,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Mimetogen Pharmaceuticals USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03926988,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vesalio,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03927144,0,0,0,0,0,0,2020-12-04,2021-12-04,,Amgen,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03930732,0,0,0,0,0,0,2022-01-31,2023-01-31,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03935347,0,0,0,0,0,0,2022-05-01,2023-05-01,,Roswell Park Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT03936413,0,0,0,0,0,0,2020-06-30,2021-06-30,,New York Presbyterian Hospital,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,15
NCT03938467,0,0,0,0,0,0,2021-10-01,2022-10-01,,"Orthopaedic Associates of Michigan, PC",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03939819,0,0,0,0,0,0,2021-05-31,2022-05-31,,Emory University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT03941496,0,0,0,0,0,0,2021-07-31,2022-07-31,,Andrew Dinardo,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03949842,0,0,0,0,0,0,2022-11-30,2023-11-30,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3276
NCT03951610,0,0,0,0,0,0,2019-04-05,2020-04-05,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,85
NCT03951831,0,0,0,0,0,0,2020-09-30,2021-09-30,,Mark Stein,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03952143,0,0,0,0,0,0,2020-12-31,2021-12-31,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03952806,0,0,0,0,0,0,2021-10-20,2022-10-20,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,18
NCT03953820,0,0,0,0,0,0,2019-07-31,2020-07-31,,Aquestive Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03954977,0,0,0,0,0,0,2019-08-30,2020-08-30,,Seattle Children's Hospital,Other,0,0,0,5.0,,0,2019.0,1,0,0,0,1,0,0,0,0,1,0,137
NCT03956277,0,0,0,0,0,0,2019-12-31,2020-12-31,,CoapTech,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03956862,0,0,0,0,0,0,2020-07-31,2021-07-31,,"GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03957551,0,0,0,0,0,0,2021-07-01,2022-07-01,,Yousef Zakharia,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03958006,0,0,0,0,0,0,2019-12-04,2020-12-04,,Ascension South East Michigan,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03959306,0,0,0,0,0,0,2019-08-31,2020-08-31,,Ain Shams University,Other,0,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,2,1,0,460
NCT03961854,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Florida,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03962855,0,0,0,0,0,0,2021-06-30,2022-06-30,,Jeffrey Rade,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03962959,0,0,0,0,0,0,2023-04-01,2024-04-01,,University of Arizona,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,265
NCT03964467,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of the Sciences in Philadelphia,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03965208,0,0,0,0,0,0,2020-12-31,2021-12-31,,Legacy Health System,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,26
NCT03967288,0,0,0,0,0,0,2020-12-01,2021-12-01,,Oregon Health and Science University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT03968978,0,0,0,0,0,0,2020-07-23,2021-07-23,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03970850,0,0,0,0,0,0,2019-12-15,2020-12-15,,"NeuMoDx Molecular, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1
NCT03973879,0,0,0,0,0,0,2023-09-01,2024-09-01,,"Darell D. Bigner, MD, PhD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,4
NCT03976102,0,0,0,0,0,0,2020-09-01,2021-09-01,,Dr. Reddy's Laboratories Limited,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,212
NCT03977727,0,0,0,0,0,0,2020-02-01,2021-02-01,,"Texas Diabetes & Endocrinology, P.A.",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,2
NCT03978195,0,0,0,0,0,0,2021-08-01,2022-08-01,,Yuinvent Innovations Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03981796,0,0,0,0,0,0,2021-11-26,2022-11-26,,"Tesaro, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,31
NCT03982069,0,0,0,0,0,0,2020-07-31,2021-07-31,,Richard Zimmerman MD,Other,0,0,1,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03983668,0,0,0,0,0,0,2021-04-01,2022-04-01,,Umar Farooq,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03986138,0,0,0,0,0,0,2020-04-30,2021-04-30,,Guerbet,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,34
NCT03987568,0,0,0,0,0,0,2021-09-30,2022-09-30,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,616
NCT03988439,0,0,0,0,0,0,2022-07-08,2023-07-08,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,180
NCT03989102,0,0,0,0,0,0,2021-05-31,2022-05-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2133
NCT03994185,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Merit Medical Systems, Inc.",Industry,1,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,12
NCT03996655,0,0,0,0,0,0,2019-09-30,2020-09-30,,"National Cancer Institute, Egypt",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,19
NCT03997123,0,0,0,0,0,0,2021-09-01,2022-09-01,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03998163,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Cara Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT04000555,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of South Florida,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT04000763,0,0,0,0,0,0,2021-06-30,2022-06-30,,Katherine Shapiro,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04002141,0,0,0,0,0,0,2020-07-01,2021-07-01,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT04003285,0,0,0,0,0,0,2023-06-30,2024-06-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT04007055,0,0,0,0,0,0,2021-12-31,2022-12-31,,Kyle Markel,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,1
NCT04007367,0,0,0,0,0,0,2021-12-31,2022-12-31,,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,24
NCT04009473,0,0,0,0,0,0,2020-12-31,2021-12-31,,Forever Young d.o.o.,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,0,0,1,0,2,1,0,1
NCT04014387,0,0,0,0,0,0,2021-02-15,2022-02-15,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT04014790,0,0,0,0,0,0,2021-08-31,2022-08-31,,Regimmune Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04016324,0,0,0,0,0,0,2020-05-01,2021-05-01,,MedtronicNeuro,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,57
NCT04019015,0,0,0,0,0,0,2021-08-31,2022-08-31,,Oregon Health and Science University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,475
NCT04019327,0,0,0,0,0,0,2022-07-31,2023-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT04022343,0,0,0,0,0,0,2020-08-31,2021-08-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT04023552,0,0,0,0,0,0,2022-04-19,2023-04-19,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT04024163,0,0,0,0,0,0,2026-08-30,2027-08-30,,Insud Pharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT04027686,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Los Angeles",Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,3,1,0,692
NCT04028063,0,0,0,0,0,0,2021-11-24,2022-11-24,,"University of Colorado, Denver",Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,882
NCT04029688,0,0,0,0,0,0,2024-05-16,2025-05-16,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT04030104,0,0,0,0,0,0,2019-10-15,2020-10-15,,Seno Medical Instruments Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT04031014,0,0,0,0,0,0,2020-07-31,2021-07-31,,Boston Urogynecology Associates,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT04032093,0,0,0,0,0,0,2021-02-25,2022-02-25,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2856
NCT04033146,0,0,0,0,0,0,2020-08-15,2021-08-15,,Georgia Institute of Technology,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,10
NCT04033926,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Kezar Life Sciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT04038359,0,0,0,0,0,0,2022-05-30,2023-05-30,,"Verastem, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,35
NCT04039503,0,0,0,0,0,0,2021-01-25,2022-01-25,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT04040075,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Southampton Healthcare, Inc.",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04040816,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Shanton Pharma Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04042753,0,0,0,0,0,0,2021-07-31,2022-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT04044768,0,0,0,0,0,0,2022-01-01,2023-01-01,,Adaptimmune,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,0,1,1,1,0,11
NCT04047446,0,0,0,0,0,0,2020-05-27,2021-05-27,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT04047992,0,0,0,0,0,0,2020-09-30,2021-09-30,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,41
NCT04048356,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of New Mexico,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,200
NCT04049331,0,0,0,0,0,0,2024-09-01,2025-09-01,,Seattle Institute for Biomedical and Clinical Research,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT04049669,0,0,0,0,0,0,2024-09-30,2025-09-30,,Theodore S. Johnson,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT04050605,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,85
NCT04053764,0,0,0,0,0,0,2022-07-29,2023-07-29,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT04054024,0,0,0,0,0,0,2021-10-31,2022-10-31,,Danish Headache Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,75
NCT04054635,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Manitoba,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,344
NCT04060251,0,0,0,0,0,0,2020-04-04,2021-04-04,,"Wolfgang Fitz, M.D.",Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04061044,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Ocular Therapeutix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,19
NCT04063033,0,0,0,0,0,0,2022-08-31,2023-08-31,,Rambam Health Care Campus,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,381
NCT04065490,0,0,0,0,0,0,2021-09-01,2022-09-01,,"LumiThera, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT04065841,0,0,0,0,0,0,2020-05-12,2021-05-12,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT04066244,0,0,0,0,0,0,2021-02-11,2022-02-11,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT04067141,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,85
NCT04069156,0,0,0,0,0,0,2022-05-31,2023-05-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,419
NCT04070157,0,0,0,0,0,0,2020-02-15,2021-02-15,,US WorldMeds LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT04071769,0,0,0,0,0,0,2021-10-01,2022-10-01,,Duke University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT04072289,0,0,0,0,0,0,2021-04-30,2022-04-30,,"United States Naval Medical Center, San Diego",U.S. Fed,2,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,52
NCT04074616,0,0,0,0,0,0,2021-03-31,2022-03-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT04075591,0,0,0,0,0,0,2022-05-31,2023-05-31,,"Johnson & Johnson Surgical Vision, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT04077099,0,0,0,0,0,0,2024-01-19,2025-01-19,,Regeneron Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,176
NCT04077437,0,0,0,0,0,0,2021-06-10,2022-06-10,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,1,1,0,24
NCT04080882,0,0,0,0,0,0,2020-04-30,2021-04-30,,Q-Med AB,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,56
NCT04082442,0,0,0,0,0,0,2021-08-31,2022-08-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT04082819,0,0,0,0,0,0,2019-11-08,2020-11-08,,SE Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT04083222,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,69
NCT04083781,0,0,0,0,0,0,2020-10-30,2021-10-30,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,981
NCT04084483,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Kowa Research Institute, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,33
NCT04085458,0,0,0,0,0,0,2022-05-11,2023-05-11,,Bayer,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1343
NCT04088734,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Abeona Therapeutics, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT00116337,1,0,1,1,0,1,2017-10-10,2018-10-10,2019-08-01,Case Western Reserve University,Other,0,0,1,5.0,,0,2004.0,1,0,0,1,0,0,0,0,0,0,1,89
NCT00137800,0,0,0,0,0,0,2020-05-31,2021-05-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT00255346,1,1,0,1,0,1,2017-03-03,2018-03-03,2018-04-17,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00276783,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT00306098,0,0,0,0,0,0,2020-05-31,2021-05-31,,Rodolfo Alejandro,Other,0,0,1,1.0,Phase 2,0,2000.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT00382200,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2006.0,0,1,0,0,0,0,0,1,0,0,1,1432
NCT00392756,0,0,0,0,0,0,2021-02-28,2022-02-28,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,1989.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT00392990,0,0,1,1,0,0,2019-10-31,2020-10-31,2019-08-26,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT00429585,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston Medical Center,Other,0,0,0,5.0,,0,2007.0,0,0,0,1,0,0,0,0,1,0,1,225
NCT00475020,1,1,0,1,0,1,2017-10-04,2018-10-04,2018-11-07,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00499525,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,1,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT00551460,1,1,0,1,0,0,2017-06-30,2018-06-30,2017-11-21,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,288
NCT00568373,0,0,0,0,0,0,2020-12-31,2021-12-31,,Indiana University,Other,0,0,0,5.0,,0,2007.0,0,0,0,1,0,0,0,0,0,0,1,497
NCT00572195,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-04-25,NeuroPace,Industry,1,0,0,4.0,Phase 4,0,2006.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT00579124,0,0,0,0,0,0,2019-12-31,2020-12-31,,Children's Hospital of Philadelphia,Other,0,0,0,1.0,Phase 2,0,2005.0,0,0,0,1,0,0,0,0,0,0,1,324
NCT00591630,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00660673,0,0,0,0,0,0,2020-09-15,2021-09-15,,"AbbVie (prior sponsor, Abbott)",Industry,1,1,0,3.0,Phase 3,0,2009.0,0,1,0,1,0,0,0,0,1,0,1,227
NCT00738894,1,1,0,1,0,1,2017-04-24,2018-04-24,2018-05-16,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2008.0,0,1,0,1,0,0,0,0,1,0,1,52
NCT00759798,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00781612,0,0,0,0,0,0,2022-09-21,2023-09-21,,"Genentech, Inc.",Industry,1,1,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,1,0,1,427
NCT00787826,0,0,0,0,0,0,2019-11-30,2020-11-30,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2009.0,0,0,1,0,0,0,0,0,0,0,1,136
NCT00789776,1,1,0,1,0,0,2017-05-18,2018-05-18,2018-05-02,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2008.0,0,1,1,0,0,1,0,0,0,0,1,393
NCT00790335,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-12-18,Washington University School of Medicine,Other,0,1,1,3.0,Phase 3,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT00792077,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00801489,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2007.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT00826241,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-02-04,National Institutes of Health Clinical Center (CC),NIH,2,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,325
NCT00831792,1,1,0,1,0,1,2017-06-12,2018-06-12,2019-03-28,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00843921,1,0,0,0,1,0,2018-04-25,2019-04-25,,Mendel Tuchman,Other,0,0,1,2.0,Phase 2/Phase 3,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT00848328,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of California, Davis",Other,0,1,0,1.0,Phase 2,0,2008.0,0,1,1,0,0,0,0,0,0,0,1,530
NCT00857805,1,0,0,0,1,0,2018-01-31,2019-01-31,,Loma Linda University,Other,0,0,0,5.0,,0,2009.0,1,0,0,0,0,1,0,0,0,0,1,194
NCT00866749,1,1,0,1,0,1,2018-07-26,2019-07-26,2019-07-31,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00867815,1,1,0,1,0,0,2017-12-29,2018-12-29,2018-12-26,Bayer,Industry,1,0,0,4.0,Phase 4,1,2009.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT00887432,0,0,0,0,0,0,2019-10-21,2020-10-21,,Roswell Park Cancer Institute,Other,0,0,1,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,294
NCT00900497,0,0,0,0,0,0,2018-12-31,2019-12-31,,Dipnarine Maharaj,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,1,0,1,0,0,0,0,0,0,0,1,2
NCT00909909,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2009.0,0,0,0,0,0,1,0,0,0,0,1,227
NCT00911560,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT00943319,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-10-09,University of Chicago,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT00946270,1,1,0,1,0,0,2018-05-22,2019-05-22,2019-05-14,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00978250,0,0,0,0,0,0,2019-04-11,2020-04-11,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT00978458,0,0,0,0,0,0,2021-12-31,2022-12-31,,Eastern Cooperative Oncology Group,Other,0,0,1,3.0,Phase 3,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,175
NCT00988052,1,1,0,1,0,1,2017-07-01,2018-07-01,2018-11-28,"Teva Pharmaceutical Industries, Ltd.",Industry,1,0,0,3.0,Phase 3,1,2009.0,1,1,0,0,0,0,0,0,1,0,1,14
NCT00995215,1,0,1,1,0,1,2017-10-15,2018-10-15,2019-07-31,Case Western Reserve University,Other,0,0,1,5.0,,0,2009.0,1,0,0,1,0,0,0,0,0,0,1,89
NCT01000350,0,0,0,0,0,0,2021-06-30,2022-06-30,,Vanderbilt University,Other,0,0,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT01010217,1,0,1,1,0,1,2017-10-05,2018-10-05,2019-05-15,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01050855,0,0,0,0,0,0,2020-12-31,2021-12-31,,Children's Hospital of Philadelphia,Other,0,0,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,324
NCT01074177,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-01-24,Massachusetts General Hospital,Other,0,1,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01093326,0,0,0,0,0,0,2021-12-15,2022-12-15,,Actelion,Industry,1,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,128
NCT01097746,0,0,0,0,0,0,2019-04-30,2020-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01109992,1,1,0,1,0,1,2017-06-06,2018-06-06,2018-06-14,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT01129882,0,0,0,0,0,0,2018-12-06,2019-12-06,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,185
NCT01146834,0,0,0,0,0,0,2019-02-04,2020-02-04,,Weill Medical College of Cornell University,Other,0,1,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,586
NCT01162551,1,1,0,1,0,1,2017-02-28,2018-02-28,2019-03-22,Children's Hospital of Philadelphia,Other,0,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,324
NCT01178216,1,1,0,1,0,0,2017-07-28,2018-07-28,2018-07-27,"Stanley Jordan, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT01190176,1,1,0,1,0,0,2017-09-20,2018-09-20,2018-09-19,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,0,1,0,0,0,0,0,1,0,1,3276
NCT01199614,0,0,0,0,0,0,2020-12-31,2021-12-31,,John P. Bilezikian,Other,0,1,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01203839,0,0,0,0,0,0,2019-09-30,2020-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,1432
NCT01208389,0,0,0,0,0,0,2026-11-30,2027-11-30,,Spark Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,13
NCT01211522,1,1,0,1,0,1,2017-08-28,2018-08-28,2019-07-16,Vanderbilt University Medical Center,Other,0,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,422
NCT01234532,1,0,0,0,1,0,2017-05-31,2018-05-31,,"University of Maryland, College Park",Other,0,1,0,1.0,Phase 2,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,318
NCT01235793,1,1,0,1,0,0,2017-07-28,2018-07-28,2018-07-25,Cedars-Sinai Medical Center,Other,0,0,0,1.0,Phase 2,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,279
NCT01253161,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01258933,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01270633,1,0,0,0,1,0,2017-09-30,2018-09-30,,Integra LifeSciences Corporation,Industry,1,0,0,5.0,,1,2010.0,1,0,0,1,0,0,0,0,0,0,1,40
NCT01270724,0,0,0,0,0,0,2019-12-31,2020-12-31,,Nationwide Children's Hospital,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,161
NCT01313416,1,1,0,1,0,1,2017-01-31,2018-01-31,2019-06-18,Augusta University,Other,0,0,0,1.0,Phase 2,1,2012.0,1,1,1,0,0,0,0,0,0,0,1,117
NCT01327846,0,0,0,0,0,0,2017-03-28,2018-03-28,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01342952,0,0,0,0,0,0,2022-10-27,2023-10-27,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,3276
NCT01364597,0,0,0,0,0,0,2023-12-31,2024-12-31,,UCB Pharma SA,Industry,1,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT01368588,0,0,0,0,0,0,2027-07-31,2028-07-31,,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2011.0,0,0,0,0,0,1,0,0,1,0,1,156
NCT01371305,0,0,0,0,0,0,2017-03-31,2018-03-31,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,324
NCT01391793,1,1,0,1,0,0,2018-03-30,2019-03-30,2019-03-28,Nader Shaikh,Other,0,0,1,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01399372,0,0,0,0,0,0,2021-09-30,2022-09-30,,Radiation Therapy Oncology Group,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,1,0,0,1,0,0,1,0,1,156
NCT01404949,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,1432
NCT01414738,0,0,0,0,0,0,2020-09-01,2021-09-01,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,626
NCT01420679,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,1,2011.0,1,1,0,0,0,0,0,0,1,0,1,67
NCT01428245,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Virginia,Other,0,0,1,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,402
NCT01437709,0,0,0,0,0,0,2019-09-30,2020-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT01450826,1,1,0,1,0,0,2017-04-13,2018-04-13,2018-04-09,Katy Peters,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT01454596,0,1,0,1,0,0,2018-11-01,2019-11-01,2019-07-08,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,1,0,0,0,0,0,0,0,1,3004
NCT01460160,1,1,0,1,0,0,2017-05-28,2018-05-28,2018-05-25,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT01463670,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01473004,0,0,0,0,0,0,2019-12-01,2020-12-01,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,162
NCT01475331,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-05,Milton S. Hershey Medical Center,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT01497496,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01498484,0,0,0,0,0,0,2019-07-31,2020-07-31,,Atara Biotherapeutics,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,0,1,0,0,0,0,0,0,0,1,10
NCT01514201,1,1,0,1,0,1,2018-03-28,2019-03-28,2019-06-11,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,1,0,0,0,0,1,3004
NCT01518374,1,1,0,1,0,1,2017-05-03,2018-05-03,2018-05-16,Avid Radiopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT01527591,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,692
NCT01540565,1,1,0,1,0,0,2018-01-27,2019-01-27,2019-01-23,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01543152,1,0,0,0,1,0,2017-07-07,2018-07-07,,Sangamo Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,0,0,0,0,0,0,1,0,0,1,18
NCT01543633,0,0,0,0,0,0,2020-07-31,2021-07-31,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01543698,0,0,0,0,0,0,2021-12-31,2022-12-31,,Array BioPharma,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,65
NCT01546753,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Arkansas,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,285
NCT01547442,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ophtec USA,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,2
NCT01548768,0,0,0,0,0,0,2019-09-30,2020-09-30,,Columbia University,Other,0,0,1,4.0,Phase 4,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT01550367,1,0,1,1,0,1,2018-02-06,2019-02-06,2019-07-17,Leonard Appleman,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01573702,0,0,0,0,0,0,2020-05-31,2021-05-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT01576172,0,0,0,0,0,0,2020-01-31,2021-01-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01585194,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT01597973,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Michigan,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,934
NCT01598298,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-01-31,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,288
NCT01603641,1,1,0,1,0,0,2018-08-25,2019-08-25,2019-07-29,Allergan,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,0,1,0,0,0,0,0,1,0,1,495
NCT01619085,1,1,0,1,0,0,2017-07-05,2018-07-05,2018-07-02,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT01629498,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01632241,1,1,0,1,0,0,2018-06-18,2019-06-18,2019-06-12,"Human Genome Sciences Inc., a GSK Company",Industry,1,1,0,4.0,Phase 4,0,2013.0,1,1,1,0,0,0,0,0,1,0,1,15
NCT01642901,1,0,0,0,1,0,2018-03-31,2019-03-31,,Thomas Jefferson University,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,186
NCT01648205,1,0,0,0,1,0,2018-07-20,2019-07-20,,University of Rochester,Other,0,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,470
NCT01649388,0,0,0,0,0,0,2025-12-31,2026-12-31,,University of Louisville,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,0,1,0,0,0,0,0,3,0,1,214
NCT01652196,0,0,0,0,0,0,2019-12-31,2020-12-31,,John Hays,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,1,0,0,1,0,0,0,0,1,2
NCT01656187,1,1,0,1,0,1,2017-01-31,2018-01-31,2019-01-09,University of Texas Southwestern Medical Center,Other,0,0,1,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT01659203,0,0,0,0,0,0,2020-08-31,2021-08-31,,Massachusetts General Hospital,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,1699
NCT01661283,1,1,0,1,0,1,2017-06-30,2018-06-30,2019-01-21,Sarcoma Alliance for Research through Collaboration,Other,0,1,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT01670097,0,0,0,0,0,0,2021-01-31,2022-01-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,1,0,0,0,0,0,0,1,2066
NCT01692756,1,1,0,1,0,1,2017-02-05,2018-02-05,2018-04-02,Cale Jacobs,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01693601,1,0,0,0,1,0,2018-05-18,2019-05-18,,John Mascarenhas,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT01709747,0,0,0,0,0,0,2018-02-28,2019-02-28,,"Piramal Critical Care, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,1,0,0,0,0,0,0,1,3
NCT01715883,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-31,"Gladwin, Mark, MD",Other,0,0,0,1.0,Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT01718743,0,0,0,0,0,0,2019-12-01,2020-12-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01735955,0,0,0,0,0,0,2023-04-28,2024-04-28,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01739933,0,0,0,0,0,0,2019-07-31,2020-07-31,,Vanderbilt University Medical Center,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,422
NCT01750918,0,0,0,0,0,0,2019-12-31,2020-12-31,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01752634,0,0,0,0,0,0,2019-01-09,2020-01-09,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01757665,1,0,0,0,1,0,2018-08-31,2019-08-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,77
NCT01759537,0,0,0,0,0,0,2019-04-30,2020-04-30,,Dentsply International,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,10
NCT01761877,0,0,0,0,0,0,2019-06-30,2020-06-30,,Stony Brook University,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,119
NCT01763970,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,461
NCT01771107,0,0,0,0,0,0,2021-10-16,2022-10-16,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01776671,0,0,0,0,0,0,2018-11-30,2019-11-30,,Chicago Anesthesia Pain Specialists,Other,0,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01791543,0,0,0,0,0,0,2019-09-30,2020-09-30,,William Stevenson,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT01797120,1,1,0,1,0,0,2017-03-22,2018-03-22,2018-03-05,"PrECOG, LLC.",Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT01798641,1,1,0,1,0,0,2017-09-14,2018-09-14,2018-08-17,Johns Hopkins University,Other,0,1,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1143
NCT01820572,0,0,0,0,0,0,2020-01-09,2021-01-09,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT01823198,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01824472,1,0,0,0,1,0,2017-03-31,2018-03-31,,University of Pennsylvania,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1052
NCT01826851,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-03-23,Peter A Knight,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01829997,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-02-12,"Pioneer Surgical Technology, Inc.",Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT01843062,1,1,0,1,0,0,2018-05-18,2019-05-18,2019-03-27,AstraZeneca,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT01845740,1,0,0,0,1,0,2017-01-31,2018-01-31,,"Immunomedics, Inc.",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,36
NCT01846221,1,1,0,1,0,1,2017-01-20,2018-01-20,2018-03-08,Columbia University,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT01846611,1,1,0,1,0,0,2018-01-18,2019-01-18,2019-01-17,"Janssen Research & Development, LLC",Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT01856309,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-12,"Janssen Research & Development, LLC",Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT01864746,0,0,0,0,0,0,2020-12-31,2021-12-31,,German Breast Group,Other,0,1,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,37
NCT01869725,0,0,0,0,0,0,2018-12-26,2019-12-26,,Sue O'Dorisio,Other,0,0,1,1.0,Phase 2,0,2013.0,1,0,0,0,0,1,0,0,0,0,1,8
NCT01875237,1,1,0,1,0,1,2017-03-07,2018-03-07,2018-04-18,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01877551,1,0,1,1,0,0,2018-05-31,2019-05-31,2019-05-31,Washington University School of Medicine,Other,0,0,1,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT01878786,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-04-04,Matthew Cooper,Other,0,0,0,2.0,Phase 2/Phase 3,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01881425,0,0,0,0,0,0,2018-11-30,2019-11-30,,InnFocus Inc.,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT01883492,0,0,0,0,0,0,2019-02-06,2020-02-06,,Zimmer Biomet,Industry,1,0,0,5.0,,1,2013.0,1,0,0,1,0,0,0,0,2,0,1,215
NCT01893372,0,0,0,0,0,0,2019-01-06,2020-01-06,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01898013,1,1,0,1,0,1,2017-04-03,2018-04-03,2018-04-24,Durham VA Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT01900730,1,0,0,0,1,0,2018-06-01,2019-06-01,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01907100,1,1,0,1,0,0,2018-03-16,2019-03-16,2018-09-11,Boehringer Ingelheim,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT01911676,0,0,0,0,0,0,2019-12-31,2020-12-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT01920932,0,0,0,0,0,0,2020-11-16,2021-11-16,,St. Jude Children's Research Hospital,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,302
NCT01926197,0,0,0,0,0,0,2020-09-30,2021-09-30,,Stanford University,Other,0,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,1,0,0,1,0,1,1309
NCT01950299,0,0,0,0,0,0,2018-12-23,2019-12-23,,Virginia Commonwealth University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT01950819,0,1,0,1,0,1,2017-02-01,2018-02-01,2018-10-03,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2013.0,1,1,1,0,0,0,0,0,1,0,1,1895
NCT01954992,0,0,0,0,0,0,2021-03-31,2022-03-31,,Eleison Pharmaceuticals LLC.,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT01958476,1,0,1,1,0,1,2017-03-05,2018-03-05,2019-07-01,Tufts Medical Center,Other,0,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,121
NCT01966107,1,1,0,1,0,0,2017-09-21,2018-09-21,2018-09-19,AstraZeneca,Industry,1,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT01970007,0,0,0,0,0,0,2017-11-20,2018-11-20,,Cook Research Incorporated,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,20
NCT01970501,0,0,0,0,0,0,2017-12-28,2018-12-28,,"ARCA Biopharma, Inc.",Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,11
NCT01980342,1,1,0,1,0,0,2018-04-04,2019-04-04,2018-04-05,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT01981759,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-06-08,NYU Langone Health,Other,0,0,1,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT01986829,1,1,0,1,0,0,2017-08-08,2018-08-08,2018-07-18,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1151
NCT01988246,1,0,0,0,1,0,2018-04-30,2019-04-30,,Rishi Singh,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01989585,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01992250,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Sanarus Technologies, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT01999517,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-08-13,"Mt. Sinai Medical Center, Miami",Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,16
NCT02001623,0,0,0,0,0,0,2019-04-24,2020-04-24,,Genmab,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,20
NCT02002598,0,0,0,0,0,0,2019-03-01,2020-03-01,,Siyang Leng,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02006654,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-12,H. Lundbeck A/S,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,152
NCT02030834,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1052
NCT02036853,0,0,0,0,0,0,2022-01-31,2023-01-31,,Adrian Lacy,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02041299,0,0,0,0,0,0,2019-10-31,2020-10-31,,ApoPharma,Industry,1,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,25
NCT02044796,1,1,0,1,0,0,2018-03-09,2019-03-09,2019-03-05,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,393
NCT02048670,1,1,0,1,0,1,2017-07-31,2018-07-31,2019-04-24,Mayo Clinic,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02049502,1,1,0,1,0,1,2018-02-01,2019-02-01,2019-02-23,Virginia O. Shaffer,Other,0,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,1
NCT02052778,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Taiho Oncology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,37
NCT02061280,1,1,0,1,0,0,2017-02-17,2018-02-17,2018-02-15,Nemours Children's Clinic,Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,75
NCT02061761,0,0,0,0,0,0,2019-03-29,2020-03-29,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02063672,1,1,0,1,0,0,2017-02-13,2018-02-13,2018-02-13,C. R. Bard,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,77
NCT02065557,0,0,0,0,0,0,2020-06-26,2021-06-26,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,430
NCT02066129,1,1,0,1,0,1,2017-04-21,2018-04-21,2018-04-23,Milton S. Hershey Medical Center,Other,0,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT02093793,0,0,0,0,0,0,2018-12-31,2019-12-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,340
NCT02101853,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT02106546,0,0,0,0,0,0,2019-07-29,2020-07-29,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02107261,0,0,0,0,0,0,2020-07-31,2021-07-31,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT02112617,0,0,0,0,0,0,2024-03-31,2025-03-31,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,1699
NCT02118727,0,0,0,0,0,0,2022-10-31,2023-10-31,,University of Kansas Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT02119338,1,0,0,0,1,0,2017-06-30,2018-06-30,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT02119442,1,1,0,1,0,0,2018-02-28,2019-02-28,2019-01-30,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,692
NCT02121418,1,1,0,1,0,0,2017-02-08,2018-02-08,2018-02-08,University of Washington,Other,0,0,1,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02128763,1,1,0,1,0,0,2017-09-05,2018-09-05,2018-08-28,University of Pennsylvania,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02131389,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Iconacy Orthopedic Implants, LLC.",Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02132533,0,0,0,0,0,0,2018-10-29,2019-10-29,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT02138136,1,0,0,0,1,0,2017-04-30,2018-04-30,,Sucampo AG,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT02144155,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-30,"University of California, San Diego",Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT02147132,1,1,0,1,0,1,2017-08-25,2018-08-25,2018-10-31,University of Cincinnati,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,222
NCT02151149,1,1,0,1,0,0,2017-07-14,2018-07-14,2018-07-13,Celgene,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,306
NCT02152982,0,0,0,0,0,0,2021-01-14,2022-01-14,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02154568,1,0,0,0,1,0,2018-06-30,2019-06-30,,University of Virginia,Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT02155712,1,1,0,1,0,0,2018-04-05,2019-04-05,2019-04-04,Stryker Orthopaedics,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,24
NCT02163577,0,1,0,1,0,0,2018-10-30,2019-10-30,2019-04-29,Ultragenyx Pharmaceutical Inc,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,36
NCT02169284,1,0,0,0,1,0,2018-03-30,2019-03-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02169791,0,0,0,0,0,0,2019-08-30,2020-08-30,,"Northside Hospital, Inc.",Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,16
NCT02175030,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Utah,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,578
NCT02179255,1,0,0,0,1,0,2018-06-30,2019-06-30,,Center for Human Reproduction,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02184520,0,0,0,0,0,0,2019-05-31,2020-05-31,,Globus Medical Inc,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,13
NCT02185417,0,0,0,0,0,0,2022-10-15,2023-10-15,,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02186301,1,1,0,1,0,1,2017-06-28,2018-06-28,2019-01-10,"Clovis Oncology, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT02190084,0,0,0,0,0,0,2019-05-31,2020-05-31,,Central Arkansas Veterans Healthcare System,U.S. Fed,2,0,0,4.0,Phase 4,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,11
NCT02199184,0,0,0,0,0,0,2022-12-31,2023-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02203513,0,0,0,0,0,0,2020-06-01,2021-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02203773,0,0,0,0,0,0,2021-03-26,2022-03-26,,AbbVie,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02204761,1,1,0,1,0,0,2017-09-07,2018-09-07,2018-09-05,University of Washington,Other,0,0,1,5.0,,0,2014.0,1,0,0,0,0,1,0,0,0,0,1,910
NCT02205411,1,0,0,0,1,0,2018-03-31,2019-03-31,,ReliantHeart Inc.,Industry,1,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02206035,0,0,0,0,0,0,2018-09-30,2019-09-30,,"William R. Drobyski, MD",Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02209532,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-11-19,"Novadaq Technologies ULC, now a part of Stryker",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,4
NCT02213003,0,0,0,0,0,0,2020-05-31,2021-05-31,,Rodolfo Alejandro,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,10
NCT02213263,1,1,0,1,0,0,2017-10-23,2018-10-23,2018-10-02,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,2856
NCT02218606,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02220634,1,0,0,0,1,0,2017-05-25,2018-05-25,,National Jewish Health,Other,0,1,0,5.0,,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,81
NCT02226367,0,0,0,0,0,0,2018-09-20,2019-09-20,,Seattle Institute for Biomedical and Clinical Research,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT02227667,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02228525,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02228681,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-09-20,Gynecologic Oncology Group,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,200
NCT02229565,0,0,0,0,0,0,2020-01-30,2021-01-30,,Duke University,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT02232893,0,0,0,0,0,0,2017-05-31,2018-05-31,,Tsumura USA,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02234583,0,0,0,0,0,0,2017-04-30,2018-04-30,,"Daiichi Sankyo, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,207
NCT02241655,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-03-06,Washington University School of Medicine,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1151
NCT02251067,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Vascular Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02252172,0,0,0,0,0,0,2018-09-24,2019-09-24,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,558
NCT02257541,0,0,0,0,0,0,2019-03-25,2020-03-25,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02258854,1,0,0,0,1,0,2017-10-31,2018-10-31,,XOMA (US) LLC,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT02266433,1,0,0,0,1,0,2018-07-01,2019-07-01,,NYU Langone Health,Other,0,0,0,3.0,Phase 3,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02277548,1,0,0,0,1,0,2018-04-30,2019-04-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT02279095,0,0,0,0,0,0,2021-03-31,2022-03-31,,Clementia Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02282215,0,0,0,0,0,0,2017-09-22,2018-09-22,,Cellerant Therapeutics,Industry,1,0,1,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02284126,0,0,0,0,0,0,2019-10-31,2020-10-31,,Columbia University,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT02285062,0,0,0,0,0,0,2019-03-15,2020-03-15,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02286921,0,1,0,1,0,0,2018-12-31,2019-12-31,2019-02-22,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02288559,0,1,0,1,0,1,2017-06-02,2018-06-02,2019-01-24,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,427
NCT02296528,0,0,0,0,0,0,2022-04-30,2023-04-30,,"Peter Belafsky, MD",Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02297698,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Cancer Insight, LLC",Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,4
NCT02304991,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02306161,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,1,0,0,1,0,1,3004
NCT02308241,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02312687,0,0,0,0,0,0,2018-11-24,2019-11-24,,Ultragenyx Pharmaceutical Inc,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,36
NCT02313675,1,1,0,1,0,0,2017-05-01,2018-05-01,2018-02-20,John Fowler,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02315768,0,0,0,0,0,0,2020-11-30,2021-11-30,,"University of California, San Diego",Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02316106,0,0,0,0,0,0,2020-07-17,2021-07-17,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,558
NCT02317991,0,0,0,0,0,0,2021-01-31,2022-01-31,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,167
NCT02320292,0,0,0,0,0,0,2026-01-31,2027-01-31,,Mayo Clinic,Other,0,0,1,3.0,Phase 3,0,2015.0,0,0,1,0,0,1,0,0,0,0,1,1898
NCT02321930,1,1,0,1,0,1,2017-09-29,2018-09-29,2019-01-18,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,692
NCT02322411,1,1,0,1,0,1,2017-10-19,2018-10-19,2019-04-17,"University of Wisconsin, Madison",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,715
NCT02324335,1,1,0,1,0,0,2017-10-25,2018-10-25,2018-10-17,"Innovation Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02328768,1,0,0,0,1,0,2017-11-10,2018-11-10,,"Brian Jones, MD",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02335944,0,0,0,0,0,0,2019-09-30,2020-09-30,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02337517,0,0,0,0,0,0,2018-12-31,2019-12-31,,National Cancer Institute (NCI),NIH,2,1,0,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02339415,0,1,0,1,0,0,2018-09-30,2019-09-30,2019-02-17,Hennepin Healthcare Research Institute.,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,61
NCT02343263,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-20,Indiana University School of Medicine,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,1,0,0,0,0,0,0,0,1,94
NCT02343549,0,0,0,0,0,0,2020-06-30,2021-06-30,,Ashley Love Sumrall,Other,0,1,0,1.0,Phase 2,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02344108,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Christopher Hartnick, M.D.",Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02345070,0,0,0,0,0,0,2017-05-22,2018-05-22,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02346461,1,1,0,1,0,0,2017-12-30,2018-12-30,2018-12-27,National Human Genome Research Institute (NHGRI),NIH,2,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,191
NCT02347657,0,1,0,1,0,1,2017-01-20,2018-01-20,2018-03-14,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02350764,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02351856,0,0,0,0,0,0,2022-02-28,2023-02-28,,Array BioPharma,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,65
NCT02352753,0,0,0,0,0,0,2020-01-30,2021-01-30,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,685
NCT02352948,1,1,0,1,0,0,2018-02-09,2019-02-09,2019-02-07,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02357810,0,0,0,0,0,0,2019-07-31,2020-07-31,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02360774,1,1,0,1,0,0,2018-08-31,2019-08-31,2018-06-27,Beth Israel Deaconess Medical Center,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,377
NCT02361346,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Molecular Templates, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02365012,1,0,0,0,1,0,2017-06-30,2018-06-30,,Corporal Michael J. Crescenz VA Medical Center,U.S. Fed,2,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,15
NCT02368977,1,0,0,0,1,0,2017-10-11,2018-10-11,,Avantis Medical Systems,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02374801,0,0,0,0,0,0,2019-04-30,2020-04-30,,MicroPort CRM,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,13
NCT02375971,1,1,0,1,0,0,2017-12-14,2018-12-14,2018-06-05,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02382549,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Craig L Slingluff, Jr",Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,19
NCT02383433,1,1,0,1,0,1,2017-09-01,2018-09-01,2019-03-22,Case Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,374
NCT02388906,0,0,0,0,0,0,2018-11-26,2019-11-26,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02390960,0,0,0,0,0,0,2017-04-30,2018-04-30,,"Strategic Science & Technologies, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,8
NCT02393885,0,0,0,0,0,0,2020-11-30,2021-11-30,,"AtriCure, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,17
NCT02399813,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Advaxis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02400164,1,0,0,0,1,0,2018-01-19,2019-01-19,,Sequana Medical AG,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,10
NCT02402036,1,1,0,1,0,1,2017-11-30,2018-11-30,2018-12-13,Georgetown University,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,214
NCT02412917,1,0,0,0,1,0,2017-11-30,2018-11-30,,"ContraVir Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02414165,0,0,0,0,0,0,2019-12-31,2020-12-31,,Tocagen Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,7
NCT02420314,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Joseph J. Cullen, MD, FACS",Other,0,1,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02420795,0,0,0,0,0,0,2021-11-01,2022-11-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02420912,0,0,0,0,0,0,2021-06-30,2022-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02422381,0,0,0,0,0,0,2020-04-30,2021-04-30,,Providence Health & Services,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT02424019,0,0,0,0,0,0,2019-12-31,2020-12-31,,Alimera Sciences,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT02432144,0,1,0,1,0,0,2019-01-14,2020-01-14,2019-07-10,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT02432846,0,0,0,0,0,0,2019-08-09,2020-08-09,,Immunicum AB,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,1,0,0,0,0,0,1,0,1,5
NCT02433158,0,0,0,0,0,0,2021-06-30,2022-06-30,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02434874,0,0,0,0,0,0,2021-12-31,2022-12-31,,"StimGuard, LLC.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT02436408,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,213
NCT02436668,0,0,0,0,0,0,2018-10-31,2019-10-31,,Pharmacyclics LLC.,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,54
NCT02436993,0,0,0,0,0,0,2040-08-31,2041-08-31,,"University of California, Irvine",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,310
NCT02442765,0,0,0,0,0,0,2019-01-30,2020-01-30,,Avanir Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT02445339,0,0,0,0,0,0,2023-01-31,2024-01-31,,NYU Langone Health,Other,0,0,1,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02447302,0,0,0,0,0,0,2018-02-14,2019-02-14,,Arena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02448303,1,1,0,1,0,1,2018-03-31,2019-03-31,2019-07-19,Acerta Pharma BV,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02448875,0,1,0,1,0,1,2017-06-22,2018-06-22,2019-05-06,"Transcend Medical, Inc.",Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,2,0,1,5
NCT02452970,1,0,0,0,1,0,2018-06-30,2019-06-30,,"EpicentRx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02453334,1,0,0,0,1,0,2018-01-31,2019-01-31,,"American Regent, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT02454153,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02454972,0,0,0,0,0,0,2020-01-31,2021-01-31,,PharmaMar,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,36
NCT02457260,1,1,0,1,0,0,2017-03-06,2018-03-06,2018-03-05,"Gladwin, Mark, MD",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02459054,0,0,0,0,0,0,2023-06-30,2024-06-30,,SynCardia Systems. LLC,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT02460484,1,0,0,0,1,0,2018-06-30,2019-06-30,,"James Baumgartner, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02461927,0,0,0,0,0,0,2021-06-30,2022-06-30,,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02462759,0,0,0,0,0,0,2018-09-24,2019-09-24,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,324
NCT02467179,1,1,0,1,0,1,2017-10-30,2018-10-30,2019-05-13,"University of California, San Diego",Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,561
NCT02467387,1,0,0,0,1,0,2017-04-30,2018-04-30,,CardioCell LLC,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02468648,1,0,0,0,1,0,2018-09-14,2019-09-14,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02469701,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-04-05,howard safran,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02470780,1,0,0,0,1,0,2017-08-31,2018-08-31,,University of Cincinnati,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,222
NCT02471430,0,0,0,0,0,0,2019-09-30,2020-09-30,,Massachusetts General Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02471807,0,0,0,0,0,0,2020-01-31,2021-01-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,77
NCT02481830,1,0,1,1,0,0,2018-08-17,2019-08-17,2019-08-13,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02483078,1,0,0,0,1,0,2018-02-28,2019-02-28,,"CytoDyn, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02484456,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Institute of Mental Health (NIMH),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,330
NCT02487979,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-08-03,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,3004
NCT02489357,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-03-08,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,5.0,,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,461
NCT02494700,0,0,0,0,0,0,2019-07-01,2020-07-01,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT02495389,0,0,0,0,0,0,2020-07-31,2021-07-31,,Loyola University,Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,102
NCT02495779,1,1,0,1,0,1,2017-11-30,2018-11-30,2018-12-14,James Egan,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02502149,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-03-09,Bioverativ Therapeutics Inc.,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,19
NCT02504424,1,1,0,1,0,1,2017-05-03,2018-05-03,2018-08-08,"AirXpanders, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02505919,1,0,0,0,1,0,2017-07-14,2018-07-14,,PROCEPT BioRobotics,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,7
NCT02506049,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Tennessee,Other,0,0,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,0,0,1,99
NCT02506153,0,0,0,0,0,0,2023-09-15,2024-09-15,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,3004
NCT02512588,1,0,0,0,1,0,2018-02-28,2019-02-28,,Balance Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02514525,0,0,0,0,0,0,2019-05-31,2020-05-31,,"C2 Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,9
NCT02516332,0,0,0,0,0,0,2020-07-31,2021-07-31,,Duke University,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1342
NCT02519621,0,0,0,0,0,0,2019-01-31,2020-01-31,,Larry Lavery,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02521103,0,0,0,0,0,0,2020-12-31,2021-12-31,,Stryker Orthopaedics,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,24
NCT02522481,1,0,0,0,1,0,2017-05-31,2018-05-31,,"Bracco Diagnostics, Inc",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,46
NCT02522611,0,0,0,0,0,0,2022-06-30,2023-06-30,,National Institute of Neurological Disorders and Stroke (NINDS),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,560
NCT02523040,0,0,0,0,0,0,2019-08-31,2020-08-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02524249,0,0,0,0,0,0,2018-12-31,2019-12-31,,Wayne State University,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,145
NCT02525263,1,0,1,1,0,1,2017-05-31,2018-05-31,2018-08-06,inRegen,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02527265,0,0,0,0,0,0,2020-07-31,2021-07-31,,Mannkind Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,48
NCT02532517,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Cerenovus, Part of DePuy Synthes Products, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02535247,0,0,0,0,0,0,2020-12-31,2021-12-31,,Fox Chase Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,156
NCT02535806,1,1,0,1,0,1,2017-05-25,2018-05-25,2018-07-16,Children's Mercy Hospital Kansas City,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,138
NCT02536339,0,0,0,0,0,0,2020-03-30,2021-03-30,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,427
NCT02539303,0,0,0,0,0,0,2020-08-31,2021-08-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02540330,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Atossa Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02540954,0,0,0,0,0,0,2019-12-20,2020-12-20,,Bayer,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,1343
NCT02542384,0,0,0,0,0,0,2018-04-30,2019-04-30,,"Cara Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT02543944,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Arkansas,Other,0,0,1,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,285
NCT02544308,0,0,0,0,0,0,2021-10-31,2022-10-31,,"University College, London",Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,370
NCT02547168,0,0,0,0,0,0,2019-09-30,2020-09-30,,McMaster University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,434
NCT02547818,0,0,0,0,0,0,2020-12-31,2021-12-31,,"AZTherapies, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT02549196,1,1,0,1,0,0,2017-09-28,2018-09-28,2018-09-28,"Chase Pharmaceuticals Corporation, an affiliate of Allergan plc",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02552121,1,1,0,1,0,0,2017-12-13,2018-12-13,2018-12-12,Genmab,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,20
NCT02558894,1,1,0,1,0,0,2017-06-15,2018-06-15,2018-05-28,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02561247,0,0,0,0,0,0,2018-04-06,2019-04-06,,Baxter Healthcare Corporation,Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,101
NCT02565511,0,0,0,0,0,0,2024-12-31,2025-12-31,,Novartis Pharmaceuticals,Industry,1,1,1,2.0,Phase 2/Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,1895
NCT02568566,0,0,0,0,0,0,2020-02-29,2021-02-28,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02572817,1,1,0,1,0,0,2018-04-26,2019-04-26,2019-04-24,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2133
NCT02574520,0,0,0,0,0,0,2017-06-30,2018-06-30,,Durect,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02574728,0,0,0,0,0,0,2020-06-30,2021-06-30,,Emory University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02575950,0,1,0,1,0,1,2017-04-30,2018-04-30,2018-12-27,LEO Pharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,171
NCT02581059,1,0,0,0,1,0,2018-06-22,2019-06-22,,Rodwige J. Desnoyers,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02582749,1,1,0,1,0,1,2017-09-14,2018-09-14,2019-05-15,"Ajjai Alva, MD",Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,1,0,0,0,0,1,2
NCT02584309,0,0,0,0,0,0,2023-10-31,2024-10-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02584959,1,1,0,1,0,0,2017-07-24,2018-07-24,2018-07-17,Shire,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,342
NCT02586805,1,1,0,1,0,0,2017-04-13,2018-04-13,2018-03-20,Shire,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,342
NCT02589145,0,0,0,0,0,0,2019-04-08,2020-04-08,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02590393,0,0,0,0,0,0,2021-01-01,2022-01-01,,Duke University,Other,0,0,1,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,1342
NCT02591355,0,0,0,0,0,0,2019-04-30,2020-04-30,,Regen Lab SA,Industry,1,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT02592473,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Virginia,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,402
NCT02594163,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-09-13,"Seattle Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,77
NCT02595944,0,0,0,0,0,0,2024-07-01,2025-07-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02601833,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Michigan,Other,0,0,0,3.0,Phase 3,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT02605083,0,0,0,0,0,0,2019-01-11,2020-01-11,,Effector Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02613364,0,0,0,0,0,0,2020-11-30,2021-11-30,,Gary Morrow,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,23
NCT02614066,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Kite, A Gilead Company",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,14
NCT02614287,0,1,0,1,0,1,2017-05-12,2018-05-12,2018-08-23,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02616783,1,1,0,1,0,0,2018-02-21,2019-02-21,2019-01-31,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02620865,0,0,0,0,0,0,2020-12-31,2021-12-31,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,134
NCT02623075,0,0,0,0,0,0,2019-10-31,2020-10-31,,Northwestern University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,925
NCT02623205,0,0,0,0,0,0,2019-05-31,2020-05-31,,Stony Brook University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,119
NCT02623959,1,1,0,1,0,1,2017-05-23,2018-05-23,2019-04-16,M.D. Anderson Cancer Center,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02625909,0,0,0,0,0,0,2019-08-31,2020-08-31,,Kirby Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,67
NCT02628743,0,1,0,1,0,0,2018-12-18,2019-12-18,2019-06-12,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,1731
NCT02633501,1,1,0,1,0,0,2018-01-31,2019-01-31,2019-01-31,Guerbet,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,1,0,0,0,0,1,0,1,34
NCT02636868,1,0,0,0,1,0,2017-07-31,2018-07-31,,Windtree Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,9
NCT02639286,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT02640807,1,0,0,0,1,0,2018-08-27,2019-08-27,,Revimmune,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02641392,1,1,0,1,0,1,2018-01-04,2019-01-04,2019-01-08,Celgene,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02643290,1,0,0,0,1,0,2017-01-31,2018-01-31,,Aspen Medical Products,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,3,0,1,3
NCT02644941,0,0,0,0,0,0,2019-03-25,2020-03-25,,"Humacyte, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,1,0,0,0,0,1,0,1,8
NCT02645409,1,0,1,1,0,1,2018-03-20,2019-03-20,2019-08-21,Chandru Sundaram,Other,0,0,0,5.0,,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,1
NCT02647359,0,0,0,0,0,0,2022-02-21,2023-02-21,,PTC Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT02647892,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Nebraska,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,327
NCT02648997,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,647
NCT02649439,0,0,0,0,0,0,2020-01-01,2021-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02653742,1,0,0,0,1,0,2017-12-31,2018-12-31,,Anica Crnkovic,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02654509,0,0,0,0,0,0,2021-02-28,2022-02-28,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2008.0,0,0,1,0,0,0,0,0,0,0,1,136
NCT02658279,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02658656,0,0,0,0,0,0,2021-03-31,2022-03-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT02659020,0,0,0,0,0,0,2019-12-31,2020-12-31,,Eli Lilly and Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02662634,1,0,0,0,1,0,2018-03-31,2019-03-31,,"GU Research Network, LLC",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,1,0,0,1,0,0,0,0,1,2
NCT02667886,0,0,0,0,0,0,2019-03-31,2020-03-31,,X4 Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02669251,0,0,0,0,0,0,2020-09-30,2021-09-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02670707,0,0,0,0,0,0,2021-01-31,2022-01-31,,Baylor College of Medicine,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT02670837,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,218
NCT02673203,0,0,0,0,0,0,2018-11-30,2019-11-30,,Yale University,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1053
NCT02678000,0,0,0,0,0,0,2018-10-11,2019-10-11,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT02678130,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Vertebral Technologies, Inc.",Industry,1,0,0,4.0,Phase 4,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02678377,0,0,0,0,0,0,2019-09-30,2020-09-30,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02681809,0,0,0,0,0,0,2019-12-31,2020-12-31,,ThromboGenics,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,28
NCT02682264,0,0,0,0,0,0,2018-08-31,2019-08-31,,Cassiopea SpA,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02682901,0,0,0,0,0,0,2018-12-31,2019-12-31,,Eastern Virginia Medical School,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,33
NCT02683265,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Rhodes Pharmaceuticals, L.P.",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02683889,0,0,1,1,0,0,2020-08-31,2021-08-31,2019-08-06,Georgetown University,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT02684253,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT02685709,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Chiasma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT02686138,0,0,0,0,0,0,2017-08-31,2018-08-31,,Ardelyx,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,22
NCT02688608,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Texas Southwestern Medical Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02691923,0,0,0,0,0,0,2020-06-30,2021-06-30,,David W. Roberts,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02693275,1,0,0,0,1,0,2017-03-31,2018-03-31,,Pearson/Clinical Assessment,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02696798,0,0,0,0,0,0,2018-05-18,2019-05-18,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02700919,1,0,0,0,1,0,2017-11-08,2018-11-08,,Mereo BioPharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02701634,1,1,0,1,0,0,2017-12-19,2018-12-19,2018-12-05,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02702999,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-07-11,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,490
NCT02704403,0,0,0,0,0,0,2021-12-31,2022-12-31,,Genfit,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,15
NCT02708095,1,1,0,1,0,0,2017-10-12,2018-10-12,2018-09-28,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02713607,0,0,0,0,0,0,2027-01-31,2028-01-31,,"University of California, Davis",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,530
NCT02714595,0,0,0,0,0,0,2019-04-01,2020-04-01,,Shionogi,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,38
NCT02715804,0,0,0,0,0,0,2019-11-30,2020-11-30,,Halozyme Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,32
NCT02718833,0,0,0,0,0,0,2020-09-30,2021-09-30,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02720627,0,0,0,0,0,0,2018-03-21,2019-03-21,,Cassiopea SpA,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02722408,1,0,0,0,1,0,2017-04-30,2018-04-30,,"Gemphire Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02723162,0,0,0,0,0,0,2020-06-30,2021-06-30,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02726945,1,1,0,1,0,1,2018-04-01,2019-04-01,2019-05-29,The GID Group,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02727660,1,0,1,1,0,1,2018-03-30,2019-03-30,2019-05-22,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02729701,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Kansas Medical Center,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,219
NCT02730546,0,0,0,0,0,0,2021-04-15,2022-04-15,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,1898
NCT02732184,0,0,0,0,0,0,2017-12-31,2018-12-31,,Aeglea Biotherapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02734290,0,0,0,0,0,0,2021-05-31,2022-05-31,,Providence Health & Services,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT02734693,0,0,0,0,0,0,2017-02-28,2018-02-28,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT02735252,0,0,0,0,0,0,2023-12-31,2024-12-31,,"University of California, San Francisco",Other,0,1,0,5.0,,0,2016.0,0,0,0,0,0,0,0,0,0,0,1,1443
NCT02736695,0,0,0,0,0,0,2022-06-01,2023-06-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02736968,0,0,0,0,0,0,2020-05-31,2021-05-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,2133
NCT02737306,0,0,0,0,0,0,2019-12-31,2020-12-31,,"CytoDyn, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,14
NCT02737436,1,0,0,0,1,0,2017-04-30,2018-04-30,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02739412,0,0,0,0,0,0,2019-11-30,2020-11-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,377
NCT02739620,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Vermont,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,155
NCT02740582,0,0,0,0,0,0,2019-09-01,2020-09-01,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02741193,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,869
NCT02745145,1,1,0,1,0,0,2018-05-30,2019-05-30,2019-05-29,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02747186,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-10-11,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02748525,1,1,0,1,0,0,2018-06-14,2019-06-14,2019-06-13,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,490
NCT02749201,1,0,1,1,0,1,2017-04-30,2018-04-30,2018-11-14,Maimonides Medical Center,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,46
NCT02750319,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02754141,0,0,0,0,0,0,2020-11-15,2021-11-15,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02754440,1,1,0,1,0,0,2017-07-28,2018-07-28,2018-04-09,Terumo BCT,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT02757885,0,0,0,0,0,0,2020-12-31,2021-12-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,947
NCT02762708,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02762929,0,0,0,0,0,0,2017-02-28,2018-02-28,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT02764489,0,0,0,0,0,0,2021-03-30,2022-03-30,,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,107
NCT02766673,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-04-22,Children's Hospital of Philadelphia,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,324
NCT02767427,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-17,Columbia University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,675
NCT02768402,0,0,0,0,0,0,2023-09-30,2024-09-30,,Caisson Interventional LLC,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02769962,0,0,0,0,0,0,2022-07-01,2023-07-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02771210,0,0,0,0,0,0,2020-01-08,2021-01-08,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,2,0,1,1895
NCT02772276,0,0,0,0,0,0,2019-10-31,2020-10-31,,MediBeacon,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,6
NCT02779543,1,1,0,1,0,0,2018-07-30,2019-07-30,2018-12-10,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,586
NCT02781506,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,626
NCT02784106,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-04-30,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02785913,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-07-13,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,288
NCT02791893,0,0,0,0,0,0,2019-10-01,2020-10-01,,Benjamin Natelson,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02793635,1,0,0,0,1,0,2018-03-31,2019-03-31,,Parker Hannifin Corporation,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02796859,0,0,0,0,0,0,2019-11-30,2020-11-30,,Brian Miller,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02797184,0,0,0,0,0,0,2023-12-31,2024-12-31,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT02797262,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,692
NCT02798120,0,0,0,0,0,0,2017-04-30,2018-04-30,,"Novan, Inc.",Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02798471,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Daiichi Sankyo, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT02799745,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,135
NCT02802020,0,0,0,0,0,0,2021-03-31,2022-03-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,340
NCT02802423,0,0,0,0,0,0,2021-10-30,2022-10-30,,"BioLite, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,6
NCT02807636,0,0,0,0,0,0,2020-11-17,2021-11-17,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02809118,1,0,0,0,1,0,2018-02-28,2019-02-28,,"Auris Medical, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT02810444,0,0,0,0,0,0,2020-03-31,2021-03-31,,Biotest,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,10
NCT02812225,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Jan Medical, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,11
NCT02815540,0,0,0,0,0,0,2018-12-01,2019-12-01,,Gillette Children's Specialty Healthcare,Other,0,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,14
NCT02817841,0,0,0,0,0,0,2018-10-16,2019-10-16,,Estetra,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02818569,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-08-15,Massachusetts General Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02818894,0,0,0,0,0,0,2019-11-30,2020-11-30,,Emory University,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02819843,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT02823574,0,0,0,0,0,0,2019-01-23,2020-01-23,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02828124,1,1,0,1,0,0,2018-01-08,2019-01-08,2019-01-07,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,0,1,0,0,0,0,0,2,0,1,1104
NCT02829723,0,0,0,0,0,0,2019-06-19,2020-06-19,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02829944,0,0,0,0,0,0,2019-03-31,2020-03-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1342
NCT02830204,0,0,0,0,0,0,2019-12-31,2020-12-31,,Baylor Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,131
NCT02836470,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Leading BioSciences, Inc",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT02836899,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02841891,1,0,0,0,1,0,2018-08-13,2019-08-13,,"Cohera Medical, Inc.",Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,9
NCT02842073,1,1,0,1,0,0,2017-12-13,2018-12-13,2018-10-31,"University of North Carolina, Chapel Hill",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02844439,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Kadmon Corporation, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,29
NCT02844777,1,0,0,0,1,0,2017-05-31,2018-05-31,,Vidac Pharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02845453,0,0,0,0,0,0,2020-01-31,2021-01-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02847949,0,0,0,0,0,0,2019-12-31,2020-12-31,,"ImmunGene, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT02850601,0,0,0,0,0,0,2019-02-28,2020-02-28,,Brigham and Women's Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,698
NCT02854436,0,0,0,0,0,0,2020-02-21,2021-02-21,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,558
NCT02858453,1,0,1,1,0,0,2018-08-31,2019-08-31,2018-12-10,Aquinox Pharmaceuticals (Canada) Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02863120,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Texas Orthopaedics, Sports and Rehabilitation Associates",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02863445,0,0,0,0,0,0,2021-10-31,2022-10-31,,Oregon Health and Science University,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT02863991,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Oncoceutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02864251,0,0,0,0,0,0,2021-09-30,2022-09-30,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02865122,1,0,0,0,1,0,2018-03-22,2019-03-22,,Nutrinia,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT02865681,1,0,0,0,1,0,2017-06-07,2018-06-07,,New Hope Fertility Center,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02867813,0,0,0,0,0,0,2021-09-29,2022-09-29,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,685
NCT02870218,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Rose Research Center, LLC",Industry,1,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02871791,0,0,0,0,0,0,2019-10-31,2020-10-31,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02873195,0,0,0,0,0,0,2020-11-30,2021-11-30,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,32
NCT02873377,0,0,0,0,0,0,2018-10-11,2019-10-11,,University of Miami,Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,476
NCT02874794,0,0,0,0,0,0,2018-12-13,2019-12-13,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02876835,0,0,0,0,0,0,2020-08-17,2021-08-17,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3276
NCT02885324,0,0,0,0,0,0,2021-07-31,2022-07-31,,Indiana University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT02886728,0,0,0,0,0,0,2018-10-05,2019-10-05,,Gilead Sciences,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02889900,0,0,0,0,0,0,2019-08-30,2020-08-30,,AstraZeneca,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,2450
NCT02890992,1,1,0,1,0,0,2018-09-13,2019-09-13,2019-08-15,Sanofi,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02893293,0,0,0,0,0,0,2019-11-30,2020-11-30,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,1309
NCT02893553,0,0,0,0,0,0,2019-12-31,2020-12-31,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,41
NCT02896101,1,0,0,0,1,0,2017-06-30,2018-06-30,,Glenmark Pharmaceuticals Ltd. India,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT02898181,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Oklahoma,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,234
NCT02899962,0,0,0,0,0,0,2019-06-26,2020-06-26,,LEO Pharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,171
NCT02901626,0,0,0,0,0,0,2023-07-31,2024-07-31,,The George Washington University Biostatistics Center,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT02907177,0,0,0,0,0,0,2024-03-31,2025-03-31,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT02909439,1,0,0,0,1,0,2017-11-09,2018-11-09,,Stony Brook University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,119
NCT02910037,1,0,1,1,0,1,2017-07-31,2018-07-31,2019-06-21,"University of California, San Francisco",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1443
NCT02910414,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Ablative Solutions, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,4
NCT02910583,0,0,0,0,0,0,2020-12-31,2021-12-31,,Pharmacyclics LLC.,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,54
NCT02911285,0,0,0,0,0,0,2019-10-31,2020-10-31,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02912468,1,1,0,1,0,0,2018-07-05,2019-07-05,2019-07-03,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02915744,0,0,0,0,0,0,2020-07-31,2021-07-31,,Nektar Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,20
NCT02916433,1,0,0,0,1,0,2017-09-30,2018-09-30,,Danbury Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02917460,0,0,0,0,0,0,2050-12-31,2051-12-31,,Rady Pediatric Genomics & Systems Medicine Institute,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,0,0,1,0,0,1,3
NCT02918136,1,0,0,0,1,0,2018-07-31,2019-07-31,,"InGeneron, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,5
NCT02918370,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02918851,0,0,0,0,0,0,2019-08-09,2020-08-09,,Stony Brook University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,119
NCT02918968,0,0,0,0,0,0,2020-03-31,2021-03-31,,Astellas Pharma Inc,Industry,1,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,506
NCT02919761,0,0,0,0,0,0,2019-02-28,2020-02-28,,Mallinckrodt,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,91
NCT02920710,0,0,0,0,0,0,2020-07-31,2021-07-31,,The Cleveland Clinic,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT02921971,0,0,0,0,0,0,2019-01-14,2020-01-14,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02922582,1,0,0,0,1,0,2017-11-16,2018-11-16,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,53
NCT02923570,0,0,0,0,0,0,2021-10-31,2022-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,1432
NCT02927262,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,135
NCT02927847,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Maggie M Sweitzer, PhD",Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02927925,0,0,0,0,0,0,2020-01-02,2021-01-02,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,558
NCT02928055,0,0,0,0,0,0,2019-08-31,2020-08-31,,MetroHealth Medical Center,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,65
NCT02928640,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Precision Biopsy, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02930018,0,0,0,0,0,0,2019-12-31,2020-12-31,,NoNO Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT02930889,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,749
NCT02932410,0,0,0,0,0,0,2022-07-14,2023-07-14,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT02933606,1,0,0,0,1,0,2018-07-05,2019-07-05,,Bionomics Limited,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,3
NCT02935205,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, Davis",Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,530
NCT02939651,1,0,0,0,1,0,2018-09-02,2019-09-02,,Fox Chase Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,156
NCT02939989,0,0,0,0,0,0,2020-06-28,2021-06-28,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02940886,0,0,0,0,0,0,2018-03-31,2019-03-31,,Pharmacosmos A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,30
NCT02942368,0,0,0,0,0,0,2021-06-30,2022-06-30,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT02943473,0,0,0,0,0,0,2023-12-31,2024-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT02943590,0,0,0,0,0,0,2021-06-30,2022-06-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02943785,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Daiichi Sankyo, Inc.",Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT02945501,0,0,0,0,0,0,2019-06-30,2020-06-30,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,136
NCT02947048,1,0,0,0,1,0,2017-12-31,2018-12-31,,F Peter Halas,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02950987,0,0,0,0,0,0,2019-09-30,2020-09-30,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,647
NCT02951988,0,0,0,0,0,0,2019-02-22,2020-02-22,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02953418,0,0,0,0,0,0,2019-09-30,2020-09-30,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,146
NCT02953509,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Forty Seven, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02954198,0,0,0,0,0,0,2018-12-27,2019-12-27,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT02955069,0,0,0,0,0,0,2018-08-10,2019-08-10,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT02955784,1,0,0,0,1,0,2017-12-31,2018-12-31,,Madigan Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,13
NCT02957097,0,0,0,0,0,0,2021-06-30,2022-06-30,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02958969,1,0,0,0,1,0,2018-06-30,2019-06-30,,Gregory Piazza,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02959918,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Selecta Biosciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02960217,0,0,0,0,0,0,2019-12-31,2020-12-31,,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT02960997,0,0,0,0,0,0,2019-12-14,2020-12-14,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02963493,0,0,0,0,0,0,2020-03-31,2021-03-31,,Oncopeptides AB,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02964338,1,0,1,1,0,0,2018-07-17,2019-07-17,2019-07-16,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02965781,0,0,0,0,0,0,2018-11-30,2019-11-30,,"Squarex, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02969187,0,0,1,1,0,0,2018-10-31,2019-10-31,2019-07-09,The Cleveland Clinic,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,581
NCT02969382,0,0,0,0,0,0,2018-07-31,2019-07-31,,Sunovion,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,134
NCT02970552,0,0,0,0,0,0,2018-11-13,2019-11-13,,"University of North Carolina, Chapel Hill",Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,910
NCT02971033,0,0,0,0,0,0,2020-06-30,2021-06-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT02973477,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Michigan,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT02973594,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02973997,0,0,0,0,0,0,2021-10-08,2022-10-08,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,32
NCT02974621,0,0,0,0,0,0,2019-10-31,2020-10-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT02975336,0,0,0,0,0,0,2019-12-31,2020-12-31,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT02978222,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Marker Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT02978417,0,0,0,0,0,0,2019-06-30,2020-06-30,,Duke University,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT02979613,1,0,1,1,0,0,2018-09-10,2019-09-10,2019-08-30,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02981303,0,0,0,0,0,0,2019-04-30,2020-04-30,,Biothera,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,10
NCT02983773,0,0,0,0,0,0,2020-05-31,2021-05-31,,Brown University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,152
NCT02984683,0,0,0,0,0,0,2018-08-13,2019-08-13,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT02985879,0,0,0,0,0,0,2020-03-23,2021-03-23,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02994056,0,0,0,0,0,0,2018-09-25,2019-09-25,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,510
NCT02998229,0,0,0,0,0,0,2023-08-31,2024-08-31,,Medtronic Neurovascular Clinical Affairs,Industry,1,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,21
NCT02999633,0,0,0,0,0,0,2017-11-14,2018-11-14,,Sanofi,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03000530,0,0,0,0,0,0,2017-10-04,2018-10-04,,Sage Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT03001076,0,0,0,0,0,0,2018-01-11,2019-01-11,,Esperion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT03002389,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Virginia,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT03002571,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03004248,0,0,0,0,0,0,2018-10-17,2019-10-17,,"Revance Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,26
NCT03004638,1,1,0,1,0,0,2017-11-02,2018-11-02,2018-10-31,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,269
NCT03009396,1,0,0,0,1,0,2018-06-19,2019-06-19,,RedHill Biopharma Limited,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,12
NCT03011307,0,0,0,0,0,0,2020-01-31,2021-01-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT03011450,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Kowa Research Institute, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,33
NCT03015961,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,53
NCT03016819,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Advenchen Laboratories, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03017846,1,1,0,1,0,0,2017-09-06,2018-09-06,2018-09-06,Steven R Cohen,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03018587,1,0,0,0,1,0,2017-12-31,2018-12-31,,Cutera Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03019575,0,0,0,0,0,0,2020-04-29,2021-04-29,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2145
NCT03019939,0,0,0,0,0,0,2020-03-01,2021-03-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03020589,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03020823,0,0,0,0,0,0,2018-11-20,2019-11-20,,"SynCore Biotechnology Co., Ltd.",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,6
NCT03023046,0,0,0,0,0,0,2019-12-01,2020-12-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,910
NCT03028870,1,1,0,1,0,0,2017-11-10,2018-11-10,2018-10-17,Purdue Pharma LP,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,54
NCT03030313,1,0,0,0,1,0,2017-07-26,2018-07-26,,ResMed,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,60
NCT03031847,0,0,0,0,0,0,2020-02-29,2021-02-28,,Samir Saba,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03032523,1,1,0,1,0,0,2018-04-01,2019-04-01,2019-03-22,Stanford University,Other,0,0,0,5.0,,0,2016.0,1,0,0,0,1,0,0,0,0,0,1,1309
NCT03033615,1,0,0,0,1,0,2017-10-31,2018-10-31,,"AlgoMedica, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,1
NCT03035708,1,0,1,1,0,1,2018-07-01,2019-07-01,2019-08-30,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,96
NCT03036072,1,0,0,0,1,0,2018-04-30,2019-04-30,,Maine Medical Center,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,25
NCT03036579,0,0,0,0,0,0,2021-10-31,2022-10-31,,University of Michigan,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT03036839,0,0,0,0,0,0,2018-11-22,2019-11-22,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,510
NCT03038100,0,0,0,0,0,0,2020-04-01,2021-04-01,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03040414,0,0,0,0,0,0,2020-04-30,2021-04-30,,HealthPartners Institute,Other,0,1,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,101
NCT03040726,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,1,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03040986,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03043430,0,0,0,0,0,0,2022-06-30,2023-06-30,,Brooke Army Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,71
NCT03043599,0,0,0,0,0,0,2021-04-30,2022-04-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,344
NCT03045211,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Michigan,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT03046446,1,0,1,1,0,0,2018-07-19,2019-07-19,2019-07-17,"Flexion Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03047135,0,0,0,0,0,0,2021-03-01,2022-03-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03047395,0,0,0,0,0,0,2022-01-27,2023-01-27,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,430
NCT03049748,0,0,0,0,0,0,2019-05-30,2020-05-30,,University of Michigan,Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,934
NCT03052127,0,0,0,0,0,0,2021-07-31,2022-07-31,,Aura Biosciences,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03052400,0,0,0,0,0,0,2020-05-31,2021-05-31,,Charles Drew University of Medicine and Science,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,25
NCT03053050,0,0,0,0,0,0,2019-06-12,2020-06-12,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,510
NCT03054337,0,0,0,0,0,0,2017-07-05,2018-07-05,,Akebia Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,25
NCT03055390,1,0,0,0,1,0,2017-06-30,2018-06-30,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1190
NCT03055507,1,0,1,1,0,0,2018-08-30,2019-08-30,2018-02-21,University of Washington,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03055624,0,0,0,0,0,0,2019-02-18,2020-02-18,,"University of California, San Diego",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,561
NCT03055884,1,0,0,0,1,0,2018-02-28,2019-02-28,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,29
NCT03056248,1,0,0,0,1,0,2017-12-30,2018-12-30,,Lifespan,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,14
NCT03056443,0,0,0,0,0,0,2019-12-31,2020-12-31,,West Virginia University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,74
NCT03056755,0,0,0,0,0,0,2020-11-30,2021-11-30,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03057600,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Calithera Biosciences, Inc",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03057847,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Elizabeth Krans, MD",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03058614,0,0,0,0,0,0,2022-01-01,2023-01-01,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2020.0,0,1,0,0,1,0,0,0,3,1,0,1443
NCT03059030,0,0,0,0,0,0,2020-04-01,2021-04-01,,Northwestern University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,925
NCT03061461,1,0,0,0,1,0,2017-12-15,2018-12-15,,Kuala Lumpur General Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,4
NCT03062462,0,0,0,0,0,0,2019-07-31,2020-07-31,,First Affiliated Hospital of Harbin Medical University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03062813,0,0,0,0,0,0,2020-02-01,2021-02-01,,Guangdong General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,70
NCT03063164,0,0,0,0,0,0,2019-12-31,2020-12-31,,Edward E. Manche,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03066466,0,0,0,0,0,0,2020-02-28,2021-02-28,,Loyola University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03067129,0,0,0,0,0,0,2019-12-23,2020-12-23,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03073694,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Kansas Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03076216,0,0,0,0,0,0,2021-01-31,2022-01-31,,OncoSil Medical Limited,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03077685,0,0,0,0,0,0,2019-12-31,2020-12-31,,"NanOlogy, LLC",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03078127,1,1,0,1,0,0,2018-01-10,2019-01-10,2019-01-09,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03079050,1,0,0,0,1,0,2017-07-30,2018-07-30,,American University of Beirut Medical Center,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,94
NCT03080116,0,0,0,0,0,0,2021-12-30,2022-12-30,,Universitaire Ziekenhuizen Leuven,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,525
NCT03081481,0,0,0,0,0,0,2018-11-28,2019-11-28,,Sophiris Bio Corp,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,8
NCT03082118,0,0,0,0,0,0,2019-01-15,2020-01-15,,"Solace Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03082755,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Texas at Austin,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,135
NCT03087851,0,0,0,0,0,0,2020-09-01,2021-09-01,,Aarhus University Hospital,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,140
NCT03088033,0,0,0,0,0,0,2020-12-31,2021-12-31,,Corvia Medical,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,6
NCT03088826,0,0,0,0,0,0,2020-12-31,2021-12-31,,Antonios Likourezos,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03091348,1,0,1,1,0,1,2017-11-21,2018-11-21,2019-01-14,Men's Health Boston,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03092674,0,0,0,0,0,0,2023-08-01,2024-08-01,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03096483,1,1,0,1,0,0,2017-07-07,2018-07-07,2017-11-14,GE Healthcare,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,119
NCT03096691,1,0,0,0,1,0,2017-03-30,2018-03-30,,Zeynep Kamil Maternity and Pediatric Research and Training Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,23
NCT03097328,0,0,0,0,0,0,2020-08-25,2021-08-25,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03099005,0,0,0,0,0,0,2020-09-30,2021-09-30,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03103373,1,0,0,0,1,0,2017-12-01,2018-12-01,,Federal University of Juiz de Fora,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,22
NCT03106077,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03107247,0,0,0,0,0,0,2020-03-31,2021-03-31,,Boston Children’s Hospital,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03107871,0,0,0,0,0,0,2022-07-31,2023-07-31,,Albert Park,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03109158,0,0,0,0,0,0,2019-03-01,2020-03-01,,"NanoCarrier Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,6
NCT03110328,1,0,0,0,1,0,2018-08-31,2019-08-31,,Samsung Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,684
NCT03110575,1,0,0,0,1,0,2018-07-27,2019-07-27,,"Tonix Pharmaceuticals, Inc.",Industry,1,1,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT03111147,0,0,0,0,0,0,2020-03-31,2021-03-31,,William Beaumont Hospitals,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,84
NCT03111628,0,0,0,0,0,0,2020-05-01,2021-05-01,,Johns Hopkins University,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03113461,0,0,0,0,0,0,2022-07-01,2023-07-01,,University of Pennsylvania,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03116113,0,0,0,0,0,0,2020-08-31,2021-08-31,,NightstaRx Ltd,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,5
NCT03116698,1,1,0,1,0,1,2017-11-13,2018-11-13,2019-04-02,Dr. Reddy's Laboratories Limited,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,212
NCT03118986,0,0,0,0,0,0,2023-03-31,2024-03-31,,The Hospital for Sick Children,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,403
NCT03123328,0,0,1,1,0,1,2017-03-25,2018-03-25,2019-05-03,Masimo Corporation,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,39
NCT03124602,0,1,0,1,0,1,2017-05-11,2018-05-11,2018-12-06,Masimo Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03126370,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,882
NCT03126786,0,0,0,0,0,0,2018-04-17,2019-04-17,,"Clearside Biomedical, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03127514,0,0,0,0,0,0,2019-10-31,2020-10-31,,Amylyx Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03127956,1,1,0,1,0,0,2018-04-27,2019-04-27,2018-12-20,"Dermira, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,17
NCT03131479,1,1,0,1,0,0,2018-01-16,2019-01-16,2019-01-11,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03132675,0,0,0,0,0,0,2020-10-31,2021-10-31,,OncoSec Medical Incorporated,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,1,0,0,0,0,1,1,0,7
NCT03136185,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Imago BioSciences,Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03136965,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,715
NCT03137069,0,0,0,0,0,0,2019-12-21,2020-12-21,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03138577,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,586
NCT03138733,0,0,0,0,0,0,2021-08-31,2022-08-31,,Basilea Pharmaceutica,Industry,1,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,32
NCT03139279,1,1,0,1,0,0,2018-05-04,2019-05-04,2019-04-12,State University of New York - Downstate Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT03142334,0,0,0,0,0,0,2022-11-12,2023-11-12,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03144089,0,0,0,0,0,0,2019-02-25,2020-02-25,,Ron Abrons,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03144232,0,0,0,0,0,0,2021-04-01,2022-04-01,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,511
NCT03148795,0,0,0,0,0,0,2020-09-29,2021-09-29,,Pfizer,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03150420,0,0,0,0,0,0,2021-05-24,2022-05-24,,Hope Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03150810,0,0,0,0,0,0,2020-07-01,2021-07-01,,"BeiGene USA, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03151811,0,0,0,0,0,0,2019-12-31,2020-12-31,,Oncopeptides AB,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03152526,1,1,0,1,0,0,2018-03-21,2019-03-21,2019-03-21,Miltenyi Biotec GmbH,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03158805,0,0,0,0,0,0,2020-05-01,2021-05-01,,Lindner Center of HOPE,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03160027,1,1,0,1,0,1,2018-03-29,2019-03-29,2019-04-03,"University of California, San Francisco",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1443
NCT03163017,1,1,0,1,0,0,2018-09-11,2019-09-11,2019-08-22,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03166735,0,0,0,0,0,0,2019-06-14,2020-06-14,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1852
NCT03168581,0,0,0,0,0,0,2019-06-30,2020-06-30,,AegisCN LLC,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03169374,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,749
NCT03169842,0,0,0,0,0,0,2020-05-31,2021-05-31,,Ochsner Health System,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,37
NCT03170882,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03172780,0,0,0,0,0,0,2017-12-05,2018-12-05,,Mylan Inc.,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,30
NCT03173534,0,0,0,0,0,0,2020-12-31,2021-12-31,,Samir Kapadia,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03174184,0,0,0,0,0,0,2021-07-31,2022-07-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1143
NCT03175172,1,1,0,1,0,1,2018-01-09,2019-01-09,2019-01-26,"Aduro Biotech, Inc.",Industry,1,1,0,1.0,Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,12
NCT03176316,0,0,0,0,0,0,2020-03-31,2021-03-31,,Loyola University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03181009,1,0,1,1,0,0,2018-07-01,2019-07-01,2019-04-01,Kari Christine Nadeau,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03182686,0,0,0,0,0,0,2017-12-05,2018-12-05,,Ampio Pharmaceuticals. Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,10
NCT03182907,0,0,0,0,0,0,2022-05-09,2023-05-09,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03183908,0,0,0,0,0,0,2019-02-14,2020-02-14,,Duke University,Other,0,0,1,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,1342
NCT03184454,0,0,0,0,0,0,2021-10-31,2022-10-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1699
NCT03186443,1,0,0,0,1,0,2017-10-01,2018-10-01,,Second Affiliated Hospital of Guangzhou Medical University,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,17
NCT03187002,0,0,0,0,0,0,2019-10-31,2020-10-31,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1309
NCT03187093,0,0,0,0,0,0,2019-04-30,2020-04-30,,Oleg Levada,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,1
NCT03187301,0,0,0,0,0,0,2017-12-21,2018-12-21,,Sunovion,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,134
NCT03190174,0,0,0,0,0,0,2020-02-01,2021-02-01,,"Sarcoma Oncology Research Center, LLC",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,4
NCT03190967,0,0,0,0,0,0,2022-06-30,2023-06-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03192020,0,0,0,0,0,0,2020-12-31,2021-12-31,,Tampere University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,44
NCT03192202,0,0,0,0,0,0,2020-08-31,2021-08-31,,Ahmed Sawas,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03194217,0,0,0,0,0,0,2019-05-28,2020-05-28,,BenevolentAI Bio,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03194906,0,0,0,0,0,0,2021-01-31,2022-01-31,,St. Jude Children's Research Hospital,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,302
NCT03196349,0,1,0,1,0,0,2019-05-01,2020-05-01,2019-07-26,Duke University,Other,0,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03197506,0,0,0,0,0,0,2022-07-31,2023-07-31,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,1898
NCT03202316,0,0,0,0,0,0,2020-08-11,2021-08-11,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03204942,1,0,0,0,1,0,2018-07-30,2019-07-30,,"National Cancer Institute, Egypt",Other,0,0,0,5.0,,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,19
NCT03206086,0,0,0,0,0,0,2020-01-01,2021-01-01,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1091
NCT03209882,0,0,0,0,0,0,2019-12-31,2020-12-31,,The University of Texas at Arlington,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03213002,0,0,0,0,0,0,2021-06-30,2022-06-30,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,271
NCT03213457,0,0,0,0,0,0,2019-10-14,2020-10-14,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03215771,0,0,0,0,0,0,2020-09-30,2021-09-30,,Northwestern University,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,925
NCT03217084,0,0,0,0,0,0,2018-09-30,2019-09-30,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1190
NCT03219372,0,0,0,0,0,0,2021-06-01,2022-06-01,,Cedars-Sinai Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03220217,0,0,0,0,0,0,2019-09-30,2020-09-30,,Ipsen,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,214
NCT03220438,0,0,0,0,0,0,2019-12-25,2020-12-25,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,318
NCT03221764,0,0,0,0,0,0,2019-02-01,2020-02-01,,University of Louisville,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,214
NCT03222401,1,0,0,0,1,0,2018-03-02,2019-03-02,,"Alopexx Pharmaceuticals, LLC",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03223779,0,0,0,0,0,0,2021-01-31,2022-01-31,,Massachusetts General Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1699
NCT03224598,0,0,0,0,0,0,2019-01-08,2020-01-08,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03229499,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Pennsylvania,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03229759,0,0,0,0,0,0,2017-08-04,2018-08-04,,"Becton, Dickinson and Company",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,26
NCT03230292,0,0,0,0,0,0,2019-03-05,2020-03-05,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,75
NCT03232346,0,0,0,0,0,0,2019-08-01,2020-08-01,,New York State Psychiatric Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03232931,0,0,0,0,0,0,2022-12-31,2023-12-31,,Nationwide Children's Hospital,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,161
NCT03233217,0,0,0,0,0,0,2017-11-28,2018-11-28,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,285
NCT03233724,0,0,0,0,0,0,2025-12-31,2026-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03238079,0,0,0,0,0,0,2020-02-05,2021-02-05,,Therapure Biopharma Inc,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2
NCT03238248,0,0,0,0,0,0,2022-07-31,2023-07-31,,Vanderbilt-Ingram Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03238690,0,0,0,0,0,0,2021-06-30,2022-06-30,,STAVROS G DRAKOS,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03240575,0,0,0,0,0,0,2019-04-08,2020-04-08,,Boehringer Ingelheim,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1852
NCT03241186,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Robert R. McWilliams, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03241485,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Chicago,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03241810,0,0,0,0,0,0,2019-04-30,2020-04-30,,Merrimack Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,27
NCT03242915,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03243149,0,0,0,0,0,0,2021-01-31,2022-01-31,,Duke University,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03243955,0,0,0,0,0,0,2019-07-01,2020-07-01,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT03246685,1,0,0,0,1,0,2018-04-13,2019-04-13,,Biothera,Industry,1,1,0,1.0,Phase 2,1,2017.0,1,1,1,0,0,0,0,0,0,1,0,10
NCT03248492,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Daiichi Sankyo, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT03249272,0,0,0,0,0,0,2019-09-21,2020-09-21,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03249909,0,0,0,0,0,0,2019-12-01,2020-12-01,,Molnlycke Health Care AB,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,37
NCT03250117,0,0,0,0,0,0,2020-07-31,2021-07-31,,Titan Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03251911,0,0,0,0,0,0,2021-01-01,2022-01-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03253458,0,0,0,0,0,0,2019-12-31,2020-12-31,,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,229
NCT03255590,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03258476,0,0,0,0,0,0,2020-05-31,2021-05-31,,Daniel Connor,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03259074,0,0,0,0,0,0,2021-09-02,2022-09-02,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03260426,1,0,0,0,1,0,2018-07-31,2019-07-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,279
NCT03260569,0,0,0,0,0,0,2019-10-01,2020-10-01,,University of Cincinnati,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,222
NCT03260868,0,0,0,0,0,0,2018-11-22,2019-11-22,,Sanofi,Industry,1,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03261973,0,0,0,0,0,0,2020-08-30,2021-08-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03264248,1,1,0,1,0,1,2018-02-05,2019-02-05,2019-03-03,Jonathan Pearlman,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03266107,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Relievant Medsystems, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03266393,0,0,0,0,0,0,2022-01-15,2023-01-15,,"Meghan Pearl, MD",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03267186,0,0,0,0,0,0,2019-09-30,2020-09-30,,Andrew Rezvani,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03268395,1,0,0,0,1,0,2018-08-29,2019-08-29,,Memorial Health University Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,0,1,0,0,0,0,1,0,6
NCT03270059,0,0,0,0,0,0,2022-08-15,2023-08-15,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT03270514,0,0,0,0,0,0,2019-11-30,2020-11-30,,Kathirvel Subramaniam,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03270956,0,0,0,0,0,0,2021-05-31,2022-05-31,,inRegen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03273712,0,0,0,0,0,0,2020-01-31,2021-01-31,,Sue O'Dorisio,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,1,1,0,0,0,1,0,8
NCT03274076,0,0,0,0,0,0,2019-04-08,2020-04-08,,University of Michigan,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03275337,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Laureate Institute for Brain Research, Inc.",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,30
NCT03276065,0,0,0,0,0,0,2019-12-31,2020-12-31,,Nationwide Children's Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,161
NCT03279458,1,1,0,1,0,0,2017-09-08,2018-09-08,2017-10-24,University of Mississippi Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,88
NCT03281369,0,0,0,0,0,0,2021-11-13,2022-11-13,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1731
NCT03282396,0,0,0,0,0,0,2022-02-28,2023-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03283878,0,0,0,0,0,0,2020-10-31,2021-10-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03285321,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Greg Durm, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03285594,0,0,0,0,0,0,2019-08-24,2020-08-24,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03287089,0,0,0,0,0,0,2019-05-30,2020-05-30,,Atrium Health,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,95
NCT03287271,0,0,0,0,0,0,2023-09-30,2024-09-30,,Michael McHale,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03287765,0,0,0,0,0,0,2021-05-31,2022-05-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT03292653,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03294538,1,0,0,0,1,0,2017-02-15,2018-02-15,,Actavis Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT03294850,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Translational Research Institute for Metabolism and Diabetes, Florida",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,31
NCT03295019,0,0,0,0,0,0,2019-06-30,2020-06-30,,You First Services,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03296072,1,1,0,1,0,0,2018-01-16,2019-01-16,2019-01-03,GlaxoSmithKline,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3276
NCT03298867,0,0,0,0,0,0,2019-02-13,2020-02-13,,"Horizon Pharma USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,19
NCT03299959,0,0,0,0,0,0,2023-01-01,2024-01-01,,Cartiheal (2009) Ltd,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03300843,0,0,0,0,0,0,2019-07-09,2020-07-09,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,3004
NCT03301805,0,0,0,0,0,0,2022-10-30,2023-10-30,,Rgene Corporation,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03302741,0,0,0,0,0,0,2019-09-01,2020-09-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,490
NCT03303196,0,0,0,0,0,0,2019-09-30,2020-09-30,,Children's Hospital of Philadelphia,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,324
NCT03303989,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03304106,0,0,0,0,0,0,2019-09-30,2020-09-30,,Cochlear,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,35
NCT03304717,0,0,0,0,0,0,2020-11-30,2021-11-30,,Children's Hospital of Philadelphia,Other,0,1,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03305159,1,1,0,1,0,1,2018-04-01,2019-04-01,2019-04-11,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,925
NCT03308968,0,0,0,0,0,0,2018-10-02,2019-10-02,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,101
NCT03311672,0,0,0,0,0,0,2019-12-01,2020-12-01,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1443
NCT03312114,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03312751,0,0,0,0,0,0,2021-10-31,2022-10-31,,NovImmune SA,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03316950,0,0,0,0,0,0,2019-12-30,2020-12-30,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03317392,0,0,0,0,0,0,2020-04-30,2021-04-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,3004
NCT03319849,0,0,0,0,0,0,2021-03-31,2022-03-31,,Neurotech Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,1,1,0,10
NCT03320174,0,0,0,0,0,0,2020-10-31,2021-10-31,,60 Degrees Pharmaceuticals LLC,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03322995,0,0,0,0,0,0,2022-08-01,2023-08-01,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,315
NCT03323398,0,0,0,0,0,0,2021-09-30,2022-09-30,,"ModernaTX, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,14
NCT03323723,1,1,0,1,0,0,2018-05-01,2019-05-01,2019-03-25,"Rinovum Women's Health, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03324308,0,0,0,0,0,0,2019-10-01,2020-10-01,,Johns Hopkins University,Other,0,1,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1143
NCT03324802,0,0,0,0,0,0,2022-11-30,2023-11-30,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,1898
NCT03325556,0,0,0,0,0,0,2020-07-31,2021-07-31,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,24
NCT03326583,0,0,0,0,0,0,2019-04-30,2020-04-30,,Dominic Raj,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03327051,0,0,0,0,0,0,2018-11-30,2019-11-30,,Berkeley Limketkai,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,1
NCT03327831,1,0,1,1,0,1,2017-02-28,2018-02-28,2018-10-30,"University of California, Irvine",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,310
NCT03334396,0,0,0,0,0,0,2019-01-04,2020-01-04,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1512
NCT03335059,0,0,0,0,0,0,2022-07-31,2023-07-31,,Medical Enterprises Ltd.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,1
NCT03336866,0,0,0,0,0,0,2020-12-31,2021-12-31,,"InterveXion Therapeutics, LLC",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03337542,0,0,0,0,0,0,2019-02-07,2020-02-07,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,11
NCT03338023,0,0,0,0,0,0,2020-03-13,2021-03-13,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03338790,0,0,0,0,0,0,2020-02-18,2021-02-18,,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03340506,0,0,0,0,0,0,2023-07-17,2024-07-17,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03341923,1,1,0,1,0,0,2018-06-05,2019-06-05,2019-03-26,Alcon Research,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,492
NCT03342937,0,0,0,0,0,0,2022-12-31,2023-12-31,,Duke University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03346772,0,0,0,0,0,0,2020-07-01,2021-07-01,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1052
NCT03346902,1,1,0,1,0,0,2018-07-31,2019-07-31,2018-10-17,"Bonti, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03347617,0,0,0,0,0,0,2019-11-01,2020-11-01,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,163
NCT03348618,0,0,0,0,0,0,2019-11-30,2020-11-30,,IMMUNOe Research Centers,Industry,1,1,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03350919,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Rochester,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,470
NCT03351335,1,1,0,1,0,0,2018-08-09,2019-08-09,2019-08-02,"Merz North America, Inc.",Industry,1,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,35
NCT03353350,0,0,0,0,0,0,2020-08-31,2021-08-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03355469,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Virginia,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT03358030,0,0,0,0,0,0,2019-07-10,2020-07-10,,"Ionis Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,69
NCT03359096,0,0,0,0,0,0,2020-06-30,2021-06-30,,Emory University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT03359356,0,0,0,0,0,0,2023-06-04,2024-06-04,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03360214,0,0,0,0,0,0,2019-12-31,2020-12-31,,Columbia University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,675
NCT03361176,0,1,0,1,0,0,2018-10-12,2019-10-12,2019-03-21,"Goldman, Butterwick, Fitzpatrick and Groff",Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,1,0,0,1,0,12
NCT03361605,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03361995,0,0,0,0,0,0,2020-03-31,2021-03-31,,"ZOLL Circulation, Inc., USA",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,8
NCT03363295,0,0,0,0,0,0,2019-01-30,2020-01-30,,Universidade Federal de Pernambuco,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,128
NCT03365882,0,0,0,0,0,0,2021-04-01,2022-04-01,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,1,0,0,0,0,0,1,0,288
NCT03370133,0,0,0,0,0,0,2019-01-08,2020-01-08,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03374709,0,0,0,0,0,0,2019-11-01,2020-11-01,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,882
NCT03375047,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Translate Bio, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03376256,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Miami,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03376789,0,0,0,0,0,0,2018-10-31,2019-10-31,,Mylan Inc.,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,30
NCT03377023,0,0,0,0,0,0,2020-02-29,2021-02-28,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03377387,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03378635,0,0,0,0,0,0,2018-04-27,2019-04-27,,Zealand Pharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,21
NCT03380429,0,0,0,0,0,0,2019-01-24,2020-01-24,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,1,0,0,0,0,1,1,0,3276
NCT03381261,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03381989,0,0,0,0,0,0,2018-09-30,2019-09-30,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1091
NCT03383588,1,0,0,0,1,0,2018-08-17,2019-08-17,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03383887,0,0,0,0,0,0,2019-10-01,2020-10-01,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03384563,0,0,0,0,0,0,2021-12-31,2022-12-31,,Baylor College of Medicine,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,518
NCT03384693,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03384875,0,0,0,0,0,0,2020-08-31,2021-08-31,,"CytoSorbents, Inc",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03386032,1,0,0,0,1,0,2018-08-18,2019-08-18,,Procter and Gamble,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,59
NCT03386240,0,0,0,0,0,0,2021-01-31,2022-01-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,158
NCT03389750,0,0,0,0,0,0,2020-02-29,2021-02-28,,New York State Psychiatric Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03390738,0,0,0,0,0,0,2019-05-31,2020-05-31,,The University of Hong Kong,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,547
NCT03390842,0,0,0,0,0,0,2019-02-22,2020-02-22,,"Tricida, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,4
NCT03396471,0,0,0,0,0,0,2020-01-01,2021-01-01,,Hoosier Cancer Research Network,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,27
NCT03397771,0,0,0,0,0,0,2019-05-30,2020-05-30,,Ixaltis SA,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03401229,0,0,0,0,0,0,2020-08-07,2021-08-07,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03401853,0,0,0,0,0,0,2021-02-15,2022-02-15,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,910
NCT03403426,0,0,0,0,0,0,2019-05-31,2020-05-31,,"ReFlow Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03405818,1,1,0,1,0,0,2017-07-27,2018-07-27,2018-01-25,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2856
NCT03409588,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of Colorado, Denver",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03410030,0,0,0,0,0,0,2019-12-15,2020-12-15,,HonorHealth Research Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03410927,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Taiho Oncology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,37
NCT03411876,0,0,0,0,0,0,2019-01-31,2020-01-31,,Klaus Kenn,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03412747,0,0,0,0,0,0,2019-02-07,2020-02-07,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03415685,0,0,0,0,0,0,2019-11-01,2020-11-01,,LUTRONIC Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03417154,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,218
NCT03418532,0,0,0,0,0,0,2021-04-30,2022-04-30,,Molecular Partners AG,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,5
NCT03421561,1,0,0,0,1,0,2017-10-31,2018-10-31,,Spectranetics Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,18
NCT03424018,0,0,0,0,0,0,2024-10-31,2025-10-31,,BioMarin Pharmaceutical,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,85
NCT03427060,0,0,0,0,0,0,2019-12-31,2020-12-31,,AKARI Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03428217,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Calithera Biosciences, Inc",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03430037,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03430206,0,0,0,0,0,0,2019-09-30,2020-09-30,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03430843,0,0,0,0,0,0,2020-09-30,2021-09-30,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03433469,0,0,0,0,0,0,2021-05-31,2022-05-31,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03435055,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03436433,0,0,0,0,0,0,2021-01-31,2022-01-31,,Duke University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03437044,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03439254,0,0,0,0,0,0,2021-06-30,2022-06-30,,Intercept Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03442569,0,0,0,0,0,0,2020-12-14,2021-12-14,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03442985,0,0,0,0,0,0,2021-01-31,2022-01-31,,Clementia Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03445533,0,0,0,0,0,0,2021-06-22,2022-06-22,,"Idera Pharmaceuticals, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,13
NCT03448068,0,0,0,0,0,0,2021-02-28,2022-02-28,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03449199,0,0,0,0,0,0,2019-05-07,2020-05-07,,"Teijin America, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03452176,0,0,0,0,0,0,2019-08-29,2020-08-29,,Johns Hopkins University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1143
NCT03454334,0,0,0,0,0,0,2018-10-18,2019-10-18,,Shahid Beheshti University,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,3,0,1,24
NCT03455075,0,0,0,0,0,0,2020-03-31,2021-03-31,,Health Decisions,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03456843,0,0,0,0,0,0,2022-09-01,2023-09-01,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,227
NCT03457493,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Alabama at Birmingham,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03461705,1,0,1,1,0,0,2018-08-02,2019-08-02,2019-06-26,Columbia University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,675
NCT03462342,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Pennsylvania,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03462927,1,0,0,0,1,0,2018-08-04,2019-08-04,,MC2 Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03464019,0,0,0,0,0,0,2020-07-31,2021-07-31,,Milestone Pharmaceuticals Inc.,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,1,1,0,5
NCT03466086,1,1,0,1,0,0,2018-05-16,2019-05-16,2019-05-09,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,138
NCT03466294,0,0,0,0,0,0,2021-06-30,2022-06-30,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03467932,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Oramed, Ltd.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03468985,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03472586,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,162
NCT03473405,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Nimbic Systems, LLC",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,3,1,0,7
NCT03474432,0,0,0,0,0,0,2019-12-31,2020-12-31,,Jesse Brown VA Medical Center,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03474874,1,1,0,1,0,1,2018-04-06,2019-04-06,2019-04-19,"NeXtGen Biologics, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03475875,1,1,0,1,0,0,2018-04-18,2019-04-18,2019-04-03,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03478683,0,0,0,0,0,0,2019-03-14,2020-03-14,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,1,0,0,0,0,1,1,0,3276
NCT03479827,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Rochester,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,470
NCT03480685,1,0,0,0,1,0,2018-08-01,2019-08-01,,"Avinger, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03481023,1,0,0,0,1,0,2018-08-20,2019-08-20,,Riverside Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03482882,0,0,0,0,0,0,2019-07-10,2020-07-10,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03485053,0,0,0,0,0,0,2020-06-30,2021-06-30,,MegaPro Biomedical Co. Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03485729,0,0,0,0,0,0,2020-03-21,2021-03-21,,"Oncoceutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03486626,0,0,0,0,0,0,2018-09-30,2019-09-30,,Ain Shams Maternity Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,93
NCT03486834,0,0,0,0,0,0,2021-05-14,2022-05-14,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03489018,0,0,0,0,0,0,2020-09-30,2021-09-30,,London School of Hygiene and Tropical Medicine,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,233
NCT03490396,0,0,0,0,0,0,2019-02-15,2020-02-15,,Midatech Pharma US Inc.,Industry,1,1,0,4.0,Phase 4,0,2018.0,1,0,0,1,0,0,1,0,0,1,0,1
NCT03494348,0,0,0,0,0,0,2020-10-31,2021-10-31,,Region Skane,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,163
NCT03496012,0,0,0,0,0,0,2020-03-31,2021-03-31,,NightstaRx Ltd,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,0,0,0,0,1,1,1,0,5
NCT03496389,0,0,0,0,0,0,2019-07-01,2020-07-01,,"Hospital Authority, Hong Kong",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,64
NCT03496545,0,0,0,0,0,0,2020-07-01,2021-07-01,,"University of California, San Francisco",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03499483,0,0,0,0,0,0,2021-05-30,2022-05-30,,Fenway Community Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03501979,0,0,0,0,0,0,2022-09-30,2023-09-30,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03502187,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Tennessee,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,99
NCT03502863,1,0,0,0,1,0,2018-07-06,2019-07-06,,Opternative,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03503318,0,0,0,0,0,0,2020-01-27,2021-01-27,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,101
NCT03504865,0,0,0,0,0,0,2020-12-31,2021-12-31,,Georgetown University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03505320,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT03505957,1,0,0,0,1,0,2018-09-07,2019-09-07,,Lineus Medical,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03506425,0,0,0,0,0,0,2019-03-28,2020-03-28,,"Richard Bedlack, M.D., Ph.D.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03508830,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of California, San Francisco",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03509857,0,0,0,0,0,0,2019-11-30,2020-11-30,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,240
NCT03510910,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03511521,0,0,0,0,0,0,2019-08-15,2020-08-15,,Northwestern University,Other,0,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,925
NCT03512275,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-05-02,"XBiotech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03514108,0,0,0,0,0,0,2023-03-01,2024-03-01,,Henrik Wiggers,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03515837,0,0,0,0,0,0,2023-06-15,2024-06-15,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03518801,0,0,0,0,0,0,2023-09-30,2024-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03519997,0,0,0,0,0,0,2020-04-01,2021-04-01,,University of Texas Southwestern Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03521076,0,0,0,0,0,0,2020-07-31,2021-07-31,,Gillette Children's Specialty Healthcare,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03521258,0,0,0,0,0,0,2019-02-28,2020-02-28,,Louisiana State University Health Sciences Center in New Orleans,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,42
NCT03521687,0,0,0,0,0,0,2019-10-15,2020-10-15,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03521973,0,0,0,0,0,0,2019-10-31,2020-10-31,,Sanaria Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,21
NCT03522753,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03523715,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Southern California,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,483
NCT03525574,0,0,0,0,0,0,2021-06-30,2022-06-30,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,141
NCT03528512,0,0,0,0,0,0,2020-06-15,2021-06-15,,William Beaumont Hospitals,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,84
NCT03529110,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Daiichi Sankyo, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT03532295,0,0,0,0,0,0,2022-05-31,2023-05-31,,Washington University School of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1151
NCT03533244,0,0,0,0,0,0,2019-09-30,2020-09-30,,Allgenesis Biotherapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03534934,0,0,0,0,0,0,2022-06-01,2023-06-01,,Punam Saha,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1
NCT03544268,0,0,0,0,0,0,2021-02-28,2022-02-28,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,229
NCT03546686,0,0,0,0,0,0,2021-05-31,2022-05-31,,Cedars-Sinai Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03548051,0,0,0,0,0,0,2021-09-06,2022-09-06,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03548207,0,0,0,0,0,0,2021-09-14,2022-09-14,,"Janssen Research & Development, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,558
NCT03548987,0,0,0,0,0,0,2020-02-03,2021-02-03,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03549507,0,0,0,0,0,0,2019-07-31,2020-07-31,,Children's Hospital of Philadelphia,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03551509,0,0,0,0,0,0,2020-06-30,2021-06-30,,The Cleveland Clinic,Other,0,1,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,581
NCT03554265,0,0,0,0,0,0,2021-07-01,2022-07-01,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,158
NCT03555149,0,0,0,0,0,0,2021-05-23,2022-05-23,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03556709,0,0,0,0,0,0,2028-12-31,2029-12-31,,Baltimore VA Medical Center,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,18
NCT03556904,0,0,0,0,0,0,2022-02-01,2023-02-01,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,213
NCT03558984,0,0,0,0,0,0,2021-09-30,2022-09-30,,PolyPid Ltd.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03559218,0,0,0,0,0,0,2018-11-06,2019-11-06,,"KeraNetics, LLC",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03560466,0,0,0,0,0,0,2026-12-31,2027-12-31,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03563222,0,0,0,0,0,0,2020-11-30,2021-11-30,,Fresenius Kabi,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,41
NCT03564353,0,0,0,0,0,0,2018-12-14,2019-12-14,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03564873,0,0,0,0,0,0,2025-06-30,2026-06-30,,"University of Colorado, Denver",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03566199,0,0,0,0,0,0,2019-09-01,2020-09-01,,"Sabine Mueller, MD, PhD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03570567,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Biomerics, LLC",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03573362,0,0,0,0,0,0,2020-06-30,2021-06-30,,Centre hospitalier de l'Université de Montréal (CHUM),Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,179
NCT03573518,0,0,0,0,0,0,2019-08-31,2020-08-31,,Botanix Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03574337,0,0,0,0,0,0,2018-12-30,2019-12-30,,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,151
NCT03575208,0,0,0,0,0,0,2021-08-31,2022-08-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,495
NCT03575871,0,0,0,0,0,0,2019-08-14,2020-08-14,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,2856
NCT03576547,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03579082,0,0,0,0,0,0,2019-06-01,2020-06-01,,Mingzhi Zhang,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,13
NCT03579316,0,0,0,0,0,0,2022-10-30,2023-10-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03580031,0,0,0,0,0,0,2019-12-01,2020-12-01,,Tanta University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,69
NCT03580707,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Rosenfeld, William E., M.D.",Other,0,1,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03581292,0,0,0,0,0,0,2024-10-29,2025-10-29,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,1,1,0,3004
NCT03583554,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Marijn Lijffijt, PhD",Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03585660,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Chicago,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,594
NCT03586466,0,0,0,0,0,0,2020-09-30,2021-09-30,,"MedicaSafe, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT03586609,0,0,0,0,0,0,2020-01-03,2021-01-03,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03588741,0,0,0,0,0,0,2019-06-19,2020-06-19,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,981
NCT03588975,0,0,0,0,0,0,2025-06-30,2026-06-30,,Vericel Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,13
NCT03589768,0,0,0,0,0,0,2020-01-24,2021-01-24,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2133
NCT03590743,0,0,0,0,0,0,2021-08-15,2022-08-15,,Mayo Clinic,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03591874,0,0,0,0,0,0,2020-07-31,2021-07-31,,Ocugen,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03595878,0,0,0,0,0,0,2021-05-31,2022-05-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,229
NCT03596450,0,0,0,0,0,0,2020-11-20,2021-11-20,,Novo Nordisk A/S,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,981
NCT03596866,0,0,0,0,0,0,2021-12-04,2022-12-04,,Ariad Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,16
NCT03600805,0,0,0,0,0,0,2023-05-31,2024-05-31,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03603652,0,0,0,0,0,0,2020-07-06,2021-07-06,,"Ethicon, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,59
NCT03604159,0,0,0,0,0,0,2020-08-31,2021-08-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,869
NCT03604406,0,0,0,0,0,0,2022-12-31,2023-12-31,,Kevin Winthrop,Other,0,1,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,3
NCT03604978,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,3004
NCT03605823,0,0,0,0,0,0,2019-11-01,2020-11-01,,Cairo University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,1190
NCT03610282,0,0,0,0,0,0,2020-11-30,2021-11-30,,Massachusetts General Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03614078,0,0,0,0,0,0,2019-04-29,2020-04-29,,PRCL Research Inc.,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,2
NCT03614260,0,0,0,0,0,0,2020-12-31,2021-12-31,,"ReCor Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03614975,0,0,0,0,0,0,2018-12-13,2019-12-13,,Richard Zimmerman,Other,0,0,1,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03615469,0,0,0,0,0,0,2019-12-31,2020-12-31,,Indiana University,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT03617913,0,0,0,0,0,0,2019-11-13,2020-11-13,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1898
NCT03620357,0,0,0,0,0,0,2019-12-15,2020-12-15,,"DexCom, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,21
NCT03620643,0,0,0,0,0,0,2020-12-04,2021-12-04,,Royal Marsden NHS Foundation Trust,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,184
NCT03620890,0,0,0,0,0,0,2020-09-01,2021-09-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03621553,0,0,0,0,0,0,2023-08-31,2024-08-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03623633,0,0,0,0,0,0,2021-09-01,2022-09-01,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03624127,0,0,0,0,0,0,2020-07-19,2021-07-19,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03625323,0,0,0,0,0,0,2020-06-30,2021-06-30,,Immutep S.A.,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03629080,0,0,0,0,0,0,2021-01-15,2022-01-15,,Hookipa Biotech,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2
NCT03630198,0,0,0,0,0,0,2019-09-30,2020-09-30,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03631472,0,0,0,0,0,0,2020-08-30,2021-08-30,,"Gala Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03632031,0,0,0,0,0,0,2019-11-04,2020-11-04,,Cook Biotech Incorporated,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03632967,0,0,0,0,0,0,2020-02-29,2021-02-28,,4Tech Cardio Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03633331,0,0,0,0,0,0,2019-09-30,2020-09-30,,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,456
NCT03637400,0,0,0,0,0,0,2022-04-01,2023-04-01,,Los Angeles Biomedical Research Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,60
NCT03638011,0,0,0,0,0,0,2021-08-01,2022-08-01,,Maimonides Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,46
NCT03645057,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Rochester,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03645967,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medline Industries,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,30
NCT03647267,0,0,0,0,0,0,2020-04-30,2021-04-30,,Jaeb Center for Health Research,Other,0,0,1,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,93
NCT03647839,0,0,0,0,0,0,2022-08-31,2023-08-31,,Australasian Gastro-Intestinal Trials Group,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT03648541,0,0,0,0,0,0,2031-03-30,2032-03-30,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03650361,0,0,0,0,0,0,2019-02-16,2020-02-16,,Aleor Dermaceuticals Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1
NCT03651076,0,0,0,0,0,0,2022-09-30,2023-09-30,,Beth Israel Deaconess Medical Center,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,377
NCT03651752,0,0,0,0,0,0,2020-09-01,2021-09-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03652428,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of Maryland, Baltimore",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,144
NCT03653052,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Simon C Pacey, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03654014,0,0,0,0,0,0,2019-08-17,2020-08-17,,University of New Mexico,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,200
NCT03655080,0,0,0,0,0,0,2021-02-28,2022-02-28,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1151
NCT03657797,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Nicox Ophthalmics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03660488,0,0,0,0,0,0,2020-10-31,2021-10-31,,"University of California, Los Angeles",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03661034,0,0,0,0,0,0,2019-11-01,2020-11-01,,"Cognito Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03661437,0,0,0,0,0,0,2019-08-13,2020-08-13,,City of Hope Medical Center,Other,0,0,1,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,358
NCT03661723,0,0,0,0,0,0,2020-08-31,2021-08-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,647
NCT03662997,0,0,0,0,0,0,2019-09-30,2020-09-30,,Molnlycke Health Care AB,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,37
NCT03664921,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Syntrix Biosystems, Inc.",Industry,1,0,1,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03665831,0,0,0,0,0,0,2020-01-31,2021-01-31,,Rotman Research Institute at Baycrest,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,6
NCT03666104,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Ceevra, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03666494,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Saskatchewan,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,166
NCT03668340,0,0,0,0,0,0,2021-06-01,2022-06-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03669315,0,0,0,0,0,0,2019-12-01,2020-12-01,,CNS Onlus,Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,3
NCT03670017,0,0,0,0,0,0,2019-09-30,2020-09-30,,Washington University School of Medicine,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03670134,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03672188,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Vir Biotechnology, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03675776,0,0,0,0,0,0,2019-07-11,2020-07-11,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,2,1,0,21
NCT03676764,0,0,0,0,0,0,2023-02-01,2024-02-01,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1443
NCT03677141,0,0,0,0,0,0,2022-06-22,2023-06-22,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03678883,0,0,0,0,0,0,2022-11-30,2023-11-30,,Actuate Therapeutics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03679845,0,0,0,0,0,0,2020-06-30,2021-06-30,,Massachusetts General Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1699
NCT03683225,0,0,0,0,0,0,2019-12-01,2020-12-01,,Chase Therapeutics Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,2
NCT03684018,0,0,0,0,0,0,2022-08-31,2023-08-31,,CSL Behring,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,81
NCT03684408,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Missouri-Columbia,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT03684590,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03685773,0,0,0,0,0,0,2021-12-31,2022-12-31,,Albert Einstein College of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,155
NCT03686709,0,0,0,0,0,0,2019-06-18,2020-06-18,,University of Tennessee,Other,0,1,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,99
NCT03687242,0,0,0,0,0,0,2019-08-19,2020-08-19,,Spruce Biosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03687476,0,0,0,0,0,0,2020-04-15,2021-04-15,,"Vtesse, Inc., a Mallinckrodt Pharmaceuticals Company",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT03688178,0,0,0,0,0,0,2025-03-01,2026-03-01,,Gary Archer Ph.D.,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,12
NCT03688685,0,0,0,0,0,0,2019-12-31,2020-12-31,,Cadent Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03690375,0,0,0,0,0,0,2018-10-15,2019-10-15,,Siperstein Dermatology,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03691649,0,0,0,0,0,0,2019-12-31,2020-12-31,,Santen Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03693404,0,0,0,0,0,0,2020-11-30,2021-11-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03694158,0,0,0,0,0,0,2023-10-31,2024-10-31,,Boston Children’s Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03696290,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Dundee,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,102
NCT03698331,0,0,0,0,0,0,2019-04-03,2020-04-03,,Neurocrine Biosciences,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,34
NCT03699293,0,0,0,0,0,0,2019-09-24,2020-09-24,,Inova Health Care Services,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,41
NCT03702608,0,0,0,0,0,0,2019-05-31,2020-05-31,,Medinol Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,0,0,0,1,0,3,1,0,11
NCT03703297,0,0,0,0,0,0,2023-12-28,2024-12-28,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03704662,0,0,0,0,0,0,2021-12-01,2022-12-01,,Medical College of Wisconsin,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,315
NCT03705988,0,0,0,0,0,0,2019-03-01,2020-03-01,,Xijing Hospital,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,178
NCT03707262,0,0,0,0,0,0,2023-02-28,2024-02-28,,"Jeffrey Veale, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT03707925,0,0,0,0,0,0,2020-10-31,2021-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,2066
NCT03710161,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Nebraska,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,327
NCT03710772,0,0,0,0,0,0,2021-04-22,2022-04-22,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03712228,0,0,0,0,0,0,2020-12-14,2021-12-14,,CSL Behring,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,81
NCT03713944,0,0,0,0,0,0,2020-11-30,2021-11-30,,Big Ten Cancer Research Consortium,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03715829,0,0,0,0,0,0,2020-12-14,2021-12-14,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,1,1,0,2856
NCT03720171,0,0,0,0,0,0,2021-01-17,2022-01-17,,Integrum,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03720353,0,0,0,0,0,0,2019-10-01,2020-10-01,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03722576,0,0,0,0,0,0,2020-04-30,2021-04-30,,Elizabeth Carey,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03723590,0,0,0,0,0,0,2020-03-31,2021-03-31,,Medline Industries,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,30
NCT03725059,0,0,0,0,0,0,2031-01-24,2032-01-24,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,1,0,0,1,1,0,2145
NCT03727061,0,0,0,0,0,0,2021-11-01,2022-11-01,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT03728153,0,0,0,0,0,0,2020-02-29,2021-02-28,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1699
NCT03728361,0,0,0,0,0,0,2021-12-31,2022-12-31,,Dwight Owen,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03728972,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03730129,0,0,0,0,0,0,2020-11-30,2021-11-30,,Rochester General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03730870,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Clinical and Translational Genome Research Institute, Inc.",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1
NCT03732794,0,0,0,0,0,0,2020-07-31,2021-07-31,,"AtriCure, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,17
NCT03734536,0,0,0,0,0,0,2020-09-03,2021-09-03,,"Smith & Nephew, Inc.",Industry,1,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,83
NCT03735316,0,0,0,0,0,0,2021-04-30,2022-04-30,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03737955,0,0,0,0,0,0,2021-08-15,2022-08-15,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03738904,0,0,0,0,0,0,2019-05-31,2020-05-31,,Cedars-Sinai Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,1,0,0,0,0,0,1,0,0,1,0,279
NCT03739021,0,0,0,0,0,0,2020-03-01,2021-03-01,,University of South Florida,Other,0,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,240
NCT03739684,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Progenics Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03740282,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Treace Medical Concepts, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03741933,0,0,0,0,0,0,2019-12-31,2020-12-31,,Alison Ehrlich,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03742531,0,0,0,0,0,0,2018-12-15,2019-12-15,,Zeynep Kamil Maternity and Pediatric Research and Training Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,23
NCT03742986,0,0,0,0,0,0,2025-06-30,2026-06-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03743636,0,0,0,0,0,0,2022-04-30,2023-04-30,,Northwestern University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03744026,0,0,0,0,0,0,2020-01-01,2021-01-01,,CarThera,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,1
NCT03744793,0,0,0,0,0,0,2020-01-01,2021-01-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03746002,0,0,0,0,0,0,2020-06-01,2021-06-01,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,144
NCT03749616,0,0,0,0,0,0,2020-03-01,2021-03-01,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03750552,0,0,0,0,0,0,2020-09-01,2021-09-01,,Theravance Biopharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,53
NCT03755089,0,0,0,0,0,0,2020-06-30,2021-06-30,,Women and Infants Hospital of Rhode Island,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,50
NCT03756688,0,0,0,0,0,0,2021-11-30,2022-11-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03757312,0,0,0,0,0,0,2020-12-31,2021-12-31,,Marco Corridore,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1
NCT03762616,0,0,0,0,0,0,2019-11-28,2020-11-28,,Exact Imaging,Industry,1,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,3
NCT03762759,0,0,0,0,0,0,2025-12-31,2026-12-31,,Emory University,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,947
NCT03763747,0,0,0,0,0,0,2020-01-30,2021-01-30,,OrbusNeich,Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03767595,0,0,0,0,0,0,2022-12-01,2023-12-01,,Uromedica,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03769090,0,0,0,0,0,0,2020-09-15,2021-09-15,,Bond Avillion 2 Development LP,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,1,1,0,3
NCT03769844,0,0,0,0,0,0,2021-12-05,2022-12-05,,Nationwide Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,161
NCT03770728,0,0,0,0,0,0,2021-06-30,2022-06-30,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1222
NCT03773172,0,0,0,0,0,0,2019-10-31,2020-10-31,,Columbia University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03774407,0,0,0,0,0,0,2020-01-10,2021-01-10,,Texas Tech University Health Sciences Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,78
NCT03774836,0,0,0,0,0,0,2019-05-30,2020-05-30,,"Avenue Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03775200,0,0,0,0,0,0,2019-12-31,2020-12-31,,COMPASS Pathways,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03775421,0,0,0,0,0,0,2022-10-31,2023-10-31,,Actelion,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03777176,0,0,0,0,0,0,2020-03-31,2021-03-31,,Zealand Pharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03777982,0,0,0,0,0,0,2026-12-31,2027-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03780478,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Southern California,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03782064,0,0,0,0,0,0,2024-01-31,2025-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,647
NCT03782675,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Nimbic Systems, LLC",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,3,1,0,7
NCT03784963,0,0,0,0,0,0,2021-01-01,2022-01-01,,University of Chicago,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03785405,0,0,0,0,0,0,2022-04-21,2023-04-21,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03786380,0,0,0,0,0,0,2023-12-23,2024-12-23,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03789214,0,0,0,0,0,0,2021-07-31,2022-07-31,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03789591,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03791489,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Arrinex, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03793010,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Flexion Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03793595,0,0,0,0,0,0,2019-09-01,2020-09-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03794258,0,0,0,0,0,0,2020-10-31,2021-10-31,,Humanity & Health Medical Group Limited,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT03795753,0,0,0,0,0,0,2019-07-08,2020-07-08,,Emory University,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,947
NCT03796195,0,0,0,0,0,0,2020-01-31,2021-01-31,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,925
NCT03800927,0,0,0,0,0,0,2020-01-01,2021-01-01,,"ZetrOZ, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT03802123,0,0,0,0,0,0,2019-12-31,2020-12-31,,"ImaginAb, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03804879,0,0,0,0,0,0,2022-10-28,2023-10-28,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03806231,0,0,0,0,0,0,2021-09-01,2022-09-01,,"Intermountain Health Care, Inc.",Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,93
NCT03806686,0,0,0,0,0,0,2020-03-31,2021-03-31,,Quratis Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,2
NCT03808103,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Intralytix, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03809078,0,0,0,0,0,0,2021-01-31,2022-01-31,,Andrei Iagaru,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,12
NCT03809481,0,0,0,0,0,0,2020-10-31,2021-10-31,,Aspen Global Incorporated,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03810105,0,0,0,0,0,0,2021-02-28,2022-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03812224,0,0,0,0,0,0,2020-07-22,2021-07-22,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,685
NCT03812588,0,0,0,0,0,0,2021-01-23,2022-01-23,,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03813121,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Arkansas,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,285
NCT03813238,0,0,0,0,0,0,2021-09-27,2022-09-27,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,101
NCT03814369,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Queen Elizabeth Hospital, Hong Kong",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,8
NCT03815175,0,0,0,0,0,0,2020-12-31,2021-12-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,1,1,0,419
NCT03818516,0,0,0,0,0,0,2023-02-28,2024-02-28,,Emory University,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03818828,0,0,0,0,0,0,2019-12-31,2020-12-31,,Tissue Tech Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,10
NCT03819049,0,0,0,0,0,0,2020-05-13,2021-05-13,,"Janssen Research & Development, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,558
NCT03821376,0,0,0,0,0,0,2020-07-01,2021-07-01,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,497
NCT03823417,0,0,0,0,0,0,2020-08-31,2021-08-31,,Boston Children’s Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03825315,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Revance Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,26
NCT03826199,0,0,0,0,0,0,2022-09-01,2023-09-01,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,692
NCT03826472,0,0,0,0,0,0,2020-03-01,2021-03-01,,Penn State University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,145
NCT03827720,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Sense Diagnostics, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03828539,0,0,0,0,0,0,2020-06-17,2021-06-17,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,1,0,0,0,0,0,2,1,0,1895
NCT03830918,0,0,0,0,0,0,2020-01-03,2021-01-03,,Jonsson Comprehensive Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,277
NCT03831165,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Sao Paulo General Hospital,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,1,0,2,0,1,368
NCT03839940,0,0,0,0,0,0,2020-02-01,2021-02-01,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,456
NCT03843307,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Avazzia, Inc",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03843671,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Baromedical Services,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,1,1,0,3
NCT03844997,0,0,0,0,0,0,2021-01-01,2022-01-01,,Aziz Nazha,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03845712,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Modis Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03846024,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Vermont Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,16
NCT03846505,0,0,0,0,0,0,2023-09-30,2024-09-30,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03847909,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Dicerna Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT03848845,0,0,0,0,0,0,2023-08-31,2024-08-31,,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03851250,0,0,0,0,0,0,2020-09-30,2021-09-30,,4D pharma plc,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,4
NCT03851705,0,0,0,0,0,0,2021-06-30,2022-06-30,,The Medicines Company,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,59
NCT03854019,0,0,0,0,0,0,2019-11-01,2020-11-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03857659,0,0,0,0,0,0,2020-04-01,2021-04-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,490
NCT03858634,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Kiniksa Pharmaceuticals, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03860844,0,0,0,0,0,0,2022-03-31,2023-03-31,,Sanofi,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1222
NCT03867396,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03868150,0,0,0,0,0,0,2025-12-31,2026-12-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,1309
NCT03875508,0,0,0,0,0,0,2020-03-02,2021-03-02,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,430
NCT03877224,0,0,0,0,0,0,2020-02-21,2021-02-21,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03879655,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Vtesse, Inc., a Mallinckrodt Pharmaceuticals Company",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT03879837,0,0,0,0,0,0,2020-06-30,2021-06-30,,Actavis Inc.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,93
NCT03880019,0,0,0,0,0,0,2022-06-07,2023-06-07,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03881735,0,0,0,0,0,0,2021-11-19,2022-11-19,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,294
NCT03883269,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Centre for Human Drug Research, Netherlands",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03885934,0,0,0,0,0,0,2020-03-30,2021-03-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2145
NCT03886246,0,0,0,0,0,0,2026-01-31,2027-01-31,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03887052,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Kestra Medical Technologies, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03887299,0,0,0,0,0,0,2020-04-01,2021-04-01,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,158
NCT03889158,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Illinois at Chicago,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,242
NCT03890666,0,0,0,0,0,0,2021-03-16,2022-03-16,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,101
NCT03891862,0,0,0,0,0,0,2020-09-30,2021-09-30,,Neurocrine Biosciences,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,34
NCT03893032,0,0,0,0,0,0,2019-10-31,2020-10-31,,United States Army Aeromedical Research Laboratory,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03893318,0,0,0,0,0,0,2022-12-31,2023-12-31,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03893448,0,0,0,0,0,0,2020-12-22,2021-12-22,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03894969,0,0,0,0,0,0,2020-07-01,2021-07-01,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,3276
NCT03895697,0,0,0,0,0,0,2019-07-26,2020-07-26,,Zealand Pharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,1,1,0,0,0,0,0,0,2,1,0,21
NCT03897361,0,0,0,0,0,0,2023-08-31,2024-08-31,,"University of California, San Diego",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,0,0,0,1,0,1,0,561
NCT03897595,0,0,0,0,0,0,2022-12-31,2023-12-31,,Medacta USA,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,11
NCT03900754,0,0,0,0,0,0,2024-09-30,2025-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03900923,0,0,0,0,0,0,2021-01-31,2022-01-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03901482,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Satsuma Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03907046,0,0,0,0,0,0,2024-04-30,2025-04-30,,Yale University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1053
NCT03910660,0,0,0,0,0,0,2022-04-02,2023-04-02,,BioXcel Therapeutics Inc,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03913455,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Shadia Jalal, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03915951,0,0,0,0,0,0,2022-03-31,2023-03-31,,Array BioPharma,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,65
NCT03919669,0,0,0,0,0,0,2022-01-31,2023-01-31,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03920228,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Palvella Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03922139,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of Wisconsin, Madison",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03922542,0,0,0,0,0,0,2025-04-01,2026-04-01,,Price Vision Group,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,7
NCT03924427,0,0,0,0,0,0,2020-11-10,2021-11-10,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1104
NCT03925675,0,0,0,0,0,0,2021-03-31,2022-03-31,,Loma Linda University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,194
NCT03927833,0,0,0,0,0,0,2021-12-31,2022-12-31,,NICHD Neonatal Research Network,Other,0,0,1,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,59
NCT03928847,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of California, San Francisco",Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03932461,0,0,0,0,0,0,2022-09-01,2023-09-01,,Odense University Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,2,1,0,292
NCT03935893,0,0,0,0,0,0,2029-06-01,2030-06-01,,Udai Kammula,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3
NCT03936751,0,0,0,0,0,0,2020-04-01,2021-04-01,,University of Sao Paulo,Other,0,1,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,767
NCT03939780,0,0,0,0,0,0,2023-01-31,2024-01-31,,Johns Hopkins University,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1143
NCT03940573,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Pelvalon, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03946319,0,0,0,0,0,0,2019-08-31,2020-08-31,,Introspect Health,Industry,1,0,0,5.0,,0,2019.0,1,0,0,0,1,0,0,0,0,1,0,1
NCT03946527,0,0,0,0,0,0,2021-05-31,2022-05-31,,Antonio Fojo,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03947437,0,0,0,0,0,0,2021-06-30,2022-06-30,,IDRI,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,17
NCT03947684,0,0,0,0,0,0,2022-04-30,2023-04-30,,University of Texas Southwestern Medical Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03948334,0,0,0,0,0,0,2022-01-25,2023-01-25,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03955146,0,0,0,0,0,0,2023-03-31,2024-03-31,,FibroGen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT03956355,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dermavant Sciences GmbH,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03958877,0,0,0,0,0,0,2023-03-31,2024-03-31,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03959176,0,0,0,0,0,0,2019-09-30,2020-09-30,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03964532,0,0,0,0,0,0,2020-05-01,2021-05-01,,Georgetown University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03965845,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Calithera Biosciences, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03969212,0,0,0,0,0,0,2020-05-11,2021-05-11,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03971266,0,0,0,0,0,0,2021-03-27,2022-03-27,,University of Southern California,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,483
NCT03971487,0,0,0,0,0,0,2021-03-31,2022-03-31,,The Methodist Hospital System,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,1,0,0,0,0,1,0,36
NCT03972397,0,0,0,0,0,0,2020-08-01,2021-08-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,490
NCT03972826,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Iowa,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,0,0,0,3,0,1,158
NCT03974932,0,0,0,0,0,0,2019-09-30,2020-09-30,,Heron Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,18
NCT03976401,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Akero Therapeutics, Inc",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03977662,0,0,0,0,0,0,2023-01-30,2024-01-30,,"University of California, San Francisco",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,1443
NCT03982407,0,0,0,0,0,0,2021-06-01,2022-06-01,,"Ajit H. Goenka, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03983395,0,0,0,0,0,0,2021-08-31,2022-08-31,,Glenmark Pharmaceuticals S.A.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,6
NCT03988647,0,0,0,0,0,0,2026-06-30,2027-06-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1309
NCT03989232,0,0,0,0,0,0,2020-09-16,2021-09-16,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03992755,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Liquidia Technologies, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03994601,0,0,0,0,0,0,2023-02-13,2024-02-13,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03995147,0,0,0,0,0,0,2022-08-20,2023-08-20,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03998527,0,0,0,0,0,0,2025-12-31,2026-12-31,,University of Louisville,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT04000009,0,0,0,0,0,0,2022-05-31,2023-05-31,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT04001946,0,0,0,0,0,0,2020-04-01,2021-04-01,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT04005053,0,0,0,0,0,0,2021-12-01,2022-12-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT04010539,0,0,0,0,0,0,2021-04-28,2022-04-28,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3276
NCT04012931,0,0,0,0,0,0,2023-02-09,2024-02-09,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,558
NCT04013672,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Manmeet Ahluwalia, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04013854,0,0,0,0,0,0,2026-08-31,2027-08-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT04014075,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Daiichi Sankyo, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,207
NCT04018677,0,0,0,0,0,0,2021-05-31,2022-05-31,,Stanford University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT04018859,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,925
NCT04021290,0,0,0,0,0,0,2021-06-07,2022-06-07,,ViiV Healthcare,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,200
NCT04021914,0,0,0,0,0,0,2020-07-31,2021-07-31,,Emory University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT04028388,0,0,0,0,0,0,2020-12-31,2021-12-31,,Modra Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT04029116,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Scynexis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,11
NCT04029311,0,0,0,0,0,0,2019-02-06,2020-02-06,,Joseph Adame,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT04030247,0,0,0,0,0,0,2020-09-01,2021-09-01,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1309
NCT04031846,0,0,0,0,0,0,2020-07-30,2021-07-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2145
NCT04032158,0,0,0,0,0,0,2026-10-26,2027-10-26,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT04037241,0,0,0,0,0,0,2022-01-01,2023-01-01,,"Sorrento Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,9
NCT04040192,0,0,0,0,0,0,2022-06-24,2023-06-24,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2856
NCT04044430,0,0,0,0,0,0,2022-06-01,2023-06-01,,"University of California, San Francisco",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,1443
NCT04046900,0,0,0,0,0,0,2021-07-31,2022-07-31,,Douglas Kwon,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,1
NCT04047732,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Krystal Biotech, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT04049266,0,0,0,0,0,0,2021-11-30,2022-11-30,,Kodiak Sciences Inc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT04049617,0,0,0,0,0,0,2024-08-31,2025-08-31,,Gilead Sciences,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,510
NCT04051944,0,0,0,0,0,0,2021-06-30,2022-06-30,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,75
NCT04053387,0,0,0,0,0,0,2020-11-30,2021-11-30,,Dermavant Sciences GmbH,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04054375,0,0,0,0,0,0,2021-07-01,2022-07-01,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT04057573,0,0,0,0,0,0,2021-04-16,2022-04-16,,Incyte Corporation,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,143
NCT04057794,0,0,0,0,0,0,2020-04-15,2021-04-15,,University of Rochester,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,470
NCT04059757,0,0,0,0,0,0,2020-09-30,2021-09-30,,Leland Metheny,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT04060342,0,0,0,0,0,0,2023-03-31,2024-03-31,,"GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04061421,0,0,0,0,0,0,2023-11-30,2024-11-30,,Michael Savona,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04064762,0,0,0,0,0,0,2021-01-31,2022-01-31,,Baylor Research Institute,Other,0,0,1,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,131
NCT04066088,0,0,0,0,0,0,2020-03-30,2021-03-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT04066881,0,0,0,0,0,0,2023-03-31,2024-03-31,,MRC/UVRI Uganda Research Unit on Aids,Other,0,1,0,1.0,Phase 2,0,2020.0,0,1,1,0,0,0,0,0,2,1,0,5
NCT04068402,0,0,0,0,0,0,2019-10-31,2020-10-31,,Avicena LLC,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT04071158,0,0,0,0,0,0,2019-12-18,2020-12-18,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,2856
NCT04071600,0,0,0,0,0,0,2022-10-31,2023-10-31,,New York Medical College,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT04072315,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Pliant Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT04073576,0,0,0,0,0,0,2019-10-11,2020-10-11,,Christchurch Clinical Studies Trust Ltd,Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT04073680,0,0,0,0,0,0,2021-07-15,2022-07-15,,Petra Pharma,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04075136,0,0,0,0,0,0,2020-12-31,2021-12-31,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,616
NCT04076696,0,0,0,0,0,0,2020-09-30,2021-09-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,229
NCT04078074,0,0,0,0,0,0,2021-10-31,2022-10-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT04079088,0,0,0,0,0,0,2022-05-11,2023-05-11,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,324
NCT04080791,0,0,0,0,0,0,2021-10-31,2022-10-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT04083976,0,0,0,0,0,0,2022-06-14,2023-06-14,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT04085601,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,14
NCT04088227,0,0,0,0,0,0,2022-09-30,2023-09-30,,Andrews Research & Education Foundation,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04088409,0,0,0,0,0,0,2022-03-03,2023-03-03,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT04088760,0,0,0,0,0,0,2024-12-31,2025-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT00004124,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-02-13,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,1999.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT00058188,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,1,0,3.0,Phase 3,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT00072358,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2003.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT00082706,0,0,0,0,0,0,2019-04-30,2020-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2003.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00130377,0,0,0,0,0,0,2020-12-31,2021-12-31,,Amit N. Patel MD MS,Other,0,0,0,2.0,Phase 2/Phase 3,0,2002.0,0,0,1,0,0,0,0,0,0,0,1,1
NCT00254423,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00278538,0,0,0,0,0,0,2018-12-31,2019-12-31,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2005.0,0,0,1,0,0,0,0,0,0,0,1,925
NCT00319657,0,0,0,0,0,0,2021-07-31,2022-07-31,,Stanford University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2004.0,0,0,1,0,0,1,0,0,0,0,1,1309
NCT00395538,1,1,0,1,0,1,2017-09-30,2018-09-30,2018-10-01,National Institute of Dental and Craniofacial Research (NIDCR),NIH,2,0,0,3.0,Phase 3,1,2006.0,1,1,0,0,0,0,0,0,0,0,1,88
NCT00497952,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Louisville,Other,0,0,0,0.0,Phase 1/Phase 2,0,2007.0,0,0,1,0,0,0,0,0,3,0,1,214
NCT00505063,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2007.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT00554788,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-06-05,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2008.0,0,1,1,0,0,1,0,0,1,0,1,389
NCT00563784,1,0,1,1,0,1,2018-05-30,2019-05-30,2019-09-03,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2007.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT00674479,1,0,1,1,0,1,2017-03-23,2018-03-23,2018-04-17,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00715273,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Washington,Other,0,1,1,4.0,Phase 4,0,2001.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT00749892,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00775801,1,0,0,0,1,0,2018-07-31,2019-07-31,,AxioMed Spine Corporation,Industry,1,0,0,5.0,,0,2008.0,1,0,0,1,0,0,0,0,1,0,1,2
NCT00777491,1,1,0,1,0,1,2018-02-18,2019-02-18,2019-05-31,Radiation Therapy Oncology Group,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,0,0,0,1,0,0,1,0,1,156
NCT00785525,0,0,0,0,0,0,2022-01-31,2023-01-31,,Center for International Blood and Marrow Transplant Research,Other,0,0,0,3.0,Phase 3,0,1997.0,0,1,0,0,0,0,0,0,0,0,1,25
NCT00794339,1,0,0,0,1,0,2017-06-30,2018-06-30,,American College of Radiology Imaging Network,Other,0,0,1,1.0,Phase 2,0,2009.0,1,1,0,0,0,1,0,0,0,0,1,31
NCT00832598,1,1,0,1,0,0,2017-03-21,2018-03-21,2018-02-22,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2009.0,1,0,0,0,0,1,0,0,0,0,1,1432
NCT00841789,1,0,0,0,1,0,2018-01-31,2019-01-31,,Michael Portman,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT00862680,0,0,0,0,0,0,2019-04-28,2020-04-28,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2009.0,1,0,0,0,0,0,0,0,0,0,1,2066
NCT00880074,0,0,0,0,0,0,2022-09-30,2023-09-30,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT00902577,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-09-18,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT00912340,1,1,0,1,0,1,2017-07-31,2018-07-31,2018-08-13,Emory University,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,1,0,0,0,0,0,0,0,1,947
NCT00919503,0,0,0,0,0,0,2023-02-01,2024-02-01,,Fred Hutchinson Cancer Research Center,Other,0,1,1,1.0,Phase 2,0,2009.0,0,1,1,0,0,1,0,0,0,0,1,393
NCT00925002,0,0,0,0,0,0,2021-12-31,2022-12-31,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT00932828,1,1,0,1,0,0,2017-02-01,2018-02-01,2018-02-01,"University of North Carolina, Chapel Hill",Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT00938145,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,198
NCT00955929,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00962728,0,0,0,0,0,0,2023-07-31,2024-07-31,,Alfredo Gamboa,Other,0,0,0,5.0,,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT00962884,0,0,0,0,0,0,2019-12-31,2020-12-31,,Alfredo Gamboa,Other,0,0,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT00967369,1,0,1,1,0,1,2018-05-02,2019-05-02,2019-05-08,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00969332,0,0,1,1,0,0,2019-08-31,2020-08-31,2019-07-01,"University of California, Los Angeles",Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,692
NCT00983619,0,0,0,0,0,0,2019-03-21,2020-03-21,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,269
NCT01075321,0,0,1,1,0,0,2018-11-30,2019-11-30,2018-08-21,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,1,0,0,1,1898
NCT01096602,0,0,0,0,0,0,2020-06-30,2021-06-30,,Beth Israel Deaconess Medical Center,Other,0,1,1,1.0,Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,377
NCT01101438,0,0,0,0,0,0,2022-02-28,2023-02-28,,Canadian Cancer Trials Group,Other,0,0,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,57
NCT01109069,0,0,0,0,0,0,2019-04-26,2020-04-26,,Pharmacyclics LLC.,Industry,1,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT01169259,0,0,0,0,0,0,2018-11-30,2019-11-30,,Brigham and Women's Hospital,Other,0,0,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT01169636,1,0,0,0,1,0,2017-05-17,2018-05-17,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01185171,1,0,0,0,1,0,2018-07-31,2019-07-31,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2003.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT01187368,0,0,0,0,0,0,2020-12-01,2021-12-01,,"Evaheart, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT01189786,0,0,0,0,0,0,2020-10-31,2021-10-31,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,0,0,1,518
NCT01191333,1,1,0,1,0,0,2017-02-15,2018-02-15,2018-01-10,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT01192828,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-04-26,"University of Colorado, Denver",Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT01198028,0,0,0,0,0,0,2019-05-01,2020-05-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01208974,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Miami,Other,0,0,0,5.0,,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,476
NCT01217437,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-02-05,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT01220687,1,0,0,0,1,0,2017-01-31,2018-01-31,,University of Oklahoma,Other,0,1,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,234
NCT01241708,0,0,0,0,0,0,2023-02-28,2024-02-28,,Hackensack Meridian Health,Other,0,0,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT01267812,0,0,0,0,0,0,2019-06-30,2020-06-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,1,0,0,0,0,1,0,0,1,358
NCT01267955,1,0,0,0,1,0,2018-06-30,2019-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,2,0,1,3004
NCT01283997,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01305499,0,0,0,0,0,0,2019-09-30,2020-09-30,,Hetty Carraway,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01313533,0,0,0,0,0,0,2019-12-31,2020-12-31,,"St. Luke's Hospital, Chesterfield, Missouri",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT01319565,0,0,0,0,0,0,2024-06-01,2025-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,1,0,0,1,0,0,0,0,1,3004
NCT01352637,0,1,0,1,0,0,2018-09-30,2019-09-30,2019-05-06,Weill Medical College of Cornell University,Other,0,0,1,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,586
NCT01367444,0,0,0,0,0,0,2019-06-03,2020-06-03,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT01369147,0,0,0,0,0,0,2019-10-31,2020-10-31,,Emory University,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT01371656,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-05-25,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,389
NCT01381172,1,0,0,0,1,0,2017-09-30,2018-09-30,,Impulse Dynamics,Industry,1,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,1,0,1,7
NCT01417286,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,227
NCT01432171,1,1,0,1,0,0,2017-06-20,2018-06-20,2018-06-20,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01458366,1,0,1,1,0,0,2018-08-27,2019-08-27,2019-08-27,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,1,0,0,1,162
NCT01478581,1,1,0,1,0,0,2018-08-31,2019-08-31,2018-01-22,Pharmacyclics LLC.,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT01489111,0,0,0,0,0,0,2018-12-10,2019-12-10,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT01489813,0,0,0,0,0,0,2020-05-31,2021-05-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT01492361,0,0,0,0,0,0,2018-05-31,2019-05-31,,Amarin Pharma Inc.,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,3
NCT01494155,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,1699
NCT01497808,0,0,0,0,0,0,2019-12-31,2020-12-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,273
NCT01502813,0,0,0,0,0,0,2018-10-30,2019-10-30,,Deborah Yurgelun-Todd,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01503632,0,0,0,0,0,0,2019-06-30,2020-06-30,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,389
NCT01506973,0,0,0,0,0,0,2020-12-31,2021-12-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT01507428,0,0,0,0,0,0,2019-10-31,2020-10-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,1,0,1,3004
NCT01510119,1,0,0,0,1,0,2017-01-31,2018-01-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,273
NCT01529060,1,1,0,1,0,0,2017-09-02,2018-09-02,2017-09-18,Brendan Lee,Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01537393,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-03-14,Case Western Reserve University,Other,0,0,1,4.0,Phase 4,0,2012.0,1,0,1,0,0,0,0,0,0,0,1,89
NCT01539720,0,0,0,0,0,0,2018-11-30,2019-11-30,,Planned Parenthood of the St. Louis Region and Southwest Missouri,Other,0,0,0,5.0,,0,2012.0,1,1,0,1,0,0,0,0,0,0,1,1
NCT01542021,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01546571,0,0,0,0,0,0,2019-01-01,2020-01-01,,Polynoma LLC,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,0,1,0,0,0,0,0,1,0,1,1
NCT01546987,0,0,0,0,0,0,2025-06-30,2026-06-30,,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,156
NCT01548690,1,1,0,1,0,1,2017-02-23,2018-02-23,2018-05-04,William Lee,Other,0,1,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01552408,1,1,0,1,0,0,2017-05-18,2018-05-18,2017-12-20,"David M. Brown, M.D.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT01563341,0,0,0,0,0,0,2025-01-31,2026-01-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT01566695,0,0,0,0,0,0,2019-01-25,2020-01-25,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01572480,0,0,0,0,0,0,2022-06-01,2023-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01572662,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01576874,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-09-07,"Kevin Gray, MD",Other,0,0,1,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01585805,0,0,0,0,0,0,2021-07-01,2022-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01586260,0,0,0,0,0,0,2019-12-31,2020-12-31,,Giselle Sholler,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT01592968,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,3.0,Phase 3,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01606787,1,1,0,1,0,0,2018-02-28,2019-02-28,2018-05-18,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01607879,1,0,0,0,1,0,2018-07-31,2019-07-31,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,315
NCT01613469,1,0,0,0,1,0,2017-03-16,2018-03-16,,"Marks, John, M.D.",Other,0,0,0,1.0,Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01614652,1,0,0,0,1,0,2017-06-30,2018-06-30,,"CardioKinetix, Inc",Industry,1,0,0,3.0,Phase 3,1,2012.0,1,0,0,1,0,0,0,0,1,0,1,7
NCT01624090,0,0,0,0,0,0,2019-08-20,2020-08-20,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01636609,0,0,0,0,0,0,2019-07-04,2020-07-04,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01637402,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Terence Friedlander, MD",Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01638013,0,0,0,0,0,0,2020-03-31,2021-03-31,,Astellas Pharma Inc,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,2,0,1,506
NCT01652976,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-03-01,University of Florida,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT01658878,0,0,0,0,0,0,2019-01-31,2020-01-31,,Bristol-Myers Squibb,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT01673373,1,1,0,1,0,0,2018-06-27,2019-06-27,2019-06-27,Atrium Medical Corporation,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT01676311,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-07-24,Spaulding Rehabilitation Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,69
NCT01679990,1,0,0,0,1,0,2018-03-29,2019-03-29,,Pluristem Ltd.,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,0,1,0,0,0,0,0,1,0,1,9
NCT01691859,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-04-19,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT01696955,1,1,0,1,0,1,2017-05-05,2018-05-05,2018-07-13,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,1,0,0,0,0,0,0,0,1,3004
NCT01701986,0,0,0,0,0,0,2019-10-25,2020-10-25,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01712308,0,0,0,0,0,0,2020-02-28,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT01712815,0,0,0,0,0,0,2019-11-22,2020-11-22,,University of Southern California,Other,0,0,1,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,483
NCT01716208,0,0,0,0,0,0,2019-04-30,2020-04-30,,"University of California, Davis",Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,530
NCT01731886,0,0,0,0,0,0,2017-04-11,2018-04-11,,Columbia University,Other,0,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT01732107,1,1,0,1,0,1,2017-03-06,2018-03-06,2018-07-25,"Noah Hahn, M.D.",Other,0,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT01734928,0,0,0,0,0,0,2022-05-01,2023-05-01,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01736852,0,0,0,0,0,0,2018-12-31,2019-12-31,,Cook Group Incorporated,Industry,1,0,0,5.0,,0,2012.0,1,1,0,1,0,0,0,0,0,0,1,75
NCT01744093,1,1,0,1,0,0,2017-10-25,2018-10-25,2018-08-31,Weill Medical College of Cornell University,Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT01751425,0,0,0,0,0,0,2020-07-31,2021-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01756352,1,0,1,1,0,1,2018-08-31,2019-08-31,2019-09-12,"Marcelo F. Di Carli, MD, FACC",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01756729,1,0,0,0,1,0,2018-01-31,2019-01-31,,NovoCure Ltd.,Industry,1,0,0,4.0,Phase 4,1,2012.0,1,0,0,1,0,0,0,0,0,0,1,14
NCT01757132,0,0,0,0,0,0,2023-12-31,2024-12-31,,"VisionCare, Inc.",Industry,1,0,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,0,0,1,6
NCT01760655,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,1,0,0,1,0,0,0,0,1,162
NCT01763346,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-08-28,University of Southern California,Other,0,0,1,5.0,,0,2013.0,1,1,0,1,0,0,0,0,0,0,1,483
NCT01767636,0,0,0,0,0,0,2019-02-02,2020-02-02,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01773395,0,0,0,0,0,0,2019-07-31,2020-07-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,647
NCT01781572,0,0,0,0,0,0,2018-01-15,2019-01-15,,Array BioPharma,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,65
NCT01781975,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-25,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1443
NCT01790243,0,0,0,0,0,0,2018-09-30,2019-09-30,,C. R. Bard,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,77
NCT01807117,0,0,0,0,0,0,2020-11-30,2021-11-30,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,374
NCT01807598,1,1,0,1,0,1,2017-09-30,2018-09-30,2018-12-14,Jason Robert Gotlib,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01817517,0,0,0,0,0,0,2030-04-30,2031-04-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT01829113,1,1,0,1,0,0,2017-04-19,2018-04-19,2018-04-18,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,167
NCT01832753,1,1,0,1,0,1,2017-10-18,2018-10-18,2018-11-19,Children's Hospital of Philadelphia,Other,0,0,1,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,324
NCT01833520,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01835626,0,0,0,0,0,0,2019-06-30,2020-06-30,,Sue Yom,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,1,0,0,0,0,1,2
NCT01845792,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-04-11,"University of Colorado, Denver",Other,0,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT01846182,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT01847027,1,1,0,1,0,1,2017-07-17,2018-07-17,2018-12-21,University of North Texas Health Science Center,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT01851083,0,0,0,0,0,0,2020-02-29,2021-02-28,,"The University of Texas Health Science Center, Houston",Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,490
NCT01852045,0,0,0,0,0,0,2018-10-11,2019-10-11,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,0,1,0,0,0,0,0,1,0,1,495
NCT01856907,1,1,0,1,0,0,2017-09-05,2018-09-05,2017-09-13,Woman's,Other,0,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT01858532,1,1,0,1,0,0,2018-03-29,2019-03-29,2019-03-29,AbbVie,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,3,0,1,430
NCT01863550,0,0,0,0,0,0,2023-11-01,2024-11-01,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,75
NCT01889186,0,0,0,0,0,0,2020-05-12,2021-05-12,,AbbVie,Industry,1,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT01892813,1,0,0,0,1,0,2018-01-31,2019-01-31,,Mark Vander Weg,Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01897688,0,0,0,0,0,0,2025-03-31,2026-03-31,,Northwestern University,Other,0,0,0,3.0,Phase 3,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,925
NCT01897896,1,1,0,1,0,1,2017-08-21,2018-08-21,2019-01-28,"Auspex Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT01902004,0,0,1,1,0,0,2019-01-23,2020-01-23,2019-08-07,"University of California, Los Angeles",Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,692
NCT01903330,0,0,0,0,0,0,2023-03-31,2024-03-31,,Daniela A. Bota,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01917136,0,1,0,1,0,0,2018-10-31,2019-10-31,2018-11-30,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01919411,0,0,0,0,0,0,2018-09-30,2019-09-30,,Massachusetts Eye and Ear Infirmary,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT01920737,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,1,0,0,0,0,0,0,1,1432
NCT01921270,1,1,0,1,0,0,2017-02-08,2018-02-08,2017-07-24,Emory University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT01921868,1,0,0,0,1,0,2017-06-30,2018-06-30,,University of South Florida,Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT01922258,0,0,0,0,0,0,2017-03-31,2018-03-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,185
NCT01924793,1,0,0,0,1,0,2017-05-31,2018-05-31,,"Ansun Biopharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT01925612,1,1,0,1,0,0,2017-05-01,2018-05-01,2018-04-18,"Seattle Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,77
NCT01927627,1,1,0,1,0,1,2017-03-29,2018-03-29,2019-02-19,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,374
NCT01928329,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-09-03,Yale University,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT01928446,0,0,0,0,0,0,2019-05-31,2020-05-31,,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01928719,1,1,0,1,0,0,2018-01-05,2019-01-05,2019-01-04,Milton S. Hershey Medical Center,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT01935947,1,1,0,1,0,0,2017-04-30,2018-04-30,2017-12-29,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01937117,1,1,0,1,0,0,2018-03-20,2019-03-20,2019-03-18,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT01938716,0,0,0,0,0,0,2019-06-03,2020-06-03,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01940276,0,0,0,0,0,0,2018-10-25,2019-10-25,,Duke University,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1342
NCT01940887,1,0,1,1,0,1,2017-08-31,2018-08-31,2019-06-18,Ophthotech Corporation,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,15
NCT01962103,1,1,0,1,0,0,2017-12-05,2018-12-05,2018-12-05,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT01965704,0,0,0,0,0,0,2021-03-30,2022-03-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT01968382,0,0,0,0,0,0,2018-12-22,2019-12-22,,Virginia Commonwealth University,Other,0,1,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT01969123,1,0,0,0,1,0,2017-01-31,2018-01-31,,FORUM Pharmaceuticals Inc,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT01973283,0,0,0,0,0,0,2019-07-31,2020-07-31,,New York State Psychiatric Institute,Other,0,0,1,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT01975701,0,0,0,0,0,0,2017-09-29,2018-09-29,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01976936,1,0,1,1,0,1,2017-01-31,2018-01-31,2018-03-29,Mitchell S Elkind,Other,0,0,1,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01977417,0,0,0,0,0,0,2019-12-31,2020-12-31,,Gary L. Pierce,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01980706,1,1,0,1,0,0,2017-10-26,2018-10-26,2018-10-03,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01983293,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-11-07,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,419
NCT01985763,1,1,0,1,0,1,2017-01-19,2018-01-19,2019-03-26,Sofya Pintova,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01990209,0,0,0,0,0,0,2020-02-01,2021-02-01,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,167
NCT01990352,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Arizona,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,265
NCT01993836,0,0,0,0,0,0,2019-01-10,2020-01-10,,Duke University,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02003183,0,0,0,0,0,0,2018-10-31,2019-10-31,,"University of California, Los Angeles",Other,0,0,0,1.0,Phase 2,0,2013.0,1,0,0,0,0,1,0,0,0,0,1,692
NCT02010021,1,1,0,1,0,0,2017-12-08,2018-12-08,2018-12-02,Dartmouth-Hitchcock Medical Center,Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,306
NCT02010203,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-07-31,Heat Biologics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT02012491,1,1,0,1,0,1,2017-05-15,2018-05-15,2018-08-28,University of Pennsylvania,Other,0,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02016872,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02017964,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-12,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,389
NCT02019524,1,0,0,0,1,0,2017-10-31,2018-10-31,,"COL George Peoples, MD, FACS",U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT02019758,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-04-03,"University of North Carolina, Chapel Hill",Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02020070,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02021279,0,0,0,0,0,0,2020-01-31,2021-01-31,,ACell Inc.,Industry,1,0,0,4.0,Phase 4,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02023996,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,5.0,,0,2013.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02024477,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-08-14,George Washington University,Other,0,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,85
NCT02033876,1,1,0,1,0,1,2017-01-31,2018-01-31,2019-04-18,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02035137,0,0,0,0,0,0,2020-01-31,2021-01-31,,New Approaches to Neuroblastoma Therapy Consortium,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,1,0,1,15
NCT02035787,0,0,0,0,0,0,2019-09-30,2020-09-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT02038920,0,0,0,0,0,0,2019-01-25,2020-01-25,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,2,0,1,650
NCT02047318,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Mirum Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,2,0,1,16
NCT02049905,1,0,0,0,1,0,2017-05-31,2018-05-31,,CytRx,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,20
NCT02051465,1,0,0,0,1,0,2017-12-31,2018-12-31,,Mercy Medical Center,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT02053376,1,1,0,1,0,0,2018-01-07,2019-01-07,2018-12-03,"Nathan Bahary, MD",Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02058420,0,0,0,0,0,0,2019-09-30,2020-09-30,,Texas Tech University Health Sciences Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,78
NCT02064725,1,0,0,0,1,0,2018-01-31,2019-01-31,,Kevelt AS,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT02065700,0,0,0,0,0,0,2023-05-31,2024-05-31,,Gilead Sciences,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02069366,0,0,0,0,0,0,2019-12-31,2020-12-31,,Wayne State University,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,145
NCT02072668,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02073123,0,0,0,0,0,0,2018-01-17,2019-01-17,,NewLink Genetics Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02073487,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Jenny C. Chang, MD",Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02076074,0,0,0,0,0,0,2023-04-13,2024-04-13,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,1151
NCT02076152,0,0,0,0,0,0,2019-04-30,2020-04-30,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2014.0,1,1,0,1,0,0,0,0,0,0,1,1699
NCT02078960,1,1,0,1,0,1,2017-07-06,2018-07-06,2018-12-19,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02080195,1,1,0,1,0,1,2017-03-28,2018-03-28,2018-09-06,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,1,0,0,1,0,0,0,0,1,461
NCT02080494,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Tennessee,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,99
NCT02090114,0,0,0,0,0,0,2021-04-30,2022-04-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02096588,1,1,0,1,0,1,2017-04-25,2018-04-25,2019-05-14,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02100696,0,0,0,0,0,0,2020-04-24,2021-04-24,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02101775,0,0,0,0,0,0,2019-12-01,2020-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02102555,1,0,0,0,1,0,2017-05-03,2018-05-03,,MercyOne Des Moines Medical Center,Other,0,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02102698,0,0,0,0,0,0,2019-12-31,2020-12-31,,Psyadon Pharma,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02104817,0,0,0,0,0,0,2020-09-30,2021-09-30,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02106975,0,0,1,1,0,1,2017-11-16,2018-11-16,2019-06-28,Virginia Commonwealth University,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT02110706,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-31,Yale University,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02112045,1,1,0,1,0,0,2017-12-13,2018-12-13,2018-12-05,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02115308,1,1,0,1,0,0,2018-01-16,2019-01-16,2018-06-27,Timothy M. Bateman,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02118467,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Chicago,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02119156,0,0,0,0,0,0,2018-12-14,2019-12-14,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02120157,1,1,0,1,0,0,2018-06-15,2019-06-15,2019-03-28,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,1,0,1,461
NCT02124174,0,0,0,0,0,0,2020-01-31,2021-01-31,,Patrick Stiff,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02124902,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02129647,0,0,0,0,0,0,2019-02-24,2020-02-24,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02131584,0,0,0,0,0,0,2022-09-30,2023-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02135042,0,0,0,0,0,0,2021-07-31,2022-07-31,,NRG Oncology,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,1,0,0,1,0,1,27
NCT02139150,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02139358,1,1,0,1,0,0,2018-04-24,2019-04-24,2018-06-25,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02140970,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02145949,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Oregon,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02147301,1,1,0,1,0,1,2017-01-27,2018-01-27,2019-04-03,"University of California, San Francisco",Other,0,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1443
NCT02150343,1,1,0,1,0,0,2017-04-13,2018-04-13,2018-03-29,Circassia Limited,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,35
NCT02151448,0,0,0,0,0,0,2019-02-18,2020-02-18,,David Bartlett,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,4
NCT02152761,0,0,0,0,0,0,2018-05-14,2019-05-14,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02155920,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT02161406,1,1,0,1,0,0,2018-09-12,2019-09-12,2019-04-04,"Dinesh Khanna, MD, MS",Other,0,1,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02164721,0,0,0,0,0,0,2019-02-06,2020-02-06,,University of Rochester,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,470
NCT02165397,0,0,0,0,0,0,2019-12-31,2020-12-31,,Pharmacyclics LLC.,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,54
NCT02166463,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT02167204,0,0,0,0,0,0,2018-11-21,2019-11-21,,University of Washington,Other,0,0,1,5.0,,0,2012.0,1,0,0,0,0,1,0,0,0,0,1,910
NCT02167945,0,0,0,0,0,0,2020-05-05,2021-05-05,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,430
NCT02174627,0,0,0,0,0,0,2018-10-04,2019-10-04,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02178410,0,0,0,0,0,0,2021-04-30,2022-04-30,,Brigham and Women's Hospital,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT02178566,0,0,0,0,0,0,2020-07-31,2021-07-31,,Inova Health Care Services,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,41
NCT02179749,0,0,0,0,0,0,2019-11-30,2020-11-30,,The Scripps Research Institute,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,14
NCT02180217,0,0,0,0,0,0,2018-02-21,2019-02-21,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02187172,1,1,0,1,0,0,2018-09-11,2019-09-11,2019-06-17,University of Pennsylvania,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02192099,0,0,0,0,0,0,2018-11-08,2019-11-08,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02192502,0,0,0,0,0,0,2019-09-30,2020-09-30,,The Cleveland Clinic,Other,0,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02194387,0,0,0,0,0,0,2019-09-28,2020-09-28,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2014.0,0,0,0,0,0,0,0,0,0,0,1,2066
NCT02194998,1,1,0,1,0,0,2018-05-17,2019-05-17,2019-05-16,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT02198664,0,0,0,0,0,0,2018-04-11,2019-04-11,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,11
NCT02199197,1,1,0,1,0,0,2018-04-19,2019-04-19,2019-04-19,University of Utah,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,578
NCT02200276,0,0,0,0,0,0,2021-05-31,2022-05-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1143
NCT02201108,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Genzyme, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02201589,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Rodney A. White, M.D.",Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02205762,0,0,0,0,0,0,2023-07-31,2024-07-31,,North American Consortium for Histiocytosis,Other,0,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,1
NCT02215200,1,0,1,1,0,1,2017-08-31,2018-08-31,2019-05-30,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,1,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02215616,1,1,0,1,0,0,2018-06-19,2019-06-19,2019-05-29,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02218983,1,0,0,0,1,0,2018-06-30,2019-06-30,,Riverside University Health System Medical Center,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02219321,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02219373,0,0,0,0,0,0,2021-12-31,2022-12-31,,Boston Children’s Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT02219555,0,0,0,0,0,0,2021-01-31,2022-01-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02220894,1,1,0,1,0,0,2018-02-26,2019-02-26,2019-02-14,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02224391,0,0,0,0,0,0,2026-01-30,2027-01-30,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02225197,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Community Cancer Center, Normal, Illinois",Other,0,0,0,5.0,,0,2007.0,1,0,0,0,0,1,0,0,0,0,1,2
NCT02226146,1,0,0,0,1,0,2018-04-30,2019-04-30,,Immune Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,2
NCT02227277,1,0,0,0,1,0,2018-02-07,2019-02-07,,The Wistar Institute,Other,0,1,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02237196,0,0,0,0,0,0,2019-03-18,2020-03-18,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2133
NCT02240121,1,1,0,1,0,1,2017-08-16,2018-08-16,2019-08-15,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02244918,1,1,0,1,0,1,2017-11-01,2018-11-01,2018-11-07,University of Kansas Medical Center,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,219
NCT02246465,1,0,0,0,1,0,2017-12-31,2018-12-31,,"RXi Pharmaceuticals, Corp.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT02252406,0,0,0,0,0,0,2018-12-17,2019-12-17,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,849
NCT02252588,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02254278,0,0,0,0,0,0,2019-06-10,2020-06-10,,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,1,0,1,27
NCT02258542,1,1,0,1,0,0,2017-10-18,2018-10-18,2018-10-18,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,2450
NCT02267876,0,0,0,0,0,0,2018-12-12,2019-12-12,,"Becton, Dickinson and Company",Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,26
NCT02273362,0,0,0,0,0,0,2020-02-28,2021-02-28,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02274493,1,1,0,1,0,0,2018-03-07,2019-03-07,2018-12-04,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,2066
NCT02279173,0,1,0,1,0,0,2018-08-30,2019-08-30,2019-08-08,Amgen,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02288897,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Provectus Biopharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02289898,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-21,"OncoMed Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,28
NCT02293005,0,0,0,0,0,0,2021-05-31,2022-05-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02296801,1,0,0,0,1,0,2018-07-31,2019-07-31,,NSABP Foundation Inc,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,63
NCT02297100,1,1,0,1,0,0,2018-01-10,2019-01-10,2018-03-21,Wake Forest University Health Sciences,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT02308020,0,0,0,0,0,0,2018-11-08,2019-11-08,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02310399,0,0,0,0,0,0,2020-05-31,2021-05-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT02311361,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,1,0,0,0,0,1,3004
NCT02311894,1,1,0,1,0,0,2017-11-08,2018-11-08,2018-10-19,"Genentech, Inc.",Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,427
NCT02320149,0,1,0,1,0,1,2017-02-01,2018-02-01,2018-04-17,"Almirall, S.A.",Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,33
NCT02321514,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Tendyne Holdings, Inc.",Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,3
NCT02322047,0,0,0,0,0,0,2018-11-30,2019-11-30,,Seattle Institute for Biomedical and Clinical Research,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,40
NCT02323126,0,0,0,0,0,0,2022-04-11,2023-04-11,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02323867,0,0,0,0,0,0,2019-10-31,2020-10-31,,Children's Hospital of Philadelphia,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,324
NCT02324842,1,1,0,1,0,0,2018-03-28,2019-03-28,2019-03-26,The University of Texas Health Science Center at San Antonio,Other,0,1,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02325557,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Advaxis, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT02326337,1,0,0,0,1,0,2018-02-05,2019-02-05,,AOTI Ltd.,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,2
NCT02326974,1,0,0,0,1,0,2018-06-18,2019-06-18,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02328547,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-09-04,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02329652,0,0,0,0,0,0,2022-05-31,2023-05-31,,Kevin Kilgore,Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02339064,0,0,0,0,0,0,2018-12-31,2019-12-31,,US WorldMeds LLC,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,20
NCT02340676,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-09,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02342691,1,0,0,0,1,0,2017-09-28,2018-09-28,,The Forsyth Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02343406,0,0,0,0,0,0,2019-06-24,2020-06-24,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02345967,1,0,0,0,1,0,2018-05-30,2019-05-30,,GlySens Incorporated,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02347631,1,0,0,0,1,0,2018-06-30,2019-06-30,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,626
NCT02348489,0,0,0,0,0,0,2018-05-31,2019-05-31,,Astex Pharmaceuticals,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,38
NCT02348918,1,1,0,1,0,1,2017-05-16,2018-05-16,2018-08-31,"Allegro Ophthalmics, LLC",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02350647,0,0,0,0,0,0,2019-03-31,2020-03-31,,The Hawkins Foundation,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,13
NCT02350816,0,0,0,0,0,0,2019-03-06,2020-03-06,,Shire,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,342
NCT02352844,1,1,0,1,0,0,2017-08-15,2018-08-15,2018-07-18,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02354170,1,0,0,0,1,0,2017-04-27,2018-04-27,,"Roger Goldberg, M.D., MBA",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02354859,1,1,0,1,0,0,2018-02-01,2019-02-01,2019-01-28,University of Washington,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02355886,1,1,0,1,0,0,2018-02-28,2019-02-28,2019-02-25,University of Washington,Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02357290,0,0,0,0,0,0,2018-09-24,2019-09-24,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02366754,0,0,0,0,0,0,2020-02-29,2021-02-28,,Edward Hines Jr. VA Hospital,U.S. Fed,2,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02369159,0,0,0,0,0,0,2021-04-30,2022-04-30,,BioCryst Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT02370511,0,0,0,0,0,0,2022-12-31,2023-12-31,,Mayra Guerrero,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02370797,0,0,0,0,0,0,2029-02-28,2030-02-28,,Avera McKennan Hospital & University Health Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,29
NCT02372799,1,0,1,1,0,0,2018-09-11,2019-09-11,2019-09-11,Forest Laboratories,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,169
NCT02375204,0,0,0,0,0,0,2024-06-30,2025-06-30,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,456
NCT02378714,0,0,0,0,0,0,2019-08-31,2020-08-31,,Northwestern University,Other,0,0,1,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02378883,1,1,0,1,0,1,2018-02-20,2019-02-20,2019-03-01,Medtronic Neurovascular Clinical Affairs,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,21
NCT02379442,1,1,0,1,0,1,2017-12-13,2018-12-13,2019-04-08,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,0,1,0,0,0,0,0,0,0,1,1091
NCT02381353,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02386293,0,0,0,0,0,0,2019-11-30,2020-11-30,,Augusta University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,117
NCT02387853,1,1,0,1,0,0,2018-03-28,2019-03-28,2018-09-28,LEO Pharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,171
NCT02392234,0,1,0,1,0,1,2017-02-28,2018-02-28,2018-03-14,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02399462,0,0,0,0,0,0,2022-06-30,2023-06-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT02401347,0,0,0,0,0,0,2021-08-31,2022-08-31,,Melinda Telli,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02403271,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-29,Pharmacyclics LLC.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT02405780,1,1,0,1,0,0,2018-01-18,2019-01-18,2019-01-18,"Fujifilm Kyowa Kirin Biologics Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02410382,1,1,0,1,0,1,2018-02-16,2019-02-16,2019-03-29,University of Arizona,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,265
NCT02410577,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-02-22,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,1432
NCT02413970,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Inspire Medical Systems, Inc.",Industry,1,0,0,4.0,Phase 4,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT02414958,0,1,0,1,0,1,2017-04-20,2018-04-20,2018-10-22,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02417974,0,0,0,0,0,0,2019-08-31,2020-08-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,377
NCT02420717,0,0,0,0,0,0,2023-07-31,2024-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02422979,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Rakuten Medical, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,2
NCT02423954,1,0,0,0,1,0,2017-11-01,2018-11-01,,Western Regional Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT02424968,0,0,0,0,0,0,2020-07-31,2021-07-31,,Robert Lowsky,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,1,0,0,0,0,1,5
NCT02427451,0,0,0,0,0,0,2019-08-29,2020-08-29,,Kerry Rogers,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2
NCT02428296,1,0,0,0,1,0,2018-02-14,2019-02-14,,National Human Genome Research Institute (NHGRI),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,191
NCT02428855,1,0,0,0,1,0,2018-02-28,2019-02-28,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02439125,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Amarantus BioScience Holdings, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02439775,0,0,0,0,0,0,2020-11-30,2021-11-30,,Medtronic Vascular,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,51
NCT02440425,0,0,0,0,0,0,2019-10-31,2020-10-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02440581,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Hartmut Malluche, MD",Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02441660,0,0,0,0,0,0,2020-07-30,2021-07-30,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02443181,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Washington,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT02445040,1,0,0,0,1,0,2018-05-08,2019-05-08,,"Draeger Medical Systems, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02445976,0,0,0,0,0,0,2018-12-31,2019-12-31,,Innocrin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02453711,0,0,0,0,0,0,2017-03-30,2018-03-30,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02464657,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02466009,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Rochester,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,470
NCT02469168,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-03-09,"Rubin, J. Peter, MD",Other,0,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02469415,1,1,0,1,0,0,2017-06-03,2018-06-03,2018-02-15,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02470741,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-11-30,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02473016,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Capnia, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02474199,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2133
NCT02476526,1,0,0,0,1,0,2017-11-20,2018-11-20,,VA Greater Los Angeles Healthcare System,U.S. Fed,2,1,0,4.0,Phase 4,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT02477618,0,1,0,1,0,1,2017-07-18,2018-07-18,2019-04-11,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,24
NCT02479620,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Mercator MedSystems, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02481206,1,0,0,0,1,0,2017-12-31,2018-12-31,,Zoll Medical Corporation,Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,17
NCT02481414,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Arkansas,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,285
NCT02482376,0,0,0,0,0,0,2019-09-30,2020-09-30,,Duke University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,1342
NCT02483468,0,0,0,0,0,0,2020-01-31,2021-01-31,,Medical University of South Carolina,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,511
NCT02484287,1,0,0,0,1,0,2018-07-31,2019-07-31,,University of Oklahoma,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,234
NCT02484443,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,3004
NCT02485925,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-07-03,"Biosense Webster, Inc.",Industry,1,0,0,4.0,Phase 4,0,2015.0,1,0,0,1,0,0,0,0,2,0,1,41
NCT02494778,1,0,0,0,1,0,2018-01-12,2019-01-12,,Prilenia,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02495168,1,0,0,0,1,0,2018-05-31,2019-05-31,,Actavis Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT02495415,0,0,0,0,0,0,2021-07-31,2022-07-31,,"CerRx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02495935,0,0,0,0,0,0,2019-06-30,2020-06-30,,Wills Eye,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,69
NCT02496780,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02497781,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-03-12,Pfizer,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02499354,0,0,0,0,0,0,2019-08-31,2020-08-31,,Auerbach Hematology Oncology Associates P C,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02501265,0,0,0,0,0,0,2021-09-30,2022-09-30,,Duke University,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT02504645,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-02-12,ImmuPharma,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02505334,1,1,0,1,0,0,2017-05-02,2018-05-02,2018-04-26,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,981
NCT02510456,0,0,0,0,0,0,2021-01-31,2022-01-31,,Boston Medical Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,225
NCT02510560,0,0,0,0,0,0,2019-05-31,2020-05-31,,Nutrinia,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT02513784,0,0,0,0,0,0,2017-12-31,2018-12-31,,Columbia University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02514174,0,0,0,0,0,0,2019-03-28,2020-03-28,,Boehringer Ingelheim,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1852
NCT02514252,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02514577,0,0,0,0,0,0,2017-05-02,2018-05-02,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02515227,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Craig L Slingluff, Jr",Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,19
NCT02515669,1,1,0,1,0,0,2018-02-08,2019-02-08,2019-02-07,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02520141,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02527434,1,1,0,1,0,0,2018-02-17,2019-02-17,2019-02-13,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,2450
NCT02530073,0,0,0,0,0,0,2022-08-31,2023-08-31,,Medical City Children's Hospital,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02531932,0,0,0,0,0,0,2019-12-01,2020-12-01,,Amy Tiersten,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02532257,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02533180,0,0,0,0,0,0,2019-09-30,2020-09-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,2133
NCT02538471,0,0,0,0,0,0,2019-02-20,2020-02-20,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,1,0,0,0,0,1,586
NCT02545049,0,0,0,0,0,0,2021-06-21,2022-06-21,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02548351,0,0,0,0,0,0,2022-10-31,2023-10-31,,Intercept Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,14
NCT02551874,1,1,0,1,0,0,2017-05-08,2018-05-08,2018-05-07,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02555215,0,0,0,0,0,0,2018-09-24,2019-09-24,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,324
NCT02555683,0,0,0,0,0,0,2019-10-24,2020-10-24,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02557945,1,0,0,0,1,0,2018-03-31,2019-03-31,,New York State Psychiatric Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02560051,1,1,0,1,0,0,2017-09-12,2018-09-12,2018-09-12,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02562066,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Catalyst Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02562482,1,1,0,1,0,0,2018-03-06,2019-03-06,2019-03-05,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,2133
NCT02567799,0,0,0,0,0,0,2019-04-30,2020-04-30,,Humanetics Corporation,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,4
NCT02568449,0,0,0,0,0,0,2019-06-01,2020-06-01,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT02569073,0,0,0,0,0,0,2019-10-31,2020-10-31,,Temple University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,152
NCT02569658,1,1,0,1,0,0,2017-04-30,2018-04-30,2017-04-14,Rush University Medical Center,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,227
NCT02570282,0,0,0,0,0,0,2017-05-31,2018-05-31,,"Strategic Science & Technologies, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02570503,0,0,0,0,0,0,2019-12-31,2020-12-31,,Virginia Commonwealth University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,417
NCT02575300,0,0,1,1,0,0,2020-03-31,2021-03-31,2019-08-16,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02576067,0,0,0,0,0,0,2019-03-29,2020-03-29,,Icahn School of Medicine at Mount Sinai,Other,0,0,1,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,412
NCT02576444,0,0,0,0,0,0,2020-03-31,2021-03-31,,Joseph Paul Eder,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02576717,0,0,0,0,0,0,2020-05-31,2021-05-31,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02577367,0,0,0,0,0,0,2020-10-31,2021-10-31,,Jocelyne Karam,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02579759,1,0,0,0,1,0,2018-07-31,2019-07-31,,Pharnext SA,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02581345,0,1,0,1,0,1,2017-04-04,2018-04-04,2018-05-18,"Momenta Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,12
NCT02586233,0,0,0,0,0,0,2019-05-16,2020-05-16,,"Daiichi Sankyo, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,207
NCT02586623,0,0,0,0,0,0,2021-03-31,2022-03-31,,Lundbeck Northera Ltd.,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02587572,0,0,0,0,0,0,2020-10-31,2021-10-31,,Longeveron LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,5
NCT02589665,0,0,0,0,0,0,2017-12-19,2018-12-19,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02597049,1,1,0,1,0,0,2017-02-28,2018-02-28,2018-02-02,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02597660,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Hospital for Special Surgery, New York",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT02598557,0,0,0,0,0,0,2019-10-30,2020-10-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02600715,1,1,0,1,0,0,2017-06-26,2018-06-26,2018-06-26,"Edgar LeClaire, MD",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02605785,0,0,0,0,0,0,2020-11-30,2021-11-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02607865,0,0,0,0,0,0,2017-02-14,2018-02-14,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02609399,1,1,0,1,0,0,2017-05-26,2018-05-26,2018-04-11,Johns Hopkins University,Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02610296,1,0,0,0,1,0,2018-06-28,2019-06-28,,Quark Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02612454,0,0,0,0,0,0,2023-11-16,2024-11-16,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,176
NCT02615184,0,0,0,0,0,0,2019-11-01,2020-11-01,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,650
NCT02620579,0,0,0,0,0,0,2020-12-31,2021-12-31,,Duke University,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1342
NCT02621593,1,0,0,0,1,0,2017-01-31,2018-01-31,,Lumenis Ltd.,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,16
NCT02625428,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02625610,0,0,0,0,0,0,2019-09-13,2020-09-13,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT02629861,0,1,0,1,0,1,2017-04-10,2018-04-10,2018-10-10,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02634710,0,0,0,0,0,0,2021-12-31,2022-12-31,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,315
NCT02638103,1,1,0,1,0,0,2018-06-06,2019-06-06,2019-06-05,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02640508,0,0,0,0,0,0,2019-12-31,2020-12-31,,Virginia G. Kaklamani,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02640612,1,1,0,1,0,0,2017-11-01,2018-11-01,2018-10-22,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02649166,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Florida,Other,0,1,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT02649387,0,0,0,0,0,0,2021-02-08,2022-02-08,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02649894,0,0,0,0,0,0,2018-04-18,2019-04-18,,CareFusion,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,9
NCT02650999,0,0,0,0,0,0,2019-02-25,2020-02-25,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT02651714,1,0,0,0,1,0,2017-09-30,2018-09-30,,Vanda Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,37
NCT02652052,0,0,0,0,0,0,2019-11-30,2020-11-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02653391,1,0,0,0,1,0,2018-03-31,2019-03-31,,Stealth BioTherapeutics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT02654132,1,1,0,1,0,0,2018-01-17,2019-01-17,2019-01-17,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02655692,0,0,0,0,0,0,2020-03-01,2021-03-01,,VA Office of Research and Development,U.S. Fed,2,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02656472,1,0,1,1,0,1,2017-04-30,2018-04-30,2019-07-14,"Andrew VanBergen, MD",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02656875,0,0,0,0,0,0,2017-05-31,2018-05-31,,Trevena Inc.,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT02657551,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02658487,0,0,0,0,0,0,2020-01-31,2021-01-31,,Vanderbilt-Ingram Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,180
NCT02659514,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,67
NCT02659787,1,1,0,1,0,1,2017-04-30,2018-04-30,2019-04-09,University of Chicago,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02660073,0,0,0,0,0,0,2019-09-30,2020-09-30,,United States Department of Defense,U.S. Fed,2,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,13
NCT02660827,0,1,0,1,0,0,2018-11-28,2019-11-28,2018-10-22,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,48
NCT02664961,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-16,Tracon Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT02666950,0,1,0,1,0,0,2018-09-25,2019-09-25,2019-07-22,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1898
NCT02668146,1,0,0,0,1,0,2017-03-31,2018-03-31,,VA Greater Los Angeles Healthcare System,U.S. Fed,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT02668874,1,0,1,1,0,1,2017-08-21,2018-08-21,2019-05-14,Arwa Owais,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02669030,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Institute for Advanced Medical Research, Alpharetta, GA",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02670434,1,0,0,0,1,0,2017-07-31,2018-07-31,,"Kowa Research Institute, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,33
NCT02672033,1,0,0,0,1,0,2018-07-17,2019-07-17,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,1,2015.0,1,0,0,0,0,1,0,0,0,0,1,277
NCT02672722,1,0,0,0,1,0,2017-08-31,2018-08-31,,University of Virginia,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT02673333,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02674568,0,0,0,0,0,0,2018-10-16,2019-10-16,,Stemcentrx,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02683239,0,0,0,0,0,0,2021-08-01,2022-08-01,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,176
NCT02683928,0,0,0,0,0,0,2017-06-30,2018-06-30,,Glenmark Pharmaceuticals S.A.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,6
NCT02684097,1,0,0,0,1,0,2017-11-28,2018-11-28,,Emma.Guttman,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02684227,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02692391,0,0,0,0,0,0,2021-06-30,2022-06-30,,Georgios Papachristou,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02692716,0,0,0,0,0,0,2018-09-25,2019-09-25,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02696044,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Center for Rare Neurological Diseases, Norcross, GA",Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02701985,1,1,0,1,0,0,2017-07-10,2018-07-10,2018-05-30,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02704130,1,0,0,0,1,0,2018-01-31,2019-01-31,,Atrium Health,Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,95
NCT02704689,1,1,0,1,0,1,2017-01-19,2018-01-19,2018-03-22,Stryker Spine,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02706483,0,0,0,0,0,0,2017-05-31,2018-05-31,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02709109,0,0,0,0,0,0,2017-09-30,2018-09-30,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02709538,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-23,Glenmark Specialty S.A.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02710422,0,1,0,1,0,0,2019-01-22,2020-01-22,2019-07-27,University of Miami,Other,0,0,0,1.0,Phase 2,1,2016.0,1,0,1,0,0,0,0,0,0,0,1,476
NCT02710890,0,0,0,0,0,0,2019-06-28,2020-06-28,,"UCB BIOSCIENCES, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,21
NCT02714036,0,0,0,0,0,0,2019-09-28,2020-09-28,,MediciNova,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,15
NCT02716974,0,0,0,0,0,0,2022-04-30,2023-04-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT02718300,0,0,0,0,0,0,2021-01-31,2022-01-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,143
NCT02719327,0,0,0,0,0,0,2021-11-30,2022-11-30,,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT02721017,1,0,1,1,0,0,2018-08-28,2019-08-28,2019-08-27,Michael Harrison,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,3
NCT02724371,0,0,0,0,0,0,2026-09-01,2027-09-01,,"Mentor Worldwide, LLC",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,17
NCT02725515,1,1,0,1,0,0,2018-07-17,2019-07-17,2019-06-06,"Xencor, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,13
NCT02727101,1,0,0,0,1,0,2017-07-31,2018-07-31,,"Mid-Atlantic Epilepsy and Sleep Center, LLC",Other,0,1,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02727699,0,0,0,0,0,0,2019-03-15,2020-03-15,,Actinogen Medical,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3
NCT02729961,0,0,0,0,0,0,2023-07-01,2024-07-01,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT02730247,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Liza Villaruz, MD",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT02733588,1,1,0,1,0,1,2017-04-05,2018-04-05,2018-08-21,Xeris Pharmaceuticals,Industry,1,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02737202,0,0,0,0,0,0,2019-07-30,2020-07-30,,Baylor College of Medicine,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT02737930,0,0,0,0,0,0,2020-06-30,2021-06-30,,Bogachan Sahin,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02738333,1,1,0,1,0,0,2017-02-14,2018-02-14,2018-02-12,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02740127,0,0,0,0,0,0,2021-06-30,2022-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02741570,0,0,0,0,0,0,2021-02-04,2022-02-04,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02743494,0,0,0,0,0,0,2021-05-24,2022-05-24,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02744677,1,0,0,0,1,0,2018-07-17,2019-07-17,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,77
NCT02744911,0,0,0,0,0,0,2018-12-31,2019-12-31,,"SpeechVive, Inc",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT02748889,1,1,0,1,0,0,2017-05-09,2018-05-09,2018-04-24,Giuseppe Giaccone,Other,0,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,1,0,0,0,0,0,0,0,1,3
NCT02753595,0,0,0,0,0,0,2019-06-28,2020-06-28,,Eisai Inc.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,328
NCT02755597,0,0,0,0,0,0,2019-09-02,2020-09-02,,AbbVie,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02757105,1,1,0,1,0,0,2017-06-16,2018-06-16,2018-06-15,RedHill Biopharma Limited,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02761980,1,1,0,1,0,0,2017-12-06,2018-12-06,2018-11-08,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2856
NCT02763735,0,0,0,0,0,0,2019-06-30,2020-06-30,,Vanderbilt University,Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,499
NCT02764333,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT02767323,0,0,0,0,0,0,2021-01-31,2022-01-31,,Duke University,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT02767531,1,1,0,1,0,0,2018-05-31,2019-05-31,2018-11-19,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT02777593,0,0,0,0,0,0,2019-11-30,2020-11-30,,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,52
NCT02778399,0,0,0,0,0,0,2018-04-30,2019-04-30,,ObsEva SA,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,12
NCT02781779,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Kansas Medical Center,Other,0,0,0,4.0,Phase 4,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,219
NCT02782715,0,0,0,0,0,0,2021-01-01,2022-01-01,,"University of Wisconsin, Madison",Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,715
NCT02784392,1,0,1,1,0,0,2018-03-31,2019-03-31,2018-07-20,Lyric Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02784756,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University Health Network, Toronto",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,931
NCT02785406,0,0,0,0,0,0,2018-11-15,2019-11-15,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02788981,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,594
NCT02797470,0,0,0,0,0,0,2021-09-30,2022-09-30,,AIDS Malignancy Consortium,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,46
NCT02798211,0,0,0,0,0,0,2018-12-05,2019-12-05,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02799784,1,1,0,1,0,0,2017-04-27,2018-04-27,2018-04-03,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02800486,0,0,0,0,0,0,2021-05-31,2022-05-31,,Northwell Health,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,271
NCT02803203,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02807376,1,1,0,1,0,0,2017-08-23,2018-08-23,2018-08-21,Ethicon Endo-Surgery,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,38
NCT02808975,0,0,0,0,0,0,2019-05-16,2020-05-16,,AbbVie,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02809976,1,0,1,1,0,1,2017-01-31,2018-01-31,2018-04-27,Tufts Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,121
NCT02811159,0,1,0,1,0,1,2017-05-04,2018-05-04,2019-05-29,Repros Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02819297,0,0,0,0,0,0,2017-06-30,2018-06-30,,Braintree Laboratories,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,43
NCT02828436,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,749
NCT02834975,0,0,0,0,0,0,2020-12-31,2021-12-31,,Marilyn Huang,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02837575,1,0,0,0,1,0,2018-04-30,2019-04-30,,Vical,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,13
NCT02838420,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-29,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,1731
NCT02840240,0,0,0,0,0,0,2018-11-30,2019-11-30,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02840799,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02841033,0,0,0,0,0,0,2020-06-30,2021-06-30,,Vaishali Sanchorawala,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT02844517,1,0,0,0,1,0,2017-10-31,2018-10-31,,University of Virginia,Other,0,1,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,402
NCT02851849,1,0,0,0,1,0,2017-06-30,2018-06-30,,Ligand Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02863328,0,0,0,0,0,0,2017-08-01,2018-08-01,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02864043,0,0,0,0,0,0,2019-12-01,2020-12-01,,NinePoint Medical,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,6
NCT02865135,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02865395,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-12-26,Campbell Grant,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02865629,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Cincinnati,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,222
NCT02865850,0,0,0,0,0,0,2020-05-31,2021-05-31,,Akebia Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,25
NCT02867709,1,1,0,1,0,0,2018-01-25,2019-01-25,2019-01-09,Allergan,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02872103,1,1,0,1,0,1,2017-12-20,2018-12-20,2019-01-09,Generon (Shanghai) Corporation Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02876172,0,0,0,0,0,0,2018-05-31,2019-05-31,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02878330,1,0,1,1,0,0,2018-07-17,2019-07-17,2019-07-17,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,269
NCT02885025,0,0,0,0,0,0,2019-03-12,2020-03-12,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02885181,1,1,0,1,0,0,2017-08-22,2018-08-22,2018-08-21,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02886585,0,0,0,0,0,0,2020-04-30,2021-04-30,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,1699
NCT02888301,1,0,0,0,1,0,2018-04-30,2019-04-30,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,1,2015.0,1,0,0,0,0,1,0,0,0,0,1,277
NCT02891798,0,0,0,0,0,0,2020-04-30,2021-04-30,,Brian Williams,U.S. Fed,2,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02892955,0,0,0,0,0,0,2020-12-31,2021-12-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,419
NCT02899052,0,0,0,0,0,0,2020-03-27,2021-03-27,,AbbVie,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT02903940,0,0,0,0,0,0,2019-09-30,2020-09-30,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,419
NCT02904226,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Jounce Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02905565,0,0,0,0,0,0,2020-11-30,2021-11-30,,"CSPC-NBP Pharmaceutical Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02906007,0,0,0,0,0,0,2020-03-31,2021-03-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2133
NCT02908074,1,0,0,0,1,0,2018-09-08,2019-09-08,,Mereo BioPharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02908620,1,1,0,1,0,0,2017-04-02,2018-04-02,2018-03-23,Cetylite Industries,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,1,0,0,0,1,2
NCT02912312,0,0,0,0,0,0,2030-02-28,2031-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,2066
NCT02913495,0,0,0,0,0,0,2019-08-31,2020-08-31,,Thomas Jefferson University,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,186
NCT02914236,1,1,0,1,0,0,2017-07-21,2018-07-21,2018-01-08,Aerin Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02915159,1,0,1,1,0,0,2018-08-07,2019-08-07,2019-08-07,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02915705,1,1,0,1,0,1,2018-02-12,2019-02-12,2019-02-28,Ultragenyx Pharmaceutical Inc,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,1,0,0,0,0,0,1,0,1,36
NCT02918019,0,0,0,0,0,0,2019-04-05,2020-04-05,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02918877,0,0,0,0,0,0,2019-09-30,2020-09-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT02920450,0,0,1,1,0,0,2019-01-02,2020-01-02,2019-07-16,University of Florida,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT02921997,0,0,0,0,0,0,2017-03-28,2018-03-28,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,2133
NCT02923011,0,0,0,0,0,0,2020-11-30,2021-11-30,,Matthew Bucknor,Other,0,0,0,3.0,Phase 3,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02923193,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Shockwave Medical, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,1,1,0,9
NCT02925000,0,0,0,0,0,0,2019-06-30,2020-06-30,,Taiwan Liposome Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,15
NCT02925650,0,0,0,0,0,0,2019-12-31,2020-12-31,,QR Pharma Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02928289,0,0,0,0,0,0,2019-01-17,2020-01-17,,"Sight Sciences, Inc.",Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT02929316,0,0,0,0,0,0,2018-10-05,2019-10-05,,"AGA Clinical Research Associates, LLC",Other,0,1,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02929485,1,0,0,0,1,0,2018-01-31,2019-01-31,,"University of California, Berkeley",Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,51
NCT02931240,0,0,0,0,0,0,2020-12-31,2021-12-31,,BioVentrix,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,6
NCT02932904,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-22,Takeda,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,650
NCT02935673,0,0,0,0,0,0,2018-07-17,2019-07-17,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02936635,0,0,0,0,0,0,2018-10-26,2019-10-26,,Cytokinetics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT02938793,0,0,0,0,0,0,2020-02-28,2021-02-28,,Prisma Health-Upstate,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,32
NCT02939560,1,0,1,1,0,1,2018-06-01,2019-06-01,2019-06-24,Medical University of South Carolina,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,511
NCT02942004,0,1,0,1,0,1,2017-09-24,2018-09-24,2019-04-11,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02949024,0,0,0,0,0,0,2017-04-12,2018-04-12,,"Clearside Biomedical, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02949271,1,1,0,1,0,0,2017-11-01,2018-11-01,2018-11-01,Duke University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02950025,1,1,0,1,0,0,2018-03-19,2019-03-19,2019-02-26,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1151
NCT02950480,0,0,1,1,0,0,2018-12-20,2019-12-20,2019-09-11,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1443
NCT02951130,0,0,0,0,0,0,2020-02-29,2021-02-28,,NICHD Neonatal Research Network,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,59
NCT02953314,1,0,0,0,1,0,2018-08-31,2019-08-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02955121,0,0,0,0,0,0,2019-11-30,2020-11-30,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2016.0,0,0,0,0,0,0,0,1,0,0,1,497
NCT02956642,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of California, San Francisco",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT02963922,1,0,1,1,0,0,2018-09-10,2019-09-10,2019-09-04,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,981
NCT02964585,0,0,0,0,0,0,2019-09-30,2020-09-30,,George Washington University,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,85
NCT02966795,1,1,0,1,0,0,2018-06-06,2019-06-06,2019-06-06,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,430
NCT02968641,0,0,0,0,0,0,2020-12-31,2021-12-31,,Eiger BioPharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,13
NCT02969525,0,0,0,0,0,0,2017-11-30,2018-11-30,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,75
NCT02970305,0,0,0,0,0,0,2019-10-31,2020-10-31,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,24
NCT02970942,0,0,0,0,0,0,2019-11-27,2020-11-27,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,981
NCT02971748,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT02972658,0,1,0,1,0,0,2018-10-02,2019-10-02,2019-06-11,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,1512
NCT02978443,0,0,0,0,0,0,2019-12-31,2020-12-31,,Georgetown University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT02983045,0,0,0,0,0,0,2020-06-30,2021-06-30,,Nektar Therapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,20
NCT02983617,0,0,0,0,0,0,2019-02-20,2020-02-20,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,510
NCT02983799,0,0,0,0,0,0,2020-05-21,2021-05-21,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02986087,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,437
NCT02987153,0,0,0,0,0,0,2019-11-30,2020-11-30,,Northwell Health,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,271
NCT02988466,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,218
NCT02989584,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02990793,0,0,0,0,0,0,2019-11-30,2020-11-30,,Wave Neuroscience,Industry,1,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT02991430,1,1,0,1,0,0,2018-05-11,2019-05-11,2019-05-09,Scion NeuroStim,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,1,1,0,6
NCT02992288,1,1,0,1,0,0,2018-03-28,2019-03-28,2019-03-11,Bayer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1343
NCT02996487,0,0,0,0,0,0,2020-09-30,2021-09-30,,William Beaumont Hospitals,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,84
NCT02998268,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT02998554,0,0,0,0,0,0,2019-05-16,2020-05-16,,Shire,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,342
NCT02998840,1,0,0,0,1,0,2017-04-25,2018-04-25,,AOBiome LLC,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,10
NCT02999009,0,0,0,0,0,0,2024-02-29,2025-02-28,,Stryker Orthopaedics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,24
NCT03000010,0,0,0,0,0,0,2020-01-18,2021-01-18,,University of Michigan,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT03000179,0,0,0,0,0,0,2022-04-15,2023-04-15,,Vanderbilt-Ingram Cancer Center,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03001219,0,0,0,0,0,0,2018-11-06,2019-11-06,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT03002623,1,1,0,1,0,0,2018-02-12,2019-02-12,2018-07-27,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT03003468,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Lawrence Feldman, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT03006770,0,0,0,0,0,0,2020-05-31,2021-05-31,,Pluristem Ltd.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,9
NCT03007407,0,0,0,0,0,0,2019-07-31,2020-07-31,,NSABP Foundation Inc,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,63
NCT03008889,0,0,0,0,0,0,2019-09-30,2020-09-30,,Emory University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03010462,1,0,0,0,1,0,2018-08-15,2019-08-15,,Nexstim Ltd,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03012061,1,1,0,1,0,0,2018-05-30,2019-05-30,2019-05-28,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03018080,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Antoinette Tan, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03018405,0,0,0,0,0,0,2021-05-31,2022-05-31,,Celyad (formerly named Cardio3 BioSciences),Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,10
NCT03019133,0,0,0,0,0,0,2021-06-30,2022-06-30,,Brian Gehlbach,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT03021291,1,0,0,0,1,0,2017-12-08,2018-12-08,,"Gelesis, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,9
NCT03024255,0,0,0,0,0,0,2017-08-31,2018-08-31,,"Brickell Biotech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT03024437,0,0,0,0,0,0,2020-01-31,2021-01-31,,Roberto Pili,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03025698,0,0,0,0,0,0,2025-04-01,2026-04-01,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03026738,0,0,0,0,0,0,2018-12-31,2019-12-31,,Assiut University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,3,1,0,1331
NCT03027557,0,0,0,0,0,0,2019-04-01,2020-04-01,,Peter Vestergaard,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03027960,0,0,0,0,0,0,2019-05-14,2020-05-14,,Yale University,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1053
NCT03029650,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-03-29,University of Iowa,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,158
NCT03033069,0,0,0,0,0,0,2018-11-08,2019-11-08,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,185
NCT03033576,0,0,0,0,0,0,2022-03-15,2023-03-15,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03042533,1,0,0,0,1,0,2018-05-29,2019-05-29,,University of Washington,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03043053,0,0,0,0,0,0,2021-04-01,2022-04-01,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03044197,1,1,0,1,0,1,2018-04-12,2019-04-12,2019-04-18,"The University of Texas Medical Branch, Galveston",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,158
NCT03045328,0,0,0,0,0,0,2021-09-30,2022-09-30,,Steven E. Coutre,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03050801,0,0,0,0,0,0,2020-02-01,2021-02-01,,National Institute of Neurological Disorders and Stroke (NINDS),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,560
NCT03051971,1,0,0,0,1,0,2018-03-31,2019-03-31,,Medstar Health Research Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,79
NCT03052816,1,0,0,0,1,0,2018-06-01,2019-06-01,,University Hospitals Cleveland Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,185
NCT03053089,1,0,0,0,1,0,2018-02-01,2019-02-01,,"ArmaGen, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,5
NCT03053427,1,1,0,1,0,0,2018-06-25,2019-06-25,2019-06-18,Astellas Pharma Inc,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,506
NCT03054285,0,0,0,0,0,0,2020-04-01,2021-04-01,,Loyola University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03054922,0,0,0,0,0,0,2018-09-30,2019-09-30,,Nationwide Children's Hospital,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,161
NCT03055260,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,749
NCT03055832,1,1,0,1,0,1,2017-07-20,2018-07-20,2019-04-22,"Tear Film Innovations, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03057132,1,1,0,1,0,1,2017-02-28,2018-02-28,2019-04-25,3M,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,56
NCT03059355,0,0,0,0,0,0,2025-06-30,2026-06-30,,Joshua M Hare,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,15
NCT03060577,1,0,0,0,1,0,2018-08-29,2019-08-29,,The Medicines Company,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,59
NCT03064672,0,0,0,0,0,0,2020-04-30,2021-04-30,,Hadassah Medical Organization,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,3,1,0,588
NCT03066505,0,0,0,0,0,0,2019-04-17,2020-04-17,,Wave Neuroscience,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT03066869,0,0,0,0,0,0,2020-02-29,2021-02-28,,Ocular Immunology and Uveitis Foundation,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03067571,0,0,0,0,0,0,2021-05-01,2022-05-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03068130,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Reata Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,44
NCT03069677,1,1,0,1,0,1,2018-05-11,2019-05-11,2019-06-17,University of Pennsylvania,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1052
NCT03070782,1,0,0,0,1,0,2018-07-18,2019-07-18,,Akcea Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,10
NCT03071263,0,0,0,0,0,0,2018-11-27,2019-11-27,,"Relypsa, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,9
NCT03071861,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of New Mexico,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,200
NCT03072732,0,0,0,0,0,0,2017-02-01,2018-02-01,,Zoll Medical Corporation,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,17
NCT03076554,0,0,0,0,0,0,2020-09-30,2021-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03078075,0,0,0,0,0,0,2019-07-03,2020-07-03,,University of Texas Southwestern Medical Center,Other,0,1,1,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,626
NCT03078192,0,0,0,0,0,0,2020-11-14,2021-11-14,,Bastiaan Driehuys,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,6
NCT03080194,1,0,0,0,1,0,2018-04-30,2019-04-30,,Maosheng Fang,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,1
NCT03080896,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Louisville,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT03081117,0,0,0,0,0,0,2021-07-31,2022-07-31,,Johns Hopkins University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03085147,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03086044,0,0,0,0,0,0,2020-12-31,2021-12-31,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03086343,0,0,0,0,0,0,2020-02-29,2021-02-28,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03089554,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rachel Miller,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03090607,0,0,0,0,0,0,2021-07-31,2022-07-31,,Impleo Medical Inc.,Industry,1,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT03091478,0,0,0,0,0,0,2020-05-30,2021-05-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03091777,0,0,1,1,0,1,2017-11-15,2018-11-15,2019-08-01,"Gage Development Company, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03092518,0,0,0,0,0,0,2020-10-01,2021-10-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03093870,0,0,0,0,0,0,2019-07-31,2020-07-31,,Aslan Pharmaceuticals,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,16
NCT03094429,0,0,0,0,0,0,2019-06-30,2020-06-30,,SyneuRx International (Taiwan) Corp,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03095573,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,66
NCT03096366,0,0,0,0,0,0,2019-08-31,2020-08-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT03096782,0,0,0,0,0,0,2020-10-31,2021-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,2066
NCT03097588,0,0,0,0,0,0,2019-04-30,2020-04-30,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,163
NCT03098732,0,0,0,0,0,0,2019-12-31,2020-12-31,,Pulse Therapeutics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03099486,0,0,0,0,0,0,2019-10-22,2020-10-22,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03102047,0,0,0,0,0,0,2019-12-31,2020-12-31,,NSABP Foundation Inc,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,63
NCT03103750,0,0,0,0,0,0,2022-01-31,2023-01-31,,Yale University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03104491,0,0,0,0,0,0,2020-05-31,2021-05-31,,Leland Metheny,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03104595,0,0,0,0,0,0,2018-12-31,2019-12-31,,Enzychem Lifesciences Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,5
NCT03106740,0,0,0,0,0,0,2021-09-30,2022-09-30,,Marco Loggia,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,1,0,0,0,0,1,0,1
NCT03106948,1,0,0,0,1,0,2018-01-31,2019-01-31,,Southeast Renal Research Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03107052,0,0,0,0,0,0,2019-06-11,2020-06-11,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,101
NCT03107546,0,0,0,0,0,0,2022-04-30,2023-04-30,,Gillette Children's Specialty Healthcare,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03108846,0,0,0,0,0,0,2021-12-31,2022-12-31,,JHSPH Center for Clinical Trials,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03110978,0,0,0,0,0,0,2022-06-30,2023-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,1,0,0,0,1,0,2066
NCT03112720,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Rutgers, The State University of New Jersey",Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,227
NCT03114020,0,0,0,0,0,0,2020-03-31,2021-03-31,,Gerard Turino,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03115151,0,0,0,0,0,0,2019-06-01,2020-06-01,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,626
NCT03116529,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of Maryland, College Park",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,0,1,0,0,1,0,318
NCT03117998,0,0,0,0,0,0,2020-07-31,2021-07-31,,"REMD Biotherapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03118505,0,0,0,0,0,0,2020-06-30,2021-06-30,,Medtronic Spinal and Biologics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,52
NCT03119064,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Heinrich Elinzano, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03120325,0,0,0,0,0,0,2020-03-01,2021-03-01,,Stanford University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03120936,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Public Health Foundation Enterprises, Inc.",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03122119,0,0,0,0,0,0,2020-03-01,2021-03-01,,Star Spine and Sport,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03123289,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Rutgers, The State University of New Jersey",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,227
NCT03123822,0,0,0,0,0,0,2022-01-31,2023-01-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03126877,0,0,0,0,0,0,2020-09-30,2021-09-30,,Whitten Laser Eye,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,2
NCT03131882,1,0,0,0,1,0,2017-06-30,2018-06-30,,Mahidol University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,419
NCT03132571,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-06-28,Yale University,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1053
NCT03134222,0,0,0,0,0,0,2019-03-13,2020-03-13,,Gilead Sciences,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03135249,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03137186,1,0,0,0,1,0,2018-01-31,2019-01-31,,Mansoura University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,328
NCT03137368,0,0,0,0,0,0,2023-10-30,2024-10-30,,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,1,2,1,0,22
NCT03137992,0,0,0,0,0,0,2018-01-31,2019-01-31,,"Lupin, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03138252,1,0,1,1,0,1,2017-07-31,2018-07-31,2018-11-01,University Hospitals Cleveland Medical Center,Other,0,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,185
NCT03138382,1,1,0,1,0,1,2018-03-01,2019-03-01,2019-05-21,"University of California, San Diego",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,561
NCT03139448,1,1,0,1,0,1,2017-10-06,2018-10-06,2019-01-09,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,422
NCT03140423,0,0,0,0,0,0,2021-12-31,2022-12-31,,Harvard Pilgrim Health Care,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,25
NCT03142152,0,0,0,0,0,0,2021-10-01,2022-10-01,,"Cardiac Dimensions, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT03143153,0,0,0,0,0,0,2020-05-25,2021-05-25,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03145441,0,0,0,0,0,0,2019-12-31,2020-12-31,,Semmelweis University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,27
NCT03146468,0,0,0,0,0,0,2020-06-01,2021-06-01,,Melbourne Health,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,47
NCT03147690,0,0,0,0,0,0,2019-12-31,2020-12-31,,David Mooney,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03152409,0,0,0,0,0,0,2020-07-31,2021-07-31,,Jessica Harder,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03158064,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03159078,0,0,0,0,0,0,2019-12-01,2020-12-01,,University of Puerto Rico,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03159702,0,0,0,0,0,0,2020-07-01,2021-07-01,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,315
NCT03160001,1,0,0,0,1,0,2018-08-15,2019-08-15,,Faiq Gorial,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03161379,0,0,0,0,0,0,2023-01-31,2024-01-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,461
NCT03161483,0,0,0,0,0,0,2020-01-22,2021-01-22,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03162328,1,1,0,1,0,0,2017-11-10,2018-11-10,2018-11-08,Philips Respironics,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,33
NCT03163810,1,0,0,0,1,0,2017-12-13,2018-12-13,,Erchonia Corporation,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,29
NCT03164057,0,0,0,0,0,0,2025-06-30,2026-06-30,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,1,0,0,1,0,302
NCT03165994,0,0,0,0,0,0,2019-07-01,2020-07-01,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1443
NCT03168776,0,0,0,0,0,0,2020-06-30,2021-06-30,,Sino Medical Sciences Technology Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,8
NCT03169231,0,0,0,0,0,0,2020-06-30,2021-06-30,,Longeveron LLC,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03170258,0,0,0,0,0,0,2020-07-31,2021-07-31,,Duke University,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03170648,0,0,0,0,0,0,2020-05-31,2021-05-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT03171168,0,0,0,0,0,0,2019-11-30,2020-11-30,,Montefiore Medical Center,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,240
NCT03172793,0,0,0,0,0,0,2019-04-17,2020-04-17,,"Joseph L. Kuti, PharmD",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03173703,0,0,0,0,0,0,2020-06-30,2021-06-30,,LeMaitre Vascular,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,3
NCT03178942,1,1,0,1,0,1,2017-11-11,2018-11-11,2019-02-15,Encube Ethicals Pvt. Ltd.,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3
NCT03180372,0,0,0,0,0,0,2019-08-30,2020-08-30,,Sciton,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03180684,0,0,0,0,0,0,2020-06-30,2021-06-30,,Inovio Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,1,0,0,0,0,0,1,0,25
NCT03180866,1,0,0,0,1,0,2018-03-31,2019-03-31,,Illumicure Inc,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT03181594,1,0,0,0,1,0,2018-07-31,2019-07-31,,"Arrinex, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03182933,1,1,0,1,0,0,2018-07-16,2019-07-16,2019-05-10,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,1,0,0,0,0,0,1,0,715
NCT03184571,0,0,0,0,0,0,2019-12-31,2020-12-31,,BerGenBio ASA,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03185013,0,0,0,0,0,0,2020-04-30,2021-04-30,,Inovio Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,1,0,0,0,0,1,1,0,25
NCT03186638,0,0,0,0,0,0,2020-12-01,2021-12-01,,Gary Morrow,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,23
NCT03191149,0,0,0,0,0,0,2022-07-31,2023-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03201809,0,0,0,0,0,0,2020-01-01,2021-01-01,,"University of California, Davis",Other,0,0,0,5.0,,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,530
NCT03202940,0,0,0,0,0,0,2019-08-30,2020-08-30,,Massachusetts General Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03204812,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03205150,0,0,0,0,0,0,2019-11-05,2020-11-05,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03205995,0,0,0,0,0,0,2020-02-29,2021-02-28,,Omeros Corporation,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,19
NCT03207009,0,0,0,0,0,0,2021-04-30,2022-04-30,,bluebird bio,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,0,0,0,0,0,1,1,1,0,11
NCT03207815,0,0,0,0,0,0,2020-12-31,2021-12-31,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03212885,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03213210,0,0,0,0,0,0,2020-03-31,2021-03-31,,Sunstar Americas,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03215914,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Pennsylvania,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03218384,0,0,0,0,0,0,2019-08-31,2020-08-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03218917,0,0,0,0,0,0,2020-06-30,2021-06-30,,Insmed Incorporated,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,15
NCT03219983,1,0,0,0,1,0,2017-06-30,2018-06-30,,The Christ Hospital,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT03220646,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03221400,0,0,0,0,0,0,2021-12-31,2022-12-31,,Tarveda Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03221543,0,0,0,0,0,0,2022-08-01,2023-08-01,,Baylor Research Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,131
NCT03222076,0,0,0,0,0,0,2022-09-30,2023-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03223922,0,0,0,0,0,0,2022-07-21,2023-07-21,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,461
NCT03226392,0,0,0,0,0,0,2019-07-05,2020-07-05,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03228186,0,0,0,0,0,0,2020-09-01,2021-09-01,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03228667,0,0,0,0,0,0,2020-06-30,2021-06-30,,Altor BioScience,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03228823,0,0,0,0,0,0,2021-08-31,2022-08-31,,Hunter Holmes Mcguire Veteran Affairs Medical Center,U.S. Fed,2,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,19
NCT03229889,0,0,0,0,0,0,2019-06-01,2020-06-01,,"University of California, Irvine",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,1,0,0,1,0,310
NCT03231345,1,1,0,1,0,1,2017-09-06,2018-09-06,2018-10-15,University Medical Center of Southern Nevada,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT03232450,0,0,0,0,0,0,2023-12-31,2024-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1898
NCT03233529,1,1,0,1,0,0,2018-05-04,2019-05-04,2019-04-26,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,2856
NCT03235544,0,0,0,0,0,0,2020-07-31,2021-07-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03237845,0,0,0,0,0,0,2018-01-25,2019-01-25,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03239418,0,0,0,0,0,0,2019-12-31,2020-12-31,,Brooks Rehabilitation,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT03240588,0,0,0,0,0,0,2023-12-31,2024-12-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT03241927,0,0,0,0,0,0,2018-09-18,2019-09-18,,Nina Bhardwaj,Other,0,0,0,1.0,Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,7
NCT03242252,0,0,0,0,0,0,2019-04-04,2020-04-04,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03244072,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Jason Ahee, M.D.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03244475,0,0,0,0,0,0,2021-09-30,2022-09-30,,VA Office of Research and Development,U.S. Fed,2,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03245255,0,0,0,0,0,0,2020-03-31,2021-03-31,,Thomas Jefferson University,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,186
NCT03245437,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,692
NCT03246919,0,0,0,0,0,0,2020-05-31,2021-05-31,,Loyola University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03248037,0,0,0,0,0,0,2019-07-09,2020-07-09,,Cornea Research Foundation of America,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03248739,0,0,0,0,0,0,2020-06-30,2021-06-30,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03250273,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03252431,0,0,0,0,0,0,2019-09-30,2020-09-30,,Generon (Shanghai) Corporation Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03252964,1,1,0,1,0,0,2018-05-23,2019-05-23,2018-10-02,"Savvysherpa, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03253393,0,0,0,0,0,0,2019-02-27,2020-02-27,,The University of New South Wales,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,60
NCT03254199,1,0,0,0,1,0,2018-07-27,2019-07-27,,"Flex Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03257358,0,0,0,0,0,0,2019-03-05,2020-03-05,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03259555,0,0,0,0,0,0,2019-01-02,2020-01-02,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,185
NCT03259789,0,0,0,0,0,0,2019-01-21,2020-01-21,,Theracos,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,21
NCT03263026,0,0,0,0,0,0,2020-10-31,2021-10-31,,Denovo Biopharma LLC,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03264066,0,0,0,0,0,0,2019-07-18,2020-07-18,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03264404,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Rachael A Safyan, MD",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03268382,0,0,0,0,0,0,2019-03-20,2020-03-20,,Aprea Therapeutics AB,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,6
NCT03270839,1,0,0,0,1,0,2018-03-01,2019-03-01,,"Medical Corps, Israel Defense Force",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,23
NCT03271047,0,0,0,0,0,0,2019-12-31,2020-12-31,,Array BioPharma,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,65
NCT03271918,1,0,0,0,1,0,2017-02-01,2018-02-01,,University of Sao Paulo General Hospital,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,368
NCT03272698,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Saskatchewan,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,166
NCT03275870,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Elena Gonzalez Brant, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03277261,0,0,0,0,0,0,2021-03-31,2022-03-31,,"TG Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03277690,0,0,0,0,0,0,2019-12-01,2020-12-01,,Cortendo AB,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03280446,1,0,0,0,1,0,2018-08-31,2019-08-31,,SHERRY Thomas,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03282123,0,0,0,0,0,0,2019-08-31,2020-08-31,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03283670,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT03284710,0,0,0,0,0,0,2020-01-09,2021-01-09,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,2133
NCT03287336,0,0,0,0,0,0,2019-10-31,2020-10-31,,Homa Ahmadzia,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03288454,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Perosphere, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03288714,0,0,0,0,0,0,2019-03-01,2020-03-01,,"NeoSync, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03292458,0,0,0,0,0,0,2022-08-31,2023-08-31,,Kristina Simonyan,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03293498,1,0,0,0,1,0,2018-03-14,2019-03-14,,Novavax,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,25
NCT03297177,0,0,0,0,0,0,2023-01-01,2024-01-01,,Regeneris Medical,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03298412,0,0,0,0,0,0,2025-03-31,2026-03-31,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03301857,0,0,0,0,0,0,2023-07-19,2024-07-19,,Amgen,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03302910,0,0,0,0,0,0,2021-03-31,2022-03-31,,Indiana University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT03303144,1,0,0,0,1,0,2018-02-28,2019-02-28,,"Rockwell Medical Technologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03303339,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Trovagene, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03305341,0,0,0,0,0,0,2020-04-08,2021-04-08,,"Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03305653,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03306277,0,0,0,0,0,0,2019-11-12,2020-11-12,,"AveXis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,8
NCT03307174,0,0,0,0,0,0,2019-02-28,2020-02-28,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT03307512,0,0,0,0,0,0,2019-07-30,2020-07-30,,Dance Biopharm Inc.,Industry,1,1,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03312595,1,0,0,0,1,0,2018-07-15,2019-07-15,,"Acera Surgical, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03313076,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03313362,0,0,0,0,0,0,2019-08-31,2020-08-31,,Brain Sentinel,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03314974,0,0,0,0,0,0,2023-11-10,2024-11-10,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,218
NCT03316586,0,0,0,0,0,0,2021-05-31,2022-05-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03317444,0,0,0,0,0,0,2018-05-04,2019-05-04,,"Tricida, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,4
NCT03318393,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03319485,0,0,0,0,0,0,2019-12-31,2020-12-31,,InSightec,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,61
NCT03320863,0,0,0,0,0,0,2019-12-30,2020-12-30,,"Thimble Bioelectronics, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03321188,0,0,0,0,0,0,2020-12-15,2021-12-15,,Andrea Jewell,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03321513,0,0,0,0,0,0,2019-12-06,2020-12-06,,Jaeb Center for Health Research,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,93
NCT03322566,0,0,0,0,0,0,2018-12-13,2019-12-13,,Incyte Corporation,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03324880,0,0,0,0,0,0,2020-03-30,2021-03-30,,Shire,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,342
NCT03325426,0,0,0,0,0,0,2021-06-01,2022-06-01,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03328702,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Davis",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,530
NCT03330119,1,0,0,0,1,0,2018-06-20,2019-06-20,,"Brest, Norman A., M.D.",Other,0,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03331042,1,1,0,1,0,1,2018-03-20,2019-03-20,2019-04-16,Sequential Medicine Ltd,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03332095,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2133
NCT03333408,0,0,0,0,0,0,2019-09-30,2020-09-30,,Our Lady of the Lake Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03334721,0,0,0,0,0,0,2019-07-01,2020-07-01,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,511
NCT03335800,0,0,0,0,0,0,2019-02-21,2020-02-21,,Apple Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03336398,0,0,0,0,0,0,2022-12-31,2023-12-31,,New York State Psychiatric Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03337308,0,0,0,0,0,0,2018-06-18,2019-06-18,,Esperion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,1,0,0,1,0,21
NCT03338205,0,0,0,0,0,0,2021-12-31,2022-12-31,,Augusta University,Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,117
NCT03338322,1,0,0,0,1,0,2018-06-30,2019-06-30,,Cairo University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,1190
NCT03342235,0,0,0,0,0,0,2022-03-31,2023-03-31,,Jaeb Center for Health Research,Other,0,0,1,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,93
NCT03342404,0,0,0,0,0,0,2020-08-19,2021-08-19,,Celgene,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03344276,0,0,0,0,0,0,2020-02-29,2021-02-28,,"University of California, San Diego",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,561
NCT03345173,0,0,0,0,0,0,2021-10-31,2022-10-31,,New York State Psychiatric Institute,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03347188,0,0,0,0,0,0,2020-10-21,2021-10-21,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,101
NCT03347838,0,0,0,0,0,0,2021-07-31,2022-07-31,,"University of Colorado, Denver",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03348683,0,0,0,0,0,0,2018-12-11,2019-12-11,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03349060,0,0,0,0,0,0,2019-03-26,2020-03-26,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2856
NCT03350035,0,0,0,0,0,0,2019-12-31,2020-12-31,,Marinus Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03350217,0,0,0,0,0,0,2019-01-07,2020-01-07,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,497
NCT03350815,0,0,0,0,0,0,2020-11-27,2021-11-27,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1895
NCT03351777,1,0,0,0,1,0,2018-04-30,2019-04-30,,"Realm Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03352453,0,0,0,0,0,0,2019-06-17,2020-06-17,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03355326,0,0,0,0,0,0,2022-10-01,2023-10-01,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT03359161,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Steward St. Elizabeth's Medical Center of Boston, Inc.",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,0,0,0,0,0,1,0,0,1,0,16
NCT03360916,0,0,0,0,0,0,2022-07-01,2023-07-01,,University of Kansas Medical Center,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03361917,1,1,0,1,0,0,2018-04-18,2019-04-18,2019-04-05,Indiana University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,497
NCT03362931,0,0,0,0,0,0,2020-06-12,2021-06-12,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,495
NCT03363373,0,0,0,0,0,0,2020-12-31,2021-12-31,,Y-mAbs Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,5
NCT03363854,0,0,0,0,0,0,2018-10-29,2019-10-29,,LEO Pharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,171
NCT03365622,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Rochester,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03368339,1,0,0,0,1,0,2018-01-21,2019-01-21,,"Realm Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03369613,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03371108,0,0,0,0,0,0,2019-10-11,2020-10-11,,"Gan and Lee Pharmaceuticals, USA",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03371823,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Delaware,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,52
NCT03372941,0,0,0,0,0,0,2020-03-04,2021-03-04,,Washington University School of Medicine,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03373773,0,0,0,0,0,0,2020-01-31,2021-01-31,,Yale University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1053
NCT03379441,0,0,0,0,0,0,2023-01-01,2024-01-01,,"University of Turin, Italy",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,110
NCT03382899,0,0,0,0,0,0,2019-11-30,2020-11-30,,Eli Lilly and Company,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1512
NCT03383874,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,626
NCT03384420,0,0,0,0,0,0,2021-01-01,2022-01-01,,Minovia Therapeutics Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2
NCT03385993,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Florida,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03386474,0,0,0,0,0,0,2018-09-06,2019-09-06,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03387462,1,0,0,0,1,0,2018-08-30,2019-08-30,,"Public Health Foundation Enterprises, Inc.",Other,0,1,1,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03389308,0,0,0,0,0,0,2019-11-15,2020-11-15,,"Castle Creek Pharmaceuticals, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03391284,1,0,0,0,1,0,2018-02-28,2019-02-28,,Scripps Health,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,28
NCT03392649,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Chicago,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,594
NCT03393884,0,0,0,0,0,0,2022-02-28,2023-02-28,,Celsion,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,12
NCT03394677,1,0,0,0,1,0,2018-07-02,2019-07-02,,Dermavant Sciences GmbH,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,10
NCT03395223,0,0,0,0,0,0,2020-03-31,2021-03-31,,Provepharm SAS,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03395639,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Daiichi Sankyo, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT03398135,0,0,0,0,0,0,2022-12-04,2023-12-04,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03401190,0,0,0,0,0,0,2019-02-14,2020-02-14,,"CalciMedica, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03401489,0,0,0,0,0,0,2020-08-31,2021-08-31,,Northern California Institute of Research and Education,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03401918,0,0,0,0,0,0,2021-07-01,2022-07-01,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,1309
NCT03403205,0,0,0,0,0,0,2021-02-28,2022-02-28,,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,86
NCT03405155,0,0,0,0,0,0,2022-10-11,2023-10-11,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,162
NCT03407430,1,1,0,1,0,0,2017-06-03,2018-06-03,2018-04-06,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,229
NCT03409120,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03410524,0,0,0,0,0,0,2018-10-31,2019-10-31,,"University of Nevada, Reno",Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03410992,0,0,0,0,0,0,2018-12-28,2019-12-28,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03412760,0,0,0,0,0,0,2025-11-30,2026-11-30,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1443
NCT03412942,0,0,0,0,0,0,2018-12-31,2019-12-31,,Morris Innovative Incorporated,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03414541,1,0,0,0,1,0,2018-08-31,2019-08-31,,Afimmune,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,3
NCT03415581,0,0,0,0,0,0,2019-12-30,2020-12-30,,New York State Psychiatric Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03417687,0,0,0,0,0,0,2019-12-30,2020-12-30,,Polarean Imaging Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03418610,0,0,0,0,0,0,2019-01-09,2020-01-09,,Clinical Research Center of the Carolinas,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03420313,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Vermont,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03421353,0,0,0,0,0,0,2020-03-31,2021-03-31,,AstraZeneca,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03426761,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Infectious Diseases Physicians, Inc.",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03427892,1,1,0,1,0,0,2018-03-15,2019-03-15,2018-11-13,University of Texas Southwestern Medical Center,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,626
NCT03430531,0,0,0,0,0,0,2020-03-31,2021-03-31,,Milton S. Hershey Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03432260,0,0,0,0,0,0,2019-09-30,2020-09-30,,Durect,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03433339,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Cincinnati,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,222
NCT03434119,0,0,0,0,0,0,2019-01-09,2020-01-09,,Sanofi,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,1222
NCT03437278,0,0,0,0,0,0,2021-02-26,2022-02-26,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03437512,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Michigan,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03439657,0,0,0,0,0,0,2019-05-06,2020-05-06,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,3276
NCT03440047,0,0,0,0,0,0,2020-12-14,2021-12-14,,Mayo Clinic,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03442556,0,0,0,0,0,0,2024-05-15,2025-05-15,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03442751,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Avedro, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,11
NCT03443973,0,0,0,0,0,0,2022-05-31,2023-05-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03446547,0,0,0,0,0,0,2021-12-31,2022-12-31,,Vastra Gotaland Region,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,72
NCT03447132,0,0,0,0,0,0,2023-09-01,2024-09-01,,"International Cancer Research Group, United Arab Emirates",Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03448107,0,0,0,0,0,0,2023-04-30,2024-04-30,,NYU College of Dentistry,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03449108,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03451422,0,0,0,0,0,0,2023-06-15,2024-06-15,,Amgen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03452891,0,0,0,0,0,0,2020-07-01,2021-07-01,,University of Nebraska,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,327
NCT03456102,0,0,0,0,0,0,2021-04-30,2022-04-30,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1143
NCT03456856,0,0,0,0,0,0,2019-04-19,2020-04-19,,Amgen,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,685
NCT03457701,0,0,0,0,0,0,2020-02-24,2021-02-24,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3276
NCT03459222,0,0,0,0,0,0,2022-04-04,2023-04-04,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03460756,0,0,0,0,0,0,2019-06-30,2020-06-30,,Marinus Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03462641,0,0,0,0,0,0,2021-11-15,2022-11-15,,University of Michigan,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03463954,0,0,0,0,0,0,2021-10-31,2022-10-31,,Novian Health Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT03464136,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Janssen Scientific Affairs, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,34
NCT03465722,0,0,0,0,0,0,2021-04-30,2022-04-30,,Blueprint Medicines Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03467958,0,0,0,0,0,0,2022-12-30,2023-12-30,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03472872,0,0,0,0,0,0,2018-09-30,2019-09-30,,Spectrum Health - Lakeland,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03473847,0,0,0,0,0,0,2020-06-01,2021-06-01,,London Vision Clinic,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03475147,0,0,0,0,0,0,2020-01-01,2021-01-01,,Randy Kardon,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03476135,0,0,0,0,0,0,2018-09-10,2019-09-10,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,2,1,0,285
NCT03479229,0,0,0,0,0,0,2019-12-31,2020-12-31,,Viveve Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,3
NCT03479697,0,0,0,0,0,0,2020-07-31,2021-07-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03479944,0,0,0,0,0,0,2018-11-19,2019-11-19,,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,492
NCT03480568,0,0,0,0,0,0,2019-12-31,2020-12-31,,Baylor Research Institute,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,131
NCT03481725,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of California, San Diego",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,561
NCT03482713,1,1,0,1,0,0,2018-06-07,2019-06-07,2019-06-06,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,2145
NCT03484494,0,0,0,0,0,0,2021-03-31,2022-03-31,,Mclean Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,126
NCT03487913,0,0,0,0,0,0,2019-08-31,2020-08-31,,Palladio Biosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03488693,0,0,0,0,0,0,2027-09-01,2028-09-01,,Canadian Cancer Trials Group,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,1,1,0,57
NCT03491046,0,0,0,0,0,0,2019-12-31,2020-12-31,,Ohio State University,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,315
NCT03495024,0,0,0,0,0,0,2020-04-30,2021-04-30,,Corporal Michael J. Crescenz VA Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03498391,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03501550,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Cocrystal Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03501693,1,0,0,0,1,0,2018-05-24,2019-05-24,,"Fujifilm Medical Systems USA, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03503344,0,0,0,0,0,0,2023-12-31,2024-12-31,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1443
NCT03504917,0,0,0,0,0,0,2020-12-31,2021-12-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03505372,0,0,0,0,0,0,2019-06-28,2020-06-28,,Dana-Farber Cancer Institute,Other,0,1,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,647
NCT03506347,0,0,0,0,0,0,2019-01-17,2020-01-17,,Mayo Clinic,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1898
NCT03512067,1,1,0,1,0,0,2018-09-02,2019-09-02,2019-08-09,Brigham and Women's Hospital,Other,0,0,1,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,698
NCT03513445,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03514420,0,0,0,0,0,0,2019-07-30,2020-07-30,,Akcea Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03517566,0,0,0,0,0,0,2020-03-16,2021-03-16,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03518008,1,1,0,1,0,0,2018-06-11,2019-06-11,2019-03-14,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03518203,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03518333,0,0,0,0,0,0,2020-12-01,2021-12-01,,"Tissue Genesis, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03518840,0,0,0,0,0,0,2019-06-30,2020-06-30,,Loyola University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,102
NCT03519269,0,0,0,0,0,0,2022-08-01,2023-08-01,,Columbia University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03519659,0,0,0,0,0,0,2021-12-31,2022-12-31,,Ohio State University,Other,0,0,1,5.0,,0,2015.0,0,0,0,0,1,0,0,0,0,0,1,315
NCT03520491,0,0,0,0,0,0,2021-01-31,2022-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03521804,0,0,0,0,0,0,2019-06-30,2020-06-30,,"SoundBite Medical Solutions, Inc.",Industry,1,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03522350,1,1,0,1,0,0,2018-06-04,2019-06-04,2019-05-06,Weill Medical College of Cornell University,Other,0,1,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,586
NCT03523520,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,214
NCT03525431,0,0,0,0,0,0,2021-04-30,2022-04-30,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,1443
NCT03525613,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03526055,1,1,0,1,0,0,2018-05-31,2019-05-31,2018-11-12,Amol Soin,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03527212,0,0,0,0,0,0,2019-03-15,2020-03-15,,"Senju Pharmaceutical Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03527966,1,1,0,1,0,0,2018-07-27,2019-07-27,2019-07-12,"Virtua Health, Inc.",Other,0,0,0,4.0,Phase 4,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,4
NCT03528694,0,0,0,0,0,0,2021-11-24,2022-11-24,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,2450
NCT03529773,0,0,0,0,0,0,2019-11-01,2020-11-01,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2856
NCT03530696,0,0,0,0,0,0,2020-08-01,2021-08-01,,University of Arizona,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,265
NCT03531242,0,0,0,0,0,0,2023-12-31,2024-12-31,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,136
NCT03531840,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03534141,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03535272,0,0,0,0,0,0,2020-05-01,2021-05-01,,Centers for Disease Control and Prevention,U.S. Fed,2,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,267
NCT03535688,0,0,0,0,0,0,2021-08-31,2022-08-31,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03536754,0,0,0,0,0,0,2020-02-29,2021-02-28,,ChemoCentryx,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,17
NCT03537144,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Tennessee,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,99
NCT03537599,0,0,0,0,0,0,2021-09-30,2022-09-30,,Sumithira Vasu,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03537768,0,0,0,0,0,0,2019-08-01,2020-08-01,,Health Decisions,Other,0,0,1,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03539601,0,0,0,0,0,0,2021-03-01,2022-03-01,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03541499,0,0,0,0,0,0,2019-11-01,2020-11-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03541889,0,0,0,0,0,0,2023-11-30,2024-11-30,,University of Oklahoma,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,234
NCT03544229,0,0,0,0,0,0,2020-08-07,2021-08-07,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03545165,0,0,0,0,0,0,2021-06-30,2022-06-30,,Weill Medical College of Cornell University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03546816,0,0,0,0,0,0,2020-02-29,2021-02-28,,Menlo Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03549260,0,0,0,0,0,0,2018-11-09,2019-11-09,,LIB Therapeutics LLC,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,4
NCT03550118,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Washington,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT03550391,0,0,0,0,0,0,2021-12-31,2022-12-31,,Canadian Cancer Trials Group,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,1,0,0,1,1,0,57
NCT03555448,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03555968,0,0,0,0,0,0,2020-07-31,2021-07-31,,Lakehead University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,11
NCT03556943,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Ceevra, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03557775,0,0,0,0,0,0,2019-06-25,2020-06-25,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,511
NCT03557970,0,0,0,0,0,0,2022-12-20,2023-12-20,,OHSU Knight Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT03558074,0,0,0,0,0,0,2018-11-29,2019-11-29,,"Alkahest, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,6
NCT03558412,0,0,0,0,0,0,2019-12-01,2020-12-01,,Mingzhi Zhang,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,1,0,2,1,0,13
NCT03558555,0,0,0,0,0,0,2018-12-30,2019-12-30,,Yan Lai,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03560037,0,0,0,0,0,0,2020-07-01,2021-07-01,,"University of California, Davis",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,530
NCT03560986,0,0,0,0,0,0,2019-08-01,2020-08-01,,Grünenthal GmbH,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,71
NCT03562156,0,0,0,0,0,0,2020-07-20,2021-07-20,,Mycovia Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03562377,0,0,0,0,0,0,2019-07-04,2020-07-04,,LEO Pharma,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,171
NCT03563066,0,0,0,0,0,0,2019-07-31,2020-07-31,,McMaster University,Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,434
NCT03563573,0,0,0,0,0,0,2018-11-04,2019-11-04,,"AlkaliDx, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03565536,0,0,0,0,0,0,2019-04-30,2020-04-30,,Fujian Medical University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,2,1,0,52
NCT03566485,0,0,0,0,0,0,2023-07-31,2024-07-31,,Vanderbilt-Ingram Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03567005,1,1,0,1,0,0,2018-08-26,2019-08-26,2019-05-28,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03567655,0,0,0,0,0,0,2022-10-31,2023-10-31,,Asan Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,395
NCT03568331,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vanda Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,37
NCT03568942,0,0,0,0,0,0,2019-01-07,2020-01-07,,GlaxoSmithKline,Industry,1,0,1,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3276
NCT03569475,0,0,0,0,0,0,2021-05-19,2022-05-19,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03570749,0,0,0,0,0,0,2020-12-09,2021-12-09,,Eli Lilly and Company,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03571802,0,0,0,0,0,0,2019-09-30,2020-09-30,,"National University Hospital, Singapore",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,290
NCT03572387,0,0,0,0,0,0,2021-02-28,2022-02-28,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03572634,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Tolero Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,1,0,0,1,0,9
NCT03573882,0,0,0,0,0,0,2019-12-31,2020-12-31,,Global Blood Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03578276,0,0,0,0,0,0,2019-06-15,2020-06-15,,"Carolina Eyecare Physicians, LLC",Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03578549,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Michigan,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03578965,0,0,0,0,0,0,2019-08-31,2020-08-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1151
NCT03579160,0,0,0,0,0,0,2019-07-02,2020-07-02,,Brigham and Women's Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03579875,0,0,0,0,0,0,2026-02-28,2027-02-28,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,218
NCT03582124,0,0,0,0,0,0,2021-06-30,2022-06-30,,Eben Rosenthal,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03583450,0,0,0,0,0,0,2019-03-27,2020-03-27,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1443
NCT03586024,0,0,0,0,0,0,2021-07-03,2022-07-03,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03586284,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of California, San Francisco",Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1443
NCT03586869,0,0,0,0,0,0,2019-12-31,2020-12-31,,"NantKwest, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03587311,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,3004
NCT03587805,0,0,0,0,0,0,2021-06-07,2022-06-07,,LEO Pharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,171
NCT03589885,0,0,0,0,0,0,2019-11-21,2020-11-21,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03592992,0,0,0,0,0,0,2020-06-30,2021-06-30,,Lawson Health Research Institute,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,468
NCT03593213,0,0,0,0,0,0,2021-06-07,2022-06-07,,Forest Laboratories,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,169
NCT03594058,0,0,0,0,0,0,2019-04-29,2020-04-29,,"Velicept Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03595176,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Shockwave Medical, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,9
NCT03596645,0,0,0,0,0,0,2021-12-22,2022-12-22,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03597009,0,0,0,0,0,0,2020-12-30,2021-12-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03597516,0,0,0,0,0,0,2019-07-02,2020-07-02,,"Ritter Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03598309,0,0,0,0,0,0,2022-10-31,2023-10-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03599336,0,0,0,0,0,0,2020-08-01,2021-08-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03599622,0,0,0,0,0,0,2021-09-27,2022-09-27,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03603314,0,0,0,0,0,0,2018-10-31,2019-10-31,,Sensorion,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03603509,0,0,0,0,0,0,2019-01-02,2020-01-02,,Mayo Clinic,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03604302,0,0,0,0,0,0,2021-07-31,2022-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1432
NCT03604471,0,0,0,0,0,0,2019-08-27,2020-08-27,,Université Catholique de Louvain,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,41
NCT03604705,0,0,0,0,0,0,2020-08-31,2021-08-31,,Amplyx Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03608423,0,0,0,0,0,0,2020-07-31,2021-07-31,,Radboud University,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,606
NCT03609619,0,1,0,1,0,0,2018-11-23,2019-11-23,2019-06-25,Aevi Genomic Medicine,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03610438,0,0,0,0,0,0,2022-11-30,2023-11-30,,Gruppo Italiano Malattie EMatologiche dell'Adulto,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,81
NCT03610737,0,0,0,0,0,0,2020-07-30,2021-07-30,,"Vertos Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03610971,0,0,0,0,0,0,2021-01-31,2022-01-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03611153,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03611751,0,0,0,0,0,0,2020-07-07,2021-07-07,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03613987,0,0,0,0,0,0,2019-04-26,2020-04-26,,New York Medical College,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,40
NCT03615105,0,0,0,0,0,0,2021-07-31,2022-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,1,0,0,0,1,0,1432
NCT03616899,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Kala Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03619005,0,0,0,0,0,0,2020-12-31,2021-12-31,,EndoCeutics Inc.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03619252,0,0,0,0,0,0,2019-08-01,2020-08-01,,Minsk State Clinical Hospital No 9,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,2
NCT03619785,0,0,0,0,0,0,2019-08-31,2020-08-31,,Andrew A Herring,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03621319,0,0,0,0,0,0,2020-07-31,2021-07-31,,Erbe Elektromedizin GmbH,Industry,1,1,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03628378,0,0,0,0,0,0,2020-12-20,2021-12-20,,Columbia University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03629249,0,0,0,0,0,0,2021-05-31,2022-05-31,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03630211,0,0,0,0,0,0,2023-08-01,2024-08-01,,Paul Szabolcs,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,5
NCT03630705,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,285
NCT03631732,0,0,0,0,0,0,2019-08-12,2020-08-12,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,510
NCT03633279,0,0,0,0,0,0,2019-07-31,2020-07-31,,Dayanand Medical College and Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,8
NCT03634540,0,0,0,0,0,0,2021-09-01,2022-09-01,,"Peloton Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03637764,0,0,0,0,0,0,2024-04-30,2025-04-30,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03639779,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Central Florida,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03642457,0,0,0,0,0,0,2019-12-31,2020-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03642990,0,0,0,0,0,0,2021-06-21,2022-06-21,,"Donna Hammond, PhD",Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03647189,0,0,0,0,0,0,2019-10-30,2020-10-30,,Sciton,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03648073,0,0,0,0,0,0,2020-03-01,2021-03-01,,University of Alabama at Birmingham,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,801
NCT03648268,0,0,0,0,0,0,2023-12-31,2024-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,377
NCT03649464,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Oblato, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03650114,0,0,0,0,0,0,2025-06-04,2026-06-04,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03653416,0,0,0,0,0,0,2019-12-31,2020-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,412
NCT03653715,0,0,0,0,0,0,2018-08-27,2019-08-27,,"Clerio Vision, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03653897,1,0,0,0,1,0,2018-09-15,2019-09-15,,"EtectRX, Inc.",Industry,1,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03655444,0,0,0,0,0,0,2022-06-30,2023-06-30,,Washington University School of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03656926,0,0,0,0,0,0,2021-09-30,2022-09-30,,Breath Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03660865,0,0,0,0,0,0,2019-09-01,2020-09-01,,"RxSight, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03661346,1,0,1,1,0,1,2018-03-30,2019-03-30,2019-05-20,"The University of Texas Medical Branch, Galveston",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,158
NCT03661645,0,0,0,0,0,0,2021-01-31,2022-01-31,,Emory University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03662074,0,0,0,0,0,0,2020-09-10,2021-09-10,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,616
NCT03662659,0,0,0,0,0,0,2020-12-27,2021-12-27,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03663933,0,0,0,0,0,0,2023-05-27,2024-05-27,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03664739,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,180
NCT03665155,0,0,0,0,0,0,2021-09-30,2022-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1432
NCT03665285,0,0,0,0,0,0,2021-05-01,2022-05-01,,"NextCure, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03666663,0,0,0,0,0,0,2022-10-01,2023-10-01,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03667326,0,0,0,0,0,0,2019-12-31,2020-12-31,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03672773,0,0,0,0,0,0,2019-11-01,2020-11-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,277
NCT03673956,0,0,0,0,0,0,2019-12-01,2020-12-01,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03674112,0,0,0,0,0,0,2020-03-31,2021-03-31,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03679481,0,0,0,0,0,0,2019-12-01,2020-12-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03679676,0,0,0,0,0,0,2020-07-30,2021-07-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1309
NCT03681093,0,0,0,0,0,0,2020-07-06,2021-07-06,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03681262,0,0,0,0,0,0,2021-12-31,2022-12-31,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03684928,0,0,0,0,0,0,2018-12-14,2019-12-14,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03686657,0,0,0,0,0,0,2021-05-31,2022-05-31,,ARKAY Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03690206,0,0,0,0,0,0,2020-09-25,2021-09-25,,Zealand Pharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03691714,0,0,0,0,0,0,2021-10-31,2022-10-31,,Trisha Wise-Draper,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03694626,0,0,0,0,0,0,2020-07-01,2021-07-01,,Randy Kardon,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT03696212,0,0,0,0,0,0,2020-09-30,2021-09-30,,Arrys Therapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03697408,0,0,0,0,0,0,2026-01-31,2027-01-31,,University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03699319,0,0,0,0,0,0,2021-01-01,2022-01-01,,Jeffrey Hardacre,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03700021,0,0,0,0,0,0,2019-11-30,2020-11-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03701074,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of South Alabama,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03701334,0,0,0,0,0,0,2025-12-26,2026-12-26,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03703310,0,0,0,0,0,0,2020-05-01,2021-05-01,,"PellePharm, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03704077,0,0,0,0,0,0,2019-05-17,2020-05-17,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,1,2019.0,1,1,1,0,0,0,0,0,1,1,0,1104
NCT03706053,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Virginia,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT03707444,0,0,0,0,0,0,2019-10-31,2020-10-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,461
NCT03707587,0,0,0,0,0,0,2020-07-07,2021-07-07,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03711162,0,0,0,0,0,0,2021-12-31,2022-12-31,,Galapagos NV,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03712124,0,0,0,0,0,0,2019-07-30,2020-07-30,,"Censa Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03713528,0,0,0,0,0,0,2022-01-01,2023-01-01,,"OrthoCarolina Research Institute, Inc.",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,26
NCT03715946,0,0,0,0,0,0,2020-08-31,2021-08-31,,Robert Ferris,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,6
NCT03716739,0,0,0,0,0,0,2024-01-01,2025-01-01,,Dana-Farber Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03717675,0,0,0,0,0,0,2019-04-30,2020-04-30,,Nitiloop Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03719430,0,0,0,0,0,0,2020-12-31,2021-12-31,,Columbia University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03719885,0,0,0,0,0,0,2019-07-25,2020-07-25,,University of Pennsylvania,Other,0,1,0,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03720717,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,801
NCT03720847,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-11-15,"University of North Carolina, Chapel Hill",Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT03721510,0,0,0,0,0,0,2020-11-30,2021-11-30,,International AIDS Vaccine Initiative,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,21
NCT03721679,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Oncovir, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03723850,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Chicago,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,594
NCT03724149,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Pennsylvania,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03727542,0,0,0,0,0,0,2018-11-15,2019-11-15,,Istanbul University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,155
NCT03730051,0,0,0,0,0,0,2021-01-31,2022-01-31,,Boston Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,225
NCT03730402,0,0,0,0,0,0,2019-09-30,2020-09-30,,Santa Barbara Cottage Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03730753,0,0,0,0,0,0,2020-06-30,2021-06-30,,Université de Sherbrooke,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,156
NCT03731260,0,0,0,0,0,0,2020-12-31,2021-12-31,,Blueprint Medicines Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03734588,0,0,0,0,0,0,2020-04-30,2021-04-30,,Spark Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,0,0,0,1,0,1,0,13
NCT03735173,0,0,0,0,0,0,2023-12-01,2024-12-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03736629,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03737032,0,0,0,0,0,0,2021-02-28,2022-02-28,,Erika Forbes,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03737812,0,0,0,0,0,0,2020-09-17,2021-09-17,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03738241,0,0,0,0,0,0,2020-04-20,2021-04-20,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03738800,0,0,0,0,0,0,2020-02-10,2021-02-10,,Mayne Pharma International Pty Ltd,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,6
NCT03739801,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Southern California,Other,0,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,483
NCT03741062,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Manitoba,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,344
NCT03743649,0,0,0,0,0,0,2023-05-31,2024-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2066
NCT03744468,0,0,0,0,0,0,2021-06-01,2022-06-01,,BeiGene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03745040,0,0,0,0,0,0,2020-11-30,2021-11-30,,Allina Health System,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,33
NCT03745898,0,0,0,0,0,0,2023-02-28,2024-02-28,,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03750461,0,0,0,0,0,0,2019-12-01,2020-12-01,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,306
NCT03750825,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Southern California,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,483
NCT03751098,0,0,0,0,0,0,2019-01-21,2020-01-21,,Eyenovia Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03751436,0,0,0,0,0,0,2021-09-05,2022-09-05,,Roswell Park Cancer Institute,Other,0,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,294
NCT03756389,0,0,0,0,0,0,2022-09-30,2023-09-30,,"BioMimetix JV, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03756896,0,0,0,0,0,0,2021-01-30,2022-01-30,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03758950,0,0,0,0,0,0,2023-06-30,2024-06-30,,Jeffrey Glassberg,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03759392,0,0,0,0,0,0,2021-02-15,2022-02-15,,Amgen,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03759678,0,0,0,0,0,0,2020-04-01,2021-04-01,,IntraBio Inc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03760484,0,0,0,0,0,0,2021-12-16,2022-12-16,,University of Alberta,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,2,1,0,432
NCT03760640,0,0,0,0,0,0,2019-10-09,2020-10-09,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1512
NCT03762317,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Hennepin County Medical Center, Minneapolis",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03762473,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03762850,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Retrophin, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03766269,0,0,0,0,0,0,2019-06-01,2020-06-01,,"Daisy Pharma Opioid Venture, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03766971,0,0,0,0,0,0,2024-11-30,2025-11-30,,New York State Psychiatric Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,361
NCT03767894,0,0,0,0,0,0,2019-06-27,2020-06-27,,Columbia University,Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,675
NCT03769402,1,0,1,1,0,0,2018-05-01,2019-05-01,2018-12-14,Ain Shams University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,460
NCT03769727,0,0,0,0,0,0,2019-07-01,2020-07-01,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT03773133,0,0,0,0,0,0,2020-06-04,2021-06-04,,Ipsen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,214
NCT03773965,0,0,0,0,0,0,2027-12-06,2028-12-06,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03775486,0,0,0,0,0,0,2021-06-02,2022-06-02,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03777007,0,0,0,0,0,0,2020-12-20,2021-12-20,,Derek Amanatullah,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03778112,0,0,0,0,0,0,2021-05-31,2022-05-31,,Rush University Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,227
NCT03781323,0,0,0,0,0,0,2022-06-01,2023-06-01,,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03784170,0,0,0,0,0,0,2019-08-31,2020-08-31,,FemPulse Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03786692,0,0,0,0,0,0,2022-01-31,2023-01-31,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03787095,0,0,0,0,0,0,2021-09-02,2022-09-02,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03787680,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03789773,0,0,0,0,0,0,2020-12-14,2021-12-14,,University of Southern California,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,483
NCT03794661,0,0,0,0,0,0,2020-06-30,2021-06-30,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,419
NCT03796988,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Miami,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03797326,0,0,0,0,0,0,2022-04-11,2023-04-11,,Merck Sharp & Dohme Corp.,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03799445,0,0,0,0,0,0,2022-08-01,2023-08-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,1,0,0,0,1,0,2066
NCT03801642,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Jeff Burns, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03802110,0,0,0,0,0,0,2020-11-15,2021-11-15,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,340
NCT03803202,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,135
NCT03804502,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Sight Sciences, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03804684,0,0,0,0,0,0,2019-06-30,2020-06-30,,Wills Eye,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,69
NCT03808948,0,0,0,0,0,0,2019-08-31,2020-08-31,,FAST BioMedical,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,3
NCT03811171,0,0,0,0,0,0,2021-03-30,2022-03-30,,SonoMotion,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03811301,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Neuroscience Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03811912,0,0,0,0,0,0,2019-12-31,2020-12-31,,Concert Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03812328,0,0,0,0,0,0,2019-12-31,2020-12-31,,Tetherex Pharmaceuticals Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,2,1,0,1
NCT03814382,0,0,0,0,0,0,2020-06-30,2021-06-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03815760,0,0,0,0,0,0,2019-05-30,2020-05-30,,George Fox University,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03818737,0,0,0,0,0,0,2021-12-31,2022-12-31,,Emory University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03819322,0,0,0,0,0,0,2024-05-01,2025-05-01,,Naudia Jonassaint,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03820726,0,0,0,0,0,0,2022-08-31,2023-08-31,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03824912,0,1,0,1,0,0,2019-01-24,2020-01-24,2019-04-11,Encube Ethicals Pvt. Ltd.,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,3
NCT03825809,0,0,0,0,0,0,2020-01-20,2021-01-20,,Henry Ford Health System,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,151
NCT03826186,0,0,0,0,0,0,2022-01-01,2023-01-01,,YATISH SIDDAPURA RANGANATH,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03827447,0,0,0,0,0,0,2021-06-01,2022-06-01,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03827655,0,0,0,0,0,0,2020-05-08,2021-05-08,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03829410,0,0,0,0,0,0,2021-05-25,2022-05-25,,"Trovagene, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3
NCT03832179,0,0,0,0,0,0,2019-10-01,2020-10-01,,Bay Area Retina Associates,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03832361,0,0,0,0,0,0,2023-10-31,2024-10-31,,Alessandro Santin,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03835078,0,0,0,0,0,0,2019-03-27,2020-03-27,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03835728,0,0,0,0,0,0,2022-01-22,2023-01-22,,University of Texas Southwestern Medical Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03836664,1,1,0,1,0,0,2018-04-14,2019-04-14,2019-04-10,University of Kansas Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,219
NCT03838445,0,0,0,0,0,0,2020-12-31,2021-12-31,,V-Wave Ltd,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,4
NCT03838978,0,0,0,0,0,0,2021-12-31,2022-12-31,,Moximed,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03842696,0,0,0,0,0,0,2023-10-31,2024-10-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03843788,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Rutgers, The State University of New Jersey",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,227
NCT03843996,0,0,0,0,0,0,2018-12-14,2019-12-14,,Stratpharma AG,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03844074,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Outlook Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,2
NCT03848481,0,0,0,0,0,0,2020-10-31,2021-10-31,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03851068,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Foldax, Inc",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03852381,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University Health Network, Toronto",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,931
NCT03854266,0,0,0,0,0,0,2021-04-01,2022-04-01,,University of Aarhus,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,831
NCT03855046,0,0,0,0,0,0,2019-09-01,2020-09-01,,"State Scientific Centre of Coloproctology, Russian Federation",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,14
NCT03859401,0,0,0,0,0,0,2019-12-30,2020-12-30,,Marc Breton,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03861143,0,0,0,0,0,0,2019-12-31,2020-12-31,,Landos Biopharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03863223,0,0,0,0,0,0,2022-07-30,2023-07-30,,"Jiangsu HengRui Medicine Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,187
NCT03864588,0,0,0,0,0,0,2019-06-30,2020-06-30,,Rothman Institute Orthopaedics,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,58
NCT03865732,0,0,0,0,0,0,2021-04-30,2022-04-30,,Marinus Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03868293,0,0,0,0,0,0,2020-02-07,2021-02-07,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,698
NCT03869008,0,0,0,0,0,0,2020-01-16,2021-01-16,,University of Toledo Health Science Campus,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,31
NCT03871075,0,0,0,0,0,0,2024-04-30,2025-04-30,,Northwestern University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,925
NCT03871829,0,0,0,0,0,0,2022-09-14,2023-09-14,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03874013,0,0,0,0,0,0,2019-12-31,2020-12-31,,"OPKO Health, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,10
NCT03879408,0,0,0,0,0,0,2019-10-11,2020-10-11,,"Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03880266,0,0,0,0,0,0,2019-09-01,2020-09-01,,"Dermira, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03881020,0,0,0,0,0,0,2020-05-31,2021-05-31,,Ain Shams University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,460
NCT03881852,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Axsome Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03883906,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,437
NCT03884283,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Prosidyan, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03886493,0,0,0,0,0,0,2020-02-15,2021-02-15,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03887273,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Q Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,2
NCT03888391,1,1,0,1,0,0,2018-05-30,2019-05-30,2019-04-03,James McGough,Other,0,0,1,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT03892746,0,0,0,0,0,0,2022-09-29,2023-09-29,,The Cleveland Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03893539,0,0,0,0,0,0,2020-10-31,2021-10-31,,Intuitive Surgical,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,18
NCT03894046,0,0,0,0,0,0,2020-07-19,2021-07-19,,Entasis Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03896022,0,0,0,0,0,0,2020-06-30,2021-06-30,,Columbia University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03896867,0,0,0,0,0,0,2024-10-01,2025-10-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,749
NCT03897075,0,0,0,0,0,0,2021-03-31,2022-03-31,,Sun Pharma Global FZE,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,17
NCT03897335,0,0,0,0,0,0,2021-02-01,2022-02-01,,Le Bonheur Children's Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03898180,0,0,0,0,0,0,2022-12-30,2023-12-30,,Merck Sharp & Dohme Corp.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03901469,0,0,0,0,0,0,2020-09-30,2021-09-30,,Zenith Epigenetics,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03905512,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Selecta Biosciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03909815,0,0,0,0,0,0,2022-08-31,2023-08-31,,Uppsala University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,216
NCT03910803,0,0,0,0,0,0,2019-12-01,2020-12-01,,Florida Academic Dermatology Centers,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03911843,0,0,0,0,0,0,2018-12-31,2019-12-31,,Azienda Ospedaliero Universitaria Maggiore della Carita,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,3,0,1,31
NCT03914612,0,0,0,0,0,0,2023-06-30,2024-06-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03918213,0,0,0,0,0,0,2022-04-25,2023-04-25,,Russian Academy of Medical Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,2,1,0,30
NCT03919435,0,0,0,0,0,0,2020-03-27,2021-03-27,,University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03919799,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Kadmon Corporation, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03919955,0,0,0,0,0,0,2020-05-31,2021-05-31,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03921671,0,0,0,0,0,0,2020-07-16,2021-07-16,,Marina Garassino,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,1,0,2,1,0,2
NCT03922620,0,0,0,0,0,0,2020-05-01,2021-05-01,,Gerard Cush,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03922802,0,0,0,0,0,0,2021-12-31,2022-12-31,,Shirley Ryan AbilityLab,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,71
NCT03924414,0,0,0,0,0,0,2023-05-31,2024-05-31,,California Pacific Medical Center Research Institute,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,35
NCT03926520,0,0,0,0,0,0,2023-03-31,2024-03-31,,Brent Forester,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03927105,0,0,0,0,0,0,2024-05-31,2025-05-31,,Big Ten Cancer Research Consortium,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03927781,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Missouri-Columbia,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03928522,0,0,0,0,0,0,2020-01-28,2021-01-28,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1151
NCT03929640,0,0,0,0,0,0,2020-03-30,2021-03-30,,Milton S. Hershey Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03930680,0,0,0,0,0,0,2023-06-30,2024-06-30,,Hui-Ming Chang,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03931070,0,0,0,0,0,0,2020-01-31,2021-01-31,,Rhode Island Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,120
NCT03935217,0,0,0,0,0,0,2020-03-31,2021-03-31,,Lupin Research Inc,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03936556,1,0,0,0,1,0,2018-06-03,2019-06-03,,Procter and Gamble,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,59
NCT03937596,0,0,0,0,0,0,2021-02-28,2022-02-28,,University of Calgary,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,361
NCT03938272,0,0,0,0,0,0,2022-11-30,2023-11-30,,OxThera,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,6
NCT03938948,0,0,0,0,0,0,2020-12-31,2021-12-31,,Awareable Technologies Inc,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03939637,0,0,0,0,0,0,2022-05-01,2023-05-01,,Baylor College of Medicine,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,518
NCT03940703,0,0,0,0,0,0,2022-03-30,2023-03-30,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03945019,0,0,0,0,0,0,2021-06-30,2022-06-30,,Celltrion,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,31
NCT03945513,0,0,0,0,0,0,2020-12-31,2021-12-31,,Insud Pharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03947697,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of Texas, El Paso",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03949517,0,0,0,0,0,0,2022-04-30,2023-04-30,,Andrei Iagaru,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,12
NCT03950817,0,0,0,0,0,0,2021-06-30,2022-06-30,,Antonios Likourezos,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03951649,0,0,0,0,0,0,2021-01-01,2022-01-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,801
NCT03952130,0,0,0,0,0,0,2022-05-31,2023-05-31,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03953144,0,0,0,0,0,0,2020-08-01,2021-08-01,,St. Joseph's Healthcare Hamilton,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,84
NCT03956082,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mercy Research,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,15
NCT03958383,0,0,0,0,0,0,2024-08-15,2025-08-15,,"University of Wisconsin, Madison",Other,0,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,1,0,0,0,1,0,715
NCT03961048,0,0,0,0,0,0,2020-09-30,2021-09-30,,Virginia Commonwealth University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03961256,0,0,0,0,0,0,2021-04-22,2022-04-22,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03962114,0,0,0,0,0,0,2019-12-01,2020-12-01,,Radboud University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,0,0,2,1,0,606
NCT03962725,0,0,0,0,0,0,2021-06-30,2022-06-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03963011,0,0,0,0,0,0,2020-10-01,2021-10-01,,Children's Mercy Hospital Kansas City,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,138
NCT03964415,0,0,0,0,0,0,2023-01-03,2024-01-03,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,29
NCT03967249,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,69
NCT03968965,0,0,0,0,0,0,2020-12-31,2021-12-31,,7D Surgical Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03969329,0,0,0,0,0,0,2022-06-30,2023-06-30,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,685
NCT03970252,0,0,0,0,0,0,2021-04-15,2022-04-15,,Jonsson Comprehensive Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,277
NCT03971461,0,0,0,0,0,0,2020-05-31,2021-05-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03971643,0,0,0,0,0,0,2021-04-30,2022-04-30,,InflaRx GmbH,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,8
NCT03973918,0,0,0,0,0,0,2021-07-31,2022-07-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,461
NCT03974828,0,0,0,0,0,0,2024-01-01,2025-01-01,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1151
NCT03977311,0,0,0,0,0,0,2023-11-30,2024-11-30,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,1,0,0,0,1,0,1151
NCT03980171,0,0,0,0,0,0,2026-11-30,2027-11-30,,"Peter MacCallum Cancer Centre, Australia",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT03980522,0,0,0,0,0,0,2019-05-17,2020-05-17,,"Kiniksa Pharmaceuticals, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03980769,0,0,0,0,0,0,2027-07-01,2028-07-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,393
NCT03984110,0,0,0,0,0,0,2020-06-15,2021-06-15,,Texas Retina Associates,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03984643,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03985982,0,0,0,0,0,0,2020-03-31,2021-03-31,,Croma-Pharma GmbH,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03991637,1,0,0,0,1,0,2018-09-11,2019-09-11,,Joseph Allen Jr.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03992261,0,0,0,0,0,0,2019-09-30,2020-09-30,,Mayne Pharma International Pty Ltd,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03995667,0,0,0,0,0,0,2021-06-20,2022-06-20,,OHSU Knight Cancer Institute,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,163
NCT03997318,0,0,0,0,0,0,2023-03-31,2024-03-31,,Cook MyoSite,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,9
NCT03999216,0,0,0,0,0,0,2021-01-31,2022-01-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03999411,0,0,0,0,0,0,2021-02-28,2022-02-28,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT04002297,0,0,0,0,0,0,2021-07-31,2022-07-31,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,57
NCT04002674,0,0,0,0,0,0,2023-08-31,2024-08-31,,Georgetown University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT04003142,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT04004702,0,0,0,0,0,0,2024-12-31,2025-12-31,,Walter Reed National Military Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,47
NCT04006119,0,0,0,0,0,0,2022-06-30,2023-06-30,,Ziopharm,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,34
NCT04008043,0,0,0,0,0,0,2020-08-31,2021-08-31,,Boston University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,188
NCT04016792,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,26
NCT04017962,0,0,0,0,0,0,2021-07-31,2022-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT04019197,0,0,0,0,0,0,2023-10-31,2024-10-31,,Case Western Reserve University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,89
NCT04021524,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Washington,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT04023526,0,0,0,0,0,0,2020-12-29,2021-12-29,,"Janssen Research & Development, LLC",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,558
NCT04025177,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Manitoba,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,344
NCT04029038,0,0,0,0,0,0,2022-08-31,2023-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT04029844,0,0,0,0,0,0,2020-10-31,2021-10-31,,Colibri Heart Valve LLC,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT04029974,0,0,0,0,0,0,2020-07-31,2021-07-31,,Methodist Rehabilitation Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT04030169,0,0,0,0,0,0,2021-05-31,2022-05-31,,MAPS Europe B.V.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT04030455,0,0,0,0,0,0,2021-10-31,2022-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT04031859,0,0,0,0,0,0,2019-07-14,2020-07-14,,"Ministry of Health, Saudi Arabia",Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,3
NCT04036435,0,0,0,0,0,0,2022-08-31,2023-08-31,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1104
NCT04036968,0,0,0,0,0,0,2021-06-30,2022-06-30,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT04037072,0,0,0,0,0,0,2022-03-15,2023-03-15,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,156
NCT04038125,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Retina Macula Specialists of Miami, LLC",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04038502,0,0,0,0,0,0,2024-08-30,2025-08-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT04039477,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Kezar Life Sciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT04042025,0,0,0,0,0,0,2034-12-31,2035-12-31,,"AveXis, Inc.",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,8
NCT04042922,0,0,0,0,0,0,2021-04-30,2022-04-30,,Massachusetts Institute of Technology,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT04045990,0,0,0,0,0,0,2020-12-31,2021-12-31,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,698
NCT04047979,0,0,0,0,0,0,2021-12-31,2022-12-31,,Emory University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,947
NCT04048577,0,0,0,0,0,0,2020-02-01,2021-02-01,,"Berkovich, Regina MD, PhD Inc.",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04048876,0,0,0,0,0,0,2021-11-16,2022-11-16,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,306
NCT04049760,0,0,0,0,0,0,2022-06-01,2023-06-01,,Amicus Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,34
NCT04050436,0,0,0,0,0,0,2022-10-31,2023-10-31,,Replimune Inc.,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,2,1,0,2
NCT04051996,0,0,0,0,0,0,2021-09-15,2022-09-15,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT04054141,0,0,0,0,0,0,2020-09-01,2021-09-01,,"Hospital for Special Surgery, New York",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,157
NCT04054999,0,0,0,0,0,0,2021-01-01,2022-01-01,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT04055649,0,0,0,0,0,0,2020-01-01,2021-01-01,,Ira Winer,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04056299,0,0,0,0,0,0,2021-03-01,2022-03-01,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,11
NCT04056988,0,0,0,0,0,0,2024-12-31,2025-12-31,,University of Washington,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT04058132,0,0,0,0,0,0,2021-04-01,2022-04-01,,Uniformed Services University of the Health Sciences,U.S. Fed,2,0,1,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,35
NCT04061980,0,0,0,0,0,0,2021-02-01,2022-02-01,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,163
NCT04062708,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Alliance Foundation Trials, LLC.",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,16
NCT04063436,0,0,0,0,0,0,2019-10-11,2020-10-11,,Fisher and Paykel Healthcare,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,56
NCT04065373,0,0,0,0,0,0,2019-06-21,2020-06-21,,"ivWatch, LLC",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT04066647,0,0,0,0,0,0,2019-07-24,2020-07-24,,Cedars-Sinai Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2019.0,1,1,0,0,0,0,0,0,0,1,0,279
NCT04067011,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Emergent Product Development Gaithersburg, Inc.",Industry,1,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT04068051,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Axsome Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04073303,0,0,0,0,0,0,2020-03-12,2021-03-12,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,495
NCT04074330,0,0,0,0,0,0,2023-08-19,2024-08-19,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,209
NCT04076059,0,0,0,0,0,0,2023-09-30,2024-09-30,,"Astellas Pharma China, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,16
NCT04076462,0,0,0,0,0,0,2021-01-31,2022-01-31,,Camurus AB,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT04076644,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Missouri-Columbia,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,214
NCT04079803,0,0,0,0,0,0,2020-01-15,2021-01-15,,"Cassava Sciences, Inc.",Industry,1,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04080284,0,0,0,0,0,0,2022-07-01,2023-07-01,,Northwell Health,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,271
NCT04081311,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Manitoba,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,344
NCT04082780,0,0,0,0,0,0,2020-09-15,2021-09-15,,Hunter Holmes Mcguire Veteran Affairs Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,19
NCT04088357,0,0,0,0,0,0,2020-08-31,2021-08-31,,"BioMendics, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04088591,0,0,0,0,0,0,2021-11-30,2022-11-30,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,417
NCT00001849,0,0,0,0,0,0,2019-04-26,2020-04-26,,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,0,0.0,Phase 1/Phase 2,0,1999.0,1,1,0,0,0,0,0,0,0,0,1,413
NCT00053989,1,0,0,0,1,0,2018-07-19,2019-07-19,,Roswell Park Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2002.0,1,1,1,0,0,0,0,0,0,0,1,294
NCT00077285,0,0,0,0,0,0,2019-10-31,2020-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2003.0,0,1,1,0,0,1,0,0,0,0,1,1432
NCT00100854,1,0,0,0,1,0,2018-09-05,2019-09-05,,Translational Oncology Research International,Other,0,0,1,1.0,Phase 2,0,2004.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT00107289,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2006.0,0,0,0,0,0,1,0,0,0,0,1,1432
NCT00117936,0,0,0,0,0,0,2022-03-31,2023-03-31,,"CardioVascular BioTherapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2020.0,0,0,0,0,0,0,1,0,3,1,0,3
NCT00217594,1,1,0,1,0,1,2017-02-06,2018-02-06,2018-08-23,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT00397579,1,1,0,1,0,1,2017-07-27,2018-07-27,2018-11-21,University of Texas Southwestern Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT00402779,1,0,0,0,1,0,2018-06-04,2019-06-04,,M.D. Anderson Cancer Center,Other,0,1,1,3.0,Phase 3,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00422591,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-02-26,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00445601,1,1,0,1,0,0,2017-06-30,2018-06-30,2017-12-21,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,288
NCT00466921,0,0,0,0,0,0,2020-02-29,2021-02-28,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT00486889,0,0,0,0,0,0,2025-12-31,2026-12-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,4.0,Phase 4,0,2008.0,0,0,1,0,0,0,0,0,0,0,1,300
NCT00515528,1,0,0,0,1,0,2018-06-30,2019-06-30,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT00567359,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-10-26,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT00581477,0,0,0,0,0,0,2020-12-31,2021-12-31,,Vanderbilt University,Other,0,0,0,3.0,Phase 3,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT00583752,0,0,0,0,0,0,2020-07-31,2021-07-31,,David M Lubaroff,Other,0,0,1,1.0,Phase 2,0,2007.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT00667823,0,0,0,0,0,0,2021-09-15,2022-09-15,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2008.0,0,1,0,0,0,0,0,0,1,0,1,128
NCT00691158,0,0,0,0,0,0,2020-07-31,2021-07-31,,Oregon Health and Science University,Other,0,0,0,5.0,,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,475
NCT00773513,1,1,0,1,0,0,2017-07-27,2018-07-27,2018-07-18,Hoffmann-La Roche,Industry,1,0,0,4.0,Phase 4,0,2008.0,1,1,0,0,0,0,0,0,2,0,1,1731
NCT00777920,0,0,0,0,0,0,2020-05-31,2021-05-31,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2008.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT00811785,0,0,0,0,0,0,2021-12-31,2022-12-31,,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,1,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,413
NCT00836927,1,1,0,1,0,0,2017-04-03,2018-04-03,2018-04-03,Merck Sharp & Dohme Corp.,Industry,1,1,0,1.0,Phase 2,1,2009.0,1,1,0,0,0,0,0,0,3,0,1,2145
NCT00843726,0,0,0,0,0,0,2020-04-15,2021-04-15,,Roswell Park Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2008.0,0,0,0,0,0,1,0,0,0,0,1,294
NCT00855803,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2009.0,0,0,0,0,0,1,0,0,0,0,1,626
NCT00860379,0,0,0,0,0,0,2019-12-31,2020-12-31,,Shriners Hospitals for Children,Other,0,0,0,4.0,Phase 4,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,51
NCT00875342,0,0,0,0,0,0,2019-12-31,2020-12-31,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT00911508,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-26,Mayo Clinic,Other,0,1,1,5.0,,0,2009.0,1,1,0,1,0,0,0,0,1,0,1,1898
NCT00936390,0,0,0,0,0,0,2022-05-31,2023-05-31,,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2009.0,0,1,0,0,0,1,0,0,1,0,1,156
NCT00938912,0,0,0,0,0,0,2022-06-30,2023-06-30,,UCB Pharma,Industry,1,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,246
NCT00952380,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-19,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT00959140,0,0,0,0,0,0,2019-10-31,2020-10-31,,Donna Salzman,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT00961064,1,1,0,1,0,1,2017-08-10,2018-08-10,2019-08-08,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT00967798,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-04-10,Emory University,Other,0,0,0,3.0,Phase 3,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT00991029,1,1,0,1,0,0,2018-04-09,2019-04-09,2018-10-04,"University of California, San Francisco",Other,0,1,0,3.0,Phase 3,1,2010.0,1,1,0,0,0,0,0,0,1,0,1,1443
NCT01002755,1,1,0,1,0,0,2018-01-31,2019-01-31,2019-01-17,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01030861,0,0,0,0,0,0,2018-11-30,2019-11-30,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,1,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT01054144,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01066702,0,0,0,0,0,0,2019-03-31,2020-03-31,,Histogenics Corporation,Industry,1,0,0,3.0,Phase 3,1,2010.0,1,0,1,0,0,0,0,0,1,0,1,2
NCT01088789,0,0,0,0,0,0,2023-04-30,2024-04-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,461
NCT01092117,1,0,0,0,1,0,2018-01-31,2019-01-31,,"TriVascular, Inc.",Industry,1,0,0,5.0,,0,2010.0,1,0,0,1,0,0,0,0,0,0,1,10
NCT01096992,1,0,1,1,0,1,2017-03-31,2018-03-31,2018-04-24,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01102426,1,0,0,0,1,0,2017-11-30,2018-11-30,,PharmaMar,Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT01111058,1,0,0,0,1,0,2018-04-30,2019-04-30,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT01117844,1,0,0,0,1,0,2017-02-28,2018-02-28,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,273
NCT01119066,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT01134575,1,1,0,1,0,1,2018-04-18,2019-04-18,2019-04-30,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01143389,1,1,0,1,0,0,2017-05-30,2018-05-30,2018-04-03,Price Vision Group,Industry,1,0,0,1.0,Phase 2,0,2010.0,1,1,0,1,0,0,0,0,0,0,1,7
NCT01149083,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01180036,1,1,0,1,0,1,2017-10-01,2018-10-01,2019-04-08,Mayo Clinic,Other,0,0,0,2.0,Phase 2/Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,1898
NCT01200355,1,1,0,1,0,0,2017-04-20,2018-04-20,2017-05-05,Memorial Sloan Kettering Cancer Center,Other,0,1,0,4.0,Phase 4,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01202409,1,0,1,1,0,1,2018-07-03,2019-07-03,2019-07-23,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01205776,0,1,0,1,0,0,2019-05-03,2020-05-03,2018-03-01,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2010.0,1,0,0,1,0,0,0,0,0,0,1,419
NCT01222260,0,0,0,0,0,0,2019-03-31,2020-03-31,,Columbia University,Other,0,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT01223248,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2010.0,0,0,0,0,0,1,0,0,1,0,1,1432
NCT01234935,1,0,0,0,1,0,2017-11-27,2018-11-27,,Translational Oncology Research International,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,1,0,0,1,11
NCT01237041,1,1,0,1,0,1,2017-10-17,2018-10-17,2018-11-14,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,0,0.0,Phase 1/Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,413
NCT01246063,1,1,0,1,0,0,2017-12-28,2018-12-28,2018-12-17,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT01251861,1,0,0,0,1,0,2018-07-17,2019-07-17,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01252667,0,0,0,0,0,0,2019-01-25,2020-01-25,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT01263769,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01263951,0,0,0,0,0,0,2018-12-31,2019-12-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT01266083,1,0,0,0,1,0,2018-02-28,2019-02-28,,Sellas Life Sciences Group,Industry,1,0,0,1.0,Phase 2,0,2010.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT01268579,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01270321,0,0,0,0,0,0,2019-02-28,2020-02-28,,Emory University,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT01287078,1,0,0,0,1,0,2018-08-08,2019-08-08,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT01288222,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,1,5.0,,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,218
NCT01294670,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,1432
NCT01295645,0,0,0,0,0,0,2021-03-31,2022-03-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01301183,0,0,0,0,0,0,2020-04-30,2021-04-30,,Massachusetts General Hospital,Other,0,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01302847,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT01319981,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01321437,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Irvine",Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,310
NCT01321541,1,0,0,0,1,0,2018-06-28,2019-06-28,,CTI BioPharma,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT01322490,1,1,0,1,0,1,2017-09-25,2018-09-25,2019-07-16,Bavarian Nordic,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,1,0,0,0,0,0,1,0,1,33
NCT01327612,0,0,0,0,0,0,2019-09-01,2020-09-01,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2011.0,0,1,1,0,0,0,0,0,1,0,1,685
NCT01328587,1,1,0,1,0,0,2018-03-30,2019-03-30,2019-03-29,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT01370213,1,0,1,1,0,1,2017-01-31,2018-01-31,2019-07-31,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,1,0,0,0,0,0,0,0,1,218
NCT01371591,1,0,0,0,1,0,2018-08-31,2019-08-31,,Andrew Meltzer,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT01401959,1,1,0,1,0,1,2017-04-03,2018-04-03,2018-04-04,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,167
NCT01409161,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01422148,0,0,0,0,0,0,2023-05-15,2024-05-15,,Baystate Medical Center,Other,0,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,34
NCT01427608,1,1,0,1,0,1,2017-11-30,2018-11-30,2018-12-17,Weill Medical College of Cornell University,Other,0,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,586
NCT01451515,0,0,0,0,0,0,2021-06-30,2022-06-30,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,302
NCT01463072,0,0,0,0,0,0,2019-11-30,2020-11-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT01464034,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Criterium, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT01464268,0,0,0,0,0,0,2020-02-29,2021-02-28,,Cornea and Laser Eye Institute,Other,0,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01496417,1,0,0,0,1,0,2017-02-28,2018-02-28,,"University of Maryland, College Park",Other,0,1,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,318
NCT01496976,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01497860,1,1,0,1,0,1,2017-01-31,2018-01-31,2019-04-22,Eugene Hwang,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01506453,1,1,0,1,0,0,2018-01-02,2019-01-02,2019-01-02,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,302
NCT01543659,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01544595,1,1,0,1,0,0,2017-06-26,2018-06-26,2018-06-25,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01554514,0,0,0,0,0,0,2022-06-30,2023-06-30,,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,1151
NCT01557790,1,0,0,0,1,0,2017-12-31,2018-12-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,5.0,,1,2012.0,1,0,0,0,0,1,0,0,0,0,1,273
NCT01560637,0,0,0,0,0,0,2021-05-31,2022-05-31,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,72
NCT01566591,0,0,0,0,0,0,2018-12-31,2019-12-31,,Brainsway,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,0,0,1,0,0,0,0,1,0,1,16
NCT01573273,1,1,0,1,0,0,2017-12-19,2018-12-19,2018-12-11,Medical University of South Carolina,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT01574274,0,0,0,0,0,0,2020-07-31,2021-07-31,,Dana-Farber Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,647
NCT01594333,0,0,0,0,0,0,2018-12-31,2019-12-31,,Brigham and Women's Hospital,Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,698
NCT01599793,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-09-10,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT01605006,1,0,0,0,1,0,2017-09-30,2018-09-30,,Synapse Biomedical,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT01621906,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT01624220,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01624285,0,0,0,0,0,0,2020-07-31,2021-07-31,,Jonsson Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,277
NCT01643603,0,0,1,1,0,0,2019-01-31,2020-01-31,2019-04-10,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT01655407,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Amarantus BioScience Holdings, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01672736,1,1,0,1,0,0,2017-03-27,2018-03-27,2018-03-15,"University Health Network, Toronto",Other,0,1,0,0.0,Phase 1/Phase 2,1,2012.0,1,1,0,0,0,0,0,0,1,0,1,931
NCT01676259,0,0,0,0,0,0,2019-11-30,2020-11-30,,Silenseed Ltd,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT01690468,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Prescient Therapeutics, Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT01693120,1,1,0,1,0,0,2017-02-07,2018-02-07,2018-02-07,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,1,2013.0,1,0,0,1,0,0,0,0,1,0,1,169
NCT01693614,1,1,0,1,0,0,2017-07-21,2018-07-21,2018-07-19,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01719562,0,0,0,0,0,0,2021-03-31,2022-03-31,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,616
NCT01729494,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Cincinnati,Other,0,0,0,4.0,Phase 4,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,222
NCT01740258,0,0,0,0,0,0,2019-12-31,2020-12-31,,Duke University,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,1342
NCT01745120,1,1,0,1,0,0,2018-02-08,2019-02-08,2019-02-07,bluebird bio,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,0,0,0,0,0,1,1,0,1,11
NCT01747499,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-08-20,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT01758588,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-05-31,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,586
NCT01767792,0,0,0,0,0,0,2019-12-15,2020-12-15,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT01802567,0,0,0,0,0,0,2019-12-31,2020-12-31,,Giselle Sholler,Other,0,1,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,18
NCT01809691,0,0,0,0,0,0,2022-03-31,2023-03-31,,Southwest Oncology Group,Other,0,1,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT01812668,0,0,0,0,0,0,2019-06-30,2020-06-30,,Barbara Ann Karmanos Cancer Institute,Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,1,0,0,0,0,1,134
NCT01822587,0,0,0,0,0,0,2018-11-05,2019-11-05,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT01827046,0,0,1,1,0,0,2018-09-30,2019-09-30,2019-07-23,Johns Hopkins University,Other,0,1,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1143
NCT01830595,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-05-30,Jason Baker,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01832259,1,1,0,1,0,1,2017-02-07,2018-02-07,2018-05-09,University of Utah,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,578
NCT01839656,1,1,0,1,0,0,2017-08-21,2018-08-21,2018-08-16,Biogen,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,324
NCT01844076,0,0,0,0,0,0,2020-04-30,2021-04-30,,Fox Chase Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,156
NCT01845116,0,0,0,0,0,0,2019-07-31,2020-07-31,,Atrium Health,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,95
NCT01846663,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,180
NCT01854359,0,0,0,0,0,0,2018-10-31,2019-10-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT01858948,1,0,0,0,1,0,2018-04-30,2019-04-30,,University of Cincinnati,Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,222
NCT01859130,0,0,0,0,0,0,2021-12-31,2022-12-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,215
NCT01862029,1,1,0,1,0,1,2017-07-25,2018-07-25,2018-07-26,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT01874756,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-05-29,Indiana University,Other,0,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,497
NCT01877187,0,0,0,0,0,0,2019-11-30,2020-11-30,,Yale University,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT01878617,0,0,0,0,0,0,2023-06-30,2024-06-30,,St. Jude Children's Research Hospital,Other,0,1,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,1,0,1,302
NCT01880047,1,1,0,1,0,1,2017-02-15,2018-02-15,2019-04-04,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,586
NCT01886105,0,0,0,0,0,0,2019-06-30,2020-06-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT01886794,0,0,0,0,0,0,2020-05-31,2021-05-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,158
NCT01888640,1,0,1,1,0,1,2018-04-02,2019-04-02,2019-06-24,Kathleen Sluka,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT01892397,0,0,0,0,0,0,2019-06-30,2020-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1432
NCT01893320,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01893996,1,0,0,0,1,0,2017-07-31,2018-07-31,,"University of California, San Francisco",Other,0,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT01896869,0,0,0,0,0,0,2021-01-31,2022-01-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,461
NCT01898130,1,1,0,1,0,0,2018-06-26,2019-06-26,2019-03-29,Northwestern University,Other,0,1,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,925
NCT01902810,0,0,0,0,0,0,2019-06-30,2020-06-30,,"The University of Texas Medical Branch, Galveston",Other,0,0,1,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,158
NCT01903811,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-06-20,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT01908699,0,0,0,0,0,0,2019-02-19,2020-02-19,,Lung Biotechnology PBC,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT01921205,1,1,0,1,0,0,2017-01-24,2018-01-24,2018-01-23,UCB Pharma,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,246
NCT01925677,1,0,1,1,0,1,2017-08-31,2018-08-31,2019-05-15,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,318
NCT01928862,1,1,0,1,0,0,2017-02-15,2018-02-15,2018-02-15,Ferring Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,208
NCT01932502,1,0,0,0,1,0,2017-06-30,2018-06-30,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT01933594,1,1,0,1,0,0,2018-04-16,2019-04-16,2019-04-03,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT01943994,0,0,0,0,0,0,2021-12-31,2022-12-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT01946152,0,0,0,0,0,0,2021-03-01,2022-03-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01953705,0,0,0,0,0,0,2019-07-31,2020-07-31,,Oregon Health and Science University,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT01953926,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Puma Biotechnology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,34
NCT01954966,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Pennsylvania,Other,0,0,1,4.0,Phase 4,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT01958437,1,1,0,1,0,1,2017-03-23,2018-03-23,2018-04-16,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT01966809,1,1,0,1,0,1,2017-12-19,2018-12-19,2019-07-18,"Harry T Whelan, MD",Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01968590,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Utah,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,578
NCT01976364,0,0,0,0,0,0,2019-05-20,2020-05-20,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT01977547,0,0,0,0,0,0,2018-12-31,2019-12-31,,Washington University School of Medicine,Other,0,0,1,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,1151
NCT01982682,1,1,0,1,0,0,2017-03-27,2018-03-27,2018-03-26,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,1,0,0,1,0,0,0,0,1,162
NCT01985087,0,0,0,0,0,0,2025-05-31,2026-05-31,,University of Louisville,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,214
NCT01986205,0,0,0,0,0,0,2020-12-31,2021-12-31,,Lindell Weaver,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,0,0,0,1,0,0,1,0,2
NCT01988571,0,0,0,0,0,0,2020-05-31,2021-05-31,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02003209,0,0,0,0,0,0,2021-08-31,2022-08-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,1,0,0,0,0,1,3004
NCT02006433,1,0,1,1,0,0,2017-09-30,2018-09-30,2018-05-15,Jonathan Jagid,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02008877,1,1,0,1,0,0,2018-04-30,2019-04-30,2018-09-06,Sarcoma Alliance for Research through Collaboration,Other,0,1,1,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT02012959,1,1,0,1,0,1,2017-07-24,2018-07-24,2018-07-31,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,185
NCT02013674,1,0,1,1,0,0,2017-03-02,2018-03-02,2017-10-19,Joshua M Hare,Other,0,1,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,15
NCT02023372,0,0,0,0,0,0,2020-06-30,2021-06-30,,"NuTech Medical, Inc",Industry,1,1,0,5.0,,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,10
NCT02023697,1,1,0,1,0,0,2017-03-01,2018-03-01,2018-02-28,Bayer,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT02026908,0,0,0,0,0,0,2020-06-01,2021-06-01,,Northwestern University,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,925
NCT02027701,1,1,0,1,0,0,2017-07-10,2018-07-10,2018-07-09,CSL Behring,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,81
NCT02034474,1,1,0,1,0,1,2017-02-06,2018-02-06,2018-03-15,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02037126,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02038569,1,1,0,1,0,0,2018-02-28,2019-02-28,2018-08-10,LEO Pharma,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,171
NCT02039505,1,1,0,1,0,0,2018-02-27,2019-02-27,2019-02-25,Takeda,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,2,0,1,650
NCT02046070,1,1,0,1,0,0,2018-06-29,2019-06-29,2019-06-24,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,209
NCT02047344,0,0,0,0,0,0,2018-12-07,2019-12-07,,Golden Biotechnology Corporation,Industry,1,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,9
NCT02047604,1,0,1,1,0,1,2017-02-23,2018-02-23,2018-04-05,"Bausch Health Americas, Inc.",Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02047734,0,0,0,0,0,0,2017-03-27,2018-03-27,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02049957,1,0,1,1,0,0,2018-07-03,2019-07-03,2019-06-28,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,209
NCT02054104,0,0,0,0,0,0,2023-11-05,2024-11-05,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02055820,1,1,0,1,0,0,2017-06-28,2018-06-28,2018-06-26,Hoffmann-La Roche,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02060370,0,0,0,0,0,0,2019-01-02,2020-01-02,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02060487,0,0,0,0,0,0,2023-06-30,2024-06-30,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02061969,1,1,0,1,0,1,2017-04-10,2018-04-10,2018-05-08,Emory University,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02067975,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Maryland, College Park",Other,0,1,1,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,318
NCT02068092,0,0,0,0,0,0,2022-08-31,2023-08-31,,"Tejal Patel, MD",Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02073565,1,1,0,1,0,1,2017-07-14,2018-07-14,2018-09-19,OrbusNeich,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,9
NCT02078102,0,0,0,0,0,0,2019-11-01,2020-11-01,,Sherif S. Farag,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02079909,0,1,0,1,0,1,2017-05-05,2018-05-05,2018-05-07,"FUJIFILM Toyama Chemical Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02082678,1,0,0,0,1,0,2018-03-31,2019-03-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT02087826,0,0,0,0,0,0,2020-03-31,2021-03-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02089685,0,0,0,0,0,0,2020-06-17,2021-06-17,,Merck Sharp & Dohme Corp.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,3,0,1,2145
NCT02096055,0,0,0,0,0,0,2026-04-30,2027-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02098876,0,0,0,0,0,0,2020-06-30,2021-06-30,,Emory University,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,947
NCT02100930,0,0,0,0,0,0,2019-03-07,2020-03-07,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,1432
NCT02101385,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Bryan Schneider, MD",Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02108860,0,0,0,0,0,0,2023-08-31,2024-08-31,,University of South Florida,Other,0,1,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,240
NCT02111174,1,1,0,1,0,1,2017-03-24,2018-03-24,2018-06-22,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,461
NCT02112916,0,0,0,0,0,0,2020-03-31,2021-03-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,1,0,0,1,0,1,3004
NCT02114229,0,0,0,0,0,0,2023-05-31,2024-05-31,,St. Jude Children's Research Hospital,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,302
NCT02120287,1,1,0,1,0,1,2018-03-31,2019-03-31,2019-04-02,Ajay Niranjan,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02124772,0,0,0,0,0,0,2020-12-31,2021-12-31,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02128906,0,0,0,0,0,0,2020-12-31,2021-12-31,,Dwight Heron,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,6
NCT02133885,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Florida,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT02135133,0,0,0,0,0,0,2020-06-30,2021-06-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02135614,0,1,0,1,0,0,2017-03-27,2018-03-27,2018-03-27,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02143050,0,0,0,0,0,0,2019-06-30,2020-06-30,,James Graham Brown Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02151175,0,0,0,0,0,0,2020-11-30,2021-11-30,,BrainSonix Inc.,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02155257,1,1,0,1,0,1,2017-10-31,2018-10-31,2018-11-07,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT02156739,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02157974,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02163317,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,1,0,0,0,0,1,374
NCT02168686,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Adverum Biotechnologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,0,0,0,0,0,1,0,1,0,4
NCT02168946,1,1,0,1,0,1,2017-07-21,2018-07-21,2018-09-27,"Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)",Industry,1,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT02171429,0,0,0,0,0,0,2020-10-06,2021-10-06,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02173093,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Virginia,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,402
NCT02174198,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-05-22,Columbia University,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,675
NCT02174848,1,1,0,1,0,1,2018-03-16,2019-03-16,2019-05-01,ApoPharma,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,25
NCT02177175,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02179086,0,0,0,0,0,0,2021-05-31,2022-05-31,,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,1,0,1,27
NCT02180724,1,0,0,0,1,0,2018-02-28,2019-02-28,,Acerta Pharma BV,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT02182947,0,0,0,0,0,0,2018-12-30,2019-12-30,,Children's Mercy Hospital Kansas City,Other,0,1,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,138
NCT02188459,0,0,0,0,0,0,2021-12-31,2022-12-31,,Henry Kranzler,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02192970,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,715
NCT02197897,1,0,0,0,1,0,2018-07-31,2019-07-31,,Baylor College of Medicine,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02200939,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,83
NCT02201992,0,0,0,0,0,0,2022-05-01,2023-05-01,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,75
NCT02213042,0,0,0,0,0,0,2019-12-04,2020-12-04,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,1,0,1,1895
NCT02217254,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of California, San Francisco",Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,1443
NCT02224313,1,0,0,0,1,0,2018-08-31,2019-08-31,,Intira Sriprasert,Other,0,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02225600,0,0,0,0,0,0,2020-12-31,2021-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT02226341,0,0,0,0,0,0,2024-01-31,2025-01-31,,Columbia University,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT02226796,0,0,0,0,0,0,2018-12-01,2019-12-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,749
NCT02229175,0,0,0,0,0,0,2025-01-01,2026-01-01,,"University of California, San Francisco",Other,0,0,0,2.0,Phase 2/Phase 3,0,2020.0,0,1,0,1,0,0,0,0,0,1,0,1443
NCT02234323,0,0,0,0,0,0,2019-09-30,2020-09-30,,Bioverativ Therapeutics Inc.,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,19
NCT02234778,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Tissue Genesis, LLC",Industry,1,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02234986,1,0,0,0,1,0,2018-06-30,2019-06-30,,"CASI Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02247349,0,0,0,0,0,0,2019-10-23,2020-10-23,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02249949,0,1,0,1,0,0,2018-10-04,2019-10-04,2019-06-10,Alliance for Clinical Trials in Oncology,Other,0,1,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT02252666,1,1,0,1,0,1,2017-01-31,2018-01-31,2019-05-15,"University of Wisconsin, Madison",Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,715
NCT02255487,1,0,0,0,1,0,2017-06-30,2018-06-30,,Irrimax Corporation,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02258659,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,594
NCT02260934,1,1,0,1,0,1,2018-03-12,2019-03-12,2019-03-13,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,2133
NCT02267603,1,1,0,1,0,0,2018-02-06,2019-02-06,2019-02-05,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02281500,0,0,0,0,0,0,2019-11-30,2020-11-30,,Grifols Therapeutics LLC,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,40
NCT02283463,1,0,0,0,1,0,2018-02-28,2019-02-28,,Bioceptive,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02285439,0,0,0,0,0,0,2019-12-31,2020-12-31,,Children's Hospital Los Angeles,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,82
NCT02285985,0,0,0,0,0,0,2019-12-31,2020-12-31,,Phoenix VA Health Care System,U.S. Fed,2,1,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02286960,0,0,0,0,0,0,2018-12-31,2019-12-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02292537,1,1,0,1,0,0,2017-02-20,2018-02-20,2017-10-17,Biogen,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,324
NCT02294253,1,0,0,0,1,0,2017-12-31,2018-12-31,,New York State Psychiatric Institute,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02296112,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-07-15,Vanderbilt-Ingram Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,180
NCT02298504,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,144
NCT02300727,0,1,0,1,0,0,2018-10-25,2019-10-25,2019-03-25,Amy Beres,Other,0,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02301143,1,1,0,1,0,0,2017-11-21,2018-11-21,2018-11-21,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02302807,1,1,0,1,0,0,2017-03-13,2018-03-13,2018-03-13,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02307058,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Miami,Other,0,0,0,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,476
NCT02308163,0,0,0,0,0,0,2017-01-23,2018-01-23,,Astellas Pharma Inc,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,1,0,0,0,0,0,2,0,1,506
NCT02310906,0,0,0,0,0,0,2019-03-25,2020-03-25,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,32
NCT02312557,0,0,0,0,0,0,2019-01-01,2020-01-01,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,163
NCT02323399,0,0,0,0,0,0,2022-06-30,2023-06-30,,West-Ward Pharmaceutical,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02325414,0,0,0,0,0,0,2020-08-31,2021-08-31,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02332655,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Anne Comi, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02334579,0,0,0,0,0,0,2023-12-31,2024-12-31,,Swedish Medical Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,34
NCT02335905,0,0,0,0,0,0,2020-02-29,2021-02-28,,Baylor College of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT02339558,1,1,0,1,0,1,2018-06-16,2019-06-16,2019-08-16,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,3004
NCT02340000,1,1,0,1,0,0,2017-02-27,2018-02-27,2017-07-16,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,51
NCT02340663,1,1,0,1,0,0,2017-05-10,2018-05-10,2018-05-04,University of Michigan,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,934
NCT02341807,0,0,0,0,0,0,2019-10-31,2020-10-31,,Spark Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,13
NCT02344004,1,1,0,1,0,1,2017-07-07,2018-07-07,2018-10-25,Insmed Incorporated,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,15
NCT02347111,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Illinois at Chicago,Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,242
NCT02354352,1,0,1,1,0,1,2018-05-31,2019-05-31,2019-09-03,Ohio State University,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,315
NCT02355002,0,0,0,0,0,0,2020-01-31,2021-01-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1699
NCT02359851,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-02-07,Vanderbilt-Ingram Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,180
NCT02360579,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Iovance Biotherapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,5
NCT02371187,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-02-01,Christopher Bell,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02380443,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Immunovative Therapies, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,12
NCT02385201,0,0,0,0,0,0,2017-06-30,2018-06-30,,Nevro Corp,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT02386553,0,0,0,0,0,0,2022-01-25,2023-01-25,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,324
NCT02388932,1,1,0,1,0,1,2017-02-06,2018-02-06,2018-10-15,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,1,2015.0,1,0,0,1,0,1,0,0,0,0,1,374
NCT02389894,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-12-12,Icahn School of Medicine at Mount Sinai,Other,0,0,1,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,412
NCT02395627,0,0,0,0,0,0,2019-12-20,2020-12-20,,Pamela Munster,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02396199,0,0,0,0,0,0,2020-11-30,2021-11-30,,Cook Research Incorporated,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,20
NCT02402543,1,0,0,0,1,0,2017-05-31,2018-05-31,,University of Vermont,Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,155
NCT02403323,0,0,0,0,0,0,2024-04-19,2025-04-19,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02407028,0,0,0,0,0,0,2022-03-31,2023-03-31,,Hennepin Healthcare Research Institute.,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,61
NCT02407405,0,0,0,0,0,0,2021-08-31,2022-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02412111,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-09-30,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02412982,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Cincinnati,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,222
NCT02413372,0,0,0,0,0,0,2017-01-18,2018-01-18,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1104
NCT02428712,0,0,0,0,0,0,2020-01-31,2021-01-31,,Plexxikon,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,21
NCT02431507,0,0,0,0,0,0,2019-12-31,2020-12-31,,Michael Harrison,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02431559,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-06-07,Ludwig Institute for Cancer Research,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,46
NCT02431897,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Texas Southwestern Medical Center,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02432404,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Washington,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02432703,0,0,0,0,0,0,2018-08-09,2019-08-09,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02435433,1,1,0,1,0,1,2018-03-15,2019-03-15,2019-04-08,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02437318,0,1,0,1,0,1,2018-06-12,2019-06-12,2019-06-17,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02439749,0,0,0,0,0,0,2020-06-30,2021-06-30,,Medtronic Vascular,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,51
NCT02440789,0,0,0,0,0,0,2017-11-02,2018-11-02,,AIDS Clinical Trials Group,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,62
NCT02441491,0,0,0,0,0,0,2022-03-31,2023-03-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02443155,0,0,0,0,0,0,2018-08-31,2019-08-31,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02446405,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Sydney,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,60
NCT02446769,1,1,0,1,0,1,2018-05-03,2019-05-03,2019-05-17,Philips Respironics,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,33
NCT02450552,1,1,0,1,0,0,2018-01-31,2019-01-31,2019-01-08,Brian Wainger,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02452008,0,0,0,0,0,0,2019-07-31,2020-07-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02452320,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-11-16,Weill Medical College of Cornell University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,586
NCT02454842,1,0,0,0,1,0,2017-01-31,2018-01-31,,Threshold Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,22
NCT02455167,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02461758,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-06-26,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,715
NCT02464904,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02468453,0,0,0,0,0,0,2019-03-31,2020-03-31,,Syneron Medical,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02468934,1,1,0,1,0,0,2017-07-17,2018-07-17,2018-07-17,"SPR Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT02471313,1,1,0,1,0,0,2018-03-07,2019-03-07,2019-02-26,National Institutes of Health Clinical Center (CC),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,325
NCT02471651,0,1,0,1,0,0,2018-10-24,2019-10-24,2019-01-02,California Retina Consultants,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02472977,1,1,0,1,0,0,2017-01-27,2018-01-27,2018-01-26,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02477748,1,0,0,0,1,0,2017-01-31,2018-01-31,,Alcobra Ltd.,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02483247,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Boston Biomedical, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT02485834,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-08-07,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,1,2015.0,1,1,0,0,0,1,0,0,0,0,1,456
NCT02488915,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-17,Neuravi Inc.,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,1
NCT02490878,0,0,0,0,0,0,2020-04-30,2021-04-30,,Alliance for Clinical Trials in Oncology,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,456
NCT02492711,0,0,0,0,0,0,2020-03-31,2021-03-31,,MacroGenics,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,31
NCT02494583,0,0,0,0,0,0,2019-04-25,2020-04-25,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02496585,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02496767,0,0,0,0,0,0,2017-03-09,2018-03-09,,Cytokinetics,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT02498418,1,0,0,0,1,0,2017-02-28,2018-02-28,,Actavis Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT02499328,0,0,0,0,0,0,2020-04-10,2021-04-10,,AstraZeneca,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02499770,0,0,0,0,0,0,2017-07-03,2018-07-03,,"G1 Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,9
NCT02500121,0,0,0,0,0,0,2019-07-01,2020-07-01,,Matthew Galsky,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT02500706,1,1,0,1,0,0,2017-07-17,2018-07-17,2018-07-16,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02504892,1,1,0,1,0,0,2018-04-17,2019-04-17,2018-12-17,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02505542,0,0,0,0,0,0,2019-02-28,2020-02-28,,UCB BIOSCIENCES GmbH,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,21
NCT02506244,0,0,0,0,0,0,2020-09-30,2021-09-30,,Scripps Translational Science Institute,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,41
NCT02507765,0,0,0,0,0,0,2018-10-31,2019-10-31,,Ohio State University Comprehensive Cancer Center,Other,0,1,0,5.0,,0,2015.0,1,0,0,0,0,1,0,0,0,0,1,198
NCT02509260,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,581
NCT02511106,0,0,0,0,0,0,2022-02-08,2023-02-08,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02513303,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Vascular Therapies, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02514070,0,0,0,0,0,0,2019-07-23,2020-07-23,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT02514447,0,0,0,0,0,0,2018-09-28,2019-09-28,,"G1 Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,9
NCT02516150,1,1,0,1,0,0,2017-05-31,2018-05-31,2017-07-13,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02519322,0,0,0,0,0,0,2020-02-01,2021-02-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02521870,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dynavax Technologies Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,21
NCT02522715,0,0,0,0,0,0,2019-01-31,2020-01-31,,OHSU Knight Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT02523690,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02524847,0,0,0,0,0,0,2022-01-31,2023-01-31,,Mallinckrodt,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,91
NCT02525653,0,0,0,0,0,0,2019-08-31,2020-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT02528253,0,0,0,0,0,0,2017-10-31,2018-10-31,,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,2856
NCT02534077,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Mednax Center for Research, Education, Quality and Safety",Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,30
NCT02534233,0,0,0,0,0,0,2019-08-31,2020-08-31,,Johns Hopkins University,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02535078,0,0,0,0,0,0,2020-05-31,2021-05-31,,Immunocore Ltd,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02535286,0,0,0,0,0,0,2020-11-30,2021-11-30,,"TG Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,27
NCT02535364,1,1,0,1,0,0,2017-04-24,2018-04-24,2018-04-24,"Juno Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2015.0,1,0,1,0,0,0,0,0,0,0,1,8
NCT02539459,1,0,0,0,1,0,2018-08-20,2019-08-20,,Fox Chase Cancer Center,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,156
NCT02542631,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-30,"Calibra Medical, Inc.",Industry,1,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,2
NCT02544529,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Danbury Eye Physicians & Surgeons, PC",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02544633,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-30,Mirati Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT02548143,1,1,0,1,0,1,2017-08-06,2018-08-06,2019-08-13,"LFB USA, Inc.",Industry,1,1,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,2
NCT02548754,0,0,0,0,0,0,2019-05-31,2020-05-31,,University of Oklahoma,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,234
NCT02549170,0,0,0,0,0,0,2021-12-31,2022-12-31,,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,107
NCT02551159,0,0,0,0,0,0,2019-09-30,2020-09-30,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,2450
NCT02553135,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-06-30,Byron Lam,Other,0,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,1
NCT02556372,0,0,0,0,0,0,2018-09-30,2019-09-30,,"TaiwanJ Pharmaceuticals Co., Ltd",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02560389,1,1,0,1,0,1,2018-05-01,2019-05-01,2019-05-07,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,715
NCT02561000,0,0,0,0,0,0,2019-09-30,2020-09-30,,Tufts Medical Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,121
NCT02561273,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Nebraska,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,327
NCT02561481,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of Massachusetts, Worcester",Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT02564419,0,0,0,0,0,0,2019-12-01,2020-12-01,,Jonathan Jagid,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02564796,0,0,0,0,0,0,2021-02-28,2022-02-28,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT02564887,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Pittsburgh,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1054
NCT02564978,0,0,0,0,0,0,2024-12-31,2025-12-31,,National Eye Institute (NEI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,263
NCT02567435,0,0,0,0,0,0,2025-01-01,2026-01-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,1,0,0,1,0,1,3004
NCT02572453,0,0,0,0,0,0,2019-08-31,2020-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02573246,0,0,0,0,0,0,2020-03-31,2021-03-31,,Duke University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT02573402,1,1,0,1,0,0,2017-10-27,2018-10-27,2018-08-09,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,490
NCT02580448,0,0,0,0,0,0,2019-01-31,2020-01-31,,Innocrin Pharmaceutical,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02581137,1,1,0,1,0,1,2017-10-12,2018-10-12,2019-04-29,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02581982,0,0,0,0,0,0,2020-03-31,2021-03-31,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,616
NCT02582242,1,1,0,1,0,0,2017-03-18,2018-03-18,2018-03-16,Novo Nordisk A/S,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,981
NCT02584647,0,0,0,0,0,0,2020-10-31,2021-10-31,,Gulam Manji,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02584855,0,0,0,0,0,0,2018-10-30,2019-10-30,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02585934,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-09-30,Axovant Sciences Ltd.,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02592330,0,0,0,0,0,0,2020-02-29,2021-02-28,,Massachusetts Eye and Ear Infirmary,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,50
NCT02592993,1,0,0,0,1,0,2017-06-30,2018-06-30,,Syneron Medical,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02595905,0,0,0,0,0,0,2021-10-31,2022-10-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02600494,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Intra-Cellular Therapies, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02604485,1,0,0,0,1,0,2017-01-31,2018-01-31,,XOMA (US) LLC,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,25
NCT02605447,0,0,0,0,0,0,2019-07-17,2020-07-17,,Boston Scientific Corporation,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,1,0,0,0,0,1,0,1,340
NCT02605954,1,1,0,1,0,0,2017-06-14,2018-06-14,2018-06-13,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02607124,1,0,0,0,1,0,2018-04-30,2019-04-30,,"Children's Hospital Medical Center, Cincinnati",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT02607930,1,1,0,1,0,0,2017-05-09,2018-05-09,2018-05-02,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02611037,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02612428,1,1,0,1,0,0,2018-03-31,2019-03-31,2018-12-28,"Vital Therapies, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,0,1,0,0,0,0,0,1,0,1,10
NCT02618915,1,1,0,1,0,0,2017-10-18,2018-10-18,2018-10-16,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,0,0,0,0,0,0,1,1,0,1,36
NCT02620046,0,0,0,0,0,0,2021-08-11,2022-08-11,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,650
NCT02621892,0,0,0,0,0,0,2017-03-31,2018-03-31,,Ardelyx,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,22
NCT02623361,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-03-20,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02624856,1,0,0,0,1,0,2017-11-30,2018-11-30,,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,51
NCT02625324,1,1,0,1,0,0,2017-12-11,2018-12-11,2018-12-10,Medtronic Endovascular,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,64
NCT02626208,1,0,0,0,1,0,2017-03-31,2018-03-31,,Health Decisions,Other,0,0,1,1.0,Phase 2,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,21
NCT02626338,0,0,0,0,0,0,2018-02-28,2019-02-28,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT02627196,0,0,0,0,0,0,2021-12-31,2022-12-31,,"CVRx, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,1,0,1,0,0,0,0,1,0,1,15
NCT02629809,0,0,0,0,0,0,2022-03-31,2023-03-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02631772,1,1,0,1,0,0,2018-05-30,2019-05-30,2019-03-19,Medical University of South Carolina,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT02633163,0,0,0,0,0,0,2021-06-30,2022-06-30,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT02633683,0,0,0,0,0,0,2024-05-31,2025-05-31,,"XenoPort, Inc.",Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,22
NCT02634151,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Gemphire Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02641093,0,0,0,0,0,0,2019-07-31,2020-07-31,,Trisha Wise-Draper,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,3
NCT02643082,1,1,0,1,0,0,2017-01-26,2018-01-26,2018-01-26,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,42
NCT02643667,0,0,0,0,0,0,2021-03-31,2022-03-31,,Washington University School of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02648620,0,0,0,0,0,0,2017-01-31,2018-01-31,,"SurModics, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02649855,0,0,0,0,0,0,2020-01-01,2021-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02651675,0,0,0,0,0,0,2022-07-31,2023-07-31,,Regenxbio Inc.,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,7
NCT02653482,0,0,0,0,0,0,2019-05-31,2020-05-31,,Saint Luke's Health System,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,21
NCT02653755,0,0,0,0,0,0,2019-06-30,2020-06-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,647
NCT02654483,1,1,0,1,0,0,2018-06-28,2019-06-28,2019-04-24,Jean Yuh Tang,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02661464,0,0,0,0,0,0,2022-05-01,2023-05-01,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,29
NCT02661958,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Sol-Gel Technologies, Ltd.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02662582,0,0,0,0,0,0,2018-06-08,2019-06-08,,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,135
NCT02664220,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-06,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02664922,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,692
NCT02665052,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT02666664,0,0,0,0,0,0,2018-02-21,2019-02-21,,Esperion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02669121,0,0,0,0,0,0,2018-06-16,2019-06-16,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,650
NCT02669914,1,1,0,1,0,0,2017-09-21,2018-09-21,2018-09-12,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02670915,1,1,0,1,0,0,2018-02-05,2019-02-05,2019-01-30,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02680756,0,0,0,0,0,0,2018-09-30,2019-09-30,,Shield Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02682056,0,0,0,0,0,0,2018-01-29,2019-01-29,,Emory University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,947
NCT02682485,0,0,0,0,0,0,2022-12-01,2023-12-01,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,594
NCT02682784,0,0,0,0,0,0,2020-07-31,2021-07-31,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02682927,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02683200,0,0,0,0,0,0,2020-06-03,2021-06-03,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,277
NCT02684123,0,0,0,0,0,0,2018-12-31,2019-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02687360,0,0,0,0,0,0,2021-08-31,2022-08-31,,New York State Psychiatric Institute,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,361
NCT02688192,1,0,1,1,0,0,2018-05-22,2019-05-22,2019-05-10,"Rutgers, The State University of New Jersey",Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,227
NCT02688933,1,1,0,1,0,0,2017-06-19,2018-06-19,2018-06-19,Sanofi,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1222
NCT02692157,1,0,0,0,1,0,2017-07-31,2018-07-31,,New York State Psychiatric Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02694328,0,0,0,0,0,0,2018-11-07,2019-11-07,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,70
NCT02699359,1,0,0,0,1,0,2017-06-30,2018-06-30,,HeadSense Medical,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT02701257,1,0,1,1,0,1,2018-05-31,2019-05-31,2019-08-05,Massachusetts General Hospital,Other,0,0,0,5.0,,1,2016.0,1,1,0,1,0,0,0,0,0,0,1,1699
NCT02701764,0,1,0,1,0,0,2018-12-01,2019-12-01,2019-08-09,University of Miami,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,476
NCT02702414,0,0,0,0,0,0,2021-05-30,2022-05-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,3,0,1,2145
NCT02703714,0,0,0,0,0,0,2019-03-31,2020-03-31,,Robin Kate Kelley,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02709785,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-06-26,St. Louis University,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,126
NCT02710669,0,0,0,0,0,0,2020-12-31,2021-12-31,,Vanderbilt University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT02716246,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Abeona Therapeutics, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,3
NCT02718066,0,0,0,0,0,0,2021-10-31,2022-10-31,,HUYA Bioscience International,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02720159,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Encore Medical, L.P.",Industry,1,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,19
NCT02720484,1,1,0,1,0,1,2017-04-17,2018-04-17,2019-04-11,Northwestern University,Other,0,0,1,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT02722837,1,1,0,1,0,0,2017-06-26,2018-06-26,2018-06-20,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02725060,0,0,0,0,0,0,2021-02-28,2022-02-28,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,422
NCT02725528,0,0,0,0,0,0,2019-07-31,2020-07-31,,McMaster University,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,434
NCT02732938,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-09-09,Pfizer,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,2856
NCT02736656,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02737501,0,0,0,0,0,0,2020-07-31,2021-07-31,,Ariad Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02742129,1,1,0,1,0,0,2017-12-13,2018-12-13,2018-12-06,Adrian Hernandez,Other,0,1,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02743221,1,1,0,1,0,0,2018-01-15,2019-01-15,2019-01-15,Institut de Recherches Internationales Servier,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,28
NCT02745080,0,0,0,0,0,0,2019-09-05,2020-09-05,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT02747407,0,0,0,0,0,0,2019-09-30,2020-09-30,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,616
NCT02748512,1,0,0,0,1,0,2017-09-19,2018-09-19,,pSivida Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02749292,0,0,0,0,0,0,2020-10-31,2021-10-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02749721,0,0,0,0,0,0,2019-01-31,2020-01-31,,Rush University Medical Center,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,227
NCT02751359,0,0,0,0,0,0,2021-12-31,2022-12-31,,New York State Psychiatric Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02752035,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,135
NCT02757352,0,0,0,0,0,0,2019-03-01,2020-03-01,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02758431,0,0,0,0,0,0,2021-01-31,2022-01-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02758626,0,0,0,0,0,0,2021-12-31,2022-12-31,,NYU Langone Health,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02763384,0,0,0,0,0,0,2020-05-31,2021-05-31,,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02769611,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Tennessee,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,99
NCT02770287,1,0,1,1,0,0,2017-11-30,2018-11-30,2018-04-06,Venus Concept,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,23
NCT02773082,0,0,0,0,0,0,2020-04-30,2021-04-30,,"The University of Texas Health Science Center, Houston",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT02776683,0,0,0,0,0,0,2018-10-03,2019-10-03,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02781454,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Washington,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02781649,1,1,0,1,0,0,2017-05-03,2018-05-03,2018-01-17,Johns Hopkins University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02783716,0,0,0,0,0,0,2022-12-31,2023-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02784444,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Cirius Therapeutics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02787304,1,0,1,1,0,0,2018-07-27,2019-07-27,2019-06-28,"Mirum Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,16
NCT02787681,1,0,1,1,0,1,2017-07-14,2018-07-14,2019-03-08,Loma Linda University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,194
NCT02787785,0,0,0,0,0,0,2021-10-31,2022-10-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,340
NCT02788149,1,0,0,0,1,0,2017-05-31,2018-05-31,,Henry Ford Health System,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,151
NCT02790632,1,0,0,0,1,0,2018-06-30,2019-06-30,,Edge Therapeutics Inc,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,3
NCT02792218,0,0,0,0,0,0,2019-07-05,2020-07-05,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02794428,0,0,0,0,0,0,2020-07-31,2021-07-31,,Vanderbilt-Ingram Cancer Center,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,180
NCT02799381,0,0,0,0,0,0,2019-09-23,2020-09-23,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT02800642,0,0,0,0,0,0,2019-07-31,2020-07-31,,Bayer,Industry,1,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,1343
NCT02802267,0,0,0,0,0,0,2018-12-31,2019-12-31,,Hybrigenics Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02803229,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York State Psychiatric Institute,Other,0,0,1,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02803749,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,470
NCT02805894,0,0,0,0,0,0,2020-11-30,2021-11-30,,Nanobiotix,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02807558,0,0,0,0,0,0,2020-06-30,2021-06-30,,Syros Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02810418,0,0,0,0,0,0,2021-04-30,2022-04-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,3004
NCT02810704,0,0,0,0,0,0,2020-08-31,2021-08-31,,Medical University of South Carolina,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,511
NCT02813577,0,0,0,0,0,0,2019-02-18,2020-02-18,,C. R. Bard,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,77
NCT02814916,0,0,0,0,0,0,2019-10-25,2020-10-25,,"Durata Therapeutics Inc., an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT02815566,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University Health Network, Toronto",Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,931
NCT02816021,0,0,0,0,0,0,2025-02-28,2026-02-28,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT02818777,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-10-23,"University of Colorado, Denver",Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT02827032,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Vascular Dynamics, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,5
NCT02828020,1,1,0,1,0,0,2017-12-13,2018-12-13,2018-12-13,Allergan,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02831764,1,1,0,1,0,0,2018-04-04,2019-04-04,2019-03-28,ViiV Healthcare,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,200
NCT02836574,0,0,0,0,0,0,2022-12-31,2023-12-31,,inRegen,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,3
NCT02839096,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Missouri-Columbia,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT02839330,0,1,0,1,0,1,2017-10-04,2018-10-04,2019-02-26,Seqirus,Industry,1,0,1,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,41
NCT02841709,0,0,0,0,0,0,2017-06-29,2018-06-29,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,79
NCT02842424,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Nebraska,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,327
NCT02843035,0,0,0,0,0,0,2023-10-31,2024-10-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02847429,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,17
NCT02851511,0,0,0,0,0,0,2022-08-31,2023-08-31,,University of Florida,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT02852356,1,0,0,0,1,0,2017-12-22,2018-12-22,,Ovation Fertility,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02854631,1,1,0,1,0,0,2018-02-16,2019-02-16,2018-12-21,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02858895,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Medicenna Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02859246,1,0,0,0,1,0,2018-07-31,2019-07-31,,Massachusetts Eye and Ear Infirmary,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02860000,0,0,0,0,0,0,2021-12-15,2022-12-15,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT02861131,0,0,0,0,0,0,2019-12-30,2020-12-30,,Oregon Health and Science University,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT02863419,0,0,0,0,0,0,2017-08-19,2018-08-19,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02865343,0,0,0,0,0,0,2019-07-31,2020-07-31,,Spaulding Rehabilitation Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,69
NCT02865538,0,0,0,0,0,0,2017-03-28,2018-03-28,,Nerre Therapeutics Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02867618,0,0,0,0,0,0,2019-10-31,2020-10-31,,Changchun Deng,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02868918,0,0,0,0,0,0,2019-01-01,2020-01-01,,Cairo University,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,1190
NCT02869438,1,0,1,1,0,0,2018-08-01,2019-08-01,2019-07-23,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02870205,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-31,Glenmark Specialty S.A.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02871297,0,0,0,0,0,0,2019-09-30,2020-09-30,,H. Lundbeck A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,152
NCT02872935,0,0,0,0,0,0,2018-12-31,2019-12-31,,Kokila N Thenuwara,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02876107,0,0,0,0,0,0,2023-10-31,2024-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02877082,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-02-16,Emory University,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,1,0,0,0,0,0,0,0,1,947
NCT02878785,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of Maryland, College Park",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,318
NCT02880956,0,0,0,0,0,0,2021-04-30,2022-04-30,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02881567,1,0,1,1,0,0,2018-09-12,2019-09-12,2019-09-05,Biogen,Industry,1,1,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,324
NCT02885636,1,1,0,1,0,1,2017-09-30,2018-09-30,2019-01-13,Mayo Clinic,Other,0,0,1,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02887040,0,0,0,0,0,0,2023-06-30,2024-06-30,,Burzynski Research Institute,Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,1,0,0,3,1,0,65
NCT02887183,0,0,0,0,0,0,2018-10-22,2019-10-22,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02888093,1,0,0,0,1,0,2017-11-30,2018-11-30,,Joseph Kowalski,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02888665,0,0,0,0,0,0,2020-06-01,2021-06-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,393
NCT02892422,0,0,0,0,0,0,2019-11-30,2020-11-30,,H. Lundbeck A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,152
NCT02893917,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02896192,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Rhythm Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT02896712,0,0,0,0,0,0,2020-01-31,2021-01-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,490
NCT02901431,0,0,0,0,0,0,2021-07-06,2022-07-06,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1731
NCT02903368,0,0,0,0,0,0,2020-03-31,2021-03-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02904356,0,0,0,0,0,0,2018-10-31,2019-10-31,,Columbia University,Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,675
NCT02905240,0,0,0,0,0,0,2019-07-31,2020-07-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,215
NCT02907359,0,0,0,0,0,0,2020-06-30,2021-06-30,,Astex Pharmaceuticals,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,38
NCT02910011,0,0,0,0,0,0,2018-11-30,2019-11-30,,University of Florida,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,849
NCT02911324,0,0,0,0,0,0,2019-01-31,2020-01-31,,New York State Psychiatric Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02911961,0,0,0,0,0,0,2020-06-30,2021-06-30,,Denver Health and Hospital Authority,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,66
NCT02913430,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Pittsburgh,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1054
NCT02917993,0,0,0,0,0,0,2020-02-29,2021-02-28,,Incyte Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT02920021,1,0,0,0,1,0,2018-03-31,2019-03-31,,"AnaptysBio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02921022,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02923167,0,0,0,0,0,0,2019-12-31,2020-12-31,,Spaulding Rehabilitation Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,69
NCT02924194,0,0,0,0,0,0,2020-12-31,2021-12-31,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,48
NCT02926235,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,157
NCT02926729,0,0,0,0,0,0,2020-08-31,2021-08-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT02928445,1,0,1,1,0,0,2018-02-28,2019-02-28,2019-02-27,Axovant Sciences Ltd.,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02929589,0,0,0,0,0,0,2020-04-30,2021-04-30,,Mike O'Callaghan Military Hospital,U.S. Fed,2,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT02930109,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Prescient Therapeutics, Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02932306,0,0,0,0,0,0,2017-02-14,2018-02-14,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02932475,0,0,0,0,0,0,2021-06-30,2022-06-30,,"University of North Carolina, Chapel Hill",Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT02932878,1,1,0,1,0,1,2017-04-10,2018-04-10,2018-11-12,Taro Pharmaceuticals USA,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02936037,0,0,0,0,0,0,2019-08-31,2020-08-31,,MedDay Pharmaceuticals SA,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02937675,0,0,0,0,0,0,2018-11-12,2019-11-12,,Effector Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT02939274,0,0,0,0,0,0,2018-12-31,2019-12-31,,Rogers Sciences Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,3
NCT02940353,0,0,0,0,0,0,2022-04-30,2023-04-30,,Nobel Biocare,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,15
NCT02940626,1,1,0,1,0,0,2018-07-19,2019-07-19,2019-06-20,"Arsanis, Inc.",Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT02942420,1,0,0,0,1,0,2018-03-31,2019-03-31,,"Revive Therapeutics, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT02944565,1,1,0,1,0,1,2017-07-20,2018-07-20,2019-02-15,Ohio State University Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,198
NCT02946424,0,0,0,0,0,0,2021-09-30,2022-09-30,,Craig Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT02947178,1,0,0,0,1,0,2017-03-01,2018-03-01,,Walter Reed National Military Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,47
NCT02947386,0,0,0,0,0,0,2019-08-31,2020-08-31,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,294
NCT02948959,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT02949830,0,0,0,0,0,0,2020-10-31,2021-10-31,,Alnylam Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,45
NCT02949934,0,0,0,0,0,0,2020-12-31,2021-12-31,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02950337,0,0,0,0,0,0,2020-12-31,2021-12-31,,Loyola University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,102
NCT02950922,0,0,0,0,0,0,2017-07-03,2018-07-03,,Dermavant Sciences GmbH,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02951351,1,1,0,1,0,1,2018-02-01,2019-02-01,2019-04-01,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02952222,0,0,0,0,0,0,2019-12-31,2020-12-31,,Keira Mason,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02952586,0,0,0,0,0,0,2021-04-08,2022-04-08,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02955147,0,0,0,0,0,0,2020-02-29,2021-02-28,,Massachusetts General Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02956473,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,647
NCT02956590,0,0,0,0,0,0,2024-04-30,2025-04-30,,New England Research Institutes,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,49
NCT02956746,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-28,"Synermore Biologics Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT02957994,1,0,1,1,0,1,2017-06-21,2018-06-21,2018-06-25,Asian Pacific Liver Center at St. Vincent Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,1
NCT02958449,1,0,0,0,1,0,2018-02-28,2019-02-28,,"Cohera Medical, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,9
NCT02959996,1,1,0,1,0,0,2017-09-25,2018-09-25,2018-05-11,Massachusetts General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1699
NCT02964325,0,0,0,0,0,0,2021-11-30,2022-11-30,,Terumo BCTbio,Industry,1,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT02967432,0,0,0,0,0,0,2019-08-31,2020-08-31,,Crouse Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02968212,0,0,0,0,0,0,2021-02-28,2022-02-28,,Oregon Health and Science University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT02968368,1,0,0,0,1,0,2017-12-31,2018-12-31,,Shield Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02968810,0,0,0,0,0,0,2020-01-01,2021-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02968992,0,0,0,0,0,0,2019-02-25,2020-02-25,,Johns Hopkins University,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1143
NCT02970097,0,0,0,0,0,0,2018-10-05,2019-10-05,,University of Pennsylvania,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02970318,0,0,0,0,0,0,2019-01-15,2020-01-15,,Acerta Pharma BV,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT02974010,1,0,0,0,1,0,2018-08-31,2019-08-31,,"NeuroRx, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT02974140,1,1,0,1,0,0,2017-07-25,2018-07-25,2018-07-23,"Alcon, a Novartis Company",Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,13
NCT02974855,0,0,0,0,0,0,2018-12-03,2019-12-03,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,2856
NCT02975297,0,0,0,0,0,0,2020-06-30,2021-06-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,490
NCT02980341,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Daiichi Sankyo Co., Ltd.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,60
NCT02981381,0,0,0,0,0,0,2018-10-26,2019-10-26,,Providence VA Medical Center,U.S. Fed,2,1,0,1.0,Phase 2,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,14
NCT02981524,0,0,1,1,0,0,2021-03-31,2022-03-31,2019-08-29,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,461
NCT02982720,1,1,0,1,0,1,2018-02-09,2019-02-09,2019-05-16,"Aiwu Ruth He, MD",Other,0,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02984384,0,0,0,0,0,0,2021-01-31,2022-01-31,,Major Extremity Trauma Research Consortium,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,22
NCT02984995,0,0,0,0,0,0,2018-03-28,2019-03-28,,"Daiichi Sankyo Co., Ltd.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,60
NCT02986659,0,0,0,0,0,0,2018-11-15,2019-11-15,,Wake Forest University Health Sciences,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT02990806,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Nichi-Iko Pharmaceutical Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,4
NCT02992964,0,0,0,0,0,0,2021-09-30,2022-09-30,,The Hospital for Sick Children,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,403
NCT02993198,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02994069,0,0,0,0,0,0,2020-10-31,2021-10-31,,Susanne Arnold,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,9
NCT02994498,0,0,0,0,0,0,2025-09-30,2026-09-30,,"Chung Mei Biopharma Co., Ltd",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT02995915,0,0,0,0,0,0,2020-02-29,2021-02-28,,Duke University,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1342
NCT02996305,1,0,0,0,1,0,2018-06-07,2019-06-07,,Ovid Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT02996682,1,1,0,1,0,0,2018-02-13,2019-02-13,2019-02-01,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02999854,0,0,0,0,0,0,2021-02-28,2022-02-28,,Kiadis Pharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,8
NCT03001557,0,0,0,0,0,0,2018-07-26,2019-07-26,,Eisai Inc.,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,328
NCT03003299,0,0,0,0,0,0,2021-12-31,2022-12-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,0,1,77
NCT03003689,1,0,0,0,1,0,2018-03-31,2019-03-31,,Tufts University School of Dental Medicine,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03004183,0,0,0,0,0,0,2022-05-31,2023-05-31,,"Jenny C. Chang, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,11
NCT03004924,0,0,0,0,0,0,2018-10-01,2019-10-01,,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,342
NCT03007238,0,0,0,0,0,0,2020-12-31,2021-12-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,358
NCT03007394,0,0,0,0,0,0,2019-03-31,2020-03-31,,National Institute on Drug Abuse (NIDA),NIH,2,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,370
NCT03008070,0,0,0,0,0,0,2019-12-31,2020-12-31,,Inventiva Pharma,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03011554,0,0,0,0,0,0,2019-12-31,2020-12-31,,"VisionCare, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03012386,0,0,0,0,0,0,2020-07-31,2021-07-31,,Vanderbilt University Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03012880,0,0,0,0,0,0,2019-06-26,2020-06-26,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03014362,0,0,0,0,0,0,2020-01-31,2021-01-31,,Eisenhower Army Medical Center,U.S. Fed,2,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03014687,0,0,0,0,0,0,2019-01-31,2020-01-31,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,48
NCT03016598,0,0,0,0,0,0,2019-12-27,2020-12-27,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03021499,0,0,0,0,0,0,2019-12-31,2020-12-31,,Aurinia Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03023449,0,0,0,0,0,0,2020-02-29,2021-02-28,,Steven Messe,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03029000,1,1,0,1,0,1,2017-10-30,2018-10-30,2018-11-14,"Teva Pharmaceutical Industries, Ltd.",Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,14
NCT03029624,1,0,0,0,1,0,2017-12-30,2018-12-30,,Valencia Technologies Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,3
NCT03031782,0,0,0,0,0,0,2019-10-22,2020-10-22,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03032172,0,0,0,0,0,0,2021-12-31,2022-12-31,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03032666,1,0,0,0,1,0,2018-08-06,2019-08-06,,Ala'a Sharara,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03034915,1,1,0,1,0,0,2018-06-18,2019-06-18,2019-06-16,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03037983,0,0,0,0,0,0,2019-07-01,2020-07-01,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1012
NCT03038087,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Sense Diagnostics, LLC",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03039218,1,0,0,0,1,0,2018-03-29,2019-03-29,,Dornier MedTech Systems,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03041311,0,0,0,0,0,0,2018-07-28,2019-07-28,,"G1 Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03042559,1,0,1,1,0,0,2018-01-31,2019-01-31,2018-05-22,Loma Linda University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,194
NCT03042780,1,1,0,1,0,0,2018-01-03,2019-01-03,2018-11-19,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,344
NCT03043807,0,0,0,0,0,0,2022-02-28,2023-02-28,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,461
NCT03044249,0,0,0,0,0,0,2020-08-31,2021-08-31,,Mediti Pharma Inc.,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03044964,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Amit Malhotra, MD",Industry,1,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03045406,0,0,0,0,0,0,2019-06-01,2020-06-01,,"Fadoi Foundation, Italy",Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,7
NCT03049930,0,0,0,0,0,0,2020-08-31,2021-08-31,,Loyola University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03050827,1,0,0,0,1,0,2017-08-17,2018-08-17,,Eastern Virginia Medical School,Other,0,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,33
NCT03055286,0,0,0,0,0,0,2020-10-31,2021-10-31,,JW Pharmaceutical,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,37
NCT03055377,0,0,0,0,0,0,2021-11-30,2022-11-30,,Medical University of South Carolina,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03055598,0,0,0,0,0,0,2019-09-30,2020-09-30,,Sreedhar Mandayam,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03055767,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Irvine",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,310
NCT03056092,0,0,0,0,0,0,2020-02-28,2021-02-28,,"St. Michael's Hospital, Toronto",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,303
NCT03059082,1,0,0,0,1,0,2018-08-31,2019-08-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,882
NCT03059485,0,0,0,0,0,0,2020-09-30,2021-09-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,647
NCT03061539,0,0,0,0,0,0,2019-04-30,2020-04-30,,"University College, London",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,370
NCT03061721,0,0,0,0,0,0,2019-08-22,2020-08-22,,Zydus Discovery DMCC,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03065231,0,0,0,0,0,0,2022-01-01,2023-01-01,,"University of California, San Diego",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,0,1,561
NCT03065881,1,0,0,0,1,0,2017-12-31,2018-12-31,,"LKC Technologies, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03066778,0,0,0,0,0,0,2019-12-16,2020-12-16,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03070301,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03070483,0,0,0,0,0,0,2018-11-01,2019-11-01,,Loyola University,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,102
NCT03074318,0,0,0,0,0,0,2021-04-01,2022-04-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,393
NCT03078465,0,0,0,0,0,0,2021-05-30,2022-05-30,,"Nanjing First Hospital, Nanjing Medical University",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,41
NCT03079271,1,0,0,0,1,0,2017-06-30,2018-06-30,,Virginia Eye Consultants,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT03080077,0,0,0,0,0,0,2019-06-30,2020-06-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT03082508,0,0,0,0,0,0,2020-01-31,2021-01-31,,"LoneStar Heart, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,3,1,0,5
NCT03085719,0,0,0,0,0,0,2020-10-31,2021-10-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,647
NCT03086369,0,0,0,0,0,0,2020-04-01,2021-04-01,,Eli Lilly and Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03086993,0,0,0,0,0,0,2023-01-31,2024-01-31,,Delcath Systems Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,1,0,0,1,0,8
NCT03087617,0,0,0,0,0,0,2019-10-31,2020-10-31,,Imbio,Industry,1,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03088592,0,0,0,0,0,0,2019-02-28,2020-02-28,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,48
NCT03089047,0,0,0,0,0,0,2019-12-31,2020-12-31,,Duke University,Other,0,1,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1342
NCT03090100,1,0,1,1,0,0,2018-08-02,2019-08-02,2019-08-01,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT03092011,0,0,0,0,0,0,2022-12-31,2023-12-31,,The Cooper Health System,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,37
NCT03093272,0,0,0,0,0,0,2020-08-31,2021-08-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03093415,0,0,0,0,0,0,2019-06-06,2020-06-06,,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,475
NCT03095066,0,0,0,0,0,0,2020-06-30,2021-06-30,,Avanir Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03097133,0,0,0,0,0,0,2019-04-11,2020-04-11,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT03098030,0,0,0,0,0,0,2019-11-30,2020-11-30,,United Therapeutics,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,72
NCT03101501,1,0,0,0,1,0,2018-02-01,2019-02-01,,Key-Whitman Eye Center,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,1,0,0,0,0,0,1,0,1
NCT03102710,0,0,0,0,0,0,2019-03-31,2020-03-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1699
NCT03104400,0,0,0,0,0,0,2019-09-20,2020-09-20,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03106779,0,0,0,0,0,0,2022-01-19,2023-01-19,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03108495,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Iovance Biotherapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,5
NCT03110133,0,0,0,0,0,0,2019-12-31,2020-12-31,,Finch Research and Development LLC.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03111121,0,0,0,0,0,0,2020-12-15,2021-12-15,,West Virginia University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,74
NCT03113825,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Avelas Biosciences, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,2
NCT03115489,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Alabama at Birmingham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03116009,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Illinois at Chicago,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,242
NCT03116945,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Rutgers, The State University of New Jersey",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,227
NCT03118765,0,1,0,1,0,1,2017-07-31,2018-07-31,2019-06-13,Glenmark Specialty S.A.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03122171,0,0,0,0,0,0,2020-12-01,2021-12-01,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03123549,0,0,0,0,0,0,2020-11-30,2021-11-30,,Simplify Medical Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03124875,0,0,0,0,0,0,2019-06-08,2020-06-08,,"LimFlow, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03125798,0,0,0,0,0,0,2020-09-30,2021-09-30,,Wielkopolskie Centrum Pulmonologii i Torakochirurgii,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03126019,0,0,0,0,0,0,2020-10-31,2021-10-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03126916,0,0,0,0,0,0,2026-06-30,2027-06-30,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,1,0,0,1,0,0,1,1,0,389
NCT03130439,0,0,0,0,0,0,2020-11-30,2021-11-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03134274,1,0,0,0,1,0,2017-10-31,2018-10-31,,Healthy.io Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03137888,0,0,0,0,0,0,2021-07-31,2022-07-31,,Emory University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,947
NCT03138590,1,0,0,0,1,0,2018-01-09,2019-01-09,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03138967,1,1,0,1,0,0,2018-09-01,2019-09-01,2019-06-27,M.D. Anderson Cancer Center,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03141203,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Birmingham,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,115
NCT03141983,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Pennsylvania,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03142191,0,0,0,0,0,0,2021-06-30,2022-06-30,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03144687,0,0,0,0,0,0,2020-07-31,2021-07-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03150589,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Samsung Bioepis Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,19
NCT03152136,1,1,0,1,0,1,2018-03-08,2019-03-08,2019-03-20,"Cala Health, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03152552,1,1,0,1,0,0,2018-06-06,2019-06-06,2019-04-11,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03156010,0,0,0,0,0,0,2019-06-30,2020-06-30,,Walter Reed National Military Medical Center,U.S. Fed,2,1,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,47
NCT03156361,1,0,0,0,1,0,2018-01-15,2019-01-15,,Diasome Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03158038,1,1,0,1,0,0,2017-12-14,2018-12-14,2018-12-10,MedImmune LLC,Industry,1,1,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,269
NCT03160079,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Matthew Wieduwilt, M.D., Ph.D.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03161678,0,0,0,0,0,0,2020-10-31,2021-10-31,,"University of Maryland, College Park",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03162783,0,0,0,0,0,0,2017-07-06,2018-07-06,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03163342,1,1,0,1,0,1,2017-11-21,2018-11-21,2019-03-06,"Altimmune, Inc.",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,6
NCT03164590,1,0,0,0,1,0,2018-08-01,2019-08-01,,Assiut University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1331
NCT03165617,0,0,0,0,0,0,2019-07-23,2020-07-23,,Seqirus,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,41
NCT03165981,1,1,0,1,0,0,2018-01-15,2019-01-15,2018-12-31,Duke University,Other,0,0,1,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,1342
NCT03167203,0,0,0,0,0,0,2029-12-31,2030-12-31,,Astellas Institute for Regenerative Medicine,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,9
NCT03167619,0,0,0,0,0,0,2020-04-30,2021-04-30,,Duke University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03168061,0,0,0,0,0,0,2020-07-31,2021-07-31,,"NanoCarrier Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03168906,1,0,0,0,1,0,2018-04-23,2019-04-23,,Tufts Medical Center,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,121
NCT03170609,1,1,0,1,0,0,2018-06-25,2019-06-25,2019-06-13,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,2856
NCT03173456,0,0,0,0,0,0,2019-09-30,2020-09-30,,Albert Einstein College of Medicine,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03176693,0,0,0,0,0,0,2023-05-31,2024-05-31,,"University of California, Los Angeles",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03176927,0,0,0,0,0,0,2020-08-31,2021-08-31,,Vanderbilt University Medical Center,Other,0,0,1,5.0,,0,2012.0,0,0,0,0,1,0,0,0,0,0,1,422
NCT03179592,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medical University of South Carolina,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03180294,0,0,0,0,0,0,2019-10-30,2020-10-30,,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03184545,0,0,0,0,0,0,2021-06-30,2022-06-30,,Northwell Health,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03187756,0,0,0,0,0,0,2018-12-18,2019-12-18,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,869
NCT03191396,1,1,0,1,0,0,2018-07-09,2019-07-09,2019-07-08,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,981
NCT03193398,0,0,0,0,0,0,2018-11-12,2019-11-12,,"BlackThorn Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03196076,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of North Carolina, Chapel Hill",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03197662,0,0,0,0,0,0,2020-02-29,2021-02-28,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03198221,0,0,0,0,0,0,2021-01-31,2022-01-31,,The Cleveland Clinic,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03198767,1,1,0,1,0,0,2017-09-04,2018-09-04,2018-08-27,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03199963,0,0,0,0,0,0,2019-03-31,2020-03-31,,"BHR Pharma, LLC",Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,4
NCT03201094,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,318
NCT03202303,0,0,0,0,0,0,2021-06-30,2022-06-30,,Eric Hollander,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03205488,0,0,0,0,0,0,2020-10-31,2021-10-31,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03206060,0,0,0,0,0,0,2022-01-01,2023-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03207399,0,1,0,1,0,0,2019-03-25,2020-03-25,2019-06-03,Duke University,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03208231,0,0,0,0,0,0,2020-09-01,2021-09-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2133
NCT03215030,0,0,0,0,0,0,2021-10-08,2022-10-08,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,209
NCT03216499,0,0,0,0,0,0,2019-08-31,2020-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03217201,0,0,0,0,0,0,2022-04-30,2023-04-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,412
NCT03217331,0,0,0,0,0,0,2018-10-10,2019-10-10,,Cardiora Pty. Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03218163,1,1,0,1,0,0,2018-04-15,2019-04-15,2018-04-27,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,461
NCT03219307,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Aesculap Biologics, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,2
NCT03219840,1,0,1,1,0,0,2018-09-08,2019-09-08,2019-09-08,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,490
NCT03221023,0,0,0,0,0,0,2020-09-15,2021-09-15,,University of British Columbia,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,881
NCT03225209,1,0,0,0,1,0,2018-07-15,2019-07-15,,Moahad S Dar,Other,0,1,1,1.0,Phase 2,0,2018.0,1,0,0,0,0,0,0,0,0,1,0,1
NCT03225547,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03226899,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Ironwood Pharmaceuticals, Inc.",Industry,1,1,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,22
NCT03228212,1,1,0,1,0,0,2017-09-18,2018-09-18,2018-09-14,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03232151,0,0,0,0,0,0,2020-05-01,2021-05-01,,"University of Wisconsin, Madison",Other,0,0,1,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,715
NCT03233737,1,1,0,1,0,1,2018-02-20,2019-02-20,2019-06-05,Cetylite Industries,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,0,1,0,0,1,0,0,1,0,2
NCT03235024,0,0,0,0,0,0,2019-02-27,2020-02-27,,AOBiome LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,10
NCT03235531,0,0,0,0,0,0,2019-07-11,2020-07-11,,CAMC Health System,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,38
NCT03238326,0,0,0,0,0,0,2023-11-30,2024-11-30,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,185
NCT03238911,0,0,0,0,0,0,2018-06-19,2019-06-19,,Pharmacosmos A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,30
NCT03239210,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03241420,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Jewish Health,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,81
NCT03241563,1,0,1,1,0,0,2017-02-28,2018-02-28,2017-10-24,"Goldman, Butterwick, Fitzpatrick and Groff",Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT03241745,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03242343,0,0,0,0,0,0,2019-12-31,2020-12-31,,Laminate Medical Technologies,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03242772,0,0,0,0,0,0,2021-07-31,2022-07-31,,Duke University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03245450,0,0,0,0,0,0,2021-06-30,2022-06-30,,Eisai Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,328
NCT03245827,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Sandeep Singh Dhindsa, M.D., F.A.C.E",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03247712,0,0,0,0,0,0,2025-12-31,2026-12-31,,Providence Health & Services,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,55
NCT03249740,1,0,0,0,1,0,2018-09-13,2019-09-13,,Graybug Vision,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03250442,0,0,0,0,0,0,2020-09-30,2021-09-30,,Georgetown University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT03251092,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Proteostasis Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03253198,1,0,0,0,1,0,2017-06-30,2018-06-30,,Rothman Institute Orthopaedics,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT03254485,0,0,0,0,0,0,2019-09-30,2020-09-30,,Cyclerion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03255057,0,0,0,0,0,0,2019-12-31,2020-12-31,,Alung Technologies,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03256045,0,0,0,0,0,0,2021-05-16,2022-05-16,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03256487,1,0,0,0,1,0,2018-02-01,2019-02-01,,Alameda Health System,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03257033,0,0,0,0,0,0,2022-09-30,2023-09-30,,RenovoRx,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,3
NCT03258567,0,0,0,0,0,0,2022-09-01,2023-09-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03258853,0,0,0,0,0,0,2022-12-31,2023-12-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03260894,1,1,0,1,0,0,2018-08-22,2019-08-22,2019-08-21,Incyte Corporation,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03262909,0,0,0,0,0,0,2021-04-30,2022-04-30,,Regentis Biomaterials,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03263559,0,0,0,0,0,0,2023-12-31,2024-12-31,,Medical College of Wisconsin,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,315
NCT03263897,0,0,0,0,0,0,2019-12-31,2020-12-31,,Caps Research Network,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03265145,0,0,0,0,0,0,2020-08-30,2021-08-30,,Boehringer Ingelheim,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1852
NCT03268005,0,0,0,0,0,0,2019-01-07,2020-01-07,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,981
NCT03269435,0,0,0,0,0,0,2020-08-31,2021-08-31,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03269552,0,0,0,0,0,0,2018-12-28,2019-12-28,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,1,0,0,0,0,0,0,1,0,910
NCT03270501,0,0,0,0,0,0,2020-12-31,2021-12-31,,University Ghent,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,151
NCT03271229,0,0,0,0,0,0,2021-01-31,2022-01-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03272633,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,227
NCT03275064,0,0,0,0,0,0,2020-01-30,2021-01-30,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03277313,0,0,0,0,0,0,2023-10-30,2024-10-30,,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,107
NCT03278106,0,0,1,1,0,0,2018-11-30,2019-11-30,2019-09-11,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03278405,0,0,0,0,0,0,2019-09-20,2020-09-20,,Sunnybrook Health Sciences Centre,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,352
NCT03279250,0,0,0,0,0,0,2022-02-28,2023-02-28,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03279510,0,0,0,0,0,0,2020-07-31,2021-07-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03284203,0,0,0,0,0,0,2019-05-01,2020-05-01,,University of Chicago,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,594
NCT03285581,1,0,0,0,1,0,2018-08-31,2019-08-31,,Cutera Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03285711,0,0,0,0,0,0,2019-08-31,2020-08-31,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,510
NCT03287076,0,0,0,0,0,0,2020-12-31,2021-12-31,,Neuroscience Trials Australia,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,12
NCT03287960,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Rhythm Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03289741,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03289910,0,0,0,0,0,0,2020-06-01,2021-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03290547,0,0,0,0,0,0,2022-12-31,2023-12-31,,Cutera Inc.,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,37
NCT03292016,0,0,0,0,0,0,2019-03-05,2020-03-05,,Sunovion,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,134
NCT03292731,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Steve N. Caritis, MD",Other,0,0,1,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03293485,1,0,1,1,0,0,2018-09-14,2019-09-14,2019-08-23,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,2145
NCT03297216,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of North Carolina, Chapel Hill",Other,0,1,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,910
NCT03298022,0,0,0,0,0,0,2020-05-31,2021-05-31,,"AbGenomics International, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03301168,0,0,0,0,0,0,2020-02-29,2021-02-28,,Bellicum Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,15
NCT03306329,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Dart NeuroScience, LLC",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03306472,0,0,0,0,0,0,2019-12-01,2020-12-01,,Cambridge University Hospitals NHS Foundation Trust,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,98
NCT03306602,0,0,0,0,0,0,2019-01-30,2020-01-30,,Melaka Manipal Medical College,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,4
NCT03307616,0,0,0,0,0,0,2021-10-31,2022-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,1,0,0,0,1,0,2066
NCT03308942,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Tesaro, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,31
NCT03311581,0,0,0,0,0,0,2022-02-01,2023-02-01,,Kaohsiung Medical University Chung-Ho Memorial Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,2,1,0,142
NCT03312023,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of Maryland, Baltimore",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,144
NCT03312192,0,0,0,0,0,0,2020-12-31,2021-12-31,,Rush University Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,227
NCT03312400,0,0,0,0,0,0,2021-09-01,2022-09-01,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1091
NCT03313180,0,0,0,0,0,0,2021-07-31,2022-07-31,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03315533,0,0,0,0,0,0,2020-12-31,2021-12-31,,Rhode Island Hospital,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,120
NCT03315689,0,0,0,0,0,0,2019-06-20,2020-06-20,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03315793,0,0,0,0,0,0,2020-02-04,2021-02-04,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03317795,0,0,0,0,0,0,2020-06-30,2021-06-30,,Shannon K. Laughlin-Tommaso,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03318003,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Michigan,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03318562,1,0,0,0,1,0,2018-07-05,2019-07-05,,Effector Therapeutics,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03321929,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Lumicell, Inc.",Industry,1,0,1,1.0,Phase 2,0,2018.0,1,0,0,0,0,0,1,0,0,1,0,7
NCT03323801,0,0,0,0,0,0,2019-05-16,2020-05-16,,University of Washington,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03328403,0,0,0,0,0,0,2018-12-31,2019-12-31,,The University of Hong Kong,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,2,0,1,547
NCT03330275,1,1,0,1,0,0,2017-12-11,2018-12-11,2018-05-07,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,138
NCT03331250,0,0,0,0,0,0,2021-05-31,2022-05-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03331523,0,0,0,0,0,0,2018-10-25,2019-10-25,,Glenmark Pharmaceuticals Ltd. India,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03332524,0,0,0,0,0,0,2019-01-31,2020-01-31,,Sephoris Pharmaceuticals LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03333746,1,1,0,1,0,0,2018-08-13,2019-08-13,2019-02-14,Yvonne Efebera,Other,0,1,1,1.0,Phase 2,1,2018.0,1,1,1,0,0,0,0,0,0,1,0,3
NCT03334422,0,0,0,0,0,0,2018-12-12,2019-12-12,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1512
NCT03335293,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03338010,0,0,0,0,0,0,2020-04-27,2021-04-27,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03338569,0,0,0,0,0,0,2019-11-20,2020-11-20,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03339297,0,0,0,0,0,0,2020-01-31,2021-01-31,,Jazz Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,55
NCT03339921,0,0,0,0,0,0,2019-12-31,2020-12-31,,"375th Medical Group, Scott Air Force Base",U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03342664,0,0,0,0,0,0,2022-07-31,2023-07-31,,Penumbra Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT03344419,0,0,0,0,0,0,2021-04-30,2022-04-30,,New York State Psychiatric Institute,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03345849,0,0,0,0,0,0,2019-12-19,2020-12-19,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03348163,0,0,0,0,0,0,2020-04-01,2021-04-01,,"The University of Texas Health Science Center, Houston",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03349892,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,692
NCT03350256,0,0,0,0,0,0,2019-07-02,2020-07-02,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,419
NCT03353233,0,0,0,0,0,0,2018-11-13,2019-11-13,,Duke University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03355573,0,0,0,0,0,0,2022-12-31,2023-12-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03355976,0,0,0,0,0,0,2020-02-29,2021-02-28,,Don Dizon,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03356444,0,0,0,0,0,0,2020-12-31,2021-12-31,,West China Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,114
NCT03357471,1,0,1,1,0,0,2018-07-03,2019-07-03,2019-07-02,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,75
NCT03359174,0,0,0,0,0,0,2020-12-01,2021-12-01,,Yale University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03361865,1,1,0,1,0,0,2018-08-09,2019-08-09,2019-08-09,Incyte Corporation,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03364218,0,0,0,0,0,0,2020-05-31,2021-05-31,,Carilion Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,22
NCT03364335,1,1,0,1,0,0,2018-08-06,2019-08-06,2018-10-29,NuSirt Biopharma,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03369717,0,0,0,0,0,0,2020-01-31,2021-01-31,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03370172,0,0,0,0,0,0,2022-06-30,2023-06-30,,Baxalta now part of Shire,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,107
NCT03370718,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03373162,1,1,0,1,0,1,2017-11-01,2018-11-01,2019-02-26,"University of California, Irvine",Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,310
NCT03374488,1,1,0,1,0,0,2018-07-27,2019-07-27,2019-07-26,Incyte Corporation,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03376516,0,0,0,0,0,0,2018-11-03,2019-11-03,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,54
NCT03377179,0,0,0,0,0,0,2020-01-31,2021-01-31,,RedHill Biopharma Limited,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03378076,1,1,0,1,0,0,2018-03-14,2019-03-14,2019-03-04,"Flexion Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03381677,0,0,0,0,0,0,2022-10-26,2023-10-26,,Innovative Surgical Designs,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03381859,0,0,0,0,0,0,2020-06-01,2021-06-01,,Shyamasundaran Kottilil,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03383198,0,0,0,0,0,0,2019-08-14,2020-08-14,,Prisma Health-Upstate,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,32
NCT03383666,0,0,0,0,0,0,2021-09-30,2022-09-30,,Pulsar Vascular,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03384173,0,0,0,0,0,0,2019-09-01,2020-09-01,,"University of Wisconsin, Madison",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,715
NCT03385330,0,0,0,0,0,0,2020-02-01,2021-02-01,,Children's Hospital of Philadelphia,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,324
NCT03386487,0,0,0,0,0,0,2022-12-31,2023-12-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03386721,0,0,0,0,0,0,2022-01-28,2023-01-28,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03387215,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Intra-Cellular Therapies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03388268,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,1151
NCT03388905,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sheba Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,553
NCT03390933,0,0,0,0,0,0,2023-11-30,2024-11-30,,MetroHealth Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,65
NCT03392142,0,0,0,0,0,0,2020-11-30,2021-11-30,,Atara Biotherapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,10
NCT03393000,0,0,0,0,0,0,2021-06-28,2022-06-28,,Diffusion Pharmaceuticals Inc,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03394911,0,0,0,0,0,0,2020-11-30,2021-11-30,,Bubba Nicholson,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT03395080,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Leap Therapeutics, Inc.",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03395678,0,0,0,0,0,0,2020-08-31,2021-08-31,,Boston University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,188
NCT03396484,0,0,0,0,0,0,2022-03-31,2023-03-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,495
NCT03397394,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Clovis Oncology, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT03398200,0,0,0,0,0,0,2020-05-01,2021-05-01,,Omar Aljitawi,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03399552,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03400579,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03403751,0,0,0,0,0,0,2020-12-31,2021-12-31,,Atox Bio Ltd,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03404401,1,0,0,0,1,0,2018-07-10,2019-07-10,,Braintree Laboratories,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,43
NCT03406403,1,0,0,0,1,0,2018-05-31,2019-05-31,,Cairo University,Other,0,0,0,5.0,,0,2018.0,1,1,0,1,0,0,0,0,2,1,0,1190
NCT03406715,0,0,0,0,0,0,2020-04-30,2021-04-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,344
NCT03407144,0,0,0,0,0,0,2027-02-13,2028-02-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,1,0,0,1,1,0,2145
NCT03409432,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Basem William, MD",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03409744,0,0,0,0,0,0,2022-04-11,2023-04-11,,Regeneron Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03410550,0,0,0,0,0,0,2020-12-30,2021-12-30,,McGuire Research Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03410875,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03411902,0,0,0,0,0,0,2020-01-31,2021-01-31,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03412565,0,0,0,0,0,0,2020-09-27,2021-09-27,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03414034,0,0,0,0,0,0,2021-10-16,2022-10-16,,"Trovagene, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03417284,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03417739,0,0,0,0,0,0,2021-08-31,2022-08-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03418649,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Cincinnati,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,222
NCT03419091,0,0,0,0,0,0,2018-12-30,2019-12-30,,University of British Columbia,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,881
NCT03420521,0,0,0,0,0,0,2023-01-15,2024-01-15,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03420781,0,0,0,0,0,0,2020-12-06,2021-12-06,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03424161,0,0,0,0,0,0,2019-04-30,2020-04-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03426267,0,0,0,0,0,0,2019-12-30,2020-12-30,,Sun Pharma Advanced Research Company Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03427619,0,0,0,0,0,0,2018-10-22,2019-10-22,,Richard JH Smith,Other,0,0,0,4.0,Phase 4,0,1998.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03428295,0,0,0,0,0,0,2019-08-31,2020-08-31,,Dose Safety Inc.,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03428802,0,0,0,0,0,0,2020-10-02,2021-10-02,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,227
NCT03429270,0,0,0,0,0,0,2018-10-17,2019-10-17,,Laborie Medical Technologies Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03430011,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Juno Therapeutics, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,8
NCT03431168,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03433430,1,0,0,0,1,0,2018-05-31,2019-05-31,,Cutera Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03434353,0,0,0,0,0,0,2020-04-30,2021-04-30,,Gilead Sciences,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,510
NCT03435172,0,0,0,0,0,0,2020-07-31,2021-07-31,,Cytori Therapeutics,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,17
NCT03437577,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03438747,0,0,0,0,0,0,2021-09-30,2022-09-30,,"CeraPedics, Inc",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03439072,1,1,0,1,0,0,2018-04-18,2019-04-18,2019-04-17,Xeris Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,14
NCT03440814,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Soleno Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03442036,0,0,0,0,0,0,2019-04-01,2020-04-01,,"University of California, San Diego",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,561
NCT03443713,0,0,0,0,0,0,2019-05-08,2020-05-08,,Oregon Health and Science University,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,475
NCT03443856,0,0,0,0,0,0,2023-04-30,2024-04-30,,European Organisation for Research and Treatment of Cancer - EORTC,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,320
NCT03446807,0,0,0,0,0,0,2019-03-01,2020-03-01,,Loma Linda University,Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,194
NCT03447730,0,0,0,0,0,0,2019-08-20,2020-08-20,,Synlogic,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03448536,1,0,1,1,0,0,2018-09-05,2019-09-05,2019-08-14,Bayer,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1343
NCT03448939,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Sol-Gel Technologies, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03449147,0,0,0,0,0,0,2021-01-08,2022-01-08,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03451292,0,0,0,0,0,0,2021-10-31,2022-10-31,,Grifols Therapeutics LLC,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,40
NCT03452488,0,0,0,0,0,0,2019-07-31,2020-07-31,,Biophytis,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03453190,0,0,0,0,0,0,2020-03-01,2021-03-01,,Washington Dermatology Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,1
NCT03453489,0,0,0,0,0,0,2020-06-01,2021-06-01,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,134
NCT03457129,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Arizona,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,265
NCT03458000,0,0,0,0,0,0,2019-05-31,2020-05-31,,George Washington University,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,85
NCT03458416,0,0,0,0,0,0,2020-05-31,2021-05-31,,INSYS Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,50
NCT03459131,1,1,0,1,0,0,2018-03-26,2019-03-26,2019-02-13,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03461861,0,0,0,0,0,0,2020-03-31,2021-03-31,,Medical College of Wisconsin,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03462758,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Diego",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,561
NCT03466320,0,0,0,0,0,0,2021-08-31,2022-08-31,,Celyad (formerly named Cardio3 BioSciences),Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,10
NCT03469271,0,0,0,0,0,0,2020-04-02,2021-04-02,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1898
NCT03470272,0,0,0,0,0,0,2018-11-30,2019-11-30,,Manamed Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03473665,0,0,0,0,0,0,2019-03-01,2020-03-01,,Columbia University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,675
NCT03474081,0,0,0,0,0,0,2019-07-17,2020-07-17,,GlaxoSmithKline,Industry,1,1,0,4.0,Phase 4,0,2018.0,1,1,0,1,0,0,0,0,1,1,0,3276
NCT03478215,0,0,0,0,0,0,2021-07-31,2022-07-31,,The Methodist Hospital System,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,36
NCT03478566,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Hospital for Sick Children,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,403
NCT03480360,0,0,0,0,0,0,2021-12-31,2022-12-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,306
NCT03481660,0,0,0,0,0,0,2020-07-15,2021-07-15,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03482791,0,0,0,0,0,0,2022-04-30,2023-04-30,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,1151
NCT03485950,0,0,0,0,0,0,2020-05-31,2021-05-31,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03487185,0,0,0,0,0,0,2023-12-31,2024-12-31,,The George Washington University Biostatistics Center,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT03487848,0,0,0,0,0,0,2021-04-29,2022-04-29,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1104
NCT03489291,0,0,0,0,0,0,2018-10-30,2019-10-30,,UniQure Biopharma B.V.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,0,1,0,1,0,6
NCT03491553,0,0,0,0,0,0,2019-03-22,2020-03-22,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03493126,0,0,0,0,0,0,2020-06-01,2021-06-01,,Pamela Smith,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03493945,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03495102,0,0,0,0,0,0,2019-05-28,2020-05-28,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03497676,0,0,0,0,0,0,2021-04-15,2022-04-15,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03500094,0,0,0,0,0,0,2020-09-01,2021-09-01,,Amicus Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,34
NCT03501368,0,0,0,0,0,0,2021-06-30,2022-06-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03502018,0,0,0,0,0,0,2019-07-01,2020-07-01,,Maimonides Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,46
NCT03503058,0,0,0,0,0,0,2021-04-30,2022-04-30,,Sanaria Inc.,Industry,1,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,21
NCT03504774,0,0,0,0,0,0,2021-12-01,2022-12-01,,"Kari Christine Nadeau, MD PhD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03506308,0,0,0,0,0,0,2020-03-31,2021-03-31,,C. R. Bard,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,77
NCT03510598,0,0,0,0,0,0,2020-05-31,2021-05-31,,Zeltiq Aesthetics,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,32
NCT03513406,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Kansas Medical Center,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03515577,0,0,0,0,0,0,2019-04-25,2020-04-25,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,277
NCT03515798,0,0,0,0,0,0,2020-12-30,2021-12-30,,Institut Paoli-Calmettes,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,126
NCT03517722,0,0,0,0,0,0,2021-01-22,2022-01-22,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03519061,0,0,0,0,0,0,2019-06-30,2020-06-30,,Kaiser Permanente,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,255
NCT03519711,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Censa Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03520075,0,0,0,0,0,0,2021-08-01,2022-08-01,,Astex Pharmaceuticals,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,38
NCT03520790,0,0,0,0,0,0,2021-11-30,2022-11-30,,Dana-Farber Cancer Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03522675,1,1,0,1,0,0,2018-04-26,2019-04-26,2019-04-18,"NeXtGen Biologics, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03527043,0,0,0,0,0,0,2020-12-01,2021-12-01,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03528551,0,0,0,0,0,0,2020-12-03,2021-12-03,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03531645,0,0,0,0,0,0,2021-05-01,2022-05-01,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03531788,0,0,0,0,0,0,2019-10-31,2020-10-31,,Roxanna Marie Bendixen,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03532308,0,0,0,0,0,0,2020-12-31,2021-12-31,,Yale University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03532490,0,0,0,0,0,0,2020-04-30,2021-04-30,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03533595,0,0,0,0,0,0,2019-05-31,2020-05-31,,Thomas Jefferson University,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,186
NCT03534609,0,0,0,0,0,0,2019-10-31,2020-10-31,,LUTRONIC Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03536143,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Krystal Biotech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03536884,0,0,0,0,0,0,2019-09-30,2020-09-30,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03537534,0,0,0,0,0,0,2019-02-28,2020-02-28,,San Antonio Uniformed Services Health Education Consortium,U.S. Fed,2,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03538899,0,0,0,0,0,0,2038-06-30,2039-06-30,,"University of California, San Francisco",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1443
NCT03539458,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Tendyne Holdings, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03539887,0,0,0,0,0,0,2020-10-30,2021-10-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03540147,0,0,0,0,0,0,2019-05-26,2020-05-26,,University of Texas at Austin,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,135
NCT03541187,0,0,0,0,0,0,2021-06-30,2022-06-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03541928,0,0,0,0,0,0,2023-07-31,2024-07-31,,The Methodist Hospital System,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,36
NCT03542682,0,0,0,0,0,0,2019-04-30,2020-04-30,,Yale University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1053
NCT03544281,0,0,0,0,0,0,2023-01-03,2024-01-03,,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03547167,0,0,0,0,0,0,2020-01-17,2021-01-17,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03547700,0,0,0,0,0,0,2020-07-31,2021-07-31,,Ryan Wilcox,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03547869,0,0,0,0,0,0,2021-03-12,2022-03-12,,The University of Texas at Dallas,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03549234,0,0,0,0,0,0,2019-05-08,2020-05-08,,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,561
NCT03549598,0,0,0,0,0,0,2019-06-01,2020-06-01,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03557359,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Fabio Iwamoto, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03561324,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Arkansas,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,285
NCT03561454,0,0,0,0,0,0,2028-08-01,2029-08-01,,MedStar Franklin Square Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03561584,0,0,0,0,0,0,2020-01-01,2021-01-01,,Brigham and Women's Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03562507,0,0,0,0,0,0,2023-10-31,2024-10-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03565991,0,0,0,0,0,0,2021-03-08,2022-03-08,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03567889,0,0,0,0,0,0,2020-06-30,2021-06-30,,Philogen S.p.A.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,26
NCT03569098,0,0,0,0,0,0,2020-02-03,2021-02-03,,Ipsen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,214
NCT03569891,0,0,0,0,0,0,2020-03-31,2021-03-31,,UniQure Biopharma B.V.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,0,1,1,1,0,6
NCT03570697,0,0,0,0,0,0,2020-12-11,2021-12-11,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,685
NCT03571646,0,0,0,0,0,0,2019-07-30,2020-07-30,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,146
NCT03573323,0,0,0,0,0,0,2019-07-15,2020-07-15,,Eli Lilly and Company,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03583333,0,0,0,0,0,0,2021-04-25,2022-04-25,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2145
NCT03584373,0,0,0,0,0,0,2020-06-11,2021-06-11,,Montefiore Medical Center,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03584854,0,0,0,0,0,0,2020-03-31,2021-03-31,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03587272,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Allistair Abraham, MD",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03588130,0,0,0,0,0,0,2019-07-31,2020-07-31,,MediWound Ltd,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,10
NCT03589300,0,0,0,0,0,0,2020-09-30,2021-09-30,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,215
NCT03590457,0,0,0,0,0,0,2019-12-01,2020-12-01,,Rush University Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,227
NCT03591068,0,0,0,0,0,0,2019-02-22,2020-02-22,,Optinose US Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03591276,0,0,0,0,0,0,2020-03-15,2021-03-15,,Shaare Zedek Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,155
NCT03592368,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03594175,0,0,0,0,0,0,2021-11-30,2022-11-30,,Chiesi Farmaceutici S.p.A.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,130
NCT03596905,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Bausch Health Americas, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03598036,0,0,0,0,0,0,2020-03-31,2021-03-31,,Aurinia Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03598816,0,0,0,0,0,0,2022-02-28,2023-02-28,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,1,0,0,0,0,0,1,0,1151
NCT03600233,0,0,0,0,0,0,2021-11-30,2022-11-30,,"TaiRx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,4
NCT03600714,0,0,0,0,0,0,2020-11-14,2021-11-14,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03601052,0,0,0,0,0,0,2020-04-30,2021-04-30,,"miRagen Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03601507,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Arizona,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,265
NCT03602911,0,0,0,0,0,0,2019-07-30,2020-07-30,,West Virginia University,Other,0,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,74
NCT03605654,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Medeor Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,3
NCT03605849,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,185
NCT03608514,0,0,0,0,0,0,2020-07-31,2021-07-31,,National Hepatology & Tropical Medicine Research Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT03611699,0,0,0,0,0,0,2020-04-01,2021-04-01,,Gary L. Pierce,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03611868,0,0,0,0,0,0,2020-09-15,2021-09-15,,Ascentage Pharma Group Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03615066,0,0,0,0,0,0,2019-12-31,2020-12-31,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,510
NCT03616184,0,0,0,0,0,0,2023-04-30,2024-04-30,,University of Nebraska,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,327
NCT03617263,0,0,0,0,0,0,2019-10-31,2020-10-31,,Zydus Discovery DMCC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03618030,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Purdue Pharma, Canada",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03618186,0,0,0,0,0,0,2023-05-31,2024-05-31,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,1898
NCT03620773,0,0,0,0,0,0,2023-08-31,2024-08-31,,University of Colorado Denver School of Medicine Barbara Davis Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03621735,0,0,0,0,0,0,2022-09-30,2023-09-30,,University of Michigan,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03622216,0,0,0,0,0,0,2019-05-07,2020-05-07,,"Attenua, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03622580,0,0,0,0,0,0,2021-09-30,2022-09-30,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03624036,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Kite, A Gilead Company",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,14
NCT03628157,0,0,0,0,0,0,2018-12-31,2019-12-31,,Cairo University,Other,0,0,0,1.0,Phase 2,0,2018.0,1,0,0,0,0,0,0,0,2,1,0,1190
NCT03628703,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,437
NCT03631368,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Roy G. Geronemus, M.D.",Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03631784,0,0,0,0,0,0,2020-12-15,2021-12-15,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,1,1,0,2145
NCT03632915,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Maryland, College Park",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03633084,0,0,0,0,0,0,2019-06-26,2020-06-26,,Ribomic USA Inc,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03633227,0,0,0,0,0,0,2020-06-01,2021-06-01,,Intercept Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03635515,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of Minnesota, MN",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,10
NCT03635905,0,0,0,0,0,0,2018-12-26,2019-12-26,,Medstar Health Research Institute,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,79
NCT03636061,0,0,0,0,0,0,2018-09-26,2019-09-26,,"Oyster Point Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03636269,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Cara Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,17
NCT03638258,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Arcutis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03638635,0,1,0,1,0,0,2019-01-16,2020-01-16,2019-04-22,Inova Health Care Services,Other,0,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,41
NCT03640507,0,0,0,0,0,0,2019-05-08,2020-05-08,,Columbia University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,675
NCT03640689,0,0,0,0,0,0,2024-09-01,2025-09-01,,"National University of Ireland, Galway, Ireland",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,21
NCT03643224,0,0,0,0,0,0,2019-10-15,2020-10-15,,EPIX Therapeutics,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03643874,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Concentrx Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03644069,0,0,0,0,0,0,2019-09-30,2020-09-30,,"ImmusanT, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,3
NCT03644316,1,0,0,0,1,0,2018-08-30,2019-08-30,,BandGrip,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03646916,0,0,0,0,0,0,2021-06-30,2022-06-30,,Genesys Regional Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03654417,0,0,0,0,0,0,2019-05-01,2020-05-01,,Duke University,Other,0,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03656744,0,0,0,0,0,0,2019-09-30,2020-09-30,,HighTide Biopharma Pty Ltd,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03657134,0,0,0,0,0,0,2019-12-15,2020-12-15,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,869
NCT03657212,0,0,0,0,0,0,2018-11-01,2019-11-01,,"University of California, Irvine",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,310
NCT03659448,0,0,0,0,0,0,2020-11-30,2021-11-30,,Surgimab,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03660618,1,0,1,1,0,1,2018-03-02,2019-03-02,2019-05-07,University of Iowa,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,158
NCT03661398,0,0,0,0,0,0,2020-08-31,2021-08-31,,Caisson Interventional LLC,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03664960,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Allakos, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03665077,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Arizona,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,265
NCT03670043,0,0,0,0,0,0,2020-03-31,2021-03-31,,West Side Institute for Science and Education,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03674970,0,0,0,0,0,0,2019-11-30,2020-11-30,,Milton S. Hershey Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03675893,0,0,0,0,0,0,2021-05-01,2022-05-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03676829,0,0,0,0,0,0,2019-08-31,2020-08-31,,Vascular Institute of Virginia,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03677648,0,0,0,0,0,0,2020-05-26,2021-05-26,,Reistone Biopharma Company Limited,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03678246,0,0,0,0,0,0,2018-11-30,2019-11-30,,Singapore General Hospital,Other,0,0,0,5.0,,0,2018.0,1,0,0,0,0,0,0,0,2,1,0,134
NCT03679741,0,0,0,0,0,0,2018-11-01,2019-11-01,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03682965,0,0,0,0,0,0,2019-03-06,2020-03-06,,"Christopher Thompson, MD",Other,0,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,1
NCT03686215,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Lumicell, Inc.",Industry,1,0,1,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,7
NCT03686488,0,0,0,0,0,0,2021-01-01,2022-01-01,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03686969,0,0,0,0,0,0,2018-11-22,2019-11-22,,Octapharma,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,2,1,0,54
NCT03688438,0,0,0,0,0,0,2019-10-15,2020-10-15,,Norton Leatherman Spine Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03689582,0,0,0,0,0,0,2022-10-15,2023-10-15,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03689855,0,0,0,0,0,0,2021-08-31,2022-08-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03691831,0,0,0,0,0,0,2019-04-21,2020-04-21,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03692312,0,0,0,0,0,0,2019-10-31,2020-10-31,,AMO Pharma Limited,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03693612,0,0,0,0,0,0,2022-06-16,2023-06-16,,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03694444,0,0,0,0,0,0,2020-01-31,2021-01-31,,Amyndas Pharmaceuticals S.A.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03694808,0,0,0,0,0,0,2020-09-30,2021-09-30,,David H. Canaday,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03695185,0,0,0,0,0,0,2020-12-18,2021-12-18,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03696953,0,0,0,0,0,0,2020-06-30,2021-06-30,,Marquette University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,19
NCT03697122,0,0,0,0,0,0,2019-06-15,2020-06-15,,Duke University,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT03698019,0,0,0,0,0,0,2022-09-01,2023-09-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03705312,0,0,0,0,0,0,2021-12-31,2022-12-31,,Montreal Heart Institute,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,57
NCT03705650,0,0,0,0,0,0,2019-01-01,2020-01-01,,Sara Guttas,Industry,1,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,2
NCT03706040,0,0,0,0,0,0,2020-07-27,2021-07-27,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,430
NCT03707054,0,0,0,0,0,0,2019-04-28,2020-04-28,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,1,0,0,0,1,0,0,0,0,1,0,581
NCT03707951,0,0,0,0,0,0,2023-04-30,2024-04-30,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03708588,0,0,0,0,0,0,2019-12-31,2020-12-31,,Aurora Health Care,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03708809,0,0,0,0,0,0,2020-01-01,2021-01-01,,Sheba Medical Center,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,553
NCT03710603,0,0,0,0,0,0,2029-05-31,2030-05-31,,European Myeloma Network,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03711175,0,0,0,0,0,0,2028-12-31,2029-12-31,,"Encore Medical, L.P.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,19
NCT03713073,0,0,0,0,0,0,2020-10-01,2021-10-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,490
NCT03713645,0,0,0,0,0,0,2019-08-31,2020-08-31,,Temple University,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,152
NCT03714776,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,69
NCT03717922,0,0,0,0,0,0,2022-10-31,2023-10-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,692
NCT03718091,0,0,0,0,0,0,2022-04-30,2023-04-30,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03718455,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03719014,0,0,0,0,0,0,2019-04-30,2020-04-30,,Nitiloop Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03721939,0,0,0,0,0,0,2019-10-31,2020-10-31,,VentureMed Group Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03722966,0,0,0,0,0,0,2020-08-30,2021-08-30,,University of Oklahoma,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,234
NCT03723408,1,0,0,0,1,0,2017-12-21,2018-12-21,,ClearLine MD,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,1
NCT03724968,0,0,0,0,0,0,2023-02-28,2024-02-28,,Elizabeth Davis,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03726879,0,0,0,0,0,0,2021-04-21,2022-04-21,,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03727451,0,0,0,0,0,0,2019-08-31,2020-08-31,,Bellerophon,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,3
NCT03727750,0,0,0,0,0,0,2022-06-06,2023-06-06,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03731000,0,0,0,0,0,0,2022-12-31,2023-12-31,,Alejandro Berenstein,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03731364,0,0,0,0,0,0,2019-04-30,2020-04-30,,Concentric Analgesics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03733132,0,0,0,0,0,0,2020-05-01,2021-05-01,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03733730,0,0,0,0,0,0,2023-07-31,2024-07-31,,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,492
NCT03734991,0,0,0,0,0,0,2019-12-30,2020-12-30,,"Scynexis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03736928,0,0,0,0,0,0,2019-11-30,2020-11-30,,Q-Med AB,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,56
NCT03737240,0,0,0,0,0,0,2021-12-31,2022-12-31,,Emory University,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03738215,0,0,0,0,0,0,2021-07-09,2022-07-09,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03739112,0,0,0,0,0,0,2019-05-05,2020-05-05,,Medicago,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,13
NCT03740048,0,0,0,0,0,0,2020-06-30,2021-06-30,,Wake Forest University Health Sciences,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03742037,0,0,0,0,0,0,2021-05-17,2022-05-17,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03743025,0,0,0,0,0,0,2022-10-31,2023-10-31,,Emory University,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03743194,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Cleveland Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03744910,0,0,0,0,0,0,2028-01-31,2029-01-31,,Vitaeris INC,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,9
NCT03745287,0,0,0,0,0,0,2021-02-28,2022-02-28,,Vertex Pharmaceuticals Incorporated,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,141
NCT03745690,0,0,0,0,0,0,2020-02-01,2021-02-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,277
NCT03745794,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03746483,0,0,0,0,0,0,2019-06-30,2020-06-30,,"AzurRx BioPharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,1,1,0,1
NCT03747120,0,0,0,0,0,0,2022-07-31,2023-07-31,,Cedars-Sinai Medical Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03747939,0,0,0,0,0,0,2021-01-28,2022-01-28,,Celgene,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03751124,0,0,0,0,0,0,2020-08-30,2021-08-30,,Myovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03754465,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Anterogen Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,24
NCT03754790,0,0,0,0,0,0,2024-12-31,2025-12-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,300
NCT03755934,0,0,0,0,0,0,2021-06-01,2022-06-01,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,2450
NCT03758079,0,0,0,0,0,0,2018-10-08,2019-10-08,,University of Balamand,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03760068,0,0,0,0,0,0,2020-01-07,2021-01-07,,Mylan Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,30
NCT03762161,0,0,0,0,0,0,2021-07-31,2022-07-31,,Rahul Parikh,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03763227,0,0,0,0,0,0,2019-03-24,2020-03-24,,Sultan Qaboos University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,3,0,1,12
NCT03764735,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Mitotech, SA",Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03767244,0,0,0,0,0,0,2024-04-22,2025-04-22,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03768440,0,0,0,0,0,0,2020-01-31,2021-01-31,,Boston Children’s Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03769766,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03771560,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-09-05,"University of California, San Francisco",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1443
NCT03773302,0,0,0,0,0,0,2021-10-31,2022-10-31,,"QED Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03774446,0,0,0,0,0,0,2022-11-30,2023-11-30,,Cedars-Sinai Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03778060,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03778294,0,0,0,0,0,0,2021-11-26,2022-11-26,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1898
NCT03779659,0,0,0,0,0,0,2020-08-31,2021-08-31,,Boston University,Other,0,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,188
NCT03779906,0,0,0,0,0,0,2024-12-01,2025-12-01,,"Bracco Diagnostics, Inc",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,46
NCT03783299,0,0,0,0,0,0,2018-11-30,2019-11-30,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,1,0,0,0,1,1,0,1443
NCT03785366,0,0,0,0,0,0,2024-12-30,2025-12-30,,Sebela Pharmaceuticals Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03789110,0,0,0,0,0,0,2022-04-19,2023-04-19,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03791814,0,0,0,0,0,0,2019-06-30,2020-06-30,,Albert Einstein Healthcare Network,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,45
NCT03796572,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,692
NCT03798691,0,0,0,0,0,0,2020-04-01,2021-04-01,,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,715
NCT03802864,0,0,0,0,0,0,2020-01-01,2021-01-01,,Weill Medical College of Cornell University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03803059,0,0,0,0,0,0,2020-01-07,2021-01-07,,"Bellus Medical, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03803761,0,0,0,0,0,0,2020-03-31,2021-03-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03805841,0,0,0,0,0,0,2021-03-15,2022-03-15,,Rain Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03809611,0,0,0,0,0,0,2019-07-31,2020-07-31,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1895
NCT03811561,0,0,0,0,0,0,2025-02-05,2026-02-05,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03814187,0,0,0,0,0,0,2023-08-31,2024-08-31,,The Medicines Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,59
NCT03815929,0,0,0,0,0,0,2023-08-31,2024-08-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03817580,0,0,0,0,0,0,2019-06-04,2020-06-04,,"Professional Disposables International, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,1,1,0,0,0,0,0,0,2,1,0,2
NCT03818581,0,0,0,0,0,0,2021-03-15,2022-03-15,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03820778,0,0,0,0,0,0,2022-07-12,2023-07-12,,Children's Research Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,51
NCT03820986,0,0,0,0,0,0,2024-04-06,2025-04-06,,Merck Sharp & Dohme Corp.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03822845,0,0,0,0,0,0,2025-12-31,2026-12-31,,Michael Graham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03825939,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT03826628,0,0,0,0,0,0,2021-04-30,2022-04-30,,Dermatology Specialties Limited Partnership,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03828617,0,0,0,0,0,0,2019-12-16,2020-12-16,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2856
NCT03828890,0,0,0,0,0,0,2019-08-15,2020-08-15,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,1,0,0,0,1,0,0,0,0,1,0,1898
NCT03829683,0,0,0,0,0,0,2021-02-28,2022-02-28,,Virginia Commonwealth University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03831477,0,0,0,0,0,0,2019-12-12,2020-12-12,,Venus Concept,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT03831880,0,0,0,0,0,0,2020-03-26,2021-03-26,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03832634,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,586
NCT03834142,0,0,0,0,0,0,2019-06-30,2020-06-30,,Jacques E. Chelly,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03835221,0,0,0,0,0,0,2019-03-27,2020-03-27,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03836716,0,0,0,0,0,0,2022-08-01,2023-08-01,,Orphazyme,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03839082,0,0,0,0,0,0,2020-05-01,2021-05-01,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,934
NCT03840096,0,0,0,0,0,0,2020-01-31,2021-01-31,,The Hawkins Foundation,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,13
NCT03840278,0,0,0,0,0,0,2019-11-30,2020-11-30,,Massachusetts General Hospital,Other,0,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1699
NCT03843125,0,0,0,0,0,0,2024-04-30,2025-04-30,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03846492,0,0,0,0,0,0,2022-06-30,2023-06-30,,Centre for Addiction and Mental Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,207
NCT03846700,0,0,0,0,0,0,2019-10-01,2020-10-01,,University of Bari,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,33
NCT03846947,0,0,0,0,0,0,2020-02-18,2021-02-18,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,229
NCT03847389,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Hill Dermaceuticals, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03848221,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Alabama at Birmingham,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03848832,0,0,0,0,0,0,2021-08-31,2022-08-31,,GW Research Ltd,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,29
NCT03850535,0,0,0,0,0,0,2021-03-31,2022-03-31,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03852498,0,0,0,0,0,0,2023-02-16,2024-02-16,,bluebird bio,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03854344,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Kansas Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03856359,0,0,0,0,0,0,2021-02-28,2022-02-28,,Duke University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03857867,0,0,0,0,0,0,2019-09-30,2020-09-30,,Casey H. Halpern,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03858751,0,0,0,0,0,0,2021-09-30,2022-09-30,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03858972,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Odonate Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03860207,0,0,0,0,0,0,2022-02-28,2023-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1432
NCT03860974,0,0,0,0,0,0,2020-12-01,2021-12-01,,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03861988,0,0,0,0,0,0,2020-01-31,2021-01-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03864926,0,0,0,0,0,0,2021-02-28,2022-02-28,,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03865706,0,0,0,0,0,0,2023-04-01,2024-04-01,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03866317,0,0,0,0,0,0,2020-05-31,2021-05-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1699
NCT03867097,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Eicos Sciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03867734,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Washington,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03872180,0,0,0,0,0,0,2021-04-30,2022-04-30,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03872427,0,0,0,0,0,0,2021-06-01,2022-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03872856,0,0,0,0,0,0,2020-12-31,2021-12-31,,Southcentral Foundation,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03875482,0,0,0,0,0,0,2020-04-12,2021-04-12,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03876769,0,0,0,0,0,0,2026-11-26,2027-11-26,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03877055,0,0,0,0,0,0,2021-03-31,2022-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03877692,0,0,0,0,0,0,2021-03-01,2022-03-01,,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03879798,0,0,0,0,0,0,2022-03-31,2023-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03880058,0,0,0,0,0,0,2020-12-30,2021-12-30,,"Scarless Laboratories, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03880240,0,0,0,0,0,0,2023-11-30,2024-11-30,,Beth Israel Deaconess Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,377
NCT03882177,0,0,0,0,0,0,2020-06-01,2021-06-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2133
NCT03886779,1,0,0,0,1,0,2017-02-15,2018-02-15,,Silverstein Eye Centers,Other,0,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,3,0,1,1
NCT03886987,1,0,0,0,1,0,2018-06-08,2019-06-08,,Central Medicare Sdn. Bhd.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03887429,0,0,0,0,0,0,2019-07-02,2020-07-02,,"Promentis Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03888989,0,0,0,0,0,0,2022-12-31,2023-12-31,,Stanford University,Other,0,0,1,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1309
NCT03889119,0,0,0,0,0,0,2020-12-31,2021-12-31,,Hoag Memorial Hospital Presbyterian,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,22
NCT03891667,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Research Foundation for Mental Hygiene, Inc.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,22
NCT03893500,0,0,0,0,0,0,2020-05-01,2021-05-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1309
NCT03893734,0,0,0,0,0,0,2020-08-12,2021-08-12,,NorthShore University HealthSystem,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,61
NCT03895372,0,0,0,0,0,0,2020-12-29,2021-12-29,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03896659,0,0,0,0,0,0,2024-03-31,2025-03-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03897699,0,0,0,0,0,0,2021-10-01,2022-10-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03897881,0,0,0,0,0,0,2021-12-31,2022-12-31,,"ModernaTX, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,14
NCT03899753,0,0,0,0,0,0,2019-06-30,2020-06-30,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,240
NCT03900728,0,0,0,0,0,0,2020-03-31,2021-03-31,,Columbia University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03901807,0,0,0,0,0,0,2020-12-31,2021-12-31,,Spectral Diagnostics (US) Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT03906227,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03907176,0,0,0,0,0,0,2019-07-31,2020-07-31,,Heron Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,1,1,0,1,0,0,0,0,0,1,0,18
NCT03907397,0,0,0,0,0,0,2022-08-31,2023-08-31,,Scott Sicherer,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03909165,0,0,0,0,0,0,2023-03-23,2024-03-23,,Merck Sharp & Dohme Corp.,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2145
NCT03909334,0,0,0,0,0,0,2021-06-30,2022-06-30,,Xiuning Le,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03909607,0,0,0,0,0,0,2021-12-31,2022-12-31,,Antonios Likourezos,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03910036,1,0,0,0,1,0,2017-12-05,2018-12-05,,Alexandria University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,19
NCT03912532,0,0,0,0,0,0,2020-09-30,2021-09-30,,"NGM Biopharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,13
NCT03913104,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03915470,0,0,0,0,0,0,2019-11-30,2020-11-30,,Destiny Pharma Plc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03917927,0,0,0,0,0,0,2021-12-31,2022-12-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,215
NCT03918109,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Otonomy, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03920267,0,0,0,0,0,0,2022-04-06,2023-04-06,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03922308,0,0,0,0,0,0,2020-12-30,2021-12-30,,Shire,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,342
NCT03923699,0,0,0,0,0,0,2024-07-31,2025-07-31,,Washington University School of Medicine,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03924323,0,0,0,0,0,0,2021-07-02,2022-07-02,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03925324,0,0,0,0,0,0,2021-05-31,2022-05-31,,Rebecca Torguson,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03927248,0,0,0,0,0,0,2020-12-31,2021-12-31,,HealthPartners Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,101
NCT03927404,0,0,0,0,0,0,2020-06-30,2021-06-30,,Indiana University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT03928275,0,0,0,0,0,0,2025-01-01,2026-01-01,,Carman Giacomantonio,Other,0,0,0,2.0,Phase 2/Phase 3,0,2020.0,0,0,1,0,0,0,0,0,3,1,0,2
NCT03929666,0,0,0,0,0,0,2022-02-28,2023-02-28,,Zymeworks Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03932682,0,0,0,0,0,0,2021-02-08,2022-02-08,,Seqirus,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,41
NCT03934372,0,0,0,0,0,0,2021-10-31,2022-10-31,,Incyte Biosciences International Sàrl,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,8
NCT03935737,0,0,0,0,0,0,2019-03-22,2020-03-22,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,490
NCT03937505,0,0,0,0,0,0,2019-12-31,2020-12-31,,Intuitive Surgical,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03937999,0,0,0,0,0,0,2020-09-15,2021-09-15,,Montefiore Medical Center,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,240
NCT03940534,0,0,0,0,0,0,2019-02-26,2020-02-26,,"Intent Solutions, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03941093,0,0,0,0,0,0,2022-09-30,2023-09-30,,FibroGen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT03941834,0,0,0,0,0,0,2020-02-01,2021-02-01,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03942042,0,0,0,0,0,0,2020-10-30,2021-10-30,,Eli Lilly and Company,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03943901,0,0,0,0,0,0,2021-08-20,2022-08-20,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,715
NCT03945058,0,0,0,0,0,0,2021-05-01,2022-05-01,,University of Oklahoma,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,234
NCT03946111,0,0,0,0,0,0,2024-07-31,2025-07-31,,Yale University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03949244,0,0,0,0,0,0,2020-04-30,2021-04-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,412
NCT03949465,0,0,0,0,0,0,2023-04-30,2024-04-30,,University of Calgary,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,361
NCT03949673,0,0,0,0,0,0,2021-06-21,2022-06-21,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03952637,0,0,0,0,0,0,2023-04-30,2024-04-30,,National Human Genome Research Institute (NHGRI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,1,0,0,0,0,1,0,191
NCT03952832,0,0,0,0,0,0,2021-06-11,2022-06-11,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,358
NCT03953235,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Gritstone Oncology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03954080,0,0,0,0,0,0,2020-02-15,2021-02-15,,Millennium Pain Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03954236,0,0,0,0,0,0,2021-05-31,2022-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03956797,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Recens Medical, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03958747,0,0,0,0,0,0,2021-08-31,2022-08-31,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,616
NCT03959488,0,0,0,0,0,0,2021-12-03,2022-12-03,,MedImmune LLC,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,269
NCT03961009,0,0,0,0,0,0,2021-02-16,2022-02-16,,Kedrion S.p.A.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,4
NCT03961555,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Synermore Biologics Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,4
NCT03961815,0,0,0,0,0,0,2024-04-28,2025-04-28,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03968562,0,0,0,0,0,0,2022-05-14,2023-05-14,,State University of New York - Downstate Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,19
NCT03969719,0,0,0,0,0,0,2021-02-10,2022-02-10,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03970317,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sciton,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03972709,0,0,0,0,0,0,2022-03-03,2023-03-03,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,427
NCT03973814,0,0,0,0,0,0,2021-12-31,2022-12-31,,Karolinska University Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,180
NCT03974022,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Dizal (Jiangsu) Pharmaceutical Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03975192,0,0,0,0,0,0,2020-07-01,2021-07-01,,Medical College of Wisconsin,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,315
NCT03975387,0,0,0,0,0,0,2023-04-22,2024-04-22,,"Astex Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03976362,0,0,0,0,0,0,2024-05-06,2025-05-06,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03976973,0,0,0,0,0,0,2020-12-31,2021-12-31,,David Morris,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,1,0,0,0,3,1,0,1
NCT03978598,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of New Mexico,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,200
NCT03979508,0,0,0,0,0,0,2022-07-31,2023-07-31,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03980314,0,0,0,0,0,0,2021-08-26,2022-08-26,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03982186,0,0,0,0,0,0,2021-01-15,2022-01-15,,Janssen Sciences Ireland UC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,24
NCT03984201,0,0,0,0,0,0,2022-08-31,2023-08-31,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03986320,0,0,0,0,0,0,2020-03-31,2021-03-31,,"B-Temia, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT03988842,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Victor Tapson, MD",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03990883,0,0,0,0,0,0,2020-09-20,2021-09-20,,Croma-Pharma GmbH,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,15
NCT03991130,0,0,0,0,0,0,2021-08-31,2022-08-31,,Mina Nikanjam,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03991962,0,0,0,0,0,0,2022-08-01,2023-08-01,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,3,1,0,1053
NCT03992404,0,0,0,0,0,0,2023-06-30,2024-06-30,,Merz Pharmaceuticals GmbH,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,58
NCT03993210,0,0,0,0,0,0,2020-08-31,2021-08-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT03995641,0,0,0,0,0,0,2019-12-31,2020-12-31,,Kettering Health Network,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03996148,0,0,0,0,0,0,2018-09-19,2019-09-19,,The Cooper Health System,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,37
NCT03996447,0,0,0,0,0,0,2020-04-30,2021-04-30,,Guerbet,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,34
NCT03997383,0,0,0,0,0,0,2021-10-01,2022-10-01,,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,45
NCT03997760,0,0,0,0,0,0,2021-08-27,2022-08-27,,Shire,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,342
NCT03998488,0,0,0,0,0,0,2022-09-30,2023-09-30,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT04002661,0,0,0,0,0,0,2023-05-31,2024-05-31,,Mohit Khera,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT04004442,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Oklahoma,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,234
NCT04006210,0,0,0,0,0,0,2020-09-28,2021-09-28,,NeuroDerm Ltd.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,1,0,3,1,0,14
NCT04007393,0,0,0,0,0,0,2024-08-31,2025-08-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,749
NCT04007588,0,0,0,0,0,0,2023-01-01,2024-01-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT04010357,0,0,0,0,0,0,2021-12-31,2022-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT04012918,0,0,0,0,0,0,2020-08-31,2021-08-31,,Ain Shams University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,460
NCT04016714,0,0,0,0,0,0,2021-06-14,2022-06-14,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2145
NCT04024228,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,285
NCT04024436,0,0,0,0,0,0,2021-06-15,2022-06-15,,"Taiho Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,37
NCT04024813,0,0,0,0,0,0,2021-02-28,2022-02-28,,"CymaBay Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT04025008,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Micro Medical Solution, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT04025372,0,0,0,0,0,0,2022-09-01,2023-09-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,647
NCT04027023,0,0,0,0,0,0,2019-11-30,2020-11-30,,Sciema UG,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT04031833,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Matinas BioPharma Nanotechnologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT04034368,0,0,0,0,0,0,2021-06-30,2022-06-30,,First Hospital of Jilin University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,32
NCT04035668,0,0,0,0,0,0,2022-09-02,2023-09-02,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT04036682,0,0,0,0,0,0,2021-09-15,2022-09-15,,Cullinan Pearl,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04038580,0,0,0,0,0,0,2022-08-31,2023-08-31,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT04039022,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Axsome Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04039230,0,0,0,0,0,0,2023-08-31,2024-08-31,,Massachusetts General Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT04040127,0,0,0,0,0,0,2020-01-15,2021-01-15,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1443
NCT04041284,0,0,0,0,0,0,2021-04-10,2022-04-10,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,101
NCT04042324,0,0,0,0,0,0,2019-09-10,2020-09-10,,"Rockwell Medical Technologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT04042506,0,0,0,0,0,0,2023-03-31,2024-03-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,461
NCT04043897,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Eugene F Yen, MD",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04045756,0,0,0,0,0,0,2020-08-02,2021-08-02,,University of Rome Tor Vergata,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,35
NCT04046263,0,0,0,0,0,0,2021-05-31,2022-05-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,882
NCT04046406,0,0,0,0,0,0,2021-12-30,2022-12-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1143
NCT04046952,0,0,0,0,0,0,2020-08-30,2021-08-30,,VA Long Beach Healthcare System,U.S. Fed,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT04048863,0,0,0,0,0,0,2020-11-30,2021-11-30,,B. Braun Medical Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT04050384,0,0,0,0,0,0,2019-12-31,2020-12-31,,Lance Relland,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04051242,0,0,0,0,0,0,2022-05-31,2023-05-31,,"J. Peter Rubin, MD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT04055012,0,0,0,0,0,0,2022-04-30,2023-04-30,,Gwendolyn Sowa,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04057846,0,0,0,0,0,0,2023-08-31,2024-08-31,,John Gasdal Karstensen,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT04059770,0,0,0,0,0,0,2020-07-31,2021-07-31,,Alessandro Pasqualotto,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04060680,0,0,0,0,0,0,2021-08-31,2022-08-31,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,169
NCT04060862,0,0,0,0,0,0,2023-05-19,2024-05-19,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT04063761,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Advanced Cooling Therapy, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT04063930,0,0,0,0,0,0,2020-12-31,2021-12-31,,Steno Diabetes Center Copenhagen,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,47
NCT04064866,0,0,0,0,0,0,2018-12-31,2019-12-31,,Neurological Associates of West Los Angeles,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT04066348,0,0,0,0,0,0,2022-09-30,2023-09-30,,Wayne State University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,145
NCT04067050,0,0,0,0,0,0,2019-11-02,2020-11-02,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,85
NCT04068181,0,0,0,0,0,0,2021-04-23,2022-04-23,,Amgen,Industry,1,1,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,685
NCT04071626,0,0,0,0,0,0,2021-06-30,2022-06-30,,University Hospitals Cleveland Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,185
NCT04071743,0,0,0,0,0,0,2020-09-01,2021-09-01,,University of Texas Southwestern Medical Center,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT04072445,0,0,0,0,0,0,2021-05-15,2022-05-15,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT04072887,0,0,0,0,0,0,2021-07-29,2022-07-29,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT04073056,0,0,0,0,0,0,2020-12-01,2021-12-01,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT04076618,0,0,0,0,0,0,2024-09-30,2025-09-30,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT04077073,0,0,0,0,0,0,2024-09-15,2025-09-15,,Northwestern University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,925
NCT04077346,0,0,0,0,0,0,2023-01-31,2024-01-31,,University of Louisville,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT04079998,0,0,0,0,0,0,2021-03-31,2022-03-31,,The Metis Foundation,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT04080206,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,16
NCT04080804,0,0,0,0,0,0,2021-07-31,2022-07-31,,Robert Ferris,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT04082663,0,0,0,0,0,0,2019-11-01,2020-11-01,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT04083105,0,0,0,0,0,0,2021-07-11,2022-07-11,,Children's Hospital Colorado,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT04084730,0,0,0,0,0,0,2022-08-30,2023-08-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,1432
NCT04086615,0,0,0,0,0,0,2021-09-01,2022-09-01,,University of Tennessee,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,99
NCT04087044,0,0,0,0,0,0,2020-05-31,2021-05-31,,Neuro Kinetics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT04089735,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Formosa Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT00118209,1,0,0,0,1,0,2017-10-31,2018-10-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2005.0,0,1,1,0,0,0,0,0,0,0,1,456
NCT00129740,1,1,0,1,0,1,2018-07-11,2019-07-11,2019-08-19,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00150800,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-09-18,UCB PHARMA Inc. (US),Industry,1,0,0,3.0,Phase 3,0,2006.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT00203021,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-06-24,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,4.0,Phase 4,0,1994.0,1,1,0,0,0,0,0,0,0,0,1,101
NCT00217737,0,0,0,0,0,0,2020-03-01,2021-03-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2005.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT00290511,0,0,0,0,0,0,2019-08-24,2020-08-24,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00408005,1,1,0,1,0,1,2017-09-30,2018-09-30,2019-03-22,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2007.0,1,1,0,0,0,1,0,0,1,0,1,3004
NCT00430183,0,0,0,0,0,0,2018-10-02,2019-10-02,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2006.0,0,1,0,0,0,0,0,0,1,0,1,456
NCT00489307,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00530868,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT00536042,0,0,0,0,0,0,2020-06-30,2021-06-30,,State University of New York - Downstate Medical Center,Other,0,0,0,1.0,Phase 2,0,1997.0,0,1,0,0,0,0,0,0,0,0,1,19
NCT00565851,0,0,0,0,0,0,2019-12-19,2020-12-19,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2007.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT00582504,0,0,0,0,0,0,2019-06-30,2020-06-30,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2007.0,0,0,1,0,0,0,0,0,0,0,1,136
NCT00625846,0,0,0,0,0,0,2018-12-21,2019-12-21,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT00643994,0,0,0,0,0,0,2022-01-31,2023-01-31,,Accuray Incorporated,Industry,1,0,0,5.0,,0,2007.0,0,0,0,0,0,1,0,0,0,0,1,6
NCT00707473,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT00761267,1,1,0,1,0,0,2018-02-28,2019-02-28,2018-08-14,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT00782756,1,1,0,1,0,0,2017-03-23,2018-03-23,2017-12-13,Memorial Sloan Kettering Cancer Center,Other,0,1,1,1.0,Phase 2,0,2008.0,1,0,0,0,0,0,0,0,0,0,1,1432
NCT00790842,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-07-29,"PrECOG, LLC.",Other,0,1,0,0.0,Phase 1/Phase 2,1,2009.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT00805129,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00812383,0,0,0,0,0,0,2019-07-31,2020-07-31,,Medstar Health Research Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2003.0,1,0,0,1,0,0,0,0,0,0,1,79
NCT00813358,0,0,0,0,0,0,2020-10-31,2021-10-31,,Cook Research Incorporated,Industry,1,0,0,5.0,,0,2009.0,0,0,0,1,0,0,0,0,1,0,1,20
NCT00820235,1,0,0,0,1,0,2017-06-30,2018-06-30,,Dentsply Sirona Implants,Industry,1,0,0,5.0,,0,2009.0,0,0,0,1,0,0,0,0,1,0,1,27
NCT00828009,1,1,0,1,0,0,2018-08-20,2019-08-20,2019-03-03,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,1,0,0,1,0,0,0,0,1,75
NCT00834093,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2009.0,0,0,1,0,0,0,0,0,0,0,1,647
NCT00843882,0,0,0,0,0,0,2019-09-30,2020-09-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2009.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT00865566,1,1,0,1,0,1,2017-10-06,2018-10-06,2018-10-08,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,1,2009.0,1,0,1,0,0,0,0,0,0,0,1,2133
NCT00900575,0,0,0,0,0,0,2020-06-30,2021-06-30,,Duke University,Other,0,0,0,5.0,,0,2006.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT00906269,0,0,0,0,0,0,2020-07-31,2021-07-31,,Hartford Hospital,Other,0,0,0,4.0,Phase 4,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,65
NCT00940602,1,0,1,1,0,0,2018-02-27,2019-02-27,2019-02-25,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01042015,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Maryland, Baltimore",Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,0,1,0,0,0,1,144
NCT01053013,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Rogosin Institute,Other,0,0,0,1.0,Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,21
NCT01112306,0,0,0,0,0,0,2021-02-01,2022-02-01,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,128
NCT01118026,0,0,0,0,0,0,2020-08-31,2021-08-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,456
NCT01120249,0,0,0,0,0,0,2021-10-31,2022-10-31,,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,288
NCT01148225,1,1,0,1,0,0,2018-05-21,2019-05-21,2019-02-01,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,3,0,1,430
NCT01164228,1,0,0,0,1,0,2018-05-31,2019-05-31,,Eastern Cooperative Oncology Group,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,175
NCT01174121,0,0,0,0,0,0,2023-12-29,2024-12-29,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01180959,0,0,0,0,0,0,2020-03-01,2021-03-01,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01208662,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Paul G. Richardson, MD",Other,0,1,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01209234,0,0,1,1,0,0,2019-06-30,2020-06-30,2019-08-12,"University of California, Irvine",Other,0,0,1,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,310
NCT01223235,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-03-16,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2010.0,1,0,1,0,0,0,0,0,0,0,1,1432
NCT01227044,1,1,0,1,0,1,2017-08-31,2018-08-31,2019-01-24,Yale University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT01230411,1,0,0,0,1,0,2017-06-30,2018-06-30,,Thomas Jefferson University,Other,0,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,186
NCT01232946,1,1,0,1,0,1,2017-09-08,2018-09-08,2019-02-18,Indiana University,Other,0,1,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,497
NCT01246986,0,0,0,0,0,0,2019-06-06,2020-06-06,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT01266460,0,0,0,0,0,0,2018-10-02,2019-10-02,,Gynecologic Oncology Group,Other,0,1,1,1.0,Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,200
NCT01275677,1,0,0,0,1,0,2017-07-31,2018-07-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2011.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT01298999,0,0,0,0,0,0,2017-12-31,2018-12-31,,"Julian A Abrams, MD",Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT01301391,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-31,"Tiziana Life Sciences, PLC",Industry,1,0,0,1.0,Phase 2,1,2011.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT01305863,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Tissue Genesis, LLC",Industry,1,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT01312909,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-05-29,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT01323517,1,1,0,1,0,0,2017-08-14,2018-08-14,2018-03-12,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01345851,0,0,0,0,0,0,2020-05-01,2021-05-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,277
NCT01361711,0,0,0,0,0,0,2019-05-31,2020-05-31,,Northwestern University,Other,0,1,0,1.0,Phase 2,0,2011.0,0,0,1,0,0,0,0,0,1,0,1,925
NCT01362803,0,0,0,0,0,0,2022-09-10,2023-09-10,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01375140,1,1,0,1,0,0,2018-09-05,2019-09-05,2019-07-08,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01386645,0,0,0,0,0,0,2019-07-31,2020-07-31,,Seattle Institute for Biomedical and Clinical Research,Other,0,0,1,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,40
NCT01388777,1,1,0,1,0,0,2017-06-14,2018-06-14,2018-05-18,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,1,2012.0,1,0,0,1,0,0,0,0,0,0,1,2066
NCT01404312,1,1,0,1,0,0,2017-11-14,2018-11-14,2018-11-14,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,2133
NCT01431794,0,1,0,1,0,0,2018-11-05,2019-11-05,2019-03-01,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,0.0,Phase 1/Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,461
NCT01440803,1,1,0,1,0,1,2018-01-01,2019-01-01,2019-03-05,Columbia University,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT01460498,0,0,0,0,0,0,2019-08-07,2020-08-07,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01471964,1,0,0,0,1,0,2017-02-07,2018-02-07,,Fox Chase Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,156
NCT01476410,0,0,0,0,0,0,2019-05-31,2020-05-31,,Northwestern University,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,1,0,0,1,925
NCT01476787,0,0,0,0,0,0,2024-06-01,2025-06-01,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01504841,1,0,1,1,0,0,2018-07-17,2019-07-17,2019-07-16,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT01505062,0,0,0,0,0,0,2021-01-13,2022-01-13,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,0,0,0,0,0,0,1,1,0,1,1222
NCT01516684,1,1,0,1,0,1,2018-06-26,2019-06-26,2019-06-27,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT01519869,0,0,0,0,0,0,2019-11-30,2020-11-30,,Rachel Miller,Other,0,0,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01528709,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-07-10,Boca Raton Regional Hospital,Other,0,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT01547780,1,0,0,0,1,0,2017-09-28,2018-09-28,,National Institute of Mental Health (NIMH),NIH,2,0,1,0.0,Phase 1/Phase 2,0,2012.0,1,0,0,0,0,1,0,0,0,0,1,330
NCT01548651,1,0,0,0,1,0,2017-08-25,2018-08-25,,Baylor College of Medicine,Other,0,0,0,4.0,Phase 4,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT01570036,0,0,1,1,0,0,2018-09-28,2019-09-28,2019-06-17,George E. Peoples,Industry,1,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01583283,0,0,0,0,0,0,2019-12-31,2020-12-31,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,306
NCT01588951,1,1,0,1,0,0,2017-04-30,2018-04-30,2017-05-01,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,2.0,Phase 2/Phase 3,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,461
NCT01590277,0,0,0,0,0,0,2020-06-30,2021-06-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT01592370,0,0,0,0,0,0,2022-01-13,2023-01-13,,Bristol-Myers Squibb,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT01601535,1,1,0,1,0,0,2018-07-25,2019-07-25,2019-05-30,New Approaches to Neuroblastoma Therapy Consortium,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,15
NCT01605318,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Immunomedics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,36
NCT01620268,1,0,0,0,1,0,2018-06-30,2019-06-30,,Changzheng-Cinkate,Industry,1,0,0,1.0,Phase 2,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01624142,1,1,0,1,0,0,2018-05-11,2019-05-11,2018-12-14,Amgen,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2012.0,1,0,1,0,0,0,0,0,1,0,1,685
NCT01630590,0,0,0,0,0,0,2020-01-08,2021-01-08,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01639131,0,0,0,0,0,0,2020-08-31,2021-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,461
NCT01641549,0,0,0,0,0,0,2019-03-31,2020-03-31,,"All India Institute of Medical Sciences, New Delhi",Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,122
NCT01658150,1,1,0,1,0,0,2018-01-02,2019-01-02,2018-11-09,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT01659658,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT01665794,0,0,0,0,0,0,2020-11-01,2021-11-01,,University of Chicago,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,594
NCT01666665,0,0,0,0,0,0,2020-08-31,2021-08-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,2.0,Phase 2/Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,158
NCT01667029,1,1,0,1,0,0,2017-08-10,2018-08-10,2018-07-26,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01669538,1,1,0,1,0,1,2017-11-30,2018-11-30,2018-12-11,University of Pennsylvania,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01670877,0,0,0,0,0,0,2022-11-30,2023-11-30,,Washington University School of Medicine,Other,0,1,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,1151
NCT01677689,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Far East Bio-Tec Co., Ltd",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT01679132,0,0,0,0,0,0,2026-03-31,2027-03-31,,"CVRx, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,15
NCT01690143,1,1,0,1,0,0,2017-11-01,2018-11-01,2018-03-21,University of Alabama at Birmingham,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT01694277,0,0,0,0,0,0,2021-12-31,2022-12-31,,AB Science,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,30
NCT01694563,1,1,0,1,0,1,2017-10-23,2018-10-23,2018-10-29,"AtriCure, Inc.",Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,17
NCT01701973,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-01-18,Vanderbilt University,Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,499
NCT01703039,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-06-24,Brigham and Women's Hospital,Other,0,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT01703949,0,0,0,0,0,0,2021-01-15,2022-01-15,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,910
NCT01705548,0,0,0,0,0,0,2022-12-31,2023-12-31,,Emory University,Other,0,0,0,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,947
NCT01707004,1,1,0,1,0,1,2017-07-22,2018-07-22,2019-04-03,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,1,0,0,1,0,0,0,0,1,715
NCT01709292,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01711541,1,1,0,1,0,1,2018-02-15,2019-02-15,2019-03-20,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,3004
NCT01712620,0,0,0,0,0,0,2021-10-01,2022-10-01,,National Institutes of Health Clinical Center (CC),NIH,2,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,325
NCT01739764,0,0,0,0,0,0,2019-12-31,2020-12-31,,Hoffmann-La Roche,Industry,1,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT01740557,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01743976,0,0,0,0,0,0,2020-12-31,2021-12-31,,Wake Forest University,Other,0,0,1,4.0,Phase 4,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,102
NCT01744665,0,0,0,0,0,0,2018-09-28,2019-09-28,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT01747486,1,1,0,1,0,0,2017-12-13,2018-12-13,2018-12-11,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,1052
NCT01747915,0,1,0,1,0,0,2019-02-20,2020-02-20,2019-08-08,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT01750567,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,213
NCT01753193,1,1,0,1,0,0,2018-07-18,2019-07-18,2019-07-11,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,1,0,1,269
NCT01754857,0,0,0,0,0,0,2020-10-01,2021-10-01,,"University of Wisconsin, Madison",Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,715
NCT01760252,1,0,0,0,1,0,2018-02-21,2019-02-21,,Beth Israel Medical Center,Other,0,0,0,1.0,Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,51
NCT01779362,0,0,0,0,0,0,2019-01-31,2020-01-31,,RISE Study Group,Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01781468,0,0,0,0,0,0,2020-05-31,2021-05-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT01787331,1,1,0,1,0,1,2017-05-30,2018-05-30,2018-06-01,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT01793129,0,0,0,0,0,0,2020-08-31,2021-08-31,,NICHD Neonatal Research Network,Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,59
NCT01793610,0,0,0,0,0,0,2017-02-28,2018-02-28,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT01797575,1,1,0,1,0,0,2017-02-01,2018-02-01,2018-02-01,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT01801007,0,0,0,0,0,0,2018-01-31,2019-01-31,,"Microvention-Terumo, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,14
NCT01804296,0,0,0,0,0,0,2019-12-31,2020-12-31,,Paul E. Croarkin,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT01812447,1,0,0,0,1,0,2017-11-30,2018-11-30,,"Spiration, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,9
NCT01815359,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01819831,0,0,0,0,0,0,2024-03-31,2025-03-31,,Loma Linda University,Other,0,0,0,1.0,Phase 2,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,194
NCT01820754,1,1,0,1,0,0,2018-04-30,2019-04-30,2018-04-23,Duke University,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT01821833,0,0,0,0,0,0,2019-12-31,2020-12-31,,New Mexico Cancer Care Alliance,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,67
NCT01823107,1,1,0,1,0,1,2017-06-30,2018-06-30,2019-08-20,Kensey Nash Corporation,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT01823835,0,0,0,0,0,0,2020-03-28,2021-03-28,,"Genentech, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,427
NCT01824836,0,0,0,0,0,0,2020-01-31,2021-01-31,,Eastern Cooperative Oncology Group,Other,0,0,1,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,175
NCT01841333,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT01850888,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,218
NCT01852071,0,0,0,0,0,0,2018-08-27,2019-08-27,,Orchard Therapeutics,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2013.0,1,0,0,0,0,0,0,1,0,0,1,12
NCT01855828,1,0,0,0,1,0,2018-07-31,2019-07-31,,Yale University,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT01867333,0,0,0,0,0,0,2020-01-01,2021-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT01871454,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Louisville,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,1,0,0,0,0,1,214
NCT01878513,1,0,0,0,1,0,2018-07-31,2019-07-31,,Northwell Health,Other,0,0,0,5.0,,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,271
NCT01880073,0,0,0,0,0,0,2020-05-31,2021-05-31,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,586
NCT01885689,0,0,0,0,0,0,2021-12-31,2022-12-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT01891344,0,0,0,0,0,0,2019-02-01,2020-02-01,,"Clovis Oncology, Inc.",Industry,1,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT01892371,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01893138,0,0,0,0,0,0,2019-10-31,2020-10-31,,Cook MyoSite,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,0,1,0,0,0,0,0,1,0,1,9
NCT01908426,1,1,0,1,0,0,2017-10-16,2018-10-16,2018-10-16,Exelixis,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,36
NCT01910012,0,0,0,0,0,0,2017-05-05,2018-05-05,,Polaris Group,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,15
NCT01915498,0,0,0,0,0,0,2019-07-25,2020-07-25,,Celgene,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01915810,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01919346,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Heeger, Peter, M.D.",Other,0,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01919515,1,0,0,0,1,0,2017-06-30,2018-06-30,,"NuSmile, Ltd.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT01931098,0,0,0,0,0,0,2019-10-01,2020-10-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01932788,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-09-25,Medical University of South Carolina,Other,0,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT01932996,0,0,0,0,0,0,2018-10-31,2019-10-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT01933724,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of South Florida,Other,0,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT01938092,1,0,1,1,0,1,2017-03-31,2018-03-31,2018-07-25,University of Missouri-Columbia,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,214
NCT01939275,1,0,0,0,1,0,2017-03-30,2018-03-30,,City of Hope Medical Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,1,0,0,0,0,1,358
NCT01941316,0,0,0,0,0,0,2018-12-31,2019-12-31,,Cancer Research and Biostatistics Clinical Trials Consortium,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01943851,0,0,0,0,0,0,2023-01-12,2024-01-12,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,3276
NCT01945775,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-09-05,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT01952847,0,0,0,0,0,0,2020-03-01,2021-03-01,,M.D. Anderson Cancer Center,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01954927,1,1,0,1,0,0,2018-01-03,2019-01-03,2019-01-03,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,302
NCT01967433,1,0,1,1,0,1,2017-06-30,2018-06-30,2018-08-24,University of Oklahoma,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,234
NCT01967823,0,0,0,0,0,0,2027-07-05,2028-07-05,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01967888,1,0,0,0,1,0,2018-01-31,2019-01-31,,Dompé Farmaceutici S.p.A,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,28
NCT01968213,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-05-08,"Clovis Oncology, Inc.",Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT01972217,1,1,0,1,0,0,2017-09-22,2018-09-22,2018-09-06,AstraZeneca,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT01978262,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-08,Johns Hopkins Bloomberg School of Public Health,Other,0,0,1,4.0,Phase 4,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,221
NCT01979211,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Cincinnati,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,222
NCT01981551,0,0,0,0,0,0,2018-12-30,2019-12-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01981720,0,0,0,0,0,0,2021-03-31,2022-03-31,,Protalix,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,0,1,0,0,0,0,0,1,0,1,17
NCT01988584,0,0,0,0,0,0,2018-02-21,2019-02-21,,"The University of Texas Health Science Center, Houston",Other,0,1,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,0,0,1,490
NCT01991743,1,0,1,1,0,0,2017-06-30,2018-06-30,2018-03-29,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT01991977,0,0,0,0,0,0,2018-12-14,2019-12-14,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,1898
NCT01997125,0,0,1,1,0,0,2019-04-30,2020-04-30,2019-08-29,Marcia Bockbrader,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02004522,0,1,0,1,0,1,2017-05-19,2018-05-19,2018-10-23,"Verastem, Inc.",Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,35
NCT02014740,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-02-20,University of Miami,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,476
NCT02018562,1,1,0,1,0,1,2017-02-21,2018-02-21,2018-02-22,Johns Hopkins University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1143
NCT02019069,1,1,0,1,0,0,2017-12-04,2018-12-04,2018-10-03,Rondeep Brar,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02027935,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02028884,0,0,0,0,0,0,2018-06-06,2019-06-06,,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02029235,1,1,0,1,0,0,2017-11-17,2018-11-17,2018-10-22,"Alexander Payatakes, M.D.",Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02033941,0,0,0,0,0,0,2020-09-30,2021-09-30,,Hillel Grossman,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02034409,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT02048332,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,437
NCT02048722,0,0,0,0,0,0,2019-11-30,2020-11-30,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02049307,0,0,0,0,0,0,2018-12-14,2019-12-14,,Hennepin Healthcare Research Institute.,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,61
NCT02050113,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of Massachusetts, Worcester",Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,163
NCT02053909,0,0,0,0,0,0,2022-08-31,2023-08-31,,Boca Raton Regional Hospital,Other,0,1,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02054520,0,0,0,0,0,0,2018-04-05,2019-04-05,,NewLink Genetics Corporation,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,34
NCT02055118,1,1,0,1,0,0,2017-09-28,2018-09-28,2018-09-27,Shire,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,342
NCT02076022,1,1,0,1,0,0,2018-07-18,2019-07-18,2019-07-17,"J. Peter Rubin, MD",Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02076893,1,0,0,0,1,0,2017-02-28,2018-02-28,,Children's Hospitals and Clinics of Minnesota,Other,0,0,0,4.0,Phase 4,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,44
NCT02076997,0,0,0,0,0,0,2018-10-31,2019-10-31,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02078323,1,0,0,0,1,0,2017-10-04,2018-10-04,,Augusta University,Other,0,1,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,117
NCT02080260,1,1,0,1,0,1,2017-06-28,2018-06-28,2018-07-12,"Stuart Salmon, MD",Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02083354,0,0,0,0,0,0,2018-02-23,2019-02-23,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,2,0,1,1895
NCT02086578,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02087085,1,1,0,1,0,0,2018-03-30,2019-03-30,2019-03-29,Allergan,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02088554,1,0,1,1,0,0,2018-07-27,2019-07-27,2019-07-24,Medtronic Cardiovascular,Industry,1,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,34
NCT02090998,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Rutgers, The State University of New Jersey",Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,227
NCT02091141,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,427
NCT02094794,0,0,0,0,0,0,2019-11-30,2020-11-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,358
NCT02094872,1,0,0,0,1,0,2018-04-30,2019-04-30,,Yale University,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02098538,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02098993,1,1,0,1,0,0,2018-06-27,2019-06-27,2019-05-28,Craig Seaman,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02099331,0,0,0,0,0,0,2020-11-30,2021-11-30,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02100969,1,0,1,1,0,1,2017-11-30,2018-11-30,2019-03-11,"Mazen Dimachkie, MD",Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT02101463,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Northside Hospital, Inc.",Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,16
NCT02101788,0,0,0,0,0,0,2019-04-04,2020-04-04,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02111746,1,1,0,1,0,1,2017-05-03,2018-05-03,2018-07-18,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02112994,1,1,0,1,0,0,2017-12-28,2018-12-28,2018-12-26,Alexion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,86
NCT02113982,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Stemline Therapeutics, Inc.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02115048,0,0,0,0,0,0,2018-11-30,2019-11-30,,Translational Research in Oncology,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT02115802,1,0,0,0,1,0,2017-12-31,2018-12-31,,Colorado Neurological Institute,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02116777,0,0,0,0,0,0,2018-12-31,2019-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02116946,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of British Columbia,Other,0,0,0,1.0,Phase 2,1,2014.0,1,0,1,0,0,0,0,0,1,0,1,881
NCT02122198,1,0,0,0,1,0,2017-09-15,2018-09-15,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT02122380,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vanderbilt University,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT02127125,0,0,0,0,0,0,2019-04-30,2020-04-30,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02128646,1,0,0,0,1,0,2017-01-31,2018-01-31,,"Michael Moncure, MD",Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02129751,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT02131597,0,0,0,0,0,0,2019-11-01,2020-11-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02131805,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,1432
NCT02132195,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-03-04,Emory University,Other,0,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02133196,0,0,0,0,0,0,2024-10-23,2025-10-23,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02134925,1,1,0,1,0,1,2017-01-27,2018-01-27,2018-03-15,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02137239,0,0,0,0,0,0,2019-10-04,2020-10-04,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02145039,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2014.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT02152670,0,0,0,0,0,0,2021-05-31,2022-05-31,,Yale University,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02153918,1,1,0,1,0,1,2017-07-28,2018-07-28,2018-07-30,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,3004
NCT02154490,0,0,0,0,0,0,2022-04-01,2023-04-01,,Southwest Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,0,1,1,0,0,0,0,0,1,0,1,288
NCT02160288,1,0,0,0,1,0,2018-08-31,2019-08-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02162433,1,0,0,0,1,0,2018-04-30,2019-04-30,,Massachusetts Eye and Ear Infirmary,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02162810,0,0,0,0,0,0,2020-02-29,2021-02-28,,Francis Schneck,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02163057,0,0,0,0,0,0,2017-01-23,2018-01-23,,Inovio Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,25
NCT02163681,1,0,0,0,1,0,2018-06-30,2019-06-30,,University of Virginia,Other,0,1,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT02165384,1,1,0,1,0,0,2018-03-01,2019-03-01,2018-11-16,"Preceptis Medical, Inc.",Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02168062,1,0,0,0,1,0,2018-05-22,2019-05-22,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02170389,1,0,0,0,1,0,2017-03-17,2018-03-17,,Roswell Park Cancer Institute,Other,0,0,1,5.0,,1,2014.0,1,0,1,0,0,0,0,0,0,0,1,294
NCT02172950,0,0,0,0,0,0,2022-07-29,2023-07-29,,CSL Behring,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,81
NCT02174549,0,0,0,0,0,0,2020-08-31,2021-08-31,,Teclison Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02176382,0,0,0,0,0,0,2020-01-31,2021-01-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02187991,0,0,0,0,0,0,2019-09-30,2020-09-30,,US Oncology Research,Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02188368,0,0,0,0,0,0,2019-12-31,2020-12-31,,Oncotherapeutics,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,17
NCT02189213,0,0,0,0,0,0,2019-09-30,2020-09-30,,New York State Psychiatric Institute,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02192775,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Arkansas,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,285
NCT02193282,0,0,0,0,0,0,2020-11-04,2021-11-04,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02202434,0,1,0,1,0,1,2017-03-08,2018-03-08,2019-05-17,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,340
NCT02213289,0,0,0,0,0,0,2020-02-01,2021-02-01,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02214160,0,0,0,0,0,0,2021-09-30,2022-09-30,,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,36
NCT02218242,1,1,0,1,0,0,2018-06-27,2019-06-27,2018-06-28,"Joel Thompson, PhD",Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02218619,0,0,0,0,0,0,2019-10-01,2020-10-01,,"Robin Goland, MD",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02230410,0,0,0,0,0,0,2019-08-31,2020-08-31,,Mayo Clinic,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02231749,1,1,0,1,0,0,2017-06-26,2018-06-26,2018-06-21,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02234128,0,0,0,0,0,0,2019-10-31,2020-10-31,,Lung Bioengineering Inc.,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02234310,0,0,0,0,0,0,2019-08-20,2020-08-20,,Bioverativ Therapeutics Inc.,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,19
NCT02240693,1,1,0,1,0,0,2017-09-18,2018-09-18,2018-09-11,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02246621,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-31,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02252536,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-04-09,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,96
NCT02255357,1,0,1,1,0,1,2018-02-14,2019-02-14,2019-08-09,New York State Psychiatric Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02258464,0,0,0,0,0,0,2019-08-13,2020-08-13,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT02259725,0,0,0,0,0,0,2020-08-16,2021-08-16,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,483
NCT02260388,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-03-02,University of Kansas Medical Center,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,219
NCT02262325,0,0,0,0,0,0,2018-12-31,2019-12-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,1,0,0,0,0,1,198
NCT02262819,0,0,0,0,0,0,2019-04-24,2020-04-24,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT02263885,0,0,0,0,0,0,2019-10-31,2020-10-31,,InSightec,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,61
NCT02267278,1,1,0,1,0,0,2018-06-01,2019-06-01,2019-05-15,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02268253,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Stemline Therapeutics, Inc.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02269943,1,1,0,1,0,0,2017-04-20,2018-04-20,2018-04-16,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02271906,1,1,0,1,0,1,2017-08-16,2018-08-16,2018-11-29,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02273960,1,1,0,1,0,0,2018-01-22,2019-01-22,2019-01-17,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02279524,1,0,0,0,1,0,2018-05-22,2019-05-22,,Galmed Pharmaceuticals Ltd,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02282163,1,0,0,0,1,0,2018-05-31,2019-05-31,,"Bracco Diagnostics, Inc",Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,46
NCT02284737,0,0,0,0,0,0,2021-07-30,2022-07-30,,"Nanjing First Hospital, Nanjing Medical University",Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,2,0,1,41
NCT02286687,0,0,0,0,0,0,2019-12-30,2020-12-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02291055,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Advaxis, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT02298491,0,0,0,0,0,0,2019-07-31,2020-07-31,,"University of Maryland, Baltimore",Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,144
NCT02303977,0,0,0,0,0,0,2019-04-30,2020-04-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT02304458,0,0,0,0,0,0,2029-10-24,2030-10-24,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,3004
NCT02307916,0,0,0,0,0,0,2019-10-31,2020-10-31,,Dr. Bradley Welling,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02310763,1,1,0,1,0,1,2018-04-26,2019-04-26,2019-04-29,Pfizer,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,1,1,0,0,0,0,0,1,0,1,2856
NCT02317887,0,0,0,0,0,0,2023-07-31,2024-07-31,,National Eye Institute (NEI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,263
NCT02321111,0,0,1,1,0,0,2018-09-30,2019-09-30,2019-08-08,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02322320,0,0,0,0,0,0,2019-06-07,2020-06-07,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,1,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT02331134,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02332369,0,0,0,0,0,0,2018-12-31,2019-12-31,,"EyeKon Medical, Inc.",Industry,1,0,0,5.0,,0,2005.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02332928,0,0,0,0,0,0,2023-08-31,2024-08-31,,Virginia Commonwealth University,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,417
NCT02334735,0,0,0,0,0,0,2019-12-31,2020-12-31,,Nina Bhardwaj,Other,0,1,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,7
NCT02336282,1,1,0,1,0,0,2017-06-09,2018-06-09,2018-04-05,St. Jude Children's Research Hospital,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,302
NCT02342743,1,1,0,1,0,1,2017-04-11,2018-04-11,2018-07-11,Cefaly Technology,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT02344329,1,0,1,1,0,1,2017-11-30,2018-11-30,2019-05-06,University of North Dakota,Other,0,0,0,4.0,Phase 4,0,2014.0,1,0,1,1,0,0,0,0,0,0,1,1
NCT02348203,0,0,0,0,0,0,2019-02-22,2020-02-22,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02351544,0,0,0,0,0,0,2019-12-31,2020-12-31,,Ohio State University,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,315
NCT02358031,0,0,0,0,0,0,2019-02-25,2020-02-25,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02358343,1,1,0,1,0,1,2017-11-15,2018-11-15,2019-05-31,University of Washington,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02362048,1,0,1,1,0,1,2017-09-30,2018-09-30,2019-07-19,Acerta Pharma BV,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02363491,0,0,0,0,0,0,2018-12-31,2019-12-31,,Opsona Therapeutics Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02363933,1,1,0,1,0,0,2017-03-14,2018-03-14,2018-02-27,Duke University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02364999,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-07,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02370329,0,0,0,0,0,0,2020-03-31,2021-03-31,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1898
NCT02370498,1,1,0,1,0,0,2017-10-26,2018-10-26,2018-10-22,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02374957,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-29,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT02377466,1,1,0,1,0,0,2017-07-24,2018-07-24,2018-01-22,GlaxoSmithKline,Industry,1,1,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02383589,0,0,0,0,0,0,2018-11-28,2019-11-28,,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02389517,0,0,0,0,0,0,2020-03-02,2021-03-02,,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02390856,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Hospital for Special Surgery, New York",Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,157
NCT02392351,1,0,1,1,0,1,2018-01-31,2019-01-31,2019-03-31,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,340
NCT02394028,0,0,0,0,0,0,2021-06-04,2022-06-04,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02402465,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Chicago,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02409316,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02411656,0,0,0,0,0,0,2020-06-01,2021-06-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02411708,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-05-29,Prolong Pharmaceuticals,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02412787,0,0,0,0,0,0,2025-07-09,2026-07-09,,Shire,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,342
NCT02414854,1,1,0,1,0,0,2017-07-29,2018-07-29,2018-07-27,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02420379,0,0,0,0,0,0,2018-12-17,2019-12-17,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT02420860,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02421380,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02421588,0,0,0,0,0,0,2018-10-12,2019-10-12,,PharmaMar,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,36
NCT02421757,0,0,0,0,0,0,2017-06-22,2018-06-22,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,318
NCT02424734,1,1,0,1,0,0,2017-12-26,2018-12-26,2018-06-19,Pfizer,Industry,1,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02425683,1,0,0,0,1,0,2017-09-21,2018-09-21,,US Oncology Research,Industry,1,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,26
NCT02425891,0,0,0,0,0,0,2020-04-30,2021-04-30,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02428192,0,0,0,0,0,0,2018-09-20,2019-09-20,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,3004
NCT02440685,1,0,0,0,1,0,2018-06-30,2019-06-30,,Asana BioSciences,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,11
NCT02441283,0,0,0,0,0,0,2019-10-24,2020-10-24,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02443805,1,0,1,1,0,1,2018-06-21,2019-06-21,2019-08-29,Stallergenes Greer,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,24
NCT02445768,0,0,0,0,0,0,2021-02-28,2022-02-28,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,749
NCT02446210,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Miami,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,476
NCT02446808,1,0,0,0,1,0,2018-06-30,2019-06-30,,"ProPep Surgical, LLC",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02447874,0,0,0,0,0,0,2020-07-31,2021-07-31,,Emory University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02448537,1,1,0,1,0,0,2017-02-28,2018-02-28,2018-02-05,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02450331,0,0,0,0,0,0,2020-01-10,2021-01-10,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02451696,0,0,0,0,0,0,2020-06-30,2021-06-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02455336,1,1,0,1,0,0,2018-08-01,2019-08-01,2019-05-15,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT02457546,1,1,0,1,0,0,2017-09-13,2018-09-13,2018-09-13,"Ethicon, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,1,0,0,0,0,1,0,1,59
NCT02459119,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02460224,0,0,0,0,0,0,2020-05-19,2021-05-19,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02460692,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of California, San Diego",Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02460874,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Alabama at Birmingham,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT02461745,1,0,1,1,0,1,2017-05-31,2018-05-31,2018-07-16,Kaiser Permanente,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,255
NCT02462967,0,0,0,0,0,0,2017-10-31,2018-10-31,,Galectin Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02464436,0,0,0,0,0,0,2020-01-31,2021-01-31,,ReNeuron Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02465359,1,0,0,0,1,0,2018-03-31,2019-03-31,,University of South Florida,Other,0,1,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,240
NCT02465957,1,0,0,0,1,0,2018-05-31,2019-05-31,,"NantKwest, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,27
NCT02468778,0,0,0,0,0,0,2020-12-31,2021-12-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,419
NCT02469519,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Mednax Center for Research, Education, Quality and Safety",Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,30
NCT02472145,1,1,0,1,0,0,2018-01-25,2019-01-25,2019-01-24,"Janssen Research & Development, LLC",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02477423,1,0,0,0,1,0,2018-01-31,2019-01-31,,University of Chicago,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02489539,0,0,0,0,0,0,2020-12-31,2021-12-31,,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,52
NCT02491632,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02492867,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Michigan Rogel Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,1,0,1,0,0,0,0,1,213
NCT02493426,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02496611,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02497001,0,0,0,0,0,0,2018-01-05,2019-01-05,,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02498600,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02499497,0,0,0,0,0,0,2019-06-30,2020-06-30,,Dana-Farber Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02500602,0,0,0,0,0,0,2019-09-30,2020-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02503501,0,0,0,0,0,0,2019-09-30,2020-09-30,,HealthPartners Institute,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,101
NCT02504151,0,0,0,0,0,0,2019-08-31,2020-08-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02504489,0,0,0,0,0,0,2019-10-31,2020-10-31,,BeyondSpring Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT02505477,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,692
NCT02507960,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,318
NCT02508389,0,0,0,0,0,0,2017-09-18,2018-09-18,,"Galera Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,1,0,0,1,0,1,11
NCT02510794,0,0,0,0,0,0,2018-04-10,2019-04-10,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,427
NCT02518139,0,1,0,1,0,1,2017-06-30,2018-06-30,2018-12-06,Theravance Biopharma,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,53
NCT02519231,1,0,1,1,0,1,2017-11-30,2018-11-30,2019-04-06,University of Washington,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02519348,0,0,0,0,0,0,2021-04-30,2022-04-30,,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,269
NCT02522572,0,0,0,0,0,0,2019-09-30,2020-09-30,,E. Steve Woodle,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02522871,0,0,0,0,0,0,2019-12-31,2020-12-31,,TransMedics,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,11
NCT02524834,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Rodney A. White, M.D.",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02525523,1,0,0,0,1,0,2018-07-09,2019-07-09,,Atlantic Pharmaceuticals Ltd,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02525874,1,1,0,1,0,1,2017-04-24,2018-04-24,2019-04-23,Biogen,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,324
NCT02544204,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Juventas Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,6
NCT02545075,0,0,0,0,0,0,2018-12-31,2019-12-31,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,1104
NCT02545868,1,1,0,1,0,0,2017-02-14,2018-02-14,2018-02-13,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,1731
NCT02549209,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Daniela Matei, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT02550652,0,0,0,0,0,0,2019-12-27,2020-12-27,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02551770,0,0,1,1,0,1,2018-06-30,2019-06-30,2019-08-30,Institut Straumann AG,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,26
NCT02552355,1,1,0,1,0,1,2017-08-31,2018-08-31,2018-11-29,Colorado State University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT02553330,0,0,0,0,0,0,2017-10-03,2018-10-03,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,143
NCT02555371,0,0,0,0,0,0,2019-07-24,2020-07-24,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,1,0,0,0,0,0,1,0,1,3276
NCT02556606,0,0,0,0,0,0,2020-03-31,2021-03-31,,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02557321,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Provectus Biopharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02557516,0,0,0,0,0,0,2018-10-31,2019-10-31,,Innate Pharma,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,13
NCT02564939,0,0,0,0,0,0,2018-12-31,2019-12-31,,Hartford Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,65
NCT02566109,1,1,0,1,0,1,2017-10-04,2018-10-04,2019-02-19,Wake Forest University Health Sciences,Other,0,0,0,5.0,,1,2016.0,1,0,0,0,1,0,0,0,0,0,1,616
NCT02566928,0,0,0,0,0,0,2018-11-30,2019-11-30,,Clinical Directors Network,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02567409,0,0,0,0,0,0,2020-08-31,2021-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02568046,1,1,0,1,0,1,2017-05-15,2018-05-15,2018-12-19,Symphogen A/S,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,14
NCT02572570,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT02576561,1,0,0,0,1,0,2018-05-31,2019-05-31,,THEVAX Genetics Vaccine,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,1
NCT02576678,1,1,0,1,0,0,2017-09-04,2018-09-04,2018-08-27,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02577601,1,1,0,1,0,1,2017-06-17,2018-06-17,2018-09-23,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,475
NCT02578680,1,1,0,1,0,0,2017-11-08,2018-11-08,2018-09-11,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02581787,0,0,0,0,0,0,2020-01-31,2021-01-31,,Maximilian Diehn,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,1,0,0,0,0,1,1
NCT02584608,0,0,0,0,0,0,2019-12-31,2020-12-31,,Indiana University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,497
NCT02588586,0,0,0,0,0,0,2018-02-28,2019-02-28,,Rockefeller University,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,104
NCT02589067,1,0,0,0,1,0,2017-08-31,2018-08-31,,Los Angeles Biomedical Research Institute,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,60
NCT02589977,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Marvin W. Kronenberg, M.D.",Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02590588,1,1,0,1,0,0,2017-03-27,2018-03-27,2017-03-30,John Mark Sloan,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02591615,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Alliance Foundation Trials, LLC.",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,16
NCT02592434,0,0,0,0,0,0,2019-05-16,2020-05-16,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02593227,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Marker Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2
NCT02595398,0,0,0,0,0,0,2018-01-18,2019-01-18,,"Clearside Biomedical, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,11
NCT02597712,0,0,0,0,0,0,2018-12-31,2019-12-31,,Trio Medicines Ltd.,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02597933,0,0,0,0,0,0,2018-10-31,2019-10-31,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02603146,0,0,0,0,0,0,2020-03-31,2021-03-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2133
NCT02603835,1,0,0,0,1,0,2017-08-31,2018-08-31,,TherOx,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02606461,0,0,0,0,0,0,2019-11-30,2020-11-30,,Karyopharm Therapeutics Inc,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,22
NCT02608463,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Arkansas,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,285
NCT02609386,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Brooklyn ImmunoTherapeutics, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,2
NCT02610231,0,0,0,0,0,0,2017-12-20,2018-12-20,,"Kyowa Hakko Kirin Pharma, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,20
NCT02611609,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Athersys, Inc",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,7
NCT02612311,0,0,0,0,0,0,2019-11-30,2020-11-30,,"TG Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,27
NCT02613182,1,1,0,1,0,0,2018-05-31,2019-05-31,2018-10-17,Prothena Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02613897,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-06-14,The University of Texas Health Science Center at San Antonio,Other,0,1,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02618759,1,1,0,1,0,1,2017-03-16,2018-03-16,2018-11-12,Taro Pharmaceuticals USA,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02620384,1,1,0,1,0,1,2017-11-29,2018-11-29,2018-12-21,Aultman Health Foundation,Other,0,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02622386,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT02624947,0,0,0,0,0,0,2019-03-31,2020-03-31,,Novavax,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,25
NCT02628028,0,0,1,1,0,1,2018-04-25,2019-04-25,2019-08-09,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02628899,0,0,0,0,0,0,2023-01-31,2024-01-31,,Medstar Health Research Institute,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,79
NCT02632175,0,0,0,0,0,0,2023-05-19,2024-05-19,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,430
NCT02633293,0,0,0,0,0,0,2022-11-30,2023-11-30,,United Therapeutics,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,72
NCT02638935,1,0,0,0,1,0,2018-08-31,2019-08-31,,Heidelberg University,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,248
NCT02640664,0,0,0,0,0,0,2022-10-30,2023-10-30,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02642042,0,0,0,0,0,0,2020-10-15,2021-10-15,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02645539,0,0,0,0,0,0,2019-12-31,2020-12-31,,NuPulseCV,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02651428,0,0,0,0,0,0,2018-10-31,2019-10-31,,CorMedix,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02652429,0,0,0,0,0,0,2018-12-31,2019-12-31,,Bellerophon Pulse Technologies,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02652598,0,0,0,0,0,0,2020-01-31,2021-01-31,,Sheppard Pratt Health System,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT02657369,0,0,0,0,0,0,2018-09-26,2019-09-26,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,328
NCT02657889,1,0,0,0,1,0,2018-05-31,2019-05-31,,"Tesaro, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,31
NCT02658851,1,0,0,0,1,0,2017-06-27,2018-06-27,,Apyx Medical (formerly Bovie Medical Corp.),Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02660411,0,0,0,0,0,0,2020-12-31,2021-12-31,,Peking University First Hospital,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,106
NCT02661022,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Stemline Therapeutics, Inc.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02661451,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Cardiovascular Research Foundation, New York",Other,0,1,0,5.0,,0,2016.0,0,0,1,1,0,0,0,0,1,0,1,3
NCT02662764,1,1,0,1,0,0,2017-04-14,2018-04-14,2018-04-13,"AcelRx Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT02665117,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02665286,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-04-30,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02669849,0,0,0,0,0,0,2018-11-30,2019-11-30,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,2.0,Phase 2/Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02670044,0,0,0,0,0,0,2019-06-20,2020-06-20,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02670551,0,1,0,1,0,1,2017-07-19,2018-07-19,2019-01-10,Forest Laboratories,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,169
NCT02671461,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-30,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02675959,0,0,0,0,0,0,2021-12-31,2022-12-31,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT02677922,0,0,0,0,0,0,2019-11-20,2020-11-20,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02679560,0,0,0,0,0,0,2019-11-01,2020-11-01,,Ian Elliott Brown,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02682407,0,0,0,0,0,0,2018-12-31,2019-12-31,,Omeros Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,19
NCT02682992,0,0,0,0,0,0,2020-03-31,2021-03-31,,"David A. Clump, MD, PhD",Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02683707,1,1,0,1,0,0,2017-05-25,2018-05-25,2018-04-05,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02684006,0,0,0,0,0,0,2019-01-28,2020-01-28,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02685735,0,0,0,0,0,0,2021-12-01,2022-12-01,,Wake Forest University Health Sciences,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02686749,1,0,0,0,1,0,2018-07-19,2019-07-19,,Oussama Wazni,Other,0,1,0,4.0,Phase 4,1,2016.0,1,1,0,1,0,0,0,0,0,0,1,1
NCT02687815,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Juan Celedon, MD",Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02689349,0,0,0,0,0,0,2021-01-31,2022-01-31,,Envoy Medical Corporation,Industry,1,0,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02690701,0,1,0,1,0,1,2017-04-26,2018-04-26,2019-02-19,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,1895
NCT02693717,0,0,0,0,0,0,2020-05-31,2021-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT02697292,0,0,0,0,0,0,2018-12-03,2019-12-03,,Mayo Clinic,Other,0,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02699450,0,0,0,0,0,0,2017-09-15,2018-09-15,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1731
NCT02703779,0,0,0,0,0,0,2019-11-30,2020-11-30,,Siddhartha Ganguly,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02710084,0,0,0,0,0,0,2020-07-31,2021-07-31,,Alexander Kolevzon,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02710968,0,0,0,0,0,0,2021-03-31,2022-03-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02712151,0,0,0,0,0,0,2020-11-30,2021-11-30,,Boston Children’s Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,400
NCT02712996,0,0,0,0,0,0,2019-08-01,2020-08-01,,Vanderbilt University,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,499
NCT02713230,1,0,0,0,1,0,2017-07-31,2018-07-31,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,53
NCT02713490,1,0,0,0,1,0,2017-03-31,2018-03-31,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,53
NCT02714218,0,1,0,1,0,1,2017-04-20,2018-04-20,2019-01-02,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02719392,0,0,0,0,0,0,2020-04-30,2021-04-30,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02721082,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Kansas Medical Center,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,219
NCT02721979,0,0,0,0,0,0,2020-02-02,2021-02-02,,University of Washington,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT02722941,0,0,0,0,0,0,2020-06-30,2021-06-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02723591,0,0,0,0,0,0,2019-06-14,2020-06-14,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,135
NCT02724527,1,0,0,0,1,0,2017-04-30,2018-04-30,,"Nivalis Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02725567,0,0,0,0,0,0,2020-06-30,2021-06-30,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,141
NCT02726763,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT02728050,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,910
NCT02728206,1,1,0,1,0,0,2018-01-16,2019-01-16,2019-01-07,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02730299,0,0,0,0,0,0,2019-12-31,2020-12-31,,Gamida Cell ltd,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02731612,0,0,0,0,0,0,2022-12-31,2023-12-31,,Nazlin Walji,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT02732119,0,0,0,0,0,0,2018-10-17,2019-10-17,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1895
NCT02737826,0,0,0,0,0,0,2020-05-31,2021-05-31,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02738866,0,0,0,0,0,0,2020-01-31,2021-01-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02743611,0,0,0,0,0,0,2019-12-31,2020-12-31,,Bellicum Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,15
NCT02747238,0,0,0,0,0,0,2019-12-31,2020-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,412
NCT02750358,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02750514,0,0,0,0,0,0,2021-04-28,2022-04-28,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02752074,1,1,0,1,0,1,2018-01-08,2019-01-08,2019-02-26,Incyte Corporation,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,143
NCT02754518,1,0,1,1,0,0,2018-04-30,2019-04-30,2019-04-09,University of Chicago,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02755272,0,0,0,0,0,0,2019-10-31,2020-10-31,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,156
NCT02757768,1,0,1,1,0,0,2018-08-14,2019-08-14,2019-08-05,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,135
NCT02759900,0,0,0,0,0,0,2022-03-31,2023-03-31,,The Skin Center Dermatology Group,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02760433,0,0,0,0,0,0,2019-09-30,2020-09-30,,R-Pharm,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,44
NCT02761993,0,0,0,0,0,0,2017-10-31,2018-10-31,,"Noveome Biotherapeutics, formerly Stemnion",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,10
NCT02763488,1,0,0,0,1,0,2017-06-30,2018-06-30,,San Antonio Military Medical Center,U.S. Fed,2,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT02769624,0,0,0,0,0,0,2018-09-21,2019-09-21,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,437
NCT02770586,0,0,0,0,0,0,2019-08-31,2020-08-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02770820,0,0,0,0,0,0,2022-01-01,2023-01-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,393
NCT02772588,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT02773238,0,0,0,0,0,0,2021-12-01,2022-12-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,910
NCT02775903,0,0,0,0,0,0,2018-10-31,2019-10-31,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02777190,0,0,0,0,0,0,2020-01-31,2021-01-31,,Milton S. Hershey Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT02780609,0,0,0,0,0,0,2020-08-31,2021-08-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT02781571,1,1,0,1,0,0,2017-07-28,2018-07-28,2018-07-25,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02782676,1,1,0,1,0,0,2017-05-04,2018-05-04,2018-04-13,Abbott Medical Optics,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,33
NCT02795780,0,0,0,0,0,0,2017-08-28,2018-08-28,,Avid Radiopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02796001,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Ronald Turner, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT02797275,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02797821,1,1,0,1,0,0,2017-06-21,2018-06-21,2018-06-11,Alexion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,86
NCT02800148,0,0,0,0,0,0,2017-10-31,2018-10-31,,Perrigo Company,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,39
NCT02810951,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Fibrocell Technologies, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,0,0,0,0,1,0,0,1,10
NCT02812147,0,0,0,0,0,0,2019-06-30,2020-06-30,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT02812342,1,1,0,1,0,0,2018-07-31,2019-07-31,2018-09-12,Yale University,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02815592,0,0,0,0,0,0,2019-08-04,2020-08-04,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,1104
NCT02818036,1,1,0,1,0,0,2018-06-21,2019-06-21,2019-05-29,Tristen Inagaki,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02819141,0,0,0,0,0,0,2021-11-30,2022-11-30,,Mayo Clinic,Other,0,0,1,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02819323,1,0,0,0,1,0,2018-03-27,2019-03-27,,Braintree Laboratories,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,43
NCT02822001,0,0,0,0,0,0,2019-11-01,2020-11-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,490
NCT02822573,0,0,0,0,0,0,2020-10-12,2021-10-12,,Wake Forest University Health Sciences,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT02828592,0,0,0,0,0,0,2022-08-31,2023-08-31,,"Northside Hospital, Inc.",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,16
NCT02832037,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT02832687,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Rutgers, The State University of New Jersey",Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,227
NCT02833415,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-02-26,University of Texas Southwestern Medical Center,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT02834403,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Polly A. Niravath, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02835846,1,0,0,0,1,0,2018-03-31,2019-03-31,,Loyola University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,102
NCT02836873,0,0,0,0,0,0,2018-01-11,2019-01-11,,Theracos,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02839850,0,0,0,0,0,0,2024-06-01,2025-06-01,,DePuy Orthopaedics,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,39
NCT02840097,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Daniel Nishijima, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02842021,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Sol-Gel Technologies, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02843451,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02843945,0,0,0,0,0,0,2020-07-31,2021-07-31,,CivaTech Oncology,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT02845674,1,1,0,1,0,1,2017-08-15,2018-08-15,2018-11-14,Sun Pharma Global FZE,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,17
NCT02846792,1,1,0,1,0,0,2018-07-12,2019-07-12,2019-01-22,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,1,2017.0,1,1,1,0,0,0,0,0,0,1,0,910
NCT02847559,0,0,0,0,0,0,2019-09-30,2020-09-30,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2016.0,0,0,1,1,0,0,0,0,0,0,1,925
NCT02849457,0,0,0,0,0,0,2020-05-31,2021-05-31,,Martina Bebin,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02850107,0,0,0,0,0,0,2019-04-30,2020-04-30,,VIVA Physicians,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02850965,1,1,0,1,0,0,2018-01-17,2019-01-17,2019-01-16,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02852265,1,1,0,1,0,0,2017-07-26,2018-07-26,2018-03-27,"University of California, Davis",Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,530
NCT02853318,0,0,0,0,0,0,2020-08-03,2021-08-03,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,294
NCT02859519,0,0,0,0,0,0,2019-11-30,2020-11-30,,Moberg Pharma AB,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,11
NCT02860286,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Epizyme, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,11
NCT02862574,1,1,0,1,0,0,2017-06-26,2018-06-26,2018-05-31,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,510
NCT02863354,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Charles C Wykoff, PhD, MD",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02864888,0,0,0,0,0,0,2021-12-31,2022-12-31,,Burzynski Research Institute,Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,1,0,0,3,1,0,65
NCT02866643,0,0,0,0,0,0,2019-09-30,2020-09-30,,Stanford University,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02867371,0,0,0,0,0,0,2018-12-31,2019-12-31,,Broncus Medical Inc,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,5
NCT02868242,0,1,0,1,0,0,2018-11-12,2019-11-12,2019-07-29,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02871479,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-04-11,"Santalis Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT02872701,0,0,0,0,0,0,2018-10-31,2019-10-31,,"On Target Laboratories, LLC",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,1,0,0,0,0,1,1,0,3
NCT02872857,0,0,0,0,0,0,2019-09-30,2020-09-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,490
NCT02873312,0,0,0,0,0,0,2019-11-30,2020-11-30,,Bioness Inc,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,8
NCT02874092,0,0,0,0,0,0,2019-04-19,2020-04-19,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02876328,0,0,0,0,0,0,2020-01-31,2021-01-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,2133
NCT02878798,0,0,0,0,0,0,2022-03-31,2023-03-31,,Virginia Commonwealth University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT02879617,0,0,0,0,0,0,2020-05-15,2021-05-15,,"Liza Villaruz, MD",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT02953431,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Vermont,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,155
NCT02953561,0,0,0,0,0,0,2020-02-28,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT02954159,0,0,0,0,0,0,2019-01-31,2020-01-31,,Medical College of Wisconsin,Other,0,1,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,315
NCT02959268,1,0,0,0,1,0,2017-06-30,2018-06-30,,Common Sense,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT02959476,1,0,0,0,1,0,2018-08-10,2019-08-10,,"BioQ Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02960113,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Rutgers, The State University of New Jersey",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,227
NCT02960763,0,0,0,0,0,0,2021-09-30,2022-09-30,,Washington University School of Medicine,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1151
NCT02961699,0,0,0,0,0,0,2021-10-31,2022-10-31,,"InGeneron, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT02962063,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,1432
NCT02962414,0,0,0,0,0,0,2027-08-04,2028-08-04,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT02963090,0,0,0,0,0,0,2019-05-20,2020-05-20,,"Alliance Foundation Trials, LLC.",Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,16
NCT02965716,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT02965976,0,0,0,0,0,0,2020-10-05,2021-10-05,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,294
NCT02966834,0,0,0,0,0,0,2020-04-01,2021-04-01,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,3276
NCT02969408,1,1,0,1,0,1,2018-02-02,2019-02-02,2019-04-12,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,101
NCT02969876,0,0,0,0,0,0,2018-11-30,2019-11-30,,Massachusetts General Hospital,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1699
NCT02970292,0,0,0,0,0,0,2019-05-28,2020-05-28,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,24
NCT02973087,0,0,0,0,0,0,2019-05-20,2020-05-20,,Baxalta now part of Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,107
NCT02973438,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Miami,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,476
NCT02973711,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT02975934,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Clovis Oncology, Inc.",Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT02978235,1,0,0,0,1,0,2018-03-06,2019-03-06,,"Taiho Oncology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,37
NCT02978781,0,0,0,0,0,0,2017-11-22,2018-11-22,,Sage Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02979522,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT02981017,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,692
NCT02981407,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Rutgers, The State University of New Jersey",Other,0,0,1,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,227
NCT02987543,0,0,0,0,0,0,2019-06-04,2020-06-04,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT02988986,0,0,0,0,0,0,2019-02-01,2020-02-01,,"Jenny C. Chang, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT02990819,0,0,0,0,0,0,2023-12-31,2024-12-31,,Children's Hospital of Philadelphia,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,324
NCT02991469,0,0,0,0,0,0,2022-06-30,2023-06-30,,Sanofi,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT02992314,0,0,0,0,0,0,2018-09-18,2019-09-18,,You First Services,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT02993263,1,0,0,0,1,0,2018-05-14,2019-05-14,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,581
NCT02996500,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-07-29,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02997722,1,0,0,0,1,0,2017-05-19,2018-05-19,,University of Mississippi Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,88
NCT02998541,0,0,0,0,0,0,2019-05-13,2020-05-13,,Shire,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,342
NCT03001011,0,0,0,0,0,0,2019-08-16,2020-08-16,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1222
NCT03006562,0,0,0,0,0,0,2019-03-01,2020-03-01,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03008603,0,0,0,0,0,0,2019-04-30,2020-04-30,,Xact Robotics Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,1
NCT03011814,0,0,0,0,0,0,2019-09-30,2020-09-30,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT03012100,0,0,0,0,0,0,2021-07-31,2022-07-31,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,32
NCT03012477,0,0,0,0,0,0,2020-09-30,2021-09-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03014635,1,0,0,0,1,0,2017-11-03,2018-11-03,,"Revance Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,26
NCT03016312,0,0,0,0,0,0,2020-11-11,2021-11-11,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT03017235,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-09-03,Ferring Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,208
NCT03021577,0,0,0,0,0,0,2019-03-16,2020-03-16,,Columbia University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,675
NCT03022279,0,0,0,0,0,0,2020-01-31,2021-01-31,,Brian Wallace Gray,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,0,1,1
NCT03023722,0,0,0,0,0,0,2019-08-06,2020-08-06,,Yale University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03025035,0,0,0,0,0,0,2020-01-30,2021-01-30,,Monica Mita,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03027661,1,1,0,1,0,0,2018-06-30,2019-06-30,2018-08-07,University of Tennessee,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,99
NCT03028974,1,1,0,1,0,0,2017-11-20,2018-11-20,2018-11-20,Stanford University,Other,0,0,1,4.0,Phase 4,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,1309
NCT03030989,0,0,0,0,0,0,2019-01-02,2020-01-02,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,594
NCT03032783,0,0,0,0,0,0,2020-07-24,2021-07-24,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,162
NCT03033043,0,0,0,0,0,0,2019-05-17,2020-05-17,,Bolton Medical,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03034018,0,0,0,0,0,0,2019-12-31,2020-12-31,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03034135,0,0,0,0,0,0,2018-07-10,2019-07-10,,Cantex Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03034538,1,0,0,0,1,0,2018-04-01,2019-04-01,,The Cooper Health System,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,37
NCT03036488,0,0,0,0,0,0,2025-09-30,2026-09-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03040752,1,0,0,0,1,0,2017-01-31,2018-01-31,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1190
NCT03041090,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-11-29,St. Louis University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,126
NCT03041636,0,0,0,0,0,0,2021-03-08,2022-03-08,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03042767,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Miriam Vos, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03047005,0,0,0,0,0,0,2023-10-31,2024-10-31,,Yale University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03049735,0,0,0,0,0,0,2019-04-25,2020-04-25,,Myovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03051503,1,0,0,0,1,0,2017-04-30,2018-04-30,,South Egypt Cancer Institute,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,10
NCT03051984,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Vermont,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,0,1,155
NCT03052517,0,0,0,0,0,0,2022-11-22,2023-11-22,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03054428,1,1,0,1,0,0,2018-04-04,2019-04-04,2019-04-04,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,176
NCT03056950,0,0,0,0,0,0,2019-03-31,2020-03-31,,Brooke Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,71
NCT03058666,1,0,0,0,1,0,2018-06-01,2019-06-01,,ONY,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,4
NCT03061071,1,0,0,0,1,0,2018-07-12,2019-07-12,,NightBalance,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03061630,0,0,0,0,0,0,2019-12-31,2020-12-31,,Samsung Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,684
NCT03064035,0,0,0,0,0,0,2019-04-17,2020-04-17,,HealthPartners Institute,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,101
NCT03067077,0,0,0,0,0,0,2020-12-31,2021-12-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,0,0,0,0,0,0,0,1,0,1309
NCT03069378,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03069534,0,0,0,0,0,0,2019-06-01,2020-06-01,,The First Affiliated Hospital with Nanjing Medical University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2009.0,0,1,0,0,0,0,0,0,2,0,1,90
NCT03070184,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03073525,0,0,0,0,0,0,2020-01-01,2021-01-01,,"Gradalis, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,15
NCT03076281,0,0,0,0,0,0,2018-12-03,2019-12-03,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,162
NCT03077438,0,0,0,0,0,0,2017-10-10,2018-10-10,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,285
NCT03078010,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03078543,0,0,0,0,0,0,2028-12-30,2029-12-30,,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,83
NCT03080441,1,0,1,1,0,1,2017-04-01,2018-04-01,2018-11-08,Nimedical,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,1,0,0,0,0,3,0,1,1
NCT03082261,0,0,0,0,0,0,2019-11-30,2020-11-30,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT03082677,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03086330,1,1,0,1,0,0,2018-07-04,2019-07-04,2019-07-02,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,981
NCT03090620,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03093025,0,0,0,0,0,0,2018-11-08,2019-11-08,,Taisho Pharmaceutical R&D Inc.,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03093961,0,0,0,0,0,0,2020-06-30,2021-06-30,,Corvia Medical,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,6
NCT03094637,0,0,0,0,0,0,2021-11-30,2022-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03095001,0,0,0,0,0,0,2020-06-01,2021-06-01,,Chinese PLA General Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,217
NCT03095248,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03096743,0,0,0,0,0,0,2021-05-01,2022-05-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,0,1,1898
NCT03098797,0,0,0,0,0,0,2018-10-05,2019-10-05,,Stealth BioTherapeutics Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,25
NCT03099278,1,0,0,0,1,0,2017-06-30,2018-06-30,,Ziauddin Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,2
NCT03101046,0,0,0,0,0,0,2021-04-01,2022-04-01,,UNICANCER,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,150
NCT03104413,0,0,0,0,0,0,2020-06-22,2021-06-22,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03107286,0,0,0,0,0,0,2020-03-31,2021-03-31,,Boston Children’s Hospital,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03107754,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Hawaii,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,64
NCT03108313,1,0,0,0,1,0,2018-04-30,2019-04-30,,Cairo University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1190
NCT03108482,1,1,0,1,0,0,2017-11-09,2018-11-09,2018-11-08,"Laboratorios del Dr. Esteve, S.A.",Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03109015,0,0,0,0,0,0,2019-10-30,2020-10-30,,Duke University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03109418,1,0,0,0,1,0,2018-09-12,2019-09-12,,University of Alabama at Birmingham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT03109795,0,0,0,0,0,0,2023-06-30,2024-06-30,,Seth Holwerda,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03110185,0,0,0,0,0,0,2019-03-08,2020-03-08,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1151
NCT03111186,1,0,0,0,1,0,2017-10-31,2018-10-31,,University of Southern California,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,483
NCT03112603,0,0,0,0,0,0,2019-07-31,2020-07-31,,Incyte Corporation,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03119571,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,1,1,0,749
NCT03121599,0,0,0,0,0,0,2018-10-15,2019-10-15,,Hamad Medical Corporation,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,47
NCT03122301,0,0,0,0,0,0,2020-05-01,2021-05-01,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03123055,0,0,0,0,0,0,2021-12-31,2022-12-31,,Rainier Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03123809,0,0,0,0,0,0,2020-05-15,2021-05-15,,"Texas Tech University Health Sciences Center, El Paso",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,0,1,30
NCT03128268,0,0,0,0,0,0,2019-09-30,2020-09-30,,Northwell Health,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03128879,0,0,0,0,0,0,2022-06-01,2023-06-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03131544,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Prostate Laser Center, PLLC",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03133767,1,1,0,1,0,0,2017-11-01,2018-11-01,2018-05-29,Nicholas M Mohr,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03134703,0,0,0,0,0,0,2019-03-26,2020-03-26,,Johns Hopkins All Children's Hospital,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03135262,0,0,0,0,0,0,2022-10-27,2023-10-27,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03136159,0,0,0,0,0,0,2019-06-30,2020-06-30,,Loyola University,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,102
NCT03136328,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-11-28,Charito Love,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,1
NCT03140280,0,0,0,0,0,0,2019-06-01,2020-06-01,,Ehab L Atallah,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03142451,0,0,0,0,0,0,2018-09-28,2019-09-28,,Foamix Ltd.,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,16
NCT03143842,1,0,0,0,1,0,2018-04-27,2019-04-27,,The University of Texas at Dallas,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03145636,0,0,0,0,0,0,2024-12-31,2025-12-31,,ReShape Lifesciences,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,10
NCT03146845,1,0,0,0,1,0,2018-06-12,2019-06-12,,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,83
NCT03150914,0,0,0,0,0,0,2021-06-06,2022-06-06,,University of Cincinnati,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,222
NCT03153475,0,0,0,0,0,0,2025-02-24,2026-02-24,,DePuy Orthopaedics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,39
NCT03155620,0,0,0,0,0,0,2027-09-30,2028-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03161028,0,0,0,0,0,0,2021-04-01,2022-04-01,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1012
NCT03164902,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Proteus Digital Health, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03165695,0,0,0,0,0,0,2019-12-31,2020-12-31,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03166800,0,0,0,0,0,0,2020-01-15,2021-01-15,,Oregon Health and Science University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT03168334,0,0,0,0,0,0,2018-04-26,2019-04-26,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,180
NCT03171818,0,0,0,0,0,0,2019-10-01,2020-10-01,,UMC Utrecht,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,237
NCT03172130,0,0,0,0,0,0,2020-05-31,2021-05-31,,Krishna M. Sundar,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT03175055,1,0,0,0,1,0,2018-05-31,2019-05-31,,US Bionics,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,1
NCT03176186,0,0,0,0,0,0,2020-10-15,2021-10-15,,"NeuroproteXeon, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,1,1,0,1
NCT03179202,0,0,0,0,0,0,2021-02-28,2022-02-28,,"SPR Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03181399,0,0,0,0,0,0,2020-05-30,2021-05-30,,University of Texas Southwestern Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03187262,0,0,0,0,0,0,2021-01-31,2022-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03187834,0,0,0,0,0,0,2019-09-01,2020-09-01,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1443
NCT03188978,0,0,0,0,0,0,2019-12-31,2020-12-31,,Albany Medical College,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03189238,0,0,0,0,0,0,2019-05-31,2020-05-31,,Center for Vulvovaginal Disorders,Other,0,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,7
NCT03191058,0,0,0,0,0,0,2022-07-31,2023-07-31,,University of Texas Southwestern Medical Center,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,626
NCT03192488,1,0,1,1,0,0,2018-05-31,2019-05-31,2019-05-07,Indiana University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,497
NCT03193021,1,0,0,0,1,0,2018-04-13,2019-04-13,,"Cardiva Medical, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03194646,0,0,0,0,0,0,2021-09-13,2022-09-13,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03196310,0,0,0,0,0,0,2020-07-01,2021-07-01,,Kettering Health Network,Other,0,0,0,5.0,,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03196635,1,1,0,1,0,0,2017-06-29,2018-06-29,2017-09-18,GE Healthcare,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,119
NCT03199638,1,0,0,0,1,0,2017-06-30,2018-06-30,,Nemours Children's Clinic,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,75
NCT03204539,0,0,0,0,0,0,2022-12-01,2023-12-01,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03206203,0,0,0,0,0,0,2020-02-29,2021-02-28,,Vanderbilt-Ingram Cancer Center,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03207256,0,0,0,0,0,0,2024-11-30,2025-11-30,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03208933,0,0,0,0,0,0,2020-02-14,2021-02-14,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1731
NCT03209609,0,0,0,0,0,0,2020-06-01,2021-06-01,,Vascular Graft Solutions Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,5
NCT03210337,1,1,0,1,0,1,2018-03-16,2019-03-16,2019-03-18,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03211065,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rochester General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03213652,0,0,0,0,0,0,2024-09-30,2025-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03214666,0,0,0,0,0,0,2024-02-01,2025-02-01,,"GT Biopharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03216291,1,0,0,0,1,0,2018-03-31,2019-03-31,,Augusta University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,117
NCT03217188,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,1432
NCT03217734,0,0,0,0,0,0,2018-12-31,2019-12-31,,Jeffrey J Crowley MD,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,1,0,0,0,0,0,0,1,0,1
NCT03221270,0,0,0,0,0,0,2020-10-31,2021-10-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03223272,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT03225716,0,0,0,0,0,0,2021-01-31,2022-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03226457,0,0,0,0,0,0,2018-12-11,2019-12-11,,University of Dundee,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,102
NCT03226821,0,0,0,0,0,0,2021-04-30,2022-04-30,,Columbia University,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03227224,0,0,0,0,0,0,2019-01-12,2020-01-12,,"Janssen Research & Development, LLC",Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT03228407,1,0,0,0,1,0,2018-06-30,2019-06-30,,McGuire Research Institute,Other,0,0,1,5.0,,0,2017.0,1,0,0,0,1,0,0,0,0,1,0,4
NCT03228914,0,0,0,0,0,0,2019-06-01,2020-06-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,490
NCT03229460,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,96
NCT03230565,0,0,0,0,0,0,2019-09-30,2020-09-30,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03231800,0,0,0,0,0,0,2019-03-15,2020-03-15,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,134
NCT03232736,0,0,0,0,0,0,2019-08-30,2020-08-30,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,882
NCT03232892,0,0,0,0,0,0,2019-09-22,2020-09-22,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03240016,0,0,0,0,0,0,2021-10-01,2022-10-01,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03240601,0,0,0,0,0,0,2019-09-11,2020-09-11,,"Shepherd Center, Atlanta GA",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03245359,0,0,0,0,0,0,2019-01-08,2020-01-08,,Florida Hospital,Other,0,1,0,5.0,,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,63
NCT03246061,0,0,0,0,0,0,2019-01-18,2020-01-18,,"Relievant Medsystems, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03249103,0,0,0,0,0,0,2019-04-18,2020-04-18,,Aptinyx,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03249623,0,0,0,0,0,0,2018-12-30,2019-12-30,,Chelsea and Westminster NHS Foundation Trust,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,26
NCT03250507,0,0,0,0,0,0,2019-01-30,2020-01-30,,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,151
NCT03250676,0,0,0,0,0,0,2019-11-30,2020-11-30,,H3 Biomedicine Inc.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03251924,0,0,0,0,0,0,2022-10-04,2023-10-04,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03252925,0,0,0,0,0,0,2019-06-01,2020-06-01,,The First Affiliated Hospital of Soochow University,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,30
NCT03253094,1,0,0,0,1,0,2018-05-04,2019-05-04,,"Scynexis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03255473,0,0,0,0,0,0,2027-09-30,2028-09-30,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03257189,1,1,0,1,0,1,2017-08-25,2018-08-25,2018-12-04,MC10 Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03259867,0,0,0,0,0,0,2020-10-30,2021-10-30,,Teclison Ltd.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,1,0,0,1,0,3
NCT03260920,0,0,0,0,0,0,2021-09-01,2022-09-01,,Lawson Health Research Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,468
NCT03261531,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03262701,0,0,1,1,0,0,2019-03-31,2020-03-31,2019-06-07,Loma Linda University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,194
NCT03265288,0,0,0,0,0,0,2019-12-31,2020-12-31,,Laurent Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03268902,0,0,0,0,0,0,2020-09-30,2021-09-30,,Haydom Lutheran Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03269526,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Virginia,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT03269968,0,0,0,0,0,0,2019-06-30,2020-06-30,,Medstar Health Research Institute,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,79
NCT03270722,0,0,0,0,0,0,2020-05-31,2021-05-31,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03271944,0,0,0,0,0,0,2018-12-31,2019-12-31,,SHERRY Thomas,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT03272685,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03273153,0,0,0,0,0,0,2021-11-11,2022-11-11,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03275701,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mills Clinical Research,Industry,1,1,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT03276676,0,0,0,0,0,0,2022-11-30,2023-11-30,,University of Utah,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03279523,0,0,0,0,0,0,2021-05-31,2022-05-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT03280121,0,0,0,0,0,0,2019-06-30,2020-06-30,,EndoGastric Solutions,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03281486,0,0,0,0,0,0,2019-10-31,2020-10-31,,You First Services,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03281954,0,0,0,0,0,0,2023-12-31,2024-12-31,,NSABP Foundation Inc,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,63
NCT03283319,0,0,1,1,0,1,2017-12-15,2018-12-15,2019-08-28,Biomedical Advanced Research and Development Authority,U.S. Fed,2,1,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,4
NCT03284346,0,0,0,0,0,0,2020-08-17,2021-08-17,,University of Southern California,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,483
NCT03286842,0,0,0,0,0,0,2020-11-30,2021-11-30,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03289299,0,0,0,0,0,0,2022-06-01,2023-06-01,,International Myeloma Foundation,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03290131,0,0,0,0,0,0,2018-12-03,2019-12-03,,Osmotica Pharmaceutical US LLC,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,8
NCT03292471,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03292640,1,0,0,0,1,0,2018-05-14,2019-05-14,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,212
NCT03294109,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03296345,1,0,0,0,1,0,2017-01-31,2018-01-31,,UCSF Benioff Children’s Hospital Oakland,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,53
NCT03297021,0,0,0,0,0,0,2019-04-05,2020-04-05,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03298334,0,0,0,0,0,0,2023-07-01,2024-07-01,,Inova Health Care Services,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,41
NCT03298802,0,0,0,0,0,0,2020-04-30,2021-04-30,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,158
NCT03299166,0,0,0,0,0,0,2019-11-18,2020-11-18,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03299881,1,0,0,0,1,0,2018-04-01,2019-04-01,,"Elira Therapeutics, Inc.",Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03301038,0,0,0,0,0,0,2023-12-31,2024-12-31,,Children's Hospital of Philadelphia,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03302936,0,0,0,0,0,0,2019-07-01,2020-07-01,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03303521,0,0,0,0,0,0,2018-11-07,2019-11-07,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2450
NCT03304262,1,0,0,0,1,0,2018-02-28,2019-02-28,,University of New Mexico,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,200
NCT03305393,0,0,0,0,0,0,2020-02-27,2021-02-27,,"Stern Cardiovascular Foundation, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03306394,0,0,0,0,0,0,2020-01-15,2021-01-15,,Institut de Recherches Internationales Servier,Other,0,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,28
NCT03308799,1,0,1,1,0,1,2018-06-08,2019-06-08,2019-07-11,MC2 Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03310970,0,0,0,0,0,0,2019-10-31,2020-10-31,,Nicole K Brogden,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03315026,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03315910,0,0,0,0,0,0,2021-10-31,2022-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03316170,0,0,0,0,0,0,2020-07-31,2021-07-31,,Jessica Burris,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03317028,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Center Laboratories, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03319745,0,0,0,0,0,0,2020-11-30,2021-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03321955,0,0,0,0,0,0,2019-06-30,2020-06-30,,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,1,0,0,0,0,0,1,51
NCT03322579,0,0,0,0,0,0,2018-11-30,2019-11-30,,Hillel Yaffe Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,263
NCT03323164,0,0,0,0,0,0,2018-12-31,2019-12-31,,Wills Eye,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,69
NCT03326336,0,0,0,0,0,0,2020-09-30,2021-09-30,,GenSight Biologics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,0,1,0,1,1,0,8
NCT03326596,0,0,0,0,0,0,2019-06-30,2020-06-30,,"United States Naval Medical Center, San Diego",U.S. Fed,2,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,52
NCT03327064,0,0,0,0,0,0,2022-08-01,2023-08-01,,University of Alabama at Birmingham,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,801
NCT03327324,0,0,0,0,0,0,2022-12-31,2023-12-31,,NYU Langone Health,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,869
NCT03327948,0,0,0,0,0,0,2019-01-18,2020-01-18,,"Axonics Modulation Technologies, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,2
NCT03332459,0,0,0,0,0,0,2020-04-27,2021-04-27,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,558
NCT03335761,0,0,0,0,0,0,2019-11-15,2020-11-15,,MedtronicNeuro,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,57
NCT03337620,0,0,0,0,0,0,2019-01-01,2020-01-01,,Tian Medical Inc.,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03338816,0,0,0,0,0,0,2019-01-31,2020-01-31,,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,45
NCT03341078,0,0,0,0,0,0,2022-01-01,2023-01-01,,VA Office of Research and Development,U.S. Fed,2,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03342157,0,0,0,0,0,0,2019-10-31,2020-10-31,,Aurora Health Care,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03345914,0,0,0,0,0,0,2019-06-20,2020-06-20,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,176
NCT03346434,0,0,0,0,0,0,2021-06-03,2022-06-03,,Regeneron Pharmaceuticals,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03346759,1,1,0,1,0,0,2017-09-11,2018-09-11,2018-05-01,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,934
NCT03348670,0,0,0,0,0,0,2020-04-08,2021-04-08,,"Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03348904,1,1,0,1,0,0,2018-05-22,2019-05-22,2019-05-22,Incyte Corporation,Industry,1,1,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,143
NCT03349476,0,0,0,0,0,0,2019-09-30,2020-09-30,,Vivek Reddy,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,15
NCT03350503,0,0,0,0,0,0,2019-05-23,2020-05-23,,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,492
NCT03351244,0,0,0,0,0,0,2020-12-03,2021-12-03,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03351738,0,0,0,0,0,0,2018-11-09,2019-11-09,,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,269
NCT03352557,0,0,0,0,0,0,2021-07-09,2022-07-09,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03354273,0,0,0,0,0,0,2020-08-31,2021-08-31,,GE Healthcare,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,119
NCT03354754,0,0,0,0,0,0,2018-09-24,2019-09-24,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03355053,0,0,0,0,0,0,2022-04-01,2023-04-01,,Massachusetts General Hospital,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03360344,0,0,1,1,0,0,2018-10-23,2019-10-23,2019-08-29,Loma Linda University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,194
NCT03363776,0,0,0,0,0,0,2022-09-28,2023-09-28,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03364309,0,0,0,0,0,0,2020-06-30,2021-06-30,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03367988,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of South Florida,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03369223,0,0,0,0,0,0,2022-10-30,2023-10-30,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03369977,1,0,0,0,1,0,2018-06-24,2019-06-24,,"CryoLife, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,11
NCT03371459,1,1,0,1,0,0,2018-03-26,2019-03-26,2019-03-26,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2450
NCT03372057,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Verastem, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,35
NCT03372551,0,1,0,1,0,1,2017-12-22,2018-12-22,2019-02-21,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03374631,0,0,0,0,0,0,2020-12-31,2021-12-31,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03374982,1,0,0,0,1,0,2018-04-03,2019-04-03,,University of Nebraska,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,327
NCT03377517,0,0,0,0,0,0,2023-05-01,2024-05-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,461
NCT03379545,0,0,0,0,0,0,2019-06-05,2020-06-05,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,0,1,869
NCT03379974,0,0,0,0,0,0,2019-08-30,2020-08-30,,Nationwide Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,161
NCT03380104,0,0,0,0,0,0,2019-06-01,2020-06-01,,Matthew Howard,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,3,1,0,1
NCT03382561,0,0,0,0,0,0,2020-06-02,2021-06-02,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03387852,0,0,0,0,0,0,2019-08-07,2020-08-07,,Sanofi,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03389893,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03390257,1,0,0,0,1,0,2018-03-21,2019-03-21,,3NT Medical Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03391323,0,0,0,0,0,0,2023-12-31,2024-12-31,,"David F. Scott, MD",Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT03391869,0,0,0,0,0,0,2022-12-31,2023-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,3.0,Phase 3,0,2017.0,0,0,1,0,0,1,0,0,0,1,0,2066
NCT03392168,1,0,0,0,1,0,2018-04-26,2019-04-26,,"Arcutis, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,4
NCT03392324,0,0,0,0,0,0,2020-08-31,2021-08-31,,Pixium Vision SA,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03392974,0,0,0,0,0,0,2022-12-01,2023-12-01,,BioMarin Pharmaceutical,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,85
NCT03393754,0,0,0,0,0,0,2019-04-08,2020-04-08,,VBI Vaccines Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,4
NCT03394027,0,0,0,0,0,0,2022-08-01,2023-08-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03395730,1,0,1,1,0,0,2018-01-15,2019-01-15,2018-04-20,Eslam Mohammed Abbas,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03396432,0,0,0,0,0,0,2019-08-19,2020-08-19,,Children's Hospital of Philadelphia,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,324
NCT03397264,0,0,0,0,0,0,2019-03-31,2020-03-31,,Opthea Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,3
NCT03398447,0,0,0,0,0,0,2019-04-30,2020-04-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,869
NCT03400163,0,0,0,0,0,0,2017-01-18,2018-01-18,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1104
NCT03400956,0,0,0,0,0,0,2021-11-13,2022-11-13,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03402893,1,1,0,1,0,1,2017-11-15,2018-11-15,2019-01-30,"Derm Research, PLLC",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03404518,0,0,0,0,0,0,2019-01-31,2020-01-31,,Loma Linda University,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,194
NCT03406611,0,0,0,0,0,0,2020-06-30,2021-06-30,,Orphan Technologies Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03407404,0,0,0,0,0,0,2019-06-15,2020-06-15,,Makerere University,Other,0,0,0,2.0,Phase 2/Phase 3,1,2017.0,1,0,0,0,0,0,1,0,2,1,0,88
NCT03408171,1,0,1,1,0,0,2018-08-17,2019-08-17,2019-08-02,Geisinger Clinic,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03408730,0,0,0,0,0,0,2019-10-22,2020-10-22,,VBI Vaccines Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,4
NCT03410043,0,0,0,0,0,0,2022-01-01,2023-01-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,2066
NCT03412604,0,0,0,0,0,0,2019-05-15,2020-05-15,,Beth Israel Deaconess Medical Center,Other,0,0,1,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,377
NCT03412773,0,0,0,0,0,0,2022-01-31,2023-01-31,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03416621,0,0,0,0,0,0,2020-01-31,2021-01-31,,Duke University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03416946,1,0,0,0,1,0,2017-05-01,2018-05-01,,Orthopaedic Innovation Centre,Other,0,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,2,0,1,3
NCT03417388,0,0,0,0,0,0,2021-12-30,2022-12-30,,University of Florida,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03419364,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03420014,0,0,0,0,0,0,2020-12-31,2021-12-31,,Philogen S.p.A.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,1,0,0,1,0,26
NCT03420339,0,0,0,0,0,0,2021-01-01,2022-01-01,,"Matthew J O'Brien, PhD, BCBA-D",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03420508,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,1432
NCT03421197,0,0,0,0,0,0,2019-08-31,2020-08-31,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,212
NCT03422198,0,0,0,0,0,0,2022-01-08,2023-01-08,,University of Utah,Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,578
NCT03422341,1,0,0,0,1,0,2018-07-11,2019-07-11,,GenePOC,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,1,1,0,4
NCT03422627,0,0,0,0,0,0,2021-12-17,2022-12-17,,Amgen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03422822,0,0,0,0,0,0,2022-09-12,2023-09-12,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03427333,1,0,0,0,1,0,2018-06-30,2019-06-30,,Talon Surgical,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03427814,0,0,0,0,0,0,2020-06-01,2021-06-01,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03428815,0,0,0,0,0,0,2020-08-30,2021-08-30,,Goeran Fiedler,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03429777,0,0,0,0,0,0,2023-05-01,2024-05-01,,Kasra Zarei,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03435640,0,0,0,0,0,0,2021-09-30,2022-09-30,,Nektar Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03436797,0,0,0,0,0,0,2018-10-19,2019-10-19,,"Allakos, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03436953,0,0,0,0,0,0,2020-09-30,2021-09-30,,Jazz Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,55
NCT03440385,0,0,0,0,0,0,2020-03-31,2021-03-31,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03443024,0,0,0,0,0,0,2019-02-07,2020-02-07,,"Dermira, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,1,0,0,0,0,0,0,1,0,17
NCT03443869,0,0,0,0,0,0,2021-09-19,2022-09-19,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03446573,0,0,0,0,0,0,2019-05-20,2020-05-20,,ViiV Healthcare,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,200
NCT03448692,0,0,0,0,0,0,2021-03-15,2022-03-15,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03452137,0,0,0,0,0,0,2023-08-28,2024-08-28,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03458325,0,0,0,0,0,0,2020-03-31,2021-03-31,,"scPharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,3,1,0,6
NCT03461419,0,0,0,0,0,0,2024-01-01,2025-01-01,,Healeon Medical Inc,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,8
NCT03463265,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Aadi, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,7
NCT03465709,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03466099,0,0,0,0,0,0,2019-09-30,2020-09-30,,"KalVista Pharmaceuticals, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03466476,0,0,0,0,0,0,2020-05-01,2021-05-01,,University of Miami,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03470012,1,0,1,1,0,1,2018-03-20,2019-03-20,2019-07-01,3M,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,56
NCT03470493,0,0,0,0,0,0,2019-04-30,2020-04-30,,ResMed,Industry,1,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,60
NCT03471117,0,0,0,0,0,0,2020-04-01,2021-04-01,,The University of Texas at Arlington,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03471754,0,0,0,0,0,0,2019-01-31,2020-01-31,,Annecto LLC,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03472924,0,0,0,0,0,0,2020-06-30,2021-06-30,,Oregon State University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,18
NCT03473132,0,0,0,0,0,0,2019-12-31,2020-12-31,,Brigham and Women's Hospital,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03473977,0,0,0,0,0,0,2020-03-30,2021-03-30,,"Children's Hospital Medical Center, Cincinnati",Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,437
NCT03476083,0,0,0,0,0,0,2020-05-31,2021-05-31,,New Discovery LLC,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03476317,0,0,0,0,0,0,2020-12-31,2021-12-31,,Children's Hospital of Philadelphia,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03476642,0,0,0,0,0,0,2020-02-29,2021-02-28,,Milton S. Hershey Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03477903,1,0,1,1,0,0,2018-08-29,2019-08-29,2019-08-26,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,209
NCT03483038,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Florida,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03485417,0,0,0,0,0,0,2021-12-30,2022-12-30,,The University of Hong Kong,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,547
NCT03486444,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ohio State University,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,315
NCT03486873,0,0,0,0,0,0,2028-05-10,2029-05-10,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03487666,0,0,0,0,0,0,2021-12-31,2022-12-31,,Georgetown University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03488251,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Molecular Templates, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03488667,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Kansas Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03490292,0,0,0,0,0,0,2021-02-28,2022-02-28,,"University of Wisconsin, Madison",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,1,0,0,1,0,715
NCT03492359,0,0,0,0,0,0,2018-10-01,2019-10-01,,Landon Pediatric Foundation,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03493464,0,0,0,0,0,0,2021-12-01,2022-12-01,,"Bracco Diagnostics, Inc",Industry,1,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,46
NCT03495453,0,0,0,0,0,0,2021-03-31,2022-03-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03495817,0,0,0,0,0,0,2019-10-30,2020-10-30,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03496610,0,0,0,0,0,0,2019-12-01,2020-12-01,,Duke University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03496701,0,0,0,0,0,0,2018-06-01,2019-06-01,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,85
NCT03500484,0,0,0,0,0,0,2020-04-30,2021-04-30,,Yale University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03500731,0,0,0,0,0,0,2023-12-31,2024-12-31,,Paul Szabolcs,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,5
NCT03502785,0,0,0,0,0,0,2020-03-31,2021-03-31,,Inovio Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,1,0,0,0,0,1,1,0,25
NCT03503292,0,0,0,0,0,0,2019-12-30,2020-12-30,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03508674,0,0,0,0,0,0,2019-05-30,2020-05-30,,Levita Magnetics,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,4
NCT03511638,0,0,0,0,0,0,2019-03-29,2020-03-29,,Bausch & Lomb Incorporated,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,142
NCT03512405,0,0,0,0,0,0,2022-04-30,2023-04-30,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,358
NCT03512964,0,0,0,0,0,0,2019-11-13,2020-11-13,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT03513458,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,910
NCT03516812,0,0,0,0,0,0,2021-03-01,2022-03-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03518138,0,0,0,0,0,0,2019-11-30,2020-11-30,,Que Oncology,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03519256,0,0,0,0,0,0,2022-01-23,2023-01-23,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03520322,0,0,0,0,0,0,2021-02-01,2022-02-01,,University of Rochester,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,470
NCT03520959,0,0,0,0,0,0,2018-11-19,2019-11-19,,Immune Design,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,0,1,0,0,0,0,0,1,1,0,7
NCT03521934,0,0,0,0,0,0,2021-01-31,2022-01-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03525795,0,0,0,0,0,0,2019-12-31,2020-12-31,,Constellation Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03525886,0,0,0,0,0,0,2019-12-31,2020-12-31,,Neurocrine Biosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,34
NCT03527173,0,0,0,0,0,0,2019-05-09,2020-05-09,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3276
NCT03527537,0,0,0,0,0,0,2021-06-01,2022-06-01,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03528343,1,0,0,0,1,0,2018-09-05,2019-09-05,,University of Utah,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,578
NCT03529461,1,1,0,1,0,0,2018-04-18,2019-04-18,2019-03-27,Bristol Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03531957,0,0,0,0,0,0,2019-07-22,2020-07-22,,Asana BioSciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,11
NCT03532542,0,0,0,0,0,0,2026-06-30,2027-06-30,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,32
NCT03533673,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Asklepios Biopharmaceutical, Inc.",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03539055,0,0,0,0,0,0,2019-08-31,2020-08-31,,Christopher Ellis,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03541603,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Tenax Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03542383,0,0,0,0,0,0,2019-09-29,2020-09-29,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03543410,0,0,0,0,0,0,2020-03-27,2021-03-27,,Sunovion,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,134
NCT03545607,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Athersys, Inc",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,7
NCT03546374,0,0,0,0,0,0,2022-05-31,2023-05-31,,Medtronic Cardiovascular,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,34
NCT03548779,0,0,0,0,0,0,2021-05-31,2022-05-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,910
NCT03549468,0,0,0,0,0,0,2019-05-31,2020-05-31,,University of Oklahoma,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,234
NCT03549897,1,0,0,0,1,0,2018-08-31,2019-08-31,,Amneal Ireland Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03553836,0,0,0,0,0,0,2022-10-26,2023-10-26,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03556956,0,0,0,0,0,0,2020-12-31,2021-12-31,,AB Science,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,30
NCT03557918,0,0,0,0,0,0,2020-07-31,2021-07-31,,Matthew Galsky,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03558061,0,0,0,0,0,0,2018-11-18,2019-11-18,,"Alkahest, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,6
NCT03559010,0,0,0,0,0,0,2018-09-09,2019-09-09,,HRA Pharma,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03559933,0,0,0,0,0,0,2019-05-29,2020-05-29,,"Stimdia Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03560349,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03560622,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vibhor Krishna,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03566238,0,0,0,0,0,0,2019-12-31,2020-12-31,,Albireo,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03567291,0,0,0,0,0,0,2021-01-15,2022-01-15,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,101
NCT03570892,0,0,0,0,0,0,2025-10-03,2026-10-03,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03571568,0,0,0,0,0,0,2020-06-30,2021-06-30,,BioInvent International AB,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,6
NCT03572049,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Alabama at Birmingham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03573271,0,0,0,0,0,0,2019-01-15,2020-01-15,,"Cytrellis Biosystems, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03574376,0,0,0,0,0,0,2020-08-01,2021-08-01,,OSF Healthcare System,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03574818,0,0,0,0,0,0,2021-02-26,2022-02-26,,Montefiore Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,240
NCT03575000,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Pittsburgh Healthcare System,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03576638,0,0,0,0,0,0,2019-01-31,2020-01-31,,Intec Pharma Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,7
NCT03580369,0,0,0,0,0,0,2020-05-04,2021-05-04,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03581500,0,0,0,0,0,0,2019-07-11,2020-07-11,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,2066
NCT03582384,0,0,0,0,0,0,2022-01-31,2023-01-31,,Boston Children’s Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,400
NCT03583151,0,0,0,0,0,0,2018-12-31,2019-12-31,,J&M Shuler,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,8
NCT03584009,0,0,0,0,0,0,2022-03-03,2023-03-03,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03584633,0,0,0,0,0,0,2019-06-30,2020-06-30,,Wei Chen,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03585790,0,0,0,0,0,0,2018-11-02,2019-11-02,,"Pete Kollbaum, OD, PhD",Other,0,1,0,4.0,Phase 4,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03585959,0,0,0,0,0,0,2019-05-20,2020-05-20,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,146
NCT03587116,0,0,0,0,0,0,2021-10-05,2022-10-05,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03589469,0,0,0,0,0,0,2020-02-22,2021-02-22,,ADC Therapeutics S.A.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03590353,0,0,0,0,0,0,2019-05-01,2020-05-01,,The Second Hospital of Hebei Medical University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,10
NCT03591354,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Virginia,Other,0,1,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,402
NCT03592173,0,0,0,0,0,0,2019-09-30,2020-09-30,,Kathleen Friel,Other,0,0,0,1.0,Phase 2,0,2013.0,0,0,0,0,1,0,0,0,0,0,1,2
NCT03593538,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT03593902,0,0,0,0,0,0,2025-01-31,2026-01-31,,Northwestern University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03594110,0,0,0,0,0,0,2022-06-02,2023-06-02,,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03595618,0,0,0,0,0,0,2020-12-31,2021-12-31,,Galapagos NV,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,79
NCT03596151,0,0,0,0,0,0,2018-08-20,2019-08-20,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,2133
NCT03597035,1,0,0,0,1,0,2018-07-31,2019-07-31,,University Hospitals Cleveland Medical Center,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,185
NCT03599193,1,0,0,0,1,0,2018-04-30,2019-04-30,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,212
NCT03599765,0,0,0,0,0,0,2022-12-31,2023-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,2066
NCT03600701,0,0,0,0,0,0,2021-07-17,2022-07-17,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03601806,0,0,0,0,0,0,2021-05-31,2022-05-31,,AIDS Malignancy Consortium,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,46
NCT03603223,0,0,0,0,0,0,2021-06-01,2022-06-01,,Jonsson Comprehensive Cancer Center,Other,0,1,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,277
NCT03605758,0,0,0,0,0,0,2021-12-31,2022-12-31,,Albert Einstein College of Medicine,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,155
NCT03608033,0,0,0,0,0,0,2020-08-31,2021-08-31,,Omeros Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,19
NCT03608696,0,0,0,0,0,0,2019-07-11,2020-07-11,,Thomas Jefferson University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,186
NCT03612791,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Gustave Roussy, Cancer Campus, Grand Paris",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,2,1,0,164
NCT03613129,0,0,0,0,0,0,2019-04-30,2020-04-30,,"LUCINDA BATEMAN, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03614156,0,0,0,0,0,0,2019-07-11,2020-07-11,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,21
NCT03615144,0,0,0,0,0,0,2021-07-31,2022-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03617523,0,0,0,0,0,0,2018-11-12,2019-11-12,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,4.0,Phase 4,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,285
NCT03621280,0,0,0,0,0,0,2021-04-30,2022-04-30,,Cortendo AB,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03625076,0,0,0,0,0,0,2020-05-02,2021-05-02,,"Kendall Healthcare Group, Ltd.",Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03626688,0,0,0,0,0,0,2021-12-31,2022-12-31,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,72
NCT03630120,0,0,0,0,0,0,2022-12-31,2023-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03631355,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,869
NCT03632252,0,0,0,0,0,0,2020-04-01,2021-04-01,,University of Michigan,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03633396,0,0,0,0,0,0,2019-09-30,2020-09-30,,"AnaptysBio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,6
NCT03633552,0,0,0,0,0,0,2021-03-03,2022-03-03,,Mashhad University of Medical Sciences,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,80
NCT03633721,0,0,0,0,0,0,2019-12-31,2020-12-31,,Albert Einstein College of Medicine,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,155
NCT03635827,0,0,0,0,0,0,2020-06-30,2021-06-30,,Nobilis Therapeutics Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,0,0,0,0,1,0,3,1,0,1
NCT03635892,0,0,0,0,0,0,2021-08-31,2022-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03639623,0,0,0,0,0,0,2020-04-30,2021-04-30,,Zydus Discovery DMCC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03641560,0,0,0,0,0,0,2020-05-31,2021-05-31,,Astellas Pharma Inc,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,506
NCT03642184,0,0,0,0,0,0,2020-12-31,2021-12-31,,RenJi Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,136
NCT03646123,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Seattle Genetics, Inc.",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,77
NCT03649711,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Arkansas,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,285
NCT03652259,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT03653429,0,0,0,0,0,0,2018-12-31,2019-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03655691,0,0,0,0,0,0,2018-11-09,2019-11-09,,Eirion Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,4
NCT03656510,0,0,0,0,0,0,2020-11-27,2021-11-27,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03661996,0,0,0,0,0,0,2019-10-31,2020-10-31,,Centrexion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,12
NCT03662282,0,0,0,0,0,0,2019-01-07,2020-01-07,,University of South Florida,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03663231,0,0,0,0,0,0,2019-09-15,2020-09-15,,University of Rochester,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,470
NCT03663335,0,0,0,0,0,0,2021-05-12,2022-05-12,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1895
NCT03664752,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,180
NCT03666871,0,0,0,0,0,0,2024-01-31,2025-01-31,,Case Western Reserve University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,89
NCT03667222,0,0,0,0,0,0,2019-05-17,2020-05-17,,"BioPharmX, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03667703,0,0,0,0,0,0,2020-06-30,2021-06-30,,Boston Children’s Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03667820,0,0,0,0,0,0,2021-04-01,2022-04-01,,University of Texas Southwestern Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,626
NCT03668119,0,0,0,0,0,0,2021-03-14,2022-03-14,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03669588,0,0,0,0,0,0,2020-06-30,2021-06-30,,argenx BVBA,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,12
NCT03671304,0,0,0,0,0,0,2019-10-30,2020-10-30,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,626
NCT03672630,0,0,0,0,0,0,2023-02-28,2024-02-28,,Kevin Winthrop,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03675282,0,0,0,0,0,0,2021-01-31,2022-01-31,,Weill Medical College of Cornell University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03675620,0,0,0,0,0,0,2022-10-31,2023-10-31,,Andrews Research & Education Foundation,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,10
NCT03682289,0,0,0,0,0,0,2021-03-19,2022-03-19,,Rahul Aggarwal,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03683251,0,0,0,0,0,0,2022-06-24,2023-06-24,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1731
NCT03684811,0,0,0,0,0,0,2021-09-01,2022-09-01,,"Forma Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,5
NCT03686397,0,0,0,0,0,0,2020-11-30,2021-11-30,,Salvat,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,9
NCT03687372,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03688100,0,0,0,0,0,0,2021-06-01,2022-06-01,,Cedars-Sinai Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03689920,0,0,0,0,0,0,2020-09-30,2021-09-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT03690921,0,0,0,0,0,0,2022-05-23,2023-05-23,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,2066
NCT03691662,0,0,0,0,0,0,2019-12-31,2020-12-31,,Santen Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03694249,0,0,0,0,0,0,2022-01-31,2023-01-31,,Vanderbilt-Ingram Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03695367,0,0,0,0,0,0,2018-11-20,2019-11-20,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,18
NCT03695510,0,0,0,0,0,0,2021-04-30,2022-04-30,,National Taiwan University Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1559
NCT03696524,0,0,0,0,0,0,2020-05-01,2021-05-01,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT03696758,0,0,0,0,0,0,2020-09-30,2021-09-30,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03697109,0,0,0,0,0,0,2020-12-31,2021-12-31,,Corcept Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,40
NCT03697460,0,0,0,0,0,0,2019-11-30,2020-11-30,,Aaron R. Mangold,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03699124,0,0,0,0,0,0,2019-11-30,2020-11-30,,Bavarian Nordic,Industry,1,0,1,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,33
NCT03700801,0,0,0,0,0,0,2019-03-31,2020-03-31,,Zhujiang Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,70
NCT03701763,0,0,0,0,0,0,2020-10-14,2021-10-14,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03707977,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,2,1,0,2133
NCT03710083,0,0,0,0,0,0,2019-07-25,2020-07-25,,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,48
NCT03710655,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Apimeds, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03711474,0,0,0,0,0,0,2020-08-01,2021-08-01,,West Virginia University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,74
NCT03712202,0,0,0,0,0,0,2020-11-30,2021-11-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,358
NCT03713593,0,0,0,0,0,0,2022-07-23,2023-07-23,,Merck Sharp & Dohme Corp.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03717181,0,0,0,0,0,0,2019-12-31,2020-12-31,,Palladio Biosciences,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03717272,0,0,0,0,0,0,2020-07-31,2021-07-31,,Aelis Farma,Industry,1,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03719131,0,0,0,0,0,0,2021-10-31,2022-10-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03719300,0,0,0,0,0,0,2021-11-30,2022-11-30,,Anchiano Therapeutics Israel Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03719690,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Kura Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,7
NCT03720470,0,0,0,0,0,0,2020-02-17,2021-02-17,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03724175,0,0,0,0,0,0,2025-12-31,2026-12-31,,Stanford University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03724357,0,0,0,0,0,0,2026-10-31,2027-10-31,,"University of Maryland, College Park",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03724773,0,0,0,0,0,0,2020-05-31,2021-05-31,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03725293,0,0,0,0,0,0,2019-12-01,2020-12-01,,William Beaumont Hospitals,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,84
NCT03728426,0,0,0,0,0,0,2020-07-31,2021-07-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03728634,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,69
NCT03728790,0,0,0,0,0,0,2019-07-28,2020-07-28,,Columbia University,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03729245,0,0,0,0,0,0,2021-12-31,2022-12-31,,Nektar Therapeutics,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,20
NCT03732677,0,0,0,0,0,0,2025-12-18,2026-12-18,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03734016,0,0,0,0,0,0,2021-02-28,2022-02-28,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03735407,0,0,0,0,0,0,2019-08-01,2020-08-01,,Ceck Cap Ltd.,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03735979,0,0,0,0,0,0,2022-09-30,2023-09-30,,University of Cincinnati,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,222
NCT03736785,0,0,0,0,0,0,2019-12-30,2020-12-30,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03739710,0,0,0,0,0,0,2020-06-16,2021-06-16,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03740724,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Fibrocell Technologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,1,0,1,0,10
NCT03745014,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Accelerate Diagnostics, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,3,1,0,3
NCT03747419,0,0,0,0,0,0,2021-01-31,2022-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,647
NCT03748992,0,0,0,0,0,0,2019-11-30,2020-11-30,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03752827,0,0,0,0,0,0,2020-09-15,2021-09-15,,"InGeneron, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,5
NCT03753204,0,0,0,0,0,0,2020-03-01,2021-03-01,,Vanderbilt University Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03756038,0,0,0,0,0,0,2019-03-27,2020-03-27,,Maria Pacella,Other,0,0,0,1.0,Phase 2,1,2019.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03756350,0,0,0,0,0,0,2019-07-02,2020-07-02,,Venus Concept,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,23
NCT03757039,0,0,0,0,0,0,2019-03-06,2020-03-06,,Alcon Research,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,1,1,0,492
NCT03758690,0,0,0,0,0,0,2019-09-09,2020-09-09,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT03759041,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Seres Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03761108,0,0,0,0,0,0,2022-12-19,2023-12-19,,Regeneron Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03761784,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Sol-Gel Technologies, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03762395,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of Colorado, Denver",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,882
NCT03763331,0,0,0,0,0,0,2021-12-31,2022-12-31,,Indiana University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT03763708,0,0,0,0,0,0,2029-01-31,2030-01-31,,MedtronicNeuro,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,57
NCT03767348,0,0,0,0,0,0,2021-11-30,2022-11-30,,Replimune Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2
NCT03768349,0,0,0,0,0,0,2020-12-01,2021-12-01,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03769181,0,0,0,0,0,0,2023-05-31,2024-05-31,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1222
NCT03770000,0,0,0,0,0,0,2020-08-31,2021-08-31,,Rhizen Pharmaceuticals SA,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03771274,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Carolina Eyecare Physicians, LLC",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03771963,0,0,0,0,0,0,2019-10-12,2020-10-12,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,650
NCT03772665,0,0,0,0,0,0,2022-02-28,2023-02-28,,Acucela Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03775681,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2066
NCT03778229,0,0,0,0,0,0,2021-08-24,2022-08-24,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03779048,0,0,0,0,0,0,2023-03-31,2024-03-31,,University of Pennsylvania,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03781089,0,0,0,0,0,0,2021-06-20,2022-06-20,,Duke University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03781388,0,0,0,0,0,0,2020-05-31,2021-05-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03781817,0,0,0,0,0,0,2020-01-01,2021-01-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03782259,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Washington,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03784066,0,0,0,0,0,0,2020-03-31,2021-03-31,,Universitaire Ziekenhuizen Leuven,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,1,0,2,1,0,525
NCT03785145,0,0,0,0,0,0,2020-02-01,2021-02-01,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03786926,0,0,0,0,0,0,2022-04-30,2023-04-30,,Hutchison Medipharma Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,53
NCT03787602,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Kartos Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03788889,0,0,0,0,0,0,2021-03-01,2022-03-01,,Santa Barbara Cottage Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,9
NCT03789552,0,0,0,0,0,0,2022-04-01,2023-04-01,,"Tasly Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03793218,0,0,0,0,0,0,2021-11-07,2022-11-07,,University of Virginia,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,402
NCT03793842,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03794297,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03795597,0,0,0,0,0,0,2022-11-01,2023-11-01,,Loyola University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03795922,0,0,0,0,0,0,2020-02-01,2021-02-01,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03796442,0,0,0,0,0,0,2022-12-31,2023-12-31,,Seoul National University Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1227
NCT03797001,0,0,0,0,0,0,2023-06-30,2024-06-30,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03799562,0,0,0,0,0,0,2024-12-01,2025-12-01,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03801083,0,0,0,0,0,0,2021-01-31,2022-01-31,,Udai Kammula,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03801265,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sharad Khetarpal,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03803683,0,0,0,0,0,0,2022-10-31,2023-10-31,,"Rebecca Schnall, RN, MPH, PhD",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03804060,0,0,0,0,0,0,2024-03-31,2025-03-31,,"ZOLL Circulation, Inc., USA",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03809000,0,0,0,0,0,0,2024-09-15,2025-09-15,,"RTOG Foundation, Inc.",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,5
NCT03810235,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03811028,0,0,0,0,0,0,2021-12-31,2022-12-31,,Swedish Orphan Biovitrum,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,40
NCT03811249,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Refocus Group, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03812159,0,0,0,0,0,0,2021-11-20,2022-11-20,,"Gary F. Rogers, MD",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03812393,0,0,0,0,0,0,2020-10-15,2021-10-15,,West Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03812991,0,0,0,0,0,0,2023-12-31,2024-12-31,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,214
NCT03815058,0,0,0,0,0,0,2022-09-01,2023-09-01,,"Genentech, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,427
NCT03815656,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Dennis Turner, M.D.",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03817190,0,0,0,0,0,0,2020-07-31,2021-07-31,,DS Biopharma,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,6
NCT03818074,0,0,0,0,0,0,2021-03-31,2022-03-31,,Barts & The London NHS Trust,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,76
NCT03818321,0,0,0,0,0,0,2020-07-31,2021-07-31,,TriHealth Inc.,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,74
NCT03818672,0,0,0,0,0,0,2019-05-01,2020-05-01,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,180
NCT03818815,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Novus Therapeutics, Inc",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03819218,0,0,0,0,0,0,2020-07-17,2021-07-17,,MC2 Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT03819608,0,0,0,0,0,0,2022-03-31,2023-03-31,,Theresa Pape,U.S. Fed,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03820141,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Jenny C. Chang, MD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03821129,0,0,0,0,0,0,2025-12-31,2026-12-31,,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,52
NCT03823404,0,0,0,0,0,0,2021-12-31,2022-12-31,,Cortexyme Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03824535,0,0,0,0,0,0,2022-08-01,2023-08-01,,Andrei Iagaru,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03825536,0,0,0,0,0,0,2021-08-30,2022-08-30,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03828929,0,0,0,0,0,0,2021-11-20,2022-11-20,,New York Methodist Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03829241,0,0,0,0,0,0,2019-10-20,2020-10-20,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03829722,0,0,0,0,0,0,2024-09-30,2025-09-30,,University of Michigan Rogel Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,213
NCT03830177,0,0,0,0,0,0,2019-08-01,2020-08-01,,Ann & Robert H Lurie Children's Hospital of Chicago,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,112
NCT03830281,0,0,0,0,0,0,2019-11-25,2020-11-25,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03832998,0,0,0,0,0,0,2024-04-17,2025-04-17,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03834688,0,0,0,0,0,0,2022-03-31,2023-03-31,,"PrECOG, LLC.",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03835117,0,0,0,0,0,0,2021-04-30,2022-04-30,,Phoenix Children's Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,35
NCT03835351,0,0,0,0,0,0,2020-08-31,2021-08-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03837691,0,0,0,0,0,0,2019-04-30,2020-04-30,,USGI Medical,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03841058,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Hospital for Special Surgery, New York",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,157
NCT03844269,0,0,0,0,0,0,2020-01-01,2021-01-01,,"Akili Interactive Labs, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03844633,0,0,0,0,0,0,2021-02-28,2022-02-28,,Ohio State University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03845504,0,0,0,0,0,0,2020-06-30,2021-06-30,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03846843,0,0,0,0,0,0,2017-11-30,2018-11-30,,Ocera Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT03848182,0,0,0,0,0,0,2019-06-30,2020-06-30,,Albert Einstein College of Medicine,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,1,0,0,0,0,0,0,1,0,155
NCT03854032,0,0,0,0,0,0,2025-12-31,2026-12-31,,Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,186
NCT03856034,0,0,0,0,0,0,2020-11-02,2021-11-02,,USFetus,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03856216,0,0,0,0,0,0,2021-03-31,2022-03-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03856645,0,0,0,0,0,0,2019-09-30,2020-09-30,,Okogen,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03859908,0,0,0,0,0,0,2021-03-31,2022-03-31,,Universidad de El Salvador,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03861403,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Leap Therapeutics, Inc.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03861780,0,0,0,0,0,0,2019-06-06,2020-06-06,,"Professional Disposables International, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03865316,0,0,0,0,0,0,2020-07-25,2021-07-25,,Masimo Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,39
NCT03866577,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Momenta Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,12
NCT03867162,0,0,0,0,0,0,2024-03-04,2025-03-04,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,136
NCT03868033,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Taiwan University Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1559
NCT03869190,0,0,0,0,0,0,2020-09-30,2021-09-30,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03870048,0,0,0,0,0,0,2020-03-30,2021-03-30,,University of Iowa,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,158
NCT03870308,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,1898
NCT03871101,1,0,0,0,1,0,2018-07-10,2019-07-10,,Yuzuncu Yıl University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,35
NCT03871257,0,0,0,0,0,0,2027-05-01,2028-05-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03875092,0,0,0,0,0,0,2020-03-10,2021-03-10,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT03875313,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Calithera Biosciences, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03878914,0,0,0,0,0,0,2020-12-31,2021-12-31,,Wayne State University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,145
NCT03882918,0,0,0,0,0,0,2020-07-31,2021-07-31,,Ovid Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03883113,0,0,0,0,0,0,2019-12-16,2020-12-16,,Vaccitech Limited,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,4
NCT03884101,0,0,0,0,0,0,2023-04-10,2024-04-10,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03885726,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Vapotherm, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03886337,0,0,0,0,0,0,2024-12-31,2025-12-31,,University of Iowa,Other,0,0,0,5.0,,0,2022.0,0,0,0,1,0,0,0,0,0,1,0,158
NCT03886961,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Florida,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03887533,0,0,0,0,0,0,2022-01-01,2023-01-01,,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,413
NCT03887702,0,0,0,0,0,0,2025-02-21,2026-02-21,,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,288
NCT03889782,0,0,0,0,0,0,2021-10-31,2022-10-31,,Mina Nikanjam,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03891173,0,0,0,0,0,0,2021-06-30,2022-06-30,,Helix BioPharma Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03891875,0,0,0,0,0,0,2020-10-31,2021-10-31,,Stealth BioTherapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,25
NCT03892889,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,3,1,0,185
NCT03894904,0,0,0,0,0,0,2021-04-01,2022-04-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,490
NCT03895996,0,0,0,0,0,0,2020-11-30,2021-11-30,,Avotres Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03896581,0,0,0,0,0,0,2021-02-28,2022-02-28,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03897127,0,0,0,0,0,0,2023-06-30,2024-06-30,,University of Ulm,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,106
NCT03898154,0,0,0,0,0,0,2021-05-31,2022-05-31,,C. Liam Dwyer,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03898362,0,0,0,0,0,0,2022-06-30,2023-06-30,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03898973,0,0,0,0,0,0,2024-12-31,2025-12-31,,Stanford University,Other,0,0,1,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1309
NCT03899805,0,0,0,0,0,0,2022-08-01,2023-08-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03902522,0,0,0,0,0,0,2019-12-31,2020-12-31,,"CytoDyn, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03903653,0,0,0,0,0,0,2019-11-01,2020-11-01,,Hamilton Health Sciences Corporation,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,189
NCT03905707,0,0,0,0,0,0,2022-11-05,2023-11-05,,Zealand Pharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03907124,0,0,0,0,0,0,2020-11-30,2021-11-30,,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT03910387,0,0,0,0,0,0,2021-04-30,2022-04-30,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03912571,0,0,0,0,0,0,2019-09-30,2020-09-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2011.0,0,0,0,0,1,0,0,0,0,0,1,869
NCT03913377,0,0,0,0,0,0,2019-06-14,2020-06-14,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03919292,0,0,0,0,0,0,2022-01-31,2023-01-31,,Virginia Commonwealth University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03920670,0,0,0,0,0,0,2021-01-30,2022-01-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,1898
NCT03921073,0,0,0,0,0,0,2021-05-01,2022-05-01,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03921294,0,0,0,0,0,0,2023-05-31,2024-05-31,,"Indiana Hemophilia &Thrombosis Center, Inc.",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03921541,0,0,0,0,0,0,2021-03-31,2022-03-31,,Aeglea Biotherapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03922711,0,0,0,0,0,0,2020-04-30,2021-04-30,,Prilenia,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03928015,0,0,0,0,0,0,2020-05-31,2021-05-31,,Centura Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03928353,0,0,0,0,0,0,2019-12-31,2020-12-31,,PhaseBio Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03929367,0,0,0,0,0,0,2019-12-15,2020-12-15,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03929549,0,0,0,0,0,0,2021-10-31,2022-10-31,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,934
NCT03935269,0,0,0,0,0,0,2021-05-31,2022-05-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03937570,0,0,0,0,0,0,2019-06-30,2020-06-30,,Universita di Verona,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,69
NCT03938636,0,0,0,0,0,0,2020-10-31,2021-10-31,,Navidea Biopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03939715,0,0,0,0,0,0,2022-05-05,2023-05-05,,Colorado Pelvic Floor Consultants,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT03941236,0,0,0,0,0,0,2021-03-31,2022-03-31,,Zealand Pharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03941483,0,0,0,0,0,0,2020-07-31,2021-07-31,,Astellas Pharma Inc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,506
NCT03942081,0,0,0,0,0,0,2019-12-31,2020-12-31,,Linnea Polgreen,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03942224,0,0,0,0,0,0,2024-07-31,2025-07-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03946124,1,0,0,0,1,0,2017-07-19,2018-07-19,,University of Pennsylvania,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,3,0,1,1052
NCT03949764,0,0,0,0,0,0,2022-08-31,2023-08-31,,Jennifer Havens,Other,0,1,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03951779,0,0,0,0,0,0,2020-02-04,2021-02-04,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03952481,0,0,0,0,0,0,2020-02-29,2021-02-28,,Weill Medical College of Cornell University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,586
NCT03952546,0,0,0,0,0,0,2020-05-01,2021-05-01,,Northwell Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03953417,0,0,0,0,0,0,2021-07-01,2022-07-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03954223,0,0,0,0,0,0,2021-08-30,2022-08-30,,Children's Hospital Los Angeles,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,82
NCT03954431,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Arizona,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,265
NCT03954626,0,0,0,0,0,0,2019-07-05,2020-07-05,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,1,0,1,0,0,0,0,0,0,1,0,1895
NCT03958903,0,0,0,0,0,0,2021-01-01,2022-01-01,,Stanford University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03959085,0,0,0,0,0,0,2027-05-31,2028-05-31,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,1,0,0,1,0,0,3,1,0,389
NCT03959553,0,0,0,0,0,0,2021-08-31,2022-08-31,,GemVax & Kael,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT03960138,0,0,0,0,0,0,2024-07-31,2025-07-31,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,511
NCT03964727,0,0,0,0,0,0,2022-04-30,2023-04-30,,"Immunomedics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,36
NCT03965091,0,0,0,0,0,0,2021-07-09,2022-07-09,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,101
NCT03965689,0,0,0,0,0,0,2020-02-02,2021-02-02,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03966911,0,0,0,0,0,0,2020-02-29,2021-02-28,,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,48
NCT03969901,0,0,0,0,0,0,2022-11-13,2023-11-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2145
NCT03970655,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Florida,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03972046,0,0,0,0,0,0,2021-06-24,2022-06-24,,"David Lee, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03976843,0,0,0,0,0,0,2025-08-31,2026-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03977649,0,0,0,0,0,0,2020-11-16,2021-11-16,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03979781,0,0,0,0,0,0,2020-11-06,2021-11-06,,State University of New York - Upstate Medical University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,125
NCT03980483,0,0,0,0,0,0,2021-07-03,2022-07-03,,GlaxoSmithKline,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3276
NCT03981549,0,0,0,0,0,0,2022-12-31,2023-12-31,,"The Emmes Company, LLC",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03981757,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Louisville,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,214
NCT03982342,0,0,0,0,0,0,2020-06-01,2021-06-01,,Nationwide Children's Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,161
NCT03985384,0,0,0,0,0,0,2020-09-30,2021-09-30,,Los Angeles Biomedical Research Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,60
NCT03985748,0,0,0,0,0,0,2021-07-31,2022-07-31,,Rhode Island Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,120
NCT03986905,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Repurposed Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03988920,0,0,0,0,0,0,2021-02-28,2022-02-28,,Ardelyx,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,22
NCT03990207,0,0,0,0,0,0,2020-10-31,2021-10-31,,Olympus Corporation of the Americas,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03990649,0,0,0,0,0,0,2020-05-17,2021-05-17,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,209
NCT03990896,0,0,0,0,0,0,2022-07-31,2023-07-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03992378,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Oklahoma,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,234
NCT03995108,0,0,0,0,0,0,2021-08-31,2022-08-31,,X4 Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,7
NCT03997786,0,0,0,0,0,0,2023-11-01,2024-11-01,,Sun Pharma Global FZE,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,17
NCT03999684,0,0,0,0,0,0,2022-04-01,2023-04-01,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03999918,0,0,0,0,0,0,2021-07-31,2022-07-31,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,24
NCT04002401,0,0,0,0,0,0,2020-12-31,2021-12-31,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,510
NCT04003610,0,0,0,0,0,0,2022-11-30,2023-11-30,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,143
NCT04003974,0,0,0,0,0,0,2020-06-30,2021-06-30,,Fulcrum Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT04006873,0,0,0,0,0,0,2020-08-31,2021-08-31,,Nottingham University Hospitals NHS Trust,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,39
NCT04007094,0,0,0,0,0,0,2021-12-31,2022-12-31,,Ohio State University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT04007237,0,0,0,0,0,0,2018-12-30,2019-12-30,,Indonesia University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,112
NCT04009291,0,0,0,0,0,0,2020-03-31,2021-03-31,,Ascendis Pharma A/S,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,1,1,0,10
NCT04011020,0,0,0,0,0,0,2021-10-31,2022-10-31,,Tianhe Stem Cell Biotechnologies Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,6
NCT04011410,0,0,0,0,0,0,2021-05-31,2022-05-31,,University of Kentucky,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,77
NCT04012996,0,0,0,0,0,0,2023-01-31,2024-01-31,,Centinel Spine,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04015596,0,0,0,0,0,0,2020-10-31,2021-10-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1699
NCT04016272,0,0,0,0,0,0,2022-07-31,2023-07-31,,"The University of Texas Health Science Center, Houston",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT04017650,0,0,0,0,0,0,2024-06-30,2025-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT04018872,0,0,0,0,0,0,2022-06-24,2023-06-24,,Dallas VA Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,23
NCT04019262,0,0,0,0,0,0,2023-06-30,2024-06-30,,John Flickinger,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT04020094,0,0,0,0,0,0,2023-03-31,2024-03-31,,University of Utah,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,578
NCT04023760,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Saskatchewan,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,166
NCT04026165,0,0,0,0,0,0,2024-12-31,2025-12-31,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT04027439,0,0,0,0,0,0,2019-05-23,2020-05-23,,Verona Pharma plc,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT04035200,0,0,0,0,0,0,2020-08-31,2021-08-31,,Imbrium Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04036292,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Oyster Point Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT04037358,0,0,0,0,0,0,2024-08-31,2025-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,461
NCT04040322,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Eicos Sciences, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04041219,0,0,0,0,0,0,2020-06-30,2021-06-30,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT04041596,0,0,0,0,0,0,2021-01-31,2022-01-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT04042857,0,0,0,0,0,0,2020-10-01,2021-10-01,,Next Science TM,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT04043715,0,0,0,0,0,0,2025-12-31,2026-12-31,,University of Washington,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT04044664,0,0,0,0,0,0,2020-05-30,2021-05-30,,Aptinyx,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT04046328,0,0,0,0,0,0,2020-04-30,2021-04-30,,Pharmascience Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT04046549,0,0,0,0,0,0,2021-04-30,2022-04-30,,Viela Bio,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT04050371,1,0,0,0,1,0,2018-05-23,2019-05-23,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1443
NCT04054193,0,0,0,0,0,0,2021-04-13,2022-04-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT04054687,0,0,0,0,0,0,2020-03-31,2021-03-31,,Mercy Health Ohio,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,7
NCT04055116,0,0,0,0,0,0,2019-12-31,2020-12-31,,Geisinger Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,39
NCT04056182,0,0,0,0,0,0,2020-09-30,2021-09-30,,Frances R Levin,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04056637,0,0,0,0,0,0,2021-09-01,2022-09-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT04057248,0,0,0,0,0,0,2019-06-01,2020-06-01,,LabStyle Innovations Ltd.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT04057898,0,0,0,0,0,0,2021-12-31,2022-12-31,,MediciNova,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,15
NCT04058652,0,0,0,0,0,0,2020-04-30,2021-04-30,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT04059094,0,0,0,0,0,0,2020-09-02,2021-09-02,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1852
NCT04066023,0,0,0,0,0,0,2021-04-30,2022-04-30,,Zosano Pharma Corporation,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,6
NCT04068792,0,0,0,0,0,0,2020-06-02,2021-06-02,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,558
NCT04069117,0,0,0,0,0,0,2021-08-31,2022-08-31,,Mansoura University Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,4
NCT04071366,0,0,0,0,0,0,2021-02-28,2022-02-28,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,143
NCT04075812,0,0,0,0,0,0,2019-06-21,2020-06-21,,Ohio State University,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,315
NCT04078022,0,0,0,0,0,0,2021-02-28,2022-02-28,,"University of Maryland, Baltimore",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,144
NCT04078555,0,0,0,0,0,0,2021-09-01,2022-09-01,,"Energenesis Biomedical Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT04080778,0,0,0,0,0,0,2022-12-01,2023-12-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT04082429,0,0,0,0,0,0,2020-10-30,2021-10-30,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,981
NCT04083690,0,0,0,0,0,0,2021-10-01,2022-10-01,,Allina Health System,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,33
NCT04084106,0,0,0,0,0,0,2021-06-01,2022-06-01,,Uppsala University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,216
NCT04084860,0,0,0,0,0,0,2023-08-31,2024-08-31,,New York State Psychiatric Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT04084990,0,0,0,0,0,0,2022-09-30,2023-09-30,,Washington University School of Medicine,Other,0,0,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1151
NCT04085393,0,0,0,0,0,0,2021-12-01,2022-12-01,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT04085614,0,0,0,0,0,0,2020-06-01,2021-06-01,,Philips Healthcare,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,45
NCT04086823,0,0,0,0,0,0,2020-05-30,2021-05-30,,Raziel Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT04087629,0,0,0,0,0,0,2020-08-31,2021-08-31,,Columbia University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT04088396,0,0,0,0,0,0,2022-10-13,2023-10-13,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT04089553,0,0,0,0,0,0,2021-03-18,2022-03-18,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2450
NCT00085982,0,0,0,0,0,0,2030-01-01,2031-01-01,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT00200200,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00212134,0,1,0,1,0,0,2019-09-21,2020-09-21,2013-07-15,Stanford University,Other,0,1,1,5.0,,0,2004.0,0,0,0,1,0,0,0,0,0,0,1,1309
NCT00254410,1,1,0,1,0,1,2017-09-14,2018-09-14,2018-11-13,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00295932,1,1,0,1,0,0,2018-03-11,2019-03-11,2018-05-11,Memorial Sloan Kettering Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2005.0,1,1,1,0,0,0,0,0,0,0,1,1432
NCT00345865,0,0,0,0,0,0,2019-06-28,2020-06-28,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2005.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT00346125,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2006.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT00375050,1,0,0,0,1,0,2018-05-31,2019-05-31,,Yale University,Other,0,0,0,5.0,,0,2002.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT00375830,1,0,0,0,1,0,2017-04-17,2018-04-17,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT00450463,1,1,0,1,0,1,2017-04-27,2018-04-27,2018-06-19,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2007.0,1,1,1,0,0,0,0,0,0,0,1,3004
NCT00470574,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,5.0,,0,2007.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT00482092,1,0,0,0,1,0,2018-07-31,2019-07-31,,Mesoblast International Sàrl,Industry,1,0,0,3.0,Phase 3,0,2007.0,0,1,0,0,0,0,0,0,1,0,1,17
NCT00492778,0,0,0,0,0,0,2022-07-01,2023-07-01,,Gynecologic Oncology Group,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,0,0,0,1,0,0,1,0,1,200
NCT00503035,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00512070,0,0,0,0,0,0,2020-12-31,2021-12-31,,Seattle Institute for Biomedical and Clinical Research,Other,0,1,0,5.0,,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT00538031,0,0,0,0,0,0,2019-08-31,2020-08-31,,City of Hope Medical Center,Other,0,0,0,1.0,Phase 2,0,2003.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT00544830,0,0,0,0,0,0,2020-03-31,2021-03-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2006.0,0,1,0,0,0,1,0,0,0,0,1,358
NCT00547339,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2006.0,1,0,0,0,0,1,0,0,0,0,1,626
NCT00566618,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00583817,0,0,0,0,0,0,2027-12-31,2028-12-31,,Matthew Eagleton,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT00585559,0,0,0,0,0,0,2020-07-31,2021-07-31,,Vanderbilt University,Other,0,0,1,5.0,,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT00592501,0,0,0,0,0,0,2019-04-30,2020-04-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,1,0,0,0,0,1,1699
NCT00606294,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2004.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT00610051,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Biopeutics Co., Ltd",Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,2,0,1,1
NCT00667888,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,0,3.0,Phase 3,0,2001.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT00701701,0,0,0,0,0,0,2022-07-05,2023-07-05,,"Genzyme, a Sanofi Company",Industry,1,0,0,4.0,Phase 4,0,2008.0,0,0,1,0,0,0,0,0,1,0,1,300
NCT00733408,1,1,0,1,0,0,2017-07-05,2018-07-05,2018-07-03,University of Washington,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,1,0,0,0,0,0,0,0,1,910
NCT00784225,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-05-10,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2004.0,1,1,0,0,0,0,0,0,0,0,1,288
NCT00807599,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-02-15,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00812240,1,0,0,0,1,0,2018-07-31,2019-07-31,,AB Science,Industry,1,0,0,3.0,Phase 3,1,2009.0,1,1,0,0,0,0,0,0,1,0,1,30
NCT00840177,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-26,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,288
NCT00854295,0,0,0,0,0,0,2019-12-31,2020-12-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,215
NCT00856401,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT00871260,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Chicago,Other,0,1,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT00913978,0,0,0,0,0,0,2018-12-21,2019-12-21,,Northwestern University,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,925
NCT00928135,1,0,0,0,1,0,2018-04-09,2019-04-09,,Joseph Zabner,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT00939523,0,0,0,0,0,0,2018-12-31,2019-12-31,,Cedars-Sinai Medical Center,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,279
NCT00956007,0,0,0,0,0,0,2021-08-31,2022-08-31,,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2009.0,0,0,1,0,0,1,0,0,1,0,1,156
NCT00957359,0,0,1,1,0,0,2019-12-31,2020-12-31,2019-02-19,NYU Langone Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT00962520,0,0,0,0,0,0,2022-04-30,2023-04-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT00977977,0,0,0,0,0,0,2020-01-01,2021-01-01,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT00981474,0,0,0,0,0,0,2020-09-30,2021-09-30,,Northwestern University,Other,0,0,1,5.0,,0,2009.0,0,1,0,1,0,0,0,0,0,0,1,925
NCT00987480,1,1,0,1,0,0,2017-07-10,2018-07-10,2018-03-02,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,1,0,0,0,0,0,0,1,1432
NCT01029587,0,0,0,0,0,0,2020-07-31,2021-07-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT01033552,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,218
NCT01049854,1,0,0,0,1,0,2017-11-30,2018-11-30,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,40
NCT01051037,1,0,0,0,1,0,2017-12-20,2018-12-20,,Jonsson Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2010.0,1,0,0,0,0,1,0,0,0,0,1,277
NCT01067287,0,0,0,0,0,0,2019-12-31,2020-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,1,0,1,377
NCT01089374,0,0,0,0,0,0,2025-01-31,2026-01-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,5.0,,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,306
NCT01090154,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Washington,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT01096368,0,0,0,0,0,0,2020-12-31,2021-12-31,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,1,0,0,1,0,1,389
NCT01101035,1,1,0,1,0,0,2017-05-15,2018-05-15,2018-05-11,Takeda,Industry,1,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT01121120,0,0,0,0,0,0,2020-06-30,2021-06-30,,Tarix Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT01128218,0,0,0,0,0,0,2018-09-30,2019-09-30,,Southern Illinois University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,26
NCT01145209,1,0,1,1,0,1,2017-10-31,2018-10-31,2019-03-22,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,0,0,1,1091
NCT01188096,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Donald Durden, M.D.",Other,0,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01189266,0,0,1,1,0,0,2020-11-30,2021-11-30,2019-07-05,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,1,0,0,1,0,1,3004
NCT01194063,0,0,0,0,0,0,2018-11-30,2019-11-30,,Kapiolani Medical Center For Women & Children,Other,0,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01199263,0,0,1,1,0,0,2019-09-01,2020-09-01,2019-08-28,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01203722,0,0,0,0,0,0,2023-09-30,2024-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT01222351,0,0,0,0,0,0,2020-01-31,2021-01-31,,New York State Psychiatric Institute,Other,0,1,1,5.0,,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT01230866,0,0,0,0,0,0,2020-12-31,2021-12-31,,Proton Collaborative Group,Other,0,0,0,3.0,Phase 3,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,9
NCT01239368,1,1,0,1,0,0,2017-08-16,2018-08-16,2018-07-26,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,1,2010.0,1,0,1,0,0,0,0,0,0,0,1,3004
NCT01263704,1,1,0,1,0,0,2017-04-03,2018-04-03,2018-03-19,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,2,0,1,1731
NCT01282424,0,1,0,1,0,0,2018-05-02,2019-05-02,2014-08-22,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT01284283,0,0,0,0,0,0,2021-03-31,2022-03-31,,Stryker Trauma GmbH,Industry,1,0,0,5.0,,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,10
NCT01297400,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Skingenix, Inc.",Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT01345552,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dwight Heron,Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,6
NCT01347970,0,0,0,0,0,0,2019-11-30,2020-11-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,1,1,0,1,358
NCT01349101,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,1,0,0,1,162
NCT01359046,1,1,0,1,0,1,2018-03-02,2019-03-02,2019-04-04,Mayo Clinic,Other,0,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT01364467,0,0,0,0,0,0,2018-03-05,2019-03-05,,Virginia Commonwealth University,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT01367964,0,0,0,0,0,0,2018-12-31,2019-12-31,,Ann & Robert H Lurie Children's Hospital of Chicago,Other,0,0,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,112
NCT01373242,1,1,0,1,0,0,2018-04-16,2019-04-16,2019-04-11,"University of North Carolina, Chapel Hill",Other,0,0,1,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01381692,0,0,0,0,0,0,2020-06-01,2021-06-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01409915,0,0,0,0,0,0,2020-05-01,2021-05-01,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT01411345,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Miami,Other,0,0,0,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,476
NCT01419704,0,0,0,0,0,0,2025-05-31,2026-05-31,,University of Louisville,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,214
NCT01428635,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01431313,1,1,0,1,0,1,2017-10-31,2018-10-31,2018-11-19,"Schmidhofer, Mark, MD",Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01436227,0,0,0,0,0,0,2021-04-30,2022-04-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01436357,1,1,0,1,0,0,2018-05-25,2019-05-25,2019-05-24,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,0,1,0,0,0,0,0,0,0,1,2133
NCT01436968,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Advantagene, Inc.",Industry,1,0,0,3.0,Phase 3,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,9
NCT01437449,1,0,0,0,1,0,2018-09-11,2019-09-11,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT01438476,1,0,0,0,1,0,2017-10-18,2018-10-18,,M.D. Anderson Cancer Center,Other,0,0,0,3.0,Phase 3,0,2012.0,1,0,0,0,0,0,0,0,0,0,1,2066
NCT01445821,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,0,0,3.0,Phase 3,0,2011.0,0,1,1,0,0,0,0,0,0,0,1,925
NCT01458405,0,0,0,0,0,0,2017-07-03,2018-07-03,,Capricor Inc.,Industry,1,0,1,0.0,Phase 1/Phase 2,1,2012.0,1,1,1,0,0,0,0,0,0,0,1,6
NCT01461928,1,1,0,1,0,0,2018-06-02,2019-06-02,2019-05-31,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,2,0,1,1731
NCT01484470,0,0,0,0,0,0,2018-11-21,2019-11-21,,Loyola University,Other,0,1,0,1.0,Phase 2,0,2010.0,1,0,1,0,0,0,0,0,0,0,1,102
NCT01495819,0,0,0,0,0,0,2019-06-30,2020-06-30,,Yale University,Other,0,0,0,5.0,,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT01508312,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01515527,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01522417,0,0,0,0,0,0,2018-12-31,2019-12-31,,Medicure,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT01522495,0,0,0,0,0,0,2019-12-31,2020-12-31,,Georgetown University,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,214
NCT01527045,0,0,0,0,0,0,2018-10-26,2019-10-26,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT01536743,0,0,0,0,0,0,2020-05-10,2021-05-10,,Jonsson Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,277
NCT01538056,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Washington,Other,0,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT01539291,1,1,0,1,0,0,2018-05-21,2019-05-21,2019-05-09,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,1,2012.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT01551030,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01553461,0,0,0,0,0,0,2036-10-20,2037-10-20,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT01578551,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-09-18,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,461
NCT01582061,1,1,0,1,0,0,2017-01-26,2018-01-26,2018-01-26,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01584024,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-22,University of Michigan,Other,0,1,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,934
NCT01609816,0,0,1,1,0,0,2019-05-31,2020-05-31,2019-04-10,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT01616160,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-03-20,Massachusetts General Hospital,Other,0,1,0,4.0,Phase 4,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01627067,0,0,0,0,0,0,2019-02-01,2020-02-01,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01636934,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01652235,0,0,0,0,0,0,2024-04-30,2025-04-30,,Cook Research Incorporated,Industry,1,0,0,5.0,,0,2008.0,0,0,0,1,0,0,0,0,0,0,1,20
NCT01656603,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York Blood Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,5
NCT01657682,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT01658995,0,0,0,0,0,0,2019-12-31,2020-12-31,,Petra M. Casey,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01665092,1,1,0,1,0,1,2018-03-31,2019-03-31,2019-04-23,University of Mississippi Medical Center,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,88
NCT01680965,0,0,0,0,0,0,2019-09-30,2020-09-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01681810,1,1,0,1,0,0,2018-02-08,2019-02-08,2019-02-01,"Gladwin, Mark, MD",Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT01682213,0,0,0,0,0,0,2019-05-31,2020-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01684904,0,0,0,0,0,0,2024-08-31,2025-08-31,,Loma Linda University,Other,0,0,0,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,194
NCT01685138,1,1,0,1,0,0,2018-01-22,2019-01-22,2019-01-22,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01693523,0,0,0,0,0,0,2018-09-19,2019-09-19,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01697293,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Prescient Therapeutics, Ltd.",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT01697709,1,1,0,1,0,1,2017-04-30,2018-04-30,2019-01-17,New York State Psychiatric Institute,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT01700673,0,0,0,0,0,0,2019-11-30,2020-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,461
NCT01702155,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Delta-Fly Pharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT01711970,1,0,0,0,1,0,2017-05-03,2018-05-03,,Vascular Biogenics Ltd. operating as VBL Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT01713946,1,1,0,1,0,0,2017-10-25,2018-10-25,2018-04-25,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01720836,0,0,0,0,0,0,2021-07-31,2022-07-31,,Olivera Finn,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT01724489,0,0,0,0,0,0,2018-11-30,2019-11-30,,Massachusetts General Hospital,Other,0,1,1,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01725165,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,0,0,0,0,1,0,0,1,0,1,2066
NCT01727089,1,1,0,1,0,0,2017-08-08,2018-08-08,2018-04-24,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,0,1,0,0,0,0,0,1,0,1,3004
NCT01730937,0,0,0,0,0,0,2020-06-30,2021-06-30,,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,1,0,0,1,0,1,156
NCT01734512,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT01739400,1,1,0,1,0,0,2018-01-12,2019-01-12,2019-01-09,Actelion,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,128
NCT01746836,0,0,0,0,0,0,2030-12-31,2031-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01753362,1,0,0,0,1,0,2017-12-31,2018-12-31,,University at Buffalo,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,65
NCT01757067,1,0,0,0,1,0,2017-05-17,2018-05-17,,"University of Maryland, College Park",Other,0,1,0,5.0,,1,2013.0,1,0,0,1,0,0,0,0,1,0,1,318
NCT01757535,0,0,0,0,0,0,2019-07-15,2020-07-15,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01776190,0,0,0,0,0,0,2022-09-30,2023-09-30,,Ben Chong,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT01776307,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Boston Biomedical, Inc",Industry,1,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT01781611,0,0,0,0,0,0,2019-02-28,2020-02-28,,Oklahoma Medical Research Foundation,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,11
NCT01782027,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Pennsylvania,Other,0,0,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT01785563,0,0,0,0,0,0,2018-12-31,2019-12-31,,Tarah T Colaizy,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT01790295,1,1,0,1,0,0,2017-10-26,2018-10-26,2018-10-08,John Mascarenhas,Other,0,1,1,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT01794520,0,0,0,0,0,0,2021-12-31,2022-12-31,,AbbVie,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT01796171,0,0,0,0,0,0,2020-12-31,2021-12-31,,Nordic Nanovector,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,4
NCT01800526,0,0,0,0,0,0,2018-12-31,2019-12-31,,Bloodworks,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT01808690,1,0,0,0,1,0,2017-12-31,2018-12-31,,"University of Colorado, Denver",Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT01809002,0,0,0,0,0,0,2021-08-31,2022-08-31,,Axogen Corporation,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,1,0,0,0,0,0,0,1,6
NCT01821729,1,0,1,1,0,1,2018-07-31,2019-07-31,2019-08-27,Massachusetts General Hospital,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,1,0,0,0,0,1,1699
NCT01827111,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01833208,1,0,0,0,1,0,2018-08-06,2019-08-06,,Roswell Park Cancer Institute,Other,0,1,1,5.0,,0,2013.0,1,0,0,0,0,1,0,0,0,0,1,294
NCT01838863,1,1,0,1,0,0,2017-04-03,2018-04-03,2018-03-22,Denver Health and Hospital Authority,Other,0,0,1,1.0,Phase 2,1,2014.0,1,1,1,0,0,0,0,0,0,0,1,66
NCT01842503,0,0,0,0,0,0,2018-11-30,2019-11-30,,Laboratorio Farmaceutico Ct S.r.l.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01850524,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT01853280,1,1,0,1,0,0,2017-02-28,2018-02-28,2017-06-19,Massachusetts General Hospital,Other,0,1,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01854775,0,0,0,0,0,0,2020-10-31,2021-10-31,,Gilead Sciences,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT01858688,1,0,0,0,1,0,2018-05-31,2019-05-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,647
NCT01858740,0,0,0,0,0,0,2021-10-26,2022-10-26,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,1,0,0,0,0,1,393
NCT01862640,0,0,0,0,0,0,2017-03-31,2018-03-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,185
NCT01871545,0,0,0,0,0,0,2020-01-14,2021-01-14,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,412
NCT01883817,1,0,0,0,1,0,2017-03-03,2018-03-03,,University of Cincinnati,Other,0,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,222
NCT01884311,1,1,0,1,0,0,2017-05-25,2018-05-25,2018-02-28,Bio Products Laboratory,Other,0,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,27
NCT01894061,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,1,1,1.0,Phase 2,0,2013.0,0,0,1,1,0,0,0,0,0,0,1,374
NCT01901809,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-04-18,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT01914393,0,0,0,0,0,0,2018-10-17,2019-10-17,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,134
NCT01920152,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2013.0,0,0,1,1,0,0,0,0,0,0,1,882
NCT01920711,0,0,0,0,0,0,2019-06-07,2020-06-07,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01931163,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Jenny C. Chang, MD",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT01936480,0,0,0,0,0,0,2019-09-30,2020-09-30,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01953120,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of California, Los Angeles",Other,0,1,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,692
NCT01961687,0,0,0,0,0,0,2020-03-31,2021-03-31,,C. R. Bard,Industry,1,1,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,77
NCT01967537,1,1,0,1,0,0,2017-12-17,2018-12-17,2018-11-19,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01970176,0,0,0,0,0,0,2019-06-30,2020-06-30,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01975519,0,0,0,0,0,0,2019-03-31,2020-03-31,,Tracon Pharmaceuticals Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT01977677,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-06-05,Lawrence Recht,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,1,0,0,0,0,1,3
NCT01983475,0,0,0,0,0,0,2020-05-31,2021-05-31,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,41
NCT01983683,1,1,0,1,0,0,2017-03-09,2018-03-09,2018-03-09,Actelion,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,128
NCT01987830,0,0,0,0,0,0,2019-04-30,2020-04-30,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1699
NCT01989598,0,0,0,0,0,0,2019-08-31,2020-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,2,0,1,3004
NCT01990768,1,1,0,1,0,0,2017-11-07,2018-11-07,2018-11-07,University of Washington,Other,0,1,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,910
NCT02005081,1,0,0,0,1,0,2017-10-31,2018-10-31,,Wayne State University,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,145
NCT02005445,1,1,0,1,0,1,2017-12-29,2018-12-29,2019-03-19,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT02008357,0,0,0,0,0,0,2022-07-22,2023-07-22,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02009644,1,0,0,0,1,0,2017-05-31,2018-05-31,,Bolton Medical,Industry,1,0,0,1.0,Phase 2,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,12
NCT02017171,0,0,0,0,0,0,2019-06-30,2020-06-30,,Alessandro Doria,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT02019446,0,0,0,0,0,0,2020-12-31,2021-12-31,,BCDiabetes.Ca,Other,0,1,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,2,1,0,4
NCT02019667,0,0,0,0,0,0,2019-01-31,2020-01-31,,National Institute of Neurological Disorders and Stroke (NINDS),NIH,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,560
NCT02022033,0,0,0,0,0,0,2019-06-30,2020-06-30,,howard safran,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02024607,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Boston Biomedical, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT02052141,1,1,0,1,0,0,2017-05-04,2018-05-04,2018-04-24,Shire,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,342
NCT02057939,1,1,0,1,0,0,2018-03-02,2019-03-02,2019-02-27,Duke University,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,1,0,0,0,0,1,1342
NCT02066298,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-03-28,Milton S. Hershey Medical Center,Other,0,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT02068794,0,0,0,0,0,0,2021-03-10,2022-03-10,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1898
NCT02089607,0,0,0,0,0,0,2025-03-31,2026-03-31,,Gustavo S. Oderich,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02099864,0,0,0,0,0,0,2019-08-31,2020-08-31,,OHSU Knight Cancer Institute,Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT02104739,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-20,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02111577,0,0,0,0,0,0,2019-12-16,2020-12-16,,Sotio a.s.,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,0,0,0,1,0,1,13
NCT02117024,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-04-26,Heat Biologics,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02117232,1,0,0,0,1,0,2017-12-31,2018-12-31,,Mercy Medical Center,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT02117349,0,0,0,0,0,0,2018-09-30,2019-09-30,,Mallinckrodt,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,91
NCT02117713,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Mirum Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02124512,0,1,0,1,0,0,2019-05-31,2020-05-31,2019-07-16,Philip Kern,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02126124,0,0,0,0,0,0,2018-12-31,2019-12-31,,Brainsway,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,16
NCT02128958,0,0,0,0,0,0,2019-03-31,2020-03-31,,Can-Fite BioPharma,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02129075,0,0,0,0,0,0,2020-02-02,2021-02-02,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02129803,0,0,0,0,0,0,2019-12-31,2020-12-31,,Virginia Commonwealth University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,417
NCT02130297,0,0,0,0,0,0,2019-03-19,2020-03-19,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,412
NCT02133573,0,0,0,0,0,0,2021-12-31,2022-12-31,,Children's Hospital of Philadelphia,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,324
NCT02135874,0,0,0,0,0,0,2019-10-30,2020-10-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02137096,1,1,0,1,0,1,2017-05-09,2018-05-09,2019-05-29,University of Florida,Other,0,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,849
NCT02138110,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-06,InVivo Therapeutics,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02144142,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,561
NCT02145247,1,1,0,1,0,1,2017-02-28,2018-02-28,2019-03-28,"University of California, San Diego",Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT02152137,0,0,0,0,0,0,2019-02-27,2020-02-27,,Alliance for Clinical Trials in Oncology,Other,0,1,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT02155738,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-28,"Halina M Zyczynski, MD",Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02164916,1,1,0,1,0,0,2017-11-13,2018-11-13,2017-07-13,Southwest Oncology Group,Other,0,1,1,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,288
NCT02175576,0,0,0,0,0,0,2026-10-31,2027-10-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,215
NCT02180672,0,0,0,0,0,0,2019-12-31,2020-12-31,,Children's Hospital of Philadelphia,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,324
NCT02180867,0,0,0,0,0,0,2019-06-30,2020-06-30,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,1,0,0,1,0,1,3004
NCT02185014,1,1,0,1,0,0,2017-11-03,2018-11-03,2018-10-15,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,3,0,1,430
NCT02186847,0,0,0,0,0,0,2019-04-16,2020-04-16,,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,1,0,1,27
NCT02191618,0,0,0,0,0,0,2017-09-30,2018-09-30,,"Sequent Medical, Inc",Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,5
NCT02199041,1,1,0,1,0,0,2017-05-23,2018-05-23,2017-08-01,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,1,1,0,1,0,0,0,0,1,302
NCT02210559,0,0,0,0,0,0,2019-12-31,2020-12-31,,FibroGen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT02213107,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,470
NCT02217527,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-06-18,"Chengappa, K.N. Roy, MD",Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02218372,1,1,0,1,0,0,2018-03-07,2019-03-07,2018-10-23,Astellas Pharma Europe B.V.,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,93
NCT02225366,0,0,0,0,0,0,2020-07-31,2021-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02230527,0,0,0,0,0,0,2019-10-31,2020-10-31,,The Cleveland Clinic,Other,0,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02236000,0,0,0,0,0,0,2019-10-31,2020-10-31,,NSABP Foundation Inc,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,63
NCT02239354,0,0,0,0,0,0,2021-01-31,2022-01-31,,ViaCyte,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT02240680,1,1,0,1,0,0,2017-04-18,2018-04-18,2018-04-17,Boehringer Ingelheim,Industry,1,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02246751,0,0,0,0,0,0,2019-05-31,2020-05-31,,University of Hartford,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02247843,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Donald B. Kohn, M.D.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT02249429,0,0,0,0,0,0,2018-09-11,2019-09-11,,PIQUR Therapeutics AG,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,9
NCT02251548,0,0,0,0,0,0,2019-01-31,2020-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02253810,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Hospital for Special Surgery, New York",Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,157
NCT02255656,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Genzyme, a Sanofi Company",Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02256696,0,0,0,0,0,0,2020-09-30,2021-09-30,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,1143
NCT02257424,0,0,0,0,0,0,2024-10-31,2025-10-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT02258230,1,0,0,0,1,0,2018-03-31,2019-03-31,,Olympus Corporation of the Americas,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02262806,0,0,0,0,0,0,2025-07-21,2026-07-21,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT02263859,0,0,0,0,0,0,2019-06-30,2020-06-30,,"ImThera Medical, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,3
NCT02264236,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Arkansas,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,285
NCT02272413,0,0,0,0,0,0,2017-06-30,2018-06-30,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02276547,0,0,0,0,0,0,2020-02-29,2021-02-28,,Neovasc Inc.,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,5
NCT02277782,0,0,0,0,0,0,2019-12-31,2020-12-31,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT02279745,0,0,0,0,0,0,2019-09-30,2020-09-30,,United Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,72
NCT02281760,1,0,0,0,1,0,2018-08-29,2019-08-29,,National Human Genome Research Institute (NHGRI),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,191
NCT02291432,0,0,0,0,0,0,2019-06-28,2020-06-28,,Cook MyoSite,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,9
NCT02292758,0,0,0,0,0,0,2019-03-20,2020-03-20,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,32
NCT02295475,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Scott C. Woller, MD",Other,0,1,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02296892,0,1,0,1,0,1,2017-03-31,2018-03-31,2019-02-12,Paion UK Ltd.,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02301611,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Cancer Insight, LLC",Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02304705,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-11-20,Maya Guglin,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02306265,1,1,0,1,0,1,2017-07-07,2018-07-07,2018-10-09,GE Healthcare,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,119
NCT02309515,0,0,0,0,0,0,2020-07-10,2021-07-10,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,1898
NCT02315703,0,0,0,0,0,0,2017-08-29,2018-08-29,,Janssen Vaccines & Prevention B.V.,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,1,0,1,29
NCT02315872,1,1,0,1,0,1,2017-06-20,2018-06-20,2019-01-14,Providence Health & Services,Other,0,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,55
NCT02316340,0,0,0,0,0,0,2019-09-30,2020-09-30,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02318602,1,1,0,1,0,1,2017-06-22,2018-06-22,2018-06-26,INSYS Therapeutics Inc,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02321319,0,0,0,0,0,0,2019-01-31,2020-01-31,,Mallinckrodt,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,91
NCT02321540,0,0,0,0,0,0,2020-03-31,2021-03-31,,M.D. Anderson Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02323321,0,0,0,0,0,0,2019-12-31,2020-12-31,,TransMedics,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,11
NCT02324387,0,0,0,0,0,0,2020-03-31,2021-03-31,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02324465,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-05-22,Vanderbilt University,Other,0,0,0,5.0,,1,2013.0,1,0,0,1,0,0,0,0,0,0,1,499
NCT02331251,1,0,0,0,1,0,2018-01-31,2019-01-31,,Western Regional Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT02339376,0,0,0,0,0,0,2020-01-31,2021-01-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,377
NCT02346253,0,0,0,0,0,0,2020-02-29,2021-02-28,,Stanford University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,1309
NCT02348216,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Kite, A Gilead Company",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,14
NCT02348593,0,1,0,1,0,1,2017-02-28,2018-02-28,2019-04-19,Jazz Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,55
NCT02363738,1,0,0,0,1,0,2018-04-30,2019-04-30,,"University Health Network, Toronto",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,931
NCT02365285,1,1,0,1,0,1,2017-10-05,2018-10-05,2019-01-16,Vanderbilt University Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,422
NCT02365636,0,1,0,1,0,1,2017-05-09,2018-05-09,2018-09-22,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,101
NCT02367859,0,0,0,0,0,0,2019-10-31,2020-10-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT02369458,0,0,0,0,0,0,2020-06-30,2021-06-30,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02369653,0,0,0,0,0,0,2021-04-15,2022-04-15,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02371668,0,0,0,0,0,0,2018-11-30,2019-11-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2133
NCT02376361,0,0,0,0,0,0,2019-07-31,2020-07-31,,Albany Medical College,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,51
NCT02382848,1,1,0,1,0,0,2018-03-09,2019-03-09,2019-03-08,Milton S. Hershey Medical Center,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT02387216,0,0,0,0,0,0,2018-12-31,2019-12-31,,Merrimack Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT02387905,0,0,0,0,0,0,2020-03-31,2021-03-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT02390284,0,0,0,0,0,0,2024-07-31,2025-07-31,,University of Miami,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,476
NCT02390661,1,0,0,0,1,0,2017-08-31,2018-08-31,,Michigan State University,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,70
NCT02396849,0,0,0,0,0,0,2020-01-31,2021-01-31,,Indiana University,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,497
NCT02397057,1,0,0,0,1,0,2018-04-18,2019-04-18,,"American Regent, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT02399137,1,0,0,0,1,0,2018-08-31,2019-08-31,,Merrimack Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT02401048,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-11-16,Pharmacyclics LLC.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT02403778,1,1,0,1,0,0,2018-08-31,2019-08-31,2018-12-21,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT02407041,0,0,0,0,0,0,2018-03-31,2019-03-31,,Galectin Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02409732,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-06-28,Dartmouth-Hitchcock Medical Center,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,306
NCT02414139,0,0,0,0,0,0,2021-05-10,2022-05-10,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02418871,0,0,0,0,0,0,2018-09-05,2019-09-05,,PowerVision,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,2,0,1,2
NCT02420353,0,0,0,0,0,0,2018-10-31,2019-10-31,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT02420691,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02421419,1,1,0,1,0,0,2017-01-25,2018-01-25,2017-07-10,"Kenneth Taylor, M.D.",Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02422498,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT02422615,1,1,0,1,0,0,2017-11-03,2018-11-03,2018-08-18,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02427620,0,0,0,0,0,0,2021-06-30,2022-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02428595,1,0,1,1,0,1,2017-07-31,2018-07-31,2019-05-09,"Pelvalon, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02432170,1,0,1,1,0,1,2017-04-30,2018-04-30,2019-04-16,University of Washington,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02432209,0,0,0,0,0,0,2019-12-28,2020-12-28,,Yale University,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02433483,1,1,0,1,0,0,2017-05-08,2018-05-08,2017-09-05,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,1,0,0,0,0,0,0,0,1,302
NCT02435381,0,0,0,0,0,0,2018-12-31,2019-12-31,,Baylor College of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT02435901,0,0,0,0,0,0,2019-01-31,2020-01-31,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2008.0,0,1,1,0,0,0,0,0,0,0,1,271
NCT02436239,1,1,0,1,0,0,2018-07-23,2019-07-23,2019-07-23,Forest Laboratories,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,169
NCT02437136,0,0,0,0,0,0,2019-08-31,2020-08-31,,Syndax Pharmaceuticals,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02437383,1,1,0,1,0,0,2018-04-04,2019-04-04,2019-04-04,"University of North Carolina, Chapel Hill",Other,0,1,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02438904,0,0,0,0,0,0,2021-05-31,2022-05-31,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02439450,0,0,0,0,0,0,2019-12-31,2020-12-31,,Heat Biologics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,4
NCT02440464,0,0,0,0,0,0,2021-03-31,2022-03-31,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT02445586,0,0,0,0,0,0,2018-09-26,2019-09-26,,Hoffmann-La Roche,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1731
NCT02451982,0,0,0,0,0,0,2022-06-30,2023-06-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,461
NCT02452476,0,0,0,0,0,0,2018-05-24,2019-05-24,,Chiesi Farmaceutici S.p.A.,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,130
NCT02453256,1,1,0,1,0,1,2018-01-15,2019-01-15,2019-02-06,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02466386,0,0,0,0,0,0,2020-01-03,2021-01-03,,Shire,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,342
NCT02466685,0,0,0,0,0,0,2019-07-31,2020-07-31,,Herbert Meltzer,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02467270,0,0,0,0,0,0,2020-05-13,2021-05-13,,Ariad Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02470091,0,0,0,0,0,0,2019-12-31,2020-12-31,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,389
NCT02473536,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,626
NCT02473965,0,0,0,0,0,0,2019-02-28,2020-02-28,,Grifols Therapeutics LLC,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,40
NCT02474667,0,0,0,0,0,0,2020-04-30,2021-04-30,,Angion Biomedica Corp,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT02475733,1,1,0,1,0,1,2017-06-01,2018-06-01,2018-07-12,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02477826,0,0,0,0,0,0,2020-11-08,2021-11-08,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02483429,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT02485652,0,0,0,0,0,0,2018-10-31,2019-10-31,,Hanmi Pharmaceutical Company Limited,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,123
NCT02485938,0,0,0,0,0,0,2017-09-30,2018-09-30,,Capricor Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02487225,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-09-25,Mayo Clinic,Other,0,0,1,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02487797,0,0,0,0,0,0,2020-09-30,2021-09-30,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02489019,0,0,0,0,0,0,2020-07-31,2021-07-31,,Loyola University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT02492334,0,0,0,0,0,0,2019-09-30,2020-09-30,,Medical University of South Carolina,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,511
NCT02496884,0,0,0,0,0,0,2017-07-06,2018-07-06,,"Daiichi Sankyo, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,207
NCT02497469,0,0,0,0,0,0,2018-09-26,2019-09-26,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT02501538,0,0,0,0,0,0,2019-01-10,2020-01-10,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,626
NCT02502786,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,1432
NCT02504216,0,0,0,0,0,0,2019-11-22,2020-11-22,,Bayer,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02506465,0,0,0,0,0,0,2018-10-31,2019-10-31,,Medi-Tate Ltd.,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,6
NCT02512692,0,0,0,0,0,0,2020-08-31,2021-08-31,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,511
NCT02513485,0,0,0,0,0,0,2020-06-30,2021-06-30,,Emory University,Other,0,0,1,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02516670,0,0,0,0,0,0,2024-01-31,2025-01-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02517619,1,0,0,0,1,0,2018-04-20,2019-04-20,,"Eyegate Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,13
NCT02518685,0,1,0,1,0,1,2017-12-31,2018-12-31,2019-04-20,"BaroNova, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02519777,0,0,0,0,0,0,2019-12-30,2020-12-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT02520063,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Alabama at Birmingham,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02522780,0,0,0,0,0,0,2018-09-19,2019-09-19,,Ferring Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,208
NCT02523235,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-05-30,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT02527343,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Ionis Pharmaceuticals, Inc.",Industry,1,1,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,69
NCT02530515,1,0,1,1,0,1,2018-04-30,2019-04-30,2019-07-31,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2066
NCT02541955,0,0,0,0,0,0,2021-06-30,2022-06-30,,Dr. Veena Ranganath,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02549820,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Holly L Hedrick, MD",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02551679,0,0,0,0,0,0,2020-12-31,2021-12-31,,Hemostemix,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,2
NCT02551991,0,0,0,0,0,0,2019-02-28,2020-02-28,,Ipsen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,214
NCT02553265,0,0,0,0,0,0,2019-05-10,2020-05-10,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02555150,1,0,0,0,1,0,2017-01-31,2018-01-31,,"Rhodes Pharmaceuticals, L.P.",Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02557100,0,0,0,0,0,0,2019-03-28,2020-03-28,,Bristol-Myers Squibb,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02557672,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,1898
NCT02558010,0,0,0,0,0,0,2020-04-01,2021-04-01,,Medical College of Wisconsin,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,315
NCT02558491,1,0,0,0,1,0,2017-02-28,2018-02-28,,University of Virginia,Other,0,0,1,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,402
NCT02562898,0,0,0,0,0,0,2018-12-31,2019-12-31,,Margaret Tempero,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02569710,1,1,0,1,0,0,2018-05-11,2019-05-11,2019-05-09,Alios Biopharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,21
NCT02576301,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mateon Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,13
NCT02576990,0,0,0,0,0,0,2019-06-29,2020-06-29,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,3,0,1,2145
NCT02577146,1,1,0,1,0,0,2018-05-07,2019-05-07,2019-05-07,Washington University School of Medicine,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1151
NCT02577822,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-07-30,Northwestern University,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,925
NCT02579876,1,1,0,1,0,1,2017-12-20,2018-12-20,2019-03-27,Children's Hospital of Philadelphia,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,324
NCT02581631,0,0,0,0,0,0,2020-03-01,2021-03-01,,Bristol-Myers Squibb,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02581904,1,0,0,0,1,0,2017-12-31,2018-12-31,,Thomas Jefferson University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,186
NCT02581995,1,1,0,1,0,0,2017-08-09,2018-08-09,2018-07-26,Bayer,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1343
NCT02584660,1,1,0,1,0,0,2017-03-22,2018-03-22,2018-03-21,"Janssen Scientific Affairs, LLC",Industry,1,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02587520,0,0,0,0,0,0,2017-02-22,2018-02-22,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,285
NCT02588027,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02590640,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,882
NCT02596711,1,0,1,1,0,0,2017-08-22,2018-08-22,2018-05-14,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02597127,1,1,0,1,0,1,2017-06-07,2018-06-07,2019-02-04,The Medicines Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,59
NCT02598349,0,0,0,0,0,0,2039-10-31,2040-10-31,,Proton Collaborative Group,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,9
NCT02598661,0,0,0,0,0,0,2022-08-15,2023-08-15,,Geron Corporation,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,13
NCT02599324,0,0,0,0,0,0,2021-05-31,2022-05-31,,Pharmacyclics LLC.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,54
NCT02600507,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Intra-Cellular Therapies, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02600871,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-01-22,The University of Texas Health Science Center at San Antonio,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02605616,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Virginia,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,402
NCT02606604,1,0,1,1,0,1,2017-07-31,2018-07-31,2018-09-26,Stony Brook University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,119
NCT02607618,1,1,0,1,0,0,2017-08-08,2018-08-08,2018-06-14,Motif Bio,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02612155,0,0,0,0,0,0,2019-09-30,2020-09-30,,Michael Cotten,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT02612558,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rigel Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT02614794,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Seattle Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,77
NCT02615873,0,0,0,0,0,0,2019-12-31,2020-12-31,,Intec Pharma Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02620020,0,1,0,1,0,1,2017-02-03,2018-02-03,2019-05-11,Regeneron Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,176
NCT02621021,0,0,0,0,0,0,2025-06-16,2026-06-16,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02623972,0,0,0,0,0,0,2021-12-31,2022-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02624180,0,0,0,0,0,0,2020-08-31,2021-08-31,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02627742,1,0,0,0,1,0,2017-08-31,2018-08-31,,Hill-Rom,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,22
NCT02628067,0,0,0,0,0,0,2023-08-28,2024-08-28,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,2145
NCT02628626,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mayo Clinic,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02633111,0,0,0,0,0,0,2019-10-31,2020-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT02634346,1,1,0,1,0,0,2017-05-25,2018-05-25,2018-05-25,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,70
NCT02635035,0,0,0,0,0,0,2018-12-31,2019-12-31,,NYU Langone Health,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02636946,0,0,0,0,0,0,2019-11-26,2020-11-26,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,495
NCT02637960,0,0,0,0,0,0,2017-07-31,2018-07-31,,Vantia Ltd,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02638298,0,0,0,0,0,0,2020-12-31,2021-12-31,,Medical University of South Carolina,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,511
NCT02638805,0,0,0,0,0,0,2017-10-31,2018-10-31,,Intarcia Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02640235,0,0,0,0,0,0,2017-07-21,2018-07-21,,Baxter Healthcare Corporation,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,101
NCT02642913,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02647320,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-26,"Daiichi Sankyo, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,207
NCT02649946,0,1,0,1,0,0,2018-08-31,2019-08-31,2019-03-15,C. R. Bard,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,77
NCT02652195,0,0,0,0,0,0,2022-06-30,2023-06-30,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,578
NCT02654587,0,0,0,0,0,0,2021-12-31,2022-12-31,,OSE Immunotherapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,4
NCT02656394,1,0,0,0,1,0,2017-12-04,2018-12-04,,"Glia, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02657031,1,1,0,1,0,0,2017-03-21,2018-03-21,2017-10-25,University Medical Center of Southern Nevada,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02658084,0,1,0,1,0,0,2018-10-11,2019-10-11,2019-03-18,University of Miami,Other,0,1,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,476
NCT02659215,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Anika Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,9
NCT02661035,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,218
NCT02661217,0,0,1,1,0,1,2018-02-20,2019-02-20,2019-06-20,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,1895
NCT02662036,1,1,0,1,0,0,2018-02-26,2019-02-26,2019-01-16,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02662985,0,0,0,0,0,0,2020-11-23,2021-11-23,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02666105,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,218
NCT02670330,1,1,0,1,0,0,2018-09-03,2019-09-03,2019-07-10,"Scioderm, Inc.",Industry,1,1,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT02672111,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-08-03,Braeburn Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02673398,0,0,0,0,0,0,2019-10-22,2020-10-22,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT02674204,1,1,0,1,0,0,2018-05-25,2019-05-25,2019-03-25,Cedars-Sinai Medical Center,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,279
NCT02674854,0,1,0,1,0,1,2017-03-31,2018-03-31,2019-04-11,Aerie Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,28
NCT02677051,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Rutgers, The State University of New Jersey",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,227
NCT02680288,0,0,0,0,0,0,2018-09-30,2019-09-30,,Midwest Biomedical Research Foundation,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,22
NCT02681042,0,0,0,0,0,0,2019-03-31,2020-03-31,,Baylor Research Institute,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,131
NCT02683772,0,1,0,1,0,1,2017-03-01,2018-03-01,2018-03-21,ResMed,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,60
NCT02684162,0,0,0,0,0,0,2021-06-30,2022-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02684292,0,0,0,0,0,0,2023-12-30,2024-12-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,3,0,1,2145
NCT02689284,0,0,0,0,0,0,2020-09-30,2021-09-30,,MacroGenics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,31
NCT02693743,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Arkansas,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,285
NCT02693990,0,0,0,0,0,0,2020-02-29,2021-02-28,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,1699
NCT02696512,1,0,0,0,1,0,2017-03-31,2018-03-31,,International Brain Research Foundation,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,1
NCT02697227,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02699086,0,0,0,0,0,0,2020-03-31,2021-03-31,,"BioLite, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT02699346,1,0,0,0,1,0,2017-06-30,2018-06-30,,HeadSense Medical,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT02700451,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Hospital for Special Surgery, New York",Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,157
NCT02701283,0,0,0,0,0,0,2021-04-30,2022-04-30,,Medtronic Cardiovascular,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,34
NCT02703207,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT02704754,0,0,0,0,0,0,2019-03-31,2020-03-31,,Howard University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02706171,0,0,0,0,0,0,2018-12-31,2019-12-31,,The Cooper Health System,Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,37
NCT02706691,0,1,0,1,0,0,2019-02-11,2020-02-11,2019-03-18,University of Chicago,Other,0,1,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,594
NCT02706951,0,0,0,0,0,0,2017-10-02,2018-10-02,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02709018,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Diego",Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02709486,1,1,0,1,0,0,2018-06-08,2019-06-08,2019-06-06,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,2856
NCT02717611,0,0,0,0,0,0,2020-02-29,2021-02-28,,Acerta Pharma BV,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02718417,0,0,1,1,0,0,2018-09-30,2019-09-30,2019-09-06,Pfizer,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02720510,1,1,0,1,0,0,2017-05-22,2018-05-22,2018-05-18,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02721069,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Neurelis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02722044,0,1,0,1,0,1,2017-02-21,2018-02-21,2018-03-29,"Momenta Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,1,0,0,0,0,0,0,1,12
NCT02724579,0,0,0,0,0,0,2025-05-31,2026-05-31,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,1,1,0,389
NCT02727751,1,0,0,0,1,0,2017-10-31,2018-10-31,,Ardelyx,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,22
NCT02727998,0,0,0,0,0,0,2020-12-31,2021-12-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02728102,0,0,0,0,0,0,2020-08-31,2021-08-31,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,1091
NCT02730962,1,0,1,1,0,1,2018-01-31,2019-01-31,2019-06-28,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02731326,0,0,0,0,0,0,2019-09-30,2020-09-30,,Columbia University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,675
NCT02734667,0,0,0,0,0,0,2020-03-31,2021-03-31,,Korey Hood,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02734849,0,0,0,0,0,0,2018-01-31,2019-01-31,,"Allakos, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02736344,0,0,0,0,0,0,2021-08-31,2022-08-31,,Medinol Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,11
NCT02736578,1,1,0,1,0,1,2017-04-24,2018-04-24,2018-12-06,Eben Rosenthal,Other,0,0,1,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02738775,1,0,0,0,1,0,2018-08-31,2019-08-31,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,27
NCT02740660,1,0,1,1,0,1,2017-10-24,2018-10-24,2019-09-02,Pennington Biomedical Research Center,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,179
NCT02741323,0,0,0,0,0,0,2021-04-30,2022-04-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,2133
NCT02744430,0,0,0,0,0,0,2019-07-31,2020-07-31,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,518
NCT02744898,1,0,1,1,0,1,2018-03-15,2019-03-15,2019-08-09,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02747420,0,0,0,0,0,0,2020-03-31,2021-03-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT02748070,0,0,0,0,0,0,2019-01-31,2020-01-31,,Stanford University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02749968,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Cincinnati,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,222
NCT02764801,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,1,3.0,Phase 3,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,162
NCT02765282,0,0,0,0,0,0,2020-06-30,2021-06-30,,Great Lakes NeuroTechnologies Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,16
NCT02768363,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Advantagene, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,9
NCT02768662,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Otonomy, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02770170,0,0,0,0,0,0,2019-12-25,2020-12-25,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT02770768,0,0,0,0,0,0,2019-06-01,2020-06-01,,University of Chicago,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02775162,0,0,0,0,0,0,2019-12-31,2020-12-31,,OrganOx Ltd.,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02779855,0,0,0,0,0,0,2021-08-31,2022-08-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,344
NCT02781584,0,0,0,0,0,0,2019-08-31,2020-08-31,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02782403,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT02782741,0,0,0,0,0,0,2020-03-31,2021-03-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT02784613,1,1,0,1,0,1,2017-02-07,2018-02-07,2018-04-20,Sue Goldstein,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02785029,0,0,0,0,0,0,2019-12-31,2020-12-31,,Heidelberg Engineering GmbH,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,10
NCT02785952,0,0,0,0,0,0,2022-04-01,2023-04-01,,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,288
NCT02792322,0,0,0,0,0,0,2020-05-31,2021-05-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02793128,0,0,0,0,0,0,2019-04-05,2020-04-05,,UroGen Pharma Ltd.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT02793492,0,0,0,0,0,0,2020-10-31,2021-10-31,,Terumo Medical Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,5
NCT02796261,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Orbus Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT02799823,1,0,0,0,1,0,2018-04-14,2019-04-14,,HLT Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT02804087,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Vascular Dynamics, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,5
NCT02804750,0,0,1,1,0,0,2018-09-30,2019-09-30,2019-09-05,Corcept Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,40
NCT02805179,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,213
NCT02805790,1,0,0,0,1,0,2017-03-10,2018-03-10,,Stealth BioTherapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT02807181,0,0,0,0,0,0,2021-06-30,2022-06-30,,Sirtex Medical,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,1,0,0,0,0,1,1,0,6
NCT02809053,0,0,0,0,0,0,2020-02-29,2021-02-28,,Archigen Biotech Limited,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2
NCT02814019,0,0,0,0,0,0,2021-08-31,2022-08-31,,Santhera Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT02815280,0,0,0,0,0,0,2017-10-13,2018-10-13,,Foamix Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,16
NCT02816736,0,0,0,0,0,0,2020-08-31,2021-08-31,,Duke University,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT02824198,0,1,0,1,0,1,2017-03-18,2018-03-18,2019-05-24,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,2,0,1,285
NCT02827877,0,0,0,0,0,0,2020-02-29,2021-02-28,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,1,0,0,0,0,1,358
NCT02828358,0,0,0,0,0,0,2021-06-30,2022-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3004
NCT02830893,1,0,0,0,1,0,2018-08-20,2019-08-20,,"University of California, Irvine",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,310
NCT02834013,0,0,0,0,0,0,2020-08-31,2021-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT02844751,0,0,0,0,0,0,2019-07-31,2020-07-31,,"VivaTech International, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3
NCT02849548,0,0,0,0,0,0,2020-12-31,2021-12-31,,Howard University,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT02851173,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Texas at Austin,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,135
NCT02855268,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,300
NCT02856555,0,0,0,0,0,0,2017-07-18,2018-07-18,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,510
NCT02856893,0,0,0,0,0,0,2022-02-28,2023-02-28,,European Organisation for Research and Treatment of Cancer - EORTC,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,320
NCT02863068,0,0,0,0,0,0,2021-12-30,2022-12-30,,Montefiore Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT02865499,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-10-19,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,257
NCT02865928,0,0,0,0,0,0,2019-12-01,2020-12-01,,Northwell Health,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,271
NCT02866279,0,0,0,0,0,0,2019-10-31,2020-10-31,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,240
NCT02867358,0,0,0,0,0,0,2019-08-31,2020-08-31,,Yiling Pharmaceutical Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02869295,0,0,0,0,0,0,2018-10-31,2019-10-31,,Nektar Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02870101,1,1,0,1,0,1,2018-03-12,2019-03-12,2019-04-04,Duke University,Other,0,0,1,5.0,,0,2017.0,1,0,0,0,1,0,0,0,0,1,0,1342
NCT02873286,0,0,0,0,0,0,2018-12-31,2019-12-31,,Bavarian Nordic,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,33
NCT02878603,0,0,0,0,0,0,2020-10-31,2021-10-31,,Ablynx,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,26
NCT02879305,0,0,0,0,0,0,2020-04-14,2021-04-14,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3276
NCT02881775,1,1,0,1,0,0,2018-06-26,2019-06-26,2019-05-02,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02882633,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-04-15,University of Pennsylvania,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02888080,0,0,0,0,0,0,2019-03-04,2020-03-04,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02892591,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of Colorado, Denver",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT02892799,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Intermountain Health Care, Inc.",Other,0,0,0,5.0,,0,2015.0,0,0,0,0,0,0,0,0,0,0,1,93
NCT02896127,0,0,0,0,0,0,2018-05-14,2019-05-14,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,1895
NCT02898116,1,1,0,1,0,0,2017-08-04,2018-08-04,2018-07-26,Ludwig Institute for Cancer Research,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,46
NCT02899689,1,0,1,1,0,0,2018-02-28,2019-02-28,2019-02-26,"The University of Texas Medical Branch, Galveston",Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,158
NCT02900651,0,0,0,0,0,0,2019-08-05,2020-08-05,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02903121,0,0,0,0,0,0,2019-06-05,2020-06-05,,Oregon Health and Science University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,475
NCT02903394,1,1,0,1,0,0,2017-10-24,2018-10-24,2018-10-17,Duke University,Other,0,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1342
NCT02904915,1,1,0,1,0,0,2017-10-09,2018-10-09,2018-10-09,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,0,0,1,490
NCT02906020,0,0,0,0,0,0,2021-10-31,2022-10-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,300
NCT02910531,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT02914275,0,1,0,1,0,1,2017-03-09,2018-03-09,2018-09-17,Seqirus,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,41
NCT02918149,0,0,0,0,0,0,2020-06-30,2021-06-30,,Children's Hospital of Philadelphia,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,324
NCT02918357,1,0,0,0,1,0,2017-10-31,2018-10-31,,"University of California, San Francisco",Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02918864,0,0,0,0,0,0,2020-04-30,2021-04-30,,Rush University Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,227
NCT02919917,0,0,0,0,0,0,2021-09-30,2022-09-30,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,41
NCT02921061,0,0,0,0,0,0,2023-06-07,2024-06-07,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,393
NCT02921386,1,1,0,1,0,1,2017-01-21,2018-01-21,2018-03-05,"Clarus Therapeutics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02923778,0,0,0,0,0,0,2020-12-01,2021-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,1,0,0,0,1,0,3004
NCT02924376,0,0,0,0,0,0,2019-12-31,2020-12-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT02925117,0,0,0,0,0,0,2017-08-10,2018-08-10,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02926027,0,0,0,0,0,0,2019-09-30,2020-09-30,,Los Angeles Biomedical Research Institute,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,60
NCT02926573,1,1,0,1,0,0,2017-06-21,2018-06-21,2018-06-14,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02927405,1,0,0,0,1,0,2017-12-31,2018-12-31,,State University of New York - Downstate Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT02930941,0,0,0,0,0,0,2019-10-21,2020-10-21,,"University of California, Davis",Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,530
NCT02932007,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of South Florida,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT02932280,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1432
NCT02932579,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Rochester,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT02935894,1,1,0,1,0,0,2017-06-08,2018-06-08,2017-06-23,"USDA, Western Human Nutrition Research Center",U.S. Fed,2,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,45
NCT02939287,0,0,0,0,0,0,2020-11-30,2021-11-30,,Rush University Medical Center,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,227
NCT02942017,0,1,0,1,0,1,2017-09-17,2018-09-17,2019-04-11,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02947750,0,0,0,0,0,0,2021-11-30,2022-11-30,,Emory University,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02953639,0,0,0,0,0,0,2019-12-14,2020-12-14,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1731
NCT02954133,0,0,0,0,0,0,2019-04-30,2020-04-30,,Biolux Research Ltd.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT02954991,0,0,0,0,0,0,2020-11-30,2021-11-30,,Mirati Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT02955329,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of California, San Francisco",Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1443
NCT02956278,0,0,1,1,0,0,2019-12-31,2020-12-31,2019-05-27,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02956382,0,0,0,0,0,0,2019-11-30,2020-11-30,,Georgetown University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT02961764,0,0,0,0,0,0,2019-03-27,2020-03-27,,Allergan,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02963935,1,1,0,1,0,0,2018-05-23,2019-05-23,2019-05-21,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,981
NCT02967458,1,1,0,1,0,0,2018-02-01,2019-02-01,2018-11-20,Thomas Jefferson University,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,186
NCT02968004,0,0,0,0,0,0,2019-09-30,2020-09-30,,Opko Biologics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,11
NCT02969018,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-02-13,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02972502,1,1,0,1,0,1,2017-04-24,2018-04-24,2018-08-20,OhioHealth,Other,0,0,0,4.0,Phase 4,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02972970,1,0,0,0,1,0,2017-05-16,2018-05-16,,Metamason,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02977715,0,0,0,0,0,0,2020-02-29,2021-02-28,,Centers for Disease Control and Prevention,U.S. Fed,2,1,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,267
NCT02980133,0,0,0,0,0,0,2019-04-07,2020-04-07,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02981069,0,0,0,0,0,0,2020-03-31,2021-03-31,,The University of Texas Health Science Center at San Antonio,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,257
NCT02981472,0,0,0,0,0,0,2021-09-30,2022-09-30,,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02985515,0,0,0,0,0,0,2019-02-28,2020-02-28,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2016.0,0,0,0,0,0,0,1,0,0,0,1,1151
NCT02986139,1,1,0,1,0,0,2017-09-08,2018-09-08,2018-08-20,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,685
NCT02989194,1,0,0,0,1,0,2017-11-30,2018-11-30,,"Visterra, Inc.",Industry,1,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02989714,0,0,0,0,0,0,2019-02-25,2020-02-25,,University of Michigan Rogel Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT02991456,0,0,0,0,0,0,2021-03-15,2022-03-15,,Duke University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT02992041,1,0,0,0,1,0,2018-04-30,2019-04-30,,"Vivozon, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02996448,1,0,0,0,1,0,2018-07-22,2019-07-22,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT02997228,0,0,0,0,0,0,2022-04-30,2023-04-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03000452,1,1,0,1,0,0,2017-09-18,2018-09-18,2018-09-18,Celgene,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,306
NCT03006848,0,0,0,0,0,0,2021-05-31,2022-05-31,,St. Jude Children's Research Hospital,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,302
NCT03008408,0,0,0,0,0,0,2022-08-31,2023-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03009981,0,0,0,0,0,0,2023-01-31,2024-01-31,,"Alliance Foundation Trials, LLC.",Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03011034,0,0,0,0,0,0,2019-01-23,2020-01-23,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03012815,0,0,0,0,0,0,2021-02-01,2022-02-01,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03013985,0,0,0,0,0,0,2019-03-22,2020-03-22,,Emory University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,947
NCT03018730,0,0,0,0,0,0,2019-06-30,2020-06-30,,Protalix,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,17
NCT03019406,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,300
NCT03020719,0,0,0,0,0,0,2018-12-12,2019-12-12,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,749
NCT03021187,0,0,0,0,0,0,2018-01-18,2019-01-18,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,981
NCT03024996,0,0,0,0,0,0,2022-05-24,2023-05-24,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT03027934,1,0,0,0,1,0,2017-10-31,2018-10-31,,"CirQuest Labs, LLC",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,3
NCT03029208,0,0,0,0,0,0,2020-10-08,2021-10-08,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03029884,0,0,0,0,0,0,2024-06-30,2025-06-30,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03031678,0,0,0,0,0,0,2019-12-31,2020-12-31,,Med-El Corporation,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,8
NCT03032263,1,1,0,1,0,0,2017-08-07,2018-08-07,2018-06-14,Wake Forest University Health Sciences,Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,616
NCT03033303,0,0,0,0,0,0,2022-06-30,2023-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,1432
NCT03033914,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03034954,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-05-18,University of Michigan,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,934
NCT03036319,0,0,0,0,0,0,2026-04-30,2027-04-30,,University of Michigan,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT03036930,0,0,0,0,0,0,2020-11-01,2021-11-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03038438,0,0,0,0,0,0,2020-01-31,2021-01-31,,Medtronic Endovascular,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,64
NCT03040024,0,0,0,0,0,0,2020-03-31,2021-03-31,,Emory University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,947
NCT03040778,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Washington,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03041324,0,0,0,0,0,0,2021-02-28,2022-02-28,,Sangamo Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,18
NCT03042104,0,0,0,0,0,0,2021-12-31,2022-12-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,77
NCT03043365,0,0,0,0,0,0,2019-05-29,2020-05-29,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1091
NCT03044106,1,1,0,1,0,1,2017-07-31,2018-07-31,2018-10-03,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03044574,0,0,0,0,0,0,2018-09-30,2019-09-30,,Pirogov Russian National Research Medical University,Other,0,1,0,5.0,,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,12
NCT03045341,0,0,0,0,0,0,2023-10-31,2024-10-31,,Yale University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03046238,1,0,0,0,1,0,2017-04-02,2018-04-02,,South Egypt Cancer Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,10
NCT03047330,0,0,0,0,0,0,2020-12-31,2021-12-31,,Brigham and Women's Hospital,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03048357,1,0,0,0,1,0,2017-09-01,2018-09-01,,Northeast Center for Rehabilitation and Brain Injury,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,2
NCT03049969,0,0,0,0,0,0,2019-09-30,2020-09-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03050086,1,0,0,0,1,0,2018-06-19,2019-06-19,,"BioPharmX, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03050216,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,218
NCT03050372,0,0,0,0,0,0,2018-12-31,2019-12-31,,Medical University of South Carolina,Other,0,1,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,511
NCT03051178,0,0,0,0,0,0,2020-12-01,2021-12-01,,University of Florida,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03051659,0,0,0,0,0,0,2020-08-25,2021-08-25,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03052608,0,0,0,0,0,0,2020-12-31,2021-12-31,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03054064,1,0,1,1,0,1,2017-12-28,2018-12-28,2019-04-17,Parker Hannifin Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03056040,1,1,0,1,0,0,2018-03-08,2019-03-08,2019-02-15,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,86
NCT03057613,0,0,0,0,0,0,2020-01-15,2021-01-15,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,374
NCT03061331,1,1,0,1,0,0,2017-09-06,2018-09-06,2018-09-06,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,141
NCT03062540,1,0,0,0,1,0,2018-07-27,2019-07-27,,"Tonix Pharmaceuticals, Inc.",Industry,1,1,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT03063619,0,0,0,0,0,0,2019-09-18,2020-09-18,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03066336,1,0,0,0,1,0,2018-06-30,2019-06-30,,Erchonia Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,29
NCT03066739,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Irvine",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,310
NCT03066908,0,0,0,0,0,0,2018-12-31,2019-12-31,,Sinopsys Surgical,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03067272,1,0,0,0,1,0,2018-02-15,2019-02-15,,Femasys Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03068897,1,0,0,0,1,0,2018-07-11,2019-07-11,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03069391,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Union College, New York",Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03070509,0,0,0,0,0,0,2019-07-31,2020-07-31,,North Dakota State University,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03071341,1,0,0,0,1,0,2018-02-01,2019-02-01,,"ArmaGen, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,5
NCT03071406,0,0,0,0,0,0,2023-07-31,2024-07-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,344
NCT03075254,0,0,0,0,0,0,2022-06-30,2023-06-30,,University of Florida,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03076515,1,0,1,1,0,1,2018-01-31,2019-01-31,2019-09-10,Theranica,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,1,1,0,4
NCT03077243,0,0,0,0,0,0,2020-05-31,2021-05-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,229
NCT03078530,1,0,0,0,1,0,2018-05-31,2019-05-31,,Ashok Tuteja,U.S. Fed,2,0,1,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT03078816,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03081052,0,0,0,0,0,0,2020-05-31,2021-05-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03081884,0,0,0,0,0,0,2027-01-31,2028-01-31,,Emory University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03084718,0,0,0,0,0,0,2018-11-28,2019-11-28,,Chiesi Farmaceutici S.p.A.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,130
NCT03085680,0,0,0,0,0,0,2020-07-01,2021-07-01,,University of Florida,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03087786,1,0,1,1,0,1,2017-08-12,2018-08-12,2018-08-29,Niconovum USA,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03088605,0,0,0,0,0,0,2017-06-15,2018-06-15,,Topivert Pharma Ltd,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03088709,0,0,0,0,0,0,2020-01-31,2021-01-31,,Loyola University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03090165,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Ruth O'Regan, M.D.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03090698,1,0,0,0,1,0,2017-04-30,2018-04-30,,Universidade Federal Fluminense,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,32
NCT03091439,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-27,Allergan,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,495
NCT03091816,0,0,0,0,0,0,2020-05-08,2021-05-08,,University of Southern California,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,1,0,0,0,1,0,483
NCT03091920,0,0,0,0,0,0,2017-07-14,2018-07-14,,Cyclerion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,14
NCT03093636,0,0,0,0,0,0,2019-03-19,2020-03-19,,Stacey Anderson,Other,0,1,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03094325,1,0,1,1,0,1,2018-05-30,2019-05-30,2019-07-15,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,869
NCT03094936,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Sao Paulo General Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,368
NCT03095287,0,0,0,0,0,0,2021-10-31,2022-10-31,,Grifols Therapeutics LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,40
NCT03099304,1,0,0,0,1,0,2018-09-12,2019-09-12,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03099538,0,0,0,0,0,0,2019-06-06,2020-06-06,,Mayo Clinic,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1898
NCT03102606,0,0,0,0,0,0,2019-04-15,2020-04-15,,BeyondSpring Pharmaceuticals Inc.,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3
NCT03103685,0,0,0,0,0,0,2018-12-30,2019-12-30,,Chiang Mai University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,73
NCT03104517,0,0,0,0,0,0,2022-09-30,2023-09-30,,Cook MyoSite,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,9
NCT03107104,1,0,0,0,1,0,2017-08-30,2018-08-30,,"Topcon Medical Systems, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,27
NCT03107182,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,594
NCT03107507,1,0,0,0,1,0,2017-10-30,2018-10-30,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1190
NCT03107793,0,0,0,0,0,0,2020-04-03,2021-04-03,,Janssen-Cilag Ltd.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,22
NCT03109639,1,0,0,0,1,0,2017-11-30,2018-11-30,,Singapore General Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,134
NCT03110003,1,1,0,1,0,0,2017-12-01,2018-12-01,2018-08-06,University of Alabama at Birmingham,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT03110770,0,0,0,0,0,0,2020-01-31,2021-01-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2133
NCT03111381,0,0,0,0,0,0,2019-07-31,2020-07-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03112681,0,0,0,0,0,0,2019-09-30,2020-09-30,,Zydus Discovery DMCC,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03113487,0,0,0,0,0,0,2020-02-01,2021-02-01,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,358
NCT03114527,0,0,0,0,0,0,2019-12-31,2020-12-31,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03119584,0,0,0,0,0,0,2019-10-30,2020-10-30,,"Texas Tech University Health Sciences Center, El Paso",Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,30
NCT03120728,1,0,0,0,1,0,2018-06-30,2019-06-30,,University of Southern California,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,483
NCT03121690,0,0,0,0,0,0,2020-07-01,2021-07-01,,Assiut University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,1331
NCT03122535,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Utah,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,578
NCT03122860,0,0,0,0,0,0,2018-04-30,2019-04-30,,Samumed LLC,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,16
NCT03123393,0,0,0,0,0,0,2019-09-12,2020-09-12,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,209
NCT03123874,1,1,0,1,0,1,2017-10-02,2018-10-02,2019-04-30,Cornell University,Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,58
NCT03124329,0,0,0,0,0,0,2019-06-19,2020-06-19,,University of Southern California,Other,0,0,0,5.0,,1,2017.0,1,0,1,1,0,0,0,0,0,1,0,483
NCT03127943,1,1,0,1,0,0,2018-04-01,2019-04-01,2019-01-14,"University of North Carolina, Chapel Hill",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03128996,0,0,0,0,0,0,2022-04-30,2023-04-30,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03129464,1,0,0,0,1,0,2018-07-01,2019-07-01,,Cleveland Clinic Florida,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03131206,0,0,1,1,0,0,2019-08-01,2020-08-01,2019-08-23,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03135184,0,0,0,0,0,0,2019-01-07,2020-01-07,,HDL Therapeutics,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03135535,0,0,0,0,0,0,2018-11-15,2019-11-15,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,518
NCT03141372,1,1,0,1,0,0,2018-04-30,2019-04-30,2018-06-29,Sara Farag,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03142178,1,0,0,0,1,0,2018-01-30,2019-01-30,,"CDA Research Group, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03142919,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Laureate Institute for Brain Research, Inc.",Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,30
NCT03143894,0,0,0,0,0,0,2020-06-30,2021-06-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03146741,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pennsylvania,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03148262,1,1,0,1,0,0,2017-08-28,2018-08-28,2018-06-06,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,626
NCT03150693,0,0,0,0,0,0,2023-03-31,2024-03-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,456
NCT03153488,0,0,0,0,0,0,2020-07-01,2021-07-01,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,1699
NCT03155997,0,0,0,0,0,0,2021-04-12,2022-04-12,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03159169,0,0,0,0,0,0,2021-04-30,2022-04-30,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,419
NCT03159598,0,0,0,0,0,0,2020-02-29,2021-02-28,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT03163511,0,0,0,0,0,0,2020-09-30,2021-09-30,,ViaCyte,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,0,1,0,1,1,0,4
NCT03164928,0,0,0,0,0,0,2026-03-31,2027-03-31,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03165721,0,0,0,0,0,0,2020-12-01,2021-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03166046,1,0,0,0,1,0,2018-04-01,2019-04-01,,BioElectronics Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03166761,0,0,0,0,0,0,2020-09-30,2021-09-30,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03168321,0,0,0,0,0,0,2018-03-16,2019-03-16,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,180
NCT03170232,0,0,0,0,0,0,2018-11-15,2019-11-15,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,1,0,0,0,0,0,1,0,3276
NCT03172481,1,1,0,1,0,1,2017-08-19,2018-08-19,2019-04-01,"Purdue Pharma, Canada",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03173781,1,0,1,1,0,0,2017-10-31,2018-10-31,2018-07-02,Colorado Springs Neurological Associates,Other,0,1,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03173924,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03174275,0,0,0,0,0,0,2021-09-01,2022-09-01,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,229
NCT03175887,0,0,0,0,0,0,2020-05-01,2021-05-01,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,306
NCT03176394,0,0,0,0,0,0,2019-12-31,2020-12-31,,Next Science TM,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03176784,0,0,0,0,0,0,2022-08-01,2023-08-01,,"University of Wisconsin, Madison",Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03176966,0,0,0,0,0,0,2020-06-30,2021-06-30,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,422
NCT03177798,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-08-20,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,422
NCT03178734,0,0,0,0,0,0,2019-09-01,2020-09-01,,charbel salamon,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT03179930,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03180840,0,0,0,0,0,0,2019-08-31,2020-08-31,,Protalix,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,17
NCT03181867,0,0,0,0,0,0,2021-10-01,2022-10-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03186209,0,0,0,0,0,0,2021-02-26,2022-02-26,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,2450
NCT03186729,0,0,0,0,0,0,2021-06-30,2022-06-30,,Oslo University Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,535
NCT03187769,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,70
NCT03189264,1,0,0,0,1,0,2017-08-31,2018-08-31,,Dr Carlos Hernández,Other,0,0,0,5.0,,0,2017.0,1,0,0,0,0,0,0,0,2,1,0,1
NCT03189446,0,0,0,0,0,0,2022-06-01,2023-06-01,,University of Oklahoma,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,234
NCT03189563,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Dong-A ST Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,61
NCT03191916,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sanford Health,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,23
NCT03192215,0,0,0,0,0,0,2022-01-18,2023-01-18,,Columbia University,Other,0,1,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03194321,0,0,0,0,0,0,2020-05-09,2021-05-09,,Cedars-Sinai Medical Center,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03195140,1,0,0,0,1,0,2018-02-06,2019-02-06,,"Tandem Diabetes Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03197480,0,0,0,0,0,0,2020-12-31,2021-12-31,,Singapore National Eye Centre,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,69
NCT03199534,0,0,0,0,0,0,2019-08-31,2020-08-31,,EvergreenHealth,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03203681,0,0,0,0,0,0,2020-12-01,2021-12-01,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT03204123,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,1,0,0,0,0,1,0,1432
NCT03204318,0,0,0,0,0,0,2019-12-15,2020-12-15,,Myovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03206723,0,0,0,0,0,0,2018-12-31,2019-12-31,,Los Angeles Biomedical Research Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,60
NCT03207451,1,0,0,0,1,0,2018-07-01,2019-07-01,,Inova Health Care Services,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,41
NCT03209531,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Michigan,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03210740,0,0,0,0,0,0,2018-02-13,2019-02-13,,AmDerma,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03211416,0,0,0,0,0,0,2019-09-11,2020-09-11,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT03214224,0,1,0,1,0,0,2018-09-30,2019-09-30,2019-01-14,Milton S. Hershey Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,334
NCT03214601,0,0,0,0,0,0,2020-09-30,2021-09-30,,Bolton Medical,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03217591,0,0,0,0,0,0,2019-07-31,2020-07-31,,Cyclerion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03218397,0,0,0,0,0,0,2018-11-03,2019-11-03,,Duke University,Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT03218969,1,0,1,1,0,0,2018-09-15,2019-09-15,2019-08-28,"William Ondo, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03219320,0,0,0,0,0,0,2018-11-02,2019-11-02,,Aptinyx,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03219580,0,0,0,0,0,0,2020-04-30,2021-04-30,,Eyelid and Facial Consultants,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03221257,0,0,0,0,0,0,2021-06-30,2022-06-30,,Michael Roth,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03221751,0,0,0,0,0,0,2020-07-31,2021-07-31,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT03222037,1,1,0,1,0,0,2017-08-04,2018-08-04,2018-07-27,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03222531,0,0,0,0,0,0,2019-07-01,2020-07-01,,University of Pittsburgh,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1054
NCT03226522,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Axsome Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03229265,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Rogosin Institute,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03231397,0,0,0,0,0,0,2020-08-01,2021-08-01,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,1,0,0,0,0,1,0,1151
NCT03233438,0,0,0,0,0,0,2018-10-30,2019-10-30,,Allergan,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,495
NCT03236155,1,0,0,0,1,0,2018-07-01,2019-07-01,,Rush University Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,227
NCT03236441,0,0,0,0,0,0,2020-08-30,2021-08-30,,"Oladipupo Olafiranye, MD, MS",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03237611,0,0,0,0,0,0,2019-10-30,2020-10-30,,Albert Einstein College of Medicine,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03237858,0,0,0,0,0,0,2024-10-31,2025-10-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT03244020,0,0,0,0,0,0,2023-12-31,2024-12-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03248440,1,0,0,0,1,0,2018-08-17,2019-08-17,,"Senju USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03249558,0,0,0,0,0,0,2021-01-31,2022-01-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03253926,0,0,0,0,0,0,2019-09-30,2020-09-30,,New York State Psychiatric Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03254459,1,1,0,1,0,0,2017-11-13,2018-11-13,2018-09-25,INSYS Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,50
NCT03259035,0,0,0,0,0,0,2020-09-30,2021-09-30,,Canadian Cancer Trials Group,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03260556,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Cincinnati,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,222
NCT03260699,1,1,0,1,0,1,2018-01-01,2019-01-01,2019-05-23,The Cleveland Clinic,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,581
NCT03261349,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Taiwan University Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,1559
NCT03262012,0,0,0,0,0,0,2018-06-15,2019-06-15,,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,42
NCT03263572,0,0,0,0,0,0,2023-11-30,2024-11-30,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03263806,1,1,0,1,0,0,2018-04-04,2019-04-04,2018-04-30,William Beaumont Hospitals,Other,0,0,0,5.0,,1,2017.0,1,0,0,0,1,0,0,0,0,1,0,84
NCT03264300,0,0,0,0,0,0,2022-06-26,2023-06-26,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,1,5.0,,0,2017.0,0,0,0,0,0,0,0,0,0,1,0,48
NCT03266653,0,0,0,0,0,0,2020-12-31,2021-12-31,,New York Medical College,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03267576,0,0,0,0,0,0,2018-10-01,2019-10-01,,"Janssen Research & Development, LLC",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,558
NCT03270085,0,0,0,0,0,0,2019-05-31,2020-05-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1898
NCT03274492,0,0,0,0,0,0,2021-01-15,2022-01-15,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03277729,0,0,0,0,0,0,2022-11-16,2023-11-16,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,393
NCT03279939,1,0,0,0,1,0,2018-01-12,2019-01-12,,Heidelberg Engineering GmbH,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,10
NCT03281304,0,0,0,0,0,0,2019-10-31,2020-10-31,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03284424,0,0,0,0,0,0,2019-12-16,2020-12-16,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03285061,0,0,0,0,0,0,2019-07-01,2020-07-01,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,698
NCT03285646,0,0,0,0,0,0,2018-05-05,2019-05-05,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,176
NCT03286530,0,0,0,0,0,0,2020-09-01,2021-09-01,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03287232,0,0,0,0,0,0,2019-03-08,2020-03-08,,EndoCeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,9
NCT03287869,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,185
NCT03288779,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-06-20,Duke University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT03290248,0,0,0,0,0,0,2018-12-21,2019-12-21,,AOBiome LLC,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,10
NCT03291041,1,0,0,0,1,0,2017-11-30,2018-11-30,,Vanda Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,37
NCT03292133,0,0,0,0,0,0,2021-03-31,2022-03-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03292315,0,0,0,0,0,0,2021-12-31,2022-12-31,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,41
NCT03293030,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of California, San Francisco",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03295643,1,0,0,0,1,0,2018-07-31,2019-07-31,,Carrot Sense,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03297658,0,0,0,0,0,0,2019-09-30,2020-09-30,,West Virginia University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,74
NCT03298035,0,0,0,0,0,0,2018-12-31,2019-12-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03302793,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-17,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,490
NCT03304379,0,0,0,0,0,0,2019-11-25,2020-11-25,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03305055,1,1,0,1,0,0,2018-03-28,2019-03-28,2019-02-18,Johns Hopkins University,Other,0,0,1,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1143
NCT03305666,0,0,0,0,0,0,2020-04-30,2021-04-30,,Denver Health and Hospital Authority,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,66
NCT03305809,0,0,0,0,0,0,2020-06-22,2021-06-22,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03307005,0,0,0,0,0,0,2019-01-25,2020-01-25,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1143
NCT03308396,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Ajjai Alva, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03308825,1,1,0,1,0,0,2017-11-22,2018-11-22,2018-11-22,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,285
NCT03310619,0,0,0,0,0,0,2022-03-04,2023-03-04,,Celgene,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,306
NCT03311269,1,0,0,0,1,0,2018-03-31,2019-03-31,,"Vascular Insights, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,1
NCT03311724,0,0,0,0,0,0,2018-04-24,2019-04-24,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1512
NCT03312010,0,0,0,0,0,0,2019-08-01,2020-08-01,,Stimwave Technologies,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,5
NCT03315039,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Moleculin Biotech, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03315286,0,0,1,1,0,0,2019-01-31,2020-01-31,2019-09-04,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,586
NCT03315780,1,1,0,1,0,0,2018-02-28,2019-02-28,2019-02-25,Eli Lilly and Company,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1512
NCT03318172,0,0,0,0,0,0,2019-06-30,2020-06-30,,Seoul National University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,11
NCT03318783,0,0,0,0,0,0,2021-06-30,2022-06-30,,Oregon Health and Science University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT03323385,1,0,0,0,1,0,2018-07-31,2019-07-31,,"Recro Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT03324425,0,0,0,0,0,0,2022-12-31,2023-12-31,,Baylor Breast Care Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03325972,0,0,0,0,0,0,2019-02-28,2020-02-28,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT03326063,0,0,0,0,0,0,2020-10-31,2021-10-31,,Brigham and Women's Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03326232,1,0,0,0,1,0,2018-07-31,2019-07-31,,Eastern Virginia Medical School,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,33
NCT03329404,0,0,0,0,0,0,2020-06-30,2021-06-30,,Terumo BCTbio,Industry,1,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,8
NCT03330795,0,0,0,0,0,0,2023-11-30,2024-11-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03332498,0,0,0,0,0,0,2021-02-28,2022-02-28,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03332771,0,0,0,0,0,0,2019-08-06,2020-08-06,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03334903,0,0,0,0,0,0,2019-04-24,2020-04-24,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,698
NCT03335813,0,0,0,0,0,0,2020-01-31,2021-01-31,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT03336853,1,1,0,1,0,1,2017-07-21,2018-07-21,2019-01-18,Dr Riccardo Pace,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT03339999,0,0,0,0,0,0,2018-03-22,2019-03-22,,"Vitae Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03340740,0,0,0,0,0,0,2019-12-31,2020-12-31,,New York City Health and Hospitals Corporation,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03341130,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of British Columbia,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,881
NCT03342638,0,0,0,0,0,0,2023-01-01,2024-01-01,,Northwestern University,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03344172,0,0,0,0,0,0,2021-01-01,2022-01-01,,"Nathan Bahary, MD",Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03345485,0,0,0,0,0,0,2020-06-30,2021-06-30,,Mundipharma-EDO GmbH,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03348423,1,0,0,0,1,0,2018-04-30,2019-04-30,,"Recro Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT03348930,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Chicago,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03349437,1,1,0,1,0,1,2018-02-20,2019-02-20,2019-03-25,Philips Respironics,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,33
NCT03351478,0,0,0,0,0,0,2019-05-16,2020-05-16,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03353363,0,0,0,0,0,0,2018-10-18,2019-10-18,,Brooke Army Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,71
NCT03353571,1,0,0,0,1,0,2018-03-31,2019-03-31,,Dr. Gaines W. Hammond Jr. MD FACS,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03353688,0,0,0,0,0,0,2022-06-30,2023-06-30,,University of Alabama at Birmingham,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03354728,0,0,0,0,0,0,2021-08-31,2022-08-31,,City of Hope Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,358
NCT03355755,0,0,0,0,0,0,2018-12-13,2019-12-13,,Ekso Bionics,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03364686,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Gladwin, Mark, MD",Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,12
NCT03365011,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-04-23,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT03366207,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-07-31,"Iterum Therapeutics, International Limited",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03367741,0,0,0,0,0,0,2021-01-23,2022-01-23,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,3004
NCT03368469,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03369951,0,0,0,0,0,0,2019-07-20,2020-07-20,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2133
NCT03370341,0,0,0,0,0,0,2019-12-31,2020-12-31,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03371212,0,0,0,0,0,0,2019-12-01,2020-12-01,,Rush University Medical Center,Other,0,1,0,4.0,Phase 4,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,227
NCT03371836,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,47
NCT03372148,0,0,0,0,0,0,2022-05-31,2023-05-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,461
NCT03373981,0,0,0,0,0,0,2019-11-20,2020-11-20,,"Hospital for Special Surgery, New York",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,157
NCT03374956,0,0,0,0,0,0,2020-12-01,2021-12-01,,Mayo Clinic,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03375307,0,0,0,0,0,0,2023-08-21,2024-08-21,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03377790,0,0,0,0,0,0,2018-11-26,2019-11-26,,Verrica Pharmaceuticals Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,5
NCT03378973,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT03379506,0,0,0,0,0,0,2019-12-01,2020-12-01,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03382457,0,0,0,0,0,0,2020-06-30,2021-06-30,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,77
NCT03382912,0,0,0,0,0,0,2019-08-28,2020-08-28,,Eli Lilly and Company,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1512
NCT03383705,0,0,0,0,0,0,2018-11-15,2019-11-15,,Syneron Medical,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,41
NCT03385759,0,0,0,0,0,0,2020-01-31,2021-01-31,,Anderson Orthopaedic Research Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,13
NCT03386526,0,0,0,0,0,0,2019-12-11,2020-12-11,,Ascentage Pharma Group Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03387085,0,0,0,0,0,0,2019-12-31,2020-12-31,,"NantKwest, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03389685,0,0,0,0,0,0,2020-02-29,2021-02-28,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,869
NCT03389854,0,0,0,0,0,0,2019-05-30,2020-05-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1898
NCT03390504,0,0,0,0,0,0,2020-11-24,2021-11-24,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,1,1,0,558
NCT03392935,0,0,0,0,0,0,2018-11-30,2019-11-30,,University of Utah,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,578
NCT03398798,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03399786,0,0,0,0,0,0,2019-05-27,2020-05-27,,Regeneron Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03400150,0,0,0,0,0,0,2020-02-29,2021-02-28,,BioProtect,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,3
NCT03401112,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Imara, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03403036,1,1,0,1,0,0,2018-08-18,2019-08-18,2019-06-18,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03404115,0,0,0,0,0,0,2018-07-11,2019-07-11,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03404804,0,0,0,0,0,0,2018-12-04,2019-12-04,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,315
NCT03405662,0,0,0,0,0,0,2019-05-31,2020-05-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03405870,0,0,0,0,0,0,2020-02-15,2021-02-15,,University of Florida,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03409952,0,0,0,0,0,0,2018-12-20,2019-12-20,,LUTRONIC Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,9
NCT03413800,0,0,0,0,0,0,2021-01-29,2022-01-29,,Ciusss de L'Est de l'Île de Montréal,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,23
NCT03413995,0,0,0,0,0,0,2020-05-31,2021-05-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03414255,0,0,0,0,0,0,2019-12-31,2020-12-31,,"MiMedx Group, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,32
NCT03417921,0,0,0,0,0,0,2022-03-30,2023-03-30,,Ability Pharmaceuticals SL,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03420222,0,0,0,0,0,0,2018-12-28,2019-12-28,,Avanir Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,29
NCT03421340,0,0,0,0,0,0,2020-10-31,2021-10-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,340
NCT03421496,0,0,0,0,0,0,2019-12-31,2020-12-31,,INSYS Therapeutics Inc,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,50
NCT03421886,0,0,0,0,0,0,2019-07-21,2020-07-21,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,801
NCT03422679,0,0,0,0,0,0,2021-06-30,2022-06-30,,Cellestia Biotech AG,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03423173,0,0,0,0,0,0,2018-07-20,2019-07-20,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,650
NCT03423823,0,0,0,0,0,0,2018-12-07,2019-12-07,,Kapil Kapoor,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03424005,0,0,0,0,0,0,2021-08-17,2022-08-17,,Hoffmann-La Roche,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03425006,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1052
NCT03428750,0,0,0,0,0,0,2018-09-26,2019-09-26,,Endo Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,91
NCT03431090,0,0,0,0,0,0,2021-12-31,2022-12-31,,Nationwide Children's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,161
NCT03431831,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Nebraska,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,327
NCT03432065,0,0,0,0,0,0,2020-08-31,2021-08-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03432286,0,0,0,0,0,0,2022-04-30,2023-04-30,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1512
NCT03434652,0,0,0,0,0,0,2019-12-30,2020-12-30,,Medical College of Wisconsin,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03434834,0,0,0,0,0,0,2019-12-31,2020-12-31,,Duke University,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03436615,0,0,0,0,0,0,2018-11-03,2019-11-03,,"Novan, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,20
NCT03442088,0,0,0,0,0,0,2019-06-01,2020-06-01,,University Hospitals Cleveland Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,185
NCT03444298,0,0,0,0,0,0,2021-02-28,2022-02-28,,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03446508,0,0,0,0,0,0,2023-01-10,2024-01-10,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03446846,0,0,0,0,0,0,2019-12-01,2020-12-01,,Minerva Neurosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03447249,0,0,0,0,0,0,2019-02-05,2020-02-05,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03447782,0,0,0,0,0,0,2020-09-30,2021-09-30,,Boston Children’s Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03449238,0,0,0,0,0,0,2024-12-30,2025-12-30,,Weill Medical College of Cornell University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03450850,0,0,0,0,0,0,2023-06-30,2024-06-30,,Daniela A. Bota,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03452007,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Louisville,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT03452189,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03453801,0,0,0,0,0,0,2019-01-14,2020-01-14,,Stanford University,Other,0,0,1,4.0,Phase 4,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,1309
NCT03454802,0,0,0,0,0,0,2020-10-01,2021-10-01,,Region MidtJylland Denmark,Other,0,1,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,3,1,0,3
NCT03455374,0,0,0,0,0,0,2019-05-13,2020-05-13,,Arkansas Heart Hospital,Other,0,1,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03456063,0,0,0,0,0,0,2025-03-30,2026-03-30,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03457103,0,0,0,0,0,0,2019-12-01,2020-12-01,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03458234,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03459079,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Florida,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03459287,0,0,0,0,0,0,2021-01-31,2022-01-31,,Cerus Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03459846,0,0,0,0,0,0,2020-02-28,2021-02-28,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03461003,0,0,0,0,0,0,2020-01-31,2021-01-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03462719,0,0,0,0,0,0,2021-02-02,2022-02-02,,"Janssen Research & Development, LLC",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03464097,0,0,0,0,0,0,2021-04-30,2022-04-30,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03467516,0,0,0,0,0,0,2020-04-01,2021-04-01,,Udai Kammula,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03469297,0,0,0,0,0,0,2019-12-31,2020-12-31,,MicroOptx,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03469947,1,0,0,0,1,0,2018-07-31,2019-07-31,,Arrowhead Regional Medical Center,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,3,0,1,4
NCT03470480,0,0,0,0,0,0,2019-09-01,2020-09-01,,Oregon Health and Science University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,475
NCT03470675,0,0,0,0,0,0,2021-12-31,2022-12-31,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03471624,0,0,0,0,0,0,2021-08-31,2022-08-31,,Stanford University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1309
NCT03472144,0,0,0,0,0,0,2019-07-07,2020-07-07,,LifeBridge Health,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03472378,0,0,0,0,0,0,2019-04-12,2020-04-12,,Hartford Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,65
NCT03473249,0,0,0,0,0,0,2020-06-30,2021-06-30,,Children's Hospital of Philadelphia,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03474679,0,0,0,0,0,0,2022-02-28,2023-02-28,,Janssen Pharmaceutical K.K.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,102
NCT03476174,0,0,0,0,0,0,2021-05-31,2022-05-31,,Ralph Hauke,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03476343,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,437
NCT03477396,0,0,0,0,0,0,2020-06-14,2021-06-14,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,358
NCT03477604,0,0,0,0,0,0,2018-12-12,2019-12-12,,"Micro Medical Solution, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03480152,0,0,0,0,0,0,2019-06-25,2020-06-25,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,3004
NCT03481907,0,0,0,0,0,0,2018-10-18,2019-10-18,,Adam Friedman,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03484819,0,0,0,0,0,0,2021-10-01,2022-10-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03487172,0,0,0,0,0,0,2019-04-17,2020-04-17,,"Goldman, Butterwick, Fitzpatrick and Groff",Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,12
NCT03488147,0,0,0,0,0,0,2021-04-02,2022-04-02,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03488472,0,0,0,0,0,0,2022-04-30,2023-04-30,,Drexell Hunter Boggs,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,1,0,0,0,1,0,1
NCT03489863,0,0,0,0,0,0,2019-03-20,2020-03-20,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,849
NCT03490656,0,0,0,0,0,0,2020-02-15,2021-02-15,,Ohio State University,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,1,0,0,0,0,0,1,315
NCT03490812,0,0,0,0,0,0,2020-01-01,2021-01-01,,Ohio State University,Other,0,0,0,5.0,,0,2015.0,0,0,0,0,1,0,0,0,0,0,1,315
NCT03491007,0,0,0,0,0,0,2023-01-02,2024-01-02,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03492554,1,1,0,1,0,0,2018-05-14,2019-05-14,2019-05-13,Apple Inc.,Industry,1,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03493282,0,0,0,0,0,0,2020-01-31,2021-01-31,,Cognition Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03493451,0,0,0,0,0,0,2020-04-30,2021-04-30,,BeiGene,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03495713,0,0,0,0,0,0,2020-03-02,2021-03-02,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03498287,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Pressure Profile Systems, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03499873,0,0,0,0,0,0,2018-10-31,2019-10-31,,Actavis Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,93
NCT03500159,1,1,0,1,0,0,2018-07-17,2019-07-17,2018-12-20,Aquinox Pharmaceuticals (Canada) Inc.,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,7
NCT03501381,0,0,0,0,0,0,2022-04-30,2023-04-30,,Roberto Pili,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03504488,0,0,0,0,0,0,2020-05-13,2021-05-13,,"BioAtla, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03504852,0,0,0,0,0,0,2020-02-24,2021-02-24,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03506139,0,0,0,0,0,0,2024-12-31,2025-12-31,,John M. Buatti,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,2
NCT03508765,0,0,0,0,0,0,2020-03-31,2021-03-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1432
NCT03510208,0,0,0,0,0,0,2021-05-14,2022-05-14,,Eben Rosenthal,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,9
NCT03512314,0,0,0,0,0,0,2020-03-31,2021-03-31,,AB2 Bio Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03513952,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03514537,0,0,0,0,0,0,2022-03-15,2023-03-15,,Healeon Medical Inc,Industry,1,0,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,8
NCT03515551,0,0,0,0,0,0,2020-08-31,2021-08-31,,Immunocore Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03517540,0,0,0,0,0,0,2020-07-28,2021-07-28,,Novartis Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03518034,0,0,0,0,0,0,2022-06-30,2023-06-30,,AbbVie,Industry,1,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03521479,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Squarex, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03521830,0,0,0,0,0,0,2023-11-30,2024-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03522714,0,0,0,0,0,0,2020-08-31,2021-08-31,,Northwestern University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,925
NCT03522844,0,0,0,0,0,0,2021-01-15,2022-01-15,,Georgetown University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03523312,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03525418,0,0,0,0,0,0,2021-02-28,2022-02-28,,Longeveron LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03525873,0,0,0,0,0,0,2021-06-30,2022-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03527264,0,0,0,0,0,0,2020-12-31,2021-12-31,,Don Dizon,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,2
NCT03529799,0,0,0,0,0,0,2020-07-04,2021-07-04,,University of Miami,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03533400,0,0,0,0,0,0,2019-12-31,2020-12-31,,My Music Machines Inc.,Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03534323,0,0,0,0,0,0,2022-06-01,2023-06-01,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03535740,0,0,0,0,0,0,2019-12-18,2020-12-18,,Ariad Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,16
NCT03536767,0,0,0,0,0,0,2023-07-31,2024-07-31,,Eidos Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03538236,0,0,0,0,0,0,2020-05-30,2021-05-30,,Johns Hopkins University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1143
NCT03539744,0,0,0,0,0,0,2021-01-12,2022-01-12,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03540745,0,0,0,0,0,0,2019-04-30,2020-04-30,,University of Arizona,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,265
NCT03541902,0,0,0,0,0,0,2020-07-31,2021-07-31,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03542266,0,0,0,0,0,0,2021-05-30,2022-05-30,,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03543358,0,0,0,0,0,0,2024-02-05,2025-02-05,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03543839,0,0,0,0,0,0,2022-11-30,2023-11-30,,Northwell Health,Other,0,1,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,271
NCT03545503,0,0,0,0,0,0,2019-01-31,2020-01-31,,"South East Area Health Education Center, Wilmington, NC",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03548506,0,0,0,0,0,0,2020-12-31,2021-12-31,,University Hospital Tuebingen,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,281
NCT03553576,0,0,0,0,0,0,2023-12-31,2024-12-31,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03556683,0,0,0,0,0,0,2021-07-31,2022-07-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03556891,0,0,0,0,0,0,2020-01-31,2021-01-31,,Valencia Technologies Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03557996,0,0,0,0,0,0,2019-11-01,2020-11-01,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1190
NCT03558568,0,0,0,0,0,0,2019-08-12,2020-08-12,,Mustafa Kemal University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,15
NCT03559062,0,0,0,0,0,0,2018-12-21,2019-12-21,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,141
NCT03559517,0,0,0,0,0,0,2021-08-27,2022-08-27,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,342
NCT03561506,0,0,0,0,0,0,2019-06-11,2020-06-11,,The Catholic University of Korea,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,119
NCT03561883,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Ironwood Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,22
NCT03565211,0,0,0,0,0,0,2019-07-29,2020-07-29,,Ferring Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,208
NCT03566043,0,0,0,0,0,0,2019-08-31,2020-08-31,,Regenxbio Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,0,0,1,0,1,0,7
NCT03566290,0,0,0,0,0,0,2018-09-21,2019-09-21,,GTx,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT03566927,0,0,0,0,0,0,2021-12-31,2022-12-31,,VentureMed Group Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,4
NCT03570827,0,0,0,0,0,0,2023-05-08,2024-05-08,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1898
NCT03575052,0,0,0,0,0,0,2021-05-31,2022-05-31,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,24
NCT03575572,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Michigan,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03575936,1,0,0,0,1,0,2017-06-30,2018-06-30,,University of South Florida,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,240
NCT03576079,1,0,0,0,1,0,2017-09-30,2018-09-30,,Cairo University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,3,0,1,1190
NCT03576963,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Southern California,Other,0,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,483
NCT03577106,0,0,0,0,0,0,2021-08-25,2022-08-25,,Carmen Andreescu,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03578809,0,0,0,0,0,0,2020-07-30,2021-07-30,,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,269
NCT03579927,0,0,0,0,0,0,2020-01-01,2021-01-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03580356,0,0,0,0,0,0,2020-05-04,2021-05-04,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03581487,0,0,0,0,0,0,2021-04-16,2022-04-16,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03581877,0,0,0,0,0,0,2021-12-31,2022-12-31,,Northwell Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,271
NCT03585257,0,0,0,0,0,0,2020-06-20,2021-06-20,,Hunter Holmes Mcguire Veteran Affairs Medical Center,U.S. Fed,2,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,19
NCT03586336,0,0,0,0,0,0,2019-12-01,2020-12-01,,"University of California, San Francisco",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03587740,0,0,0,0,0,0,2022-01-31,2023-01-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03591289,0,0,0,0,0,0,2020-12-31,2021-12-31,,Rainer Lenhardt,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03592342,0,0,0,0,0,0,2020-05-31,2021-05-31,,Dermtreat,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03593655,0,0,0,0,0,0,2021-11-30,2022-11-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,2133
NCT03593811,0,0,0,0,0,0,2023-09-30,2024-09-30,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,422
NCT03594227,0,0,0,0,0,0,2019-06-06,2020-06-06,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03595995,0,0,0,0,0,0,2021-12-31,2022-12-31,,United BioPharma,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,0,1,0,0,0,0,0,3,1,0,9
NCT03596086,0,0,0,0,0,0,2023-12-30,2024-12-30,,David Baskin MD,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03598426,0,0,0,0,0,0,2021-01-31,2022-01-31,,Loma Linda University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,194
NCT03599245,0,0,0,0,0,0,2024-12-31,2025-12-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1731
NCT03603002,0,0,0,0,0,0,2021-08-01,2022-08-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,461
NCT03603496,0,0,0,0,0,0,2022-08-31,2023-08-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03604549,0,0,0,0,0,0,2020-06-30,2021-06-30,,Milton S. Hershey Medical Center,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03605680,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,185
NCT03606512,0,0,0,0,0,0,2020-11-02,2021-11-02,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,29
NCT03607422,0,0,0,0,0,0,2020-02-14,2021-02-14,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03613493,0,1,0,1,0,0,2018-10-01,2019-10-01,2019-07-10,University of Miami,Other,0,0,0,5.0,,1,2018.0,1,0,0,0,1,0,0,0,0,1,0,476
NCT03614923,0,0,0,0,0,0,2019-12-31,2020-12-31,,"AnaptysBio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,6
NCT03615508,0,0,0,0,0,0,2019-08-01,2020-08-01,,Denver Health and Hospital Authority,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,66
NCT03617718,0,0,0,0,0,0,2021-09-30,2022-09-30,,University Hospitals Cleveland Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,185
NCT03617861,0,0,0,0,0,0,2019-07-01,2020-07-01,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1898
NCT03620084,0,0,0,0,0,0,2020-03-31,2021-03-31,,Singapore General Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,134
NCT03620708,0,0,0,0,0,0,2018-10-01,2019-10-01,,"Rutgers, The State University of New Jersey",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,227
NCT03621592,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Miami,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03621761,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03622788,0,0,0,0,0,0,2021-07-01,2022-07-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,2066
NCT03624010,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Tenax Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03627767,0,0,0,0,0,0,2020-08-27,2021-08-27,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03629379,0,0,0,0,0,0,2021-01-01,2022-01-01,,Universitaire Ziekenhuizen Leuven,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,525
NCT03630016,1,1,0,1,0,1,2017-12-17,2018-12-17,2019-05-09,"Owlet Baby Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,0,1,0,0,0,0,1,0,1
NCT03631654,0,0,0,0,0,0,2021-08-31,2022-08-31,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,144
NCT03633617,0,0,0,0,0,0,2022-05-18,2023-05-18,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03635034,0,0,0,0,0,0,2020-07-31,2021-07-31,,St. Vincent Cardiovascular Research Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03635112,0,0,0,0,0,0,2020-02-29,2021-02-28,,Theravance Biopharma,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,53
NCT03636126,0,0,0,0,0,0,2018-11-30,2019-11-30,,Baylor Research Institute,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,131
NCT03638466,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,26
NCT03644277,0,0,0,0,0,0,2023-06-29,2024-06-29,,Shirley Ryan AbilityLab,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,71
NCT03644472,0,0,0,0,0,0,2022-09-03,2023-09-03,,Penn State University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,145
NCT03644849,0,0,0,0,0,0,2020-06-30,2021-06-30,,St. Louis University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,126
NCT03645434,0,0,0,0,0,0,2019-08-07,2020-08-07,,AstraZeneca,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,2450
NCT03647475,0,0,0,0,0,0,2020-07-31,2021-07-31,,Medtronic Vascular,Industry,1,0,0,5.0,,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,51
NCT03648996,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Missouri-Columbia,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03650257,0,0,0,0,0,0,2021-08-20,2022-08-20,,"Cure&Sure Biotech Co., LTD",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,1,0,0,2,1,0,3
NCT03650712,0,0,0,0,0,0,2021-08-31,2022-08-31,,Katie Larson Ode,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1
NCT03651271,0,0,0,0,0,0,2020-09-14,2021-09-14,,Parker Institute for Cancer Immunotherapy,Other,0,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03651726,0,0,0,0,0,0,2019-11-30,2020-11-30,,Therapix Biosciences Ltd.,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03653663,0,0,0,0,0,0,2019-07-30,2020-07-30,,Hartford Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,65
NCT03654209,0,0,0,0,0,0,2019-12-31,2020-12-31,,Indiana University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT03654690,0,0,0,0,0,0,2022-12-01,2023-12-01,,Brown University,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,152
NCT03654989,0,0,0,0,0,0,2021-04-30,2022-04-30,,"University Hospital, Grenoble",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,464
NCT03658668,0,0,0,0,0,0,2020-02-29,2021-02-28,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03660826,0,0,0,0,0,0,2020-09-04,2021-09-04,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03672292,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Scynexis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03673579,0,0,0,0,0,0,2020-11-30,2021-11-30,,Philips Healthcare,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,45
NCT03674047,0,0,0,0,0,0,2022-03-31,2023-03-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03682224,0,0,0,0,0,0,2021-07-05,2022-07-05,,Southern Illinois University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,26
NCT03683719,0,0,0,0,0,0,2020-04-30,2021-04-30,,LEO Pharma,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,171
NCT03684304,0,0,0,0,0,0,2019-05-31,2020-05-31,,University Hospitals Cleveland Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,185
NCT03685708,0,0,0,0,0,0,2025-05-13,2026-05-13,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1091
NCT03688802,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Oyster Point Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03690284,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03691493,0,0,0,0,0,0,2021-06-30,2022-06-30,,Emory University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,947
NCT03692910,0,0,0,0,0,0,2019-03-23,2020-03-23,,Sage Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03693105,0,0,0,0,0,0,2020-02-29,2021-02-28,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03695237,0,0,0,0,0,0,2020-05-06,2021-05-06,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03698994,0,0,0,0,0,0,2025-12-31,2026-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03700320,0,0,0,0,0,0,2020-06-22,2021-06-22,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03700970,0,0,0,0,0,0,2021-07-31,2022-07-31,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03702192,0,0,0,0,0,0,2021-11-30,2022-11-30,,David N. Rosenthal,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03703856,0,0,0,0,0,0,2023-08-31,2024-08-31,,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03706027,0,0,0,0,0,0,2025-11-15,2026-11-15,,University of Rochester,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,470
NCT03706456,0,0,0,0,0,0,2020-05-15,2021-05-15,,Takeda,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,650
NCT03709550,0,0,0,0,0,0,2020-09-30,2021-09-30,,Roswell Park Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,294
NCT03712098,0,0,0,0,0,0,2021-05-31,2022-05-31,,Rebecca Ashare,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03712449,0,0,0,0,0,0,2020-08-30,2021-08-30,,Allergan,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,495
NCT03713424,0,0,0,0,0,0,2020-01-31,2021-01-31,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03717012,0,0,0,0,0,0,2020-11-19,2021-11-19,,Boehringer Ingelheim,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1852
NCT03718325,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03718494,0,0,0,0,0,0,2022-06-30,2023-06-30,,Mayo Clinic,Other,0,0,1,4.0,Phase 4,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,1898
NCT03722589,0,0,0,0,0,0,2018-11-30,2019-11-30,,Centers for Disease Control and Prevention,U.S. Fed,2,1,0,4.0,Phase 4,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,267
NCT03724084,0,0,0,0,0,0,2020-06-01,2021-06-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03725761,0,0,0,0,0,0,2020-06-01,2021-06-01,,"University of Wisconsin, Madison",Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03726398,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Franz Rischard, DO",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03726749,0,0,0,0,0,0,2021-12-31,2022-12-31,,Massachusetts General Hospital,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03729271,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,934
NCT03729869,0,0,0,0,0,0,2023-10-30,2024-10-30,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03731182,0,0,0,0,0,0,2020-08-27,2021-08-27,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03732365,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Sonescence, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,1,0,3,1,0,2
NCT03733626,0,0,0,0,0,0,2022-11-01,2023-11-01,,William Beaumont Hospitals,Other,0,1,0,5.0,,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,84
NCT03735875,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03736083,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Florida,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03737292,0,0,0,0,0,0,2021-03-31,2022-03-31,,Milton S. Hershey Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03737721,0,0,0,0,0,0,2023-06-30,2024-06-30,,AHS Cancer Control Alberta,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,2,1,0,136
NCT03737994,0,0,0,0,0,0,2025-12-13,2026-12-13,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03745638,0,0,0,0,0,0,2020-08-31,2021-08-31,,Incyte Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03747458,0,0,0,0,0,0,2020-10-29,2021-10-29,,Optinose US Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03748641,0,0,0,0,0,0,2022-07-21,2023-07-21,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03750292,0,0,0,0,0,0,2020-10-01,2021-10-01,,University of Rochester,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,470
NCT03750656,0,0,0,0,0,0,2021-11-30,2022-11-30,,University of Kansas Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03751371,0,0,0,0,0,0,2020-09-30,2021-09-30,,Ohio State University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03755492,0,0,0,0,0,0,2020-03-31,2021-03-31,,Albert Einstein Healthcare Network,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,45
NCT03758924,0,0,0,0,0,0,2019-11-01,2020-11-01,,Anavex Life Sciences Corp.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03759366,0,0,0,0,0,0,2021-06-30,2022-06-30,,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,86
NCT03760458,0,0,0,0,0,0,2021-02-28,2022-02-28,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03764137,0,0,0,0,0,0,2025-01-31,2026-01-31,,University of Alabama at Birmingham,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03765983,0,0,0,0,0,0,2021-11-30,2022-11-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03768492,0,0,0,0,0,0,2024-04-30,2025-04-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03769246,0,0,0,0,0,0,2019-08-31,2020-08-31,,Columbia University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03771378,0,0,0,0,0,0,2019-09-01,2020-09-01,,"Wuhan Union Hospital, China",Other,0,0,0,4.0,Phase 4,0,2019.0,1,1,0,0,0,0,0,0,2,1,0,37
NCT03772834,0,0,0,0,0,0,2023-11-30,2024-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03774472,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03775265,0,0,0,0,0,0,2025-06-01,2026-06-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,3004
NCT03776487,0,0,0,0,0,0,2020-03-01,2021-03-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,2066
NCT03780244,0,0,0,0,0,0,2020-03-14,2021-03-14,,Q-Med AB,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,56
NCT03781557,0,0,0,0,0,0,2019-04-01,2020-04-01,,Sulaiman AlRajhi Colleges,Other,0,0,0,4.0,Phase 4,0,2019.0,1,0,0,0,0,0,0,0,3,1,0,4
NCT03781752,0,0,0,0,0,0,2023-07-31,2024-07-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03782701,0,0,0,0,0,0,2021-07-31,2022-07-31,,Wendy Lee,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03786770,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Revance Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,26
NCT03788967,0,0,0,0,0,0,2020-05-31,2021-05-31,,Spero Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03795233,0,0,0,0,0,0,2020-02-29,2021-02-28,,Boston Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,225
NCT03795675,0,0,0,0,0,0,2021-12-31,2022-12-31,,Ohio State University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03797300,0,0,0,0,0,0,2018-12-14,2019-12-14,,Spry Health,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03800134,0,0,0,0,0,0,2020-07-27,2021-07-27,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03801889,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Abfero Pharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03805659,0,0,0,0,0,0,2021-05-31,2022-05-31,,Medical College of Wisconsin,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03814798,0,0,0,0,0,0,2020-09-30,2021-09-30,,Grifols Therapeutics LLC,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,40
NCT03815344,0,0,0,0,0,0,2019-12-31,2020-12-31,,Maimonides Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,46
NCT03815916,0,0,0,0,0,0,2020-06-30,2021-06-30,,Clene Nanomedicine,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03818399,0,0,0,0,0,0,2020-12-31,2021-12-31,,Virginia Commonwealth University,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03818880,0,0,0,0,0,0,2022-02-28,2023-02-28,,"SightGlass Vision, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,3
NCT03819244,1,0,0,0,1,0,2018-05-24,2019-05-24,,Yuzuncu Yıl University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,35
NCT03819634,0,0,0,0,0,0,2019-06-01,2020-06-01,,Stanford University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03821623,0,0,0,0,0,0,2023-12-31,2024-12-31,,Douglas Seals,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03823768,0,0,0,0,0,0,2020-09-30,2021-09-30,,Medical University of South Carolina,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,511
NCT03824587,0,0,0,0,0,0,2019-08-31,2020-08-31,,Ardelyx,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,22
NCT03826784,0,0,0,0,0,0,2022-01-31,2023-01-31,,Carmell Therapeutics Corporation,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,2
NCT03827044,0,0,0,0,0,0,2024-07-31,2025-07-31,,Royal Marsden NHS Foundation Trust,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,184
NCT03829657,0,0,0,0,0,0,2021-02-28,2022-02-28,,Theravance Biopharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,53
NCT03830216,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Companion Medical, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03831152,0,0,0,0,0,0,2021-03-30,2022-03-30,,Advicenne Pharma,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03831321,0,0,0,0,0,0,2019-04-22,2020-04-22,,Taha Uçar,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,1,0,0,0,0,2,1,0,1
NCT03834519,0,0,0,0,0,0,2021-10-12,2022-10-12,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03836287,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Brickell Biotech, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,11
NCT03836950,0,0,0,0,0,0,2024-06-26,2025-06-26,,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03837626,0,0,0,0,0,0,2024-06-30,2025-06-30,,University of Missouri-Columbia,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03841097,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Roy D. Bloom, MD",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03843775,0,0,0,0,0,0,2022-02-28,2023-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03844750,0,0,0,0,0,0,2020-03-01,2021-03-01,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,1443
NCT03845192,0,0,0,0,0,0,2019-08-31,2020-08-31,,Johannes Gutenberg University Mainz,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,106
NCT03845907,0,0,0,0,0,0,2019-08-30,2020-08-30,,Seno Medical Instruments Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03846427,0,0,0,0,0,0,2021-04-01,2022-04-01,,BeiGene,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03847428,0,0,0,0,0,0,2022-06-29,2023-06-29,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03848143,0,0,0,0,0,0,2020-08-31,2021-08-31,,Isabel Moreno Hay,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03850379,0,0,0,0,0,0,2022-03-30,2023-03-30,,Henry Ford Health System,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,151
NCT03852537,0,0,0,0,0,0,2021-07-31,2022-07-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03853798,0,0,0,0,0,0,2025-01-31,2026-01-31,,"Agios Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,33
NCT03856255,0,0,0,0,0,0,2019-07-31,2020-07-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,869
NCT03857919,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Sight Sciences, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03861039,0,0,0,0,0,0,2021-03-21,2022-03-21,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03862079,0,0,0,0,0,0,2021-12-31,2022-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03862495,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2020.0,0,1,0,0,1,0,0,0,2,1,0,910
NCT03863834,0,0,0,0,0,0,2019-12-31,2020-12-31,,InMode MD Ltd.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03865615,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03868124,0,0,0,0,0,0,2021-06-30,2022-06-30,,Glaukos Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,1,0,0,1,0,34
NCT03869268,0,0,0,0,0,0,2020-08-31,2021-08-31,,Sheffield Teaching Hospitals NHS Foundation Trust,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,155
NCT03870880,0,0,0,0,0,0,2020-01-31,2021-01-31,,Rovi Pharmaceuticals Laboratories,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,13
NCT03872388,0,0,0,0,0,0,2021-12-31,2022-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03872778,0,0,0,0,0,0,2022-09-30,2023-09-30,,Advanced Accelerator Applications,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03873259,0,0,0,0,0,0,2022-04-30,2023-04-30,,University of Washington,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,910
NCT03875664,0,0,0,0,0,0,2019-03-12,2020-03-12,,Atrium Health,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,95
NCT03876262,0,0,0,0,0,0,2023-03-31,2024-03-31,,Medicines Development Limited,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT03877718,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Charleston Laboratories, Inc",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03878485,0,0,0,0,0,0,2020-10-31,2021-10-31,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,1,0,0,0,1,0,1151
NCT03878849,0,0,0,0,0,0,2021-09-30,2022-09-30,,Oncology Venture,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,6
NCT03879044,0,0,0,0,0,0,2021-03-19,2022-03-19,,Ohio State University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03880539,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Kansas Medical Center,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03883412,0,0,0,0,0,0,2022-03-31,2023-03-31,,University of Virginia,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT03884296,0,0,0,0,0,0,2024-12-31,2025-12-31,,Stanford University,Other,0,0,1,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1309
NCT03884465,0,0,0,0,0,0,2020-01-09,2021-01-09,,"Liquidia Technologies, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03887754,1,0,0,0,1,0,2018-01-31,2019-01-31,,Minia University,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,1,0,0,0,0,3,0,1,34
NCT03887936,0,0,0,0,0,0,2024-09-30,2025-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03888222,0,0,0,0,0,0,2021-04-30,2022-04-30,,Georgetown University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03891407,0,0,0,0,0,0,2020-01-01,2021-01-01,,University of South Carolina,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,2,1,0,79
NCT03891550,0,0,0,0,0,0,2024-04-15,2025-04-15,,Kaohsiung Medical University Chung-Ho Memorial Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,142
NCT03893370,0,0,0,0,0,0,2022-06-30,2023-06-30,,"CSA Medical, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,18
NCT03893565,0,0,0,0,0,0,2021-08-30,2022-08-30,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,3276
NCT03894215,0,0,0,0,0,0,2023-09-30,2024-09-30,,Agenus Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,19
NCT03895203,0,0,0,0,0,0,2021-07-31,2022-07-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03896503,0,0,0,0,0,0,2021-12-30,2022-12-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03897348,0,0,0,0,0,0,2019-06-12,2020-06-12,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1443
NCT03897543,0,0,0,0,0,0,2021-01-01,2022-01-01,,Abivax S.A.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,14
NCT03898986,0,0,0,0,0,0,2023-12-31,2024-12-31,,Stanford University,Other,0,0,1,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1309
NCT03901768,0,0,0,0,0,0,2020-01-01,2021-01-01,,The University of Hong Kong,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,547
NCT03902314,0,0,0,0,0,0,2020-04-30,2021-04-30,,Rhode Island Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,120
NCT03904316,0,0,0,0,0,0,2019-10-03,2020-10-03,,Ascension South East Michigan,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,7
NCT03907852,0,0,0,0,0,0,2021-06-30,2022-06-30,,TCR2 Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,1
NCT03911414,0,0,0,0,0,0,2021-05-31,2022-05-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03912337,0,0,0,0,0,0,2021-03-10,2022-03-10,,Amgen,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,685
NCT03913195,0,0,0,0,0,0,2020-05-15,2021-05-15,,TaiMed Biologics Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03913845,0,0,0,0,0,0,2022-07-01,2023-07-01,,West Penn Allegheny Health System,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,23
NCT03914222,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Theranova, L.L.C.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03914794,0,0,0,0,0,0,2022-05-31,2023-05-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03916185,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03916731,0,0,0,0,0,0,2019-11-30,2020-11-30,,Healionics Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03917407,0,0,0,0,0,0,2022-09-24,2023-09-24,,Craig James McClain,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03920072,0,0,0,0,0,0,2019-12-31,2020-12-31,,Kyowa Kirin Pharmaceutical Development Ltd,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,9
NCT03921060,0,0,0,0,0,0,2026-07-31,2027-07-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03922321,0,0,0,0,0,0,2019-12-31,2020-12-31,,Immunovant Sciences GmbH,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03923348,0,0,0,0,0,0,2020-04-30,2021-04-30,,The Christ Hospital,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03923556,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,882
NCT03923959,0,0,0,0,0,0,2021-06-01,2022-06-01,,Lancaster General Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03925350,0,0,0,0,0,0,2021-02-28,2022-02-28,,California Pacific Medical Center Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,35
NCT03926780,0,0,0,0,0,0,2019-11-01,2020-11-01,,The Young Investigator Group of Cardiovascular Research,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03926975,0,0,0,0,0,0,2020-01-01,2021-01-01,,University of Houston,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,47
NCT03927716,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Novan, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03929224,0,0,0,0,0,0,2019-10-02,2020-10-02,,Ascension South East Michigan,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03929588,0,0,0,0,0,0,2019-09-30,2020-09-30,,EyeQue Corp.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03934099,0,0,0,0,0,0,2020-09-30,2021-09-30,,LG Chem,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,23
NCT03935295,0,0,0,0,0,0,2022-11-30,2023-11-30,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,1143
NCT03937141,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Aduro Biotech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03937713,0,0,0,0,0,0,2023-07-30,2024-07-30,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03937869,0,0,0,0,0,0,2019-12-31,2020-12-31,,Lupin Research Inc,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03938246,0,0,0,0,0,0,2020-05-31,2021-05-31,,"3V Biosciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03939182,0,0,0,0,0,0,2021-05-31,2022-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03940560,0,0,0,0,0,0,2020-12-31,2021-12-31,,Wigmore Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03942484,0,0,0,0,0,0,2020-11-01,2021-11-01,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT03943290,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Acceleron Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03944278,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sciton,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03945188,0,0,0,0,0,0,2021-11-30,2022-11-30,,Arena Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03947255,0,0,0,0,0,0,2024-12-31,2025-12-31,,"Seattle Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,77
NCT03950622,0,0,0,0,0,0,2020-03-13,2021-03-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03952156,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Homology Medicines, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,0,0,0,0,0,1,0,1,0,1
NCT03952468,0,0,0,0,0,0,2023-03-31,2024-03-31,,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03953170,0,0,0,0,0,0,2021-06-30,2022-06-30,,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,10
NCT03953300,0,0,0,0,0,0,2022-04-21,2023-04-21,,AstraZeneca,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03953768,0,0,0,0,0,0,2020-05-14,2021-05-14,,University of Louisville,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,214
NCT03953963,0,0,0,0,0,0,2021-07-30,2022-07-30,,Medality Medical,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03955055,0,0,0,0,0,0,2021-07-31,2022-07-31,,David Cave,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03958045,0,0,0,0,0,0,2023-07-31,2024-07-31,,Aman Chauhan,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,1
NCT03959566,0,0,0,0,0,0,2020-01-31,2021-01-31,,Michael Hoelscher,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,12
NCT03966924,0,0,0,0,0,0,2019-09-01,2020-09-01,,"Recros Medica, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03968419,0,0,0,0,0,0,2021-06-28,2022-06-28,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03968640,0,0,0,0,0,0,2022-06-30,2023-06-30,,American Burn Association,Other,0,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,0,0,3,1,0,7
NCT03969004,0,0,0,0,0,0,2025-06-30,2026-06-30,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03972137,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,227
NCT03973177,0,0,0,0,0,0,2020-07-31,2021-07-31,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03973957,0,0,0,0,0,0,2021-01-31,2022-01-31,,The Cooper Health System,Other,0,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,37
NCT03974802,0,0,0,0,0,0,2019-07-24,2020-07-24,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,85
NCT03975829,0,0,0,0,0,0,2026-05-29,2027-05-29,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03978520,0,0,0,0,0,0,2021-09-16,2022-09-16,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03980457,0,0,0,0,0,0,2022-09-01,2023-09-01,,University of Oklahoma,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,234
NCT03980730,0,0,0,0,0,0,2023-04-30,2024-04-30,,vTv Therapeutics,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03981523,0,0,0,0,0,0,2020-08-30,2021-08-30,,"University of Texas, El Paso",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,4
NCT03981861,1,0,0,0,1,0,2018-07-09,2019-07-09,,Children's Mercy Hospital Kansas City,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,138
NCT03983993,0,0,0,0,0,0,2025-06-30,2026-06-30,,Emory University,Other,0,1,0,1.0,Phase 2,0,2020.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03985293,0,0,0,0,0,0,2020-07-28,2021-07-28,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03985657,0,0,0,0,0,0,2019-12-18,2020-12-18,,Johns Hopkins University,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03986944,0,0,0,0,0,0,2022-01-31,2023-01-31,,ObsEva SA,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03988023,0,0,0,0,0,0,2020-03-31,2021-03-31,,Ampio Pharmaceuticals. Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,10
NCT03990766,0,0,0,0,0,0,2020-06-30,2021-06-30,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03991169,0,0,0,0,0,0,2021-12-31,2022-12-31,,Weill Medical College of Cornell University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03992456,0,0,0,0,0,0,2021-08-07,2022-08-07,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,32
NCT03993379,0,0,0,0,0,0,2021-01-31,2022-01-31,,CytomX Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03994172,0,0,0,0,0,0,2023-06-30,2024-06-30,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03995680,0,0,0,0,0,0,2019-10-08,2020-10-08,,Swiss Tropical & Public Health Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,28
NCT03995901,0,0,0,0,0,0,2023-04-30,2024-04-30,,Talaris Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03997305,0,0,0,0,0,0,2020-10-31,2021-10-31,,"4C Medical Technologies, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT04002934,0,0,0,0,0,0,2021-02-15,2022-02-15,,"Riley Bove, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04003155,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,135
NCT04004624,0,0,0,0,0,0,2019-09-16,2020-09-16,,Center for Cardiovascular Reseach and Innovation,Industry,1,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,3,0,1,1
NCT04006145,0,0,0,0,0,0,2020-04-30,2021-04-30,,Albireo,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04006392,0,0,0,0,0,0,2019-12-31,2020-12-31,,Erchonia Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT04007601,0,0,0,0,0,0,2023-04-01,2024-04-01,,St. Jude Children's Research Hospital,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,302
NCT04014842,0,0,0,0,0,0,2024-11-30,2025-11-30,,Zoll Medical Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,17
NCT04016116,0,0,0,0,0,0,2020-12-31,2021-12-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT04023240,0,0,0,0,0,0,2021-07-14,2022-07-14,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT04027049,0,0,0,0,0,0,2020-03-31,2021-03-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT04027829,0,0,0,0,0,0,2019-11-30,2020-11-30,,Seoul National University Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1227
NCT04028765,0,0,0,0,0,0,2021-08-30,2022-08-30,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT04029584,0,0,0,0,0,0,2020-04-25,2021-04-25,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT04032327,0,0,0,0,0,0,2020-07-01,2021-07-01,,Walter Reed National Military Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,47
NCT04033081,0,0,0,0,0,0,2021-03-31,2022-03-31,,CivaTech Oncology,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT04035135,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Annexon, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT04039217,0,0,0,0,0,0,2020-07-31,2021-07-31,,Emory University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT04040062,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT04040387,0,0,0,0,0,0,2020-07-24,2021-07-24,,NightWare,Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT04042545,0,0,0,0,0,0,2020-11-30,2021-11-30,,Tetra Bio-Pharma,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT04042831,0,0,0,0,0,0,2021-09-30,2022-09-30,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT04043442,0,0,0,0,0,0,2023-07-01,2024-07-01,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT04044560,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of British Columbia,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,881
NCT04050215,0,0,0,0,0,0,2021-04-01,2022-04-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,277
NCT04051710,0,0,0,0,0,0,2019-09-30,2020-09-30,,Aurobindo Pharma Ltd,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT04056195,0,0,0,0,0,0,2021-02-28,2022-02-28,,Oscotec Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT04056910,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Jason J. Luke, MD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04060407,0,0,0,0,0,0,2022-12-30,2023-12-30,,"OncoImmune, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT04061603,0,0,0,0,0,0,2019-11-07,2020-11-07,,Adagio Medical,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT04064684,0,0,0,0,0,0,2021-08-31,2022-08-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT04065113,0,0,0,0,0,0,2021-08-18,2022-08-18,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,1151
NCT04069936,0,0,0,0,0,0,2021-07-31,2022-07-31,,WindMIL Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT04071756,0,0,0,0,0,0,2021-10-01,2022-10-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT04074161,0,0,0,0,0,0,2021-04-08,2022-04-08,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,981
NCT04075474,0,0,0,0,0,0,2022-06-30,2023-06-30,,The University of Hong Kong,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,547
NCT04075825,0,0,0,0,0,0,2024-12-30,2025-12-30,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,209
NCT04076579,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Michigan Rogel Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT04079712,0,0,0,0,0,0,2021-10-01,2022-10-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2020.0,0,1,1,0,0,0,0,0,3,1,0,3004
NCT04080908,0,0,0,0,0,0,2020-10-31,2021-10-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT04082572,0,0,0,0,0,0,2021-05-03,2022-05-03,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT04083378,0,0,0,0,0,0,2022-12-31,2023-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,2066
NCT04083599,0,0,0,0,0,0,2020-12-31,2021-12-31,,Genmab,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,20
NCT04084366,0,0,0,0,0,0,2023-04-15,2024-04-15,,"OBI Pharma, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT04085523,0,0,0,0,0,0,2021-06-30,2022-06-30,,Ascendis Pharma A/S,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT04086745,0,0,0,0,0,0,2024-11-29,2025-11-29,,Eli Lilly and Company,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1512
NCT04088318,0,0,0,0,0,0,2020-12-31,2021-12-31,,OnQuality Pharmaceuticals (USA) LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04089722,0,0,0,0,0,0,2020-06-11,2021-06-11,,Juva Skin & Laser Center,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT00058422,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2003.0,0,1,1,0,0,1,0,0,0,0,1,1432
NCT00116142,0,0,0,0,0,0,2020-01-31,2021-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,3.0,Phase 3,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT00185744,0,0,0,0,0,0,2029-03-31,2030-03-31,,Stanford University,Other,0,0,0,5.0,,0,2002.0,0,0,0,0,0,1,0,0,0,0,1,1309
NCT00186992,0,0,0,0,0,0,2024-01-31,2025-01-31,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2003.0,0,0,0,0,0,1,0,0,0,0,1,302
NCT00368355,0,0,0,0,0,0,2019-04-30,2020-04-30,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2000.0,0,1,1,0,0,1,0,0,0,0,1,518
NCT00432094,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2006.0,0,1,1,0,0,0,0,0,0,0,1,218
NCT00450814,1,0,1,1,0,1,2018-07-10,2019-07-10,2019-08-12,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2006.0,0,1,1,0,0,0,0,0,0,0,1,1898
NCT00458484,0,0,0,0,0,0,2019-08-26,2020-08-26,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2007.0,1,0,0,0,0,1,0,0,0,0,1,374
NCT00492050,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00506909,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-30,David Feifel,Other,0,0,0,5.0,,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT00550238,1,1,0,1,0,0,2018-05-30,2019-05-30,2019-05-29,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2007.0,1,1,0,0,0,0,0,0,1,0,1,24
NCT00578643,1,1,0,1,0,1,2017-07-31,2018-07-31,2018-08-21,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2004.0,1,1,1,0,0,0,0,0,0,0,1,518
NCT00584233,0,0,0,0,0,0,2020-02-29,2021-02-28,,"University of California, Davis",Other,0,0,1,5.0,,0,2004.0,0,0,0,1,0,0,0,0,0,0,1,530
NCT00587301,0,0,0,0,0,0,2019-08-31,2020-08-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2005.0,1,0,0,1,0,0,0,0,0,0,1,869
NCT00590824,0,0,1,1,0,0,2020-01-31,2021-01-31,2019-08-01,"University of Wisconsin, Madison",Other,0,1,1,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,715
NCT00609791,0,0,0,0,0,0,2019-08-16,2020-08-16,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT00634634,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Rutgers, The State University of New Jersey",Other,0,1,1,0.0,Phase 1/Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,227
NCT00647387,0,0,0,0,0,0,2020-12-31,2021-12-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2008.0,0,0,0,1,0,0,0,0,1,0,1,419
NCT00659126,0,0,0,0,0,0,2019-12-31,2020-12-31,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT00659776,0,0,0,0,0,0,2020-12-31,2021-12-31,,Oregon Health and Science University,Other,0,0,1,1.0,Phase 2,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,475
NCT00670774,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-23,Mark Stegall,Other,0,1,0,0.0,Phase 1/Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT00675714,0,0,0,0,0,0,2018-09-30,2019-09-30,,"The University of Texas Medical Branch, Galveston",Other,0,0,1,2.0,Phase 2/Phase 3,0,2004.0,1,1,0,0,0,0,0,0,0,0,1,158
NCT00682318,0,0,0,0,0,0,2024-11-30,2025-11-30,,"Carsten Skarke, MD",Other,0,0,0,5.0,,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT00690924,1,1,0,1,0,0,2017-03-07,2018-03-07,2017-07-13,Roswell Park Cancer Institute,Other,0,0,1,5.0,,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,294
NCT00719888,0,0,0,0,0,0,2022-12-31,2023-12-31,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2005.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT00723099,1,0,1,1,0,0,2018-07-31,2019-07-31,2019-07-30,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT00745134,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT00790933,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-10-31,Takeda,Industry,1,0,0,3.0,Phase 3,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT00794950,0,0,1,1,0,0,2019-07-31,2020-07-31,2019-08-26,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT00820170,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-01-25,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00824993,1,1,0,1,0,0,2017-04-07,2018-04-07,2018-03-09,M.D. Anderson Cancer Center,Other,0,1,0,3.0,Phase 3,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00862433,0,0,0,0,0,0,2025-12-31,2026-12-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT00876863,1,0,0,0,1,0,2017-12-31,2018-12-31,,Sangamo Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2008.0,1,0,0,0,0,0,0,1,0,0,1,18
NCT00910429,0,0,0,0,0,0,2019-08-19,2020-08-19,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT00915005,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT00915681,0,0,0,0,0,0,2018-12-31,2019-12-31,,Madaus Inc,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT00928226,1,0,0,0,1,0,2017-10-31,2018-10-31,,Stanford University,Other,0,0,0,5.0,,0,2009.0,0,0,0,0,0,1,0,0,0,0,1,1309
NCT00936611,0,0,0,0,0,0,2021-07-31,2022-07-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT00943618,0,0,0,0,0,0,2020-05-31,2021-05-31,,M.D. Anderson Cancer Center,Other,0,1,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00977691,1,0,1,1,0,1,2018-08-01,2019-08-01,2019-08-23,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT00995150,0,0,0,0,0,0,2023-05-31,2024-05-31,,Medicines360,Other,0,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01025089,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01034670,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stanford University,Other,0,0,1,5.0,,0,2009.0,0,1,0,1,0,0,0,0,0,0,1,1309
NCT01072370,0,0,0,0,0,0,2019-06-30,2020-06-30,,Augusta University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,0,1,0,0,0,0,0,0,0,1,117
NCT01090414,1,1,0,1,0,0,2018-06-18,2019-06-18,2019-06-07,Gilead Sciences,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2010.0,1,1,0,0,0,0,0,0,0,0,1,510
NCT01125176,0,1,0,1,0,0,2018-12-20,2019-12-20,2019-06-28,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,586
NCT01131169,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01133678,1,0,0,0,1,0,2018-08-31,2019-08-31,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT01141023,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Ken Marek, MD",Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT01190189,1,1,0,1,0,0,2017-11-23,2018-11-23,2018-11-22,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,0,1,0,0,0,0,0,1,0,1,3276
NCT01192568,0,0,0,0,0,0,2020-06-18,2021-06-18,,Allergan,Industry,1,0,0,4.0,Phase 4,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT01244737,0,0,0,0,0,0,2019-08-31,2020-08-31,,Frederick Daniel Grant,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01258855,1,1,0,1,0,1,2018-03-29,2019-03-29,2019-04-09,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,1,0,1,0,0,0,0,0,0,0,1,3004
NCT01264705,1,0,0,0,1,0,2018-04-30,2019-04-30,,University of Texas Southwestern Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT01269034,0,0,0,0,0,0,2019-12-31,2020-12-31,,Albert Einstein College of Medicine,Other,0,0,1,4.0,Phase 4,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,155
NCT01291719,0,0,0,0,0,0,2020-11-30,2021-11-30,,Admetsys Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2008.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT01297309,1,1,0,1,0,0,2018-06-08,2019-06-08,2019-06-07,Shire,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,342
NCT01301521,0,0,0,0,0,0,2019-04-30,2020-04-30,,Mike O'Callaghan Military Hospital,U.S. Fed,2,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT01306045,0,0,0,0,0,0,2020-12-30,2021-12-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01339559,0,0,0,0,0,0,2019-04-18,2020-04-18,,"UCB BIOSCIENCES, Inc.",Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT01345136,0,0,0,0,0,0,2020-02-01,2021-02-01,,Jonsson Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,277
NCT01366612,0,0,0,0,0,0,2019-11-30,2020-11-30,,Hackensack Meridian Health,Other,0,0,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT01370447,0,0,0,0,0,0,2021-12-31,2022-12-31,,Edison Pharmaceuticals Inc,Industry,1,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT01370512,0,0,0,0,0,0,2020-06-30,2021-06-30,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01386658,1,1,0,1,0,0,2018-03-12,2019-03-12,2019-02-14,Shire,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,342
NCT01387932,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Merit Medical Systems, Inc.",Industry,1,0,0,3.0,Phase 3,0,2011.0,0,0,0,1,0,0,0,0,1,0,1,12
NCT01394952,1,0,1,1,0,0,2018-08-21,2019-08-21,2019-08-09,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT01408563,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-09-14,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,1,0,0,1,0,0,0,0,1,1699
NCT01410825,1,0,0,0,1,0,2018-01-31,2019-01-31,,David Williams,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,4
NCT01410890,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Genzyme, a Sanofi Company",Industry,1,0,0,4.0,Phase 4,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,300
NCT01413178,0,0,0,0,0,0,2019-03-10,2020-03-10,,M.D. Anderson Cancer Center,Other,0,1,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01425723,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-10-05,Bioverativ Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,0,1,0,0,0,0,0,1,0,1,19
NCT01427595,0,0,0,0,0,0,2019-06-28,2020-06-28,,University of Virginia,Other,0,0,1,5.0,,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,402
NCT01444209,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,626
NCT01444742,1,1,0,1,0,1,2017-01-29,2018-01-29,2018-03-13,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01451736,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Los Angeles",Other,0,1,1,4.0,Phase 4,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,692
NCT01454739,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-10-05,Bioverativ Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,19
NCT01461668,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-01-13,"University of California, Irvine",Other,0,0,1,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,310
NCT01489865,0,0,0,0,0,0,2019-12-31,2020-12-31,,Georgetown University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT01520519,1,0,1,1,0,1,2018-08-09,2019-08-09,2019-08-19,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01524211,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Lee, W. Anthony, M.D. FACS",Other,0,1,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT01526928,1,0,1,1,0,0,2018-07-03,2019-07-03,2019-06-11,"Clovis Oncology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT01530659,0,0,0,0,0,0,2019-08-31,2020-08-31,,Neurotech Pharmaceuticals,Industry,1,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT01535937,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-04-12,New York State Psychiatric Institute,Other,0,0,1,0.0,Phase 1/Phase 2,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT01538966,0,0,0,0,0,0,2020-03-31,2021-03-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,279
NCT01553188,1,1,0,1,0,1,2017-04-20,2018-04-20,2018-06-21,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01555905,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Florida,Other,0,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,849
NCT01556490,0,0,0,0,0,0,2020-02-29,2021-02-28,,BTG International Inc.,Other,0,1,0,3.0,Phase 3,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,34
NCT01582204,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01584609,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-05-17,Penumbra Inc.,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,20
NCT01585831,1,0,0,0,1,0,2017-10-31,2018-10-31,,"University of Colorado, Denver",Other,0,0,1,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT01592721,0,0,0,0,0,0,2024-01-31,2025-01-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,257
NCT01600170,0,0,0,0,0,0,2017-10-31,2018-10-31,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01638936,0,0,0,0,0,0,2018-10-30,2019-10-30,,Biotest Pharmaceuticals Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT01654133,0,0,0,0,0,0,2021-08-31,2022-08-31,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT01656733,1,0,1,1,0,1,2017-07-02,2018-07-02,2019-01-31,UConn Health,Other,0,0,1,4.0,Phase 4,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,148
NCT01661101,1,0,0,0,1,0,2018-03-01,2019-03-01,,Population Health Research Institute,Other,0,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,77
NCT01664741,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-03-27,Johns Hopkins University,Other,0,0,1,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT01666808,0,0,0,0,0,0,2022-05-31,2023-05-31,,Emory University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,947
NCT01667120,0,0,0,0,0,0,2018-12-31,2019-12-31,,Nationwide Children's Hospital,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,161
NCT01675960,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-09,Gillette Children's Specialty Healthcare,Other,0,0,0,1.0,Phase 2,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT01681264,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,0,1,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01697566,0,0,0,0,0,0,2021-09-30,2022-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01702844,0,0,0,0,0,0,2020-01-31,2021-01-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT01703117,0,0,0,0,0,0,2020-11-30,2021-11-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT01712490,1,1,0,1,0,0,2017-04-20,2018-04-20,2018-04-18,"Millennium Pharmaceuticals, Inc.",Industry,1,1,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT01717482,0,1,0,1,0,0,2019-05-22,2020-05-22,2019-05-28,Mayo Clinic,Other,0,0,0,1.0,Phase 2,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT01720667,1,1,0,1,0,1,2017-10-31,2018-10-31,2019-07-03,Richard H. Haas,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01724346,0,0,0,0,0,0,2023-04-30,2024-04-30,,Pharmacyclics LLC.,Industry,1,1,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,54
NCT01730534,1,0,1,1,0,0,2018-09-11,2019-09-11,2019-09-06,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT01746043,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-03-23,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01746251,0,0,0,0,0,0,2019-08-31,2020-08-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01750073,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Nebraska,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,1,0,0,1,0,0,0,0,1,327
NCT01750697,1,1,0,1,0,0,2018-05-10,2019-05-10,2019-05-03,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT01751451,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01757184,0,1,0,1,0,0,2019-01-31,2020-01-31,2016-01-14,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,86
NCT01772420,0,0,0,0,0,0,2020-01-31,2021-01-31,,Amit Verma,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01773967,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-06-25,Washington University School of Medicine,Other,0,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT01777152,1,1,0,1,0,0,2018-08-15,2019-08-15,2019-07-10,"Seattle Genetics, Inc.",Industry,1,1,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,77
NCT01778946,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vanderbilt University Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,422
NCT01779024,1,1,0,1,0,0,2017-06-01,2018-06-01,2018-05-23,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,96
NCT01781429,1,0,0,0,1,0,2018-02-28,2019-02-28,,"BioMed Valley Discoveries, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT01786265,0,0,0,0,0,0,2020-02-01,2021-02-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01786603,1,0,0,0,1,0,2017-08-31,2018-08-31,,"Richard Barohn, MD",Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01804049,1,0,0,0,1,0,2018-08-31,2019-08-31,,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01804270,0,0,0,0,0,0,2019-12-31,2020-12-31,,Paul E. Croarkin,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT01804465,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT01812174,0,0,0,0,0,0,2019-12-31,2020-12-31,,"On-X Life Technologies, Inc.",Industry,1,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT01816165,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT01818427,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-08-08,Jason Sperry,Other,0,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT01824082,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of California, San Diego",Other,0,0,1,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT01824875,0,0,0,0,0,0,2023-06-01,2024-06-01,,Eastern Cooperative Oncology Group,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,175
NCT01827384,0,0,0,0,0,0,2020-05-05,2021-05-05,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01827904,0,0,0,0,0,0,2019-12-31,2020-12-31,,InSightec,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,61
NCT01828697,0,0,0,0,0,0,2020-12-31,2021-12-31,,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,229
NCT01829217,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-01-30,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT01833143,0,0,0,0,0,0,2019-08-28,2020-08-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01834326,0,0,0,0,0,0,2019-09-30,2020-09-30,,Stephen E. Feinberg,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT01841450,0,0,0,0,0,0,2021-05-31,2022-05-31,,Glaukos Corporation,Industry,1,0,0,4.0,Phase 4,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,34
NCT01850355,0,0,0,0,0,0,2019-04-30,2020-04-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01852058,0,0,0,0,0,0,2018-11-22,2019-11-22,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,495
NCT01853644,0,0,0,0,0,0,2019-03-31,2020-03-31,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT01854034,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-02-08,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01857934,0,0,0,0,0,0,2021-01-31,2022-01-31,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,1,1,0,1,0,0,0,0,1,302
NCT01858194,1,0,0,0,1,0,2017-09-01,2018-09-01,,Vivek Reddy,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,1,0,1,15
NCT01860612,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Clinical Research Consultants, Inc.",Industry,1,1,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT01874197,0,0,0,0,0,0,2025-08-31,2026-08-31,,University of Washington,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT01880957,1,0,0,0,1,0,2017-05-31,2018-05-31,,Stony Brook University,Other,0,0,1,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,119
NCT01881503,0,0,0,0,0,0,2019-12-31,2020-12-31,,Englewood Hospital and Medical Center,Other,0,1,0,5.0,,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,14
NCT01885078,0,0,0,0,0,0,2024-02-14,2025-02-14,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT01891500,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT01895777,0,0,0,0,0,0,2019-10-16,2020-10-16,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1852
NCT01897532,1,1,0,1,0,0,2018-01-18,2019-01-18,2018-12-21,Boehringer Ingelheim,Industry,1,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT01912716,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-25,Indiana University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,497
NCT01928290,0,0,0,0,0,0,2018-12-03,2019-12-03,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT01931202,0,0,0,0,0,0,2019-02-28,2020-02-28,,New York State Psychiatric Institute,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT01933815,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Cortice Biosciences, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT01937559,0,0,0,0,0,0,2018-12-31,2019-12-31,,The Hawkins Foundation,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,13
NCT01952288,0,0,0,0,0,0,2017-06-20,2018-06-20,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01957176,0,0,0,0,0,0,2024-01-01,2025-01-01,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,2,0,1,1895
NCT01962896,1,1,0,1,0,1,2017-06-13,2018-06-13,2019-01-11,Theodore Laetsch,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01964755,1,0,1,1,0,0,2018-06-07,2019-06-07,2019-05-06,University of Miami,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,1,0,0,0,0,0,0,0,1,476
NCT01970865,1,1,0,1,0,0,2017-03-15,2018-03-15,2018-03-05,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT01990196,0,0,0,0,0,0,2019-09-30,2020-09-30,,Jonsson Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,277
NCT01996254,0,0,0,0,0,0,2019-01-28,2020-01-28,,"SPR Therapeutics, Inc.",Industry,1,1,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT01996436,0,0,0,0,0,0,2020-08-31,2021-08-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,490
NCT01996826,1,0,0,0,1,0,2018-04-30,2019-04-30,,"Reza Dana, MD",Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT01999946,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,1,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02002884,0,0,0,0,0,0,2017-07-04,2018-07-04,,Merz Pharmaceuticals GmbH,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,58
NCT02003144,0,0,0,0,0,0,2020-06-30,2021-06-30,,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,86
NCT02018367,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Anandasabapathy, Sharmila, M.D.",Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02021929,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-02-25,University of Pennsylvania,Other,0,0,1,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02025010,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,1,0,0,1,647
NCT02026063,1,0,1,1,0,0,2018-09-12,2019-09-12,2019-08-22,Lexicon Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,41
NCT02028988,0,0,0,0,0,0,2020-01-31,2021-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,647
NCT02030028,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dr. Larry W. Moreland,Other,0,1,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02032004,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Mesoblast, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,1
NCT02042950,1,1,0,1,0,1,2017-12-20,2018-12-20,2019-04-09,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02043678,1,1,0,1,0,0,2018-02-15,2019-02-15,2019-02-12,Bayer,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02045901,1,0,0,0,1,0,2017-03-31,2018-03-31,,Duchesnay Inc.,Industry,1,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02046096,0,0,0,0,0,0,2018-12-18,2019-12-18,,Cook Research Incorporated,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,20
NCT02046395,0,0,0,0,0,0,2019-12-31,2020-12-31,,Tulane University Health Sciences Center,Other,0,0,0,4.0,Phase 4,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,15
NCT02050841,1,1,0,1,0,1,2017-12-04,2018-12-04,2019-01-07,Octapharma,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,54
NCT02052310,0,0,0,0,0,0,2018-09-21,2019-09-21,,FibroGen,Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT02056873,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Florida,Other,0,1,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,849
NCT02058940,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-06-01,"University of North Carolina, Chapel Hill",Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02061332,0,0,0,0,0,0,2018-12-31,2019-12-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,1,0,1,0,0,0,0,0,0,0,1,273
NCT02061800,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Diane George, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,1,0,0,0,0,0,0,1,2
NCT02065687,0,0,0,0,0,0,2019-09-01,2020-09-01,,Gynecologic Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,200
NCT02067819,0,0,0,0,0,0,2019-12-31,2020-12-31,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,586
NCT02071173,0,0,0,0,0,0,2017-04-19,2018-04-19,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,340
NCT02071901,0,0,0,0,0,0,2018-10-20,2019-10-20,,Case Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,374
NCT02073279,0,0,0,0,0,0,2018-10-12,2019-10-12,,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02074436,0,0,0,0,0,0,2021-05-31,2022-05-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02075047,0,0,0,0,0,0,2020-09-03,2021-09-03,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2856
NCT02090725,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-03-26,"Jeffrey A. Cohen, MD",Other,0,1,0,1.0,Phase 2,1,2004.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02092298,0,0,0,0,0,0,2020-06-01,2021-06-01,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02098161,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02098265,0,0,0,0,0,0,2023-06-30,2024-06-30,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,715
NCT02102113,0,0,0,0,0,0,2020-01-31,2021-01-31,,Yale University,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02102243,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02108600,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02115282,0,0,0,0,0,0,2021-01-14,2022-01-14,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02120794,1,1,0,1,0,0,2017-06-16,2018-06-16,2018-06-16,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,48
NCT02122185,0,0,0,0,0,0,2020-02-25,2021-02-25,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02125721,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-07-17,NYU Langone Health,Other,0,0,1,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02126579,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Craig L Slingluff, Jr",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,19
NCT02126969,1,1,0,1,0,1,2018-03-31,2019-03-31,2019-05-03,University of Kentucky,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,77
NCT02132130,0,0,0,0,0,0,2019-10-09,2020-10-09,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1895
NCT02137759,0,0,0,0,0,0,2020-07-31,2021-07-31,,Emory University,Other,0,1,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,947
NCT02137850,0,0,0,0,0,0,2021-11-13,2022-11-13,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,981
NCT02138253,1,0,1,1,0,1,2018-02-15,2019-02-15,2019-05-02,Conatus Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT02141282,0,0,0,0,0,0,2021-11-08,2022-11-08,,AbbVie,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,430
NCT02142283,1,1,0,1,0,0,2017-05-15,2018-05-15,2018-05-15,Stryker Neurovascular,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,18
NCT02147067,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-31,Emory University,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02148796,0,0,0,0,0,0,2023-12-31,2024-12-31,,University of Arizona,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,265
NCT02150967,0,0,0,0,0,0,2022-03-31,2023-03-31,,"QED Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT02151383,1,1,0,1,0,0,2017-04-03,2018-04-03,2017-09-27,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02152696,0,0,0,0,0,0,2019-08-31,2020-08-31,,Yale University,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02152956,0,0,0,0,0,0,2020-01-31,2021-01-31,,MacroGenics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02153229,0,0,0,0,0,0,2020-05-31,2021-05-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,273
NCT02158585,1,0,1,1,0,1,2017-03-31,2018-03-31,2019-02-08,Dent Neuroscience Research Center,Other,0,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02159872,0,0,0,0,0,0,2019-09-15,2020-09-15,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02162550,0,0,0,0,0,0,2019-04-30,2020-04-30,,Phoenix VA Health Care System,U.S. Fed,2,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02165124,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-09-24,Johns Hopkins University,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1143
NCT02167009,0,0,0,0,0,0,2020-05-31,2021-05-31,,Tampa General Hospital,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,9
NCT02168101,0,0,0,0,0,0,2020-01-31,2021-01-31,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,167
NCT02168764,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Autonomic Technologies, Inc.",Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02169752,1,0,0,0,1,0,2017-05-25,2018-05-25,,National Jewish Health,Other,0,0,0,5.0,,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,81
NCT02175004,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,69
NCT02176161,0,0,0,0,0,0,2021-06-01,2022-06-01,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02186457,0,0,1,1,0,0,2020-08-31,2021-08-31,2019-08-14,Indiana University,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,497
NCT02186834,1,1,0,1,0,0,2017-11-08,2018-11-08,2018-08-30,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02189395,1,0,0,0,1,0,2017-04-30,2018-04-30,,Riverside University Health System Medical Center,Other,0,0,0,4.0,Phase 4,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02189798,0,0,0,0,0,0,2020-06-30,2021-06-30,,Advanced Bionics,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02196181,0,0,0,0,0,0,2020-06-15,2021-06-15,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02201277,1,1,0,1,0,1,2018-04-13,2019-04-13,2019-04-16,"University of California, San Francisco",Other,0,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1443
NCT02215070,0,0,0,0,0,0,2019-05-04,2020-05-04,,"Anthony Sung, MD",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02218736,1,1,0,1,0,0,2017-11-01,2018-11-01,2018-11-01,Duke University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02224781,0,0,0,0,0,0,2022-10-02,2023-10-02,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02230189,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1443
NCT02232191,0,0,0,0,0,0,2019-09-01,2020-09-01,,"University of California, Davis",Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,530
NCT02235909,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Arbor Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,13
NCT02238626,0,0,0,0,0,0,2017-08-31,2018-08-31,,MediciNova,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT02243371,0,0,1,1,0,0,2019-01-31,2020-01-31,2019-08-06,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,461
NCT02251236,1,0,0,0,1,0,2017-01-18,2018-01-18,,"University of California, San Diego",Other,0,1,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT02253394,1,0,1,1,0,1,2018-02-28,2019-02-28,2019-08-28,Brigham and Women's Hospital,Other,0,1,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT02253992,0,0,0,0,0,0,2019-03-29,2020-03-29,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,1104
NCT02255929,0,0,0,0,0,0,2019-09-30,2020-09-30,,Swedish Medical Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,34
NCT02264678,0,0,0,0,0,0,2021-04-21,2022-04-21,,AstraZeneca,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02265874,0,0,0,0,0,0,2019-10-31,2020-10-31,,Ohio State University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,315
NCT02266329,0,0,0,0,0,0,2019-09-30,2020-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02266719,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,626
NCT02269241,1,1,0,1,0,1,2017-10-04,2018-10-04,2019-06-14,"Laboratories Leon Farma, S.A.",Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02272803,1,1,0,1,0,0,2017-02-09,2018-02-09,2018-01-26,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,2,0,1,1104
NCT02282358,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02283749,1,1,0,1,0,0,2018-07-05,2019-07-05,2018-03-28,Angela Taber MD,Other,0,1,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2
NCT02289690,0,0,0,0,0,0,2019-04-17,2020-04-17,,AbbVie,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02290028,0,0,0,0,0,0,2023-05-31,2024-05-31,,Biotronik SE & Co. KG,Industry,1,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,65
NCT02292017,1,0,0,0,1,0,2018-02-01,2019-02-01,,"Tennessee Neurovascular Institute, LLC",Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02292238,0,0,0,0,0,0,2019-11-30,2020-11-30,,Burke Medical Research Institute,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,11
NCT02294435,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sanford Health,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,23
NCT02296580,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Nativis, Inc.",Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,3
NCT02313909,1,1,0,1,0,0,2018-02-15,2019-02-15,2018-11-20,Bayer,Industry,1,1,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT02320058,0,0,0,0,0,0,2022-11-03,2023-11-03,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1104
NCT02320812,1,1,0,1,0,1,2017-07-19,2018-07-19,2018-08-07,"jCyte, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2
NCT02322125,1,0,0,0,1,0,2018-07-30,2019-07-30,,University of Alberta,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,2,0,1,432
NCT02323854,1,1,0,1,0,0,2017-03-13,2018-03-13,2018-03-09,Medtronic - MITG,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,146
NCT02330094,1,1,0,1,0,1,2017-09-01,2018-09-01,2019-04-15,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02332291,0,0,0,0,0,0,2020-10-31,2021-10-31,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,422
NCT02334293,1,0,0,0,1,0,2017-07-31,2018-07-31,,Carle Foundation Hospital,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02334384,1,1,0,1,0,1,2017-08-01,2018-08-01,2018-08-02,Eastern Virginia Medical School,Other,0,1,1,0.0,Phase 1/Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,33
NCT02335242,0,0,0,0,0,0,2021-04-30,2022-04-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02335424,1,1,0,1,0,0,2018-06-19,2019-06-19,2019-05-29,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,3,0,1,2145
NCT02336984,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,344
NCT02337465,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,1,0,0,0,0,1,374
NCT02338050,0,0,0,0,0,0,2020-05-31,2021-05-31,,Center for International Blood and Marrow Transplant Research,Other,0,1,0,1.0,Phase 2,1,2015.0,0,0,1,0,0,0,0,0,0,0,1,25
NCT02338609,0,0,0,0,0,0,2026-09-25,2027-09-25,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02340156,0,0,0,0,0,0,2018-11-30,2019-11-30,,"SynerGene Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,1,1,0,1,6
NCT02343575,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-05-31,Stanford University,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02346708,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of Colorado, Denver",Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,882
NCT02349893,1,0,0,0,1,0,2018-02-28,2019-02-28,,Olympus Surgical Technologies Europe,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02351258,0,0,0,0,0,0,2019-09-30,2020-09-30,,Johns Hopkins University,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02352363,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-06-04,Acorda Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,38
NCT02355184,0,0,0,0,0,0,2020-03-31,2021-03-31,,"CytoDyn, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,14
NCT02357992,0,0,0,0,0,0,2025-04-30,2026-04-30,,M.D. Anderson Cancer Center,Other,0,1,0,5.0,,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT02362035,0,0,0,0,0,0,2021-04-30,2022-04-30,,Acerta Pharma BV,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT02362646,1,0,0,0,1,0,2018-08-10,2019-08-10,,Annetine Gelijns,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,1,0,0,0,0,0,1,0,1,2
NCT02369835,0,0,1,1,0,0,2019-09-30,2020-09-30,2019-07-31,Stanford University,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02370693,0,0,0,0,0,0,2020-06-30,2021-06-30,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02370784,0,0,0,0,0,0,2018-12-15,2019-12-15,,"Robyn T. Domsic, MD, MPH",Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02372240,1,0,0,0,1,0,2017-05-24,2018-05-24,,Vivolux AB,Industry,1,1,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02383407,1,0,0,0,1,0,2018-01-31,2019-01-31,,George Washington University,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,85
NCT02388165,0,0,0,0,0,0,2019-06-26,2020-06-26,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,2856
NCT02393794,0,0,0,0,0,0,2019-07-31,2020-07-31,,Priyanka Sharma,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02395666,0,0,0,0,0,0,2019-12-31,2020-12-31,,Giselle Sholler,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT02396134,0,0,0,0,0,0,2020-05-31,2021-05-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,358
NCT02399371,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,594
NCT02401230,1,1,0,1,0,0,2017-01-25,2018-01-25,2017-12-19,Emory University,Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,947
NCT02408549,0,0,0,0,0,0,2024-01-31,2025-01-31,,"UCB BIOSCIENCES, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT02414230,0,0,0,0,0,0,2020-03-31,2021-03-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02414841,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-05-24,Proteon Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02417298,1,0,0,0,1,0,2018-04-01,2019-04-01,,Billy Sin,Other,0,0,0,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02419469,1,1,0,1,0,0,2017-06-22,2018-06-22,2018-05-09,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02420015,0,1,0,1,0,0,2019-01-24,2020-01-24,2019-06-19,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT02420873,1,1,0,1,0,0,2017-06-06,2018-06-06,2018-05-03,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02426684,0,0,0,0,0,0,2017-12-30,2018-12-30,,Cedars-Sinai Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,279
NCT02429570,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02429934,0,0,0,0,0,0,2019-08-01,2020-08-01,,"University of California, Los Angeles",Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,692
NCT02441062,0,0,0,0,0,0,2019-09-30,2020-09-30,,Sue O'Dorisio,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02444234,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-04-25,University of Southern California,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,483
NCT02444741,0,0,0,0,0,0,2020-09-17,2021-09-17,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,1,0,0,0,0,1,2066
NCT02446132,0,0,0,0,0,0,2022-06-30,2023-06-30,,Avanir Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,29
NCT02447991,0,0,0,0,0,0,2019-06-30,2020-06-30,,Robert W. Baloh,Other,0,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02448342,1,0,0,0,1,0,2017-11-30,2018-11-30,,Sensible Medical Innovations Ltd.,Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02449681,1,0,0,0,1,0,2017-01-31,2018-01-31,,Threshold Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,22
NCT02450539,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-30,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02452398,1,0,1,1,0,1,2017-03-27,2018-03-27,2018-04-09,Venus Concept,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,23
NCT02452554,1,1,0,1,0,1,2017-06-30,2018-06-30,2019-07-17,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,389
NCT02455076,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-31,Emory University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02456857,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02457910,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vanderbilt-Ingram Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,180
NCT02462083,0,0,0,0,0,0,2017-01-31,2018-01-31,,"Bausch Health Americas, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02463799,0,0,0,0,0,0,2019-11-30,2020-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,461
NCT02465515,1,1,0,1,0,0,2018-02-20,2019-02-20,2019-02-11,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,3276
NCT02472769,1,0,0,0,1,0,2017-08-07,2018-08-07,,Infant Bacterial Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02475369,0,0,0,0,0,0,2019-06-30,2020-06-30,,Beth Israel Deaconess Medical Center,Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT02475447,1,0,0,0,1,0,2017-06-30,2018-06-30,,Tioga Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02484430,0,0,0,0,0,0,2020-05-31,2021-05-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02485990,0,0,0,0,0,0,2019-09-30,2020-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02488759,0,0,0,0,0,0,2022-05-12,2023-05-12,,Bristol-Myers Squibb,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02492750,0,0,0,0,0,0,2019-06-05,2020-06-05,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,1898
NCT02492880,1,1,0,1,0,1,2017-02-21,2018-02-21,2018-07-11,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,340
NCT02494570,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Aadi, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02494713,1,1,0,1,0,0,2017-09-14,2018-09-14,2018-09-12,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02497287,0,1,0,1,0,1,2017-10-28,2018-10-28,2019-04-03,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02498769,1,1,0,1,0,0,2017-09-28,2018-09-28,2018-09-27,"Joseph Mathew, M.D.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02501161,0,0,0,0,0,0,2018-10-03,2019-10-03,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02503657,0,0,0,0,0,0,2020-04-30,2021-04-30,,MediciNova,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,15
NCT02503852,1,0,1,1,0,1,2018-03-02,2019-03-02,2019-08-27,"Kerastem Technologies, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02504008,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Axsome Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02507206,1,0,0,0,1,0,2018-01-12,2019-01-12,,Antonia New,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02507297,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,934
NCT02508077,1,1,0,1,0,0,2017-09-13,2018-09-13,2018-07-20,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,1,2016.0,1,1,1,0,0,0,0,0,0,0,1,358
NCT02510885,0,0,0,0,0,0,2020-05-31,2021-05-31,,Duke University,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT02513563,0,0,0,0,0,0,2019-10-31,2020-10-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02513667,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Texas Southwestern Medical Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,626
NCT02513797,0,0,0,0,0,0,2021-06-30,2022-06-30,,"SentreHEART, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02514824,0,0,0,0,0,0,2019-09-30,2020-09-30,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02515331,1,1,0,1,0,0,2017-08-17,2018-08-17,2018-06-05,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02516202,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-07,Fred Hutchinson Cancer Research Center,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,393
NCT02518594,0,0,0,0,0,0,2024-08-31,2025-08-31,,The George Washington University Biostatistics Center,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,20
NCT02519842,1,1,0,1,0,0,2017-02-24,2018-02-24,2018-01-16,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,3,0,1,2145
NCT02521285,0,0,0,0,0,0,2019-08-17,2020-08-17,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02523274,0,0,0,0,0,0,2019-05-31,2020-05-31,,University of Florida,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,849
NCT02525029,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,218
NCT02531217,1,0,0,0,1,0,2017-03-14,2018-03-14,,"aTyr Pharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,6
NCT02532543,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,910
NCT02532764,1,1,0,1,0,1,2017-09-14,2018-09-14,2018-12-11,ProQR Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02535065,1,1,0,1,0,1,2017-01-23,2018-01-23,2018-04-11,Cook Research Incorporated,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,20
NCT02538042,1,1,0,1,0,0,2017-09-08,2018-09-08,2018-08-24,"Francis McClernon, Ph.D.",Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02538965,1,1,0,1,0,0,2017-07-22,2018-07-22,2018-07-13,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02545972,0,0,0,0,0,0,2018-11-30,2019-11-30,,Newark Beth Israel Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02553317,0,1,0,1,0,1,2017-08-31,2018-08-31,2019-02-25,Ablynx,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,26
NCT02555189,0,0,0,0,0,0,2020-04-14,2021-04-14,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,162
NCT02555306,1,0,0,0,1,0,2017-08-31,2018-08-31,,Santen Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT02556203,0,0,0,0,0,0,2018-11-27,2019-11-27,,Bayer,Industry,1,1,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT02558348,1,0,0,0,1,0,2017-02-14,2018-02-14,,"Advenchen Laboratories, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02559570,1,1,0,1,0,0,2018-04-20,2019-04-20,2019-04-19,Forest Laboratories,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,169
NCT02560766,0,0,0,0,0,0,2023-10-31,2024-10-31,,"XenoPort, Inc.",Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,22
NCT02563522,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Helixmith Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,1,0,1,0,13
NCT02566304,0,0,0,0,0,0,2020-04-23,2021-04-23,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,1,0,0,0,0,1,162
NCT02569541,1,0,0,0,1,0,2017-10-17,2018-10-17,,Arrevus Inc.,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02569853,1,1,0,1,0,1,2017-05-30,2018-05-30,2018-06-27,Dr. Reddy's Laboratories Limited,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,212
NCT02570308,0,0,0,0,0,0,2020-03-31,2021-03-31,,Immunocore Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02574481,1,1,0,1,0,0,2017-12-28,2018-12-28,2018-10-17,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,340
NCT02579096,0,0,0,0,0,0,2021-02-26,2022-02-26,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT02580058,0,0,1,1,0,0,2018-09-19,2019-09-19,2019-09-09,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,2856
NCT02586831,0,0,0,0,0,0,2022-12-31,2023-12-31,,Camillo Ricordi and Jay Skyler,Other,0,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02587065,1,0,0,0,1,0,2017-10-02,2018-10-02,,Biogen,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,324
NCT02597829,1,0,0,0,1,0,2018-05-31,2019-05-31,,Shafran Gastroenterology Center,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02598895,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Washington,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02600819,1,1,0,1,0,0,2017-09-29,2018-09-29,2018-09-21,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02605967,0,0,0,0,0,0,2020-01-30,2021-01-30,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02606123,1,0,0,0,1,0,2017-12-31,2018-12-31,,ESSA Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT02610868,0,0,1,1,0,1,2017-06-30,2018-06-30,2019-09-06,US WorldMeds LLC,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,20
NCT02612857,1,0,1,1,0,1,2018-05-16,2019-05-16,2019-08-13,"Idera Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02613416,0,0,0,0,0,0,2020-11-30,2021-11-30,,Stony Brook University,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,119
NCT02615067,0,0,0,0,0,0,2017-12-28,2018-12-28,,"Molecular Insight Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,1,0,0,0,1,0,1,19
NCT02615535,1,0,1,1,0,1,2017-12-31,2018-12-31,2019-08-09,Spaulding Rehabilitation Hospital,Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,69
NCT02616029,0,0,0,0,0,0,2018-10-11,2019-10-11,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02616900,1,1,0,1,0,1,2017-03-31,2018-03-31,2019-02-06,eSight Corporation,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,1,0,1,1
NCT02618343,0,0,0,0,0,0,2019-03-01,2020-03-01,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02620683,1,1,0,1,0,0,2017-08-31,2018-08-31,2017-09-25,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02622542,0,0,0,0,0,0,2023-12-31,2024-12-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT02624518,0,0,0,0,0,0,2020-11-30,2021-11-30,,Andrei Iagaru,Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02625454,0,0,0,0,0,0,2019-05-31,2020-05-31,,Richmond University Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT02625961,0,0,0,0,0,0,2022-06-15,2023-06-15,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,2145
NCT02626715,0,0,0,0,0,0,2020-09-30,2021-09-30,,Randy Windreich,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02628873,0,0,0,0,0,0,2018-09-30,2019-09-30,,Wright State University,Other,0,1,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,15
NCT02629094,1,1,0,1,0,0,2017-09-11,2018-09-11,2018-05-07,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT02631876,0,0,0,0,0,0,2019-01-31,2020-01-31,,"ImmunoGen, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,16
NCT02633020,0,0,0,0,0,0,2017-04-11,2018-04-11,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,685
NCT02633397,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Gregory J. Kato, MD",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02634320,1,1,0,1,0,0,2017-07-11,2018-07-11,2018-07-11,"Alkermes, Inc.",Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,70
NCT02635776,0,0,0,0,0,0,2017-12-21,2018-12-21,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,11
NCT02636322,0,0,0,0,0,0,2023-03-31,2024-03-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02636582,0,0,0,0,0,0,2019-06-27,2020-06-27,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02637557,0,0,0,0,0,0,2017-04-30,2018-04-30,,"Ironwood Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,22
NCT02648347,0,0,0,0,0,0,2020-08-31,2021-08-31,,Akebia Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,25
NCT02654015,0,0,0,0,0,0,2020-01-31,2021-01-31,,J. Mocco,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT02654119,0,0,0,0,0,0,2025-11-20,2026-11-20,,University of Nebraska,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,327
NCT02654314,1,1,0,1,0,1,2017-11-03,2018-11-03,2019-01-22,Yale University,Other,0,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02654808,1,0,1,1,0,1,2017-04-30,2018-04-30,2019-03-24,Columbia University,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,675
NCT02655523,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02656290,0,0,0,0,0,0,2019-12-31,2020-12-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,77
NCT02656706,0,0,0,0,0,0,2019-03-31,2020-03-31,,Maria Constantinou,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02657343,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02658019,0,0,0,0,0,0,2019-11-30,2020-11-30,,Lynn Feun,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,1,0,0,1,2
NCT02658149,1,1,0,1,0,0,2017-05-11,2018-05-11,2018-02-16,William Beaumont Hospitals,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,84
NCT02659293,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Chicago,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,594
NCT02660944,0,0,0,0,0,0,2020-01-31,2021-01-31,,Resolve Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02661048,0,0,0,0,0,0,2018-12-31,2019-12-31,,CyberHeart Inc.,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02664181,0,0,0,0,0,0,2019-07-02,2020-07-02,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,374
NCT02666742,1,0,0,0,1,0,2018-05-01,2019-05-01,,Kansas City Heart Rhythm Institute,Other,0,1,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT02667327,0,0,0,0,0,0,2020-04-30,2021-04-30,,"FirstString Research, Inc.",Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT02673229,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Kansas Medical Center,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,219
NCT02674984,0,0,0,0,0,0,2019-08-31,2020-08-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02675829,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02677896,0,0,0,0,0,0,2018-10-14,2019-10-14,,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,135
NCT02679287,0,0,0,0,0,0,2019-04-30,2020-04-30,,University of Virginia,Other,0,1,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,402
NCT02681757,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,882
NCT02682030,0,0,0,0,0,0,2018-12-31,2019-12-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,279
NCT02685995,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pennsylvania,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1052
NCT02687035,1,0,0,0,1,0,2017-10-31,2018-10-31,,Edwards Lifesciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,77
NCT02688530,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,157
NCT02689063,0,0,0,0,0,0,2017-06-30,2018-06-30,,"AFT Pharmaceuticals, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02689921,0,0,0,0,0,0,2018-12-31,2019-12-31,,Midwestern Regional Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02690714,1,0,0,0,1,0,2017-12-17,2018-12-17,,"Prometic Biotherapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,5
NCT02694029,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,626
NCT02696902,0,0,0,0,0,0,2019-12-10,2020-12-10,,MedImmune LLC,Industry,1,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,269
NCT02700048,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02700386,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,0,1,0,0,0,1,882
NCT02702388,0,0,0,0,0,0,2019-12-20,2020-12-20,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,328
NCT02703675,1,0,0,0,1,0,2018-06-12,2019-06-12,,Michel Torbey,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02705352,0,0,0,0,0,0,2019-01-25,2020-01-25,,Massachusetts Eye and Ear Infirmary,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02706249,0,0,0,0,0,0,2019-03-07,2020-03-07,,Dana-Farber Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT02706847,0,0,0,0,0,0,2017-04-03,2018-04-03,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02707601,1,1,0,1,0,0,2017-09-14,2018-09-14,2018-09-12,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,510
NCT02708433,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-07-27,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02709369,0,0,0,0,0,0,2018-10-25,2019-10-25,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,616
NCT02711618,1,0,0,0,1,0,2017-10-31,2018-10-31,,Syneron Medical,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02713256,1,1,0,1,0,0,2017-04-24,2018-04-24,2018-04-20,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02713529,0,0,0,0,0,0,2020-05-19,2021-05-19,,Amgen,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,685
NCT02715258,0,0,0,0,0,0,2017-04-30,2018-04-30,,Theracos,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02715609,0,0,0,0,0,0,2021-04-30,2022-04-30,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,1151
NCT02716727,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT02718001,0,0,0,0,0,0,2019-12-31,2020-12-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,77
NCT02718898,1,1,0,1,0,0,2017-02-22,2018-02-22,2018-02-17,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02720744,0,0,0,0,0,0,2020-09-30,2021-09-30,,Avadel,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT02727322,1,1,0,1,0,0,2018-03-27,2019-03-27,2019-03-25,"Halina M Zyczynski, MD",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02727881,1,0,0,0,1,0,2017-12-31,2018-12-31,,Ohr Pharmaceutical Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02731157,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-11-09,Duke University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02731729,1,0,0,0,1,0,2018-08-27,2019-08-27,,Parker Institute for Cancer Immunotherapy,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02734940,1,1,0,1,0,0,2017-02-01,2018-02-01,2018-01-22,Virginia Commonwealth University,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT02735577,0,0,0,0,0,0,2020-03-31,2021-03-31,,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02736188,1,1,0,1,0,0,2018-01-10,2019-01-10,2019-01-07,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT02744066,1,1,0,1,0,0,2017-10-05,2018-10-05,2018-08-31,"Michael Balsan, MD",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT02744391,1,1,0,1,0,0,2018-09-14,2019-09-14,2019-04-18,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02745353,1,1,0,1,0,1,2017-06-22,2018-06-22,2019-04-19,Joseph Ma,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02746328,1,0,0,0,1,0,2018-02-28,2019-02-28,,GTx,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT02749071,0,0,0,0,0,0,2019-08-31,2020-08-31,,EndoStim Inc.,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT02750215,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02756611,0,0,0,0,0,0,2022-03-05,2023-03-05,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02760030,0,0,0,0,0,0,2020-07-31,2021-07-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,198
NCT02760485,0,0,0,0,0,0,2019-12-29,2020-12-29,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,143
NCT02761057,0,0,0,0,0,0,2021-01-01,2022-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02768558,0,0,0,0,0,0,2019-01-23,2020-01-23,,"RTOG Foundation, Inc.",Other,0,1,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,1,0,0,0,0,1,5
NCT02769520,0,0,0,0,0,0,2020-06-30,2021-06-30,,Ezra Cohen,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02771509,0,0,0,0,0,0,2020-04-30,2021-04-30,,Angion Biomedica Corp,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT02773732,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Florida,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT02774226,0,0,0,0,0,0,2019-01-31,2020-01-31,,Augusta University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,117
NCT02775214,0,0,0,0,0,0,2019-12-31,2020-12-31,,Indiana University,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,497
NCT02779192,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Sound Pharmaceuticals, Incorporated",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT02780869,1,1,0,1,0,1,2017-02-01,2018-02-01,2018-10-08,Biom'Up SA,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,8
NCT02783482,1,0,0,0,1,0,2018-01-31,2019-01-31,,Green Cross Corporation,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,59
NCT02789319,1,0,0,0,1,0,2017-12-31,2018-12-31,,Diabetes Technology Society,Other,0,1,0,4.0,Phase 4,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02790034,0,0,0,0,0,0,2019-04-30,2020-04-30,,Newron Pharmaceuticals SPA,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,20
NCT02790294,0,0,0,0,0,0,2019-11-30,2020-11-30,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,374
NCT02792192,0,0,0,0,0,0,2019-12-31,2020-12-31,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,1731
NCT02794285,0,0,0,0,0,0,2021-12-14,2022-12-14,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,2450
NCT02795741,1,0,0,0,1,0,2018-03-31,2019-03-31,,Englewood Hospital and Medical Center,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,14
NCT02797951,0,0,0,0,0,0,2020-07-29,2021-07-29,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02799472,1,1,0,1,0,0,2017-10-30,2018-10-30,2018-10-16,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02809677,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Texas Southwestern Medical Center,Other,0,0,1,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02813694,0,0,1,1,0,1,2018-01-31,2019-01-31,2019-08-28,Nabriva Therapeutics AG,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02816138,1,1,0,1,0,0,2017-08-23,2018-08-23,2018-06-26,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,422
NCT02819024,0,0,0,0,0,0,2020-06-30,2021-06-30,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,5.0,,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,134
NCT02819635,0,0,0,0,0,0,2021-04-27,2022-04-27,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02826837,0,0,0,0,0,0,2022-02-01,2023-02-01,,Taiwan Leader Biotech Corp.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT02827838,0,0,0,0,0,0,2019-09-30,2020-09-30,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,616
NCT02829073,1,0,0,0,1,0,2017-12-31,2018-12-31,,United States Army Aeromedical Research Laboratory,U.S. Fed,2,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02831933,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Eric Bernicker, MD",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,2
NCT02832115,0,0,0,0,0,0,2019-06-30,2020-06-30,,Aultman Health Foundation,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02833350,1,1,0,1,0,0,2018-07-02,2019-07-02,2019-07-02,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT02841241,1,1,0,1,0,1,2017-03-31,2018-03-31,2018-08-07,"Intermountain Health Care, Inc.",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,93
NCT02843568,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of Wisconsin, Madison",Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,715
NCT02844933,0,0,0,0,0,0,2019-06-30,2020-06-30,,INSYS Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,50
NCT02845336,0,0,0,0,0,0,2020-07-31,2021-07-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT02847650,1,1,0,1,0,0,2018-01-29,2019-01-29,2018-12-18,Pfizer,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02848651,0,0,0,0,0,0,2019-05-14,2020-05-14,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,427
NCT02849171,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,1,0,0,0,0,1,1432
NCT02849743,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Shana McCormack, MD",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02850016,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rockefeller University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,104
NCT02858310,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT02859324,0,0,0,0,0,0,2020-03-01,2021-03-01,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02859558,0,0,0,0,0,0,2019-07-31,2020-07-31,,AIDS Clinical Trials Group,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,62
NCT02860039,0,0,0,0,0,0,2020-01-31,2021-01-31,,Vanderbilt-Ingram Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,180
NCT02867995,1,1,0,1,0,0,2018-03-30,2019-03-30,2018-12-11,Boston Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,225
NCT02868892,1,1,0,1,0,1,2017-07-31,2018-07-31,2018-10-05,Western Regional Medical Center,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT02872285,0,1,0,1,0,1,2017-06-22,2018-06-22,2019-01-29,Lycera Corp.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02872831,1,0,0,0,1,0,2017-07-31,2018-07-31,,Thomas Jefferson University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,186
NCT02873962,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02881957,0,0,0,0,0,0,2018-10-10,2019-10-10,,University of Utah,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,578
NCT02886702,1,1,0,1,0,0,2017-08-02,2018-08-02,2018-07-30,Fougera Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02891226,0,0,0,0,0,0,2019-09-27,2020-09-27,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02892110,0,0,0,0,0,0,2018-11-08,2019-11-08,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,511
NCT02899468,1,0,1,1,0,1,2017-10-31,2018-10-31,2019-04-09,Henry M. Jackson Foundation for the Advancement of Military Medicine,Other,0,1,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,37
NCT02899793,0,0,0,0,0,0,2020-12-31,2021-12-31,,Yale University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02900781,1,1,0,1,0,1,2017-11-30,2018-11-30,2018-12-13,Texas Tech University Health Sciences Center,Other,0,1,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,78
NCT02901548,0,0,0,0,0,0,2020-12-31,2021-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT02902484,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Texas Southwestern Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT02903381,0,0,0,0,0,0,2020-06-30,2021-06-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02903914,0,0,0,0,0,0,2019-11-30,2020-11-30,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT02905435,1,0,0,0,1,0,2018-09-06,2019-09-06,,PolyNovo Biomaterials Pty Ltd.,Industry,1,1,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02908100,0,0,0,0,0,0,2019-06-29,2020-06-29,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,427
NCT02909504,0,0,0,0,0,0,2018-11-30,2019-11-30,,Keming Gao,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02910466,0,0,0,0,0,0,2021-06-18,2022-06-18,,Shire,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,342
NCT02911701,1,0,1,1,0,0,2017-12-18,2018-12-18,2018-03-14,University of New Mexico,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,200
NCT02911909,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Missouri-Columbia,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT02912559,0,0,0,0,0,0,2020-12-12,2021-12-12,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02919683,0,0,0,0,0,0,2020-04-30,2021-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02921269,0,0,0,0,0,0,2020-08-01,2021-08-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT02923921,0,0,0,0,0,0,2019-09-09,2020-09-09,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1512
NCT02925455,0,0,0,0,0,0,2019-04-01,2020-04-01,,MetroHealth Medical Center,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,65
NCT02925793,1,0,0,0,1,0,2018-07-31,2019-07-31,,DS Biopharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02926768,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Checkpoint Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02927964,0,0,0,0,0,0,2021-11-30,2022-11-30,,Robert Lowsky,Other,0,1,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,5
NCT02928497,0,0,0,0,0,0,2023-12-31,2024-12-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,1,1,0,340
NCT02929823,1,1,0,1,0,1,2017-05-03,2018-05-03,2018-05-14,"Senju Pharmaceutical Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02932267,1,0,1,1,0,0,2018-01-10,2019-01-10,2018-09-26,Galderma,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,77
NCT02933255,0,0,0,0,0,0,2021-08-01,2022-08-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT02933528,1,1,0,1,0,1,2017-08-11,2018-08-11,2018-11-12,Taro Pharmaceuticals USA,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02933879,1,1,0,1,0,0,2018-03-06,2019-03-06,2018-11-12,Taro Pharmaceuticals USA,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02935517,0,0,0,0,0,0,2021-08-31,2022-08-31,,Applied Genetic Technologies Corp,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,9
NCT02935686,0,0,0,0,0,0,2022-01-03,2023-01-03,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,29
NCT02938442,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Arkansas,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,285
NCT02938923,0,0,0,0,0,0,2021-09-30,2022-09-30,,Washington University School of Medicine,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT02939599,0,0,0,0,0,0,2018-11-06,2019-11-06,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT02940223,0,0,0,0,0,0,2022-03-16,2023-03-16,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT02942160,0,0,0,0,0,0,2018-06-14,2019-06-14,,Endo Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,91
NCT02945046,0,0,0,0,0,0,2019-05-17,2020-05-17,,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,101
NCT02946463,1,1,0,1,0,0,2018-01-25,2019-01-25,2019-01-24,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,86
NCT02949297,0,0,0,0,0,0,2019-03-06,2020-03-06,,Endologix,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,14
NCT02950233,1,0,0,0,1,0,2018-06-30,2019-06-30,,Population Health Research Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,77
NCT02953392,0,0,0,0,0,0,2020-05-31,2021-05-31,,NYU College of Dentistry,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02954458,0,0,0,0,0,0,2019-09-30,2020-09-30,,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,1,0,0,0,0,1,0,1,342
NCT02954887,0,0,0,0,0,0,2018-12-31,2019-12-31,,GW Research Ltd,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,29
NCT02955797,0,0,0,0,0,0,2017-10-26,2018-10-26,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,285
NCT02957149,0,0,0,0,0,0,2021-06-30,2022-06-30,,Matthew Gettman,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02957968,0,0,0,0,0,0,2022-02-28,2023-02-28,,Virginia Commonwealth University,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT02958267,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-08-06,OhioHealth,Other,0,0,0,1.0,Phase 2,0,2016.0,1,0,1,1,0,0,0,0,0,0,1,21
NCT02958553,1,0,0,0,1,0,2018-07-31,2019-07-31,,Otto Bock Healthcare Products GmbH,Industry,1,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02958865,0,0,0,0,0,0,2020-12-06,2021-12-06,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT02960308,0,0,0,0,0,0,2020-10-20,2021-10-20,,University of Southern California,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,483
NCT02962102,0,0,0,0,0,0,2019-08-01,2020-08-01,,David Leaf,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02963311,0,0,0,0,0,0,2018-10-08,2019-10-08,,The Medicines Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,59
NCT02963597,1,0,1,1,0,1,2017-10-31,2018-10-31,2019-03-29,Albert Einstein Healthcare Network,Other,0,0,0,4.0,Phase 4,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,45
NCT02963766,0,0,0,0,0,0,2021-06-21,2022-06-21,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02965378,0,0,0,0,0,0,2022-04-01,2023-04-01,,Southwest Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,288
NCT02969863,1,1,0,1,0,0,2017-06-01,2018-06-01,2018-02-07,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1699
NCT02973269,1,0,0,0,1,0,2017-05-31,2018-05-31,,"Revance Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,26
NCT02973360,1,0,0,0,1,0,2017-09-26,2018-09-26,,Micelle BioPharma Inc,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02974153,0,0,0,0,0,0,2017-11-30,2018-11-30,,"Alder Biopharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,6
NCT02977780,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Patrick Y. Wen, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT02978638,0,0,0,0,0,0,2019-09-30,2020-09-30,,Palo Alto Veterans Institute for Research,Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,31
NCT02979587,0,0,0,0,0,0,2019-11-30,2020-11-30,,Medtronic Heart Valves,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,3
NCT02980224,1,1,0,1,0,1,2017-02-28,2018-02-28,2019-08-19,OmegaD LLC,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02987257,0,0,0,0,0,0,2025-05-31,2026-05-31,,Vanderbilt University Medical Center,Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT02989662,0,0,0,0,0,0,2022-01-31,2023-01-31,,Johns Hopkins University,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02989948,0,0,0,0,0,0,2024-06-30,2025-06-30,,David P. Kuwayama,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02992132,1,1,0,1,0,0,2018-01-25,2019-01-25,2019-01-25,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,24
NCT02996721,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Intermountain Health Care, Inc.",Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,93
NCT02998684,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-25,Medical University of South Carolina,Other,0,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,511
NCT03000127,0,0,0,0,0,0,2023-06-30,2024-06-30,,"University of California, Los Angeles",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03000569,0,0,0,0,0,0,2017-09-18,2018-09-18,,Sage Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT03001882,0,0,0,0,0,0,2020-09-27,2021-09-27,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03003520,1,0,1,1,0,0,2018-08-02,2019-08-02,2019-08-02,Celgene,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03004443,0,0,0,0,0,0,2021-11-30,2022-11-30,,Emory University,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03008590,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03012165,0,0,0,0,0,0,2017-05-31,2018-05-31,,"Aldeyra Therapeutics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,13
NCT03012529,0,0,0,0,0,0,2021-10-01,2022-10-01,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03013790,1,0,0,0,1,0,2018-01-31,2019-01-31,,MICE Trial Group,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03014050,0,0,0,0,0,0,2019-06-01,2020-06-01,,Boston University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,188
NCT03014726,0,0,0,0,0,0,2018-10-31,2019-10-31,,Urotronic Inc.,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT03015610,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Jason Lang, M.D., M.P.H.",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03022916,1,0,1,1,0,0,2017-12-31,2018-12-31,2018-08-14,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT03025334,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Manitoba,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,344
NCT03026257,1,1,0,1,0,0,2017-08-18,2018-08-18,2018-07-20,"Alcon, a Novartis Company",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,13
NCT03028350,0,0,0,0,0,0,2021-04-30,2022-04-30,,Cumberland Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,48
NCT03028753,0,0,0,0,0,0,2018-12-31,2019-12-31,,Tufts Medical Center,Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,121
NCT03029442,0,0,0,0,0,0,2021-12-31,2022-12-31,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,41
NCT03029598,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,910
NCT03030222,0,0,0,0,0,0,2019-09-30,2020-09-30,,Saint Luke's Health System,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03031301,1,0,0,0,1,0,2018-07-31,2019-07-31,,Vibrant Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03032406,0,0,0,0,0,0,2022-01-23,2023-01-23,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03034811,0,0,0,0,0,0,2027-09-30,2028-09-30,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,215
NCT03035331,0,0,0,0,0,0,2021-02-15,2022-02-15,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03036475,0,0,0,0,0,0,2018-12-31,2019-12-31,,Yolanda Chan,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,1
NCT03036813,0,0,0,0,0,0,2019-10-31,2020-10-31,,Global Blood Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,14
NCT03037164,0,0,0,0,0,0,2020-06-30,2021-06-30,,Cerus Corporation,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03037385,0,0,0,0,0,0,2020-03-31,2021-03-31,,Blueprint Medicines Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03037801,1,0,0,0,1,0,2018-05-31,2019-05-31,,Soroka University Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,129
NCT03039231,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Palo Alto Health Sciences, Inc.",Industry,1,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03040427,0,0,0,0,0,0,2019-12-31,2020-12-31,,Wael Jaber,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03041025,0,0,0,0,0,0,2020-02-28,2021-02-28,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03042546,1,0,1,1,0,0,2018-05-29,2019-05-29,2019-04-22,University of Washington,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03048578,0,0,0,0,0,0,2020-07-31,2021-07-31,,NYU Langone Health,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03048682,0,0,0,0,0,0,2019-09-30,2020-09-30,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,0,1,581
NCT03050814,0,0,0,0,0,0,2020-08-01,2021-08-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03051607,1,1,0,1,0,0,2018-01-16,2019-01-16,2019-01-14,Biotie Therapies Inc.,Industry,1,1,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,10
NCT03053362,1,0,0,0,1,0,2018-08-08,2019-08-08,,Brain and Cognition Discovery Foundation,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,4
NCT03053492,0,0,0,0,0,0,2019-02-08,2020-02-08,,Medical University of South Carolina,Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,0,1,511
NCT03054532,0,0,0,0,0,0,2021-01-31,2022-01-31,,Singapore General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,134
NCT03054740,1,1,0,1,0,0,2017-04-28,2018-04-28,2018-04-20,Aultman Health Foundation,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03057704,1,1,0,1,0,0,2017-01-20,2018-01-20,2017-11-13,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT03061032,0,0,0,0,0,0,2018-12-31,2019-12-31,,Iran Hepatitis Network,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,1
NCT03061214,0,0,0,0,0,0,2019-03-14,2020-03-14,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,981
NCT03063073,1,0,0,0,1,0,2017-05-30,2018-05-30,,South Egypt Cancer Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,10
NCT03064438,1,0,0,0,1,0,2018-07-15,2019-07-15,,"Accuitis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03065205,1,0,0,0,1,0,2018-06-30,2019-06-30,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,882
NCT03065465,0,0,0,0,0,0,2019-10-31,2020-10-31,,CURE Digestive Diseases Research Center,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT03066219,1,0,0,0,1,0,2017-05-20,2018-05-20,,BRIM Biotechnology Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03068247,0,0,0,0,0,0,2021-05-31,2022-05-31,,University of Utah,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03070600,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Washington,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,910
NCT03071094,0,0,0,0,0,0,2019-04-30,2020-04-30,,Transgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,2,1,0,14
NCT03071276,0,0,0,0,0,0,2019-04-30,2020-04-30,,St. Jude Children's Research Hospital,Other,0,1,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,302
NCT03071393,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Florida,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03071874,0,0,0,0,0,0,2020-07-25,2021-07-25,,Massachusetts General Hospital,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03072550,1,1,0,1,0,1,2018-04-01,2019-04-01,2019-07-21,"DeviceFarm, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03073330,1,0,0,0,1,0,2017-03-31,2018-03-31,,Thomas Jefferson University,Other,0,0,0,5.0,,0,2016.0,1,0,0,0,1,0,0,0,0,0,1,186
NCT03073486,1,1,0,1,0,0,2017-12-21,2018-12-21,2018-12-20,"Dermira, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,17
NCT03074812,0,0,0,0,0,0,2020-03-31,2021-03-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT03075826,0,0,0,0,0,0,2019-12-15,2020-12-15,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT03076658,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,882
NCT03079024,0,0,0,0,0,0,2021-05-19,2022-05-19,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03085797,0,0,0,0,0,0,2019-12-11,2020-12-11,,GlaxoSmithKline,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03086447,1,1,0,1,0,0,2017-05-04,2018-05-04,2018-04-30,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03087344,1,0,0,0,1,0,2018-06-30,2019-06-30,,VA Connecticut Healthcare System,U.S. Fed,2,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,36
NCT03087708,0,0,0,0,0,0,2027-08-31,2028-08-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,456
NCT03093480,0,0,0,0,0,0,2021-06-30,2022-06-30,,Bioverativ Therapeutics Inc.,Industry,1,1,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,19
NCT03093935,0,0,0,0,0,0,2019-12-01,2020-12-01,,Bioness Inc,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03096288,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03096444,1,1,0,1,0,1,2017-07-19,2018-07-19,2019-02-19,Gil Yosipovitch,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,1,0,0,1,0,1
NCT03098979,1,1,0,1,0,0,2018-05-23,2019-05-23,2019-05-23,Bayer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1343
NCT03101085,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Russell Swerdlow, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03101241,0,0,0,0,0,0,2018-09-25,2019-09-25,,Jazz Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,55
NCT03101358,0,0,0,0,0,0,2019-10-31,2020-10-31,,"NanOlogy, LLC",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03101566,0,0,0,0,0,0,2019-12-07,2020-12-07,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,213
NCT03102125,0,0,0,0,0,0,2020-04-30,2021-04-30,,Paul Kim,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03103061,1,1,0,1,0,0,2018-06-14,2019-06-14,2019-06-05,Medical University of South Carolina,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT03103581,0,0,0,0,0,0,2017-04-10,2018-04-10,,Braintree Laboratories,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,43
NCT03106454,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Southern California,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,483
NCT03106558,0,0,0,0,0,0,2019-06-30,2020-06-30,,Rothman Institute Orthopaedics,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,58
NCT03107026,0,0,0,0,0,0,2018-05-16,2019-05-16,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,134
NCT03110380,0,0,0,0,0,0,2018-11-12,2019-11-12,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03113422,0,0,0,0,0,0,2022-04-30,2023-04-30,,"PrECOG, LLC.",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03115827,0,0,0,0,0,0,2018-12-21,2019-12-21,,Vanderbilt University Medical Center,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,422
NCT03115983,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Empirical Spine, Inc.",Industry,1,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03118466,0,0,0,0,0,0,2020-09-30,2021-09-30,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03122587,0,0,0,0,0,0,2019-02-01,2020-02-01,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03122730,0,0,0,0,0,0,2019-03-01,2020-03-01,,Aerogen Pharma Limited,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,0,0,0,0,1,0,0,1,0,2
NCT03123588,0,0,0,0,0,0,2020-05-31,2021-05-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03124108,0,0,1,1,0,0,2018-10-31,2019-10-31,2019-08-16,Genfit,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,15
NCT03126968,0,0,0,0,0,0,2020-07-30,2021-07-30,,"University of Maryland, College Park",Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03127345,0,0,0,0,0,0,2023-09-30,2024-09-30,,Boston Children’s Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,400
NCT03128359,0,0,0,0,0,0,2020-01-31,2021-01-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,358
NCT03131908,0,0,0,0,0,0,2020-07-31,2021-07-31,,M.D. Anderson Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03132155,0,0,0,0,0,0,2020-10-31,2021-10-31,,"NantPharma, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03136198,0,0,0,0,0,0,2019-06-30,2020-06-30,,Indiana University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,497
NCT03139435,0,0,0,0,0,0,2019-10-31,2020-10-31,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2017.0,0,0,0,0,0,0,0,0,0,1,0,616
NCT03139747,0,0,0,0,0,0,2019-04-03,2020-04-03,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03141034,0,0,0,0,0,0,2020-09-30,2021-09-30,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,1,0,1,0,1151
NCT03142438,0,0,0,0,0,0,2017-06-23,2018-06-23,,Fisher and Paykel Healthcare,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,56
NCT03142568,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of North Carolina, Chapel Hill",Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03147612,0,0,0,0,0,0,2024-02-08,2025-02-08,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03148418,0,0,0,0,0,0,2027-08-05,2028-08-05,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03150524,0,0,0,0,0,0,2019-05-31,2020-05-31,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,1,0,0,0,0,1,0,1143
NCT03151408,0,0,0,0,0,0,2021-05-31,2022-05-31,,Helsinn Healthcare SA,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03153319,0,0,0,0,0,0,2020-06-30,2021-06-30,,Los Angeles Biomedical Research Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,60
NCT03153449,0,0,0,0,0,0,2025-03-04,2026-03-04,,DePuy Orthopaedics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,39
NCT03153982,0,0,0,0,0,0,2019-09-29,2020-09-29,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03156621,0,0,0,0,0,0,2019-09-11,2020-09-11,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03162796,0,0,0,0,0,0,2019-03-14,2020-03-14,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03166319,0,0,0,0,0,0,2020-06-24,2021-06-24,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03167255,0,0,0,0,0,0,2020-12-31,2021-12-31,,"NS Pharma, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03167723,0,0,0,0,0,0,2020-05-30,2021-05-30,,Atrium Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,95
NCT03168295,0,0,1,1,0,0,2019-10-31,2020-10-31,2019-06-14,The University of Texas Health Science Center at San Antonio,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT03168464,0,0,0,0,0,0,2021-12-30,2022-12-30,,Weill Medical College of Cornell University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03171129,0,0,0,0,0,0,2019-07-31,2020-07-31,,Loma Linda University,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,194
NCT03171389,0,0,0,0,0,0,2018-09-22,2019-09-22,,Sebastian Bauer,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03174197,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,2066
NCT03175367,0,0,0,0,0,0,2020-04-06,2021-04-06,,Regeneron Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03178201,0,0,0,0,0,0,2020-05-31,2021-05-31,,Changchun Deng,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03178487,0,0,0,0,0,0,2020-11-11,2021-11-11,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03179397,0,0,0,0,0,0,2019-09-01,2020-09-01,,"CORD, LLC",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03179904,0,0,0,0,0,0,2021-07-30,2022-07-30,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03180307,0,0,0,0,0,0,2020-04-30,2021-04-30,,"On Target Laboratories, LLC",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,1,1,0,3
NCT03181542,0,0,0,0,0,0,2020-02-29,2021-02-28,,Milton S. Hershey Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,334
NCT03185143,1,0,0,0,1,0,2018-05-07,2019-05-07,,"Allodynic Therapeutics, LLC",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03187132,0,0,0,0,0,0,2019-12-05,2020-12-05,,Cedars-Sinai Medical Center,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,279
NCT03187418,0,0,0,0,0,0,2019-02-28,2020-02-28,,Centre hospitalier de l'Université de Montréal (CHUM),Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,179
NCT03187678,1,1,0,1,0,0,2018-05-29,2019-05-29,2019-04-19,Actelion,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,128
NCT03191903,1,0,0,0,1,0,2018-04-23,2019-04-23,,"Anika Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,9
NCT03194542,0,0,0,0,0,0,2019-06-15,2020-06-15,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03194893,0,0,0,0,0,0,2024-06-12,2025-06-12,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03195478,0,0,0,0,0,0,2024-11-12,2025-11-12,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1104
NCT03197935,0,0,0,0,0,0,2020-09-30,2021-09-30,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03198754,0,0,0,0,0,0,2019-10-31,2020-10-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,412
NCT03200093,0,0,0,0,0,0,2019-06-30,2020-06-30,,Rochester General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03201250,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Muhamed Baljevic, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03201393,1,0,0,0,1,0,2018-07-26,2019-07-26,,"Allodynic Therapeutics, LLC",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03201562,1,0,0,0,1,0,2018-05-20,2019-05-20,,"Presbyopia Therapies, LLC",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03201900,0,0,0,0,0,0,2019-01-28,2020-01-28,,"Eisai Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,129
NCT03202355,0,0,0,0,0,0,2019-03-11,2020-03-11,,Biolux Research Ltd.,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03202628,0,0,0,0,0,0,2022-07-24,2023-07-24,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03204851,0,0,0,0,0,0,2018-12-01,2019-12-01,,"Mission Health System, Asheville, NC",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT03207906,1,0,0,0,1,0,2018-07-17,2019-07-17,,Veloce BioPharma LLC,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03208166,1,0,0,0,1,0,2018-05-30,2019-05-30,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,511
NCT03208296,0,0,0,0,0,0,2019-12-31,2020-12-31,,Ascend Biopharmaceuticals Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03208985,0,0,0,0,0,0,2018-06-14,2019-06-14,,HRA Pharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03210402,0,0,0,0,0,0,2020-02-29,2021-02-28,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,169
NCT03211858,1,1,0,1,0,0,2018-07-16,2019-07-16,2019-07-15,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1222
NCT03213678,0,0,0,0,0,0,2024-09-30,2025-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03214588,0,0,0,0,0,0,2019-01-02,2020-01-02,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,650
NCT03217110,0,0,0,0,0,0,2021-08-01,2022-08-01,,"Krystal Parker, PhD",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03217422,0,0,0,0,0,0,2022-07-29,2023-07-29,,Novartis Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03219359,0,0,0,0,0,0,2020-09-30,2021-09-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03227471,0,0,0,0,0,0,2018-03-27,2019-03-27,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03228940,0,0,0,0,0,0,2020-09-30,2021-09-30,,Resverlogix Corp,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,9
NCT03230838,0,0,0,0,0,0,2021-01-23,2022-01-23,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03232918,0,0,0,0,0,0,2021-04-30,2022-04-30,,Unyime Ituk,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03233204,0,0,0,0,0,0,2024-09-30,2025-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03235115,1,1,0,1,0,1,2017-09-22,2018-09-22,2018-10-15,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03235479,0,0,0,0,0,0,2018-01-21,2019-01-21,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03238495,0,0,0,0,0,0,2019-08-01,2020-08-01,,Qamar Khan,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03239392,0,0,0,0,0,0,2019-08-30,2020-08-30,,Bioniz Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03240081,0,0,0,0,0,0,2019-06-30,2020-06-30,,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT03241173,0,0,0,0,0,0,2019-11-30,2020-11-30,,Incyte Biosciences International Sàrl,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03243734,0,0,0,0,0,0,2021-11-30,2022-11-30,,"CSA Medical, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,18
NCT03245385,1,0,0,0,1,0,2017-07-24,2018-07-24,,Sun Pharmaceutical Industries Limited,Industry,1,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,11
NCT03247530,1,0,0,0,1,0,2018-09-12,2019-09-12,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,26
NCT03248167,0,0,0,0,0,0,2019-08-31,2020-08-31,,NYU Langone Health,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,869
NCT03249805,0,0,0,0,0,0,2018-12-31,2019-12-31,,MiracleFeet,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03251508,0,0,0,0,0,0,2021-09-30,2022-09-30,,"University of North Carolina, Chapel Hill",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03251846,1,0,0,0,1,0,2018-07-31,2019-07-31,,Children's Hospitals and Clinics of Minnesota,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,44
NCT03254394,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03255174,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Ethicon, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,59
NCT03255824,0,0,0,0,0,0,2019-08-23,2020-08-23,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03257722,0,0,0,0,0,0,2020-08-31,2021-08-31,,Zhonglin Hao,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03258554,0,0,0,0,0,0,2025-12-31,2026-12-31,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,0,1,0,0,1,0,0,0,1,0,3004
NCT03261726,0,0,0,0,0,0,2020-08-04,2021-08-04,,"Eric W. Sargent, MD",Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03262389,0,0,0,0,0,0,2018-11-23,2019-11-23,,"Michael C Roarke, MD",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03262688,0,0,0,0,0,0,2018-12-31,2019-12-31,,Innocoll,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT03263494,0,0,0,0,0,0,2019-05-06,2020-05-06,,Jaeb Center for Health Research,Other,0,0,0,3.0,Phase 3,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,93
NCT03264989,0,0,0,0,0,0,2021-02-19,2022-02-19,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1895
NCT03266770,0,0,0,0,0,0,2019-10-31,2020-10-31,,University Hospitals Cleveland Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,185
NCT03267108,0,0,0,0,0,0,2019-12-31,2020-12-31,,Bellerophon Pulse Technologies,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03268603,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03268954,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03271151,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT03271307,1,0,1,1,0,0,2018-06-13,2019-06-13,2019-05-15,"University of California, Los Angeles",Other,0,0,1,5.0,,0,2017.0,1,0,0,0,1,0,0,0,2,1,0,692
NCT03272373,0,0,0,0,0,0,2020-04-30,2021-04-30,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,215
NCT03273413,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03275142,1,0,0,0,1,0,2018-07-31,2019-07-31,,Comprehensive EyeCare of Central Ohio,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03278626,0,0,0,0,0,0,2019-09-30,2020-09-30,,NYU Langone Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03284866,0,0,0,0,0,0,2022-01-31,2023-01-31,,AIDS Malignancy Consortium,Other,0,1,1,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,46
NCT03285243,1,0,0,0,1,0,2017-12-31,2018-12-31,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,518
NCT03286556,0,0,0,0,0,0,2021-08-01,2022-08-01,,University of Alabama at Birmingham,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03287635,0,0,0,0,0,0,2020-05-31,2021-05-31,,Toyos Clinic,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03288792,0,0,0,0,0,0,2019-04-09,2020-04-09,,Real Imaging Ltd.,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,10
NCT03289416,0,0,0,0,0,0,2019-12-31,2020-12-31,,Andrews Research & Education Foundation,Other,0,0,0,4.0,Phase 4,0,2013.0,0,0,0,0,0,0,1,0,0,0,1,10
NCT03290534,0,0,0,0,0,0,2020-09-30,2021-09-30,,CivaTech Oncology,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03291847,0,0,0,0,0,0,2022-06-30,2023-06-30,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1143
NCT03292588,0,0,0,0,0,0,2019-09-30,2020-09-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03296033,0,0,0,0,0,0,2020-06-30,2021-06-30,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03298087,0,0,0,0,0,0,2022-09-30,2023-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1012
NCT03301467,0,0,0,0,0,0,2019-12-30,2020-12-30,,ChemoCentryx,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,17
NCT03302234,0,0,0,0,0,0,2023-02-28,2024-02-28,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03303469,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03304626,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Cincinnati,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,222
NCT03307382,0,0,0,0,0,0,2019-12-31,2020-12-31,,Chinese University of Hong Kong,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,2,0,1,557
NCT03309696,0,0,0,0,0,0,2019-10-30,2020-10-30,,University of Arkansas,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,285
NCT03310021,0,0,0,0,0,0,2019-09-30,2020-09-30,,Portola Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,28
NCT03313414,0,0,0,0,0,0,2022-12-31,2023-12-31,,Massachusetts General Hospital,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03314857,1,0,0,0,1,0,2018-07-06,2019-07-06,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,77
NCT03315871,0,0,0,0,0,0,2019-12-01,2020-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03316105,1,1,0,1,0,0,2018-06-21,2019-06-21,2019-05-09,Mayo Clinic,Other,0,1,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1898
NCT03317496,0,0,0,0,0,0,2020-09-04,2021-09-04,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03318952,0,0,0,0,0,0,2020-12-31,2021-12-31,,Boston University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,188
NCT03319407,0,0,0,0,0,0,2018-12-30,2019-12-30,,Mayo Clinic,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1898
NCT03319537,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03320096,0,1,0,1,0,1,2017-06-19,2018-06-19,2019-06-14,"Ulthera, Inc",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,46
NCT03321006,0,0,0,0,0,0,2020-05-31,2021-05-31,,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,361
NCT03322384,0,0,0,0,0,0,2020-10-01,2021-10-01,,"University of California, Davis",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,530
NCT03323463,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,1,1,0,0,0,1,0,1432
NCT03324776,0,0,0,0,0,0,2020-09-15,2021-09-15,,Model Clinical Research LLC,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03325790,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Sound Pharmaceuticals, Incorporated",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03326128,0,0,0,0,0,0,2023-08-31,2024-08-31,,University of Southern California,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03328507,0,0,0,0,0,0,2019-05-31,2020-05-31,,Braintree Laboratories,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,43
NCT03330821,0,0,0,0,0,0,2020-04-18,2021-04-18,,University of Southern California,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03331835,0,0,0,0,0,0,2019-03-21,2020-03-21,,LEO Pharma,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,1,0,0,0,0,0,2,1,0,171
NCT03333109,0,0,0,0,0,0,2019-11-15,2020-11-15,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,1895
NCT03334175,0,0,0,0,0,0,2019-07-31,2020-07-31,,"University of California, San Francisco",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1443
NCT03334630,0,0,0,0,0,0,2019-12-31,2020-12-31,,EPIX Therapeutics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03338244,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1443
NCT03338400,1,1,0,1,0,0,2018-08-21,2019-08-21,2018-08-21,The Cleveland Clinic,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,581
NCT03339258,0,0,0,0,0,0,2021-06-30,2022-06-30,,San Francisco Veterans Affairs Medical Center,U.S. Fed,2,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03341143,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Zarour, Hassane, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03342560,1,0,1,1,0,1,2018-08-14,2019-08-14,2019-08-27,Massachusetts General Hospital,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1699
NCT03343080,0,0,1,1,0,0,2018-10-01,2019-10-01,2019-09-04,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1898
NCT03346070,0,0,0,0,0,0,2019-01-29,2020-01-29,,Merck Sharp & Dohme Corp.,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,2145
NCT03347526,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of Colorado, Denver",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03352765,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03354611,0,0,0,0,0,0,2019-06-30,2020-06-30,,Koning Corporation,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,1,0,0,0,1,0,8
NCT03355209,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03356184,1,0,0,0,1,0,2018-05-15,2019-05-15,,Darma Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03359395,0,0,0,0,0,0,2019-12-31,2020-12-31,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03359525,0,0,0,0,0,0,2019-06-30,2020-06-30,,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03359746,0,0,0,0,0,0,2018-10-31,2019-10-31,,King Faisal Specialist Hospital & Research Center,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,69
NCT03360019,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Florida,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03360656,0,0,0,0,0,0,2018-11-30,2019-11-30,,CoolTech LLC,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03361345,0,0,0,0,0,0,2020-12-31,2021-12-31,,Wayne State University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,145
NCT03364153,0,0,0,0,0,0,2020-09-30,2021-09-30,,Ophthotech Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,15
NCT03365999,0,0,0,0,0,0,2019-07-01,2020-07-01,,Universidad Autonoma de Nuevo Leon,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,28
NCT03371355,0,0,0,0,0,0,2019-02-28,2020-02-28,,Akcea Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,10
NCT03372161,0,0,0,0,0,0,2020-01-01,2021-01-01,,"Semnur Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03373227,0,0,0,0,0,0,2022-12-31,2023-12-31,,Baylor Research Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,131
NCT03373968,0,0,0,0,0,0,2023-12-31,2024-12-31,,Italfarmaco,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,20
NCT03374163,1,0,0,0,1,0,2017-06-30,2018-06-30,,King Fahad Medical City,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,3,0,1,15
NCT03375879,0,0,0,0,0,0,2018-12-01,2019-12-01,,St. Joseph's Healthcare Hamilton,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,84
NCT03377699,0,0,0,0,0,0,2021-10-15,2022-10-15,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,981
NCT03378531,0,0,0,0,0,0,2021-06-30,2022-06-30,,Aeglea Biotherapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03379675,0,0,0,0,0,0,2020-06-03,2021-06-03,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03382821,0,0,0,0,0,0,2020-01-15,2021-01-15,,University of Utah,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03383783,1,1,0,1,0,0,2018-05-02,2019-05-02,2019-04-25,Domenick Zero,Other,0,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03386578,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2133
NCT03389451,0,0,0,0,0,0,2020-12-31,2021-12-31,,Michael Graham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03390530,0,0,0,0,0,0,2024-01-01,2025-01-01,,Albert Einstein College of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT03390920,0,0,0,0,0,0,2020-06-01,2021-06-01,,R3 Stem Cell,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03391609,0,0,0,0,0,0,2018-11-01,2019-11-01,,Assiut University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1331
NCT03392337,0,0,0,0,0,0,2019-12-01,2020-12-01,,Psoriasis Treatment Center of Central New Jersey,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03395236,0,0,0,0,0,0,2019-12-31,2020-12-31,,Spectranetics Corporation,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,0,0,0,0,1,0,2,1,0,18
NCT03395353,0,0,0,0,0,0,2021-03-31,2022-03-31,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03396003,1,0,0,0,1,0,2018-08-01,2019-08-01,,Ziemer Ophthalmic Systems AG,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,5
NCT03396952,0,0,0,0,0,0,2022-06-07,2023-06-07,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1443
NCT03397173,0,0,0,0,0,0,2019-10-31,2020-10-31,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT03399539,0,0,0,0,0,0,2022-03-02,2023-03-02,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03400800,0,0,0,0,0,0,2019-10-31,2020-10-31,,The Medicines Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,59
NCT03406364,0,0,0,0,0,0,2019-12-31,2020-12-31,,Metagone Biotech Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03409614,0,0,0,0,0,0,2023-02-22,2024-02-22,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03411850,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Arthritis & Rheumatism Associates, P.C.",Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT03412045,0,0,0,0,0,0,2020-12-01,2021-12-01,,University of Nebraska,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,327
NCT03412630,0,0,0,0,0,0,2020-03-31,2021-03-31,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,75
NCT03412890,0,0,0,0,0,0,2020-02-28,2021-02-28,,Myovant Sciences GmbH,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03417570,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03419169,0,0,0,0,0,0,2019-02-01,2020-02-01,,University College London Hospitals,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,46
NCT03419715,0,0,0,0,0,0,2019-04-25,2020-04-25,,Manistee Partners,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03420482,0,0,0,0,0,0,2021-12-31,2022-12-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03420638,0,0,0,0,0,0,2020-07-01,2021-07-01,,Paul Hoff,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03421210,0,0,0,0,0,0,2019-05-31,2020-05-31,,Duke University,Other,0,0,1,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03421431,0,0,0,0,0,0,2019-06-30,2020-06-30,,Enanta Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,22
NCT03422302,0,0,0,0,0,0,2020-05-31,2021-05-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,1,0,1,0,0,0,1,0,2066
NCT03422510,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Complexa, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03424733,0,0,0,0,0,0,2020-05-01,2021-05-01,,"Holy Name Medical Center, Inc.",Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03425253,0,0,0,0,0,0,2019-09-24,2020-09-24,,Allergan,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,2,1,0,495
NCT03426345,0,0,0,0,0,0,2020-01-18,2021-01-18,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03428477,0,0,0,0,0,0,2022-01-31,2023-01-31,,"Mark A Hull, PhD FRCP",Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03432533,0,0,0,0,0,0,2019-04-11,2020-04-11,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,1,0,0,0,0,1,1,0,685
NCT03432936,0,0,0,0,0,0,2020-03-31,2021-03-31,,Mayo Clinic,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03433742,0,0,0,0,0,0,2020-02-26,2021-02-26,,"Hospital for Special Surgery, New York",Other,0,1,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,157
NCT03436121,0,0,0,0,0,0,2019-12-31,2020-12-31,,Maria Pacella,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03436420,0,0,0,0,0,0,2019-08-31,2020-08-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,947
NCT03436862,0,0,0,0,0,0,2021-09-30,2022-09-30,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,167
NCT03437031,0,0,0,0,0,0,2019-07-01,2020-07-01,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,279
NCT03437811,0,0,0,0,0,0,2018-12-24,2019-12-24,,"Mack Biotech, Corp.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03437967,0,0,0,0,0,0,2019-06-01,2020-06-01,,LiteCure LLC,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03440554,0,0,0,0,0,0,2020-08-01,2021-08-01,,"University of California, San Diego",Other,0,0,1,5.0,,0,2016.0,0,0,0,0,1,0,0,0,0,0,1,561
NCT03441360,0,0,0,0,0,0,2020-06-30,2021-06-30,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,328
NCT03442400,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Cleveland Clinic,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03442764,0,0,0,0,0,0,2020-02-29,2021-02-28,,"MyoKardia, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03444870,0,0,0,0,0,0,2022-05-31,2023-05-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03446417,0,0,0,0,0,0,2022-06-20,2023-06-20,,"Zeno Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03446599,0,0,0,0,0,0,2020-05-31,2021-05-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,306
NCT03446781,0,0,0,0,0,0,2018-09-26,2019-09-26,,Endo Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,91
NCT03450707,0,0,0,0,0,0,2023-02-28,2024-02-28,,Michael Donnino,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03451617,0,0,0,0,0,0,2019-10-05,2020-10-05,,University of Groningen,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,15
NCT03451773,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03456284,0,0,0,0,0,0,2023-06-30,2024-06-30,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03456830,0,0,0,0,0,0,2019-07-31,2020-07-31,,Allena Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03461120,0,0,0,0,0,0,2021-09-30,2022-09-30,,"University of California, San Diego",Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03461757,0,0,0,0,0,0,2018-10-08,2019-10-08,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03463460,0,0,0,0,0,0,2020-07-30,2021-07-30,,Dwight Owen,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2
NCT03466827,0,0,0,0,0,0,2020-07-01,2021-07-01,,Morten Mau-Soerensen,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03467217,0,0,0,0,0,0,2020-04-30,2021-04-30,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03467477,0,0,0,0,0,0,2018-11-15,2019-11-15,,Avid Radiopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,50
NCT03469999,0,0,0,0,0,0,2019-11-30,2020-11-30,,Columbia University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03471143,0,0,0,0,0,0,2022-02-28,2023-02-28,,Washington University School of Medicine,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03472053,0,0,0,0,0,0,2019-11-30,2020-11-30,,"BioMarck Pharmaceuticals, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03473223,0,0,0,0,0,0,2021-10-31,2022-10-31,,CSL Behring,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,81
NCT03484702,0,0,0,0,0,0,2022-08-02,2023-08-02,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,306
NCT03485274,0,0,0,0,0,0,2019-08-31,2020-08-31,,The University of Hong Kong,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,547
NCT03485911,0,0,0,0,0,0,2020-10-31,2021-10-31,,BioCryst Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03487549,0,0,0,0,0,0,2019-05-16,2020-05-16,,Verrica Pharmaceuticals Inc.,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,5
NCT03489629,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03489941,1,0,0,0,1,0,2018-04-29,2019-04-29,,"EyeMax, LLC",Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03492710,0,0,0,0,0,0,2021-06-30,2022-06-30,,Green Cross Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,3,1,0,59
NCT03496298,0,0,0,0,0,0,2021-04-30,2022-04-30,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03498716,0,0,0,0,0,0,2022-01-15,2023-01-15,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03502031,0,0,0,0,0,0,2020-12-31,2021-12-31,,"NephroNet, Inc.",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03504046,1,0,0,0,1,0,2018-09-04,2019-09-04,,Sansum Diabetes Research Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,26
NCT03504826,0,0,0,0,0,0,2021-03-31,2022-03-31,,Brooks Rehabilitation,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03506061,0,0,0,0,0,0,2023-05-31,2024-05-31,,Emory University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03508609,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Caladrius Biosciences, Inc.",Industry,1,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,10
NCT03508934,0,0,0,0,0,0,2022-06-30,2023-06-30,,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03509350,0,0,0,0,0,0,2019-12-31,2020-12-31,,Emory University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03510273,0,0,0,0,0,0,2019-07-31,2020-07-31,,PATH,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,78
NCT03510455,0,0,0,0,0,0,2023-02-01,2024-02-01,,National Institute of Dental and Craniofacial Research (NIDCR),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,88
NCT03510884,0,0,0,0,0,0,2022-02-28,2023-02-28,,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03511625,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Attune Health Research, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,1
NCT03513068,0,0,0,0,0,0,2020-12-30,2021-12-30,,ResMed,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,60
NCT03517436,0,0,0,0,0,0,2020-12-31,2021-12-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,77
NCT03517995,0,0,0,0,0,0,2021-12-31,2022-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03520751,0,0,0,0,0,0,2020-04-01,2021-04-01,,Nationwide Children's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,161
NCT03521570,0,0,0,0,0,0,2020-12-31,2021-12-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,947
NCT03523091,0,0,0,0,0,0,2021-05-31,2022-05-31,,William Beaumont Hospitals,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,84
NCT03523988,1,1,0,1,0,1,2017-06-23,2018-06-23,2018-08-03,University of Washington,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03524612,0,0,0,0,0,0,2022-05-13,2023-05-13,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03526536,0,0,0,0,0,0,2019-12-31,2020-12-31,,State University of New York - Downstate Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,19
NCT03526861,0,0,0,0,0,0,2020-04-20,2021-04-20,,LEO Pharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,171
NCT03528408,0,0,0,0,0,0,2020-07-31,2021-07-31,,Suthee Rapisuwon,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03528902,0,0,0,0,0,0,2022-06-30,2023-06-30,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03530098,0,0,0,0,0,0,2019-09-30,2020-09-30,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03530345,0,0,0,0,0,0,2019-07-31,2020-07-31,,Grünenthal GmbH,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,71
NCT03531294,0,0,0,0,0,0,2019-12-31,2020-12-31,,Greater Houston Retina Research,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03531710,0,0,0,0,0,0,2019-10-31,2020-10-31,,United Neuroscience Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,3
NCT03531853,0,0,0,0,0,0,2019-12-31,2020-12-31,,Duke University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03532009,0,0,0,0,0,0,2020-10-12,2021-10-12,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03533036,0,0,1,1,0,0,2018-11-29,2019-11-29,2019-09-12,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,692
NCT03533582,0,0,0,0,0,0,2025-06-30,2026-06-30,,Children's Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,389
NCT03535727,0,0,0,0,0,0,2021-06-30,2022-06-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03536182,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,1,0,0,1,1,0,626
NCT03536559,0,0,0,0,0,0,2019-12-30,2020-12-30,,Clene Nanomedicine,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03537014,0,0,0,0,0,0,2020-06-10,2021-06-10,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,24
NCT03539952,0,0,0,0,0,0,2020-01-31,2021-01-31,,GMP-Orphan SAS,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03541083,0,0,0,0,0,0,2022-12-15,2023-12-15,,Stichting Hemato-Oncologie voor Volwassenen Nederland,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,18
NCT03541356,0,0,0,0,0,0,2019-06-11,2020-06-11,,Impel NeuroPharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,0,0,0,0,1,0,2,1,0,4
NCT03543189,0,0,0,0,0,0,2020-09-30,2021-09-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,344
NCT03543813,0,0,0,0,0,0,2020-12-31,2021-12-31,,CytomX Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03546842,0,0,0,0,0,0,2019-01-29,2020-01-29,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,2,1,0,2145
NCT03547973,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Immunomedics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,36
NCT03548961,0,0,0,0,0,0,2022-03-01,2023-03-01,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03550313,0,0,0,0,0,0,2020-06-09,2021-06-09,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2856
NCT03553602,0,0,0,0,0,0,2023-06-01,2024-06-01,,Loyola University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,102
NCT03556085,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Serenity Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03557008,0,0,0,0,0,0,2022-12-31,2023-12-31,,Emory University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03557242,0,0,0,0,0,0,2023-07-30,2024-07-30,,Medstar Health Research Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,79
NCT03559270,0,0,0,0,0,0,2020-03-10,2021-03-10,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03563313,0,0,0,0,0,0,2019-04-08,2020-04-08,,University of Virginia,Other,0,1,1,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,402
NCT03565146,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Focus Medical, LLC",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03568461,0,0,0,0,0,0,2021-02-19,2022-02-19,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT03569033,0,0,0,0,0,0,2018-11-04,2019-11-04,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,2,1,0,2145
NCT03569631,0,0,0,0,0,0,2019-12-31,2020-12-31,,Tetra Discovery Partners,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03570554,0,0,0,0,0,0,2019-06-14,2020-06-14,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1343
NCT03572062,0,0,0,0,0,0,2021-03-01,2022-03-01,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2856
NCT03572959,1,0,0,0,1,0,2017-03-20,2018-03-20,,Sherine Adel Nasry,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,1,0,0,0,0,3,0,1,1
NCT03573336,0,0,0,0,0,0,2020-06-30,2021-06-30,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03578237,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of California, San Diego",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,561
NCT03580382,0,0,0,0,0,0,2022-04-30,2023-04-30,,NYU Langone Health,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03581136,0,0,0,0,0,0,2028-05-25,2029-05-25,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03582085,0,0,0,0,0,0,2022-01-01,2023-01-01,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1699
NCT03584464,0,0,0,0,0,0,2020-05-31,2021-05-31,,Medtronic Vascular,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,51
NCT03585270,0,0,0,0,0,0,2020-11-01,2021-11-01,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03589326,0,0,0,0,0,0,2021-05-15,2022-05-15,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03589729,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03591458,0,1,0,1,0,0,2019-06-03,2020-06-03,2019-06-06,University of Utah,Other,0,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,578
NCT03593200,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Apellis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,14
NCT03595228,0,0,0,0,0,0,2021-01-31,2022-01-31,,Bavarian Nordic,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,33
NCT03597503,0,0,0,0,0,0,2019-07-29,2020-07-29,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,26
NCT03600428,0,0,0,0,0,0,2020-03-20,2021-03-20,,Vanderbilt University Medical Center,Other,0,0,1,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,422
NCT03601078,0,0,0,0,0,0,2025-03-12,2026-03-12,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,306
NCT03605641,0,0,0,0,0,0,2018-12-02,2019-12-02,,"Juul Labs, Inc.",Industry,1,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,7
NCT03606980,0,0,0,0,0,0,2022-02-17,2023-02-17,,"Children's Health System, Inc.",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03607825,0,0,0,0,0,0,2019-12-31,2020-12-31,,Minnetronix,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03607994,0,0,0,0,0,0,2019-11-30,2020-11-30,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03610490,0,0,0,0,0,0,2021-09-30,2022-09-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03611790,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vesalio,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03612999,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Savvysherpa, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03616912,0,0,0,0,0,0,2021-05-21,2022-05-21,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03621644,0,0,0,0,0,0,2021-05-31,2022-05-31,,Viewray Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,1
NCT03622775,0,0,0,0,0,0,2020-03-15,2021-03-15,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03624517,0,0,0,0,0,0,2020-12-31,2021-12-31,,Medical University of South Carolina,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03624881,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Biosense Webster, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,41
NCT03626623,0,0,0,0,0,0,2019-09-30,2020-09-30,,ACell Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03628690,0,0,0,0,0,0,2019-12-31,2020-12-31,,BandGrip,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03628924,0,0,0,0,0,0,2020-08-10,2021-08-10,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03630809,0,0,0,0,0,0,2023-12-31,2024-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,344
NCT03631706,0,0,0,0,0,0,2021-10-28,2022-10-28,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03635073,0,0,0,0,0,0,2023-03-21,2024-03-21,,Takeda,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,650
NCT03635567,0,0,0,0,0,0,2022-11-23,2023-11-23,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03637374,0,0,0,0,0,0,2023-12-31,2024-12-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03637556,0,0,0,0,0,0,2020-07-31,2021-07-31,,"DisperSol Technologies, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03637959,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03638622,0,0,0,0,0,0,2019-05-31,2020-05-31,,Massachusetts General Hospital,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,1,0,0,0,0,0,1,0,2,1,0,1699
NCT03638960,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Southern California,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03639857,0,0,0,0,0,0,2019-10-31,2020-10-31,,David Weinstein,Other,0,0,0,5.0,,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1
NCT03640221,0,0,0,0,0,0,2020-05-31,2021-05-31,,Cedars-Sinai Medical Center,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,279
NCT03642639,0,0,0,0,0,0,2021-01-29,2022-01-29,,"Cerenovus, Part of DePuy Synthes Products, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03646617,0,0,0,0,0,0,2022-02-23,2023-02-23,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,273
NCT03647891,0,0,0,0,0,0,2020-02-28,2021-02-28,,Kaiser Permanente,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,255
NCT03648229,0,0,0,0,0,0,2022-06-30,2023-06-30,,West Virginia University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,74
NCT03649958,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Brain State Technologies, LLC",Industry,1,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03652337,0,0,0,0,0,0,2018-12-01,2019-12-01,,University of the Incarnate Word,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03652610,0,0,0,0,0,0,2019-01-17,2020-01-17,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,2,1,0,3276
NCT03653507,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT03654066,0,0,0,0,0,0,2023-06-30,2024-06-30,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,1,0,0,0,0,1,0,422
NCT03654651,0,0,0,0,0,0,2019-10-01,2020-10-01,,Penn State University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,145
NCT03655106,0,0,0,0,0,0,2019-03-12,2020-03-12,,William Beaumont Hospitals,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,84
NCT03655236,0,0,0,0,0,0,2021-02-28,2022-02-28,,Sun Pharma Advanced Research Company Limited,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03656692,0,0,0,0,0,0,2020-02-27,2021-02-27,,Mallinckrodt,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,91
NCT03657108,0,0,0,0,0,0,2020-12-31,2021-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,412
NCT03658304,0,0,0,0,0,0,2025-12-31,2026-12-31,,University of Florida,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03659916,0,0,0,0,0,0,2021-12-31,2022-12-31,,Albireo,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03661697,0,0,0,0,0,0,2019-08-01,2020-08-01,,University of Miami,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,476
NCT03661814,0,0,0,0,0,0,2020-08-31,2021-08-31,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,412
NCT03662685,0,0,0,0,0,0,2019-11-07,2020-11-07,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1443
NCT03663049,0,0,0,0,0,0,2021-05-31,2022-05-31,,Loyola University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03664674,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Otonomy, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,20
NCT03665740,0,0,0,0,0,0,2022-08-31,2023-08-31,,VISN 17 Center of Excellence,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03667690,0,0,0,0,0,0,2020-09-30,2021-09-30,,Cidara Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03668847,0,0,0,0,0,0,2021-12-31,2022-12-31,,"DEKK-TEC, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03669718,0,0,0,0,0,0,2020-02-29,2021-02-28,,ISA Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2
NCT03670030,0,0,0,0,0,0,2020-05-01,2021-05-01,,Robert Ramirez,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03670966,0,0,0,0,0,0,2023-09-01,2024-09-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,393
NCT03671148,0,0,0,0,0,0,2021-01-29,2022-01-29,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,430
NCT03672240,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Asieris Pharmaceutical Technologies Co., Ltd.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03673124,0,0,0,0,0,0,2020-07-30,2021-07-30,,Gynecologic Oncology Group,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,200
NCT03676816,0,0,0,0,0,0,2021-06-01,2022-06-01,,"Brian Chinnock, MD",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03678493,0,0,0,0,0,0,2026-11-30,2027-11-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,218
NCT03678792,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Alabama at Birmingham,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03679598,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Alabama at Birmingham,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03680287,0,0,0,0,0,0,2021-12-31,2022-12-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03684889,0,0,0,0,0,0,2021-12-31,2022-12-31,,Seattle Children's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,137
NCT03686813,0,0,0,0,0,0,2020-10-01,2021-10-01,,Duke University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03689946,0,0,0,0,0,0,2021-12-31,2022-12-31,,Cedars-Sinai Medical Center,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,279
NCT03691181,1,0,0,0,1,0,2018-06-30,2019-06-30,,Landon Pediatric Foundation,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03691623,0,0,0,0,0,0,2019-09-30,2020-09-30,,Enanta Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,22
NCT03691974,0,0,0,0,0,0,2019-09-27,2020-09-27,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03693040,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, San Diego",Other,0,1,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,561
NCT03696576,0,0,0,0,0,0,2023-01-31,2024-01-31,,Emory University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT03697161,0,0,0,0,0,0,2019-07-31,2020-07-31,,Ovid Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03697811,0,0,0,0,0,0,2019-10-31,2020-10-31,,Santen Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03699956,0,0,0,0,0,0,2020-11-01,2021-11-01,,"EpicentRx, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,1,0,0,1,0,12
NCT03702127,0,0,0,0,0,0,2025-10-31,2026-10-31,,Aaron Boes,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03702231,0,0,0,0,0,0,2020-05-15,2021-05-15,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1091
NCT03702816,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Aaron Ritter, MD",Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1
NCT03703492,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03703908,0,0,0,0,0,0,2020-12-31,2021-12-31,,ChemoCentryx,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03705273,0,0,0,0,0,0,2019-04-30,2020-04-30,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,422
NCT03707184,0,0,0,0,0,0,2023-09-17,2024-09-17,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03709082,0,0,0,0,0,0,2025-10-15,2026-10-15,,University of Kansas Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03709342,0,0,0,0,0,0,2019-03-07,2020-03-07,,"CalciMedica, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03711565,0,0,0,0,0,0,2026-09-30,2027-09-30,,"University of California, Davis",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,530
NCT03712787,0,0,0,0,0,0,2026-10-08,2027-10-08,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03713957,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Alkahest, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03714256,0,0,0,0,0,0,2018-11-19,2019-11-19,,"Permobil, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03714425,0,0,0,0,0,0,2020-05-01,2021-05-01,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,698
NCT03714815,0,0,0,0,0,0,2023-11-30,2024-11-30,,Actelion,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03717506,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Gage Development Company, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03718637,0,0,0,0,0,0,2020-03-30,2021-03-30,,Henry Ford Health System,Other,0,1,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,1,0,0,0,1,0,151
NCT03719612,0,0,0,0,0,0,2019-09-30,2020-09-30,,Lantheus Medical Imaging,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,23
NCT03721107,0,0,0,0,0,0,2020-03-31,2021-03-31,,4D pharma plc,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,4
NCT03721419,0,0,0,0,0,0,2019-04-09,2020-04-09,,Barnes-Jewish Hospital,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,9
NCT03727048,1,0,0,0,1,0,2018-03-31,2019-03-31,,Rothman Institute Orthopaedics,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,58
NCT03727347,0,0,0,0,0,0,2020-02-01,2021-02-01,,Aerin Medical,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03728933,0,0,0,0,0,0,2020-06-30,2021-06-30,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,75
NCT03730012,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,135
NCT03730961,0,0,0,0,0,0,2019-12-22,2020-12-22,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1104
NCT03731091,0,0,0,0,0,0,2019-10-31,2020-10-31,,Glenmark Pharmaceuticals Ltd. India,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03732534,0,0,0,0,0,0,2019-02-18,2020-02-18,,Neurocrine Biosciences,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,34
NCT03732755,0,0,0,0,0,0,2019-11-30,2020-11-30,,Neurohabilitation Corporation,Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03733119,0,0,0,0,0,0,2021-04-01,2022-04-01,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03733444,0,0,0,0,0,0,2021-12-31,2022-12-31,,Galapagos NV,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03734692,0,0,0,0,0,0,2021-02-20,2022-02-20,,Robert Edwards,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03735667,0,0,0,0,0,0,2020-05-31,2021-05-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,340
NCT03737981,0,0,0,0,0,0,2027-06-01,2028-06-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03744676,0,0,0,0,0,0,2022-08-30,2023-08-30,,"Juno Therapeutics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,8
NCT03746015,0,0,0,0,0,0,2020-04-15,2021-04-15,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,650
NCT03747575,0,0,0,0,0,0,2020-04-24,2021-04-24,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03748342,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03752073,0,0,0,0,0,0,2020-11-15,2021-11-15,,Ochsner Health System,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,37
NCT03754049,0,0,0,0,0,0,2020-01-09,2021-01-09,,Taiwan Liposome Company,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03757715,0,0,0,0,0,0,2021-05-31,2022-05-31,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03758755,0,0,0,0,0,0,2021-11-30,2022-11-30,,Inova Health Care Services,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,41
NCT03759379,0,0,0,0,0,0,2021-02-28,2022-02-28,,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,45
NCT03760185,0,0,0,0,0,0,2019-07-01,2020-07-01,,Denver Health and Hospital Authority,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,66
NCT03761537,0,0,0,0,0,0,2019-11-30,2020-11-30,,LEO Pharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,171
NCT03762382,0,0,0,0,0,0,2019-08-31,2020-08-31,,CONRAD,Other,0,0,1,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,39
NCT03762863,0,0,0,0,0,0,2019-06-30,2020-06-30,,Somerville Office of Emergency Management,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03763929,0,0,0,0,0,0,2020-09-01,2021-09-01,,Diffusion Pharmaceuticals Inc,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03764098,0,0,0,0,0,0,2020-08-31,2021-08-31,,Yale University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03764618,0,0,0,0,0,0,2020-09-30,2021-09-30,,Rigel Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03767452,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Manhattan Medical Research Practice, PLLC",Industry,1,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03768531,0,0,0,0,0,0,2023-01-31,2024-01-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03769116,0,0,0,0,0,0,2022-07-25,2023-07-25,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT03769714,0,0,0,0,0,0,2019-06-30,2020-06-30,,Maimonides Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,46
NCT03770286,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Brian Lee, DDS",Other,0,0,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03770442,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Liverpool,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,43
NCT03771664,0,0,0,0,0,0,2020-05-31,2021-05-31,,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,24
NCT03772314,0,0,0,0,0,0,2022-02-28,2023-02-28,,Emory University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03773575,0,0,0,0,0,0,2020-12-15,2021-12-15,,Thomas Jefferson University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,186
NCT03774186,0,0,0,0,0,0,2020-05-15,2021-05-15,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT03774810,0,0,0,0,0,0,2022-06-30,2023-06-30,,University of Pennsylvania,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03775512,0,0,0,0,0,0,2019-12-25,2020-12-25,,"Biosense Webster, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,41
NCT03779854,0,0,0,0,0,0,2020-12-31,2021-12-31,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,393
NCT03782038,0,0,0,0,0,0,2019-09-17,2020-09-17,,"Cytrellis Biosystems, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03782415,0,0,0,0,0,0,2019-12-31,2020-12-31,,MediciNova,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03782545,0,0,0,0,0,0,2019-05-31,2020-05-31,,Cutera Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03783052,0,0,0,0,0,0,2020-06-01,2021-06-01,,Universitaire Ziekenhuizen Leuven,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,525
NCT03785210,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03786094,0,0,0,0,0,0,2021-03-31,2022-03-31,,Polyphor Ltd.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03786302,1,0,0,0,1,0,2018-08-15,2019-08-15,,Nourhan M.Aly,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,3,0,1,7
NCT03786796,0,0,0,0,0,0,2021-03-31,2022-03-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03787290,0,0,0,0,0,0,2021-02-01,2022-02-01,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,1699
NCT03787615,0,0,0,0,0,0,2019-12-01,2020-12-01,,Penn State University,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,145
NCT03790540,0,0,0,0,0,0,2019-03-10,2020-03-10,,Nourhan M.Aly,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,1,0,0,0,0,2,1,0,7
NCT03791398,0,0,0,0,0,0,2021-12-31,2022-12-31,,Khaldoun Almhanna,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03792750,0,0,0,0,0,0,2020-06-28,2021-06-28,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,1104
NCT03793478,0,0,0,0,0,0,2027-05-01,2028-05-01,,"Daiichi Sankyo, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,207
NCT03794570,0,0,0,0,0,0,2019-06-01,2020-06-01,,Steadman Philippon Research Institute,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03795987,0,0,0,0,0,0,2019-08-15,2020-08-15,,NightWare,Industry,1,0,1,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03796962,0,0,0,0,0,0,2020-07-31,2021-07-31,,Xenon Pharmaceuticals Inc.,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03801525,0,0,0,0,0,0,2022-01-31,2023-01-31,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03802565,0,0,0,0,0,0,2019-06-28,2020-06-28,,"Neurana Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03805698,0,0,0,0,0,0,2023-12-31,2024-12-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,279
NCT03806842,0,0,0,0,0,0,2021-11-28,2022-11-28,,"FX Shoulder USA, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03813056,0,0,0,0,0,0,2020-02-01,2021-02-01,,"Michael D. Straiko, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03816293,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Illinois at Chicago,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,242
NCT03816995,0,0,0,0,0,0,2021-12-31,2022-12-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03818919,0,0,0,0,0,0,2020-01-20,2021-01-20,,Henry Ford Health System,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,151
NCT03819543,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Manitoba,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,344
NCT03820258,0,0,0,0,0,0,2022-06-30,2023-06-30,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,510
NCT03821324,0,0,0,0,0,0,2019-07-01,2020-07-01,,Venus Concept,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT03824275,0,0,0,0,0,0,2022-12-31,2023-12-31,,Columbia University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03827018,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Kiniksa Pharmaceuticals, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,1,0,1,1,0,5
NCT03827434,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of Maryland, College Park",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,318
NCT03827564,0,0,0,0,0,0,2019-12-31,2020-12-31,,Allergan,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,495
NCT03828448,0,0,0,0,0,0,2022-02-28,2023-02-28,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03829618,0,0,0,0,0,0,2020-07-01,2021-07-01,,Milton S. Hershey Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT03831048,0,0,0,0,0,0,2021-08-01,2022-08-01,,TransMedics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,11
NCT03832569,0,0,0,0,0,0,2022-02-28,2023-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03833167,0,0,0,0,0,0,2026-04-06,2027-04-06,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03834350,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Chicago,Other,0,0,1,5.0,,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,594
NCT03834961,0,0,0,0,0,0,2025-03-22,2026-03-22,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,389
NCT03835481,0,0,0,0,0,0,2025-07-21,2026-07-21,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03836677,0,0,0,0,0,0,2019-11-12,2020-11-12,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,2,1,0,2450
NCT03837509,0,0,0,0,0,0,2021-06-30,2022-06-30,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,143
NCT03839459,0,0,0,0,0,0,2021-06-01,2022-06-01,,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03839693,0,0,0,0,0,0,2019-04-18,2020-04-18,,Eirion Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03840915,0,0,0,0,0,0,2021-10-28,2022-10-28,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03841448,0,0,0,0,0,0,2021-11-05,2022-11-05,,Alnylam Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,45
NCT03841708,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Stefano Malinverni, MD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03843853,0,0,0,0,0,0,2021-11-01,2022-11-01,,The First Affiliated Hospital with Nanjing Medical University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,90
NCT03844061,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Hospital for Special Surgery, New York",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT03845517,0,0,0,0,0,0,2022-09-07,2023-09-07,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03846973,0,0,0,0,0,0,2020-12-31,2021-12-31,,Hamad Medical Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,47
NCT03850795,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Hinova Pharmaceuticals USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03852472,0,0,0,0,0,0,2020-05-21,2021-05-21,,ChemoCentryx,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03853707,0,0,0,0,0,0,2022-06-21,2023-06-21,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,358
NCT03858777,0,0,0,0,0,0,2020-03-15,2021-03-15,,Nabeel Hamzeh,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,2
NCT03859336,0,0,0,0,0,0,2020-04-30,2021-04-30,,Phoenix Children's Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,35
NCT03859648,0,0,0,0,0,0,2021-04-30,2022-04-30,,Med-El Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,8
NCT03859869,0,0,0,0,0,0,2022-01-27,2023-01-27,,AbbVie,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03861052,0,0,0,0,0,0,2021-04-17,2022-04-17,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03861936,0,0,0,0,0,0,2020-04-14,2021-04-14,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,495
NCT03863080,0,0,0,0,0,0,2019-12-31,2020-12-31,,Immunovant Sciences GmbH,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03863886,0,0,0,0,0,0,2020-01-31,2021-01-31,,Carilion Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,22
NCT03864133,0,0,0,0,0,0,2020-07-31,2021-07-31,,Wake Forest University Health Sciences,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03866538,0,0,0,0,0,0,2020-09-01,2021-09-01,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03866668,0,0,0,0,0,0,2020-12-31,2021-12-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03867214,0,0,0,0,0,0,2021-03-01,2022-03-01,,Yanzhao,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03869736,0,0,0,0,0,0,2020-10-10,2021-10-10,,Bayside Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,104
NCT03870763,0,0,0,0,0,0,2020-02-28,2021-02-28,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03871699,0,0,0,0,0,0,2020-12-31,2021-12-31,,Hospital Moinhos de Vento,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,12
NCT03872336,0,0,0,0,0,0,2021-03-01,2022-03-01,,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03872843,0,0,0,0,0,0,2020-07-31,2021-07-31,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03873272,0,0,0,0,0,0,2021-04-30,2022-04-30,,Columbia University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03873493,0,0,0,0,0,0,2022-09-21,2023-09-21,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03881176,0,0,0,0,0,0,2019-11-30,2020-11-30,,Neurohabilitation Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03882034,0,0,0,0,0,0,2022-01-01,2023-01-01,,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,413
NCT03882970,0,0,0,0,0,0,2020-10-19,2021-10-19,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03888066,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Relypsa, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03888287,0,0,0,0,0,0,2020-10-01,2021-10-01,,Hackensack Meridian Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,55
NCT03888482,0,0,0,0,0,0,2019-06-28,2020-06-28,,Alcon Research,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03888846,0,0,0,0,0,0,2019-09-30,2020-09-30,,Ipekyolu Ilac Ltd. Sti,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03889704,0,0,0,0,0,0,2019-12-15,2020-12-15,,Edward Burton,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03889886,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Silk Technologies, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03891901,0,0,0,0,0,0,2020-06-15,2021-06-15,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2133
NCT03892460,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Vermont,Other,0,0,0,3.0,Phase 3,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,155
NCT03892642,0,0,0,0,0,0,2022-10-31,2023-10-31,,University of Oklahoma,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,234
NCT03893578,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Synecor, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03895437,0,0,0,0,0,0,2021-08-14,2022-08-14,,"Tolerion, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03895853,0,0,0,0,0,0,2020-01-15,2021-01-15,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,0,0,0,1,0,2066
NCT03898791,0,0,0,0,0,0,2021-02-15,2022-02-15,,Eli Lilly and Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03899259,0,0,0,0,0,0,2021-05-12,2022-05-12,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03900429,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Madrigal Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03900624,0,0,0,0,0,0,2020-05-21,2021-05-21,,Johns Hopkins All Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03900897,0,0,0,0,0,0,2022-07-31,2023-07-31,,Med-El Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03901339,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Immunomedics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,36
NCT03903640,0,0,0,0,0,0,2021-12-31,2022-12-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,1,1,0,0,0,0,0,1,0,1151
NCT03904043,0,0,0,0,0,0,2023-02-28,2024-02-28,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1151
NCT03907475,0,0,0,0,0,0,2021-06-01,2022-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03908255,0,0,0,0,0,0,2019-10-30,2020-10-30,,Louisiana State University Health Sciences Center in New Orleans,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,42
NCT03908762,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Amalgam Rx, Inc.",Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03909503,0,0,0,0,0,0,2019-12-01,2020-12-01,,Medline Industries,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,30
NCT03909971,0,0,0,0,0,0,2020-07-21,2021-07-21,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2856
NCT03910790,0,0,0,0,0,0,2020-04-30,2021-04-30,,Florida Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,63
NCT03913559,0,0,0,0,0,0,2022-12-31,2023-12-31,,St. Jude Children's Research Hospital,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,302
NCT03915431,0,0,0,0,0,0,2021-10-31,2022-10-31,,NC Medial Research Inc,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT03915860,0,0,0,0,0,0,2020-01-31,2021-01-31,,Galderma R&D,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,28
NCT03916042,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03918499,0,0,0,0,0,0,2020-12-24,2021-12-24,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT03919071,0,0,0,0,0,0,2022-06-01,2023-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,3,1,0,3004
NCT03919617,0,0,0,0,0,0,2019-12-01,2020-12-01,,"University of California, San Diego",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,561
NCT03920215,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Oyster Point Pharma, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03923322,0,0,0,0,0,0,2020-09-30,2021-09-30,,Stamford Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03924765,0,0,0,0,0,0,2021-12-31,2022-12-31,,Georgia Institute of Technology,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,10
NCT03926117,0,0,0,0,0,0,2020-09-30,2021-09-30,,Corvidia Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03929601,0,0,0,0,0,0,2025-07-31,2026-07-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,495
NCT03930615,0,0,0,0,0,0,2022-06-11,2023-06-11,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03932318,0,0,0,0,0,0,2021-01-31,2022-01-31,,Actinium Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,5
NCT03935594,0,0,0,0,0,0,2022-09-30,2023-09-30,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,422
NCT03936608,0,0,0,0,0,0,2021-12-31,2022-12-31,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03938545,0,0,0,0,0,0,2020-06-30,2021-06-30,,Immunovant Sciences GmbH,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03939026,0,0,0,0,0,0,2021-10-31,2022-10-31,,Allogene Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,1,0,1,0,1
NCT03941964,0,0,0,0,0,0,2020-11-11,2021-11-11,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03949283,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Cordgenics, LLC",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,3
NCT03952377,0,0,0,0,0,0,2020-04-30,2021-04-30,,SpineThera Australia PTY LTD,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03952585,0,0,0,0,0,0,2025-02-28,2026-02-28,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,3004
NCT03955471,0,0,0,0,0,0,2021-01-30,2022-01-30,,"Tesaro, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,31
NCT03956550,0,0,0,0,0,0,2020-09-29,2021-09-29,,Regeneron Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03960541,0,0,0,0,0,0,2021-06-30,2022-06-30,,"OncoImmune, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03961568,0,0,0,0,0,0,2023-05-31,2024-05-31,,"SK Life Science, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,30
NCT03964493,0,0,0,0,0,0,2019-11-30,2020-11-30,,TenNor Therapeutics Limited,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03965195,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Insight Therapeutics, LLC",Other,0,1,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,7
NCT03965403,0,0,0,0,0,0,2019-10-31,2020-10-31,,Spaulding Rehabilitation Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,69
NCT03965923,0,0,0,0,0,0,2023-04-30,2024-04-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2133
NCT03966768,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mesh Suture Inc.,Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03968822,0,0,0,0,0,0,2020-09-01,2021-09-01,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT03969368,0,0,0,0,0,0,2020-12-01,2021-12-01,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT03969615,0,0,0,0,0,0,2019-10-15,2020-10-15,,Vyaire Medical,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03970330,0,0,0,0,0,0,2023-05-01,2024-05-01,,Milton S. Hershey Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,334
NCT03971201,0,0,0,0,0,0,2020-12-31,2021-12-31,,White Plains Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03971357,0,0,0,0,0,0,2020-06-30,2021-06-30,,Price Vision Group,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03973281,0,0,0,0,0,0,2021-07-31,2022-07-31,,Materna Medical,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03974412,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Alberta,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,2,1,0,432
NCT03975283,0,0,0,0,0,0,2021-08-31,2022-08-31,,McMaster University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,434
NCT03975660,0,0,0,0,0,0,2021-01-30,2022-01-30,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03978624,0,0,0,0,0,0,2021-10-01,2022-10-01,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03979365,0,0,0,0,0,0,2021-06-01,2022-06-01,,Mayo Clinic,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03982693,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Mt. Sinai Medical Center, Miami",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03984565,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Staci Gruber, Ph.D.",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03985943,0,0,0,0,0,0,2021-12-31,2022-12-31,,Galderma R&D,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03988634,0,0,0,0,0,0,2021-02-11,2022-02-11,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03989947,0,0,0,0,0,0,2026-09-30,2027-09-30,,BioMarin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,85
NCT03991208,0,0,0,0,0,0,2020-05-23,2021-05-23,,Walter Reed Army Institute of Research (WRAIR),U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03991988,0,0,0,0,0,0,2021-08-31,2022-08-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03994731,0,0,0,0,0,0,2021-02-28,2022-02-28,,Horizon Pharma Rheumatology LLC,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03995017,0,0,0,0,0,0,2021-05-31,2022-05-31,,Anwaar Saeed,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03995758,0,0,0,0,0,0,2020-05-31,2021-05-31,,Indiana University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT03997968,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Cyteir Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03999658,0,0,0,0,0,0,2022-01-31,2023-01-31,,"Sorrento Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2020.0,0,0,1,0,0,0,0,0,3,1,0,9
NCT04000659,0,0,0,0,0,0,2022-06-30,2023-06-30,,Episurf Medical Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT04000867,0,0,0,0,0,0,2019-12-01,2020-12-01,,ZyGood LLC,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT04002037,0,0,0,0,0,0,2025-06-15,2026-06-15,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT04003246,0,0,0,0,0,0,2025-08-31,2026-08-31,,University of Texas Southwestern Medical Center,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,626
NCT04003636,0,0,0,0,0,0,2023-08-31,2024-08-31,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2145
NCT04004325,0,0,0,0,0,0,2020-01-10,2021-01-10,,"Forma Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT04008030,0,0,0,0,0,0,2024-10-30,2025-10-30,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT04012073,0,0,0,0,0,0,2021-10-31,2022-10-31,,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,45
NCT04013880,0,0,0,0,0,0,2021-03-31,2022-03-31,,Vanderbilt-Ingram Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT04015336,0,0,0,0,0,0,2023-04-28,2024-04-28,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT04015518,0,0,0,0,0,0,2020-08-29,2021-08-29,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT04016779,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,26
NCT04018482,0,0,0,0,0,0,2019-12-02,2020-12-02,,California Retina Consultants,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,0,0,0,0,0,3,1,0,10
NCT04018612,0,0,0,0,0,0,2019-07-26,2020-07-26,,"Nevakar, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT04018794,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT04019964,0,0,0,0,0,0,2024-08-31,2025-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT04020822,0,0,0,0,0,0,2019-08-27,2020-08-27,,Medtronic Diabetes,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,48
NCT04024800,0,0,0,0,0,0,2023-06-30,2024-06-30,,"Antigen Express, Inc",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT04025632,0,0,0,0,0,0,2020-11-30,2021-11-30,,Ra Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT04026178,0,0,0,0,0,0,2022-01-31,2023-01-31,,"Aegerion Pharmaceuticals, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT04026347,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Solace Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,6
NCT04029519,0,0,0,0,0,0,2019-09-30,2020-09-30,,Prollenium Medical Technologies Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT04030052,0,0,0,0,0,0,2024-07-31,2025-07-31,,Emory University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT04030299,0,0,0,0,0,0,2021-08-31,2022-08-31,,Yu-Hsiang Wu,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT04033445,0,0,0,0,0,0,2022-06-29,2023-06-29,,"Janssen Research & Development, LLC",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT04037969,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Waterloo,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,53
NCT04038515,0,0,0,0,0,0,2022-06-15,2023-06-15,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT04039347,0,0,0,0,0,0,2023-03-31,2024-03-31,,Breath Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT04039516,0,0,0,0,0,0,2024-11-30,2025-11-30,,King's College Hospital NHS Trust,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,68
NCT04043806,0,0,0,0,0,0,2022-05-31,2023-05-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,141
NCT04044690,0,0,0,0,0,0,2022-07-31,2023-07-31,,CSL Behring,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,81
NCT04044872,0,0,0,0,0,0,2021-10-31,2022-10-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,626
NCT04050293,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,26
NCT04050865,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Ocular Therapeutix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,19
NCT04052425,0,0,0,0,0,0,2021-04-16,2022-04-16,,Incyte Corporation,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,143
NCT04053803,0,0,0,0,0,0,2024-06-30,2025-06-30,,"Imara, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT04054167,0,0,0,0,0,0,2021-05-29,2022-05-29,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT04056429,0,0,0,0,0,0,2022-02-28,2023-02-28,,Carmell Therapeutics Corporation,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,3,1,0,2
NCT04057937,0,0,0,0,0,0,2020-11-20,2021-11-20,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,306
NCT04060030,0,0,0,0,0,0,2021-12-31,2022-12-31,,Phoenix Children's Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,35
NCT04060277,0,0,0,0,0,0,2022-07-22,2023-07-22,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT04062565,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Arizona,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,265
NCT04064060,0,0,0,0,0,0,2028-01-11,2029-01-11,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT04067518,0,0,0,0,0,0,2021-04-30,2022-04-30,,Institut de Recherches Internationales Servier,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,28
NCT04071223,0,0,0,0,0,0,2021-06-15,2022-06-15,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,3,1,0,3004
NCT04071457,0,0,0,0,0,0,2029-07-01,2030-07-01,,Southwest Oncology Group,Other,0,1,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,288
NCT04074811,0,0,0,0,0,0,2020-08-31,2021-08-31,,Wayne State University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,145
NCT04076072,0,0,0,0,0,0,2020-05-01,2021-05-01,,Vanderbilt University Medical Center,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,422
NCT04078152,0,0,0,0,0,0,2022-09-30,2023-09-30,,AstraZeneca,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT04079218,0,0,0,0,0,0,2022-08-31,2023-08-31,,Albert Einstein College of Medicine,Other,0,1,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,155
NCT04079452,0,0,0,0,0,0,2019-11-30,2020-11-30,,Fundacio Lluita Contra la SIDA,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,15
NCT04080011,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Metis Foundation,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT04084288,0,0,0,0,0,0,2020-02-01,2021-02-01,,"Hospital for Special Surgery, New York",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,157
NCT04084769,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,285
NCT04085406,0,0,0,0,0,0,2024-06-30,2025-06-30,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,692
NCT04086485,0,0,0,0,0,0,2025-07-01,2026-07-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,3004
NCT04086810,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Soleno Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT04089891,0,0,0,0,0,0,2024-10-31,2025-10-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,3,1,0,218
NCT00001521,0,0,0,0,0,0,2020-12-31,2021-12-31,,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,0,1.0,Phase 2,0,1996.0,0,1,0,0,0,0,0,0,0,0,1,413
NCT00003042,0,0,0,0,0,0,2019-12-31,2020-12-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,1997.0,0,1,1,0,0,0,0,0,0,0,1,358
NCT00080756,0,0,0,0,0,0,2019-09-30,2020-09-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2004.0,0,1,1,0,0,0,0,0,0,0,1,358
NCT00167180,1,1,0,1,0,0,2017-11-21,2018-11-21,2017-04-28,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,1,2004.0,1,1,0,0,0,0,0,0,0,0,1,218
NCT00176930,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2001.0,0,1,0,0,0,1,0,0,0,0,1,218
NCT00199862,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00275067,0,0,0,0,0,0,2020-05-31,2021-05-31,,Northwestern University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2005.0,0,1,0,0,0,1,0,0,0,0,1,925
NCT00358657,0,0,0,0,0,0,2023-12-01,2024-12-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2006.0,0,1,0,0,0,1,0,0,0,0,1,393
NCT00367003,0,0,0,0,0,0,2019-11-30,2020-11-30,,Emory University,Other,0,0,0,5.0,,0,2006.0,0,0,0,1,0,0,0,0,0,0,1,947
NCT00383656,0,0,0,0,0,0,2020-09-30,2021-09-30,,Massachusetts General Hospital,Other,0,0,1,1.0,Phase 2,0,1989.0,0,1,0,1,0,0,0,0,0,0,1,1699
NCT00476190,0,0,0,0,0,0,2019-06-30,2020-06-30,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,1,0,1,647
NCT00515411,0,0,0,0,0,0,2018-10-26,2019-10-26,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00524173,1,1,0,1,0,1,2017-02-16,2018-02-16,2018-03-20,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,1,2007.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT00534118,1,0,0,0,1,0,2018-07-26,2019-07-26,,Roswell Park Cancer Institute,Other,0,0,0,5.0,,0,2003.0,1,0,1,0,0,0,0,0,0,0,1,294
NCT00540761,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2007.0,0,0,0,1,0,0,0,0,0,0,1,1699
NCT00543439,1,1,0,1,0,0,2018-04-30,2019-04-30,2018-09-21,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2007.0,1,0,1,0,0,0,0,0,1,0,1,2856
NCT00557193,1,1,0,1,0,0,2017-09-30,2018-09-30,2018-09-26,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2008.0,1,1,1,0,0,0,0,0,1,0,1,389
NCT00567580,0,0,0,0,0,0,2020-12-31,2021-12-31,,Radiation Therapy Oncology Group,Other,0,0,1,3.0,Phase 3,0,2008.0,0,1,0,0,0,1,0,0,1,0,1,156
NCT00588523,0,0,0,0,0,0,2019-09-30,2020-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2002.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00630565,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,2.0,Phase 2/Phase 3,0,2006.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT00752206,1,0,1,1,0,1,2017-08-31,2018-08-31,2019-04-12,Sarcoma Alliance for Research through Collaboration,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT00761774,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-20,UCB Pharma,Industry,1,0,0,3.0,Phase 3,0,2008.0,1,1,0,0,0,0,0,0,1,0,1,246
NCT00770224,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-06-27,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2009.0,1,1,1,0,0,1,0,0,0,0,1,288
NCT00792142,0,0,0,0,0,0,2019-04-30,2020-04-30,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,1,0,0,1,358
NCT00799110,0,0,0,0,0,0,2020-12-31,2021-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,1,0,0,0,0,0,0,0,1,377
NCT00800046,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Ancora Heart, Inc.",Industry,1,0,0,5.0,,0,2008.0,0,0,0,1,0,0,0,0,2,0,1,8
NCT00823459,1,1,0,1,0,0,2017-06-12,2018-06-12,2017-05-24,Susan Chang,Other,0,0,1,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT00828919,0,0,0,0,0,0,2021-05-31,2022-05-31,,Pfizer,Industry,1,0,0,5.0,,0,2003.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT00862446,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vanderbilt University,Other,0,0,0,4.0,Phase 4,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT00863681,0,0,0,0,0,0,2019-08-19,2020-08-19,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT00869713,0,0,0,0,0,0,2019-06-30,2020-06-30,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2009.0,1,0,1,0,0,0,0,0,0,0,1,136
NCT00874614,0,1,0,1,0,1,2017-02-14,2018-02-14,2018-08-22,"Molecular Insight Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2009.0,0,0,0,0,0,1,0,0,0,0,1,19
NCT00907166,1,0,0,0,1,0,2017-12-31,2018-12-31,,Rafael Pharmaceuticals Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2009.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT00908947,0,0,1,1,0,0,2018-09-18,2019-09-18,2019-09-06,C. R. Bard,Industry,1,0,0,5.0,,1,2011.0,1,0,0,1,0,0,0,0,0,0,1,77
NCT00920972,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2001.0,0,1,0,0,0,0,0,0,1,0,1,1151
NCT00924703,0,0,0,0,0,0,2019-01-31,2020-01-31,,BioMarin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,85
NCT00939770,0,0,0,0,0,0,2018-12-31,2019-12-31,,Children's Oncology Group,Other,0,0,1,0.0,Phase 1/Phase 2,0,2009.0,1,1,0,0,0,0,0,0,1,0,1,389
NCT00945152,0,0,0,0,0,0,2019-12-31,2020-12-31,,Robert S Berman MD,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT00980395,1,0,0,0,1,0,2018-08-14,2019-08-14,,University of Arizona,Other,0,0,1,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,265
NCT00981578,0,0,0,0,0,0,2020-06-30,2021-06-30,,InSightec,Industry,1,0,0,5.0,,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,61
NCT01009788,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Steven J Isakoff, MD, PhD",Other,0,1,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01009918,1,0,0,0,1,0,2017-08-31,2018-08-31,,University of South Florida,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT01077154,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-13,Amgen,Industry,1,1,0,3.0,Phase 3,1,2010.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT01081561,0,0,0,0,0,0,2020-12-30,2021-12-30,,Yaron S. Rabinowitz M.D.,Other,0,0,0,2.0,Phase 2/Phase 3,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01101451,0,0,0,0,0,0,2020-12-31,2021-12-31,,Gynecologic Oncology Group,Other,0,0,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,1,0,0,1,0,1,200
NCT01114555,0,0,0,0,0,0,2018-11-02,2019-11-02,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01142401,1,0,0,0,1,0,2017-06-01,2018-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01149850,0,0,0,0,0,0,2020-01-01,2021-01-01,,Jonsson Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,1,0,0,1,277
NCT01152541,0,0,0,0,0,0,2019-12-31,2020-12-31,,Cornea and Laser Eye Institute,Other,0,0,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01157091,0,0,0,0,0,0,2020-01-31,2021-01-31,,City of Hope Medical Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT01167907,1,1,0,1,0,0,2017-09-07,2018-09-07,2017-09-07,Wake Forest University Health Sciences,Other,0,1,0,5.0,,0,2010.0,1,1,0,1,0,0,0,0,0,0,1,616
NCT01174082,1,1,0,1,0,1,2017-02-23,2018-02-23,2018-03-22,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,1,2010.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01189851,0,0,0,0,0,0,2020-09-30,2021-09-30,,Hoag Memorial Hospital Presbyterian,Other,0,0,0,5.0,,0,2010.0,0,0,0,1,0,0,0,0,0,0,1,22
NCT01206166,1,0,0,0,1,0,2017-03-31,2018-03-31,,Clinical Evaluation Research Unit at Kingston General Hospital,Other,0,1,0,3.0,Phase 3,1,2011.0,1,1,0,0,0,0,0,0,1,0,1,9
NCT01213082,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-05-07,"University of California, Davis",Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,530
NCT01215253,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-05-24,University of Rochester,Other,0,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,470
NCT01242800,0,0,0,0,0,0,2022-06-30,2023-06-30,,Eastern Cooperative Oncology Group,Other,0,0,1,3.0,Phase 3,0,2011.0,0,0,0,0,0,1,0,0,1,0,1,175
NCT01254864,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01261312,0,0,0,0,0,0,2019-01-31,2020-01-31,,Astex Pharmaceuticals,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,38
NCT01265030,0,0,0,0,0,0,2019-12-31,2020-12-31,,Maine Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,25
NCT01277744,1,0,1,1,0,1,2018-02-16,2019-02-16,2019-09-12,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01286038,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01289353,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,869
NCT01290055,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Sri Edupuganti, MD MPH",Other,0,0,1,5.0,,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT01297764,0,0,0,0,0,0,2020-08-31,2021-08-31,,Hackensack Meridian Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT01304485,0,0,0,0,0,0,2019-01-31,2020-01-31,,Phoenix Molecular Imaging,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01312389,0,0,0,0,0,0,2019-03-31,2020-03-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,273
NCT01326871,1,0,0,0,1,0,2017-07-31,2018-07-31,,Altor BioScience,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2011.0,1,1,1,0,0,0,0,0,0,0,1,18
NCT01328808,0,0,0,0,0,0,2019-09-30,2020-09-30,,John van den Anker,Other,0,0,0,2.0,Phase 2/Phase 3,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT01341548,0,0,0,0,0,0,2023-11-30,2024-11-30,,Winston Laboratories,Industry,1,0,0,3.0,Phase 3,0,2021.0,0,1,0,0,0,0,0,0,3,1,0,10
NCT01348490,0,0,0,0,0,0,2018-12-19,2019-12-19,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,143
NCT01351896,0,0,0,0,0,0,2020-07-31,2021-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01363128,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01372228,0,0,0,0,0,0,2025-04-30,2026-04-30,,University of Louisville,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,214
NCT01375114,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01384513,0,0,0,0,0,0,2019-12-01,2020-12-01,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,1,1,0,1,0,0,0,0,1,162
NCT01391962,0,0,0,0,0,0,2020-12-15,2021-12-15,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01393223,1,0,0,0,1,0,2018-06-14,2019-06-14,,"Lipella Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01399918,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01413100,0,0,0,0,0,0,2023-10-31,2024-10-31,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,1,0,0,0,0,0,1,0,1,393
NCT01415882,0,0,0,0,0,0,2020-09-01,2021-09-01,,Mayo Clinic,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01423851,0,0,0,0,0,0,2019-10-31,2020-10-31,,"NS Pharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01446016,0,0,0,0,0,0,2019-03-01,2020-03-01,,"Jenny C. Chang, MD",Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT01446159,0,1,0,1,0,0,2019-06-28,2020-06-28,2018-05-30,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,269
NCT01456013,1,0,0,0,1,0,2018-03-31,2019-03-31,,"CardioRenal Systems, Inc.",Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,1,0,0,0,0,0,0,1,3
NCT01461837,0,0,0,0,0,0,2019-06-30,2020-06-30,,New York Medical College,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT01466686,0,0,0,0,0,0,2021-09-30,2022-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT01474304,1,0,0,0,1,0,2017-06-30,2018-06-30,,Swedish Medical Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,34
NCT01474889,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pennsylvania,Other,0,0,1,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,1052
NCT01478854,1,1,0,1,0,1,2018-04-25,2019-04-25,2019-05-23,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2011.0,1,1,0,0,0,1,0,0,0,0,1,461
NCT01483144,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Cancer Prevention Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,3
NCT01502072,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01506609,0,0,0,0,0,0,2018-12-13,2019-12-13,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT01511562,0,0,0,0,0,0,2026-10-31,2027-10-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT01515787,0,0,0,0,0,0,2021-12-31,2022-12-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,2.0,Phase 2/Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,456
NCT01532089,0,0,0,0,0,0,2020-02-15,2021-02-15,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,32
NCT01532687,0,0,0,0,0,0,2020-06-30,2021-06-30,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT01535924,0,0,0,0,0,0,2019-02-20,2020-02-20,,Beth Christian,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01547741,0,0,0,0,0,0,2019-12-31,2020-12-31,,NSABP Foundation Inc,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,63
NCT01553149,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01573533,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mayo Clinic,Other,0,1,1,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,1,0,1,1898
NCT01587040,1,1,0,1,0,0,2018-05-23,2019-05-23,2019-05-21,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT01591733,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-02,Massachusetts General Hospital,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,1,0,0,0,0,1,1699
NCT01593020,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01595321,0,0,0,0,0,0,2020-08-31,2021-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,5.0,,0,2012.0,0,1,1,0,0,1,0,0,0,0,1,461
NCT01595516,1,1,0,1,0,1,2017-10-31,2018-10-31,2019-05-01,"University of Colorado, Boulder",Other,0,1,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,49
NCT01599286,0,0,0,0,0,0,2019-04-30,2020-04-30,,Mendel Tuchman,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01601873,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-29,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,1,2012.0,1,0,0,1,0,0,0,0,0,0,1,490
NCT01612884,1,1,0,1,0,0,2017-03-31,2018-03-31,2017-12-29,Indiana University,Other,0,0,0,4.0,Phase 4,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,497
NCT01613768,1,1,0,1,0,0,2017-08-23,2018-08-23,2018-07-10,University of Washington,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01626079,1,0,1,1,0,0,2018-07-31,2019-07-31,2019-07-30,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,419
NCT01627314,1,0,0,0,1,0,2017-02-28,2018-02-28,,Fate Therapeutics,Industry,1,0,0,1.0,Phase 2,1,2012.0,1,0,1,0,0,0,0,0,0,0,1,9
NCT01629511,1,0,1,1,0,0,2018-04-25,2019-04-25,2019-03-28,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,1,2012.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01639339,0,0,0,0,0,0,2019-07-25,2020-07-25,,"Human Genome Sciences Inc., a GSK Company",Industry,1,1,0,3.0,Phase 3,0,2012.0,0,1,1,0,0,0,0,0,1,0,1,15
NCT01640301,0,0,0,0,0,0,2020-10-01,2021-10-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,393
NCT01670500,0,0,0,0,0,0,2021-10-31,2022-10-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT01678794,0,0,0,0,0,0,2019-06-01,2020-06-01,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01680588,0,0,0,0,0,0,2018-12-31,2019-12-31,,Navidea Biopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT01682083,0,1,0,1,0,0,2017-06-30,2018-06-30,2018-05-29,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01685008,0,0,0,0,0,0,2020-02-29,2021-02-28,,MorphoSys AG,Industry,1,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,8
NCT01687413,0,0,0,0,0,0,2021-08-09,2022-08-09,,Washington University School of Medicine,Other,0,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,1151
NCT01698918,0,0,0,0,0,0,2020-06-04,2021-06-04,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01700959,1,1,0,1,0,0,2017-04-19,2018-04-19,2018-03-29,St. Jude Children's Research Hospital,Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,302
NCT01706432,1,0,0,0,1,0,2018-06-30,2019-06-30,,University of Chicago,Other,0,0,1,5.0,,0,2009.0,1,0,0,0,0,1,0,0,0,0,1,594
NCT01706705,1,0,1,1,0,1,2018-04-22,2019-04-22,2019-09-03,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,2066
NCT01711294,1,0,0,0,1,0,2017-07-07,2018-07-07,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,1,0,1,340
NCT01715571,0,0,0,0,0,0,2019-06-30,2020-06-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1143
NCT01717170,1,0,0,0,1,0,2017-06-30,2018-06-30,,University of Nebraska,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,327
NCT01720524,0,0,0,0,0,0,2018-10-17,2019-10-17,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT01732718,1,1,0,1,0,0,2018-01-09,2019-01-09,2018-12-13,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01743950,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of Wisconsin, Madison",Other,0,1,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,715
NCT01749371,1,0,0,0,1,0,2017-08-31,2018-08-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,158
NCT01756885,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-04-19,University of Pennsylvania,Other,0,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01767675,0,0,0,0,0,0,2020-01-31,2021-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01772472,1,0,1,1,0,0,2018-07-25,2019-07-25,2019-07-24,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT01775501,1,0,0,0,1,0,2018-07-31,2019-07-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01775930,0,0,0,0,0,0,2019-01-18,2020-01-18,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01780454,0,0,0,0,0,0,2020-06-30,2021-06-30,,Massachusetts General Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,1699
NCT01782989,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Paul Yates, MD, PhD",Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01792102,0,0,0,0,0,0,2018-12-31,2019-12-31,,Oncotherapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT01797523,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01808222,1,1,0,1,0,1,2017-09-13,2018-09-13,2018-12-12,"David M. Schuster, MD",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01810588,0,0,0,0,0,0,2021-12-31,2022-12-31,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,1,0,1,0,0,0,0,1,586
NCT01810913,0,0,0,0,0,0,2020-05-31,2021-05-31,,Radiation Therapy Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2013.0,0,1,1,0,0,1,0,0,1,0,1,156
NCT01813318,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT01813877,0,0,0,0,0,0,2020-09-22,2021-09-22,,Jonsson Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,277
NCT01815333,0,0,0,0,0,0,2019-07-25,2020-07-25,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01827137,1,0,0,0,1,0,2018-04-30,2019-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,1432
NCT01828034,0,0,0,0,0,0,2019-05-30,2020-05-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01829295,1,1,0,1,0,1,2018-02-21,2019-02-21,2019-04-03,"University of California, San Francisco",Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1443
NCT01834235,1,0,0,0,1,0,2017-03-13,2018-03-13,,"Precision Biologics, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01843504,0,0,0,0,0,0,2023-12-31,2024-12-31,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,715
NCT01844986,1,1,0,1,0,0,2018-05-17,2019-05-17,2019-05-09,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT01853748,0,0,0,0,0,0,2020-01-31,2021-01-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01860807,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-01-06,"University of California, Los Angeles",Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,692
NCT01861106,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01866839,1,0,0,0,1,0,2018-05-23,2019-05-23,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,1091
NCT01869114,0,0,0,0,0,0,2020-01-01,2021-01-01,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,162
NCT01880567,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01888484,0,0,0,0,0,0,2020-07-31,2021-07-31,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,54
NCT01888835,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Phillip Coffin, MD, MIA",Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01898793,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,1151
NCT01902173,1,0,1,1,0,1,2017-06-30,2018-06-30,2019-05-13,National Cancer Institute (NCI),NIH,2,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01902381,0,0,0,0,0,0,2019-09-30,2020-09-30,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT01904448,1,1,0,1,0,0,2017-10-01,2018-10-01,2018-03-27,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT01909791,1,0,1,1,0,0,2018-09-11,2019-09-11,2019-09-11,Jaeb Center for Health Research,Other,0,1,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,93
NCT01911455,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT01913106,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-09-11,The Methodist Hospital System,Other,0,0,0,0.0,Phase 1/Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,36
NCT01917929,0,0,0,0,0,0,2023-04-30,2024-04-30,,Stryker Orthopaedics,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,24
NCT01918683,0,0,0,0,0,0,2020-07-31,2021-07-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,273
NCT01927731,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01928589,0,0,0,0,0,0,2025-01-31,2026-01-31,,Richard Zellars,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,2
NCT01928849,1,1,0,1,0,0,2017-09-26,2018-09-26,2018-09-26,Duke University,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT01930175,0,0,0,0,0,0,2019-09-20,2020-09-20,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01937884,1,0,0,0,1,0,2018-08-31,2019-08-31,,University of Arizona,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,265
NCT01946880,0,0,0,0,0,0,2019-07-03,2020-07-03,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT01950039,1,0,1,1,0,0,2017-12-31,2018-12-31,2018-08-16,Joslin Diabetes Center,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,60
NCT01958320,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-10-09,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1443
NCT01959698,0,0,0,0,0,0,2023-07-15,2024-07-15,,Roswell Park Cancer Institute,Other,0,1,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,294
NCT01966302,0,0,0,0,0,0,2019-06-02,2020-06-02,,Los Angeles Biomedical Research Institute,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,60
NCT01968109,0,0,0,0,0,0,2023-12-31,2024-12-31,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT01969916,1,1,0,1,0,0,2018-06-30,2019-06-30,2018-11-12,University of Chicago,Other,0,1,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT01972074,1,1,0,1,0,1,2018-05-07,2019-05-07,2019-08-01,Massachusetts General Hospital,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01975376,1,1,0,1,0,0,2017-03-22,2018-03-22,2018-03-14,Pfizer,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT01983969,1,0,1,1,0,1,2017-11-22,2018-11-22,2019-04-16,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01993147,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT01993719,0,0,0,0,0,0,2028-10-27,2029-10-27,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01996449,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02000882,0,0,0,0,0,0,2019-12-31,2020-12-31,,US Oncology Research,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02002819,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02005471,1,1,0,1,0,0,2017-05-08,2018-05-08,2018-05-03,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02016235,0,0,0,0,0,0,2019-01-31,2020-01-31,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02019264,1,1,0,1,0,0,2018-05-14,2019-05-14,2019-05-14,Eisai Inc.,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,328
NCT02027025,1,1,0,1,0,1,2017-04-28,2018-04-28,2018-10-16,Sun Pharma Advanced Research Company Limited,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,29
NCT02030015,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02032823,0,0,0,0,0,0,2020-11-30,2021-11-30,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02042443,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-07-12,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02053246,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Florida,Other,0,0,1,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT02053350,1,0,0,0,1,0,2017-04-05,2018-04-05,,University of Virginia,Other,0,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT02058095,0,0,0,0,0,0,2019-06-30,2020-06-30,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02059239,0,0,0,0,0,0,2020-06-30,2021-06-30,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,586
NCT02059291,1,1,0,1,0,0,2017-07-04,2018-07-04,2016-11-21,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02064582,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,626
NCT02066311,1,0,0,0,1,0,2018-06-30,2019-06-30,,Northwell Health,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,271
NCT02068586,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,162
NCT02069847,0,0,0,0,0,0,2020-01-31,2021-01-31,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02070952,1,0,0,0,1,0,2017-07-31,2018-07-31,,"Riverside Community Hospital, California",Other,0,0,0,5.0,,0,2013.0,1,0,0,0,0,1,0,0,0,0,1,1
NCT02072148,0,0,0,0,0,0,2020-10-31,2021-10-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,412
NCT02072824,1,1,0,1,0,0,2018-03-13,2019-03-13,2018-09-10,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02077010,0,0,0,0,0,0,2020-03-01,2021-03-01,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT02077881,0,0,0,0,0,0,2018-01-17,2019-01-17,,NewLink Genetics Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02078895,1,0,1,1,0,1,2017-02-28,2018-02-28,2018-10-22,"University of California, Irvine",Other,0,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,310
NCT02086552,1,1,0,1,0,1,2018-01-15,2019-01-15,2019-05-06,Mayo Clinic,Other,0,1,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02087865,0,0,0,0,0,0,2020-02-27,2021-02-27,,The Cleveland Clinic,Other,0,0,1,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02091960,1,1,0,1,0,0,2017-02-28,2018-02-28,2018-02-27,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,135
NCT02095132,0,0,0,0,0,0,2021-04-30,2022-04-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02095678,0,0,1,1,0,0,2020-05-31,2021-05-31,2019-08-23,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,374
NCT02097134,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-04-26,Children's Oncology Group,Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,389
NCT02121158,0,0,0,0,0,0,2020-08-01,2021-08-01,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT02127073,0,0,0,0,0,0,2022-03-31,2023-03-31,,Sheldon Feldman,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02128100,1,0,0,0,1,0,2018-05-31,2019-05-31,,University of Louisville,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,1,0,0,0,0,1,214
NCT02131467,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University Health Network, Toronto",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,931
NCT02134028,0,0,0,0,0,0,2019-11-01,2020-11-01,,Sanofi,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT02140554,0,0,0,0,0,0,2022-02-28,2023-02-28,,bluebird bio,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,1,0,0,1,11
NCT02141074,0,0,0,0,0,0,2022-10-30,2023-10-30,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,981
NCT02152631,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-08-23,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02158520,1,0,0,0,1,0,2017-05-24,2018-05-24,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,32
NCT02159066,0,0,0,0,0,0,2021-12-31,2022-12-31,,Array BioPharma,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,65
NCT02160041,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-23,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02162420,0,0,0,0,0,0,2024-07-31,2025-07-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2015.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT02162732,0,0,0,0,0,0,2020-06-30,2021-06-30,,Giselle Sholler,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,18
NCT02163434,0,0,0,0,0,0,2019-06-30,2020-06-30,,University at Buffalo,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,65
NCT02163759,0,0,0,0,0,0,2020-10-06,2021-10-06,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02164981,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-30,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02171104,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,218
NCT02176863,0,0,0,0,0,0,2021-01-31,2022-01-31,,Grifols Therapeutics LLC,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,40
NCT02177578,0,0,0,0,0,0,2020-06-30,2021-06-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT02177721,0,0,0,0,0,0,2025-07-31,2026-07-31,,Emergent BioSolutions,Industry,1,1,1,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,23
NCT02178241,0,0,0,0,0,0,2019-03-18,2020-03-18,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,3004
NCT02180438,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-04-07,University of Washington,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,2,0,1,910
NCT02181413,1,1,0,1,0,0,2018-04-16,2019-04-16,2019-04-15,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT02193867,1,0,1,1,0,1,2018-04-30,2019-04-30,2019-07-26,Alexion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,86
NCT02194985,0,0,0,0,0,0,2019-10-31,2020-10-31,,Amicus Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,34
NCT02195479,1,1,0,1,0,0,2017-11-21,2018-11-21,2018-11-21,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,558
NCT02197104,1,0,0,0,1,0,2017-01-31,2018-01-31,,Rush University Medical Center,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,227
NCT02200614,1,0,1,1,0,0,2018-09-03,2019-09-03,2019-08-30,Bayer,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02203604,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,227
NCT02208063,1,0,0,0,1,0,2018-04-12,2019-04-12,,Cumberland Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT02208375,0,0,0,0,0,0,2020-11-30,2021-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02211313,1,1,0,1,0,0,2018-04-03,2019-04-03,2019-04-01,Washington University School of Medicine,Other,0,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1151
NCT02224755,0,0,0,0,0,0,2018-09-28,2019-09-28,,Abbott Medical Devices,Industry,1,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,419
NCT02225262,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Community Cancer Center, Normal, Illinois",Other,0,0,0,5.0,,0,2008.0,0,0,0,0,0,1,0,0,0,0,1,2
NCT02227199,0,0,0,0,0,0,2019-09-15,2020-09-15,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02232022,1,1,0,1,0,1,2017-09-28,2018-09-28,2019-03-11,Northwell Health,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,271
NCT02232659,0,0,0,0,0,0,2019-12-31,2020-12-31,,SynCardia Systems. LLC,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT02245841,0,0,0,0,0,0,2019-05-31,2020-05-31,,The Cleveland Clinic,Other,0,1,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02246270,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Oklahoma,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,234
NCT02248636,0,0,0,0,0,0,2019-10-01,2020-10-01,,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02251509,1,0,0,0,1,0,2017-09-30,2018-09-30,,Creighton University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,110
NCT02259517,0,0,0,0,0,0,2020-07-31,2021-07-31,,New York State Psychiatric Institute,Other,0,1,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02260869,0,0,0,0,0,0,2018-10-15,2019-10-15,,Millennium Pain Center,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02266875,1,1,0,1,0,0,2017-01-30,2018-01-30,2017-05-19,OhioHealth,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02267616,0,0,0,0,0,0,2022-12-31,2023-12-31,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,497
NCT02268175,0,0,0,0,0,0,2019-05-31,2020-05-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02268305,1,0,0,0,1,0,2018-06-05,2019-06-05,,Mike O'Callaghan Military Hospital,U.S. Fed,2,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02270242,0,0,0,0,0,0,2019-07-10,2020-07-10,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02276872,1,1,0,1,0,1,2017-07-20,2018-07-20,2018-09-28,United Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,72
NCT02279160,0,0,0,0,0,0,2017-06-30,2018-06-30,,Arena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02281409,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT02283762,1,1,0,1,0,0,2017-12-15,2018-12-15,2018-12-13,Bayer,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT02287038,1,1,0,1,0,0,2017-03-02,2018-03-02,2018-02-13,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT02289300,0,0,0,0,0,0,2020-01-31,2021-01-31,,A2 Healthcare Taiwan Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT02289560,0,0,0,0,0,0,2020-12-31,2021-12-31,,InSightec,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,61
NCT02291029,1,1,0,1,0,0,2018-06-29,2019-06-29,2019-06-28,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02293837,0,0,0,0,0,0,2019-07-10,2020-07-10,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT02298933,1,1,0,1,0,1,2017-08-08,2018-08-08,2018-12-12,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT02308111,0,0,0,0,0,0,2024-12-31,2025-12-31,,Intercept Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,14
NCT02313428,1,0,0,0,1,0,2018-06-30,2019-06-30,,Ohio State University,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,315
NCT02315196,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,227
NCT02315326,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02315534,0,0,0,0,0,0,2018-10-09,2019-10-09,,"Boston Biomedical, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT02315625,0,0,0,0,0,0,2019-05-22,2020-05-22,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02316353,1,1,0,1,0,0,2017-09-21,2018-09-21,2018-09-18,CSL Behring,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,81
NCT02319005,1,1,0,1,0,0,2017-03-30,2018-03-30,2018-03-27,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,45
NCT02322814,1,0,1,1,0,0,2018-08-10,2019-08-10,2019-08-09,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02325739,0,0,0,0,0,0,2018-12-07,2019-12-07,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,1,0,0,0,0,0,1,0,1,1895
NCT02328105,1,1,0,1,0,0,2017-06-15,2018-06-15,2018-06-14,Kathryn Mileham,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02334722,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT02335918,0,0,0,0,0,0,2018-12-12,2019-12-12,,Celldex Therapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,27
NCT02337218,1,0,0,0,1,0,2017-03-31,2018-03-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,626
NCT02340650,0,0,0,0,0,0,2020-04-30,2021-04-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,490
NCT02341625,0,0,0,0,0,0,2021-06-14,2022-06-14,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02346747,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Gradalis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,15
NCT02347098,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-04-29,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,1012
NCT02347891,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwell Health,Other,0,1,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,271
NCT02348008,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Arkadiusz Z. Dudek, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02348359,1,1,0,1,0,0,2017-12-12,2018-12-12,2018-05-30,Tyrogenex,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02351180,0,0,0,0,0,0,2020-04-30,2021-04-30,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT02354703,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of Maryland, College Park",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,318
NCT02356159,0,0,0,0,0,0,2023-01-01,2024-01-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02357576,0,0,0,0,0,0,2017-10-12,2018-10-12,,University of Michigan,Other,0,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT02359994,0,0,0,0,0,0,2019-01-11,2020-01-11,,"CryoLife, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,11
NCT02360397,1,0,1,1,0,1,2017-09-30,2018-09-30,2019-08-22,"Kent Hospital, Rhode Island",Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02360631,1,1,0,1,0,0,2018-07-12,2019-07-12,2019-06-05,"Lisa Sanderson Cox, PhD",Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02362308,0,0,0,0,0,0,2020-01-31,2021-01-31,,Vanderbilt University,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,499
NCT02363283,1,0,0,0,1,0,2018-07-02,2019-07-02,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT02367781,1,1,0,1,0,0,2018-03-15,2019-03-15,2019-03-13,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02379377,0,0,0,0,0,0,2020-01-31,2021-01-31,,Vanderbilt-Ingram Cancer Center,Other,0,0,1,5.0,,0,2015.0,0,0,0,1,0,1,0,0,0,0,1,180
NCT02380677,0,0,0,0,0,0,2017-10-04,2018-10-04,,NewLink Genetics Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,34
NCT02384460,1,1,0,1,0,1,2017-07-05,2018-07-05,2018-09-19,"Scioderm, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT02387008,0,1,0,1,0,0,2018-11-28,2019-11-28,2019-05-29,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT02392559,0,0,0,0,0,0,2019-11-14,2020-11-14,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,685
NCT02395172,1,1,0,1,0,0,2017-11-22,2018-11-22,2018-11-20,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT02397720,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02397889,0,0,0,0,0,0,2020-01-31,2021-01-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT02399449,0,0,0,0,0,0,2019-03-22,2020-03-22,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,144
NCT02400255,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,17
NCT02401035,0,0,0,0,0,0,2022-04-11,2023-04-11,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT02407171,0,0,0,0,0,0,2018-12-31,2019-12-31,,Yale University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,1,0,0,0,0,1,1053
NCT02410252,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-03-20,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1699
NCT02410772,0,0,0,0,0,0,2020-04-30,2021-04-30,,Centers for Disease Control and Prevention,U.S. Fed,2,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,267
NCT02412631,0,0,0,0,0,0,2020-08-31,2021-08-31,,Mayo Clinic,Other,0,0,1,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02413398,1,1,0,1,0,0,2017-11-07,2018-11-07,2018-06-22,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02415660,0,0,0,0,0,0,2020-08-31,2021-08-31,,Brooke Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,71
NCT02416492,0,0,0,0,0,0,2019-01-31,2020-01-31,,"SanBio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,3
NCT02421887,1,1,0,1,0,1,2018-06-11,2019-06-11,2019-06-24,Yale University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02424175,1,1,0,1,0,1,2017-08-30,2018-08-30,2019-07-07,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,698
NCT02425306,1,0,0,0,1,0,2017-08-18,2018-08-18,,"Craig L Slingluff, Jr",Other,0,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,1,0,0,0,0,0,0,0,1,19
NCT02425904,0,0,0,0,0,0,2021-01-31,2022-01-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,647
NCT02426658,1,0,0,0,1,0,2018-04-19,2019-04-19,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02430077,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02431468,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-04-30,"Neurotrope Bioscience, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02440672,0,0,0,0,0,0,2026-12-31,2027-12-31,,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,83
NCT02442622,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT02445391,0,0,0,0,0,0,2019-05-31,2020-05-31,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,75
NCT02451137,1,1,0,1,0,0,2018-03-02,2019-03-02,2019-03-01,Sanofi,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02455453,0,0,0,0,0,0,2019-01-03,2020-01-03,,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,1151
NCT02455557,0,0,0,0,0,0,2019-11-28,2020-11-28,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,294
NCT02455804,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medinol Ltd.,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,11
NCT02458014,0,0,0,0,0,0,2020-09-30,2021-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02458469,0,0,0,0,0,0,2019-03-30,2020-03-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT02460900,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of Maryland, College Park",Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,318
NCT02462200,0,0,0,0,0,0,2019-10-31,2020-10-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1151
NCT02463032,0,0,0,0,0,0,2019-03-31,2020-03-31,,GTx,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,19
NCT02463487,0,0,0,0,0,0,2018-12-28,2019-12-28,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,626
NCT02464176,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-11-15,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT02466750,0,0,0,0,0,0,2020-06-30,2021-06-30,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,136
NCT02475837,1,1,0,1,0,1,2017-10-23,2018-10-23,2018-12-04,Ken Mahaffey,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02477696,0,0,0,0,0,0,2019-06-30,2020-06-30,,Acerta Pharma BV,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02479451,0,0,0,0,0,0,2020-07-31,2021-07-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02483676,0,0,0,0,0,0,2019-04-01,2020-04-01,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT02484404,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02484690,0,0,0,0,0,0,2017-09-26,2018-09-26,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1731
NCT02487082,0,0,0,0,0,0,2020-12-31,2021-12-31,,Stony Brook University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,119
NCT02494921,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rahul Aggarwal,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02497976,1,1,0,1,0,0,2017-04-16,2018-04-16,2018-01-25,"ICStudy, LLC",Other,0,1,0,3.0,Phase 3,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,2
NCT02498613,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT02498951,0,0,0,0,0,0,2021-04-18,2022-04-18,,OHSU Knight Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,163
NCT02499120,1,0,1,1,0,0,2018-07-19,2019-07-19,2019-06-23,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02500576,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02501096,0,0,0,0,0,0,2020-02-29,2021-02-28,,Eisai Inc.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,328
NCT02503735,1,0,0,0,1,0,2017-09-30,2018-09-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02509065,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-05-05,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1699
NCT02510014,0,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-31,Indivior Inc.,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,45
NCT02514590,0,0,0,0,0,0,2019-01-31,2020-01-31,,Stimwave Technologies,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,5
NCT02516046,0,0,0,0,0,0,2018-06-13,2019-06-13,,Avid Radiopharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,50
NCT02517697,0,0,0,0,0,0,2024-07-31,2025-07-31,,"Gladwin, Mark, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT02518971,1,1,0,1,0,0,2018-06-05,2019-06-05,2019-03-21,University of Michigan,Other,0,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT02521051,0,0,0,0,0,0,2019-10-31,2020-10-31,,Massachusetts General Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02525757,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,2066
NCT02527564,0,0,0,0,0,0,2019-08-31,2020-08-31,,Stanford University,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02530437,0,0,0,0,0,0,2023-03-31,2024-03-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,2066
NCT02531906,1,0,0,0,1,0,2018-06-14,2019-06-14,,Roswell Park Cancer Institute,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,294
NCT02534038,0,0,0,0,0,0,2017-10-03,2018-10-03,,Avanir Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT02542462,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-29,"Children's Hospital Medical Center, Cincinnati",Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,437
NCT02542839,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Florida,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,849
NCT02543281,0,0,0,0,0,0,2020-05-31,2021-05-31,,Larisa Tereshchenko,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02544061,1,0,0,0,1,0,2017-10-31,2018-10-31,,Neumedicines Inc.,Industry,1,0,1,1.0,Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,5
NCT02544321,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,882
NCT02544607,1,1,0,1,0,0,2017-12-29,2018-12-29,2018-08-14,Massachusetts General Hospital,Other,0,0,1,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02545504,0,0,0,0,0,0,2019-05-15,2020-05-15,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02546102,0,0,0,0,0,0,2019-12-31,2020-12-31,,Precision Life Sciences Group,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,3
NCT02546492,0,0,0,0,0,0,2021-06-30,2022-06-30,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,144
NCT02547935,1,1,0,1,0,0,2018-05-18,2019-05-18,2019-05-15,AstraZeneca,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02549092,0,0,0,0,0,0,2020-01-02,2021-01-02,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02555878,1,1,0,1,0,0,2018-08-24,2019-08-24,2019-08-22,"Janssen Research & Development, LLC",Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02558400,0,1,0,1,0,1,2017-05-17,2018-05-17,2019-04-11,Aerie Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,28
NCT02560779,0,0,0,0,0,0,2019-11-30,2020-11-30,,Tracon Pharmaceuticals Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT02562430,0,0,0,0,0,0,2019-08-31,2020-08-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02563561,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,67
NCT02563925,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT02578641,0,0,0,0,0,0,2020-12-31,2021-12-31,,Tessa Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,1,0,0,0,0,0,1,0,1,1
NCT02579265,0,0,0,0,0,0,2019-09-30,2020-09-30,,Fresenius Kabi,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,41
NCT02581215,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Walid Shaib, MD",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02581384,0,0,0,0,0,0,2025-02-28,2026-02-28,,Dana-Farber Cancer Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,647
NCT02584634,0,0,0,0,0,0,2020-03-05,2021-03-05,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02585713,1,0,0,0,1,0,2018-04-02,2019-04-02,,Academic and Community Cancer Research United,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,32
NCT02585960,1,1,0,1,0,0,2018-08-05,2019-08-05,2019-08-05,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,107
NCT02588261,1,1,0,1,0,0,2017-12-21,2018-12-21,2018-12-10,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,135
NCT02592421,0,0,0,0,0,0,2018-10-01,2019-10-01,,The University of Texas Health Science Center at San Antonio,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02592707,0,0,0,0,0,0,2022-05-31,2023-05-31,,Ipsen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,214
NCT02592876,1,1,0,1,0,0,2018-04-20,2019-04-20,2019-04-19,"Seattle Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,77
NCT02597101,0,0,0,0,0,0,2019-06-10,2020-06-10,,"Nick Giannoukakis, PhD",Other,0,1,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02597465,0,0,0,0,0,0,2019-03-01,2020-03-01,,Sun Pharma Advanced Research Company Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT02601950,0,0,0,0,0,0,2022-01-31,2023-01-31,,"Epizyme, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,11
NCT02603328,0,0,0,0,0,0,2022-08-31,2023-08-31,,University of Chicago,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT02604368,0,0,0,0,0,0,2020-12-31,2021-12-31,,Micelle BioPharma Inc,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT02609607,0,0,0,0,0,0,2018-11-30,2019-11-30,,David Levinthal,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02611206,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,749
NCT02611960,0,0,0,0,0,0,2020-03-05,2021-03-05,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02612337,1,0,0,0,1,0,2017-07-18,2018-07-18,,"Otonomy, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,20
NCT02613507,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-09-13,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,1104
NCT02616393,1,0,0,0,1,0,2018-08-28,2019-08-28,,"Kadmon Corporation, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT02621073,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-05-01,Brett Crist,Other,0,0,0,5.0,,1,2015.0,1,1,0,1,0,0,0,0,0,0,1,1
NCT02624765,0,0,0,0,0,0,2021-03-31,2022-03-31,,Edgar Jaeggi,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT02627508,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02629822,0,0,0,0,0,0,2018-11-28,2019-11-28,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,3,0,1,2145
NCT02630719,1,1,0,1,0,1,2017-08-01,2018-08-01,2018-11-18,"University of Missouri, Kansas City",Other,0,0,0,5.0,,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,30
NCT02631590,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02633956,1,1,0,1,0,0,2017-03-21,2018-03-21,2018-03-21,Intercept Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02634684,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02635009,0,0,0,0,0,0,2022-04-30,2023-04-30,,NRG Oncology,Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,0,0,0,0,0,1,0,0,1,0,1,27
NCT02637895,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Miami,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,476
NCT02638090,0,0,0,0,0,0,2019-11-30,2020-11-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT02638207,0,0,0,0,0,0,2019-12-31,2020-12-31,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,54
NCT02641236,0,0,0,0,0,0,2019-10-31,2020-10-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02652676,0,0,0,0,0,0,2022-12-31,2023-12-31,,Loma Linda University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,194
NCT02652767,0,0,0,0,0,0,2019-01-31,2020-01-31,,GenSight Biologics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,0,1,0,0,0,1,1,0,1,8
NCT02660346,1,0,1,1,0,1,2017-09-15,2018-09-15,2019-05-23,Sharp HealthCare,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT02663908,0,0,0,0,0,0,2021-07-31,2022-07-31,,Ferring Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,208
NCT02668523,1,0,0,0,1,0,2018-03-31,2019-03-31,,"ReVision Optics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02669043,1,1,0,1,0,0,2017-02-28,2018-02-28,2017-02-24,Massachusetts General Hospital,Other,0,0,1,5.0,,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02676544,0,0,0,0,0,0,2020-12-31,2021-12-31,,Rhode Island Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,120
NCT02678442,0,0,0,0,0,0,2018-11-16,2019-11-16,,Mayo Clinic,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02679144,0,0,0,0,0,0,2021-02-28,2022-02-28,,Giselle Sholler,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,18
NCT02682147,0,0,0,0,0,0,2023-02-28,2024-02-28,,Eric A. Hoffman,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT02683746,1,1,0,1,0,0,2017-04-03,2018-04-03,2018-03-13,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3276
NCT02690948,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-01-31,Anne Chang,Other,0,1,1,0.0,Phase 1/Phase 2,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,5
NCT02692651,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Michigan,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT02695212,1,0,0,0,1,0,2017-08-31,2018-08-31,,Florida Academic Dermatology Centers,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02696434,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-10-31,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,70
NCT02700529,0,0,0,0,0,0,2018-10-31,2019-10-31,,Eiger BioPharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02701777,0,0,0,0,0,0,2020-01-01,2021-01-01,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,1012
NCT02702518,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Illinois at Chicago,Other,0,1,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,242
NCT02703610,0,0,0,0,0,0,2020-07-30,2021-07-30,,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT02709330,1,1,0,1,0,0,2017-09-13,2018-09-13,2018-07-25,"Richard Bedlack, M.D., Ph.D.",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02709746,0,0,0,0,0,0,2019-07-05,2020-07-05,,H. Lundbeck A/S,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,152
NCT02711826,0,0,0,0,0,0,2021-10-01,2022-10-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2133
NCT02712723,1,0,0,0,1,0,2018-08-27,2019-08-27,,Qamar Khan,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02713269,0,0,0,0,0,0,2022-08-31,2023-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT02713386,0,0,0,0,0,0,2020-09-30,2021-09-30,,NRG Oncology,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT02716428,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Trek Therapeutics, PBC",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02717299,0,0,0,0,0,0,2019-04-30,2020-04-30,,TriHealth Inc.,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,74
NCT02720445,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,483
NCT02722525,0,0,0,0,0,0,2020-02-29,2021-02-28,,Ohio State University Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,198
NCT02722668,0,0,0,0,0,0,2028-05-31,2029-05-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,218
NCT02725593,0,0,0,0,0,0,2020-04-10,2021-04-10,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02730351,1,1,0,1,0,0,2017-02-03,2018-02-03,2017-07-28,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02730884,0,0,0,0,0,0,2019-08-22,2020-08-22,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2066
NCT02731690,1,1,0,1,0,0,2018-01-10,2019-01-10,2019-01-07,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT02733185,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Mt. Sinai Medical Center, Miami",Other,0,0,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,16
NCT02734147,1,0,0,0,1,0,2017-10-08,2018-10-08,,Christiana Care Health Services,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,76
NCT02734862,0,0,0,0,0,0,2019-06-30,2020-06-30,,Cidara Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02735343,1,0,0,0,1,0,2017-05-31,2018-05-31,,Mike O'Callaghan Military Hospital,U.S. Fed,2,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02735473,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02736149,0,0,0,0,0,0,2018-03-31,2019-03-31,,Eiger BioPharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,13
NCT02737748,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Transwell Biotech Co., Ltd.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT02738151,1,1,0,1,0,0,2017-08-15,2018-08-15,2018-08-14,Sanofi,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02741505,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT02742090,0,0,0,0,0,0,2020-08-31,2021-08-31,,"TG Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT02742883,0,0,0,0,0,0,2021-03-31,2022-03-31,,Burzynski Research Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,65
NCT02743078,0,0,0,0,0,0,2020-08-31,2021-08-31,,"RTOG Foundation, Inc.",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,5
NCT02743598,0,0,0,0,0,0,2019-04-30,2020-04-30,,Temple University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,152
NCT02743897,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Pennsylvania,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02747004,1,1,0,1,0,0,2018-06-15,2019-06-15,2019-06-14,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02750501,1,1,0,1,0,0,2017-03-30,2018-03-30,2018-03-30,"Alcresta Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02753530,0,0,0,0,0,0,2021-12-31,2022-12-31,,Orphazyme,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT02755545,1,0,0,0,1,0,2017-04-04,2018-04-04,,"Galderma Laboratories, L.P.",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,49
NCT02755831,0,0,0,0,0,0,2020-02-29,2021-02-28,,"United States Naval Medical Center, San Diego",U.S. Fed,2,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,52
NCT02760277,1,1,0,1,0,0,2018-04-26,2019-04-26,2019-02-25,"ReveraGen BioPharma, Inc.",Industry,1,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02762513,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,213
NCT02766582,0,0,0,0,0,0,2020-12-31,2021-12-31,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,315
NCT02768597,0,0,0,0,0,0,2022-02-28,2023-02-28,,Mayo Clinic,Other,0,1,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02771275,1,0,0,0,1,0,2017-12-31,2018-12-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,77
NCT02773030,0,0,0,0,0,0,2021-04-16,2022-04-16,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02775435,1,1,0,1,0,0,2018-04-03,2019-04-03,2019-02-19,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02777749,1,1,0,1,0,1,2017-09-19,2018-09-19,2019-01-30,Columbia University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02778880,1,0,0,0,1,0,2017-02-22,2018-02-22,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,437
NCT02780115,0,0,0,0,0,0,2017-10-31,2018-10-31,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02781311,1,1,0,1,0,0,2018-03-15,2019-03-15,2019-03-15,Allergan,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02782117,0,0,0,0,0,0,2019-02-06,2020-02-06,,Luminopia,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT02782663,0,0,0,0,0,0,2025-09-17,2026-09-17,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02783170,1,1,0,1,0,0,2018-04-03,2019-04-03,2019-03-29,Duke University,Other,0,0,1,4.0,Phase 4,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,1342
NCT02786732,1,0,0,0,1,0,2017-06-30,2018-06-30,,MedDerm Associates,Industry,1,0,0,3.0,Phase 3,1,2012.0,1,0,1,0,0,0,0,0,0,0,1,2
NCT02786836,0,0,0,0,0,0,2020-08-31,2021-08-31,,William Lee,Other,0,1,1,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02790437,0,0,0,0,0,0,2017-12-12,2018-12-12,,Hansa Biopharma AB,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02790606,0,1,0,1,0,1,2017-08-31,2018-08-31,2018-12-04,C. R. Bard,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,77
NCT02791581,0,0,0,0,0,0,2021-11-17,2022-11-17,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,616
NCT02792231,0,0,0,0,0,0,2019-07-10,2020-07-10,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02794246,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,1,2016.0,1,0,1,0,0,0,0,0,0,0,1,1052
NCT02795429,0,0,0,0,0,0,2019-12-24,2020-12-24,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02796209,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02800928,1,1,0,1,0,1,2018-01-02,2019-01-02,2019-03-04,Yale University,Other,0,1,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02802345,1,1,0,1,0,0,2017-12-19,2018-12-19,2018-12-17,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02804594,1,0,1,1,0,1,2018-06-01,2019-06-01,2019-07-12,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02808390,1,1,0,1,0,1,2017-07-31,2018-07-31,2018-09-07,PPM Services S.A.,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT02813551,1,1,0,1,0,0,2017-07-28,2018-07-28,2018-07-27,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,490
NCT02815917,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02817776,0,0,0,0,0,0,2019-06-05,2020-06-05,,"Biosense Webster, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,41
NCT02818972,0,0,0,0,0,0,2019-07-31,2020-07-31,,Bolton Medical,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT02819479,0,0,0,0,0,0,2018-11-30,2019-11-30,,Norton Healthcare,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02824029,0,0,0,0,0,0,2019-04-30,2020-04-30,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT02824913,1,1,0,1,0,0,2017-03-31,2018-03-31,2017-12-22,Parion Sciences,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02825849,0,0,0,0,0,0,2019-03-31,2020-03-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,1443
NCT02826603,1,1,0,1,0,0,2018-07-09,2019-07-09,2019-06-17,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02828761,0,0,0,0,0,0,2022-10-31,2023-10-31,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,240
NCT02830438,1,0,0,0,1,0,2018-06-10,2019-06-10,,Albert Einstein Healthcare Network,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,45
NCT02831387,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-29,Parion Sciences,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02832167,0,0,0,0,0,0,2019-06-16,2020-06-16,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02836236,1,1,0,1,0,1,2017-02-24,2018-02-24,2018-03-19,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,510
NCT02837042,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02839265,0,0,0,0,0,0,2020-07-31,2021-07-31,,Albert Einstein College of Medicine,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,155
NCT02839915,0,0,0,0,0,0,2022-01-01,2023-01-01,,Emory University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT02845323,0,0,0,0,0,0,2019-09-30,2020-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02847494,1,1,0,1,0,1,2017-09-21,2018-09-21,2018-12-18,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02847988,0,0,0,0,0,0,2021-06-30,2022-06-30,,RML Specialty Hospital,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02848326,1,1,0,1,0,0,2018-04-02,2019-04-02,2018-11-13,Allergan,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02850068,1,1,0,1,0,0,2018-08-03,2019-08-03,2019-07-08,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT02850406,0,0,0,0,0,0,2022-05-31,2023-05-31,,Global Blood Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,14
NCT02853344,0,0,0,0,0,0,2020-03-19,2021-03-19,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,3,0,1,2145
NCT02853604,0,0,0,0,0,0,2023-06-30,2024-06-30,,"Advaxis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,10
NCT02855567,1,1,0,1,0,1,2017-12-05,2018-12-05,2019-05-24,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,412
NCT02858180,0,0,0,0,0,0,2019-04-11,2020-04-11,,Duke University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02859454,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-04-24,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02862938,0,0,0,0,0,0,2020-08-31,2021-08-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02864862,0,0,0,0,0,0,2019-09-30,2020-09-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2016.0,0,0,1,1,0,0,0,0,0,0,1,490
NCT02865460,0,0,0,0,0,0,2019-09-30,2020-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT02866227,0,0,0,0,0,0,2017-06-10,2018-06-10,,"Toltec Pharmaceuticals, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02869165,1,0,0,0,1,0,2018-01-31,2019-01-31,,University of Louisville,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,214
NCT02871726,0,0,0,0,0,0,2019-10-31,2020-10-31,,Johns Hopkins University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1143
NCT02872142,0,0,0,0,0,0,2019-10-31,2020-10-31,,Grifols Therapeutics LLC,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,40
NCT02875288,0,0,0,0,0,0,2018-11-30,2019-11-30,,"United States Naval Medical Center, San Diego",U.S. Fed,2,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,52
NCT02875548,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Epizyme, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,11
NCT02881242,0,0,0,0,0,0,2020-01-31,2021-01-31,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,277
NCT02884492,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-07-28,William Charles Kreisl,Other,0,0,1,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02884895,1,0,0,0,1,0,2018-08-31,2019-08-31,,Bnai Zion Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,69
NCT02889796,0,0,0,0,0,0,2018-07-04,2019-07-04,,Gilead Sciences,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02896400,0,0,0,0,0,0,2019-08-31,2020-08-31,,Yale University,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT02898103,1,0,1,1,0,0,2018-07-20,2019-07-20,2019-05-30,"University of California, San Diego",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,561
NCT02899065,0,0,0,0,0,0,2020-02-29,2021-02-28,,"University of California, Davis",Other,0,1,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,530
NCT02899195,0,0,0,0,0,0,2020-08-31,2021-08-31,,"PrECOG, LLC.",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT02900976,0,0,0,0,0,0,2021-12-31,2022-12-31,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,389
NCT02902211,0,0,0,0,0,0,2022-04-30,2023-04-30,,University of Nebraska,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,327
NCT02902796,0,0,0,0,0,0,2019-09-30,2020-09-30,,"The Center for Clinical Research, Winston-Salem, NC",Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02903407,0,0,0,0,0,0,2019-06-30,2020-06-30,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT02906202,0,0,0,0,0,0,2020-01-31,2021-01-31,,bluebird bio,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,0,0,0,0,0,1,1,0,1,11
NCT02906566,1,1,0,1,0,0,2018-03-09,2019-03-09,2019-02-27,Stanford University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02910960,1,0,0,0,1,0,2018-07-28,2019-07-28,,Florida Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,63
NCT02911103,0,0,0,0,0,0,2029-02-02,2030-02-02,,National Institute of Neurological Disorders and Stroke (NINDS),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,560
NCT02911818,0,1,0,1,0,0,2018-11-30,2019-11-30,2019-03-11,University of Pennsylvania,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02914561,0,0,0,0,0,0,2021-10-31,2022-10-31,,Gilead Sciences,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02917005,0,0,0,0,0,0,2021-11-30,2022-11-30,,Hamdy A. Azim,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT02919969,0,0,0,0,0,0,2020-03-31,2021-03-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02920476,0,0,0,0,0,0,2018-12-03,2019-12-03,,University of Florida,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT02921295,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-01-08,Angela DeCandia,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02921893,0,0,0,0,0,0,2021-10-15,2022-10-15,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02923830,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-04-08,TriHealth Inc.,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,74
NCT02924129,1,0,0,0,1,0,2018-06-21,2019-06-21,,"Saluda Medical Americas, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02927067,0,0,0,0,0,0,2021-08-13,2022-08-13,,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,342
NCT02928094,0,0,0,0,0,0,2022-01-01,2023-01-01,,Angionetics Inc.,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT02928224,0,0,0,0,0,0,2019-02-28,2020-02-28,,Array BioPharma,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,65
NCT02929498,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-02-12,GlaxoSmithKline,Industry,1,1,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT02933827,0,0,0,0,0,0,2020-12-31,2021-12-31,,UnicoCell Biomed CO. LTD,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT02935361,0,0,0,0,0,0,2020-11-02,2021-11-02,,University of Southern California,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,483
NCT02935543,0,0,0,0,0,0,2018-12-17,2019-12-17,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,1,2016.0,1,0,1,0,0,0,0,0,0,0,1,1052
NCT02935660,1,0,0,0,1,0,2018-06-30,2019-06-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,37
NCT02937168,1,1,0,1,0,1,2017-05-24,2018-05-24,2019-07-12,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,101
NCT02937558,0,0,0,0,0,0,2018-09-30,2019-09-30,,Xeris Pharmaceuticals,Industry,1,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02939326,1,1,0,1,0,1,2017-07-12,2018-07-12,2018-10-17,"Bonti, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02940301,0,0,0,0,0,0,2020-05-31,2021-05-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,198
NCT02940496,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02943564,0,0,0,0,0,0,2018-12-10,2019-12-10,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02944500,0,0,0,0,0,0,2021-12-31,2022-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT02945553,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Vermont,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,155
NCT02945657,1,1,0,1,0,1,2017-06-08,2018-06-08,2018-10-16,"Medimetriks Pharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT02947945,0,0,0,0,0,0,2018-12-31,2019-12-31,,National Jewish Health,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,81
NCT02949219,0,0,0,0,0,0,2019-09-04,2020-09-04,,Academic and Community Cancer Research United,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,32
NCT02952534,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Clovis Oncology, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT02953613,0,0,0,0,0,0,2019-12-31,2020-12-31,,William Beaumont Hospitals,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,84
NCT02953860,0,0,0,0,0,0,2020-11-30,2021-11-30,,"University of Colorado, Denver",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT02954874,0,0,0,0,0,0,2026-05-31,2027-05-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,1,0,0,0,0,1,3004
NCT02962895,0,0,0,0,0,0,2020-06-30,2021-06-30,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1895
NCT02963610,1,0,0,0,1,0,2017-10-03,2018-10-03,,Fox Chase Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,156
NCT02964312,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Spirox, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02965027,0,0,0,0,0,0,2020-12-31,2021-12-31,,Seattle Institute for Biomedical and Clinical Research,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT02965456,0,0,0,0,0,0,2017-02-23,2018-02-23,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02966223,0,0,0,0,0,0,2018-12-31,2019-12-31,,Indiana University,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,497
NCT02967692,0,0,0,0,0,0,2019-09-09,2020-09-09,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1895
NCT02970968,0,0,0,0,0,0,2018-12-31,2019-12-31,,Vanda Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,37
NCT02971605,1,1,0,1,0,0,2018-08-21,2019-08-21,2019-07-31,Johns Hopkins University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1143
NCT02973789,0,0,0,0,0,0,2021-12-31,2022-12-31,,NovoCure Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,1,0,0,0,0,1,0,1,14
NCT02975349,0,0,0,0,0,0,2018-01-24,2019-01-24,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,42
NCT02976038,0,0,0,0,0,0,2021-12-31,2022-12-31,,Stealth BioTherapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,25
NCT02978326,0,0,0,0,0,0,2018-11-15,2019-11-15,,Sage Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02980874,0,0,0,0,0,0,2018-12-10,2019-12-10,,"Clearside Biomedical, Inc.",Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,11
NCT02983227,0,0,0,0,0,0,2019-07-27,2020-07-27,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT02985541,0,0,0,0,0,0,2021-06-04,2022-06-04,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1343
NCT02986854,1,1,0,1,0,0,2017-07-17,2018-07-17,2018-07-04,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,3276
NCT02994251,0,0,0,0,0,0,2020-06-30,2021-06-30,,Yale University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02994940,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,530
NCT02997202,0,0,0,0,0,0,2025-04-30,2026-04-30,,"Astellas Pharma Global Development, Inc.",Industry,1,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT02999178,0,0,0,0,0,0,2019-04-23,2020-04-23,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT03001843,0,0,0,0,0,0,2018-12-21,2019-12-21,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,849
NCT03002012,1,0,1,1,0,1,2018-03-13,2019-03-13,2019-07-24,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,749
NCT03004287,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Arkansas,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,285
NCT03005106,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Stratatech, a Mallinckrodt Company",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03005288,0,0,0,0,0,0,2019-03-21,2020-03-21,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03008382,0,0,0,0,0,0,2020-07-31,2021-07-31,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03012841,0,0,0,0,0,0,2019-08-31,2020-08-31,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,169
NCT03017937,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,437
NCT03018340,0,0,1,1,0,0,2018-09-30,2019-09-30,2019-09-06,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT03019003,0,0,0,0,0,0,2020-07-31,2021-07-31,,Massachusetts General Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03021018,1,1,0,1,0,0,2018-04-27,2019-04-27,2019-04-26,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,75
NCT03022708,0,0,0,0,0,0,2018-12-31,2019-12-31,,Xeltis,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03022981,0,0,0,0,0,0,2019-10-31,2020-10-31,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03026062,0,0,0,0,0,0,2021-03-31,2022-03-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03026816,0,0,0,0,0,0,2022-01-31,2023-01-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03027869,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Manitoba,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,344
NCT03028012,0,0,0,0,0,0,2020-02-20,2021-02-20,,University of Utah,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03030235,0,0,0,0,0,0,2020-10-31,2021-10-31,,Saint Luke's Health System,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03030794,0,0,0,0,0,0,2018-12-31,2019-12-31,,Veterans Medical Research Foundation,Other,0,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,30
NCT03032380,0,0,0,0,0,0,2019-02-26,2020-02-26,,Shionogi,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,38
NCT03035227,1,0,0,0,1,0,2018-05-01,2019-05-01,,Kansas City Heart Rhythm Institute,Other,0,1,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03035890,0,0,0,0,0,0,2019-12-31,2020-12-31,,West Virginia University,Other,0,0,0,5.0,,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,74
NCT03036280,0,0,0,0,0,0,2023-11-21,2024-11-21,,"Eisai Co., Ltd.",Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,129
NCT03040141,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Visterra, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,5
NCT03043560,0,0,0,0,0,0,2019-08-30,2020-08-30,,James Murrough,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03051490,1,0,1,1,0,0,2018-02-28,2019-02-28,2018-04-24,Anthera Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,25
NCT03052049,0,0,0,0,0,0,2020-03-01,2021-03-01,,Northwestern University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,925
NCT03052231,1,0,0,0,1,0,2017-02-28,2018-02-28,,Landon Pediatric Foundation,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,11
NCT03053375,1,0,0,0,1,0,2017-08-30,2018-08-30,,University of Bridgeport,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03053453,0,0,0,0,0,0,2020-09-30,2021-09-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,869
NCT03056079,0,0,0,0,0,0,2020-02-28,2021-02-28,,"St. Michael's Hospital, Toronto",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,303
NCT03056586,0,0,0,0,0,0,2018-12-20,2019-12-20,,Meir Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,3,1,0,336
NCT03056690,0,0,0,0,0,0,2018-02-27,2019-02-27,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,135
NCT03057054,0,0,0,0,0,0,2023-08-01,2024-08-01,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,389
NCT03057496,0,0,0,0,0,0,2019-09-30,2020-09-30,,Massachusetts Eye and Ear Infirmary,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,50
NCT03057977,0,0,0,0,0,0,2020-06-19,2021-06-19,,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03060473,0,0,0,0,0,0,2020-03-31,2021-03-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,158
NCT03063437,0,0,0,0,0,0,2018-09-19,2019-09-19,,Microbiome Health Research Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,4
NCT03064490,0,0,0,0,0,0,2020-05-31,2021-05-31,,Duke University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03070132,0,0,0,0,0,0,2022-08-09,2023-08-09,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,324
NCT03073603,0,0,0,0,0,0,2022-02-28,2023-02-28,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03073967,0,0,0,0,0,0,2020-03-31,2021-03-31,,AiCuris Anti-infective Cures GmbH,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03074474,0,0,0,0,0,0,2019-11-30,2020-11-30,,Tela Bio Inc,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03075176,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Utah,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,578
NCT03075488,1,0,0,0,1,0,2018-04-03,2019-04-03,,Istituto Ortopedico Rizzoli,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,80
NCT03077347,0,0,0,0,0,0,2022-12-01,2023-12-01,,"University of California, Davis",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,530
NCT03078322,0,0,0,0,0,0,2019-11-15,2020-11-15,,"VistaGen Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03078478,0,0,0,0,0,0,2019-02-13,2020-02-13,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,981
NCT03080935,0,0,0,0,0,0,2022-12-04,2023-12-04,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,685
NCT03082729,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Pennsylvania,Other,0,1,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03083366,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Utah,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,578
NCT03084796,0,0,0,0,0,0,2018-05-23,2019-05-23,,Chiesi Farmaceutici S.p.A.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,130
NCT03085810,0,0,0,0,0,0,2024-02-22,2025-02-22,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03087760,0,0,0,0,0,0,2020-12-18,2021-12-18,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03089281,0,0,0,0,0,0,2020-05-31,2021-05-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,340
NCT03090295,1,0,0,0,1,0,2018-03-30,2019-03-30,,University of Virginia,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,402
NCT03091712,0,0,0,0,0,0,2019-08-08,2020-08-08,,Glooko,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03092544,0,0,0,0,0,0,2018-12-31,2019-12-31,,Multiple Sclerosis Center of Northeastern New York,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT03093428,0,0,0,0,0,0,2020-06-30,2021-06-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03096093,0,0,0,0,0,0,2020-10-31,2021-10-31,,Cancer Vaccines Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,1
NCT03097315,0,0,0,0,0,0,2018-01-24,2019-01-24,,"Clearside Biomedical, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,0,0,0,0,1,0,0,1,0,11
NCT03097575,0,0,0,0,0,0,2020-01-01,2021-01-01,,Massachusetts General Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,1699
NCT03099863,0,0,0,0,0,0,2020-06-30,2021-06-30,,MetroHealth Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,65
NCT03101371,0,0,0,0,0,0,2019-02-15,2020-02-15,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,882
NCT03102736,0,0,0,0,0,0,2020-03-31,2021-03-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03103490,0,0,0,0,0,0,2020-04-30,2021-04-30,,Stanford University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03104270,0,0,0,0,0,0,2020-02-29,2021-02-28,,Oncotherapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03105336,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Kite, A Gilead Company",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,14
NCT03105700,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,306
NCT03106753,1,0,1,1,0,1,2018-05-05,2019-05-05,2019-05-17,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03106974,1,0,0,0,1,0,2018-05-01,2019-05-01,,AnestesiaR,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03107091,0,0,0,0,0,0,2019-04-01,2020-04-01,,BioVie Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03107208,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,882
NCT03109314,0,0,0,0,0,0,2018-12-01,2019-12-01,,Dennis Levi,Other,0,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03110159,1,1,0,1,0,0,2018-07-24,2019-07-24,2018-12-04,University of Arizona,Other,0,1,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,265
NCT03110484,0,0,0,0,0,0,2021-06-30,2022-06-30,,Samsung Medical Center,Other,0,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,2,1,0,684
NCT03113617,0,0,0,0,0,0,2020-04-10,2021-04-10,,Andrei Iagaru,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03115918,0,0,0,0,0,0,2020-09-30,2021-09-30,,Florida Hospital,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,63
NCT03116087,1,0,0,0,1,0,2018-05-31,2019-05-31,,Charles Drew University of Medicine and Science,Other,0,0,0,5.0,,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT03116828,0,0,0,0,0,0,2019-06-06,2020-06-06,,Sunovion,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,134
NCT03117738,0,0,0,0,0,0,2019-08-31,2020-08-31,,Nature Cell Co. Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03118297,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-06-27,Washington University School of Medicine,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1151
NCT03119363,0,0,0,0,0,0,2020-08-31,2021-08-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,412
NCT03121586,0,0,0,0,0,0,2020-08-31,2021-08-31,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,24
NCT03122548,1,1,0,1,0,1,2017-12-27,2018-12-27,2019-01-26,"Aduro Biotech, Inc.",Industry,1,1,0,1.0,Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,12
NCT03123354,1,1,0,1,0,0,2017-03-13,2018-03-13,2018-03-13,Masimo Corporation,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,39
NCT03124160,0,0,0,0,0,0,2021-05-01,2022-05-01,,Health Decisions,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03124784,1,1,0,1,0,0,2017-01-20,2018-01-20,2018-01-19,Masimo Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,0,1,39
NCT03125395,0,0,0,0,0,0,2019-07-17,2020-07-17,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03125824,1,0,0,0,1,0,2018-05-23,2019-05-23,,Soliton,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03126539,0,0,0,0,0,0,2019-10-18,2020-10-18,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1143
NCT03126682,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-21,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03128034,0,0,0,0,0,0,2021-06-30,2022-06-30,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,1,0,1,0,0,0,1,0,393
NCT03129399,1,0,0,0,1,0,2018-05-20,2019-05-20,,Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,45
NCT03130907,0,0,0,0,0,0,2019-09-30,2020-09-30,,San Antonio Uniformed Services Health Education Consortium,U.S. Fed,2,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03132246,1,0,0,0,1,0,2018-06-30,2019-06-30,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2014.0,1,0,0,0,1,0,0,0,0,0,1,318
NCT03136146,0,0,0,0,0,0,2025-08-01,2026-08-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03137225,1,0,0,0,1,0,2017-09-20,2018-09-20,,Virginia Commonwealth University,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,417
NCT03137303,0,0,0,0,0,0,2019-08-03,2020-08-03,,University of Illinois at Chicago,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,242
NCT03140488,0,0,0,0,0,0,2019-04-30,2020-04-30,,University of Arizona,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,265
NCT03140969,0,0,0,0,0,0,2019-12-31,2020-12-31,,ProQR Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03142958,0,0,0,0,0,0,2021-02-28,2022-02-28,,Integra LifeSciences Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,40
NCT03145662,0,0,0,0,0,0,2019-03-23,2020-03-23,,University of Toledo Health Science Campus,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,31
NCT03146403,1,1,0,1,0,0,2017-12-22,2018-12-22,2018-12-21,"Genocea Biosciences, Inc.",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,9
NCT03147638,0,0,0,0,0,0,2019-01-11,2020-01-11,,Marshall University,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT03148665,0,0,0,0,0,0,2019-12-30,2020-12-30,,Joseph Califano,Other,0,1,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03150485,0,1,0,1,0,0,2017-03-31,2018-03-31,2018-03-30,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03151304,0,0,0,0,0,0,2020-03-31,2021-03-31,,Helsinn Healthcare SA,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,28
NCT03152929,0,0,0,0,0,0,2022-02-01,2023-02-01,,Spectrum Health Hospitals,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,43
NCT03153111,0,0,0,0,0,0,2020-05-18,2021-05-18,,Actelion,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03155932,0,0,0,0,0,0,2019-01-31,2020-01-31,,Arena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,21
NCT03159260,1,1,0,1,0,0,2017-06-01,2018-06-01,2017-12-29,Sport and Spine Rehab Clinical Research Foundation,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,15
NCT03160898,0,0,0,0,0,0,2019-03-07,2020-03-07,,Cytokinetics,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,18
NCT03162224,0,0,0,0,0,0,2020-08-10,2021-08-10,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,269
NCT03162614,1,1,0,1,0,0,2018-07-09,2019-07-09,2019-07-01,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,3276
NCT03167359,0,0,0,0,0,0,2020-10-31,2021-10-31,,Emory University,Other,0,0,0,5.0,,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,947
NCT03171025,0,0,0,0,0,0,2024-06-30,2025-06-30,,University of Utah,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03171207,1,0,0,0,1,0,2017-08-31,2018-08-31,,Lite Run Inc.,Industry,1,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,1
NCT03173248,0,0,0,0,0,0,2022-04-30,2023-04-30,,"Agios Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,33
NCT03179917,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03180528,0,0,0,0,0,0,2019-06-28,2020-06-28,,Kavita Sarin,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03181516,0,0,0,0,0,0,2021-08-31,2022-08-31,,Georgetown University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,214
NCT03185130,0,0,0,0,0,0,2019-05-31,2020-05-31,,University Medical Center of Southern Nevada,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03185481,1,1,0,1,0,1,2017-10-24,2018-10-24,2018-11-01,Pfizer,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,2856
NCT03187080,0,0,0,0,0,0,2021-09-01,2022-09-01,,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03187730,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03188718,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of Colorado, Denver",Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,882
NCT03189667,0,0,0,0,0,0,2019-02-05,2020-02-05,,King Abdullah International Medical Research Center,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,24
NCT03190330,0,0,0,0,0,0,2021-09-29,2022-09-29,,Johnson & Johnson Private Limited,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03192150,0,0,0,0,0,0,2019-09-30,2020-09-30,,InSite Vision,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03192462,0,0,0,0,0,0,2021-05-01,2022-05-01,,Baylor College of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,518
NCT03193190,0,0,0,0,0,0,2019-11-16,2020-11-16,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03196232,0,0,0,0,0,0,2019-09-30,2020-09-30,,Pamela L. Kunz,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,4
NCT03197870,0,0,0,0,0,0,2019-01-09,2020-01-09,,Aerpio Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03198156,0,0,0,0,0,0,2019-06-30,2020-06-30,,Ohio State University,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03199456,1,0,0,0,1,0,2018-07-25,2019-07-25,,ZipLine Medical Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,6
NCT03203642,0,0,0,0,0,0,2020-08-10,2021-08-10,,"Kadmon Corporation, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03204279,0,0,0,0,0,0,2019-09-30,2020-09-30,,Helsinn Healthcare SA,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03204981,0,0,0,0,0,0,2020-12-31,2021-12-31,,Vivek Reddy,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,15
NCT03206047,0,0,0,0,0,0,2020-03-31,2021-03-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03210259,0,0,0,0,0,0,2020-03-12,2021-03-12,,Boehringer Ingelheim,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03211247,0,0,0,0,0,0,2020-05-30,2021-05-30,,DBV Technologies,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,11
NCT03214380,0,0,0,0,0,0,2018-08-14,2019-08-14,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1512
NCT03219385,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Mirabilis Medica, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03219528,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03221569,0,0,0,0,0,0,2020-02-01,2021-02-01,,The Brooklyn Hospital Center,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT03224000,0,0,0,0,0,0,2025-01-31,2026-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,2066
NCT03224299,0,0,0,0,0,0,2017-08-24,2018-08-24,,"Becton, Dickinson and Company",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,26
NCT03229057,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Pennsylvania,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03230032,0,0,0,0,0,0,2021-06-30,2022-06-30,,Nationwide Children's Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,161
NCT03231930,1,0,0,0,1,0,2017-11-01,2018-11-01,,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,6
NCT03236246,0,0,0,0,0,0,2019-09-30,2020-09-30,,Keryx Biopharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03238352,1,1,0,1,0,0,2017-10-27,2018-10-27,2018-10-15,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,3276
NCT03242564,1,0,1,1,0,0,2017-07-21,2018-07-21,2017-12-15,"Vevazz, LLC",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03243305,0,0,0,0,0,0,2019-01-31,2020-01-31,,Evofem Inc.,Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03244059,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,801
NCT03245580,0,0,0,0,0,0,2019-08-31,2020-08-31,,Parkview Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,4
NCT03245736,0,0,0,0,0,0,2019-01-10,2020-01-10,,Genmab,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,20
NCT03251144,0,0,0,0,0,0,2020-01-08,2021-01-08,,"University of California, Los Angeles",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03252093,0,0,0,0,0,0,2019-03-15,2020-03-15,,University of Arizona,Other,0,0,1,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,265
NCT03252587,0,0,0,0,0,0,2020-07-20,2021-07-20,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03255798,0,0,0,0,0,0,2021-12-31,2022-12-31,,Glaukos Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,34
NCT03256799,1,1,0,1,0,1,2017-07-10,2018-07-10,2018-08-07,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,801
NCT03257046,1,0,0,0,1,0,2018-09-06,2019-09-06,,"Intra-Cellular Therapies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,12
NCT03258398,0,0,0,0,0,0,2019-03-26,2020-03-26,,Effector Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03262116,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1699
NCT03262441,0,0,0,0,0,0,2019-08-31,2020-08-31,,Fred Hutchinson Cancer Research Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,393
NCT03262779,0,0,0,0,0,0,2019-11-01,2020-11-01,,Yale University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1053
NCT03263442,0,0,0,0,0,0,2020-06-30,2021-06-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03267277,0,0,0,0,0,0,2021-05-12,2022-05-12,,National Institute of Environmental Health Sciences (NIEHS),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,168
NCT03272334,0,0,0,0,0,0,2020-10-30,2021-10-30,,University of Virginia,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT03272906,0,0,0,0,0,0,2019-05-31,2020-05-31,,Louisiana State University and A&M College,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03274258,0,0,0,0,0,0,2020-07-01,2021-07-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03274440,0,0,0,0,0,0,2019-03-01,2020-03-01,,New York State Psychiatric Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,361
NCT03276780,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03278808,0,0,0,0,0,0,2019-12-30,2020-12-30,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,136
NCT03279081,0,0,0,0,0,0,2021-10-01,2022-10-01,,Tigenix S.A.U.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03281681,0,0,0,0,0,0,2022-03-31,2023-03-31,,"DelMar Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2021.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03281876,0,0,0,0,0,0,2020-03-09,2021-03-09,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,3276
NCT03282591,1,0,1,1,0,0,2018-08-15,2019-08-15,2019-07-29,Menlo Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,10
NCT03285477,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Athenex, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03285698,0,0,0,0,0,0,2019-08-31,2020-08-31,,Georgetown University,Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,214
NCT03286283,1,1,0,1,0,0,2018-08-20,2019-08-20,2019-05-28,Apyx Medical (formerly Bovie Medical Corp.),Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03290378,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-05-10,"Avenue Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03291054,0,0,0,0,0,0,2019-09-30,2020-09-30,,Richard D. Carvajal,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03298048,0,0,0,0,0,0,2019-03-30,2020-03-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,490
NCT03301506,0,0,0,0,0,0,2020-12-31,2021-12-31,,"CymaBay Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,18
NCT03302247,0,0,0,0,0,0,2019-03-21,2020-03-21,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,1,2018.0,1,1,1,0,0,0,0,0,0,1,0,156
NCT03303625,0,0,0,0,0,0,2020-04-17,2021-04-17,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,29
NCT03303794,1,0,0,0,1,0,2018-06-27,2019-06-27,,Montefiore Medical Center,Other,0,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03304054,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Catalyst Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03304821,0,0,0,0,0,0,2022-06-30,2023-06-30,,Emory University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03305575,1,0,1,1,0,1,2018-08-24,2019-08-24,2019-09-10,Tufts Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,121
NCT03309007,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of New Mexico,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,200
NCT03310580,0,0,0,0,0,0,2018-10-25,2019-10-25,,Aerie Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,28
NCT03310905,0,0,0,0,0,0,2022-01-01,2023-01-01,,Linda Cendales,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03311503,0,0,0,0,0,0,2021-01-01,2022-01-01,,David Williams,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,4
NCT03311854,0,0,0,0,0,0,2021-05-31,2022-05-31,,NovImmune SA,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03313050,0,0,0,0,0,0,2019-05-24,2020-05-24,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,2856
NCT03315143,0,0,0,0,0,0,2022-03-31,2023-03-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03319823,0,0,0,0,0,0,2019-10-01,2020-10-01,,Cedars-Sinai Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03321734,0,0,0,0,0,0,2022-05-31,2023-05-31,,Children's Research Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03322657,0,0,0,0,0,0,2019-10-30,2020-10-30,,The Cleveland Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03323151,0,0,0,0,0,0,2024-01-31,2025-01-31,,"PrECOG, LLC.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03326102,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Daehwa Pharmaceutical Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03326999,0,0,0,0,0,0,2019-11-30,2020-11-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03327922,0,0,0,0,0,0,2019-08-26,2020-08-26,,"University of California, Davis",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,530
NCT03328936,0,0,0,0,0,0,2021-03-31,2022-03-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,198
NCT03329131,0,0,0,0,0,0,2019-12-31,2020-12-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,257
NCT03331198,0,0,0,0,0,0,2020-12-01,2021-12-01,,"Juno Therapeutics, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,8
NCT03331562,0,0,0,0,0,0,2020-12-30,2021-12-30,,Translational Genomics Research Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03331965,0,0,0,0,0,0,2019-10-31,2020-10-31,,Duke University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03335254,1,1,0,1,0,0,2018-05-03,2019-05-03,2019-03-04,"TesoRx Pharma, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03339128,0,0,0,0,0,0,2021-01-25,2022-01-25,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03340090,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medical Universtity of Lodz,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,56
NCT03340207,0,0,0,0,0,0,2019-12-31,2020-12-31,,University at Buffalo,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,65
NCT03340337,1,0,0,0,1,0,2017-12-30,2018-12-30,,Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT03340675,0,0,0,0,0,0,2021-05-31,2022-05-31,,Cumberland Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,48
NCT03341156,0,0,0,0,0,0,2021-07-01,2022-07-01,,Kathirvel Subramaniam,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03341520,0,0,0,0,0,0,2021-06-30,2022-06-30,,Heidelberg University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,2,1,0,248
NCT03342196,0,0,0,0,0,0,2020-06-30,2021-06-30,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT03342807,0,0,0,0,0,0,2019-11-30,2020-11-30,,Peking Union Medical College Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,3,1,0,325
NCT03345160,0,0,0,0,0,0,2020-01-31,2021-01-31,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03348995,0,0,0,0,0,0,2022-04-17,2023-04-17,,Boston Children’s Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,400
NCT03353792,0,0,0,0,0,0,2022-01-31,2023-01-31,,Yale University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1053
NCT03354663,1,1,0,1,0,0,2018-08-02,2019-08-02,2019-08-01,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT03358355,1,0,1,1,0,1,2017-08-30,2018-08-30,2019-03-28,Northwestern University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT03359811,0,0,0,0,0,0,2021-11-30,2022-11-30,,M.D. Anderson Cancer Center,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03363945,0,0,0,0,0,0,2022-01-31,2023-01-31,,"Medeor Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03365154,0,0,0,0,0,0,2018-02-22,2019-02-22,,"Cardio Flow, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03366792,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03367156,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03367819,0,0,0,0,0,0,2021-06-30,2022-06-30,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03368729,0,0,0,0,0,0,2021-11-01,2022-11-01,,University of Alabama at Birmingham,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03369756,0,0,0,0,0,0,2019-09-30,2020-09-30,,B. Braun Medical Inc.,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03370913,0,0,0,0,0,0,2022-12-31,2023-12-31,,BioMarin Pharmaceutical,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,85
NCT03375112,0,0,0,0,0,0,2018-11-01,2019-11-01,,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,151
NCT03375905,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Sommetrics, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03376412,0,0,0,0,0,0,2020-12-31,2021-12-31,,Whitten Laser Eye,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03376555,0,0,0,0,0,0,2019-06-30,2020-06-30,,Lacy M. Alexander,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03377556,0,0,0,0,0,0,2022-05-01,2023-05-01,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,288
NCT03384940,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Daiichi Sankyo Co., Ltd.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,60
NCT03385239,0,0,0,0,0,0,2019-11-30,2020-11-30,,Akcea Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03387098,0,0,0,0,0,0,2019-12-31,2020-12-31,,"NantKwest, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03389620,0,0,0,0,0,0,2021-02-01,2022-02-01,,Duke University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03390426,0,0,0,0,0,0,2018-10-27,2019-10-27,,Duke University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03393975,0,0,0,0,0,0,2022-12-16,2023-12-16,,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,107
NCT03394924,0,0,0,0,0,0,2020-09-30,2021-09-30,,Enanta Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,22
NCT03397706,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Viracta Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1
NCT03398148,0,0,0,0,0,0,2020-09-23,2021-09-23,,AbbVie,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03401450,0,0,0,0,0,0,2020-03-31,2021-03-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03404895,0,0,0,0,0,0,2020-02-29,2021-02-28,,Windsor Ting,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03406507,0,0,0,0,0,0,2019-08-31,2020-08-31,,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,86
NCT03406702,0,0,0,0,0,0,2019-12-31,2020-12-31,,Jazz Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,55
NCT03406897,0,0,0,0,0,0,2022-09-30,2023-09-30,,Rodolfo Alejandro,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03407651,0,0,0,0,0,0,2019-03-15,2020-03-15,,Catalyst Biosciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,4
NCT03409458,0,0,0,0,0,0,2020-02-01,2021-02-01,,Phosplatin Therapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3
NCT03409666,0,0,0,0,0,0,2020-09-30,2021-09-30,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,215
NCT03411863,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03415997,0,0,0,0,0,0,2018-11-09,2019-11-09,,Nova Scotia Health Authority,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,140
NCT03416179,0,0,0,0,0,0,2021-06-13,2022-06-13,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03417102,0,0,0,0,0,0,2020-02-10,2021-02-10,,"Genzyme, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,300
NCT03418090,0,0,0,0,0,0,2019-09-30,2020-09-30,,Polarean Imaging Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03418857,0,0,0,0,0,0,2020-06-30,2021-06-30,,Penn State University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,145
NCT03422640,0,0,0,0,0,0,2019-01-31,2020-01-31,,Bellevue Dermatology,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03424148,0,0,0,0,0,0,2018-11-30,2019-11-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03427151,0,0,0,0,0,0,2019-02-05,2020-02-05,,ImmuPharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,2
NCT03428945,0,0,0,0,0,0,2024-08-31,2025-08-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03429803,0,0,0,0,0,0,2024-12-31,2025-12-31,,Karen D. Wright MD,Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03429946,0,0,0,0,0,0,2020-01-04,2021-01-04,,Brigham and Women's Hospital,Other,0,0,1,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT03431337,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Paul Sorum, MD",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03433313,0,0,0,0,0,0,2020-08-05,2021-08-05,,"EirGenix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03435848,0,0,0,0,0,0,2021-01-01,2022-01-01,,BioSight Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03437395,0,0,0,0,0,0,2022-12-31,2023-12-31,,Sentara Norfolk General Hospital,Other,0,0,0,5.0,,0,2009.0,0,0,0,1,0,1,0,0,0,0,1,5
NCT03438227,0,0,0,0,0,0,2020-06-30,2021-06-30,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03439514,0,0,0,0,0,0,2020-04-30,2021-04-30,,Array BioPharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,65
NCT03440372,0,0,0,0,0,0,2020-02-20,2021-02-20,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03443700,0,0,0,0,0,0,2021-11-30,2022-11-30,,Montecatone Rehabilitation Institute S.p.A.,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,5
NCT03444766,0,0,0,0,0,0,2019-07-17,2020-07-17,,Bristol-Myers Squibb,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1104
NCT03448887,0,0,0,0,0,0,2019-06-30,2020-06-30,,Seoul National University Hospital,Other,0,1,0,4.0,Phase 4,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,1227
NCT03449901,0,0,0,0,0,0,2020-05-09,2021-05-09,,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03451578,0,0,0,0,0,0,2020-08-01,2021-08-01,,Duke University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03452111,0,0,0,0,0,0,2021-07-31,2022-07-31,,Health Decisions,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03452527,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Iconic Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,4
NCT03453281,1,0,0,0,1,0,2018-04-09,2019-04-09,,Indonesia University,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,112
NCT03455309,0,0,0,0,0,0,2019-07-19,2020-07-19,,"NovaDigm Therapeutics, Inc.",Industry,1,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03455764,0,0,0,0,0,0,2021-09-30,2022-09-30,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03457675,0,0,0,0,0,0,2022-06-30,2023-06-30,,Baylor College of Medicine,Other,0,1,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,518
NCT03458728,0,0,0,0,0,0,2023-01-03,2024-01-03,,Bayer,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1343
NCT03459339,0,0,0,0,0,0,2020-09-30,2021-09-30,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03459690,0,0,0,0,0,0,2019-12-31,2020-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,377
NCT03460067,0,0,0,0,0,0,2020-07-31,2021-07-31,,Melissa Mitchell,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,2
NCT03461211,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Horizon Pharma USA, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,19
NCT03461406,0,0,0,0,0,0,2020-06-30,2021-06-30,,Grifols Therapeutics LLC,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,40
NCT03463057,0,0,0,0,0,0,2022-04-30,2023-04-30,,Stichting Hemato-Oncologie voor Volwassenen Nederland,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,18
NCT03466411,0,0,0,0,0,0,2022-06-03,2023-06-03,,"Janssen Research & Development, LLC",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03469258,0,0,0,0,0,0,2020-12-31,2021-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03471767,0,0,0,0,0,0,2019-03-31,2020-03-31,,James Davis,Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03472950,0,0,0,0,0,0,2019-10-01,2020-10-01,,University of Kansas Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03473548,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03475082,0,0,0,0,0,0,2019-12-31,2020-12-31,,Kathleen Sluka,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,3,0,1,2
NCT03478163,0,0,0,0,0,0,2021-12-31,2022-12-31,,Cedars-Sinai Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03478371,1,1,0,1,0,0,2018-07-18,2019-07-18,2019-07-01,Procter and Gamble,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,59
NCT03478982,0,0,0,0,0,0,2019-08-31,2020-08-31,,"EngageTherapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,2
NCT03480763,0,0,0,0,0,0,2019-12-30,2020-12-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03482102,0,0,0,0,0,0,2021-10-31,2022-10-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1699
NCT03482479,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03484923,0,0,0,0,0,0,2021-06-11,2022-06-11,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03491462,0,0,0,0,0,0,2020-12-31,2021-12-31,,Orphazyme,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03492463,0,0,0,0,0,0,2021-08-01,2022-08-01,,Duke University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03493919,0,0,0,0,0,0,2023-09-22,2024-09-22,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,3276
NCT03497806,0,0,0,0,0,0,2020-02-01,2021-02-01,,Finch Research and Development LLC.,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,3
NCT03500575,0,0,0,0,0,0,2021-12-10,2022-12-10,,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,66
NCT03503175,0,0,0,0,0,0,2020-05-01,2021-05-01,,Atlantic Health System,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,40
NCT03503331,0,0,0,0,0,0,2024-04-01,2025-04-01,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03504397,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT03505762,0,0,0,0,0,0,2022-06-30,2023-06-30,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,616
NCT03507790,0,0,0,0,0,0,2020-06-30,2021-06-30,,Cognition Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03508739,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Pennsylvania,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03510897,0,0,0,0,0,0,2021-07-31,2022-07-31,,Quark Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,13
NCT03513601,0,0,0,0,0,0,2019-05-31,2020-05-31,,Mingzhi Zhang,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,13
NCT03515213,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, Irvine",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,310
NCT03519386,0,0,0,0,0,0,2021-06-30,2022-06-30,,Glaukos Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,1,0,0,1,0,34
NCT03519919,0,0,0,0,0,0,2018-09-22,2019-09-22,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03520374,0,0,0,0,0,0,2019-05-31,2020-05-31,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1309
NCT03520686,0,0,0,0,0,0,2021-04-18,2022-04-18,,Altor BioScience,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03523585,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Daiichi Sankyo, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT03525444,0,0,0,0,0,0,2019-04-24,2020-04-24,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,141
NCT03526458,0,0,0,0,0,0,2023-07-31,2024-07-31,,"University of Wisconsin, Madison",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,715
NCT03530605,0,0,0,0,0,0,2022-10-31,2023-10-31,,Scott G. Turner,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03532178,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03532750,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03533686,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Miami,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,476
NCT03534804,0,0,0,0,0,0,2023-09-30,2024-09-30,,University of Utah,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03534986,1,1,0,1,0,0,2018-03-16,2019-03-16,2018-08-09,International Biophysics Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03536637,0,0,0,0,0,0,2018-12-30,2019-12-30,,Dermata Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03537742,0,0,0,0,0,0,2023-09-30,2024-09-30,,Stanford University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1309
NCT03538015,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Owen Chan, PhD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03538691,0,0,0,0,0,0,2022-09-30,2023-09-30,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,185
NCT03539549,0,0,0,0,0,0,2019-02-27,2020-02-27,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,495
NCT03539900,0,0,0,0,0,0,2024-04-30,2025-04-30,,Yale University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03541200,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Mitsubishi Tanabe Pharma Development America, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03543878,0,0,0,0,0,0,2019-12-31,2020-12-31,,Emory University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT03544138,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Preceptis Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03544515,0,0,0,0,0,0,2019-09-30,2020-09-30,,Columbia University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03547089,0,0,0,0,0,0,2020-03-01,2021-03-01,,"W. Grant Stevens, MD",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03547934,0,0,0,0,0,0,2019-05-15,2020-05-15,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,20
NCT03551496,0,0,0,0,0,0,2020-10-31,2021-10-31,,Boston Scientific Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,1,0,1,1,0,340
NCT03553186,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Hospital for Special Surgery, New York",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT03556332,0,0,0,0,0,0,2021-06-30,2022-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03558958,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Phrixus Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03562871,0,0,0,0,0,0,2020-11-30,2021-11-30,,IO Biotech,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,1
NCT03565835,0,0,0,0,0,0,2021-08-31,2022-08-31,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03566394,0,0,0,0,0,0,2019-06-30,2020-06-30,,British Columbia Cancer Agency,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,109
NCT03566680,0,0,0,0,0,0,2019-04-15,2020-04-15,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,801
NCT03568318,0,0,0,0,0,0,2022-06-06,2023-06-06,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03570983,0,0,0,0,0,0,2021-06-30,2022-06-30,,Swedish Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,34
NCT03573206,0,0,0,0,0,0,2018-12-27,2019-12-27,,"Cardiva Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03573401,0,0,0,0,0,0,2019-11-30,2020-11-30,,Biofrontera Bioscience GmbH,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,6
NCT03576066,0,0,0,0,0,0,2019-06-30,2020-06-30,,Assembly Biosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03579433,0,0,0,0,0,0,2019-04-16,2020-04-16,,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03579693,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,910
NCT03581942,0,0,0,0,0,0,2021-07-31,2022-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03582137,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03583424,0,0,0,0,0,0,2021-12-31,2022-12-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,198
NCT03591770,0,0,0,0,0,0,2020-08-31,2021-08-31,,Boston Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,225
NCT03592277,0,0,0,0,0,0,2019-12-01,2020-12-01,,Saint Francis Care,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03592641,0,0,0,0,0,0,2022-01-31,2023-01-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03593239,1,0,0,0,1,0,2018-07-26,2019-07-26,,"Juul Labs, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,7
NCT03593759,0,0,0,0,0,0,2022-12-31,2023-12-31,,Ottawa Heart Institute Research Corporation,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,117
NCT03596723,0,0,0,0,0,0,2018-09-28,2019-09-28,,"Kala Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT03597464,0,0,0,0,0,0,2021-08-31,2022-08-31,,Aurinia Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03598998,0,0,0,0,0,0,2021-04-27,2022-04-27,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,358
NCT03599752,0,0,0,0,0,0,2023-01-31,2024-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2066
NCT03601247,0,0,0,0,0,0,2019-08-01,2020-08-01,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,240
NCT03602950,0,0,0,0,0,0,2019-02-28,2020-02-28,,Minia University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,0,1,0,0,0,0,0,3,1,0,34
NCT03603288,0,0,0,0,0,0,2023-12-31,2024-12-31,,Santhera Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03603600,0,0,0,0,0,0,2021-05-31,2022-05-31,,Bausch & Lomb Incorporated,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,142
NCT03604341,0,0,0,0,0,0,2019-05-07,2020-05-07,,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,475
NCT03604523,0,0,0,0,0,0,2020-08-13,2021-08-13,,"University of Massachusetts, Worcester",Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,163
NCT03604991,0,0,0,0,0,0,2023-12-31,2024-12-31,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,3004
NCT03605303,1,1,0,1,0,0,2018-07-05,2019-07-05,2019-07-03,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03606109,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,869
NCT03610269,1,1,0,1,0,0,2018-08-16,2019-08-16,2019-04-19,Masimo Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03610646,0,0,0,0,0,0,2020-02-28,2021-02-28,,Mylan Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,30
NCT03618537,0,0,0,0,0,0,2021-08-31,2022-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03623854,0,0,0,0,0,0,2021-04-03,2022-04-03,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,277
NCT03624465,0,0,0,0,0,0,2019-05-30,2020-05-30,,Levita Magnetics,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,4
NCT03625648,0,0,0,0,0,0,2028-01-03,2029-01-03,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03626038,0,0,0,0,0,0,2021-01-31,2022-01-31,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,215
NCT03627468,0,0,0,0,0,0,2020-01-01,2021-01-01,,"Brickell Biotech, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03629184,0,0,0,0,0,0,2019-04-02,2020-04-02,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1731
NCT03630133,0,0,0,0,0,0,2020-02-08,2021-02-08,,"Relievant Medsystems, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03631641,0,0,0,0,0,0,2020-12-31,2021-12-31,,Joanne Jeter,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03632837,0,0,0,0,0,0,2019-05-31,2020-05-31,,Universitätsklinikum Hamburg-Eppendorf,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,215
NCT03634319,0,0,0,0,0,0,2019-12-31,2020-12-31,,MicroOptx,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,3
NCT03635957,0,0,0,0,0,0,2019-10-31,2020-10-31,,Horizon Pharma Rheumatology LLC,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03637543,0,0,0,0,0,0,2022-03-31,2023-03-31,,Beth Israel Deaconess Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03639077,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Oklahoma,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,234
NCT03639246,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Aravive, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03641183,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Alabama at Birmingham,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03642028,0,0,0,0,0,0,2023-09-30,2024-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03643159,0,0,0,0,0,0,2018-10-17,2019-10-17,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,1,0,0,1,0,185
NCT03643965,0,0,0,0,0,0,2020-10-31,2021-10-31,,Calliditas Therapeutics AB,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03645499,0,0,0,0,0,0,2019-10-15,2020-10-15,,Taro Pharmaceuticals USA,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,58
NCT03646461,0,0,0,0,0,0,2021-05-30,2022-05-30,,"University of California, San Diego",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03649659,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Michigan,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03649880,0,0,0,0,0,0,2021-09-30,2022-09-30,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT03650387,0,0,0,0,0,0,2020-06-30,2021-06-30,,Merz Pharmaceuticals GmbH,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,58
NCT03650556,0,0,0,0,0,0,2021-05-31,2022-05-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT03650894,0,0,0,0,0,0,2024-04-30,2025-04-30,,Providence Health & Services,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,55
NCT03652064,0,0,0,0,0,0,2024-03-29,2025-03-29,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03653351,0,0,0,0,0,0,2020-09-30,2021-09-30,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03655847,0,0,0,0,0,0,2019-03-23,2020-03-23,,Second Affiliated Hospital of Wenzhou Medical University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,24
NCT03656380,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of North Carolina, Chapel Hill",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03658785,0,0,0,0,0,0,2023-12-31,2024-12-31,,Tongji Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,71
NCT03660878,0,0,0,0,0,0,2018-11-19,2019-11-19,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03661047,0,0,0,0,0,0,2021-09-30,2022-09-30,,Mingyang Song,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03663387,0,0,0,0,0,0,2022-06-30,2023-06-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03665584,0,0,0,0,0,0,2019-08-14,2020-08-14,,Center for Vulvovaginal Disorders,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03667846,0,0,0,0,0,0,2023-04-30,2024-04-30,,NYU Langone Health,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03668041,0,0,0,0,0,0,2023-05-01,2024-05-01,,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03669614,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Aridis Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03669965,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Kartos Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03671512,0,0,0,0,0,0,2019-10-30,2020-10-30,,"Periovance, Inc",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03673462,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,285
NCT03678467,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Epibone, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,0,0,0,0,0,1,0,0,1,0,1
NCT03679624,0,0,0,0,0,0,2022-10-31,2023-10-31,,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03680508,0,0,0,0,0,0,2021-10-31,2022-10-31,,University of Hawaii,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,64
NCT03681951,0,0,0,0,0,0,2022-11-01,2023-11-01,,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3276
NCT03682809,0,0,0,0,0,0,2019-03-23,2020-03-23,,University of Alabama at Birmingham,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,801
NCT03686618,0,0,0,0,0,0,2019-10-01,2020-10-01,,"ChiRhoClin, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03691727,0,0,0,0,0,0,2022-11-30,2023-11-30,,David Hasan,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,3
NCT03691909,0,0,0,0,0,0,2020-02-01,2021-02-01,,Hope Biosciences,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03692052,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Agios Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,33
NCT03692403,0,0,0,0,0,0,2021-11-30,2022-11-30,,Ferring Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,208
NCT03695471,0,0,0,0,0,0,2022-10-11,2023-10-11,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03697252,0,0,0,0,0,0,2019-11-05,2020-11-05,,Karuna Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03698162,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Southern California,Other,0,0,1,5.0,,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,483
NCT03698370,0,0,0,0,0,0,2020-09-01,2021-09-01,,Andrei Iagaru,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,12
NCT03699644,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,1,0,0,0,0,1,0,934
NCT03700788,0,0,0,0,0,0,2021-10-31,2022-10-31,,University of Southern California,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,483
NCT03701399,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03703050,0,0,0,0,0,0,2023-10-31,2024-10-31,,"Gustave Roussy, Cancer Campus, Grand Paris",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,164
NCT03703375,0,0,0,0,0,0,2021-12-31,2022-12-31,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,306
NCT03704688,0,0,0,0,0,0,2021-04-30,2022-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03704922,0,0,0,0,0,0,2021-03-30,2022-03-30,,Blood Center of Wisconsin,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT03705234,0,0,0,0,0,0,2024-12-31,2025-12-31,,University of Oxford,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,501
NCT03706521,0,0,0,0,0,0,2020-07-31,2021-07-31,,Samumed LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03706690,0,0,0,0,0,0,2021-03-25,2022-03-25,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2450
NCT03708198,0,0,0,0,0,0,2019-06-11,2020-06-11,,University of Virginia,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,402
NCT03708367,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Johnson & Johnson Surgical Vision, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03708900,0,0,0,0,0,0,2021-12-21,2022-12-21,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03709043,0,0,0,0,0,0,2023-03-31,2024-03-31,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1443
NCT03709446,0,0,0,0,0,0,2021-10-20,2022-10-20,,Charles L Shapiro MD,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03709810,0,0,0,0,0,0,2019-01-24,2020-01-24,,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2019.0,1,0,0,0,0,0,1,0,0,1,0,3276
NCT03710122,0,0,0,0,0,0,2022-05-31,2023-05-31,,Elizabeth Carey,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03710642,0,0,0,0,0,0,2021-12-31,2022-12-31,,Alzheimer's Disease Cooperative Study (ADCS),Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03710889,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Radius Health, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03712280,0,0,0,0,0,0,2019-10-30,2020-10-30,,Mallinckrodt,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,91
NCT03713619,0,0,0,0,0,0,2021-06-16,2022-06-16,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03716505,0,0,0,0,0,0,2020-06-30,2021-06-30,,ElectroCore INC,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,19
NCT03718143,0,0,0,0,0,0,2021-05-01,2022-05-01,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,869
NCT03721965,0,0,0,0,0,0,2022-11-10,2023-11-10,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03723655,0,0,0,0,0,0,2022-06-30,2023-06-30,,"MyoKardia, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03723915,0,0,0,0,0,0,2020-07-01,2021-07-01,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,925
NCT03725098,0,0,0,0,0,0,2019-06-28,2020-06-28,,Biom'Up SA,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03726996,0,0,0,0,0,0,2020-11-30,2021-11-30,,Duke University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03727425,0,0,0,0,0,0,2019-08-30,2020-08-30,,"Auris Health, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03730207,0,0,0,0,0,0,2019-10-31,2020-10-31,,Medtronic Spinal and Biologics,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,52
NCT03732287,0,0,0,0,0,0,2019-04-26,2020-04-26,,"Recens Medical, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03734601,0,0,0,0,0,0,2020-11-30,2021-11-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1309
NCT03735433,0,0,0,0,0,0,2020-01-31,2021-01-31,,Ohio State University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03737123,0,0,0,0,0,0,2020-01-31,2021-01-31,,Nabil Adra,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03738475,0,0,0,0,0,0,2019-07-31,2020-07-31,,"COUR Pharmaceutical Development Company, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03739203,0,0,0,0,0,0,2021-07-09,2022-07-09,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03740009,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03740737,0,0,0,0,0,0,2021-07-31,2022-07-31,,Ferring Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,208
NCT03741803,0,0,0,0,0,0,2019-10-31,2020-10-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT03742102,0,0,0,0,0,0,2020-11-01,2021-11-01,,AstraZeneca,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03743571,0,0,0,0,0,0,2021-04-01,2022-04-01,,"University of Nevada, Reno",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,15
NCT03744312,0,0,0,0,0,0,2021-07-20,2022-07-20,,William Charles Kreisl,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03744728,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Accelerate Diagnostics, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,3
NCT03746132,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Neogenix, LLC dba Ogenix",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,5
NCT03748719,0,0,0,0,0,0,2021-11-30,2022-11-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,344
NCT03749252,0,0,0,0,0,0,2019-11-30,2020-11-30,,Guerbet,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,34
NCT03749460,0,0,0,0,0,0,2022-12-22,2023-12-22,,University of Washington,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,1,0,0,0,1,0,910
NCT03750786,0,0,0,0,0,0,2021-10-31,2022-10-31,,Isofol Medical AB,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03755310,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Diego García-Borreguero, MD, PhD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03757234,0,0,0,0,0,0,2019-08-31,2020-08-31,,Paratek Pharmaceuticals Inc,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,8
NCT03757585,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03758404,0,0,0,0,0,0,2021-05-31,2022-05-31,,MeiraGTx UK II Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,10
NCT03759028,0,0,0,0,0,0,2019-12-01,2020-12-01,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03760263,0,0,0,0,0,0,2020-12-01,2021-12-01,,Sentara Norfolk General Hospital,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03761810,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Sol-Gel Technologies, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03762200,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Ethicon, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,59
NCT03762746,0,0,0,0,0,0,2018-12-01,2019-12-01,,Dr Cipto Mangunkusumo General Hospital,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,1,0,0,0,0,2,1,0,8
NCT03764683,0,0,0,0,0,0,2021-01-31,2022-01-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1699
NCT03765073,0,0,0,0,0,0,2022-05-31,2023-05-31,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2856
NCT03766685,0,0,0,0,0,0,2020-07-31,2021-07-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,75
NCT03767582,0,0,0,0,0,0,2022-03-31,2023-03-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,461
NCT03767790,0,0,0,0,0,0,2019-06-27,2020-06-27,,Sansum Diabetes Research Institute,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,26
NCT03768414,0,0,0,0,0,0,2024-01-01,2025-01-01,,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,288
NCT03781986,0,0,0,0,0,0,2022-09-15,2023-09-15,,Ascentage Pharma Group Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03782376,0,0,0,0,0,0,2020-06-29,2021-06-29,,Janssen-Cilag Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,22
NCT03783117,0,0,0,0,0,0,2019-08-09,2020-08-09,,Cardiovascular Therapy LLC,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03783702,0,0,0,0,0,0,2019-06-01,2020-06-01,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1309
NCT03785587,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Brickell Biotech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03785925,0,0,0,0,0,0,2020-11-30,2021-11-30,,Nektar Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,20
NCT03786783,0,0,0,0,0,0,2021-07-31,2022-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,1,0,0,1,1,0,3004
NCT03790826,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Nellie Medical, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03792919,0,0,0,0,0,0,2023-12-31,2024-12-31,,Humanity & Health Medical Group Limited,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03794349,0,0,0,0,0,0,2022-03-31,2023-03-31,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,389
NCT03795051,0,0,0,0,0,0,2019-06-10,2020-06-10,,Magstim,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03795961,0,0,0,0,0,0,2020-01-31,2021-01-31,,Suez Canal University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,21
NCT03799484,0,0,0,0,0,0,2019-07-01,2020-07-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2019.0,1,1,0,1,0,0,0,0,0,1,0,490
NCT03799718,0,0,0,0,0,0,2020-02-29,2021-02-28,,Brainstorm-Cell Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03802344,0,0,0,0,0,0,2019-09-30,2020-09-30,,MC2 Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT03803553,0,0,0,0,0,0,2021-02-01,2022-02-01,,Massachusetts General Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03805789,0,0,0,0,0,0,2022-08-31,2023-08-31,,CSL Behring,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,81
NCT03808922,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Ansun Biopharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03812185,0,0,0,0,0,0,2019-12-31,2020-12-31,,Henry Ford Health System,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,151
NCT03813160,0,0,0,0,0,0,2021-12-31,2022-12-31,,Corbus Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03815331,0,0,0,0,0,0,2019-07-31,2020-07-31,,Men's Health Boston,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03816397,0,0,0,0,0,0,2022-06-30,2023-06-30,,Nisha Acharya,Other,0,0,1,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,1
NCT03817684,0,0,0,0,0,0,2020-06-30,2021-06-30,,Tetra Discovery Partners,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03818256,0,0,0,0,0,0,2020-10-31,2021-10-31,,Corcept Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,40
NCT03819023,0,0,1,1,0,0,2019-03-02,2020-03-02,2019-07-26,"Bioresp Technologies, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,1
NCT03821038,0,0,0,0,0,0,2020-06-30,2021-06-30,,Revimmune,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2
NCT03821337,0,0,0,0,0,0,2021-05-31,2022-05-31,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03821675,0,0,0,0,0,0,2019-12-15,2020-12-15,,Baylor College of Medicine,Other,0,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,518
NCT03822182,0,0,0,0,0,0,2019-12-31,2020-12-31,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT03822351,0,0,0,0,0,0,2023-10-23,2024-10-23,,MedImmune LLC,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,269
NCT03822936,0,0,0,0,0,0,2021-02-08,2022-02-08,,CNAO National Center of Oncological Hadrontherapy,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,2,1,0,3
NCT03823378,0,0,0,0,0,0,2020-12-15,2021-12-15,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,430
NCT03824483,0,0,0,0,0,0,2021-02-28,2022-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03827473,0,0,0,0,0,0,2024-02-04,2025-02-04,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03828136,0,0,0,0,0,0,2023-02-28,2024-02-28,,Bio2 Technologies,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03828487,0,0,0,0,0,0,2019-06-14,2020-06-14,,Masimo Corporation,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03828656,0,0,0,0,0,0,2021-02-01,2022-02-01,,NightWare,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03829475,0,0,0,0,0,0,2021-06-01,2022-06-01,,Brigham and Women's Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03830333,0,0,0,0,0,0,2020-11-03,2021-11-03,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2145
NCT03830866,0,0,0,0,0,0,2023-08-16,2024-08-16,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,1,0,0,1,1,0,2450
NCT03831724,0,0,0,0,0,0,2020-02-29,2021-02-28,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,146
NCT03831932,0,0,0,0,0,0,2021-06-01,2022-06-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03833921,0,0,0,0,0,0,2024-11-30,2025-11-30,,Martha Mims,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03834493,0,0,0,0,0,0,2023-11-12,2024-11-12,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03836352,0,0,0,0,0,0,2022-12-31,2023-12-31,,"ImmunoVaccine Technologies, Inc. (IMV Inc.)",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03837353,0,0,0,0,0,0,2021-03-31,2022-03-31,,NYU Langone Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,869
NCT03837899,0,0,0,0,0,0,2021-10-18,2022-10-18,,AstraZeneca,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03838692,0,0,0,0,0,0,2020-12-31,2021-12-31,,Antonio Fojo,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03838874,0,0,0,0,0,0,2021-02-01,2022-02-01,,Mayo Clinic,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03840057,0,0,0,0,0,0,2021-06-30,2022-06-30,,Waihong Chung,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03843879,0,0,0,0,0,0,2021-03-01,2022-03-01,,Benaroya Research Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,23
NCT03845894,0,0,0,0,0,0,2020-07-31,2021-07-31,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03846258,0,0,0,0,0,0,2021-04-01,2022-04-01,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03846453,0,0,0,0,0,0,2019-11-30,2020-11-30,,"HanAll BioPharma Co., Ltd.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,12
NCT03850509,0,0,0,0,0,0,2021-01-12,2022-01-12,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,185
NCT03851549,0,0,0,0,0,0,2019-04-19,2020-04-19,,LifeScan Scotland Ltd,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,2
NCT03852654,0,0,0,0,0,0,2019-12-30,2020-12-30,,Lida Jafari,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03852732,0,0,0,0,0,0,2019-11-30,2020-11-30,,Neurohabilitation Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03853317,0,0,0,0,0,0,2022-03-31,2023-03-31,,"NantKwest, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,27
NCT03853980,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Recros Medica, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03858231,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sanford Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,23
NCT03858894,0,0,0,0,0,0,2019-06-20,2020-06-20,,Santen Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,29
NCT03861611,0,0,0,0,0,0,2020-01-31,2021-01-31,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03864627,0,0,0,0,0,0,2020-06-30,2021-06-30,,Galapagos NV,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,79
NCT03867175,0,0,0,0,0,0,2027-07-31,2028-07-31,,Wake Forest University Health Sciences,Other,0,0,1,3.0,Phase 3,0,2019.0,0,0,1,0,0,1,0,0,0,1,0,616
NCT03867487,0,0,0,0,0,0,2021-05-01,2022-05-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03867682,0,0,0,0,0,0,2020-11-30,2021-11-30,,Actinium Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,5
NCT03869073,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of British Columbia,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,881
NCT03870022,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Jennifer Marler, MD",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03870685,0,0,0,0,0,0,2020-07-05,2021-07-05,,Danbury Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03872479,0,0,0,0,0,0,2024-03-22,2025-03-22,,Allergan,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03872700,0,0,0,0,0,0,2019-12-31,2020-12-31,,Montefiore Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,240
NCT03873337,0,0,0,0,0,0,2021-03-10,2022-03-10,,"Rutgers, The State University of New Jersey",Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,227
NCT03875235,0,0,0,0,0,0,2022-03-25,2023-03-25,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03877068,0,0,0,0,0,0,2021-12-31,2022-12-31,,Emory University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,1,0,0,0,0,1,0,947
NCT03877237,0,0,0,0,0,0,2020-01-31,2021-01-31,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03878888,0,0,0,0,0,0,2020-01-14,2021-01-14,,"St. Luke's Hospital, Pennsylvania",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03881202,0,0,0,0,0,0,2019-11-30,2020-11-30,,Neurohabilitation Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03881696,0,0,0,0,0,0,2020-10-31,2021-10-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03883217,0,0,0,0,0,0,2021-08-31,2022-08-31,,Virginia Commonwealth University,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,417
NCT03886220,0,0,0,0,0,0,2022-08-03,2023-08-03,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03887377,0,0,0,0,0,0,2019-09-30,2020-09-30,,Henry Ford Health System,Other,0,1,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,151
NCT03891784,0,0,0,0,0,0,2023-09-30,2024-09-30,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03891979,0,0,0,0,0,0,2021-05-31,2022-05-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03892772,0,0,0,0,0,0,2020-04-15,2021-04-15,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03896516,0,0,0,0,0,0,2020-11-26,2021-11-26,,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,96
NCT03897296,0,0,0,0,0,0,2022-04-15,2023-04-15,,Russian Academy of Medical Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,2,1,0,30
NCT03897647,0,0,0,0,0,0,2019-07-30,2020-07-30,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,240
NCT03899402,0,0,0,0,0,0,2022-05-01,2023-05-01,,State University of New York at Buffalo,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,105
NCT03899636,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Angiodynamics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,12
NCT03900715,0,0,0,0,0,0,2021-11-19,2022-11-19,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,306
NCT03901963,0,0,0,0,0,0,2021-05-30,2022-05-30,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,558
NCT03902938,0,0,0,0,0,0,2019-10-02,2020-10-02,,Ascension South East Michigan,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,7
NCT03904498,0,0,0,0,0,0,2024-03-31,2025-03-31,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03904693,0,0,0,0,0,0,2023-01-04,2024-01-04,,Actelion,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03905330,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Mirum Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03905694,0,0,0,0,0,0,2020-03-31,2021-03-31,,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,45
NCT03907241,0,0,0,0,0,0,2020-11-30,2021-11-30,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,54
NCT03907657,0,0,0,0,0,0,2020-07-31,2021-07-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03909854,0,0,0,0,0,0,2019-10-31,2020-10-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03911102,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Revance Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,26
NCT03916081,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Arcutis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03919175,0,0,0,0,0,0,2022-11-30,2023-11-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03922750,0,0,0,0,0,0,2019-12-19,2020-12-19,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03923387,0,0,0,0,0,0,2020-12-01,2021-12-01,,Cordis Corporation,Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,69
NCT03924024,0,0,0,0,0,0,2020-01-01,2021-01-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03924401,0,0,0,0,0,0,2023-12-31,2024-12-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03924869,0,0,0,0,0,0,2025-04-11,2026-04-11,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,1,0,0,1,1,0,2145
NCT03927157,0,0,0,0,0,0,2023-06-23,2024-06-23,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2450
NCT03929302,0,0,0,0,0,0,2020-12-31,2021-12-31,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03930641,0,0,0,0,0,0,2019-07-02,2020-07-02,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03931330,0,0,0,0,0,0,2019-09-30,2020-09-30,,Medical College of Wisconsin,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,315
NCT03931941,0,0,0,0,0,0,2020-04-30,2021-04-30,,Rebiotix Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03932240,0,0,0,0,0,0,2020-02-29,2021-02-28,,Emory University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03932773,0,0,0,0,0,0,2023-07-31,2024-07-31,,The University of Texas at Dallas,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03933410,0,0,0,0,0,0,2020-04-30,2021-04-30,,Kaleido Biosciences,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03933631,0,0,0,0,0,0,2022-12-31,2023-12-31,,Montefiore Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03934684,0,0,0,0,0,0,2022-04-28,2023-04-28,,Amgen,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,685
NCT03935425,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Flint Rehabilitation Devices, LLC",Industry,1,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03937219,0,0,0,0,0,0,2021-11-30,2022-11-30,,Exelixis,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,36
NCT03939923,0,0,0,0,0,0,2022-12-31,2023-12-31,,West Virginia University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,74
NCT03942419,0,0,0,0,0,0,2023-05-31,2024-05-31,,Eyenovia Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03945591,0,0,0,0,0,0,2022-11-30,2023-11-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03947385,0,0,0,0,0,0,2021-12-15,2022-12-15,,IDEAYA Biosciences,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03949855,0,0,0,0,0,0,2024-03-31,2025-03-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2133
NCT03951805,0,0,0,0,0,0,2019-12-15,2020-12-15,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03952559,0,0,0,0,0,0,2021-02-08,2022-02-08,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03954340,0,0,0,0,0,0,2021-06-30,2022-06-30,,BestBrain Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03954743,0,0,0,0,0,0,2020-12-16,2021-12-16,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,3276
NCT03955991,0,0,0,0,0,0,2020-12-01,2021-12-01,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,476
NCT03959527,0,0,0,0,0,0,2021-02-28,2022-02-28,,Global Antibiotics Research and Development Partnership,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03960463,0,0,0,0,0,0,2019-12-15,2020-12-15,,Baylor College of Medicine,Other,0,1,0,2.0,Phase 2/Phase 3,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,518
NCT03961893,0,0,0,0,0,0,2021-10-25,2022-10-25,,Institut Paoli-Calmettes,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,126
NCT03969342,0,0,0,0,0,0,2019-11-30,2020-11-30,,Bridge to Health Medical and Dental,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03970109,0,0,0,0,0,0,2020-08-01,2021-08-01,,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,96
NCT03970837,0,0,0,0,0,0,2021-07-02,2022-07-02,,GlaxoSmithKline,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,3276
NCT03976882,0,0,0,0,0,0,2020-08-30,2021-08-30,,"Jiangsu HengRui Medicine Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,187
NCT03977155,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03978442,0,0,0,0,0,0,2024-04-01,2025-04-01,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03979742,0,0,0,0,0,0,2020-09-01,2021-09-01,,"StemCyte, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,1
NCT03981380,0,0,0,0,0,0,2023-06-30,2024-06-30,,José A. Luchsinger,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03982368,0,0,0,0,0,0,2019-09-30,2020-09-30,,Dompé Farmaceutici S.p.A,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,28
NCT03982875,0,0,0,0,0,0,2021-09-01,2022-09-01,,11 Heath and Technologies Limited,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03983941,0,0,0,0,0,0,2021-12-31,2022-12-31,,Sujana Dontukurthy,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03984188,0,0,0,0,0,0,2022-01-01,2023-01-01,,Johns Hopkins University,Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,1143
NCT03986086,0,0,0,0,0,0,2022-12-31,2023-12-31,,Nelson Chao,Other,0,1,1,0.0,Phase 1/Phase 2,0,2021.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03986671,0,0,0,0,0,0,2019-07-31,2020-07-31,,Powell Mansfield Inc.,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03987074,0,0,0,0,0,0,2020-06-30,2021-06-30,,Gilead Sciences,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,510
NCT03987503,0,0,0,0,0,0,2021-06-30,2022-06-30,,"University of California, San Francisco",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1443
NCT03987763,0,0,0,0,0,0,2020-07-08,2021-07-08,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,180
NCT03988374,1,0,0,0,1,0,2018-08-24,2019-08-24,,"Church & Dwight Company, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,13
NCT03989440,0,0,0,0,0,0,2021-07-31,2022-07-31,,"ReNetX Bio, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03990961,0,0,0,0,0,0,2022-08-20,2023-08-20,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03993106,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Vasgene Therapeutics, Inc",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03996057,0,0,0,0,0,0,2021-07-05,2022-07-05,,Washington University School of Medicine,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1151
NCT03996603,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03997266,0,0,0,0,0,0,2023-09-30,2024-09-30,,Michael Morowitz,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03997851,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Miami,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT03997994,0,0,0,0,0,0,2021-03-21,2022-03-21,,GIE Medical,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,3
NCT03998176,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Nebraska,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,327
NCT03998566,0,0,0,0,0,0,2020-04-30,2021-04-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT03999749,0,0,0,0,0,0,2020-06-30,2021-06-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT04003480,0,0,0,0,0,0,2021-09-30,2022-09-30,,Vascular Graft Solutions Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,5
NCT04003766,0,0,0,0,0,0,2020-10-31,2021-10-31,,Florida Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,63
NCT04004000,0,0,0,0,0,0,2020-12-31,2021-12-31,,Fulcrum Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT04004416,0,0,0,0,0,0,2024-03-31,2025-03-31,,University of Michigan,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT04005690,0,0,0,0,0,0,2020-06-01,2021-06-01,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT04005885,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,85
NCT04009577,0,0,0,0,0,0,2019-12-13,2020-12-13,,Eisai Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,328
NCT04010695,0,0,0,0,0,0,2019-08-31,2020-08-31,,PATH,Other,0,0,0,5.0,,0,2019.0,1,0,0,0,1,0,0,0,0,1,0,78
NCT04015908,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Utah,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT04016844,0,0,0,0,0,0,2019-08-31,2020-08-31,,University of Iowa,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,158
NCT04017936,0,0,0,0,0,0,2022-10-31,2023-10-31,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,417
NCT04018729,0,0,0,0,0,0,2019-11-30,2020-11-30,,Hospital de Clinicas de Porto Alegre,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,0,1,1,0,0,0,0,3,1,0,314
NCT04019041,0,0,0,0,0,0,2020-07-31,2021-07-31,,"XBiotech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,15
NCT04021862,0,0,0,0,0,0,2020-07-31,2021-07-31,,"XBiotech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,15
NCT04022876,0,0,0,0,0,0,2021-03-31,2022-03-31,,Aileron Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT04023331,0,0,0,0,0,0,2022-09-30,2023-09-30,,Clarity Pharmaceuticals Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT04026464,0,0,0,0,0,0,2022-09-30,2023-09-30,,University of Florida,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT04027335,0,0,0,0,0,0,2020-02-01,2021-02-01,,"Renovia, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT04032080,0,0,0,0,0,0,2021-06-30,2022-06-30,,Baylor Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,131
NCT04032704,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Seattle Genetics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,77
NCT04033406,0,0,0,0,0,0,2020-10-30,2021-10-30,,"Vir Biotechnology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT04037735,0,0,0,0,0,0,2022-09-01,2023-09-01,,Peter den Hollander,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT04039087,0,0,0,0,0,0,2022-06-30,2023-06-30,,National Jewish Health,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,81
NCT04040959,0,0,0,0,0,0,2024-05-15,2025-05-15,,"University of Colorado, Denver",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT04042233,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Methodist Hospital System,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,36
NCT04043286,0,0,0,0,0,0,2020-08-31,2021-08-31,,Loma Linda University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,194
NCT04044716,0,0,0,0,0,0,2019-12-31,2020-12-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT04044937,0,0,0,0,0,0,2021-08-01,2022-08-01,,Thomas Hope,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT04045665,0,0,0,0,0,0,2022-12-31,2023-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,412
NCT04046991,0,0,0,0,0,0,2023-07-31,2024-07-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT04051320,0,0,0,0,0,0,2021-07-31,2022-07-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT04051957,0,0,0,0,0,0,2020-03-31,2021-03-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT04052204,0,0,0,0,0,0,2022-05-15,2023-05-15,,Pfizer,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT04053946,0,0,0,0,0,0,2021-10-01,2022-10-01,,Next Science TM,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,8
NCT04054310,0,0,0,0,0,0,2020-09-01,2021-09-01,,Perspectum Diagnostics Ltd,Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,10
NCT04054895,0,0,0,0,0,0,2022-09-01,2023-09-01,,Josep Lluis Mont Girbau,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT04055740,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Chicago,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,594
NCT04060199,0,0,0,0,0,0,2024-11-30,2025-11-30,,"NS Pharma, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT04061590,0,0,0,0,0,0,2021-05-01,2022-05-01,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,1443
NCT04064229,0,0,0,0,0,0,2019-04-09,2020-04-09,,"ivWatch, LLC",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT04068610,0,0,0,0,0,0,2024-02-22,2025-02-22,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,269
NCT04070378,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Marc L Gordon, MD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04073563,0,0,0,0,0,0,2025-06-30,2026-06-30,,Medtronic Spinal and Biologics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,52
NCT04074928,0,0,0,0,0,0,2020-05-15,2021-05-15,,Seqirus,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,41
NCT04075396,0,0,0,0,0,0,2021-08-01,2022-08-01,,"Janssen Research & Development, LLC",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,558
NCT04075890,0,0,0,0,0,0,2023-08-31,2024-08-31,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT04079179,0,0,0,0,0,0,2024-08-31,2025-08-31,,Carl Allen,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04080076,0,0,0,0,0,0,2020-09-04,2021-09-04,,"NephroNet, Inc.",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04083651,0,0,0,0,0,0,2023-10-15,2024-10-15,,"Bausch Health Americas, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,180
NCT04084210,0,0,0,0,0,0,2022-02-01,2023-02-01,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,715
NCT04084678,0,0,0,0,0,0,2022-12-15,2023-12-15,,United Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,72
NCT04088266,0,0,0,0,0,0,2020-12-31,2021-12-31,,Teva Pharmaceuticals USA,Industry,1,0,0,4.0,Phase 4,0,2020.0,0,0,0,0,0,0,1,0,3,1,0,171
NCT04089579,0,0,0,0,0,0,2021-10-01,2022-10-01,,"Joanne Kurtzberg, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,15
NCT04089904,0,0,0,0,0,0,2023-02-01,2024-02-01,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT00001305,1,1,0,1,0,1,2017-05-19,2018-05-19,2018-11-14,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),NIH,2,0,0,3.0,Phase 3,0,1991.0,1,1,0,0,0,0,0,0,0,0,1,413
NCT00175916,0,0,0,0,0,0,2019-05-31,2020-05-31,,UCB Pharma,Industry,1,0,0,3.0,Phase 3,0,2005.0,1,1,0,0,0,0,0,0,1,0,1,246
NCT00179465,0,0,0,0,0,0,2019-09-30,2020-09-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,3.0,Phase 3,0,2003.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT00290498,1,0,0,0,1,0,2017-08-11,2018-08-11,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00295893,0,0,0,0,0,0,2019-12-31,2020-12-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2005.0,0,1,1,0,0,0,0,0,0,0,1,358
NCT00389610,0,0,0,0,0,0,2021-07-31,2022-07-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2006.0,0,0,1,0,0,0,0,0,0,0,1,461
NCT00411632,1,0,1,1,0,1,2018-02-23,2019-02-23,2019-09-03,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00412594,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00445692,1,1,0,1,0,0,2017-04-24,2018-04-24,2018-02-22,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,393
NCT00576979,0,0,0,0,0,0,2020-06-30,2021-06-30,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2008.0,0,1,0,0,0,1,0,0,0,0,1,358
NCT00577993,1,0,0,0,1,0,2017-08-24,2018-08-24,,M.D. Anderson Cancer Center,Other,0,1,0,3.0,Phase 3,0,1998.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00590187,0,0,0,0,0,0,2018-12-01,2019-12-01,,"Cyclacel Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,13
NCT00602602,1,0,0,0,1,0,2017-12-31,2018-12-31,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,1,1.0,Phase 2,0,2007.0,0,1,1,0,0,1,0,0,0,0,1,273
NCT00645710,1,1,0,1,0,0,2018-02-07,2019-02-07,2018-12-21,City of Hope Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2005.0,1,1,0,0,0,1,0,1,0,0,1,358
NCT00669669,1,1,0,1,0,0,2018-07-06,2019-07-06,2018-11-07,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2009.0,0,1,1,0,0,1,0,0,0,0,1,393
NCT00679042,0,0,0,0,0,0,2017-07-31,2018-07-31,,CellTrans Inc.,Industry,1,0,0,3.0,Phase 3,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT00680992,1,1,0,1,0,0,2018-05-17,2019-05-17,2018-11-12,Amgen,Industry,1,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT00694577,0,0,0,0,0,0,2020-10-31,2021-10-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2003.0,0,0,0,0,0,1,0,0,0,0,1,1699
NCT00741455,0,0,0,0,0,0,2023-01-31,2024-01-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,5.0,,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,306
NCT00756600,1,0,0,0,1,0,2018-06-30,2019-06-30,,Boston Children’s Hospital,Other,0,0,1,4.0,Phase 4,0,2006.0,1,1,0,0,0,0,0,0,1,0,1,400
NCT00759291,1,0,0,0,1,0,2017-12-01,2018-12-01,,Brigham and Women's Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT00777244,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of Turin, Italy",Other,0,0,0,3.0,Phase 3,0,2008.0,0,1,0,0,0,0,0,0,1,0,1,110
NCT00777439,1,0,0,0,1,0,2017-01-31,2018-01-31,,"Arnold, George, M.D.",Other,0,0,0,5.0,,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT00786825,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2004.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT00826059,1,0,0,0,1,0,2018-06-30,2019-06-30,,BrainsGate,Industry,1,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,1,0,1,7
NCT00857389,0,0,0,0,0,0,2019-03-09,2020-03-09,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00869232,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Arkansas,Other,0,0,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,285
NCT00878254,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Miami,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,1,0,0,0,0,0,0,0,1,476
NCT00879437,0,0,0,0,0,0,2018-09-30,2019-09-30,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,1,0,0,0,0,1,518
NCT00887536,1,0,0,0,1,0,2017-12-31,2018-12-31,,NSABP Foundation Inc,Other,0,1,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,63
NCT00904046,0,0,0,0,0,0,2019-04-30,2020-04-30,,University of Texas Southwestern Medical Center,Other,0,1,1,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT00929214,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00942578,1,1,0,1,0,0,2017-07-31,2018-07-31,2018-07-25,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT00950846,0,0,0,0,0,0,2025-01-31,2026-01-31,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT00954174,0,0,0,0,0,0,2018-11-01,2019-11-01,,Gynecologic Oncology Group,Other,0,0,1,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,1,0,1,200
NCT01004978,0,0,0,0,0,0,2020-01-31,2021-01-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01011439,1,1,0,1,0,0,2017-05-31,2018-05-31,2018-05-31,"Tiziana Life Sciences, PLC",Industry,1,0,0,1.0,Phase 2,1,2010.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT01013649,0,0,0,0,0,0,2020-08-31,2021-08-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,1,0,0,1,0,1,3004
NCT01025453,1,1,0,1,0,0,2018-01-16,2019-01-16,2018-04-02,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01028846,0,0,0,0,0,0,2022-09-30,2023-09-30,,Albert Einstein College of Medicine,Other,0,0,1,1.0,Phase 2,0,2011.0,0,1,0,1,0,0,0,0,0,0,1,155
NCT01030900,0,0,0,0,0,0,2020-09-01,2021-09-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2009.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01064466,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair",Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT01066663,0,0,0,0,0,0,2022-02-28,2023-02-28,,Dana-Farber Cancer Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01115465,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Uroplasty, Inc",Industry,1,0,0,5.0,,0,2008.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT01122173,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-08-14,Hansen Medical,Industry,1,0,0,5.0,,1,2013.0,1,0,0,1,0,0,0,0,1,0,1,3
NCT01124136,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Jerry Estep, MD",Other,0,0,0,5.0,,0,2010.0,1,1,0,1,0,0,0,0,0,0,1,1
NCT01126697,1,0,0,0,1,0,2017-12-31,2018-12-31,,Cooperative International Neuromuscular Research Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,17
NCT01169337,0,0,0,0,0,0,2020-03-15,2021-03-15,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01196390,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2010.0,0,1,1,0,0,1,0,0,0,0,1,3004
NCT01208103,1,0,0,0,1,0,2018-03-07,2019-03-07,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01209325,1,0,0,0,1,0,2017-12-12,2018-12-12,,AIDS Malignancy Consortium,Other,0,1,1,1.0,Phase 2,0,2011.0,1,0,1,0,0,0,0,0,0,0,1,46
NCT01236547,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,3004
NCT01248962,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-06-26,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01251575,0,0,0,0,0,0,2018-11-23,2019-11-23,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,0,0,0,1,0,0,1,0,1,393
NCT01260181,1,1,0,1,0,0,2017-09-29,2018-09-29,2018-09-26,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,2,0,1,1731
NCT01263782,1,1,0,1,0,1,2017-08-15,2018-08-15,2018-09-10,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01266603,0,0,0,0,0,0,2018-11-01,2019-11-01,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT01273610,0,0,0,0,0,0,2019-06-30,2020-06-30,,City of Hope Medical Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT01276041,0,0,0,0,0,0,2019-08-07,2020-08-07,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01295515,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-12-19,National Cancer Institute (NCI),NIH,2,0,1,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01308905,1,0,0,0,1,0,2018-02-28,2019-02-28,,Barbara Ann Karmanos Cancer Institute,Other,0,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,134
NCT01309230,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Gradalis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,15
NCT01312779,0,0,0,0,0,0,2018-11-30,2019-11-30,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,1,0,1,77
NCT01323907,0,0,0,0,0,0,2019-01-31,2020-01-31,,Sivan Kinberg,Other,0,0,0,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01365429,1,0,0,0,1,0,2017-12-31,2018-12-31,,XVIVO Perfusion,Industry,1,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT01372579,0,0,0,0,0,0,2020-06-30,2021-06-30,,Northwestern University,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT01376778,0,0,0,0,0,0,2018-12-31,2019-12-31,,The George Washington University Biostatistics Center,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,20
NCT01383161,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-01-04,"University of California, Los Angeles",Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,692
NCT01389024,0,0,0,0,0,0,2019-08-31,2020-08-31,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT01405456,1,1,0,1,0,0,2017-05-03,2018-05-03,2018-04-16,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01406873,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-03-01,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,470
NCT01411332,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Miami,Other,0,0,0,5.0,,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,476
NCT01414426,1,0,0,0,1,0,2018-03-31,2019-03-31,,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT01416831,0,0,0,0,0,0,2018-10-31,2019-10-31,,Providence Health & Services,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,55
NCT01450943,1,0,1,1,0,1,2017-12-14,2018-12-14,2019-07-31,VA Office of Research and Development,U.S. Fed,2,0,1,3.0,Phase 3,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT01461278,0,0,0,0,0,0,2020-12-31,2021-12-31,,Glaukos Corporation,Industry,1,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,34
NCT01465841,1,0,0,0,1,0,2017-06-30,2018-06-30,,Penumbra Inc.,Industry,1,0,0,4.0,Phase 4,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,20
NCT01466036,0,0,0,0,0,0,2019-10-31,2020-10-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01468909,1,1,0,1,0,1,2018-01-27,2019-01-27,2019-02-08,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01470612,0,0,0,0,0,0,2020-07-27,2021-07-27,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT01492673,0,0,0,0,0,0,2018-10-31,2019-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,1432
NCT01500551,0,0,0,0,0,0,2021-03-31,2022-03-31,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT01505868,0,0,0,0,0,0,2029-07-11,2030-07-11,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01522768,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,1,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01525589,0,0,0,0,0,0,2018-10-31,2019-10-31,,PharmaMar,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT01525901,0,0,0,0,0,0,2021-04-30,2022-04-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT01525966,0,0,0,0,0,0,2023-02-28,2024-02-28,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT01538719,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-05,Boston University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,188
NCT01543490,0,0,0,0,0,0,2019-10-31,2020-10-31,,InSite Vision,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT01553201,0,0,0,0,0,0,2018-07-31,2019-07-31,,National Institute of Neurological Disorders and Stroke (NINDS),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,560
NCT01554371,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, San Francisco",Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT01583686,0,0,1,1,0,0,2018-12-17,2019-12-17,2019-08-29,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,1,2012.0,1,1,1,0,0,0,0,0,0,0,1,3004
NCT01591746,1,0,1,1,0,1,2017-07-18,2018-07-18,2019-04-10,Mayo Clinic,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT01592383,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-04-27,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT01593748,0,0,0,0,0,0,2019-04-24,2020-04-24,,Medical University of South Carolina,Other,0,1,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT01598831,1,0,0,0,1,0,2018-04-06,2019-04-06,,Asahi Kasei Pharma America Corporation,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT01613170,1,0,1,1,0,0,2018-04-30,2019-04-30,2018-08-23,The Cleveland Clinic,Other,0,1,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,581
NCT01618656,0,0,0,0,0,0,2019-12-31,2020-12-31,,Yale University,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT01628159,0,0,0,0,0,0,2018-09-30,2019-09-30,,C. R. Bard,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,1,0,1,77
NCT01631214,0,1,0,1,0,1,2017-02-27,2018-02-27,2018-11-20,Amgen,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,1,0,0,0,0,0,1,0,1,685
NCT01643850,0,0,1,1,0,1,2017-12-07,2018-12-07,2019-06-20,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01648751,0,0,0,0,0,0,2020-12-31,2021-12-31,,Pamela Moalli,Other,0,1,1,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01650090,0,0,0,0,0,0,2018-11-30,2019-11-30,,Eleison Pharmaceuticals LLC.,Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01659021,0,1,0,1,0,0,2018-08-15,2019-08-15,2017-02-14,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,1,2012.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT01661335,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Oklahoma,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,234
NCT01666730,1,0,0,0,1,0,2018-08-01,2019-08-01,,Case Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,374
NCT01669798,1,1,0,1,0,0,2017-09-10,2018-09-10,2018-09-07,AA Secord,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01680835,0,0,0,0,0,0,2019-02-04,2020-02-04,,Medtronic Endovascular,Industry,1,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,64
NCT01686841,1,0,0,0,1,0,2017-06-30,2018-06-30,,Zeltiq Aesthetics,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,32
NCT01687608,0,0,0,0,0,0,2030-10-28,2031-10-28,,Baxalta now part of Shire,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,107
NCT01712659,0,0,0,0,0,0,2021-01-01,2022-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01727336,1,0,0,0,1,0,2017-06-30,2018-06-30,,"Acceleron Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT01730950,1,0,0,0,1,0,2018-09-03,2019-09-03,,Radiation Therapy Oncology Group,Other,0,0,1,1.0,Phase 2,0,2012.0,0,0,1,0,0,1,0,0,0,0,1,156
NCT01732874,1,0,0,0,1,0,2018-07-16,2019-07-16,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,437
NCT01753908,1,0,0,0,1,0,2018-07-23,2019-07-23,,Roswell Park Cancer Institute,Other,0,0,1,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,294
NCT01773707,0,0,0,0,0,0,2020-11-30,2021-11-30,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,495
NCT01779375,1,1,0,1,0,1,2017-07-12,2018-07-12,2018-08-30,RISE Study Group,Other,0,0,1,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01780545,1,1,0,1,0,0,2017-10-31,2018-10-31,2017-10-18,"Noah Hahn, M.D.",Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT01782443,0,0,0,0,0,0,2020-01-31,2021-01-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01786967,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-09-21,"University of North Carolina, Chapel Hill",Other,0,0,1,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01788423,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-05-23,Indiana University,Other,0,0,1,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,497
NCT01799993,1,1,0,1,0,0,2017-04-07,2018-04-07,2018-03-27,Bayer,Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT01807897,0,0,0,0,0,0,2019-12-31,2020-12-31,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT01811225,1,0,1,1,0,1,2017-06-30,2018-06-30,2018-10-18,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT01811498,0,0,0,0,0,0,2020-01-31,2021-01-31,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,271
NCT01816984,1,0,0,0,1,0,2018-04-30,2019-04-30,,University of Chicago,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,594
NCT01821560,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-10-31,University of Pennsylvania,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01824420,1,0,0,0,1,0,2017-02-28,2018-02-28,,Buddhist Tzu Chi General Hospital,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,2,0,1,36
NCT01828554,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-30,"University of Wisconsin, Madison",Other,0,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,715
NCT01829711,1,1,0,1,0,0,2017-05-24,2018-05-24,2018-05-24,MedImmune LLC,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,269
NCT01833832,1,1,0,1,0,0,2018-08-09,2019-08-09,2019-04-25,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01841281,1,0,0,0,1,0,2018-08-31,2019-08-31,,Nicholas Kenyon,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01842308,1,0,1,1,0,1,2018-04-09,2019-04-09,2019-06-25,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01843023,1,0,0,0,1,0,2018-01-31,2019-01-31,,"Friends Research Institute, Inc.",Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT01847001,0,0,0,0,0,0,2018-12-31,2019-12-31,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT01847469,0,0,0,0,0,0,2019-01-01,2020-01-01,,Yale University,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT01850004,1,1,0,1,0,0,2017-09-20,2018-09-20,2018-09-20,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT01851369,0,0,0,0,0,0,2020-12-24,2021-12-24,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01851694,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Pennsylvania,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT01852201,1,0,0,0,1,0,2018-05-31,2019-05-31,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,511
NCT01856920,0,0,0,0,0,0,2019-09-01,2020-09-01,,"NantCell, Inc.",Industry,1,0,1,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,12
NCT01858558,0,0,0,0,0,0,2023-09-30,2024-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,461
NCT01861093,0,0,0,0,0,0,2037-11-30,2038-11-30,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1091
NCT01869374,1,0,0,0,1,0,2017-07-31,2018-07-31,,New York State Psychiatric Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,0,1,1,0,0,0,0,0,0,1,361
NCT01871571,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,483
NCT01873248,1,0,0,0,1,0,2017-06-16,2018-06-16,,Jonsson Comprehensive Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,277
NCT01873326,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01876446,1,1,0,1,0,1,2017-07-18,2018-07-18,2019-01-17,Roswell Park Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,294
NCT01890265,0,0,0,0,0,0,2017-07-28,2018-07-28,,FibroGen,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,31
NCT01890980,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT01898806,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-03-22,Columbia University,Other,0,0,0,4.0,Phase 4,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT01900093,1,0,0,0,1,0,2018-03-31,2019-03-31,,Aaron Miller,Other,0,1,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01901562,0,0,0,0,0,0,2020-03-31,2021-03-31,,Sheldon Feldman,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT01902966,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01903447,1,0,0,0,1,0,2018-02-21,2019-02-21,,University of Illinois at Chicago,Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,242
NCT01905384,0,0,0,0,0,0,2020-12-31,2021-12-31,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,422
NCT01912274,0,0,0,0,0,0,2017-06-30,2018-06-30,,Helsinn Healthcare SA,Industry,1,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,28
NCT01921517,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Pennsylvania,Other,0,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,1052
NCT01922921,1,0,0,0,1,0,2018-03-31,2019-03-31,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,910
NCT01926158,1,0,1,1,0,1,2017-02-04,2018-02-04,2018-10-03,Turku University Hospital,Other,0,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,2,0,1,173
NCT01934335,0,0,0,0,0,0,2018-12-21,2019-12-21,,Ronald Weigel,Other,0,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01935336,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,882
NCT01938547,0,0,0,0,0,0,2018-12-31,2019-12-31,,Chiesi Farmaceutici S.p.A.,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,130
NCT01942837,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01945593,1,1,0,1,0,0,2018-03-02,2019-03-02,2019-02-27,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2013.0,1,0,1,0,0,0,0,0,1,0,1,107
NCT01950455,1,0,0,0,1,0,2018-01-31,2019-01-31,,Navidea Biopharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT01956279,0,0,0,0,0,0,2018-10-10,2019-10-10,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01956669,0,0,0,0,0,0,2019-11-26,2020-11-26,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01958073,1,0,1,1,0,0,2017-12-31,2018-12-31,2018-12-30,"University of California, San Diego",Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT01959542,0,0,1,1,0,1,2017-06-30,2018-06-30,2019-02-06,Dana-Farber Cancer Institute,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,1,0,0,0,0,1,647
NCT01961843,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT01962415,0,0,0,0,0,0,2020-11-30,2021-11-30,,Paul Szabolcs,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01970345,0,0,0,0,0,0,2020-01-31,2021-01-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT01975389,1,1,0,1,0,0,2017-04-03,2018-04-03,2018-03-21,Pfizer,Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT01987505,1,1,0,1,0,0,2017-04-11,2018-04-11,2018-04-04,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,2,0,1,1731
NCT01989507,0,0,0,0,0,0,2020-01-31,2021-01-31,,Brown University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,152
NCT01996865,0,0,0,0,0,0,2023-04-08,2024-04-08,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01997515,1,0,1,1,0,0,2018-07-31,2019-07-31,2019-07-26,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT01998035,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Owen A, O'Connor, M.D., Ph.D.",Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01999673,1,0,0,0,1,0,2017-03-31,2018-03-31,,Peregrine Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,1,0,0,0,0,0,1,0,1,19
NCT02002182,0,0,0,0,0,0,2022-08-31,2023-08-31,,Andrew Sikora,Other,0,1,0,1.0,Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,1
NCT02003092,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Rexahn Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02003222,0,0,0,0,0,0,2021-06-30,2022-06-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2013.0,0,1,1,0,0,0,0,0,1,0,1,3004
NCT02007044,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02008656,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT02009332,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Aadi, LLC",Industry,1,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02009397,0,0,0,0,0,0,2018-12-31,2019-12-31,,James Graham Brown Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02010645,0,0,0,0,0,0,2019-01-02,2020-01-02,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02011971,0,0,0,0,0,0,2019-08-31,2020-08-31,,Stanford University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02012920,0,0,0,0,0,0,2018-12-31,2019-12-31,,Innocrin Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02014597,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Benjamin Frankfort, MD, PhD",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02017704,0,0,0,0,0,0,2020-10-31,2021-10-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT02018107,1,0,0,0,1,0,2018-02-16,2019-02-16,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2014.0,1,0,0,0,1,0,0,0,0,0,1,647
NCT02018458,0,0,0,0,0,0,2019-07-25,2020-07-25,,Baylor Research Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,131
NCT02022826,1,1,0,1,0,0,2017-03-31,2018-03-31,2017-08-20,Medtronic - MITG,Industry,1,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,146
NCT02030067,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Rexahn Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02034461,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Utah,Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,578
NCT02036476,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02037230,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,213
NCT02037529,0,0,0,0,0,0,2020-08-08,2021-08-08,,Academic and Community Cancer Research United,Other,0,0,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,32
NCT02038881,1,0,0,0,1,0,2017-05-10,2018-05-10,,Bavarian Nordic,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,33
NCT02039219,1,0,1,1,0,1,2018-05-31,2019-05-31,2019-06-14,Naga P. Chalasani,Other,0,1,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02039908,1,0,1,1,0,1,2018-05-31,2019-05-31,2019-07-29,Florida International University,Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT02041936,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,318
NCT02046174,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Rogosin Institute,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,21
NCT02049437,0,0,0,0,0,0,2019-12-29,2020-12-29,,Case Western Reserve University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,89
NCT02049515,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Verastem, Inc.",Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,35
NCT02051608,0,0,0,0,0,0,2020-11-20,2021-11-20,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02052648,0,0,0,0,0,0,2018-04-18,2019-04-18,,NewLink Genetics Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,1,0,0,0,0,1,34
NCT02054156,1,0,1,1,0,0,2018-08-23,2019-08-23,2019-08-02,Bonnie Ramsey,Other,0,0,1,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02057107,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pittsburgh,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,1054
NCT02065596,0,0,0,0,0,0,2019-12-15,2020-12-15,,Case Comprehensive Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,374
NCT02065791,0,0,0,0,0,0,2018-10-30,2019-10-30,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT02075671,0,0,0,0,0,0,2019-02-28,2020-02-28,,Alison Ehrlich,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,1,0,0,0,0,0,0,1,3
NCT02078648,1,0,0,0,1,0,2017-09-01,2018-09-01,,"Stemline Therapeutics, Inc.",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,6
NCT02085941,0,0,0,0,0,0,2019-06-30,2020-06-30,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,647
NCT02086175,0,0,0,0,0,0,2018-10-11,2019-10-11,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT02092909,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-03-22,"Idera Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,13
NCT02094118,0,0,0,0,0,0,2019-06-30,2020-06-30,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,1898
NCT02096003,1,1,0,1,0,1,2017-05-05,2018-05-05,2019-07-11,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02096952,1,1,0,1,0,0,2018-01-31,2019-01-31,2018-01-24,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02104622,0,0,0,0,0,0,2018-12-31,2019-12-31,,Shirley Ryan AbilityLab,Other,0,0,1,1.0,Phase 2,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,71
NCT02105766,0,0,0,0,0,0,2021-08-31,2022-08-31,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,1,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT02107131,1,1,0,1,0,1,2017-05-15,2018-05-15,2018-08-22,California Retina Consultants,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02107703,1,1,0,1,0,0,2017-02-14,2018-02-14,2018-02-12,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02124746,0,0,0,0,0,0,2018-12-06,2019-12-06,,"Sierra Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,19
NCT02125279,1,0,0,0,1,0,2018-05-31,2019-05-31,,Galderma,Industry,1,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,77
NCT02126553,0,0,0,0,0,0,2022-11-30,2023-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02128282,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Senhwa Biosciences, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02129348,0,0,0,0,0,0,2020-01-31,2021-01-31,,New York State Psychiatric Institute,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02130700,1,0,0,0,1,0,2017-09-30,2018-09-30,,Innocrin Pharmaceutical,Industry,1,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02139280,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,306
NCT02139397,0,0,0,0,0,0,2019-12-31,2020-12-31,,Giselle Sholler,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT02140801,1,0,0,0,1,0,2017-03-08,2018-03-08,,"Nanjing First Hospital, Nanjing Medical University",Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,2,0,1,41
NCT02141399,1,1,0,1,0,1,2017-11-20,2018-11-20,2018-11-21,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,70
NCT02149173,0,0,0,0,0,0,2018-12-27,2019-12-27,,University of Washington,Other,0,0,1,5.0,,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02157038,0,0,0,0,0,0,2019-07-31,2020-07-31,,Northwestern University,Other,0,0,1,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,925
NCT02158507,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Alabama at Birmingham,Other,0,1,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02158663,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-04-09,James A. Haley Veterans Administration Hospital,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,8
NCT02159027,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Hawaii,Other,0,1,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,64
NCT02161822,0,0,0,0,0,0,2019-12-31,2020-12-31,,Samsung Medical Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,2,0,1,684
NCT02168816,1,1,0,1,0,1,2017-02-02,2018-02-02,2018-05-08,Loyola University,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,102
NCT02176213,0,0,0,0,0,0,2019-05-07,2020-05-07,,Ajai Chari,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02178436,0,0,0,0,0,0,2018-12-31,2019-12-31,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT02178722,0,0,0,0,0,0,2018-11-26,2019-11-26,,Incyte Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,143
NCT02179476,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Zyga Technology, Inc.",Industry,1,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02183792,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-05-02,University of Southern California,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,483
NCT02185040,0,0,0,0,0,0,2018-09-25,2019-09-25,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,306
NCT02187848,0,0,0,0,0,0,2021-06-30,2022-06-30,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT02188576,1,0,0,0,1,0,2017-12-31,2018-12-31,,Boston Children’s Hospital,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,400
NCT02189889,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02195869,1,1,0,1,0,1,2017-09-15,2018-09-15,2019-04-30,Pharmacyclics LLC.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT02198209,0,0,0,0,0,0,2020-07-31,2021-07-31,,Cedars-Sinai Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT02203695,0,0,0,0,0,0,2020-08-31,2021-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT02203851,1,0,1,1,0,0,2018-09-04,2019-09-04,2019-05-10,AbbVie,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02209597,1,0,1,1,0,0,2018-02-28,2019-02-28,2018-06-20,Washington University School of Medicine,Other,0,0,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02210065,0,0,0,0,0,0,2019-05-13,2020-05-13,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,2066
NCT02221934,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Neuros Medical, Inc.",Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02223182,0,0,0,0,0,0,2017-12-14,2018-12-14,,DBV Technologies,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,11
NCT02223819,0,0,0,0,0,0,2019-08-31,2020-08-31,,Columbia University,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02224352,0,0,0,0,0,0,2020-06-30,2021-06-30,,Edward Hines Jr. VA Hospital,U.S. Fed,2,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02228174,1,1,0,1,0,1,2017-10-18,2018-10-18,2018-11-26,Gynesonics,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,1,0,1,7
NCT02231879,0,0,0,0,0,0,2020-10-05,2021-10-05,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2133
NCT02234843,0,0,0,0,0,0,2019-01-30,2020-01-30,,Bayer,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1343
NCT02238977,1,1,0,1,0,0,2018-03-01,2019-03-01,2018-04-02,University of Arkansas,Other,0,0,1,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,285
NCT02243358,1,0,0,0,1,0,2018-02-28,2019-02-28,,Henry Ford Health System,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,151
NCT02245568,0,0,0,0,0,0,2017-05-31,2018-05-31,,TauRx Therapeutics Ltd,Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,11
NCT02249377,1,0,1,1,0,0,2017-04-01,2018-04-01,2018-03-07,NYU Langone Health,Other,0,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02251275,0,0,0,0,0,0,2018-11-09,2019-11-09,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,185
NCT02259621,0,0,0,0,0,0,2023-01-31,2024-01-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,461
NCT02265965,1,0,0,0,1,0,2018-07-01,2019-07-01,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02270957,0,0,0,0,0,0,2018-12-31,2019-12-31,,Oklahoma Medical Research Foundation,Other,0,1,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,11
NCT02271919,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02272049,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,437
NCT02272946,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02276716,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02279719,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Boston Biomedical, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT02292186,1,1,0,1,0,0,2017-02-22,2018-02-22,2018-02-22,Alnylam Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,45
NCT02296346,1,1,0,1,0,1,2017-06-13,2018-06-13,2019-05-20,University of Utah,Other,0,1,0,5.0,,1,2014.0,1,1,0,1,0,0,0,0,0,0,1,578
NCT02301897,0,1,0,1,0,1,2017-06-02,2018-06-02,2019-05-29,Repros Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,58
NCT02305186,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Craig L Slingluff, Jr",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,1,0,0,0,0,1,19
NCT02308046,0,0,0,0,0,0,2017-06-30,2018-06-30,,"Curatek Pharmaceuticals, LLC",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02309138,0,0,0,0,0,0,2019-07-03,2020-07-03,,"Esa M Davis, MD MPH FAAFP",Other,0,0,0,5.0,,0,2015.0,0,0,0,0,1,0,0,0,0,0,1,1
NCT02316717,1,0,0,0,1,0,2017-10-30,2018-10-30,,Immuron Ltd.,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,3
NCT02322021,0,0,0,0,0,0,2018-03-27,2019-03-27,,Eisai Inc.,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,328
NCT02324608,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Rutgers, The State University of New Jersey",Other,0,0,1,5.0,,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,227
NCT02327312,0,0,0,0,0,0,2021-02-28,2022-02-28,,Glaukos Corporation,Industry,1,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,34
NCT02332980,0,0,0,0,0,0,2020-01-05,2021-01-05,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,1898
NCT02336165,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-07-24,Ludwig Institute for Cancer Research,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,1,0,0,1,0,1,46
NCT02338232,0,0,0,0,0,0,2020-07-31,2021-07-31,,Hackensack Meridian Health,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT02339974,0,0,0,0,0,0,2021-01-31,2022-01-31,,Temple University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,152
NCT02340585,0,0,0,0,0,0,2019-12-31,2020-12-31,,Stryker Neurovascular,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,18
NCT02342639,0,0,0,0,0,0,2019-03-01,2020-03-01,,"Jason Stubbs, MD",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02343172,0,0,0,0,0,0,2019-09-06,2020-09-06,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1895
NCT02346201,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins Bloomberg School of Public Health,Other,0,0,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,221
NCT02351037,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-04-04,Pharmacyclics LLC.,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT02352883,0,0,0,0,0,0,2027-11-30,2028-11-30,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,1,0,0,0,0,1,75
NCT02360280,0,0,0,0,0,0,2018-10-22,2019-10-22,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT02362997,0,0,0,0,0,0,2020-09-30,2021-09-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02363621,1,1,0,1,0,1,2017-10-31,2018-10-31,2018-11-04,Arshad Khanani,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02365818,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Cold Genesys, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02366143,0,0,0,0,0,0,2019-09-13,2020-09-13,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02367521,1,1,0,1,0,0,2017-10-01,2018-10-01,2018-07-05,Johns Hopkins University,Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,1,0,0,1,0,0,1,0,0,0,1,1143
NCT02369016,0,0,0,0,0,0,2019-12-20,2020-12-20,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,1343
NCT02369874,1,0,1,1,0,0,2018-09-10,2019-09-10,2019-09-10,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02376790,1,1,0,1,0,0,2018-01-09,2019-01-09,2019-01-08,Amgen,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02386098,1,1,0,1,0,0,2017-06-07,2018-06-07,2018-06-04,ViiV Healthcare,Industry,1,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,200
NCT02391961,0,0,0,0,0,0,2019-01-31,2020-01-31,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT02392507,1,1,0,1,0,0,2018-01-29,2019-01-29,2019-01-18,Eli Lilly and Company,Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1512
NCT02393417,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-04-09,"Nielsen BioSciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT02401061,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Protalex, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02406651,0,0,0,0,0,0,2019-04-09,2020-04-09,,Generon (Shanghai) Corporation Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02407054,0,0,0,0,0,0,2018-09-26,2019-09-26,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1512
NCT02407600,1,0,0,0,1,0,2018-02-28,2019-02-28,,Ajeet Gajra,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02408120,0,0,0,0,0,0,2019-12-31,2020-12-31,,Emory University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02414282,0,0,0,0,0,0,2020-03-31,2021-03-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02416193,1,0,0,0,1,0,2018-07-12,2019-07-12,,Loyola University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,102
NCT02416453,0,0,0,0,0,0,2018-01-19,2019-01-19,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,2,0,1,29
NCT02417701,0,0,0,0,0,0,2019-12-01,2020-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02418000,1,1,0,1,0,1,2017-06-08,2018-06-08,2018-11-08,"Spirita Oncology, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02419807,0,0,0,0,0,0,2019-02-28,2020-02-28,,Case Comprehensive Cancer Center,Other,0,1,1,5.0,,0,2015.0,1,1,0,0,0,1,0,0,0,0,1,374
NCT02423863,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Oncovir, Inc.",Industry,1,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2
NCT02425943,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Galderma Laboratories, L.P.",Industry,1,0,0,4.0,Phase 4,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,49
NCT02430428,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Carl Zeiss Meditec, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,13
NCT02435173,0,0,0,0,0,0,2020-07-09,2021-07-09,,Novartis Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02435992,0,0,0,0,0,0,2020-06-27,2021-06-27,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02447887,1,0,1,1,0,1,2017-04-25,2018-04-25,2019-09-04,Fox Chase Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,156
NCT02448654,0,0,0,0,0,0,2019-06-30,2020-06-30,,Yale University,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02450773,0,0,0,0,0,0,2019-05-31,2020-05-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02451488,0,0,0,0,0,0,2019-11-30,2020-11-30,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02451748,1,0,0,0,1,0,2017-09-30,2018-09-30,,University of Illinois at Chicago,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,242
NCT02451943,0,0,0,0,0,0,2018-12-05,2019-12-05,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02453373,0,0,0,0,0,0,2020-01-25,2021-01-25,,Life Recovery Systems,Other,0,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,5
NCT02455011,1,0,0,0,1,0,2018-01-31,2019-01-31,,"REMD Biotherapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02455622,0,0,0,0,0,0,2025-07-09,2026-07-09,,Shire,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,342
NCT02456103,0,0,0,0,0,0,2017-06-30,2018-06-30,,PTC Therapeutics,Industry,1,0,0,3.0,Phase 3,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,42
NCT02461433,1,1,0,1,0,0,2017-03-31,2018-03-31,2017-10-05,Johns Hopkins University,Other,0,1,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,1143
NCT02465268,0,0,0,0,0,0,2023-06-30,2024-06-30,,University of Florida,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,849
NCT02467166,0,0,0,0,0,0,2019-03-30,2020-03-30,,"University of California, San Diego",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,561
NCT02467361,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Boston Biomedical, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,27
NCT02468674,0,0,0,0,0,0,2018-12-03,2019-12-03,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02469857,0,0,0,0,0,0,2019-07-31,2020-07-31,,Atox Bio Ltd,Industry,1,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,4
NCT02471638,0,0,0,0,0,0,2018-09-30,2019-09-30,,"PQ Bypass, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,2,0,1,4
NCT02478489,0,0,0,0,0,0,2020-08-31,2021-08-31,,Boston University,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,188
NCT02479906,0,0,0,0,0,0,2019-06-30,2020-06-30,,Brainsway,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,16
NCT02481258,1,0,1,1,0,1,2018-07-31,2019-07-31,2019-08-06,Mayo Clinic,Other,0,1,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02484391,0,0,0,0,0,0,2018-10-31,2019-10-31,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02485899,0,0,0,0,0,0,2020-07-31,2021-07-31,,BioMarin Pharmaceutical,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,1,0,0,0,0,1,0,1,85
NCT02487277,0,0,0,0,0,0,2019-12-31,2020-12-31,,Andrew Ko,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02489448,0,0,0,0,0,0,2019-10-31,2020-10-31,,Yale University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02491411,1,1,0,1,0,0,2018-03-31,2019-03-31,2018-05-16,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,5.0,,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,461
NCT02495259,1,1,0,1,0,0,2017-07-27,2018-07-27,2018-02-05,Emory University,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,947
NCT02498483,1,1,0,1,0,1,2017-01-31,2018-01-31,2019-03-26,Columbia University,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02501473,0,0,0,0,0,0,2020-12-31,2021-12-31,,Immune Design,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02501811,0,0,0,0,0,0,2019-11-30,2020-11-30,,"The University of Texas Health Science Center, Houston",Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,490
NCT02502162,0,0,0,0,0,0,2019-06-30,2020-06-30,,Stanford University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02502799,0,0,0,0,0,0,2019-08-31,2020-08-31,,Florida International University,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,40
NCT02502864,1,1,0,1,0,0,2017-09-29,2018-09-29,2018-08-13,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,344
NCT02503475,0,0,0,0,0,0,2019-03-31,2020-03-31,,Stanford University,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1309
NCT02506959,0,0,0,0,0,0,2019-09-14,2020-09-14,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02507284,1,0,0,0,1,0,2018-09-10,2019-09-10,,Azevan Pharmaceuticals,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02508207,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-29,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,141
NCT02512874,1,1,0,1,0,1,2017-03-16,2018-03-16,2018-08-30,Mayo Clinic,Other,0,0,1,5.0,,0,2015.0,1,0,0,1,0,1,0,0,0,0,1,1898
NCT02513459,0,0,0,0,0,0,2019-06-19,2020-06-19,,AbbVie,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02516696,0,0,0,0,0,0,2020-08-31,2021-08-31,,Weill Medical College of Cornell University,Other,0,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT02519543,0,0,0,0,0,0,2019-01-31,2020-01-31,,Cynthia Calkin,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT02521363,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,1432
NCT02525796,0,0,0,0,0,0,2020-12-31,2021-12-31,,Brigham and Women's Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,698
NCT02526212,0,0,0,0,0,0,2019-05-31,2020-05-31,,Montefiore Medical Center,Other,0,0,1,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02527421,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Promius Pharma, LLC",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT02528643,1,1,0,1,0,0,2017-10-02,2018-10-02,2018-10-01,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,135
NCT02530307,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Dart NeuroScience, LLC",Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02534350,0,1,0,1,0,1,2017-02-20,2018-02-20,2018-09-18,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02536794,0,0,0,0,0,0,2019-09-30,2020-09-30,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,925
NCT02537444,1,1,0,1,0,1,2018-07-31,2019-07-31,2019-08-05,Acerta Pharma BV,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02538510,0,0,0,0,0,0,2019-09-25,2020-09-25,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,910
NCT02539342,1,1,0,1,0,1,2017-03-02,2018-03-02,2018-12-11,Medical College of Wisconsin,Other,0,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,315
NCT02540161,0,0,0,0,0,0,2019-07-10,2020-07-10,,Annick Desjardins,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,10
NCT02542046,1,0,1,1,0,1,2017-01-31,2018-01-31,2019-03-25,"University of California, San Francisco",Other,0,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02542267,0,0,0,0,0,0,2019-07-31,2020-07-31,,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,1,0,1,52
NCT02545127,0,0,0,0,0,0,2021-04-30,2022-04-30,,Ferring Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,208
NCT02546193,1,1,0,1,0,1,2017-06-08,2018-06-08,2018-09-27,Mayo Clinic,Other,0,0,0,5.0,,1,2015.0,1,1,0,1,0,0,0,0,0,0,1,1898
NCT02546765,0,0,0,0,0,0,2019-04-30,2020-04-30,,Beth Israel Deaconess Medical Center,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,377
NCT02547116,0,0,0,0,0,0,2020-12-31,2021-12-31,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT02552238,1,0,0,0,1,0,2017-04-14,2018-04-14,,"Bracco Diagnostics, Inc",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,46
NCT02552888,0,0,0,0,0,0,2017-06-30,2018-06-30,,Tulane University,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,33
NCT02553642,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02554890,0,0,1,1,0,1,2018-06-29,2019-06-29,2019-07-19,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02555657,0,0,0,0,0,0,2019-04-11,2020-04-11,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02556788,0,1,0,1,0,1,2017-02-07,2018-02-07,2019-04-18,Galderma R&D,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,28
NCT02558231,0,0,0,0,0,0,2019-08-29,2020-08-29,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,128
NCT02559180,0,0,0,0,0,0,2018-11-30,2019-11-30,,Rishi Singh,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02559817,0,0,0,0,0,0,2020-10-18,2021-10-18,,Forest Laboratories,Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,169
NCT02560623,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02562235,0,0,0,0,0,0,2020-06-12,2021-06-12,,Bayer,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02566044,1,1,0,1,0,0,2018-04-24,2019-04-24,2019-04-15,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT02568189,0,0,0,0,0,0,2019-07-31,2020-07-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,412
NCT02568267,0,0,0,0,0,0,2019-10-31,2020-10-31,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02579629,0,0,0,0,0,0,2019-07-31,2020-07-31,,Emory University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,947
NCT02581007,0,0,0,0,0,0,2018-10-22,2019-10-22,,"Northside Hospital, Inc.",Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,16
NCT02583490,1,0,0,0,1,0,2018-08-31,2019-08-31,,Augusta University,Other,0,0,0,3.0,Phase 3,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,117
NCT02584478,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Advenchen Laboratories, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02585726,1,0,0,0,1,0,2017-07-31,2018-07-31,,Lake Washington Vascular,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02586012,0,0,0,0,0,0,2020-06-30,2021-06-30,,Craig Seaman,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02590939,1,1,0,1,0,0,2017-03-31,2018-03-31,2018-02-07,Cefaly Technology,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT02605122,1,1,0,1,0,0,2018-03-21,2019-03-21,2018-11-06,"Melinta Therapeutics, Inc.",Industry,1,0,1,2.0,Phase 2/Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,25
NCT02605837,0,0,0,0,0,0,2019-01-24,2020-01-24,,Shire,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,342
NCT02609633,1,1,0,1,0,0,2017-01-20,2018-01-20,2018-01-04,Hoffmann-La Roche,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1731
NCT02612272,1,0,0,0,1,0,2017-10-31,2018-10-31,,"St. Luke's Hospital, Pennsylvania",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02619617,0,0,0,0,0,0,2018-09-25,2019-09-25,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02620800,0,0,0,0,0,0,2018-10-29,2019-10-29,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,306
NCT02623803,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-03-21,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02624700,0,0,0,0,0,0,2019-07-10,2020-07-10,,Virginia Commonwealth University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,417
NCT02625974,1,0,1,1,0,0,2018-07-25,2019-07-25,2019-07-22,Bayer,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,1343
NCT02626455,0,0,0,0,0,0,2021-09-30,2022-09-30,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02630472,1,1,0,1,0,1,2017-05-04,2018-05-04,2018-12-19,University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02632396,0,0,0,0,0,0,2021-04-30,2022-04-30,,Emory University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,947
NCT02633059,0,0,0,0,0,0,2021-05-13,2022-05-13,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02633241,1,1,0,1,0,1,2018-01-20,2019-01-20,2019-05-15,Joseph Cravero,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02634580,1,1,0,1,0,0,2017-08-10,2018-08-10,2018-08-01,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,1,0,0,0,0,0,2,0,1,685
NCT02637856,0,0,0,0,0,0,2019-12-30,2020-12-30,,"Genentech, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,427
NCT02639065,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Shadia Jalal, MD",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02639429,1,1,0,1,0,1,2018-06-24,2019-06-24,2019-08-07,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,490
NCT02640950,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sheppard Pratt Health System,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,10
NCT02643420,1,0,0,0,1,0,2017-08-18,2018-08-18,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,67
NCT02645487,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,626
NCT02648282,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT02648477,0,0,0,0,0,0,2019-10-31,2020-10-31,,City of Hope Medical Center,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,358
NCT02649218,0,0,0,0,0,0,2019-05-02,2020-05-02,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,1895
NCT02651116,0,0,0,0,0,0,2020-04-30,2021-04-30,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,2856
NCT02653625,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-08-31,"Tobira Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,12
NCT02654145,1,1,0,1,0,0,2017-05-31,2018-05-31,2017-11-28,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02656017,0,0,0,0,0,0,2020-12-30,2021-12-30,,"Kyongtae Ty Bae, M.D., Ph.D.",Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02656173,1,1,0,1,0,0,2017-07-21,2018-07-21,2018-07-09,Astellas Pharma Inc,Industry,1,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,506
NCT02658175,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Ionis Pharmaceuticals, Inc.",Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,69
NCT02663674,1,1,0,1,0,0,2018-06-21,2019-06-21,2019-06-13,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT02674529,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Pittsburgh,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1054
NCT02675465,0,0,0,0,0,0,2021-09-30,2022-09-30,,Amicus Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,34
NCT02677038,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02677870,1,0,0,0,1,0,2018-06-30,2019-06-30,,University Hospitals Cleveland Medical Center,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,185
NCT02680587,0,0,0,0,0,0,2020-04-30,2021-04-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT02681549,0,0,0,0,0,0,2023-05-31,2024-05-31,,Yale University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02683525,0,0,0,0,0,0,2019-02-13,2020-02-13,,Sherif S. Farag,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02684136,1,0,1,1,0,1,2018-07-01,2019-07-01,2019-08-22,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,151
NCT02684461,0,0,0,0,0,0,2023-02-28,2024-02-28,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT02686697,0,0,0,0,0,0,2020-04-30,2021-04-30,,Avraham Reichenberg,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02688881,0,0,0,0,0,0,2019-12-31,2020-12-31,,Samsung Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,684
NCT02688985,0,0,0,0,0,0,2019-09-20,2020-09-20,,"Genentech, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,427
NCT02691494,0,0,0,0,0,0,2018-02-14,2019-02-14,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02692417,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-02-21,Timothy Bruns,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02694393,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Schmidhofer, Mark, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02698475,0,0,0,0,0,0,2017-12-21,2018-12-21,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,558
NCT02700152,0,0,0,0,0,0,2020-06-30,2021-06-30,,Syneron Medical,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,41
NCT02700841,0,0,0,0,0,0,2018-12-01,2019-12-01,,Emory University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,947
NCT02701400,0,0,0,0,0,0,2020-01-31,2021-01-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,1,0,0,0,0,1,947
NCT02703090,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston Children’s Hospital,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,400
NCT02703623,0,0,0,0,0,0,2020-05-01,2021-05-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02705105,1,0,0,0,1,0,2018-08-22,2019-08-22,,"Kyowa Kirin Pharmaceutical Development, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,23
NCT02706717,1,1,0,1,0,0,2017-06-05,2018-06-05,2018-05-30,AIDS Clinical Trials Group,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,62
NCT02709005,1,1,0,1,0,0,2017-12-11,2018-12-11,2018-12-06,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT02709993,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Kiromic, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT02712788,1,1,0,1,0,0,2017-10-24,2018-10-24,2018-08-24,Indiana University,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,497
NCT02714049,0,0,0,0,0,0,2019-01-18,2020-01-18,,San Diego Sexual Medicine,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT02717507,0,0,0,0,0,0,2022-04-01,2023-04-01,,Children's Oncology Group,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,389
NCT02718326,1,0,1,1,0,0,2018-08-06,2019-08-06,2019-08-06,Regeneron Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,176
NCT02724384,0,0,0,0,0,0,2018-12-31,2019-12-31,,Moe Medical Devices,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02725489,0,0,0,0,0,0,2020-01-31,2021-01-31,,Mary Crowley Medical Research Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,3
NCT02725580,0,0,0,0,0,0,2021-10-31,2022-10-31,,Amicus Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,0,0,0,0,1,0,0,1,34
NCT02731079,0,0,0,0,0,0,2020-03-31,2021-03-31,,William Beaumont Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT02735044,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-29,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02736617,0,0,0,0,0,0,2021-07-31,2022-07-31,,OHSU Knight Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,163
NCT02738606,0,0,0,0,0,0,2020-05-01,2021-05-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02740699,0,0,0,0,0,0,2020-05-04,2021-05-04,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT02745392,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-19,Zosano Pharma Corporation,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02747043,0,0,0,0,0,0,2019-06-28,2020-06-28,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02748564,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,227
NCT02750930,1,1,0,1,0,0,2017-03-21,2018-03-21,2017-12-06,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,1,2016.0,1,1,0,1,0,0,0,0,0,0,1,3276
NCT02754076,0,0,0,0,0,0,2019-03-31,2020-03-31,,BioMarin Pharmaceutical,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,85
NCT02754726,0,0,0,0,0,0,2019-07-31,2020-07-31,,HonorHealth Research Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT02759315,1,1,0,1,0,0,2017-07-27,2018-07-27,2018-07-10,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,3,0,1,2145
NCT02762500,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-01-29,Lycera Corp.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02764541,0,0,0,0,0,0,2019-11-30,2020-11-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02765256,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02765425,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Arkansas,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,285
NCT02766543,0,0,0,0,0,0,2019-02-19,2020-02-19,,Profound Medical Inc.,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,2
NCT02768701,0,0,0,0,0,0,2019-12-31,2020-12-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT02770326,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT02770716,0,0,0,0,0,0,2019-07-24,2020-07-24,,Mallinckrodt,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,91
NCT02772562,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medical University of South Carolina,Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,511
NCT02772718,1,0,0,0,1,0,2017-09-30,2018-09-30,,XOMA (US) LLC,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT02776891,0,0,0,0,0,0,2018-12-31,2019-12-31,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,1443
NCT02777931,1,1,0,1,0,0,2017-02-10,2018-02-10,2018-01-25,Aevi Genomic Medicine,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02781480,0,0,0,0,0,0,2018-12-31,2019-12-31,,MeiraGTx UK II Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,10
NCT02781701,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,586
NCT02782546,0,0,0,0,0,0,2020-11-30,2021-11-30,,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1151
NCT02783573,0,1,0,1,0,0,2018-09-28,2019-09-28,2019-06-11,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02788474,0,1,0,1,0,1,2017-08-04,2018-08-04,2019-05-29,Boehringer Ingelheim,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1852
NCT02792699,0,0,0,0,0,0,2018-10-08,2019-10-08,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02793154,1,1,0,1,0,0,2017-03-16,2018-03-16,2018-03-13,GlaxoSmithKline,Industry,1,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,3276
NCT02798627,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Pennsylvania,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02804230,0,0,0,0,0,0,2022-06-30,2023-06-30,,InSightec,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,61
NCT02804763,0,0,0,0,0,0,2018-05-31,2019-05-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,75
NCT02806024,1,0,0,0,1,0,2018-07-31,2019-07-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02807428,0,0,0,0,0,0,2017-10-23,2018-10-23,,"Adynxx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT02807883,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02808585,0,0,0,0,0,0,2017-12-06,2018-12-06,,PhaseBio Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,14
NCT02808871,0,0,0,0,0,0,2021-11-30,2022-11-30,,Ivan O. Rosas,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT02819310,0,0,0,0,0,0,2017-08-31,2018-08-31,,Braintree Laboratories,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,43
NCT02826577,0,0,0,0,0,0,2019-06-01,2020-06-01,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,594
NCT02827708,0,0,0,0,0,0,2018-04-10,2019-04-10,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02829268,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT02831673,1,1,0,1,0,0,2018-03-29,2019-03-29,2019-03-26,ViiV Healthcare,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,200
NCT02837731,0,0,0,0,0,0,2019-03-31,2020-03-31,,Cheetah Medical Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,2
NCT02839200,0,0,0,0,0,0,2017-04-12,2018-04-12,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,79
NCT02841748,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT02841995,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Kadmon Corporation, LLC",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,29
NCT02843074,0,0,0,0,0,0,2021-07-31,2022-07-31,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,167
NCT02843633,0,0,0,0,0,0,2018-10-11,2019-10-11,,Biosensors Europe SA,Industry,1,0,0,5.0,,0,2017.0,0,1,0,1,0,0,0,0,1,1,0,17
NCT02847637,1,1,0,1,0,0,2017-09-15,2018-09-15,2018-09-14,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02849951,0,0,0,0,0,0,2019-03-31,2020-03-31,,Prometheus Laboratories,Industry,1,1,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02851303,1,0,0,0,1,0,2017-10-31,2018-10-31,,University of New Mexico,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,200
NCT02851888,1,0,0,0,1,0,2018-04-30,2019-04-30,,Georgetown University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,214
NCT02855164,0,0,0,0,0,0,2019-07-31,2020-07-31,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02855944,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Clovis Oncology, Inc.",Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02857426,0,0,0,0,0,0,2019-06-11,2020-06-11,,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02858037,0,0,0,0,0,0,2018-10-10,2019-10-10,,"International Partnership for Microbicides, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,0,0,0,0,1,0,2,0,1,43
NCT02858726,0,0,0,0,0,0,2017-03-14,2018-03-14,,"Cara Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT02859064,0,0,0,0,0,0,2020-04-30,2021-04-30,,"SCRI Development Innovations, LLC",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,167
NCT02859896,0,0,0,0,0,0,2022-04-05,2023-04-05,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT02863783,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Southern California,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,483
NCT02868229,0,0,0,0,0,0,2018-12-31,2019-12-31,,Corvidia Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02873221,1,1,0,1,0,0,2018-08-02,2019-08-02,2019-08-02,Allergan,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02875561,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,882
NCT02876302,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT02880371,0,0,0,0,0,0,2020-04-30,2021-04-30,,Array BioPharma,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,65
NCT02881320,0,0,0,0,0,0,2019-10-31,2020-10-31,,Gilead Sciences,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02888171,0,0,0,0,0,0,2019-02-12,2020-02-12,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT02890979,0,0,0,0,0,0,2018-12-31,2019-12-31,,OHSU Knight Cancer Institute,Other,0,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,163
NCT02891239,1,0,0,0,1,0,2017-09-30,2018-09-30,,Syneron Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT02896335,0,0,0,0,0,0,2020-08-31,2021-08-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02896751,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,437
NCT02898259,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Brian Hill, MD, PhD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02899299,0,0,0,0,0,0,2021-04-15,2022-04-15,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02900560,0,0,0,0,0,0,2019-06-30,2020-06-30,,Translational Research in Oncology,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,7
NCT02904096,0,0,0,0,0,0,2019-01-09,2020-01-09,,"Merz North America, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,35
NCT02904512,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of Maryland, College Park",Other,0,1,0,2.0,Phase 2/Phase 3,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,318
NCT02906332,0,0,0,0,0,0,2019-12-31,2020-12-31,,Hackensack Meridian Health,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT02908880,0,1,0,1,0,1,2017-10-31,2018-10-31,2019-04-12,"Essential Medical, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,4
NCT02910063,0,0,0,0,0,0,2020-03-12,2021-03-12,,Amgen,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT02913664,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of Texas Southwestern Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02914600,0,0,0,0,0,0,2024-08-31,2025-08-31,,Gilead Sciences,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT02916771,0,0,0,0,0,0,2020-04-30,2021-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02918071,1,1,0,1,0,0,2017-08-21,2018-08-21,2018-08-01,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,1,0,1,2450
NCT02920008,0,0,0,0,0,0,2019-12-31,2020-12-31,,Astex Pharmaceuticals,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,38
NCT02920996,0,0,0,0,0,0,2020-10-31,2021-10-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02921256,0,0,0,0,0,0,2019-04-30,2020-04-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,3004
NCT02927223,0,0,0,0,0,0,2019-02-28,2020-02-28,,Vanderbilt University,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,499
NCT02927301,0,0,0,0,0,0,2020-02-07,2021-02-07,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,427
NCT02927431,1,1,0,1,0,0,2017-05-24,2018-05-24,2018-04-20,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT02932150,0,0,0,0,0,0,2023-02-28,2024-02-28,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02932618,0,0,0,0,0,0,2020-11-24,2021-11-24,,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,107
NCT02933671,0,0,0,0,0,0,2020-01-01,2021-01-01,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT02934789,1,0,1,1,0,1,2018-04-30,2019-04-30,2019-07-24,"All For Women Healthcare, Illinois",Other,0,1,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02936479,0,1,0,1,0,0,2018-10-30,2019-10-30,2018-12-24,NYU Langone Health,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT02937571,0,0,0,0,0,0,2019-10-31,2020-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02938013,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT02938377,0,0,0,0,0,0,2021-08-31,2022-08-31,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT02938975,0,0,0,0,0,0,2019-01-31,2020-01-31,,Ifakara Health Institute,Other,0,0,1,3.0,Phase 3,0,2017.0,1,0,0,0,0,0,0,0,2,1,0,4
NCT02941705,0,0,0,0,0,0,2019-12-31,2020-12-31,,Cedars-Sinai Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,279
NCT02942407,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Christopher Granger, MD",Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02943915,0,0,0,0,0,0,2019-09-10,2020-09-10,,Ekso Bionics,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02945631,0,0,0,0,0,0,2023-04-30,2024-04-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,412
NCT02947022,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-02-05,"University of North Carolina, Chapel Hill",Other,0,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02951182,0,0,0,0,0,0,2017-08-31,2018-08-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,141
NCT02951884,1,1,0,1,0,0,2018-05-03,2019-05-03,2018-07-19,Loyola University,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,102
NCT02952209,0,0,0,0,0,0,2020-07-31,2021-07-31,,NYU College of Dentistry,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02952508,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Cellectar Biosciences, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT02952820,0,0,0,0,0,0,2019-01-08,2020-01-08,,Eisai Inc.,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,328
NCT02953665,0,0,0,0,0,0,2020-09-30,2021-09-30,,Cedars-Sinai Medical Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT02955381,0,0,0,0,0,0,2019-04-18,2020-04-18,,"Schweiger Dermatology, PLLC",Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT02955758,0,0,0,0,0,0,2020-10-31,2021-10-31,,Joel Neal,Other,0,1,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,3
NCT02956291,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT02956629,1,1,0,1,0,0,2017-12-22,2018-12-22,2018-12-03,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,3,0,1,2145
NCT02959190,0,0,0,0,0,0,2019-08-10,2020-08-10,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1512
NCT02959437,0,0,0,0,0,0,2019-02-15,2020-02-15,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT02959983,1,1,0,1,0,0,2018-01-22,2019-01-22,2019-01-22,Allergan,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02963506,0,0,0,0,0,0,2017-10-31,2018-10-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,75
NCT02964078,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT02969707,0,0,0,0,0,0,2021-03-31,2022-03-31,,Stanford University,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT02970929,0,0,0,0,0,0,2019-01-29,2020-01-29,,Sunovion,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,134
NCT02972424,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Hospital for Special Surgery, New York",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,157
NCT02975557,1,0,0,0,1,0,2017-03-28,2018-03-28,,University of Illinois at Chicago,Other,0,0,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,242
NCT02976129,0,0,0,0,0,0,2018-12-31,2019-12-31,,VHsquared Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,3
NCT02977286,0,0,0,0,0,0,2019-12-31,2020-12-31,,Tufts Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,121
NCT02978339,0,0,0,0,0,0,2018-11-16,2019-11-16,,John E. Eaton,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02978508,1,0,0,0,1,0,2017-05-31,2018-05-31,,"bioRASI, LLC",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02978625,0,0,0,0,0,0,2020-01-01,2021-01-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT02979093,0,0,0,0,0,0,2020-01-31,2021-01-31,,Lane Strathearn,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02979249,0,0,0,0,0,0,2019-07-19,2020-07-19,,Icahn School of Medicine at Mount Sinai,Other,0,0,1,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT02980705,0,0,0,0,0,0,2019-02-21,2020-02-21,,Sun Pharma Global FZE,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,17
NCT02980926,1,0,0,0,1,0,2017-03-31,2018-03-31,,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,151
NCT02981602,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,69
NCT02986178,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Istari Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT02987387,0,0,0,0,0,0,2020-01-31,2021-01-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,77
NCT02987972,0,0,0,0,0,0,2018-10-04,2019-10-04,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,2145
NCT02988401,0,0,0,0,0,0,2020-06-30,2021-06-30,,Johns Hopkins University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT02988622,1,1,0,1,0,0,2018-01-15,2019-01-15,2017-08-29,Marta Hemmingson-Van Beek,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02990546,1,0,0,0,1,0,2018-05-02,2019-05-02,,University of Virginia,Other,0,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,402
NCT02994654,1,0,0,0,1,0,2017-12-31,2018-12-31,,Avita Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,9
NCT02997761,0,0,0,0,0,0,2020-08-31,2021-08-31,,Brian Jonas,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3
NCT02997904,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-06-28,"Piedmont Pharmaceuticals, LLC",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02999763,1,1,0,1,0,0,2018-05-03,2019-05-03,2019-03-14,Syneron Medical,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,0,1,41
NCT03002077,0,0,0,0,0,0,2018-12-06,2019-12-06,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03007589,0,0,0,0,0,0,2030-01-31,2031-01-31,,Sun Protection Foundation,Industry,1,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT03009045,0,0,0,0,0,0,2020-07-31,2021-07-31,,Los Angeles Biomedical Research Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,60
NCT03012672,0,0,0,0,0,0,2020-07-15,2021-07-15,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,393
NCT03014700,1,1,0,1,0,0,2018-04-25,2019-04-25,2019-04-14,Stanford University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,1309
NCT03018704,0,0,0,0,0,0,2022-01-31,2023-01-31,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03019029,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,0,0,0,0,1,0,1898
NCT03021928,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Texas at Austin,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,0,0,0,0,0,0,1,0,135
NCT03022578,0,0,0,0,0,0,2021-11-01,2022-11-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03023085,0,0,0,0,0,0,2017-08-31,2018-08-31,,Braintree Laboratories,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,43
NCT03028025,1,1,0,1,0,0,2017-08-01,2018-08-01,2017-11-17,VA Long Beach Healthcare System,U.S. Fed,2,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT03028675,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,869
NCT03029104,0,0,0,0,0,0,2019-12-31,2020-12-31,,Cxlusa,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,0,0,0,0,1,0,0,0,1,7
NCT03029234,0,0,0,0,0,0,2018-11-05,2019-11-05,,Amgen,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,685
NCT03029429,0,0,0,0,0,0,2021-07-01,2022-07-01,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03029832,1,1,0,1,0,0,2018-04-25,2019-04-25,2019-04-24,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,427
NCT03031197,1,0,0,0,1,0,2018-05-25,2019-05-25,,University of New England,Other,0,0,0,5.0,,0,2017.0,1,0,0,0,0,0,1,0,2,1,0,8
NCT03032432,0,0,0,0,0,0,2020-01-05,2021-01-05,,Loma Linda University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,194
NCT03034772,0,0,0,0,0,0,2018-11-28,2019-11-28,,Wills Eye,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,69
NCT03034967,0,0,0,0,0,0,2018-10-05,2019-10-05,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03036891,0,0,0,0,0,0,2020-01-30,2021-01-30,,Temple University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,152
NCT03042312,0,0,0,0,0,0,2019-02-28,2020-02-28,,Endocyte,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,28
NCT03042702,1,1,0,1,0,0,2017-11-10,2018-11-10,2018-11-06,"Innovation Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03043794,0,0,0,0,0,0,2022-08-01,2023-08-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,461
NCT03046056,0,0,0,0,0,0,2020-06-30,2021-06-30,,Gilead Sciences,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03047473,0,0,0,0,0,0,2019-09-30,2020-09-30,,Clinique Neuro-Outaouais,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,2,1,0,6
NCT03049267,1,0,0,0,1,0,2017-12-06,2018-12-06,,M.B.A. van Doorn,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,2
NCT03051165,1,1,0,1,0,0,2017-12-14,2018-12-14,2018-11-15,Emory University,Other,0,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,947
NCT03052270,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Illinois at Chicago,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,242
NCT03052647,1,0,0,0,1,0,2017-11-30,2018-11-30,,Rubino Ob-Gyn Group,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT03052764,0,0,0,0,0,0,2018-12-10,2019-12-10,,Allergan,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,1,0,0,0,0,0,0,0,1,495
NCT03053063,0,0,0,0,0,0,2019-04-30,2020-04-30,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,510
NCT03055338,1,1,0,1,0,0,2018-01-09,2019-01-09,2018-12-06,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2145
NCT03057015,0,0,0,0,0,0,2019-02-28,2020-02-28,,University of Vermont,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,155
NCT03057730,0,0,0,0,0,0,2021-06-30,2022-06-30,,Tufts University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,152
NCT03058809,0,0,0,0,0,0,2019-04-30,2020-04-30,,Viatar LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,2
NCT03059446,0,0,0,0,0,0,2029-11-27,2030-11-27,,"Tobira Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03060512,1,1,0,1,0,0,2017-08-23,2018-08-23,2018-06-06,AstraZeneca,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2450
NCT03063203,0,0,0,0,0,0,2023-07-31,2024-07-31,,Washington University School of Medicine,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03065972,0,0,0,0,0,0,2021-02-28,2022-02-28,,"E. Peden, MD",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT03066180,0,0,0,0,0,0,2018-11-30,2019-11-30,,Dr. Bruce B. Allan,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03066544,0,0,0,0,0,0,2019-12-31,2020-12-31,,Hartford HealthCare,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT03067987,0,0,0,0,0,0,2019-05-22,2020-05-22,,University of Miami,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,476
NCT03068468,0,0,0,0,0,0,2019-09-30,2020-09-30,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03069482,0,0,0,0,0,0,2019-01-17,2020-01-17,,Duke University,Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,1342
NCT03070951,0,0,0,0,0,0,2019-09-30,2020-09-30,,ObsEva SA,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03071965,0,0,0,0,0,0,2021-04-15,2022-04-15,,Neurotech Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,10
NCT03072160,0,0,0,0,0,0,2019-12-01,2020-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03073785,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Chi Lin, MD",Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,2
NCT03074331,1,1,0,1,0,1,2018-02-07,2019-02-07,2019-02-25,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,510
NCT03075072,0,0,0,0,0,0,2021-03-30,2022-03-30,,Dana-Farber Cancer Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,647
NCT03075553,0,0,0,0,0,0,2021-09-30,2022-09-30,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03077165,0,0,0,0,0,0,2020-01-31,2021-01-31,,Ilkos Therapeutic Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03078504,0,0,0,0,0,0,2019-12-31,2020-12-31,,St. Louis University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,126
NCT03078868,0,0,0,0,0,0,2019-05-02,2020-05-02,,University of Chicago,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,594
NCT03083483,1,1,0,1,0,0,2017-12-21,2018-12-21,2018-10-17,Duke University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT03085784,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Amy C Schefler, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03087448,0,0,0,0,0,0,2020-03-31,2021-03-31,,"University of California, San Francisco",Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03088930,0,0,0,0,0,0,2021-08-31,2022-08-31,,"University of Colorado, Denver",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03090633,0,0,0,0,0,0,2024-04-30,2025-04-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03091660,0,0,0,0,0,0,2022-02-15,2023-02-15,,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,288
NCT03093402,0,0,0,0,0,0,2020-02-29,2021-02-28,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03094169,0,0,0,0,0,0,2020-09-01,2021-09-01,,Formation Biologics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03094611,0,0,0,0,0,0,2023-11-30,2024-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03097029,0,0,0,0,0,0,2019-02-01,2020-02-01,,Children's Hospital of Philadelphia,Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,324
NCT03097289,1,1,0,1,0,0,2017-11-24,2018-11-24,2018-10-30,Terumo BCT,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,12
NCT03097614,1,1,0,1,0,0,2017-06-26,2018-06-26,2018-06-25,"Oculeve, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03098420,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Alabama at Birmingham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT03099655,0,0,0,0,0,0,2019-05-31,2020-05-31,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,169
NCT03101644,0,0,0,0,0,0,2019-06-12,2020-06-12,,Université Catholique de Louvain,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,41
NCT03101917,0,0,0,0,0,0,2021-12-31,2022-12-31,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,422
NCT03107325,0,0,0,0,0,0,2020-03-31,2021-03-31,,Boston Children’s Hospital,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03107611,0,0,0,0,0,0,2017-05-15,2018-05-15,,Mylan Inc.,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,30
NCT03108456,0,0,0,0,0,0,2020-12-31,2021-12-31,,Cardiovascular Systems Inc,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,10
NCT03109847,0,0,0,0,0,0,2021-06-08,2022-06-08,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,162
NCT03110029,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-08-14,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT03110562,0,0,0,0,0,0,2020-06-30,2021-06-30,,Karyopharm Therapeutics Inc,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,22
NCT03112642,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Rutgers, The State University of New Jersey",Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,227
NCT03112824,0,0,0,0,0,0,2020-03-31,2021-03-31,,Loma Linda University,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,194
NCT03113383,0,0,0,0,0,0,2024-01-31,2025-01-31,,Vanderbilt University Medical Center,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,422
NCT03114657,0,0,0,0,0,0,2019-05-31,2020-05-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1731
NCT03116685,0,0,0,0,0,0,2020-11-30,2021-11-30,,OxThera,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,6
NCT03117569,0,0,1,1,0,0,2018-12-19,2019-12-19,2019-07-17,Kirby Institute,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,67
NCT03120247,0,0,0,0,0,0,2019-06-01,2020-06-01,,Assiut University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1331
NCT03120676,0,0,0,0,0,0,2018-11-12,2019-11-12,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1432
NCT03120949,0,0,0,0,0,0,2021-07-31,2022-07-31,,R-Pharm,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,44
NCT03125642,0,0,0,0,0,0,2023-04-30,2024-04-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,218
NCT03125902,0,0,0,0,0,0,2020-01-30,2021-01-30,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03127228,0,0,0,0,0,0,2018-11-02,2019-11-02,,University of Michigan,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,934
NCT03131219,0,0,0,0,0,0,2020-11-30,2021-11-30,,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,86
NCT03131453,0,0,0,0,0,0,2024-07-30,2025-07-30,,Novartis Pharmaceuticals,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03133312,1,0,0,0,1,0,2017-12-30,2018-12-30,,"Metro Health, Michigan",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03134183,1,1,0,1,0,0,2017-08-01,2018-08-01,2018-06-25,Virginia Commonwealth University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT03136484,0,0,0,0,0,0,2018-10-16,2019-10-16,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,981
NCT03137381,0,0,0,0,0,0,2019-07-08,2020-07-08,,Concert Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,20
NCT03137784,1,1,0,1,0,0,2017-12-29,2018-12-29,2018-12-07,Novartis Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03138798,1,1,0,1,0,1,2017-11-07,2018-11-07,2018-11-16,Angela Bianco,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT03141359,0,0,0,0,0,0,2022-05-31,2023-05-31,,Atrium Health,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,95
NCT03143101,1,1,0,1,0,0,2017-09-29,2018-09-29,2018-09-26,MedImmune LLC,Industry,1,1,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,269
NCT03148899,0,0,0,0,0,0,2019-08-31,2020-08-31,,George Washington University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,85
NCT03149029,0,0,0,0,0,0,2020-12-31,2021-12-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03149549,0,0,0,0,0,0,2019-12-31,2020-12-31,,CytomX Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03150667,0,0,0,0,0,0,2019-04-30,2020-04-30,,North Texas Veterans Healthcare System,U.S. Fed,2,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT03150797,0,0,0,0,0,0,2021-06-30,2022-06-30,,Amy Gelfand,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03151746,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03152786,0,0,0,0,0,0,2020-02-29,2021-02-28,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03153137,0,0,0,0,0,0,2020-03-28,2021-03-28,,Actelion,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,128
NCT03154658,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,626
NCT03155178,0,0,1,1,0,1,2017-04-25,2018-04-25,2019-03-13,3M,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,56
NCT03156465,0,0,0,0,0,0,2021-09-30,2022-09-30,,Bruce J Gantz,Other,0,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT03157089,0,0,0,0,0,0,2020-04-27,2021-04-27,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03158116,0,0,0,0,0,0,2018-12-31,2019-12-31,,UCSF Benioff Children’s Hospital Oakland,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,53
NCT03158688,0,0,0,0,0,0,2019-07-14,2020-07-14,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03160521,0,0,0,0,0,0,2018-12-17,2019-12-17,,Rovi Pharmaceuticals Laboratories,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,13
NCT03160911,0,0,0,0,0,0,2019-10-01,2020-10-01,,Chinese University of Hong Kong,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,557
NCT03161756,0,0,0,0,0,0,2021-06-30,2022-06-30,,Melanoma and Skin Cancer Trials Limited,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,10
NCT03161964,0,0,0,0,0,0,2020-07-31,2021-07-31,,Anu Sharma,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03165747,0,0,0,0,0,0,2019-03-23,2020-03-23,,Emory University,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,947
NCT03165916,0,0,0,0,0,0,2019-09-30,2020-09-30,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,422
NCT03168659,0,0,0,0,0,0,2021-10-31,2022-10-31,,CardioFocus,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03168958,0,0,0,0,0,0,2020-05-25,2021-05-25,,NorthShore University HealthSystem,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,61
NCT03172026,0,0,0,0,0,0,2019-07-31,2020-07-31,,"University of California, Los Angeles",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03172520,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-05-30,Mayo Clinic,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1898
NCT03172754,0,0,0,0,0,0,2023-04-06,2024-04-06,,Fox Chase Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03173950,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03175627,0,0,0,0,0,0,2020-03-31,2021-03-31,,Louisiana State University Health Sciences Center in New Orleans,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,42
NCT03175744,0,0,0,0,0,0,2020-12-31,2021-12-31,,Spectranetics Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,18
NCT03177239,0,0,0,0,0,0,2021-12-31,2022-12-31,,Australian and New Zealand Urogenital and Prostate Cancer Trials Group,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03178825,0,0,0,0,0,0,2019-08-30,2020-08-30,,Sciton,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03179995,0,0,0,0,0,0,2020-06-18,2021-06-18,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03180255,1,0,0,0,1,0,2017-11-07,2018-11-07,,"Eyegate Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,0,0,0,0,1,0,0,1,0,13
NCT03180385,1,0,1,1,0,1,2018-04-10,2019-04-10,2019-08-19,Children's Hospitals and Clinics of Minnesota,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,44
NCT03180502,0,0,0,0,0,0,2025-01-31,2026-01-31,,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,27
NCT03182751,0,0,0,0,0,0,2019-10-01,2020-10-01,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03183245,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Humacyte, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,8
NCT03183895,0,0,0,0,0,0,2022-05-31,2023-05-31,,"Ancora Heart, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,8
NCT03188666,0,0,0,0,0,0,2019-09-16,2020-09-16,,Regeneron Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03189719,0,0,0,0,0,0,2021-08-22,2022-08-22,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03192176,0,0,0,0,0,0,2018-09-19,2019-09-19,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,135
NCT03193593,1,1,0,1,0,0,2018-04-26,2019-04-26,2018-10-17,"Bonti, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03194503,0,0,0,0,0,0,2019-07-31,2020-07-31,,Children's Hospital of Philadelphia,Other,0,0,1,5.0,,0,2018.0,1,0,0,1,0,0,0,0,1,1,0,324
NCT03194685,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Fujifilm Pharmaceuticals U.S.A., Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03195010,0,0,0,0,0,0,2018-12-21,2019-12-21,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,393
NCT03196284,0,0,0,0,0,0,2018-09-19,2019-09-19,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03197064,0,0,0,0,0,0,2020-01-31,2021-01-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03198689,0,0,0,0,0,0,2021-03-01,2022-03-01,,Lawson Health Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,468
NCT03199560,0,0,0,0,0,0,2019-06-22,2020-06-22,,Memorial Health University Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03199885,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03202550,0,0,0,0,0,0,2019-06-01,2020-06-01,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1143
NCT03210376,0,0,1,1,0,0,2019-11-30,2020-11-30,2019-05-09,M.D. Anderson Cancer Center,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03211117,1,1,0,1,0,1,2018-02-12,2019-02-12,2019-07-08,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,1898
NCT03217071,0,0,0,0,0,0,2020-09-01,2021-09-01,,Sue Yom,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,2
NCT03219762,0,0,0,0,0,0,2019-01-31,2020-01-31,,Gruppo Oncologico Italiano di Ricerca Clinica,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,13
NCT03220854,0,0,0,0,0,0,2023-04-30,2024-04-30,,Virginia Commonwealth University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,417
NCT03223194,0,0,0,0,0,0,2019-12-31,2020-12-31,,Audentes Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,0,0,1,1,1,0,5
NCT03224585,0,0,0,0,0,0,2019-11-05,2020-11-05,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03224767,0,0,0,0,0,0,2021-12-31,2022-12-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,456
NCT03225664,0,0,0,0,0,0,2020-09-30,2021-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03226249,0,0,0,0,0,0,2020-08-01,2021-08-01,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,925
NCT03226444,0,0,0,0,0,0,2019-09-30,2020-09-30,,"TearSolutions, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03226769,0,0,0,0,0,0,2017-10-29,2018-10-29,,Allergan,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,495
NCT03232580,0,0,0,0,0,0,2018-11-12,2019-11-12,,Advanced Accelerator Applications,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,14
NCT03232749,0,0,0,0,0,0,2019-06-06,2020-06-06,,University of Florida,Other,0,0,0,4.0,Phase 4,1,2018.0,1,1,0,1,0,0,0,0,0,1,0,849
NCT03233646,0,0,0,0,0,0,2021-04-01,2022-04-01,,Duke University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03234556,0,0,0,0,0,0,2020-09-25,2021-09-25,,University of Southern California,Other,0,0,1,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,483
NCT03235180,0,0,0,0,0,0,2022-08-31,2023-08-31,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,1898
NCT03235414,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,1,0,0,0,0,1,0,437
NCT03235739,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Cleveland Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03236389,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,437
NCT03237377,0,0,0,0,0,0,2019-09-01,2020-09-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,461
NCT03238300,0,0,0,0,0,0,2021-09-30,2022-09-30,,Medical University of South Carolina,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03240809,0,0,0,0,0,0,2019-04-15,2020-04-15,,"Bausch Health Americas, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,1,0,1,0,0,0,0,0,3,1,0,180
NCT03241368,0,0,0,0,0,0,2019-11-30,2020-11-30,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,146
NCT03242590,1,1,0,1,0,1,2017-03-31,2018-03-31,2019-08-16,Lipocine Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,4
NCT03244982,0,0,0,0,0,0,2019-07-17,2020-07-17,,Kresge Eye Institute,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03245151,0,0,0,0,0,0,2022-05-31,2023-05-31,,Eisai Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,328
NCT03245840,0,0,0,0,0,0,2021-04-30,2022-04-30,,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,342
NCT03246425,1,0,0,0,1,0,2017-09-11,2018-09-11,,State University of New York - Upstate Medical University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,125
NCT03246529,0,0,0,0,0,0,2019-04-22,2020-04-22,,"BioLineRx, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03247556,0,0,0,0,0,0,2019-02-14,2020-02-14,,"Supernus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,26
NCT03249376,0,0,0,0,0,0,2019-03-05,2020-03-05,,"Intra-Cellular Therapies, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,12
NCT03250975,0,0,0,0,0,0,2020-12-30,2021-12-30,,Vanderbilt University Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03251937,0,0,0,0,0,0,2019-01-09,2020-01-09,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT03252600,0,0,0,0,0,0,2020-09-30,2021-09-30,,Barbara Ann Karmanos Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,134
NCT03255018,0,0,0,0,0,0,2020-07-01,2021-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03255785,0,0,0,0,0,0,2020-06-30,2021-06-30,,Glaukos Corporation,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,34
NCT03256578,0,0,0,0,0,0,2019-05-17,2020-05-17,,University of Pennsylvania,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03257956,1,0,0,0,1,0,2017-09-20,2018-09-20,,Darma Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03258723,0,0,0,0,0,0,2021-06-30,2022-06-30,,Yale University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1053
NCT03258931,0,0,0,0,0,0,2022-11-30,2023-11-30,,"Arog Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03260205,0,0,0,0,0,0,2018-10-17,2019-10-17,,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,342
NCT03261986,0,0,0,0,0,0,2020-10-09,2021-10-09,,Central DuPage Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,6
NCT03262233,1,1,0,1,0,1,2018-02-20,2019-02-20,2019-03-01,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2015.0,1,0,0,0,0,0,1,0,0,0,1,715
NCT03263702,0,0,0,0,0,0,2019-06-07,2020-06-07,,Vivek Reddy,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03265249,0,0,0,0,0,0,2028-10-01,2029-10-01,,Duke University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03266835,0,0,0,0,0,0,2019-01-18,2020-01-18,,"SoundBite Medical Solutions, Inc.",Industry,1,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,4
NCT03267810,0,0,0,0,0,0,2021-10-01,2022-10-01,,University of Miami,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,476
NCT03268941,1,1,0,1,0,1,2018-03-09,2019-03-09,2019-05-16,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,209
NCT03272763,0,0,0,0,0,0,2017-10-29,2018-10-29,,Fisher and Paykel Healthcare,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,56
NCT03274024,0,0,0,0,0,0,2020-10-30,2021-10-30,,Singapore Eye Research Institute,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,11
NCT03276026,0,1,0,1,0,0,2018-11-08,2019-11-08,2019-04-17,"Virtua Health, Inc.",Other,0,1,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03277222,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Calgary,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,361
NCT03278223,1,0,1,1,0,1,2017-11-17,2018-11-17,2019-08-30,OTE North America,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,1
NCT03280563,0,0,0,0,0,0,2021-02-19,2022-02-19,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03281811,0,0,0,0,0,0,2019-08-28,2020-08-28,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1898
NCT03283072,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Florida,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03283202,0,0,0,0,0,0,2019-07-30,2020-07-30,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,306
NCT03283709,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Kentucky,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,77
NCT03284385,0,0,0,0,0,0,2021-08-30,2022-08-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03284853,0,0,0,0,0,0,2019-11-30,2020-11-30,,Aerie Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,28
NCT03290768,1,1,0,1,0,0,2018-06-01,2019-06-01,2019-05-23,"Savvysherpa, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03291470,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Kolon TissueGene, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,3,1,0,4
NCT03292562,0,0,0,0,0,0,2019-03-01,2020-03-01,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03292809,0,0,0,0,0,0,2018-05-22,2019-05-22,,Novaliq GmbH,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03292926,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,157
NCT03295981,0,0,0,0,0,0,2021-01-31,2022-01-31,,St. Louis University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,126
NCT03297398,0,0,0,0,0,0,2019-04-18,2020-04-18,,Transition Therapeutics Ireland Limited,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03298477,0,0,0,0,0,0,2020-05-31,2021-05-31,,Endologix,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03298945,0,0,0,0,0,0,2020-12-21,2021-12-21,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03299842,0,0,0,0,0,0,2020-01-01,2021-01-01,,"Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03304925,0,0,0,0,0,0,2020-08-31,2021-08-31,,Zeltiq Aesthetics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,32
NCT03305445,0,0,0,0,0,0,2019-11-27,2020-11-27,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03307447,0,0,0,0,0,0,2020-10-31,2021-10-31,,Narrows Institute for Biomedical Research,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03307980,0,0,0,0,0,0,2026-06-08,2027-06-08,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2856
NCT03309514,0,0,0,0,0,0,2020-12-31,2021-12-31,,NeuroGeneration,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,2
NCT03309943,0,0,0,0,0,0,2019-07-15,2020-07-15,,Duke University,Other,0,0,1,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03311451,1,0,0,0,1,0,2018-08-31,2019-08-31,,"C2 Therapeutics, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,9
NCT03312517,0,0,0,0,0,0,2018-10-25,2019-10-25,,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,151
NCT03312699,0,0,0,0,0,0,2022-12-31,2023-12-31,,Stanford University,Other,0,0,1,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1309
NCT03313037,0,0,0,0,0,0,2018-12-10,2019-12-10,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,2856
NCT03313804,0,0,0,0,0,0,2020-09-30,2021-09-30,,"John L. Villano, MD, PhD",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,2
NCT03314454,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,849
NCT03315078,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,2133
NCT03316222,0,0,0,0,0,0,2020-01-15,2021-01-15,,Genoscience Pharma,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03316573,0,0,0,0,0,0,2021-05-31,2022-05-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03318341,0,1,0,1,0,0,2018-10-22,2019-10-22,2019-01-04,"TheraBracelet, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03319732,0,0,0,0,0,0,2020-02-29,2021-02-28,,Osmotica Pharmaceutical US LLC,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03320070,0,0,0,0,0,0,2019-11-30,2020-11-30,,Mallinckrodt,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,91
NCT03322072,0,0,0,0,0,0,2021-12-31,2022-12-31,,CancerCare Manitoba,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,10
NCT03323021,0,0,0,0,0,0,2019-02-21,2020-02-21,,"MiMedx Group, Inc.",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,32
NCT03323307,0,0,0,0,0,0,2018-12-13,2019-12-13,,Duke University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT03324581,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,185
NCT03326843,0,0,0,0,0,0,2019-02-25,2020-02-25,,Dova Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03327649,0,0,0,0,0,0,2019-12-01,2020-12-01,,University of Oklahoma,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,234
NCT03329092,0,0,0,0,0,0,2021-09-08,2022-09-08,,Pfizer,Industry,1,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03331289,0,0,0,0,0,0,2021-12-31,2022-12-31,,Ralph DeFronzo,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03334253,0,0,0,0,0,0,2022-08-31,2023-08-31,,Jaeb Center for Health Research,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,93
NCT03335072,0,0,0,0,0,0,2022-07-01,2023-07-01,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1443
NCT03337477,0,0,0,0,0,0,2018-12-21,2019-12-21,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,2450
NCT03338036,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Western University, Canada",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,104
NCT03338764,0,0,0,0,0,0,2020-06-30,2021-06-30,,Sequential Medicine Ltd,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03338920,0,0,0,0,0,0,2019-11-30,2020-11-30,,Avanir Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03339557,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Coxa, Hospital for Joint Replacement",Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,2,0,1,6
NCT03340025,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03341936,0,0,0,0,0,0,2021-06-30,2022-06-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03344211,0,0,0,0,0,0,2022-11-21,2023-11-21,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,483
NCT03345134,0,0,0,0,0,0,2021-01-01,2022-01-01,,Shaheen Alanee,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03345407,0,0,0,0,0,0,2019-01-10,2020-01-10,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03347721,1,0,0,0,1,0,2018-06-30,2019-06-30,,Louisiana State University Health Sciences Center in New Orleans,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,42
NCT03348631,0,0,0,0,0,0,2025-01-31,2026-01-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03351114,0,0,0,0,0,0,2019-12-31,2020-12-31,,Duke University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03351231,1,0,1,1,0,0,2018-08-28,2019-08-28,2019-08-22,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,1,0,0,0,0,0,0,1,0,1104
NCT03351348,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03353740,0,0,0,0,0,0,2020-09-01,2021-09-01,,Thomas Hope,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03355365,0,0,0,0,0,0,2020-11-30,2021-11-30,,Tisch Multiple Sclerosis Research Center of New York,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03358147,0,0,0,0,0,0,2019-09-06,2020-09-06,,"Pearl Therapeutics, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,42
NCT03359902,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Florida,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03360643,0,0,0,0,0,0,2019-12-31,2020-12-31,,Children's Hospitals and Clinics of Minnesota,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,44
NCT03360903,1,0,0,0,1,0,2018-05-01,2019-05-01,,University of Chicago,Other,0,0,1,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,594
NCT03361293,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,749
NCT03363841,0,0,0,0,0,0,2020-11-15,2021-11-15,,"Scynexis, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03364660,0,0,0,0,0,0,2022-11-30,2023-11-30,,University of Louisville,Other,0,0,0,5.0,,0,2017.0,0,0,1,1,0,0,0,0,0,1,0,214
NCT03366142,0,0,0,0,0,0,2020-10-31,2021-10-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2133
NCT03367403,0,0,0,0,0,0,2020-12-11,2021-12-11,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03369067,1,0,0,0,1,0,2018-04-15,2019-04-15,,University of Virginia,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,402
NCT03369236,0,0,0,0,0,0,2019-10-31,2020-10-31,,Achillion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,21
NCT03372733,0,0,0,0,0,0,2020-07-31,2021-07-31,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1091
NCT03373760,0,0,0,0,0,0,2022-04-01,2023-04-01,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,288
NCT03387579,0,0,0,0,0,0,2020-03-31,2021-03-31,,Indiana University,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT03391388,0,0,0,0,0,0,2020-08-20,2021-08-20,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,1898
NCT03391765,0,0,0,0,0,0,2022-09-22,2023-09-22,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03394885,0,0,0,0,0,0,2021-01-31,2022-01-31,,Duke University,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03396601,0,0,0,0,0,0,2020-09-30,2021-09-30,,"NeuroRx, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03398694,0,0,0,0,0,0,2021-02-28,2022-02-28,,Indiana University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,497
NCT03399903,0,0,0,0,0,0,2019-12-31,2020-12-31,,AIDS Healthcare Foundation,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03400033,0,0,0,0,0,0,2020-07-08,2021-07-08,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03400917,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Aivita Biomedical, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03401398,0,0,0,0,0,0,2023-09-20,2024-09-20,,Jerry Zimmerman,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03404375,0,0,0,0,0,0,2018-11-01,2019-11-01,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,158
NCT03406156,0,0,0,0,0,0,2022-04-03,2023-04-03,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03406962,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Magenta Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03407482,0,0,0,0,0,0,2020-04-09,2021-04-09,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03410693,0,0,0,0,0,0,2022-04-25,2023-04-25,,Bayer,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03414047,0,0,0,0,0,0,2019-06-03,2020-06-03,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03414268,0,0,0,0,0,0,2019-10-31,2020-10-31,,"MiMedx Group, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT03417245,0,0,0,0,0,0,2020-04-09,2021-04-09,,"Genzyme, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,300
NCT03418129,0,0,0,0,0,0,2021-02-01,2022-02-01,,Duke University,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03418961,0,0,0,0,0,0,2023-02-01,2024-02-01,,Southwest Oncology Group,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,288
NCT03423277,0,0,0,0,0,0,2019-10-31,2020-10-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,158
NCT03423511,0,0,0,0,0,0,2021-06-01,2022-06-01,,Micell Technologies,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,5
NCT03425097,0,0,0,0,0,0,2020-03-31,2021-03-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03425331,0,0,0,0,0,0,2021-08-28,2022-08-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03425799,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Exela Pharma Sciences, LLC.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03427411,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03427866,0,0,0,0,0,0,2021-09-30,2022-09-30,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03428607,0,0,0,0,0,0,2020-12-31,2021-12-31,,Samsung Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,684
NCT03432364,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sangamo Therapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,0,0,1,0,1,0,18
NCT03433755,0,0,0,0,0,0,2020-10-09,2021-10-09,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,685
NCT03434678,0,0,0,0,0,0,2021-01-31,2022-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03435081,0,0,0,0,0,0,2019-11-15,2020-11-15,,Eli Lilly and Company,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03435718,0,0,0,0,0,0,2020-05-31,2021-05-31,,Oxfendazole Development Group,Other,0,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03437668,0,0,0,0,0,0,2020-02-01,2021-02-01,,"Chengappa, K.N. Roy, MD",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03437733,0,0,0,0,0,0,2019-01-03,2020-01-03,,"Biosense Webster, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,41
NCT03438396,0,0,0,0,0,0,2019-12-31,2020-12-31,,Genmab,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,20
NCT03439293,0,0,0,0,0,0,2019-12-02,2020-12-02,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03441022,0,0,0,0,0,0,2021-08-31,2022-08-31,,Mayo Clinic,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03441113,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Sierra Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,19
NCT03441581,0,0,0,0,0,0,2019-09-30,2020-09-30,,Allergan,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03442179,0,0,0,0,0,0,2020-04-30,2021-04-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03442309,0,0,0,0,0,0,2023-06-30,2024-06-30,,NYU College of Dentistry,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03444038,0,0,0,0,0,0,2019-06-30,2020-06-30,,Neurocrine Biosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,34
NCT03444961,1,0,1,1,0,1,2018-06-20,2019-06-20,2019-07-25,The Cleveland Clinic,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,581
NCT03445286,0,0,0,0,0,0,2020-05-31,2021-05-31,,Texas A & M University Baylor College Of Dentistry,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03446404,0,0,0,0,0,0,2020-04-01,2021-04-01,,Neil A Segal,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,1,0,0,0,0,0,1,1
NCT03449342,0,0,0,0,0,0,2019-03-25,2020-03-25,,Novo Nordisk A/S,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,981
NCT03449446,0,0,0,0,0,0,2019-10-31,2020-10-31,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03450421,0,0,0,0,0,0,2019-11-30,2020-11-30,,Actamax Surgical Materials LLC,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT03451916,0,0,0,0,0,0,2020-07-01,2021-07-01,,Pluristem Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03452397,0,0,0,0,0,0,2018-05-16,2019-05-16,,"Oyster Point Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03453151,0,0,0,0,0,0,2019-06-27,2020-06-27,,Duke University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03455725,0,0,0,0,0,0,2022-12-31,2023-12-31,,"BioCardia, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT03457142,0,0,0,0,0,0,2019-11-08,2020-11-08,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,294
NCT03458429,0,0,0,0,0,0,2020-02-05,2021-02-05,,Dipnarine Maharaj,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03459040,0,0,0,0,0,0,2019-12-31,2020-12-31,,John Levine,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03461198,0,0,0,0,0,0,2020-04-01,2021-04-01,,"Goldman, Butterwick, Fitzpatrick and Groff",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,12
NCT03463161,0,0,0,0,0,0,2018-12-04,2019-12-04,,University of Chicago,Other,0,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,594
NCT03463850,0,0,0,0,0,0,2020-11-30,2021-11-30,,State University of New York - Upstate Medical University,Other,0,0,0,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,125
NCT03467542,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Microvention-Terumo, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03468296,0,0,0,0,0,0,2018-10-31,2019-10-31,,Tennessee Retina,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03468933,0,0,0,0,0,0,2019-12-30,2020-12-30,,Tulane University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,33
NCT03469934,0,0,0,0,0,0,2018-10-29,2019-10-29,,"AnaptysBio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,6
NCT03470532,1,0,0,0,1,0,2018-03-01,2019-03-01,,Melaka Manipal Medical College,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,4
NCT03471065,0,0,0,0,0,0,2019-04-30,2020-04-30,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,77
NCT03471208,1,0,1,1,0,1,2018-01-01,2019-01-01,2019-08-06,Istanbul University,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,3,0,1,155
NCT03471260,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03471702,0,0,0,0,0,0,2018-11-01,2019-11-01,,Aqueduct Critical Care,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03474497,0,0,0,0,0,0,2021-07-01,2022-07-01,,Arta Monjazeb,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1
NCT03474965,0,0,0,0,0,0,2020-12-31,2021-12-31,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03476187,0,0,0,0,0,0,2021-03-31,2022-03-31,,Zoll Medical Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,17
NCT03478787,0,0,0,0,0,0,2019-11-29,2020-11-29,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03479905,0,0,0,0,0,0,2019-04-25,2020-04-25,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,626
NCT03481114,0,0,0,0,0,0,2019-11-30,2020-11-30,,Albert Einstein College of Medicine,Other,0,0,0,3.0,Phase 3,0,2017.0,0,0,0,0,0,0,1,0,0,1,0,155
NCT03483103,0,0,0,0,0,0,2021-12-30,2022-12-30,,"Juno Therapeutics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,8
NCT03483675,0,0,0,0,0,0,2020-05-15,2021-05-15,,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,393
NCT03485222,0,0,0,0,0,0,2020-12-31,2021-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03486327,0,0,0,0,0,0,2021-08-01,2022-08-01,,"Bracco Diagnostics, Inc",Industry,1,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,46
NCT03486912,0,0,0,0,0,0,2020-01-09,2021-01-09,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03488225,0,0,0,0,0,0,2022-03-30,2023-03-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03489850,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, Los Angeles",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03490032,0,0,0,0,0,0,2019-08-20,2020-08-20,,Advanced Accelerator Applications,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03490929,0,0,0,0,0,0,2021-05-31,2022-05-31,,Children's Hospital of Philadelphia,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,324
NCT03493607,0,0,0,0,0,0,2020-07-31,2021-07-31,,Alexander Kolevzon,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03493854,0,0,0,0,0,0,2019-07-04,2020-07-04,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,1,0,0,1,1,0,1731
NCT03495154,0,0,0,0,0,0,2020-07-01,2021-07-01,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,146
NCT03496974,0,1,0,1,0,0,2018-12-04,2019-12-04,2019-05-02,"XBiotech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03497975,0,0,0,0,0,0,2020-03-31,2021-03-31,,Trevi Therapeutics,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03498313,0,0,0,0,0,0,2020-08-01,2021-08-01,,University of Illinois at Chicago,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,242
NCT03500211,0,0,0,0,0,0,2019-03-01,2020-03-01,,Oregon Health and Science University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,475
NCT03500302,0,0,0,0,0,0,2019-11-30,2020-11-30,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03500445,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03502616,0,0,0,0,0,0,2020-01-10,2021-01-10,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03507127,0,0,0,0,0,0,2020-07-31,2021-07-31,,Brown University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,152
NCT03508440,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Missouri-Columbia,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03509987,1,0,0,0,1,0,2018-04-01,2019-04-01,,Kecioren Education and Training Hospital,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,12
NCT03512197,0,0,0,0,0,0,2019-10-15,2020-10-15,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03513471,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,910
NCT03514277,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Virtua Health, Inc.",Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT03515044,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Bausch Health Americas, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03516617,0,0,0,0,0,0,2025-03-15,2026-03-15,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03518112,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03518567,0,0,0,0,0,0,2020-04-30,2021-04-30,,Brown University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,152
NCT03518684,0,0,0,0,0,0,2018-09-28,2019-09-28,,American University of Beirut Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,94
NCT03520426,0,0,0,0,0,0,2020-01-30,2021-01-30,,"Walden, Jennifer L., M.D.,P.L.L.C.",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03520712,0,0,0,0,0,0,2024-06-30,2025-06-30,,BioMarin Pharmaceutical,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,85
NCT03521141,0,0,0,0,0,0,2019-04-11,2020-04-11,,Vanderbilt University Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,1,1,0,0,0,0,0,1,0,1,0,422
NCT03522077,0,0,0,0,0,0,2019-12-01,2020-12-01,,Aurora Health Care,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,13
NCT03523507,0,0,0,0,0,0,2021-07-01,2022-07-01,,Henry M. Jackson Foundation for the Advancement of Military Medicine,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,37
NCT03523728,0,0,0,0,0,0,2023-01-31,2024-01-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,300
NCT03524339,0,0,0,0,0,0,2019-12-31,2020-12-31,,University Hospitals Cleveland Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,185
NCT03529877,0,0,0,0,0,0,2020-01-31,2021-01-31,,RHEACELL GmbH & Co. KG,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,7
NCT03531827,0,0,0,0,0,0,2020-06-30,2021-06-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03532022,0,0,0,0,0,0,2021-10-31,2022-10-31,,Diurnal Limited,Industry,1,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03534102,0,0,0,0,0,0,2021-09-01,2022-09-01,,Brigham and Women's Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03534960,0,0,0,0,0,0,2018-11-12,2019-11-12,,"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,96
NCT03535298,0,0,0,0,0,0,2022-12-31,2023-12-31,,The Cleveland Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,581
NCT03537898,0,0,0,0,0,0,2019-02-07,2020-02-07,,Vanderbilt University Medical Center,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,422
NCT03538444,0,0,0,0,0,0,2020-06-01,2021-06-01,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,511
NCT03539432,0,0,0,0,0,0,2018-12-30,2019-12-30,,The Mind Research Network,Other,0,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,9
NCT03539614,0,0,0,0,0,0,2023-04-03,2024-04-03,,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03542565,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Ceevra, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03543254,0,0,0,0,0,0,2020-05-31,2021-05-31,,Norwegian University of Science and Technology,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,408
NCT03546647,0,0,0,0,0,0,2018-12-21,2019-12-21,,University of Houston,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,47
NCT03547271,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,285
NCT03547583,0,0,0,0,0,0,2019-10-11,2020-10-11,,Bayer,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03548454,0,0,0,0,0,0,2020-07-31,2021-07-31,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03549299,0,0,0,0,0,0,2021-09-30,2022-09-30,,RHEACELL GmbH & Co. KG,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,7
NCT03552393,0,0,0,0,0,0,2021-10-28,2022-10-28,,Hoffmann-La Roche,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03553914,0,0,0,0,0,0,2024-01-31,2025-01-31,,Conjupro Biotherapeutics,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2021.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03555825,0,0,0,0,0,0,2019-07-31,2020-07-31,,Burke Medical Research Institute,Other,0,0,0,3.0,Phase 3,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,11
NCT03557385,0,0,0,0,0,0,2020-12-31,2021-12-31,,Duke University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1342
NCT03560245,0,0,0,0,0,0,2019-07-25,2020-07-25,,"Neurotrope Bioscience, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03560752,0,0,0,0,0,0,2020-03-18,2021-03-18,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,358
NCT03563599,0,0,0,0,0,0,2019-09-09,2020-09-09,,"Qurient Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,5
NCT03564145,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Sol-Gel Technologies, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03564886,0,0,0,0,0,0,2020-06-08,2021-06-08,,University of Missouri-Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03565237,0,0,0,0,0,0,2021-04-21,2022-04-21,,Baxalta now part of Shire,Industry,1,1,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,107
NCT03567382,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,910
NCT03568292,0,0,0,0,0,0,2020-08-11,2021-08-11,,University of Southern California,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,483
NCT03568474,0,0,0,0,0,0,2019-10-31,2020-10-31,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,1190
NCT03568838,0,0,0,0,0,0,2020-05-01,2021-05-01,,Sheffield Teaching Hospitals NHS Foundation Trust,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,155
NCT03570476,0,0,0,0,0,0,2022-01-01,2023-01-01,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03570632,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Maisa N. Feghali, MD",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03571516,0,0,0,0,0,0,2020-01-31,2021-01-31,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,2,1,0,342
NCT03572244,0,0,0,0,0,0,2019-09-06,2020-09-06,,Christopher Barwacz,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,3
NCT03573024,0,0,0,0,0,0,2022-06-30,2023-06-30,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03573947,0,0,0,0,0,0,2022-06-30,2023-06-30,,Jeffrey Clarke,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03574363,0,0,0,0,0,0,2019-10-31,2020-10-31,,KBP Biosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03575507,0,0,0,0,0,0,2018-09-30,2019-09-30,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,20
NCT03576001,0,0,0,0,0,0,2023-01-31,2024-01-31,,Brigham and Women's Hospital,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,698
NCT03576131,0,0,0,0,0,0,2021-12-31,2022-12-31,,Genmab,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,20
NCT03576833,0,0,0,0,0,0,2019-06-01,2020-06-01,,Norwegian Department of Health and Social Affairs,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,6
NCT03577171,0,0,0,0,0,0,2019-06-30,2020-06-30,,Assembly Biosciences,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03578367,0,0,0,0,0,0,2021-03-12,2022-03-12,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03579459,0,0,0,0,0,0,2019-08-06,2020-08-06,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,2856
NCT03579758,0,0,0,0,0,0,2026-04-30,2027-04-30,,Emory University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03583710,0,0,0,0,0,0,2025-01-22,2026-01-22,,M.D. Anderson Cancer Center,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03585569,0,0,0,0,0,0,2019-05-31,2020-05-31,,Neurology Center of New England P.C.,Other,0,1,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03586544,0,0,0,0,0,0,2020-12-30,2021-12-30,,"University of Nevada, Las Vegas",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03586934,0,0,0,0,0,0,2020-06-01,2021-06-01,,Rush University Medical Center,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,227
NCT03587662,0,0,0,0,0,0,2021-01-06,2022-01-06,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03589807,0,0,0,0,0,0,2020-08-21,2021-08-21,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03594292,0,0,0,0,0,0,2019-02-28,2020-02-28,,China Medical University Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,211
NCT03594461,0,0,0,0,0,0,2020-03-31,2021-03-31,,Vitreous -Retina- Macula Consultants of New York,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03594955,0,0,0,0,0,0,2021-07-31,2022-07-31,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1222
NCT03595683,0,0,0,0,0,0,2021-11-02,2022-11-02,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,594
NCT03595982,0,0,0,0,0,0,2020-06-11,2021-06-11,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03598699,0,0,0,0,0,0,2019-03-31,2020-03-31,,"AxeroVision, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03600740,0,0,0,0,0,0,2020-12-31,2021-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03600883,0,0,0,0,0,0,2022-12-27,2023-12-27,,Amgen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03602079,0,0,0,0,0,0,2020-10-31,2021-10-31,,Klus Pharma Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03603080,0,0,0,0,0,0,2019-11-01,2020-11-01,,Hartford Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,65
NCT03603912,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Mina Chung, MD",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03604068,0,0,0,0,0,0,2018-12-01,2019-12-01,,BioElectronics Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,6
NCT03604419,0,0,0,0,0,0,2019-04-01,2020-04-01,,"PegBio Co., Ltd.",Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,7
NCT03605069,0,0,0,0,0,0,2020-08-23,2021-08-23,,Wings Therapeutics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03605537,0,0,0,0,0,0,2023-07-31,2024-07-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03605745,0,0,0,0,0,0,2020-09-30,2021-09-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT03610711,0,0,0,0,0,0,2022-04-30,2023-04-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03614663,0,0,0,0,0,0,2019-07-23,2020-07-23,,"Zynerba Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03614949,0,0,0,0,0,0,2021-12-31,2022-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,344
NCT03615482,0,0,0,0,0,0,2019-06-24,2020-06-24,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,2145
NCT03623958,0,0,0,0,0,0,2020-07-31,2021-07-31,,Brigham and Women's Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,698
NCT03625765,0,0,0,0,0,0,2020-07-31,2021-07-31,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT03628053,0,0,0,0,0,0,2023-11-01,2024-11-01,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,1895
NCT03633110,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Genocea Biosciences, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,9
NCT03634228,0,0,0,0,0,0,2020-05-01,2021-05-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03634813,0,0,0,0,0,0,2019-09-01,2020-09-01,,Yale University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1053
NCT03635814,0,0,0,0,0,0,2019-08-16,2020-08-16,,Se Hee Han,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03636451,0,0,0,0,0,0,2020-01-01,2021-01-01,,"University of California, San Diego",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,561
NCT03637491,0,0,0,0,0,0,2022-03-15,2023-03-15,,Pfizer,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03638141,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03639051,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Nuvaira, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,6
NCT03639766,0,0,0,0,0,0,2019-08-17,2020-08-17,,University of Central Florida,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03640052,0,0,0,0,0,0,2019-09-30,2020-09-30,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03641313,0,0,0,0,0,0,2020-05-31,2021-05-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03642067,0,0,0,0,0,0,2023-02-28,2024-02-28,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03642964,0,0,0,0,0,0,2019-05-30,2020-05-30,,Chase Therapeutics Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03646162,0,0,0,0,0,0,2020-02-29,2021-02-28,,Veru Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03646552,0,0,0,0,0,0,2019-04-30,2020-04-30,,Therapix Biosciences Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,2
NCT03650452,0,0,0,0,0,0,2021-03-21,2022-03-21,,Takeda,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,650
NCT03650803,0,0,0,0,0,0,2020-09-01,2021-09-01,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT03651531,0,0,0,0,0,0,2020-05-31,2021-05-31,,Women and Infants Hospital of Rhode Island,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,50
NCT03651804,0,0,0,0,0,0,2020-03-01,2021-03-01,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03652012,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Arizona,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,265
NCT03655535,0,0,0,0,0,0,2019-08-30,2020-08-30,,Boston Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03656783,0,0,0,0,0,0,2019-11-30,2020-11-30,,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03657069,0,0,0,0,0,0,2020-07-01,2021-07-01,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03657407,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-09-06,Anna Reinert,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03658343,0,0,0,0,0,0,2020-12-31,2021-12-31,,Bryan Allen,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,3
NCT03658538,0,0,0,0,0,0,2024-06-30,2025-06-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03661320,0,0,0,0,0,0,2023-11-28,2024-11-28,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03663673,0,0,0,0,0,0,2020-06-01,2021-06-01,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03664986,0,0,0,0,0,0,2020-05-01,2021-05-01,,Atlantic Health System,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03672006,0,0,0,0,0,0,2019-08-31,2020-08-31,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,1,0,0,0,0,0,3,1,0,315
NCT03673501,0,0,0,0,0,0,2021-06-30,2022-06-30,,Deciphera Pharmaceuticals LLC,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03675308,0,0,0,0,0,0,2021-01-08,2022-01-08,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,430
NCT03677154,0,0,0,0,0,0,2023-04-19,2024-04-19,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03678675,0,0,0,0,0,0,2019-09-30,2020-09-30,,Tufts Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,121
NCT03679767,0,0,0,0,0,0,2020-09-30,2021-09-30,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03679975,0,0,0,0,0,0,2018-09-26,2019-09-26,,Aquestive Therapeutics,Industry,1,1,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03680846,0,0,0,0,0,0,2020-06-30,2021-06-30,,Nevro Corp,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03682302,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,53
NCT03683030,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Biosense Webster, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,41
NCT03684642,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03687268,0,0,0,0,0,0,2019-11-30,2020-11-30,,Develco Pharma Schweiz AG,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03688230,0,0,0,0,0,0,2020-12-31,2021-12-31,,"SFJ Pharmaceuticals X, LTD.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,1,0,3,1,0,1
NCT03689712,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Galera Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03690141,0,0,0,0,0,0,2019-09-30,2020-09-30,,Effector Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03690752,0,0,0,0,0,0,2018-10-01,2019-10-01,,Texas Tech University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,30
NCT03693014,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,1432
NCT03693807,0,0,0,0,0,0,2020-09-30,2021-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1432
NCT03694197,0,0,0,0,0,0,2023-11-23,2024-11-23,,Regeneron Pharmaceuticals,Industry,1,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03698279,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,285
NCT03699475,0,0,0,0,0,0,2023-12-31,2024-12-31,,Bellicum Pharmaceuticals,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,15
NCT03701516,0,0,0,0,0,0,2018-12-11,2019-12-11,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03701698,0,0,0,0,0,0,2021-10-31,2022-10-31,,"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,45
NCT03702023,0,0,0,0,0,0,2020-06-01,2021-06-01,,Genesys Regional Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03702244,0,0,0,0,0,0,2019-12-31,2020-12-31,,"HeartFlow, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,5
NCT03702842,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Florida,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03703206,0,0,0,0,0,0,2019-12-20,2020-12-20,,University of Pennsylvania,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03704584,0,0,0,0,0,0,2021-08-31,2022-08-31,,Emory University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03706365,0,0,0,0,0,0,2021-09-15,2022-09-15,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03708315,0,0,0,0,0,0,2020-11-30,2021-11-30,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03708926,0,0,0,0,0,0,2022-02-28,2023-02-28,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03710291,0,0,0,0,0,0,2022-10-31,2023-10-31,,"Tricida, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03714620,0,0,0,0,0,0,2019-08-30,2020-08-30,,Loyola University,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,102
NCT03717194,0,0,0,0,0,0,2020-09-30,2021-09-30,,Soo Lim,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03717415,0,0,0,0,0,0,2020-11-01,2021-11-01,,Deciphera Pharmaceuticals LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03718403,0,0,0,0,0,0,2030-04-10,2031-04-10,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1699
NCT03719391,0,0,0,0,0,0,2018-11-21,2019-11-21,,"Juul Labs, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03719586,0,0,0,0,0,0,2023-11-30,2024-11-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2133
NCT03724032,0,0,0,0,0,0,2021-07-31,2022-07-31,,University of Michigan,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03727932,1,0,0,0,1,0,2018-04-11,2019-04-11,,"Avioq, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03728218,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Houston,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,47
NCT03730662,0,0,0,0,0,0,2021-05-15,2022-05-15,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03732833,0,0,0,0,0,0,2020-02-01,2021-02-01,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03733041,0,0,0,0,0,0,2023-03-31,2024-03-31,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03733691,0,0,0,0,0,0,2023-12-20,2024-12-20,,"James R. Berenson, MD Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03734237,0,0,0,0,0,0,2020-05-31,2021-05-31,,Henry M. Jackson Foundation for the Advancement of Military Medicine,Other,0,0,1,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,37
NCT03735290,0,0,0,0,0,0,2022-12-31,2023-12-31,,Immunicum AB,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,5
NCT03737851,0,0,0,0,0,0,2020-12-03,2021-12-03,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03739372,0,0,0,0,0,0,2020-11-01,2021-11-01,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,1443
NCT03739502,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Rochester,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,470
NCT03740100,0,0,0,0,0,0,2020-12-31,2021-12-31,,PIQUR Therapeutics AG,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03741192,0,0,0,0,0,0,2021-01-31,2022-01-31,,Brain Sentinel,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,11
NCT03744715,0,0,0,0,0,0,2023-10-05,2024-10-05,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,67
NCT03746197,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Jewish Health,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,81
NCT03746951,0,0,0,0,0,0,2020-12-31,2021-12-31,,Nationwide Children's Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,161
NCT03747328,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Aadi, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,7
NCT03750240,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,1,5.0,,0,2017.0,1,0,0,0,1,0,0,0,0,1,0,869
NCT03751033,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Clinical Research Consultants, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03753789,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Ethicon, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,59
NCT03754725,0,0,0,0,0,0,2022-07-01,2023-07-01,,David Hasan,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03756168,0,0,0,0,0,0,2019-07-02,2020-07-02,,Venus Concept,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,23
NCT03756558,0,0,0,0,0,0,2020-03-31,2021-03-31,,Terumo Medical Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03756883,0,0,0,0,0,0,2019-08-31,2020-08-31,,Actavis Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,93
NCT03757091,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2066
NCT03764111,0,0,0,0,0,0,2019-07-11,2020-07-11,,Yale University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1053
NCT03765138,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Research Foundation for Mental Hygiene, Inc.",Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,22
NCT03766581,0,0,0,0,0,0,2021-05-31,2022-05-31,,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03768726,0,0,0,0,0,0,2021-04-04,2022-04-04,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2856
NCT03770377,0,0,0,0,0,0,2019-08-30,2020-08-30,,University of Florida,Other,0,0,1,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,849
NCT03772587,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Momenta Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,12
NCT03773562,0,0,0,0,0,0,2020-09-03,2021-09-03,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03774719,0,0,0,0,0,0,2020-09-30,2021-09-30,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03774823,0,0,0,0,0,0,2019-08-31,2020-08-31,,Venus Concept,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT03775044,0,0,0,0,0,0,2020-10-31,2021-10-31,,Terrapin Pharmacy,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03776162,0,0,0,0,0,0,2023-01-31,2024-01-31,,The Cleveland Clinic,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03777917,0,0,0,0,0,0,2019-06-18,2020-06-18,,"Merz North America, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,35
NCT03778996,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Sarcoma Oncology Research Center, LLC",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT03779191,0,0,0,0,0,0,2020-07-01,2021-07-01,,Instituto Nacional de Cancerologia de Mexico,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,26
NCT03783780,0,1,0,1,0,0,2018-12-18,2019-12-18,2019-06-12,Masimo Corporation,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,39
NCT03784079,0,0,0,0,0,0,2019-11-22,2020-11-22,,ViiV Healthcare,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,200
NCT03785327,0,0,0,0,0,0,2020-07-31,2021-07-31,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03785964,0,0,0,0,0,0,2021-03-31,2022-03-31,,"SpringWorks Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03789656,0,0,0,0,0,0,2020-06-30,2021-06-30,,Crinetics Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03792633,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1052
NCT03793166,0,0,0,0,0,0,2021-09-15,2022-09-15,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03797677,1,0,0,0,1,0,2017-11-30,2018-11-30,,Hill-Rom,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,22
NCT03799120,0,0,0,0,0,0,2021-12-31,2022-12-31,,Gundersen Lutheran Medical Foundation,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03799458,0,0,0,0,0,0,2021-09-30,2022-09-30,,University of New Mexico,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,200
NCT03799627,0,0,0,0,0,0,2020-02-29,2021-02-28,,Akebia Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,25
NCT03800420,0,0,0,0,0,0,2020-03-01,2021-03-01,,"Bridge Biotherapeutics, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03800979,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Institute of Dermatology, Thailand",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03801369,0,0,0,0,0,0,2020-12-31,2021-12-31,,OHSU Knight Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,163
NCT03801707,0,0,0,0,0,0,2021-01-31,2022-01-31,,Ohio State University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03806556,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Triulzi, Darrell, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03806777,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of British Columbia,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,881
NCT03810313,0,0,0,0,0,0,2023-01-12,2024-01-12,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03811574,0,0,0,0,0,0,2020-10-19,2021-10-19,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,981
NCT03811951,0,0,0,0,0,0,2019-09-12,2020-09-12,,University of Illinois at Chicago,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,242
NCT03812380,0,0,0,0,0,0,2020-12-30,2021-12-30,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03815643,0,0,0,0,0,0,2024-01-28,2025-01-28,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,42
NCT03816176,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,135
NCT03819153,0,0,0,0,0,0,2024-08-19,2025-08-19,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03823703,0,0,0,0,0,0,2020-12-31,2021-12-31,,Corcept Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,40
NCT03824236,0,0,0,0,0,0,2019-07-31,2020-07-31,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2019.0,1,0,1,0,0,0,0,0,0,1,0,3276
NCT03824392,0,0,0,0,0,0,2020-06-21,2021-06-21,,"aTyr Pharma, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,6
NCT03825367,0,0,0,0,0,0,2022-03-30,2023-03-30,,Therapeutic Advances in Childhood Leukemia Consortium,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03828019,0,0,0,0,0,0,2022-08-30,2023-08-30,,JHSPH Center for Clinical Trials,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,9
NCT03828734,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03829501,0,0,0,0,0,0,2023-05-31,2024-05-31,,Kymab Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03831191,0,0,0,0,0,0,2020-02-14,2021-02-14,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03832946,0,0,0,0,0,0,2021-03-31,2022-03-31,,Galecto Biotech AB,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03833154,0,0,0,0,0,0,2023-10-02,2024-10-02,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03834311,0,0,0,0,0,0,2019-12-06,2020-12-06,,Cukurova University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,58
NCT03834883,0,0,0,0,0,0,2022-06-30,2023-06-30,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT03836040,0,0,0,0,0,0,2022-12-17,2023-12-17,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,685
NCT03836989,0,0,0,0,0,0,2019-08-31,2020-08-31,,Oregon Health and Science University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,475
NCT03837457,0,0,0,0,0,0,2021-12-31,2022-12-31,,"miRagen Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,6
NCT03838042,0,0,0,0,0,0,2022-09-30,2023-09-30,,University Hospital Heidelberg,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,87
NCT03840486,0,0,0,0,0,0,2020-04-30,2021-04-30,,Emory University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,947
NCT03841500,1,0,1,1,0,1,2017-01-31,2018-01-31,2019-03-10,Kelsey-Seybold Clinic,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT03845127,0,0,0,0,0,0,2020-12-31,2021-12-31,,BioVentrix,Industry,1,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,6
NCT03845582,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Alkeus Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03847636,0,0,0,0,0,0,2022-05-31,2023-05-31,,Johns Hopkins University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03847974,0,0,0,0,0,0,2019-10-28,2020-10-28,,LIB Therapeutics LLC,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03850418,0,0,0,0,0,0,2024-02-20,2025-02-20,,Henry Ford Health System,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,151
NCT03851445,0,0,0,0,0,0,2024-01-28,2025-01-28,,Southwest Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,288
NCT03858530,0,0,0,0,0,0,2020-12-31,2021-12-31,,Children's Mercy Hospital Kansas City,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,138
NCT03859024,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03861390,0,0,0,0,0,0,2022-02-28,2023-02-28,,"University of North Carolina, Chapel Hill",Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03861871,0,0,0,0,0,0,2021-04-30,2022-04-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03862053,0,0,0,0,0,0,2019-12-01,2020-12-01,,Toyos Clinic,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03862755,1,0,0,0,1,0,2017-09-12,2018-09-12,,Shen Lei,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03865381,0,0,0,0,0,0,2019-08-30,2020-08-30,,Verily Life Sciences LLC,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03865927,0,0,0,0,0,0,2023-07-31,2024-07-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03866967,0,0,0,0,0,0,2020-06-15,2021-06-15,,Akeso,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,6
NCT03867084,0,0,0,0,0,0,2025-06-30,2026-06-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03869684,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Senju Pharmaceutical Co., Ltd.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03870334,0,0,0,0,0,0,2020-10-31,2021-10-31,,Landos Biopharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03870737,1,1,0,1,0,0,2018-05-30,2019-05-30,2019-04-03,"University of California, Los Angeles",Other,0,0,1,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,692
NCT03872505,0,0,0,0,0,0,2021-01-31,2022-01-31,,Cedars-Sinai Medical Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,279
NCT03875729,0,0,0,0,0,0,2022-05-31,2023-05-31,,"Provention Bio, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,4
NCT03878095,0,0,0,0,0,0,2020-05-01,2021-05-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03878758,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Becton, Dickinson and Company",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,26
NCT03880227,0,0,0,0,0,0,2020-03-31,2021-03-31,,The University of Texas at Dallas,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,29
NCT03881059,0,0,0,0,0,0,2020-04-20,2021-04-20,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03882554,0,0,0,0,0,0,2019-11-30,2020-11-30,,Neurohabilitation Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT03883581,0,0,0,0,0,0,2020-12-01,2021-12-01,,University of Florida,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03888144,0,0,0,0,0,0,2020-07-31,2021-07-31,,The Cleveland Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03888378,0,0,0,0,0,0,2020-03-31,2021-03-31,,Hovione Scientia Limited,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03888820,0,0,0,0,0,0,2019-03-30,2020-03-30,,Sport and Spine Rehab Clinical Research Foundation,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03897062,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Florey Institute of Neuroscience and Mental Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03901534,0,0,0,0,0,0,2022-12-31,2023-12-31,,Columbia University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03902093,0,0,0,0,0,0,2021-06-01,2022-06-01,,University of Southern California,Other,0,0,0,5.0,,0,2020.0,0,0,0,0,1,0,0,0,3,1,0,483
NCT03903068,0,0,0,0,0,0,2020-08-15,2021-08-15,,"Xuanwu Hospital, Beijing",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,58
NCT03903510,0,0,0,0,0,0,2020-09-30,2021-09-30,,Gillette Children's Specialty Healthcare,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,14
NCT03905265,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medicines Development Limited,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,7
NCT03908476,0,0,0,0,0,0,2022-12-31,2023-12-31,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,419
NCT03909737,0,0,0,0,0,0,2022-02-01,2023-02-01,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,144
NCT03910244,0,0,0,0,0,0,2022-03-31,2023-03-31,,The Cleveland Clinic,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,581
NCT03911505,0,0,0,0,0,0,2021-02-28,2022-02-28,,Amicus Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,34
NCT03911973,0,0,0,0,0,0,2021-05-31,2022-05-31,,Kari Wisinski,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03913026,0,0,0,0,0,0,2023-12-31,2024-12-31,,Ciusss de L'Est de l'Île de Montréal,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,23
NCT03914326,0,0,0,0,0,0,2024-07-29,2025-07-29,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03916328,0,0,0,0,0,0,2022-06-06,2023-06-06,,MU-JHU CARE,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03917420,0,0,0,0,0,0,2019-09-04,2020-09-04,,"University of North Carolina, Chapel Hill",Other,0,0,1,4.0,Phase 4,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03918629,0,0,0,0,0,0,2020-06-09,2021-06-09,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2856
NCT03921827,0,0,0,0,0,0,2023-01-07,2024-01-07,,"National University, Singapore",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,73
NCT03922048,0,0,0,0,0,0,2021-10-31,2022-10-31,,Heron Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,18
NCT03922945,0,0,0,0,0,0,2020-09-30,2021-09-30,,"VIVUS, Inc.",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03926195,0,0,0,0,0,0,2021-01-31,2022-01-31,,Galapagos NV,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,79
NCT03927222,0,0,0,0,0,0,2023-12-31,2024-12-31,,Gary Archer Ph.D.,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,12
NCT03928184,0,0,0,0,0,0,2020-12-31,2021-12-31,,Samumed LLC,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03929146,0,0,0,0,0,0,2021-12-01,2022-12-01,,University of Cincinnati,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,222
NCT03931746,0,0,0,0,0,0,2020-04-30,2021-04-30,,Northwell Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03933163,0,0,0,0,0,0,2020-12-31,2021-12-31,,Murdoch Childrens Research Institute,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,28
NCT03933397,0,0,0,0,0,0,2021-12-31,2022-12-31,,Duke University,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03935984,0,0,0,0,0,0,2021-04-01,2022-04-01,,ProMedica Health System,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03936777,0,0,0,0,0,0,2023-04-30,2024-04-30,,"Zogenix, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03937154,0,0,0,0,0,0,2021-08-27,2022-08-27,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,685
NCT03937791,0,0,0,0,0,0,2020-07-31,2021-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03938038,0,0,0,0,0,0,2020-10-31,2021-10-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,490
NCT03938532,0,0,0,0,0,0,2020-12-31,2021-12-31,,Baystate Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,34
NCT03942601,0,0,0,0,0,0,2020-06-15,2021-06-15,,"Mercator MedSystems, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03943368,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Ceevra, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03944473,0,0,0,0,0,0,2020-07-20,2021-07-20,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,240
NCT03945084,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of Turin, Italy",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,110
NCT03945422,0,0,0,0,0,0,2020-04-03,2021-04-03,,InMode MD Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03946449,0,0,0,0,0,0,2021-07-15,2022-07-15,,Arrowhead Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,18
NCT03947671,0,0,0,0,0,0,2021-09-01,2022-09-01,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,417
NCT03950856,0,0,0,0,0,0,2020-04-03,2021-04-03,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2145
NCT03953118,0,0,0,0,0,0,2019-12-01,2020-12-01,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03955432,0,0,0,0,0,0,2022-03-31,2023-03-31,,Northwell Health,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03956225,0,0,0,0,0,0,2020-10-31,2021-10-31,,Alcon Research,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,492
NCT03959592,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Felipe Medeiros, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03959982,0,0,0,0,0,0,2021-12-31,2022-12-31,,Spyridon Fortis,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,1,0,0,0,3,1,0,1
NCT03960606,0,0,0,0,0,0,2020-06-30,2021-06-30,,Pulmatrix Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,1,1,0,12
NCT03962634,0,0,0,0,0,0,2020-04-30,2021-04-30,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,417
NCT03969485,0,0,0,0,0,0,2020-05-31,2021-05-31,,Sciton,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03970733,0,0,0,0,0,0,2020-04-30,2021-04-30,,Valneva Austria GmbH,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,31
NCT03973866,0,0,0,0,0,0,2021-03-31,2022-03-31,,Sequana Medical AG,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,10
NCT03978832,0,0,0,0,0,0,2020-05-15,2021-05-15,,Indivior Inc.,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,45
NCT03980145,0,0,0,0,0,0,2020-03-01,2021-03-01,,Indiana University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,497
NCT03980938,0,0,0,0,0,0,2020-06-30,2021-06-30,,EIP Pharma Inc,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03981419,0,0,0,0,0,0,2020-07-15,2021-07-15,,"Alkahest, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,6
NCT03982537,0,0,0,0,0,0,2021-10-31,2022-10-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,616
NCT03983252,0,0,0,0,0,0,2024-05-01,2025-05-01,,Brigham and Women's Hospital,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT03984305,0,0,0,0,0,0,2021-05-31,2022-05-31,,Global Kinetics Corporation,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03986580,0,0,0,0,0,0,2020-09-30,2021-09-30,,Intrinsic Therapeutics,Industry,1,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03987451,0,0,0,0,0,0,2020-12-29,2021-12-29,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03989271,0,0,0,0,0,0,2020-05-31,2021-05-31,,Temple University,Other,0,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,152
NCT03990389,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Chicago,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,594
NCT03992092,0,0,0,0,0,0,2020-08-31,2021-08-31,,Lawson Health Research Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,468
NCT03992443,0,0,0,0,0,0,2021-11-30,2022-11-30,,Chiesi Farmaceutici S.p.A.,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,130
NCT03993509,0,0,0,0,0,0,2023-08-01,2024-08-01,,University of Pennsylvania,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT03993691,0,0,0,0,0,0,2021-08-31,2022-08-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03995628,0,0,0,0,0,0,2020-05-31,2021-05-31,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03998254,0,0,0,0,0,0,2027-02-01,2028-02-01,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,2145
NCT03998709,0,0,0,0,0,0,2020-10-31,2021-10-31,,Mayo Clinic,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT04002440,0,0,0,0,0,0,2021-10-31,2022-10-31,,"University of California, San Diego",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,1,0,0,1,0,561
NCT04003012,0,0,0,0,0,0,2020-06-25,2021-06-25,,CAMC Health System,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,38
NCT04004611,0,0,0,0,0,0,2022-08-25,2023-08-25,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1512
NCT04005339,0,0,0,0,0,0,2021-07-31,2022-07-31,,Georgetown University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT04013555,0,0,0,0,0,0,2024-03-31,2025-03-31,,"University of Maryland, Baltimore",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,144
NCT04016610,0,0,0,0,0,0,2019-10-28,2020-10-28,,Soliton,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT04017390,0,0,0,0,0,0,2021-01-31,2022-01-31,,John Fowler,Other,0,1,0,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT04017819,0,0,0,0,0,0,2021-12-31,2022-12-31,,Stanford University,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT04018027,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Cara Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT04021238,0,0,0,0,0,0,2021-12-31,2022-12-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT04026113,0,0,0,0,0,0,2022-01-31,2023-01-31,,Allergan,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT04028492,0,0,0,0,0,0,2020-07-31,2021-07-31,,Vanda Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,37
NCT04029467,0,0,0,0,0,0,2021-07-17,2022-07-17,,Lebanese American University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,8
NCT04030000,0,0,0,0,0,0,2022-08-31,2023-08-31,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,1,0,0,3,1,0,271
NCT04030559,0,0,0,0,0,0,2024-08-01,2025-08-01,,"University of California, Davis",Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT04031066,0,0,0,0,0,0,2021-03-15,2022-03-15,,Chiesi Farmaceutici S.p.A.,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,130
NCT04032860,0,0,0,0,0,0,2023-02-10,2024-02-10,,West China Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,114
NCT04034030,0,0,0,0,0,0,2020-04-30,2021-04-30,,Children's Mercy Hospital Kansas City,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,138
NCT04034225,0,0,0,0,0,0,2021-02-01,2022-02-01,,"Sensei Biotherapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT04035460,0,0,0,0,0,0,2020-09-30,2021-09-30,,Baystate Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,34
NCT04039490,0,0,0,0,0,0,2021-08-31,2022-08-31,,Clear Guide Medical,Industry,1,0,1,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,8
NCT04042116,0,0,0,0,0,0,2023-07-31,2024-07-31,,"Clovis Oncology, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT04042402,0,0,0,0,0,0,2023-12-31,2024-12-31,,"Dicerna Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,7
NCT04042714,0,0,0,0,0,0,2023-08-15,2024-08-15,,Baylor Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,131
NCT04043312,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Pennsylvania,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1052
NCT04044950,0,0,0,0,0,0,2023-07-03,2024-07-03,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT04047186,0,0,0,0,0,0,2024-04-30,2025-04-30,,Tongji Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,71
NCT04047641,0,0,0,0,0,0,2022-02-01,2023-02-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT04049357,0,0,0,0,0,0,2020-10-15,2021-10-15,,Odense University Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,292
NCT04050982,0,0,0,0,0,0,2020-09-01,2021-09-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT04052698,0,0,0,0,0,0,2021-04-30,2022-04-30,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,1,1,0,54
NCT04055714,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Piedmont Ear, Nose, Throat and Related Allergy, PC",Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT04055909,0,0,0,0,0,0,2021-04-30,2022-04-30,,Inotrem,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT04057378,0,0,0,0,0,0,2022-11-15,2023-11-15,,Region Örebro County,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,57
NCT04057768,0,0,0,0,0,0,2020-07-19,2021-07-19,,Venus Concept,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT04058249,0,0,0,0,0,0,2022-12-01,2023-12-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT04059159,0,0,0,0,0,0,2020-08-31,2021-08-31,,Spinal Singularity,Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT04059679,0,0,0,0,0,0,2020-03-31,2021-03-31,,LifeBridge Health,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT04060316,0,0,0,0,0,0,2020-08-31,2021-08-31,,"GeneOne Life Science, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT04060927,0,0,0,0,0,0,2022-11-30,2023-11-30,,Atrium Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,95
NCT04061330,0,0,0,0,0,0,2020-05-31,2021-05-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT04064346,0,0,0,0,0,0,2023-03-31,2024-03-31,,Palladio Biosciences,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT04065308,0,0,0,0,0,0,2019-12-21,2020-12-21,,Seoul National University Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1227
NCT04069273,0,0,0,0,0,0,2021-09-30,2022-09-30,,Harry H Yoon,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04072016,0,0,0,0,0,0,2021-12-31,2022-12-31,,MicroOptx,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,3
NCT04079738,0,0,0,0,0,0,2022-10-31,2023-10-31,,H Scott Boswell,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04080752,0,0,0,0,0,0,2021-05-24,2022-05-24,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT04085172,0,0,0,0,0,0,2024-04-29,2025-04-29,,Shire,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,342
NCT00038727,0,1,0,1,0,0,2024-10-31,2025-10-31,2017-02-21,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,1,3.0,Phase 3,0,2002.0,0,1,0,0,0,0,0,0,0,0,1,495
NCT00121251,1,0,1,1,0,1,2017-03-14,2018-03-14,2019-04-30,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT00200161,1,1,0,1,0,0,2017-05-04,2018-05-04,2018-01-10,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00303719,0,0,0,0,0,0,2019-04-29,2020-04-29,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,1,2002.0,1,1,1,0,0,1,0,0,0,0,1,218
NCT00408447,0,0,0,0,0,0,2019-12-31,2020-12-31,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2004.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT00416351,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00423514,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2006.0,0,1,1,0,0,0,0,0,0,0,1,1432
NCT00424866,0,0,0,0,0,0,2021-12-31,2022-12-31,,"CardioVascular BioTherapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT00507728,0,0,0,0,0,0,2019-12-01,2020-12-01,,M.D. Anderson Cancer Center,Other,0,0,1,2.0,Phase 2/Phase 3,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00526253,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Bioheart, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2007.0,0,0,1,0,0,0,0,0,0,0,1,9
NCT00543777,0,0,0,0,0,0,2019-09-30,2020-09-30,,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2007.0,0,0,0,0,1,0,0,0,0,0,1,2066
NCT00565773,0,0,0,0,0,0,2019-08-31,2020-08-31,,Emory University,Other,0,1,0,1.0,Phase 2,0,2007.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT00577278,0,0,0,0,0,0,2019-12-31,2020-12-31,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2007.0,0,1,1,0,0,1,0,0,0,0,1,358
NCT00578721,1,0,0,0,1,0,2017-12-31,2018-12-31,,"University of California, Irvine",Other,0,0,0,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,310
NCT00583050,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2001.0,0,0,0,1,0,0,0,0,0,0,1,581
NCT00591838,1,1,0,1,0,0,2018-06-12,2019-06-12,2019-06-04,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2006.0,1,0,0,0,0,1,0,0,0,0,1,1151
NCT00618657,0,0,0,0,0,0,2021-02-28,2022-02-28,,"University of California, Irvine",Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,310
NCT00618917,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pittsburgh,Other,0,0,0,0.0,Phase 1/Phase 2,0,2005.0,0,0,0,0,0,0,0,1,0,0,1,1054
NCT00696111,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Chicago,Other,0,0,0,5.0,,0,2007.0,1,1,0,1,0,0,0,0,0,0,1,594
NCT00703820,1,1,0,1,0,0,2017-03-30,2018-03-30,2018-03-02,St. Jude Children's Research Hospital,Other,0,1,1,3.0,Phase 3,0,2008.0,0,1,0,1,0,0,0,0,1,0,1,302
NCT00732498,0,1,0,1,0,0,2018-10-15,2019-10-15,2019-07-18,University of Arizona,Other,0,0,1,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,265
NCT00738101,0,0,0,0,0,0,2018-11-30,2019-11-30,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT00863369,0,0,0,0,0,0,2020-07-31,2021-07-31,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2005.0,0,1,1,0,0,0,0,0,0,0,1,358
NCT00899431,0,0,1,1,0,0,2018-10-07,2019-10-07,2019-08-29,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00911079,0,0,0,0,0,0,2020-09-30,2021-09-30,,"University of California, San Francisco",Other,0,0,1,5.0,,0,2009.0,0,0,0,0,0,1,0,0,0,0,1,1443
NCT00917462,1,1,0,1,0,0,2018-08-31,2019-08-31,2019-02-20,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT00923013,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT00926237,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Arkansas,Other,0,0,1,5.0,,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,285
NCT00935012,0,0,0,0,0,0,2021-12-31,2022-12-31,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,2856
NCT00969111,0,0,0,0,0,0,2031-08-31,2032-08-31,,Proton Collaborative Group,Other,0,0,0,5.0,,0,2009.0,0,0,0,0,0,1,0,0,0,0,1,9
NCT01013441,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2009.0,1,0,1,0,0,0,0,0,0,0,1,1052
NCT01028937,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-03-28,"NTK Enterprises, Inc.",Industry,1,0,0,5.0,,1,2009.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT01035463,1,0,1,1,0,1,2017-07-27,2018-07-27,2019-08-07,University of Nebraska,Other,0,0,1,0.0,Phase 1/Phase 2,0,2009.0,1,1,1,0,0,0,0,0,0,0,1,327
NCT01046825,0,0,0,0,0,0,2022-10-31,2023-10-31,,St. Jude Children's Research Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,302
NCT01050699,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Arizona,Other,0,0,1,4.0,Phase 4,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,265
NCT01068249,0,0,0,0,0,0,2020-04-30,2021-04-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01089426,0,0,0,0,0,0,2019-04-30,2020-04-30,,Children's Hospital Los Angeles,Other,0,0,0,5.0,,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,82
NCT01112072,0,0,0,0,0,0,2019-12-31,2020-12-31,,Cornea and Laser Eye Institute,Other,0,0,0,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01128816,0,0,0,0,0,0,2020-06-30,2021-06-30,,Toronto Rehabilitation Institute,Other,0,1,0,4.0,Phase 4,0,2010.0,0,0,0,1,0,0,0,0,1,0,1,32
NCT01129544,0,0,0,0,0,0,2022-03-31,2023-03-31,,David Williams,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,4
NCT01141309,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01141478,1,0,1,1,0,0,2017-06-30,2018-06-30,2017-09-12,Loma Linda University,Other,0,0,0,5.0,,0,2010.0,1,1,0,0,0,1,0,0,0,0,1,194
NCT01176604,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01182766,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Virginia,Other,0,0,1,2.0,Phase 2/Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,402
NCT01183416,0,0,0,0,0,0,2018-10-31,2019-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01185366,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01211457,0,0,0,0,0,0,2020-06-20,2021-06-20,,"Cyclacel Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,13
NCT01212952,1,0,1,1,0,1,2017-08-15,2018-08-15,2019-05-06,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT01216683,0,0,0,0,0,0,2020-06-01,2021-06-01,,Eastern Cooperative Oncology Group,Other,0,0,1,1.0,Phase 2,0,2010.0,0,1,1,0,0,0,0,0,0,0,1,175
NCT01243190,0,0,0,0,0,0,2022-03-31,2023-03-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01253460,1,1,0,1,0,0,2018-03-28,2019-03-28,2019-03-27,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01259856,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-29,Ronald Hoffman,Other,0,1,1,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT01263938,1,1,0,1,0,1,2017-10-31,2018-10-31,2019-02-06,University of Pennsylvania,Other,0,0,1,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT01266642,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01272037,0,0,0,0,0,0,2022-02-01,2023-02-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01289457,1,0,1,1,0,0,2017-06-28,2018-06-28,2018-06-18,M.D. Anderson Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01331239,0,0,0,0,0,0,2019-11-11,2020-11-11,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01360593,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dwight Heron,Other,0,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,1,0,0,0,0,1,6
NCT01393405,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-01-09,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT01399827,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-05-17,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01407952,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-31,Northwestern University,Other,0,1,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,1,0,1,925
NCT01414608,1,0,0,0,1,0,2018-07-09,2019-07-09,,Gynecologic Oncology Group,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,1,0,0,1,0,1,200
NCT01431105,1,1,0,1,0,1,2018-01-31,2019-01-31,2019-04-01,"University of California, San Diego",Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT01439555,1,1,0,1,0,1,2017-11-30,2018-11-30,2019-05-23,"University of Massachusetts, Worcester",Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,163
NCT01444716,0,0,0,0,0,0,2020-12-31,2021-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT01453127,0,0,0,0,0,0,2022-12-31,2023-12-31,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2011.0,0,1,0,1,0,0,0,0,0,0,1,1898
NCT01456481,0,0,0,0,0,0,2018-12-20,2019-12-20,,Dr. Bob Sheldon,Other,0,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,1
NCT01460654,0,0,0,0,0,0,2019-06-30,2020-06-30,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01464164,0,0,0,0,0,0,2020-03-31,2021-03-31,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,271
NCT01465295,1,0,0,0,1,0,2017-12-29,2018-12-29,,SpineForm LLC,Industry,1,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT01475643,1,1,0,1,0,0,2017-06-02,2018-06-02,2018-04-11,Bausch & Lomb Incorporated,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,142
NCT01503515,0,0,0,0,0,0,2019-09-30,2020-09-30,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,389
NCT01504438,0,0,0,0,0,0,2020-01-31,2021-01-31,,Duke University,Other,0,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT01531959,0,0,0,0,0,0,2019-06-30,2020-06-30,,Massachusetts General Hospital,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1699
NCT01533207,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-02-27,Gynecologic Oncology Group,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,1,0,0,0,0,0,1,0,1,200
NCT01536392,0,0,0,0,0,0,2020-03-31,2021-03-31,,M.D. Anderson Cancer Center,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01536535,1,1,0,1,0,1,2018-04-30,2019-04-30,2019-08-06,Connecticut Children's Medical Center,Other,0,0,1,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,35
NCT01539239,1,1,0,1,0,1,2017-06-30,2018-06-30,2019-08-14,"Ivantis, Inc.",Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,5
NCT01554618,0,0,0,0,0,0,2020-06-22,2021-06-22,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT01557244,0,0,0,0,0,0,2020-03-05,2021-03-05,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT01573442,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-04-24,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT01589263,0,0,0,0,0,0,2019-09-30,2020-09-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1012
NCT01596257,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT01601353,0,0,0,0,0,0,2019-05-31,2020-05-31,,"Tissue Genesis, LLC",Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT01603615,1,1,0,1,0,0,2018-09-03,2019-09-03,2019-07-29,Allergan,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,0,1,0,0,0,0,0,1,0,1,495
NCT01621113,1,0,0,0,1,0,2017-10-09,2018-10-09,,Kessler Foundation,Other,0,1,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,79
NCT01621568,0,0,0,0,0,0,2020-04-30,2021-04-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01625234,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Xcovery Holding Company, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01630733,1,0,0,0,1,0,2017-07-31,2018-07-31,,Achieve Life Sciences,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,23
NCT01639872,1,0,0,0,1,0,2017-03-29,2018-03-29,,Dartmouth-Hitchcock Medical Center,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,306
NCT01646645,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,0,0,1,1432
NCT01663857,0,1,0,1,0,1,2017-05-25,2018-05-25,2019-05-08,Eli Lilly and Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT01672814,1,0,0,0,1,0,2017-06-01,2018-06-01,,Cornea and Laser Eye Institute,Other,0,0,0,3.0,Phase 3,0,2012.0,1,1,0,1,0,0,0,0,0,0,1,5
NCT01683994,1,0,1,1,0,1,2018-07-01,2019-07-01,2019-08-27,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01690520,0,0,0,0,0,0,2018-09-18,2019-09-18,,"Nohla Therapeutics, Inc.",Industry,1,0,1,1.0,Phase 2,0,2012.0,0,1,1,0,0,1,0,0,0,0,1,6
NCT01693783,0,0,0,0,0,0,2020-12-31,2021-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,1,0,1,3004
NCT01696734,0,0,0,0,0,0,2019-10-31,2020-10-31,,M.D. Anderson Cancer Center,Other,0,0,1,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01700946,0,0,0,0,0,0,2021-04-30,2022-04-30,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,1,1,0,0,0,0,0,0,1,302
NCT01711632,0,0,0,0,0,0,2019-10-31,2020-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01723826,0,0,0,0,0,0,2017-02-08,2018-02-08,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT01728194,0,0,0,0,0,0,2019-07-31,2020-07-31,,Weill Medical College of Cornell University,Other,0,0,1,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,586
NCT01736592,0,0,0,0,0,0,2034-06-01,2035-06-01,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT01736943,0,0,0,0,0,0,2019-07-31,2020-07-31,,Joseph Tuscano,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01738243,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of California, Los Angeles",Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,692
NCT01743131,1,0,0,0,1,0,2018-06-30,2019-06-30,,Boston Children’s Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,400
NCT01753401,1,0,0,0,1,0,2017-05-31,2018-05-31,,Mallinckrodt,Industry,1,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,91
NCT01757223,0,0,0,0,0,0,2030-10-31,2031-10-31,,Weill Medical College of Cornell University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,0,1,0,0,0,0,0,3,1,0,586
NCT01759303,0,0,0,0,0,0,2017-01-31,2018-01-31,,George Clinical Pty Ltd,Industry,1,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01760291,0,0,0,0,0,0,2019-04-30,2020-04-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,340
NCT01767909,0,0,0,0,0,0,2018-12-11,2019-12-11,,University of Southern California,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,483
NCT01771679,0,0,0,0,0,0,2018-11-30,2019-11-30,,"Stemedica Cell Technologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT01776723,0,0,0,0,0,0,2019-12-31,2020-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,344
NCT01779050,0,0,0,0,0,0,2019-10-31,2020-10-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,1,0,0,0,0,0,0,0,1,1151
NCT01787474,0,0,0,0,0,0,2020-05-30,2021-05-30,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT01794143,0,0,0,0,0,0,2021-07-31,2022-07-31,,GRADE Study Group,Other,0,1,1,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT01794559,0,0,0,0,0,0,2019-12-31,2020-12-31,,CNS Response,Industry,1,0,0,3.0,Phase 3,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT01794793,0,0,0,0,0,0,2023-06-09,2024-06-09,,Novartis Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT01821690,0,0,0,0,0,0,2020-12-31,2021-12-31,,Indiana University,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,497
NCT01822496,1,1,0,1,0,1,2018-06-04,2019-06-04,2019-06-19,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,1,0,0,0,0,1,3004
NCT01832363,0,0,0,0,0,0,2018-12-31,2019-12-31,,Xemed LLC,Industry,1,0,1,2.0,Phase 2/Phase 3,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT01834729,1,1,0,1,0,1,2017-09-06,2018-09-06,2018-11-15,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT01843413,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,374
NCT01845805,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT01852942,0,0,0,0,0,0,2019-01-17,2020-01-17,,University of Minnesota - Clinical and Translational Science Institute,Other,0,1,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT01854554,0,0,0,0,0,0,2019-05-31,2020-05-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01854918,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-20,Amgen,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,1,0,0,0,0,0,1,0,1,685
NCT01859741,1,1,0,1,0,1,2017-04-18,2018-04-18,2018-08-28,"OncoMed Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,28
NCT01865617,0,0,0,0,0,0,2029-04-01,2030-04-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2013.0,0,0,1,0,0,0,0,0,0,0,1,393
NCT01868451,0,0,0,0,0,0,2020-05-31,2021-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,5.0,,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,1432
NCT01869764,1,0,1,1,0,1,2018-07-31,2019-07-31,2019-08-01,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT01870401,0,0,0,0,0,0,2018-05-17,2019-05-17,,C. R. Bard,Industry,1,1,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,1,0,1,77
NCT01871766,0,0,0,0,0,0,2021-06-30,2022-06-30,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,302
NCT01876212,1,1,0,1,0,0,2018-07-11,2019-07-11,2019-06-20,Walter J. Storkus,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,1,0,0,0,0,0,0,0,1,1
NCT01891994,1,1,0,1,0,1,2017-10-16,2018-10-16,2018-11-14,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1091
NCT01896271,0,0,0,0,0,0,2018-12-20,2019-12-20,,University of Texas Southwestern Medical Center,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,0,0,1,626
NCT01896856,0,0,0,0,0,0,2022-10-31,2023-10-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,461
NCT01896999,0,0,0,0,0,0,2025-03-20,2026-03-20,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT01908751,0,0,0,0,0,0,2019-03-18,2020-03-18,,McMaster University,Other,0,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,434
NCT01917006,1,1,0,1,0,0,2017-08-15,2018-08-15,2018-08-15,Allergan,Industry,1,0,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT01923662,0,0,0,0,0,0,2020-04-10,2021-04-10,,VA Office of Research and Development,U.S. Fed,2,0,1,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT01931852,0,0,0,0,0,0,2019-10-31,2020-10-31,,Wake Forest University Health Sciences,Other,0,0,1,5.0,,0,2013.0,0,0,0,0,0,0,0,0,0,0,1,616
NCT01949337,0,0,0,0,0,0,2018-11-02,2019-11-02,,Alliance for Clinical Trials in Oncology,Other,0,1,1,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,456
NCT01957722,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Aesculap Biologics, LLC",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,0,1,0,0,0,0,0,1,0,1,2
NCT01959672,0,0,1,1,0,0,2019-12-31,2020-12-31,2019-09-08,University of Nebraska,Other,0,0,1,1.0,Phase 2,0,2013.0,0,1,1,0,0,1,0,0,0,0,1,327
NCT01960465,0,0,0,0,0,0,2019-08-30,2020-08-30,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1012
NCT01961531,0,0,0,0,0,0,2020-05-31,2021-05-31,,Brown University,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,152
NCT01962792,0,0,0,0,0,0,2019-03-31,2020-03-31,,Pharmacyclics LLC.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,54
NCT01964261,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Richard A. Andersen, PhD",Other,0,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT01966471,0,0,0,0,0,0,2024-01-31,2025-01-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT01972061,0,0,0,0,0,0,2018-12-11,2019-12-11,,University of Pittsburgh,Other,0,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,1054
NCT01978912,0,0,0,0,0,0,2018-10-16,2019-10-16,,"Teijin America, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT01989546,0,0,0,0,0,0,2020-08-06,2021-08-06,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01994850,1,0,1,1,0,1,2017-07-31,2018-07-31,2019-06-21,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,273
NCT02003625,0,0,0,0,0,0,2019-02-28,2020-02-28,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02003924,1,1,0,1,0,0,2017-06-28,2018-06-28,2018-06-15,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02025426,0,0,0,0,0,0,2020-01-31,2021-01-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1342
NCT02025543,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Wisconsin, Madison",Other,0,0,0,5.0,,0,2013.0,0,0,0,0,0,0,0,0,0,0,1,715
NCT02028455,0,0,0,0,0,0,2019-09-30,2020-09-30,,Seattle Children's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,137
NCT02029443,0,0,0,0,0,0,2021-01-31,2022-01-31,,Acerta Pharma BV,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02046525,0,1,0,1,0,0,2018-12-31,2019-12-31,2019-03-25,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,1151
NCT02047461,0,0,0,0,0,0,2020-12-31,2021-12-31,,Origin Biosciences,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02049567,0,0,0,0,0,0,2017-11-06,2018-11-06,,PowerVision,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,2,0,1,2
NCT02053363,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,1,0,2.0,Phase 2/Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02054416,0,0,0,0,0,0,2018-12-31,2019-12-31,,Temple University,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,152
NCT02055963,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02057458,1,0,0,0,1,0,2018-07-31,2019-07-31,,Augusta University,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,117
NCT02061293,0,0,0,0,0,0,2020-10-31,2021-10-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02061397,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02065011,0,0,0,0,0,0,2033-11-02,2034-11-02,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,1222
NCT02066532,0,0,0,0,0,0,2020-11-30,2021-11-30,,Kevin Kalinsky,Other,0,1,1,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02072226,1,1,0,1,0,0,2017-03-22,2018-03-22,2018-03-07,"Genentech, Inc.",Industry,1,0,0,3.0,Phase 3,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,427
NCT02078882,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Christopher Bowlus, MD",Other,0,1,0,4.0,Phase 4,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,1
NCT02079246,1,1,0,1,0,0,2017-07-06,2018-07-06,2018-07-06,H. Lundbeck A/S,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,152
NCT02080819,1,1,0,1,0,0,2017-01-21,2018-01-21,2018-01-19,Virginia Commonwealth University,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT02085421,0,0,0,0,0,0,2024-03-31,2025-03-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT02086188,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Theodore R. Brown, MD MPH",Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02093663,0,0,0,0,0,0,2018-11-28,2019-11-28,,Shire,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,342
NCT02095145,1,0,0,0,1,0,2018-01-23,2019-01-23,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02097641,1,1,0,1,0,1,2017-03-09,2018-03-09,2019-01-15,Michael A. Matthay,Other,0,0,1,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02100956,0,0,0,0,0,0,2020-12-31,2021-12-31,,Wake Forest University Health Sciences,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,616
NCT02101736,0,0,0,0,0,0,2021-05-31,2022-05-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02103478,0,0,0,0,0,0,2019-09-30,2020-09-30,,Astex Pharmaceuticals,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,38
NCT02110472,0,0,0,0,0,0,2018-12-31,2019-12-31,,"PresbiBio, LLC",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02112838,1,1,0,1,0,0,2018-03-23,2019-03-23,2019-03-21,Rigel Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02122172,0,0,0,0,0,0,2019-06-12,2020-06-12,,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02124707,0,0,0,0,0,0,2020-02-27,2021-02-27,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,229
NCT02134314,1,1,0,1,0,0,2017-03-13,2018-03-13,2018-03-13,Cedars-Sinai Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,279
NCT02138305,1,0,0,0,1,0,2018-03-30,2019-03-30,,East Carolina University,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,51
NCT02138669,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,626
NCT02143726,0,0,0,0,0,0,2020-08-31,2021-08-31,,Alliance for Clinical Trials in Oncology,Other,0,1,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT02154061,1,1,0,1,0,1,2017-05-26,2018-05-26,2018-05-30,Emory University,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02155647,0,0,0,0,0,0,2019-05-03,2020-05-03,,EMD Serono,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,97
NCT02157610,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Oklahoma,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,234
NCT02161757,1,1,0,1,0,0,2017-02-28,2018-02-28,2017-12-21,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,2450
NCT02169869,1,1,0,1,0,1,2017-01-31,2018-01-31,2019-04-08,Oregon Health and Science University,Other,0,0,0,5.0,,1,2014.0,1,0,0,1,0,0,0,0,0,0,1,475
NCT02175225,1,1,0,1,0,1,2018-02-10,2019-02-10,2019-05-08,Beth Israel Deaconess Medical Center,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,377
NCT02177773,1,0,0,0,1,0,2017-05-31,2018-05-31,,"University of California, San Francisco",Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02178358,0,0,0,0,0,0,2017-06-30,2018-06-30,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,2,0,1,1512
NCT02178956,1,0,0,0,1,0,2017-12-01,2018-12-01,,"Boston Biomedical, Inc",Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT02194699,1,1,0,1,0,0,2017-05-10,2018-05-10,2018-02-23,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,2450
NCT02197767,1,1,0,1,0,1,2017-04-30,2018-04-30,2019-01-16,Mayo Clinic,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02201212,0,0,0,0,0,0,2019-06-30,2020-06-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02203019,0,0,0,0,0,0,2019-09-30,2020-09-30,,Texas Tech University Health Sciences Center,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,78
NCT02203305,0,0,0,0,0,0,2020-07-31,2021-07-31,,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT02207062,0,0,0,0,0,0,2021-03-31,2022-03-31,,University of Washington,Other,0,0,1,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02213926,1,1,0,1,0,1,2017-02-28,2018-02-28,2018-08-16,Acerta Pharma BV,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02225132,1,1,0,1,0,1,2018-05-24,2019-05-24,2019-07-15,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT02225548,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of South Florida,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02227446,1,0,0,0,1,0,2018-06-30,2019-06-30,,Major Extremity Trauma Research Consortium,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,22
NCT02229149,0,0,0,0,0,0,2019-12-31,2020-12-31,,US Oncology Research,Industry,1,1,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02232620,1,0,0,0,1,0,2017-07-25,2018-07-25,,"Boston Biomedical, Inc",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,27
NCT02245308,1,1,0,1,0,0,2018-03-30,2019-03-30,2019-02-06,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT02257567,0,0,0,0,0,0,2019-12-17,2020-12-17,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02265341,1,1,0,1,0,1,2018-05-01,2019-05-01,2019-06-03,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02267226,1,1,0,1,0,0,2018-02-14,2019-02-14,2018-12-21,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,54
NCT02273726,0,0,0,0,0,0,2018-09-19,2019-09-19,,FibroGen,Industry,1,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02276885,0,0,0,0,0,0,2019-06-11,2020-06-11,,NYU Langone Health,Other,0,0,0,5.0,,0,2014.0,0,0,0,0,0,1,0,0,0,0,1,869
NCT02278120,0,1,0,1,0,0,2017-08-21,2018-08-21,2018-08-17,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02280291,0,0,1,1,0,0,2018-12-13,2019-12-13,2019-08-28,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,1,0,0,0,0,0,0,1,869
NCT02283528,1,1,0,1,0,0,2017-12-21,2018-12-21,2018-10-17,Emory University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,947
NCT02283996,0,0,0,0,0,0,2021-12-31,2022-12-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02285114,0,0,0,0,0,0,2020-07-31,2021-07-31,,Gilead Sciences,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02287233,0,0,0,0,0,0,2021-05-12,2022-05-12,,AbbVie,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02302846,1,1,0,1,0,0,2017-05-30,2018-05-30,2018-05-03,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02304367,0,0,0,0,0,0,2017-07-27,2018-07-27,,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,36
NCT02307565,0,0,0,0,0,0,2019-12-31,2020-12-31,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,41
NCT02308033,0,0,0,0,0,0,2017-06-30,2018-06-30,,"Curatek Pharmaceuticals, LLC",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02310672,0,0,0,0,0,0,2019-09-01,2020-09-01,,Actelion,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,128
NCT02310919,1,0,0,0,1,0,2018-06-20,2019-06-20,,"University of California, San Francisco",Other,0,1,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02311933,0,0,0,0,0,0,2020-07-01,2021-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02323295,0,0,0,0,0,0,2019-07-31,2020-07-31,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2015.0,1,0,0,0,0,1,0,0,0,0,1,1699
NCT02324049,1,1,0,1,0,0,2017-10-16,2018-10-16,2018-06-12,Alexion Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,86
NCT02324725,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02326454,0,0,0,0,0,0,2017-03-29,2018-03-29,,Light Sciences Oncology,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,1,0,1,0,0,0,0,0,0,1,7
NCT02326805,0,0,0,0,0,0,2018-11-30,2019-11-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02327078,0,0,0,0,0,0,2019-02-01,2020-02-01,,Incyte Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT02328755,0,0,0,0,0,0,2019-07-31,2020-07-31,,University of Michigan Rogel Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,213
NCT02330562,0,0,0,0,0,0,2020-02-18,2021-02-18,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02334306,1,1,0,1,0,0,2018-01-16,2019-01-16,2019-01-16,MedImmune LLC,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,269
NCT02335411,0,0,0,0,0,0,2020-05-27,2021-05-27,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02336815,0,0,0,0,0,0,2019-04-30,2020-04-30,,Karyopharm Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,22
NCT02337686,0,0,0,0,0,0,2019-11-30,2020-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02337829,0,0,0,0,0,0,2021-07-31,2022-07-31,,Acerta Pharma BV,Industry,1,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,31
NCT02339571,0,0,0,0,0,0,2021-11-01,2022-11-01,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02341209,0,0,0,0,0,0,2020-02-06,2021-02-06,,Rochester General Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT02343224,0,0,0,0,0,0,2019-12-31,2020-12-31,,Emory University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02344290,0,0,0,0,0,0,2023-03-24,2024-03-24,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT02351739,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-07-19,Acerta Pharma BV,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02354781,1,0,0,0,1,0,2017-11-30,2018-11-30,,Jerry R. Mendell,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,3
NCT02356705,1,0,0,0,1,0,2017-12-31,2018-12-31,,Bassett Healthcare,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,18
NCT02357342,1,1,0,1,0,0,2017-01-31,2018-01-31,2017-02-23,"Maturi, Raj K., M.D., P.C.",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02357966,1,0,0,0,1,0,2017-01-31,2018-01-31,,"XBiotech, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,15
NCT02366091,0,0,0,0,0,0,2020-08-31,2021-08-31,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02366819,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Chicago,Other,0,0,1,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,594
NCT02372253,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-14,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02376543,0,0,0,0,0,0,2019-03-15,2020-03-15,,Parkview Health,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,4
NCT02379247,1,0,0,0,1,0,2017-11-30,2018-11-30,,Priyanka Sharma,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02379390,1,1,0,1,0,0,2018-05-10,2019-05-10,2019-05-10,Sanofi,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02389959,0,0,0,0,0,0,2019-09-30,2020-09-30,,Stanford University,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02390752,0,0,0,0,0,0,2020-12-01,2021-12-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02393248,0,0,0,0,0,0,2020-07-31,2021-07-31,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT02393716,0,0,0,0,0,0,2021-03-31,2022-03-31,,Medtronic Endovascular,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,64
NCT02395042,1,1,0,1,0,0,2017-06-29,2018-06-29,2018-06-29,Allergan,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,495
NCT02395614,0,0,0,0,0,0,2021-12-31,2022-12-31,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,422
NCT02399085,0,0,0,0,0,0,2018-11-30,2019-11-30,,MorphoSys AG,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,8
NCT02399475,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Pennsylvania,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02403505,0,0,0,0,0,0,2020-08-31,2021-08-31,,"Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT02404896,0,0,0,0,0,0,2025-01-31,2026-01-31,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT02409368,0,0,0,0,0,0,2019-09-15,2020-09-15,,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02410707,1,0,0,0,1,0,2018-01-31,2019-01-31,,Albert Einstein Healthcare Network,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,45
NCT02412670,0,0,0,0,0,0,2020-02-29,2021-02-28,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,75
NCT02414607,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Missouri-Columbia,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,214
NCT02416908,0,0,0,0,0,0,2019-12-20,2020-12-20,,Washington University School of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02419508,1,1,0,1,0,0,2018-02-27,2019-02-27,2018-10-16,Alcon Research,Industry,1,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,492
NCT02420652,0,0,0,0,0,0,2022-01-08,2023-01-08,,"Rutgers, The State University of New Jersey",Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,227
NCT02420821,1,1,0,1,0,0,2017-09-29,2018-09-29,2018-08-21,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02427191,1,0,0,0,1,0,2018-08-31,2019-08-31,,"MiMedx Group, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT02427568,1,0,0,0,1,0,2018-05-31,2019-05-31,,Multidisciplinary Association for Psychedelic Studies,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,24
NCT02434965,0,0,0,0,0,0,2021-01-31,2022-01-31,,New York Medical College,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT02438306,0,0,0,0,0,0,2020-06-30,2021-06-30,,"BioCardia, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,3
NCT02438722,0,0,0,0,0,0,2020-02-29,2021-02-28,,Southwest Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,288
NCT02442830,1,1,0,1,0,0,2017-07-02,2018-07-02,2018-06-26,"University of Massachusetts, Worcester",Other,0,1,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,163
NCT02443337,0,0,0,0,0,0,2017-09-01,2018-09-01,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,1512
NCT02446457,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT02451358,1,1,0,1,0,1,2017-01-28,2018-01-28,2018-01-29,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,2,0,1,285
NCT02452346,1,1,0,1,0,0,2017-10-25,2018-10-25,2018-05-02,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,586
NCT02453646,1,0,0,0,1,0,2017-09-30,2018-09-30,,Marvao Medical,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02457481,1,0,0,0,1,0,2018-08-31,2019-08-31,,National Foundation for Fertility Research,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT02460835,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Michigan Rogel Cancer Center,Other,0,0,0,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,213
NCT02470897,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Wisconsin, Madison",Other,0,0,1,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,715
NCT02490631,0,0,0,0,0,0,2018-12-30,2019-12-30,,Vanderbilt University,Other,0,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,499
NCT02497937,1,1,0,1,0,0,2017-08-21,2018-08-21,2018-08-07,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3276
NCT02507336,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Miami,Other,0,0,0,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,476
NCT02508935,1,0,0,0,1,0,2017-04-26,2018-04-26,,Mallinckrodt,Industry,1,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,91
NCT02509546,0,0,0,0,0,0,2019-12-31,2020-12-31,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT02510599,0,0,0,0,0,0,2017-01-27,2018-01-27,,"Melinta Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT02513199,0,0,0,0,0,0,2019-12-31,2020-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,1,0,0,0,0,1,412
NCT02516241,0,0,0,0,0,0,2019-09-23,2020-09-23,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02519023,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-10-09,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,749
NCT02520154,0,0,0,0,0,0,2020-07-31,2021-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02521792,0,0,0,0,0,0,2019-06-30,2020-06-30,,Clementia Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02525939,0,0,0,0,0,0,2020-08-31,2021-08-31,,DalCor Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT02530489,0,0,0,0,0,0,2021-02-28,2022-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02530619,0,0,0,0,0,0,2019-07-31,2020-07-31,,Northwestern University,Other,0,1,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02531373,1,1,0,1,0,0,2017-04-14,2018-04-14,2018-03-16,Merck Sharp & Dohme Corp.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,3,0,1,2145
NCT02533778,1,0,0,0,1,0,2018-07-01,2019-07-01,,Abington Memorial Hospital,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,9
NCT02533934,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02538666,0,0,0,0,0,0,2018-10-01,2019-10-01,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,1104
NCT02540226,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,157
NCT02542956,0,0,0,0,0,0,2018-12-31,2019-12-31,,Henry Ford Health System,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,151
NCT02543203,1,0,1,1,0,1,2018-03-16,2019-03-16,2019-04-30,Jill Hollway,Other,0,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,1
NCT02543983,0,0,0,0,0,0,2021-07-21,2022-07-21,,National Institute of Mental Health (NIMH),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,330
NCT02544451,1,0,1,1,0,0,2018-08-31,2019-08-31,2019-08-29,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,141
NCT02546362,1,1,0,1,0,1,2018-05-15,2019-05-15,2019-06-05,Cefaly Technology,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,7
NCT02547662,0,0,0,0,0,0,2020-12-15,2021-12-15,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02549508,1,0,0,0,1,0,2018-03-31,2019-03-31,,Fisher and Paykel Healthcare,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,56
NCT02550873,1,1,0,1,0,0,2018-05-02,2019-05-02,2018-11-20,"Promedior, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,4
NCT02552316,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Pennsylvania,Other,0,1,0,4.0,Phase 4,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1052
NCT02560025,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-09-07,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02573883,0,0,0,0,0,0,2019-09-30,2020-09-30,,Medstar Health Research Institute,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,79
NCT02575079,1,1,0,1,0,0,2018-03-29,2019-03-29,2019-03-29,Emory University,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,947
NCT02576795,0,0,0,0,0,0,2022-02-28,2023-02-28,,BioMarin Pharmaceutical,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,0,0,0,0,0,1,2,0,1,85
NCT02576860,0,0,0,0,0,0,2017-02-27,2018-02-27,,"Maruho Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,26
NCT02577406,0,0,0,0,0,0,2020-03-31,2021-03-31,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02579044,0,0,0,0,0,0,2020-12-31,2021-12-31,,Boston Children’s Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,400
NCT02581943,0,0,0,0,0,0,2022-06-30,2023-06-30,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,616
NCT02582905,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Texas Southwestern Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,626
NCT02587962,0,0,0,0,0,0,2021-06-30,2022-06-30,,Medivir,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT02588248,0,0,0,0,0,0,2019-04-12,2020-04-12,,University Hospitals Cleveland Medical Center,Other,0,0,0,3.0,Phase 3,1,2019.0,1,1,0,0,0,0,0,0,0,1,0,185
NCT02591199,1,0,0,0,1,0,2018-05-14,2019-05-14,,Urigen,Industry,1,0,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02592629,1,1,0,1,0,0,2017-06-20,2018-06-20,2018-06-20,Milton S. Hershey Medical Center,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT02593123,0,0,0,0,0,0,2025-12-31,2026-12-31,,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,417
NCT02593409,1,0,0,0,1,0,2018-04-30,2019-04-30,,MRC/UVRI Uganda Research Unit on Aids,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,5
NCT02594124,0,0,0,0,0,0,2023-08-29,2024-08-29,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,324
NCT02594735,0,0,0,0,0,0,2019-07-31,2020-07-31,,George Washington University,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,85
NCT02597504,0,0,0,0,0,0,2020-06-30,2021-06-30,,"ImPACT Applications, Inc.",Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT02603809,0,0,0,0,0,0,2017-03-31,2018-03-31,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,79
NCT02604940,1,0,0,0,1,0,2018-06-25,2019-06-25,,West Virginia University,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,74
NCT02605421,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,218
NCT02605824,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-02-11,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02606045,0,0,0,0,0,0,2022-08-15,2023-08-15,,Margaret Ragni,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT02607228,0,0,0,0,0,0,2017-10-25,2018-10-25,,Gilead Sciences,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,510
NCT02608450,0,0,0,0,0,0,2018-04-11,2019-04-11,,Cassiopea SpA,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02610777,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT02612779,0,0,0,0,0,0,2019-10-27,2020-10-27,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02614183,0,1,0,1,0,1,2017-03-22,2018-03-22,2018-10-08,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02615691,0,0,0,0,0,0,2023-06-29,2024-06-29,,Baxalta now part of Shire,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,1,0,1,107
NCT02617472,1,0,1,1,0,0,2017-07-31,2018-07-31,2018-06-30,Lelo Inc.,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02617628,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Pennsylvania,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02618382,1,0,1,1,0,1,2017-06-30,2018-06-30,2018-11-19,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT02620813,1,0,0,0,1,0,2017-10-12,2018-10-12,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,530
NCT02621424,0,0,0,0,0,0,2018-12-28,2019-12-28,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1012
NCT02629692,0,0,0,0,0,0,2020-03-31,2021-03-31,,Sun Pharma Advanced Research Company Limited,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,29
NCT02631070,0,0,0,0,0,0,2017-11-21,2018-11-21,,Celgene,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02632045,0,0,0,0,0,0,2019-11-30,2020-11-30,,Kevin Kalinsky,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02632448,0,0,0,0,0,0,2019-12-31,2020-12-31,,Esperas Pharma Inc.,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1
NCT02633046,0,0,0,0,0,0,2021-06-30,2022-06-30,,Mallinckrodt,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,91
NCT02633306,0,0,0,0,0,0,2019-07-01,2020-07-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,749
NCT02633969,1,0,0,0,1,0,2017-01-31,2018-01-31,,"Iroko Pharmaceuticals, LLC",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,13
NCT02636283,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,749
NCT02636517,0,0,0,0,0,0,2023-12-31,2024-12-31,,Children's Hospital of Philadelphia,Other,0,0,0,5.0,,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,324
NCT02638909,1,0,0,0,1,0,2018-03-29,2019-03-29,,"Criterium, Inc.",Industry,1,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,5
NCT02639182,0,0,0,0,0,0,2021-09-30,2022-09-30,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,135
NCT02639910,0,0,0,0,0,0,2018-11-30,2019-11-30,,MorphoSys AG,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,1,0,1,8
NCT02640053,1,1,0,1,0,0,2017-09-05,2018-09-05,2018-09-05,Academic and Community Cancer Research United,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT02648724,0,0,0,0,0,0,2019-12-31,2020-12-31,,Symphogen A/S,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,14
NCT02649192,1,0,1,1,0,0,2018-06-29,2019-06-29,2019-06-25,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,302
NCT02649426,0,0,0,0,0,0,2020-03-31,2021-03-31,,"ReCor Medical, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,4
NCT02649959,0,0,0,0,0,0,2019-12-31,2020-12-31,,Curemark,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02651324,1,0,0,0,1,0,2017-12-31,2018-12-31,,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,51
NCT02652780,1,0,0,0,1,0,2018-01-31,2019-01-31,,GenSight Biologics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,0,1,0,0,0,1,1,0,1,8
NCT02652923,0,0,0,0,0,0,2020-05-31,2021-05-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,162
NCT02653495,1,1,0,1,0,0,2017-03-31,2018-03-31,2017-06-08,Rockefeller University,Other,0,0,0,5.0,,1,2016.0,1,0,1,0,0,0,0,0,0,0,1,104
NCT02655016,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Tesaro, Inc.",Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,31
NCT02656069,1,1,0,1,0,1,2017-08-14,2018-08-14,2018-08-31,Xeris Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,14
NCT02657356,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Reata Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,44
NCT02660359,0,0,0,0,0,0,2018-11-09,2019-11-09,,Ipsen,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,1,0,0,0,0,0,2,0,1,214
NCT02661542,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Fujifilm Pharmaceuticals U.S.A., Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT02663895,0,0,0,0,0,0,2019-06-30,2020-06-30,,Stanford University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02665065,0,0,0,0,0,0,2019-12-31,2020-12-31,,Actinium Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,5
NCT02665273,1,0,0,0,1,0,2018-01-31,2019-01-31,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT02665741,1,0,1,1,0,1,2017-02-28,2018-02-28,2019-04-15,"University of California, Davis",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,530
NCT02667067,0,0,0,0,0,0,2020-02-29,2021-02-28,,Simplify Medical Inc.,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02669758,1,1,0,1,0,0,2018-06-29,2019-06-29,2019-06-18,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,70
NCT02670083,0,0,0,0,0,0,2019-05-31,2020-05-31,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02676843,0,0,0,0,0,0,2018-11-25,2019-11-25,,Columbia University,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,675
NCT02677324,0,0,0,0,0,0,2020-02-29,2021-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02678247,0,0,0,0,0,0,2019-09-30,2020-09-30,,Northwestern University,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,925
NCT02678572,0,0,0,0,0,0,2020-04-01,2021-04-01,,Delcath Systems Inc.,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,0,0,0,0,0,1,0,1,0,1,8
NCT02680041,1,1,0,1,0,0,2017-11-01,2018-11-01,2018-10-31,Blue Earth Diagnostics,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02681302,0,0,0,0,0,0,2020-03-31,2021-03-31,,Hackensack Meridian Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT02685826,1,1,0,1,0,0,2017-12-15,2018-12-15,2018-12-04,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02689206,1,1,0,1,0,0,2017-01-25,2018-01-25,2018-01-23,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,3276
NCT02696564,0,0,0,0,0,0,2020-01-31,2021-01-31,,JHSPH Center for Clinical Trials,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT02697344,0,0,0,0,0,0,2021-06-15,2022-06-15,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT02697734,0,0,0,0,0,0,2019-06-19,2020-06-19,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02703259,1,1,0,1,0,1,2017-07-31,2018-07-31,2018-10-24,Christiana Care Health Services,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,76
NCT02708641,0,0,0,0,0,0,2020-10-31,2021-10-31,,Michael Boyiadzis,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02709083,1,1,0,1,0,0,2018-07-31,2019-07-31,2018-08-23,Emory University,Other,0,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02713126,0,0,0,0,0,0,2020-04-30,2021-04-30,,Barry Borlaug,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,1,0,0,0,0,0,0,1,2
NCT02714972,1,0,0,0,1,0,2017-03-31,2018-03-31,,Jaeb Center for Health Research,Other,0,0,1,1.0,Phase 2,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,93
NCT02715115,0,0,0,0,0,0,2017-01-31,2018-01-31,,Neuren Pharmaceuticals Limited,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02716038,0,0,0,0,0,0,2020-04-30,2021-04-30,,Columbia University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT02717962,0,0,0,0,0,0,2020-09-30,2021-09-30,,"DelMar Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT02718157,1,1,0,1,0,1,2017-02-07,2018-02-07,2018-10-16,GenePOC,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,4
NCT02719613,0,0,0,0,0,0,2020-05-28,2021-05-28,,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02720094,0,0,0,0,0,0,2022-03-30,2023-03-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2133
NCT02721732,0,0,0,0,0,0,2020-08-20,2021-08-20,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02723994,0,0,0,0,0,0,2024-02-29,2025-02-28,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT02725177,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Cleveland Clinic,Other,0,1,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,581
NCT02725476,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-11-09,"Xencor, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,13
NCT02728726,0,0,0,0,0,0,2019-02-28,2020-02-28,,Mayo Clinic,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02729896,1,0,1,1,0,0,2018-09-03,2019-09-03,2019-08-28,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02731638,1,0,1,1,0,0,2018-07-31,2019-07-31,2019-06-26,"University of California, San Francisco",Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1443
NCT02733614,0,0,0,0,0,0,2020-06-30,2021-06-30,,Azevan Pharmaceuticals,Industry,1,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,8
NCT02739347,0,0,0,0,0,0,2019-06-30,2020-06-30,,Baylor College of Medicine,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,518
NCT02754596,1,0,0,0,1,0,2017-09-30,2018-09-30,,Glaukos Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,34
NCT02756364,0,0,0,0,0,0,2019-10-22,2020-10-22,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT02758184,0,0,0,0,0,0,2020-06-30,2021-06-30,,Duke University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1342
NCT02763254,1,1,0,1,0,1,2018-02-17,2019-02-17,2019-02-19,Cell Medica Ltd,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,0,1,0,0,0,0,0,0,0,1,8
NCT02763579,1,1,0,1,0,0,2018-04-24,2019-04-24,2019-04-19,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02767804,0,0,0,0,0,0,2018-11-04,2019-11-04,,"Xcovery Holding Company, LLC",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02768675,1,0,0,0,1,0,2018-06-30,2019-06-30,,Intellirod Spine,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02768844,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Massachusetts, Worcester",Other,0,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,163
NCT02769832,0,0,0,0,0,0,2023-04-30,2024-04-30,,Muhammad Furqan,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02770014,0,0,0,0,0,0,2019-11-30,2020-11-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02771197,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Northside Hospital, Inc.",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,16
NCT02772783,1,0,0,0,1,0,2018-05-31,2019-05-31,,Boston Children’s Hospital,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,400
NCT02773576,1,0,0,0,1,0,2017-09-30,2018-09-30,,Braeburn Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02777372,0,0,0,0,0,0,2021-12-31,2022-12-31,,University of Pennsylvania,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1052
NCT02780349,1,1,0,1,0,0,2017-08-30,2018-08-30,2018-01-18,Gardia Medical,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,4
NCT02781792,0,0,0,0,0,0,2020-05-31,2021-05-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02781883,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Bio-Path Holdings, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02785042,0,0,0,0,0,0,2019-12-31,2020-12-31,,Heidelberg Engineering GmbH,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,10
NCT02788656,0,0,0,0,0,0,2018-11-09,2019-11-09,,Brigham and Women's Hospital,Other,0,1,0,4.0,Phase 4,1,2016.0,1,1,0,1,0,0,0,0,0,0,1,698
NCT02793817,0,1,0,1,0,1,2017-03-31,2018-03-31,2018-10-25,"Kala Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02794857,1,0,0,0,1,0,2017-12-12,2018-12-12,,"Neuraltus Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,4
NCT02796937,0,0,0,0,0,0,2025-12-31,2026-12-31,,Grifols Therapeutics LLC,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,40
NCT02802293,0,0,0,0,0,0,2020-07-31,2021-07-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,257
NCT02803164,0,0,0,0,0,0,2019-10-31,2020-10-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT02807493,0,0,0,0,0,0,2021-06-30,2022-06-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT02807844,0,0,0,0,0,0,2019-11-15,2020-11-15,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1895
NCT02815293,1,1,0,1,0,0,2017-06-21,2018-06-21,2018-06-18,Allergan,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02815995,0,0,0,0,0,0,2019-08-31,2020-08-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02817087,0,0,0,0,0,0,2019-03-13,2020-03-13,,"David Chiu, MD",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02818582,0,0,0,0,0,0,2021-01-01,2022-01-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,2133
NCT02818920,0,0,0,0,0,0,2020-01-31,2021-01-31,,Neal Ready,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT02819557,0,0,0,0,0,0,2018-02-09,2019-02-09,,PTC Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,42
NCT02820740,0,0,0,0,0,0,2019-06-24,2020-06-24,,Monteris Medical,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT02822560,1,0,0,0,1,0,2017-02-28,2018-02-28,,Wilhelminenspital Vienna,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,7
NCT02823600,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-06-21,"University of North Carolina, Chapel Hill",Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02824211,0,0,0,0,0,0,2019-07-31,2020-07-31,,Loma Linda University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,194
NCT02824445,1,0,0,0,1,0,2018-05-28,2019-05-28,,"72nd Medical Group, Tinker Air Force Base",U.S. Fed,2,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02829060,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of California, San Diego",Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02831998,0,0,0,0,0,0,2017-04-09,2018-04-09,,"Zurex Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02833805,0,0,0,0,0,0,2020-08-31,2021-08-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,1,0,0,0,0,1,461
NCT02834793,0,0,0,0,0,0,2021-03-02,2022-03-02,,Eisai Inc.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,328
NCT02839720,0,0,0,0,0,0,2021-12-31,2022-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02839889,1,1,0,1,0,0,2018-01-11,2019-01-11,2018-11-21,"Hospice of Henderson County, Inc.",Other,0,1,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02842853,0,0,0,0,0,0,2017-02-28,2018-02-28,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,285
NCT02844764,0,0,0,0,0,0,2019-07-31,2020-07-31,,"VivaTech International, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3
NCT02844907,0,0,0,0,0,0,2020-12-01,2021-12-01,,VA Office of Research and Development,U.S. Fed,2,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT02846571,0,0,0,0,0,0,2021-12-31,2022-12-31,,Midhat H. Abdulreda,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT02847598,0,0,0,0,0,0,2019-08-29,2020-08-29,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,324
NCT02854800,1,0,0,0,1,0,2017-04-30,2018-04-30,,West Virginia University,Other,0,1,1,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,74
NCT02856594,0,0,0,0,0,0,2021-02-28,2022-02-28,,Massachusetts General Hospital,Other,0,0,1,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02859441,0,0,0,0,0,0,2019-07-09,2020-07-09,,National Eye Institute (NEI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,263
NCT02859961,0,0,0,0,0,0,2020-07-31,2021-07-31,,"CytoDyn, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,14
NCT02862912,0,0,0,0,0,0,2020-12-31,2021-12-31,,Columbia University,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT02864381,0,0,0,0,0,0,2017-11-08,2018-11-08,,Gilead Sciences,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,510
NCT02864992,0,0,0,0,0,0,2019-06-25,2020-06-25,,"EMD Serono Research & Development Institute, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,42
NCT02869633,0,0,0,0,0,0,2021-10-31,2022-10-31,,Vanderbilt-Ingram Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,180
NCT02871427,0,0,0,0,0,0,2019-01-17,2020-01-17,,Axovant Sciences Ltd.,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,10
NCT02873975,0,0,0,0,0,0,2020-04-30,2021-04-30,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02877732,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-03-27,Stanford University,Other,0,0,1,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,1309
NCT02884648,0,0,0,0,0,0,2020-11-30,2021-11-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02886286,1,0,0,0,1,0,2017-12-31,2018-12-31,,University Hospitals Cleveland Medical Center,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,185
NCT02889861,0,0,0,0,0,0,2019-04-22,2020-04-22,,Immunocore Ltd,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,0,1,7
NCT02891174,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-19,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT02891915,0,0,0,0,0,0,2020-11-01,2021-11-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2133
NCT02892149,0,0,0,0,0,0,2020-03-31,2021-03-31,,Akebia Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,25
NCT02893930,0,0,0,0,0,0,2020-07-31,2021-07-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT02901275,0,0,0,0,0,0,2019-09-30,2020-09-30,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02901613,1,0,0,0,1,0,2017-08-31,2018-08-31,,Albany Medical College,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,51
NCT02901717,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Leonard-Meron Biosciences, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02903446,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT02903836,1,0,1,1,0,1,2017-07-31,2018-07-31,2019-02-27,Wockhardt,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,32
NCT02905331,1,1,0,1,0,0,2018-02-06,2019-02-06,2018-08-09,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT02906930,0,0,0,0,0,0,2017-10-30,2018-10-30,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02907983,0,0,0,0,0,0,2022-08-31,2023-08-31,,David Walega,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02909101,0,0,0,0,0,0,2019-02-23,2020-02-23,,Duke University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT02910219,0,0,0,0,0,0,2019-06-30,2020-06-30,,Georgetown University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT02910700,0,0,0,0,0,0,2021-12-31,2022-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02910882,1,0,0,0,1,0,2018-08-31,2019-08-31,,Scripps Health,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,1,0,0,0,0,1,28
NCT02911935,0,0,0,0,0,0,2021-05-31,2022-05-31,,Washington University School of Medicine,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02912260,1,0,0,0,1,0,2017-10-31,2018-10-31,,"Madrigal Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT02920918,0,0,0,0,0,0,2018-09-30,2019-09-30,,Virginia Commonwealth University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT02923115,0,0,0,0,0,0,2019-07-05,2020-07-05,,"Daiichi Sankyo, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,207
NCT02924428,1,0,0,0,1,0,2018-06-05,2019-06-05,,Venus Concept,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,23
NCT02924688,0,0,0,0,0,0,2019-02-22,2020-02-22,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,1,0,0,0,0,1,0,1,3276
NCT02926638,0,0,0,0,0,0,2022-04-01,2023-04-01,,Southwest Oncology Group,Other,0,0,1,2.0,Phase 2/Phase 3,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,288
NCT02929667,0,0,0,0,0,0,2019-03-06,2020-03-06,,Rup Sainju,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02930044,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of Maryland, College Park",Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,318
NCT02931253,1,0,0,0,1,0,2018-07-10,2019-07-10,,The Guthrie Clinic,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,14
NCT02933489,1,0,0,0,1,0,2018-06-30,2019-06-30,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2016.0,0,0,0,0,0,0,0,0,1,0,1,75
NCT02934503,0,0,0,0,0,0,2019-10-31,2020-10-31,,NYU Langone Health,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,1,0,0,0,1,0,869
NCT02935699,1,0,0,0,1,0,2018-04-30,2019-04-30,,"JDP Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,4
NCT02936323,0,0,0,0,0,0,2020-06-30,2021-06-30,,Tarveda Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,2
NCT02936999,0,0,0,0,0,0,2019-01-31,2020-01-31,,Inova Health Care Services,Other,0,0,0,5.0,,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,41
NCT02937584,1,1,0,1,0,0,2018-05-28,2019-05-28,2019-05-10,"Pearl Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,42
NCT02940262,0,0,0,0,0,0,2021-08-01,2022-08-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,277
NCT02943577,0,0,0,0,0,0,2018-10-26,2019-10-26,,"Naurex, Inc, an affiliate of Allergan plc",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02945839,0,0,0,0,0,0,2019-12-31,2020-12-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,869
NCT02946021,1,1,0,1,0,0,2018-02-28,2019-02-28,2019-02-26,Tactile Medical,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,8
NCT02950506,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT02952313,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-07,"Spirox, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02954510,0,0,0,0,0,0,2021-11-01,2022-11-01,,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,698
NCT02954601,1,1,0,1,0,0,2017-02-24,2018-02-24,2018-02-15,"Oramed, Ltd.",Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02956005,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-14,Georgetown University,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,214
NCT02957331,1,0,1,1,0,1,2018-05-31,2019-05-31,2019-07-23,University of Tennessee,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,99
NCT02960022,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,135
NCT02961062,0,1,0,1,0,1,2018-01-15,2019-01-15,2019-02-19,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1895
NCT02961946,1,0,1,1,0,1,2017-10-31,2018-10-31,2019-08-03,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1699
NCT02964559,0,0,0,0,0,0,2022-02-28,2023-02-28,,Emory University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,947
NCT02969369,0,0,0,0,0,0,2020-05-01,2021-05-01,,Sunovion,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,134
NCT02970162,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-09-24,"Catalyst Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02971683,0,0,0,0,0,0,2020-06-17,2021-06-17,,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT02972554,1,1,0,1,0,1,2017-10-10,2018-10-10,2018-10-19,"University of North Carolina, Chapel Hill",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02974257,0,0,0,0,0,0,2021-08-31,2022-08-31,,Beth Israel Deaconess Medical Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT02974868,0,0,0,0,0,0,2019-05-31,2020-05-31,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02975999,0,0,0,0,0,0,2019-12-31,2020-12-31,,Advocate Health Care,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,29
NCT02976103,1,0,0,0,1,0,2017-12-31,2018-12-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT02977507,1,1,0,1,0,0,2017-10-09,2018-10-09,2018-10-09,Allergan,Industry,1,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02978586,0,0,0,0,0,0,2020-09-30,2021-09-30,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,374
NCT02981342,1,1,0,1,0,0,2018-04-20,2019-04-20,2019-04-18,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02985749,0,0,0,0,0,0,2019-09-30,2020-09-30,,Massachusetts General Hospital,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT02985866,1,0,0,0,1,0,2018-09-04,2019-09-04,,Stacey Anderson,Other,0,1,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT02986373,1,1,0,1,0,0,2018-07-08,2019-07-08,2019-05-03,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,3,0,1,430
NCT02989597,0,0,0,0,0,0,2019-12-31,2020-12-31,,Montefiore Medical Center,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT02991807,0,0,0,0,0,0,2020-06-30,2021-06-30,,Boston Children’s Hospital,Other,0,1,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT02993731,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Boston Biomedical, Inc",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT02995642,0,0,0,0,0,0,2020-09-30,2021-09-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,1309
NCT02996773,0,0,0,0,0,0,2022-11-29,2023-11-29,,University of Arizona,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,265
NCT02998476,0,0,0,0,0,0,2019-12-31,2020-12-31,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,143
NCT03000270,1,0,0,0,1,0,2018-06-19,2019-06-19,,Abiomed Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,13
NCT03005327,0,0,0,0,0,0,2022-09-30,2023-09-30,,X4 Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT03012724,0,0,0,0,0,0,2019-01-31,2020-01-31,,Brainsway,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,16
NCT03014492,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,437
NCT03014648,0,0,0,0,0,0,2022-10-31,2023-10-31,,"Liza Villaruz, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03016169,0,0,0,0,0,0,2023-02-28,2024-02-28,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT03016741,0,0,0,0,0,0,2020-08-31,2021-08-31,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03017261,0,0,0,0,0,0,2019-06-26,2020-06-26,,Think Surgical Inc.,Industry,1,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03019302,1,0,0,0,1,0,2017-08-31,2018-08-31,,Teleflex,Industry,1,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT03020615,0,0,0,0,0,0,2020-06-08,2021-06-08,,St. Jude Children's Research Hospital,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,302
NCT03022825,0,0,0,0,0,0,2019-12-31,2020-12-31,,Altor BioScience,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03028519,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Oklahoma,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,234
NCT03029351,0,0,0,0,0,0,2020-02-29,2021-02-28,,University at Buffalo,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,65
NCT03030183,1,0,1,1,0,1,2018-03-28,2019-03-28,2019-08-13,Ra Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03033745,0,0,0,0,0,0,2018-12-14,2019-12-14,,CSL Behring,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,81
NCT03037736,0,0,0,0,0,0,2019-04-01,2020-04-01,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,1443
NCT03038022,1,0,0,0,1,0,2017-12-18,2018-12-18,,"Madrigal Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,9
NCT03038399,0,0,0,0,0,0,2020-04-30,2021-04-30,,"ReveraGen BioPharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03038672,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03040011,0,0,0,0,0,0,2019-04-11,2020-04-11,,"Lauren Giugale, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03040973,0,0,0,0,0,0,2020-12-31,2021-12-31,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03041701,0,0,0,0,0,0,2021-01-01,2022-01-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03042611,0,0,0,0,0,0,2019-02-12,2020-02-12,,LSK BioPartners Inc.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,5
NCT03048058,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-29,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,616
NCT03048500,0,0,0,0,0,0,2020-08-31,2021-08-31,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,925
NCT03049085,1,0,0,0,1,0,2018-05-31,2019-05-31,,Medinet Heart Centre,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,2
NCT03049306,0,0,0,0,0,0,2023-01-01,2024-01-01,,Johns Hopkins University,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,1143
NCT03049618,0,0,0,0,0,0,2021-03-10,2022-03-10,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,483
NCT03051282,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT03052322,1,1,0,1,0,0,2018-05-28,2019-05-28,2019-03-29,Fresenius Kabi SwissBioSim GmbH,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,6
NCT03056352,1,1,0,1,0,0,2017-07-20,2018-07-20,2018-05-08,Montefiore Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,240
NCT03058783,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,180
NCT03059849,1,0,0,0,1,0,2018-05-01,2019-05-01,,McMaster University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,3,1,0,434
NCT03061682,0,0,0,0,0,0,2019-01-31,2020-01-31,,Rabin Medical Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,3,1,0,309
NCT03061734,1,0,0,0,1,0,2018-02-08,2019-02-08,,"Allodynic Therapeutics, LLC",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03065075,1,1,0,1,0,0,2018-08-28,2019-08-28,2019-01-25,"University of Massachusetts, Worcester",Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,163
NCT03067181,0,0,0,0,0,0,2027-06-30,2028-06-30,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,389
NCT03073200,0,0,0,0,0,0,2019-02-07,2020-02-07,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03073733,0,0,0,0,0,0,2019-08-31,2020-08-31,,"jCyte, Inc",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03074864,0,0,0,0,0,0,2019-06-30,2020-06-30,,Guangdong General Hospital,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,70
NCT03075891,1,0,0,0,1,0,2018-02-15,2019-02-15,,Galderma,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,77
NCT03076255,0,0,0,0,0,0,2021-02-28,2022-02-28,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,162
NCT03077009,0,0,0,0,0,0,2020-03-20,2021-03-20,,Fortius Clinic,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03077412,0,0,0,0,0,0,2020-12-31,2021-12-31,,Gilead Sciences,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03079869,0,0,0,0,0,0,2018-12-31,2019-12-31,,Kaiser Permanente,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,255
NCT03080142,0,0,0,0,0,0,2019-12-16,2020-12-16,,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03081156,0,0,0,0,0,0,2019-01-01,2020-01-01,,Los Angeles Biomedical Research Institute,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,60
NCT03084471,0,0,0,0,0,0,2023-03-26,2024-03-26,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03085914,0,0,0,0,0,0,2019-01-25,2020-01-25,,Incyte Corporation,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,143
NCT03086265,0,0,0,0,0,0,2019-02-26,2020-02-26,,Stanford University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1309
NCT03086408,0,0,0,0,0,0,2019-06-10,2020-06-10,,Stanford University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1309
NCT03086473,0,0,0,0,0,0,2021-01-31,2022-01-31,,Jennifer Shepherd,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03088072,0,0,0,0,0,0,2018-11-30,2019-11-30,,Scripps Health,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,28
NCT03088267,1,1,0,1,0,1,2017-02-25,2018-02-25,2019-05-16,"Tris Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03089606,0,0,0,0,0,0,2019-09-30,2020-09-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,1,0,0,0,0,1,0,229
NCT03089944,0,0,0,0,0,0,2019-07-31,2020-07-31,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03092856,0,0,0,0,0,0,2020-07-19,2021-07-19,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,483
NCT03094052,0,0,0,0,0,0,2018-12-01,2019-12-01,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT03097107,1,0,0,0,1,0,2018-01-18,2019-01-18,,Zydus Discovery DMCC,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03098836,0,0,0,0,0,0,2021-06-01,2022-06-01,,"Daniel George, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03101007,0,0,0,0,0,0,2020-06-30,2021-06-30,,Spaarne Gasthuis,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,2
NCT03101254,0,0,0,0,0,0,2019-04-12,2020-04-12,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03103919,1,1,0,1,0,0,2018-01-02,2019-01-02,2019-01-02,UCB Biopharma S.P.R.L.,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,75
NCT03108625,0,0,0,0,0,0,2020-05-31,2021-05-31,,H. Lundbeck A/S,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,152
NCT03112590,0,0,0,0,0,0,2021-06-30,2022-06-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,344
NCT03113760,0,0,0,0,0,0,2019-11-30,2020-11-30,,AB2 Bio Ltd.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03115112,0,0,0,0,0,0,2018-07-11,2019-07-11,,Theracos,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,21
NCT03115476,1,1,0,1,0,1,2018-03-12,2019-03-12,2019-03-18,LEO Pharma,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,171
NCT03117751,0,0,0,0,0,0,2026-09-30,2027-09-30,,St. Jude Children's Research Hospital,Other,0,1,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,302
NCT03118739,1,0,1,1,0,0,2018-08-13,2019-08-13,2019-07-15,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,2450
NCT03119038,1,0,0,0,1,0,2018-04-30,2019-04-30,,Rush University Medical Center,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,227
NCT03119168,0,1,0,1,0,0,2019-04-10,2020-04-10,2019-04-18,"Texas Tech University Health Sciences Center, El Paso",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,30
NCT03119662,1,0,0,0,1,0,2018-09-13,2019-09-13,,GE Healthcare,Industry,1,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,1,1,0,119
NCT03121014,0,0,0,0,0,0,2023-04-24,2024-04-24,,University of Illinois at Chicago,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,242
NCT03122223,0,0,0,0,0,0,2019-09-30,2020-09-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2133
NCT03122509,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03123250,1,0,0,0,1,0,2018-03-27,2019-03-27,,PROCEPT BioRobotics,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,7
NCT03123861,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03124459,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Acceleron Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03126331,0,0,0,0,0,0,2020-06-30,2021-06-30,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT03126435,0,0,0,0,0,0,2019-12-31,2020-12-31,,"SynCore Biotechnology Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,6
NCT03128424,0,0,0,0,0,0,2020-07-31,2021-07-31,,"PQ Bypass, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,3,0,1,4
NCT03128619,0,0,0,0,0,0,2020-08-02,2021-08-02,,Jonsson Comprehensive Cancer Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,277
NCT03131960,0,0,0,0,0,0,2019-06-30,2020-06-30,,MicroTransponder Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,5
NCT03132636,0,0,0,0,0,0,2021-10-14,2022-10-14,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03133637,0,0,0,0,0,0,2019-08-31,2020-08-31,,Sanjiv Amin,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT03134248,1,1,0,1,0,1,2017-04-12,2018-04-12,2018-05-14,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,2,0,1,85
NCT03136068,1,0,0,0,1,0,2018-05-31,2019-05-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1443
NCT03137407,1,0,0,0,1,0,2018-02-20,2019-02-20,,"Revance Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,26
NCT03137537,0,0,0,0,0,0,2020-04-30,2021-04-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03137771,0,0,0,0,0,0,2020-09-30,2021-09-30,,NRG Oncology,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,1,1,0,27
NCT03140670,0,0,0,0,0,0,2021-06-30,2022-06-30,,Abramson Cancer Center of the University of Pennsylvania,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03141060,0,0,0,0,0,0,2021-01-31,2022-01-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2133
NCT03141684,0,0,0,0,0,0,2020-10-31,2021-10-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03142256,0,0,0,0,0,0,2019-06-30,2020-06-30,,Desmond Tutu HIV Centre,Other,0,0,1,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,3
NCT03146650,0,0,0,0,0,0,2021-07-31,2022-07-31,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,925
NCT03148756,0,1,0,1,0,1,2017-08-04,2018-08-04,2018-08-08,Allergan,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,495
NCT03149809,0,0,0,0,0,0,2021-08-31,2022-08-31,,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03150004,0,0,0,0,0,0,2020-10-01,2021-10-01,,Medical College of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03151967,1,0,0,0,1,0,2018-05-31,2019-05-31,,University of Washington,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT03156543,0,0,0,0,0,0,2019-10-01,2020-10-01,,University of Michigan,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03158129,0,0,0,0,0,0,2021-07-31,2022-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,2066
NCT03158285,0,0,0,0,0,0,2019-02-25,2020-02-25,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03158974,0,0,0,0,0,0,2019-08-31,2020-08-31,,ViroXis Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03160859,0,0,0,0,0,0,2022-04-29,2023-04-29,,VA Office of Research and Development,U.S. Fed,2,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03163641,0,0,0,0,0,0,2018-10-31,2019-10-31,,"Eyegate Pharmaceuticals, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,13
NCT03164629,0,1,0,1,0,0,2018-10-19,2019-10-19,2019-04-28,University of Miami,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,476
NCT03169062,0,0,0,0,0,0,2019-04-10,2020-04-10,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03169244,0,0,0,0,0,0,2019-08-19,2020-08-19,,"University of North Carolina, Chapel Hill",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03169816,0,0,0,0,0,0,2019-10-30,2020-10-30,,New York State Psychiatric Institute,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,361
NCT03170388,0,0,0,0,0,0,2019-04-30,2020-04-30,,"Bausch Health Americas, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,180
NCT03172975,0,0,0,0,0,0,2020-04-15,2021-04-15,,Baylor College of Medicine,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,518
NCT03175549,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Scripps Research Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03175978,0,0,0,0,0,0,2020-06-30,2021-06-30,,"IGF Oncology, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03177603,0,0,0,0,0,0,2019-05-07,2020-05-07,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT03179410,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Andrew J. Armstrong, MD",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03179605,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Encore Dermatology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03179943,0,0,0,0,0,0,2020-07-31,2021-07-31,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03180424,1,0,0,0,1,0,2017-08-31,2018-08-31,,Hospital de Clínicas Dr. Manuel Quintela,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,0,1,2
NCT03182036,1,0,0,0,1,0,2017-11-30,2018-11-30,,ResMed,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,60
NCT03183063,0,0,0,0,0,0,2019-07-31,2020-07-31,,Thomas Guerrero,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03184077,1,1,0,1,0,0,2017-08-27,2018-08-27,2018-06-07,Virginia Commonwealth University,Other,0,0,0,5.0,,0,2014.0,1,0,0,0,0,0,0,0,0,0,1,417
NCT03184792,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Washington,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT03185065,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03185208,0,0,0,0,0,0,2022-03-31,2023-03-31,,Ariel Gildengers,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03186755,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Michael Marchand, MD",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03187795,0,0,0,0,0,0,2021-09-30,2022-09-30,,Kessler Foundation,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,79
NCT03188185,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,70
NCT03192397,0,0,0,0,0,0,2021-07-01,2022-07-01,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,294
NCT03193216,0,0,0,0,0,0,2020-06-30,2021-06-30,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03194529,0,0,0,0,0,0,2022-06-30,2023-06-30,,Children's Hospital Los Angeles,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,82
NCT03194867,0,0,0,0,0,0,2020-04-30,2021-04-30,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03195777,0,0,0,0,0,0,2022-03-31,2023-03-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03195920,1,0,0,0,1,0,2018-06-25,2019-06-25,,"Applaud Medical, Inc.",Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03196375,1,0,0,0,1,0,2018-07-27,2019-07-27,,"Flex Pharma, Inc.",Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03198026,0,0,0,0,0,0,2021-11-30,2022-11-30,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,162
NCT03199053,0,0,0,0,0,0,2021-12-20,2022-12-20,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03200340,0,0,0,0,0,0,2020-06-20,2021-06-20,,Enzychem Lifesciences Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03201419,0,0,0,0,0,0,2019-11-02,2020-11-02,,Ferring Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,208
NCT03206502,0,0,0,0,0,0,2026-05-31,2027-05-31,,"Empatica, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,3,0,1,2
NCT03207750,0,0,0,0,0,0,2018-10-09,2019-10-09,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,3276
NCT03210714,0,0,0,0,0,0,2024-12-31,2025-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03212170,0,0,0,0,0,0,2022-05-01,2023-05-01,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03214510,0,0,0,0,0,0,2022-08-31,2023-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,2066
NCT03215277,0,0,0,0,0,0,2019-07-31,2020-07-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03217968,1,1,0,1,0,0,2018-01-10,2019-01-10,2018-05-04,Cefaly Technology,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03218995,0,0,0,0,0,0,2021-03-15,2022-03-15,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,32
NCT03219333,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Astellas Pharma Global Development, Inc.",Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT03222349,0,0,0,0,0,0,2019-09-30,2020-09-30,,Aquestive Therapeutics,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03222505,1,1,0,1,0,0,2018-05-31,2019-05-31,2019-05-17,Shirley Ryan AbilityLab,Other,0,0,0,5.0,,0,2010.0,1,0,0,1,0,0,0,0,0,0,1,71
NCT03222973,0,0,0,0,0,0,2020-04-29,2021-04-29,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03225989,0,0,0,0,0,0,2021-12-31,2022-12-31,,Lokon Pharma AB,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03226353,1,1,0,1,0,1,2017-09-27,2018-09-27,2018-10-26,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03227861,0,0,0,0,0,0,2019-01-03,2020-01-03,,"Janssen Scientific Affairs, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,34
NCT03229694,1,0,0,0,1,0,2018-04-01,2019-04-01,,Xuzhou Medical University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,24
NCT03230890,0,0,0,0,0,0,2020-01-31,2021-01-31,,Wake Forest University Health Sciences,Other,0,1,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,616
NCT03233711,0,0,0,0,0,0,2019-12-30,2020-12-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,3004
NCT03240770,1,0,0,0,1,0,2017-07-20,2018-07-20,,Mani Alikhani,Industry,1,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03241030,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Texas at Austin,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,135
NCT03243084,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-10-19,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03246087,0,0,0,0,0,0,2019-02-13,2020-02-13,,Mike O'Callaghan Military Hospital,U.S. Fed,2,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,31
NCT03247413,0,0,0,0,0,0,2019-09-30,2020-09-30,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03251495,0,0,0,0,0,0,2020-11-30,2021-11-30,,Emory University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03252847,0,0,0,0,0,0,2020-11-30,2021-11-30,,MeiraGTx UK II Ltd,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,0,0,0,0,0,1,1,1,0,10
NCT03253809,0,0,0,0,0,0,2019-05-25,2020-05-25,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,581
NCT03260881,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT03261310,1,0,0,0,1,0,2018-07-31,2019-07-31,,Brooke Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,71
NCT03261999,0,0,0,0,0,0,2018-11-19,2019-11-19,,"Foresee Pharmaceuticals Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,7
NCT03262662,0,0,0,0,0,0,2021-05-31,2022-05-31,,State University of New York at Buffalo,Other,0,1,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,105
NCT03263650,0,0,0,0,0,0,2020-10-31,2021-10-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03264235,0,0,0,0,0,0,2019-10-31,2020-10-31,,Shirley Ryan AbilityLab,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,71
NCT03265431,0,0,0,0,0,0,2022-06-01,2023-06-01,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT03265808,0,0,0,0,0,0,2025-02-28,2026-02-28,,Joshua M Hare,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03266094,0,0,0,0,0,0,2019-06-21,2020-06-21,,Medtronic - MITG,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,1,1,0,146
NCT03267511,1,1,0,1,0,0,2017-12-02,2018-12-02,2018-11-30,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3276
NCT03268590,1,0,1,1,0,1,2018-05-02,2019-05-02,2019-07-30,Case Western Reserve University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,89
NCT03269344,0,0,0,0,0,0,2019-01-31,2020-01-31,,Henry Ford Health System,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,151
NCT03270462,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03272737,0,0,0,0,0,0,2019-10-04,2020-10-04,,Hospital Israelita Albert Einstein,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,1,0,0,0,2,1,0,59
NCT03273062,1,0,0,0,1,0,2018-07-20,2019-07-20,,Sheppard Pratt Health System,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03273270,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medical University of South Carolina,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,511
NCT03274661,0,0,0,0,0,0,2025-03-15,2026-03-15,,Baptist Health South Florida,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03275623,0,0,0,0,0,0,2019-07-15,2020-07-15,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03276494,1,1,0,1,0,1,2018-04-21,2019-04-21,2019-05-10,Ohio State University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,315
NCT03276975,0,0,0,0,0,0,2020-04-30,2021-04-30,,Duke University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03277105,0,0,0,0,0,0,2019-06-27,2020-06-27,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03279263,0,0,0,0,0,0,2019-09-30,2020-09-30,,Melior Pharmaceuticals,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03279952,0,0,0,0,0,0,2019-07-31,2020-07-31,,Milton S. Hershey Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,334
NCT03283761,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Al B. Benson, III, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03284333,0,0,0,0,0,0,2018-09-30,2019-09-30,,Cutera Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03285178,0,0,0,0,0,0,2020-07-31,2021-07-31,,Cyclerion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03285542,0,0,0,0,0,0,2019-03-25,2020-03-25,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,581
NCT03285672,0,0,0,0,0,0,2018-10-29,2019-10-29,,Fervent Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03286335,0,0,0,0,0,0,2020-09-30,2021-09-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,1699
NCT03289039,0,0,0,0,0,0,2021-03-31,2022-03-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03290664,0,0,0,0,0,0,2019-02-13,2020-02-13,,"Masonic Cancer Center, University of Minnesota",Other,0,1,0,1.0,Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,218
NCT03290781,0,0,0,0,0,0,2021-08-08,2022-08-08,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,342
NCT03295721,0,0,0,0,0,0,2018-01-08,2019-01-08,,Heron Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,18
NCT03300557,0,0,0,0,0,0,2021-12-01,2022-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3004
NCT03301272,0,0,0,0,0,0,2019-08-21,2020-08-21,,"University of North Carolina, Chapel Hill",Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,910
NCT03301415,0,0,0,0,0,0,2024-07-01,2025-07-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03305848,0,0,0,0,0,0,2019-04-04,2020-04-04,,HealthPartners Institute,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,101
NCT03306043,0,0,0,0,0,0,2020-01-02,2021-01-02,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03314181,0,0,0,0,0,0,2020-11-04,2021-11-04,,AbbVie,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03315754,0,0,0,0,0,0,2020-12-15,2021-12-15,,Steba Biotech S.A.,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03316378,1,1,0,1,0,0,2018-05-10,2019-05-10,2019-04-29,Ruth Chimenti,Other,0,0,0,2.0,Phase 2/Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT03318315,0,0,0,0,0,0,2019-07-19,2020-07-19,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,1,1,1,0,0,0,0,0,0,1,0,2133
NCT03319667,0,0,0,0,0,0,2022-12-31,2023-12-31,,Sanofi,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03320564,0,1,0,1,0,0,2019-02-13,2020-02-13,2019-02-18,Wake Forest University Health Sciences,Other,0,0,0,5.0,,1,2018.0,1,0,0,0,1,0,0,0,0,1,0,616
NCT03321656,0,0,0,0,0,0,2019-12-31,2020-12-31,,Roberto Gedaly,Other,0,1,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03321916,0,0,0,0,0,0,2020-12-31,2021-12-31,,The Lowy Medical Research Institute Limited,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03322267,0,0,0,0,0,0,2023-01-31,2024-01-31,,National Taiwan University Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1559
NCT03324984,0,0,0,0,0,0,2020-04-20,2021-04-20,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03325101,0,0,0,0,0,0,2022-10-31,2023-10-31,,Mayo Clinic,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,1898
NCT03326180,0,0,0,0,0,0,2019-05-31,2020-05-31,,University of Leeds,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,128
NCT03328052,0,0,0,0,0,0,2020-10-01,2021-10-01,,Cota Inc.,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03328299,0,0,0,0,0,0,2018-12-01,2019-12-01,,Assiut University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1331
NCT03328624,1,1,0,1,0,1,2018-03-06,2019-03-06,2019-04-18,University of Southern California,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,483
NCT03329508,0,0,0,0,0,0,2020-03-30,2021-03-30,,Pharma Two B Ltd.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03330236,0,0,0,0,0,0,2019-08-31,2020-08-31,,Yale University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,1053
NCT03333551,0,0,0,0,0,0,2021-08-31,2022-08-31,,Medical College of Wisconsin,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,315
NCT03335371,0,0,0,0,0,0,2019-12-31,2020-12-31,,vTv Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03335488,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Horizon Therapeutics, LLC",Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03335774,0,0,0,0,0,0,2019-05-31,2020-05-31,,Nivagen Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03336333,0,0,0,0,0,0,2020-09-30,2021-09-30,,BeiGene,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03337919,0,0,0,0,0,0,2022-05-31,2023-05-31,,"University College, London",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,370
NCT03343535,0,0,0,0,0,0,2019-12-31,2020-12-31,,TransMedics,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT03344510,1,1,0,1,0,0,2018-01-27,2019-01-27,2018-12-11,University of Pennsylvania,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1052
NCT03345576,0,0,0,0,0,0,2022-06-30,2023-06-30,,VA Office of Research and Development,U.S. Fed,2,0,1,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1012
NCT03345836,0,0,0,0,0,0,2020-01-09,2021-01-09,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03349463,0,0,0,0,0,0,2019-12-31,2020-12-31,,Bital Savir-Baruch,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03349645,0,0,0,0,0,0,2018-10-04,2019-10-04,,Ampio Pharmaceuticals. Inc.,Industry,1,0,0,3.0,Phase 3,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,10
NCT03354221,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03358290,0,0,0,0,0,0,2018-10-22,2019-10-22,,Akros Pharma Inc.,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,1,1,0,22
NCT03358576,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Iterum Therapeutics, International Limited",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03360396,0,0,0,0,0,0,2019-12-31,2020-12-31,,"PneumRx, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,10
NCT03361371,0,0,0,0,0,0,2022-04-30,2023-04-30,,The Hospital for Sick Children,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,403
NCT03362515,0,0,0,0,0,0,2018-11-30,2019-11-30,,Thomas Jefferson University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,186
NCT03363165,0,0,0,0,0,0,2020-12-31,2021-12-31,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT03365947,0,0,0,0,0,0,2019-10-30,2020-10-30,,Arrowhead Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,18
NCT03366103,0,0,0,0,0,0,2020-05-31,2021-05-31,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03366766,0,0,0,0,0,0,2021-07-31,2022-07-31,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,162
NCT03367871,0,0,0,0,0,0,2022-10-31,2023-10-31,,University of Miami,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT03368391,1,0,0,0,1,0,2018-06-30,2019-06-30,,Louisiana State University Health Sciences Center in New Orleans,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,42
NCT03368534,0,0,0,0,0,0,2019-09-01,2020-09-01,,Stanford University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1309
NCT03368664,0,0,0,0,0,0,2026-07-31,2027-07-31,,"Genzyme, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,300
NCT03369379,1,0,0,0,1,0,2017-12-31,2018-12-31,,Universidad Autonoma de Nuevo Leon,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,28
NCT03370536,1,0,0,0,1,0,2018-07-18,2019-07-18,,Vivek Reddy,Other,0,1,0,5.0,,1,2017.0,1,1,0,1,0,0,0,0,0,1,0,15
NCT03372122,1,0,0,0,1,0,2018-01-08,2019-01-08,,Caroline Scott,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,1,0,0,1,0,1
NCT03373201,1,0,0,0,1,0,2018-03-05,2019-03-05,,Vanda Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,37
NCT03373604,0,0,0,0,0,0,2021-08-20,2022-08-20,,William Charles Kreisl,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03373929,0,0,0,0,0,0,2019-11-20,2020-11-20,,HeartStitch.Com,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03374332,0,0,0,0,0,0,2021-03-31,2022-03-31,,John Reagan,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03375320,0,0,0,0,0,0,2021-01-01,2022-01-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03379051,0,0,0,0,0,0,2021-08-31,2022-08-31,,"TG Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03379428,0,0,0,0,0,0,2019-12-31,2020-12-31,,US Oncology Research,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,26
NCT03380000,0,0,0,0,0,0,2019-09-30,2020-09-30,,Penn State University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,145
NCT03380962,0,0,0,0,0,0,2020-07-31,2021-07-31,,"Stanley Jordan, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03381274,0,0,0,0,0,0,2022-03-23,2023-03-23,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,269
NCT03382925,0,0,0,0,0,0,2020-01-15,2021-01-15,,University of Utah,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03383146,0,0,0,0,0,0,2020-09-28,2021-09-28,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03386370,0,0,0,0,0,0,2019-03-31,2020-03-31,,Azienda Ospedaliera Universitaria Senese,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,8
NCT03387033,0,0,0,0,0,0,2019-12-01,2020-12-01,,Duke University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03387813,0,0,0,0,0,0,2023-04-30,2024-04-30,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT03389477,0,0,0,0,0,0,2020-06-30,2021-06-30,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,1151
NCT03390036,1,0,0,0,1,0,2018-07-30,2019-07-30,,"Anika Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,1,0,0,0,0,2,1,0,9
NCT03392246,0,0,0,0,0,0,2021-06-30,2022-06-30,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03392740,0,0,0,0,0,0,2019-03-15,2020-03-15,,Genesys Regional Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03393117,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT03395288,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03395405,0,0,0,0,0,0,2021-05-22,2022-05-22,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03397134,0,0,0,0,0,0,2019-12-31,2020-12-31,,Minerva Neurosciences,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03398824,0,0,0,0,0,0,2021-03-31,2022-03-31,,Boston Children’s Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03399370,0,0,0,0,0,0,2019-10-31,2020-10-31,,The Medicines Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,59
NCT03400254,0,0,0,0,0,0,2023-02-28,2024-02-28,,Abramson Cancer Center of the University of Pennsylvania,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,273
NCT03400852,0,0,0,0,0,0,2020-07-31,2021-07-31,,Mallinckrodt,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,91
NCT03401788,0,0,0,0,0,0,2020-03-01,2021-03-01,,"Peloton Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03403712,0,0,0,0,0,0,2018-09-19,2019-09-19,,Helsinn Healthcare SA,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,28
NCT03404193,0,0,0,0,0,0,2020-12-30,2021-12-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03404570,0,0,0,0,0,0,2018-10-31,2019-10-31,,Atacama Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03406078,0,0,0,0,0,0,2020-12-04,2021-12-04,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03406858,0,0,0,0,0,0,2019-12-01,2020-12-01,,Barbara Ann Karmanos Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,134
NCT03407313,0,0,0,0,0,0,2018-12-28,2019-12-28,,"Recros Medica, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03407495,0,0,0,0,0,0,2019-12-31,2020-12-31,,MegaPro Biomedical Co. Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,4
NCT03408483,0,0,0,0,0,0,2020-04-15,2021-04-15,,University of Alabama at Birmingham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03409107,0,0,0,0,0,0,2020-11-05,2021-11-05,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03413384,0,0,0,0,0,0,2020-07-31,2021-07-31,,BrainX Corporation,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03422003,0,0,0,0,0,0,2021-10-31,2022-10-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,647
NCT03422536,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Arizona,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,265
NCT03422978,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of British Columbia,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,881
NCT03423121,0,0,0,0,0,0,2020-02-29,2021-02-28,,Johns Hopkins University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03423264,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03426137,0,0,0,0,0,0,2020-06-15,2021-06-15,,"University of Maryland, College Park",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03430063,0,0,0,0,0,0,2020-04-30,2021-04-30,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03430791,0,0,0,0,0,0,2020-08-31,2021-08-31,,Baptist Health South Florida,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,17
NCT03431441,1,1,0,1,0,0,2018-02-14,2019-02-14,2019-02-07,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03433482,0,0,0,0,0,0,2019-07-18,2020-07-18,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,3276
NCT03440632,0,0,0,0,0,0,2021-08-31,2022-08-31,,Maastricht University Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,585
NCT03441334,0,0,0,0,0,0,2019-12-31,2020-12-31,,Texas Woman's University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,53
NCT03441464,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Lumicell, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,7
NCT03441607,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Applied Biologics, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03442868,0,0,0,0,0,0,2018-12-31,2019-12-31,,Texas Woman's University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,53
NCT03446885,0,0,0,0,0,0,2018-12-31,2019-12-31,,Gregory Fabiano,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03447639,0,1,0,1,0,0,2018-10-18,2019-10-18,2019-04-04,William Beaumont Hospitals,Other,0,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,84
NCT03447990,0,0,0,0,0,0,2019-12-31,2020-12-31,,"MyoKardia, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,10
NCT03448419,0,0,0,0,0,0,2019-09-26,2020-09-26,,Boehringer Ingelheim,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03449524,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Complexa, Inc.",Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03450629,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sun Pharma Advanced Research Company Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,29
NCT03453541,0,0,0,0,0,0,2020-11-30,2021-11-30,,Albany Medical College,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,51
NCT03454893,0,0,0,0,0,0,2021-07-31,2022-07-31,,AvroBio,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03455543,0,0,0,0,0,0,2019-07-15,2020-07-15,,"Regenesis Biomedical, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,10
NCT03456700,0,0,0,0,0,0,2023-03-15,2024-03-15,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03456882,0,0,0,0,0,0,2019-04-30,2020-04-30,,Mario Negri Institute for Pharmacological Research,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,83
NCT03457818,0,0,0,0,0,0,2021-06-30,2022-06-30,,Mishaela Rubin,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03457948,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Nicholas Fidelman, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,0,1,1,0,0,0,0,0,1,0,2
NCT03460652,0,0,0,0,0,0,2019-06-20,2020-06-20,,"KemPharm, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03461952,0,0,0,0,0,0,2021-05-31,2022-05-31,,Canadian Cancer Trials Group,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03463915,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Olivia Cardenas-Trowers, M.D.",Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03467789,0,0,0,0,0,0,2021-11-30,2022-11-30,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,374
NCT03471078,0,0,0,0,0,0,2020-11-30,2021-11-30,,Dova Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3
NCT03472092,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03474913,0,0,0,0,0,0,2023-03-08,2024-03-08,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,412
NCT03479307,0,0,0,0,0,0,2018-08-09,2019-08-09,,"Faes Farma, S.A.",Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03480737,0,0,0,0,0,0,2020-01-30,2021-01-30,,Bradley Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,3,1,0,6
NCT03480919,1,0,1,1,0,1,2018-07-31,2019-07-31,2019-09-06,"Hospital for Special Surgery, New York",Other,0,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,157
NCT03481556,0,0,0,0,0,0,2019-12-31,2020-12-31,,Oncopeptides AB,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03482141,0,0,0,0,0,0,2021-04-30,2022-04-30,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1443
NCT03482583,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Florida,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03483012,0,0,0,0,0,0,2021-09-30,2022-09-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03483363,0,0,0,0,0,0,2022-03-31,2023-03-31,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03486223,0,0,0,0,0,0,2020-10-01,2021-10-01,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03486392,0,0,0,0,0,0,2019-03-08,2020-03-08,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT03491917,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Fujifilm Medical Systems USA, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03492099,0,0,0,0,0,0,2020-06-30,2021-06-30,,Johns Hopkins University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03494504,0,0,0,0,0,0,2018-11-05,2019-11-05,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03496168,0,0,0,0,0,0,2021-02-28,2022-02-28,,"MyoKardia, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03497182,0,0,0,0,0,0,2018-10-06,2019-10-06,,Landon Pediatric Foundation,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03498612,0,0,0,0,0,0,2020-03-14,2021-03-14,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,910
NCT03499249,0,0,0,0,0,0,2019-12-31,2020-12-31,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,518
NCT03501680,0,0,0,0,0,0,2020-03-08,2021-03-08,,First Affiliated Hospital of Wenzhou Medical University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,1,0,0,0,0,3,1,0,6
NCT03502005,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Midland Research Group, Inc.",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03502447,0,0,0,0,0,0,2019-01-02,2020-01-02,,"Sight Sciences, Inc.",Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03502707,0,0,0,0,0,0,2021-04-30,2022-04-30,,Janssen Vaccines & Prevention B.V.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,29
NCT03506373,0,0,0,0,0,0,2025-05-01,2026-05-01,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03507777,0,0,0,0,0,0,2021-07-31,2022-07-31,,Abbott Medical Devices,Industry,1,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT03508687,0,0,0,0,0,0,2019-07-31,2020-07-31,,Elif Oral,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03511560,0,0,0,0,0,0,2020-01-31,2021-01-31,,Columbia University,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03512418,0,0,0,0,0,0,2022-05-01,2023-05-01,,Fenway Community Health,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,16
NCT03514329,0,0,0,0,0,0,2020-12-30,2021-12-30,,"Uptake Medical Technology, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT03515291,0,0,0,0,0,0,2020-09-30,2021-09-30,,Cell Therapy Ltd.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,2
NCT03516279,0,0,0,0,0,0,2021-08-31,2022-08-31,,ECOG-ACRIN Cancer Research Group,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,75
NCT03516981,0,0,0,0,0,0,2022-05-30,2023-05-30,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03518073,0,0,0,0,0,0,2021-08-23,2022-08-23,,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03519581,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Davis",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,530
NCT03519737,0,0,0,0,0,0,2021-11-30,2022-11-30,,"Cerevast Medical, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03520114,0,0,0,0,0,0,2020-06-30,2021-06-30,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,616
NCT03521089,0,0,0,0,0,0,2020-05-31,2021-05-31,,Mayo Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03527108,0,0,0,0,0,0,2023-04-01,2024-04-01,,Fox Chase Cancer Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03527589,0,0,0,0,0,0,2022-09-01,2023-09-01,,"Merit Medical Systems, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,12
NCT03529162,0,0,0,0,0,0,2021-05-31,2022-05-31,,St. Louis University,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,126
NCT03532139,0,0,0,0,0,0,2021-05-31,2022-05-31,,Beth Israel Deaconess Medical Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03533257,0,0,0,0,0,0,2020-07-01,2021-07-01,,Amylyx Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03535194,0,0,0,0,0,0,2020-03-03,2021-03-03,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03536923,1,1,0,1,0,0,2017-08-12,2018-08-12,2018-08-10,"Renovia, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03538340,0,0,0,0,0,0,2020-01-31,2021-01-31,,"University of Maryland, College Park",Other,0,1,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,318
NCT03539861,0,0,0,0,0,0,2021-10-31,2022-10-31,,University of Michigan,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03540030,0,0,0,0,0,0,2018-12-31,2019-12-31,,"OrthoCarolina Research Institute, Inc.",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,26
NCT03544723,0,0,0,0,0,0,2020-01-01,2021-01-01,,"MultiVir, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03545516,0,0,0,0,0,0,2018-11-01,2019-11-01,,Richmond University Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03545893,0,0,0,0,0,0,2019-02-07,2020-02-07,,University of Pennsylvania,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1052
NCT03547999,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Darren Carpizo, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1
NCT03548220,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Agios Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,33
NCT03548935,0,0,0,0,0,0,2020-03-02,2021-03-02,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03551249,0,0,0,0,0,0,2021-12-31,2022-12-31,,InSightec,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,61
NCT03557307,0,0,0,0,0,0,2020-10-30,2021-10-30,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03560167,0,0,0,0,0,0,2019-08-30,2020-08-30,,"Ancora Heart, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,8
NCT03561259,0,0,0,0,0,0,2021-03-31,2022-03-31,,Jubilant DraxImage Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03562923,0,0,0,0,0,0,2019-05-31,2020-05-31,,Amneal Ireland Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,3
NCT03563157,0,0,0,0,0,0,2019-12-30,2020-12-30,,"NantKwest, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,27
NCT03563534,0,0,0,0,0,0,2019-06-30,2020-06-30,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1190
NCT03564119,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Sol-Gel Technologies, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03564496,0,0,0,0,0,0,2020-06-30,2021-06-30,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,0,1,0,869
NCT03564912,0,0,0,0,0,0,2020-12-30,2021-12-30,,Zhejiang University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,96
NCT03566693,0,0,0,0,0,0,2021-05-31,2022-05-31,,"DexCom, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,21
NCT03567018,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ohio State University,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,315
NCT03568539,0,0,0,0,0,0,2020-07-31,2021-07-31,,Innovent Biologics (Suzhou) Co. Ltd.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,29
NCT03569618,0,0,0,0,0,0,2018-11-01,2019-11-01,,"University of California, San Francisco",Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1443
NCT03571672,0,0,0,0,0,0,2019-09-30,2020-09-30,,Lantheus Medical Imaging,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,23
NCT03571919,0,0,0,0,0,0,2019-06-01,2020-06-01,,Michael Lin,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03572257,0,0,0,0,0,0,2020-09-01,2021-09-01,,Medical College of Wisconsin,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03573297,0,0,0,0,0,0,2021-07-17,2022-07-17,,Forest Laboratories,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,169
NCT03575325,0,0,0,0,0,0,2021-10-31,2022-10-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03578081,0,0,0,0,0,0,2023-05-31,2024-05-31,,Alliance for Clinical Trials in Oncology,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,456
NCT03582774,0,0,0,0,0,0,2023-09-30,2024-09-30,,Jonsson Comprehensive Cancer Center,Other,0,0,1,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,277
NCT03582891,0,0,0,0,0,0,2025-07-01,2026-07-01,,"University of California, San Francisco",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,1,0,0,0,0,1,0,1443
NCT03585179,0,0,0,0,0,0,2019-12-31,2020-12-31,,Centro Dermatológico Dr. Ladislao de la Pascua,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03586453,0,0,0,0,0,0,2021-03-01,2022-03-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03586882,0,0,0,0,0,0,2020-02-29,2021-02-28,,Texas Back Institute,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,7
NCT03587142,0,0,0,0,0,0,2020-05-31,2021-05-31,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03587584,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,749
NCT03588754,0,0,0,0,0,0,2019-07-31,2020-07-31,,Yale University,Other,0,0,1,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1053
NCT03594045,0,0,0,0,0,0,2021-12-31,2022-12-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03594435,0,0,0,0,0,0,2021-09-30,2022-09-30,,"University of California, Los Angeles",Other,0,1,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT03596164,0,0,0,0,0,0,2021-06-25,2022-06-25,,Shire,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,2,1,0,342
NCT03597347,0,0,0,0,0,0,2021-01-15,2022-01-15,,Savara Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,8
NCT03600909,0,0,0,0,0,0,2022-05-31,2023-05-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,1432
NCT03601117,0,0,0,0,0,0,2020-07-01,2021-07-01,,Stanford University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03601936,0,0,0,0,0,0,2019-04-24,2020-04-24,,"Evolve BioSystems, Inc.",Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03603028,0,0,0,0,0,0,2018-09-30,2019-09-30,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,801
NCT03604198,0,0,0,0,0,0,2021-07-31,2022-07-31,,Corcept Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,40
NCT03605927,0,0,0,0,0,0,2024-01-31,2025-01-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03606174,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mirati Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03606668,0,0,0,0,0,0,2019-07-31,2020-07-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,869
NCT03607838,0,0,0,0,0,0,2020-02-29,2021-02-28,,Seikagaku Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03608670,0,0,0,0,0,0,2019-03-11,2020-03-11,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,169
NCT03608826,0,0,0,0,0,0,2022-07-31,2023-07-31,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,169
NCT03609593,0,0,0,0,0,0,2021-12-31,2022-12-31,,Nicole Lamanna,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03610048,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,70
NCT03610516,0,0,0,0,0,0,2021-03-17,2022-03-17,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03611010,0,0,0,0,0,0,2020-12-31,2021-12-31,,Cumberland Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,48
NCT03612856,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Aronora, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03613454,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,801
NCT03613870,0,0,0,0,0,0,2020-08-31,2021-08-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,158
NCT03615001,0,0,0,0,0,0,2018-10-04,2019-10-04,,Laborie Medical Technologies Inc.,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03616223,0,0,0,0,0,0,2018-12-31,2019-12-31,,Frequency Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03616821,0,0,0,0,0,0,2019-11-08,2020-11-08,,Allergan,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,495
NCT03617458,0,0,0,0,0,0,2022-12-31,2023-12-31,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,422
NCT03617679,0,0,0,0,0,0,2021-09-30,2022-09-30,,"University of Colorado, Denver",Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03617783,0,0,0,0,0,0,2021-09-30,2022-09-30,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,144
NCT03619135,1,1,0,1,0,1,2017-08-24,2018-08-24,2018-11-15,Kyle Stein,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT03622866,0,0,0,0,0,0,2020-01-31,2021-01-31,,Nuvectra,Industry,1,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03623256,0,0,0,0,0,0,2021-10-01,2022-10-01,,Augusta University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,117
NCT03625037,0,0,0,0,0,0,2022-01-30,2023-01-30,,Genmab,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,20
NCT03627091,0,0,0,0,0,0,2022-08-26,2023-08-26,,Shire,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,342
NCT03631433,1,0,0,0,1,0,2017-05-01,2018-05-01,,Ohio State University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,315
NCT03632720,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,2,1,0,285
NCT03633799,0,0,0,0,0,0,2024-09-30,2025-09-30,,Sebela Pharmaceuticals Inc.,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03634306,0,0,0,0,0,0,2018-12-21,2019-12-21,,Mercy Research,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03634488,0,0,0,0,0,0,2020-05-31,2021-05-31,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,422
NCT03638908,1,0,1,1,0,1,2017-05-31,2018-05-31,2019-01-15,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,626
NCT03639558,0,0,0,0,0,0,2019-07-01,2020-07-01,,Joseph Dib,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,1
NCT03642132,0,0,0,0,0,0,2021-11-20,2022-11-20,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03650309,0,0,0,0,0,0,2021-01-23,2022-01-23,,"University Health Network, Toronto",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,931
NCT03650764,0,0,0,0,0,0,2021-11-30,2022-11-30,,Washington University School of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03653338,0,0,0,0,0,0,2023-08-01,2024-08-01,,"Beth Carella, DO",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1
NCT03654729,0,0,0,0,0,0,2020-07-31,2021-07-31,,PledPharma AB,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03656068,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Pinnacle Clinical Research, PLLC",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03657849,0,0,0,0,0,0,2019-01-25,2020-01-25,,HealthPartners Institute,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,101
NCT03659136,0,0,0,0,0,0,2021-05-03,2022-05-03,,Boehringer Ingelheim,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1852
NCT03660930,0,0,0,0,0,0,2020-02-28,2021-02-28,,University of Washington,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03670160,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Tennessee Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03670316,0,0,0,0,0,0,2023-01-01,2024-01-01,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03672539,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03676231,0,0,0,0,0,0,2019-05-01,2020-05-01,,Second Genome,Industry,1,0,0,1.0,Phase 2,1,2019.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03677011,0,0,0,0,0,0,2019-07-01,2020-07-01,,Lo.Li.Pharma s.r.l,Industry,1,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,7
NCT03677206,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Arizona,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,265
NCT03677401,0,0,0,0,0,0,2020-01-31,2021-01-31,,Menlo Therapeutics Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,10
NCT03678688,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,185
NCT03680898,0,0,0,0,0,0,2019-05-31,2020-05-31,,GenePOC,Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,1,1,0,4
NCT03681470,0,0,0,0,0,0,2019-09-30,2020-09-30,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03682068,0,0,0,0,0,0,2022-04-27,2023-04-27,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03683576,0,0,0,0,0,0,2020-06-30,2021-06-30,,"GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03685058,0,0,0,0,0,0,2019-07-31,2020-07-31,,King Abdulaziz University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,30
NCT03686033,0,0,0,0,0,0,2019-11-18,2020-11-18,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,328
NCT03686683,0,0,0,0,0,0,2023-05-31,2024-05-31,,Dendreon,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,19
NCT03689972,0,0,0,0,0,0,2021-09-30,2022-09-30,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03691636,0,0,0,0,0,0,2019-04-02,2020-04-02,,"D.E.L., LLC",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03694262,0,0,0,0,0,0,2021-06-28,2022-06-28,,Medical College of Wisconsin,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03695913,0,0,0,0,0,0,2019-02-07,2020-02-07,,University of Michigan,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,934
NCT03701308,0,0,0,0,0,0,2025-12-01,2026-12-01,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03702400,0,0,0,0,0,0,2020-06-01,2021-06-01,,Hospital dos Servidores do Estado do Rio de Janeiro,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,4
NCT03702582,0,0,0,0,0,0,2022-04-01,2023-04-01,,Massachusetts General Hospital,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03705000,0,0,0,0,0,0,2020-12-31,2021-12-31,,Alon Kahana,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03705299,1,0,0,0,1,0,2018-04-06,2019-04-06,,The Cooper Health System,Other,0,1,0,5.0,,0,2012.0,1,0,0,1,0,0,0,0,3,0,1,37
NCT03706313,0,0,0,0,0,0,2019-09-01,2020-09-01,,Duke University,Other,0,0,0,4.0,Phase 4,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,1342
NCT03706833,0,0,0,0,0,0,2023-12-31,2024-12-31,,Edwards Lifesciences,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,77
NCT03707821,0,0,0,0,0,0,2018-11-01,2019-11-01,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03709706,0,0,0,0,0,0,2021-07-02,2022-07-02,,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3276
NCT03710876,0,0,0,0,0,0,2023-11-30,2024-11-30,,Trizell Ltd,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,1
NCT03713827,1,0,0,0,1,0,2018-06-30,2019-06-30,,Hacettepe University,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,3,0,1,204
NCT03714373,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Soleno Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03714555,0,0,0,0,0,0,2020-12-01,2021-12-01,,HonorHealth Research Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,1,0,0,0,3,1,0,9
NCT03714919,0,0,0,0,0,0,2019-12-31,2020-12-31,,Arlyne Thung,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03716167,0,0,0,0,0,0,2019-10-31,2020-10-31,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03716531,0,0,0,0,0,0,2023-11-30,2024-11-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,1699
NCT03717480,0,0,0,0,0,0,2022-05-01,2023-05-01,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,647
NCT03718000,1,1,0,1,0,1,2018-01-30,2019-01-30,2019-04-23,University of Georgia,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,37
NCT03720483,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of Colorado, Denver",Other,0,0,0,0.0,Phase 1/Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT03720639,0,0,0,0,0,0,2020-05-31,2021-05-31,,Sparrow Clinical Research Institute,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03721328,0,0,0,0,0,0,2020-09-30,2021-09-30,,Joint Purification Systems,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,1
NCT03722446,0,0,0,0,0,0,2019-11-05,2020-11-05,,University of Michigan,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03727737,0,0,0,0,0,0,2021-09-30,2022-09-30,,Palo Alto Veterans Institute for Research,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,31
NCT03727880,0,0,0,0,0,0,2023-05-31,2024-05-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03728504,0,0,0,0,0,0,2020-04-30,2021-04-30,,Asana BioSciences,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03729817,0,0,0,0,0,0,2024-04-30,2025-04-30,,University of Illinois at Chicago,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,242
NCT03729999,0,0,0,0,0,0,2020-12-31,2021-12-31,,Nationwide Children's Hospital,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,161
NCT03730454,0,0,0,0,0,0,2020-05-31,2021-05-31,,Phoenix Children's Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,35
NCT03732820,0,0,0,0,0,0,2021-04-13,2022-04-13,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03734575,0,0,0,0,0,0,2019-07-09,2020-07-09,,"Precision Biopsy, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,4
NCT03738579,0,0,0,0,0,0,2019-06-25,2020-06-25,,Next Science TM,Industry,1,0,0,5.0,,1,2018.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03738696,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Alabama at Birmingham,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,801
NCT03739840,0,0,0,0,0,0,2020-12-31,2021-12-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03740997,0,0,0,0,0,0,2021-09-30,2022-09-30,,GE Healthcare,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,119
NCT03741920,0,0,0,0,0,0,2021-12-31,2022-12-31,,Global Kinetics Corporation,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03742271,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,138
NCT03742440,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Texas Southwestern Medical Center,Other,0,1,0,4.0,Phase 4,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,626
NCT03743051,0,0,0,0,0,0,2020-12-31,2021-12-31,,Helsinn Healthcare SA,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03746106,0,0,0,0,0,0,2019-10-31,2020-10-31,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03748082,0,0,0,0,0,0,2019-10-30,2020-10-30,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,1,0,0,0,0,1,0,1699
NCT03748290,0,0,0,0,0,0,2019-11-30,2020-11-30,,Sheba Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,553
NCT03748706,0,0,0,0,0,0,2019-05-08,2020-05-08,,Pain Therapeutics,Industry,1,0,1,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,16
NCT03751631,0,0,0,0,0,0,2019-01-11,2020-01-11,,Eyenovia Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03752099,0,0,0,0,0,0,2020-08-22,2021-08-22,,Veru Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03756129,0,0,0,0,0,0,2020-03-13,2021-03-13,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03756454,0,0,0,0,0,0,2021-07-31,2022-07-31,,"Michael E Villarreal, MD",Other,0,1,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,1
NCT03757819,0,0,0,0,0,0,2019-12-31,2020-12-31,,Thorsten Rudroff,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03759600,0,0,0,0,0,0,2019-07-01,2020-07-01,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,650
NCT03760081,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,135
NCT03760445,0,0,0,0,0,0,2021-07-22,2022-07-22,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1895
NCT03762655,0,0,0,0,0,0,2020-12-31,2021-12-31,,InVivo Therapeutics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03764475,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Arcutis, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03765567,0,0,0,0,0,0,2022-01-31,2023-01-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,257
NCT03767491,0,0,0,0,0,0,2022-06-01,2023-06-01,,Massachusetts General Hospital,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT03768856,0,0,0,0,0,0,2020-01-01,2021-01-01,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,374
NCT03769194,0,0,0,0,0,0,2020-01-31,2021-01-31,,Valneva Austria GmbH,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,31
NCT03770455,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Jodi Layton, MD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03773107,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Saad Z. Usmani, MD",Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03774121,0,0,0,0,0,0,2020-02-29,2021-02-28,,Hospital of South West Jutland,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,6
NCT03774745,0,0,0,0,0,0,2019-07-29,2020-07-29,,"University of California, Davis",Other,0,0,0,0.0,Phase 1/Phase 2,1,2019.0,1,1,0,0,0,0,0,0,0,1,0,530
NCT03774875,0,0,0,0,0,0,2020-06-19,2021-06-19,,Celgene,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,306
NCT03775434,0,0,0,0,0,0,2019-05-18,2020-05-18,,AOBiome LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03776136,0,0,0,0,0,0,2021-06-15,2022-06-15,,Merck Sharp & Dohme Corp.,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03781167,0,0,0,0,0,0,2021-04-23,2022-04-23,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03781804,0,0,0,0,0,0,2020-12-31,2021-12-31,,Optinose US Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03785340,0,0,0,0,0,0,2019-02-28,2020-02-28,,Ocugen,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03785756,0,0,0,0,0,0,2019-12-31,2020-12-31,,Reckitt Benckiser Healthcare (UK) Limited,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03794583,0,0,0,0,0,0,2020-12-31,2021-12-31,,United Therapeutics,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,72
NCT03795298,0,0,0,0,0,0,2021-09-30,2022-09-30,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,340
NCT03795610,0,0,0,0,0,0,2020-06-30,2021-06-30,,Ezra Cohen,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03797014,0,0,0,0,0,0,2021-02-28,2022-02-28,,"University of Maryland, Baltimore",Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,144
NCT03797144,0,0,0,0,0,0,2021-12-31,2022-12-31,,Medtronic Spinal and Biologics,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,52
NCT03797391,0,0,0,0,0,0,2021-09-09,2022-09-09,,"Shanghai EpimAb Biotherapeutics Co., Ltd.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03798873,0,0,0,0,0,0,2020-07-31,2021-07-31,,Feelwell Compression,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03805412,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Nicole Ehrhardt, MD",Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03808337,0,0,0,0,0,0,2022-01-31,2023-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT03809520,0,0,0,0,0,0,2021-12-31,2022-12-31,,J L Marsh,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,0,1,1
NCT03810911,0,0,0,0,0,0,2022-07-15,2023-07-15,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03811405,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Florida,Other,0,0,1,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT03816163,0,0,0,0,0,0,2022-02-28,2023-02-28,,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,135
NCT03817502,0,0,0,0,0,0,2022-12-17,2023-12-17,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03817931,0,0,0,0,0,0,2020-05-01,2021-05-01,,Baylor Research Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,1,0,0,0,0,1,0,131
NCT03819140,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03822377,0,0,0,0,0,0,2020-02-29,2021-02-28,,Azienda Ospedaliero Universitaria di Sassari,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03822637,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03823950,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Mississippi Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,88
NCT03827798,0,0,0,0,0,0,2020-06-17,2021-06-17,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03828747,0,0,0,0,0,0,2021-09-24,2022-09-24,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,427
NCT03830164,0,0,0,0,0,0,2022-09-17,2023-09-17,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03831698,0,0,0,0,0,0,2021-02-28,2022-02-28,,University of Kansas Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03832738,0,0,0,0,0,0,2020-05-31,2021-05-31,,Akros Pharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,22
NCT03834753,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Outlook Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03835975,0,0,0,0,0,0,2020-02-22,2021-02-22,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,2856
NCT03837665,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Kansas Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,219
NCT03839446,0,0,0,0,0,0,2020-10-10,2021-10-10,,Michael Boyiadzis,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03843710,0,0,0,0,0,0,2020-07-31,2021-07-31,,Clene Nanomedicine,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03844932,0,0,0,0,0,0,2020-11-30,2021-11-30,,Sublimity Therapeutics Holdco Limited,Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03846479,0,0,0,0,0,0,2019-12-31,2020-12-31,,John Levine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03847519,0,0,0,0,0,0,2023-01-15,2024-01-15,,"Advaxis, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03848949,0,0,0,0,0,0,2019-10-01,2020-10-01,,Rush University Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,227
NCT03851042,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Arizona,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,265
NCT03851406,0,0,0,0,0,0,2022-03-31,2023-03-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03852628,0,0,0,0,0,0,2021-06-30,2022-06-30,,Pharmacotherapies for Alcohol and Substance Abuse Consortium,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03853694,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Pacira Pharmaceuticals, Inc",Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,53
NCT03854110,0,0,0,0,0,0,2020-12-15,2021-12-15,,Geistlich Pharma AG,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03856658,0,0,0,0,0,0,2020-04-30,2021-04-30,,Spectrum Health Hospitals,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,43
NCT03861702,0,0,0,0,0,0,2021-01-31,2022-01-31,,Big Ten Cancer Research Consortium,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT03862131,0,0,0,0,0,0,2022-12-31,2023-12-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03863184,0,0,0,0,0,0,2022-09-01,2023-09-01,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03868059,0,0,0,0,0,0,2019-02-19,2020-02-19,,Lipocine Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03868787,0,0,0,0,0,0,2020-06-01,2021-06-01,,Ashley Turner,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03871153,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Greg Durm, MD",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,1,0,1,0,0,3,1,0,3
NCT03871543,0,0,0,0,0,0,2019-12-15,2020-12-15,,"Johnson & Johnson Vision Care, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,138
NCT03872453,0,0,0,0,0,0,2019-09-06,2020-09-06,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,18
NCT03874637,1,0,0,0,1,0,2017-05-17,2018-05-17,,FemPulse Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03875638,0,0,0,0,0,0,2023-08-31,2024-08-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03878459,0,0,0,0,0,0,2020-12-31,2021-12-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,257
NCT03879135,0,0,0,0,0,0,2021-06-30,2022-06-30,,Baxalta now part of Shire,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,107
NCT03879577,0,0,0,0,0,0,2022-04-10,2023-04-10,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,594
NCT03880279,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Triumvira Immunologics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1
NCT03881553,0,0,0,0,0,0,2021-07-31,2022-07-31,,Elisabeth Salisbury,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03882723,0,0,0,0,0,0,2019-08-30,2020-08-30,,Rush University Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,227
NCT03883828,0,0,0,0,0,0,2020-06-03,2021-06-03,,Montefiore Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03886727,0,0,0,0,0,0,2020-06-01,2021-06-01,,"Zafer Cavit Cehreli, DDS, PhD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03887650,0,0,0,0,0,0,2020-01-01,2021-01-01,,Hartford Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,65
NCT03895801,0,0,0,0,0,0,2021-03-31,2022-03-31,,InflaRx GmbH,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,8
NCT03896230,0,0,0,0,0,0,2019-12-31,2020-12-31,,Hackensack Meridian Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,55
NCT03897439,0,0,0,0,0,0,2022-04-30,2023-04-30,,University of Kansas Medical Center,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,219
NCT03901417,0,0,0,0,0,0,2019-12-31,2020-12-31,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1699
NCT03904108,0,0,0,0,0,0,2021-05-31,2022-05-31,,ROGER S MD KERESZTES,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03904862,0,0,0,0,0,0,2022-05-01,2023-05-01,,Pediatric Brain Tumor Consortium,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03905655,0,0,0,0,0,0,2022-12-01,2023-12-01,,Romark Laboratories L.C.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,23
NCT03907488,0,0,0,0,0,0,2024-03-01,2025-03-01,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,3004
NCT03909100,0,0,0,0,0,0,2019-12-15,2020-12-15,,Allergan,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,495
NCT03911908,0,0,0,0,0,0,2020-07-01,2021-07-01,,Dr. Serge Thal,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,0,0,0,0,1,0,2,1,0,1
NCT03914300,0,0,0,0,0,0,2021-01-15,2022-01-15,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT03915015,0,0,0,0,0,0,2030-12-31,2031-12-31,,Oregon Health and Science University,Other,0,0,0,5.0,,0,2012.0,0,0,0,0,1,0,0,0,0,0,1,475
NCT03916926,0,0,0,0,0,0,2022-12-31,2023-12-31,,Case Western Reserve University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,89
NCT03917472,0,0,0,0,0,0,2021-07-30,2022-07-30,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03917654,0,0,0,0,0,0,2020-08-31,2021-08-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,2133
NCT03919162,0,0,0,0,0,0,2022-12-31,2023-12-31,,Probiodrug AG,Industry,1,0,1,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03921424,0,0,0,0,0,0,2021-02-17,2022-02-17,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,2145
NCT03924297,0,0,0,0,0,0,2020-09-30,2021-09-30,,Wake Forest University Health Sciences,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,616
NCT03926143,0,0,0,0,0,0,2024-10-31,2025-10-31,,Bayer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1343
NCT03926624,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Delta-Fly Pharma, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,4
NCT03928496,1,0,0,0,1,0,2017-02-02,2018-02-02,,VA Greater Los Angeles Healthcare System,U.S. Fed,2,1,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,23
NCT03928704,0,0,0,0,0,0,2021-02-28,2022-02-28,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03930056,0,0,0,0,0,0,2025-11-30,2026-11-30,,Shirley Ryan AbilityLab,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,71
NCT03930186,0,0,0,0,0,0,2020-08-06,2021-08-06,,Celgene,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,306
NCT03930745,0,0,0,0,0,0,2020-07-01,2021-07-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03932071,0,0,0,0,0,0,2020-01-01,2021-01-01,,"Second Affiliated Hospital, School of Medicine, Zhejiang University",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,0,1,121
NCT03933020,0,0,0,0,0,0,2020-06-24,2021-06-24,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,490
NCT03933449,0,0,0,0,0,0,2019-02-13,2020-02-13,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,2,1,0,2145
NCT03934216,0,0,0,0,0,0,2021-08-16,2022-08-16,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03935308,0,0,0,0,0,0,2021-12-31,2022-12-31,,Henry Ford Health System,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,151
NCT03936244,1,0,0,0,1,0,2017-12-12,2018-12-12,,Hospital Universitario de Fuenlabrada,Other,0,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,2,0,1,2
NCT03937830,0,0,0,0,0,0,2022-12-31,2023-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03938389,0,0,0,0,0,0,2021-08-31,2022-08-31,,Ohio State University,Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,315
NCT03939065,0,0,0,0,0,0,2022-12-31,2023-12-31,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,882
NCT03941327,0,0,0,0,0,0,2020-05-01,2021-05-01,,University of Mississippi Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,88
NCT03941548,0,0,0,0,0,0,2020-03-31,2021-03-31,,Concert Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,20
NCT03943147,0,0,0,0,0,0,2021-07-07,2022-07-07,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03944577,0,0,0,0,0,0,2021-07-01,2022-07-01,,University of Nebraska,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,327
NCT03946670,0,0,0,0,0,0,2021-02-11,2022-02-11,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03948386,0,0,0,0,0,0,2020-05-31,2021-05-31,,Thomas Jefferson University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,186
NCT03951077,0,0,0,0,0,0,2021-03-15,2022-03-15,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,430
NCT03953898,0,0,0,0,0,0,2020-12-01,2021-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3004
NCT03954041,0,0,0,0,0,0,2021-12-31,2022-12-31,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,324
NCT03954444,0,0,0,0,0,0,2020-01-30,2021-01-30,,Actavis Inc.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,93
NCT03955445,0,0,0,0,0,0,2024-12-02,2025-12-02,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03958955,0,0,0,0,0,0,2019-12-31,2020-12-31,,LEO Pharma,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,171
NCT03960580,0,0,0,0,0,0,2021-04-30,2022-04-30,,Optinose US Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT03963895,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Aronora, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03966053,0,0,0,0,0,0,2020-06-01,2021-06-01,,Adrianna Vlachos,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03971799,0,0,0,0,0,0,2024-12-31,2025-12-31,,Center for International Blood and Marrow Transplant Research,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,25
NCT03972488,0,0,0,0,0,0,2022-12-31,2023-12-31,,Advanced Accelerator Applications,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,14
NCT03976375,0,0,0,0,0,0,2023-08-21,2024-08-21,,Merck Sharp & Dohme Corp.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03978000,0,0,0,0,0,0,2020-11-30,2021-11-30,,Infant Bacterial Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03978767,0,0,0,0,0,0,2021-05-27,2022-05-27,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03980717,0,0,0,0,0,0,2028-12-31,2029-12-31,,Michael Belfort,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03983343,0,0,0,0,0,0,2021-06-01,2022-06-01,,"HaEmek Medical Center, Israel",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,209
NCT03985423,0,0,0,0,0,0,2021-09-30,2022-09-30,,NovImmune SA,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03988855,0,0,0,0,0,0,2020-06-05,2021-06-05,,Deinove,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03989024,0,0,0,0,0,0,2020-12-30,2021-12-30,,RenJi Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,136
NCT03989206,0,0,0,0,0,0,2023-09-30,2024-09-30,,Galderma R&D,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,28
NCT03989635,0,0,0,0,0,0,2021-06-14,2022-06-14,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03990298,0,0,0,0,0,0,2020-11-30,2021-11-30,,University of Pennsylvania,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1052
NCT03992872,0,0,0,0,0,0,2020-09-15,2021-09-15,,"PaxVax, Inc.",Industry,1,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,12
NCT03994822,0,0,0,0,0,0,2020-12-31,2021-12-31,,phenox Inc.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03997838,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Vivozon, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT04000373,0,0,0,0,0,0,2020-07-31,2021-07-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT04003506,0,0,0,0,0,0,2020-08-31,2021-08-31,,The University of Hong Kong,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,547
NCT04004065,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Sarepta Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT04005352,0,0,0,0,0,0,2022-08-11,2023-08-11,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,3,1,0,1895
NCT04005755,0,0,0,0,0,0,2019-10-31,2020-10-31,,"AFT Pharmaceuticals, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,5
NCT04006691,0,0,0,0,0,0,2020-09-16,2021-09-16,,UroGen Pharma Ltd.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,11
NCT04009044,0,0,0,0,0,0,2022-06-09,2023-06-09,,Northwestern University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,925
NCT04009408,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Calgary,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,361
NCT04009668,0,0,0,0,0,0,2021-01-31,2022-01-31,,University of Michigan,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,934
NCT04010461,0,0,0,0,0,0,2021-04-30,2022-04-30,,University of Michigan,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT04011722,0,0,0,0,0,0,2020-11-30,2021-11-30,,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,419
NCT04012853,0,0,0,0,0,0,2021-10-30,2022-10-30,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT04013126,0,0,0,0,0,0,2021-08-31,2022-08-31,,"HaEmek Medical Center, Israel",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,3,1,0,209
NCT04014335,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,69
NCT04015141,0,0,0,0,0,0,2021-10-13,2022-10-13,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,328
NCT04015739,0,0,0,0,0,0,2020-06-30,2021-06-30,,ARCAGY/ GINECO GROUP,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,38
NCT04016285,0,0,0,0,0,0,2021-05-31,2022-05-31,,Stephen Duncan,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04016870,0,0,0,0,0,0,2022-10-31,2023-10-31,,University of Michigan,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,934
NCT04017442,0,0,0,0,0,0,2020-07-01,2021-07-01,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT04020055,0,0,0,0,0,0,2020-03-31,2021-03-31,,Amicus Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,34
NCT04020341,0,0,0,0,0,0,2021-04-28,2022-04-28,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3276
NCT04021043,0,0,0,0,0,0,2023-08-29,2024-08-29,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,2066
NCT04021927,0,0,0,0,0,0,2021-12-01,2022-12-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT04022161,0,0,0,0,0,0,2021-02-28,2022-02-28,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1699
NCT04025671,1,0,0,0,1,0,2017-09-03,2018-09-03,,State University of New York - Upstate Medical University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,125
NCT04026880,0,0,0,0,0,0,2021-01-01,2022-01-01,,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,698
NCT04026997,0,0,0,0,0,0,2020-06-30,2021-06-30,,"CinDome Pharma, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT04028700,0,0,0,0,0,0,2023-10-01,2024-10-01,,Blood Center of Wisconsin,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,4
NCT04031404,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,910
NCT04032262,0,0,0,0,0,0,2019-12-31,2020-12-31,,Augusta University,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,117
NCT04032418,0,0,0,0,0,0,2022-09-03,2023-09-03,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,294
NCT04033432,0,0,0,0,0,0,2021-06-03,2022-06-03,,Northwestern University,Other,0,1,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,925
NCT04034121,1,0,0,0,1,0,2017-01-22,2018-01-22,,Elixir Medical Corporation,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,2,0,1,10
NCT04035070,0,0,0,0,0,0,2021-01-31,2022-01-31,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2020.0,0,0,0,0,0,0,1,0,2,1,0,1190
NCT04035655,0,0,0,0,0,0,2018-09-30,2019-09-30,,Groupe Hospitalier Pitie-Salpetriere,Other,0,0,0,5.0,,0,2015.0,1,0,0,0,1,0,0,0,2,0,1,52
NCT04037852,0,0,0,0,0,0,2021-08-31,2022-08-31,,Changhua Christian Hospital,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,44
NCT04042077,0,0,0,0,0,0,2020-09-30,2021-09-30,,Menarini Group,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,26
NCT04044742,0,0,0,0,0,0,2021-06-30,2022-06-30,,"Sorrento Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,9
NCT04046094,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Kansas Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,219
NCT04046939,0,0,0,0,0,0,2020-09-30,2021-09-30,,Knopp Biosciences,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT04050618,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,85
NCT04052880,0,0,0,0,0,0,2021-08-31,2022-08-31,,Ajai Chari,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT04053543,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Complexa, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT04055376,0,0,0,0,0,0,2021-04-30,2022-04-30,,Massachusetts Institute of Technology,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT04057885,1,0,0,0,1,0,2018-07-31,2019-07-31,,LifeBridge Health,Other,0,1,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,21
NCT04058054,0,0,0,0,0,0,2019-08-02,2020-08-02,,"KeraNetics, LLC",Industry,1,0,0,5.0,,0,2019.0,1,1,0,1,0,0,0,0,0,1,0,3
NCT04059406,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,69
NCT04062448,0,0,0,0,0,0,2023-06-01,2024-06-01,,Janssen Pharmaceutical K.K.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,102
NCT04063787,0,0,0,0,0,0,2020-08-13,2021-08-13,,University of Chicago,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,594
NCT04063878,0,0,0,0,0,0,2022-03-30,2023-03-30,,Dentsply Sirona Implants,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,1,1,0,27
NCT04065074,0,0,0,0,0,0,2019-08-30,2020-08-30,,"Flexion Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT04065399,0,0,0,0,0,0,2022-07-01,2023-07-01,,Syndax Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,21
NCT04066192,0,0,0,0,0,0,2024-06-30,2025-06-30,,"University of Colorado, Denver",Other,0,0,1,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT04066751,0,0,0,0,0,0,2024-10-31,2025-10-31,,University of Alabama at Birmingham,Other,0,1,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,801
NCT04067544,0,0,0,0,0,0,2021-02-28,2022-02-28,,University of Utah,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,578
NCT04072367,0,0,0,0,0,0,2020-12-31,2021-12-31,,Vesalio,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,4
NCT04072822,0,0,0,0,0,0,2024-06-30,2025-06-30,,Indiana University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT04074356,0,0,0,0,0,0,2024-09-30,2025-09-30,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,422
NCT04078191,0,0,0,0,0,0,2020-10-31,2021-10-31,,Navidea Biopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,17
NCT04083183,0,0,0,0,0,0,2028-01-09,2029-01-09,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,393
NCT04083495,0,0,0,0,0,0,2021-09-30,2022-09-30,,UNC Lineberger Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,229
NCT04083898,0,0,0,0,0,0,2021-07-31,2022-07-31,,Washington University School of Medicine,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,1151
NCT04084093,0,0,0,0,0,0,2021-01-01,2022-01-01,,Medline Industries,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,30
NCT04085367,0,0,0,0,0,0,2020-10-06,2021-10-06,,Galderma R&D,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,28
NCT04085887,0,0,0,0,0,0,2022-09-30,2023-09-30,,Stanford University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2021.0,0,1,0,1,0,0,0,0,0,1,0,1309
NCT00001481,0,0,0,0,0,0,2021-06-13,2022-06-13,,National Institute of Mental Health (NIMH),NIH,2,0,0,1.0,Phase 2,0,1996.0,0,1,0,0,0,0,0,0,0,0,1,330
NCT00061282,1,0,0,0,1,0,2018-06-30,2019-06-30,,Paul Rufo,Other,0,0,0,0.0,Phase 1/Phase 2,0,2002.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT00108745,0,0,0,0,0,0,2022-01-01,2023-01-01,,Gynecologic Oncology Group,Other,0,0,1,3.0,Phase 3,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,200
NCT00271505,1,0,0,0,1,0,2017-07-27,2018-07-27,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2005.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00273364,0,0,0,0,0,0,2023-09-30,2024-09-30,,Northwestern University,Other,0,0,0,1.0,Phase 2,0,2005.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT00287287,0,0,0,0,0,0,2021-04-30,2022-04-30,,Kenneth Ain,Other,0,1,0,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT00305682,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2005.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT00329043,0,0,0,0,0,0,2019-05-31,2020-05-31,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00345345,1,1,0,1,0,1,2017-08-01,2018-08-01,2019-04-11,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2006.0,0,0,1,0,0,0,0,0,0,0,1,1091
NCT00367666,0,0,0,0,0,0,2020-08-01,2021-08-01,,University of Pennsylvania,Other,0,0,0,5.0,,0,2002.0,0,0,0,1,0,0,0,0,0,0,1,1052
NCT00378482,0,0,0,0,0,0,2020-02-28,2021-02-28,,AstraZeneca,Industry,1,0,0,1.0,Phase 2,0,2007.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT00387075,0,0,0,0,0,0,2020-08-31,2021-08-31,,Institute for Neurodegenerative Disorders,Other,0,0,1,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,41
NCT00390325,1,1,0,1,0,1,2017-01-30,2018-01-30,2018-05-08,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2006.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT00466531,0,0,0,0,0,0,2020-12-31,2021-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2007.0,0,1,1,0,0,0,0,0,0,0,1,1432
NCT00495170,1,1,0,1,0,0,2017-06-14,2018-06-14,2018-02-26,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2006.0,1,1,0,0,0,1,0,0,0,0,1,2066
NCT00514046,0,0,0,0,0,0,2022-04-01,2023-04-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2007.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT00525057,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,5.0,,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT00539643,0,0,0,0,0,0,2020-02-29,2021-02-28,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2007.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT00547196,0,0,0,0,0,0,2019-09-30,2020-09-30,,City of Hope Medical Center,Other,0,0,1,5.0,,0,2005.0,0,1,1,0,0,1,0,0,0,0,1,358
NCT00556842,0,0,0,0,0,0,2019-05-30,2020-05-30,,McMaster University,Other,0,0,1,5.0,,0,2009.0,1,0,0,1,0,0,0,0,1,0,1,434
NCT00582088,0,0,0,0,0,0,2019-04-30,2020-04-30,,U.S. Army Medical Research and Development Command,U.S. Fed,2,0,0,1.0,Phase 2,0,2008.0,1,0,1,0,0,0,0,0,0,0,1,136
NCT00601003,0,0,0,0,0,0,2020-05-01,2021-05-01,,Giselle Sholler,Other,0,1,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,18
NCT00604201,0,0,0,0,0,0,2020-12-31,2021-12-31,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2008.0,0,0,1,0,0,0,0,0,0,0,1,1091
NCT00631852,0,0,0,0,0,0,2019-12-30,2020-12-30,,Southern Illinois University,Other,0,0,0,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT00643617,0,0,0,0,0,0,2022-06-30,2023-06-30,,Accuray Incorporated,Industry,1,0,0,5.0,,0,2007.0,0,0,0,0,0,1,0,0,0,0,1,6
NCT00678145,0,0,0,0,0,0,2022-08-31,2023-08-31,,Albert Einstein College of Medicine,Other,0,0,1,1.0,Phase 2,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,155
NCT00692939,0,0,0,0,0,0,2025-12-31,2026-12-31,,Paul Szabolcs,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,1,0,0,0,0,0,0,0,1,5
NCT00734877,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Arkansas,Other,0,1,0,3.0,Phase 3,0,2008.0,0,1,0,0,0,0,0,0,0,0,1,285
NCT00788125,0,0,0,0,0,0,2019-09-30,2020-09-30,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2008.0,0,1,0,0,0,1,0,1,0,0,1,358
NCT00810797,0,0,0,0,0,0,2019-06-26,2020-06-26,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT00841802,0,0,0,0,0,0,2019-05-31,2020-05-31,,Northwestern University,Other,0,0,1,4.0,Phase 4,1,2008.0,1,1,0,0,0,0,0,0,0,0,1,925
NCT00859781,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT00880594,0,0,0,0,0,0,2020-05-31,2021-05-31,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT00896181,0,0,0,0,0,0,2019-07-31,2020-07-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,1,0,0,0,0,1,1309
NCT00936936,0,0,0,0,0,0,2019-09-01,2020-09-01,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT00942877,0,0,0,0,0,0,2019-12-31,2020-12-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT00945061,1,0,0,0,1,0,2018-07-06,2019-07-06,,Case Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2008.0,1,0,0,0,0,1,0,0,0,0,1,374
NCT00950248,1,1,0,1,0,0,2018-04-30,2019-04-30,2018-11-15,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2009.0,1,1,0,0,0,0,0,0,0,0,1,2133
NCT00957073,0,0,0,0,0,0,2021-12-31,2022-12-31,,"CVRx, Inc.",Industry,1,0,0,5.0,,0,2009.0,0,0,0,1,0,0,0,0,0,0,1,15
NCT00970203,0,0,0,0,0,0,2018-10-05,2019-10-05,,Roswell Park Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2009.0,0,0,1,0,0,0,0,0,0,0,1,294
NCT00984399,0,0,0,0,0,0,2019-09-30,2020-09-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2009.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT00998010,1,0,0,0,1,0,2018-04-19,2019-04-19,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,277
NCT01026532,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of Wisconsin, Madison",Other,0,0,1,5.0,,0,2011.0,1,0,1,0,0,0,0,0,0,0,1,715
NCT01039376,1,1,0,1,0,0,2017-02-20,2018-02-20,2015-02-12,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2010.0,1,0,1,0,0,0,0,0,1,0,1,1895
NCT01064648,1,0,1,1,0,1,2018-06-01,2019-06-01,2019-08-08,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01130519,0,0,0,0,0,0,2021-12-01,2022-12-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01132482,1,1,0,1,0,1,2017-05-31,2018-05-31,2018-09-06,National Jewish Health,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,81
NCT01173692,0,0,0,0,0,0,2019-07-31,2020-07-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01183429,1,1,0,1,0,0,2018-09-13,2019-09-13,2019-07-24,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01190410,1,1,0,1,0,0,2017-11-27,2018-11-27,2018-11-27,UCB Pharma,Industry,1,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,1,0,1,246
NCT01191697,0,0,0,0,0,0,2020-07-31,2021-07-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT01216176,1,1,0,1,0,1,2018-02-07,2019-02-07,2019-05-02,Joyce Marie Slingerland,Other,0,0,0,0.0,Phase 1/Phase 2,0,2008.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01226979,0,0,0,0,0,0,2020-09-30,2021-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,461
NCT01231906,0,0,0,0,0,0,2019-12-31,2020-12-31,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2010.0,0,1,0,0,0,0,0,0,1,0,1,389
NCT01237951,1,0,1,1,0,0,2017-09-20,2018-09-20,2018-06-25,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01240304,0,0,0,0,0,0,2020-03-31,2021-03-31,,University of Arkansas,Other,0,0,0,1.0,Phase 2,0,2010.0,0,1,0,0,0,1,0,0,0,0,1,285
NCT01245712,0,0,0,0,0,0,2021-11-01,2022-11-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2010.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01248247,0,0,0,0,0,0,2019-06-30,2020-06-30,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01266096,0,0,0,0,0,0,2019-12-31,2020-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,5.0,,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01273207,0,0,0,0,0,0,2019-05-10,2020-05-10,,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1091
NCT01275365,1,1,0,1,0,0,2017-01-19,2018-01-19,2018-01-19,Brigham and Women's Hospital,Other,0,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,698
NCT01280669,0,0,0,0,0,0,2020-05-31,2021-05-31,,Stanford University,Other,0,1,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT01281956,1,1,0,1,0,1,2017-10-05,2018-10-05,2018-10-10,National Institute of Neurological Disorders and Stroke (NINDS),NIH,2,0,0,1.0,Phase 2,1,2011.0,1,1,0,0,0,0,0,0,0,0,1,560
NCT01295944,0,0,0,0,0,0,2022-07-01,2023-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01297413,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Stemedica Cell Technologies, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,0,1,0,0,0,0,0,0,0,1,4
NCT01318317,0,0,0,0,0,0,2022-08-31,2023-08-31,,City of Hope Medical Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2011.0,0,1,1,0,0,0,0,1,0,0,1,358
NCT01325441,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Boston Biomedical, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2011.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT01345175,0,0,0,0,0,0,2020-04-30,2021-04-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01371981,0,0,0,0,0,0,2019-03-31,2020-03-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2011.0,1,1,0,0,0,0,0,0,1,0,1,3004
NCT01379573,0,0,0,0,0,0,2019-08-31,2020-08-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT01396486,0,0,0,0,0,0,2019-04-11,2020-04-11,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01414985,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2010.0,0,0,1,0,0,0,0,0,0,0,1,586
NCT01441063,0,0,0,0,0,0,2020-07-01,2021-07-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01446809,0,1,0,1,0,0,2019-01-31,2020-01-31,2017-09-19,University of Washington,Other,0,0,1,5.0,,0,2012.0,1,1,0,0,0,1,0,0,0,0,1,910
NCT01457352,1,1,0,1,0,1,2017-08-25,2018-08-25,2018-11-15,Sun Pharma Advanced Research Company Limited,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,29
NCT01467466,1,1,0,1,0,1,2017-09-29,2018-09-29,2018-10-02,VA Office of Research and Development,U.S. Fed,2,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1012
NCT01498445,0,0,0,0,0,0,2020-06-30,2021-06-30,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT01502280,1,0,0,0,1,0,2018-01-31,2019-01-31,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,3.0,Phase 3,0,2010.0,1,1,0,0,0,0,0,0,0,0,1,48
NCT01536873,1,0,0,0,1,0,2018-08-31,2019-08-31,,ViiV Healthcare,Industry,1,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,200
NCT01541215,1,1,0,1,0,0,2017-11-15,2018-11-15,2018-11-15,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT01557517,1,1,0,1,0,1,2017-06-09,2018-06-09,2018-08-10,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01559363,0,0,0,0,0,0,2019-02-08,2020-02-08,,"Kadmon Corporation, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,29
NCT01566890,0,0,0,0,0,0,2022-01-30,2023-01-30,,Blood Center of Wisconsin,Other,0,0,0,5.0,,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT01568918,0,0,0,0,0,0,2019-12-31,2020-12-31,,Mayo Clinic,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01571284,1,1,0,1,0,0,2017-01-31,2018-01-31,2018-01-29,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT01579812,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-02-28,University of Michigan Rogel Cancer Center,Other,0,0,0,1.0,Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,213
NCT01586910,1,0,1,1,0,0,2018-07-31,2019-07-31,2019-07-17,Medtronic Cardiovascular,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,34
NCT01587352,1,0,0,0,1,0,2018-08-16,2019-08-16,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,1,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01593254,1,1,0,1,0,0,2017-11-08,2018-11-08,2018-11-08,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT01595620,0,0,0,0,0,0,2019-12-31,2020-12-31,,Yale University,Other,0,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,1053
NCT01603602,1,1,0,1,0,0,2017-06-29,2018-06-29,2018-06-12,Allergan,Industry,1,0,0,3.0,Phase 3,0,2012.0,1,1,1,0,0,0,0,0,1,0,1,495
NCT01617161,0,0,0,0,0,0,2021-12-31,2022-12-31,,Massachusetts General Hospital,Other,0,0,1,5.0,,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,1699
NCT01619488,1,0,0,0,1,0,2018-05-31,2019-05-31,,Kirk Reichard,Other,0,0,0,3.0,Phase 3,0,2007.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT01619865,1,0,0,0,1,0,2017-08-27,2018-08-27,,Sue O'Dorisio,Other,0,0,0,0.0,Phase 1/Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT01621737,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-08-30,"University of California, San Diego",Other,0,0,1,5.0,,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT01625923,0,1,0,1,0,0,2019-06-30,2020-06-30,2019-06-24,University of Michigan,Other,0,0,0,5.0,,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT01627041,0,0,0,0,0,0,2022-10-01,2023-10-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2011.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01627301,0,0,0,0,0,0,2020-12-31,2021-12-31,,Emory University,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,947
NCT01629862,1,1,0,1,0,0,2017-02-28,2018-02-28,2018-01-22,Sanjay R Patel,Other,0,0,1,1.0,Phase 2,0,2012.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT01631552,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Immunomedics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,36
NCT01633112,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-29,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,1,2012.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01642186,0,0,0,0,0,0,2020-07-31,2021-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01644591,0,0,0,0,0,0,2020-08-31,2021-08-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2012.0,0,0,0,0,0,1,0,0,0,0,1,2066
NCT01644669,0,0,0,0,0,0,2023-02-28,2024-02-28,,"Xoft, Inc.",Industry,1,1,0,5.0,,0,2012.0,0,0,0,0,0,1,0,0,1,0,1,8
NCT01660711,1,0,0,0,1,0,2018-08-22,2019-08-22,,NorthShore University HealthSystem,Other,0,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,61
NCT01663402,1,1,0,1,0,0,2018-01-23,2019-01-23,2019-01-21,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2012.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT01683331,1,1,0,1,0,0,2018-02-27,2019-02-27,2019-02-26,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,934
NCT01688024,1,0,0,0,1,0,2017-09-30,2018-09-30,,"Li, Zhiping, M.D.",Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01688856,1,0,0,0,1,0,2018-08-31,2019-08-31,,MetroHealth Medical Center,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,65
NCT01688973,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-04-12,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,3004
NCT01692197,1,1,0,1,0,0,2017-06-07,2018-06-07,2018-06-04,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01693562,0,0,0,0,0,0,2019-11-29,2020-11-29,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,269
NCT01695291,1,1,0,1,0,1,2017-02-28,2018-02-28,2019-02-07,New York State Psychiatric Institute,Other,0,0,1,1.0,Phase 2,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT01697267,0,0,0,0,0,0,2019-12-31,2020-12-31,,Cambridge University Hospitals NHS Foundation Trust,Other,0,1,0,3.0,Phase 3,0,2013.0,0,1,1,0,0,0,0,0,1,0,1,98
NCT01705977,1,0,1,1,0,0,2018-07-30,2019-07-30,2019-07-19,"Human Genome Sciences Inc., a GSK Company",Industry,1,1,0,4.0,Phase 4,0,2012.0,0,0,1,0,0,0,0,0,1,0,1,15
NCT01706939,0,0,0,0,0,0,2021-12-31,2022-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,1,0,0,0,0,1,412
NCT01708538,0,0,0,0,0,0,2020-10-31,2021-10-31,,Rush Eye Associates,Other,0,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT01711658,0,0,0,0,0,0,2020-03-31,2021-03-31,,Radiation Therapy Oncology Group,Other,0,1,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,1,0,0,1,0,1,156
NCT01723202,0,0,0,0,0,0,2018-12-31,2019-12-31,,Manisha Shah,Other,0,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT01723839,0,0,0,0,0,0,2019-08-31,2020-08-31,,Hackensack Meridian Health,Other,0,1,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,55
NCT01729104,0,0,0,0,0,0,2018-10-03,2019-10-03,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT01742117,0,0,0,0,0,0,2019-11-30,2020-11-30,,Mayo Clinic,Other,0,1,1,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,1,1,0,1,1898
NCT01742338,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Rutgers, The State University of New Jersey",Other,0,0,0,4.0,Phase 4,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,227
NCT01748318,1,0,0,0,1,0,2018-05-31,2019-05-31,,"R. Stephen Rankin, M.D.",Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT01752400,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-03-05,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT01754909,1,0,1,1,0,1,2018-04-01,2019-04-01,2019-06-14,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1012
NCT01755195,0,0,0,0,0,0,2020-09-30,2021-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2012.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01758523,1,1,0,1,0,0,2018-02-28,2019-02-28,2019-02-25,UConn Health,Other,0,0,1,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,148
NCT01765218,0,0,0,0,0,0,2020-05-31,2021-05-31,,Kristin R Hoffman,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT01767155,1,1,0,1,0,0,2017-01-30,2018-01-30,2018-01-15,AEterna Zentaris,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,33
NCT01767857,1,0,0,0,1,0,2017-06-30,2018-06-30,,"XBiotech, Inc.",Industry,1,0,0,3.0,Phase 3,1,2013.0,1,1,0,0,0,0,0,0,1,0,1,15
NCT01770418,0,0,0,0,0,0,2038-01-31,2039-01-31,,Proton Collaborative Group,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,0,0,0,0,1,0,0,0,0,1,9
NCT01774487,0,0,0,0,0,0,2019-01-31,2020-01-31,,Baylor College of Medicine,Other,0,0,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,518
NCT01781390,0,0,0,0,0,0,2018-07-17,2019-07-17,,"Mesoblast, Ltd.",Industry,1,0,0,1.0,Phase 2,0,2012.0,0,0,1,0,0,0,0,0,3,0,1,15
NCT01781455,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Boston Biomedical, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2012.0,0,1,0,0,0,0,0,0,1,0,1,27
NCT01802944,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Bronx Veterans Medical Research Foundation, Inc",Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT01806064,0,0,0,0,0,0,2018-12-21,2019-12-21,,Tracon Pharmaceuticals Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,18
NCT01806571,1,0,0,0,1,0,2017-07-31,2018-07-31,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT01807611,0,0,0,0,0,0,2020-02-29,2021-02-28,,St. Jude Children's Research Hospital,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,1,1,0,1,0,0,0,0,1,302
NCT01807741,1,0,0,0,1,0,2017-07-31,2018-07-31,,University of Cincinnati,Other,0,1,0,1.0,Phase 2,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,222
NCT01811147,1,0,1,1,0,1,2018-06-30,2019-06-30,2019-08-29,The Cleveland Clinic,Other,0,0,0,4.0,Phase 4,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,581
NCT01816971,1,0,0,0,1,0,2018-04-30,2019-04-30,,University of Chicago,Other,0,0,1,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,594
NCT01824290,0,0,0,0,0,0,2019-03-18,2020-03-18,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT01827163,0,0,0,0,0,0,2019-01-31,2020-01-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01831895,0,0,0,0,0,0,2017-12-31,2018-12-31,,"Vascular Dynamics, Inc.",Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT01834911,1,0,0,0,1,0,2018-01-01,2019-01-01,,New York Medical College,Other,0,0,0,4.0,Phase 4,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,40
NCT01837069,1,0,0,0,1,0,2018-04-02,2019-04-02,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,869
NCT01840345,1,1,0,1,0,0,2017-03-01,2018-03-01,2018-02-15,Virginia Commonwealth University,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,417
NCT01849822,0,0,0,0,0,0,2019-01-31,2020-01-31,,"Richard A. Andersen, PhD",Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,3
NCT01853618,1,0,0,0,1,0,2017-06-07,2018-06-07,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT01854229,0,0,0,0,0,0,2022-02-28,2023-02-28,,Flowonix Medical,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT01860404,0,0,0,0,0,0,2022-01-31,2023-01-31,,Children's Hospital of Philadelphia,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,324
NCT01863732,1,1,0,1,0,0,2018-03-16,2019-03-16,2019-03-13,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,0,1,0,0,0,0,0,1,0,1,1895
NCT01870778,1,1,0,1,0,0,2017-01-23,2018-01-23,2018-01-18,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01877915,1,1,0,1,0,0,2018-04-19,2019-04-19,2019-04-18,"Janssen Research & Development, LLC",Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,558
NCT01881789,0,0,0,0,0,0,2019-09-23,2020-09-23,,Amgen,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,685
NCT01882816,0,0,0,0,0,0,2020-06-30,2021-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,1,0,1,0,0,0,0,1,1432
NCT01883648,1,0,1,1,0,1,2017-02-01,2018-02-01,2018-09-18,University of South Florida,Other,0,0,0,2.0,Phase 2/Phase 3,1,2013.0,1,1,0,0,0,0,0,0,0,0,1,240
NCT01896102,0,0,0,0,0,0,2020-07-31,2021-07-31,,bluebird bio,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,0,0,0,0,0,0,1,1,0,1,11
NCT01898299,1,0,0,0,1,0,2017-12-14,2018-12-14,,New York State Psychiatric Institute,Other,0,0,0,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,361
NCT01912651,0,0,0,0,0,0,2022-09-30,2023-09-30,,University of Michigan,Other,0,0,0,4.0,Phase 4,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,934
NCT01913639,0,0,0,0,0,0,2019-06-30,2020-06-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,1432
NCT01914081,0,0,0,0,0,0,2019-11-30,2020-11-30,,St. Boniface General Hospital Research Centre,Other,0,0,0,3.0,Phase 3,0,2018.0,0,0,0,0,0,0,0,0,2,1,0,23
NCT01917721,0,0,0,0,0,0,2022-11-30,2023-11-30,,Hawaii Pacific Health,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,7
NCT01917968,0,0,0,0,0,0,2019-12-31,2020-12-31,,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2013.0,0,0,0,1,0,0,0,0,0,0,1,340
NCT01921309,0,0,0,0,0,0,2020-08-31,2021-08-31,,Corin,Industry,1,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,1,0,1,10
NCT01923168,1,1,0,1,0,0,2017-07-07,2018-07-07,2018-07-04,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT01925729,0,0,0,0,0,0,2019-03-22,2020-03-22,,Cuneyt M. Alper,Other,0,0,1,5.0,,0,2013.0,1,1,1,0,0,0,0,0,0,0,1,4
NCT01928537,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Onconova Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,27
NCT01928758,1,1,0,1,0,0,2018-01-11,2019-01-11,2019-01-11,Milton S. Hershey Medical Center,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT01929239,1,0,0,0,1,0,2017-12-31,2018-12-31,,Roger Williams Medical Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2006.0,1,1,0,0,0,0,0,0,0,0,1,16
NCT01935934,0,0,0,0,0,0,2019-08-31,2020-08-31,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,1,0,1,3004
NCT01944293,1,1,0,1,0,1,2017-09-30,2018-09-30,2018-10-03,New York State Psychiatric Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT01946477,0,0,0,0,0,0,2024-12-31,2025-12-31,,Celgene,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT01954394,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-06-29,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT01957449,0,0,0,0,0,0,2019-12-31,2020-12-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,2.0,Phase 2/Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,158
NCT01957787,1,1,0,1,0,1,2017-03-09,2018-03-09,2019-08-07,Galil Medical,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,8
NCT01959425,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Biosense Webster, Inc.",Industry,1,0,0,4.0,Phase 4,0,2013.0,0,0,0,0,0,0,0,0,1,0,1,41
NCT01960075,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Virginia,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,402
NCT01962636,0,0,0,0,0,0,2023-10-31,2024-10-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,5.0,,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,218
NCT01965925,1,0,1,1,0,1,2017-11-09,2018-11-09,2018-11-13,Icahn School of Medicine at Mount Sinai,Other,0,0,1,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,412
NCT01967862,0,0,0,0,0,0,2018-09-17,2019-09-17,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2013.0,1,0,0,0,0,1,0,0,0,0,1,358
NCT01975571,0,0,0,0,0,0,2021-08-31,2022-08-31,,Bruce J Gantz,Other,0,0,0,5.0,,0,2011.0,0,0,0,1,0,0,0,0,0,0,1,3
NCT01976104,1,1,0,1,0,0,2017-01-30,2018-01-30,2017-12-27,Eisai Inc.,Industry,1,0,0,3.0,Phase 3,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,328
NCT01981850,1,0,0,0,1,0,2017-08-30,2018-08-30,,"Promedior, Inc.",Industry,1,0,0,1.0,Phase 2,0,2013.0,1,0,1,0,0,0,0,0,1,0,1,4
NCT01983462,0,0,0,0,0,0,2019-12-31,2020-12-31,,Gary L. Pierce,Other,0,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT01991379,0,0,0,0,0,0,2021-11-30,2022-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT01992549,0,0,0,0,0,0,2018-12-27,2019-12-27,,Octapharma,Industry,1,0,0,3.0,Phase 3,0,2014.0,1,0,1,0,0,0,0,0,1,0,1,54
NCT01999868,1,1,0,1,0,0,2017-12-07,2018-12-07,2018-12-04,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2014.0,1,1,1,0,0,0,0,0,1,0,1,2133
NCT02004028,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Verastem, Inc.",Industry,1,0,0,1.0,Phase 2,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,35
NCT02006108,1,1,0,1,0,0,2017-04-11,2018-04-11,2017-04-11,Stanford University,Other,0,0,0,5.0,,0,2012.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02014558,0,1,0,1,0,1,2017-08-04,2018-08-04,2018-12-19,"Astellas Pharma Global Development, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2013.0,1,1,0,0,0,0,0,0,1,0,1,135
NCT02036970,0,0,0,0,0,0,2018-01-19,2019-01-19,,"Reata Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,44
NCT02037555,1,1,0,1,0,0,2018-01-25,2019-01-25,2019-01-24,Grifols Therapeutics LLC,Industry,1,1,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,40
NCT02048007,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1443
NCT02048384,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,461
NCT02049476,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-06-10,Johns Hopkins University,Other,0,1,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1143
NCT02051933,1,0,1,1,0,0,2017-01-31,2018-01-31,2017-08-09,Atrium Health,Other,0,0,0,5.0,,1,2013.0,0,1,0,0,0,0,0,0,0,0,1,95
NCT02059499,0,0,0,0,0,0,2019-09-30,2020-09-30,,AIDS Malignancy Consortium,Other,0,1,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,46
NCT02060188,0,0,0,0,0,0,2019-12-03,2020-12-03,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02061202,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-10-26,Jeffrey Glassberg,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02061605,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Laser Tissue Welding, Inc.",Industry,1,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,2
NCT02064270,1,1,0,1,0,0,2017-09-07,2018-09-07,2018-03-12,University of Missouri-Columbia,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,214
NCT02065245,0,0,0,0,0,0,2020-12-31,2021-12-31,,Joshua M Hare,Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,15
NCT02065570,0,0,0,0,0,0,2020-02-03,2021-02-03,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,430
NCT02065869,0,0,0,0,0,0,2019-12-31,2020-12-31,,Bellicum Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,2,0,1,15
NCT02075593,0,0,0,0,0,0,2021-10-01,2022-10-01,,ViiV Healthcare,Industry,1,1,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,200
NCT02079740,0,0,0,0,0,0,2020-03-01,2021-03-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,3004
NCT02089334,1,0,0,0,1,0,2018-04-26,2019-04-26,,"Rexahn Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02089880,0,0,0,0,0,0,2019-05-31,2020-05-31,,Shirley Ryan AbilityLab,Other,0,1,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,71
NCT02091843,0,0,0,0,0,0,2024-12-31,2025-12-31,,VA Greater Los Angeles Healthcare System,U.S. Fed,2,0,0,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,23
NCT02096354,0,0,0,0,0,0,2019-01-31,2020-01-31,,"EpicentRx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02101034,0,0,0,0,0,0,2019-08-31,2020-08-31,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,1,0,0,0,0,0,0,0,1,1151
NCT02104310,0,0,0,0,0,0,2020-04-30,2021-04-30,,Mayo Clinic,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1898
NCT02105415,1,1,0,1,0,0,2017-11-28,2018-11-28,2018-11-26,Mayo Clinic,Other,0,0,0,2.0,Phase 2/Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02118714,1,1,0,1,0,0,2018-04-18,2019-04-18,2019-04-08,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02124759,0,0,0,0,0,0,2019-04-30,2020-04-30,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02128152,0,0,0,0,0,0,2019-09-30,2020-09-30,,Shirley Ryan AbilityLab,Other,0,0,1,5.0,,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,71
NCT02129738,1,0,0,0,1,0,2017-02-17,2018-02-17,,Wellspect HealthCare,Industry,1,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,1,0,1,12
NCT02137252,1,0,0,0,1,0,2017-11-30,2018-11-30,,Dana-Farber Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT02141451,0,0,0,0,0,0,2019-01-23,2020-01-23,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,218
NCT02142049,1,1,0,1,0,0,2017-08-31,2018-08-31,2018-05-31,Pharmacyclics LLC.,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,54
NCT02145403,0,0,0,0,0,0,2018-10-25,2019-10-25,,University of Michigan Rogel Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,213
NCT02148146,0,0,0,0,0,0,2018-12-01,2019-12-01,,"University of California, San Diego",Other,0,0,0,0.0,Phase 1/Phase 2,0,2011.0,1,1,0,0,0,0,0,0,0,0,1,561
NCT02151877,1,0,0,0,1,0,2018-08-15,2019-08-15,,Chawki Elzein,Other,0,1,0,5.0,,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02153905,1,1,0,1,0,0,2018-09-10,2019-09-10,2019-05-10,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,1,2014.0,1,1,1,0,0,0,0,0,0,0,1,3004
NCT02161705,0,0,0,0,0,0,2019-12-31,2020-12-31,,Johns Hopkins University,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1143
NCT02162511,0,0,0,0,0,0,2019-12-31,2020-12-31,,Rajni Agarwal,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02165215,0,0,0,0,0,0,2020-04-21,2021-04-21,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02167256,1,1,0,1,0,1,2018-02-27,2019-02-27,2019-06-19,Yale University,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,1053
NCT02174861,1,1,0,1,0,0,2017-05-26,2018-05-26,2018-05-24,Amgen,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,685
NCT02176031,0,0,0,0,0,0,2019-02-28,2020-02-28,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT02178553,0,0,0,0,0,0,2018-10-09,2019-10-09,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02178644,0,0,0,0,0,0,2019-09-30,2020-09-30,,Yale University,Other,0,0,0,5.0,,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02178709,1,0,0,0,1,0,2018-06-30,2019-06-30,,Safi Shahda,Other,0,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02178800,1,1,0,1,0,1,2017-04-05,2018-04-05,2018-04-30,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2133
NCT02180412,0,0,0,0,0,0,2020-08-31,2021-08-31,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,1,0,0,0,0,0,0,0,1,158
NCT02184195,0,0,0,0,0,0,2019-01-15,2020-01-15,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT02187003,0,0,0,0,0,0,2019-06-26,2020-06-26,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02206152,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,749
NCT02209272,1,1,0,1,0,1,2018-02-28,2019-02-28,2019-03-04,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02209545,0,0,0,0,0,0,2019-11-30,2020-11-30,,Northwestern University,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02210078,0,0,0,0,0,0,2020-02-28,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,2066
NCT02215369,1,0,0,0,1,0,2018-03-31,2019-03-31,,"Angiodynamics, Inc.",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,12
NCT02217709,0,0,0,0,0,0,2019-09-08,2020-09-08,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,483
NCT02222610,0,0,0,0,0,0,2019-03-31,2020-03-31,,Greater Houston Retina Research,Other,0,1,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02224144,0,0,0,0,0,0,2019-12-31,2020-12-31,,Columbia University,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,675
NCT02224924,0,0,0,0,0,0,2020-08-31,2021-08-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,3.0,Phase 3,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT02226159,0,0,0,0,0,0,2019-07-31,2020-07-31,,"OrthoCarolina Research Institute, Inc.",Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,26
NCT02226276,0,0,0,0,0,0,2020-05-31,2021-05-31,,City of Hope Medical Center,Other,0,0,1,5.0,,0,2015.0,0,0,1,0,0,1,0,0,0,0,1,358
NCT02228096,0,0,0,0,0,0,2018-05-29,2019-05-29,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,0,1,0,0,0,0,0,0,0,1,1895
NCT02228382,0,0,0,0,0,0,2021-09-18,2022-09-18,,Pfizer,Industry,1,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02229084,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Arkansas,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,285
NCT02229422,0,0,0,0,0,0,2019-05-31,2020-05-31,,"University of California, San Diego",Other,0,1,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02240186,1,1,0,1,0,1,2017-06-30,2018-06-30,2018-10-03,Mayo Clinic,Other,0,0,0,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,1898
NCT02245737,0,1,0,1,0,0,2018-10-04,2019-10-04,2019-06-11,Eli Lilly and Company,Industry,1,1,0,2.0,Phase 2/Phase 3,1,2014.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02252783,0,0,0,0,0,0,2019-05-30,2020-05-30,,"Fluoropharma, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT02255175,0,0,0,0,0,0,2018-10-17,2019-10-17,,"University of North Carolina, Chapel Hill",Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,910
NCT02255305,0,0,0,0,0,0,2019-09-30,2020-09-30,,NorthShore University HealthSystem,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,61
NCT02255422,0,0,0,0,0,0,2017-11-02,2018-11-02,,"Reata Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,44
NCT02255799,0,0,0,0,0,0,2018-09-30,2019-09-30,,Baylor College of Medicine,Other,0,0,0,3.0,Phase 3,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,518
NCT02256111,1,1,0,1,0,0,2018-02-21,2019-02-21,2019-02-21,Duke University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1342
NCT02259231,0,0,0,0,0,0,2018-05-09,2019-05-09,,"Reata Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,44
NCT02260817,1,0,1,1,0,0,2017-03-31,2018-03-31,2018-03-31,"Global Isotopes, LLC d/b/a Zevacor Molecular",Industry,1,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02261883,0,0,0,0,0,0,2022-12-31,2023-12-31,,United Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,72
NCT02263079,0,0,0,0,0,0,2020-02-06,2021-02-06,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02264613,0,0,0,0,0,0,2020-03-31,2021-03-31,,Aileron Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02269280,0,0,0,0,0,0,2026-10-31,2027-10-31,,M.D. Anderson Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02270814,0,0,0,0,0,0,2020-05-31,2021-05-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,1151
NCT02273375,0,0,0,0,0,0,2023-01-31,2024-01-31,,Canadian Cancer Trials Group,Other,0,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,57
NCT02277925,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02278367,0,0,0,0,0,0,2019-04-30,2020-04-30,,Avid Radiopharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02278471,1,0,1,1,0,0,2018-06-27,2019-06-27,2019-06-25,Vanderbilt University,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,499
NCT02280252,0,0,0,0,0,0,2019-06-30,2020-06-30,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2005.0,0,1,0,0,0,1,0,0,0,0,1,869
NCT02283853,0,0,0,0,0,0,2020-09-25,2021-09-25,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,324
NCT02287467,1,0,0,0,1,0,2018-06-07,2019-06-07,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,2133
NCT02289417,0,1,0,1,0,0,2017-09-25,2018-09-25,2018-09-25,Celgene,Industry,1,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,1,0,1,306
NCT02293954,0,0,0,0,0,0,2019-06-30,2020-06-30,,City of Hope Medical Center,Other,0,0,1,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,358
NCT02294175,1,0,0,0,1,0,2017-12-31,2018-12-31,,North Florida Foundation for Research and Education,Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,8
NCT02297139,0,0,0,0,0,0,2021-12-31,2022-12-31,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,2,0,1,1104
NCT02303405,1,0,0,0,1,0,2017-11-30,2018-11-30,,Charles Drew University of Medicine and Science,Other,0,0,0,1.0,Phase 2,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,25
NCT02304302,0,0,0,0,0,0,2019-11-30,2020-11-30,,University Hospitals Cleveland Medical Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,185
NCT02307513,0,1,0,1,0,1,2017-09-25,2018-09-25,2019-08-16,Celgene,Industry,1,0,0,3.0,Phase 3,0,2014.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02309385,1,0,0,0,1,0,2017-03-03,2018-03-03,,Aciont Inc,Other,0,0,1,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02310100,1,1,0,1,0,1,2017-02-28,2018-02-28,2019-01-31,Abbott Medical Devices,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,419
NCT02311998,0,0,0,0,0,0,2020-04-01,2021-04-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02312245,0,0,0,0,0,0,2020-06-30,2021-06-30,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,1898
NCT02312401,0,0,0,0,0,0,2021-12-31,2022-12-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2014.0,0,0,0,1,0,0,0,0,0,0,1,1432
NCT02318277,0,0,0,0,0,0,2019-04-10,2020-04-10,,Incyte Corporation,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,143
NCT02323113,0,0,0,0,0,0,2018-06-08,2019-06-08,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,209
NCT02324205,1,1,0,1,0,1,2017-08-29,2018-08-29,2018-12-19,GE Healthcare,Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,1,0,1,119
NCT02325791,1,1,0,1,0,0,2017-07-05,2018-07-05,2018-07-05,Regeneron Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,176
NCT02337634,0,0,0,0,0,0,2019-10-31,2020-10-31,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,594
NCT02339922,0,0,0,0,0,0,2021-12-30,2022-12-30,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,910
NCT02340169,0,0,0,0,0,0,2019-11-30,2020-11-30,,Taro Pharmaceuticals USA,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,58
NCT02340975,0,0,0,0,0,0,2019-04-29,2020-04-29,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,269
NCT02345733,0,0,0,0,0,0,2020-12-31,2021-12-31,,Prof. Arie Levine,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,9
NCT02348632,0,1,0,1,0,1,2017-12-31,2018-12-31,2019-04-19,Jazz Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,55
NCT02349386,1,0,0,0,1,0,2017-06-14,2018-06-14,,"BHR Pharma, LLC",Industry,1,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02349633,0,0,0,0,0,0,2019-01-31,2020-01-31,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,2856
NCT02349958,0,0,0,0,0,0,2022-01-31,2023-01-31,,Bay Area Gynecology Oncology,Other,0,0,0,1.0,Phase 2,0,2006.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02351167,0,0,0,0,0,0,2018-12-26,2019-12-26,,Washington University School of Medicine,Other,0,0,1,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02353247,1,0,0,0,1,0,2018-08-15,2019-08-15,,Norton Healthcare,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,4
NCT02356198,1,1,0,1,0,1,2017-10-31,2018-10-31,2019-01-15,Mayo Clinic,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1898
NCT02358187,0,0,0,0,0,0,2022-08-31,2023-08-31,,"Ian F. Pollack, M.D.",Other,0,0,1,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,5
NCT02359097,0,0,0,0,0,0,2020-01-01,2021-01-01,,OHSU Knight Cancer Institute,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,163
NCT02360215,1,0,0,0,1,0,2018-04-30,2019-04-30,,NRG Oncology,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,1,0,0,1,0,1,27
NCT02362425,1,0,1,1,0,0,2018-05-30,2019-05-30,2019-03-27,National Institute of Nursing Research (NINR),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,51
NCT02365207,0,0,0,0,0,0,2019-12-31,2020-12-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,5.0,,0,2013.0,0,1,0,0,0,0,0,0,0,0,1,257
NCT02367040,0,0,0,0,0,0,2020-05-31,2021-05-31,,Bayer,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1343
NCT02370173,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Arizona,Other,0,0,1,5.0,,0,2014.0,1,0,0,1,0,0,0,0,0,0,1,265
NCT02374918,0,0,0,0,0,0,2018-12-31,2019-12-31,,University of Arizona,Other,0,0,1,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,265
NCT02375672,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Safi Shahda, M.D.",Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02377921,1,1,0,1,0,0,2017-06-09,2018-06-09,2018-06-07,Ultragenyx Pharmaceutical Inc,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,36
NCT02379156,0,0,0,0,0,0,2019-10-31,2020-10-31,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,41
NCT02381795,1,1,0,1,0,0,2017-04-30,2018-04-30,2018-03-28,"Cady, Roger, M.D.",Other,0,1,0,1.0,Phase 2,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,12
NCT02382588,0,0,0,0,0,0,2019-12-31,2020-12-31,,Northwestern University,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,925
NCT02387957,1,1,0,1,0,1,2017-01-31,2018-01-31,2018-10-23,Ophthotech Corporation,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT02390518,0,0,0,0,0,0,2020-05-31,2021-05-31,,University of Utah,Other,0,0,0,5.0,,0,2015.0,0,0,0,0,0,1,0,0,0,0,1,578
NCT02392442,0,0,0,0,0,0,2021-06-08,2022-06-08,,National Institutes of Health Clinical Center (CC),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,325
NCT02392572,0,0,0,0,0,0,2022-11-30,2023-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02392637,0,0,0,0,0,0,2019-04-30,2020-04-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02393755,1,0,1,1,0,1,2017-11-01,2018-11-01,2019-07-12,Roswell Park Cancer Institute,Other,0,1,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,294
NCT02395978,0,0,0,0,0,0,2019-06-10,2020-06-10,,"BioLite, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,6
NCT02399917,1,0,1,1,0,1,2018-07-12,2019-07-12,2019-08-15,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,1,0,0,0,0,0,0,0,1,2066
NCT02400112,0,0,0,0,0,0,2018-10-31,2019-10-31,,University of Tennessee,Other,0,0,0,4.0,Phase 4,1,2015.0,1,1,0,0,0,0,0,0,0,0,1,99
NCT02400359,0,0,0,0,0,0,2020-10-31,2021-10-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,4.0,Phase 4,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,377
NCT02400476,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Puma Biotechnology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,34
NCT02408523,0,0,0,0,0,0,2019-04-30,2020-04-30,,"UCB BIOSCIENCES, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02411448,0,0,0,0,0,0,2019-01-23,2020-01-23,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02412228,0,0,0,0,0,0,2019-05-31,2020-05-31,,John Reagan,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02412501,1,1,0,1,0,0,2017-02-13,2018-02-13,2018-02-12,Medtronic Vascular,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,51
NCT02417246,0,0,1,1,0,0,2019-03-31,2020-03-31,2019-07-29,University of Florida,Other,0,0,1,4.0,Phase 4,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,849
NCT02417870,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Anil K. Chandraker, MD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1
NCT02419417,0,0,0,0,0,0,2023-07-12,2024-07-12,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02419612,1,1,0,1,0,0,2017-08-29,2018-08-29,2018-07-12,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2450
NCT02422511,0,0,0,0,0,0,2020-04-30,2021-04-30,,Brigham and Women's Hospital,Other,0,0,1,5.0,,0,2015.0,0,0,0,0,0,0,0,1,0,0,1,698
NCT02423330,1,0,0,0,1,0,2017-01-31,2018-01-31,,Rush University Medical Center,Other,0,0,0,4.0,Phase 4,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,227
NCT02423876,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of Wisconsin, Madison",Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,715
NCT02425111,1,1,0,1,0,0,2017-06-02,2018-06-02,2018-05-18,Takeda,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,650
NCT02426125,0,1,0,1,0,1,2017-04-21,2018-04-21,2019-01-25,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1512
NCT02436590,0,0,0,0,0,0,2018-12-31,2019-12-31,,Orthofix Inc.,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,10
NCT02436889,1,1,0,1,0,1,2017-12-31,2018-12-31,2019-03-05,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1443
NCT02438358,0,0,0,0,0,0,2017-09-30,2018-09-30,,"Lumicell, Inc.",Industry,1,0,1,5.0,,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,7
NCT02441686,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02443298,0,1,0,1,0,1,2017-10-13,2018-10-13,2019-02-01,AbbVie,Industry,1,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,430
NCT02448173,0,0,0,0,0,0,2020-07-31,2021-07-31,,Vaccinogen Inc,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1
NCT02455245,0,0,0,0,0,0,2020-04-30,2021-04-30,,Natasha Pillay Smiley,Other,0,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02457273,1,0,0,0,1,0,2018-04-18,2019-04-18,,"National Health Research Institutes, Taiwan",Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,80
NCT02461134,1,1,0,1,0,0,2017-03-02,2018-03-02,2018-03-02,Actelion,Industry,1,0,0,1.0,Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,128
NCT02462278,1,0,0,0,1,0,2018-06-30,2019-06-30,,"Prima-Temp, Inc",Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02462889,0,0,0,0,0,0,2018-12-31,2019-12-31,,Jeffrey S Heier,Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02464228,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Kura Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,7
NCT02468024,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,3.0,Phase 3,0,2015.0,0,0,0,0,0,1,0,0,1,0,1,626
NCT02469675,1,0,0,0,1,0,2018-07-31,2019-07-31,,Bronx VA Medical Center,U.S. Fed,2,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,15
NCT02472795,0,0,0,0,0,0,2017-02-01,2018-02-01,,Idorsia Pharmaceuticals Ltd.,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,79
NCT02473042,0,0,0,0,0,0,2020-02-29,2021-02-28,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02478164,1,1,0,1,0,0,2017-07-08,2018-07-08,2018-03-01,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,647
NCT02486042,0,0,0,0,0,0,2019-12-31,2020-12-31,,"University of California, San Diego",Other,0,0,0,1.0,Phase 2,0,2014.0,0,1,0,0,0,0,0,0,0,0,1,561
NCT02488044,0,0,0,0,0,0,2019-02-28,2020-02-28,,Aeglea Biotherapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,6
NCT02489123,0,0,0,0,0,0,2023-07-01,2024-07-01,,University of Washington,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02489903,0,0,0,0,0,0,2019-06-30,2020-06-30,,"EpicentRx, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02491359,1,1,0,1,0,0,2018-02-19,2019-02-19,2018-12-19,Fred Hutchinson Cancer Research Center,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,393
NCT02494102,1,1,0,1,0,0,2018-04-01,2019-04-01,2019-03-26,Milton S. Hershey Medical Center,Other,0,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,334
NCT02500043,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Taiho Oncology, Inc.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,37
NCT02500797,0,0,0,0,0,0,2022-01-30,2023-01-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3004
NCT02509767,1,0,1,1,0,1,2017-04-30,2018-04-30,2019-01-04,Planned Parenthood Federation of America,Other,0,1,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02510261,0,0,0,0,0,0,2022-08-31,2023-08-31,,Alnylam Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,45
NCT02511431,1,1,0,1,0,1,2017-02-23,2018-02-23,2018-04-24,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,2,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,495
NCT02512432,0,0,0,0,0,0,2021-12-31,2022-12-31,,"University of California, San Diego",Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,3,1,0,561
NCT02513940,1,1,0,1,0,1,2017-10-19,2018-10-19,2019-02-14,Indiana University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,497
NCT02514551,1,1,0,1,0,0,2017-10-27,2018-10-27,2018-08-23,Eli Lilly and Company,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02516423,0,0,0,0,0,0,2024-09-30,2025-09-30,,Alliance for Clinical Trials in Oncology,Other,0,1,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,456
NCT02518113,1,1,0,1,0,0,2018-01-15,2019-01-15,2019-01-14,Eli Lilly and Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,1512
NCT02521311,0,0,0,0,0,0,2020-08-31,2021-08-31,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1443
NCT02521493,0,0,0,0,0,0,2022-03-31,2023-03-31,,Children's Oncology Group,Other,0,0,1,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,389
NCT02525861,0,0,0,0,0,0,2020-05-29,2021-05-29,,Baxalta now part of Shire,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,107
NCT02526277,0,0,0,0,0,0,2019-07-31,2020-07-31,,Ariane Park,Other,0,0,0,3.0,Phase 3,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02529852,0,0,0,0,0,0,2021-11-30,2022-11-30,,M.D. Anderson Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02530463,0,0,0,0,0,0,2021-09-30,2022-09-30,,M.D. Anderson Cancer Center,Other,0,1,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,2066
NCT02532972,0,0,0,0,0,0,2018-11-30,2019-11-30,,Dr. Daniel Lee,Other,0,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02535572,0,0,0,0,0,0,2019-08-31,2020-08-31,,Medical University of South Carolina,Other,0,0,0,2.0,Phase 2/Phase 3,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,511
NCT02535949,0,0,0,0,0,0,2018-12-31,2019-12-31,,Washington University School of Medicine,Other,0,0,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1151
NCT02536105,1,0,1,1,0,1,2018-07-31,2019-07-31,2019-09-04,Massachusetts General Hospital,Other,0,1,1,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02536196,0,0,0,0,0,0,2019-06-30,2020-06-30,,Keystone Heart,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,5
NCT02536404,0,0,0,0,0,0,2018-11-28,2019-11-28,,Arena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,21
NCT02537431,1,1,0,1,0,0,2017-08-30,2018-08-30,2018-08-27,Ultragenyx Pharmaceutical Inc,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,0,1,0,0,0,0,0,1,0,1,36
NCT02539511,1,1,0,1,0,1,2017-09-30,2018-09-30,2019-01-25,New York State Psychiatric Institute,Other,0,0,1,2.0,Phase 2/Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT02539823,1,0,0,0,1,0,2017-05-24,2018-05-24,,"Hurd,Yasmin, Ph.D.",Other,0,1,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02540083,1,1,0,1,0,1,2017-05-30,2018-05-30,2019-01-04,GE Healthcare,Industry,1,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,119
NCT02541604,0,0,0,0,0,0,2019-06-06,2020-06-06,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,1,2015.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02541903,0,0,0,0,0,0,2019-01-31,2020-01-31,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,801
NCT02542657,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of California, Davis",Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,530
NCT02545933,0,0,0,0,0,0,2019-05-31,2020-05-31,,University of Florida,Other,0,1,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,849
NCT02546388,1,0,0,0,1,0,2018-08-31,2019-08-31,,"Marcelo F. Di Carli, MD, FACC",Other,0,1,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT02546570,1,0,1,1,0,1,2017-09-30,2018-09-30,2019-01-28,Yale University,Other,0,0,0,4.0,Phase 4,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1053
NCT02546986,1,1,0,1,0,0,2017-04-13,2018-04-13,2018-04-09,Celgene,Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02548962,1,1,0,1,0,0,2018-06-13,2019-06-13,2019-03-20,Pharmacyclics LLC.,Industry,1,1,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,54
NCT02558790,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-03-14,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1699
NCT02559310,0,0,1,1,0,1,2017-04-30,2018-04-30,2019-08-28,Nabriva Therapeutics AG,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,8
NCT02560584,1,1,0,1,0,0,2017-04-05,2018-04-05,2018-03-21,Photocure,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,1,0,0,0,0,0,0,1,21
NCT02561234,0,0,0,0,0,0,2019-05-31,2020-05-31,,Aeglea Biotherapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02565901,0,0,0,0,0,0,2021-02-01,2022-02-01,,University of Washington,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,910
NCT02566967,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Norman B. Gaylis, MD",Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02569632,1,0,1,1,0,0,2017-05-31,2018-05-31,2017-05-10,UCSF Benioff Children’s Hospital Oakland,Other,0,0,0,4.0,Phase 4,0,2015.0,1,0,1,0,0,0,0,0,0,0,1,53
NCT02569723,0,0,0,0,0,0,2019-12-31,2020-12-31,,Edward Kim,Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,3
NCT02569801,0,0,0,0,0,0,2020-03-28,2021-03-28,,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,427
NCT02573233,1,1,0,1,0,0,2018-01-03,2019-01-03,2018-12-19,Sanofi,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1222
NCT02574078,0,0,0,0,0,0,2020-03-15,2021-03-15,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1104
NCT02576288,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Southern California,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,483
NCT02576847,0,0,0,0,0,0,2017-07-14,2018-07-14,,"Maruho Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,26
NCT02576977,1,1,0,1,0,0,2018-07-09,2019-07-09,2019-07-08,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02578095,1,0,0,0,1,0,2017-11-15,2018-11-15,,"Viking Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,2
NCT02583672,0,0,0,0,0,0,2020-07-31,2021-07-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,749
NCT02584504,1,1,0,1,0,0,2017-04-05,2018-04-05,2018-04-03,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,2,0,1,1222
NCT02586649,1,0,0,0,1,0,2018-07-31,2019-07-31,,James J. Peters Veterans Affairs Medical Center,U.S. Fed,2,0,0,1.0,Phase 2,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,41
NCT02586909,1,0,0,0,1,0,2018-03-31,2019-03-31,,Axovant Sciences Ltd.,Industry,1,0,0,3.0,Phase 3,1,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02589600,0,0,0,0,0,0,2021-07-31,2022-07-31,,Susan L. Greenspan,Other,0,0,1,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02590523,0,0,0,0,0,0,2021-01-31,2022-01-31,,"Panhandle Eye Group, LLP",Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT02590692,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Regenerative Patch Technologies, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,1
NCT02592668,0,0,0,0,0,0,2020-04-30,2021-04-30,,Mayo Clinic,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1898
NCT02594501,0,0,0,0,0,0,2020-06-30,2021-06-30,,"CeloNova BioSciences, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,6
NCT02596035,1,1,0,1,0,0,2018-05-01,2019-05-01,2019-04-29,Bristol-Myers Squibb,Industry,1,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1104
NCT02598193,1,1,0,1,0,0,2017-05-16,2018-05-16,2018-05-16,Hoffmann-La Roche,Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1731
NCT02598596,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Ampel BioSolutions, LLC",Industry,1,1,0,1.0,Phase 2,0,2015.0,0,1,1,0,0,0,0,0,0,0,1,2
NCT02598960,0,0,0,0,0,0,2020-01-31,2021-01-31,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02599922,0,0,0,0,0,0,2020-06-30,2021-06-30,,Applied Genetic Technologies Corp,Industry,1,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,9
NCT02601014,0,0,0,0,0,0,2019-09-30,2020-09-30,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,461
NCT02601716,1,0,0,0,1,0,2017-09-30,2018-09-30,,Sanaria Inc.,Industry,1,0,1,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,21
NCT02603107,1,1,0,1,0,0,2017-05-15,2018-05-15,2018-05-03,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2015.0,0,1,0,0,0,0,0,0,1,0,1,510
NCT02604433,0,0,0,0,0,0,2017-11-24,2018-11-24,,Celgene,Industry,1,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,306
NCT02605486,0,0,0,0,0,0,2020-11-30,2021-11-30,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1432
NCT02605993,0,1,0,1,0,1,2017-02-23,2018-02-23,2019-01-18,Alexion Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,0,1,0,0,0,0,0,2,0,1,86
NCT02608476,0,0,0,0,0,0,2018-02-21,2019-02-21,,Cassiopea SpA,Industry,1,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,1,0,1,5
NCT02608684,0,0,0,0,0,0,2020-01-31,2021-01-31,,Cedars-Sinai Medical Center,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,279
NCT02611167,0,0,0,0,0,0,2019-11-30,2020-11-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,490
NCT02613572,0,0,0,0,0,0,2019-02-15,2020-02-15,,University of Pennsylvania,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02614703,1,1,0,1,0,0,2018-07-30,2019-07-30,2019-03-20,Doctors Hospital at Renaissance,Other,0,0,0,2.0,Phase 2/Phase 3,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT02614859,0,0,0,0,0,0,2020-04-30,2021-04-30,,Fox Chase Cancer Center,Other,0,0,1,1.0,Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,156
NCT02615119,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Laureate Institute for Brain Research, Inc.",Other,0,0,1,5.0,,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,30
NCT02615509,1,0,0,0,1,0,2018-02-20,2019-02-20,,Philips Digital Mammography Sweden AB,Industry,1,0,0,5.0,,1,2016.0,1,0,0,0,0,1,0,0,0,0,1,2
NCT02616302,0,0,0,0,0,0,2021-01-13,2022-01-13,,Takeda,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,650
NCT02616484,0,0,0,0,0,0,2022-12-31,2023-12-31,,University of Florida,Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,1,0,1,0,849
NCT02621151,0,0,0,0,0,0,2025-12-31,2026-12-31,,NYU Langone Health,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,1,0,0,0,0,1,869
NCT02623322,1,1,0,1,0,0,2017-11-13,2018-11-13,2018-10-31,"Genentech, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,427
NCT02624596,0,0,0,0,0,0,2020-06-30,2021-06-30,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02624869,0,0,0,0,0,0,2021-05-27,2022-05-27,,Amgen,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,685
NCT02627963,0,0,0,0,0,0,2018-12-31,2019-12-31,,"AVEO Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,29
NCT02629419,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Matinas BioPharma Nanotechnologies, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,6
NCT02630186,1,1,0,1,0,1,2017-09-05,2018-09-05,2018-11-01,"Clovis Oncology, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,1,2016.0,1,1,0,0,0,0,0,0,0,0,1,31
NCT02632344,0,0,0,0,0,0,2019-10-31,2020-10-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02632838,1,1,0,1,0,0,2017-09-30,2018-09-30,2017-12-09,"Rutgers, The State University of New Jersey",Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,227
NCT02634333,0,0,0,0,0,0,2020-01-31,2021-01-31,,Jaeb Center for Health Research,Other,0,1,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,93
NCT02636725,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Matteo Trucco, MD",Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02639546,0,0,0,0,0,0,2023-02-21,2024-02-21,,Hoffmann-La Roche,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1731
NCT02642094,0,0,0,0,0,0,2021-12-31,2022-12-31,,LuZhe Sun,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1
NCT02642315,0,0,0,0,0,0,2019-05-06,2020-05-06,,University of Missouri-Columbia,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,214
NCT02642393,0,0,0,0,0,0,2019-05-31,2020-05-31,,Michael Alan Schwarzschild,Other,0,0,1,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,2
NCT02642653,1,1,0,1,0,0,2018-07-31,2019-07-31,2019-07-23,"University of California, Davis",Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,530
NCT02646839,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Michael Pulsipher, MD",Other,0,0,0,1.0,Phase 2,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,4
NCT02649673,0,0,0,0,0,0,2019-07-27,2020-07-27,,"SCRI Development Innovations, LLC",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,167
NCT02649790,0,0,0,0,0,0,2020-03-31,2021-03-31,,Karyopharm Therapeutics Inc,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,22
NCT02651259,0,0,0,0,0,0,2019-04-10,2020-04-10,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,2133
NCT02652481,1,1,0,1,0,1,2017-04-30,2018-04-30,2018-06-07,Boston Scientific Corporation,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,340
NCT02656329,1,1,0,1,0,0,2018-05-04,2019-05-04,2019-04-26,GE Healthcare,Industry,1,1,0,3.0,Phase 3,1,2015.0,1,1,0,1,0,0,0,0,1,0,1,119
NCT02658890,0,0,0,0,0,0,2021-02-28,2022-02-28,,Bristol-Myers Squibb,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02661282,0,0,0,0,0,0,2020-06-01,2021-06-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02661919,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Emfit, Corp.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02664077,0,0,0,0,0,0,2019-10-31,2020-10-31,,NSABP Foundation Inc,Other,0,1,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,63
NCT02664545,0,0,0,0,0,0,2020-05-31,2021-05-31,,Boston Children’s Hospital,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,400
NCT02669433,1,1,0,1,0,0,2017-12-31,2018-12-31,2018-12-31,Axovant Sciences Ltd.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,10
NCT02671435,0,0,0,0,0,0,2021-10-14,2022-10-14,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,0,0,0,1,0,1,0,1,269
NCT02673489,1,1,0,1,0,0,2017-03-02,2018-03-02,2018-03-01,Bristol-Myers Squibb,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1104
NCT02674386,0,0,0,0,0,0,2019-07-15,2020-07-15,,Pfizer,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,2856
NCT02675114,0,0,0,0,0,0,2020-01-31,2021-01-31,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,77
NCT02677220,1,1,0,1,0,1,2017-08-23,2018-08-23,2019-01-30,Cochlear,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,35
NCT02677519,1,0,0,0,1,0,2017-04-30,2018-04-30,,"Rhodes Pharmaceuticals, L.P.",Industry,1,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT02678351,0,0,0,0,0,0,2021-06-30,2022-06-30,,Andrei Iagaru,Other,0,0,1,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,12
NCT02678741,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Cancer Insight, LLC",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,4
NCT02681055,1,0,0,0,1,0,2018-05-30,2019-05-30,,MediciNova,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,15
NCT02683941,0,0,0,0,0,0,2020-02-29,2021-02-28,,Ipsen,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,214
NCT02684279,0,0,0,0,0,0,2019-06-24,2020-06-24,,Sunovion,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,134
NCT02685267,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-07-29,Prostate Cancer Clinical Trials Consortium,Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2
NCT02696967,0,0,0,0,0,0,2019-01-14,2020-01-14,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02698527,1,0,0,0,1,0,2018-04-30,2019-04-30,,Women and Infants Hospital of Rhode Island,Other,0,0,0,5.0,,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02698891,0,0,0,0,0,0,2019-12-31,2020-12-31,,Dana-Farber Cancer Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,647
NCT02700425,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Chicago,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,594
NCT02703571,0,0,0,0,0,0,2019-09-04,2020-09-04,,Novartis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,1895
NCT02704481,0,0,0,0,0,0,2020-12-31,2021-12-31,,Gynuity Health Projects,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,102
NCT02704741,0,0,0,0,0,0,2019-06-30,2020-06-30,,Syneron Medical,Industry,1,0,0,5.0,,0,2015.0,0,0,0,1,0,0,0,0,0,0,1,41
NCT02705755,0,0,0,0,0,0,2018-07-31,2019-07-31,,Theravance Biopharma,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,53
NCT02706886,0,0,0,0,0,0,2019-01-23,2020-01-23,,Alnylam Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,45
NCT02708680,0,0,0,0,0,0,2019-01-31,2020-01-31,,Syndax Pharmaceuticals,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,21
NCT02709512,0,0,0,0,0,0,2020-10-31,2021-10-31,,Polaris Group,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,15
NCT02711800,1,1,0,1,0,0,2017-09-18,2018-09-18,2018-09-13,Nancy Zucker,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02712398,0,0,0,0,0,0,2019-11-30,2020-11-30,,C. R. Bard,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,77
NCT02713204,1,1,0,1,0,0,2017-10-03,2018-10-03,2018-10-03,Regeneron Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,176
NCT02715375,0,0,0,0,0,0,2019-02-01,2020-02-01,,"General Innovations and Goods, Inc.",Industry,1,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02716116,0,0,0,0,0,0,2020-01-28,2021-01-28,,"Millennium Pharmaceuticals, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,209
NCT02716818,1,1,0,1,0,0,2018-07-28,2019-07-28,2019-07-10,Diurnal Limited,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,16
NCT02717195,0,0,1,1,0,0,2018-10-08,2019-10-08,2019-08-30,H. Lundbeck A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,152
NCT02720185,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of Wisconsin, Madison",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT02722148,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-03-08,"University of North Carolina, Chapel Hill",Other,0,0,1,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,910
NCT02724033,0,0,0,0,0,0,2018-09-30,2019-09-30,,Indiana University,Other,0,0,0,4.0,Phase 4,1,2014.0,1,1,0,0,0,0,0,0,0,0,1,497
NCT02725008,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-11-30,Geoffrey W Jara-Almonte,Other,0,0,0,3.0,Phase 3,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02729480,0,0,0,0,0,0,2019-07-31,2020-07-31,,"StimRelieve, LLC",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT02730455,1,1,0,1,0,0,2017-11-20,2018-11-20,2018-10-18,Biogen,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,324
NCT02732704,0,0,0,0,0,0,2019-07-31,2020-07-31,,"JenaValve Technology, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,1,0,1,3
NCT02734498,0,1,0,1,0,1,2017-03-19,2018-03-19,2019-06-13,Wake Forest University Health Sciences,Other,0,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,0,1,0,616
NCT02734836,0,0,0,0,0,0,2018-10-02,2019-10-02,,Arkansas Heart Hospital,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,6
NCT02738138,1,1,0,1,0,0,2017-03-15,2018-03-15,2018-02-27,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,3,0,1,430
NCT02739360,1,1,0,1,0,0,2017-12-28,2018-12-28,2018-12-17,Gilead Sciences,Industry,1,0,0,4.0,Phase 4,1,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02741596,0,0,0,0,0,0,2019-11-04,2020-11-04,,Shire,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,342
NCT02743351,0,0,0,0,0,0,2020-04-30,2021-04-30,,Fate Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,0,0,1,9
NCT02743585,0,0,0,0,0,0,2019-07-02,2020-07-02,,Tan Tock Seng Hospital,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,32
NCT02743728,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,749
NCT02744352,0,0,0,0,0,0,2018-10-05,2019-10-05,,University of Pennsylvania,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1052
NCT02744534,1,1,0,1,0,0,2018-03-31,2019-03-31,2019-03-28,Emory University,Other,0,0,1,1.0,Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,947
NCT02748356,0,0,1,1,0,0,2018-12-31,2019-12-31,2019-02-07,Medstar Health Research Institute,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,79
NCT02755935,1,1,0,1,0,0,2017-06-30,2018-06-30,2018-01-23,Cochlear,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,35
NCT02756962,0,0,0,0,0,0,2024-07-31,2025-07-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1151
NCT02757313,0,0,0,0,0,0,2020-05-31,2021-05-31,,Yale University,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02760498,0,0,0,0,0,0,2020-02-26,2021-02-26,,Regeneron Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,176
NCT02763319,0,0,0,0,0,0,2020-03-31,2021-03-31,,MorphoSys AG,Industry,1,1,0,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,8
NCT02765802,0,0,0,0,0,0,2018-06-20,2019-06-20,,Eiger BioPharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,13
NCT02772081,0,0,0,0,0,0,2021-01-31,2022-01-31,,Chiesi Farmaceutici S.p.A.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,1,0,2,1,0,130
NCT02773368,1,1,0,1,0,0,2017-09-26,2018-09-26,2018-09-24,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02776059,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Timothy Morgan, MD",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT02776488,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Los Angeles",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,692
NCT02777528,0,0,0,0,0,0,2020-07-31,2021-07-31,,W.L.Gore & Associates,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,52
NCT02786498,0,0,0,0,0,0,2019-09-30,2020-09-30,,"University of Maryland, College Park",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,318
NCT02786901,0,0,0,0,0,0,2017-06-13,2018-06-13,,"Bausch Health Americas, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,180
NCT02787005,0,0,0,0,0,0,2020-12-14,2021-12-14,,Merck Sharp & Dohme Corp.,Industry,1,0,0,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02790710,0,0,0,0,0,0,2021-06-30,2022-06-30,,New York State Psychiatric Institute,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02791958,1,0,0,0,1,0,2017-10-31,2018-10-31,,Ferrer Internacional S.A.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,16
NCT02794155,1,0,0,0,1,0,2018-04-28,2019-04-28,,Diasome Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,6
NCT02795143,0,0,0,0,0,0,2020-06-30,2021-06-30,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1699
NCT02798380,0,0,1,1,0,0,2018-10-31,2019-10-31,2019-07-23,"Hallux, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02801331,0,0,0,0,0,0,2021-07-31,2022-07-31,,"University of Massachusetts, Worcester",Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,163
NCT02801578,0,0,0,0,0,0,2019-01-28,2020-01-28,,M.D. Anderson Cancer Center,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02802241,0,0,0,0,0,0,2019-01-31,2020-01-31,,Anthony Lembo,Other,0,0,0,5.0,,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1
NCT02805972,0,0,0,0,0,0,2018-07-25,2019-07-25,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1443
NCT02806570,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Ancora Heart, Inc.",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,8
NCT02807272,0,0,0,0,0,0,2018-12-31,2019-12-31,,"Kura Oncology, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,7
NCT02807441,0,0,0,0,0,0,2019-07-31,2020-07-31,,University Hospitals Cleveland Medical Center,Other,0,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,185
NCT02807779,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of California, San Francisco",Other,0,0,1,4.0,Phase 4,0,2015.0,0,1,0,1,0,0,0,0,0,0,1,1443
NCT02808338,1,1,0,1,0,1,2017-05-31,2018-05-31,2019-01-18,Philips Respironics,Industry,1,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,33
NCT02811549,0,0,0,0,0,0,2020-04-30,2021-04-30,,Advanced Bionics,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,7
NCT02813421,1,0,1,1,0,1,2017-05-01,2018-05-01,2019-01-25,Children's Hospital Los Angeles,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,82
NCT02822794,1,1,0,1,0,0,2017-06-02,2018-06-02,2018-05-24,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,510
NCT02825251,1,1,0,1,0,1,2017-06-20,2018-06-20,2018-06-27,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,981
NCT02831959,0,0,0,0,0,0,2019-07-31,2020-07-31,,NovoCure Ltd.,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,0,1,0,0,0,0,1,0,1,14
NCT02833077,0,0,0,0,0,0,2018-02-06,2019-02-06,,Allergan,Industry,1,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,495
NCT02834052,0,0,0,0,0,0,2020-01-31,2021-01-31,,Asha Nayak,Other,0,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02836496,0,0,0,0,0,0,2019-08-08,2020-08-08,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,3276
NCT02837601,0,0,0,0,0,0,2025-11-30,2026-11-30,,Akron Children's Hospital,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,28
NCT02837952,1,1,0,1,0,0,2017-02-01,2018-02-01,2018-01-31,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2856
NCT02839707,0,0,0,0,0,0,2023-06-30,2024-06-30,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,3004
NCT02844582,0,0,0,0,0,0,2019-06-04,2020-06-04,,"University of California, Davis",Other,0,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,530
NCT02844738,0,0,0,0,0,0,2019-07-31,2020-07-31,,"VivaTech International, Inc.",Industry,1,0,0,1.0,Phase 2,0,2015.0,0,0,1,0,0,0,0,0,0,0,1,3
NCT02848079,0,0,0,0,0,0,2019-07-31,2020-07-31,,Yale University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,1053
NCT02849704,1,1,0,1,0,1,2017-11-01,2018-11-01,2019-02-26,Children's Hospital of Philadelphia,Other,0,1,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,324
NCT02852187,0,0,0,0,0,0,2018-11-30,2019-11-30,,Signus Medizintechnik GmbH,Industry,1,0,0,5.0,,1,2016.0,1,0,0,1,0,0,0,0,0,0,1,1
NCT02853305,0,0,0,0,0,0,2020-05-31,2021-05-31,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,1,0,0,0,0,0,3,0,1,2145
NCT02858076,0,0,0,0,0,0,2020-01-15,2021-01-15,,Jaeb Center for Health Research,Other,0,1,1,2.0,Phase 2/Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,93
NCT02859142,0,0,0,0,0,0,2019-04-30,2020-04-30,,University of Chicago,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT02859337,0,0,0,0,0,0,2021-10-31,2022-10-31,,Oregon Health and Science University,Other,0,0,1,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,475
NCT02861300,0,0,0,0,0,0,2020-02-29,2021-02-28,,Case Comprehensive Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,374
NCT02861898,0,0,0,0,0,0,2021-06-30,2022-06-30,,Northwell Health,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,271
NCT02866071,0,0,0,0,0,0,2019-12-31,2020-12-31,,Jason McMullan,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT02866240,1,0,0,0,1,0,2017-12-31,2018-12-31,,Neuroelectrics Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT02869789,0,0,0,0,0,0,2020-06-16,2021-06-16,,Bristol-Myers Squibb,Industry,1,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,1104
NCT02871076,0,0,0,0,0,0,2021-09-30,2022-09-30,,Southern California Institute for Research and Education,Other,0,0,1,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,25
NCT02872012,1,1,0,1,0,0,2018-06-30,2019-06-30,2019-05-28,University of Michigan,Other,0,0,0,0.0,Phase 1/Phase 2,0,2016.0,1,1,0,1,0,0,0,0,0,0,1,934
NCT02872636,1,0,0,0,1,0,2018-04-16,2019-04-16,,Minnetronix,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT02873208,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Alkermes, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,70
NCT02877303,0,0,0,0,0,0,2020-11-01,2021-11-01,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02878590,1,1,0,1,0,0,2017-11-30,2018-11-30,2018-11-30,InnoMed Healthscience Inc.,Industry,1,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,2
NCT02879994,0,0,0,0,0,0,2019-01-03,2020-01-03,,Jonsson Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,277
NCT02883049,0,0,0,0,0,0,2021-06-20,2022-06-20,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2012.0,0,1,0,0,0,1,0,0,1,0,1,3004
NCT02891070,0,1,0,1,0,0,2018-08-22,2019-08-22,2019-08-21,Baxter Healthcare Corporation,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,1,0,0,0,0,1,0,1,101
NCT02892734,0,1,0,1,0,0,2019-02-04,2020-02-04,2019-05-01,Northwestern University,Other,0,1,1,1.0,Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,925
NCT02899078,0,0,0,0,0,0,2019-11-30,2020-11-30,,"University of California, Davis",Other,0,1,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,530
NCT02901041,0,0,0,0,0,0,2021-02-28,2022-02-28,,Boston University Charles River Campus,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,63
NCT02903160,0,0,0,0,0,0,2019-10-31,2020-10-31,,Icahn School of Medicine at Mount Sinai,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,0,1,412
NCT02904954,0,0,0,0,0,0,2020-01-31,2021-01-31,,Weill Medical College of Cornell University,Other,0,1,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,586
NCT02906696,0,0,0,0,0,0,2019-08-08,2020-08-08,,M.D. Anderson Cancer Center,Other,0,1,1,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,2066
NCT02907099,0,0,0,0,0,0,2019-12-31,2020-12-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,1,0,0,0,0,0,0,0,1,2066
NCT02908516,1,1,0,1,0,1,2017-11-14,2018-11-14,2019-06-28,Yale University,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1053
NCT02912364,1,1,0,1,0,0,2018-04-20,2019-04-20,2019-03-20,Stanford University,Other,0,1,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,1309
NCT02913924,0,0,0,0,0,0,2020-01-31,2021-01-31,,New York State Psychiatric Institute,Other,0,0,1,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,361
NCT02915016,0,0,0,0,0,0,2019-08-07,2020-08-07,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,2133
NCT02915263,0,0,0,0,0,0,2019-09-30,2020-09-30,,Beth Israel Deaconess Medical Center,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT02915978,1,1,0,1,0,0,2017-02-10,2018-02-10,2018-01-19,INSYS Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,50
NCT02918292,0,0,0,0,0,0,2021-02-28,2022-02-28,,Medical College of Wisconsin,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,315
NCT02919475,1,0,0,0,1,0,2018-06-25,2019-06-25,,Akros Pharma Inc.,Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,22
NCT02921009,0,0,0,0,0,0,2020-12-31,2021-12-31,,McNeel Eye Center,Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,1
NCT02921568,1,0,0,0,1,0,2017-12-31,2018-12-31,,"Optos, PLC",Industry,1,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,5
NCT02922023,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of Florida,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT02924389,0,0,0,0,0,0,2020-06-30,2021-06-30,,Emory University,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,947
NCT02924857,0,0,0,0,0,0,2020-12-31,2021-12-31,,"TriReme Medical, LLC",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,1,1,0,6
NCT02927769,0,0,0,0,0,0,2021-03-28,2022-03-28,,Bristol-Myers Squibb,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT02931539,0,0,0,0,0,0,2020-09-29,2021-09-29,,Shire,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,342
NCT02933034,0,0,0,0,0,0,2019-03-31,2020-03-31,,Stanford University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,1309
NCT02933281,0,0,0,0,0,0,2021-02-15,2022-02-15,,International AIDS Vaccine Initiative,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,21
NCT02933554,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Keith Pereira, MD:",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT02940730,1,0,0,0,1,0,2018-06-18,2019-06-18,,"University of Colorado, Denver",Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,882
NCT02940860,0,0,0,0,0,0,2018-05-29,2019-05-29,,Pharmacosmos A/S,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,30
NCT02942264,0,0,0,0,0,0,2021-08-02,2022-08-02,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,3004
NCT02944201,0,0,0,0,0,0,2019-12-31,2020-12-31,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT02944448,0,0,0,0,0,0,2017-05-31,2018-05-31,,"Cara Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,17
NCT02944617,0,0,0,0,0,0,2021-06-30,2022-06-30,,City of Hope Medical Center,Other,0,0,1,5.0,,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,358
NCT02946073,1,0,0,0,1,0,2018-05-31,2019-05-31,,Braeburn Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,8
NCT02947100,0,0,0,0,0,0,2018-10-05,2019-10-05,,Robin E. Miller,Other,0,0,1,0.0,Phase 1/Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02947217,0,0,0,0,0,0,2020-12-31,2021-12-31,,Center for Human Reproduction,Other,0,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,11
NCT02947685,0,0,0,0,0,0,2020-10-31,2021-10-31,,"Alliance Foundation Trials, LLC.",Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,16
NCT02949128,0,0,0,0,0,0,2018-11-30,2019-11-30,,Alexion Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,0,1,0,0,0,0,0,1,0,1,86
NCT02949362,0,0,0,0,0,0,2019-09-30,2020-09-30,,Shire,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,1,0,1,342
NCT02949700,0,0,0,0,0,0,2019-12-31,2020-12-31,,Baylor College of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,518
NCT02949843,0,0,0,0,0,0,2021-02-28,2022-02-28,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,616
NCT02983240,0,0,0,0,0,0,2020-01-31,2021-01-31,,University of Florida,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,849
NCT02985398,0,0,0,0,0,0,2018-04-30,2019-04-30,,"Alder Biopharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,0,0,1,6
NCT02989623,0,0,0,0,0,0,2019-04-24,2020-04-24,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,1,5.0,,0,2015.0,1,0,0,0,0,1,0,0,0,0,1,162
NCT02991118,0,0,0,0,0,0,2018-08-22,2019-08-22,,Esperion Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,21
NCT02991768,0,0,0,0,0,0,2019-04-26,2020-04-26,,"Pooja Budhiraja, MD",Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT02991898,0,0,0,0,0,0,2025-01-31,2026-01-31,,"Masonic Cancer Center, University of Minnesota",Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,218
NCT02993822,0,0,0,0,0,0,2019-02-11,2020-02-11,,Nerre Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,5
NCT02996110,0,0,0,0,0,0,2022-01-17,2023-01-17,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,0,1,1104
NCT02999269,0,0,0,0,0,0,2020-09-30,2021-09-30,,University of New Mexico,Other,0,0,1,4.0,Phase 4,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,200
NCT02999984,0,0,0,0,0,0,2018-10-11,2019-10-11,,Orchard Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2016.0,0,0,0,0,0,0,0,1,0,0,1,12
NCT03002441,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Planned Parenthood of New York City, Inc.",Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,6
NCT03003962,0,0,0,0,0,0,2021-01-25,2022-01-25,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,0,1,2450
NCT03005717,1,0,0,0,1,0,2017-06-02,2018-06-02,,"Neothetics, Inc",Industry,1,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,11
NCT03006276,0,0,0,0,0,0,2017-11-30,2018-11-30,,Dr. Reddy's Laboratories Limited,Industry,1,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,212
NCT03007420,0,0,0,0,0,0,2020-12-31,2021-12-31,,Boston Children’s Hospital,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,400
NCT03007719,0,0,0,0,0,0,2019-01-11,2020-01-11,,Lawrence Fong,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,4
NCT03008005,0,0,0,0,0,0,2019-12-31,2020-12-31,,Wayne State University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,145
NCT03008837,0,0,0,0,0,0,2018-12-07,2019-12-07,,VA Office of Research and Development,U.S. Fed,2,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1012
NCT03010137,0,0,0,0,0,0,2019-07-31,2020-07-31,,"University of California, Davis",Other,0,0,0,5.0,,0,2015.0,1,0,0,1,0,0,0,0,0,0,1,530
NCT03012191,1,1,0,1,0,1,2018-05-05,2019-05-05,2019-06-03,University of Southern California,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,483
NCT03015402,0,0,0,0,0,0,2021-03-31,2022-03-31,,"Gladwin, Mark, MD",Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03016975,0,0,0,0,0,0,2020-09-30,2021-09-30,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,77
NCT03018106,1,1,0,1,0,0,2017-09-29,2018-09-29,2017-12-01,Emory University,Other,0,0,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,947
NCT03020160,1,1,0,1,0,0,2017-12-15,2018-12-15,2018-12-04,Hoffmann-La Roche,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03021993,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medical University of South Carolina,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,511
NCT03022292,0,0,0,0,0,0,2020-06-30,2021-06-30,,"University of California, Los Angeles",Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,1,0,0,0,0,0,1,0,692
NCT03023111,0,0,0,0,0,0,2019-03-31,2020-03-31,,Hospital Universitário Professor Edgard Santos,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,12
NCT03025542,0,0,0,0,0,0,2017-12-31,2018-12-31,,UCB Biopharma S.P.R.L.,Industry,1,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,1,0,1,75
NCT03027388,0,0,0,0,0,0,2021-08-30,2022-08-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03029611,0,0,0,0,0,0,2020-12-31,2021-12-31,,University of Washington,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,910
NCT03030261,0,0,0,0,0,0,2021-05-31,2022-05-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1151
NCT03033160,0,0,0,0,0,0,2019-10-31,2020-10-31,,Boston Urogynecology Associates,Other,0,0,0,4.0,Phase 4,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,9
NCT03033784,0,0,0,0,0,0,2018-10-03,2019-10-03,,Emory University,Other,0,0,1,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,947
NCT03035032,0,0,0,0,0,0,2019-11-30,2020-11-30,,Astellas Pharma Singapore Pte. Ltd.,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,6
NCT03036098,0,0,0,0,0,0,2021-07-26,2022-07-26,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1104
NCT03037437,0,0,0,0,0,0,2019-12-31,2020-12-31,,The University of Texas Health Science Center at San Antonio,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,257
NCT03037645,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sunesis Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03039764,0,0,0,0,0,0,2019-09-01,2020-09-01,,Montefiore Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,240
NCT03041441,0,0,0,0,0,0,2019-12-24,2020-12-24,,Duke University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1342
NCT03043495,1,0,0,0,1,0,2018-04-01,2019-04-01,,Eslam Ayman Mohamed Shawki,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,5
NCT03044184,0,0,0,0,0,0,2019-06-30,2020-06-30,,Kwong Wah Hospital,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,15
NCT03044314,0,0,0,0,0,0,2019-12-01,2020-12-01,,Duke University,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03046251,0,0,0,0,0,0,2020-12-31,2021-12-31,,State University of New York at Buffalo,Other,0,0,0,4.0,Phase 4,0,2015.0,0,1,0,0,0,0,0,0,0,0,1,105
NCT03047551,1,0,1,1,0,0,2018-06-30,2019-06-30,2019-04-16,Columbia University,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,675
NCT03047993,0,0,0,0,0,0,2022-04-01,2023-04-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03048422,0,0,0,0,0,0,2020-07-31,2021-07-31,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2133
NCT03048825,0,0,0,0,0,0,2021-06-30,2022-06-30,,Population Health Research Institute,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,2,1,0,77
NCT03052920,0,0,0,0,0,0,2020-02-29,2021-02-28,,Washington University School of Medicine,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03054896,0,0,0,0,0,0,2020-09-01,2021-09-01,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03055013,0,0,0,0,0,0,2023-11-30,2024-11-30,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,3004
NCT03058289,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Intensity Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,1
NCT03060083,1,0,0,0,1,0,2017-11-16,2018-11-16,,University of Vermont,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,1,0,0,0,0,0,0,0,0,1,0,155
NCT03061201,0,0,0,0,0,0,2021-11-15,2022-11-15,,Sangamo Therapeutics,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,18
NCT03062280,0,0,0,0,0,0,2020-02-29,2021-02-28,,Diurnal Limited,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,16
NCT03062657,0,0,0,0,0,0,2021-06-30,2022-06-30,,Medtronic Spinal and Biologics,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,52
NCT03063983,0,0,0,0,0,0,2019-01-02,2020-01-02,,Grupo de Apoio ao Adolescente e a Crianca com Cancer,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,0,1,9
NCT03064529,0,0,0,0,0,0,2018-12-31,2019-12-31,,Ann & Robert H Lurie Children's Hospital of Chicago,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,112
NCT03067610,0,0,0,0,0,0,2019-01-29,2020-01-29,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,1,0,0,0,1,0,626
NCT03068312,0,0,0,0,0,0,2018-12-18,2019-12-18,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,141
NCT03068715,0,0,0,0,0,0,2021-03-31,2022-03-31,,Stanford University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03068975,0,0,0,0,0,0,2024-04-30,2025-04-30,,University of Puerto Rico,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,20
NCT03069365,1,1,0,1,0,0,2018-02-20,2019-02-20,2019-02-06,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,430
NCT03070899,0,0,0,0,0,0,2019-07-31,2020-07-31,,ObsEva SA,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,12
NCT03077750,1,0,0,0,1,0,2018-03-30,2019-03-30,,Veloce BioPharma LLC,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03078452,0,0,0,0,0,0,2021-05-31,2022-05-31,,Emory University,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,947
NCT03080805,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Jiangsu HengRui Medicine Co., Ltd.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,187
NCT03080974,0,0,0,0,0,0,2021-06-01,2022-06-01,,University of Louisville,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,214
NCT03082196,0,0,0,0,0,0,2019-05-30,2020-05-30,,"Advantage Dental Services, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03083808,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Greg Durm, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03084536,0,0,0,0,0,0,2020-06-30,2021-06-30,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03085017,1,0,1,1,0,0,2018-06-07,2019-06-07,2018-03-08,Loma Linda University,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,194
NCT03085329,0,0,0,0,0,0,2018-10-31,2019-10-31,,Seattle Children's Hospital,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,137
NCT03086135,0,0,0,0,0,0,2018-10-30,2019-10-30,,Cochlear Bone Anchored Solutions,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,7
NCT03086551,0,0,0,0,0,0,2019-03-30,2020-03-30,,University of Michigan,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,0,0,1,934
NCT03088111,0,0,0,0,0,0,2021-01-01,2022-01-01,,Elusys Therapeutics,Other,0,1,1,4.0,Phase 4,0,2020.0,0,0,1,0,0,0,0,0,3,1,0,7
NCT03088813,0,0,0,0,0,0,2022-09-30,2023-09-30,,Ipsen,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,214
NCT03091192,0,0,0,0,0,0,2019-08-01,2020-08-01,,AstraZeneca,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2450
NCT03092375,0,0,0,0,0,0,2018-12-28,2019-12-28,,University of Florida,Other,0,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03092934,0,0,0,0,0,0,2019-12-01,2020-12-01,,Eli Lilly and Company,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1512
NCT03093350,0,0,0,0,0,0,2020-03-01,2021-03-01,,Baylor College of Medicine,Other,0,0,1,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,518
NCT03093662,1,0,1,1,0,1,2017-03-09,2018-03-09,2019-07-08,Brooke Army Medical Center,U.S. Fed,2,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,71
NCT03095118,0,0,0,0,0,0,2019-09-30,2020-09-30,,Fernando Fervenza,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03097835,1,0,0,0,1,0,2018-07-12,2019-07-12,,"Steve Yoelin M.D. Medical Associates, Inc.",Other,0,1,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,2
NCT03097978,1,0,1,1,0,1,2017-09-29,2018-09-29,2019-05-16,Shirley Ryan AbilityLab,Other,0,0,1,5.0,,0,2013.0,1,0,0,1,0,0,0,0,0,0,1,71
NCT03098121,0,0,0,0,0,0,2018-11-30,2019-11-30,,Taoyuan General Hospital,Other,0,1,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,5
NCT03100435,0,0,0,0,0,0,2018-12-31,2019-12-31,,Tufts University School of Dental Medicine,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,6
NCT03100942,0,0,0,0,0,0,2019-01-10,2020-01-10,,Gilead Sciences,Industry,1,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03101267,0,0,0,0,0,0,2018-01-26,2019-01-26,,Astellas Pharma Inc,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,506
NCT03102723,0,0,0,0,0,0,2020-07-31,2021-07-31,,National Heart Centre Singapore,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,36
NCT03104699,0,0,0,0,0,0,2019-09-01,2020-09-01,,Agenus Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,19
NCT03105128,0,0,0,0,0,0,2020-10-15,2021-10-15,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03110458,0,0,0,0,0,0,2019-12-31,2020-12-31,,Sensorion,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,2
NCT03110523,0,0,0,0,0,0,2021-12-10,2022-12-10,,Techfields Pharma Co. Ltd,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03111914,0,0,0,0,0,0,2020-04-30,2021-04-30,,Duke University,Other,0,1,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,1342
NCT03115411,1,1,0,1,0,0,2018-04-10,2019-04-10,2019-03-08,Stanford University,Other,0,0,0,5.0,,0,2011.0,1,0,0,1,0,0,0,0,0,0,1,1309
NCT03117309,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Michael B. Atkins, MD",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03118947,0,0,0,0,0,0,2019-02-25,2020-02-25,,ACADIA Pharmaceuticals Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,24
NCT03121352,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT03121963,0,0,0,0,0,0,2019-11-30,2020-11-30,,University of Alabama at Birmingham,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03123445,0,0,0,0,0,0,2019-04-30,2020-04-30,,"China Medical University, China",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,3,1,0,43
NCT03123848,1,1,0,1,0,0,2017-05-19,2018-05-19,2018-05-15,Janssen Pharmaceutical K.K.,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,102
NCT03125226,0,0,0,0,0,0,2020-05-16,2021-05-16,,University of Washington,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03126760,0,0,0,0,0,0,2020-02-27,2021-02-27,,Mallinckrodt,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,91
NCT03127098,1,0,0,0,1,0,2017-12-07,2018-12-07,,"NantCell, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,12
NCT03128008,0,0,0,0,0,0,2019-01-02,2020-01-02,,Duke University,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1342
NCT03128372,1,1,0,1,0,1,2017-07-19,2018-07-19,2018-07-20,Medtronic - MITG,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,146
NCT03130777,0,0,0,0,0,0,2020-04-30,2021-04-30,,Edwards Lifesciences,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,77
NCT03131154,0,0,0,0,0,0,2019-04-19,2020-04-19,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,13
NCT03131999,0,0,0,0,0,0,2019-03-07,2020-03-07,,Medical University of South Carolina,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,511
NCT03133221,0,0,0,0,0,0,2021-03-31,2022-03-31,,"University of Maryland, College Park",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03133481,1,1,0,1,0,0,2017-10-31,2018-10-31,2018-10-02,University of Alabama at Birmingham,Other,0,0,0,3.0,Phase 3,0,2014.0,1,1,0,0,0,0,0,0,0,0,1,801
NCT03136341,0,0,0,0,0,0,2020-03-31,2021-03-31,,David M. Simpson,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03137121,0,0,0,0,0,0,2019-09-30,2020-09-30,,University of Alabama at Birmingham,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03138499,0,0,0,0,0,0,2020-11-29,2021-11-29,,Bristol-Myers Squibb,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,1104
NCT03139916,0,0,0,0,0,0,2020-07-31,2021-07-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1699
NCT03141086,0,0,1,1,0,1,2018-08-30,2019-08-30,2019-09-03,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,1895
NCT03143569,1,0,1,1,0,1,2018-07-12,2019-07-12,2019-09-11,Washington University School of Medicine,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1151
NCT03144206,0,0,0,0,0,0,2022-12-31,2023-12-31,,Duke University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03145480,0,0,0,0,0,0,2018-09-28,2019-09-28,,Northwell Health,Other,0,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,271
NCT03147287,0,0,0,0,0,0,2020-12-31,2021-12-31,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03148691,1,1,0,1,0,0,2018-02-28,2019-02-28,2019-02-13,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03149783,0,0,0,0,0,0,2019-03-31,2020-03-31,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,882
NCT03149991,0,0,0,0,0,0,2019-03-31,2020-03-31,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,1699
NCT03150862,0,0,0,0,0,0,2021-06-30,2022-06-30,,"BeiGene USA, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,1,1,0,2
NCT03153969,0,0,0,0,0,0,2020-06-30,2021-06-30,,Tufts University,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,152
NCT03154307,0,0,0,0,0,0,2019-12-31,2020-12-31,,Baptist Health South Florida,Other,0,0,1,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,17
NCT03154619,0,0,0,0,0,0,2019-11-30,2020-11-30,,"SerenaGroup, Inc.",Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,5
NCT03155945,0,0,0,0,0,0,2018-09-05,2019-09-05,,Arena Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03157128,0,0,0,0,0,0,2022-03-31,2023-03-31,,"Loxo Oncology, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03159988,0,0,0,0,0,0,2019-03-31,2020-03-31,,University of Arizona,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,265
NCT03160716,1,1,0,1,0,1,2017-10-31,2018-10-31,2019-04-25,Q-Med AB,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,56
NCT03161093,0,0,0,0,0,0,2019-09-09,2020-09-09,,Regeneron Pharmaceuticals,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03166306,0,0,0,0,0,0,2019-10-31,2020-10-31,,Brigham and Women's Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,698
NCT03167437,0,0,0,0,0,0,2021-06-30,2022-06-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03168256,0,0,0,0,0,0,2020-02-15,2021-02-15,,Can-Fite BioPharma,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,16
NCT03169881,0,0,0,0,0,0,2022-09-30,2023-09-30,,NICHD Neonatal Research Network,Other,0,0,1,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,59
NCT03170206,0,0,0,0,0,0,2020-03-31,2021-03-31,,Dana-Farber Cancer Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03171415,0,1,0,1,0,0,2018-12-28,2019-12-28,2019-06-06,Raziel Therapeutics Ltd.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03173547,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Crown Laboratories, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03176953,0,0,0,0,0,0,2021-10-31,2022-10-31,,VA Office of Research and Development,U.S. Fed,2,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03179761,0,0,0,0,0,0,2020-01-01,2021-01-01,,Vanderbilt-Ingram Cancer Center,Other,0,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,180
NCT03183778,0,0,0,0,0,0,2020-04-30,2021-04-30,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03188432,0,0,0,0,0,0,2019-11-01,2020-11-01,,Wake Forest University Health Sciences,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03190083,1,0,0,0,1,0,2018-06-13,2019-06-13,,Case Comprehensive Cancer Center,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,374
NCT03190226,1,0,0,0,1,0,2017-05-27,2018-05-27,,Universitaire Ziekenhuizen Leuven,Other,0,0,0,4.0,Phase 4,0,2016.0,1,0,0,0,0,0,0,0,3,0,1,525
NCT03192046,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Texas Southwestern Medical Center,Other,0,0,0,5.0,,0,2016.0,0,0,0,1,0,0,0,0,0,0,1,626
NCT03193047,0,0,0,0,0,0,2018-01-29,2019-01-29,,Esperion Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,21
NCT03195660,1,0,0,0,1,0,2017-11-15,2018-11-15,,ResMed,Industry,1,0,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,1,1,0,60
NCT03196167,0,0,0,0,0,0,2019-06-30,2020-06-30,,Yale University,Other,0,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03196505,0,0,0,0,0,0,2019-05-31,2020-05-31,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03198000,1,1,0,1,0,0,2017-07-21,2018-07-21,2018-07-13,Johnson & Johnson Consumer Inc. (J&JCI),Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03201003,0,0,0,0,0,0,2019-02-15,2020-02-15,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,11
NCT03205163,0,0,0,0,0,0,2018-11-12,2019-11-12,,Bioverativ Therapeutics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,1,1,0,19
NCT03205371,0,0,0,0,0,0,2018-07-19,2019-07-19,,"Sanofi Pasteur, a Sanofi Company",Industry,1,0,0,3.0,Phase 3,0,2016.0,1,0,1,0,0,0,0,0,2,0,1,285
NCT03209050,0,0,0,0,0,0,2019-05-24,2020-05-24,,Bluegrass Vascular Technologies,Industry,1,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03209362,0,0,0,0,0,0,2018-08-17,2019-08-17,,Seikagaku Corporation,Industry,1,1,0,1.0,Phase 2,0,2017.0,1,0,0,0,0,0,1,0,0,1,0,11
NCT03212521,1,1,0,1,0,0,2018-08-13,2019-08-13,2019-08-12,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,430
NCT03213158,0,0,0,0,0,0,2020-05-31,2021-05-31,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03213691,0,0,0,0,0,0,2024-09-30,2025-09-30,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03215758,0,0,0,0,0,0,2019-07-02,2020-07-02,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03216772,0,0,0,0,0,0,2019-09-30,2020-09-30,,Olympus Surgical Technologies Europe,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03220737,0,0,0,0,0,0,2019-10-15,2020-10-15,,"PaxVax, Inc.",Industry,1,0,0,4.0,Phase 4,0,2017.0,0,0,1,0,0,0,0,0,0,1,0,12
NCT03220958,0,0,0,0,0,0,2020-04-30,2021-04-30,,Montefiore Medical Center,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03221582,0,0,0,0,0,0,2018-11-26,2019-11-26,,Dallas VA Medical Center,U.S. Fed,2,1,0,4.0,Phase 4,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,23
NCT03222570,0,0,0,0,0,0,2022-03-31,2023-03-31,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03222609,0,0,0,0,0,0,2021-10-20,2022-10-20,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03224182,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Spectrum Pharmaceuticals, Inc",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,67
NCT03224403,0,0,0,0,0,0,2018-04-04,2019-04-04,,"Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division",Industry,1,1,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,5
NCT03224507,0,0,0,0,0,0,2021-04-01,2022-04-01,,University of Alabama at Birmingham,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,801
NCT03225287,0,0,0,0,0,0,2020-01-31,2021-01-31,,Ra Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03226535,1,0,1,1,0,0,2018-06-22,2019-06-22,2019-04-17,Clear Guide Medical,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03227692,0,0,0,0,0,0,2019-12-20,2020-12-20,,Zimmer Biomet,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,2,1,0,215
NCT03228420,0,0,0,0,0,0,2020-01-31,2021-01-31,,Nevro Corp,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03229174,0,0,0,0,0,0,2019-08-31,2020-08-31,,"William Ondo, MD",Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,3
NCT03229408,0,0,0,0,0,0,2022-07-31,2023-07-31,,University of Illinois at Chicago,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,242
NCT03232567,1,1,0,1,0,0,2018-03-07,2019-03-07,2019-02-26,"Altimmune, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,6
NCT03234309,0,0,0,0,0,0,2021-04-14,2022-04-14,,OHSU Knight Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT03234465,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Oragenics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2
NCT03236506,0,0,0,0,0,0,2020-02-29,2021-02-28,,University of Dundee,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,102
NCT03236662,1,0,0,0,1,0,2017-11-30,2018-11-30,,"Craig McDonald, MD",Other,0,1,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,3
NCT03238001,1,1,0,1,0,0,2017-11-21,2018-11-21,2018-01-24,Digital Cognition Technologies,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03239106,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03240679,0,0,0,0,0,0,2022-04-01,2023-04-01,,Mayo Clinic,Other,0,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT03241342,0,0,0,0,0,0,2018-09-21,2019-09-21,,GTx,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,19
NCT03242642,0,0,0,0,0,0,2021-10-31,2022-10-31,,Medtronic Cardiovascular,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,34
NCT03245541,0,0,0,0,0,0,2021-09-30,2022-09-30,,Cedars-Sinai Medical Center,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,279
NCT03246152,0,0,0,0,0,0,2018-12-24,2019-12-24,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,2,1,0,1190
NCT03246347,0,0,0,0,0,0,2021-03-31,2022-03-31,,Earle Burgess,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03246971,1,0,0,0,1,0,2018-07-12,2019-07-12,,iX Biopharma Ltd.,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,6
NCT03251326,0,0,0,0,0,0,2019-08-31,2020-08-31,,New York State Psychiatric Institute,Other,0,0,1,0.0,Phase 1/Phase 2,0,2015.0,1,1,0,0,0,0,0,0,0,0,1,361
NCT03251482,0,0,0,0,0,0,2018-11-05,2019-11-05,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,558
NCT03252522,0,0,0,0,0,0,2019-12-31,2020-12-31,,Oregon Health and Science University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,0,1,0,1,1,0,475
NCT03254602,1,1,0,1,0,0,2017-04-10,2018-04-10,2017-08-21,University Foot and Ankle Foundation,Other,0,1,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,2
NCT03255629,1,0,0,0,1,0,2018-08-22,2019-08-22,,Joslin Diabetes Center,Other,0,1,1,0.0,Phase 1/Phase 2,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,60
NCT03256136,0,0,0,0,0,0,2020-10-31,2021-10-31,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03256695,1,1,0,1,0,1,2018-04-17,2019-04-17,2019-06-04,"Teva Branded Pharmaceutical Products, R&D Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,101
NCT03257436,0,0,0,0,0,0,2020-04-30,2021-04-30,,Boston Scientific Corporation,Industry,1,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,340
NCT03259308,0,0,0,0,0,0,2020-08-09,2021-08-09,,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,342
NCT03261193,0,0,0,0,0,0,2019-12-01,2020-12-01,,Nicholas Schott,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03261947,0,0,0,0,0,0,2019-11-19,2020-11-19,,"Millennium Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,209
NCT03262935,0,0,0,0,0,0,2020-07-31,2021-07-31,,Synthon Biopharmaceuticals BV,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03263481,0,0,0,0,0,0,2020-09-01,2021-09-01,,Indiana University,Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,497
NCT03265964,0,0,0,0,0,0,2022-03-01,2023-03-01,,VA Office of Research and Development,U.S. Fed,2,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1012
NCT03267498,0,0,0,0,0,0,2019-10-15,2020-10-15,,"University of California, San Francisco",Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,1,0,0,0,1,0,1443
NCT03267680,0,0,0,0,0,0,2021-11-08,2022-11-08,,University of Southern California,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,1,0,0,0,0,0,0,1,0,483
NCT03272828,1,0,0,0,1,0,2017-12-31,2018-12-31,,University of Washington,Other,0,0,0,5.0,,0,2012.0,0,0,0,1,0,0,0,0,0,0,1,910
NCT03274466,0,0,0,0,0,0,2020-02-29,2021-02-28,,"KCI USA, Inc.",Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,23
NCT03275402,0,0,0,0,0,0,2019-12-31,2020-12-31,,Y-mAbs Therapeutics,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,5
NCT03276936,0,0,0,0,0,0,2019-01-03,2020-01-03,,Foamix Ltd.,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,16
NCT03277638,0,0,0,0,0,0,2019-12-31,2020-12-31,,Case Comprehensive Cancer Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT03277846,1,0,1,1,0,0,2018-05-17,2019-05-17,2019-05-07,University of Pennsylvania,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1052
NCT03280108,0,0,0,0,0,0,2018-09-27,2019-09-27,,Alcon Research,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03280537,0,0,0,0,0,0,2019-03-07,2020-03-07,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1731
NCT03281538,0,0,0,0,0,0,2019-11-30,2020-11-30,,"Cara Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,17
NCT03281837,0,0,0,0,0,0,2020-03-31,2021-03-31,,Fidia Pharma USA Inc.,Industry,1,0,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03282357,1,0,0,0,1,0,2018-07-17,2019-07-17,,"Merz North America, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,35
NCT03283436,0,0,0,0,0,0,2019-02-21,2020-02-21,,Jon I. Einarsson,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03283566,0,0,0,0,0,0,2019-10-03,2020-10-03,,The Cleveland Clinic,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03283787,1,0,0,0,1,0,2018-07-31,2019-07-31,,ACell Inc.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,7
NCT03284307,0,0,0,0,0,0,2019-08-10,2020-08-10,,"University of Wisconsin, Madison",Other,0,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03284957,0,0,0,0,0,0,2021-06-30,2022-06-30,,Sanofi,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1222
NCT03285412,0,0,0,0,0,0,2021-02-28,2022-02-28,,Massachusetts General Hospital,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03285802,0,0,0,0,0,0,2019-09-19,2020-09-19,,Greater Baltimore Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03288103,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Children's Hospital Medical Center, Cincinnati",Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,437
NCT03289819,0,0,0,0,0,0,2019-11-30,2020-11-30,,Institut fuer Frauengesundheit,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,3
NCT03292406,0,0,0,0,0,0,2020-09-30,2021-09-30,,Galderma R&D,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03292874,0,0,0,0,0,0,2020-10-31,2021-10-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,279
NCT03295396,0,0,0,0,0,0,2019-11-01,2020-11-01,,"Oncoceutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03296098,0,0,0,0,0,0,2020-09-30,2021-09-30,,Health Decisions,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,21
NCT03299686,0,0,0,0,0,0,2019-07-05,2020-07-05,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,1895
NCT03300024,1,1,0,1,0,1,2018-02-12,2019-02-12,2019-03-29,Johns Hopkins University,Other,0,0,0,5.0,,1,2015.0,1,0,0,1,0,0,0,0,0,0,1,1143
NCT03302559,1,1,0,1,0,0,2018-04-30,2019-04-30,2019-04-30,Allergan,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,495
NCT03303950,0,0,0,0,0,0,2022-10-31,2023-10-31,,University of Utah,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,578
NCT03304444,1,0,0,0,1,0,2017-10-31,2018-10-31,,Abington Memorial Hospital,Other,0,0,0,3.0,Phase 3,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,9
NCT03305770,1,1,0,1,0,0,2018-02-21,2019-02-21,2019-01-30,Alcon Research,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03307564,0,0,0,0,0,0,2020-12-01,2021-12-01,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,461
NCT03309878,0,0,0,0,0,0,2021-07-01,2022-07-01,,National Cancer Institute (NCI),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3004
NCT03311126,0,0,0,0,0,0,2024-05-15,2025-05-15,,"University of Wisconsin, Madison",Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03313960,0,0,0,0,0,0,2018-09-30,2019-09-30,,"Informed Data Systems, Inc.",Industry,1,1,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03316859,0,0,0,0,0,0,2020-04-01,2021-04-01,,Angela N Fellner PhD CCRP,Other,0,0,0,2.0,Phase 2/Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03317288,0,0,0,0,0,0,2019-06-01,2020-06-01,,University of Illinois at Chicago,Other,0,1,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,242
NCT03320330,0,0,0,0,0,0,2021-09-19,2022-09-19,,Children's Oncology Group,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,389
NCT03321981,0,0,0,0,0,0,2019-09-30,2020-09-30,,Merus N.V.,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03325010,0,0,0,0,0,0,2018-11-01,2019-11-01,,Neurocrine Biosciences,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,34
NCT03325881,1,1,0,1,0,0,2018-06-07,2019-06-07,2019-06-07,Shire,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,342
NCT03329027,1,0,0,0,1,0,2018-03-30,2019-03-30,,Vibrant Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03329989,0,0,0,0,0,0,2018-09-05,2019-09-05,,Endo Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,91
NCT03331302,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Virginia,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,402
NCT03331796,0,0,0,0,0,0,2021-10-31,2022-10-31,,Palo Alto Veterans Institute for Research,Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,31
NCT03333928,0,0,0,0,0,0,2019-10-12,2020-10-12,,HighTide Biopharma Pty Ltd,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03334344,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Ceevra, Inc.",Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03334539,1,0,0,0,1,0,2018-05-31,2019-05-31,,"HanAll BioPharma Co., Ltd.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,12
NCT03335228,0,0,0,0,0,0,2022-06-30,2023-06-30,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,749
NCT03336242,0,0,0,0,0,0,2019-06-30,2020-06-30,,INSYS Therapeutics Inc,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,50
NCT03338296,0,0,0,0,0,0,2021-01-26,2022-01-26,,Eisai Inc.,Industry,1,0,0,4.0,Phase 4,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,328
NCT03338621,0,0,0,0,0,0,2020-03-31,2021-03-31,,Global Alliance for TB Drug Development,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,23
NCT03338998,0,0,0,0,0,0,2020-11-30,2021-11-30,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1895
NCT03339076,1,0,0,0,1,0,2018-03-31,2019-03-31,,Dr. Gaines W. Hammond Jr. MD FACS,Other,0,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03340883,0,0,0,0,0,0,2019-06-13,2020-06-13,,"Aduro Biotech, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2017.0,1,0,1,0,0,0,0,0,0,1,0,12
NCT03340974,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Galera Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,11
NCT03342001,0,0,0,0,0,0,2019-06-30,2020-06-30,,"University of Maryland, Baltimore",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,144
NCT03343639,0,1,0,1,0,0,2018-10-23,2019-10-23,2019-05-23,Menlo Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,10
NCT03344640,0,0,0,0,0,0,2019-08-02,2020-08-02,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03345342,0,0,0,0,0,0,2020-07-06,2021-07-06,,"Janssen Research & Development, LLC",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03346057,0,0,0,0,0,0,2019-09-09,2020-09-09,,Merck Sharp & Dohme Corp.,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,2145
NCT03347279,0,0,0,0,0,0,2020-09-02,2021-09-02,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2017.0,0,0,1,0,0,0,0,0,1,1,0,2450
NCT03349515,0,0,1,1,0,0,2018-09-19,2019-09-19,2019-07-25,Medical University of South Carolina,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,511
NCT03349632,1,1,0,1,0,0,2018-02-16,2019-02-16,2019-01-30,Alcon Research,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,492
NCT03351933,1,1,0,1,0,1,2018-04-27,2019-04-27,2019-07-11,Grifols Therapeutics LLC,Industry,1,0,0,4.0,Phase 4,0,2017.0,1,0,1,0,0,0,0,0,0,1,0,40
NCT03352323,0,0,0,0,0,0,2017-12-06,2018-12-06,,Perrigo Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,39
NCT03353753,0,0,0,0,0,0,2019-05-31,2020-05-31,,Deciphera Pharmaceuticals LLC,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,8
NCT03354637,0,0,0,0,0,0,2019-04-18,2020-04-18,,"Aclaris Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,24
NCT03357757,0,0,0,0,0,0,2022-03-30,2023-03-30,,AHS Cancer Control Alberta,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,136
NCT03359473,0,0,0,0,0,0,2019-11-03,2020-11-03,,GlaxoSmithKline,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,3276
NCT03360890,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Chicago,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03361189,0,0,0,0,0,0,2023-02-01,2024-02-01,,"University of California, Los Angeles",Other,0,1,0,2.0,Phase 2/Phase 3,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT03361735,0,0,0,0,0,0,2019-12-31,2020-12-31,,City of Hope Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,358
NCT03362190,0,0,0,0,0,0,2018-10-18,2019-10-18,,Ophthotech Corporation,Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,1,1,0,15
NCT03365414,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Alberta,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,3,1,0,432
NCT03366012,0,0,0,0,0,0,2021-08-31,2022-08-31,,Columbia University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03366675,0,0,0,0,0,0,2018-10-08,2019-10-08,,Samsung Medical Center,Other,0,1,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,2,1,0,684
NCT03367299,0,0,0,0,0,0,2023-09-30,2024-09-30,,Gruppo Italiano Malattie EMatologiche dell'Adulto,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,81
NCT03367910,0,0,0,0,0,0,2020-12-31,2021-12-31,,Washington University School of Medicine,Other,0,1,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1151
NCT03368066,0,0,0,0,0,0,2019-03-12,2020-03-12,,University of Virginia,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,402
NCT03368547,0,0,0,0,0,0,2021-02-01,2022-02-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,5.0,,0,2016.0,0,0,0,0,0,1,0,0,0,0,1,277
NCT03368859,0,0,0,0,0,0,2020-08-21,2021-08-21,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03369847,0,0,0,0,0,0,2019-05-30,2020-05-30,,New York City Health and Hospitals Corporation,Other,0,0,0,4.0,Phase 4,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,18
NCT03370276,0,0,0,0,0,0,2021-12-31,2022-12-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03371381,0,0,0,0,0,0,2018-10-09,2019-10-09,,"Janssen Research & Development, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,1,2018.0,1,1,1,0,0,0,0,0,1,1,0,558
NCT03373383,0,0,0,0,0,0,2019-12-31,2020-12-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03375788,0,0,0,0,0,0,2022-10-31,2023-10-31,,Massachusetts General Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03376477,0,0,0,0,0,0,2021-10-16,2022-10-16,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,461
NCT03376984,0,0,0,0,0,0,2020-12-31,2021-12-31,,"University of California, Los Angeles",Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,0,1,0,0,1,0,0,1,0,692
NCT03378570,0,0,0,0,0,0,2020-10-31,2021-10-31,,Nicholas Trapp,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03379168,0,0,0,0,0,0,2019-03-31,2020-03-31,,"Dustin L. Richter, MD",Other,0,0,0,5.0,,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,1
NCT03380026,0,0,0,0,0,0,2019-12-13,2020-12-13,,"Rochester Skin Lymphoma Medical Group, PLLC",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03380390,1,1,0,1,0,0,2018-06-15,2019-06-15,2019-06-07,"Aclaris Therapeutics, Inc.",Industry,1,0,0,4.0,Phase 4,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,24
NCT03382106,0,0,0,0,0,0,2023-02-28,2024-02-28,,Eric A. Hoffman,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03382262,0,0,0,0,0,0,2018-10-09,2019-10-09,,"Flexion Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,15
NCT03382847,0,0,0,0,0,0,2020-04-25,2021-04-25,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,869
NCT03384004,0,0,0,0,0,0,2018-12-31,2019-12-31,,KaVo Kerr,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03384784,0,0,0,0,0,0,2022-01-31,2023-01-31,,University of Pennsylvania,Other,0,0,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03384914,0,0,0,0,0,0,2022-03-31,2023-03-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,344
NCT03387267,1,0,0,0,1,0,2018-07-23,2019-07-23,,Nestlé,Industry,1,1,0,5.0,,1,2017.0,1,0,0,1,0,0,0,0,1,1,0,205
NCT03387618,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ohio State University,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,1,0,0,0,0,1,0,315
NCT03391466,0,0,0,0,0,0,2022-01-15,2023-01-15,,"Kite, A Gilead Company",Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,1,0,0,0,0,0,1,1,0,14
NCT03392272,0,0,0,0,0,0,2020-02-01,2021-02-01,,Sheba Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,553
NCT03393494,0,0,0,0,0,0,2018-09-30,2019-09-30,,Perrigo Company,Industry,1,0,0,3.0,Phase 3,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,39
NCT03395197,0,0,0,0,0,0,2022-09-14,2023-09-14,,Pfizer,Industry,1,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,1,1,0,2856
NCT03397342,0,0,0,0,0,0,2020-06-15,2021-06-15,,Albert Einstein College of Medicine,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,155
NCT03404648,0,0,0,0,0,0,2019-08-27,2020-08-27,,Mayo Clinic,Other,0,0,0,3.0,Phase 3,0,2017.0,1,1,0,1,0,0,0,0,0,1,0,1898
NCT03404843,0,0,0,0,0,0,2018-10-05,2019-10-05,,Colorado State University,Other,0,0,0,1.0,Phase 2,0,2017.0,1,1,0,0,0,0,0,0,0,1,0,48
NCT03406520,0,0,0,0,0,0,2019-12-31,2020-12-31,,Singapore General Hospital,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,134
NCT03408340,0,0,0,0,0,0,2019-12-31,2020-12-31,,Emory University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03408886,0,0,0,0,0,0,2020-10-04,2021-10-04,,Arizona State University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,100
NCT03409965,1,0,0,0,1,0,2018-08-21,2019-08-21,,LUTRONIC Corporation,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,9
NCT03411031,0,0,0,0,0,0,2021-04-30,2022-04-30,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03414424,0,0,0,0,0,0,2019-07-31,2020-07-31,,Bronx VA Medical Center,U.S. Fed,2,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,0,1,0,15
NCT03414762,0,0,0,0,0,0,2021-04-30,2022-04-30,,Northwell Health,Other,0,0,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,271
NCT03415178,1,1,0,1,0,0,2018-08-09,2019-08-09,2019-08-08,Sanofi,Industry,1,1,0,3.0,Phase 3,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,1222
NCT03416764,0,0,0,0,0,0,2022-02-20,2023-02-20,,Tel-Aviv Sourasky Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,415
NCT03418064,1,0,1,1,0,1,2018-05-16,2019-05-16,2019-08-12,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,85
NCT03418675,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Chicago,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,594
NCT03419650,0,0,0,0,0,0,2019-12-31,2020-12-31,,"IRIS Research and Development, LLC",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03420833,0,0,0,0,0,0,2021-12-31,2022-12-31,,Yong-Mei Cha,Other,0,1,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03421418,0,0,0,0,0,0,2019-02-28,2020-02-28,,"Ceevra, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,8
NCT03421808,0,0,0,0,0,0,2021-01-31,2022-01-31,,Medical University of South Carolina,Other,0,0,1,2.0,Phase 2/Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,511
NCT03422159,0,0,0,0,0,0,2019-06-05,2020-06-05,,"Community Medical Center, Toms River, NJ",Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03423147,0,0,0,0,0,0,2020-03-31,2021-03-31,,Angela Bianco,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03424239,0,0,0,0,0,0,2020-01-01,2021-01-01,,Massachusetts General Hospital,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03424681,0,0,0,0,0,0,2019-12-31,2020-12-31,,The Mind Research Network,Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03424850,0,0,0,0,0,0,2026-02-27,2027-02-27,,Washington University School of Medicine,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,1151
NCT03425279,0,0,0,0,0,0,2020-01-31,2021-01-31,,"BioAtla, LLC",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03426085,0,0,0,0,0,0,2020-04-30,2021-04-30,,Eastern Virginia Medical School,Other,0,0,0,1.0,Phase 2,0,2016.0,0,1,0,0,0,0,0,0,0,0,1,33
NCT03427125,0,0,0,0,0,0,2019-11-30,2020-11-30,,Ardelyx,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,22
NCT03430180,0,0,0,0,0,0,2019-08-30,2020-08-30,,"National Institute for Health and Welfare, Finland",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,35
NCT03430245,0,0,0,0,0,0,2019-05-30,2020-05-30,,Syneron Medical,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,41
NCT03432650,0,0,0,0,0,0,2020-06-20,2021-06-20,,"Hospital for Special Surgery, New York",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,157
NCT03433040,0,0,0,0,0,0,2020-08-23,2021-08-23,,University of South Florida,Other,0,0,0,3.0,Phase 3,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03433274,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Tendyne Holdings, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03433677,1,0,1,1,0,0,2018-09-04,2019-09-04,2019-09-02,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,1512
NCT03438214,0,0,0,0,0,0,2020-02-28,2021-02-28,,University of Sao Paulo,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,767
NCT03439085,0,0,0,0,0,0,2020-01-31,2021-01-31,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03440112,0,0,0,0,0,0,2021-11-15,2022-11-15,,"Nicolaas Bohnen, MD, PhD",Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03441061,0,0,0,0,0,0,2022-02-28,2023-02-28,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,2066
NCT03443687,0,0,0,0,0,0,2019-04-30,2020-04-30,,University of New Mexico,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,200
NCT03448458,0,0,0,0,0,0,2022-02-28,2023-02-28,,Emory University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,947
NCT03449667,0,0,0,0,0,0,2020-09-30,2021-09-30,,"University of California, San Diego",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,561
NCT03449979,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,910
NCT03450551,0,0,0,0,0,0,2019-08-31,2020-08-31,,Guy's and St Thomas' NHS Foundation Trust,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,3,1,0,133
NCT03451331,0,0,0,0,0,0,2020-05-01,2021-05-01,,Matthew Galsky,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03451500,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Snyder, Robert W., M.D., Ph.D., P.C.",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03452033,1,0,0,0,1,0,2018-08-15,2019-08-15,,Allysta Pharmaceutical,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03452228,0,0,0,0,0,0,2020-05-18,2021-05-18,,Regeneron Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,176
NCT03457116,0,0,0,0,0,0,2020-01-01,2021-01-01,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03458130,0,0,0,0,0,0,2018-10-05,2019-10-05,,Eidos Therapeutics,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03458871,0,0,0,0,0,0,2019-02-06,2020-02-06,,"The University of Texas Health Science Center, Houston",Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,490
NCT03459365,0,0,0,0,0,0,2022-03-31,2023-03-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03460158,0,0,0,0,0,0,2020-12-01,2021-12-01,,University of Pennsylvania,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1052
NCT03460704,0,0,0,0,0,0,2020-07-31,2021-07-31,,Zambon SpA,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,17
NCT03462966,0,0,0,0,0,0,2020-07-31,2021-07-31,,Cedars-Sinai Medical Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,279
NCT03463993,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Zimbabwe,Other,0,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,13
NCT03464383,0,0,0,0,0,0,2020-03-31,2021-03-31,,Wake Forest University Health Sciences,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,616
NCT03468218,0,0,0,0,0,0,2020-09-30,2021-09-30,,Emory University,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,947
NCT03474614,0,0,0,0,0,0,2020-01-24,2021-01-24,,"St. Joseph's Hospital and Medical Center, Phoenix",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,1,0,1,0,48
NCT03475004,0,0,0,0,0,0,2019-08-31,2020-08-31,,"University of Colorado, Denver",Other,0,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,882
NCT03475173,0,0,0,0,0,0,2020-01-01,2021-01-01,,Randy Kardon,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03476876,0,0,0,0,0,0,2020-03-15,2021-03-15,,Baylor College of Medicine,Other,0,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,518
NCT03477539,0,0,0,0,0,0,2020-04-01,2021-04-01,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,1898
NCT03478930,0,0,0,0,0,0,2020-03-18,2021-03-18,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03480022,0,0,0,0,0,0,2020-10-08,2021-10-08,,Woman's,Other,0,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT03480646,0,0,0,0,0,0,2020-08-31,2021-08-31,,Constellation Pharmaceuticals,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03482167,0,0,0,0,0,0,2022-03-31,2023-03-31,,University of Delaware,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,52
NCT03484598,0,0,0,0,0,0,2019-07-31,2020-07-31,,Brain Sentinel,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,11
NCT03486899,0,0,0,0,0,0,2020-01-16,2021-01-16,,Bristol-Myers Squibb,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03490344,0,0,0,0,0,0,2020-10-31,2021-10-31,,Memorial Sloan Kettering Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1432
NCT03490916,1,1,0,1,0,1,2018-04-04,2019-04-04,2019-04-18,Vincent Kan,Other,0,0,0,4.0,Phase 4,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,1
NCT03491761,0,0,0,0,0,0,2020-06-30,2021-06-30,,NorthShore University HealthSystem,Other,0,0,0,1.0,Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,61
NCT03492138,0,0,0,0,0,0,2023-03-15,2024-03-15,,Ajai Chari,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03493685,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Retrophin, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,9
NCT03494647,0,0,0,0,0,0,2020-04-30,2021-04-30,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,882
NCT03494816,0,0,0,0,0,0,2020-03-01,2021-03-01,,Scottish Clinical Trials Research Unit,Other,0,1,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03495908,0,0,0,0,0,0,2019-08-12,2020-08-12,,East Coast Institute for Research,Other,0,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,2
NCT03496220,0,0,0,0,0,0,2018-12-30,2019-12-30,,"Angulus, LLC",Industry,1,0,1,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03496571,0,0,0,0,0,0,2019-06-24,2020-06-24,,"Allakos, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03499236,0,0,0,0,0,0,2021-10-01,2022-10-01,,V-Wave Ltd,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,4
NCT03499899,0,0,0,0,0,0,2020-03-27,2021-03-27,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03500679,0,0,0,0,0,0,2018-11-05,2019-11-05,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,558
NCT03502148,0,0,0,0,0,0,2019-10-30,2020-10-30,,Privo Technologies,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03502746,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Arkadiusz Z. Dudek, MD",Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03504410,0,0,0,0,0,0,2022-10-31,2023-10-31,,Rafael Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,7
NCT03505476,0,0,0,0,0,0,2021-05-31,2022-05-31,,Jennifer Hrabe,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03506295,0,0,1,1,0,0,2018-10-03,2019-10-03,2019-07-31,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,422
NCT03506477,0,0,0,0,0,0,2019-07-29,2020-07-29,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,412
NCT03511378,0,0,0,0,0,0,2019-03-06,2020-03-06,,Lupin Ltd.,Industry,1,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,5
NCT03511664,0,0,0,0,0,0,2020-08-31,2021-08-31,,Endocyte,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03512301,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Psychology Software Tools, Inc.",Industry,1,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03512444,1,0,0,0,1,0,2018-09-04,2019-09-04,,Ahmed Aljomah,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,1
NCT03515083,0,0,0,0,0,0,2020-07-31,2021-07-31,,Sanjaya Gupta,Other,0,1,0,5.0,,0,2017.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03517137,0,0,0,0,0,0,2021-03-01,2022-03-01,,European Organisation for Research and Treatment of Cancer - EORTC,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,3,1,0,320
NCT03518125,0,0,0,0,0,0,2019-01-14,2020-01-14,,Biomedical Advanced Research and Development Authority,U.S. Fed,2,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,4
NCT03520036,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Mitsubishi Tanabe Pharma Development America, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,9
NCT03521102,0,0,0,0,0,0,2020-06-01,2021-06-01,,Montefiore Medical Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,240
NCT03521635,0,0,0,0,0,0,2020-01-07,2021-01-07,,Boehringer Ingelheim,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1852
NCT03522441,0,0,0,0,0,0,2019-04-22,2020-04-22,,"Akorn, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,1,1,0,4
NCT03523273,0,0,0,0,0,0,2022-12-31,2023-12-31,,"Michael Camilleri, MD",Other,0,1,1,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03523572,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Daiichi Sankyo, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,207
NCT03524092,0,0,0,0,0,0,2021-06-15,2022-06-15,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03529955,0,0,0,0,0,0,2020-01-31,2021-01-31,,Tulane University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,33
NCT03531918,0,0,0,0,0,0,2021-07-01,2022-07-01,,Fred Hutchinson Cancer Research Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,393
NCT03532425,0,0,0,0,0,0,2019-12-31,2020-12-31,,University of Alberta,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,432
NCT03534362,0,0,0,0,0,0,2022-04-13,2023-04-13,,St. Louis University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,126
NCT03535402,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Gaylis, Norman B., M.D.",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03535675,0,0,0,0,0,0,2021-12-31,2022-12-31,,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,461
NCT03536663,0,0,0,0,0,0,2019-04-17,2020-04-17,,Fresenius Medical Care North America,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,12
NCT03537248,0,0,0,0,0,0,2018-10-30,2019-10-30,,Asepticys LLC,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03538041,0,0,0,0,0,0,2020-09-30,2021-09-30,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03538938,0,0,0,0,0,0,2022-05-31,2023-05-31,,"University of Wisconsin, Madison",Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,715
NCT03539536,0,0,0,0,0,0,2021-10-27,2022-10-27,,AbbVie,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03541655,0,0,0,0,0,0,2019-07-31,2020-07-31,,Arthritis Innovation Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03541941,0,0,0,0,0,0,2021-06-30,2022-06-30,,The Cleveland Clinic,Other,0,1,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT03543046,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Orlando Health, Inc.",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,11
NCT03544242,0,0,0,0,0,0,2019-06-27,2020-06-27,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,1,2017.0,1,1,0,0,0,0,0,0,0,1,0,801
NCT03545633,0,0,0,0,0,0,2019-05-15,2020-05-15,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2017.0,1,0,0,1,0,0,0,0,1,1,0,20
NCT03546764,0,0,0,0,0,0,2020-02-28,2021-02-28,,University of Arizona,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,265
NCT03547206,0,0,0,0,0,0,2019-11-30,2020-11-30,,Regenera Pharma Ltd,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,6
NCT03548415,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Ionis Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,69
NCT03549429,1,1,0,1,0,0,2018-07-19,2019-07-19,2019-06-12,Tufts Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,121
NCT03551522,0,0,0,0,0,0,2019-04-30,2020-04-30,,"CymaBay Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03551691,0,0,0,0,0,0,2020-06-30,2021-06-30,,Children's Hospital of Philadelphia,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,324
NCT03553875,0,0,0,0,0,0,2020-06-30,2021-06-30,,Massachusetts General Hospital,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1699
NCT03554980,0,0,0,0,0,0,2019-11-01,2020-11-01,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,1190
NCT03556202,0,0,0,0,0,0,2024-05-16,2025-05-16,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03558503,0,0,0,0,0,0,2019-12-31,2020-12-31,,UroGen Pharma Ltd.,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03560128,0,0,0,0,0,0,2018-12-18,2019-12-18,,Indiana University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,497
NCT03560609,0,0,0,0,0,0,2020-07-31,2021-07-31,,NYU Langone Health,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,869
NCT03561701,0,0,0,0,0,0,2020-07-20,2021-07-20,,Mycovia Pharmaceuticals Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03562949,0,0,0,0,0,0,2019-05-31,2020-05-31,,Amneal Ireland Limited,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,3,1,0,3
NCT03564678,0,0,0,0,0,0,2020-12-24,2021-12-24,,M.D. Anderson Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03565341,0,0,0,0,0,0,2019-07-30,2020-07-30,,"Focus Medical, LLC",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,3
NCT03565887,0,0,0,0,0,0,2019-04-11,2020-04-11,,RevitaLid Inc.,Industry,1,0,0,3.0,Phase 3,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,4
NCT03569371,0,0,0,0,0,0,2019-04-22,2020-04-22,,Incyte Corporation,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,143
NCT03573544,0,0,0,0,0,0,2021-05-10,2022-05-10,,"OBI Pharma, Inc",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,1,0,0,0,0,0,1,0,6
NCT03573700,0,0,0,0,0,0,2023-07-01,2024-07-01,,St. Jude Children's Research Hospital,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,1,0,0,0,0,0,1,0,302
NCT03574597,0,0,0,0,0,0,2023-09-28,2024-09-28,,Novo Nordisk A/S,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03579654,0,0,0,0,0,0,2021-02-28,2022-02-28,,OncBioMune Pharmaceuticals,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03583164,0,0,0,0,0,0,2020-12-31,2021-12-31,,F2G Ltd.,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,15
NCT03584152,0,0,0,0,0,0,2020-07-31,2021-07-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1309
NCT03584880,1,0,0,0,1,0,2018-05-01,2019-05-01,,Yuzuncu Yıl University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,2,1,0,35
NCT03585478,0,0,0,0,0,0,2020-02-29,2021-02-28,,"Immunogenics, LLC",Industry,1,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03587194,0,0,0,0,0,0,2019-07-01,2020-07-01,,Psoriasis Treatment Center of Central New Jersey,Other,0,1,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,8
NCT03588559,1,0,0,0,1,0,2017-06-16,2018-06-16,,BTS International,Other,0,1,0,5.0,,0,2017.0,1,0,0,0,1,0,0,0,0,1,0,2
NCT03590327,0,0,0,0,0,0,2022-12-31,2023-12-31,,VA Office of Research and Development,U.S. Fed,2,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03593473,0,0,0,0,0,0,2022-05-31,2023-05-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,910
NCT03594123,0,0,0,0,0,0,2021-08-31,2022-08-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,185
NCT03595293,0,0,0,0,0,0,2020-12-31,2021-12-31,,Milton S. Hershey Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,334
NCT03595449,0,0,0,0,0,0,2019-05-31,2020-05-31,,Mayo Clinic,Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,1898
NCT03597529,0,0,0,0,0,0,2021-09-01,2022-09-01,,"University of California, San Francisco",Other,0,0,0,1.0,Phase 2,0,2017.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03598166,0,0,0,0,0,0,2019-12-31,2020-12-31,,Peter Liang,U.S. Fed,2,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,0,1,0,1
NCT03598790,0,0,0,0,0,0,2021-05-31,2022-05-31,,UCB Biopharma S.P.R.L.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,75
NCT03601897,0,0,0,0,0,0,2020-10-01,2021-10-01,,Deciphera Pharmaceuticals LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03602976,0,0,0,0,0,0,2020-07-01,2021-07-01,,Ethan Weinberg,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03603405,0,0,0,0,0,0,2023-12-31,2024-12-31,,The Methodist Hospital System,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,36
NCT03603639,0,0,0,0,0,0,2019-02-13,2020-02-13,,Eisai Inc.,Industry,1,0,0,1.0,Phase 2,1,2018.0,1,1,0,0,0,0,0,0,0,1,0,328
NCT03603808,0,0,0,0,0,0,2021-01-21,2022-01-21,,AIDS Malignancy Consortium,Other,0,1,1,1.0,Phase 2,0,2018.0,0,0,1,1,0,0,0,0,0,1,0,46
NCT03605914,0,0,0,0,0,0,2019-04-30,2020-04-30,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,490
NCT03607682,0,0,0,0,0,0,2021-12-31,2022-12-31,,Albert Attia,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03610633,0,0,0,0,0,0,2018-09-30,2019-09-30,,Medical University of South Carolina,Other,0,0,0,1.0,Phase 2,0,2016.0,1,1,0,0,0,0,0,0,0,0,1,511
NCT03611556,0,0,0,0,0,0,2021-11-01,2022-11-01,,MedImmune LLC,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,1,0,1,1,0,269
NCT03613181,0,0,0,0,0,0,2021-06-30,2022-06-30,,Angiochem Inc,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,8
NCT03614234,0,0,0,0,0,0,2022-01-31,2023-01-31,,Protalix,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,17
NCT03615924,0,0,0,0,0,0,2020-11-09,2021-11-09,,AstraZeneca,Industry,1,1,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,2450
NCT03618134,0,0,0,0,0,0,2022-10-01,2023-10-01,,Jonsson Comprehensive Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,1,0,0,0,1,0,277
NCT03618420,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Colorado Denver School of Medicine Barbara Davis Center,Other,0,0,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,15
NCT03618641,0,0,0,0,0,0,2020-07-01,2021-07-01,,Diwakar Davar,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,3
NCT03619850,0,0,0,0,0,0,2021-08-31,2022-08-31,,"AMAG Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,23
NCT03620019,0,0,0,0,0,0,2020-08-31,2021-08-31,,UNC Lineberger Comprehensive Cancer Center,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,229
NCT03621202,0,0,0,0,0,0,2019-06-30,2020-06-30,,"Saranas, Inc.",Industry,1,1,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03621670,0,0,0,0,0,0,2023-05-29,2024-05-29,,GlaxoSmithKline,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3276
NCT03624504,0,0,0,0,0,0,2019-09-30,2020-09-30,,Medtronic Cardiac Rhythm and Heart Failure,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,169
NCT03624699,0,0,0,0,0,0,2019-12-31,2020-12-31,,dr. Kaweh Mansouri,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,1
NCT03624920,0,0,0,0,0,0,2019-12-31,2020-12-31,,Theranexus,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03625466,0,0,0,0,0,0,2020-11-30,2021-11-30,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,141
NCT03626376,0,0,0,0,0,0,2019-10-31,2020-10-31,,NYU Langone Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,869
NCT03626545,0,0,0,0,0,0,2021-03-08,2022-03-08,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03627299,0,0,0,0,0,0,2020-05-01,2021-05-01,,Johns Hopkins University,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03628209,0,0,0,0,0,0,2021-07-31,2022-07-31,,H. Lee Moffitt Cancer Center and Research Institute,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,344
NCT03628872,0,0,0,0,0,0,2020-01-31,2021-01-31,,Columbia University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,675
NCT03629275,0,0,0,0,0,0,2019-11-30,2020-11-30,,ReNeuron Limited,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,1,0,0,1,0,7
NCT03631966,0,0,0,0,0,0,2019-08-31,2020-08-31,,Stanford University,Other,0,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,1309
NCT03633695,0,0,0,0,0,0,2020-05-30,2021-05-30,,"AcuFocus, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,9
NCT03634020,0,0,0,0,0,0,2020-04-30,2021-04-30,,Elixir Medical Corporation,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,2,1,0,10
NCT03634800,0,0,0,0,0,0,2022-12-30,2023-12-30,,Weill Medical College of Cornell University,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,1,0,0,0,1,0,586
NCT03635190,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Cardio Flow, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT03635424,0,0,0,0,0,0,2019-12-31,2020-12-31,,Medtronic Cardiovascular,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,34
NCT03636256,0,0,0,0,0,0,2020-11-30,2021-11-30,,"NanOlogy, LLC",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03637387,0,0,0,0,0,0,2022-08-09,2023-08-09,,Biogen,Industry,1,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,324
NCT03639714,0,0,0,0,0,0,2022-07-31,2023-07-31,,"Gritstone Oncology, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03639987,0,0,0,0,0,0,2021-07-09,2022-07-09,,Biogen,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,324
NCT03640377,0,0,0,0,0,0,2021-06-30,2022-06-30,,Rhode Island Hospital,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,120
NCT03641482,1,0,0,0,1,0,2017-07-15,2018-07-15,,Universidad Complutense de Madrid,Other,0,0,0,5.0,,0,2016.0,1,1,0,1,0,0,0,0,3,0,1,38
NCT03641651,0,0,0,0,0,0,2019-07-15,2020-07-15,,Markus Wirz,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,2,1,0,1
NCT03642093,0,0,0,0,0,0,2018-12-31,2019-12-31,,Siobhan Trotter,Other,0,0,0,4.0,Phase 4,0,2018.0,1,0,0,0,0,0,1,0,0,1,0,1
NCT03643887,0,0,0,0,0,0,2022-09-01,2023-09-01,,"University of Wisconsin, Madison",Other,0,0,0,1.0,Phase 2,0,2022.0,0,1,0,0,0,0,0,0,3,1,0,715
NCT03649841,0,0,0,0,0,0,2020-09-16,2021-09-16,,University of Washington,Other,0,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,1,0,0,0,1,0,910
NCT03651765,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Rhythm Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03652623,0,0,0,0,0,0,2020-05-30,2021-05-30,,Hektoen Institute for Medical Research,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT03653026,0,0,0,0,0,0,2021-02-23,2022-02-23,,AbbVie,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,430
NCT03656666,0,0,0,0,0,0,2020-12-01,2021-12-01,,Oslo University Hospital,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,535
NCT03658629,0,0,0,0,0,0,2018-11-27,2019-11-27,,Novavax,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,0,1,0,0,0,0,0,0,1,0,25
NCT03660683,0,0,0,0,0,0,2020-02-28,2021-02-28,,Sabyasachi Sen,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03661307,0,0,0,0,0,0,2021-01-01,2022-01-01,,M.D. Anderson Cancer Center,Other,0,0,1,0.0,Phase 1/Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2066
NCT03661528,0,0,0,0,0,0,2023-03-01,2024-03-01,,Portola Pharmaceuticals,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03661983,0,0,0,0,0,0,2021-12-01,2022-12-01,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,185
NCT03666429,0,0,0,0,0,0,2020-11-30,2021-11-30,,Vanderbilt University Medical Center,Other,0,0,0,5.0,,0,2020.0,0,0,0,1,0,0,0,0,0,1,0,422
NCT03667651,0,0,0,0,0,0,2021-05-08,2022-05-08,,University of Melbourne,Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,45
NCT03668613,0,0,0,0,0,0,2019-09-18,2020-09-18,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03674892,0,0,0,0,0,0,2020-10-31,2021-10-31,,Tufts Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,121
NCT03676842,0,0,0,0,0,0,2020-12-31,2021-12-31,,VentureMed Group Inc.,Industry,1,0,0,5.0,,0,2018.0,0,0,0,0,0,0,1,0,0,1,0,4
NCT03679013,0,0,0,0,0,0,2019-07-12,2020-07-12,,Inova Health Care Services,Other,0,0,0,1.0,Phase 2,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,41
NCT03679702,0,0,0,0,0,0,2019-12-01,2020-12-01,,"Michael Krychman, MD",Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03680872,0,0,0,0,0,0,2022-06-30,2023-06-30,,Chad Bouton,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03681223,0,0,0,0,0,0,2021-12-31,2022-12-31,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT03682120,0,0,0,0,0,0,2019-11-30,2020-11-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,2133
NCT03682367,0,0,0,0,0,0,2020-08-01,2021-08-01,,"University of California, Davis",Other,0,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,530
NCT03685253,0,0,0,0,0,0,2022-10-01,2023-10-01,,"University of Maryland, College Park",Other,0,0,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03687632,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Noveome Biotherapeutics, formerly Stemnion",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,10
NCT03687827,0,0,0,0,0,0,2019-12-23,2020-12-23,,Novo Nordisk A/S,Industry,1,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03692325,0,0,0,0,0,0,2021-06-30,2022-06-30,,Dana-Farber Cancer Institute,Other,0,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,647
NCT03694002,0,0,0,0,0,0,2022-06-01,2023-06-01,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,1,0,0,0,0,0,0,1,0,288
NCT03697993,0,0,0,0,0,0,2021-01-30,2022-01-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,2133
NCT03698591,0,0,0,0,0,0,2019-05-24,2020-05-24,,Duke University,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1342
NCT03700684,0,0,0,0,0,0,2020-06-01,2021-06-01,,"University of Massachusetts, Amherst",Other,0,0,1,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,25
NCT03701282,0,0,0,0,0,0,2025-10-31,2026-10-31,,National Cancer Institute (NCI),NIH,2,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,3004
NCT03709121,0,0,0,0,0,0,2019-03-20,2020-03-20,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2018.0,1,1,0,0,0,0,0,0,2,1,0,13
NCT03711032,0,0,0,0,0,0,2022-05-19,2023-05-19,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,2145
NCT03712930,0,0,0,0,0,0,2021-04-30,2022-04-30,,BeiGene,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,57
NCT03713333,0,0,0,0,0,0,2019-10-20,2020-10-20,,Scripps Health,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,1,0,0,0,3,1,0,28
NCT03714282,0,0,0,0,0,0,2020-12-31,2021-12-31,,Shirley Ryan AbilityLab,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,71
NCT03716817,0,0,0,0,0,0,2024-10-31,2025-10-31,,University of Michigan,Other,0,1,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,934
NCT03717142,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Lumicell, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,7
NCT03719898,0,0,0,0,0,0,2019-12-31,2020-12-31,,Fox Chase Cancer Center,Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,156
NCT03720392,0,0,0,0,0,0,2020-11-30,2021-11-30,,Zachariah Michael DeFilipp,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03721835,0,0,0,0,0,0,2020-09-10,2021-09-10,,"Smith & Nephew, Inc.",Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,83
NCT03722459,0,0,0,0,0,0,2021-10-31,2022-10-31,,"University of North Carolina, Chapel Hill",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,910
NCT03725722,0,0,0,0,0,0,2019-12-31,2020-12-31,,LEO Pharma,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,171
NCT03726268,0,0,0,0,0,0,2022-04-30,2023-04-30,,Duke University,Other,0,0,1,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1342
NCT03728582,0,0,0,0,0,0,2023-04-30,2024-04-30,,Johns Hopkins University,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,1143
NCT03730181,0,0,0,0,0,0,2021-02-28,2022-02-28,,Centers for Disease Control and Prevention,U.S. Fed,2,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,267
NCT03731052,0,0,0,0,0,0,2019-10-31,2020-10-31,,"Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,16
NCT03732638,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Biohaven Pharmaceuticals, Inc.",Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,18
NCT03736447,0,0,0,0,0,0,2020-11-30,2021-11-30,,"Aimmune Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,0,1,0,0,0,0,0,1,1,0,11
NCT03737110,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Kiniksa Pharmaceuticals, Ltd.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,5
NCT03738423,0,0,0,0,0,0,2020-03-31,2021-03-31,,Regeneron Pharmaceuticals,Industry,1,1,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,176
NCT03738878,0,0,0,0,0,0,2020-07-01,2021-07-01,,Vanderbilt University Medical Center,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,422
NCT03739606,0,0,0,0,0,0,2021-12-10,2022-12-10,,City of Hope Medical Center,Other,0,0,1,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,358
NCT03740165,0,0,0,0,0,0,2025-08-08,2026-08-08,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,1,0,0,0,0,0,2,1,0,2145
NCT03741751,0,0,0,0,0,0,2019-12-31,2020-12-31,,Washington University School of Medicine,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1151
NCT03742518,0,0,0,0,0,0,2020-06-30,2021-06-30,,Samumed LLC,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2018.0,0,1,0,0,0,0,0,0,2,1,0,16
NCT03743064,0,0,0,0,0,0,2020-12-31,2021-12-31,,Helsinn Healthcare SA,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,28
NCT03745352,0,0,0,0,0,0,2021-06-01,2022-06-01,,National Cancer Institute (NCI),NIH,2,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3004
NCT03745651,0,0,0,0,0,0,2020-08-31,2021-08-31,,Incyte Corporation,Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,143
NCT03746522,0,0,0,0,0,0,2020-06-30,2021-06-30,,"Rhythm Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,14
NCT03747146,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Hospital for Special Surgery, New York",Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,157
NCT03751007,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Intrexon T1D Partners, LLC",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,1,1,0,0,0,0,0,1,1,0,1
NCT03751657,0,0,0,0,0,0,2019-10-03,2020-10-03,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,1,1,0,981
NCT03752203,0,0,0,0,0,0,2021-06-30,2022-06-30,,"University of Colorado, Denver",Other,0,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,0,1,0,882
NCT03756506,0,0,0,0,0,0,2019-04-30,2020-04-30,,Prevent-Plus LLC,Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03758261,0,0,0,0,0,0,2019-11-01,2020-11-01,,Neil Shah,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03761238,0,0,0,0,0,0,2021-09-15,2022-09-15,,"Stefan Gilg, MD, PhD",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1
NCT03761849,0,0,0,0,0,0,2022-03-01,2023-03-01,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03762915,0,0,0,0,0,0,2020-08-01,2021-08-01,,University of Minnesota - Clinical and Translational Science Institute,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,749
NCT03763318,0,0,0,0,0,0,2021-05-31,2022-05-31,,Equillium,Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03764072,0,0,0,0,0,0,2019-01-17,2020-01-17,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2018.0,1,1,0,0,0,0,0,0,0,1,0,141
NCT03765164,0,0,0,0,0,0,2019-03-30,2020-03-30,,"Qure Healthcare, LLC",Industry,1,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,7
NCT03770637,0,0,0,0,0,0,2019-11-30,2020-11-30,,Xeris Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03770871,1,0,0,0,1,0,2017-08-31,2018-08-31,,Cairo University,Other,0,0,0,4.0,Phase 4,0,2016.0,1,1,0,0,0,0,0,0,2,0,1,1190
NCT03771040,0,0,0,0,0,0,2019-12-31,2020-12-31,,AB Science,Industry,1,0,0,3.0,Phase 3,0,2016.0,0,1,0,0,0,0,0,0,2,0,1,30
NCT03775096,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Michele Tagliati, MD",Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03775850,0,0,0,0,0,0,2020-12-19,2021-12-19,,"Evelo Biosciences, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2018.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03779295,0,0,0,0,0,0,2019-03-01,2020-03-01,,West Virginia University,Other,0,0,0,5.0,,0,2018.0,1,1,0,1,0,0,0,0,0,1,0,74
NCT03779503,0,0,0,0,0,0,2019-08-31,2020-08-31,,"Coopervision, Inc.",Industry,1,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,85
NCT03779711,0,0,0,0,0,0,2020-02-29,2021-02-28,,Timothy J. Nelson,Other,0,0,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,5
NCT03781414,0,0,0,0,0,0,2021-09-24,2022-09-24,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,3,1,0,1895
NCT03783676,0,0,0,0,0,0,2019-06-30,2020-06-30,,University of Vermont Medical Center,Other,0,0,0,4.0,Phase 4,0,2019.0,1,1,0,0,0,0,0,0,3,1,0,16
NCT03785249,0,0,0,0,0,0,2020-04-30,2021-04-30,,Mirati Therapeutics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,27
NCT03786354,0,0,0,0,0,0,2020-12-31,2021-12-31,,Ohio State University Comprehensive Cancer Center,Other,0,0,1,1.0,Phase 2,0,2018.0,0,0,0,0,0,1,0,0,0,1,0,198
NCT03786432,0,0,0,0,0,0,2020-12-31,2021-12-31,,William Beaumont Hospitals,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,84
NCT03790683,0,0,0,0,0,0,2019-07-31,2020-07-31,,"Advanced Cooling Therapy, LLC",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03791060,0,0,0,0,0,0,2020-12-31,2021-12-31,,Beth Israel Deaconess Medical Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,377
NCT03792724,0,0,0,0,0,0,2023-01-30,2024-01-30,,"Clinica Universidad de Navarra, Universidad de Navarra",Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,66
NCT03793348,0,0,0,0,0,0,2019-06-15,2020-06-15,,"Cytrellis Biosystems, Inc.",Industry,1,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,5
NCT03796884,0,0,0,0,0,0,2020-10-01,2021-10-01,,Sidney Kimmel Cancer Center at Thomas Jefferson University,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,162
NCT03800563,0,0,0,0,0,0,2019-08-31,2020-08-31,,Alma Lasers,Industry,1,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,1,1,0,2
NCT03802630,0,0,0,0,0,0,2021-09-17,2022-09-17,,Novartis Pharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03805100,0,0,0,0,0,0,2020-05-31,2021-05-31,,Xbrane Biopharma AB,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,1,1,0,1
NCT03808558,0,0,0,0,0,0,2020-08-01,2021-08-01,,University of Texas Southwestern Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03810183,0,0,0,0,0,0,2020-07-21,2021-07-21,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT03811015,0,0,0,0,0,0,2027-01-01,2028-01-01,,National Cancer Institute (NCI),NIH,2,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,1,0,0,0,1,0,3004
NCT03814850,0,0,0,0,0,0,2022-12-07,2023-12-07,,Robert Starke,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03815747,0,0,0,0,0,0,2019-08-11,2020-08-11,,BTL Industries Ltd.,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,20
NCT03816228,0,0,0,0,0,0,2024-12-31,2025-12-31,,Washington University School of Medicine,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1151
NCT03816761,0,0,0,0,0,0,2019-05-31,2020-05-31,,Novo Nordisk A/S,Industry,1,0,0,1.0,Phase 2,0,2019.0,1,1,0,1,0,0,0,0,0,1,0,981
NCT03817853,0,0,0,0,0,0,2020-05-01,2021-05-01,,Hoffmann-La Roche,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03818932,0,0,0,0,0,0,2020-01-20,2021-01-20,,Henry Ford Health System,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,151
NCT03819114,0,0,0,0,0,0,2020-10-01,2021-10-01,,AIDS Clinical Trials Group,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,62
NCT03819842,0,0,0,0,0,0,2019-01-14,2020-01-14,,"Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons",Other,0,0,0,5.0,,0,2018.0,1,0,0,0,1,0,0,0,0,1,0,1
NCT03822468,0,0,0,0,0,0,2026-02-02,2027-02-02,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1895
NCT03824795,0,0,0,0,0,0,2019-08-31,2020-08-31,,MGB Biopharma Limited,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03825510,0,0,0,0,0,0,2019-08-28,2020-08-28,,Crozer-Keystone Health System,Other,0,0,0,5.0,,0,2017.0,0,0,0,0,0,1,0,0,0,1,0,3
NCT03829046,0,0,0,0,0,0,2020-10-31,2021-10-31,,Robert Rosenson,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1
NCT03829878,0,0,0,0,0,0,2020-05-31,2021-05-31,,Finch Research and Development LLC.,Industry,1,0,0,1.0,Phase 2,0,2020.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT03830307,0,0,0,0,0,0,2019-04-04,2020-04-04,,"Grace Lim, MD, MS",Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,3
NCT03832010,0,0,0,0,0,0,2020-09-30,2021-09-30,,Johns Hopkins University,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT03834506,0,0,0,0,0,0,2021-09-12,2022-09-12,,Merck Sharp & Dohme Corp.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,1,0,0,0,0,0,1,1,0,2145
NCT03836261,0,0,0,0,0,0,2022-08-30,2023-08-30,,Acerta Pharma BV,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,31
NCT03837184,0,0,0,0,0,0,2021-04-01,2022-04-01,,"AveXis, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,0,1,0,0,0,0,0,2,1,0,8
NCT03838068,1,0,0,0,1,0,2018-08-30,2019-08-30,,"Gihan M Abuelniel ,PhD",Other,0,0,0,0.0,Phase 1/Phase 2,0,2017.0,1,0,1,0,0,0,0,0,2,1,0,2
NCT03839498,0,0,0,0,0,0,2021-01-31,2022-01-31,,Columbia University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,675
NCT03840577,0,0,0,0,0,0,2020-10-31,2021-10-31,,Hospital Italiano de Buenos Aires,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,67
NCT03840837,0,0,0,0,0,0,2021-04-30,2022-04-30,,"University of Maryland, College Park",Other,0,0,1,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,318
NCT03841357,0,0,0,0,0,0,2022-12-15,2023-12-15,,Duke University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1342
NCT03842137,0,0,0,0,0,0,2023-12-31,2024-12-31,,Butler Hospital,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,79
NCT03842969,0,0,0,0,0,0,2023-11-18,2024-11-18,,Hoffmann-La Roche,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1731
NCT03844451,0,0,0,0,0,0,2019-09-01,2020-09-01,,University of Texas at Austin,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,135
NCT03845296,0,0,0,0,0,0,2021-07-01,2022-07-01,,Southwest Oncology Group,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,288
NCT03854396,0,0,0,0,0,0,2021-02-28,2022-02-28,,"Olivia Cardenas-Trowers, M.D.",Other,0,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03856164,0,0,0,0,0,0,2020-06-30,2021-06-30,,University of Texas Southwestern Medical Center,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,626
NCT03856788,0,0,0,0,0,0,2020-12-31,2021-12-31,,Icahn School of Medicine at Mount Sinai,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,412
NCT03857646,0,0,0,0,0,0,2020-03-15,2021-03-15,,"The University of Texas Health Science Center, Houston",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,490
NCT03859986,0,0,0,0,0,0,2020-01-31,2021-01-31,,"Ralexar Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,2
NCT03860935,0,0,0,0,0,0,2022-10-31,2023-10-31,,Eidos Therapeutics,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,4
NCT03862482,0,0,0,0,0,0,2019-08-16,2020-08-16,,Université de Montréal,Other,0,0,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,2,1,0,79
NCT03865953,0,0,0,0,0,0,2020-03-31,2021-03-31,,Lateral Pharma Pty Ltd,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT03866174,0,0,0,0,0,0,2021-02-28,2022-02-28,,Usona Institute,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1
NCT03867253,0,0,0,0,0,0,2020-11-15,2021-11-15,,Oryzon Genomics S.A.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03867539,0,0,0,0,0,0,2019-05-31,2020-05-31,,Kettering Health Network,Other,0,0,0,4.0,Phase 4,0,2019.0,1,0,0,0,0,0,0,0,0,1,0,14
NCT03867838,0,0,0,0,0,0,2020-04-01,2021-04-01,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1309
NCT03868423,0,0,0,0,0,0,2020-12-30,2021-12-30,,Sameek Roychowdhury,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03868891,0,0,0,0,0,0,2021-10-31,2022-10-31,,Noel Jabbour,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03873714,0,0,0,0,0,0,2021-07-31,2022-07-31,,Medtronic Neurovascular Clinical Affairs,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,21
NCT03874351,0,0,0,0,0,0,2020-02-28,2021-02-28,,MJHS Institute for Innovation in Palliative Care,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03875716,0,0,0,0,0,0,2024-12-31,2025-12-31,,Dana-Farber Cancer Institute,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,647
NCT03876873,0,0,0,0,0,0,2020-04-30,2021-04-30,,University of Missouri-Columbia,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,214
NCT03877653,0,0,0,0,0,0,2020-05-01,2021-05-01,,Stimwave Technologies,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,5
NCT03878199,0,0,0,0,0,0,2021-12-31,2022-12-31,,OHSU Knight Cancer Institute,Other,0,1,1,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,163
NCT03878589,0,0,0,0,0,0,2022-10-01,2023-10-01,,University of Florida,Other,0,0,1,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,849
NCT03879863,0,0,0,0,0,0,2021-04-30,2022-04-30,,"Aldeyra Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,13
NCT03886402,0,0,0,0,0,0,2020-07-31,2021-07-31,,The GID Group,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,3
NCT03886662,0,0,0,0,0,0,2021-05-31,2022-05-31,,"Lixte Biotechnology Holdings, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,2
NCT03887455,0,0,0,0,0,0,2022-02-24,2023-02-24,,Eisai Inc.,Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,328
NCT03888729,0,0,0,0,0,0,2020-03-31,2021-03-31,,Partners in Health,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,5
NCT03889756,0,0,0,0,0,0,2022-09-30,2023-09-30,,Yale University,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1053
NCT03889925,0,0,0,0,0,0,2020-03-31,2021-03-31,,Andrews Research & Education Foundation,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,10
NCT03890120,0,0,0,0,0,0,2022-08-31,2023-08-31,,Gilead Sciences,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,510
NCT03891004,0,0,0,0,0,0,2018-12-31,2019-12-31,,St. John Hospital & Medical Center,Other,0,0,0,5.0,,0,2018.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT03891524,0,0,0,0,0,0,2021-03-23,2022-03-23,,"Janssen Research & Development, LLC",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,558
NCT03897010,0,0,0,0,0,0,2019-02-01,2020-02-01,,Ain Shams University,Other,0,0,0,4.0,Phase 4,0,2017.0,1,0,0,1,0,0,0,0,2,1,0,460
NCT03897634,0,0,0,0,0,0,2020-02-15,2021-02-15,,Northwestern University,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,925
NCT03899155,0,0,0,0,0,0,2022-10-24,2023-10-24,,Bristol-Myers Squibb,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1104
NCT03900676,0,0,0,0,0,0,2019-11-30,2020-11-30,,Vyome Therapeutics Inc.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03901105,0,0,0,0,0,0,2019-04-28,2020-04-28,,Avid Radiopharmaceuticals,Industry,1,0,0,3.0,Phase 3,0,2019.0,1,1,0,0,0,0,0,0,0,1,0,50
NCT03901378,0,0,0,0,0,0,2021-04-30,2022-04-30,,Ochsner Health System,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,37
NCT03903172,0,0,0,0,0,0,2022-06-30,2023-06-30,,Wright State University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,15
NCT03908125,0,0,0,0,0,0,2023-03-31,2024-03-31,,"Senseonics, Inc.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,6
NCT03910413,0,0,0,0,0,0,2022-07-31,2023-07-31,,University of Alabama at Birmingham,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,801
NCT03911076,0,0,0,0,0,0,2021-08-30,2022-08-30,,"PapiVax Biotech, Inc.",Other,0,1,0,1.0,Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,2
NCT03912233,0,0,0,0,0,0,2019-12-31,2020-12-31,,Vertex Pharmaceuticals Incorporated,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,141
NCT03912818,0,0,0,0,0,0,2022-02-13,2023-02-13,,Stanford University,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,1,0,0,0,0,0,0,1,0,1309
NCT03914677,0,0,0,0,0,0,2020-03-17,2021-03-17,,Wayne State University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,145
NCT03915496,0,0,0,0,0,0,2020-12-09,2021-12-09,,Pfizer,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2856
NCT03915769,0,0,0,0,0,0,2021-07-23,2022-07-23,,Celgene,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,306
NCT03918850,0,0,0,0,0,0,2023-01-31,2024-01-31,,"Theresa Winhusen, PhD",Other,0,1,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,3
NCT03922490,0,0,0,0,0,0,2021-06-01,2022-06-01,,"Hospital for Special Surgery, New York",Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,157
NCT03923257,0,0,0,0,0,0,2021-12-31,2022-12-31,,Sue O'Dorisio,Other,0,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,8
NCT03924193,0,0,0,0,0,0,2024-07-31,2025-07-31,,Yale University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03926052,0,0,0,0,0,0,2024-07-31,2025-07-31,,Yale University,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1053
NCT03928041,0,0,0,0,0,0,2020-04-30,2021-04-30,,Invibio Biomaterial Solutions,Industry,1,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT03931785,0,0,0,0,0,0,2020-09-30,2021-09-30,,"Ironwood Pharmaceuticals, Inc.",Industry,1,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,22
NCT03932383,0,0,0,0,0,0,2020-12-31,2021-12-31,,Beth Israel Deaconess Medical Center,Other,0,0,0,5.0,,0,2018.0,0,0,0,1,0,0,0,0,0,1,0,377
NCT03933670,0,0,0,0,0,0,2020-07-01,2021-07-01,,"University of California, San Francisco",Other,0,0,1,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03934658,0,0,0,0,0,0,2020-05-15,2021-05-15,,NightWare,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,4
NCT03938090,0,0,0,0,0,0,2021-07-31,2022-07-31,,Barts & The London NHS Trust,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,76
NCT03939312,0,0,0,0,0,0,2020-11-10,2021-11-10,,Allergan,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,495
NCT03943875,0,0,0,0,0,0,2022-02-28,2023-02-28,,"The University of Texas Medical Branch, Galveston",Other,0,0,0,4.0,Phase 4,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,158
NCT03944447,0,0,0,0,0,0,2025-12-31,2026-12-31,,"OMNI Medical Services, LLC",Other,0,0,0,1.0,Phase 2,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT03945383,0,0,0,0,0,0,2021-10-30,2022-10-30,,Philips Healthcare,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,45
NCT03950427,0,0,0,0,0,0,2021-07-01,2022-07-01,,"University of California, San Francisco",Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1443
NCT03952650,0,0,0,0,0,0,2020-04-30,2021-04-30,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,1,0,0,0,0,0,2,1,0,2133
NCT03953326,0,0,0,0,0,0,2019-12-31,2020-12-31,,Penn State University,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,145
NCT03953703,0,0,0,0,0,0,2021-07-01,2022-07-01,,Vanderbilt University Medical Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,422
NCT03954834,0,0,0,0,0,0,2020-09-15,2021-09-15,,Eli Lilly and Company,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,1512
NCT03957876,0,0,0,0,0,0,2022-02-28,2023-02-28,,Case Comprehensive Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,374
NCT03959852,0,0,0,0,0,0,2020-06-30,2021-06-30,,Mercy Health Ohio,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,1,0,0,1,0,7
NCT03967223,0,0,0,0,0,0,2022-01-14,2023-01-14,,GlaxoSmithKline,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3276
NCT03969420,0,0,0,0,0,0,2023-09-30,2024-09-30,,"Tolero Pharmaceuticals, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,9
NCT03970031,0,0,0,0,0,0,2021-12-31,2022-12-31,,"Cirius Therapeutics, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2
NCT03971071,0,0,0,0,0,0,2021-08-05,2022-08-05,,Amgen,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,685
NCT03972358,0,0,0,0,0,0,2020-12-31,2021-12-31,,Gynuity Health Projects,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,102
NCT03973333,0,0,0,0,0,0,2021-10-31,2022-10-31,,Immunocore Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT03974360,0,0,0,0,0,0,2019-12-31,2020-12-31,,Danish Headache Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,75
NCT03978988,0,0,0,0,0,0,2023-04-30,2024-04-30,,"Central Hospital, Nancy, France",Other,0,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,284
NCT03982160,0,0,0,0,0,0,2020-09-30,2021-09-30,,The University of Texas at Arlington,Other,0,0,0,4.0,Phase 4,0,2018.0,0,1,0,0,0,0,0,0,0,1,0,14
NCT03982615,0,0,0,0,0,0,2020-07-30,2021-07-30,,University of Illinois at Chicago,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,242
NCT03987620,0,0,0,0,0,0,2020-03-31,2021-03-31,,"Scynexis, Inc.",Industry,1,1,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,1,1,0,11
NCT03989414,0,0,0,0,0,0,2022-08-05,2023-08-05,,Celgene,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,306
NCT03991156,0,0,0,0,0,0,2021-01-31,2022-01-31,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT03991936,0,0,0,0,0,0,2020-12-31,2021-12-31,,Weill Medical College of Cornell University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,586
NCT03992131,0,0,0,0,0,0,2023-10-31,2024-10-31,,"Clovis Oncology, Inc.",Industry,1,1,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,31
NCT03993314,0,0,0,0,0,0,2020-09-01,2021-09-01,,University of Alabama at Birmingham,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,801
NCT03995173,0,0,0,0,0,0,2020-04-30,2021-04-30,,VA Office of Research and Development,U.S. Fed,2,0,0,1.0,Phase 2,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1012
NCT03996265,0,0,0,0,0,0,2023-10-13,2024-10-13,,Gary Morrow,Other,0,0,1,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,23
NCT03998033,0,0,0,0,0,0,2022-07-01,2023-07-01,,Eureka Therapeutics Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,3
NCT03998293,0,0,0,0,0,0,2021-12-31,2022-12-31,,Mayo Clinic,Other,0,0,1,4.0,Phase 4,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1898
NCT03999333,0,0,0,0,0,0,2020-07-31,2021-07-31,,Cedars-Sinai Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,279
NCT03999710,0,0,0,0,0,0,2021-07-31,2022-07-31,,Memorial Sloan Kettering Cancer Center,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1432
NCT04000919,0,0,0,0,0,0,2023-06-30,2024-06-30,,Jessica M D'Amico,Other,0,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1
NCT04003896,0,0,0,0,0,0,2023-03-31,2024-03-31,,Milton S. Hershey Medical Center,Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,334
NCT04007276,0,0,0,0,0,0,2020-06-01,2021-06-01,,Tulane University,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,33
NCT04009512,0,0,0,0,0,0,2026-08-26,2027-08-26,,Matthew Eagleton,Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,2
NCT04016662,0,0,0,0,0,0,2022-01-31,2023-01-31,,Jaeb Center for Health Research,Other,0,1,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,93
NCT04017312,0,0,0,0,0,0,2020-11-30,2021-11-30,,Hill-Rom,Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,22
NCT04019925,0,0,0,0,0,0,2020-03-30,2021-03-30,,"St. Michael's Hospital, Toronto",Other,0,1,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,303
NCT04020510,0,0,0,0,0,0,2021-07-01,2022-07-01,,Walter Reed National Military Medical Center,U.S. Fed,2,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,47
NCT04020978,0,0,0,0,0,0,2020-05-15,2021-05-15,,"University of California, Davis",Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,0,1,0,530
NCT04023773,0,0,0,0,0,0,2020-11-01,2021-11-01,,The Cleveland Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,581
NCT04025021,0,0,0,0,0,0,2021-03-31,2022-03-31,,MetroHealth Medical Center,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,65
NCT04026451,0,0,0,0,0,0,2020-08-31,2021-08-31,,University of Chile,Other,0,0,0,5.0,,0,2019.0,0,1,0,1,0,0,0,0,2,1,0,92
NCT04027348,0,0,0,0,0,0,2022-03-07,2023-03-07,,Roswell Park Cancer Institute,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,294
NCT04028167,0,0,0,0,0,0,2024-04-19,2025-04-19,,"University of Colorado, Denver",Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,882
NCT04029545,0,0,0,0,0,0,2020-02-29,2021-02-28,,Prollenium Medical Technologies Inc.,Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,5
NCT04030195,0,0,0,0,0,0,2020-05-31,2021-05-31,,"Precision BioSciences, Inc.",Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,1,3,1,0,2
NCT04030624,0,0,0,0,0,0,2020-09-01,2021-09-01,,Massachusetts General Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1699
NCT04031885,0,0,0,0,0,0,2021-04-15,2022-04-15,,Eli Lilly and Company,Industry,1,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1512
NCT04032457,0,0,0,0,0,0,2019-07-31,2020-07-31,,Vision Service Plan,Industry,1,1,0,5.0,,0,2019.0,1,0,0,1,0,0,0,0,0,1,0,1
NCT04032626,0,0,0,0,0,0,2023-09-30,2024-09-30,,The Cleveland Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,581
NCT04033367,0,0,0,0,0,0,2020-12-31,2021-12-31,,Sanofi,Industry,1,1,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,1222
NCT04033562,0,0,0,0,0,0,2021-09-01,2022-09-01,,WellSpan Health,Other,0,1,0,4.0,Phase 4,0,2019.0,0,1,0,1,0,0,0,0,3,1,0,14
NCT04038255,0,0,0,0,0,0,2020-10-31,2021-10-31,,University of Miami,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,476
NCT04039464,0,0,0,0,0,0,2024-12-31,2025-12-31,,Johns Hopkins University,Other,0,0,0,3.0,Phase 3,0,2020.0,0,1,0,0,0,0,0,0,0,1,0,1143
NCT04039750,0,0,0,0,0,0,2021-07-31,2022-07-31,,Prisma Health-Upstate,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,32
NCT04042740,0,0,0,0,0,0,2021-07-01,2022-07-01,,National Institute of Allergy and Infectious Diseases (NIAID),NIH,2,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,2133
NCT04043104,0,0,0,0,0,0,2021-12-31,2022-12-31,,MeiraGTx UK II Ltd,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04043403,0,0,0,0,0,0,2024-07-31,2025-07-31,,Stanford University,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1309
NCT04043923,0,0,0,0,0,0,2020-04-30,2021-04-30,,"Emergo Therapeutics, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,3
NCT04044209,0,0,0,0,0,0,2021-09-30,2022-09-30,,Yale University,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1053
NCT04044573,0,0,0,0,0,0,2023-04-05,2024-04-05,,University of Rome Tor Vergata,Other,0,0,0,5.0,,0,2018.0,0,0,0,0,0,0,0,0,2,1,0,35
NCT04046250,0,0,0,0,0,0,2019-10-15,2020-10-15,,"Tosk, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,2,1,0,1
NCT04047849,0,0,0,0,0,0,2021-07-01,2022-07-01,,Woman's,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,10
NCT04050462,0,0,0,0,0,0,2020-08-31,2021-08-31,,NYU Langone Health,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,869
NCT04051463,0,0,0,0,0,0,2020-11-05,2021-11-05,,Price Vision Group,Industry,1,0,0,2.0,Phase 2/Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,7
NCT04052997,0,0,0,0,0,0,2021-11-30,2022-11-30,,ADC Therapeutics S.A.,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,11
NCT04055844,0,0,0,0,0,0,2022-06-30,2023-06-30,,"Masonic Cancer Center, University of Minnesota",Other,0,1,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,218
NCT04057014,0,0,0,0,0,0,2020-03-31,2021-03-31,,Boston Children’s Hospital,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,400
NCT04060563,0,0,0,0,0,0,2021-09-30,2022-09-30,,shalease adams,U.S. Fed,2,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1
NCT04060992,0,0,0,0,0,0,2020-10-30,2021-10-30,,University of Southern California,Other,0,0,0,4.0,Phase 4,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,483
NCT04061577,0,0,0,0,0,0,2022-09-01,2023-09-01,,"University of California, Los Angeles",Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,692
NCT04062240,0,0,0,0,0,0,2020-06-30,2021-06-30,,Mayo Clinic,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,1898
NCT04064242,0,0,0,0,0,0,2022-01-13,2023-01-13,,Novartis Pharmaceuticals,Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,1895
NCT04064411,0,0,0,0,0,0,2020-12-31,2021-12-31,,"Radius Pharmaceuticals, Inc.",Industry,1,0,0,3.0,Phase 3,0,2019.0,0,0,0,0,0,0,1,0,0,1,0,7
NCT04065776,0,0,0,0,0,0,2023-05-31,2024-05-31,,St. Jude Children's Research Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,0,1,0,0,0,1,0,302
NCT04071171,0,0,0,0,0,0,2021-11-30,2022-11-30,,Medical University Innsbruck,Other,0,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,84
NCT04073225,0,0,0,0,0,0,2021-12-31,2022-12-31,,Johns Hopkins University,Other,0,0,1,5.0,,0,2019.0,0,0,0,1,0,0,0,0,3,1,0,1143
NCT04073615,0,0,0,0,0,0,2020-12-31,2021-12-31,,LSK BioPartners Inc.,Industry,1,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,5
NCT04080245,0,0,0,0,0,0,2020-06-01,2021-06-01,,University of Alabama at Birmingham,Other,0,0,0,0.0,Phase 1/Phase 2,0,2019.0,0,0,1,0,0,0,0,0,0,1,0,801
NCT04081363,0,0,0,0,0,0,2019-12-31,2020-12-31,,"Otsuka Pharmaceutical Development & Commercialization, Inc.",Industry,1,0,0,1.0,Phase 2,0,2019.0,0,1,0,0,0,0,0,0,3,1,0,185
NCT04082156,0,0,0,0,0,0,2019-09-30,2020-09-30,,"Omron Healthcare Co., Ltd.",Industry,1,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,2,1,0,4
NCT04082520,0,0,0,0,0,0,2024-09-04,2025-09-04,,Mayo Clinic,Other,0,0,1,1.0,Phase 2,0,2019.0,0,1,0,0,0,1,0,0,0,1,0,1898
NCT04084548,0,0,0,0,0,0,2021-06-30,2022-06-30,,The Cleveland Clinic,Other,0,0,0,3.0,Phase 3,0,2019.0,0,1,0,0,0,0,0,0,0,1,0,581
NCT04085055,0,0,0,0,0,0,2020-03-31,2021-03-31,,Florida Hospital,Other,0,0,0,5.0,,0,2019.0,0,0,0,0,1,0,0,0,3,1,0,63
NCT04085510,0,0,0,0,0,0,2020-10-01,2021-10-01,,Wendie Berg,Other,0,0,0,5.0,,0,2019.0,0,0,0,1,0,0,0,0,0,1,0,2
NCT04086576,1,0,0,0,1,0,2017-04-17,2018-04-17,,University of Pennsylvania,Other,0,0,0,5.0,,0,2016.0,1,0,0,1,0,0,0,0,3,0,1,1052
